PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Farber, C; Wisshak, M; Pyko, I; Bellou, N; Freiwald, A				Faerber, Claudia; Wisshak, Max; Pyko, Ines; Bellou, Nikoleta; Freiwald, Andre			Effects of Water Depth, Seasonal Exposure, and Substrate Orientation on Microbial Bioerosion in the Ionian Sea (Eastern Mediterranean)	PLOS ONE			English	Article							LAGOONS FRENCH-POLYNESIA; GREAT-BARRIER-REEF; HIGH ISLANDS; CORAL-REEFS; CARBONATE; SHELF; COMMUNITIES; RATES	The effects of water depth, seasonal exposure, and substrate orientation on microbioerosion were studied by means of a settlement experiment deployed in 15, 50, 100, and 250 m water depth south-west of the Peloponnese Peninsula (Greece). At each depth, an experimental platform was exposed for a summer period, a winter period, and about an entire year. On the up- and down-facing side of each platform, substrates were fixed to document the succession of bioerosion traces, and to measure variations in bioerosion and accretion rates. In total, 29 different bioerosion traces were recorded revealing a dominance of microborings produced by phototrophic and organotrophic microendoliths, complemented by few macroborings, attachment scars, and grazing traces. The highest bioerosion activity was recorded in 15 m up-facing substrates in the shallow euphotic zone, largely driven by phototrophic cyanobacteria. Towards the chlorophyte-dominated deep euphotic to dysphotic zones and the organotroph-dominated aphotic zone the intensity of bioerosion and the diversity of bioerosion traces strongly decreased. During summer the activity of phototrophs was higher than during winter, which was likely stimulated by enhanced light availability due to more hours of daylight and increased irradiance angles. Stable water column stratification and a resulting nutrient depletion in shallow water led to lower turbidity levels and caused a shift in the photic zonation that was reflected by more phototrophs being active at greater depth. With respect to the subordinate bioerosion activity of organotrophs, fluctuations in temperature and the trophic regime were assumed to be the main seasonal controls. The observed patterns in overall bioeroder distribution and abundance were mirrored by the calculated carbonate budget with bioerosion rates exceeding carbonate accretion rates in shallow water and distinctly higher bioerosion rates at all depths during summer. These findings highlight the relevance of bioerosion and accretion for the carbonate budget of the Ionian Sea.	[Faerber, Claudia; Wisshak, Max; Freiwald, Andre] Abt Meeresforschung, Senckenberg Meer, D-26382 Wilhelmshaven, Germany; [Pyko, Ines] Univ Erlangen Nurnberg, Fachgrp Palaoumwelt, GeoZentrum Nordbayern, D-91054 Erlangen, Germany; [Bellou, Nikoleta] Inst Oceanog, Hellen Ctr Marine Res, Anavyssos 19003, Greece	Senckenberg Gesellschaft fur Naturforschung (SGN); University of Erlangen Nuremberg; Hellenic Centre for Marine Research	Farber, C (corresponding author), Abt Meeresforschung, Senckenberg Meer, Sudstrand 40, D-26382 Wilhelmshaven, Germany.	claudia.faerber@senckenberg.de	Wisshak, Max/A-3418-2011; Bellou, Nikoleta/G-8891-2011; Freiwald, Andre/C-2061-2018	Wisshak, Max/0000-0001-7531-3317; Bellou, Nikoleta/0000-0003-3789-1903; Freiwald, Andre/0000-0002-2335-4042; Pyko, Ines/0000-0001-9227-4604	Deutsche Forschungsgemeinschaft (DFG) [Wi 3754/2]; project KM3NET (EU-FP6) [011937]; POSEIDON II (EFTA & Greek Ministry of National Economy); POSEIDON III [EL0048]; Greek-German cooperation IKYDA - Greek State Scholarship Foundation; German Academic Exchange Service (DAAD)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); project KM3NET (EU-FP6); POSEIDON II (EFTA & Greek Ministry of National Economy); POSEIDON III; Greek-German cooperation IKYDA - Greek State Scholarship Foundation; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	This study was funded by the Deutsche Forschungsgemeinschaft (DFG Wi 3754/2). The research cruises were financed by the projects KM3NET (Contract No. 011937; EU-FP6), POSEIDON II (EFTA & Greek Ministry of National Economy), and POSEIDON III (Contract no. EL0048; EEA Grants). The travels were financially supported by the Greek-German cooperation IKYDA 2008-2009, a fellowship for exchanging knowledge among young scientists that was funded by the Greek State Scholarship Foundation (IKY) and the German Academic Exchange Service (DAAD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKPAN E B, 1984, Transactions of the Royal Society of Edinburgh Earth Sciences, V75, P1; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Bongiorni L, 2002, AQUAT MICROB ECOL, V30, P49, DOI 10.3354/ame030049; Bornet E, 1889, B SOC BOT FRANCE, V36, P147, DOI [10.1080/00378941.1889.10835893, DOI 10.1080/00378941.1889.10835893, DOI 10.1080/00378941.1889.10830435]; Bornet E, 1888, J BOT, V2, P161; Bromley Richard G., 2007, P518, DOI 10.1016/B978-044452949-7/50158-3; Bromley RG, 1990, B GEOL SOC DENMARK, V38, P85; BUDD DA, 1980, J SEDIMENT PETROL, V50, P881; CHAZOTTES V, 1995, PALAEOGEOGR PALAEOCL, V113, P189, DOI 10.1016/0031-0182(95)00043-L; Chazottes V, 2002, CORAL REEFS, V21, P375, DOI 10.1007/s00338-002-0259-0; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; ERCEGOVI A., 1929, ARCH PROTISTENK, V66, P164; ERCEGOVI ANTE, 1927, ACTA BOT INST UNIV ZAGREB, V2, P78; Ercegovic A., 1932, RAD JUGOSLOVENSKE AK, V244, P129; Fornos JJ, 2006, GEOL SOC SPEC PUBL, V255, P71, DOI 10.1144/GSL.SP.2006.255.01.06; Glaub I., 2001, ICHNOS, V8, P185, DOI [10.1080/10420940109380186, DOI 10.1080/10420940109380186]; Glaub Ingrid, 2007, P368, DOI 10.1016/B978-044452949-7/50147-9; Glaub Ingrid, 1994, Courier Forschungsinstitut Senckenberg, V174, P1; Golubic S, 2005, TRENDS MICROBIOL, V13, P229, DOI 10.1016/j.tim.2005.03.007; Golubic S., 1979, Biogeochemical cycling of mineral-forming elements, P29; Golubic S., 1975, STUDY TRACE FOSSILS, P229; Gorley C.K., 2006, GETTING STARTED PRIM; Gunther A., 1990, Facies, V22, P233, DOI 10.1007/BF02536953; HOSKIN CM, 1986, MAR GEOL, V73, P125, DOI 10.1016/0025-3227(86)90115-5; HUTCHINGS PA, 1986, CORAL REEFS, V4, P239, DOI 10.1007/BF00298083; Khanaev SA, 1992, P 2 NESTOR INT WORKS, P253; KIENE WE, 1994, CORAL REEFS, V13, P91, DOI 10.1007/BF00300767; Krom M, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P49, DOI 10.1007/978-94-007-6704-1_4; LECAMPIONALSUMARD T, 1979, OCEANOL ACTA, V2, P143; Malanotte-Rizzoli P, 1997, PROG OCEANOGR, V39, P153, DOI 10.1016/S0079-6611(97)00013-X; Mater Group, 2001, MAS3CT960051; Paerl HW, 2008, SCIENCE, V320, P57, DOI 10.1126/science.1155398; Pari N, 2002, J EXP MAR BIOL ECOL, V276, P109, DOI 10.1016/S0022-0981(02)00243-5; Pari N, 1998, MAR ECOL PROG SER, V166, P119, DOI 10.3354/meps166119; PERKINS RD, 1976, GEOL SOC AM BULL, V87, P1615, DOI 10.1130/0016-7606(1976)87<1615:MIOCSP>2.0.CO;2; Perry CT, 2002, PALAEOGEOGR PALAEOCL, V186, P101, DOI 10.1016/S0031-0182(02)00446-7; Radtke G., 1991, Courier Forschungsinstitut Senckenberg, V138, P1; Ridgwell A, 2005, EARTH PLANET SC LETT, V234, P299, DOI 10.1016/j.epsl.2005.03.006; Sartoretto S, 1998, CR ACAD SCI II A, V327, P839, DOI 10.1016/S1251-8050(99)80059-7; Schlitzer R, 2014, OCEAN DATA VIEW 2014; Schmidt Horst, 1992, Frankfurter Geowissenschaftliche Arbeiten Serie A Geologie-Palaeontologie, V12, P1; Schonberg CHL, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P449, DOI 10.1007/978-94-007-6704-1_26; Stambler N, 2014, MEDITERRANEAN SEA: ITS HISTORY AND PRESENT CHALLENGES, P113, DOI 10.1007/978-94-007-6704-1_7; Tribollet A, 2005, CORAL REEFS, V24, P422, DOI 10.1007/s00338-005-0003-7; Tribollet Aline, 2011, P117; Trimonis E., 1992, P 2 NESTOR INT WORKS, P321; Vogel K, 2000, LETHAIA, V33, P190; Vogel K., 1995, NEUES JB GEOL PAL, V195, P49; Vogel K., 1996, GOTTINGER ARBEITEN G, V2, P139; Wisshak M, 2006, LECT NOTES EARTH SCI, V109, P1, DOI 10.1007/978-3-540-36849-6; Wisshak M, 2015, MAR BIODIVERS, V45, P87, DOI 10.1007/s12526-014-0231-6; Wisshak M, 2011, GEOBIOLOGY, V9, P492, DOI 10.1111/j.1472-4669.2011.00299.x; Wisshak M, 2010, BIOGEOSCIENCES, V7, P2379, DOI 10.5194/bg-7-2379-2010; Wisshak M., 2012, TRACE FOSSILS INDICA, V64, P213, DOI DOI 10.1016/B978-0-444-53813-0.00008-3; Wisshak Max, 2006, Ichnos, V13, P135, DOI 10.1080/10420940600851255; Wisshak M, 2014, ICHNOS, V21, P111, DOI 10.1080/10420940.2014.907572	56	13	13	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126495	10.1371/journal.pone.0126495	http://dx.doi.org/10.1371/journal.pone.0126495			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893244	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700143
J	Otomaru, H; Kamigaki, T; Tamaki, R; Opinion, J; Santo, A; Daya, E; Okamoto, M; Saito, M; Tallo, V; Lupisan, S; Suzuki, A; Oshitani, H				Otomaru, Hirono; Kamigaki, Taro; Tamaki, Raita; Opinion, Jamie; Santo, Arlene; Daya, Edgard; Okamoto, Michiko; Saito, Mariko; Tallo, Veronica; Lupisan, Soccoro; Suzuki, Akira; Oshitani, Hitoshi			Influenza and Other Respiratory Viruses Detected by Influenza-Like Illness Surveillance in Leyte Island, the Philippines, 2010-2013	PLOS ONE			English	Article							REAL-TIME PCR; HUMAN METAPNEUMOVIRUS; SYNCYTIAL VIRUS; SENTINEL SURVEILLANCE; MICROPLATE METHOD; VIRAL ETIOLOGY; CHILDREN; INFECTIONS; SEASONS; OUTPATIENTS	This study aimed to determine the role of influenza-like illness (ILI) surveillance conducted on Leyte Island, the Philippines, including involvement of other respiratory viruses, from 2010 to 2013. ILI surveillance was conducted from January 2010 to March 2013 with 3 sentinel sites located in Tacloban city, Palo and Tanauan of Leyte Island. ILI was defined as fever >= 38 degrees C or feverish feeling and either cough or running nose in a patient of any age. Influenza virus and other 5 respiratory viruses were searched. A total of 5,550 ILI cases visited the 3 sites and specimens were collected from 2,031 (36.6%) cases. Among the cases sampled, 1,637 (75.6%) were children aged <5 years. 874 (43.0%) cases were positive for at least one of the respiratory viruses tested. Influenza virus and respiratory syncytial virus (RSV) were predominantly detected (both were 25.7%) followed by human rhinovirus (HRV) (17.5%). The age distributions were significantly different between those who were positive for influenza, HRV, and RSV. ILI cases were reported throughout the year and influenza virus was co-detected with those viruses on approximately half of the weeks of study period (RSV in 60.5% and HRV 47.4%). In terms of clinical manifestations, only the rates of headache and sore throat were significantly higher in influenza positive cases than cases positive to other viruses. In conclusion, syndromic ILI surveillance in this area is difficult to detect the start of influenza epidemic without laboratory confirmation which requires huge resources. Age was an important factor that affected positive rates of influenza and other respiratory viruses. Involvement of older age children may be useful to detect influenza more effectively.	[Otomaru, Hirono; Kamigaki, Taro; Tamaki, Raita; Okamoto, Michiko; Saito, Mariko; Oshitani, Hitoshi] Tohoku Univ, Sch Med, Dept Virol, Sendai, Miyagi 980, Japan; [Opinion, Jamie] Tacloban City Hlth Off, Tacloban City, Philippines; [Santo, Arlene] Tanauan Rural Hlth Unit, Tanauan, Philippines; [Daya, Edgard] Leyte Prov Hlth Off, Palo, Philippines; [Saito, Mariko] Tohoku RITM Res Ctr Emerging & Reemerging Infect, Muntinlupa, Philippines; [Tallo, Veronica; Lupisan, Soccoro] Res Inst Trop Med, Muntinlupa, Philippines; [Suzuki, Akira] Sendai Med Ctr, Virus Res Ctr, Div Clin Res, Sendai, Miyagi, Japan	Tohoku University; Research Institute for Tropical Medicine - Philippines	Kamigaki, T (corresponding author), Tohoku Univ, Sch Med, Dept Virol, Sendai, Miyagi 980, Japan.	kamigakit@med.tohoku.ac.jp	Oshitani, Hitoshi/AAE-4349-2019; Okamoto, Michiko/AAE-4373-2019	Okamoto, Michiko/0000-0002-3505-5939; Suzuki, Akira/0000-0002-8223-0314	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JICA), Japan; JSPS KAKENHI [24249041]	Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JICA), Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid from the Japan Initiative for Global Research Network on Infectious Diseases (J-GRID) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT), Japan; the Science and Technology Research Partnership for Sustainable Development (SATREPS) from the Japan Science and Technology Agency (JICA), Japan; and JSPS KAKENHI Grant number 24249041. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azziz-Baumgartner E, 2012, B WORLD HEALTH ORGAN, V90, P12, DOI 10.2471/BLT.11.090209; Bellau-Pujol S, 2005, J VIROL METHODS, V126, P53, DOI 10.1016/j.jviromet.2005.01.020; Bonroy C, 2007, CLIN MICROBIOL INFEC, V13, P504, DOI 10.1111/j.1469-0691.2007.01682.x; Casas I, 2005, J CLIN MICROBIOL, V43, P6176, DOI 10.1128/JCM.43.12.6176-6182.2005; Chen SY, 2012, AM J EMERG MED, V30, P1796, DOI 10.1016/j.ajem.2012.02.016; Dennis KM, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3693; Furuse Y, 2010, J VIROL METHODS, V168, P94, DOI 10.1016/j.jviromet.2010.04.023; Galindo-Fraga A, 2013, INT J INFECT DIS, V17, pE510, DOI 10.1016/j.ijid.2013.01.006; Hombrouck A, 2012, EUR J CLIN MICROBIOL, V31, P999, DOI 10.1007/s10096-011-1398-4; Huo X, 2012, J MED VIROL, V84, P1980, DOI 10.1002/jmv.23401; Kadjo HA, 2013, INFLUENZA OTHER RESP, V7, P296, DOI 10.1111/j.1750-2659.2012.00389.x; Kiang D, 2008, J CLIN MICROBIOL, V46, P3736, DOI 10.1128/JCM.00674-08; Kono J, 2014, J MED VIROL, V86, P899, DOI 10.1002/jmv.23786; Landes MB, 2013, INFLUENZA OTHER RESP, V7, P1122, DOI 10.1111/irv.12145; Mak GC, 2012, INFLUENZA OTHER RESP, V6, pe6, DOI 10.1111/j.1750-2659.2011.00323.x; Matsuzaki Y, 2009, J CLIN MICROBIOL, V47, P2981, DOI 10.1128/JCM.00321-09; Mizuta K, 2008, JPN J INFECT DIS, V61, P196; Mizuta K, 2013, JPN J INFECT DIS, V66, P140, DOI 10.7883/yoken.66.140; Mizuta Katsumi, 2003, International Journal of Infectious Diseases, V7, P138, DOI 10.1016/S1201-9712(03)90010-5; Mmbaga VM, 2012, J INFECT DIS, V206, pS80, DOI 10.1093/infdis/jis540; Monto AS, 2000, ARCH INTERN MED, V160, P3243, DOI 10.1001/archinte.160.21.3243; National Statistical Office, 2010 CENS POP HOUS; Navarro-Mari JM, 2005, J CLIN EPIDEMIOL, V58, P275, DOI 10.1016/j.jclinepi.2004.08.014; Nguyen YT, 2013, VACCINE, V31, P4368, DOI 10.1016/j.vaccine.2013.07.018; Nicholson KG, 2006, VACCINE, V24, P102, DOI 10.1016/j.vaccine.2005.02.004; Nishimura N, 2005, PEDIATR INT, V47, P412, DOI 10.1111/j.1442-200x.2005.02099.x; Njouom R, 2012, J INFECT DIS, V206, pS29, DOI 10.1093/infdis/jis573; NUMAZAKI Y, 1987, MICROBIOL IMMUNOL, V31, P1085, DOI 10.1111/j.1348-0421.1987.tb01340.x; Peltola V, 2005, CLIN INFECT DIS, V41, P1198, DOI 10.1086/444508; Peng JS, 2012, J MED VIROL, V84, P672, DOI 10.1002/jmv.22247; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Silvennoinen H, 2009, PEDIATR INFECT DIS J, V28, P372, DOI 10.1097/INF.0b013e318191eef7; Suzuki A, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-267; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Western Pacific Region Global Influenza Surveillance and Response System Epidemiological and virological characteristics of influenza in the Western Pacific Region of the World Health Organization, 2006, PLOS ONE, V7, DOI [10.1371/journal.pone.0037568, DOI 10.1371/JOURNAL.PONE.0037568]; WHO, 2012, WHO INT GLOB EP SURV; WHO, CDC PROT REALT RTPCR; Wolf DG, 2010, J PEDIATR-US, V156, P115, DOI 10.1016/j.jpeds.2009.07.014; World Health Organization (WHO), WHO REC SURV STAND; Yang TU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084873; Zaman RU, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008452	42	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123755	10.1371/journal.pone.0123755	http://dx.doi.org/10.1371/journal.pone.0123755			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893441	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700053
J	Dale, C; Nuesch, E; Prieto-Merino, D; Choi, M; Amuzu, A; Ebrahim, S; Casas, JP; Davey-Smith, G				Dale, Caroline; Nueesch, Eveline; Prieto-Merino, David; Choi, Minkyoung; Amuzu, Antoinette; Ebrahim, Shah; Casas, Juan P.; Davey-Smith, George			Why Do Thin People Have Elevated All-Cause Mortality? Evidence on Confounding and Reverse Causality in the Association of Adiposity and COPD from the British Women's Heart and Health Study	PLOS ONE			English	Article							BODY-MASS INDEX; OBSTRUCTIVE PULMONARY-DISEASE; WEIGHT CHANGE; OLDER WOMEN; RISK; OBESITY; CANCER; COHORT; DEATH; BMI	Low adiposity has been linked to elevated mortality from several causes including respiratory disease. However, this could arise from confounding or reverse causality. We explore the association between two measures of adiposity (BMI and WHR) with COPD in the British Women's Heart and Health Study including a detailed assessment of the potential for confounding and reverse causality for each adiposity measure. Low BMI was found to be associated with increased COPD risk while low WHR was not (OR = 2.2; 95% CI 1.3-3.1 versus OR = 1.2; 95% CI 0.7-1.6). Potential confounding variables (e.g. smoking) and markers of ill-health (e.g. unintentional weight loss) were found to be higher in low BMI but not in low WHR. Women with low BMI have a detrimental profile across a broad range of health markers compared to women with low WHR, and women with low WHR do not appear to have an elevated COPD risk, lending support to the hypothesis that WHR is a less confounded measure of adiposity than BMI. Low adiposity does not in itself appear to increase the risk of respiratory disease, and the apparent adverse consequences of low BMI may be due to reverse causation and confounding.	[Dale, Caroline; Nueesch, Eveline; Prieto-Merino, David; Choi, Minkyoung; Amuzu, Antoinette; Ebrahim, Shah; Casas, Juan P.] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London WC1, England; [Casas, Juan P.] UCL, Inst Cardiovasc Sci, London, England; [Davey-Smith, George] Univ Bristol, CAiTE Ctr, Sch Social & Community Med, Bristol, Avon, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of Bristol	Dale, C (corresponding author), London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London WC1, England.	caroline.dale@ishtm.ac.uk	Davey Smith, George/A-7407-2013	Davey Smith, George/0000-0002-1407-8314; s, hema/0000-0002-3440-9475; Dale, Caroline/0000-0002-3889-8974; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Prieto-Merino, David/0000-0001-5001-0061	Department of Health Policy Research Programme (England) [0090049]; British Heart Foundation [PG/09/022]; Marie Curie Intra-European Fellowship for Career Development [FP7-PEOPLE-2010-IEF-273673]; MRC [MC_UU_12013/1] Funding Source: UKRI; British Heart Foundation [PG/13/66/30442] Funding Source: researchfish; Medical Research Council [MC_UU_12013/1] Funding Source: researchfish	Department of Health Policy Research Programme (England); British Heart Foundation(British Heart Foundation); Marie Curie Intra-European Fellowship for Career Development; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Department of Health Policy Research Programme (England) [grant 0090049] and the British Heart Foundation [grant PG/09/022]. EN was a recipient of a Marie Curie Intra-European Fellowship for Career Development [grant No FP7-PEOPLE-2010-IEF-273673]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson J, 2004, AGE AGEING, V33, P293, DOI 10.1093/ageing/afh090; Agusti AGN, 2002, PULM PHARMACOL THER, V15, P425, DOI 10.1006/pupt.2002.0385; Alley DE, 2010, AM J EPIDEMIOL, V172, P558, DOI 10.1093/aje/kwq168; Bennett A. E., 1975, QUESTIONNAIRES MED G; Bjorge T, 2008, AM J EPIDEMIOL, V168, P30, DOI 10.1093/aje/kwn096; Boffetta P, 2006, CANCER EPIDEM BIOMAR, V15, P1184, DOI 10.1158/1055-9965.EPI-06-0032; Chen ZM, 2012, INT J EPIDEMIOL, V41, P472, DOI 10.1093/ije/dyr208; Cotes JE, 2006, LUNG FUNCTION PHYSL, P87; de Hollander EL, 2012, INT J EPIDEMIOL, V41, P805, DOI 10.1093/ije/dys008; Ebrahim S, 2008, HUM GENET, V123, P15, DOI 10.1007/s00439-007-0448-6; EuroQol Group, 2009, EQ 5D STAND INSTR US; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Franzosi MG, 2006, LANCET, V368, P624, DOI 10.1016/S0140-6736(06)69222-2; Gaunt TR, 2012, EUR J HUM GENET; Gulland Anne, 2010, BMJ, V341, pc3585, DOI 10.1136/bmj.c3585; Jefferis BJ, 2010, ATHEROSCLEROSIS, V208, P550, DOI 10.1016/j.atherosclerosis.2009.07.044; Lainscak Mitja, 2007, Curr Opin Support Palliat Care, V1, P299, DOI 10.1097/SPC.0b013e3282f31667; Lawlor DA, 2004, BRIT J CANCER, V91, P512, DOI 10.1038/sj.bjc.6601916; Lawlor DA, 2002, J EPIDEMIOL COMMUN H, V56, P473, DOI 10.1136/jech.56.6.473; Lawlor DA, 2005, AM J PUBLIC HEALTH, V95, P91, DOI 10.2105/AJPH.2003.035592; Lawlor DA, 2003, J EPIDEMIOL COMMUN H, V57, P134, DOI 10.1136/jech.57.2.134; Leyland AH, 2010, INT J OBES LOND; Lopez-Jimenez F, 2009, LANCET, V373, P1055, DOI 10.1016/S0140-6736(09)60628-0; Newman AB, 2001, J AM GERIATR SOC, V49, P1309, DOI 10.1046/j.1532-5415.2001.49258.x; Nuesch E, 2012, EUR J EPIDEMIOL, V27, P633, DOI 10.1007/s10654-012-9706-6; Pischon T, 2008, NEW ENGL J MED, V359, P2105, DOI 10.1056/NEJMoa0801891; Prescott E, 2002, EUR RESPIR J, V20, P539, DOI 10.1183/09031936.02.00532002; Smith GD, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5043; Stevens J, 2008, INT J OBESITY, V32, pS60, DOI 10.1038/ijo.2008.88; The Emerging Risk Factors Collaboration, 2011, LANCET; University of Cambridge, 2010, EUR PROSP INV CANC; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yusuf S, 2005, LANCET, V366, P1640, DOI 10.1016/S0140-6736(05)67663-5	33	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0115446	10.1371/journal.pone.0115446	http://dx.doi.org/10.1371/journal.pone.0115446			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884834	gold, Green Published, Green Submitted, Green Accepted			2022-12-27	WOS:000353017000001
J	Tsai, CH; Lin, YC; Wiegand, T; Nakazawa, T; Su, SH; Hsieh, CH; Ding, TS				Tsai, Cheng-Han; Lin, Yi-Ching; Wiegand, Thorsten; Nakazawa, Takefumi; Su, Sheng-Hsin; Hsieh, Chih-Hao; Ding, Tzung-Su			Individual Species-Area Relationship of Woody Plant Communities in a Heterogeneous Subtropical Monsoon Rainforest	PLOS ONE			English	Article							NEGATIVE DENSITY-DEPENDENCE; TROPICAL FORESTS; SPATIAL-PATTERNS; DIVERSITY; ECTOMYCORRHIZAL; ASSOCIATIONS; INFORMATION; POPULATIONS; STATISTICS; MECHANISMS	The spatial structure of species richness is often characterized by the species-area relationship (SAR). However, the SAR approach rarely considers the spatial variability of individual plants that arises from species interactions and species' habitat associations. Here, we explored how the interactions of individual plants of target species influence SAR patterns at a range of neighborhood distances. We analyzed the data of 113,988 woody plants of 110 species from the Fushan Forest Dynamics Plot (25 ha), northern Taiwan, which is a subtropical rainforest heavily influenced by typhoons. We classified 34 dominant species into 3 species types (i.e., accumulator, repeller, or no effect) by testing how the individual speciesarea relationship (i.e., statistics describing how neighborhood species richness changes around individuals) of target species departs (i.e., positively, negatively, or with no obvious trend) from a null model that accounts for habitat association. Deviation from the null model suggests that the net effect of species' interactions increases (accumulate) or decreases (repel) neighborhood species richness. We found that (i) accumulators were dominant at small interaction distances (<10-30 m); (ii) the detection of accumulator species was lower at large interaction distances (>30 m); (iii) repellers were rarely detected; and (iv) largesized and abundant species tended to be accumulators. The findings suggest that positive species interactions have the potential to accumulate neighborhood species richness, particularly through size- and density-dependent mechanisms. We hypothesized that the frequently disturbed environment of this subtropical rainforest (e.g., typhoon-driven natural disturbances such as landslides, soil erosion, flooding, and windthrow) might create the spatial heterogeneity of species richness and promote positive species interactions.	[Tsai, Cheng-Han; Ding, Tzung-Su] Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan; [Tsai, Cheng-Han; Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Lin, Yi-Ching] Tunghai Univ, Dept Life Sci, Taichung 40704, Taiwan; [Wiegand, Thorsten] UFZ Helmholtz Ctr Environm Res, Dept Ecol Modelling, Leipzig, Germany; [Nakazawa, Takefumi] Natl Cheng Kung Univ, Dept Life Sci, Tainan 70101, Taiwan; [Su, Sheng-Hsin] Taiwan Forestry Res Inst, Taipei, Taiwan; [Hsieh, Chih-Hao] Natl Taiwan Univ, Inst Ecol & Evolutionary Biol, Taipei 10764, Taiwan	National Taiwan University; National Taiwan University; Tunghai University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); National Cheng Kung University; National Taiwan University	Ding, TS (corresponding author), Natl Taiwan Univ, Sch Forestry & Resource Conservat, Taipei 10764, Taiwan.	ding@ntu.edu.tw	DING, Tzung-Su/AAG-7712-2019; Wiegand, Thorsten/H-5877-2016; Hsieh, Chih-hao/B-3797-2008; Su, Sheng-Hsin/AAC-3596-2021; Wiegand, Thorsten/AAP-9709-2021	Wiegand, Thorsten/0000-0002-3721-2248; Hsieh, Chih-hao/0000-0001-5935-7272; Su, Sheng-Hsin/0000-0003-1337-3335; Wiegand, Thorsten/0000-0002-3721-2248; DING, Tzung-Su/0000-0002-1102-3879	Ministry of Science and Technology of Taiwan [NSC101-2923-I-002-001-MY2]; European Research Council [233066]; YCL	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); European Research Council(European Research Council (ERC)European Commission); YCL	This study was supported by the Ministry of Science and Technology of Taiwan (http://www.most.gov.tw) (NSC101-2923-I-002-001-MY2) to TSD. The European Research Council (http://erc.europa.eu) awarded grant 233066 to TW and supported travel expenses of YCL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler FR, 2005, ECOL LETT, V8, P438, DOI 10.1111/j.1461-0248.2005.00741.x; Balvanera P, 2006, BIOTROPICA, V38, P479, DOI 10.1111/j.1744-7429.2006.00161.x; Borcard D, 2004, ECOLOGY, V85, P1826, DOI 10.1890/03-3111; BROWN JH, 1995, ECOLOGY, V76, P2028, DOI 10.2307/1941678; Bunge J., J AM STAT ASSOC, V88, P364, DOI 10.2307/2290733; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Comita LS, 2009, J ECOL, V97, P1346, DOI 10.1111/j.1365-2745.2009.01551.x; Comita LS, 2009, ECOLOGY, V90, P2755, DOI 10.1890/08-1482.1; CONNOR EF, 1979, AM NAT, V113, P791, DOI 10.1086/283438; Dale M, 2005, SPATIAL PATTERN ANAL; Diggle P., 2003, STAT ANAL SPATIAL PO; Gardner RH, 2008, PERSPECT PLANT ECOL, V9, P211, DOI 10.1016/j.ppees.2007.08.003; Goreaud F, 2003, J VEG SCI, V14, P681, DOI 10.1658/1100-9233(2003)014[0681:AMOBIW]2.0.CO;2; Grilli J, 2012, J THEOR BIOL, V313, P87, DOI 10.1016/j.jtbi.2012.07.030; He FL, 1996, J BIOGEOGR, V23, P57, DOI 10.1046/j.1365-2699.1996.00976.x; He FL, 2002, ECOLOGY, V83, P1185, DOI 10.1890/0012-9658(2002)083[1185:SDPDFS]2.0.CO;2; Horvitz CC, 1998, ECOL APPL, V8, P947, DOI 10.1890/1051-0761(1998)008[0947:FROINI]2.0.CO;2; Hubbell SP, 2001, ECOL RES, V16, P859, DOI 10.1046/j.1440-1703.2001.00445.x; Hyatt LA, 2003, OIKOS, V103, P590, DOI 10.1034/j.1600-0706.2003.12235.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Johnson DJ, 2012, SCIENCE, V336, P904, DOI 10.1126/science.1220269; Kubota Y, 2004, J ECOL, V92, P230, DOI 10.1111/j.0022-0477.2004.00875.x; Law R, 2009, J ECOL, V97, P616, DOI 10.1111/j.1365-2745.2009.01510.x; Lin TC, 2011, ECOSYSTEMS, V14, P127, DOI 10.1007/s10021-010-9399-1; Loosmore NB, 2006, ECOLOGY, V87, P1925, DOI 10.1890/0012-9658(2006)87[1925:SIUTGO]2.0.CO;2; Luo ZR, 2012, OIKOS, V121, P1239, DOI 10.1111/j.1600-0706.2011.20079.x; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; McGuire KL, 2010, OECOLOGIA, V164, P785, DOI 10.1007/s00442-010-1686-1; Peters HA, 2003, ECOL LETT, V6, P757, DOI 10.1046/j.1461-0248.2003.00492.x; Plotkin JB, 2002, AM NAT, V160, P629, DOI 10.1086/342823; Rayburn AP, 2012, ECOGRAPHY, V35, P341, DOI 10.1111/j.1600-0587.2011.07058.x; Ricklefs RE., 1990, ECOLOGY; Shen GC, 2009, ECOLOGY, V90, P3033, DOI 10.1890/08-1646.1; Su S-H., 2007, FUSHAN SUBTROPICAL F; Su ShengHsin, 2010, Taiwan Journal of Forest Science, V25, P63; Volkov I, 2009, P NATL ACAD SCI USA, V106, P13854, DOI 10.1073/pnas.0903244106; Wang XG, 2010, J ECOL, V98, P674, DOI 10.1111/j.1365-2745.2010.01644.x; Weiner J, 2001, AM NAT, V158, P438, DOI 10.1086/321988; Whittaker R. J., 2007, ISLAND BIOGEOGRAPHY; Whittaker RJ, 2014, J BIOGEOGR, V41, P209, DOI 10.1111/jbi.12256; Wiegand T, 2014, CH HALL CRC APP ENV, P1; Wiegand T, 2003, OIKOS, V100, P209, DOI 10.1034/j.1600-0706.2003.12027.x; Wiegand T, 2007, P NATL ACAD SCI USA, V104, P19029, DOI 10.1073/pnas.0705621104; Wright SJ, 2003, ECOLOGY, V84, P3174, DOI 10.1890/02-0038; Wright SJ, 2002, OECOLOGIA, V130, P1, DOI 10.1007/s004420100809; Yang J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063192; Zhu Y, 2010, OIKOS, V119, P109, DOI 10.1111/j.1600-0706.2009.17758.x	47	9	9	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124539	10.1371/journal.pone.0124539	http://dx.doi.org/10.1371/journal.pone.0124539			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884405	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000137
J	Belter, JT; Dollar, AM				Belter, Joseph T.; Dollar, Aaron M.			Strengthening of 3D Printed Fused Deposition Manufactured Parts Using the Fill Compositing Technique	PLOS ONE			English	Article								In this paper, we present a technique for increasing the strength of thermoplastic fused deposition manufactured printed parts while retaining the benefits of the process such as ease, speed of implementation, and complex part geometries. By carefully placing voids in the printed parts and filling them with high-strength resins, we can improve the overall part strength and stiffness by up to 45% and 25%, respectively. We discuss the process parameters necessary to use this strengthening technique and the theoretically possible strength improvements to bending beam members. We then show three-point bend testing data comparing solid printed ABS samples with those strengthened through the fill compositing process, as well as examples of 3D printed parts used in real-world applications.	[Belter, Joseph T.; Dollar, Aaron M.] Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA	Yale University	Belter, JT (corresponding author), Yale Univ, Dept Mech Engn & Mat Sci, New Haven, CT 06520 USA.	joseph.belter@yale.edu		Dollar, Aaron/0000-0002-2409-4668	Defense Advanced Research Projects Agency (DARPA) [W91CRB-10-C-0141]; Gustavus and Louise Pfeiffer Research Foundation	Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Gustavus and Louise Pfeiffer Research Foundation	This work was supported in part by the Defense Advanced Research Projects Agency (DARPA) under grand W91CRB-10-C-0141, and the Gustavus and Louise Pfeiffer Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2011, ING TECHN B NATUREWO; [Anonymous], SMOOTH CAST 300 SER; [Anonymous], 2013, ABSPLUS P430 PROD GR; [Anonymous], 2013, 105 EP RES 205 FAST; [Anonymous], 2013, FDM NYL 12 PROD GRAD; [Anonymous], 2010, D79010 ASTM, DOI [10.1520/D0790-10, DOI 10.1520/D0790-10]; Belter JT, 2014, INT C INT ROB SYST I; De Laurentis K.J., 2002, P ASME 2002 INT DESI, P1239, DOI [10.1115/DETC2002/MECH-34350, DOI 10.1115/DETC2002/MECH-34350]; Duty C., 2012, CARBON FIBER REINFOR; Graybill B., 2011, P ICMET INT C MECH E; Hans A Eschenauer Niels Olhoff, 2001, APPL MECH REV, V54, P331, DOI [10.1115/1.1388075, DOI 10.1115/1.1388075]; Hibbeler Russell Charles, 2004, STATICS MECH MAT, V2; Hossain M. S., 2013, INT SOL FREEF FABR S, V2013, P380; Innothane, IE 3076 POL 300 SER; Jamalabad V. R., 1996, P SOL FREEF FABR S A; Laliberte T, 2001, IEEE ROBOT AUTOM MAG, V8, P43, DOI 10.1109/100.956813; Lee CS, 2007, J MATER PROCESS TECH, V187, P627, DOI 10.1016/j.jmatprotec.2006.11.095; Lohmann S, 2012, P 13 INT C SYNTH SIM; Ma RR, 2013, P 2013 IEEE INT C RO; Masood SH, 2004, MATER DESIGN, V25, P587, DOI 10.1016/j.matdes.2004.02.009; Masood SH, 1996, RAPID PROTOTYPING J, V2, P24, DOI 10.1108/13552549610109054; Sella, 2013, PRECISION PROTOTYPIN; Smith WC, 2013, POLYM TEST, V32, P1306, DOI 10.1016/j.polymertesting.2013.07.014; Stava O, 2012, ACM T GRAPHIC, V31, DOI 10.1145/2185520.2185544; Thryft AR, 2012, DESIGN NEWS; Vona M, 2006, P INT S EXP ROB, P431; Won J, 2000, ROB AUT 2000 P ICRA, V4, P3077, DOI [10.1109/ROBOT.2000.845136, DOI 10.1109/ROBOT.2000.845136]; Zirox, WOLL LOW HIGH ASP RA	29	76	80	0	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122915	10.1371/journal.pone.0122915	http://dx.doi.org/10.1371/journal.pone.0122915			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880807	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500032
J	Gornish, ES; Miller, TE				Gornish, Elise S.; Miller, Thomas E.			Plant Community Responses to Simultaneous Changes in Temperature, Nitrogen Availability, and Invasion	PLOS ONE			English	Article							CLIMATE-CHANGE; FIT INDEXES; GROWTH; METAANALYSIS; PHENOLOGY; IMPACTS; CARBON; DEPOSITION; ECOSYSTEMS; DIVERSITY	Background Increasing rates of change in climate have been observed across the planet and have contributed to the ongoing range shifts observed for many species. Although ecologists are now using a variety of approaches to study how much and through what mechanisms increasing temperature and nutrient pollution may influence the invasions inherent in range shifts, accurate predictions are still lacking. Methods and Results In this study, we conducted a factorial experiment, simultaneously manipulating warming, nitrogen addition and introduction of Pityopsis aspera, to determine how range-shifting species affect a plant community. We quantified the resident community using ordination scores, then used structural equation modeling to examine hypotheses related to how plants respond to a network of experimental treatments and environmental variables. Variation in soil pH explained plant community response to nitrogen addition in the absence of invasion. However, in the presence of invasion, the direct effect of nitrogen on the community was negligible and soil moisture was important for explaining nitrogen effects. We did not find effects of warming on the native plant community in the absence of invasion. In the presence of invasion, however, warming had negative effects on functional richness directly and invasion and herbivory explained the overall positive effect of warming on the plant community. Conclusions and Significance This work highlights the variation in the biotic and abiotic factors responsible for explaining independent and collective climate change effects over a short time scale. Future work should consider the complex and non-additive relationships among factors of climate change and invasion in order to capture more ecologically relevant features of our changing environment.	[Gornish, Elise S.] Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA; [Miller, Thomas E.] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	University of California System; University of California Davis; State University System of Florida; Florida State University	Gornish, ES (corresponding author), Univ Calif Davis, Dept Plant Sci, Davis, CA 95616 USA.	egornish@ucdavis.edu			Tall Timbers Research Reserve	Tall Timbers Research Reserve	The authors would like to thank the many volunteers that helped to set up the experiment and collect data. Jessica Hellmann provided helpful comments on earlier drafts of the manuscript. This work was supported, in part, by Tall Timbers Research Reserve.	Aerts R, 2006, J ECOL, V94, P713, DOI 10.1111/j.1365-2745.2006.01142.x; Ainsworth A, 2010, BIOTROPICA, V42, P647, DOI 10.1111/j.1744-7429.2010.00636.x; Arbuckle J. L., 2006, AMOS VERSION 7 0 COM; BENTLER PM, 1990, PSYCHOL BULL, V107, P238, DOI 10.1037/0033-2909.88.3.588; Blankinship JC, 2011, OECOLOGIA, V165, P553, DOI 10.1007/s00442-011-1909-0; Bradley BA, 2010, TRENDS ECOL EVOL, V25, P310, DOI 10.1016/j.tree.2009.12.003; Brook BW, 2008, WILDLIFE RES, V35, P249, DOI 10.1071/WR07116; CHAPIN FS, 1995, ECOLOGY, V76, P694, DOI 10.2307/1939337; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Cleland EE, 2006, P NATL ACAD SCI USA, V103, P13740, DOI 10.1073/pnas.0600815103; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; Dieleman WIJ, 2012, GLOBAL CHANGE BIOL, V18, P2681, DOI 10.1111/j.1365-2486.2012.02745.x; Dijkstra FA, 2010, NEW PHYTOL, V187, P426, DOI 10.1111/j.1469-8137.2010.03293.x; Dullinger S, 2012, GLOBAL ECOL BIOGEOGR, V21, P829, DOI 10.1111/j.1466-8238.2011.00732.x; Ehrenfeld JG, 2003, ECOSYSTEMS, V6, P503, DOI 10.1007/s10021-002-0151-3; Eisenhauer N, 2012, OIKOS, V121, P1121, DOI 10.1111/j.1600-0706.2011.19807.x; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Giesler R, 1998, ECOLOGY, V79, P119, DOI 10.1890/0012-9658(1998)079[0119:SCAPIF]2.0.CO;2; Gornish ES, 2014, POPULATION ECOLOGY, V5, P545; Grace JB., 2015, STRUCTURAL EQUATION; Grace JB., 2003, STRUCTURAL EQUATION; Grime JP, 2002, J VEG SCI, V13, P457, DOI 10.1111/j.1654-1103.2002.tb02072.x; Hawkes CV, 2001, ECOLOGY, V82, P2045, DOI 10.1890/0012-9658(2001)082[2045:TIOHOP]2.0.CO;2; Hellmann JJ, 2008, CONSERV BIOL, V22, P534, DOI 10.1111/j.1523-1739.2008.00951.x; Holland EA, 2005, ECOL APPL, V15, P38, DOI 10.1890/03-5162; Hovenden MJ, 2008, GLOBAL CHANGE BIOL, V14, P1018, DOI 10.1111/j.1365-2486.2008.01558.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Kareiva PM, 1993, BIOTIC INTERACTIONS, P559; Kidron GJ, 2009, EARTH SURF PROC LAND, V34, P123, DOI 10.1002/esp.1706; Kobayashi O, 2010, SOIL SCI PLANT NUTR, V56, P407, DOI 10.1111/j.1747-0765.2010.00470.x; Le Guigo P, 2012, OECOLOGIA, V169, P753, DOI 10.1007/s00442-011-2241-4; Leuzinger S, 2011, TRENDS ECOL EVOL, V26, P236, DOI 10.1016/j.tree.2011.02.011; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Marion GM, 1997, GLOB CHANGE BIOL, V3, P20, DOI 10.1111/j.1365-2486.1997.gcb136.x; Maskell LC, 2006, J VEG SCI, V17, P499, DOI 10.1111/j.1654-1103.2006.tb02471.x; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McLaughlin JF, 2002, P NATL ACAD SCI USA, V99, P6070, DOI 10.1073/pnas.052131199; Mooney HA, 2001, P NATL ACAD SCI USA, V98, P5446, DOI 10.1073/pnas.091093398; Norby RJ, 1998, NEW PHYTOL, V139, P189, DOI 10.1046/j.1469-8137.1998.00183.x; Parmesan C., 2006, PRINCIPLES CONSERVAT, P333; Parsons WFJ, 1998, RESTOR ECOL, V6, P280, DOI 10.1046/j.1526-100X.1998.06310.x; Pavlovkin J, 2009, J PLANT PHYSIOL, V166, P1479, DOI 10.1016/j.jplph.2009.03.005; Pino J, 2006, HYDROBIOLOGIA, V570, P257, DOI 10.1007/s10750-006-0189-x; Post ES, 2008, ECOLOGY, V89, P363, DOI 10.1890/06-2138.1; RICHARDS JH, 1987, OECOLOGIA, V73, P486, DOI 10.1007/BF00379405; Richardson DM, 2006, PROG PHYS GEOG, V30, P409, DOI 10.1191/0309133306pp490pr; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Schurch S, 2004, EVOL ECOL, V18, P1, DOI 10.1023/B:EVEC.0000017673.12192.3c; Sharp BR, 2003, J BIOGEOGR, V30, P783, DOI 10.1046/j.1365-2699.2003.00840.x; Sheppard CS, 2014, INVAS PLANT SCI MANA, V7, P237, DOI 10.1614/IPSM-D-13-00038.1; Siemann E, 2007, GLOBAL CHANGE BIOL, V13, P2184, DOI 10.1111/j.1365-2486.2007.01425.x; SMART RE, 1974, PLANT PHYSIOL, V53, P258, DOI 10.1104/pp.53.2.258; Thomas CD, 2010, DIVERS DISTRIB, V16, P488, DOI 10.1111/j.1472-4642.2010.00642.x; Verheyen K, 2009, PLANT BIOLOGY, V11, P49, DOI 10.1111/j.1438-8677.2009.00214.x; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; VITOUSEK PM, 1990, OIKOS, V57, P7, DOI 10.2307/3565731; Weligama C, 2010, PLANT SOIL, V328, P119, DOI 10.1007/s11104-009-0087-x; White PCL, 2008, WILDLIFE RES, V35, P171, DOI 10.1071/WR08058; Wolkovich EM, 2009, J VEG SCI, V20, P1121, DOI 10.1111/j.1654-1103.2009.01110.x; Woodward FI, 2008, ECOL LETT, V11, P1229, DOI 10.1111/j.1461-0248.2008.01240.x; Wu ZT, 2011, GLOBAL CHANGE BIOL, V17, P927, DOI 10.1111/j.1365-2486.2010.02302.x; Xia JY, 2013, ANN BOT-LONDON, V111, P1207, DOI 10.1093/aob/mct079; Xia JY, 2009, GLOBAL CHANGE BIOL, V15, P1544, DOI 10.1111/j.1365-2486.2008.01807.x; Zavaleta ES, 2004, SCIENCE, V306, P1175, DOI 10.1126/science.1102643	64	5	5	6	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123715	10.1371/journal.pone.0123715	http://dx.doi.org/10.1371/journal.pone.0123715			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879440	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500060
J	Grossini, E; Bellofatto, K; Farruggio, S; Sigaudo, L; Marotta, P; Raina, G; De Giuli, V; Mary, D; Pollesello, P; Minisini, R; Pirisi, M; Vacca, G				Grossini, Elena; Bellofatto, Kevin; Farruggio, Serena; Sigaudo, Lorenzo; Marotta, Patrizia; Raina, Giulia; De Giuli, Veronica; Mary, David; Pollesello, Piero; Minisini, Rosalba; Pirisi, Mario; Vacca, Giovanni			Levosimendan Inhibits Peroxidation in Hepatocytes by Modulating Apoptosis/Autophagy Interplay	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; ISCHEMIA-REPERFUSION INJURY; CORONARY ENDOTHELIAL-CELLS; K-ATP CHANNEL; NITRIC-OXIDE; OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; REACTIVE OXYGEN; RAT HEPATOCYTES; HEART-FAILURE	Background Levosimendan protects rat liver against peroxidative injuries through mechanisms related to nitric oxide (NO) production and mitochondrial ATP-dependent K (mitoK(ATP)) channels opening. However, whether levosimendan could modulate the cross-talk between apoptosis and autophagy in the liver is still a matter of debate. Thus, the aim of this study was to examine the role of levosimendan as a modulator of the apoptosis/autophagy interplay in liver cells subjected to peroxidation and the related involvement of NO and mitoK(ATP). Methods and Findings In primary rat hepatocytes that have been subjected to oxidative stress, Western blot was performed to examine endothelial and inducible NO synthase isoforms (eNOS, iNOS) activation, apoptosis/autophagy and survival signalling detection in response to levosimendan. In addition, NO release, cell viability, mitochondrial membrane potential and mitochondrial permeability transition pore opening (MPTP) were examined through specific dyes. Some of those evaluations were also performed in human hepatic stellate cells (HSC). Pretreatment of hepatocytes with levosimendan dose-dependently counteracted the injuries caused by oxidative stress and reduced NO release by modulating eNOS/iNOS activation. In hepatocytes, while the autophagic inhibition reduced the effects of levosimendan, after the pan-caspases inhibition, cell survival and autophagy in response to levosimendan were increased. Finally, all protective effects were prevented by both mitoK(ATP) channels inhibition and NOS blocking. In HSC, levosimendan was able to modulate the oxidative balance and inhibit autophagy without improving cell viability and apoptosis. Conclusions Levosimendan protects hepatocytes against oxidative injuries by autophagic-dependent inhibition of apoptosis and the activation of survival signalling. Such effects would involve mitoKATP channels opening and the modulation of NO release by the different NOS isoforms. In HSC, levosimendan would also play a role in cell activation and possible evolution toward fibrosis. These findings highlight the potential of levosimendan as a therapeutic agent for the treatment or prevention of liver ischemia/reperfusion injuries.	[Grossini, Elena; Bellofatto, Kevin; Farruggio, Serena; Sigaudo, Lorenzo; Marotta, Patrizia; Raina, Giulia; De Giuli, Veronica; Mary, David; Pollesello, Piero; Vacca, Giovanni] Univ Eastern Piedmont Amedeo Avogadro, Azienda Osped Univ Maggiore Carita, Dept Translat Med, Lab Physiol & Expt Surg, Novara, Italy; [Minisini, Rosalba; Pirisi, Mario] Univ Eastern Piedmont Amedeo Avogadro, Azienda Osped Univ Maggiore Carita, Dept Translat Med, Internal Med, Novara, Italy	Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera Maggiore della Carita di Novara; University of Eastern Piedmont Amedeo Avogadro	Grossini, E (corresponding author), Univ Eastern Piedmont Amedeo Avogadro, Azienda Osped Univ Maggiore Carita, Dept Translat Med, Lab Physiol & Expt Surg, Via Solaroli 17,Corso Mazzini 36, Novara, Italy.	grossini@med.unipmn.it	Pirisi, Mario/ABF-2102-2020; Minisini, Rosalba/ABF-9724-2021; Pollesello, Piero/I-6884-2019	Pollesello, Piero/0000-0001-6994-768X; Pirisi, Mario/0000-0001-9740-0155; Grossini, Elena/0000-0002-3012-259X; Vacca, Giovanni/0000-0002-0864-1887				Basel H, 2013, TOXICOL IND HEALTH, V29, P435, DOI 10.1177/0748233712436643; Bhogal RH, 2012, AUTOPHAGY, V8, P545, DOI 10.4161/auto.19012; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Caimmi PP, 2011, EUR J CARDIO-THORAC, V39, pE59, DOI 10.1016/j.ejcts.2010.11.044; Cappellano G, 2013, CAN J CARDIOL, V29, P499, DOI 10.1016/j.cjca.2012.06.003; Chowdhury AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073672; Codogno P, 2005, CELL DEATH DIFFER, V12, P1509, DOI 10.1038/sj.cdd.4401751; Crabtree MJ, 2013, J BIOL CHEM, V288, P561, DOI 10.1074/jbc.M112.415992; Czaja MJ, 2007, SEMIN LIVER DIS, V27, P378, DOI 10.1055/s-2007-991514; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Diesen DL, 2011, J SURG RES, V167, P96, DOI 10.1016/j.jss.2009.10.006; Gecit I, 2014, TOXICOL IND HEALTH, V30, P47, DOI 10.1177/0748233712451773; Grossini E, 2009, BRIT J PHARMACOL, V156, P250, DOI 10.1111/j.1476-5381.2008.00024.x; Grossini E, 2014, VASC PHARMACOL, V60, P127, DOI 10.1016/j.vph.2014.01.008; Grossini E, 2014, LIVER TRANSPLANT, V20, P361, DOI 10.1002/lt.23799; Grossini E, 2012, J PHARMACOL EXP THER, V342, P376, DOI 10.1124/jpet.112.193961; Grossini E, 2012, MOL CELL ENDOCRINOL, V350, P20, DOI 10.1016/j.mce.2011.11.018; Guan LY, 2014, WORLD J GASTRO SURG, V6, P122, DOI 10.4240/wjgs.v6.i7.122; Gupta NA, 2014, AM J PHYSIOL-GASTR L, V307, pG1088, DOI 10.1152/ajpgi.00210.2014; Hai S, 2005, TRANSPL P, V37, P428, DOI 10.1016/j.transproceed.2004.12.112; Hamacher-Brady A, 2006, CARDIOVASC DRUG THER, V20, P445, DOI 10.1007/s10557-006-0583-7; Ibrahim MA, 2014, EUR J PHARMACOL, V741, P64, DOI 10.1016/j.ejphar.2014.07.047; Jaeschke H, 2000, J GASTROEN HEPATOL, V15, P718, DOI 10.1046/j.1440-1746.2000.02207.x; Kim JS, 2004, HEPATOLOGY, V39, P1533, DOI 10.1002/hep.20197; Lee HS, 2014, MOLECULES, V19, P8189, DOI 10.3390/molecules19068189; Lenz K, 2014, MED KLIN-INTENSIVMED, V109, P267, DOI 10.1007/s00063-013-0326-z; Lepran I, 2006, J CARDIOVASC PHARM, V48, P148, DOI 10.1097/01.fjc.0000246151.39758.2a; Levijoki J, 2001, EUR J PHARMACOL, V419, P243, DOI 10.1016/S0014-2999(01)00997-9; Levine B, 2009, CELL DEATH DIFFER, V16, P1, DOI 10.1038/cdd.2008.139; Liaudet L, 2000, CRIT CARE MED, V28, pN37, DOI 10.1097/00003246-200004001-00005; Mallat A, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/869390; MARRA F, 1995, FEBS LETT, V376, P141, DOI 10.1016/0014-5793(95)01261-0; Marra F, 2008, TRENDS MOL MED, V14, P72, DOI 10.1016/j.molmed.2007.12.003; Maruyama R, 2008, AM J PHYSIOL-HEART C, V295, pH1599, DOI 10.1152/ajpheart.91449.2007; Memis D, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.008; Onody P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073758; Papp Z, 2012, INT J CARDIOL, V159, P82, DOI 10.1016/j.ijcard.2011.07.022; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Perrelli MG, 2011, WORLD J CARDIOL, V3, P186, DOI 10.4330/wjc.v3.i6.186; Raza H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036325; Razavi HM, 2005, PHARMACOL THERAPEUT, V106, P147, DOI 10.1016/j.pharmthera.2004.11.006; Sack MN, 2006, CARDIOVASC RES, V72, P210, DOI 10.1016/j.cardiores.2006.07.010; Shiva S, 2007, J EXP MED, V204, P2089, DOI 10.1084/jem.20070198; Shulman Maria, 2013, Methods Mol Biol, V945, P287, DOI 10.1007/978-1-62703-125-7_17; Svegliati-Baroni G, 2001, LIVER, V21, P1, DOI 10.1034/j.1600-0676.2001.210101.x; Thirunavukkarasu C, 2006, HEPATOLOGY, V44, P389, DOI 10.1002/hep.21254; Uberti F, 2011, J CARDIOVASC PHARM, V57, P246, DOI 10.1097/FJC.0b013e318204bb55; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076538; Wu DF, 2009, SEMIN LIVER DIS, V29, P141, DOI 10.1055/s-0029-1214370; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Zeng Z, 2012, WORLD J GASTROENTERO, V18, P1765, DOI 10.3748/wjg.v18.i15.1765; Zhang X, 2013, FREE RADICAL BIO MED, V63, P243, DOI 10.1016/j.freeradbiomed.2013.05.004	52	26	27	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124742	10.1371/journal.pone.0124742	http://dx.doi.org/10.1371/journal.pone.0124742			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880552	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500110
J	Kao, CF; Liu, JR; Hung, H; Kuo, PH				Kao, Chung-Feng; Liu, Jia-Rou; Hung, Hung; Kuo, Po-Hsiu			A Robust GWSS Method to Simultaneously Detect Rare and Common Variants for Complex Disease	PLOS ONE			English	Article							ASSOCIATION ANALYSIS; TESTS; GENES; RISK	The rapid advances in sequencing technologies and the resulting next-generation sequencing data provide the opportunity to detect disease-associated variants with a better solution, in particular for low-frequency variants. Although both common and rare variants might exert their independent effects on the risk for the trait of interest, previous methods to detect the association effects rarely consider them simultaneously. We proposed a class of test statistics, the generalized weighted-sum statistic (GWSS), to detect disease associations in the presence of common and rare variants with a case-control study design. Information of rare variants was aggregated using a weighted sum method, while signal directions and strength of the variants were considered at the same time. Permutations were performed to obtain the empirical p-values of the test statistics. Our simulation showed that, compared to the existing methods, the GWSS method had better performance in most of the scenarios. The GWSS (in particular VDWSS-t) method is particularly robust for opposite association directions, association strength, and varying distributions of minor-allele frequencies. It is therefore promising for detecting disease-associated loci. For empirical data application, we also applied our GWSS method to the Genetic Analysis Workshop 17 data, and the results were consistent with the simulation, suggesting good performance of our method. As re-sequencing studies become more popular to identify putative disease loci, we recommend the use of this newly developed GWSS to detect associations with both common and rare variants.	[Kao, Chung-Feng; Liu, Jia-Rou; Hung, Hung; Kuo, Po-Hsiu] Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei 10764, Taiwan; [Liu, Jia-Rou] Chang Gung Univ, Dept Publ Hlth, Taoyuan, Taiwan; [Hung, Hung; Kuo, Po-Hsiu] Natl Taiwan Univ, Res Ctr Genes Environm & Human Hlth, Taipei 10764, Taiwan	National Taiwan University; Chang Gung University; National Taiwan University	Hung, H (corresponding author), Natl Taiwan Univ, Inst Epidemiol & Prevent Med, Dept Publ Hlth, Taipei 10764, Taiwan.	hhung@ntu.edu.tw; phkuo@ntu.edu.tw		Kuo, Po-Hsiu/0000-0003-0365-3587; HUNG, HUNG/0000-0003-4022-2081	National Science Council [NSC 99-2314-B-002-140-MY3, 102-2628-M-002-005-MY2]; National Health Research Institute [NHRI-EX102-9918NC]; GAW grant [R01 GM031575]; NIH [R01 MH059490]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031575] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059490] Funding Source: NIH RePORTER	National Science Council(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan); GAW grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was supported by National Science Council (NSC 99-2314-B-002-140-MY3 and 102-2628-M-002-005-MY2) and National Health Research Institute (NHRI-EX102-9918NC) grants to Dr. P-H Kuo (PI). The authors would also like to acknowledge the GAW grant, R01 GM031575. Preparation of the Genetic Analysis Workshop 17 Simulated Exome Data Set was supported in part by NIH R01 MH059490 and used sequencing data from the 1000 Genomes Project (www.1000genomes.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahituv N, 2007, AM J HUM GENET, V80, P779, DOI 10.1086/513471; Asimit J, 2010, ANNU REV GENET, V44, P293, DOI 10.1146/annurev-genet-102209-163421; Azzopardi D, 2008, CANCER RES, V68, P358, DOI 10.1158/0008-5472.CAN-07-5733; Basu S, 2011, GENET EPIDEMIOL, V35, P606, DOI 10.1002/gepi.20609; Brisbin Abra, 2012, Frontiers in Genetics, V3, P173, DOI 10.3389/fgene.2012.00173; Chang HW, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-26; Evans D, 2011, EXPERT REV CARDIOVAS, V9, P637, DOI [10.1586/ERC.11.53, 10.1586/erc.11.53]; Feng T, 2011, GENET EPIDEMIOL, V35, P398, DOI 10.1002/gepi.20588; Han F, 2010, HUM HERED, V70, P42, DOI 10.1159/000288704; Ionita-Laza I, 2013, AM J HUM GENET, V92, P841, DOI 10.1016/j.ajhg.2013.04.015; Ionita-Laza I, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001289; Lee S, 2012, AM J HUM GENET, V91, P224, DOI 10.1016/j.ajhg.2012.06.007; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Liu DJJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001156; Liu DW, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-292; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Morgenthaler S, 2007, MUTAT RES-FUND MOL M, V615, P28, DOI 10.1016/j.mrfmmm.2006.09.003; Neale BM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001322; Nejentsev S, 2009, SCIENCE, V324, P387, DOI 10.1126/science.1167728; Pan W, 2011, GENET EPIDEMIOL, V35, P381, DOI 10.1002/gepi.20586; Pan W, 2009, GENET EPIDEMIOL, V33, P497, DOI 10.1002/gepi.20402; Price AL, 2010, AM J HUM GENET, V86, P832, DOI 10.1016/j.ajhg.2010.04.005; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Su GS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045293; Visscher PM, 2012, MOL PSYCHIATR, V17, P474, DOI 10.1038/mp.2011.65; Walsh T, 2008, SCIENCE, V320, P539, DOI 10.1126/science.1155174; Wang K, 2010, AM J HUM GENET, V86, P730, DOI 10.1016/j.ajhg.2010.04.003; Wessel J, 2010, NEUROPSYCHOPHARMACOL, V35, P2392, DOI 10.1038/npp.2010.120; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang L, 2012, ANN HUM GENET, V76, P74, DOI 10.1111/j.1469-1809.2011.00684.x	32	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120873	10.1371/journal.pone.0120873	http://dx.doi.org/10.1371/journal.pone.0120873			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880329	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500008
J	Liu, Q; Chen, Y; Chen, Y; Wang, YY; Chen, JJ; Zhang, TZ; Zhou, BL				Liu, Quan; Chen, Yu; Chen, Yu; Wang, Yingying; Chen, Jinjin; Zhang, Tianzhen; Zhou, Baoliang			A New Synthetic Allotetraploid (A(1)A(1)G(2)G(2)) between Gossypium herbaceum and G-australe: Bridging for Simultaneously Transferring Favorable Genes from These Two Diploid Species into Upland Cotton	PLOS ONE			English	Article							HIRSUTUM L.; ADDITION LINES; LINKAGE MAP; CHROMOSOME; DIVERSITY; GERMPLASM; INTROGRESSION; EXPRESSION; EVOLUTION; STERILITY	Gossypium herbaceum, a cultivated diploid cotton species (2n = 2x = 26, A(1)A(1)), has favorable traits such as excellent drought tolerance and resistance to sucking insects and leaf curl virus. G. australe, a wild diploid cotton species (2n = 2x = 26, G(2)G(2)), possesses numerous economically valuable characteristics such as delayed pigment gland morphogenesis (which is conducive to the production of seeds with very low levels of gossypol as a potential food source for humans and animals) and resistance to insects, wilt diseases and abiotic stress. Creating synthetic allotetraploid cotton from these two species would lay the foundation for simultaneously transferring favorable genes into cultivated tetraploid cotton. Here, we crossed G. herbaceum (as the maternal parent) with G. australe to produce an F-1 interspecific hybrid and doubled its chromosome complement with colchicine, successfully generating a synthetic tetraploid. The obtained tetraploid was confirmed by morphology, cytology and molecular markers and then self-pollinated. The S-1 seedlings derived from this tetraploid gradually became flavescent after emergence of the fifth true leaf, but they were rescued by grafting and produced S-2 seeds. The rescued S-1 plants were partially fertile due to the existence of univalents at Metaphase I of meiosis, leading to the formation of unbalanced, nonviable gametes lacking complete sets of chromosomes. The S-2 plants grew well and no flavescence was observed, implying that interspecific incompatibility, to some extent, had been alleviated in the S-2 generation. The synthetic allotetraploid will be quite useful for polyploidy evolutionary studies and as a bridge for transferring favorable genes from these two diploid species into Upland cotton through hybridization.	[Liu, Quan; Chen, Yu; Chen, Yu; Wang, Yingying; Chen, Jinjin; Zhang, Tianzhen; Zhou, Baoliang] Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, MOE, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University	Liu, Q (corresponding author), Nanjing Agr Univ, State Key Lab Crop Genet & Germplasm Enhancement, MOE, Hybrid Cotton R&D Engn Res Ctr, Nanjing, Jiangsu, Peoples R China.	baoliangzhou@njau.edu.cn			National Natural Science Foundation of China [30571184, 31271771]; National Key Technology Support Program of China during the twelfth Five-year Plan Period [2013BAD01B03-04]; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [CX (14) 2065]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Modern Crop Production of Collaborative Innovation in Jiangsu Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program of China during the twelfth Five-year Plan Period; Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China; Priority Academic Program Development of Jiangsu Higher Education Institutions; Modern Crop Production of Collaborative Innovation in Jiangsu Province	BZ: This program was financially supported in part by the National Natural Science Foundation of China [grant numbers 30571184 and 31271771] (http://www.nsfc.gov.cn/), National Key Technology Support Program of China during the twelfth Five-year Plan Period [grant number 2013BAD01B03-04] (http://www.moa.gov.cn/), the Independent Innovation Funds for Agricultural Technology of Jiangsu Province, China [grant number CX (14) 2065], the Priority Academic Program Development of Jiangsu Higher Education Institutions, and Modern Crop Production of Collaborative Innovation in Jiangsu Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KL, 2004, BIOL J LINN SOC, V82, P573, DOI 10.1111/j.1095-8312.2004.00342.x; Ahoton L, 2003, CROP SCI, V43, P1999, DOI 10.2135/cropsci2003.1999; ALTMAN DW, 1987, CROP SCI, V27, P880, DOI 10.2135/cropsci1987.0011183X002700050008x; Azhar MT, 2013, J ANIM PLANT SCI, V23, P1436; Beasley JO, 1940, AM NAT, V74, P285, DOI 10.1086/280895; Bi IV, 1999, THEOR APPL GENET, V99, P1233; Bi IV, 1999, EUPHYTICA, V106, P243, DOI 10.1023/A:1003539924238; Brubaker CL, 1999, EUPHYTICA, V108, P199, DOI 10.1023/A:1003641217653; Campbell BT, 2010, CROP SCI, V50, P1161, DOI 10.2135/cropsci2009.09.0551; Campbell BT, 2009, EUPHYTICA, V169, P285, DOI 10.1007/s10681-009-9917-4; Chen Y, 2014, THEOR APPL GENET, V127, P1105, DOI 10.1007/s00122-014-2283-1; CULP TW, 1973, CROP SCI, V13, P686, DOI 10.2135/cropsci1973.0011183X001300060030x; DILDAY RH, 1986, CROP SCI, V26, P639, DOI 10.2135/cropsci1986.0011183X002600030046x; Endrizzi J. E., 1985, Advances in Genetics, V23, P271, DOI 10.1016/S0065-2660(08)60515-5; Fang DD, 2013, EUPHYTICA, V191, P391, DOI 10.1007/s10681-013-0886-2; Flagel LE, 2009, J HERED, V100, P487, DOI 10.1093/jhered/esp003; Forrester NW, 1995, CHALLENGING FUTURE, P313; Fryxell P.A., 1992, RHEEDEA, V2, P108; Gingle AR, 2006, CROP SCI, V46, P1998, DOI 10.2135/cropsci2005.09.0328; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Gutierrez OA, 2002, CROP SCI, V42, P1841, DOI 10.2135/cropsci2002.1841; He J, 1993, ACTA GENET SINICA, V21, P52; Hu GJ, 2010, GENOME, V53, P599, DOI [10.1139/g10-038, 10.1139/G10-038]; HUTCHINSON JB, 1947, EVOLUTION GOSSYPIUM; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Jena SN, 2012, THEOR APPL GENET, V124, P565, DOI 10.1007/s00122-011-1729-y; Konan ON, 2007, PLANT BREEDING, V126, P176, DOI 10.1111/j.1439-0523.2007.01325.x; Kulkarni Venkatesh N., 2009, V3, P69, DOI 10.1007/978-0-387-70810-2_4; Li B. L., 1987, Acta Genetica Sinica, V14, P121; Mergeai G., 1997, BASE: Biotechnologie, Agronomie, Societe et Environnement, V1, P272; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; OAKES AJ, 1966, CAN J GENET CYTOL, V8, P830, DOI 10.1139/g66-099; OAKES AJ, 1966, CAN J GENET CYTOL, V8, P818, DOI 10.1139/g66-098; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Peng S, 2000, SEED, V109, P65; PRENTICE AN, 1972, COTTON SPECIAL REFER; Qian SY, 1992, SCI AGR SINICA, V25, P44, DOI [DOI 10.1093/GENETICS/51.5.689, 10.1093/genetics/51.5.689]; Ram SG, 2008, PLANT BREEDING, V127, P295, DOI 10.1111/j.1439-0523.2007.01453.x; Renny-Byfield S, 2014, GENOME BIOL EVOL, V6, P559, DOI 10.1093/gbe/evu037; Romano GB, 2009, THEOR APPL GENET, V120, P139, DOI 10.1007/s00122-009-1165-4; ROONEY WL, 1991, J HERED, V82, P151, DOI 10.1093/oxfordjournals.jhered.a111050; ROONEY WL, 1991, CROP SCI, V31, P337, DOI 10.2135/cropsci1991.0011183X003100020024x; Sacks EJ, 2008, PLANT CELL TISS ORG, V93, P15, DOI 10.1007/s11240-007-9316-2; Sacks EJ, 2009, FIELD CROP RES, V112, P1, DOI 10.1016/j.fcr.2009.01.006; Sarr D, 2011, PLANT BREEDING, V130, P60, DOI 10.1111/j.1439-0523.2010.01819.x; Tyagi P, 2014, THEOR APPL GENET, V127, P283, DOI 10.1007/s00122-013-2217-3; Van Becelaere G, 2005, CROP SCI, V45, P2281, DOI 10.2135/cropsci2004.0715; VROH BI, 1998, PLANT BREEDING, V117, P235; Wang K, 2006, THEOR APPL GENET, V113, P73, DOI 10.1007/s00122-006-0273-7; WENDEL JF, 1992, AM J BOT, V79, P1291, DOI 10.2307/2445058; ZHANG BJ, 1994, CHINESE SCI BULL, V39, P1567; Zhang J, 2002, THEOR APPL GENET, V105, P1166, DOI 10.1007/s00122-002-1100-4; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; Zhu SJ, 2004, CHINESE SCI BULL, V49, P2470, DOI 10.1360/982004-255	54	10	12	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123209	10.1371/journal.pone.0123209	http://dx.doi.org/10.1371/journal.pone.0123209			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879660	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500042
J	McNamara, HC; Wood, R; Chalmers, J; Marlow, N; Norrie, J; MacLennan, G; McPherson, G; Boachie, C; Norman, JE				McNamara, Helen Christine; Wood, Rachael; Chalmers, James; Marlow, Neil; Norrie, John; MacLennan, Graeme; McPherson, Gladys; Boachie, Charles; Norman, Jane Elizabeth			STOPPIT Baby Follow-Up Study: The Effect of Prophylactic Progesterone in Twin Pregnancy on Childhood Outcome	PLOS ONE			English	Article							PRETERM BIRTH; DOUBLE-BLIND; 17-ALPHA-HYDROXYPROGESTERONE CAPROATE; VAGINAL PROGESTERONE; PREVENTION; WOMEN; MULTICENTER; RISK; DELIVERY; TRIAL	Objectives To determine the long-term effects of in utero progesterone exposure in twin children. Methods This study evaluated the health and developmental outcomes of all surviving children born to mothers who participated in a double-blind, placebo-controlled trial of progesterone given for the prevention of preterm birth in twin pregnancies (STOPPIT, ISRCTN35782581). Followup was performed via record linkage and two parent-completed validated questionnaires, the Child Development Inventory and the Health Utilities Index. Results Record linkage was successfully performed on at least one record in 759/781 (97%) children eligible for follow-up. There were no differences between progesterone-exposed and placebo-exposed twins with respect to incidence of death, congenital anomalies and hospitalisation, nor on routine national child health assessments. Questionnaire responses were received for 324/738 (44%) children. The mean age at questionnaire follow-up was 55.5 months. Delay in at least one developmental domain on the Child Development Inventory was observed in 107/324 (33%) children, with no evidence of difference between progesterone-exposed and placebo-exposed twins. There was no evidence of difference between the progesterone and placebo groups in global health status assessed using the Health Utilities Index: 89% of children were rated as having 'excellent' health and a further 8% as having 'very good' health. Conclusions In this cohort of twin children there was no evidence of a detrimental or beneficial impact on health and developmental outcomes at three to six years of age due to in utero exposure to progesterone.	[McNamara, Helen Christine] Monash Univ, Melbourne, Vic 3004, Australia; [Wood, Rachael; Chalmers, James] NHS Natl Serv Scotland, Informat Serv Div, Edinburgh, Midlothian, Scotland; [Marlow, Neil] UCL, Inst Womens Hlth, Dept Neonatal Med, London, England; [Norrie, John; MacLennan, Graeme; McPherson, Gladys] Univ Aberdeen, Ctr Healthcare Randomised Trials CHaRT, Hlth Serv Res Unit, Aberdeen, Scotland; [Boachie, Charles] Univ Glasgow, Robertson Ctr Biostat, Glasgow, Lanark, Scotland; [Norman, Jane Elizabeth] Univ Edinburgh, Tommys Ctr Maternal & Fetal Hlth, Ctr Reprod Hlth, Queens Med Res Inst,MRC, Edinburgh, Midlothian, Scotland	Monash University; NHS National Services Scotland; University of London; University College London; University of Aberdeen; University of Glasgow; University of Edinburgh	McNamara, HC (corresponding author), Monash Univ, Melbourne, Vic 3004, Australia.	helenmcnamara1@gmail.com	Marlow, Neil/D-2918-2009	Marlow, Neil/0000-0001-5890-2953; MacLennan, Graeme/0000-0002-1039-5646; Wood, Rachael/0000-0003-4453-623X	Chief Scientist Office, Scotland [CZH/2/575]; charity, Tommy's; Chief Scientist Office [CZG/2/575, HSRU1] Funding Source: researchfish	Chief Scientist Office, Scotland; charity, Tommy's; Chief Scientist Office	This study was funded by the Chief Scientist Office, Scotland (grant number CZH/2/575) and the charity, Tommy's. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carmichael SL, 2005, ARCH PEDIAT ADOL MED, V159, P957, DOI 10.1001/archpedi.159.10.957; Claas MJ, 2011, EARLY HUM DEV, V87, P183, DOI 10.1016/j.earlhumdev.2010.12.002; Combs CA, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.12.042; da Fonseca EB, 2003, AM J OBSTET GYNECOL, V188, P419, DOI 10.1067/mob.2003.41; Dall'Oglio AM, 2010, DEV MED CHILD NEUROL, V52, P955, DOI 10.1111/j.1469-8749.2010.03730.x; Dodd JM, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004947.pub2; Dodd JM, 2008, OBSTET GYNECOL, V112, P127, DOI 10.1097/AOG.0b013e31817d0262; Fonseca EB, 2007, NEW ENGL J MED, V357, P462, DOI 10.1056/NEJMoa067815; FREEMAN JV, 1995, ARCH DIS CHILD, V73, P17, DOI 10.1136/adc.73.1.17; Furlong WJ, 2001, ANN MED, V33, P375, DOI 10.3109/07853890109002092; Hassan SS, 2011, ULTRASOUND OBST GYN, V38, P18, DOI 10.1002/uog.9017; Hemminki E, 1999, BRIT J CANCER, V80, P1092, DOI 10.1038/sj.bjc.6690469; iGrow, 2011, LMS GROWTH MICR EXC; Ireton H., 2005, CHILD DEV INVENTORY; Kenyon S, 2008, LANCET, V372, P1310, DOI 10.1016/S0140-6736(08)61202-7; Meis PJ, 2003, NEW ENGL J MED, V348, P2379, DOI 10.1056/NEJMoa035140; Ness A, 2006, AM J OBSTET GYNECOL, V195, P1174, DOI 10.1016/j.ajog.2006.06.034; Nicol MB, 1999, NEUROPHARMACOLOGY, V38, P49, DOI 10.1016/S0028-3908(98)00166-X; Norman JE, 2009, LANCET, V373, P2034, DOI 10.1016/S0140-6736(09)60947-8; Northen AT, 2007, OBSTET GYNECOL, V110, P865, DOI 10.1097/01.AOG.0000281348.51499.bc; Rode L, 2011, ULTRASOUND OBST GYN, V38, P272, DOI 10.1002/uog.9093; Romero R, 2012, AM J OBSTET GYNECOL, V206, DOI 10.1016/j.ajog.2011.12.003; Rouse DJ, 2007, NEW ENGL J MED, V357, P454, DOI 10.1056/NEJMoa070641; Serra V, 2013, BJOG-INT J OBSTET GY, V120, P50, DOI 10.1111/j.1471-0528.2012.03448.x; U. S. Food and Drug Administration, 2011, FDA APPR DRUG RED RI; Wood S, 2012, J PERINAT MED, V40, P593, DOI 10.1515/jpm-2012-0057; World Health Organization, 2009, INT STAT CLASS DIS H; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887	28	27	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122341	10.1371/journal.pone.0122341	http://dx.doi.org/10.1371/journal.pone.0122341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881289	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000353016500018
J	Rokem, A; Yeatman, JD; Pestilli, F; Kay, KN; Mezer, A; van der Walt, S; Wandell, BA				Rokem, Ariel; Yeatman, Jason D.; Pestilli, Franco; Kay, Kendrick N.; Mezer, Aviv; van der Walt, Stefan; Wandell, Brian A.			Evaluating the Accuracy of Diffusion MRI Models in White Matter	PLOS ONE			English	Article							FIBER ORIENTATION; TENSOR; BRAIN; UNCERTAINTY; BALL; DECONVOLUTION; TRACTOGRAPHY; VALIDATION; REGRESSION; ANISOTROPY	Models of diffusion MRI within a voxel are useful for making inferences about the properties of the tissue and inferring fiber orientation distribution used by tractography algorithms. A useful model must fit the data accurately. However, evaluations of model-accuracy of commonly used models have not been published before. Here, we evaluate model-accuracy of the two main classes of diffusion MRI models. The diffusion tensor model (DTM) summarizes diffusion as a 3-dimensional Gaussian distribution. Sparse fascicle models (SFM) summarize the signal as a sum of signals originating from a collection of fascicles oriented in different directions. We use cross-validation to assess model- accuracy at different gradient amplitudes (b-values) throughout the white matter. Specifically, we fit each model to all the white matter voxels in one data set and then use the model to predict a second, independent data set. This is the first evaluation of model- accuracy of these models. In most of the white matter the DTM predicts the data more accurately than test-retest reliability; SFM model- accuracy is higher than test-retest reliability and also higher than the DTM model- accuracy, particularly for measurements with (a) a b-value above 1000 in locations containing fiber crossings, and (b) in the regions of the brain surrounding the optic radiations. The SFM also has better parameter-validity: it more accurately estimates the fiber orientation distribution function (fODF) in each voxel, which is useful for fiber tracking.	[Rokem, Ariel; Yeatman, Jason D.; Pestilli, Franco; Kay, Kendrick N.; Mezer, Aviv; Wandell, Brian A.] Stanford, Dept Psychol, Stanford, CA USA; [Yeatman, Jason D.] Univ Washington, Inst Learning & Brain Sci, Seattle, WA 98195 USA; [Pestilli, Franco] Indiana Univ, Dept Psychol & Brain Sci, Program Neurosci, Bloomington, IN USA; [Kay, Kendrick N.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Mezer, Aviv] Hebrew Univ Jerusalem, Edmond & Lily Safra Ctr Brain Sci, Jerusalem, Israel; [van der Walt, Stefan] Univ Stellenbosch, Div Appl Math, ZA-7600 Stellenbosch, South Africa	Stanford University; University of Washington; University of Washington Seattle; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Hebrew University of Jerusalem; Stellenbosch University	Rokem, A (corresponding author), Stanford, Dept Psychol, Stanford, CA USA.	arokem@gmail.com	Kay, Kendrick/A-4344-2009	Kay, Kendrick/0000-0001-6604-9155; Pestilli, Franco/0000-0002-2469-0494; Yeatman, Jason/0000-0002-2686-1293; Mezer, Aviv/0000-0002-1916-1854	National Research Service award (National Eye Institute) [F32 EY022294]; National Science Foundation [BCS-1228397]; National Institutes of Health [EY-15000]; NATIONAL EYE INSTITUTE [F32EY022294, R01EY015000] Funding Source: NIH RePORTER; Direct For Social, Behav & Economic Scie [1228397] Funding Source: National Science Foundation	National Research Service award (National Eye Institute); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))	Grant support was provided through a National Research Service award to AR (National Eye Institute F32 EY022294) and grants from the National Science Foundation (BCS-1228397) and National Institutes of Health (EY-15000) to BW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aganj I, 2010, MAGN RESON MED, V64, P554, DOI 10.1002/mrm.22365; Alexander DC, 2002, MAGN RESON MED, V48, P331, DOI 10.1002/mrm.10209; Assaf Y, 2004, MAGN RESON MED, V52, P965, DOI 10.1002/mrm.20274; Assaf Y, 2008, MAGN RESON MED, V59, P1347, DOI 10.1002/mrm.21577; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Chung SW, 2006, NEUROIMAGE, V33, P531, DOI 10.1016/j.neuroimage.2006.07.001; Cote M.A, 2013, MED IMAGE ANAL; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Dell'acqua F, 2012, HUM BRAIN MAPP; Dell'Acqua F, 2007, IEEE T BIO-MED ENG, V54, P462, DOI 10.1109/TBME.2006.888830; Descoteaux M, 2007, MAGN RESON MED, V58, P497, DOI 10.1002/mrm.21277; Donoho DL, 2010, BIOSTATISTICS, V11, P385, DOI 10.1093/biostatistics/kxq028; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Dougherty RF, 2007, P NATL ACAD SCI USA, V104, P8556, DOI 10.1073/pnas.0608961104; Ekanadham C, 2011, IEEE T SIGNAL PROCES, V59, P4735, DOI 10.1109/TSP.2011.2160058; Frank LR, 2002, MAGN RESON MED, V47, P1083, DOI 10.1002/mrm.10156; Frank LR, 2001, MAGN RESON MED, V45, P935, DOI 10.1002/mrm.1125; Garyfallidis E, 2014, FRONT NEUROINFORM, V8, DOI 10.3389/fninf.2014.00008; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Hastie T, 2009, ELEMENTS STAT LEARNI, DOI [10.1016/j.neunet.2009.04.005, DOI 10.1016/J.NEUNET.2009.04.005]; Hoerl AE, 2000, TECHNOMETRICS, V42, P80, DOI 10.2307/1271436; Jeurissen B, 2012, HUM BRAIN MAPP; Jezzard P, 1995, MAGN RESON MED; Jones Derek K, 2010, Top Magn Reson Imaging, V21, P87, DOI 10.1097/RMR.0b013e31821e56ac; Jones DK, 2010, NMR BIOMED, V23, P803, DOI 10.1002/nbm.1543; Jones DK, 2004, MAGNET RESON MED, V51, P807, DOI 10.1002/mrm.20033; Jones DK, 2003, MAGN RESON MED, V49, P7, DOI 10.1002/mrm.10331; Koay CG, 2006, J MAGN RESON, V182, P115, DOI 10.1016/j.jmr.2006.06.020; Maas L. C., 2005, APPL RADIOL, V34, P44; Mattiello J, 1997, MAGNET RESON MED, V37, P292, DOI 10.1002/mrm.1910370226; Moody JE, 1992, ADV NEURAL INF PROCE; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Panagiotaki E, 2012, NEUROIMAGE, V59, P2241, DOI 10.1016/j.neuroimage.2011.09.081; Parker GD, 2013, NEUROIMAGE, V65, P433, DOI 10.1016/j.neuroimage.2012.10.022; Peled S, 2006, MAGN RESON IMAGING, V24, P1263, DOI 10.1016/j.mri.2006.07.009; Pestilli F, 2014, NAT METHODS, P1; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Sherbondy AJ, 2010, LECT NOTES COMPUT SC, V6361, P183; Sotiropoulos SN, 2012, NEUROIMAGE, V60, P1412, DOI 10.1016/j.neuroimage.2012.01.056; STEJSKAL EO, 1965, J CHEM PHYS, V42, P288, DOI 10.1063/1.1695690; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; STONE M, 1977, J R STAT SOC B, V39, P44, DOI 10.1111/j.2517-6161.1977.tb01603.x; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Tournier JD, 2008, NEUROIMAGE, V42, P617, DOI 10.1016/j.neuroimage.2008.05.002; Tournier JD, 2007, NEUROIMAGE, V35, P1459, DOI 10.1016/j.neuroimage.2007.02.016; Tournier JD, 2012, INT J IMAG SYST TECH, V22, P53, DOI 10.1002/ima.22005; Tournier JD, 2004, NEUROIMAGE, V23, P1176, DOI 10.1016/j.neuroimage.2004.07.037; Tuch DS, 2002, MAGNET RESON MED, V48, P577, DOI 10.1002/mrm.10268; Tuch DS, 2003, NEURON, V40, P885, DOI 10.1016/S0896-6273(03)00758-X; Van Anh T, 2010, Top Magn Reson Imaging, V21, P339, DOI 10.1097/RMR.0b013e31823e6303; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Whitcher B, 2008, HUM BRAIN MAPP, V29, P346, DOI 10.1002/hbm.20395; Yeatman JD, 2012, P NATL ACAD SCI USA, V109, pE3045, DOI 10.1073/pnas.1206792109; Yeatman JD, 2011, J COGNITIVE NEUROSCI, V23, P3304, DOI 10.1162/jocn_a_00061; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	60	42	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123272	10.1371/journal.pone.0123272	http://dx.doi.org/10.1371/journal.pone.0123272			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879933	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500045
J	Teixeira-Carvalho, A; Campos, FMF; Geiger, SM; Rocha, RDR; de Araujo, FF; Vitelli-Avelar, DM; Andrade, MC; Araujo, MSS; Lemos, EM; Proietti, ABDC; Sabino, EC; Caldas, RG; Freitas, CRC; Campi-Azevedo, AC; Eloi-Santos, SM; Martins, OA				Teixeira-Carvalho, Andrea; Freire Campos, Fernanda Magalhaes; Geiger, Stefan Michael; Rodrigues Rocha, Roberta Dias; de Araujo, Fernanda Fortes; Vitelli-Avelar, Danielle Marquete; Andrade, Marileia Chaves; Silva Araujo, Marcio Sobreira; Lemos, Elenice Moreira; de Freitas Carneiro Proietti, Anna Barbara; Sabino, Ester Cerdeira; Caldas, Rafaella Gaiotti; Camargos Freitas, Carolina Renata; Campi-Azevedo, Ana Carolina; Eloi-Santos, Silvana Maria; Martins-Filho, Olindo Assis			FC-TRIPLEX Chagas/Leish IgG1: A Multiplexed Flow Cytometry Method for Differential Serological Diagnosis of Chagas Disease and Leishmaniasis	PLOS ONE			English	Article							AMERICAN VISCERAL LEISHMANIASIS; POSTTHERAPEUTIC CURE ASSESSMENT; CRUZI IMMUNOGLOBULIN-G; TRYPANOSOMA-CRUZI; BLOOD-DONORS; CHEMOTHERAPEUTIC TREATMENT; SOUTHERN BRAZIL; ANTIBODIES; DEFINITION; PROGNOSIS	Differential serological diagnosis of Chagas disease and leishmaniasis is difficult owing to cross-reactivity resulting from the fact that the parasites that cause these pathologies share antigenic epitopes. Even with optimized serological assays that use parasite-specific recombinant antigens, inconclusive test results continue to be a problem. Therefore, new serological tests with high sensitivity and specificity are needed. In the present work, we developed and evaluated the performance of a new flow cytometric serological method, referred to as FC-TRIPLEX Chagas/Leish IgG1, for the all-in-one classification of inconclusive tests. The method uses antigens for the detection of visceral leishmaniasis, localized cutaneous leishmaniasis, and Chagas disease and is based on an inverted detuned algorithm for analysis of anti-Trypanosomatidae IgG1 reactivity. First, parasites were label with fluorescein isothiocyanate or Alexa Fluor 647 at various concentrations. Then serum samples were serially diluted, the dilutions were incubated with suspensions of mixed labeled parasites, and flow cytometric measurements were performed to determine percentages of positive fluorescent parasites. Using the new method, we obtained correct results for 76 of 80 analyzed serum samples (95% overall performance), underscoring the outstanding performance of the method. Moreover, we found that the fluorescently labeled parasite suspensions were stable during storage at room temperature, 4 degrees C, and -20 degrees C for 1 year. In addition, two different lots of parasite suspensions showed equivalent antigen recognition; that is, the two lots showed equivalent categorical segregation of anti-Trypanosomatidae IgG1 reactivity at selected serum dilutions. In conclusion, we have developed a sensitive and selective method for differential diagnosis of Chagas disease, visceral leishmaniasis, and localized cutaneous leishmaniasis.	[Teixeira-Carvalho, Andrea; Freire Campos, Fernanda Magalhaes; Rodrigues Rocha, Roberta Dias; de Araujo, Fernanda Fortes; Vitelli-Avelar, Danielle Marquete; Silva Araujo, Marcio Sobreira; Caldas, Rafaella Gaiotti; Camargos Freitas, Carolina Renata; Campi-Azevedo, Ana Carolina; Martins-Filho, Olindo Assis] Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil; [Geiger, Stefan Michael] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Lab Helmintoses Intestinais, Belo Horizonte, MG, Brazil; [Andrade, Marileia Chaves] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Dept Fisiopatol, Montes Claros, Brazil; [Lemos, Elenice Moreira] Univ Fed Espirito Santo, Ctr Biomed, Nucleo Doencas Infecciosas, Vitoria, Brazil; [de Freitas Carneiro Proietti, Anna Barbara] Fundacao Ctr Hematol & Hemoterapia Minas Gerais H, Serv Pesquisa, Belo Horizonte, MG, Brazil; [Sabino, Ester Cerdeira] Univ Sao Paulo, Inst Med Trop, Dept Doencas Infecciosas, Sao Paulo, Brazil; [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Fac Med, Dept Posgrad Patol Geral, Belo Horizonte, MG, Brazil; [Eloi-Santos, Silvana Maria] Univ Fed Minas Gerais, Fac Med, Dept Propedeut Complementar, Belo Horizonte, MG, Brazil	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros; Universidade Federal do Espirito Santo; Universidade de Sao Paulo; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Teixeira-Carvalho, A (corresponding author), Fundacao Oswaldo Cruz, Ctr Pesquisas Rene Rachou, Lab Biomarcadores Diagnost & Monitoracao, Belo Horizonte, MG, Brazil.	andreat@cpqrr.fiocruz.br	Martins-Filho, Olindo Assis/ABE-6278-2021; Sabino, Ester C/F-7750-2010; Geiger, Stefan M/E-6748-2016; Araujo, Marcio Sobreira Silva/ABE-7105-2021; Campi-Azevedo, Ana Carolina/ABE-8321-2021; Andrade, Marileia/GOE-5633-2022; Campos, Fernanda/GRR-6776-2022	Martins-Filho, Olindo Assis/0000-0002-5494-4889; Sabino, Ester C/0000-0003-2623-5126; Araujo, Marcio Sobreira Silva/0000-0002-7532-3360; Campi-Azevedo, Ana Carolina/0000-0001-6306-3605; Geiger, Stefan/0000-0002-9741-2727	CPqRR/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Encouraging Inovation Program-Minas Gerais Government (Inventiva Project/FAPEMIG); Programa Ciencias Sem Fronteiras-Atracao de Jovens Talentos-BJT (MEC/MCTI/CAPES/CNPq/FAPs); CNPq	CPqRR/Fundacao Oswaldo Cruz (FIOCRUZ); Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Encouraging Inovation Program-Minas Gerais Government (Inventiva Project/FAPEMIG); Programa Ciencias Sem Fronteiras-Atracao de Jovens Talentos-BJT (MEC/MCTI/CAPES/CNPq/FAPs); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the grants of the CPqRR/Fundacao Oswaldo Cruz (FIOCRUZ), Fundacao de Amparo a Pesquisa de Minas Gerais (FAPEMIG), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), and Encouraging Inovation Program-Minas Gerais Government (Inventiva Project/FAPEMIG). FFA thanks Programa Ciencias Sem Fronteiras-Atracao de Jovens Talentos-BJT (MEC/MCTI/CAPES/CNPq/FAPs) for a fellowship. ATC and OAMF thank CNPq for fellowships (PQ/CNPq). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Pereira VRA, 2012, DIAGN MICR INFEC DIS, V74, P292, DOI 10.1016/j.diagmicrobio.2012.06.025; Araujo AB, 2008, BRAZ J INFECT DIS, V12, P480, DOI 10.1590/S1413-86702008000600007; Araujo AB, 2013, BRAZ J INFECT DIS, V17, P174, DOI 10.1016/j.bjid.2012.10.013; Wendling APB, 2011, J IMMUNOL METHODS, V370, P24, DOI 10.1016/j.jim.2011.05.003; BRACHO CG, 1998, REV PANAM SALUD PUBL, V4, P94; Cooley G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000316; Cordeiro FD, 2001, CLIN DIAGN LAB IMMUN, V8, P112, DOI 10.1128/CDLI.8.1.112-118.2001; Coura JR, 2009, MEM I OSWALDO CRUZ, V104, P31, DOI 10.1590/S0074-02762009000900006; da Saude MS-Ministerio, 2005, REV SOC BRAS MED S3, V38, P12; Dias JCP, 2002, MEM I OSWALDO CRUZ, V97, P603, DOI 10.1590/S0074-02762002000500002; Ferreira-Silva MM, 2010, MEM I OSWALDO CRUZ, V105, P800, DOI 10.1590/S0074-02762010000600012; Flores-Chavez M, 2010, ENFERM INFEC MICR CL, V28, P284, DOI 10.1016/j.eimc.2009.07.005; Furucho CR, 2008, TROP MED INT HEALTH, V13, P1527, DOI 10.1111/j.1365-3156.2008.02172.x; Garcia LM, 2009, J IMMUNOL METHODS, V350, P36, DOI 10.1016/j.jim.2009.07.004; Gomes YM, 2009, MEM I OSWALDO CRUZ, V104, P115, DOI 10.1590/S0074-02762009000900017; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P389, DOI 10.1001/jama.271.5.389; Ker HG, 2013, DIAGN MICR INFEC DIS, V76, P470, DOI 10.1016/j.diagmicrobio.2013.04.007; Leiby DA, 2000, J CLIN MICROBIOL, V38, P639, DOI 10.1128/JCM.38.2.639-642.2000; Lemos EM, 2007, CLIN VACCINE IMMUNOL, V14, P569, DOI 10.1128/CVI.00354-06; MARTINS-FILHO OA, 1995, CLIN DIAGN LAB IMMUN, V2, P569, DOI 10.1128/CDLI.2.5.569-573.1995; Matos CS, 2011, J IMMUNOL METHODS, V369, P22, DOI 10.1016/j.jim.2011.03.007; Picka MCM, 2007, BRAZ J INFECT DIS, V11, P226, DOI 10.1590/S1413-86702007000200012; Moncayo A, 2003, MEM I OSWALDO CRUZ, V98, P577, DOI 10.1590/S0074-02762003000500001; Otani MM, 2009, TRANSFUSION, V49, P1076, DOI 10.1111/j.1537-2995.2009.02107.x; Panamerican Health Organization-Iniciativa del Cono Sur, 1997, 98102 OPSHPCHCT PAN; Sabino EC, 2010, TRANSFUSION, V50, P2628, DOI 10.1111/j.1537-2995.2010.02756.x; Salles NA, 1996, TRANSFUSION, V36, P969, DOI 10.1046/j.1537-2995.1996.36111297091740.x; Vitelli-Avelar DM, 2007, J IMMUNOL METHODS, V318, P102, DOI 10.1016/j.jim.2006.10.009; Wendel S, 2010, ACTA TROP, V115, P28, DOI 10.1016/j.actatropica.2009.12.006	29	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122938	10.1371/journal.pone.0122938	http://dx.doi.org/10.1371/journal.pone.0122938			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875961	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800083
J	Wagner, J; Damaschke, N; Yang, B; Truong, M; Guenther, C; McCormick, J; Huang, W; Jarrard, D				Wagner, Jennifer; Damaschke, Nathan; Yang, Bing; Truong, Matthew; Guenther, Chad; McCormick, Johnathon; Huang, Wei; Jarrard, David			Overexpression of the Novel Senescence Marker beta-Galactosidase (GLB1) in Prostate Cancer Predicts Reduced PSA Recurrence	PLOS ONE			English	Article							THERAPY-INDUCED SENESCENCE; CELLULAR SENESCENCE; INTRAEPITHELIAL NEOPLASIA; PROTEIN EXPRESSION; BIOMARKER; ARREST; CELLS; VITRO	Purpose Senescence is a terminal growth arrest that functions as a tumor suppressor in aging and precancerous cells and is a response to selected anticancer compounds. Lysosomal-beta-alactosidase (GLB1) hydrolyzes beta-galactose from glycoconjugates and is the origin of senescence-associated beta-gal activity (SA-beta-gal). Using a new GLB1 antibody, senescence biology was investigated in prostate cancer (PCa) tissues. Experimental Design In vitro characterization of GLB1 was determined in primary prostate epithelial cell cultures passaged to replicative senescence and in therapy-induced senescence in PCa lines using chemotherapeutic agents. FFPE tissue microarrays were subjected to immunofluorescent staining for GLB1, Ki67 and HP1. and automated quantitative imaging initially using AQUA in exploratory samples and Vectra in a validation series. Results GLB1 expression accumulates in replicative and induced senescence and correlates with senescent morphology and P16 (CDKN2) expression. In tissue arrays, quantitative imaging detects increased GLB1 expression in high-grade prostatic intraepithelial neoplasia (HGPIN), known to contain senescent cells, and cancer compared to benign prostate tissues (p<0.01) and senescent cells contain low Ki67 and elevated HP1 gamma. Within primary tumors, elevated GLB1 associates with lower T stage (p=0.01), localized versus metastatic disease (p=0.0003) and improved PSA-free survival (p=0.03). Increased GLB1 stratifies better PSA-free survival in intermediate grade PCa (0.01). Tissues that elaborate higher GLB1 display increased uniformity of expression. Conclusion Increased GLB1 is a valuable marker in formalin-fixed paraffin-embedded (FFPE) tissues for the senescence-like phenotype and associates with improved cancer outcomes. This protein addresses a lack of senescence markers and should be applicable to study the biologic role of senescence in other cancers.	[Wagner, Jennifer; Damaschke, Nathan; Yang, Bing; Truong, Matthew; Guenther, Chad; McCormick, Johnathon; Jarrard, David] Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA; [Huang, Wei] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pathol & Lab Med, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Jarrard, D (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Urol, Madison, WI 53706 USA.	jarrard@urology.wisc.edu	Ramon y Cajal, Santiago/H-4955-2016	Ramon y Cajal, Santiago/0000-0002-3867-1390; McCormick, Johnathon/0000-0002-1344-7886; Truong, Matthew/0000-0002-0562-6972	Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [T32CA009135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T35DK062709] Funding Source: NIH RePORTER	Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funding was provided by Prostate Cancer Foundation (http://www.pcf.org/site/c.leJRIROrEpH/b.5699537/k.BEF4/Home.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Besancenot R, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000476; Boyd LK, 2012, GENE CHROMOSOME CANC, V51, P579, DOI 10.1002/gcc.21944; Camp RL, 2002, NAT MED, V8, P1323, DOI 10.1038/nm791; Campisi J, 2013, ANNU REV PHYSIOL, V75, P685, DOI 10.1146/annurev-physiol-030212-183653; Choi J, 2000, UROLOGY, V56, P160, DOI 10.1016/S0090-4295(00)00538-0; Cicione A, 2012, UROL ONCOL; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Melo FDE, 2013, EMBO REP, V14, P686, DOI 10.1038/embor.2013.92; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Dorr JR, 2013, NATURE, V501, P421, DOI 10.1038/nature12437; Doganavsargil B, 2006, BJU INT, V97, P644, DOI 10.1111/j.1464-410X.2006.06054.x; Ewald JA, 2013, PROSTATE, V73, P337, DOI 10.1002/pros.22571; Ewald JA, 2012, TRANSL ONCOL, V5, P278, DOI 10.1593/tlo.12181; Ewald JA, 2010, JNCI-J NATL CANCER I, V102, P1536, DOI 10.1093/jnci/djq364; Ewald JA, 2009, J BIOMOL SCREEN, V14, P853, DOI 10.1177/1087057109340314; GLB1 galactosidase, 2013, PUBMED GENE DATABASE; Hassona Y, 2013, CARCINOGENESIS, V34, P1286, DOI 10.1093/carcin/bgt035; Haugstetter AM, 2010, BRIT J CANCER, V103, P505, DOI 10.1038/sj.bjc.6605784; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huang W, 2013, HUM PATHOL, V44, P29, DOI 10.1016/j.humpath.2012.05.009; Jarrard DF, 1999, CANCER RES, V59, P2957; Kolesar J, 2009, CANCER CHEMOTH PHARM, V64, P79, DOI 10.1007/s00280-008-0845-0; Krishnamurthty J, 2004, J CLIN INVEST, V114, P1299, DOI 10.1172/JCI200422475; Lee BY, 2006, AGING CELL, V5, P187, DOI 10.1111/j.1474-9726.2006.00199.x; Majumder PK, 2008, CANCER CELL, V14, P146, DOI 10.1016/j.ccr.2008.06.002; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Pierorazio PM, 2013, BJU INT, V111, P753, DOI 10.1111/j.1464-410X.2012.11611.x; Schwarze SR, 2005, NEOPLASIA, V7, P816, DOI 10.1593/neo.05250; Schwarze SR, 2001, ONCOGENE, V20, P8184, DOI 10.1038/sj.onc.1205049; Slezak J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-148; Warren M, 2009, APPL IMMUNOHISTO M M, V17, P23, DOI 10.1097/PAI.0b013e31817c3334; Zhang RG, 2007, MOL CELL BIOL, V27, P2343, DOI 10.1128/MCB.02019-06	33	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124366	10.1371/journal.pone.0124366	http://dx.doi.org/10.1371/journal.pone.0124366			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876105	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800139
J	Kanwal, M; Alyas, S; Afzal, M; Mansoor, A; Abbasi, R; Tassone, F; Malik, S; Mazhar, K				Kanwal, Madiha; Alyas, Saadia; Afzal, Muhammad; Mansoor, Atika; Abbasi, Rashda; Tassone, Flora; Malik, Sajid; Mazhar, Kehkashan			Molecular Diagnosis of Fragile X Syndrome in Subjects with Intellectual Disability of Unknown Origin: Implications of Its Prevalence in Regional Pakistan	PLOS ONE			English	Article							MENTAL-RETARDATION; EXPANDED ALLELES; CGG REPEAT; GENE; PCR; IDENTIFICATION; CHILDREN; NEWBORN; FMR-1	Fragile-X syndrome (FXS) is the most common form of inherited intellectual disability (ID) and affects 0.7-3.0% of intellectually compromised population of unknown etiology world-wide. It is mostly caused by repeat expansion mutations in the FMR1 at chromosome Xq27.3. The present study aimed to develop molecular diagnostic tools for a better detection of FXS, to assess implementation of diagnostic protocols in a developing country and to estimate the prevalence of FXS in a cohort of intellectually disabled subjects from Pakistan. From a large pool of individuals with below normal IQ range, 395 subjects with intellectual disability of unknown etiology belonging to different regions of the country were recruited. Conventional-PCR, modified-PCR and Southern blot analysis methods were employed for the detection of CGG repeat polymorphisms in the FMR1 gene. Initial screening with conventional-PCR identified 13 suspected patients. Subsequent investigations through modified-PCR and Southern blot analyses confirmed the presence of the FMR1 mutation, suggesting a prevalence of 3.5% and 2.8% (mean 3.3%) among the male and female ID patients, respectively. These diagnostic methods were further customized with the in-house conditions to offer robust screening of referral patients/families for diagnostics and genetic counseling. Prescreening and early diagnosis are crucial for designing a prudent strategy for the management of subjects with ID. Outcome of the study recommends health practitioners for implementation of molecular based FXS diagnosis in routine clinical practice to give a better care for patients similar to the ones included in the study.	[Kanwal, Madiha; Alyas, Saadia; Afzal, Muhammad; Malik, Sajid] Quaid I Azam Univ, Dept Anim Sci, Human Genet Program, Islamabad 45320, Pakistan; [Mansoor, Atika; Abbasi, Rashda; Mazhar, Kehkashan] Inst Biomed & Genet Engn, Islamabad, Pakistan; [Tassone, Flora] Univ Calif Davis, MIND Inst, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Dept Biochem & Mol Med, Davis, CA 95616 USA	Quaid I Azam University; University of California System; University of California Davis; University of California System; University of California Davis	Mazhar, K (corresponding author), Inst Biomed & Genet Engn, Islamabad, Pakistan.	kehkashan_mbhatti@yahoo.com	Kanwal, Madiha/S-2017-2019; Malik, Sajid/H-7816-2019	Kanwal, Madiha/0000-0003-2316-0368; Malik, Sajid/0000-0001-5563-9053	Pakistan Science Foundation [PSF/Res/Biotech/C-IBGE/Med (87)]	Pakistan Science Foundation	The work was supported by Pakistan Science Foundation grant no PSF/Res/Biotech/C-IBGE/Med (87).	Bhowmik DA, 2009, J CLIN DIAGN RES, V3, P1266; Charalsawadi Chariyawan, 2005, Journal of the Medical Association of Thailand, V88, P1057; Chen LJ, 2010, J MOL DIAGN, V12, P589, DOI 10.2353/jmoldx.2010.090227; DEBOULLE K, 1993, NAT GENET, V3, P31, DOI 10.1038/ng0193-31; Durkin MS, 1998, AM J EPIDEMIOL, V147, P281; Dutta S, 2009, INDIAN J MED RES, V130, P714; Filipovic-Sadic S, 2010, CLIN CHEM, V56, P399, DOI 10.1373/clinchem.2009.136101; FU YH, 1991, CELL, V67, P1047, DOI 10.1016/0092-8674(91)90283-5; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Hagerman RJ, 2002, FRAGILE X SYNDROME D, P3; Maenner MJ, 2013, AM J MED GENET B, V162B, P466, DOI 10.1002/ajmg.b.32176; Mirza I, 2009, J INTELL DISABIL RES, V53, P559, DOI 10.1111/j.1365-2788.2009.01176.x; Nolin SL, 2013, AM J MED GENET A, V161A, P771, DOI 10.1002/ajmg.a.35833; Panagopoulos I, 1999, HUM MUTAT, V14, P71, DOI 10.1002/(SICI)1098-1004(1999)14:1<71::AID-HUMU9>3.0.CO;2-5; Reiss AL, 2003, DEV PSYCHOPATHOL, V15, P927, DOI 10.1017/S0954579403000464; Roeleveld N, 1997, DEV MED CHILD NEUROL, V39, P125, DOI 10.1111/j.1469-8749.1997.tb07395.x; SHERMAN SL, 1985, HUM GENET, V69, P289, DOI 10.1007/BF00291644; Sidorov MS, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-15; Stoger R, 1997, HUM MOL GENET, V6, P1791, DOI 10.1093/hmg/6.11.1791; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Tassone F, 2008, J MOL DIAGN, V10, P43, DOI 10.2353/jmoldx.2008.070073; Tassone F, 2012, GENOME MED, V4, DOI 10.1186/gm401; Thurman AJ, 2014, RES DEV DISABIL, V35, P1072, DOI 10.1016/j.ridd.2014.01.032; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Wang X., 2006, WORLD J PEDIATR, V2, P285; Yim SY, 2008, J KOREAN MED SCI, V23, P470, DOI 10.3346/jkms.2008.23.3.470; Yrigollen CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021728	28	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122213	10.1371/journal.pone.0122213	http://dx.doi.org/10.1371/journal.pone.0122213			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875842	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700013
J	Dyson, PA; Anthony, D; Fenton, B; Stevens, DE; Champagne, B; Li, LM; Lv, J; Hernandez, JR; Thankappan, KR; Matthews, DR				Dyson, Pamela A.; Anthony, Denis; Fenton, Brenda; Stevens, Denise E.; Champagne, Beatriz; Li, Li-Ming; Lv, Jun; Hernandez, Jorge Ramirez; Thankappan, K. R.; Matthews, David R.		CIH Collaboration	Successful Up-Scaled Population Interventions to Reduce Risk Factors for Non-Communicable Disease in Adults: Results from the International Community Interventions for Health (CIH) Project in China, India and Mexico	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; TRENDS; DIET	Background Non-communicable disease (NCD) is increasing rapidly in low and middle-income countries (LMIC), and is associated with tobacco use, unhealthy diet and physical inactivity. There is little evidence for up-scaled interventions at the population level to reduce risk in LMIC. Methods The Community Interventions for Health (CIH) program was a population-scale community intervention study with comparator population group undertaken in communities in China, India, and Mexico, each with populations between 150,000-250,000. Culturally appropriate interventions were delivered over 18-24 months. Two independent cross-sectional surveys of a stratified sample of adults aged 18-64 years were conducted at baseline and follow-up. Results A total of 6,194 adults completed surveys at baseline, and 6,022 at follow-up. The proportion meeting physical activity recommendations decreased significantly in the control group (C) (44.1 to 30.2%), but not in the intervention group (I) (38.0 to 36.1%), p < 0.001. Those eating >= 5 portions of fruit and vegetables daily decreased significantly in C (19.2 to 17.2%), but did not change in I (20.0 to 19.6%,), p=0.013. The proportion adding salt to food was unchanged in C (24.9 to 25.3%) and decreased in I (25.9 to 19.6%), p < 0.001. Prevalence of obesity increased in C (8.3 to 11.2%), with no change in I (8.6 to 9.7%,) p = 0.092. Concerning tobacco, for men the difference-in-difference analysis showed that the reduction in use was significantly greater in I compared to C (p = 0.014) Conclusions Up-scaling known health promoting interventions designed to reduce the incidence of NCD in whole communities in LMIC is feasible, and has measurable beneficial outcomes on risk factors for NCD, namely tobacco use, diet, and physical inactivity.	[Dyson, Pamela A.; Matthews, David R.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [Anthony, Denis; Matthews, David R.] Univ Oxford, Harris Manchester Coll, Oxford OX1 3DT, England; [Fenton, Brenda; Stevens, Denise E.] MATRIX Publ Hlth Solut Inc, New Haven, CT 06515 USA; [Champagne, Beatriz; Hernandez, Jorge Ramirez] InterAmer Heart Fdn Inc, Dallas, TX 75231 USA; [Li, Li-Ming; Lv, Jun] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Beijing 100191, Peoples R China; [Hernandez, Jorge Ramirez] Univ Nacl Autonoma Mexico, Insurgentes Cuicuilco, Mexico City 04530, DF, Mexico; [Thankappan, K. R.] Sree Chitra Tirunal Inst Med Sci & Technol, Achutha Menon Ctr Hlth Sci Studies, Trivandrum, Kerala, India; [Matthews, David R.] Oxford NIHR Biomed Res Ctr, Oxford, England	University of Oxford; University of Oxford; Peking University; Universidad Nacional Autonoma de Mexico; Department of Science & Technology (India); Sree Chitra Tirunal Institute for Medical Sciences Technology (SCTIMST); University of Oxford	Matthews, DR (corresponding author), Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, S Parks Rd, Oxford OX3 7LJ, England.	david.matthews@ocdem.ox.ac.uk	Anthony, Denis Martin/D-9212-2018; Thankappan, Kr/ABC-9551-2021; Lv, Jun/O-4746-2019	Anthony, Denis Martin/0000-0003-1787-8832; Lv, Jun/0000-0001-7916-3870; , KR/0000-0002-4536-2684	Oxford Health Alliance; PepsiCo Foundation; Novo Nordisk A/S; National Institute for Health Research	Oxford Health Alliance; PepsiCo Foundation; Novo Nordisk A/S(Novo Nordisk); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the Oxford Health Alliance, the PepsiCo Foundation, Novo Nordisk A/S and the National Institute for Health Research. The authors are indebted to all the staff in the Community Interventions for Health sites and particularly Qingmin Liu, Yanjun Ren, and all leaders and staff working in the Bureaus of Health and Centers for Disease Control and Prevention in the city and districts of Xiacheng, Gongshu, Xihu in Hangzhou in China, Ravi Prasad Varma, Rekha M. Ravindran, N. S. Rajeev, Elezebeth Mathews, the staff of schools, industries, health centres, and the elected representatives of the local self Governments of Athiyannoor and Chirayinkeezh block Panchayat in Kerala in India, Maria Teresa Fernandez Ramos, Adriana Vianey Cortes Alejo, Diana Gomez Lopez, Samantha Nayeli De la Rosa, Marlene Medina Hernandez, Armando Ahued and Gabriela Capo in Mexico, and Javier Valenzuela at the InterAmerican Heart Foundation. None of the major sponsors, namely the National Institute of Health Research, Novo Nordisk A/S and the PepsiCo Foundation had a role in the design or conduct of the study, in the collection, management, interpretation and analysis of the data or in the preparation, review or approval of the manuscript, nor have the data been released to the funding bodies in advance of the publication. The Oxford Health Alliance was responsible for the management and reporting of the study.	[Anonymous], 2011, BURD BEST BUYS RED E; [Anonymous], 2014, LANCET, V374, P428, DOI [10.1016/S0140-6736(09)61429-X, DOI 10.1016/S0140-6736(09)61429-X]; Bloom DE, 2011, GLOBAL EC BURDEN NON, DOI DOI 10.1192/BJP.184.5.393; Capewell S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000320; CARD D, 1994, AM ECON REV, V84, P772; Craig CL, 2003, MED SCI SPORT EXER, V35, P1381, DOI 10.1249/01.MSS.0000078924.61453.FB; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Emberson JR, 2005, EUR HEART J, V26, P1774, DOI 10.1093/eurheartj/ehi224; Ezzati M, 2002, LANCET, V360, P1347, DOI 10.1016/S0140-6736(02)11403-6; Horton R, 2012, LANCET, V380, P2053, DOI 10.1016/S0140-6736(12)62133-3; International Diabetes Federation, 2014, IDF DIABETES ATLAS, V6th; Kenchaiah S, 2009, CIRCULATION, V119, P44, DOI 10.1161/CIRCULATIONAHA.108.807289; KISH L, 1949, J AM STAT ASSOC, V44, P380, DOI 10.2307/2280236; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; Luepker RV, 2008, CIRCULATION, V117, P592, DOI 10.1161/CIRCULATIONAHA.107.747477; Mozaffarian D, 2012, CIRCULATION, V126, P1514, DOI 10.1161/CIR.0b013e318260a20b; Nissinen A, 2004, J HUM HYPERTENS, V18, P553, DOI 10.1038/sj.jhh.1001696; O'Connor Duffany K., 2011, CVD PREV CONTROL, V6, P47, DOI DOI 10.1016/J.CVDPC.2011.02.005; Packianthan I, 2003, OBESITY, V31, P8; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; Puska P, 1998, B WORLD HEALTH ORGAN, V76, P419; Rose G., 1992, STRATEGY PREVENTIVE; Salopuro TM, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-350; Stevens D, 2012, COMMUNITY INTERVENTI; United Nations, 2011, REPORT SPECIAL RAPPO; Vandoros S, 2013, EUR J PUBLIC HEALTH, V23, P727, DOI 10.1093/eurpub/ckt020; VARTIAINEN E, 1994, INT J EPIDEMIOL, V23, P495, DOI 10.1093/ije/23.3.495; WHO, 2010, SCREENING DONATED BLOOD FOR TRANSFUSION: TRANSMISSIBLE INFECTIONS, P1; World Health Organisation, 2013, WHO STEPW APPR NONC; World Health Organisation, 2011, REP NONC DIS 2010; World Health Organisation, 2007, GLOB AD TOB SURV GAT; World Health Organization, 2004, GLOB STRAT DIET PHYS	33	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120941	10.1371/journal.pone.0120941	http://dx.doi.org/10.1371/journal.pone.0120941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875825	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100029
J	Li, HB; Yu, Y; Wang, ZZ; Geng, JL; Dai, Y; Xiao, W; Yao, XS				Li, Haibo; Yu, Yang; Wang, Zhenzhong; Geng, Jianliang; Dai, Yi; Xiao, Wei; Yao, Xinsheng			Chemical Profiling of Re-Du-Ning Injection by Ultra-Performance Liquid Chromatography Coupled with Electrospray Ionization Tandem Quadrupole Time-of-Flight Mass Spectrometry through the Screening of Diagnostic Ions in MSE Mode	PLOS ONE			English	Article							FLOS LONICERAE JAPONICAE; DIODE-ARRAY DETECTION; IRIDOID GLYCOSIDES; PHENOLIC-ACIDS; RAT PLASMA; CONSTITUENTS; IDENTIFICATION; FRAGMENTATION; METABOLITES; FLAVONOIDS	The broad applications and mechanism explorations of traditional Chinese medicine prescriptions (TCMPs) require a clear understanding of TCMP chemical constituents. In the present study, we describe an efficient and universally applicable analytical approach based on ultra-performance liquid chromatography coupled to electrospray ionization tandem quadrupole time-of-flight mass spectrometry (UPLC-ESI-Q/TOF-MS) with the MSE ((E) denotes collision energy) data acquisition mode, which allowed the rapid separation and reliable determination of TCMP chemical constituents. By monitoring diagnostic ions in the high energy function of MSE, target peaks of analogous compounds in TCMPs could be rapidly screened and identified. "Re-Du-Ning" injection (RDN), a eutherapeutic traditional Chinese medicine injection (TCMI) that has been widely used to reduce fever caused by viral infections in clinical practice, was studied as an example. In total, 90 compounds, including five new iridoids and one new sesquiterpene, were identified or tentatively characterized by accurate mass measurements within 5 ppm error. This analysis was accompanied by MS fragmentation and reference standard comparison analyses. Furthermore, the herbal sources of these compounds were unambiguously confirmed by comparing the extracted ion chromatograms (EICs) of RDN and ingredient herbal extracts. Our work provides a certain foundation for further studies of RDN. Moreover, the analytical approach developed herein has proven to be generally applicable for profiling the chemical constituents in TCMPs and other complicated mixtures.	[Li, Haibo; Wang, Zhenzhong; Xiao, Wei] Jiangsu Kanion Pharmaceut Co Ltd, Lianyungang, Peoples R China; [Li, Haibo; Yu, Yang; Dai, Yi; Yao, Xinsheng] Jinan Univ, Coll Pharm, Inst Tradit Chinese Med & Nat Prod, Guangzhou, Guangdong, Peoples R China; [Li, Haibo; Wang, Zhenzhong; Xiao, Wei] State Key Lab New Tech Chinese Med Pharmaceut Pro, Lianyungang, Peoples R China; [Geng, Jianliang; Yao, Xinsheng] Shenyang Pharmaceut Univ, Shenyang, Peoples R China	Jinan University; Shenyang Pharmaceutical University	Xiao, W (corresponding author), Jiangsu Kanion Pharmaceut Co Ltd, Lianyungang, Peoples R China.	kanionxw2010@126.com; tyaoxs@jnu.edu.cn			Natural Science Foundation of Jiangsu Province [BK20140441]; Jiangsu Province Postdoctoral Science Foundation [1401771C]; Programme of Introducing Talents of Discipline to Universities [B13038]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province Postdoctoral Science Foundation; Programme of Introducing Talents of Discipline to Universities(Ministry of Education, China - 111 Project)	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20140441); the Jiangsu Province Postdoctoral Science Foundation (1401771C) and the Programme of Introducing Talents of Discipline to Universities (B13038). The funders had no role in study design, data collection and analysis,	Bent S, 2004, AM J MED, V116, P478, DOI 10.1016/j.amjmed.2003.10.036; Castro-Perez JM, 2010, J PROTEOME RES, V9, P2377, DOI 10.1021/pr901094j; Cuyckens F, 2001, J MASS SPECTROM, V36, P1203, DOI 10.1002/jms.224; Fabre N, 2001, J AM SOC MASS SPECTR, V12, P707, DOI 10.1016/S1044-0305(01)00226-4; Hu ZP, 2005, DRUGS, V65, P1239, DOI 10.2165/00003495-200565090-00005; Huang X. M., 2006, CHIN J CLIN PHARM TH, V11, P470; Hvattum E, 2003, J MASS SPECTROM, V38, P43, DOI 10.1002/jms.398; Konishi Y, 2007, ANAL CHEM, V79, P1187, DOI 10.1021/ac061391o; Li HB, 2013, FITOTERAPIA, V88, P7, DOI 10.1016/j.fitote.2013.03.025; Liang X, 2010, J PHARMACEUT BIOMED, V51, P565, DOI 10.1016/j.jpba.2009.09.015; LOFFLER C, 1995, BIOCHEM SYST ECOL, V23, P121, DOI 10.1016/0305-1978(95)93846-U; March RE, 2004, RAPID COMMUN MASS SP, V18, P931, DOI 10.1002/rcm.1428; Ni SM, 2010, J CHROMATOGR B, V878, P2741, DOI 10.1016/j.jchromb.2010.08.014; Nordstrom A, 2006, ANAL CHEM, V78, P3289, DOI 10.1021/ac060245f; Pelkonen O, 2012, J ETHNOPHARMACOL, V140, P587, DOI 10.1016/j.jep.2012.01.035; Plumb RS, 2006, RAPID COMMUN MASS SP, V20, P1989, DOI 10.1002/rcm.2550; Qi LW, 2009, RAPID COMMUN MASS SP, V23, P3227, DOI 10.1002/rcm.4245; Qi Y, 2014, TALANTA, V118, P21, DOI 10.1016/j.talanta.2013.09.054; Rainville PD, 2007, J PROTEOME RES, V6, P552, DOI 10.1021/pr060611b; Ren L, 2007, RAPID COMMUN MASS SP, V21, P3039, DOI 10.1002/rcm.3189; Schutz K, 2005, RAPID COMMUN MASS SP, V19, P179, DOI 10.1002/rcm.1767; Stone R, 2008, SCIENCE, V319, P709, DOI 10.1126/science.319.5864.709; Sun L. M., 2011, CHINA MED HER, V8, P149; Tan GG, 2011, BIOMED CHROMATOGR, V25, P913, DOI 10.1002/bmc.1544; Yan JJ, 2011, CHINA MODERN DOCTOR, V49, P31; Yang B, 2011, J SEP SCI, V34, P3208, DOI 10.1002/jssc.201100632; Zhang JY, 2013, TALANTA, V104, P1, DOI 10.1016/j.talanta.2012.11.012; Zhang J, 2009, TALANTA, V78, P513, DOI 10.1016/j.talanta.2008.12.002; Zhang Y., 2011, GUIDE CHINA MED, V9, P33; Zhou TT, 2010, RAPID COMMUN MASS SP, V24, P2520, DOI 10.1002/rcm.4643; Zhou Y, 2008, ANAL CHIM ACTA, V629, P104, DOI 10.1016/j.aca.2008.09.044	31	16	18	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121031	10.1371/journal.pone.0121031	http://dx.doi.org/10.1371/journal.pone.0121031			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875968	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100034
J	Amano, S; Chang, YT; Fukui, Y				Amano, Shigeru; Chang, Yu-Tzu; Fukui, Yasuhisa			ERK5 Activation Is Essential for Osteoclast Differentiation	PLOS ONE			English	Article							DC-STAMP; RANKL; CELLS	The MEK/ERK pathways are critical for controlling cell proliferation and differentiation. In this study, we show that the MEK5/ERK5 pathway participates in osteoclast differentiation. ERK5 was activated by M-CSF, which is one of the essential factors in osteoclast differentiation. Inhibition of MEK5 by BIX02189 or inhibition of ERK5 by XMD 8-92 blocked osteoclast differentiation. MEK5 knockdown inhibited osteoclast differentiation. RAW264.7D clone cells, which are monocytic cells, differentiate into osteoclasts after stimulation with sRANKL. ERK5 was activated without any stimulation in these cells. Inhibition of the MEK5/ERK5 pathway by the inhibitors also blocked the differentiation of RAW264.7D cells into osteoclasts. Moreover, expression of the transcription factor c-Fos, which is indispensable for osteoclast differentiation, was inhibited by treatment with MEK5 or ERK5 inhibitors. Therefore, activation of ERK5 is required for the induction of c-Fos. These events were confirmed in experiments using M-CSF-dependent bone marrow macrophages. Taken together, the present results show that activation of the MEK5/ERK5 pathway with M-CSF is required for osteoclast differentiation, which may induce differentiation through the induction of c-Fos.	[Amano, Shigeru] Meikai Univ, Sch Dent, Div Microbiol & Immunol, Dept Oral Biol & Tissue Engn, Sakado, Saitama, Japan; [Chang, Yu-Tzu; Fukui, Yasuhisa] Natl Hlth Res Inst, Zhunan Town, Miaoli County, Taiwan	Meikai University; National Health Research Institutes - Taiwan	Fukui, Y (corresponding author), Natl Hlth Res Inst, Zhunan Town, Miaoli County, Taiwan.	990412@nhri.org.tw			Ministry of Education, Science, Sports, and Culture of Japan [22592047, 25670799]; Miyata Foundation, Meikai University; National Health Research Institute [01A1-CSPP04-014]; National Science Council Taiwan [101-2300-B-400-015]; Grants-in-Aid for Scientific Research [25670799] Funding Source: KAKEN	Ministry of Education, Science, Sports, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Miyata Foundation, Meikai University; National Health Research Institute(National Health Research Institutes - Taiwan); National Science Council Taiwan(Ministry of Science and Technology, Taiwan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by the grants-in-aid from the Ministry of Education, Science, Sports, and Culture of Japan (no. 22592047 and no. 25670799) and a grant from the Miyata Foundation, Meikai University to S.A. and grants from the National Health Research Institute (01A1-CSPP04-014) and the National Science Council Taiwan (101-2300-B-400-015) to Y. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2009, J CELL PHYSIOL, V221, P40, DOI 10.1002/jcp.21827; Drew BA, 2012, BBA-REV CANCER, V1825, P37, DOI 10.1016/j.bbcan.2011.10.002; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Mellis DJ, 2011, J ENDOCRINOL, V211, P131, DOI 10.1530/JOE-11-0212; Nithianandarajah-Jones GN, 2012, CELL SIGNAL, V24, P2187, DOI 10.1016/j.cellsig.2012.07.007; Shinohara M, 2010, GASTROENTEROLOGY, V139, P2050, DOI 10.1053/j.gastro.2010.08.052; Watanabe T, 2004, J ENDOCRINOL, V180, P193, DOI 10.1677/joe.0.1800193; Yagi M, 2006, J BONE MINER METAB, V24, P355, DOI 10.1007/s00774-006-0697-9	11	19	23	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125054	10.1371/journal.pone.0125054	http://dx.doi.org/10.1371/journal.pone.0125054			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885811	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000148
J	Chizimba, R; Christofides, N; Chirwa, T; Singini, I; Ozumba, C; Sikwese, S; Banda, HT; Banda, R; Chimbali, H; Ngwira, B; Munthali, A; Nyasulu, P				Chizimba, Robert; Christofides, Nicola; Chirwa, Tobias; Singini, Isaac; Ozumba, Chineme; Sikwese, Simon; Banda, Hastings T.; Banda, Rhoda; Chimbali, Henry; Ngwira, Bagrey; Munthali, Alister; Nyasulu, Peter			The Association between Multiple Sources of Information and Risk Perceptions of Tuberculosis, Ntcheu District, Malawi	PLOS ONE			English	Article							SOCIAL DETERMINANTS	Background Tuberculosis (TB) is one of the main causes of death in developing countries. Awareness and perception of risk of TB could influence early detection, diagnosis and care seeking at treatment centers. However, perceptions about TB are influenced by sources of information. Aim This study aimed to determine the association between multiple sources of information, and perceptions of risk of TB among adults aged 18-49 years. Methods A cross-sectional study was conducted in Ntcheu district in Malawi. A total of 121 adults were sampled in a three-stage simple random sampling technique. Data were collected using a structured questionnaire. Perceptions of risk were measured using specific statements that reflected common myths and misconceptions. Low risk perception implied a person having strong belief in myths and misconceptions about TB and high risk perception meant a person having no belief in myths or misconceptions and demonstrated understanding of the disease. Results Females were more likely to have low risk perceptions about TB compared to males (67.7% vs. 32.5%, p = 0.01). The higher the household asset index the more likely an individual had higher risk perceptions about TB (p = 0.006). The perception of risk of TB was associated with sources of information (p = 0.03). Use of both interpersonal communication and mass media was 2.8 times more likely to be associated with increased perception of risk of TB (Odds Ratio [OR] = 2.8; 95% Confidence interva1[CI]: 3.1-15. 6; p = 0.01). After adjusting for sex and asset ownership, use of interpersonal communication and mass media were more likely to be associated with higher perception of risk of TB (OR, 2.0; 95% CI: 1.65-10.72; p = 0.003) compared with interpersonal communication only (OR 1.6, 95%; CI: 1.13-8.98, p = 0.027). Conclusion The study found that there was association between multiple sources of information, and higher perceptions of risk of TB among adults aged 18-49 years.	[Chizimba, Robert] Save Children Int, Dept Hlth, Lilongwe, Malawi; [Ozumba, Chineme; Nyasulu, Peter] Sch Hlth Sci, Dept Publ Hlth, Monash, South Africa; [Chizimba, Robert; Christofides, Nicola; Chirwa, Tobias; Sikwese, Simon; Nyasulu, Peter] Univ Witwatersrand, Sch Publ Hlth, Fac Hlth Sci, Johannesburg, South Africa; [Singini, Isaac] Univ Malawi, Johns Hopkins Res Project, Coll Med, Blantyre, Malawi; [Sikwese, Simon] Pakachere Inst Hlth & Dev Commun, Blantyre, Malawi; [Banda, Hastings T.] Res Equ & Community Hlth REACH Trust, Lilongwe, Malawi; [Banda, Rhoda] Minist Hlth, Natl TB Control Program, Community Hlth Sci Unit, Lilongwe, Malawi; [Chimbali, Henry] Minist Hlth, Hlth Promot Serv, Lilongwe, Malawi; [Ngwira, Bagrey] Univ Malawi, Dept Community Hlth, Coll Med, Blantyre, Malawi; [Munthali, Alister] Univ Malawi, Ctr Social Res, Zomba, Malawi	Save the Children; University of Witwatersrand; University of Malawi; University of Malawi; University of Malawi	Nyasulu, P (corresponding author), Sch Hlth Sci, Dept Publ Hlth, Monash, South Africa.	peter.nyasulu@monash.edu	Chirwa, Tobias/AAI-9087-2021					Bacay-Domingo M.C.N., 2009, PEDIAT INFECT DIS SO, V10, P28; Banerjee A, 2000, INT J TUBERC LUNG D, V4, P1047; Banerjee A, 1999, T ROY SOC TROP MED H, V93, P392, DOI 10.1016/S0035-9203(99)90128-1; Fatiregun A. A., 2010, Tanzania Journal of Health Research, V12, punpaginated; Hargreaves JR, 2011, AM J PUBLIC HEALTH, V101, P654, DOI 10.2105/AJPH.2010.199505; Harries AD, 1997, T ROY SOC TROP MED H, V91, P15, DOI 10.1016/S0035-9203(97)90376-X; Hoa N. P., 2008, HLTH POLICY, V90, P8, DOI [DOI 10.1016/J.HEALTHP0L.2008.08.006, 10.1016/j.healthpol.2008.08.006]; Karim F, 2011, PUBLIC HEALTH, V125, P84, DOI 10.1016/j.puhe.2010.10.005; Dias AAL, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-595; Lonnroth K, 2009, SOC SCI MED, V68, P2240, DOI 10.1016/j.socscimed.2009.03.041; Makesh D., 2011, GLOBAL MEDIA J INDIA, V2; Nyirenda Thomas, 2006, Malawi Med J, V18, P147; Onyeonoro UU, 2013, HEALTH EDUC, V113, P536, DOI 10.1108/HE-10-2012-0050; Simwaka Bertha Nhlema, 2007, Int J Equity Health, V6, P24, DOI 10.1186/1475-9276-6-24; Waisbord S, 2008, SOC IDENT, V14, P505, DOI 10.1080/13504630802212009; WHO, 2012, WHOHTMTB20107; WHO, 2012, MAL COUNTR OFF 2012; World Health Organization, 2010, WHOHTMTB20107; World Health Organization, 2013, WHOHTMTB201311; World Health Organization, 2007, NAT TUB CONTR PROGR; Wu PS, 2009, J FORMOS MED ASSOC, V108, P377, DOI 10.1016/S0929-6646(09)60081-4	21	7	7	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122998	10.1371/journal.pone.0122998	http://dx.doi.org/10.1371/journal.pone.0122998			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25885532	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000046
J	Downie, LE; Keller, PR				Downie, Laura Elizabeth; Keller, Peter Richard			The Self-Reported Clinical Practice Behaviors of Australian Optometrists as Related to Smoking, Diet and Nutritional Supplementation	PLOS ONE			English	Article							MACULAR DEGENERATION; CIGARETTE-SMOKING; FATTY-ACIDS; GENERAL-PRACTITIONERS; AGE; RISK; CESSATION; OMEGA-3; CARE; CONSUMPTION	Objective The primary aim of this study was to examine the self-reported, routine clinical practice behaviors of Australian optometrists with respect to advice regarding smoking, diet and nutritional supplementation. The study also sought to assess the potential influence of practitioner age, gender, practice location (major city versus regional), therapeutic-endorsement status and personal nutritional supplementation habits upon management practices in these areas. Methods A survey was electronically distributed to Australian optometrists (n = 4,242). Respondents anonymously provided information about their personal demographics and lifestyle behaviors (i.e., age, gender, practice location, therapeutic-endorsement status, smoking status, nutritional supplement intake) and routine patient management practices with respect to advice across three domains: smoking, diet and nutritional supplementation. Multivariate logistic regression analyses were performed to assess for potential effects of the listed factors on practitioner behavior. Results A total of 283 completed surveys were received (completed survey response rate: 6.7%). Fewer than half of respondents indicated routinely asking their patients about smoking status. Younger practitioners were significantly (p < 0.05) less likely to enquire about patients' smoking behaviors, but this did not extend to counseling for smoking cessation. Almost two-thirds of respondents indicated routinely counseling patients about diet. About half of practitioners specified routinely asking their patients about nutritional supplement intake; this form of questioning was significantly more likely if the respondent was female (p < 0.05). Practitioners who recommended nutritional supplements most commonly did so for age-related macular degeneration (91.2%) and dry eye disease (63.9%). The primary source of evidence used to guide practitioners' nutrition-related patient management was reported to be peer-reviewed publications. Conclusions These findings demonstrate that there are no clear predictors of practitioner behavior across the three domains. Overall, this study suggests that there is scope for Australian optometrists to improve their routine engagement by questioning patients, as well as providing evidence-based clinical advice, about smoking status, diet and nutritional supplement behaviors, being key modifiable lifestyle risk factors with long-term implications for eye health.	[Downie, Laura Elizabeth; Keller, Peter Richard] Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia; [Keller, Peter Richard] Ctr Eye Res Australia, Macular Res Unit, East Melbourne, Vic 3002, Australia	University of Melbourne; Centre for Eye Research Australia	Downie, LE (corresponding author), Univ Melbourne, Dept Optometry & Vis Sci, Parkville, Vic 3010, Australia.	ldownie@unimelb.edu.au		Downie, Laura/0000-0002-1596-2259; Keller, Peter/0000-0003-4431-184X				Augood C, 2008, AM J CLIN NUTR, V88, P398, DOI 10.1093/ajcn/88.2.398; Australian Bureau of Statistics, 2010, 1216 0 AUSTR STAND G; Bernstein PS, 2010, VISION RES, V50, P716, DOI 10.1016/j.visres.2009.10.014; Brignole-Baudouin F, 2011, ACTA OPHTHALMOL, V89, pE591, DOI 10.1111/j.1755-3768.2011.02196.x; Brule J, 2012, CLIN EXP OPTOM, V95, P599, DOI 10.1111/j.1444-0938.2012.00748.x; Caban-Martinez AJ, 2011, PREV CHRONIC DIS, V8; Carroll T, 2003, TOB CONTROL, V12, P40; Chew EY, 2013, JAMA-J AM MED ASSOC, V309, P2005, DOI 10.1001/jama.2013.4997; CHRISTEN WG, 1992, JAMA-J AM MED ASSOC, V268, P989; Cockburn David M, 2005, Clin Exp Optom, V88, P2; Coleman HR, 2008, LANCET, V372, P1835, DOI 10.1016/S0140-6736(08)61759-6; Deloitte Access Economics-Macular Disease Foundation, 2011, EYES FUT CLEAR OUTL; Downie LE, 2013, OPTOMETRY VISION SCI, V90, P1385, DOI 10.1097/OPX.0000000000000087; Downie LE, 2014, OPTOMETRY VISION SCI, V91, P821, DOI 10.1097/OPX.0000000000000285; Downie LE, 2015, NUTRITION; Druesne-Pecollo N, 2010, INT J CANCER, V127, P172, DOI 10.1002/ijc.25008; Evans JR, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000254.pub3; Evans JR, 2005, BRIT J OPHTHALMOL, V89, P550, DOI 10.1136/bjo.2004.049726; Galor A, 2011, CURR OPIN OPHTHALMOL, V22, P477, DOI 10.1097/ICU.0b013e32834bbe7a; Handa S, 2011, EYE, V25, P1170, DOI 10.1038/eye.2011.143; HANKINSON SE, 1992, JAMA-J AM MED ASSOC, V268, P994, DOI 10.1001/jama.268.8.994; Health Workforce Australia, 2014, AUSTR HLTH WORKF SER; Jalbert I, 2013, EXP EYE RES, V117, P138, DOI 10.1016/j.exer.2013.08.016; Kangari H, 2013, OPHTHALMOLOGY, V120, P2191, DOI 10.1016/j.ophtha.2013.04.006; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klein ML, 2011, ARCH OPHTHALMOL-CHIC, V129, P1543, DOI 10.1001/archophthalmol.2011.216; KLEIN R, 1993, AM J EPIDEMIOL, V137, P190, DOI 10.1093/oxfordjournals.aje.a116659; Lancaster T, 2004, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000165.PUB2; Lawrenson JG, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-564; Loo DLS, 2009, CLIN EXP OPTOM, V92, P42, DOI 10.1111/j.1444-0938.2008.00283.x; Merle BMJ, 2013, J NUTR, V143, P505, DOI 10.3945/jn.112.171033; Olenik A, 2013, CLIN INTERV AGING, V8, P1133, DOI 10.2147/CIA.S48955; Optometry Australia, 2014, POS STAT OPT WORKF; Optometry Australia, 2014, REG CHANG FORC 1 DEC; Rotstein NP, 1997, J NEUROCHEM, V69, P504; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2005, PROG RETIN EYE RES, V24, P87, DOI 10.1016/j.preteyeres.2004.06.002; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Sheck LHN, 2009, CLIN EXP OPTOM, V92, P75, DOI 10.1111/j.1444-0938.2009.00348.x; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Swanson MW, 2014, OPTOMETRY VISION SCI, V91, P865, DOI 10.1097/OPX.0000000000000315; Thompson C, 2007, OPHTHAL PHYSL OPT, V27, P389, DOI 10.1111/j.1475-1313.2007.00483.x; Thornton J, 2005, EYE, V19, P935, DOI 10.1038/sj.eye.6701978; U.S. Department of Health and Human Services, 2008, TREATING TOBACCO USE; Unim B, 2013, ANN I SUPER SANITA, V49, P266, DOI 10.4415/ANN_13_03_06; Verbiest MEA, 2014, NICOTINE TOB RES, V16, P1, DOI 10.1093/ntr/ntt100; Wojtowicz JC, 2011, CORNEA, V30, P308, DOI 10.1097/ICO.0b013e3181f22e03	49	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124533	10.1371/journal.pone.0124533	http://dx.doi.org/10.1371/journal.pone.0124533			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886641	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000135
J	Fan, Y; Liu, Y; Xue, K; Gu, GB; Fan, WM; Xu, YL; Ding, ZD				Fan, Yong; Liu, Yue; Xue, Ke; Gu, Guobao; Fan, Weimin; Xu, Yali; Ding, Zhide			Diet-Induced Obesity in Male C57BL/6 Mice Decreases Fertility as a Consequence of Disrupted Blood-Testis Barrier	PLOS ONE			English	Article							BODY-MASS INDEX; SPERM DNA INTEGRITY; SEMEN QUALITY; ANDROGEN RECEPTOR; INFERTILITY; SERTOLI; TESTOSTERONE; ASSOCIATION; ENDOCYTOSIS; TGF-BETA-3	Obesity is a complex metabolic disease that is a serious detriment to both children and adult health, which induces a variety of diseases, such as cardiovascular disease, type II diabetes, hypertension and cancer. Although adverse effects of obesity on female reproduction or oocyte development have been well recognized, its harmfulness to male fertility is still unclear because of reported conflicting results. The aim of this study was to determine whether diet-induced obesity impairs male fertility and furthermore to uncover its underlying mechanisms. Thus, male C57BL/6 mice fed a high-fat diet (HFD) for 10 weeks served as a model of diet-induced obesity. The results clearly show that the percentage of sperm motility and progressive motility significantly decreased, whereas the proportion of teratozoospermia dramatically increased in HFD mice compared to those in normal diet fed controls. Besides, the sperm acrosome reaction fell accompanied by a decline in testosterone level and an increase in estradiol level in the HFD group. This alteration of sperm function parameters strongly indicated that the fertility of HFD mice was indeed impaired, which was also validated by a low pregnancy rate in their mated normal female. Moreover, testicular morphological analyses revealed that seminiferous epithelia were severely atrophic, and cell adhesions between spermatogenic cells and Sertoli cells were loosely arranged in HFD mice. Meanwhile, the integrity of the blood-testis barrier was severely interrupted consistent with declines in the tight junction related proteins, occludin, ZO-1 and androgen receptor, but instead endocytic vesicle-associated protein, clathrin rose. Taken together, obesity can impair male fertility through declines in the sperm function parameters, sex hormone level, whereas during spermatogenesis damage to the blood-testis barrier (BTB) integrity may be one of the crucial underlying factors accounting for this change.	[Fan, Yong; Liu, Yue; Xue, Ke; Fan, Weimin; Xu, Yali; Ding, Zhide] Shanghai Jiao Tong Univ, Sch Med, Dept Human Anat Histol & Embryol, Shanghai Key Lab Reprod Med, Shanghai 200030, Peoples R China; [Gu, Guobao] Cent Hosp Zhabei Dist, Dept Med Lab Sci, Shanghai, Peoples R China; [Fan, Weimin] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Human Reprod Med, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University	Ding, ZD (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Human Anat Histol & Embryol, Shanghai Key Lab Reprod Med, Shanghai 200030, Peoples R China.	zding@shsmu.edu.cn	Liu, Yue/GQP-1774-2022		National Natural Science Foundation of China [81370752]; Shanghai Municipal Education Commission [12ZZ108]; Science and Technology Commission of Shanghai Municipality [12ZR1445900, 14140901600]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	Support was provided by the National Natural Science Foundation of China (No. 81370752), Shanghai Municipal Education Commission (no. 12ZZ108), the Science and Technology Commission of Shanghai Municipality (no. 12ZR1445900 and no. 14140901600) and the Shanghai Leading Academic Discipline Project (no. S30201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggerholm AS, 2008, FERTIL STERIL, V90, P619, DOI 10.1016/j.fertnstert.2007.07.1292; Bakos HW, 2011, INT J ANDROL, V34, P402, DOI 10.1111/j.1365-2605.2010.01092.x; Cabler S, 2010, ASIAN J ANDROL, V12, P480, DOI 10.1038/aja.2010.38; Chavarro JE, 2010, FERTIL STERIL, V93, P2222, DOI 10.1016/j.fertnstert.2009.01.100; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Du Plessis SS, 2010, NAT REV UROL, V7, P153, DOI 10.1038/nrurol.2010.6; Fariello RM, 2012, BJU INT, V110, P863, DOI 10.1111/j.1464-410X.2011.10813.x; Fejes I, 2005, ANDROLOGIA, V37, P155, DOI 10.1111/j.1439-0272.2005.00671.x; Ghanayem BI, 2010, BIOL REPROD, V82, P96, DOI 10.1095/biolreprod.109.078915; GIAGULLI VA, 1994, J CLIN ENDOCR METAB, V79, P997, DOI 10.1210/jc.79.4.997; Hammiche F, 2012, HUM REPROD, V27, P2365, DOI 10.1093/humrep/des177; Hammoud AO, 2008, FERTIL STERIL, V90, P897, DOI 10.1016/j.fertnstert.2008.08.026; Hammoud AO, 2006, J ANDROL, V27, P619, DOI 10.2164/jandrol.106.000125; Hammoud AO, 2008, FERTIL STERIL, V90, P2222, DOI 10.1016/j.fertnstert.2007.10.011; Hofny ERM, 2010, FERTIL STERIL, V94, P581, DOI 10.1016/j.fertnstert.2009.03.085; Jensen TK, 2004, FERTIL STERIL, V82, P863, DOI 10.1016/j.fertnstert.2004.03.056; Kort HI, 2006, J ANDROL, V27, P450, DOI 10.2164/jandrol.05124; Law DCG, 2007, HUM REPROD, V22, P414, DOI 10.1093/humrep/de1400; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Liu Y, 2013, ANDROLOGY-US, V1, P75, DOI 10.1111/j.2047-2927.2012.00022.x; Liu Y, 2014, MOL REPROD DEV, V81, P315, DOI 10.1002/mrd.22300; Martini AC, 2010, FERTIL STERIL, V94, P1739, DOI 10.1016/j.fertnstert.2009.11.017; Mayes J S, 2004, Obes Rev, V5, P197, DOI 10.1111/j.1467-789X.2004.00152.x; Mruk DD, 2004, ENDOCR REV, V25, P747, DOI 10.1210/er.2003-0022; Nammi S, 2004, NUTR J, V3, DOI 10.1186/1475-2891-3-3; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Paasch U, 2010, FERTIL STERIL, V94, P2898, DOI 10.1016/j.fertnstert.2010.06.047; Pauli EM, 2008, FERTIL STERIL, V90, P346, DOI 10.1016/j.fertnstert.2007.06.046; Ruhayel Y, 2004, HUM REPROD, V19, P2076, DOI 10.1093/humrep/deh349; RUSSELL L, 1977, AM J ANAT, V148, P313, DOI 10.1002/aja.1001480303; Rybar R, 2011, ANDROLOGIA, V43, P286, DOI 10.1111/j.1439-0272.2010.01057.x; SCHNEIDER G, 1979, J CLIN ENDOCR METAB, V48, P633, DOI 10.1210/jcem-48-4-633; Shayeb AG, 2011, REPROD BIOMED ONLINE, V23, P717, DOI 10.1016/j.rbmo.2011.07.018; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; Tortoriello DV, 2004, ENDOCRINOLOGY, V145, P1238, DOI 10.1210/en.2003-1406; Wang RS, 2006, ENDOCRINOLOGY, V147, P5624, DOI 10.1210/en.2006-0138; Willems A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014168; Wu J, 2013, HEPATOLOGY, V58, P617, DOI 10.1002/hep.26272; Wu RC, 2013, P NATL ACAD SCI USA, V110, P4616, DOI 10.1073/pnas.1218318110; Xia WL, 2009, DEV BIOL, V327, P48, DOI 10.1016/j.ydbio.2008.11.028; Xiao X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004447; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Zain MM, 2008, WOMENS HEALTH, V4, P183, DOI 10.2217/17455057.4.2.183	44	112	123	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120775	10.1371/journal.pone.0120775	http://dx.doi.org/10.1371/journal.pone.0120775			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886196	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000011
J	Kawulok, J; Deorowicz, S				Kawulok, Jolanta; Deorowicz, Sebastian			CoMeta: Classification of Metagenomes Using k-mers	PLOS ONE			English	Article							MICROBIAL COMMUNITIES; BACTERIAL; IDENTIFICATION; DISCOVERY; PRODUCTS; RESOURCE; ESTERASE; GENE; SOIL	Nowadays, the study of environmental samples has been developing rapidly. Characterization of the environment composition broadens the knowledge about the relationship between species composition and environmental conditions. An important element of extracting the knowledge of the sample composition is to compare the extracted fragments of DNA with sequences derived from known organisms. In the presented paper, we introduce an algorithm called CoMeta (Classification of metagenomes), which assigns a query read (a DNA fragment) into one of the groups previously prepared by the user. Typically, this is one of the taxonomic rank (e.g., phylum, genus), however prepared groups may contain sequences having various functions. In CoMeta, we used the exact method for read classification using short subsequences (k-mers) and fast program for indexing large set of k-mers. In contrast to the most popular methods based on BLAST, where the query is compared with each reference sequence, we begin the classification from the top of the taxonomy tree to reduce the number of comparisons. The presented experimental study confirms that CoMeta outperforms other programs used in this context. CoMeta is available at https://github.com/jkawulok/cometa under a free GNU GPL 2 license.	[Kawulok, Jolanta; Deorowicz, Sebastian] Silesian Tech Univ, Inst Informat, Gliwice, Poland	Silesian University of Technology	Kawulok, J (corresponding author), Silesian Tech Univ, Inst Informat, Gliwice, Poland.	jolanta.kawulok@polsi.pl	Kawulok, Jolanta/AAD-9358-2020; Deorowicz, Sebastian/F-8386-2014	Kawulok, Jolanta/0000-0002-8321-7760; Deorowicz, Sebastian/0000-0002-9496-733X	Polish National Science Centre [DEC-2012/05/B/ST6/03148]; European Union from the European Social Fund [UDA-POKL.04.01.01-00-106/09]; "GeCONiI-Upper Silesian Center for Computational Science and Engineering" [POIG.02.03.01-24-099/13]; PL-Grid Infrastructure	Polish National Science Centre; European Union from the European Social Fund; "GeCONiI-Upper Silesian Center for Computational Science and Engineering"; PL-Grid Infrastructure	This work was supported by the Polish National Science Centre under the project DEC-2012/05/B/ST6/03148 and the European Union from the European Social Fund (grant agreement number: UDA-POKL.04.01.01-00-106/09). The work was performed using the infrastructure supported by POIG.02.03.01-24-099/13 grant: "GeCONiI-Upper Silesian Center for Computational Science and Engineering". This research was supported in part by PL-Grid Infrastructure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbai NS, 2012, MOL BIOTECHNOL, V50, P39, DOI 10.1007/s12033-011-9412-8; Ames SK, 2013, BIOINFORMATICS, V29, P2253, DOI 10.1093/bioinformatics/btt389; Bazinet AL, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-92; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brady A, 2009, NAT METHODS, V6, P673, DOI [10.1038/NMETH.1358, 10.1038/nmeth.1358]; Bruls T, 2011, HUM MOL GENET, V20, pR142, DOI 10.1093/hmg/ddr353; Committee on Metagenomics, 2007, NEW SCI MET REV SECR; Cui HF, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-641; Cyran KA, 2013, EMERGING PARADIGMS M, V13, P379; Deorowicz S, 2015, BIOINFORMATICS, V31, P1569, DOI 10.1093/bioinformatics/btv022; Deorowicz S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-160; Diaz NN, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-56; Fierer N, 2007, APPL ENVIRON MICROB, V73, P7059, DOI 10.1128/AEM.00358-07; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Gerlach W, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr225; GILBERT JR, 2008, NATL GEOGR, V213, P8; Gori F, 2011, BIOINFORMATICS, V27, P196, DOI 10.1093/bioinformatics/btq649; Handelsman J, 1998, CHEM BIOL, V5, pR245, DOI 10.1016/S1074-5521(98)90108-9; Handelsman J, 2004, MICROBIOL MOL BIOL R, V68, P669, DOI 10.1128/MMBR.68.4.669-685.2004; Haque MM, 2009, BIOINFORMATICS, V25, P1722, DOI 10.1093/bioinformatics/btp317; Hauser PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090934; Heath C, 2009, APPL ENVIRON MICROB, V75, P4657, DOI 10.1128/AEM.02597-08; Hess M, 2011, SCIENCE, V331, P463, DOI 10.1126/science.1200387; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Kawulok J, 2014, COMM COM INF SC, V424, P335; Kawulok M, 2012, LECT NOTES COMPUT SC, V7626, P557, DOI 10.1007/978-3-642-34166-3_61; Kennedy J, 2011, J APPL MICROBIOL, V111, P787, DOI 10.1111/j.1365-2672.2011.05106.x; Krogius-Kurikka L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-68; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Liu B, 2010, IEEE INT C BIOINFORM, P95, DOI 10.1109/BIBM.2010.5706544; Metzker ML, 2010, NAT REV GENET, V11, P31, DOI 10.1038/nrg2626; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Movahedi NS, 2012, 2012 IEEE INT C BIOI, P1; Nalbantoglu U, 2014, FOOD MICROBIOL, V41, P42, DOI 10.1016/j.fm.2014.01.014; Nguyen NH, 2012, BIOSCI BIOTECH BIOCH, V76, P1075, DOI 10.1271/bbb.110786; PACE NR, 1985, ASM NEWS, V51, P4; Patil KR, 2011, NAT METHODS, V8, P191, DOI 10.1038/nmeth0311-191; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rhee JK, 2005, APPL ENVIRON MICROB, V71, P817, DOI 10.1128/AEM.71.2.817-825.2005; Roberts M, 2004, BIOINFORMATICS, V20, P3363, DOI 10.1093/bioinformatics/bth408; Rosen GL, 2011, BIOINFORMATICS, V27, P127, DOI 10.1093/bioinformatics/btq619; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schreiber F, 2010, BIOINFORMATICS, V26, P960, DOI 10.1093/bioinformatics/btq070; Shafquat A, 2014, TRENDS MICROBIOL, V22, P261, DOI 10.1016/j.tim.2014.01.011; Simister R, 2012, ENVIRON MICROBIOL, V14, P3232, DOI 10.1111/1462-2920.12010; Simon C, 2011, APPL ENVIRON MICROB, V77, P1153, DOI 10.1128/AEM.02345-10; Simon C, 2009, APPL ENVIRON MICROB, V75, P7519, DOI 10.1128/AEM.00946-09; Stranneheim H, 2010, BIOINFORMATICS, V26, P1595, DOI 10.1093/bioinformatics/btq230; Thomas Torsten, 2012, Microb Inform Exp, V2, P3, DOI 10.1186/2042-5783-2-3; Wang DF, 2008, NEUROCOMPUTING, V71, P2772, DOI 10.1016/j.neucom.2007.09.008; Wang J, 2013, BRIEF BIOINFORM, V14, P575, DOI 10.1093/bib/bbt032; Wang ZH, 2014, RES J BIOTECHNOL, V9, P65; Wood DE, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r46; Yergeau E, 2010, APPL ENVIRON MICROB, V76, P5432, DOI 10.1128/AEM.00873-10	57	15	17	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121453	10.1371/journal.pone.0121453	http://dx.doi.org/10.1371/journal.pone.0121453			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884504	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000018
J	Stephan, K; Kavanagh, KL; Koyama, A				Stephan, Kirsten; Kavanagh, Kathleen L.; Koyama, Akihiro			Comparing the Influence of Wildfire and Prescribed Burns on Watershed Nitrogen Biogeochemistry Using N-15 Natural Abundance in Terrestrial and Aquatic Ecosystem Components	PLOS ONE			English	Article							NITRATE REDUCTASE-ACTIVITY; DIFFUSION METHOD; FIRE SEVERITY; CENTRAL IDAHO; DYNAMICS; TRANSFORMATIONS; NITRIFICATION; AVAILABILITY; ADAPTATION; DELTA-N-15	We evaluated differences in the effects of three low-severity spring prescribed burns and four wildfires on nitrogen (N) biogeochemistry in Rocky Mountain headwater watersheds. We compared paired (burned/unburned) watersheds of four wildfires and three spring prescribed burns for three growing seasons post-fire. To better understand fire effects on the entire watershed ecosystem, we measured N concentrations and delta N-15 in both the terrestrial and aquatic ecosystems components, i.e., soil, understory plants in upland and riparian areas, streamwater, and in-stream moss. In addition, we measured nitrate reductase activity in foliage of Spiraea betulifolia, a dominant understory species. We found increases of delta N-15 and N concentrations in both terrestrial and aquatic ecosystem N pools after wildfire, but responses were limited to terrestrial N pools after prescribed burns indicating that N transfer from terrestrial to aquatic ecosystem components did not occur in low-severity prescribed burns. Foliar delta N-15 differed between wildfire and prescribed burn sites; the delta N-15 of foliage of upland plants was enriched by 2.9 parts per thousand (difference between burned and unburned watersheds) in the first two years after wildfire, but only 1.3 parts per thousand after prescribed burns. In-stream moss delta N-15 in wildfire-burned watersheds was enriched by 1.3 parts per thousand, but there was no response by moss in prescription-burned watersheds, mirroring patterns of streamwater nitrate concentrations. S. betulifolia showed significantly higher nitrate reductase activity two years after wildfires relative to corresponding unburned watersheds, but no such difference was found after prescribed burns. These responses are consistent with less altered N biogeochemistry after prescribed burns relative to wildfire. We concluded that delta N-15 values in terrestrial and aquatic plants and streamwater nitrate concentrations after fire can be useful indicators of the magnitude and duration of fire effects and the fate of post-fire available N.	[Stephan, Kirsten; Kavanagh, Kathleen L.; Koyama, Akihiro] Univ Idaho, Forest Rangeland & Fire Sci, Moscow, ID 83843 USA; [Stephan, Kirsten] Lincoln Univ, Dept Life & Phys Sci & Cooperat Res, Jefferson City, MO USA	Idaho; University of Idaho; Lincoln University - Missouri	Stephan, K (corresponding author), Univ Idaho, Forest Rangeland & Fire Sci, Moscow, ID 83843 USA.	stephank@lincolnu.edu	Koyama, Akihiro/E-4868-2019	Koyama, Akihiro/0000-0002-3854-1035	Joint Fire Science Program [04-2-1-97, 05-2-1-41]; McIntire-Stennis Cooperative Forestry Research Program [MOXStephan2]	Joint Fire Science Program; McIntire-Stennis Cooperative Forestry Research Program	This work was supported by Joint Fire Science Program, Project ID: 04-2-1-97, Project ID: 05-2-1-41 (www.firescience.gov) to KLK, and McIntire-Stennis Cooperative Forestry Research Program, Project No.: MOXStephan2 to KS at Lincoln University of Missouri. http://www.csrees.usda.gov/business/awards/formula/mcintire_stennis.html The funders had no role in study design, data collection	Ashkenas LR, 2004, ECOLOGY, V85, P1725, DOI 10.1890/03-0032; Beghin R, 2011, TREES-STRUCT FUNCT, V25, P627, DOI 10.1007/s00468-011-0539-9; Belillas CM, 1998, INT J WILDLAND FIRE, V8, P87, DOI 10.1071/WF9980087; Binkley D., 2012, ECOLOGY MANAGEMENT F, V4th; Chambers C, 2004, OECOLOGIA, V140, P125, DOI 10.1007/s00442-004-1565-8; DAVIDSON EA, 1991, J SOIL SCI, V42, P335, DOI 10.1111/j.1365-2389.1991.tb00413.x; Debano L.F., 1998, FIRE EFFECTS ECOSYST; Dunnette PV, 2014, NEW PHYTOL, V203, P900, DOI 10.1111/nph.12828; Evans RD, 2001, TRENDS PLANT SCI, V6, P121, DOI 10.1016/S1360-1385(01)01889-1; FILNER P, 1966, BIOCHIM BIOPHYS ACTA, V118, P299, DOI 10.1016/S0926-6593(66)80038-3; GARTEN CT, 1994, CAN J FOREST RES, V24, P1636, DOI 10.1139/x94-212; GEBAUER G, 1984, OECOLOGIA, V63, P136, DOI 10.1007/BF00379795; GRIER C C, 1975, Canadian Journal of Forest Research, V5, P599, DOI 10.1139/x75-087; Grogan P, 2000, OECOLOGIA, V122, P537, DOI 10.1007/s004420050977; Hauer FR, 1998, INT J WILDLAND FIRE, V8, P183, DOI 10.1071/WF9980183; Hobbie EA, 2000, OECOLOGIA, V122, P273, DOI 10.1007/PL00008856; Hogberg P, 1997, NEW PHYTOL, V137, P179, DOI 10.1046/j.1469-8137.1997.00808.x; HOGBERG P, 1993, PLANT SOIL, V157, P147, DOI 10.1007/BF02390237; Hogbom L, 2002, FOREST ECOL MANAG, V160, P273, DOI 10.1016/S0378-1127(01)00475-3; Holmes RM, 1998, MAR CHEM, V60, P235, DOI 10.1016/S0304-4203(97)00099-6; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Key C., 2006, FIREMON FIRE EFFECTS, pLA1; Koyama A, 2007, THESIS U IDAHO; Koyama A, 2012, INT J WILDLAND FIRE, V21, P69, DOI 10.1071/WF10132; Koyama A, 2010, ECOSYSTEMS, V13, P1112, DOI 10.1007/s10021-010-9377-7; LeDuc SD, 2013, PLANT SOIL, V373, P955, DOI 10.1007/s11104-013-1856-0; Lee J. A., 1979, ADV BOT RES, V6, P1; Lentile LB, 2006, INT J WILDLAND FIRE, V15, P319, DOI 10.1071/WF05097; Michelsen A, 1998, OECOLOGIA, V115, P406, DOI 10.1007/s004420050535; Mulholland PJ, 2000, VERHANDLUNGEN INT VE, V27, P1320, DOI DOI 10.1080/03680770.1998.11901450; Nadelhoffer K, 1996, OECOLOGIA, V107, P386, DOI 10.1007/BF00328456; Nadelhoffer K, 1999, ENVIRON MONIT ASSESS, V55, P187, DOI 10.1023/A:1006190222768; Nakano S, 2001, P NATL ACAD SCI USA, V98, P166, DOI 10.1073/pnas.98.1.166; Pardo LH, 2002, CAN J FOREST RES, V32, P1126, DOI [10.1139/x02-041, 10.1139/X02-041]; Peterson BJ, 2001, SCIENCE, V292, P86, DOI 10.1126/science.1056874; RAISON RJ, 1979, PLANT SOIL, V51, P73, DOI 10.1007/BF02205929; Robinson D, 2001, TRENDS ECOL EVOL, V16, P153, DOI 10.1016/S0169-5347(00)02098-X; Saito L, 2007, J ENVIRON QUAL, V36, P91, DOI 10.2134/jeq2006.0233; Sanzone DM, 2003, OECOLOGIA, V134, P238, DOI 10.1007/s00442-002-1113-3; SCHOCH P, 1986, FOREST ECOL MANAG, V14, P13, DOI 10.1016/0378-1127(86)90049-6; SHEARER G, 1974, SOIL SCI SOC AM J, V38, P315, DOI 10.2136/sssaj1974.03615995003800020030x; Sigman DM, 1997, MAR CHEM, V57, P227, DOI 10.1016/S0304-4203(97)00009-1; Silins U, 2014, ECOHYDROLOGY, V7, P1508, DOI 10.1002/eco.1474; Smithwick EAH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050597; Spencer CN, 2003, FOREST ECOL MANAG, V178, P141, DOI 10.1016/S0378-1127(03)00058-6; Stark JM, 1997, NATURE, V385, P61, DOI 10.1038/385061a0; Stephan K, 2012, FOREST ECOL MANAG, V263, P240, DOI 10.1016/j.foreco.2011.09.013; Stephan K, 2010, FIRE ECOL, V6, P95, DOI 10.4996/fireecology.0601095; Stephan K, 2009, SOIL SCI SOC AM J, V73, P293, DOI 10.2136/sssaj2007.0079; STEWART GR, 1973, NEW PHYTOL, V72, P539, DOI 10.1111/j.1469-8137.1973.tb04405.x; STEWART GR, 1993, PLANT CELL ENVIRON, V16, P351, DOI 10.1111/j.1365-3040.1993.tb00881.x; Templer PH, 2012, ECOLOGY, V93, P1816, DOI 10.1890/11-1146.1; Turner MG, 2011, ECOSYSTEMS, V14, P1081, DOI 10.1007/s10021-011-9465-3; Vallano DM, 2008, NEW PHYTOL, V177, P946, DOI 10.1111/j.1469-8137.2007.02311.x; VanderSchaaf CL, 2004, FOREST ECOL MANAG, V190, P201, DOI 10.1016/j.foreco.2003.10.014; Wallenda T, 1998, NEW PHYTOL, V139, P169, DOI 10.1046/j.1469-8137.1998.00176.x; Wan SQ, 2001, ECOL APPL, V11, P1349, DOI 10.1890/1051-0761(2001)011[1349:FEONPA]2.0.CO;2	57	18	18	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119560	10.1371/journal.pone.0119560	http://dx.doi.org/10.1371/journal.pone.0119560			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885257	Green Published, gold			2022-12-27	WOS:000353017000004
J	Varga, Z; Cassoly, E; Li, QY; Oehlschlegel, C; Tapia, C; Lehr, HA; Klingbiel, D; Thurlimann, B; Ruhstaller, T				Varga, Zsuzsanna; Cassoly, Estelle; Li, Qiyu; Oehlschlegel, Christian; Tapia, Coya; Lehr, Hans Anton; Klingbiel, Dirk; Thuerlimann, Beat; Ruhstaller, Thomas			Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; PREDICTIVE-VALUE; PRIMARY THERAPY; LABELING INDEX; KI67; PROLIFERATION; REPRODUCIBILITY; HIGHLIGHTS; WOMEN	Background Proliferative activity (Ki-67 Labelling Index) in breast cancer increasingly serves as an additional tool in the decision for or against adjuvant chemotherapy in midrange hormone receptor positive breast cancer. Ki-67 Index has been previously shown to suffer from high inter-observer variability especially in midrange (G2) breast carcinomas. In this study we conducted a systematic approach using different Ki-67 assessments on large tissue sections in order to identify the method with the highest reliability and the lowest variability. Materials and Methods Five breast pathologists retrospectively analyzed proliferative activity of 50 G2 invasive breast carcinomas using large tissue sections by assessing Ki-67 immunohistochemistry. Ki-67-assessments were done on light microscopy and on digital images following these methods: 1) assessing five regions, 2) assessing only darkly stained nuclei and 3) considering only condensed proliferative areas ('hotspots'). An individual review (the first described assessment from 2008) was also performed. The assessments on light microscopy were done by estimating. All measurements were performed three times. Inter-observer and intra-observer reliabilities were calculated using the approach proposed by Eliasziw et al. Clinical cutoffs (14% and 20%) were tested using Fleiss' Kappa. Results There was a good intra-observer reliability in 5 of 7 methods (ICC: 0.76-0.89). The two highest inter-observer reliability was fair to moderate (ICC: 0.71 and 0.74) in 2 methods (region-analysis and individual-review) on light microscopy. Fleiss'-kappa-values (14% cut-off) were the highest (moderate) using the original recommendation on light-microscope (Kappa 0.58). Fleiss' kappa values (20% cut-off) were the highest (Kappa 0.48 each) in analyzing hotspots on light-microscopy and digital-analysis. No methodologies using digital-analysis were superior to the methods on light microscope. Conclusion Our results show that all methods on light-microscopy for Ki-67 assessment in large tissue sections resulted in a good intra-observer reliability. Region analysis and individual review (the original recommendation) on light-microscopy yielded the highest inter-observer reliability. These results show slight improvement to previously published data on poor-reproducibility and thus might be a practical-pragmatic way for routine assessment of Ki-67 Index in G2 breast carcinomas.	[Varga, Zsuzsanna] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland; [Cassoly, Estelle; Li, Qiyu; Klingbiel, Dirk; Thuerlimann, Beat] Swiss Grp Clin Canc Res, Bern, Switzerland; [Oehlschlegel, Christian] Cantonal Hosp St Gallen, Inst Pathol, St Gallen, Switzerland; [Tapia, Coya] Univ Bern, Inst Pathol, Bern, Switzerland; [Lehr, Hans Anton] Inst Pathol, Friedrichshafen, Friedrichshafen, Germany; [Thuerlimann, Beat; Ruhstaller, Thomas] Cantonal Hosp St Gallen, Breast Ctr, St Gallen, Switzerland	University of Zurich; University Zurich Hospital; Swiss Group for Clinical Cancer Research (SAKK); Kantonsspital St. Gallen; University of Bern; Kantonsspital St. Gallen	Varga, Z (corresponding author), Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland.	zsuzsanna.varga@usz.ch		Klingbiel, Dirk/0000-0002-9914-0243	Empiris Foundation Zurich, Switzerland; Swiss Group for Clinical Cancer Research Bern, Switzerland, SAKK [SAKK 28/12]; State Secretariat for Education, Research and Innovation, Switzerland	Empiris Foundation Zurich, Switzerland; Swiss Group for Clinical Cancer Research Bern, Switzerland, SAKK; State Secretariat for Education, Research and Innovation, Switzerland	Empiris Foundation Zurich, Switzerland (funding receiver: ZV and Swiss Group for Clinical Cancer Research). Swiss Group for Clinical Cancer Research Bern, Switzerland, SAKK (funding receiver was the study itself, numbered as SAKK 28/12). State Secretariat for Education, Research and Innovation, Switzerland (funding receiver was the SAKK).	Allison KH, 2012, BREAST CANCER RES TR, V131, P413, DOI 10.1007/s10549-011-1416-3; Christgen M, 2014, PATHOLOGE, V35, P54, DOI 10.1007/s00292-013-1843-5; Cserni G, 2014, BREAST, V23, P259, DOI 10.1016/j.breast.2014.02.003; Denkert C, 2013, ANN ONCOL, V24, P2786, DOI 10.1093/annonc/mdt350; Dowsett M, 2011, JNCI-J NATL CANCER I, V103, P1656, DOI 10.1093/jnci/djr393; ELIASZIW M, 1994, PHYS THER, V74, P777, DOI 10.1093/ptj/74.8.777; ELSTON CW, 1991, HISTOPATHOLOGY, V19, P403, DOI 10.1111/j.1365-2559.1991.tb00229.x; Fasanella S, 2011, DIAGN PATHOL, V6, DOI 10.1186/1746-1596-6-S1-S7; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gong P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054912; Gudlaugsson E, 2012, HISTOPATHOLOGY, V61, P1134, DOI 10.1111/j.1365-2559.2012.04329.x; Ingoldsby H, 2013, BREAST, V22, P879, DOI 10.1016/j.breast.2013.04.008; Luporsi E, 2012, BREAST CANCER RES TR, V132, P895, DOI 10.1007/s10549-011-1837-z; Obermann EC, 2012, PATHOLOGE, V33, P245, DOI 10.1007/s00292-012-1583-y; Pavlakis K, 2012, BREAST, V21, P529, DOI 10.1016/j.breast.2012.04.004; Polley MYC, 2013, JNCI-J NATL CANCER I, V105, P1897, DOI 10.1093/jnci/djt306; Tuominen VJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2615; Varga Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058483; Varga Z, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037379; Viale G, 2008, JNCI-J NATL CANCER I, V100, P207, DOI 10.1093/jnci/djm289; Viale G, 2008, J CLIN ONCOL, V26, P5569, DOI 10.1200/JCO.2008.17.0829; Voros A, 2014, PATHOLOGY ONCOLOGY R; Williams DJ, 2011, APPL IMMUNOHISTO M M, V19, P431, DOI 10.1097/PAI.0b013e318206d23d	24	30	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123435	10.1371/journal.pone.0123435	http://dx.doi.org/10.1371/journal.pone.0123435			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885288	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353017000064
J	Zhou, Z; He, HL; Ma, LP; Yu, XQ; Mi, Q; Pang, JS; Tang, GX; Liu, B				Zhou, Zheng; He, Hongli; Ma, Luping; Yu, Xiaoqian; Mi, Qian; Pang, Jingsong; Tang, Guixiang; Liu, Bao			Overexpression of a GmCnx1 Gene Enhanced Activity of Nitrate Reductase and Aldehyde Oxidase, and Boosted Mosaic Virus Resistance in Soybean	PLOS ONE			English	Article							MOLYBDENUM COFACTOR BIOSYNTHESIS; XANTHINE DEHYDROGENASE; ABSCISIC-ACID; ARABIDOPSIS; ACCUMULATION; MUTANTS; DROUGHT; ENCODES; BIOLOGY; STRESS	Molybdenum cofactor (Moco) is required for the activities of Moco-dependant enzymes. Cofactor for nitrate reductase and xanthine dehydrogenase (Cnx1) is known to be involved in the biosynthesis of Moco in plants. In this work, a soybean (Glycine maxL.) Cnx1-gene (GmCnx1) was transferred into soybean using Agrobacterium tumefaciens-mediated transformation method. Twenty seven positive transgenic soybean plants were identified by coating leaves with phosphinothricin, bar protein quick dip stick and PCR analysis. Moreover, Southern blot analysis was carried out to confirm the insertion of GmCnx1 gene. Furthermore, expression of GmCnx1 gene in leaf and root of all transgenic lines increased 1.04-2.12 and 1.55-3.89 folds, respectively, as compared to wild type with GmCnx1 gene and in line 10, 22 showing the highest expression. The activities of Moco-related enzymes viznitrate reductase (NR) and aldehydeoxidase (AO) of T-1 generation plants revealed that the best line among the GmCnx1 transgenic plants accumulated 4.25 mu g g(-1) h(-1) and30 pmol L-1, respectively (approximately 2.6-fold and 3.9-fold higher than non-transgenic control plants). In addition, overexpression ofGmCnx1boosted the resistance to various strains of soybean mosaic virus (SMV). DAS-ELISA analysis further revealed that infection rate of GmCnx1 transgenic plants were generally lower than those of non-transgenic plants among two different virus strains tested. Taken together, this study showed that overexpression of a GmCnx1 gene enhanced NR and AO activities and SMV resistance, suggesting its important role in soybean genetic improvement.	[Zhou, Zheng; Ma, Luping; Yu, Xiaoqian; Mi, Qian; Tang, Guixiang] Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China; [He, Hongli; Pang, Jingsong; Liu, Bao] NE Normal Univ, Minist Educ MOE, Mol Epigenetices, Changchun, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Zhejiang University; Northeast Normal University - China	Tang, GX (corresponding author), Zhejiang Univ, Inst Crop Sci, Coll Agr & Biotechnol, Hangzhou 310003, Zhejiang, Peoples R China.	tanggx@zju.edu.cn		Zhou, Zheng/0000-0002-9614-5751; Liu, Bao/0000-0001-5481-1675; zakaria, seyed moein/0000-0002-0086-1279	National Natural Science Foundation of China [31071443]; National Major Special Project for Transgenic Organisms, Ministry of Agriculture in China [2013ZX08004-004-008, 2014ZX08004-004-008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Major Special Project for Transgenic Organisms, Ministry of Agriculture in China	Support was provided by the National Natural Science Foundation of China (no. 31071443), [http://www.nsfc.gov.cn/] and the National Major Special Project for Transgenic Organisms, Ministry of Agriculture in China (nos. 2013ZX08004-004-008 and 2014ZX08004-004-008), [http://www.ny3721.com/url/2805/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bittner F, 2010, PLANT CELL MONOGR, V17, P119, DOI [10.1016/j.bbamcr.2006.03.013, 10.1007/978-3-642-10613-2_6]; Campbell WH, 1999, ANNU REV PLANT PHYS, V50, P277, DOI 10.1146/annurev.arplant.50.1.277; Campbell WH, 2001, CELL MOL LIFE SCI, V58, P194, DOI 10.1007/PL00000847; Crawford Nigel M, 2002, Arabidopsis Book, V1, pe0011, DOI 10.1199/tab.0011; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; He HL, 2011, THESIS NE NORMAL U C; Hille R, 1996, CHEM REV, V96, P2757, DOI 10.1021/cr950061t; HINCHEE MAW, 1988, BIO-TECHNOL, V6, P915, DOI 10.1038/nbt0888-915; Hoagland D.R., 1950, CALIF AES C, V347, P1, DOI DOI 10.1016/S0140-6736(00)73482-9; Kleinhofs A., 1989, Molecular and genetic aspects of nitrate assimilation., P197; Koshiba T, 1996, PLANT PHYSIOL, V110, P781, DOI 10.1104/pp.110.3.781; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Li YJ, 2013, PLANT BIOTECHNOL J, V11, P747, DOI 10.1111/pbi.12066; Mauch-Mani B, 2005, CURR OPIN PLANT BIOL, V8, P409, DOI 10.1016/j.pbi.2005.05.015; Mendel RR, 2007, J EXP BOT, V58, P2289, DOI 10.1093/jxb/erm024; Mendel RR, 2011, COORDIN CHEM REV, V255, P1145, DOI 10.1016/j.ccr.2011.01.054; MENDEL RR, 1976, BIOCHEM PHYSIOL PFL, V170, P538; Mendel RR, 2002, MET IONS BIOL SYST, V39, P317; MENDEL RR, 1978, MOL GEN GENET, V161, P77, DOI 10.1007/BF00266617; Mendel RR, 2002, J EXP BOT, V53, P1689, DOI 10.1093/jxb/erf038; Muller A. J., 1989, Molecular and genetic aspects of nitrate assimilation., P166; Paz MM, 2006, PLANT CELL REP, V25, P206, DOI 10.1007/s00299-005-0048-7; ROTHE GM, 1974, PLANT CELL PHYSIOL, V15, P493; Sagi M, 1998, PLANT SCI, V135, P17, DOI 10.1016/S0168-9452(98)00084-3; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarz G, 2000, PLANT CELL, V12, P2455, DOI 10.1105/tpc.12.12.2455; Schwarz G, 2006, ANNU REV PLANT BIOL, V57, P623, DOI 10.1146/annurev.arplant.57.032905.105437; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; STALLMEYER B, 1995, PLANT J, V8, P751, DOI 10.1046/j.1365-313X.1995.08050751.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Verslues PE, 2005, BIOCHEM SOC T, V33, P375, DOI 10.1042/BST0330375; WALKERSIMMONS M, 1989, PLANT PHYSIOL, V90, P728, DOI 10.1104/pp.90.2.728; [王晓丹 Wang Xiaodan], 2004, [分子植物育种, Molecular Plant Breeding], V2, P891; Xiong LM, 2001, PLANT CELL, V13, P2063, DOI 10.1105/tpc.13.9.2063; Xue ZG, 2012, MOL BIOL REP, V39, P1411, DOI 10.1007/s11033-011-0875-2; Yang SH, 2003, PLANT CELL PHYSIOL, V44, P1037, DOI 10.1093/pcp/pcg122; Yang XF, 2011, THESIS ZHEJIANG U HA; Yang XiaoFeng, 2013, Acta Agronomica Sinica, V39, P216, DOI 10.3724/SP.J.1006.2013.00216; Yesbergenova Z, 2005, PLANT J, V42, P862, DOI 10.1111/j.1365-313X.2005.02422.x; Zhang ZY, 1999, PLANT CELL TISS ORG, V56, P37, DOI 10.1023/A:1006298622969	40	19	24	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124273	10.1371/journal.pone.0124273	http://dx.doi.org/10.1371/journal.pone.0124273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886067	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000110
J	Beretta-Piccoli, M; D'Antona, G; Barbero, M; Fisher, B; Dieli-Conwright, CM; Clijsen, R; Cescon, C				Beretta-Piccoli, Matteo; D'Antona, Giuseppe; Barbero, Marco; Fisher, Beth; Dieli-Conwright, Christina M.; Clijsen, Ron; Cescon, Corrado			Evaluation of Central and Peripheral Fatigue in the Quadriceps Using Fractal Dimension and Conduction Velocity in Young Females	PLOS ONE			English	Article							MUSCLE-FIBER-TYPE; VASTUS LATERALIS MUSCLE; SURFACE EMG PARAMETERS; UPPER TRAPEZIUS MUSCLE; SEX-DIFFERENCES; VOLUNTARY ACTIVATION; MYOELECTRIC MANIFESTATIONS; ISOMETRIC CONTRACTIONS; NEUROMUSCULAR FUNCTION; DYNAMIC CONTRACTIONS	Purpose Over the past decade, linear and non-linear surface electromyography descriptors for central and peripheral components of fatigue have been developed. In the current study, we tested fractal dimension (FD) and conduction velocity (CV) as myoelectric descriptors of central and peripheral fatigue, respectively. To this aim, we analyzed FD and CV slopes during sustained fatiguing contractions of the quadriceps femoris in healthy humans. Methods A total of 29 recreationally active women (mean age +/- standard deviation: 24 +/- 4 years) and two female elite athletes (one power athlete, age 24 and one endurance athlete, age 30 years) performed two knee extensions: (1) at 20% maximal voluntary contraction (MVC) for 30 s, and (2) at 60% MVC held until exhaustion. Surface EMG signals were detected from the vastus lateralis and vastus medialis using bidimensional arrays. Results Central and peripheral fatigue were described as decreases in FD and CV, respectively. A positive correlation between FD and CV (R=0.51, p<0.01) was found during the sustained 60% MVC, probably as a result of simultaneous motor unit synchronization and a decrease in muscle fiber CV during the fatiguing task. Conclusions Central and peripheral fatigue can be described as changes in FD and CV, at least in young, healthy women. The significant correlation between FD and CV observed at 60% MVC suggests that a mutual interaction between central and peripheral fatigue can arise during submaximal isometric contractions.	[Beretta-Piccoli, Matteo; Barbero, Marco; Cescon, Corrado] Univ Appl Sci & Arts Southern Switzerland, SUPSI, Dept Business Econ Hlth & Social Care, Rehabil Res Lab, Manno, Switzerland; [D'Antona, Giuseppe] Univ Pavia, Dept Mol Med, I-27100 Pavia, Italy; [D'Antona, Giuseppe] Univ Pavia, Sport Med Ctr Voghera, I-27100 Pavia, Italy; [Fisher, Beth; Dieli-Conwright, Christina M.] Univ So Calif, Div Biokinesiol & Phys Therapy, Los Angeles, CA USA; [Clijsen, Ron] Univ Appl Sci & Arts Southern Switzerland, SUPSI, Dept Business Econ Hlth & Social Care, Landquart, Switzerland	University of Pavia; University of Pavia; University of Southern California	Beretta-Piccoli, M (corresponding author), Univ Appl Sci & Arts Southern Switzerland, SUPSI, Dept Business Econ Hlth & Social Care, Rehabil Res Lab, Manno, Switzerland.	matteo.berettapiccoli@supsi.ch	Barbero, Marco/G-3667-2010; Barbero, Marco/AAF-9467-2020; Fisher, Beth E/G-5430-2012	Barbero, Marco/0000-0001-8579-0686; Barbero, Marco/0000-0001-8579-0686; D'Antona, Giuseppe/0000-0002-0683-5565; Cescon, Corrado/0000-0002-1632-6684; Beretta-Piccoli, Matteo/0000-0003-4794-2540	Thim van der Laan Foundation, Landquart, Switzerland; French Muscular Dystrophy Association, Paris, France [17191]	Thim van der Laan Foundation, Landquart, Switzerland; French Muscular Dystrophy Association, Paris, France	This study was supported by the Thim van der Laan Foundation, Landquart, Switzerland (to MBP, MB, RC, and CC), and by the French Muscular Dystrophy Association (http://www.afm-telethon.com), Paris, France (grant 17191 to GD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam A, 2003, J NEUROPHYSIOL, V90, P2919, DOI 10.1152/jn.00179.2003; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; ALLEN GM, 1995, MUSCLE NERVE, V18, P593, DOI 10.1002/mus.880180605; ANMUTH CJ, 1994, MUSCLE NERVE, V17, P953, DOI 10.1002/mus.880170819; Barbero M., 2012, ATLAS MUSCLE INNERVA, DOI [10.1007/978-88-470-2463-2, DOI 10.1007/978-88-470-2463-2]; Bernardi M, 1997, Electromyogr Clin Neurophysiol, V37, P3; BIGLANDRITCHIE B, 1978, CLIN SCI MOL MED, V54, P609, DOI 10.1042/cs0540609; BIGLANDRITCHIE B, 1986, ACTA PHYSIOL SCAND, V128, P137; Bilodeau M, 1994, Electromyogr Clin Neurophysiol, V34, P149; Bilodeau M, 2003, J ELECTROMYOGR KINES, V13, P83, DOI 10.1016/S1050-6411(02)00050-0; Bilodeau M, 2006, MUSCLE NERVE, V34, P205, DOI 10.1002/mus.20572; Blijham PJ, 2006, J APPL PHYSIOL, V100, P1837, DOI 10.1152/japplphysiol.01009.2005; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; BOUISSOU P, 1989, J APPL PHYSIOL, V67, P1245, DOI 10.1152/jappl.1989.67.3.1245; BRODY LR, 1991, J APPL PHYSIOL, V71, P1878, DOI 10.1152/jappl.1991.71.5.1878; BUCHTHAL F, 1955, ACTA PHYSIOL SCAND, V35, P174, DOI 10.1111/j.1748-1716.1955.tb01276.x; Clark BC, 2003, J APPL PHYSIOL, V94, P2263, DOI 10.1152/japplphysiol.00926.2002; de Haan A, 2009, J APPL PHYSIOL, V107, P355, DOI 10.1152/japplphysiol.91220.2008a; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; Debold EP, 2012, J APPL PHYSIOL, V113, P1413, DOI 10.1152/japplphysiol.00775.2012; Dedering A, 2000, J ELECTROMYOGR KINES, V10, P151, DOI 10.1016/S1050-6411(00)00009-2; Dimitrov GV, 2006, MED SCI SPORT EXER, V38, P1971, DOI 10.1249/01.mss.0000233794.31659.6d; ECKMANN JP, 1987, EUROPHYS LETT, V4, P973, DOI 10.1209/0295-5075/4/9/004; EDGERTON VR, 1975, HISTOCHEM J, V7, P259, DOI 10.1007/BF01003594; Farina D, 2004, J APPL PHYSIOL, V97, P2035, DOI 10.1152/japplphysiol.00606.2004; Farina D, 2003, IEEE T BIO-MED ENG, V50, P1340, DOI 10.1109/TBME.2003.819847; Farina D, 2002, BIOL CYBERN, V86, P445, DOI 10.1007/s00422-002-0309-2; Farina D, 2008, J ELECTROMYOGR KINES, V18, P16, DOI 10.1016/j.jelekin.2006.08.005; Fitts RH, 2003, AM J PHYS MED REHAB, V82, P320, DOI 10.1097/01.PHM.0000059336.40487.9C; FROESE EA, 1985, J APPL PHYSIOL, V59, P309, DOI 10.1152/jappl.1985.59.2.309; Gandevia SC, 2001, PHYSIOL REV, V81, P1725, DOI 10.1152/physrev.2001.81.4.1725; Gandevia SC, 1995, ADV EXP MED BIOL, V384, P281; Gandevia SC, 1998, ACTA PHYSIOL SCAND, V162, P275, DOI 10.1046/j.1365-201X.1998.0299f.x; Gerdle B, 1997, ACTA PHYSIOL SCAND, V160, P341, DOI 10.1046/j.1365-201X.1997.00167.x; Gerdle B, 2000, EUR J APPL PHYSIOL O, V81, P2, DOI 10.1007/PL00013792; GITTER JA, 1995, J NEUROSCI METH, V58, P103, DOI 10.1016/0165-0270(94)00164-C; Gonzalez-Izal M, 2012, J ELECTROMYOGR KINES, V22, P501, DOI 10.1016/j.jelekin.2012.02.019; Gronlund C, 2009, J ELECTROMYOGR KINES, V19, P242, DOI 10.1016/j.jelekin.2007.07.012; Gupta V, 1997, INT J MED INFORM, V45, P185, DOI 10.1016/S1386-5056(97)00029-4; Hunter SK, 2014, ACTA PHYSIOL, V210, P768, DOI 10.1111/apha.12234; Hunter SK, 2006, J APPL PHYSIOL, V101, P1036, DOI 10.1152/japplphysiol.00103.2006; Hunter SK, 2009, MUSCLE NERVE, V39, P42, DOI 10.1002/mus.21203; Hunter SK, 2004, J APPL PHYSIOL, V96, P195, DOI 10.1152/japplphysiol.00893.2003; Hunter SK, 2002, J NEUROPHYSIOL, V88, P3087, DOI 10.1152/jn.00232.2002; Jayaraman A, 2006, SPINAL CORD, V44, P680, DOI 10.1038/sj.sc.3101892; JOHNSON MA, 1973, J NEUROL SCI, V20, P345, DOI 10.1016/0022-510X(73)90169-X; Karlsson JS, 2003, J ELECTROMYOGR KINES, V13, P461, DOI 10.1016/S1050-6411(03)00063-4; Kent-Braun JA, 1999, EUR J APPL PHYSIOL O, V80, P57, DOI 10.1007/s004210050558; KentBraun JA, 1996, MUSCLE NERVE, V19, P861, DOI 10.1002/(SICI)1097-4598(199607)19:7<861::AID-MUS8>3.0.CO;2-7; Kleine BU, 2001, J APPL PHYSIOL, V91, P1588, DOI 10.1152/jappl.2001.91.4.1588; Kollmitzer J, 1999, CLIN NEUROPHYSIOL, V110, P725, DOI 10.1016/S1388-2457(98)00050-9; KOMI PV, 1979, EUR J APPL PHYSIOL, V42, P41, DOI 10.1007/BF00421103; KRANZ H, 1985, J APPL PHYSIOL, V59, P821, DOI 10.1152/jappl.1985.59.3.821; KUPA EJ, 1995, J APPL PHYSIOL, V79, P23, DOI 10.1152/jappl.1995.79.1.23; LINSSEN WHJP, 1993, MUSCLE NERVE, V16, P849, DOI 10.1002/mus.880160808; Madhavan S, 2011, CLIN NEUROPHYSIOL, V122, P1588, DOI 10.1016/j.clinph.2011.01.011; Masuda K, 1999, J ELECTROMYOGR KINES, V9, P39, DOI 10.1016/S1050-6411(98)00021-2; MAUGHAN RJ, 1986, EUR J APPL PHYSIOL, V55, P395, DOI 10.1007/BF00422739; Merletti R, 1998, MUSCLE NERVE, V21, P184; Merletti R, 1996, J ORTHOP SPORT PHYS, V24, P342, DOI 10.2519/jospt.1996.24.6.342; Merletti R., 2004, ELECTROMYOGRAPHY PHY; Mesin L, 2009, J ELECTROMYOGR KINES, V19, P851, DOI 10.1016/j.jelekin.2008.08.003; Millet GY, 2011, EUR J APPL PHYSIOL, V111, P2489, DOI 10.1007/s00421-011-1996-y; Millet GY, 2002, J APPL PHYSIOL, V92, P486, DOI 10.1152/japplphysiol.00122.2001; Ng JKF, 1996, ARCH PHYS MED REHAB, V77, P259, DOI 10.1016/S0003-9993(96)90108-2; Nybo L, 2004, PROG NEUROBIOL, V72, P223, DOI 10.1016/j.pneurobio.2004.03.005; Piccoli MB, 2014, MUSCLE NERVE, V49, P413, DOI 10.1002/mus.23934; Place N, 2007, MUSCLE NERVE, V35, P486, DOI 10.1002/mus.20714; Rainoldi A, 2001, J ELECTROMYOGR KINES, V11, P425, DOI 10.1016/S1050-6411(01)00022-0; Rainoldi A, 2008, J ELECTROMYOGR KINES, V18, P1032, DOI 10.1016/j.jelekin.2007.05.008; Romani A, 2008, NEUROL SCI, V29, pS247, DOI 10.1007/s10072-008-0952-z; Russ DW, 2005, MUSCLE NERVE, V32, P647, DOI 10.1002/mus.20396; Russ DW, 2003, J APPL PHYSIOL, V94, P2414, DOI 10.1152/japplphysiol.01145.2002; SADOYAMA T, 1988, EUR J APPL PHYSIOL O, V57, P767, DOI 10.1007/BF01076001; Schillings ML, 2003, EUR J APPL PHYSIOL, V90, P562, DOI 10.1007/s00421-003-0913-4; Stalberg E, 1966, Acta Physiol Scand Suppl, V287, P1; STARON RS, 1984, J HISTOCHEM CYTOCHEM, V32, P146, DOI 10.1177/32.2.6229571; Tansey KE, 1996, J NEUROPHYSIOL, V75, P26, DOI 10.1152/jn.1996.75.1.26; Taylor JL, 2008, J APPL PHYSIOL, V104, P542, DOI 10.1152/japplphysiol.01053.2007; Taylor JL, 2009, J APPL PHYSIOL, V107, P354, DOI 10.1152/japplphysiol.91220.2008; Taylor JL, 2006, CLIN EXP PHARMACOL P, V33, P400, DOI 10.1111/j.1440-1681.2006.04363.x; TESCH PA, 1984, J APPL PHYSIOL, V56, P35, DOI 10.1152/jappl.1984.56.1.35; THOMAS CK, 1989, J APPL PHYSIOL, V67, P1835, DOI 10.1152/jappl.1989.67.5.1835; TRAVNIK L, 1995, J ANAT, V187, P403; Troiano A, 2008, GAIT POSTURE, V28, P179, DOI 10.1016/j.gaitpost.2008.04.002; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; von Tscharner V, 2011, J ELECTROMYOGR KINES, V21, P184, DOI 10.1016/j.jelekin.2010.10.004; WEBBER CL, 1994, J APPL PHYSIOL, V76, P965, DOI 10.1152/jappl.1994.76.2.965; Xu LJ, 1997, J COLLOID INTERF SCI, V190, P357, DOI 10.1006/jcis.1997.4885; Zijdewind I, 2001, J NEUROPHYSIOL, V85, P1907, DOI 10.1152/jn.2001.85.5.1907	90	46	46	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123921	10.1371/journal.pone.0123921	http://dx.doi.org/10.1371/journal.pone.0123921			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880369	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500068
J	Elewa, U; Fernandez-Fernandez, B; Alegre, R; Sanchez-Nino, MD; Mahillo-Fernandez, I; Perez-Gomez, MV; El-Fishawy, H; Belal, D; Ortiz, A				Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Sanchez-Nino, Maria D.; Mahillo-Fernandez, Ignacio; Vanessa Perez-Gomez, Maria; El-Fishawy, Hussein; Belal, Dawlat; Ortiz, Alberto			Modifiable Risk Factors for Increased Arterial Stiffness in Outpatient Nephrology	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; PULSE-WAVE VELOCITY; SERUM URIC-ACID; RANDOMIZED CONTROLLED-TRIAL; SYSTOLIC BLOOD-PRESSURE; MIDDLE-AGED MEN; CARDIOVASCULAR RISK; HYPERTENSIVE PATIENTS; MYOCARDIAL-INFARCTION; POTASSIUM SUPPLEMENTATION	Arterial stiffness, as measured by pulse wave velocity (PWV), is an independent predictor of cardiovascular events and mortality. Arterial stiffness increases with age. However, modifiable risk factors such as smoking, BP and salt intake also impact on PWV. The finding of modifiable risk factors may lead to the identification of treatable factors, and, thus, is of interest to practicing nephrologist. We have now studied the prevalence and correlates of arterial stiffness, assessed by PWV, in 191 patients from nephrology outpatient clinics in order to identify modifiable risk factors for arterial stiffness that may in the future guide therapeutic decision-making. PWV was above normal levels for age in 85/191 (44.5%) patients. Multivariate analysis showed that advanced age, systolic BP, diabetes mellitus, serum uric acid and calcium polystyrene sulfonate therapy or calcium-containing medication were independent predictors of PWV. A new parameter, Delta above upper limit of normal PWV (Delta PWV) was defined to decrease the weight of age on PWV values. Delta PWV was calculated as (measured PWV) - (upper limit of the age-adjusted PWV values for the general population). Mean +/- SD Delta PWV was 0.76 +/- 1.60 m/sec. In multivariate analysis, systolic blood pressure, active smoking and calcium polystyrene sulfonate therapy remained independent predictors of higher delta PWV, while age, urinary potassium and beta blocker therapy were independent predictors of lower delta PWV. In conclusion, arterial stiffness was frequent in nephrology outpatients. Systolic blood pressure, smoking, serum uric acid, calcium-containing medications, potassium metabolism and non-use of beta blockers are modifiable factors associated with increased arterial stiffness in Nephrology outpatients.	[Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Mahillo-Fernandez, Ignacio; Vanessa Perez-Gomez, Maria; Ortiz, Alberto] Univ Autonoma Madrid, Sch Med, IIS Fdn Jimenez Diaz, Madrid, Spain; [Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Vanessa Perez-Gomez, Maria; Ortiz, Alberto] Fdn Renal Inigo Alvarez Toledo IRSIN, Madrid, Spain; [Elewa, Usama; Fernandez-Fernandez, Beatriz; Alegre, Raquel; Vanessa Perez-Gomez, Maria; Ortiz, Alberto] REDINREN, Madrid, Spain; [Elewa, Usama; El-Fishawy, Hussein; Belal, Dawlat] Cairo Univ, Kasr El Aini Univ Hosp, Cairo, Egypt; [Sanchez-Nino, Maria D.] IDIPaz, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Egyptian Knowledge Bank (EKB); Cairo University	Elewa, U (corresponding author), Univ Autonoma Madrid, Sch Med, IIS Fdn Jimenez Diaz, Madrid, Spain.	aortiz@fjd.es	Elewa, Usama/ABE-1944-2021; ortiz, alberto/Y-7582-2018; Sanchez-Niño, Maria Dolores/B-7350-2019; Gomez, Maria Vanessa Perez/AAG-1595-2021; Mahillo-Fernandez, Ignacio/T-2042-2018	ortiz, alberto/0000-0002-9805-9523; Sanchez-Niño, Maria Dolores/0000-0001-7110-6409; Gomez, Maria Vanessa Perez/0000-0003-4558-5236; Mahillo-Fernandez, Ignacio/0000-0003-0558-6541	Fondo de Investigacion Sanitaria Instituto Carlos III (FIS ISCIII) [FIS PS09/00447, PI13/00047]; ISCIII-RETIC; FEDER funds [REDinREN/RD06/0016/, RD012/0021]; Comunidad de Madrid/CIFRA [S2010/BMD-2378]; Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM); FIS; Europoean Renal association; IIS-FJD Biobank [RD09/0076/00101]	Fondo de Investigacion Sanitaria Instituto Carlos III (FIS ISCIII); ISCIII-RETIC(Instituto de Salud Carlos III); FEDER funds(European Commission); Comunidad de Madrid/CIFRA(Comunidad de Madrid); Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM)(Instituto de Salud Carlos III); FIS(Instituto de Salud Carlos III); Europoean Renal association; IIS-FJD Biobank	Grant support: 1) Fondo de Investigacion Sanitaria Instituto Carlos III (FIS ISCIII; www.isciii.es/) FIS PS09/00447, PI13/00047, ISCIII-RETIC, REDinREN/RD06/0016/ and RD012/0021 FEDER funds, Comunidad de Madrid/CIFRA S2010/BMD-2378. Programa Intensificacion Actividad Investigadora (ISCIII/Agencia Lain-Entralgo/CM) to AO. IIS-FJD Biobank RD09/0076/00101. Salary support: FIS to MDSN (Sara Borrell), Beatriz Fernandez-Fernandez (Rio Hortega), 2. Europoean Renal association. ERA-EDTA to UE. (www.era-edta.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Rosei EA, 2007, DRUGS, V67, P1097; Agabiti-Rosei E, 2009, VASC HEALTH RISK MAN, V5, P353; Alderman MH, 1999, HYPERTENSION, V34, P144, DOI 10.1161/01.HYP.34.1.144; Berry SE, 2010, BRIT J NUTR, V104, P1839, DOI 10.1017/S0007114510002904; Blacher J, 1999, HYPERTENSION, V33, P1111, DOI 10.1161/01.HYP.33.5.1111; Bos MJ, 2006, STROKE, V37, P1503, DOI 10.1161/01.STR.0000221716.55088.d4; Boutouyrie P, 2002, HYPERTENSION, V39, P10, DOI 10.1161/hy0102.099031; Boutouyrie P, 2014, NEPHROL DIAL TRANSPL, V29, P232, DOI 10.1093/ndt/gft309; BRATER DC, 1977, CLIN PHARMACOL THER, V22, P21; Briet M, 2011, J AM SOC NEPHROL, V22, P967, DOI 10.1681/ASN.2010080863; BUCALA R, 1991, J CLIN INVEST, V87, P432, DOI 10.1172/JCI115014; Chan DT, 2013, AM J HYPERTENS, V26, P1155, DOI 10.1093/ajh/hpt077; Choo J, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-5; Chue CD, 2010, HEART, V96, P817, DOI 10.1136/hrt.2009.184879; Cockcroft J, 2007, VASC HEALTH RISK MAN, V3, P909; Cohn JN, 2000, ARCH INTERN MED, V160, P2429, DOI 10.1001/archinte.160.16.2429; Covic A, 2006, NEPHROL DIAL TRANSPL, V21, P2859, DOI 10.1093/ndt/gfl307; Crilly M, 2007, VASC MED, V12, P189, DOI 10.1177/1358863x07081134; DeLoach SS, 2008, CLIN J AM SOC NEPHRO, V3, P184, DOI 10.2215/CJN.03340807; Gosse P, 2008, J HYPERTENS, V26, P1138, DOI 10.1097/HJH.0b013e3282fa142b; Greenland P, 2010, J AM COLL CARDIOL, V56, pE50, DOI 10.1016/j.jacc.2010.09.001; Greenwald SE, 2007, J PATHOL, V211, P157, DOI 10.1002/path.2101; Haider AW, 2003, ANN INTERN MED, V138, P10, DOI 10.7326/0003-4819-138-1-200301070-00006; HARRISON MR, 1989, AM J CARDIOL, V64, P905, DOI 10.1016/0002-9149(89)90840-0; Hozawa A, 2006, ATHEROSCLEROSIS, V187, P401, DOI 10.1016/j.atherosclerosis.2005.09.020; Hu JH, 2009, HYPERTENS RES, V32, P282, DOI 10.1038/hr.2009.7; Huybrechts SAM, 2011, J HYPERTENS, V29, P1577, DOI 10.1097/HJH.0b013e3283487841; Kanbay M, 2013, HEART, V99, P759, DOI 10.1136/heartjnl-2012-302535; KAPLAN NM, 1985, NEW ENGL J MED, V312, P746, DOI 10.1056/NEJM198503213121203; Kim EJ, 2014, HYPERTENS RES, V37, P50, DOI 10.1038/hr.2013.112; Krishnan E, 2006, ARTHRITIS RHEUM-US, V54, P2688, DOI 10.1002/art.22014; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Liang J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051101; Liese AD, 1999, EPIDEMIOLOGY, V10, P391, DOI 10.1097/00001648-199907000-00009; Lilitkarntakul P, 2012, DIABETES CARE, V35, P1774, DOI 10.2337/dc11-2345; Lilitkarntakul P, 2011, ATHEROSCLEROSIS, V216, P217, DOI 10.1016/j.atherosclerosis.2011.01.045; Liu ZD, 2013, J CLIN HYPERTENS, V15, P485, DOI 10.1111/jch.12109; London GM, 2001, HYPERTENSION, V38, P434, DOI 10.1161/01.HYP.38.3.434; Mark PB, 2008, J CARDIOVASC MAGN R, V10, DOI 10.1186/1532-429X-10-39; Mattace-Raso FUS, 2010, EUR HEART J, V31, P2338, DOI 10.1093/eurheartj/ehq165; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McEniery CM, 2004, HYPERTENSION, V44, P305, DOI 10.1161/01.HYP.0000137983.45556.6e; McIntyre NJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055444; McIntyre NJ, 2011, CLIN J AM SOC NEPHRO, V6, P2356, DOI 10.2215/CJN.02420311; Mitchell GF, 2005, CIRCULATION, V112, P194, DOI 10.1161/CIRCULATIONAHA.104.530675; Ng KP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091961; Niskanen LK, 2004, ARCH INTERN MED, V164, P1546, DOI 10.1001/archinte.164.14.1546; Oberleithner H, 2009, P NATL ACAD SCI USA, V106, P2829, DOI 10.1073/pnas.0813069106; ROUJOULEH H, 1987, NEPHROLOGIE, V8, P45; Safar ME, 2004, HYPERTENSION, V43, P163, DOI 10.1161/01.HYP.0000114571.75762.b0; Safar ME, 2001, CURR OPIN NEPHROL HY, V10, P257, DOI 10.1097/00041552-200103000-00015; Safar ME, 2000, CARDIOVASC RES, V46, P269, DOI 10.1016/S0008-6363(99)00426-5; Sengstock D, 2010, NEPHROL DIAL TRANSPL, V25, P853, DOI 10.1093/ndt/gfp559; Smith A, 2005, J AM SOC NEPHROL, V16, P1069, DOI 10.1681/ASN.2004090769; Soanker R, 2012, INDIAN J PHARMACOL, V44, P407, DOI 10.4103/0253-7613.96349; Sterns RH, 2010, J AM SOC NEPHROL, V21, P733, DOI 10.1681/ASN.2010010079; Strozecki P, 2013, POL ARCH MED WEWN, V123, P609, DOI 10.20452/pamw.1974; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Temmar M, 2010, J HYPERTENS, V28, P163, DOI 10.1097/HJH.0b013e328331b81e; Tholen S, 2013, J CLIN HYPERTENS, V15, P833, DOI 10.1111/jch.12198; Tomlinson LA, 2012, CURR OPIN NEPHROL HY, V21, P655, DOI 10.1097/MNH.0b013e32835856e3; Townsend RR, 2015, CURR OPIN NEPHROL HY, V24, P47, DOI 10.1097/MNH.0000000000000086; Townsend RR, 2010, AM J HYPERTENS, V23, P282, DOI 10.1038/ajh.2009.240; Turak O, 2014, J CLIN HYPERTENS, V16, P530, DOI 10.1111/jch.12359; Upadhyay A, 2009, J AM SOC NEPHROL, V20, P2044, DOI 10.1681/ASN.2009010074; Verdecchia P, 2000, HYPERTENSION, V36, P1072, DOI 10.1161/01.HYP.36.6.1072; Watson M, 2010, CLIN J AM SOC NEPHRO, V5, P1723, DOI 10.2215/CJN.03700410; Zhang J, 2014, J ENDOCRINOL INVEST, V37, P441, DOI 10.1007/s40618-013-0034-9; Zhang MH, 2011, CLIN CARDIOL, V34, P622, DOI 10.1002/clc.20956	70	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123903	10.1371/journal.pone.0123903	http://dx.doi.org/10.1371/journal.pone.0123903			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880081	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500066
J	Kuszewska, K; Woyciechowski, M				Kuszewska, Karolina; Woyciechowski, Michal			Age at Which Larvae Are Orphaned Determines Their Development into Typical or Rebel Workers in the Honeybee (Apis mellifera L.)	PLOS ONE			English	Article							HYPOPHARYNGEAL GLAND ACTIVITY; DIFFERENTIAL GENE-EXPRESSION; REPRODUCTIVE COMPETITION; CASTE DETERMINATION; OVARY DEVELOPMENT; BEE; QUEEN; PHEROMONE; EVOLUTION; PLASTICITY	In the honeybee, diploid larvae fed with royal jelly develop into reproductive queens, whereas larvae fed with royal jelly for three days only and subsequently with honey and pollen develop into facultatively sterile workers. A recent study showed that worker larvae fed in a queenless colony develop into another female polyphenic form: rebel workers. These rebel workers are more queenlike and have greater reproductive potential than normal workers. However, it was unclear whether larvae orphaned at any time during their feeding period can develop into rebels. To answer this question, the anatomical features of newly emerged workers reared in queenless conditions at different ages during the larval period were evaluated. Our results showed that larvae orphaned during the final four or more days of their feeding life develop into rebel workers with more ovarioles in their ovaries, smaller hypo-pharyngeal glands, and larger mandibular and Dufour's glands compared with typical workers with low reproductive potential that were reared with a queen or orphaned at the third to last or a later day of feeding life.	[Kuszewska, Karolina; Woyciechowski, Michal] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland	Jagiellonian University	Kuszewska, K (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	k.kuszewska@uj.edu.pl		kuszewska, Karolina/0000-0001-8104-8740	Polish Ministry of Science and Higher Education - Iuventus Plus [IP2012 026072]; Jagiellonian University [DS/BiNoZ/INoS/761/12-14, DSC/MND/WBiNoZ/INoS/19/2013]; 7th EU FP Collaborative Project STEP (Status and Trends of European Pollinators) [244090]	Polish Ministry of Science and Higher Education - Iuventus Plus; Jagiellonian University; 7th EU FP Collaborative Project STEP (Status and Trends of European Pollinators)	This study was funded by the Polish Ministry of Science and Higher Education - Iuventus Plus (grant IP2012 026072), the Jagiellonian University (grant DS/BiNoZ/INoS/761/12-14 and grant DSC/MND/WBiNoZ/INoS/19/2013), and the 7th EU FP Collaborative Project STEP (Status and Trends of European Pollinators; 244090, www.STEP-project.net). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amdam GV, 2006, NATURE, V439, P76, DOI 10.1038/nature04340; [Anonymous], 1971, INSECT SOC; Barchuk Angel Roberto, 2002, Journal of Insect Science (Tucson), V2, P1; Barchuk AR, 2004, INSECT MOL BIOL, V13, P459, DOI 10.1111/j.0962-1075.2004.00506.x; Begna D, 2012, J PROTEOME RES, V11, P1317, DOI 10.1021/pr200974a; BUTLER CG, 1957, EXPERIENTIA, V13, P256, DOI 10.1007/BF02157449; Cnaani J, 2000, BEHAV ECOL SOCIOBIOL, V47, P346, DOI 10.1007/s002650050675; Corona M, 1999, J EXP BIOL, V202, P929; Cristino AS, 2006, INSECT MOL BIOL, V15, P703, DOI 10.1111/j.1365-2583.2006.00696.x; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Evans JD, 1999, P NATL ACAD SCI USA, V96, P5575, DOI 10.1073/pnas.96.10.5575; Gozansky Tamar Katzav, 1997, Invertebrate Neuroscience, V3, P239; HAYDAK MH, 1970, ANNU REV ENTOMOL, V15, P143, DOI 10.1146/annurev.en.15.010170.001043; HODIN J, 2009, PHENOTYPIC PLASTICIT, P65; Hoover SER, 2006, J COMP PHYSIOL B, V176, P55, DOI 10.1007/s00360-005-0032-0; Hrassnigg N, 1998, J INSECT PHYSIOL, V44, P929, DOI 10.1016/S0022-1910(98)00058-4; HUANG ZY, 1989, INSECT SOC, V36, P264, DOI 10.1007/BF02224880; KatzavGozansky T, 1997, NATURWISSENSCHAFTEN, V84, P238, DOI 10.1007/s001140050386; Kocher SD, 2009, BEHAV ECOL, V20, P1007, DOI 10.1093/beheco/arp090; Kucharski R, 2008, SCIENCE, V319, P1827, DOI 10.1126/science.1153069; Kuszewska K, 2013, ANIM BEHAV, V85, P247, DOI 10.1016/j.anbehav.2012.10.033; KUWABARA M, 1947, J FAC SCI HOKKAIDO 6, V9, P359; Le Conte Y, 2001, P ROY SOC B-BIOL SCI, V268, P163, DOI 10.1098/rspb.2000.1345; Le Conte Y, 2008, ANNU REV ENTOMOL, V53, P523, DOI 10.1146/annurev.ento.52.110405.091434; Leimar O, 2012, ECOL EVOL, V2, P3098, DOI 10.1002/ece3.414; Li JK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013455; Linksvayer TA, 2011, J EVOLUTION BIOL, V24, P1939, DOI 10.1111/j.1420-9101.2011.02331.x; Makert GR, 2006, BEHAV ECOL SOCIOBIOL, V60, P815, DOI 10.1007/s00265-006-0225-x; Malka O, 2008, NATURWISSENSCHAFTEN, V95, P553, DOI 10.1007/s00114-008-0358-z; Malka O, 2007, BEHAV ECOL SOCIOBIOL, V61, P465, DOI 10.1007/s00265-006-0274-1; Martin SJ, 2005, APIDOLOGIE, V36, P543, DOI 10.1051/apido:2005041; Martin SJ, 2004, BEHAV ECOL, V15, P839, DOI 10.1093/beheco/arh089; Nakaoka T, 2008, J INSECT PHYSIOL, V54, P806, DOI 10.1016/j.jinsphys.2008.02.007; Nieh JC, 2012, CURR BIOL, V22, pR280, DOI 10.1016/j.cub.2012.03.018; Nijhout HF, 2003, EVOL DEV, V5, P9, DOI 10.1046/j.1525-142X.2003.03003.x; PAGE RE, 1994, BEHAV ECOL SOCIOBIOL, V35, P99, DOI 10.1007/BF00171499; Randolt K, 2008, ARCH INSECT BIOCHEM, V69, P155, DOI 10.1002/arch.20269; RATNIEKS FLW, 1995, J APICULT RES, V34, P31, DOI 10.1080/00218839.1995.11100883; Richard FJ, 2013, INSECT SOC, V60, P275, DOI 10.1007/s00040-013-0306-6; Richard FJ, 2011, J CHEM ECOL, V37, P1027, DOI 10.1007/s10886-011-9999-z; ROUNTREE DB, 1995, J INSECT PHYSIOL, V41, P1141, DOI 10.1016/0022-1910(95)00051-U; Schwander T, 2010, TRENDS ECOL EVOL, V25, P275, DOI 10.1016/j.tree.2009.12.001; Shi YY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018808; Simpson SJ, 2011, CURR BIOL, V21, pR738, DOI 10.1016/j.cub.2011.06.006; Sultan SE, 2000, TRENDS PLANT SCI, V5, P537, DOI 10.1016/S1360-1385(00)01797-0; Suzuki Y, 2006, SCIENCE, V311, P650, DOI 10.1126/science.1118888; Traynor KS, 2015, ANIM BEHAV, V99, P1, DOI 10.1016/j.anbehav.2014.10.009; Traynor KS, 2014, BEHAV ECOL SOCIOBIOL, V68, P2059, DOI 10.1007/s00265-014-1811-y; VELTHUIS HH, 1970, ENTOMOL EXP APPL, V13, P377, DOI 10.1111/j.1570-7458.1970.tb00122.x; Wang Y, 2014, ANIM BEHAV, V92, P253, DOI 10.1016/j.anbehav.2014.02.012; WEAVER N, 1966, ANNU REV ENTOMOL, V11, P79, DOI 10.1146/annurev.en.11.010166.000455; Wegener J, 2009, J INSECT PHYSIOL, V55, P716, DOI 10.1016/j.jinsphys.2009.05.003; West-Eberhard Mary Jane, 2003, pi; Winston, 1987, BIOL HONEYBEE; WIRTZ P, 1972, ENTOMOL EXP APPL, V15, P517, DOI 10.1007/BF00293616; Woyciechowski M, 2012, CURR BIOL, V22, P707, DOI 10.1016/j.cub.2012.02.063; Woyke J, 1999, J APICULT RES, V38, P117, DOI 10.1080/00218839.1999.11101002	57	20	20	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123404	10.1371/journal.pone.0123404	http://dx.doi.org/10.1371/journal.pone.0123404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880669	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500051
J	Leskela, S; Serrano, A; de la Fuente, H; Rodriguez-Munoz, A; Ramos-Levi, A; Sampedro-Nunez, M; Sanchez-Madrid, F; Gonzalez-Amaro, R; Marazuela, M				Leskela, Susanna; Serrano, Ana; de la Fuente, Hortensia; Rodriguez-Munoz, Ana; Ramos-Levi, Ana; Sampedro-Nunez, Miguel; Sanchez-Madrid, Francisco; Gonzalez-Amaro, Roberto; Marazuela, Monica			Graves' Disease Is Associated with a Defective Expression of the Immune Regulatory Molecule Galectin-9 in Antigen-Presenting Dendritic Cells	PLOS ONE			English	Article							AUTOIMMUNE THYROID-DISEASE; T-CELLS; OPHTHALMOPATHY; PROLIFERATION; GLYCOSYLATION; INFLAMMATION; LYMPHOCYTES; SUPPRESSES; ACTIVATION; INDUCTION	Introduction Patients with autoimmune thyroid disease (AITD) show defects in their immune-regulatory mechanisms. Herein we assessed the expression and function of galectin-1 and galectin-9 (Gal-1, Gal-9) in dendritic cells (DCs) from patients with AITD. Materials and Methods Peripheral blood samples from 25 patients with Graves' disease (GD), 11 Hashimoto's thyroiditis (HT), and 24 healthy subjects were studied. Thyroid tissue samples from 44 patients with AITD and 22 patients with goiter were also analyzed. Expression and function of Gal-1 and Gal-9 was assessed by quantitative RT-PCR, immunofluorescence and flow cytometry. Results A diminished expression of Gal-9, but not of Gal-1, by peripheral blood DCs was observed in GD patients, mainly in those with Graves ' ophthalmopathy, and a significant negative association between disease severity and Gal-9 expression was detected. In addition, the mRNA levels of Gal-9 and its ligand TIM-3 were increased in thyroid tissue from AITD patients and its expression was associated with the levels of Th1/Th12/Th17 cytokines. Immunofluorescence studies proved that intrathyroidal Gal-9 expression was confined to DCs and macrophages. Finally, in vitro functional assays showed that exogenous Gal-9 had a suppressive effect on the release of Th1/Th2/Th17 cytokines by DC/lymphocyte autologous co-cultures from both AITD patients and healthy controls. Conclusions The altered pattern of expression of Gal-9 in peripheral blood DCs from GD patients, its correlation with disease severity as well as its ability to suppress cytokine release suggest that Gal-9 could be involved in the pathogenesis of AITD.	[Leskela, Susanna; Serrano, Ana; Rodriguez-Munoz, Ana; Ramos-Levi, Ana; Sampedro-Nunez, Miguel; Marazuela, Monica] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Dept Endocrinol, Madrid, Spain; [de la Fuente, Hortensia; Sanchez-Madrid, Francisco] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Dept Immunol,Ctr Nacl Invest Cardiovasc Carlos 3, Madrid, Spain; [Gonzalez-Amaro, Roberto] UASLP, Sch Med, Dept Immunol, San Luis Potosi, Slp, Mexico	Autonomous University of Madrid; Autonomous University of Madrid; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Universidad Autonoma de San Luis Potosi	Leskela, S (corresponding author), Univ Autonoma Madrid, Inst Invest Sanitaria Princesa, Hosp Univ La Princesa, Dept Endocrinol, Madrid, Spain.	monica.marazuela@salud.madrid.org	Sanchez-Madrid, Francisco/M-7889-2016; Gonzalez-Amaro, Roberto/AAZ-1504-2020; de la Fuente, Hortensia/J-9890-2014	Sanchez-Madrid, Francisco/0000-0001-5303-0762; de la Fuente, Hortensia/0000-0001-8708-753X	Fondo de Investigaciones Sanitarias (FISS) (Comunidad de Madrid), Spain [PI10/02521, S2010/BMD-2328 TIRONET]; Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT) [95395]; European Union-Mexico	Fondo de Investigaciones Sanitarias (FISS) (Comunidad de Madrid), Spain; Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT); European Union-Mexico	This work was supported by grants from the Fondo de Investigaciones Sanitarias (FISS) PI10/ 02521 and S2010/BMD-2328 TIRONET (Comunidad de Madrid), Spain (to MM) and the Fondo de Cooperacion Internacional en Ciencia y Tecnologia (FONCICYT) 95395, European Union-Mexico (to RGA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa T, 2009, CLIN IMMUNOL, V133, P382, DOI 10.1016/j.clim.2009.09.004; Bartalena L, 2008, EUR J ENDOCRINOL, V158, P273, DOI 10.1530/EJE-07-0666; Blaser C, 1998, EUR J IMMUNOL, V28, P2311, DOI 10.1002/(SICI)1521-4141(199808)28:08<2311::AID-IMMU2311>3.0.CO;2-G; Chou FC, 2009, EUR J IMMUNOL, V39, P2403, DOI 10.1002/eji.200839177; Cooper D, 2008, J LEUKOCYTE BIOL, V83, P1459, DOI 10.1189/jlb.1207831; de la Fuente H, 2012, FEBS LETT, V586, P2897, DOI 10.1016/j.febslet.2012.07.032; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Figueroa-Vega N, 2010, J CLIN ENDOCR METAB, V95, P953, DOI 10.1210/jc.2009-1719; Figueroa-Vega N, 2009, J CLIN ENDOCR METAB, V94, P1145, DOI 10.1210/jc.2008-1571; Imaizumi T, 2002, J LEUKOCYTE BIOL, V72, P486; Kanzaki M, 2012, ENDOCRINOLOGY, V153, P612, DOI 10.1210/en.2011-1579; Katoh S, 2007, AM J RESP CRIT CARE, V176, P27, DOI 10.1164/rccm.200608-1243OC; Leskela S, 2013, J CLIN ENDOCR METAB, V98, P2822, DOI 10.1210/jc.2013-1273; Mao CM, 2011, J IMMUNOL, V186, P4734, DOI 10.4049/jimmunol.0904135; Marazuela M, 2006, J CLIN ENDOCR METAB, V91, P3639, DOI 10.1210/jc.2005-2337; Mascanfroni ID, 2011, INT IMMUNOPHARMACOL, V11, P833, DOI 10.1016/j.intimp.2011.01.021; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Norling LV, 2008, FASEB J, V22, P682, DOI 10.1096/fj.07-9268com; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Prabhakar BS, 2003, ENDOCR REV, V24, P802, DOI 10.1210/er.2002-0020; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Ruiz-Riol M, 2011, J AUTOIMMUN, V36, P189, DOI 10.1016/j.jaut.2011.01.002; Seki M, 2008, CLIN IMMUNOL, V127, P78, DOI 10.1016/j.clim.2008.01.006; Seki M, 2007, ARTHRITIS RHEUM-US, V56, P3968, DOI 10.1002/art.23076; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; van der Leij J, 2004, J PATHOL, V204, P511, DOI 10.1002/path.1671; Weetman AP, 2004, CLIN ENDOCRINOL, V61, P405, DOI 10.1111/j.1365-2265.2004.02085.x; Wiersinga WM, 2011, J CLIN ENDOCR METAB, V96, P2386, DOI 10.1210/jc.2011-0307	28	14	14	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123938	10.1371/journal.pone.0123938	http://dx.doi.org/10.1371/journal.pone.0123938			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880730	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500071
J	Stellmann, JP; Neuhaus, A; Gotze, N; Briken, S; Lederer, C; Schimpl, M; Heesen, C; Daumer, M				Stellmann, J. P.; Neuhaus, A.; Goetze, N.; Briken, S.; Lederer, C.; Schimpl, M.; Heesen, C.; Daumer, M.			Ecological Validity of Walking Capacity Tests in Multiple Sclerosis	PLOS ONE			English	Article							TIMED 25-FOOT WALK; 6-MINUTE WALK; CLINICALLY MEANINGFUL; EXERCISE CAPACITY; PHYSICAL-ACTIVITY; CONTROLLED-TRIAL; MS; SPEED; MULTICENTER; PERFORMANCE	Background Ecological validity implicates in how far clinical assessments refer to real life. Short clinical gait tests up to ten meters and 2- or 6-Minutes Walking Tests (2MWT/6MWT) are used as performance-based outcomes in Multiple Sclerosis ( MS) studies and considered as moderately associated with real life mobility. Objective To investigate the ecological validity of 10 Meter Walking Test (10mWT), 2MWT and 6MWT. Methods Persons with MS performed 10mWT, 6MWT including 2MWT and 7 recorded days by accelerometry. Ecological validity was assumed if walking tests represented a typical walking sequence in real-life and correlations with accelerometry parameters were strong. Results In this cohort (n=28, medians: age=45, EDSS=3.2, disease duration=9 years), uninterrupted walking of 2 or 6 minutes occurred not frequent in real life (2.61 and 0.35 sequences/day). 10mWT correlated only with slow walking speed quantiles in real life. 2MWT and 6MWT correlated moderately with most real life walking parameters. Conclusion Clinical gait tests over a few meters have a poor ecological validity while validity is moderate for 2MWT and 6MWT. Mobile accelerometry offers the opportunity to control and improve the ecological validity of MS mobility outcomes.	[Stellmann, J. P.; Goetze, N.; Briken, S.; Heesen, C.] Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Hamburg, Germany; [Stellmann, J. P.; Goetze, N.; Briken, S.; Heesen, C.] Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany; [Neuhaus, A.; Lederer, C.; Daumer, M.] Sylvia Lawry Ctr Multiple Sclerosis Res, Munich, Germany; [Neuhaus, A.; Schimpl, M.; Daumer, M.] Trium Anal Online GmbH, Munich, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Stellmann, JP (corresponding author), Univ Med Ctr Hamburg Eppendorf, Inst Neuroimmunol & MS INIMS, Hamburg, Germany.	j.stellmann@uke.uni-hamburg.de	Stellmann, Jan-Patrick/ABA-7132-2020	Stellmann, Jan-Patrick/0000-0003-2565-2833	ECTRIMS; EU-FP7; BMBF; BWiMi; Hertie Foundation; Merck-Serono; Biogen-Idec; Teva-Sanofi-Aventis; Bayer-Schering	ECTRIMS; EU-FP7(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); BWiMi; Hertie Foundation; Merck-Serono(Merck & Company); Biogen-Idec(Biogen); Teva-Sanofi-Aventis(Sanofi-Aventis); Bayer-Schering(Bayer AG)	The authors of this manuscript have the following competing interests: Martin Daumer is an Academic Editor for PeerJ and has invented the "free heel running pad". He is also the Director of the Sylvia Lawry Centre for MS Research. He is one of the two managing directors of Trium Analysis Online GmbH, together with Michael Scholz (50% ownership each). Trium is a manufacturer of CTG monitoring systems. Dr. Daumer has served on the scientific advisory board for the EPOSA study; has received funding for travel from ECTRIMS; serves on the editorial board of MedNous; is coauthor with Michael Scholz on patents re: Apparatus for measuring activity (Trium Analysis Online GmbH), method and device for detecting a movement pattern (Trium Analysis Online GmbH), device and method to measure the activity of a person (Trium Analysis Online GmbH), co-Author with Christian Lederer of device and method to determine the fetal heart rate from ultrasound signals (Trium Analysis Online GmbH), author of method and device for detecting drifts, jumps and/or outliers of measurement values, coauthor of patent applications with Michael Scholz of device and method to determine the global alarm state of a patient monitoring system, method of communication of units in a patient monitoring system, and system and method for patient monitoring; serves as a consultant for University of Oxford, Imperial College London, University of Southampton, Charite, Berlin, University of Vienna, Greencoat Ltd, Biopartners, Biogen Idec, Bayer Schering Pharma, Roche, and Novartis; and receives/has received research support from the EU-FP7, BMBF, BWiMi, and Hertie Foundation. Christian Lederer and Anneke Neuhaus were employed at the SLC - The Human Motion Institute when the study was performed. Michaela Schimpl were employed at TRIUM GmBH when the study was performed. Sven Briken and Nele Gotze have declared that no competing interests exist. Jan-Patrick Stellmann and Christoph Heesen report study, travel and educational grants from Merck-Serono, Biogen-Idec, Teva-Sanofi-Aventis and Bayer-Schering. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Albrecht H, 2001, MULT SCLER J, V7, P105, DOI 10.1191/135245801678227621; [Anonymous], 2010, R LANG ENV STAT COMP; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Chabrol H, 2012, NEUROLOGY, V78, P323, DOI 10.1212/WNL.0b013e3182452985; Cohen JT, 2010, EXPERT REV PHARM OUT, V10, P595, DOI [10.1586/erp.10.60, 10.1586/ERP.10.60]; Coleman CI, 2012, CURR MED RES OPIN, V28, P49, DOI 10.1185/03007995.2011.639752; Daumer M, 2007, BIOMED TECH, V52, P149, DOI 10.1515/BMT.2007.028; Ekblom-bak E, 2013, IMPORTANCE NONEXERCI, DOI [10.1136/bjsports-2012-092038, DOI 10.1136/BJSPORTS-2012-092038]; Feys P, 2012, MULT SCLER J, V18, P351, DOI 10.1177/1352458511419881; Fischer JS, 1999, MULT SCLER J, V5, P244, DOI 10.1177/135245859900500409; Gijbels D, 2011, MULT SCLER J, V17, P1269, DOI 10.1177/1352458511408475; Gijbels D, 2012, MULT SCLER J, V18, P364, DOI 10.1177/1352458511420598; Gijbels D, 2010, MULT SCLER J, V16, P618, DOI 10.1177/1352458510361357; Goldman MD, 2008, MULT SCLER J, V14, P383, DOI 10.1177/1352458507082607; Goldman MD, 2013, NEUROLOGY, V81, P1856, DOI 10.1212/01.wnl.0000436065.97642.d2; Goodman AD, 2010, ANN NEUROL, V68, P494, DOI 10.1002/ana.22240; Goodman AD, 2009, LANCET, V373, P732, DOI 10.1016/S0140-6736(09)60442-6; GUYATT GH, 1985, CAN MED ASSOC J, V132, P919; Heesen C, 2008, MULT SCLER, V14, P988, DOI 10.1177/1352458508088916; Hobart JC, 2003, NEUROLOGY, V60, P31, DOI 10.1212/WNL.60.1.31; Hobart J, 2013, NEUROLOGY, V80, P1509, DOI 10.1212/WNL.0b013e31828cf7f3; Kieseier BC, 2012, MULT SCLER J, V18, P914, DOI 10.1177/1352458512444498; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; Moseley AM, 2004, J HEAD TRAUMA REHAB, V19, P341, DOI 10.1097/00001199-200407000-00008; Motl RW, 2013, ACTA NEUROL SCAND, V127, P384, DOI 10.1111/ane.12036; Motl RW, 2012, GAIT POSTURE, V35, P192, DOI 10.1016/j.gaitpost.2011.09.005; Paltamaa J, 2006, J REHABIL MED, V38, P339, DOI 10.1080/16501970600731537; Sandroff BM, 2014, J NEUROL SCI, V340, P50, DOI 10.1016/j.jns.2014.02.024; Savci S, 2005, DISABIL REHABIL, V27, P1365, DOI 10.1080/09638280500164479; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023299; Schimpl M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023080; Schlesinger S, 2011, KLIN NEUROPHYSIOL, V42, P17, DOI 10.1055/s-0031-1271750; Soaz C., 2012, Biomedical Engineering-Biomedizinische Technik, V57, DOI 10.1515/bmt-2012-4415; Stellmann JP, 2011, MULT SCLER J, V17, pS13; Vogel T, 2009, INT J CLIN PRACT, V63, P303, DOI 10.1111/j.1742-1241.2008.01957.x; Wens I, 2013, MULT SCLER J, V19, P1556, DOI 10.1177/1352458513504252; Wetzel JL, 2011, PHYSIOTHER CAN, V63, P166, DOI 10.3138/ptc.2009-62	37	34	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123822	10.1371/journal.pone.0123822	http://dx.doi.org/10.1371/journal.pone.0123822			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879750	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500063
J	Ye, XH; Lu, GR; Huai, JP; Ding, J				Ye, Xiaohua; Lu, Guangrong; Huai, Jiaping; Ding, Jin			Impact of Smoking on the Risk of Pancreatitis: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							POPULATION-BASED-COHORT; RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; DOSE-RESPONSE DATA; CIGARETTE-SMOKING; ALCOHOLIC PANCREATITIS; TOBACCO; CANCER; EPIDEMIOLOGY; PREVALENCE; DISEASE	Background and objective Cigarette smoking may increase the risk of developing pancreatic cancer, although its impact on pancreatitis has only been discerned in recent years. However, the results of previous studies differ. We performed a meta-analysis to provide a quantitative pooled risk estimate of the association of cigarette smoking with pancreatitis. Method A literature search of the MEDLINE and Embase databases was conducted, and studies were selected that investigated the association of cigarette smoking with pancreatitis. Summary relative risks (RRs) with 95% confidence intervals (CIs) were pooled using a random-effects model. Results Twenty-two studies were included. The summary RRs (95% CI) associated with ever, current and former smokers for acute and chronic pancreatitis (AP/CP) were as follows: 1.51 (1.10, 2.07)/3.00 (1.46, 6.17), 1.42 (1.08, 1.87)/2.72 (1.74, 4.24), and 1.22 (0.99, 1.52)/1.27 (1.00, 1.62), respectively. Moreover, studies that analyzed both AP and CP were also summarized: 1.73 (1.18, 2.54) for ever smokers, 1.67 (1.03, 2.68) for current smokers and 1.56 (1.16, 2.11) for former smokers, respectively. There was no evidence of publication bias across the studies. Conclusion The evidence suggests a positive association of cigarette smoking with the development of pancreatitis. It is possible that smoking cessation may be a useful strategy for the management of pancreatitis.	[Ye, Xiaohua; Ding, Jin] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Gastroenterol & Hepatol, Jinhua, Zhejiang, Peoples R China; [Lu, Guangrong] Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol & Hepatol, Wenzhou, Zhejiang, Peoples R China; [Huai, Jiaping] Zhejiang Univ, Jinhua Hosp, Jinhua Municipal Cent Hosp, Dept Crit Care Med, Jinhua, Zhejiang, Peoples R China	Zhejiang University; Wenzhou Medical University; Zhejiang University	Lu, GR (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Gastroenterol & Hepatol, Wenzhou, Zhejiang, Peoples R China.	530392865@qq.com						Alexandre M, 2011, PANCREATOLOGY, V11, P469, DOI 10.1159/000332196; Andriulli A, 2010, PANCREAS, V39, P1205, DOI 10.1097/MPA.0b013e3181df27c0; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BERLIN JA, 1993, EPIDEMIOLOGY, V4, P218, DOI 10.1097/00001648-199305000-00005; Blomgren KB, 2002, EUR J CLIN PHARMACOL, V58, P275, DOI 10.1007/s00228-002-0471-4; BOURLIERE M, 1991, GUT, V32, P1392, DOI 10.1136/gut.32.11.1392; Debenedet AT, 2009, CLIN GASTROENTEROL H, V7, P353, DOI 10.1016/j.cgh.2008.11.020; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DiMagno MJ, 2013, PANCREAS, V42, P996, DOI 10.1097/MPA.0b013e31827e95e9; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Gonzalez-Perez A, 2010, DIABETES CARE, V33, P2580, DOI 10.2337/dc10-0842; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; HABER PS, 1993, PANCREAS, V8, P568, DOI 10.1097/00006676-199309000-00007; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hirota M, 2012, PANCREATOLOGY, V12, P79, DOI 10.1016/j.pan.2012.02.005; Huai JP, 2014, GEN HOSP PSYCHIAT, V36, P488, DOI 10.1016/j.genhosppsych.2014.05.002; Iodice S, 2008, LANGENBECK ARCH SURG, V393, P535, DOI 10.1007/s00423-007-0266-2; Law R, 2010, PANCREATOLOGY, V10, P54, DOI 10.1159/000225927; LEVY P, 1995, PANCREAS, V10, P231, DOI 10.1097/00006676-199504000-00003; Li N, 2010, PANCREATOLOGY, V10, P238, DOI 10.1159/000279306; Lin HH, 2014, PANCREAS, V43, P1117, DOI 10.1097/MPA.0000000000000209; Lin Y, 2000, PANCREAS, V21, P109, DOI 10.1097/00006676-200008000-00001; Lindkvist B, 2008, PANCREATOLOGY, V8, P63, DOI 10.1159/000114868; LOWENFELS AB, 1987, PANCREAS, V2, P694, DOI 10.1097/00006676-198711000-00012; Lowenfels AB, 2001, JAMA-J AM MED ASSOC, V286, P169, DOI 10.1001/jama.286.2.169; Malfertheiner P, 2006, AM J GASTROENTEROL, V101, P160, DOI 10.1111/j.1572-0241.2006.00402.x; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Morton C, 2004, AM J GASTROENTEROL, V99, P731, DOI 10.1111/j.1572-0241.2004.04143.x; Rothenbacher D, 2005, SCAND J GASTROENTERO, V40, P697, DOI 10.1080/00365520510023116; Sadr-Azodi O, 2012, GUT, V61, P262, DOI 10.1136/gutjnl-2011-300566; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Talamini G, 1996, PANCREAS, V12, P131, DOI 10.1097/00006676-199603000-00004; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Tolstrup JS, 2009, ARCH INTERN MED, V169, P603, DOI 10.1001/archinternmed.2008.601; Wells GA, NEWCASTLE OTTAWA SCA, DOI [10.1371/journal.pntd.0002195, DOI 10.1371/J0URNAL.PNTD.0002195]; Wittel UA, 2006, AM J GASTROENTEROL, V101, P148, DOI 10.1111/j.1572-0241.2006.00405.x; Wittel UA, 2006, PANCREAS, V33, P364, DOI 10.1097/01.mpa.0000240601.80570.31; Yadav D, 2007, PANCREAS, V34, P390, DOI 10.1097/mpa.0b013e318040b332; Yadav D, 2006, PANCREAS, V33, P323, DOI 10.1097/01.mpa.0000236733.31617.52; Yadav D, 2013, GASTROENTEROLOGY, V144, P1252, DOI 10.1053/j.gastro.2013.01.068; Yadav D, 2011, AM J GASTROENTEROL, V106, P2192, DOI 10.1038/ajg.2011.328; Yadav D, 2009, ARCH INTERN MED, V169, P1035, DOI 10.1001/archinternmed.2009.125; Yang H, 2014, J DIGEST DIS, V15, P501, DOI 10.1111/1751-2980.12168; YEN S, 1982, AM J EPIDEMIOL, V116, P407, DOI 10.1093/oxfordjournals.aje.a113425	45	29	30	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124075	10.1371/journal.pone.0124075	http://dx.doi.org/10.1371/journal.pone.0124075			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879541	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500081
J	Bahl, K; Naslavsky, N; Caplan, S				Bahl, Kriti; Naslavsky, Naava; Caplan, Steve			Role of the EHD2 Unstructured Loop in Dimerization, Protein Binding and Subcellular Localization	PLOS ONE			English	Article							PLASMA-MEMBRANE; DOMAIN; TRAFFICKING; INTERACTS; CAVEOLAE; INSIGHTS; MOTIFS; ACTIN; NPF	The C-terminal Eps 15 Homology Domain proteins (EHD1-4) play important roles in regulating endocytic trafficking. EHD2 is the only family member whose crystal structure has been solved, and it contains an unstructured loop consisting of two proline-phenylalanine (PF) motifs: KPFRKLNPF. In contrast, despite EHD2 having nearly 70% amino acid identity with its paralogs, EHD1, EHD3 and EHD4, the latter proteins contain a single KPF or RPF motif, but no NPF motif. In this study, we sought to define the precise role of each PF motif in EHD2's homo-dimerization, binding with the protein partners, and subcellular localization. To test the role of the NPF motif, we generated an EHD2 NPF-to-NAF mutant to mimic the homologous sequences of EHD1 and EHD3. We demonstrated that this mutant lost both its ability to dimerize and bind to Syndapin2. However, it continued to localize primarily to the cytosolic face of the plasma membrane. On the other hand, EHD2 NPF-to-APA mutants displayed normal dimerization and Syndapin2 binding, but exhibited markedly increased nuclear localization and reduced association with the plasma membrane. We then hypothesized that the single PF motif of EHD1 (that aligns with the KPF of EHD2) might be responsible for both binding and localization functions of EHD1. Indeed, the EHD1 RPF motif was required for dimerization, interaction with MICAL-L1 and Syndapin2, as well as localization to tubular recycling endosomes. Moreover, recycling assays demonstrated that EHD1 RPF-to-APA was incapable of supporting normal receptor recycling. Overall, our data suggest that the EHD2 NPF phenylalanine residue is crucial for EHD2 localization to the plasma membrane, whereas the proline residue is essential for EHD2 dimerization and binding. These studies support the recently proposed model in which the EHD2 N-terminal region may regulate the availability of the unstructured loop for interactions with neighboring EHD2 dimers, thus promoting oligomerization.	[Bahl, Kriti; Naslavsky, Naava; Caplan, Steve] Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68182 USA	University of Nebraska System; University of Nebraska Medical Center	Naslavsky, N (corresponding author), Univ Nebraska, Med Ctr, Fred & Pamela Buffett Canc Ctr, Dept Biochem & Mol Biol, Omaha, NE 68182 USA.	nnaslavsky@unmc.edu; scaplan@unmc.edu			Institutional Development Award (IDeA) [5P30GM106397]; NIH from the National Institute of General Medical Sciences of the National Institutes of Health [R01GM087455, R01GM074876]; NATIONAL CANCER INSTITUTE [P30CA036727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087455, P30GM106397, R01GM074876] Funding Source: NIH RePORTER	Institutional Development Award (IDeA); NIH from the National Institute of General Medical Sciences of the National Institutes of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research reported in this publication was supported by an Institutional Development Award (IDeA; grant number 5P30GM106397) and by NIH grants R01GM087455 and R01GM074876 from the National Institute of General Medical Sciences of the National Institutes of Health.	Benjamin S, 2011, BIOCHEM J, V439, P433, DOI 10.1042/BJ20111010; Caplan S, 2002, EMBO J, V21, P2557, DOI 10.1093/emboj/21.11.2557; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; Doherty KR, 2008, J BIOL CHEM, V283, P20252, DOI 10.1074/jbc.M802306200; Grant BD, 2008, TRAFFIC, V9, P2043, DOI 10.1111/j.1600-0854.2008.00834.x; Guilherme A, 2004, J BIOL CHEM, V279, P10593, DOI 10.1074/jbc.M307702200; Hansen CG, 2011, J CELL SCI, V124, P2777, DOI 10.1242/jcs.084319; Henry GD, 2010, BIOCHEMISTRY-US, V49, P3381, DOI 10.1021/bi100065r; Kieken F, 2007, J BIOMOL NMR, V39, P323, DOI 10.1007/s10858-007-9196-0; Kieken F, 2010, J BIOL CHEM, V285, P8687, DOI 10.1074/jbc.M109.045666; Kieken F, 2009, PROTEIN SCI, V18, P2471, DOI 10.1002/pro.258; Lee DW, 2005, J BIOL CHEM, V280, P17213, DOI 10.1074/jbc.M412751200; Marg A, 2012, TRAFFIC, V13, P1286, DOI 10.1111/j.1600-0854.2012.01386.x; Moren B, 2012, MOL BIOL CELL, V23, P1316, DOI 10.1091/mbc.E11-09-0787; Naslavsky N, 2006, MOL BIOL CELL, V17, P163, DOI 10.1091/mbc.e05-05-0466; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Naslavsky N, 2011, TRENDS CELL BIOL, V21, P122, DOI 10.1016/j.tcb.2010.10.003; Park SY, 2004, BIOCHEMISTRY-US, V43, P7552, DOI 10.1021/bi049970f; Pekar O, 2012, BIOCHEM J, V444, P383, DOI 10.1042/BJ20111268; Posey AD, 2011, J BIOL CHEM, V286, P7379, DOI 10.1074/jbc.M110.157222; Reinecke JB, 2014, NOVEL FUNCTIONS ENDO; Shah C, 2014, STRUCTURE, V22, P409, DOI 10.1016/j.str.2013.12.015; Simone LC, 2014, HISTOL HISTOPATHOL, V29, P285, DOI 10.14670/HH-29.285; Simone LC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074519; Stoeber M, 2012, EMBO J, V31, P2350, DOI 10.1038/emboj.2012.98; Xie S, 2014, J BIOL CHEM	27	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123710	10.1371/journal.pone.0123710	http://dx.doi.org/10.1371/journal.pone.0123710			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875965	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800112
J	Datta-Mitra, A; Kundu-Raychaudhuri, S; Mitra, A; Raychaudhuri, SP				Datta-Mitra, Ananya; Kundu-Raychaudhuri, Smriti; Mitra, Anupam; Raychaudhuri, Siba P.			Cross Talk between Neuroregulatory Molecule and Monocyte: Nerve Growth Factor Activates the Inflammasome	PLOS ONE			English	Article							NF-KAPPA-B; NLRP3 INFLAMMASOME; INTERLEUKIN-1-BETA; RECEPTOR; INNATE; EXPRESSION; PSORIASIS; DISEASE; SUSCEPTIBILITY; NEUROTROPHINS	Background Increasing evidence points to a role for the extra-neuronal nerve growth factor (NGF) in acquired immune responses. However, very little information is available about its role and underlying mechanism in innate immunity. The role of innate immunity in autoimmune diseases is becoming increasingly important. In this study, we explored the contribution of pleiotropic NGF in the innate immune response along with its underlying molecular mechanism with respect to IL-1 beta secretion. Methods Human monocytes, null and NLRP3 deficient THP-1 cell lines were used for this purpose. We determined the effect of NGF on secretion of IL-1 beta at the protein and mRNA levels. To determine the underlying molecular mechanism, the effect of NGF on NLRP1/NLRP3 inflammasomes and its downstream key protein, activated caspase-1, were evaluated by ELISA, immunoflorescence, flow cytometry, and real-time PCR. Results In human monocytes and null THP-1 cell line, NGF significantly upregulates IL-1 beta at protein and mRNA levels in a caspase-1 dependent manner through its receptor, TrkA. Furthermore, we observed that NGF induces caspase-1 activation through NLRP1/NLRP3 inflammasomes, and it is dependent on the master transcription factor, NF-kappa B. Conclusions To best of our knowledge, this is the first report shedding light on the mechanistic aspect of a neuroregulatory molecule, NGF, in innate immune response, and thus enriches our understanding regarding its pathogenic role in inflammation. These observations add further evidence in favor of anti-NGF therapy in autoimmune diseases and also unlock a new area of research about the role of NGF in IL-1 beta mediated diseases.	[Datta-Mitra, Ananya; Kundu-Raychaudhuri, Smriti; Raychaudhuri, Siba P.] Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA; [Datta-Mitra, Ananya; Kundu-Raychaudhuri, Smriti; Mitra, Anupam; Raychaudhuri, Siba P.] VA Med Ctr Sacramento, Mather, CA 95655 USA; [Mitra, Anupam] Univ Calif Davis, Sch Med, Dept Dermatol, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis	Raychaudhuri, SP (corresponding author), Univ Calif Davis, Sch Med, Div Rheumatol Allergy & Clin Immunol, Davis, CA 95616 USA.	sraychaudhuri@ucdavis.edu	MITRA, ANANYA DATTA/AAE-4402-2019; Mitra, Anupam/AAM-6298-2020	MITRA, ANANYA DATTA/0000-0002-8097-4950; Mitra, Anupam/0000-0003-2385-7325	VA Merit grant [I01CX000201]	VA Merit grant	This project was supported by VA Merit grant, I01CX000201 awarded to Dr. Siba P. Raychaudhuri. Contents do not necessarily represent the views of the Department of Veterans Affairs or the United States Government. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aloe L, 2001, Arch Physiol Biochem, V109, P354, DOI 10.1076/apab.109.3.354.9339; Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Bresnihan B, 1998, ARTHRITIS RHEUM, V41, P2196, DOI 10.1002/1529-0131(199812)41:12<2196::AID-ART15>3.3.CO;2-U; Bryant C, 2009, TRENDS CELL BIOL, V19, P455, DOI 10.1016/j.tcb.2009.06.002; Buerger C, 2012, J INVEST DERMATOL, V132, P2206, DOI 10.1038/jid.2012.123; Cao Y, 2005, ACTA PHARMACOL SIN, V26, P150, DOI 10.1111/j.1745-7254.2005.00525.x; Carlstrom M, 2012, EXP DERMATOL, V21, P932, DOI 10.1111/exd.12049; Carter BD, 1997, NEURON, V18, P187, DOI 10.1016/S0896-6273(00)80259-7; Coccia M, 2012, J EXP MED, V209, P1595, DOI 10.1084/jem.20111453; Datta Mitra A, 2013, J INVESTIGATIVE DERM; Dieude P, 2011, ANN RHEUM DIS, V70, P668, DOI 10.1136/ard.2010.131243; FRANKLIN RA, 1995, J IMMUNOL, V154, P4965; Garcia-Rodriguez S, 2011, J EUROPEAN ACAD DERM; Gaspari AA, 2006, J AM ACAD DERMATOL, V54, pS67, DOI 10.1016/j.jaad.2005.10.057; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Goldbach-Mansky R, 2006, NEW ENGL J MED, V355, P581, DOI 10.1056/NEJMoa055137; Grabarek Jerzy, 2002, Hum Cell, V15, P1, DOI 10.1111/j.1749-0774.2002.tb00094.x; Gross O, 2011, IMMUNOL REV, V243, P136, DOI 10.1111/j.1600-065X.2011.01046.x; Guarda G, 2010, IMMUNOLOGY, V130, P329, DOI 10.1111/j.1365-2567.2010.03283.x; HISCOTT J, 1993, MOL CELL BIOL, V13, P6231, DOI 10.1128/MCB.13.10.6231; Jeong JG, 2004, BIOCHEM BIOPH RES CO, V324, P3, DOI 10.1016/j.bbrc.2004.09.011; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kennedy-Crispin M, 2012, J INVEST DERMATOL, V132, P105, DOI 10.1038/jid.2011.262; Kumar H, 2009, J IMMUNOL, V183, P8061, DOI 10.4049/jimmunol.0902477; Kummer JA, 2007, J HISTOCHEM CYTOCHEM, V55, P443, DOI 10.1369/jhc.6A7101.2006; Lachmann HJ, 2011, ARTHRITIS RHEUM-US, V63, P314, DOI 10.1002/art.30105; Lasiglie D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020014; Latz E, 2010, CURR OPIN IMMUNOL, V22, P28, DOI 10.1016/j.coi.2009.12.004; Levandowski CB, 2013, P NATL ACAD SCI USA, V110, P2952, DOI 10.1073/pnas.1222808110; Loh NK, 2012, INTERN MED J, V42, P1358, DOI 10.1111/imj.12002; Mathews RJ, 2013, ANN RHEUMATIC DIS; Mitra AD, 2012, INDIAN J DERMATOL VE, V78, P394, DOI 10.4103/0378-6323.95474; Mitra A, 2012, CYTOKINE, V60, P38, DOI 10.1016/j.cyto.2012.06.316; Naik E, 2010, J CLIN IMMUNOL, V30, P485, DOI 10.1007/s10875-010-9383-8; Park HJ, 2012, J CLIN IMMUNOL, V32, P1148, DOI 10.1007/s10875-012-9815-8; Park MJ, 2007, J BIOL CHEM, V282, P30485, DOI 10.1074/jbc.M701081200; Pontillo A, 2012, AUTOIMMUNITY, V45, P271, DOI 10.3109/08916934.2011.637532; Prencipe G, 2014, J IMMUNOL, V192, P3345, DOI 10.4049/jimmunol.1300825; Raychaudhuri SP, 2008, AM J PATHOL, V172, P961, DOI 10.2353/ajpath.2008.070710; Raychaudhuri SP, 2012, MOL CELL BIOCHEM, V359, P419, DOI 10.1007/s11010-011-1036-6; Raychaudhuri SP, 2011, ARTHRITIS RHEUM-US, V63, P3243, DOI 10.1002/art.30564; Raychaudhuri SR, 2004, J INVEST DERMATOL, V122, P812, DOI 10.1111/j.0022-202X.2003.12602.x; Schoultz I, 2009, AM J GASTROENTEROL, V104, P1180, DOI 10.1038/ajg.2009.29; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Susaki Y, 1996, BLOOD, V88, P4630, DOI 10.1182/blood.V88.12.4630.bloodjournal88124630; Tsoi LC, 2012, NAT GENET, V44, P1341, DOI 10.1038/ng.2467; TWOMEY B, 1990, BRIT J PHARMACOL, V100, P819, DOI 10.1111/j.1476-5381.1990.tb14098.x; van de Veerdonk Frank L, 2011, Trends Immunol, V32, P110, DOI 10.1016/j.it.2011.01.003; Vega JA, 2003, J ANAT, V203, P1, DOI 10.1046/j.1469-7580.2003.00203.x; Wahren-Herlenius M, 2013, LANCET, V382, P819, DOI 10.1016/S0140-6736(13)60954-X; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang JJ, 2011, GYNECOL OBSTET INVES, V72, P163, DOI 10.1159/000327934	53	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121626	10.1371/journal.pone.0121626	http://dx.doi.org/10.1371/journal.pone.0121626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876154	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800025
J	Frank, DO; Dengjel, J; Wilfling, F; Kozjak-Pavlovic, V; Hacker, G; Weber, A				Frank, Daniel O.; Dengjel, Joern; Wilfling, Florian; Kozjak-Pavlovic, Vera; Haecker, Georg; Weber, Arnim			The Pro-Apoptotic BH3-Only Protein Bim Interacts with Components of the Translocase of the Outer Mitochondrial Membrane (TOM)	PLOS ONE			English	Article							BCL-2 PROTEINS; BH3 DOMAINS; IMPORT; BAX; PREPROTEINS; FAMILY; CELLS; PHOSPHORYLATION; DEGRADATION; PROTEOMICS	The pro-apoptotic Bcl-2-family protein Bim belongs to the BH3-only proteins known as initiators of apoptosis. Recent data show that Bim is constitutively inserted in the outer mitochondrial membrane via a C-terminal transmembrane anchor from where it can activate the effector of cytochrome c-release, Bax. To identify regulators of Bim-activity, we conducted a search for proteins interacting with Bim at mitochondria. We found an interaction of Bim with Tom70, Tom20 and more weakly with Tom40, all components of the Translocase of the Outer Membrane (TOM). In vitro import assays performed on tryptically digested yeast mitochondria showed reduced Bim insertion into the outer mitochondrial membrane (OMM) indicating that protein receptors may be involved in the import process. However, RNAi against components of TOM (Tom40, Tom70, Tom22 or Tom20) by siRNA, individually or in combination, did not consistently change the amount of Bim on HeLa mitochondria, either at steady state or upon de novo-induction. In support of this, the individual or combined knockdowns of TOM receptors also failed to alter the susceptibility of HeLa cells to Bim-induced apoptosis. In isolated yeast mitochondria, lack of Tom70 or the TOM-components Tom20 or Tom22 alone did not affect the import of Bim into the outer mitochondrial membrane. In yeast, expression of Bim can sensitize the cells to Bax-dependent killing. This sensitization was unaffected by the absence of Tom70 or by an experimental reduction in Tom40. Although thus the physiological role of the Bim-TOM-interaction remains unclear, TOM complex components do not seem to be essential for Bim insertion into the OMM. Nevertheless, this association should be noted and considered when the regulation of Bim in other cells and situations is investigated.	[Frank, Daniel O.; Haecker, Georg; Weber, Arnim] Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany; [Dengjel, Joern] Univ Freiburg, Med Ctr, Dept Dermatol, Freiburg, Germany; [Dengjel, Joern] Univ Freiburg, Ctr Biol Syst Anal ZBSA, Freiburg Inst Adv Studies FRIAS, D-79106 Freiburg, Germany; [Wilfling, Florian] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany; [Kozjak-Pavlovic, Vera] Univ Wurzburg, Bioctr, Dept Microbiol, D-97070 Wurzburg, Germany; [Dengjel, Joern; Haecker, Georg] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79106 Freiburg, Germany; [Frank, Daniel O.] Univ Freiburg, Spemann Grad Sch Biol & Med SGBM, D-79106 Freiburg, Germany; [Frank, Daniel O.] Univ Freiburg, Fac Biol, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Max Planck Society; University of Wurzburg; University of Freiburg; University of Freiburg; University of Freiburg	Weber, A (corresponding author), Univ Med Ctr Freiburg, Inst Med Microbiol & Hyg, Freiburg, Germany.	arnim.weber@uniklinik-freiburg.de	Dengjel, Joern/AAI-3682-2020; Wilfling, Florian/AAJ-8921-2021; Kozjak-Pavlovic, Vera/E-1494-2013	Kozjak-Pavlovic, Vera/0000-0001-9658-7018; Dengjel, Joern/0000-0002-9453-4614; Wilfling, Florian/0000-0002-6559-7261	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); German Research Council (DFG) [FOR2036]	Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School); German Research Council (DFG)(German Research Foundation (DFG))	This study was supported in part by the Excellence Initiative of the German Research Foundation (GSC-4, Spemann Graduate School) and by a grant from the German Research Council (DFG, FOR2036, to G.H.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Clybouw C, 2012, CELL DEATH DIFFER, V19, P1060, DOI 10.1038/cdd.2011.198; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dehan E, 2009, MOL CELL, V33, P109, DOI 10.1016/j.molcel.2008.12.020; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Dukanovic J, 2011, BBA-BIOMEMBRANES, V1808, P971, DOI 10.1016/j.bbamem.2010.06.021; Geissler A, 2013, CELL DEATH DIFFER; Hardwick JM, 2009, CELL, V138, P404, DOI 10.1016/j.cell.2009.07.003; Huntington ND, 2007, NAT IMMUNOL, V8, P856, DOI 10.1038/ni1487; Kemper C, 2008, J CELL SCI, V121, P1990, DOI 10.1242/jcs.024034; Kozjak-Pavlovic V, 2007, EMBO REP, V8, P576, DOI 10.1038/sj.embor.7400982; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Meisinger C, 2001, MOL CELL BIOL, V21, P2337, DOI 10.1128/MCB.21.7.2337-2348.2001; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; MOCZKO M, 1994, J BIOL CHEM, V269, P9045; Nechushtan A, 2001, J CELL BIOL, V153, P1265, DOI 10.1083/jcb.153.6.1265; Neupert W, 2007, ANNU REV BIOCHEM, V76, P723, DOI 10.1146/annurev.biochem.76.052705.163409; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Parish IA, 2009, BLOOD, V113, P4575, DOI 10.1182/blood-2008-10-185223; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sherman F., 1986, METHODS YEAST GENETI; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Shinjyo T, 2001, MOL CELL BIOL, V21, P854, DOI 10.1128/MCB.21.3.854-864.2001; van Wilpe S, 1999, NATURE, V401, P485, DOI 10.1038/46802; Vince JE, 2008, J CELL BIOL, V182, P171, DOI 10.1083/jcb.200801010; Weber A, 2013, APOPTOSIS; Weber A, 2007, J CELL BIOL, V177, P625, DOI 10.1083/jcb.200610148; Weber K, 2013, CELL REPORTS; Wilfling F, 2012, CELL DEATH DIFFER, V19, P1328, DOI 10.1038/cdd.2012.9; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Young JC, 2003, CELL, V112, P41, DOI 10.1016/S0092-8674(02)01250-3	36	21	21	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123341	10.1371/journal.pone.0123341	http://dx.doi.org/10.1371/journal.pone.0123341			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875815	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800093
J	Wang, CY; Wang, JY; Teng, NC; Chao, TT; Tsai, SL; Chen, CL; Hsu, JY; Wu, CP; Lai, CC; Chen, L				Wang, Cheng-Yi; Wang, Jen-Yu; Teng, Nai-Chi; Chao, Ting-Ting; Tsai, Shu-Ling; Chen, Chi-Liang; Hsu, Jeng-Yuan; Wu, Chin-Pyng; Lai, Chih-Cheng; Chen, Likwang			The Secular Trends in the Incidence Rate and Outcomes of Out-of-Hospital Cardiac Arrest in Taiwan-A Nationwide Population-Based Study	PLOS ONE			English	Article							INSURANCE RESEARCH DATABASE; MYOCARDIAL-INFARCTION; UNITED-STATES; SURVIVAL; CARE; RISK; ASSOCIATION; VALIDATION; DIAGNOSIS; REGISTRY	Objective This study investigated the trends in incidence and mortality of out-of-hospital cardiac arrest (OHCA), as well as factors associated with OHCA outcomes in Taiwan. Methods Our study included OHCA patients requiring cardiopulmonary resuscitation (CPR) upon arrival at the hospital. We used national time-series data on annual OHCA incidence rates and mortality rates from 2000 to 2012, and individual demographic and clinical data for all OHCA patients requiring mechanical ventilation (MV) care from March of 2010 to September of 2011. Analytic techniques included the time-series regression and the logistic regression. Results There were 117,787 OHCAs in total. The overall incidence rate during the 13 years was 51.1 per 100,000 persons, and the secular trend indicates a sharp increase in the early 2000s and a decrease afterwards. The trend in mortality was also curvilinear, revealing a substantial increase in the early 2000s, a subsequent steep decline and finally a modest increase. Both the 30-day and 180-day mortality rates had a long-term decreasing trend over the period (p<0.01). For both incidence and mortality rates, a significant second-order auto-regressive effect emerged. Among OHCA patients with MV, 1-day, 30-day and 180-day mortality rates were 31.3%, 75.8%, and 86.0%, respectively. In this cohort, older age, the female gender, and a Charlson comorbidity index score >= 2 were associated with higher 180-day mortality; patients delivered to regional hospitals and those residing in non-metropolitan areas had higher death risk. Conclusions Overall, both the 30-day and the 180-day mortality rates after OHCA had a long-term decreasing trend, while the 1-day mortality had no long-term decline. Among OHCA patients requiring MV, those delivered to regional hospitals and those residing in non-metropolitan areas tended to have higher mortality, suggesting a need for effort to further standardize and improve in-hospital care across hospitals and to advance pre-hospital care in non-metropolitan areas.	[Wang, Cheng-Yi; Wang, Jen-Yu] Fu Jen Catholic Univ Coll Med, Cardinal Tien Hosp, Dept Internal Med, New Taipei City, Taiwan; [Teng, Nai-Chi; Chen, Likwang] Natl Hlth Res Inst, Inst Populat Hlth Sci, Zhunan Town, Miaoli County, Taiwan; [Chao, Ting-Ting] Fu Jen Catholic Univ Coll Med, Cardinal Tien Hosp, Med Res Ctr, New Taipei City, Taiwan; [Tsai, Shu-Ling] Minist Hlth & Welf, Natl Hlth Insurance Adm, Taipei, Taiwan; [Chen, Chi-Liang] Chung Yuan Christian Univ, Coll Business, Dept Accounting, Taoyuan, Taiwan; [Hsu, Jeng-Yuan] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Wu, Chin-Pyng] Landseed Hosp, Dept Internal Med, Taoyuan, Taiwan; [Lai, Chih-Cheng] Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan	Cardinal Tien Hospital; Fu Jen Catholic University; National Health Research Institutes - Taiwan; Cardinal Tien Hospital; Fu Jen Catholic University; Chung Yuan Christian University; Taichung Veterans General Hospital; Chi Mei Hospital	Lai, CC (corresponding author), Chi Mei Med Ctr, Dept Intens Care Med, Tainan, Taiwan.	dtmed141@gmail.com; likwang@nhri.org.tw	Wu, Chin-Pyng/W-8447-2019		National Health Research Institutes, Taiwan; National Health Insurance Administration, Ministry of Health and Welfare, Taiwan; Cardinal Tien Hospital	National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan); National Health Insurance Administration, Ministry of Health and Welfare, Taiwan; Cardinal Tien Hospital	The authors study was financially supported by the following three organizations: National Health Research Institutes, Taiwan; National Health Insurance Administration, Ministry of Health and Welfare, Taiwan; Cardinal Tien Hospital. The study is based on data provided by National Health Insurance Administration, Ministry of Health and Welfare, Taiwan. The interpretation and conclusions shown in this paper do not represent those of National Health Research Institutes, or National Health Insurance Administration, Ministry of Health and Welfare, Taiwan.	Atwood C, 2005, RESUSCITATION, V67, P75, DOI 10.1016/j.resuscitation.2005.03.021; Axelsson C, 2012, RESUSCITATION, V83, P1253, DOI 10.1016/j.resuscitation.2012.01.043; Berdowski J, 2010, RESUSCITATION, V81, P1479, DOI 10.1016/j.resuscitation.2010.08.006; Bobrow BJ, 2010, JAMA-J AM MED ASSOC, V304, P1447, DOI 10.1001/jama.2010.1392; Buist M, 2014, RESUSCITATION, V85, P155, DOI 10.1016/j.resuscitation.2013.12.016; Chen YC, 2011, SCIENTOMETRICS, V86, P365, DOI 10.1007/s11192-010-0289-2; Cheng CL, 2014, J EPIDEMIOL, V24, P500, DOI 10.2188/jea.JE20140076; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Cheung W, 2013, CRIT CARE RESUSC, V15, P241; Cobb LA, 2002, JAMA-J AM MED ASSOC, V288, P3008, DOI 10.1001/jama.288.23.3008; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Fowler RA, 2007, CAN MED ASSOC J, V177, P1513, DOI 10.1503/cmaj.071112; Goto Y, 2013, CRIT CARE, V17, DOI 10.1186/cc12812; Harnod D, 2013, INT J GERONTOL, V7, P216, DOI 10.1016/j.ijge.2013.08.001; Hasegawa K, 2013, RESUSCITATION, V84, P1099, DOI 10.1016/j.resuscitation.2013.03.007; Hung MC, 2011, CRIT CARE, V15, DOI 10.1186/cc10128; Kim JY, 2013, RESUSCITATION, V84, P1068, DOI 10.1016/j.resuscitation.2013.02.010; Kuo CW, 2014, J EMERG MED, V46, P782, DOI 10.1016/j.jemermed.2013.08.026; Kuo CF, 2013, RHEUMATOLOGY, V52, P111, DOI 10.1093/rheumatology/kes169; Lin CC, 2005, J FORMOS MED ASSOC, V104, P157; Lindner TW, 2011, RESUSCITATION, V82, P1508, DOI 10.1016/j.resuscitation.2011.06.016; Lu HM, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-100; McNally Bryan, 2011, Morbidity and Mortality Weekly Report, V60, P1; Nichol G, 2008, JAMA-J AM MED ASSOC, V300, P1423, DOI 10.1001/jama.300.12.1423; Nielsen N, 2012, RESUSCITATION, V83, P669, DOI 10.1016/j.resuscitation.2012.03.015; Olasveengen TM, 2009, JAMA-J AM MED ASSOC, V302, P2222, DOI 10.1001/jama.2009.1729; Ramjee V, 2013, RESUSCITATION, V84, P537, DOI 10.1016/j.resuscitation.2013.02.008; Rea TD, 2004, RESUSCITATION, V63, P17, DOI 10.1016/j.resuscitation.2004.03.025; Ro YS, 2013, RESUSCITATION, V84, P547, DOI 10.1016/j.resuscitation.2012.12.020; Roger VL, 2012, CIRCULATION, V125, pE2, DOI 10.1161/CIR.0b013e31823ac046; Sasson C, 2010, CIRC-CARDIOVASC QUAL, V3, P63, DOI 10.1161/CIRCOUTCOMES.109.889576; Shen HN, 2011, CRIT CARE, V15, DOI 10.1186/cc10323; Wu CY, 2012, JAMA-J AM MED ASSOC, V308, P1906, DOI 10.1001/2012.jama.11975; Wu SC., 2010, TAIWAN J PUBLIC HLTH, V29, P191; Wu VC, 2014, J CLIN EPIDEMIOL, V67, P1139, DOI 10.1016/j.jclinepi.2014.05.012; Wu VC, 2014, J AM SOC NEPHROL, V25, P595, DOI 10.1681/ASN.2013060610	36	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122675	10.1371/journal.pone.0122675	http://dx.doi.org/10.1371/journal.pone.0122675			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875921	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800070
J	Ma, SM; Chen, LX; Lin, YF; Yan, H; Lv, JW; Xiong, M; Li, J; Cheng, GQ; Yang, Y; Qiu, ZL; Zhou, WH				Ma, Si-Min; Chen, Long-Xia; Lin, Yi-Feng; Yan, Hu; Lv, Jing-Wen; Xiong, Man; Li, Jin; Cheng, Guo-Qiang; Yang, Yi; Qiu, Zi-Long; Zhou, Wen-Hao			Periostin Promotes Neural Stem Cell Proliferation and Differentiation following Hypoxic-Ischemic Injury	PLOS ONE			English	Article							RAT MODEL; ADULT NEUROGENESIS; BRAIN; REGENERATION; EXPRESSION; MIGRATION; ISCHEMIA/HYPOXIA; FIBROBLASTS; NEURONS	Neural stem cell (NSC) proliferation and differentiation are required to replace neurons damaged or lost after hypoxic-ischemic events and recover brain function. Periostin (POSTN), a novel matricellular protein, plays pivotal roles in the survival, migration, and regeneration of various cell types, but its function in NSCs of neonatal rodent brain is still unknown. The purpose of this study was to investigate the role of POSTN in NSCs following hypoxia-ischemia (HI). We found that POSTN mRNA levels significantly increased in differentiating NSCs. The proliferation and differentiation of NSCs in the hippocampus is compromised in POSTN knockout mice. Moreover, NSC proliferation and differentiation into neurons and astrocytes significantly increased in cultured NSCs treated with recombinant POSTN. Consistently, injection of POSTN into neonatal hypoxic-ischemic rat brains stimulated NSC proliferation and differentiation in the subventricular and subgranular zones after 7 and 14 days of brain injury. Lastly, POSTN treatment significantly improved the spatial learning deficits of rats subjected to HI. These results suggest that POSTN significantly enhances NSC proliferation and differentiation after HI, and provides new insights into therapeutic strategies for the treatment of hypoxic-ischemic encephalopathy.	[Ma, Si-Min; Cheng, Guo-Qiang; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China; [Chen, Long-Xia; Lin, Yi-Feng] Fudan Univ, Childrens Hosp, Key Lab Birth Defect, Shanghai 200433, Peoples R China; [Ma, Si-Min; Chen, Long-Xia; Lin, Yi-Feng; Yan, Hu; Lv, Jing-Wen; Xiong, Man; Yang, Yi; Zhou, Wen-Hao] Fudan Univ, Childrens Hosp, Key Lab Neonatal Dis, Minist Hlth, Shanghai 200433, Peoples R China; [Qiu, Zi-Long] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Neurosci, Shanghai, Peoples R China; [Li, Jin] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University	Zhou, WH (corresponding author), Fudan Univ, Childrens Hosp, Dept Neonatol, Shanghai 200433, Peoples R China.	zwhchfu@126.com	wenhao, zhou/AAA-1505-2020		National Natural Science Foundation of China [81170599, 81300518]; Health Industry Research Project of The Ministry of Health [201002006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Health Industry Research Project of The Ministry of Health	This study was supported by the National Natural Science Foundation of China (NO. 81170599; NO. 81300518) and The Health Industry Research Project of The Ministry of Health (No. 201002006).	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Aukkarasongsup P, 2013, BIOCHEM BIOPH RES CO, V441, P126, DOI 10.1016/j.bbrc.2013.10.027; Conway SJ, 2014, CELL MOL LIFE SCI, V71, P1279, DOI 10.1007/s00018-013-1494-y; Conway SJ, 2008, CURR GENOMICS, V9, P548, DOI 10.2174/138920208786847917; De Filippis L, 2011, CELL MOL LIFE SCI, V68, P2831, DOI 10.1007/s00018-011-0723-5; Dizon M, 2010, DEV NEUROSCI-BASEL, V32, P173, DOI 10.1159/000313468; Dorn GW, 2007, NEW ENGL J MED, V357, P1552, DOI 10.1056/NEJMcibr074816; Ferriero DM, 2004, NEW ENGL J MED, V351, P1985, DOI 10.1056/NEJMra041996; Gonzalez FF, 2008, PHARMACOL THERAPEUT, V120, P43, DOI 10.1016/j.pharmthera.2008.07.003; Hayashi T, 2005, BRAIN RES, V1038, P41, DOI 10.1016/j.brainres.2004.12.048; Huang ZH, 2009, BRAIN RES, V1301, P100, DOI 10.1016/j.brainres.2009.09.006; Ikeda T, 2005, AM J OBSTET GYNECOL, V193, P849, DOI 10.1016/j.ajog.2005.01.029; Ikeda T, 2008, CELL TISSUE RES, V331, P263, DOI 10.1007/s00441-007-0546-8; Ishikawa K, 2014, FASEB J, V28, P131, DOI 10.1096/fj.13-229740; Iwai M, 2006, NEUROL RES, V28, P461, DOI 10.1179/016164105X49283; Jackson-Boeters L, 2009, J CELL COMMUN SIGNAL, V3, P125, DOI 10.1007/s12079-009-0057-3; Kuhn B, 2007, NAT MED, V13, P962, DOI 10.1038/nm1619; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Nishiyama T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018410; Ohira K, 2011, CELL MOL LIFE SCI, V68, P1645, DOI 10.1007/s00018-010-0552-y; Oka T, 2007, CIRC RES, V101, P313, DOI 10.1161/CIRCRESAHA.107.149047; Padial-Molina M, 2014, J PERIODONTAL RES, V49, P405, DOI 10.1111/jre.12120; Pimentel-Coelho PM, 2010, STEM CELLS DEV, V19, P299, DOI 10.1089/scd.2009.0403; Sheldon RA, 1996, BIOL NEONATE, V69, P327; Shih CH, 2014, J NEUROSCI, V34, P2438, DOI 10.1523/JNEUROSCI.2947-13.2014; Shimamura M, 2014, HYPERTENS RES, V37, P494, DOI 10.1038/hr.2014.36; Shimamura M, 2012, STROKE, V43, P1108, DOI 10.1161/STROKEAHA.111.636662; Snider P, 2008, CIRC RES, V102, P752, DOI 10.1161/CIRCRESAHA.107.159517; Stansfield WE, 2009, ANN THORAC SURG, V88, P1916, DOI 10.1016/j.athoracsur.2009.07.038; Sun JQ, 2010, BIOCHEM BIOPH RES CO, V394, P146, DOI 10.1016/j.bbrc.2010.02.132; TAKESHITA S, 1993, BIOCHEM J, V294, P271, DOI 10.1042/bj2940271; Taupin P, 2007, BRAIN RES REV, V53, P198, DOI 10.1016/j.brainresrev.2006.08.002; Vannucci RC, 1999, J NEUROSCI RES, V55, P158, DOI 10.1002/(SICI)1097-4547(19990115)55:2<158::AID-JNR3>3.0.CO;2-1; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wachtel EV, 2011, CURR PROB PEDIATR AD, V41, P132, DOI 10.1016/j.cppeds.2010.12.002; Weiss S, 1996, TRENDS NEUROSCI, V19, P387, DOI 10.1016/S0166-2236(96)10035-7; Xiao ZM, 2013, BIOTECHNOL APPL BIOC, DOI [10.1002/bab.1193.s, DOI 10.1002/BAB.1193.S]; Xiong M, 2008, NEUROBIOL DIS, V32, P433, DOI 10.1016/j.nbd.2008.08.007; Yan H, 2010, BIOCHEM BIOPH RES CO, V391, P1187, DOI 10.1016/j.bbrc.2009.12.015; Zhang Z, 2014, INT J MOL MED, V34, P253, DOI 10.3892/ijmm.2014.1760; Zhou B, 2010, DEV BIOL, V338, P251, DOI 10.1016/j.ydbio.2009.12.007; Zhu SM, 2008, J HISTOCHEM CYTOCHEM, V56, P329, DOI 10.1369/jhc.7A7321.2007; Zhu SM, 2009, J CELL PHYSIOL, V218, P584, DOI 10.1002/jcp.21633	46	12	15	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123585	10.1371/journal.pone.0123585	http://dx.doi.org/10.1371/journal.pone.0123585			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894199	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700045
J	Marino, F; Tozzi, M; Schembri, L; Ferraro, S; Tarallo, A; Scanzano, A; Legnaro, M; Castelli, P; Cosentino, M				Marino, Franca; Tozzi, Matteo; Schembri, Laura; Ferraro, Stefania; Tarallo, Antonino; Scanzano, Angela; Legnaro, Massimiliano; Castelli, Patrizio; Cosentino, Marco			Production of IL-8, VEGF and Elastase by Circulating and Intraplaque Neutrophils in Patients with Carotid Atherosclerosis	PLOS ONE			English	Article							TYPE-1 RECEPTOR EXPRESSION; POLYMORPHONUCLEAR NEUTROPHILS; PLAQUE; ARTERY; INFILTRATION; ANGIOGENESIS; INSTABILITY; MECHANISMS; LEUKOCYTES; MEDIATOR	Objectives Polymorphonuclear neutrophils (PMN) in atherosclerotic plaques have been identified only recently, and their contribution to plaque development is not yet fully understood. In this study, production of elastase, interleukin (IL)-8 and vascular endothelial growth factor (VEGF) by PMN was investigated in subjects with carotid stenosis undergoing carotid endarterectomy (CEA). Methods The study enrolled 50 patients (Pts) and 10 healthy subjects (HS). Circulating PMN (cPMN) isolated from venous blood (in both Pts and HS) and from plaques (pPMN, in Pts) were cultured, alone or with 0.1 mu M fMLP. Elastase, IL-8 and VEGF mRNA were analyzed by real-time PCR. In CEA specimens, PMN were localized by immunohistochemistry. Results In both Pts cPMN and pPMN, IL-8 mRNA was higher at rest but lower after fMLP (P<0.01 vs HS), and VEGF mRNA was higher both at rest and after fMLP (P<0.01 vs HS), while elastase mRNA was not significantly different. On the contrary, protein production was always higher in cPMN of HS with respect to values measured in cells of Pts. In CEA specimens, CD66b+ cells localized to areas with massive plaque formation close to neovessels. Pts with soft and mix plaques, as defined by computed tomography, did not differ in cPMN or pPMN IL-8, VEGF or elastase mRNA, or in intraplaque CD66b+ cell density. However, Pts with soft plaques had higher white blood cell count due to increased PMN. Conclusions In Pts with carotid plaques, both circulating and intraplaque PMN produce IL-8, VEGF and elastase, which are crucial for plaque development and progression. These findings suggest mechanistic explanations to the reported correlation between PMN count and cardiovascular mortality in carotid ATH.	[Marino, Franca; Schembri, Laura; Scanzano, Angela; Legnaro, Massimiliano; Cosentino, Marco] Univ Insubria, Ctr Res Med Pharmacol, Varese, Italy; [Tozzi, Matteo; Ferraro, Stefania; Tarallo, Antonino; Castelli, Patrizio] Univ Insubria, Dept Surg & Morphol Sci, Varese, Italy	University of Insubria; University of Insubria	Marino, F (corresponding author), Univ Insubria, Ctr Res Med Pharmacol, Varese, Italy.	franca.marino@uninsubria.it	Cosentino, Marco/A-3848-2010; Tozzi, Matteo/L-1598-2019	Cosentino, Marco/0000-0002-6978-7775; Tozzi, Matteo/0000-0002-7300-8260; Castelli, Patrizio/0000-0002-0709-6936	University of Insubria; PhD Course in Clinical and Experimental Pharmacology, University of Insubria	University of Insubria; PhD Course in Clinical and Experimental Pharmacology, University of Insubria	This work was supported in part by grants from the University of Insubria (FAR 2011-2012) to FM and MT. AS was supported by a fellowship grant from the PhD Course in Clinical and Experimental Pharmacology, University of Insubria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baetta R, 2010, ATHEROSCLEROSIS, V210, P1, DOI 10.1016/j.atherosclerosis.2009.10.028; Baggiolini M, 2001, J INTERN MED, V250, P91, DOI 10.1046/j.1365-2796.2001.00867.x; Benabid R, 2012, J BIOL CHEM, V287, P34883, DOI 10.1074/jbc.M112.361352; Boisvert William A, 2004, Discov Med, V4, P288; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; de Weert TT, 2008, INT J CARDIOVAS IMAG, V24, P751, DOI 10.1007/s10554-008-9309-1; Della Bona R, 2013, INFLAMM RES, V62, P537, DOI 10.1007/s00011-013-0617-0; Dorweiler B, 2008, THROMB HAEMOSTASIS, V99, P373, DOI 10.1160/TH07-06-0387; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Glass CK, 2001, CELL, V104, P503, DOI 10.1016/S0092-8674(01)00238-0; Golledge J, 1997, BRIT J SURG, V84, P1697; Golledge J, 2000, STROKE, V31, P774, DOI 10.1161/01.STR.31.3.774; Guasti L, 2008, EUR HEART J, V29, P1118, DOI 10.1093/eurheartj/ehn138; Guasti L, 2006, J HYPERTENS, V24, P2423, DOI 10.1097/01.hjh.0000251903.62804.77; Guasti L, 2011, THROMB HAEMOSTASIS, V106, P591, DOI 10.1160/TH11-02-0096; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Henriksen PA, 2008, INT J BIOCHEM CELL B, V40, P1095, DOI 10.1016/j.biocel.2008.01.004; Ho-Tin-Noe B, 2011, TRENDS CARDIOVAS MED, V21, P183, DOI 10.1016/j.tcm.2012.05.007; Holm PW, 2009, ANN MED, V41, P257, DOI 10.1080/07853890802516507; Ionita MG, 2010, ARTERIOSCL THROM VAS, V30, P1842, DOI 10.1161/ATVBAHA.110.209296; Khuseyinova N, 2006, CURR OPIN CRIT CARE, V12, P412, DOI 10.1097/01.ccx.0000244119.16377.75; Liapis CD, 2009, EUR J VASC ENDOVASC, V37, pS1, DOI 10.1016/j.ejvs.2008.11.006; Marino F, 2007, J CARDIOVASC PHARM, V49, P299, DOI 10.1097/FJC.0b013e31803d35ce; Marino F, 2009, J CARDIOVASC PHARM, V54, P520, DOI 10.1097/FJC.0b013e3181bfadfd; Mayer FJ, 2013, ATHEROSCLEROSIS, V231, P274, DOI 10.1016/j.atherosclerosis.2013.10.002; Mocsai A, 2013, J EXP MED, V210, P1283, DOI 10.1084/jem.20122220; Moreno PR, 2012, ANN NY ACAD SCI, V1254, P7, DOI 10.1111/j.1749-6632.2012.06497.x; Naruko T, 2002, CIRCULATION, V106, P2894, DOI 10.1161/01.CIR.0000042674.89762.20; Quigley JP, 2012, FUTURE ONCOL, V8, P5, DOI [10.2217/FON.11.133, 10.2217/fon.11.133]; Quinn K, 2008, AM J PHYSIOL-HEART C, V295, pH1817, DOI 10.1152/ajpheart.00472.2008; Rotzius P, 2010, AM J PATHOL, V177, P493, DOI 10.2353/ajpath.2010.090480; Saba L, 2012, AM J NEURORADIOL, V33, P1814, DOI 10.3174/ajnr.A3073; Saba L, 2009, CLIN RADIOL, V64, P767, DOI 10.1016/j.crad.2009.03.009; Simonini A, 2000, CIRCULATION, V101, P1519, DOI 10.1161/01.CIR.101.13.1519; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Tecchio C, 2014, CHEM IMMUNOL ALLERGY, V99, P123, DOI 10.1159/000353358; van Leeuwen M, 2008, ARTERIOSCL THROM VAS, V28, P84, DOI 10.1161/ATVBAHA.107.154807; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Ye RD, 2009, PHARMACOL REV, V61, P119, DOI 10.1124/pr.109.001578; Zernecke A, 2008, CIRC RES, V102, P209, DOI 10.1161/CIRCRESAHA.107.160697	42	28	30	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124565	10.1371/journal.pone.0124565	http://dx.doi.org/10.1371/journal.pone.0124565			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893670	Green Published, gold			2022-12-27	WOS:000353211700106
J	Tang, WH; Wang, CP; Chung, FM; Huang, LLH; Yu, TH; Hung, WC; Lu, LF; Chen, PY; Luo, CH; Lee, KT; Lee, YJ; Lai, WT				Tang, Wei-Hua; Wang, Chao-Ping; Chung, Fu-Mei; Huang, Lynn L. H.; Yu, Teng-Hung; Hung, Wei-Chin; Lu, Li-Fen; Chen, Po-Yuan; Luo, Ching-Hsing; Lee, Kun-Tai; Lee, Yau-Jiunn; Lai, Wen-Ter			Uremic Retention Solute Indoxyl Sulfate Level Is Associated with Prolonged QTc Interval in Early CKD Patients	PLOS ONE			English	Article							PROTEIN-KINASE-C; SUDDEN CARDIAC DEATH; K+ CHANNELS; POTASSIUM CHANNEL; OUTWARD CURRENT; P-CRESOL; TOXINS; REPOLARIZATION; INFLAMMATION; FIBROBLASTS	Total mortality and sudden cardiac death is highly prevalent in patients with chronic kidney disease (CKD). In CKD patients, the protein-bound uremic retention solute indoxyl sulfate (IS) is independently associated with cardiovascular disease. However, the underlying mechanisms of this association have yet to be elucidated. The relationship between IS and cardiac electrocardiographic parameters was investigated in a prospective observational study among early CKD patients. IS arrhythmogenic effect was evaluated by in vitro cardiomyocyte electrophysiological study and mathematical computer simulation. In a cohort of 100 early CKD patients, patients with corrected QT (QTc) prolongation had higher IS levels. Furthermore, serum IS level was independently associated with prolonged QTc interval. In vitro, the delay rectifier potassium current (IK) was found to be significantly decreased after the treatment of IS in a dose-dependent manner. The modulation of IS to the IK was through the regulation of the major potassium ion channel protein Kv 2.1 phosphorylation. In a computer simulation, the decrease of IK by IS could prolong the action potential duration (APD) and induce early afterdepolarization, which is known to be a trigger mechanism of lethal ventricular arrhythmias. In conclusion, serum IS level is independently associated with the prolonged QTc interval in early CKD patients. IS down-regulated I-K channel protein phosphorylation and the I-K current activity that in turn increased the cardiomyocyte APD and QTc interval in vitro and in the computer ORd model. These findings suggest that IS may play a role in the development of arrhythmogenesis in CKD patients.	[Tang, Wei-Hua; Lee, Kun-Tai; Lai, Wen-Ter] Kaohsiung Med Univ, Collage Med, Grad Inst Med, Kaohsiung, Taiwan; [Tang, Wei-Hua; Lee, Kun-Tai; Lai, Wen-Ter] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Wang, Chao-Ping; Chung, Fu-Mei; Yu, Teng-Hung; Hung, Wei-Chin] I Shou Univ, E Da Hosp, Dept Internal Med, Div Cardiol, Kaohsiung, Taiwan; [Huang, Lynn L. H.] Natl Cheng Kung Univ, Inst Biotechnol, Tainan 70101, Taiwan; [Lu, Li-Fen] I Shou Univ, E Da Hosp, Dept Surg, Div Cardiac Surg, Kaohsiung, Taiwan; [Chen, Po-Yuan; Luo, Ching-Hsing] Natl Cheng Kung Univ, Inst Elect Engn, Tainan 70101, Taiwan; [Lee, Yau-Jiunn] Lees Endocrinol Clin, Pingtung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; E-Da Hospital; I Shou University; National Cheng Kung University; E-Da Hospital; I Shou University; National Cheng Kung University	Lai, WT (corresponding author), Kaohsiung Med Univ, Collage Med, Grad Inst Med, Kaohsiung, Taiwan.	kmuhep@yahoo.com.tw	Huang, Lynn/J-9237-2016; Huang, Lynn L.H./AAF-2426-2019	Huang, Lynn/0000-0002-6602-7578; Huang, Lynn L.H./0000-0002-6602-7578	Kaohsiung Medical University Hospital [KMUH101-1MO6]; I-Shou University E-Da Hospital of the Republic of China, Taiwan; I-Shou University E-DA Hospital [EDAHP101020]	Kaohsiung Medical University Hospital; I-Shou University E-Da Hospital of the Republic of China, Taiwan; I-Shou University E-DA Hospital	The authors would like to thank the Kaohsiung Medical University Hospital and the I-Shou University E-Da Hospital of the Republic of China, Taiwan, for financially supporting this research. Wei-Hua Tang received the grant from Kaohsiung Medical University Hospital with grant number KMUH101-1MO6 (URL:http://www.kmuh.org.tw/www/clireser/File/research_ resource/101%E5%AD%B8%E5%B9%B4%E5%BA%A6%E9%99%A2%E5%85%A7%E6%8C%87%E5%B0%8E%E5%9E%8B%E8%A8%88%E7%95%AB%E9%80%9A%E9%81%8E%E5%90%8D%E5%96%AE.pdf) and Chao-Ping Wang received the grant from I-Shou University E-DA Hospital with grant number EDAHP101020 (URL:http://www2.edah.org.tw/mrd/plan/EDMRP.html). Neither the Kaohsiung Medical University Hospital nor I-Shou University E-Da Hospital had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama I, 2002, NEPHRON, V92, P635, DOI 10.1159/000064108; Atoh K, 2009, DIABETES RES CLIN PR, V83, P220, DOI 10.1016/j.diabres.2008.09.053; Barreto FC, 2009, CLIN J AM SOC NEPHRO, V4, P1551, DOI 10.2215/CJN.03980609; Cain BS, 1999, J SURG RES, V81, P249, DOI 10.1006/jsre.1998.5508; CARMELIET E, 1993, FUNDAM CLIN PHARM, V7, P19, DOI 10.1111/j.1472-8206.1993.tb00214.x; Chiu Cheng-An, 2010, Rev Diabet Stud, V7, P275, DOI 10.1900/RDS.2010.7.275; Covic A, 2002, NEPHROL DIAL TRANSPL, V17, P2170, DOI 10.1093/ndt/17.12.2170; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Enomoto A, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000022017.96399.B2; Faure V, 2006, J THROMB HAEMOST, V4, P566, DOI 10.1111/j.1538-7836.2005.01780.x; Genovesi S, 2013, EUROPACE, V15, P1025, DOI 10.1093/europace/eus412; Gima K, 2002, CIRC RES, V90, P889, DOI 10.1161/01.RES.0000016960.61087.86; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hoffman BF, 1997, J CARDIOVASC ELECTR, V8, P679, DOI 10.1111/j.1540-8167.1997.tb01831.x; Hoffman BF, 1996, J CARDIOVASC ELECTR, V7, P120, DOI 10.1111/j.1540-8167.1996.tb00507.x; Hsu CC, 2013, CLIN INVEST MED, V36, pE42; Inoguchi T, 2003, J AM SOC NEPHROL, V14, pS227, DOI 10.1097/01.ASN.0000077407.90309.65; Ito S, 2013, J LEUKOCYTE BIOL, V93, P837, DOI 10.1189/jlb.0112023; Ito T, 2010, NEUROBIOL DIS, V38, P85, DOI 10.1016/j.nbd.2010.01.002; Jourde-Chiche N, 2009, SEMIN DIALYSIS, V22, P334, DOI 10.1111/j.1525-139X.2009.00576.x; Kannankeril P, 2010, PHARMACOL REV, V62, P760, DOI 10.1124/pr.110.003723; Lee CT, 2010, PERITON DIALYSIS INT, V30, P456, DOI 10.3747/pdi.2009.00092; Lee KT, 2013, CARDIOLOGY, V125, P118, DOI 10.1159/000350360; Lekawanvijit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041281; Lekawanvijit S, 2010, EUR HEART J, V31, P1771, DOI 10.1093/eurheartj/ehp574; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Magnani JW, 2013, CIRC-ARRHYTHMIA ELEC, V6, P84, DOI 10.1161/CIRCEP.112.975342; Malik M, 2004, PACE, V27, P1659, DOI 10.1111/j.1540-8159.2004.00701.x; Meijers BKI, 2009, AM J KIDNEY DIS, V54, P891, DOI 10.1053/j.ajkd.2009.04.022; Motojima M, 2003, KIDNEY INT, V63, P1671, DOI 10.1046/j.1523-1755.2003.00906.x; Murakoshi H, 1997, MOL PHARMACOL, V52, P821, DOI 10.1124/mol.52.5.821; Nattel S, 2007, PHYSIOL REV, V87, P425, DOI 10.1152/physrev.00014.2006; Neirynck N, 2013, INT UROL NEPHROL, V45, P139, DOI 10.1007/s11255-012-0258-1; NOBLE D, 1969, J PHYSIOL-LONDON, V200, P205, DOI 10.1113/jphysiol.1969.sp008689; O'Hara T, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002061; Park KS, 2006, SCIENCE, V313, P976, DOI 10.1126/science.1124254; Peng YS, 2013, TOXICOLOGY, V306, P176, DOI 10.1016/j.tox.2013.02.015; Peng YS, 2012, J CELL BIOCHEM, V113, P1034, DOI 10.1002/jcb.23435; Quan XQ, 2007, J CARDIOVASC ELECTR, V18, P1184, DOI 10.1111/j.1540-8167.2007.00923.x; Rautaharju PM, 2009, J AM COLL CARDIOL, V53, P982, DOI 10.1016/j.jacc.2008.12.014; Ronco C, 2008, J AM COLL CARDIOL, V52, P1527, DOI 10.1016/j.jacc.2008.07.051; Rosenberger D, 2011, NUTR METAB CARDIOVAS, V21, P492, DOI 10.1016/j.numecd.2009.11.014; RUSH S, 1978, IEEE T BIO-MED ENG, V25, P389, DOI 10.1109/TBME.1978.326270; Salvi V, 2011, J ELECTROCARDIOL, V44, P96, DOI 10.1016/j.jelectrocard.2010.11.010; Shamseddin MK, 2011, NAT REV NEPHROL, V7, P145, DOI 10.1038/nrneph.2010.191; Song MY, 2012, J PROTEOME RES, V11, P1018, DOI 10.1021/pr200770v; Straus SMJM, 2006, J AM COLL CARDIOL, V47, P362, DOI 10.1016/j.jacc.2005.08.067; Vanholder R, 2003, KIDNEY INT, V63, P1934, DOI 10.1046/j.1523-1755.2003.00924.x; Walsh KB, 2008, AM J PHYSIOL-HEART C, V294, pH1010, DOI 10.1152/ajpheart.01195.2007; Wang CP, 2013, J NEPHROL, V26, P111, DOI 10.5301/jn.5000111; Wang CP, 2010, ATHEROSCLEROSIS, V211, P579, DOI 10.1016/j.atherosclerosis.2010.03.036; Wang W, 2002, JPN J PHYSIOL, V52, P507, DOI 10.2170/jjphysiol.52.507; Wu IW, 2011, NEPHROL DIAL TRANSPL, V26, P938, DOI 10.1093/ndt/gfq580; Yamamoto H, 2006, KIDNEY INT, V69, P1780, DOI 10.1038/sj.ki.5000340; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhang Q, 2008, J BIOL CHEM, V283, P32570, DOI 10.1074/jbc.M800298200; Zhang T, 2011, INT J CARDIOL, V147, P239, DOI 10.1016/j.ijcard.2009.08.047	57	29	31	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119545	10.1371/journal.pone.0119545	http://dx.doi.org/10.1371/journal.pone.0119545			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893644	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700003
J	Zhan, LJ; Masoudi, FA; Li, X; Hu, S; Venkatesh, AK; Spertus, JA; Lin, ZQ; Desai, NR; Li, J; Krumholz, HM; Jiang, LX				Zhan, Lijuan; Masoudi, Frederick A.; Li, Xi; Hu, Shuang; Venkatesh, Arjun K.; Spertus, John A.; Lin, Zhenqiu; Desai, Nihar R.; Li, Jing; Krumholz, Harlan M.; Jiang, Lixin		China PEACE Collaborative Grp	Trends in Cardiac Biomarker Testing in China for Patients with Acute Myocardial Infarction, 2001 to 2011: China PEACE-Retrospective AMI Study	PLOS ONE			English	Article							3RD UNIVERSAL DEFINITION; ASSOCIATION TASK-FORCE; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; PRACTICE GUIDELINES; AMERICAN-COLLEGE; NATIONAL-ACADEMY; TROPONIN; MANAGEMENT; REFORM	Objectives To describe trends in the availability of biomarker testing in Chinese hospitals and how practice complies with established standards for the diagnosis of acute myocardial infarction (AMI). Background Cardiac biomarker testing is standard in high-income countries, but little is known about the availability and use of cardiac biomarker testing in low-and middle-income countries (LMICs) such as China. Methods Based on a nationally representative sample of Chinese hospitals in 2001, 2006 and 2011, we describe the temporal trends and regional differences in the hospital capability and rates of use of cardiac biomarker testing, as well as the variation in use across hospitals with testing capability, for patients labeled with the diagnosis of AMI. Results We sampled 175 hospitals (162 participated in the study) and 18,631 AMI admissions. 14,370 patients were included in analysis of biomarker use. The proportion of hospitals with biomarker testing capability was 57.4% in 2001 (25.0% troponin and 32.4% creatine kinase MB fraction (CK-MB) only) and 96.3% (81.4% troponin and 14.9% CK-MB only) in 2011. The proportion of hospitals with troponin testing capability in 2011 was significantly higher in urban compared with rural hospitals (96.8% vs. 71.4%, p< 0.001). In 2011, only 55.9% of hospitals with troponin testing capability (71 out of 127 hospitals) used the assay for more than 80% of their patients with AMI. Among hospitals with either biomarker testing capability, there was marked variation in use in both rural (from 7.1% to 100.0% of patients) and urban hospitals (from 57.9% to 100.0% of patients). In 2011, 36.1% of the patients with AMI did not have troponin tested and 4.9% did not have either biomarker measured. Conclusions The recommended biomarker tests for AMI diagnosis are not universally available and the testing is not consistently applied when it is available in China.	[Zhan, Lijuan; Li, Xi; Hu, Shuang; Li, Jing; Jiang, Lixin] Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China; [Zhan, Lijuan; Li, Xi; Hu, Shuang; Li, Jing; Jiang, Lixin] Peking Union Med Coll, Beijing 100021, Peoples R China; [Masoudi, Frederick A.] Univ Colorado, Div Cardiol, Aurora, CO USA; [Venkatesh, Arjun K.; Krumholz, Harlan M.] Yale Univ, Sch Med, Robert Wood Johnson Clin Scholars Program, New Haven, CT USA; [Venkatesh, Arjun K.; Desai, Nihar R.; Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Venkatesh, Arjun K.] Yale Univ, Sch Med, Dept Emergency Med, New Haven, CT USA; [Spertus, John A.] Univ Missouri, St Lukes Mid Amer Heart Inst, Kansas City, MO 64110 USA; [Desai, Nihar R.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT 06504 USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT USA; [Krumholz, Harlan M.] Yale Univ, Sch Med, Dept Hlth Policy & Management, New Haven, CT USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; University of Colorado System; University of Colorado Anschutz Medical Campus; Yale University; Yale University; Yale University; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University; Yale University; Yale University	Jiang, LX (corresponding author), Chinese Acad Med Sci, Natl Clin Res Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100730, Peoples R China.	jiangl@fwoxford.org	, Harlan/AAI-2875-2020; Spertus, John/ABD-3075-2021	Li, Xi/0000-0003-2249-688X	National Health and Family Planning Commission of China [201202025]; National Heart, Lung, and Blood Institute [U01 HL105270-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL105270] Funding Source: NIH RePORTER	National Health and Family Planning Commission of China; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	1. This project was partly supported by the Research Special Fund for Public Welfare Industry of Health (201202025) from National Health and Family Planning Commission of China. HMK is supported by grant U01 HL105270-04 (Center for Cardiovascular Outcomes Research at Yale University) from the National Heart, Lung, and Blood Institute. 2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcorn T, 2011, LANCET, V377, P1557, DOI 10.1016/S0140-6736(11)60625-9; Alpert JS, 2000, EUR HEART J, V21, P1502, DOI 10.1053/euhj.2000.2305; Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Apple FS, 1997, CLIN CHEM, V43, P2047; China Society of Cardiology of Chinese Medical Association, 2010, Zhonghua Xin Xue Guan Bing Za Zhi, V38, P675; Chinese Society of Cardiology of Chinese Medical Association, 2008, ZHONGHUA XIN XUE GUA, V36, P867; Dharmarajan K, 2013, CIRC-CARDIOVASC QUAL, V6, P732, DOI 10.1161/CIRCOUTCOMES.113.000441; Farsi D, 2013, EUR J EMERG MED, V20, P120, DOI 10.1097/MEJ.0b013e328351360f; Ferguson JL, 2002, HEART, V88, P343, DOI 10.1136/heart.88.4.343; Gerhardt W, 1999, SCAND J CLIN LAB INV, V59, P83; Guo Xiaobi, 2006, Exp Clin Cardiol, V11, P298; Hasdai D, 2003, EUR HEART J, V24, P1189, DOI 10.1016/S0195-668X(03)00204-5; He J, 2005, NEW ENGL J MED, V353, P1124, DOI 10.1056/NEJMsa050467; Huffman MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020821; Jaffe AS, 2012, CLIN CHEM, V58, P1727, DOI 10.1373/clinchem.2012.196832; Jaffe AS, 2000, CIRCULATION, V102, P1216, DOI 10.1161/01.CIR.102.11.1216; Kontos MC, 2010, AM HEART J, V160, P819, DOI 10.1016/j.ahj.2010.07.022; Li J, 2015, LANCET, V385, P441, DOI 10.1016/S0140-6736(14)60921-1; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; Mendis S, 2011, INT J EPIDEMIOL, V40, P139, DOI 10.1093/ije/dyq165; Moran A, 2010, CIRC-CARDIOVASC QUAL, V3, P243, DOI 10.1161/CIRCOUTCOMES.109.910711; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Takakuwa KM, 2009, CLIN CARDIOL, V20, P120; Tang WHW, 2007, CIRCULATION, V116, pE99, DOI 10.1161/CIRCULATIONAHA.107.185267; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Wagner GS, 2000, J ELECTROCARDIOL, V33, P57, DOI 10.1054/jelc.2000.20334; White HD, 2002, AM HEART J, V144, P933, DOI 10.1067/mhj.2002.129780; White HD, 2013, HEART; Wu AHB, 1999, CLIN CHEM, V45, P1104; Wu AHB, 2007, CLIN CHEM, V53, P2086, DOI 10.1373/clinchem.2007.095679; Yang GH, 2008, LANCET, V372, P1697, DOI 10.1016/S0140-6736(08)61366-5; Yip WCM, 2012, LANCET, V379, P833, DOI 10.1016/S0140-6736(11)61880-1; Yusuf S, 2001, CIRCULATION, V104, P2855, DOI 10.1161/hc4701.099488; Zhang XH, 2008, HEART, V94, P1126, DOI 10.1136/hrt.2007.132423; Zhang Xiao-fei, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P179	36	8	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122237	10.1371/journal.pone.0122237	http://dx.doi.org/10.1371/journal.pone.0122237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893247	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700013
J	Brookes, MJ; Hall, EL; Robson, SE; Price, D; Palaniyappan, L; Liddle, EB; Liddle, PF; Robinson, SE; Morris, PG				Brookes, Matthew J.; Hall, Emma L.; Robson, Sian E.; Price, Darren; Palaniyappan, Lena; Liddle, Elizabeth B.; Liddle, Peter F.; Robinson, Stephen E.; Morris, Peter G.			Complexity Measures in Magnetoencephalography: Measuring "Disorder" in Schizophrenia	PLOS ONE			English	Article							EEG; BEAMFORMER; NONLINEARITY	This paper details a methodology which, when applied to magnetoencephalography (MEG) data, is capable of measuring the spatio-temporal dynamics of 'disorder' in the human brain. Our method, which is based upon signal entropy, shows that spatially separate brain regions (or networks) generate temporally independent entropy time-courses. These time-courses are modulated by cognitive tasks, with an increase in local neural processing characterised by localised and transient increases in entropy in the neural signal. We explore the relationship between entropy and the more established time-frequency decomposition methods, which elucidate the temporal evolution of neural oscillations. We observe a direct but complex relationship between entropy and oscillatory amplitude, which suggests that these metrics are complementary. Finally, we provide a demonstration of the clinical utility of our method, using it to shed light on aberrant neurophysiological processing in schizophrenia. We demonstrate significantly increased task induced entropy change in patients (compared to controls) in multiple brain regions, including a cingulo-insula network, bilateral insula cortices and a right fronto-parietal network. These findings demonstrate potential clinical utility for our method and support a recent hypothesis that schizophrenia can be characterised by abnormalities in the salience network (a well characterised distributed network comprising bilateral insula and cingulate cortices).	[Brookes, Matthew J.; Hall, Emma L.; Robson, Sian E.; Price, Darren; Morris, Peter G.] Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Magnet Resonance Ctr, Nottingham NG7 2RD, England; [Palaniyappan, Lena; Liddle, Elizabeth B.; Liddle, Peter F.] Univ Nottingham, Inst Mental Hlth, Nottingham NG7 2RD, England; [Robinson, Stephen E.] NIH, Bethesda, MD 20892 USA	University of Nottingham; University of Nottingham; National Institutes of Health (NIH) - USA	Brookes, MJ (corresponding author), Univ Nottingham, Sch Phys & Astron, Sir Peter Mansfield Magnet Resonance Ctr, Univ Pk, Nottingham NG7 2RD, England.	matthew.brookes@nottingham.ac.uk	PALANIYAPPAN, LENA/L-8911-2016; Liddle, Peter/AAU-7939-2020; Liddle, Elizabeth/A-2034-2015	PALANIYAPPAN, LENA/0000-0003-1640-7182; Liddle, Elizabeth/0000-0002-9299-094X; Brookes, Matthew/0000-0002-8687-8185; Price, Darren/0000-0002-4786-3976	Dr Hadwen Trust; Medical Research Council New Investigator Grant [MR/M006301/1]; Intramural Research Program of the National Institutes of Mental Health; Wellcome Clinical Research Fellowship [WT096002/z/11]; MRC [MR/M009122/1, MR/J01186X/1, MR/M006301/1] Funding Source: UKRI; Medical Research Council [MR/M009122/1, MR/J01186X/1, MR/M006301/1] Funding Source: researchfish; NATIONAL INSTITUTE OF MENTAL HEALTH [ZICMH002889] Funding Source: NIH RePORTER	Dr Hadwen Trust; Medical Research Council New Investigator Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Intramural Research Program of the National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Wellcome Clinical Research Fellowship; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by the Dr Hadwen Trust. The Dr Hadwen Trust for Humane Research (DHT) is the UK leading medical research charity that funds and promotes exclusively human-relevant research that encourages the progress of medicine with the replacement of the use of animals in research. MJB is funded by a Medical Research Council New Investigator Grant (MR/M006301/1). SE Robinson is supported by the Intramural Research Program of the National Institutes of Mental Health. LP was funded by a Wellcome Clinical Research Fellowship (WT096002/z/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes GR, 2003, HUM BRAIN MAPP, V18, P1, DOI 10.1002/hbm.10072; Brookes MJ, 2012, NEUROIMAGE, V63, P1918, DOI 10.1016/j.neuroimage.2012.08.012; Brookes MJ, 2008, NEUROIMAGE, V39, P1788, DOI 10.1016/j.neuroimage.2007.09.050; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Costa M, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.021906; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Donner TH, 2011, TRENDS COGN SCI, V15, P191, DOI 10.1016/j.tics.2011.03.007; ELBERT T, 1992, BIOL PSYCHIAT, V32, P595, DOI 10.1016/0006-3223(92)90072-8; Engel AK, 2013, NEURON, V80, P867, DOI 10.1016/j.neuron.2013.09.038; Fernandez A, 2013, PROG NEURO-PSYCHOPH, V45, P267, DOI 10.1016/j.pnpbp.2012.03.015; Fernandez A, 2011, CLIN NEUROPHYSIOL, V122, P2227, DOI 10.1016/j.clinph.2011.04.011; Fernandez A, 2011, NEUROIMAGE, V57, P1300, DOI 10.1016/j.neuroimage.2011.05.079; FRISTON KJ, 1995, CLIN NEUROSCI, V3, P89; Friston KJ, 1998, SCHIZOPHR RES, V30, P115, DOI 10.1016/S0920-9964(97)00140-0; Garrett DD, 2013, NEUROSCI BIOBEHAV R, V37, P610, DOI 10.1016/j.neubiorev.2013.02.015; Gross J, 2001, P NATL ACAD SCI USA, V98, P694, DOI 10.1073/pnas.98.2.694; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Irisawa S, 2006, NEUROPSYCHOBIOLOGY, V54, P134, DOI 10.1159/000098264; Kotini A, 2002, BRAIN TOPOGR, V15, P107, DOI 10.1023/A:1021420507901; KOUKKOU M, 1993, BIOL PSYCHIAT, V33, P397, DOI 10.1016/0006-3223(93)90167-C; KOUKKOU M, 1995, J NEURAL TRANSM-GEN, V99, P89, DOI 10.1007/BF01271472; Lee YJ, 2001, CLIN NEUROPHYSIOL, V112, P1288, DOI 10.1016/S1388-2457(01)00544-2; Li YJ, 2008, CLIN NEUROPHYSIOL, V119, P1232, DOI 10.1016/j.clinph.2008.01.104; McIntosh AR, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000106; Misic B, 2014, CEREBRAL CORTEX; Misic B, 2010, J NEUROPHYSIOL, V104, P2667, DOI 10.1152/jn.00648.2010; Mizuno T, 2010, CLIN NEUROPHYSIOL, V121, P1438, DOI 10.1016/j.clinph.2010.03.025; Mukamel R, 2005, SCIENCE, V309, P951, DOI 10.1126/science.1110913; Palaniyappan L, 2013, NEURON, V79, P814, DOI 10.1016/j.neuron.2013.06.027; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Robinson S., 1998, RECENT ADV BIOMAGNET, P302; Robinson SE, 2013, FRONTIERS COMPUTATIO, V6, DOI [10.3389/fncom.2012.00102, DOI 10.3389/FNCOM.2012.00102]; Sabeti M, 2009, ARTIF INTELL MED, V47, P263, DOI 10.1016/j.artmed.2009.03.003; Saito N, 1998, BIOL PSYCHIAT, V43, P794, DOI 10.1016/S0006-3223(97)00547-7; SARVAS J, 1987, PHYS MED BIOL, V32, P11, DOI 10.1088/0031-9155/32/1/004; Sekihara K, 2006, IEEE T BIO-MED ENG, V53, P1755, DOI 10.1109/TBME.2006.878119; Takahashi T, 2010, NEUROIMAGE, V51, P173, DOI 10.1016/j.neuroimage.2010.02.009; vanDrongelen W, 1996, BRAIN TOPOGR, V9, P39, DOI 10.1007/BF01191641; VanVeen BD, 1997, IEEE T BIO-MED ENG, V44, P867, DOI 10.1109/10.623056; von Stein A, 2000, INT J PSYCHOPHYSIOL, V38, P301, DOI 10.1016/S0167-8760(00)00172-0; Zumer JM, 2010, NEUROIMAGE, V49, P1479, DOI 10.1016/j.neuroimage.2009.09.020	42	24	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120991	10.1371/journal.pone.0120991	http://dx.doi.org/10.1371/journal.pone.0120991			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886553	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000014
J	Guo, ZY; Zhang, Q; Li, XG; Jing, ZY				Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu			Thermochemical Ablation Therapy of VX2 Tumor Using a Permeable Oil-Packed Liquid Alkali Metal	PLOS ONE			English	Article							SOFT-TISSUE TUMOR; HEPATOCELLULAR-CARCINOMA; ANGIOGENESIS; SYSTEM	Objective Alkali metal appears to be a promising tool in thermochemical ablation, but, it requires additional data on safety is required. The objective of this study was to explore the effectiveness of permeable oil-packed liquid alkali metal in the thermochemical ablation of tumors. Methods Permeable oil-packed sodium-potassium (NaK) was prepared using ultrasonic mixing of different ratios of metal to oil. The thermal effect of the mixture during ablation of muscle tissue ex vivo was evaluated using the Fluke Ti400 Thermal Imager. The thermochemical effect of the NaK-oil mixture on VX2 tumors was evaluated by performing perfusion CT scans both before and after treatment in 10 VX2 rabbit model tumors. VX2 tumors were harvested from two rabbits immediately after treatment to assess their viability using trypan blue and hematoxylin and eosin (H.E.) staining. Results The injection of the NaK-oil mixture resulted in significantly higher heat in the ablation areas. The permeable oil controlled the rate of heat released during the NaK reaction with water in the living tissue. Perfusion computed tomography and its parameter map confirmed that the NaK-oil mixture had curative effects on VX2 tumors. Both trypan blue and H.E. staining showed partial necrosis of the VX2 tumors. Conclusions The NaK-oil mixture may be used successfully to ablate tumor tissue in vivo. With reference to the controlled thermal and chemical lethal injury to tumors, using a liquid alkali in ablation is potentially an effective and safe method to treat malignant tumors.	[Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Chinese Acad Med Sci, Dept Radiol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China; [Guo, Ziyi; Zhang, Qiang; Li, Xiaoguang; Jing, Zhengyu] Peking Union Med Coll, Beijing 100021, Peoples R China; [Guo, Ziyi] Cent S Univ, Xiangya Med Sch, Dept Radiol, Haikou Peoples Hosp, Haikou, Hainan, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Central South University	Jing, ZY (corresponding author), Chinese Acad Med Sci, Dept Radiol, Peking Union Med Coll Hosp, Beijing 100730, Peoples R China.	Xglee88@126.com; MRI_learn@163.com			Haikou Municipal Bureau of Industry and Information Bureau of the key projects [2012075]; Hainan Natural Science Foundation [813261]	Haikou Municipal Bureau of Industry and Information Bureau of the key projects; Hainan Natural Science Foundation	This work was supported by the Haikou Municipal Bureau of Industry and Information Bureau of the key projects (contract/grant numbers 2012075) and Hainan Natural Science Foundation Project (contract/grant numbers 813261). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Clark TWI, 2002, J VASC INTERV RADIOL, V13, pS245, DOI 10.1016/S1051-0443(07)61792-8; Cressman ENK, 2013, INT J HYPERTHER, V29, P71, DOI 10.3109/02656736.2012.756124; Deng ZS, 2007, MINIM INVASIV THER, V16, P341, DOI 10.1080/13645700701709494; Farnam JL, 2010, J VASC INTERV RADIOL, V21, P1573, DOI 10.1016/j.jvir.2010.06.012; Hines-Peralta A, 2006, J VASC INTERV RADIOL, V17, P351, DOI 10.1097/01.RVI.0000196355.31419.1E; Kitchin D, 2014, INT J HYPERTHER, V30, P299, DOI 10.3109/02656736.2014.936050; MACDONALD DKC, 1956, CAN J PHYS, V34, P389, DOI 10.1139/p56-045; Misselt AJ, 2009, J VASC INTERV RADIOL, V20, P1352, DOI 10.1016/j.jvir.2009.06.027; Nishikawa H, 2013, INT J HYPERTHER, V29, P558, DOI 10.3109/02656736.2013.821528; Purdie TG, 2003, PHYS MED BIOL, V48, P849, DOI 10.1088/0031-9155/48/7/303; Purdie TG, 2001, PHYS MED BIOL, V46, P3161, DOI 10.1088/0031-9155/46/12/307; Rao W, 2008, INT J HYPERTHER, V24, P675, DOI 10.1080/02656730802228465; Rao W, 2008, MINIM INVASIV THER, V17, P43, DOI 10.1080/13645700701803826; Rao W, 2009, MINIM INVASIV THER, V18, P30, DOI 10.1080/13645700802384023; Stewart EE, 2012, RADIOLOGY, V264, P68, DOI 10.1148/radiol.12110674; Versura P, 2001, OPHTHALMOLOGICA, V215, P276, DOI 10.1159/000050874; Vogl TJ, 2004, INT J HYPERTHER, V20, P713, DOI 10.1080/02656730400007212; Wang Y, 2013, INT J HYPERTHER, V29, P683, DOI 10.3109/02656736.2013.840806; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; Zheng B, 2004, ANGEW CHEM INT EDIT, V43, P2508, DOI 10.1002/anie.200453974	20	1	1	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123196	10.1371/journal.pone.0123196	http://dx.doi.org/10.1371/journal.pone.0123196			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885926	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000049
J	Helmeke, C; Grafe, L; Irmscher, HM; Gottschalk, C; Karagiannis, L; Oppermann, H				Helmeke, Carina; Graefe, Lutz; Irmscher, Hanns-Martin; Gottschalk, Constanze; Karagiannis, Loannis; Oppermann, Hanna			Effectiveness of the 2012/13 Trivalent Live and Inactivated Influenza Vaccines in Children and Adolescents in Saxony-Anhalt, Germany: A Test-Negative Case-Control Study	PLOS ONE			English	Article							REVERSE-TRANSCRIPTASE-PCR; REAL-TIME PCR; YOUNG-CHILDREN; RESPIRATORY SAMPLES; SEASONAL INFLUENZA; EFFICACY; VIRUS; AGE; METAANALYSIS; VACCINATION	A live attenuated influenza vaccine has been available in Germany since the influenza season 2012/13, which is approved for children aged 2-17 years. Using data from our laboratory-based surveillance system, we described the circulation of influenza and non-influenza respiratory viruses during the influenza season 2012/13 in Saxony-Anhalt. We estimated the effectiveness of live and inactivated trivalent influenza vaccines in preventing laboratory-confirmed cases among children and adolescents. From week 40/2012 to 19/2013, sentinel paediatricians systematically swabbed acute respiratory illness patients for testing of influenza and 5 non-influenza viruses by PCR. We compared influenza cases and influenza-negative controls. Among children aged 2-17 years, we calculated overall and vaccine type-specific effectiveness against laboratory-confirmed influenza, stratified by age group (2-6; 7-17 years). We used multivariable logistic regression to adjust estimates for age group, sex and month of illness. Out of 1,307 specimens, 647 (35%) were positive for influenza viruses and 189 (15%) for at least one of the tested non-influenza viruses. For vaccine effectiveness estimation, we included 834 patients (mean age 7.3 years, 53% males) in our analysis. Of 347 (42%) influenza-positive specimens, 61 (18%) were positive for A(H1N1) pdm09, 112 (32%) for A(H3N2) and 174 (50%) for influenza B virus. The adjusted overall vaccine effectiveness including both age groups was 38% (95% CI: 0.8-61%). The adjusted effectiveness for inactivated vaccines was 37% (95% CI: -35-70%) and for live vaccines 84% (95% CI: 45-95%). Effectiveness for the live vaccine was higher in 2-6 year-old children (90%, 95% CI: 20-99%) than in children aged 7-17 years (74%, 95% CI: -32-95%). Our study of the strong influenza season in 2012/13 suggests a high preventive effect of live attenuated influenza vaccine especially among young children, which could not be reached by inactivated vaccines. We recommend the use of live attenuated influenza vaccines in children unless there are contraindications.	[Helmeke, Carina; Karagiannis, Loannis] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Helmeke, Carina; Graefe, Lutz; Irmscher, Hanns-Martin; Gottschalk, Constanze; Oppermann, Hanna] State Agcy Consumer Protect Saxony Anhalt, Dept Hyg, Magdeburg, Germany	European Centre for Disease Prevention & Control	Helmeke, C (corresponding author), European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden.	carina.helmeke@lav.ms.sachsen-anhalt.de						Allison MA, 2006, J PEDIATR-US, V149, P755, DOI 10.1016/j.jpeds.2006.06.036; Ambrose CS, 2012, EUR J CLIN MICROBIOL, V31, P2549, DOI 10.1007/s10096-012-1595-9; Ambrose CS, 2012, VACCINE, V30, P886, DOI 10.1016/j.vaccine.2011.11.104; [Anonymous], SURV REP INFL VIR CH; Ashkenazi S, 2006, PEDIATR INFECT DIS J, V25, P870, DOI 10.1097/01.inf.0000237829.66310.85; Belshe RB, 1998, NEW ENGL J MED, V338, P1405, DOI 10.1056/NEJM199805143382002; Belshe RB, 2007, NEW ENGL J MED, V356, P685, DOI 10.1056/NEJMoa065368; Belshe RB, 2010, INFLUENZA OTHER RESP, V4, P141, DOI 10.1111/j.1750-2659.2009.00124.x; Block SL, 2011, PEDIATR INFECT DIS J, V30, P203, DOI 10.1097/INF.0b013e3181faac7c; Bohmer MM, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-938; Burggraf S, 2005, CLIN CHEM, V51, P1508, DOI 10.1373/clinchem.2005.048132; Carter NJ, 2011, DRUGS, V71, P1591, DOI 10.2165/11206860-000000000-00000; Deffernez C, 2004, J CLIN MICROBIOL, V42, P3212, DOI 10.1128/JCM.42.7.3212-3218.2004; ECDC, PROT CAS CONTR STUD; Eisenberg KW, 2008, PEDIATRICS, V122, P911, DOI 10.1542/peds.2007-3304; Fleming DM, 2006, PEDIATR INFECT DIS J, V25, P860, DOI 10.1097/01.inf.0000237797.14283.cf; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Kissling E, 2014, EURO SURVEILL, V19; Maertzdorf J, 2004, J CLIN MICROBIOL, V42, P981, DOI 10.1128/JCM.42.3.981-986.2004; Mohamed N, 2004, J CLIN VIROL, V30, P150, DOI 10.1016/j.jcv.2003.08.016; Monpoeho S, 2000, BIOTECHNIQUES, V29, P88, DOI 10.2144/00291st03; Neuzil KM, 2006, J INFECT DIS, V194, P1032, DOI 10.1086/507309; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Phillips C, 2009, NEW ORLEANS REV, V35, P11; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; RIVM, 2011, INFL PROT PCR ERASMU; RIVM, 2009, LAB PROT LIB INFL PC; RKI, ARB INFL BER EP INFL; RKI: Mitteilung der Standigen Impfkommission am Robert Koch-Institut (RKI), 2013, EPID BULL, V34, P313; RKI: Mitteilung der Standigen Impfkommission (STIKO) am Robert Koch-Institut (RKI), 2013, EPID B, V36/37, P365; Rose MA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-40; Schulze M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009966; Snacken R, 2014, EPIDEMIOL INFECT, V142, P1809, DOI 10.1017/S0950268814001228; Uphoff H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019932; Valenciano M, 2010, VACCINE, V28, P7381, DOI 10.1016/j.vaccine.2010.09.010; Weitzel T, 2007, CLIN MICROBIOL INFEC, V13, P665, DOI 10.1111/j.1469-0691.2007.01739.x; Whiley DM, 2002, J CLIN MICROBIOL, V40, P4418, DOI 10.1128/JCM.40.12.4418-4422.2002; WHO, 2012, REC COMP INFL VIR VA; Williams JV, 2004, NEW ENGL J MED, V350, P443, DOI 10.1056/NEJMoa025472	39	14	16	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122910	10.1371/journal.pone.0122910	http://dx.doi.org/10.1371/journal.pone.0122910			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885063	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000043
J	Kawamoto, H; Takayasu, H; Jensen, HJ; Takayasu, M				Kawamoto, Hirokazu; Takayasu, Hideki; Jensen, Henrik Jeldtoft; Takayasu, Misako			Precise Calculation of a Bond Percolation Transition and Survival Rates of Nodes in a Complex Network	PLOS ONE			English	Article								Through precise numerical analysis, we reveal a new type of universal loopless percolation transition in randomly removed complex networks. As an example of a real-world network, we apply our analysis to a business relation network consisting of approximately 3,000,000 links among 300,000 firms and observe the transition with critical exponents close to the mean-field values taking into account the finite size effect. We focus on the largest cluster at the critical point, and introduce survival probability as a new measure characterizing the robustness of each node. We also discuss the relation between survival probability and k-shell decomposition.	[Kawamoto, Hirokazu; Takayasu, Hideki; Takayasu, Misako] Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, Yokohama, Kanagawa 227, Japan; [Takayasu, Hideki] Sony Comp Sci Labs, Shinagawa Ku, Tokyo, Japan; [Takayasu, Hideki] Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo 101, Japan; [Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Dept Math, London, England; [Jensen, Henrik Jeldtoft] Univ London Imperial Coll Sci Technol & Med, Complex & Networks Grp, London, England	Tokyo Institute of Technology; Imperial College London; Imperial College London	Takayasu, M (corresponding author), Tokyo Inst Technol, Interdisciplinary Grad Sch Sci & Engn, Dept Computat Intelligence & Syst Sci, Midori Ku, 4259 Nagatsuta, Yokohama, Kanagawa 227, Japan.	takayasu.m.aa@m.titech.ac.jp	Takayasu, Misako/H-9890-2014	Takayasu, Misako/0000-0002-2467-614X	European project CONGAS [FP7-ICT-2011-8-317672]; Sony Computer Science Laboratories; Ministry of Education, Culture, Sports, Science and Technology (MEXT);  [24540395];  [26310207]	European project CONGAS; Sony Computer Science Laboratories; Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); ; 	Grant-in-Aid for Scientific Research (C), Grant Number 24540395 http://www.jsps.go.jp/english/e-grants/ Grant-in-Aid for Scientific Research (B), Grant Number 26310207 http://www.jsps.go.jp/english/e-grants/ European project CONGAS (Grant FP7-ICT-2011-8-317672) http://www.congas-project.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author Hideki Takayasu is employed by Sony Computer Science Laboratories. Sony Computer Science Laboratories, provided support in the form of salaries for authors HT, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section. Funder Name : The Ministry of Education, Culture, Sports, Science and Technology (MEXT), Grant Recipient : Misako Takayasu.	Achlioptas D, 2009, SCIENCE, V323, P1453, DOI 10.1126/science.1167782; ADLER J, 1990, PHYS REV B, V41, P9183, DOI 10.1103/PhysRevB.41.9183; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Baish JW, 1996, MICROVASC RES, V51, P327, DOI 10.1006/mvre.1996.0031; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Buldyrev SV, 2010, NATURE, V464, P1025, DOI 10.1038/nature08932; da Silva CR, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.056107; De Masi G, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.066112; Dorogovtsev SN, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.025101; Golden KM, 1998, SCIENCE, V282, P2238, DOI 10.1126/science.282.5397.2238; Kim J, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.055101; Kitsak M., 2010, NATURE PHYS, V29, P1746; LAST BJ, 1971, PHYS REV LETT, V27, P1719, DOI 10.1103/PhysRevLett.27.1719; Miura W, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.168701; Mizuno T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100712; MOLLOY M, 1995, RANDOM STRUCT ALGOR, V6, P161, DOI 10.1002/rsa.3240060204; Newman MEJ, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.016128; Noh JD, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.026116; Ohnishi T, 2010, J ECON INTERACT COOR, V5, P171, DOI 10.1007/s11403-010-0066-6; Ohnishi T, 2009, PROG THEOR PHYS SUPP, P157, DOI 10.1143/PTPS.179.157; Onnela JP, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/6/179; Renyi A., 1959, PUBL MATH-DEBRECEN, V6, P290, DOI DOI 10.2307/1999405; ROBINSON PC, 1983, J PHYS A-MATH GEN, V16, P605, DOI 10.1088/0305-4470/16/3/020; SAHIMI M, 1993, REV MOD PHYS, V65, P1393, DOI 10.1103/RevModPhys.65.1393; STAUFFER D, 1994, INTRO PERCOLATION TH; TAKAYASU M, 1988, PHYS LETT A, V128, P45, DOI 10.1016/0375-9601(88)91040-7; Takayasu M, 1996, PHYSICA A, V233, P824, DOI 10.1016/S0378-4371(96)00189-6; Takayasu M., 2008, MASSIVE EC DATA ANAL, P237; Tamura Koutarou, 2012, International Journal of Modern Physics: Conference Series, V16, P93, DOI 10.1142/S2010194512007805; Tanizawa T, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.046109; TOULOUSE G, 1974, NUOVO CIMENTO B, VB 23, P234, DOI 10.1007/BF02737507; Ueno H, 2007, PHYSICA A, V383, P164, DOI 10.1016/j.physa.2007.04.098; Watanabe H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/4/043034; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhao L, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.026125	35	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119979	10.1371/journal.pone.0119979	http://dx.doi.org/10.1371/journal.pone.0119979			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885791	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000008
J	Liu, JCY; Leung, JM; Ngan, DA; Nashta, NF; Guillemi, S; Harris, M; Lima, VD; Um, SJ; Li, YX; Tam, S; Shaipanich, T; Raju, R; Hague, C; Leipsic, JA; Bourbeau, J; Tan, WC; Harrigan, PR; Sin, DD; Montaner, J; Man, SFP				Liu, Joseph C. Y.; Leung, Janice M.; Ngan, David A.; Nashta, Negar F.; Guillemi, Silvia; Harris, Marianne; Lima, Viviane D.; Um, Soo-Jung; Li, Yuexin; Tam, Sheena; Shaipanich, Tawimas; Raju, Rekha; Hague, Cameron; Leipsic, Jonathon A.; Bourbeau, Jean; Tan, Wan C.; Harrigan, P. Richard; Sin, Don D.; Montaner, Julio; Man, S. F. Paul			Absolute Leukocyte Telomere Length in HIV-Infected and Uninfected Individuals: Evidence of Accelerated Cell Senescence in HIV-Associated Chronic Obstructive Pulmonary Disease	PLOS ONE			English	Article							LUNG-FUNCTION; CIRCULATING LEUKOCYTES; SHORTENED TELOMERES; T-CELL; COPD; AGE; DESIGN; COHORT; CT	Combination antiretroviral therapy (cART) has extended the longevity of human immunodeficiency virus (HIV)-infected individuals. However, this has resulted in greater awareness of age-associated diseases such as chronic obstructive pulmonary disease (COPD). Accelerated cellular senescence may be responsible, but its magnitude as measured by leukocyte telomere length is unknown and its relationship to HIV-associated COPD has not yet been established. We measured absolute telomere length (aTL) in peripheral leukocytes from 231 HIV-infected adults. Comparisons were made to 691 HIV-uninfected individuals from a population-based sample. Subject quartiles of aTL were assessed for relationships with measures of HIV disease severity, airflow obstruction, and emphysema severity on computed tomographic (CT) imaging. Multivariable regression models identified factors associated with shortened aTL. Compared to HIV-uninfected subjects, the mean aTL in HIV-infected patients was markedly shorter by 27 kbp/genome (p<0.001); however, the slopes of aTL vs. age were not different (p=0.469). Patients with longer known durations of HIV infection (p=0.019) and lower nadir CD4 cell counts (p=0.023) had shorter aTL. Shorter aTL were also associated with older age (p=0.026), smoking (p=0.005), reduced forced expiratory volume in one second (p=0.030), and worse CT emphysema severity score (p=0.049). HIV-infected subjects demonstrate advanced cellular aging, yet in a cART-treated cohort, the relationship between aTL and age appears no different from that of HIV-uninfected subjects.	[Liu, Joseph C. Y.; Leung, Janice M.; Ngan, David A.; Li, Yuexin; Tam, Sheena; Tan, Wan C.; Sin, Don D.; Man, S. F. Paul] Ctr Heart Lung Innovat, Vancouver, BC, Canada; [Nashta, Negar F.; Harris, Marianne] St Pauls Hosp, AIDS Res Program, Vancouver, BC V6Z 1Y6, Canada; [Guillemi, Silvia; Harris, Marianne] Univ British Columbia, Fac Med, Dept Family Med, Vancouver, BC, Canada; [Guillemi, Silvia; Harris, Marianne; Montaner, Julio] Univ British Columbia, Dept Med, Div HIV AIDS, Vancouver, BC, Canada; [Guillemi, Silvia; Lima, Viviane D.; Harrigan, P. Richard; Montaner, Julio] St Pauls Hosp, BC Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada; [Um, Soo-Jung] Dong A Univ, Dept Med, Div Pulm & Crit Care Med, Busan, South Korea; [Shaipanich, Tawimas; Sin, Don D.; Man, S. F. Paul] St Pauls Hosp, UBC Dept Med, Vancouver, BC V6Z 1Y6, Canada; [Shaipanich, Tawimas; Sin, Don D.; Man, S. F. Paul] St Pauls Hosp, Div Resp Med, Vancouver, BC V6Z 1Y6, Canada; [Raju, Rekha; Hague, Cameron; Leipsic, Jonathon A.] St Pauls Hosp, Dept Radiol & Diagnost Imaging, Vancouver, BC V6Z 1Y6, Canada; [Bourbeau, Jean] McGill Univ, Resp Epidemiol & Clin Res Unit, Montreal Chest Inst, Montreal, PQ, Canada	St. Paul's Hospital; University of Saskatchewan; University of British Columbia; University of British Columbia; B.C. Centre for Excellence in HIV/AIDS; St. Paul's Hospital; University of Saskatchewan; Dong A University; St. Paul's Hospital; University of British Columbia; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; St. Paul's Hospital; University of Saskatchewan; McGill University	Man, SFP (corresponding author), Ctr Heart Lung Innovat, Vancouver, BC, Canada.	pman@providencehealth.bc.ca	Shaipanich, Tawimas/AAN-6237-2020; Sin, Don/AAC-2219-2021; Leipsic, Jonathon/ABE-6194-2020		Canadian Institutes of Health Research [DCB 120265]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Funding was supplied by the Canadian Institutes of Health Research (http://www.cihr-irsc.gc.ca/e/193.html). The grant number is DCB 120265. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht E, 2014, EUR RESPIR J, V43, P983, DOI 10.1183/09031936.00046213; Barr RG, 2012, COPD, V9, P151, DOI 10.3109/15412555.2012.654923; Bourbeau J, 2014, COPD, V11, P125, DOI 10.3109/15412555.2012.665520; Cheung NKV, 2012, JAMA-J AM MED ASSOC, V307, P1062, DOI 10.1001/jama.2012.228; Crothers K, 2006, CHEST, V130, P1326, DOI 10.1378/chest.130.5.1326; Crothers K, 2011, AM J RESP CRIT CARE, V183, P388, DOI 10.1164/rccm.201006-0836OC; Dawson D, 1995, GENDER DIFFERENCES A; Deeks SG, 2012, CURR OPIN IMMUNOL, V24, P501, DOI 10.1016/j.coi.2012.05.004; Deeks SG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a3172; Effros RB, 1996, AIDS, V10, pF17, DOI 10.1097/00002030-199607000-00001; Fehrer C, 2006, EXP GERONTOL, V41, P648, DOI 10.1016/j.exger.2006.03.016; Fischer BM, 2013, AM J PHYSIOL-LUNG C, V304, pL394, DOI 10.1152/ajplung.00091.2012; Fitzpatrick ME, 2014, AIDS, V28, P2505, DOI 10.1097/QAD.0000000000000471; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Guaraldi G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109027; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hodes RJ, 2002, NAT REV IMMUNOL, V2, P699, DOI 10.1038/nri890; Kazerooni EA, 1997, AM J ROENTGENOL, V169, P977, DOI 10.2214/ajr.169.4.9308447; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035567; Leung JM, 2014, AIDS PATIENT CARE ST, V28, P240, DOI 10.1089/apc.2013.0373; Mayer S, 2006, CYTOGENET GENOME RES, V112, P194, DOI 10.1159/000089870; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; O'Callaghan NJ, 2011, BIOL PROCED ONLINE, V13, DOI 10.1186/1480-9222-13-3; Pathai S, 2013, AIDS, V27, P2375, DOI 10.1097/QAD.0b013e328363bf7f; Ribaudo HJ, 2006, ANTIVIR THER, V11, P751; Rode L, 2013, THORAX, V68, P429, DOI 10.1136/thoraxjnl-2012-202544; Saferali A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095600; Samji H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081355; Savale L, 2009, AM J RESP CRIT CARE, V179, P566, DOI 10.1164/rccm.200809-1398OC; Tan WC, 2011, INT J TUBERC LUNG D, V15, P1691, DOI 10.5588/ijtld.11.0211; Tsuji T, 2006, AM J RESP CRIT CARE, V174, P886, DOI 10.1164/rccm.200509-1374OC; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Zanet DL, 2014, CLIN INFECT DIS, V58, P1322, DOI 10.1093/cid/ciu051	33	42	42	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124426	10.1371/journal.pone.0124426	http://dx.doi.org/10.1371/journal.pone.0124426			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885433	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000125
J	Ross, CT; Roodgarz, M; Smith, DG				Ross, Cody T.; Roodgarz, Morteza; Smith, David Glenn			Evolutionary Distance of Amino Acid Sequence Orthologs across Macaque Subspecies: Identifying Candidate Genes for SIV Resistance in Chinese Rhesus Macaques	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; TRIM FAMILY PROTEINS; POSITIVE SELECTION; CDK9 INHIBITORS; HIV-1; EXPRESSION; TAT; GENOME; IDENTIFICATION; POLYMORPHISM	We use the Reciprocal Smallest Distance (RSD) algorithm to identify amino acid sequence orthologs in the Chinese and Indian rhesus macaque draft sequences and estimate the evolutionary distance between such orthologs. We then use GOanna to map gene function annotations and human gene identifiers to the rhesus macaque amino acid sequences. We conclude methodologically by cross-tabulating a list of amino acid orthologs with large divergence scores with a list of genes known to be involved in SIV or HIV pathogenesis. We find that many of the amino acid sequences with large evolutionary divergence scores, as calculated by the RSD algorithm, have been shown to be related to HIV pathogenesis in previous laboratory studies. Four of the strongest candidate genes for SIVmac resistance in Chinese rhesus macaques identified in this study are CDK9, CXCL12, TRIM21, and TRIM32. Additionally, ANKRD30A, CTSZ, GORASP2, GTF2H1, IL13RA1, MUC16, NMDAR1, Notch1, NT5M, PDCD5, RAD50, and TM9SF2 were identified as possible candidates, among others. We failed to find many laboratory experiments contrasting the effects of Indian and Chinese orthologs at these sites on SIVmac pathogenesis, but future comparative studies might hold fertile ground for research into the biological mechanisms underlying innate resistance to SIVmac in Chinese rhesus macaques.	[Ross, Cody T.; Smith, David Glenn] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Ross, Cody T.; Roodgarz, Morteza; Smith, David Glenn] Univ Calif Davis, Mol Anthropol Lab, Davis, CA 95616 USA; [Roodgarz, Morteza; Smith, David Glenn] Univ Calif Davis, Calif Natl Primate Res Ctr, Davis, CA 95616 USA; [Roodgarz, Morteza] Univ Calif Davis, Grad Grp Comparat Pathol, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Ross, CT (corresponding author), Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA.	ctross@ucdavis.edu		Ross, Cody/0000-0002-0067-4799	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011107] Funding Source: NIH RePORTER; NIH HHS [P51 OD011107] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Abdel-Mohsen M, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-106; Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Amini S, 2002, ONCOGENE, V21, P5797, DOI 10.1038/sj.onc.1205754; Ammosova T, 2011, THE FASEB JOURNAL, V25, P756; Arhel NJ, 2009, CURR TOP MICROBIOL, V339, P147, DOI 10.1007/978-3-642-02175-6_8; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Barr SD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000007; Barreiro LB, 2010, NAT REV GENET, V11, P17, DOI 10.1038/nrg2698; Biswas N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078814; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Carr A, 1998, LANCET, V351, P1881, DOI 10.1016/S0140-6736(98)03391-1; Carthagena L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004894; Chan E, 2012, HUM GENE THER, V23, P1176, DOI 10.1089/hum.2012.083; Chinn LW, 2010, J INFECT DIS, V202, P1836, DOI 10.1086/657322; DeLuca TF, 2012, BIOINFORMATICS, V28, P715, DOI 10.1093/bioinformatics/bts006; Diaz-Griffero F, 2011, VIRUSES-BASEL, V3, P423, DOI 10.3390/v3050423; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Ferguson B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-43; Festenstein R, 2000, CURR OPIN GENET DEV, V10, P199, DOI 10.1016/S0959-437X(00)00060-5; FRIDELL RA, 1995, VIROLOGY, V209, P347, DOI 10.1006/viro.1995.1266; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Gilad Y, 2008, TRENDS GENET, V24, P408, DOI 10.1016/j.tig.2008.06.001; Gupta P, 2014, VIROLOGY, V450, P336, DOI 10.1016/j.virol.2013.12.026; Habte HH, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-99; Harouse JM, 1999, SCIENCE, V284, P816, DOI 10.1126/science.284.5415.816; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; Hernandez RD, 2007, SCIENCE, V316, P240, DOI 10.1126/science.1140462; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Ishida A, 2005, CELL METAB, V2, P297, DOI 10.1016/j.cmet.2005.09.009; Kajaste-Rudnitski A, 2010, AMINO ACIDS, V39, P1, DOI 10.1007/s00726-009-0393-x; Kanthaswamy S, 2012, AM J PRIMATOL, V74, P747, DOI 10.1002/ajp.22025; Kar AK, 2008, J VIROL, V82, P11669, DOI 10.1128/JVI.01559-08; Kawai T, 2011, EMBO MOL MED, V3, P513, DOI 10.1002/emmm.201100160; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Khan SZ, 2011, J BIOL CHEM, V286, P22943, DOI 10.1074/jbc.M110.201194; Khwaja SS, 2010, J CLIN INVEST, V120, P2537, DOI 10.1172/JCI41277; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kumar M, 2005, J BIOL CHEM, V280, P40041, DOI 10.1074/jbc.M508904200; Lage K, 2008, P NATL ACAD SCI USA, V105, P20870, DOI 10.1073/pnas.0810772105; Li X, 2006, J VIROL, V80, P6198, DOI 10.1128/JVI.00283-06; Liu L, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-94; Liu SJ, 2011, CURR HIV RES, V9, P112, DOI 10.2174/157016211795569113; Louboutin JP, 2012, SCI WORLD J, P1, DOI 10.1100/2012/482575; Mameli G, 2007, J GEN VIROL, V88, P631, DOI 10.1099/vir.0.82487-0; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Mazzolini J, 2010, BLOOD, V115, P4226, DOI 10.1182/blood-2009-12-259473; Mbonye UR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003338; McCarthy FM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-229; Meisner F, 2010, THESIS; Meyerson NR, 2014, VIROLOGY, V454, P291, DOI 10.1016/j.virol.2014.02.029; Motomura K, 2004, INT IMMUNOPHARMACOL, V4, P1829, DOI 10.1016/j.intimp.2004.07.031; Narayanan A, 2012, VIROLOGY, V432, P219, DOI 10.1016/j.virol.2012.06.007; Naydenov NG, 2012, CELL CYCLE, V11, P4613, DOI 10.4161/cc.22885; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Nisole S, 2005, NAT REV MICROBIOL, V3, P799, DOI 10.1038/nrmicro1248; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Ortiz M, 2009, MOL BIOL EVOL, V26, P2865, DOI 10.1093/molbev/msp197; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Petersen DC, 2005, JAIDS-J ACQ IMM DEF, V40, P521, DOI 10.1097/01.qai.0000186360.42834.28; Petrovski S, 2011, AIDS, V25, P513, DOI 10.1097/QAD.0b013e328343817b; Pudney J, 2011, J REPROD IMMUNOL, V88, P219, DOI 10.1016/j.jri.2011.01.006; R Core Team, 2021, R LANGUAGE ENV STAT; Ryu YS, 2011, J BIOL CHEM, V286, P25729, DOI 10.1074/jbc.M111.241893; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Sancineto L, 2013, CHEMMEDCHEM, V8, P1941, DOI 10.1002/cmdc.201300287; Schaub MA, 2012, GENOME RES, V22, P1748, DOI 10.1101/gr.136127.111; Shalekoff S, 2013, CYTOKINE, V61, P792, DOI 10.1016/j.cyto.2013.01.003; Sharma M, 2010, AIDS, V24, P2161, DOI 10.1097/QAD.0b013e32833dbc31; Shoham N, 2003, VIRUS RES, V98, P57, DOI 10.1016/j.virusres.2003.08.016; Shukair SA, 2013, MUCOSAL IMMUNOL, V6, P427, DOI 10.1038/mi.2012.87; SMITH JM, 1993, J THEOR BIOL, V164, P437, DOI 10.1006/jtbi.1993.1165; Smith JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-11; Solis M, 2006, VIROLOGY, V352, P86, DOI 10.1016/j.virol.2006.04.010; Stan Development Team, 2014, STAN A C LIBRARY FOR; Stax MJ, 2009, VIROLOGY, V391, P203, DOI 10.1016/j.virol.2009.06.011; SZATHMARY E, 1993, J THEOR BIOL, V164, P447, DOI 10.1006/jtbi.1993.1166; TISSOT C, 1995, J BIOL CHEM, V270, P14891, DOI 10.1074/jbc.270.25.14891; Trask JS, 2011, J MED PRIMATOL, V40, P224, DOI 10.1111/j.1600-0684.2011.00486.x; Trichel AM, 2002, J MED PRIMATOL, V31, P171, DOI 10.1034/j.1600-0684.2002.02003.x; Uchil PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040016; Van Duyne R, 2013, J MOL BIOL, V425, P812, DOI 10.1016/j.jmb.2012.12.005; Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213; Wei P, 1998, CELL, V92, P451, DOI 10.1016/S0092-8674(00)80939-3; Wojcechowskyj JA, 2013, CELL HOST MICROBE, V13, P613, DOI 10.1016/j.chom.2013.04.011; Xin KQ, 1999, AIDS RES HUM RETROV, V15, P1461, DOI 10.1089/088922299309973; Yan GM, 2011, NAT BIOTECHNOL, V29, P1019, DOI 10.1038/nbt.1992; Yanez RJ, 2002, NUCLEIC ACIDS RES, V30, P4892, DOI 10.1093/nar/gkf614; Yilmaz S, 2010, GENOMICS, V96, P57, DOI 10.1016/j.ygeno.2010.03.011; Zhang J, 2012, J BIOL CHEM, V287, P28646, DOI 10.1074/jbc.M112.362608; Zhao J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045200; ZHARKIKH A, 1994, J MOL EVOL, V39, P315, DOI 10.1007/BF00160155; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	95	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123624	10.1371/journal.pone.0123624	http://dx.doi.org/10.1371/journal.pone.0123624			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884674	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000079
J	Wang, JN; Ma, R; Sharma, A; He, MF; Xue, J; Wu, JZ; Dun, BY; Li, G; Wang, XX; Ji, MH; She, JX; Tang, JH				Wang, Jiangnan; Ma, Rong; Sharma, Ashok; He, Mingfang; Xue, Jing; Wu, Jianzhong; Dun, Boying; Li, Gang; Wang, Xiaoxiao; Ji, Minghua; She, Jin-Xiong; Tang, Jinhai			Inflammatory Serum Proteins Are Severely Altered in Metastatic Gastric Adenocarcinoma Patients from the Chinese Population	PLOS ONE			English	Article							C-REACTIVE-PROTEIN; SQUAMOUS-CELL CARCINOMA; AMYLOID-A; ALPHA-1-ACID GLYCOPROTEIN; PROSTATE-CANCER; TUMOR-MARKER; OSTEOPONTIN; EXPRESSION; BREAST; GROWTH	Background Inflammation is one of the major hallmarks of cancer. This study was designed to profile a panel of inflammatory mediators in gastric adenocarcinoma (GA) and to identify their potential differences separately in metastatic and non-metastatic patient subgroups. Methods Serum samples from 216 GA patients and 333 healthy controls from China were analyzed for six proteins using the Luminex multiplex assay. Results The serum levels for all the six proteins were significantly elevated in metastatic GA compared to non-metastatic GA. Two acute phase proteins (SAA and CRP) and a CXC chemokine (GRO) were significantly elevated in metastatic GA (p < 0.01) but smaller changes were observed in non-metastatic GA compared to healthy controls. OPN is moderately increased in non-metastatic GA (2.05-fold) and more severely elevated in metastatic GA (3.34-fold). Surprisingly, soluble VCAM1 and AGP were significantly lower in both non-metastatic and metastatic GA patients compared to controls. Several individual proteins were shown to possess moderate diagnostic value for non-metastatic GA (AUC = 0.786, 0.833, 0.823 for OPN, sVCAM1 and AGP, respectively) and metastatic GA (AUC = 0.931, 0.720, 0.834 and 0.737 for OPN, sVCAM1, SAA and CRP, respectively). However, protein combinations further improve the diagnostic potential for both non-metastatic GA (best AUC = 0.946) and metastatic GA ( best AUC = 0.963). The protein combination with best AUC value for both comparisons is OPN+sVCAM1+AGP+SAA. Conclusions These results suggest that several serum proteins are directly related to the severity of gastric cancer. Overall, stronger associations are observed with metastatic than non-metastatic GA as the protein changes are greater with the metastatic status. A combination of these serum proteins may serve as non-invasive markers to assess the severity status and stage of gastric cancer.	[Wang, Jiangnan; He, Mingfang; Xue, Jing; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China; [Xue, Jing] Zhengjiang Jintai Biosci, Zhenjiang, Jiangsu, Peoples R China; [Ma, Rong; Wu, Jianzhong; Li, Gang; Ji, Minghua; Tang, Jinhai] Nanjing Med Univ, Jiangsu Canc Hosp, Nanjing, Jiangsu, Peoples R China; [Sharma, Ashok; Dun, Boying; Li, Gang; Wang, Xiaoxiao; Ji, Minghua; She, Jin-Xiong] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA	Nanjing Tech University; Nanjing Medical University; University System of Georgia; Augusta University	She, JX (corresponding author), Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing, Jiangsu, Peoples R China.	jshe@hotmail.com; jschtjh@126.com	ma, rong/GVU-3096-2022; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Wu, Jian/0000-0001-9933-7364; Sharma, Ashok/0000-0001-9597-4374; Wu, Jian/0000-0002-3394-1507	Nanjing Tech University; Jiangsu Cancer Hospital	Nanjing Tech University; Jiangsu Cancer Hospital	This study was supported by the Nanjing Tech University and Jiangsu Cancer Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANISOWICZ A, 1987, P NATL ACAD SCI USA, V84, P7188, DOI 10.1073/pnas.84.20.7188; Bratt T, 2000, BBA-PROTEIN STRUCT M, V1482, P318, DOI 10.1016/S0167-4838(00)00154-0; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Chan DC, 2007, ANN SURG ONCOL, V14, P84, DOI 10.1245/s10434-006-9091-z; Cho WCS, 2010, BRIT J CANCER, V102, P1731, DOI 10.1038/sj.bjc.6605700; Cidon Esther Una, 2011, J Gastrointest Cancer, V42, P127, DOI 10.1007/s12029-010-9161-0; Cocco E, 2010, CANCER-AM CANCER SOC, V116, P843, DOI 10.1002/cncr.24838; Ding YB, 2003, WORLD J GASTROENTERO, V9, P1409, DOI 10.3748/wjg.v9.i7.1409; Doll D, 2010, INT J COLORECTAL DIS, V25, P573, DOI 10.1007/s00384-010-0901-1; Fedarko NS, 2001, CLIN CANCER RES, V7, P4060; Fournier T, 2000, BBA-PROTEIN STRUCT M, V1482, P157, DOI 10.1016/S0167-4838(00)00153-9; GEWURZ H, 1982, ADV INTERNAL MED, V27, P345; Glojnaric I, 2001, CLIN CHEM LAB MED, V39, P129, DOI 10.1515/CCLM.2001.022; Gong MC, 2008, CANCER LETT, V272, P148, DOI 10.1016/j.canlet.2008.07.004; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hashimoto S, 2004, CANCER-AM CANCER SOC, V101, P2825, DOI 10.1002/cncr.20713; Heikkila K, 2007, J EPIDEMIOL COMMUN H, V61, P824, DOI 10.1136/jech.2006.051292; Ishigami S, 2006, HEPATO-GASTROENTEROL, V53, P338; Jabs WJ, 2005, KIDNEY INT, V68, P2103, DOI 10.1111/j.1523-1755.2005.00666.x; Jing JX, 2013, INT J BIOL MARKER, V28, P192, DOI [10.5301/jbm.5000023, 10.5301/JBM.5000023]; Jung K, 2001, CLIN CHEM, V47, P2061; KANETI J, 1984, UROL RES, V12, P239; Kim DH, 2011, J SURG ONCOL, V104, P585, DOI 10.1002/jso.21919; Koch A.E., 1995, ANGIOGENESIS MEDIATE; Lai IR, 2002, HEPATO-GASTROENTEROL, V49, P1157; Lehrer S, 2005, BJU INT, V95, P961, DOI 10.1111/j.1464-410X.2005.05447.x; Li AH, 2004, CLIN EXP METASTAS, V21, P571; Li J, 2005, INT J CANCER, V117, P14, DOI 10.1002/ijc.21074; Lin YS, 2011, WORLD J GASTROENTERO, V17, P4421, DOI 10.3748/wjg.v17.i39.4421; Loukinova E, 2000, ONCOGENE, V19, P3477, DOI 10.1038/sj.onc.1203687; Lu HT, 2006, MOL CANCER RES, V4, P221, DOI 10.1158/1541-7786.MCR-05-0261; Luan J, 1997, J LEUKOCYTE BIOL, V62, P588, DOI 10.1002/jlb.62.5.588; MACKIEWICZ A, 1995, GLYCOCONJUGATE J, V12, P241, DOI 10.1007/BF00731326; Malle E, 2009, CELL MOL LIFE SCI, V66, P9, DOI 10.1007/s00018-008-8321-x; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; Marrelli D, 2001, AM J SURG, V181, P16, DOI 10.1016/S0002-9610(00)00549-3; Mattar Rejane, 2002, Rev. Hosp. Clin., V57, P89, DOI 10.1590/S0041-87812002000300001; Nakata B, 1998, CANCER, V83, P2488, DOI 10.1002/(SICI)1097-0142(19981215)83:12<2488::AID-CNCR12>3.0.CO;2-1; Nozoe T, 2003, CANCER LETT, V192, P89, DOI 10.1016/S0304-3835(02)00630-4; O'Hanlon DM, 2002, EUR J CANCER, V38, P2252, DOI 10.1016/S0959-8049(02)00218-6; Pierce BL, 2009, J CLIN ONCOL, V27, P3437, DOI 10.1200/JCO.2008.18.9068; Ramankulov A, 2008, CANCER LETT, V269, P85, DOI 10.1016/j.canlet.2008.04.022; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; Schultz DR, 1990, SEMINARS ARTHRITIS R; Terry MB, 2002, SEM RAD ONC; Wai PY, 2004, J SURG RES, V121, P228, DOI 10.1016/j.jss.2004.03.028; Wang B, 2006, CANCER RES, V66, P3071, DOI 10.1158/0008-5472.CAN-05-2871; WEINSTEIN PS, 1984, SCAND J IMMUNOL, V19, P193; Wu CY, 2007, GUT, V56, P782, DOI 10.1136/gut.2006.109868; Yang L, 2006, WORLD J GASTROENTERO, V12, P17, DOI 10.3748/wjg.v12.i1.17; Yuki M, 2011, VET RES COMMUN, V35, P1, DOI 10.1007/s11259-010-9445-7	51	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123985	10.1371/journal.pone.0123985	http://dx.doi.org/10.1371/journal.pone.0123985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884401	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000097
J	Zaidi, PH; Rashid, Z; Vinayan, MT; Almeida, GD; Phagna, RK; Babu, R				Zaidi, Pervez Haider; Rashid, Zerka; Vinayan, Madhumal Thayil; Almeida, Gustavo Dias; Phagna, Ramesh Kumar; Babu, Raman			QTL Mapping of Agronomic Waterlogging Tolerance Using Recombinant Inbred Lines Derived from Tropical Maize (Zea mays L) Germplasm	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; POPULATIONS REVEALS; FLOODING TOLERANCE; DIFFERENT TESTERS; SECONDARY TRAITS; GENE-EXPRESSION; LINKAGE MAP; TEOSINTE; IDENTIFICATION; MOISTURE	Waterlogging is an important abiotic stress constraint that causes significant yield losses in maize grown throughout south and south-east Asia due to erratic rainfall patterns. The most economic option to offset the damage caused by waterlogging is to genetically incorporate tolerance in cultivars that are grown widely in the target agro-ecologies. We assessed the genetic variation in a population of recombinant inbred lines (RILs) derived from crossing a waterlogging tolerant line (CAWL-46-3-1) to an elite but sensitive line (CML311-2-1-3) and observed significant range of variation for grain yield (GY) under waterlogging stress along with a number of other secondary traits such as brace roots (BR), chlorophyll content (SPAD), % stem and root lodging (S&RL) among the RILs. Significant positive correlation of GY with BR and SPAD and negative correlation with S&RL indicated the potential use of these secondary traits in selection indices under waterlogged conditions. RILs were geno-typed with 331 polymorphic single nucleotide polymorphism (SNP) markers using KASP (Kompetitive Allele Specific PCR) Platform. QTL mapping revealed five QTL on chromosomes 1, 3, 5, 7 and 10, which together explained approximately 30% of phenotypic variance for GY based on evaluation of RIL families under waterlogged conditions, with effects ranging from 520 to 640 kg/ha for individual genomic regions. 13 QTL were identified for various secondary traits associated with waterlogging tolerance, each individually explaining from 3 to 14% of phenotypic variance. Of the 22 candidate genes with known functional domains identified within the physical intervals delimited by the flanking markers of the QTL influencing GY and other secondary traits, six have previously been demonstrated to be associated with anaerobic responses in either maize or other model species. A pair of flanking SNP markers has been identified for each of the QTL and high throughput marker assays were developed to facilitate rapid introgression of waterlogging tolerance in tropical maize breeding programs.	[Zaidi, Pervez Haider; Rashid, Zerka; Vinayan, Madhumal Thayil; Babu, Raman] Int Crop Res Inst Semiarid Trop ICRISAT, Int Maize & Wheat Improvement Ctr CIMMYT Asia, Hyderabad, Andhra Pradesh, India; [Almeida, Gustavo Dias] Directorate Maize Res DMR, New Delhi, India; [Phagna, Ramesh Kumar] Monsanto Co, Uberlandia, MG, Brazil	CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Indian Council of Agricultural Research (ICAR); ICAR - Indian Institute of Maize Research; Monsanto	Babu, R (corresponding author), Int Crop Res Inst Semiarid Trop ICRISAT, Int Maize & Wheat Improvement Ctr CIMMYT Asia, Hyderabad, Andhra Pradesh, India.	r.babu@cgiar.org	Research, ICAR-Indian Institute of Maize/ABC-7039-2020		German ministry, Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	German ministry, Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ)	The project was funded by the German ministry, Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) through a project titled "Abiotic stress tolerant maize for Asia (ATMA)" in two phases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALANI A, 1985, PLANT PHYSIOL, V79, P885, DOI 10.1104/pp.79.3.885; Almeida GD, 2014, MOL BREEDING, V34, P701, DOI 10.1007/s11032-014-0068-5; Almeida GD, 2013, THEOR APPL GENET, V126, P583, DOI 10.1007/s00122-012-2003-7; Anjos e Silva S. D. dos, 2005, Crop Breeding and Applied Biotechnology, V5, P287; Basten C.J., 1997, QTL CARTOGRAPHER REF; Bird R. McK., 2000, Maize Genetics Cooperation Newsletter, P58; Bunn HF, 1996, PHYSIOL REV, V76, P839, DOI 10.1152/physrev.1996.76.3.839; Cairns JE, 2012, ADV AGRON, V114, P1, DOI 10.1016/B978-0-12-394275-3.00006-7; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; *CIMMYT, 2001, APPL BIOT CTR MAN LA; Silva SDDE, 2007, CROP BREED APPL BIOT, V7, P165, DOI 10.12702/1984-7033.v07n02a08; Geffers R, 2001, BBA-GENE STRUCT EXPR, V1521, P120, DOI 10.1016/S0167-4781(01)00302-5; Hoeren FU, 1998, GENETICS, V149, P479; Holland JB, 2007, CURR OPIN PLANT BIOL, V10, P156, DOI 10.1016/j.pbi.2007.01.003; Kohler U, 1995, PLANT MOL BIOL, V29, P1293, DOI 10.1007/BF00020469; Kosambi DD, 1943, ANN EUGENIC, V12, P172, DOI 10.1111/j.1469-1809.1943.tb02321.x; Ku LX, MOL BREED, V30, P697; Li HH, 2007, GENETICS, V175, P361, DOI 10.1534/genetics.106.066811; Li YJ, 2011, FEBS J, V278, P156, DOI 10.1111/j.1742-4658.2010.07941.x; Lubberstedt T, 1997, CROP SCI, V37, P921, DOI 10.2135/cropsci1997.0011183X003700030037x; Mano Y, 2007, PLANT SOIL, V295, P103, DOI 10.1007/s11104-007-9266-9; Mano Y, 2006, PLANT PROD SCI, V9, P176, DOI 10.1626/pps.9.176; Mano Y., 2005, Japanese Journal of Crop Science, V74, P41, DOI 10.1626/jcs.74.41; Mano Y, 2005, EUPHYTICA, V142, P33, DOI 10.1007/s10681-005-0449-2; Mano Y, 2013, ANN BOT-LONDON, V112, P1125, DOI 10.1093/aob/mct160; Mano Y, 2002, JPN J CROP SCI, V71, P361, DOI 10.1626/jcs.71.361; Mano Y, 2007, PLANT ROOT, V1, P17, DOI 10.3117/plantroot.1.17; Mano Y, 2008, MOL BREEDING, V21, P327, DOI 10.1007/s11032-007-9132-8; Mano Y, 2009, PLANT ROOT, V3, P3, DOI 10.3117/plantroot.3.3; Mano Y, 2009, BREEDING SCI, V59, P427, DOI 10.1270/jsbbs.59.427; Mei HW, 2003, THEOR APPL GENET, V107, P89, DOI 10.1007/s00122-003-1192-5; Melchinger AE, 1998, GENETICS, V149, P383; Mihaljevic R, 2005, THESIS U HOHENHEIM G; Narusaka Y, 2004, PLANT MOL BIOL, V55, P327, DOI 10.1007/s11103-004-0685-1; Paquette SM, 2000, DNA CELL BIOL, V19, P307, DOI 10.1089/10445490050021221; PATTERSON HD, 1976, BIOMETRIKA, V63, P83, DOI 10.1093/biomet/63.1.83; Peng B, 2013, THEOR APPL GENET, V126, P773, DOI 10.1007/s00122-012-2017-1; Rathore T.R., 1997, TAMNET NEWSL, V4, P13; RAYMOND P, 1985, PLANT PHYSIOL, V79, P879, DOI 10.1104/pp.79.3.879; Reggiani R, 2000, PLANT CELL PHYSIOL, V41, P1392, DOI 10.1093/pcp/pcd073; Ribaut Jean-Marcel, 2008, V1, P21; Semagn K, 2014, MOL BREEDING, V33, P1, DOI 10.1007/s11032-013-9917-x; Setter TL, 2011, J EXP BOT, V62, P701, DOI 10.1093/jxb/erq308; Singh N.N., 1996, P 1 AS REG MAIZ WORK, P56; Subbaiah C, 1999, 39 ANN MAIZ GEN C LA, P98; Timsina J, 2010, PLANT SOIL, V335, P65, DOI 10.1007/s11104-010-0418-y; TORBERT HA, 1993, J PROD AGRIC, V6, P337, DOI 10.2134/jpa1993.0337; Tuberosa R, 2002, ANN BOT-LONDON, V89, P941, DOI 10.1093/aob/mcf134; Utz HF, 2000, GENETICS, V154, P1839; VANTOAI TT, 1995, PLANT CELL ENVIRON, V18, P937, DOI 10.1111/j.1365-3040.1995.tb00604.x; Waddington SR, 2006, S EM RIC MAIZ SYST A; Yan JB, 2010, MOL BREEDING, V25, P441, DOI 10.1007/s11032-009-9343-2; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Zaidi PH, 2007, CEREAL RES COMMUN, V35, P1427, DOI 10.1556/CRC.35.2007.3.7; Zaidi PH, 2004, FIELD CROP RES, V90, P189, DOI 10.1016/j.fcr.2004.03.002; Zaidi PH, 2003, EUR J AGRON, V19, P383, DOI 10.1016/S1161-0301(02)00090-4; ZAIDI PH, 2002, P 8 AS REG MAIZ WORK, P398; Zhang XB, 2013, PLANT MOL BIOL REP, V31, P594, DOI 10.1007/s11105-012-0526-3; Zhou MX, 2010, WATERLOGGING SIGNALLING AND TOLERANCE IN PLANTS, P267, DOI 10.1007/978-3-642-10305-6_13	59	36	39	1	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124350	10.1371/journal.pone.0124350	http://dx.doi.org/10.1371/journal.pone.0124350			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884393	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000117
J	Zhang, N; Brugger, J; Etschmann, B; Ngothai, Y; Zeng, DW				Zhang, Ning; Brugger, Joel; Etschmann, Barbara; Ngothai, Yung; Zeng, Dewen			Thermodynamic Modeling of Poorly Complexing Metals in Concentrated Electrolyte Solutions: An X-Ray Absorption and UV-Vis Spectroscopic Study of Ni(II) in the NiCl2-MgCl2-H2O System	PLOS ONE			English	Article							PARTIAL MOLAL PROPERTIES; SHARED ION-PAIRS; CHLORIDE COMPLEXES; AQUEOUS-SOLUTION; ACTIVITY-COEFFICIENTS; HIGH-PRESSURES; THEORETICAL PREDICTION; SUPERCRITICAL WATER; ZINC COMPLEXATION; PHASE-EQUILIBRIA	Knowledge of the structure and speciation of aqueous Ni(II)-chloride complexes is important for understanding Ni behavior in hydrometallurgical extraction. The effect of concentration on the first-shell structure of Ni(II) in aqueous NiCl2 and NiCl2-MgCl2 solutions was investigated by Ni K edge X-ray absorption (XAS) and UV-Vis spectroscopy at ambient conditions. Both techniques show that no large structural change (e.g., transition from octahedral to tetrahedral-like configuration) occurs. Both methods confirm that the Ni(II) aqua ion (with six coordinated water molecules at RNi-O = 2.07(2) angstrom) is the dominant species over the whole NiCl2 concentration range. However, XANES, EXAFS and UV-Vis data show subtle changes at high salinity (> 2 mol.kg(-1) NiCl2), which are consistent with the formation of small amounts of the NiCl+ complex (up to 0.44(23) Cl at a Ni-Cl distance of 2.35(2) angstrom in 5.05 mol.kg(-1) NiCl2) in the pure NiCl2 solutions. At high Cl: Ni ratio in the NiCl2-MgCl2-H2O solutions, small amounts of [ NiCl2](0) are also present. We developed a speciation-based mixed-solvent electrolyte (MSE) model to describe activity-composition relationships in NiCl2-MgCl2-H2O solutions, and at the same time predict Ni(II) speciation that is consistent with our XAS and UV-Vis data and with existing literature data up to the solubility limit, resolving a long-standing uncertainty about the role of chloride complexing in this system.	[Zhang, Ning; Zeng, Dewen] Cent South Univ, Coll Chem & Chem Engn, Changsha 410083, Hunan, Peoples R China; [Zhang, Ning; Etschmann, Barbara; Ngothai, Yung] Univ Adelaide, Sch Chem Engn, Adelaide, SA 5000, Australia; [Brugger, Joel; Etschmann, Barbara] S Australian Museum, Div Mineral, Adelaide, SA 5000, Australia; [Zhang, Ning; Brugger, Joel; Etschmann, Barbara] Monash Univ, Sch Geosci, Clayton, Vic 3800, Australia	Central South University; University of Adelaide; Monash University	Brugger, J (corresponding author), S Australian Museum, Div Mineral, Adelaide, SA 5000, Australia.	joel.brugger@monash.edu; dewen_zeng@hotmail.com	Brugger, Joël/C-7113-2008	Brugger, Joël/0000-0003-1510-5764; Etschmann, Barbara/0000-0002-7807-2763; Ngothai, Yung/0000-0002-0199-4225	National Basic Research Program of China [2014CB643401]; National Natural Science Foundation of China [20773036, 51134007, 21463010]; China Scholarship Council [201306370118]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This research was financially supported by National Basic Research Program of China (No. 2014CB643401), the National Natural Science Foundation of China (Nos: 20773036, 51134007 and 21463010), and the China Scholarship Council (No. 201306370118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS DS, 1975, AICHE J, V21, P116, DOI 10.1002/aic.690210115; Agrawal A, 2009, IND ENG CHEM RES, V48, P6145, DOI 10.1021/ie900135u; ANGELL CA, 1966, J AM CHEM SOC, V88, P5192, DOI 10.1021/ja00974a029; Aparicio JL, 1996, J SOLUTION CHEM, V25, P1055, DOI 10.1007/BF00972921; Atak K, 2013, J PHYS CHEM B, V117, P12613, DOI 10.1021/jp408212u; Azimi G, 2008, FLUID PHASE EQUILIBR, V266, P172, DOI 10.1016/j.fluid.2008.01.027; Aziz EF, 2007, J PHYS CHEM B, V111, P4440, DOI 10.1021/jp070085r; BJERRUM J, 1988, ACTA CHEM SCAND A, V42, P714, DOI 10.3891/acta.chem.scand.42a-0714; Brugger J, 2007, GEOCHIM COSMOCHIM AC, V71, P4920, DOI 10.1016/j.gca.2007.08.003; Brugger J, 2001, GEOCHIM COSMOCHIM AC, V65, P2691, DOI 10.1016/S0016-7037(01)00614-7; Brugger J, 2007, COMPUT GEOSCI-UK, V33, P248, DOI 10.1016/j.cageo.2006.06.011; CLIFFORD AA, 1966, J PHYS CHEM-US, V70, P1536, DOI 10.1021/j100877a032; de Jong P. H. K., 1996, Journal of Chemical Physics, V105, P5155, DOI 10.1063/1.472359; Farges F, 2001, GEOCHIM COSMOCHIM AC, V65, P1665, DOI 10.1016/S0016-7037(00)00625-6; FLORENCE TM, 1966, AUST J CHEM, V19, P1343, DOI 10.1071/CH9661343; FONTANA MP, 1978, J CHEM PHYS, V69, P676, DOI 10.1063/1.436633; Fulton JL, 2003, J PHYS CHEM A, V107, P4688, DOI 10.1021/jp0272264; GOLDBERG RN, 1979, J PHYS CHEM REF DATA, V8, P923, DOI 10.1063/1.555615; Harris DJ, 2003, J PHYS CHEM A, V107, P1050, DOI 10.1021/jp026098g; HARVIE CE, 1984, GEOCHIM COSMOCHIM AC, V48, P723, DOI 10.1016/0016-7037(84)90098-X; [何配华 He Peihua], 2010, [冶金分析, Metallurgical Analysis], V30, P58; HELGESON HC, 1974, AM J SCI, V274, P1199, DOI 10.2475/ajs.274.10.1199; HELGESON HC, 1981, AM J SCI, V281, P1249, DOI 10.2475/ajs.281.10.1249; Helm L, 2005, CHEM REV, V105, P1923, DOI 10.1021/cr030726o; Hoffmann MM, 1999, J PHYS CHEM A, V103, P8471, DOI 10.1021/jp990435c; Iuchi S, 2010, CHEM PHYS LETT, V485, P114, DOI 10.1016/j.cplett.2009.12.039; Kelly SD, 2008, METHODS SOIL ANAL 5, P387, DOI DOI 10.2136/SSSABOOKSER5.5.C14; KLEINBERG R, 1969, J CHEM PHYS, V50, P4690, DOI 10.1063/1.1670957; LAGARDE P, 1980, J CHEM PHYS, V72, P3061, DOI 10.1063/1.439509; Li HX, 2014, J CHEM ENG DATA, V59, P2177, DOI 10.1021/je500097j; LIBUS Z, 1975, J SOLUTION CHEM, V4, P1011, DOI 10.1007/BF01074743; LICHERI G, 1983, J CHEM PHYS, V79, P2168, DOI 10.1063/1.446063; LICHERI G, 1981, CHEM PHYS LETT, V83, P384, DOI 10.1016/0009-2614(81)85484-X; Liu HX, 2006, IND ENG CHEM RES, V45, P39, DOI 10.1021/ie050619f; Liu WH, 2007, AM MINERAL, V92, P761, DOI 10.2138/am.2007.2225; Liu W, 2006, CHEM GEOL, V231, P326, DOI 10.1016/j.chemgeo.2006.02.005; Liu WH, 2012, GEOCHIM COSMOCHIM AC, V94, P276, DOI 10.1016/j.gca.2012.04.055; Liu WH, 2012, CHEM GEOL, V298, P57, DOI 10.1016/j.chemgeo.2011.12.018; Liu WH, 2011, GEOCHIM COSMOCHIM AC, V75, P1227, DOI 10.1016/j.gca.2010.12.002; MAGINI M, 1982, J CHEM PHYS, V76, P1116, DOI 10.1063/1.443079; MAGINI M, 1981, J CHEM PHYS, V74, P2523, DOI 10.1063/1.441322; MAGINI M, 1985, J CHEM PHYS, V83, P5797, DOI 10.1063/1.449659; MALINOWSKI ER, 1977, ANAL CHEM, V49, P612, DOI 10.1021/ac50012a027; Mei Y, 2015, GEOCHIM COSMOCHIM AC, V150, P265, DOI 10.1016/j.gca.2014.09.023; Mei Y, 2013, GEOCHIM COSMOCHIM AC, V102, P45, DOI 10.1016/j.gca.2012.10.027; MILLERO FJ, 1992, MAR CHEM, V40, P19, DOI 10.1016/0304-4203(92)90046-D; MILLERO FJ, 1995, MAR CHEM, V50, P21, DOI 10.1016/0304-4203(95)00024-L; NEILSON GW, 1978, J PHYS C SOLID STATE, V11, pL625, DOI 10.1088/0022-3719/11/15/003; NEWSOME JR, 1981, CHEM PHYS LETT, V82, P399, DOI 10.1016/0009-2614(81)85406-1; OIKOVA T, 1979, ZH NEORG KHIM+, V24, P219; Paatero J, 1971, ACTA ACAD ABO MATH P, V31, P1; PITZER KS, 1980, J AM CHEM SOC, V102, P2902, DOI 10.1021/ja00529a006; PITZER KS, 1973, J PHYS CHEM-US, V77, P268, DOI 10.1021/j100621a026; Pospiech B, 2007, SEP PURIF TECHNOL, V57, P461, DOI 10.1016/j.seppur.2006.07.005; Ravel B, 2005, J SYNCHROTRON RADIAT, V12, P537, DOI 10.1107/S0909049505012719; Rousseau B, 2000, ACTA CRYSTALLOGR A, V56, P300, DOI 10.1107/S0108767300002853; SANDSTROM DR, 1979, J CHEM PHYS, V71, P2381, DOI 10.1063/1.438643; Santana-Casiano JM, 2008, J SOLUTION CHEM, V37, P749, DOI 10.1007/s10953-008-9274-2; SHARPS JA, 1993, GEOCHIM COSMOCHIM AC, V57, P721, DOI 10.1016/0016-7037(93)90164-R; SOPER AK, 1977, J PHYS C SOLID STATE, V10, P1793, DOI 10.1088/0022-3719/10/11/014; STOKES RH, 1946, J AM CHEM SOC, V68, P333, DOI 10.1021/ja01206a055; Sverjensky DA, 1997, GEOCHIM COSMOCHIM AC, V61, P1359, DOI 10.1016/S0016-7037(97)00009-4; TANGER JC, 1988, AM J SCI, V288, P19, DOI 10.2475/ajs.288.1.19; Tian Y, 2012, CHEM GEOL, V334, P345, DOI 10.1016/j.chemgeo.2012.10.010; Waizumi K, 1999, J SOLUTION CHEM, V28, P83, DOI 10.1023/A:1021741911462; WAKITA H, 1982, B CHEM SOC JPN, V55, P817, DOI 10.1246/bcsj.55.817; Wallen SL, 1998, J CHEM PHYS, V108, P4039, DOI 10.1063/1.475838; Wang P, 2006, J MOL LIQ, V125, P37, DOI 10.1016/j.molliq.2005.11.030; Wang P, 2004, FLUID PHASE EQUILIBR, V222, P11, DOI 10.1016/j.fluid.2004.06.008; Wang PM, 2002, FLUID PHASE EQUILIBR, V203, P141, DOI 10.1016/S0378-3812(02)00178-4; Wang WL, 2012, IND ENG CHEM RES, V51, P5124, DOI 10.1021/ie201721m; Xia FF, 2013, J PHYS CHEM A, V117, P8468, DOI 10.1021/jp405168r; ZABINSKY SI, 1995, PHYS REV B, V52, P2995, DOI 10.1103/PhysRevB.52.2995; Zhang N, 2014, J MOL LIQ, V198, P200, DOI 10.1016/j.molliq.2014.06.025; Zhang N, 2014, J SOLUTION CHEM, V43, P326, DOI 10.1007/s10953-014-0129-8; Zhu Z, 2012, HYDROMETALLURGY, V127, P1, DOI 10.1016/j.hydromet.2012.07.001	76	7	7	6	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119805	10.1371/journal.pone.0119805	http://dx.doi.org/10.1371/journal.pone.0119805			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885410	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000005
J	Zhou, AM; Kuang, BQ; Gao, YR; Liang, GW				Zhou, Aiming; Kuang, Beiqing; Gao, Yingrui; Liang, Guangwen			Density-Dependent Benefits in Ant-Hemipteran Mutualism? The Case of the Ghost Ant Tapinoma melanocephalum (Hymenoptera: Formicidae) and the Invasive Mealybug Phenacoccus solenopsis (Hemiptera: Pseudococcidae)	PLOS ONE			English	Article							HONEYDEW SUGAR COMPOSITION; FIRE ANTS; HOMOPTERA PSEUDOCOCCIDAE; MEMBRACID MUTUALISM; UNITED-STATES; APHID; ENCYRTIDAE; TINSLEY; COTTON; PLANT	Although density-dependent benefits to hemipterans from ant tending have been measured many times, few studies have focused on integrated effects such as interactions between ant tending, natural enemy density, and hemipteran density. In this study, we tested whether the invasive mealybug Phenacoccus solenopsis is affected by tending by ghost ants (Tapinoma melanocephalum), the presence of parasitoids, mealybug density, parasitoid density and interactions among these factors. Our results showed that mealybug colony growth rate and percentage parasitism were significantly affected by ant tending, parasitoid presence, and initial mealybug density separately. However, there were no interactions among the independent factors. There were also no significant interactions between ant tending and parasitoid density on either mealybug colony growth rate or percentage parasitism. Mealybug colony growth rate showed a negative linear relationship with initial mealybug density but a positive linear relationship with the level of ant tending. These results suggest that benefits to mealybugs are density-independent and are affected by ant tending level.	[Zhou, Aiming] Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China; [Zhou, Aiming; Kuang, Beiqing; Gao, Yingrui; Liang, Guangwen] South China Agr Univ, Red Imported Fire Ant Res Ctr, Guangzhou 510642, Guangdong, Peoples R China	Huazhong Agricultural University; South China Agricultural University	Zhou, AM (corresponding author), Huazhong Agr Univ, Coll Plant Sci & Technol, Hubei Insect Resources Utilizat & Sustainable Pes, Wuhan, Peoples R China.	zhouam@mail.hzau.edu.cn			National Natural Science Foundation of China [31401808]; Fundamental Research Funds For the Central Universities [2014QC024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds For the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the National Natural Science Foundation of China (No. 31401808) and the Fundamental Research Funds For the Central Universities (No. 2014QC024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1978, CAN J ZOOL, V56, P2093, DOI 10.1139/z78-283; ADDICOTT JF, 1979, CAN J ZOOL, V57, P558, DOI 10.1139/z79-066; AUGSPURGER CK, 1981, ECOLOGY, V62, P775, DOI 10.2307/1937745; BANKS CJ, 1958, J EXP BIOL, V35, P703; BARTON AM, 1986, ECOLOGY, V67, P495, DOI 10.2307/1938592; BRETON LM, 1992, ECOLOGY, V73, P2175, DOI 10.2307/1941465; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Bronstein JL, 2003, AM NAT, V162, pS24, DOI 10.1086/378645; BUCKLEY R, 1987, ADV ECOL RES, V16, P53; Chen Hua-Yan, 2011, Huanjing Kunchong Xuebao, V33, P269; CUSHMAN JH, 1989, ECOLOGY, V70, P1040, DOI 10.2307/1941372; Fand BB, 2010, BIOCONTROL SCI TECHN, V21, P51, DOI 10.1080/09583157.2010.522702; Fischer MK, 2001, FUNCT ECOL, V15, P544, DOI 10.1046/j.0269-8463.2001.00550.x; Flatt T, 2000, ECOLOGY, V81, P3522, DOI 10.1890/0012-9658(2000)081[3522:TEOMAO]2.0.CO;2; FUCHS TW, 1991, SOUTHWEST ENTOMOL, V16, P215; Gilbert LE, 1983, COEVOLUTION MIMICRY; Hayat Mohammad, 2009, Biosystematica, V3, P21; Itioka T, 1996, OECOLOGIA, V106, P448, DOI 10.1007/BF00329700; JOUVENAZ DP, 1977, FLA ENTOMOL, V60, P275, DOI 10.2307/3493922; Kaplan I, 2002, ENVIRON ENTOMOL, V31, P1175, DOI 10.1603/0046-225X-31.6.1175; Kaplan I, 2005, ECOLOGY, V86, P1640, DOI 10.1890/04-0016; Kay AD, 2004, ECOL LETT, V7, P1024, DOI 10.1111/j.1461-0248.2004.00667.x; Kumar Rishi, 2009, Journal of Biological Control, V23, P457; [陆永跃 LU Yong-Yue], 2008, [环境昆虫学报, Journal of Environmental Entomology], V30, P386; MCEVOY P B, 1979, Miscellaneous Publications of the Entomological Society of America, V11, P1; MESSINA FJ, 1981, ECOLOGY, V62, P1433, DOI 10.2307/1941499; Mooney KA, 2008, AM NAT, V171, pE195, DOI 10.1086/587758; Morales MA, 2000, ECOLOGY, V81, P482, DOI 10.2307/177441; Nagrare VS, 2009, B ENTOMOL RES, V99, P537, DOI 10.1017/S0007485308006573; Powell BE, 2010, BIOL CONTROL, V54, P285, DOI 10.1016/j.biocontrol.2010.05.013; Sakata H, 1995, RES POPUL ECOL, V37, P159, DOI 10.1007/BF02515816; SMITH MR, 1965, HOUSE INFESTING ANTS; Stadler B, 1998, J ANIM ECOL, V67, P454, DOI 10.1046/j.1365-2656.1998.00209.x; Stadler B, 2005, ANNU REV ECOL EVOL S, V36, P345, DOI 10.1146/annurev.ecolsys.36.091704.175531; Styrsky JD, 2007, P ROY SOC B-BIOL SCI, V274, P151, DOI 10.1098/rspb.2006.3701; Suroshe S. S., 2014, Indian Journal of Entomology, V76, P224; Suroshe Sachin S., 2013, Journal of Biological Control, V27, P204; Volkl W, 1999, OECOLOGIA, V118, P483, DOI 10.1007/s004420050751; WAY MJ, 1963, ANNU REV ENTOMOL, V8, P307, DOI 10.1146/annurev.en.08.010163.001515; Wheeler W. M., 1910, ANTS THEIR STRUCTURE, V9; Wilder SM, 2011, P NATL ACAD SCI USA, V108, P20639, DOI 10.1073/pnas.1115263108; WOOD TK, 1982, ANN ENTOMOL SOC AM, V75, P649, DOI 10.1093/aesa/75.6.649; Yao I, 2000, OIKOS, V89, P3, DOI 10.1034/j.1600-0706.2000.890101.x; Yao I, 2004, EUR J ENTOMOL, V101, P531, DOI 10.14411/eje.2004.076; Zhou AM, 2014, FLA ENTOMOL, V97, P1474, DOI 10.1653/024.097.0423; Zhou AM, 2013, ENVIRON ENTOMOL, V42, P247, DOI 10.1603/EN12168; Zhou AM, 2012, SOCIOBIOLOGY, V59, P795; Zhou AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041856	48	7	8	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123885	10.1371/journal.pone.0123885	http://dx.doi.org/10.1371/journal.pone.0123885			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886510	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000093
J	Dellinger, AL; Cunin, P; Lee, D; Kung, AL; Brooks, DB; Zhou, ZG; Nigrovic, PA; Kepley, CL				Dellinger, Anthony L.; Cunin, Pierre; Lee, David; Kung, Andrew L.; Brooks, D. Bradford; Zhou, Zhiguo; Nigrovic, Peter A.; Kepley, Christopher L.			Inhibition of Inflammatory Arthritis Using Fullerene Nanomaterials	PLOS ONE			English	Article							NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; SYNOVIAL MAST-CELLS; REACTIVE OXYGEN; RHEUMATOID-ARTHRITIS; IN-VITRO; PATHOGENESIS; LOCALIZATION; ANTIOXIDANTS; FIBROBLASTS	Inflammatory arthritis (e.g. rheumatoid arthritis; RA) is a complex disease driven by the interplay of multiple cellular lineages. Fullerene derivatives have previously been shown to have anti-inflammatory capabilities mediated, in part, by their ability to prevent inflammatory mediator release by mast cells (MC). Recognizing that MC can serve as a cellular link between autoantibodies, soluble mediators, and other effector populations in inflammatory arthritis, it was hypothesized that fullerene derivatives might be used to target this inflammatory disease. A panel of fullerene derivatives was tested for their ability to affect the function of human skin-derived MC as well as other lineages implicated in arthritis, synovial fibroblasts and osteoclasts. It is shown that certain fullerene derivatives blocked Fc gamma R-and TNF-alpha-induced mediator release from MC; TNF-alpha-induced mediator release from RA synovial fibroblasts; and maturation of human osteoclasts. MC inhibition by fullerene derivatives was mediated through the reduction of mitochondrial membrane potential and Fc gamma R-mediated increases in cellular reactive oxygen species and NF-kappa B activation. Based on these in vitro data, two fullerene derivatives (ALM and TGA) were selected for in vivo studies using K/BxN serum transfer arthritis in C57BL/6 mice and collagen-induced arthritis (CIA) in DBA/1 mice. Dye-conjugated fullerenes confirmed localization to affected joints in arthritic animals but not in healthy controls. In the K/BxN moldel, fullerenes attenuated arthritis, an effect accompanied by reduced histologic inflammation, cartilage/bone erosion, and serum levels of TNF-alpha. Fullerenes remained capable of attenuating K/BxN arthritis in mast cell-deficient mice Cre-Master mice, suggesting that lineages beyond the MC represent relevant targets in this system. These studies suggest that fullerene derivatives may hold promise both as an assessment tool and as anti-inflammatory therapy of arthritis.	[Dellinger, Anthony L.; Kepley, Christopher L.] Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA; [Cunin, Pierre; Nigrovic, Peter A.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Allergy & Immunol, Boston, MA USA; [Cunin, Pierre; Nigrovic, Peter A.] Harvard Univ, Sch Med, Div Immunol, Boston Childrens Hosp, Boston, MA USA; [Lee, David] Novartis Inst Biomed Res, Basel, Switzerland; [Kung, Andrew L.] Dana Farber Inst, Boston, MA USA; [Brooks, D. Bradford; Zhou, Zhiguo] Luna Innovat Inc, Danville, VA USA	University of North Carolina; University of North Carolina Greensboro; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Novartis; Harvard University; Dana-Farber Cancer Institute	Kepley, CL (corresponding author), Univ N Carolina, Joint Sch Nanosci & Nanoengn, Greensboro, NC 27412 USA.	clkepley@uncg.edu	Kung, Andrew L/AEU-0826-2022; Kung, Andrew/AAL-2384-2020	Kung, Andrew L/0000-0002-9091-488X; 	Novartis Institutes for Biomedical Research; Luna Innovations Incorporated	Novartis Institutes for Biomedical Research; Luna Innovations Incorporated	Novartis Institutes for Biomedical Research and Luna Innovations Incorporated provided support in the form of salaries for authors DL, DBB and ZZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adiseshaiah P, 2013, INVEST RADIOL, V48, P745, DOI 10.1097/RLI.0b013e318294de5d; Arab HH, 2013, TOXICOL APPL PHARM, V27, P00040; Avnet S, 2007, INT J ONCOL, V30, P469; Bai XC, 2005, J BIOL CHEM, V280, P17497, DOI 10.1074/jbc.M409332200; Bamborough P, 2010, DRUG NEWS PERSPECT, V23, P483, DOI 10.1358/dnp.2010.23.8.1447844; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Castor W., 2007, ARTHRITIS RHEUMATISM, V3, P140; Chirico F, 2007, EXP DERMATOL, V16, P429, DOI 10.1111/j.1600-0625.2007.00545.x; Choi Y, 2009, NAT REV RHEUMATOL, V5, P543, DOI 10.1038/nrrheum.2009.175; COSSARIZZA A, 1993, BIOCHEM BIOPH RES CO, V197, P40, DOI 10.1006/bbrc.1993.2438; Davies KJA, 1995, BIOCHEM SOC SYMP, P1, DOI 10.1042/bss0610001; Dellinger AL, 2012, J NANOMED NANOTECHNO, V3, P8; Dellinger A, 2013, J CARDIOVASC MAGN R, V15, DOI 10.1186/1532-429X-15-7; Dellinger A, 2010, NANOMED-NANOTECHNOL, V6, P575, DOI 10.1016/j.nano.2010.01.008; Dellinger A, 2009, EXP DERMATOL, V18, P1079, DOI 10.1111/j.1600-0625.2009.00904.x; Drafi Frantisek, 2012, Interdiscip Toxicol, V5, P84, DOI 10.2478/v10102-012-0015-4; Ehrich M, 2011, TOXICOL IN VITRO, V25, P301, DOI 10.1016/j.tiv.2010.09.010; Eklund KK, 2007, IMMUNOL REV, V217, P38, DOI 10.1111/j.1600-065X.2007.00504.x; Feyerabend TB, 2011, IMMUNITY, V35, P832, DOI 10.1016/j.immuni.2011.09.015; Foley S, 2002, BIOCHEM BIOPH RES CO, V294, P116, DOI 10.1016/S0006-291X(02)00445-X; Fumelli C, 2000, J INVEST DERMATOL, V115, P835, DOI 10.1046/j.1523-1747.2000.00140.x; GARRETT IR, 1990, J CLIN INVEST, V85, P632, DOI 10.1172/JCI114485; GORDON JR, 1990, NATURE, V346, P274, DOI 10.1038/346274a0; GRUBER B, 1988, CLIN EXP IMMUNOL, V71, P289; GRUBER B, 1986, ARTHRITIS RHEUM, V29, P944, DOI 10.1002/art.1780290802; Handel ML, 2000, CLIN EXP PHARMACOL P, V27, P139, DOI 10.1046/j.1440-1681.2000.03216.x; Haqqi TM, 1999, P NATL ACAD SCI USA, V96, P4524, DOI 10.1073/pnas.96.8.4524; Holmdahl R, 2002, AGEING RES REV, V1, P135, DOI 10.1016/S0047-6374(01)00371-2; Huber LC, 2006, RHEUMATOLOGY, V45, P669, DOI 10.1093/rheumatology/kel065; IRANI AMA, 1989, J HISTOCHEM CYTOCHEM, V37, P1509, DOI 10.1177/37.10.2674273; Jaswal S, 2003, CLIN CHIM ACTA, V338, P123, DOI 10.1016/j.cccn.2003.08.011; Kamata H, 1999, CELL SIGNAL, V11, P1, DOI 10.1016/S0898-6568(98)00037-0; Kepley CL, 2005, INT ARCH ALLERGY IMM, V138, P29, DOI 10.1159/000087355; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee DM, 2002, SCIENCE, V297, P1689, DOI 10.1126/science.1073176; Majumdar S, 2001, J IMMUNOL, V167, P2911, DOI 10.4049/jimmunol.167.5.2911; Malbec O, 2007, IMMUNOL REV, V217, P206, DOI 10.1111/j.1600-065X.2007.00510.x; Marcu KB, 2010, CURR DRUG TARGETS, V11, P599, DOI 10.2174/138945010791011938; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Nam NH, 2006, MINI-REV MED CHEM, V6, P945, DOI 10.2174/138955706777934937; Niedermeier M, 2010, BEST PRACT RES CL RH, V24, P527, DOI 10.1016/j.berh.2010.02.002; Nigrovic PA, 2005, ARTHRITIS RES THER, V7, P1, DOI 10.1186/ar1446; Nigrovic PA, 2007, IMMUNOL REV, V217, P19, DOI 10.1111/j.1600-065X.2007.00506.x; Nigrovic PA, 2007, P NATL ACAD SCI USA, V104, P2325, DOI 10.1073/pnas.0610852103; Nigrovic PA, 2010, ARTHRITIS RHEUM-US, V62, P3322, DOI 10.1002/art.27659; Norton SK, 2012, J ALLERGY CLIN IMMUN, V130, P761, DOI 10.1016/j.jaci.2012.04.023; Norton SK, 2010, CTS-CLIN TRANSL SCI, V3, P158, DOI 10.1111/j.1752-8062.2010.00212.x; Noss EH, 2008, IMMUNOL REV, V223, P252, DOI 10.1111/j.1600-065X.2008.00648.x; Park H, 2012, NAT REV IMMUNOL, V12, P570, DOI 10.1038/nri3261; Park MK, 2012, IMMUNOL LETT, V148, P59, DOI 10.1016/j.imlet.2012.05.008; Phillips DC, 2010, ANTIOXID REDOX SIGN, V12, P743, DOI 10.1089/ars.2009.2607; Pitman N, 2011, ANN RHEUM DIS, V70, P1170, DOI 10.1136/ard.2010.134528; Porter AE, 2006, ACTA BIOMATER, V2, P409, DOI 10.1016/j.actbio.2006.02.006; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Roman-Blas JA, 2008, INT REV IMMUNOL, V27, P351, DOI 10.1080/08830180802295740; Ryan JJ, 2007, J IMMUNOL, V179, P665, DOI 10.4049/jimmunol.179.1.665; Schubert N, 2015, ARTHRITIS RHEUMATOL, V67, P903, DOI 10.1002/art.38996; Schwartz LB, 1993, BIOL MAST CELLS BASO, P135; Skoldstam L, 2003, ANN RHEUM DIS, V62, P208, DOI 10.1136/ard.62.3.208; SMILEY ST, 1991, P NATL ACAD SCI USA, V88, P3671, DOI 10.1073/pnas.88.9.3671; Solomon S, 2005, ARTHRITIS RES THER, V7, P129, DOI 10.1186/ar1761; STEINITZ K, 1947, Harefuah, V32, P174; Sun SC, 2012, IMMUNOL REV, V246, P125, DOI 10.1111/j.1600-065X.2011.01088.x; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Winyard PG, 2011, BIOCHEM SOC T, V39, P1226, DOI 10.1042/BST0391226; Wruck CJ, 2011, ANN RHEUM DIS, V70, P844, DOI 10.1136/ard.2010.132720; Yamamoto Y, 2001, J CLIN INVEST, V107, P135, DOI 10.1172/JCI11914; Zhang W, 2012, INT IMMUNOPHARMACOL, V14, P27, DOI 10.1016/j.intimp.2012.06.001; Zhao W, 2006, J IMMUNOL, V177, P694, DOI 10.4049/jimmunol.177.1.694; Zhou ZG, 2010, BIOCONJUGATE CHEM, V21, P1656, DOI 10.1021/bc1001664; Zorov DB, 2006, BBA-BIOENERGETICS, V1757, P509, DOI 10.1016/j.bbabio.2006.04.029	72	33	36	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0126290	10.1371/journal.pone.0126290	http://dx.doi.org/10.1371/journal.pone.0126290			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879437	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500120
J	Oliver, PM; Couper, PJ; Pepper, M				Oliver, P. M.; Couper, P. J.; Pepper, M.			Independent Transitions between Monsoonal and Arid Biomes Revealed by Systematic Revison of a Complex of Australian Geckos (Diplodactylus; Diplodactylidae) (vol 9, e111895, 2014)	PLOS ONE			English	Correction																		Oliver PM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111895	1	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0126682	10.1371/journal.pone.0126682	http://dx.doi.org/10.1371/journal.pone.0126682			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879742	Green Published, gold			2022-12-27	WOS:000353016500123
J	Rydbeck, H; Sandve, GK; Ferkingstad, E; Simovski, B; Rye, M; Hovig, E				Rydbeck, Halfdan; Sandve, Geir Kjetil; Ferkingstad, Egil; Simovski, Boris; Rye, Morten; Hovig, Eivind			ClusTrack: Feature Extraction and Similarity Measures for Clustering of Genome-Wide Data Sets	PLOS ONE			English	Article							INTEGRATIVE ANALYSIS; REGULATORY ELEMENTS; AXONAL-TRANSPORT; ENCODE DATA; MITOCHONDRIA; HYPERBROWSER; DISCOVERY; BROWSER; LEVEL; UCSC	Clustering is a popular technique for explorative analysis of data, as it can reveal subgroupings and similarities between data in an unsupervised manner. While clustering is routinely applied to gene expression data, there is a lack of appropriate general methodology for clustering of sequence-level genomic and epigenomic data, e.g. ChIP-based data. We here introduce a general methodology for clustering data sets of coordinates relative to a genome assembly, i.e. genomic tracks. By defining appropriate feature extraction approaches and similarity measures, we allow biologically meaningful clustering to be performed for genomic tracks using standard clustering algorithms. An implementation of the methodology is provided through a tool, ClusTrack, which allows fine-tuned clustering analyses to be specified through a web-based interface. We apply our methods to the clustering of occupancy of the H3K4me1 histone modification in samples from a range of different cell types. The majority of samples form meaningful subclusters, confirming that the definitions of features and similarity capture biological, rather than technical, variation between the genomic tracks. Input data and results are available, and can be reproduced, through a Galaxy Pages document at http://hyperbrowser.uio.no/hb/u/hb-superuser/p/clustrack. The clustering functionality is available as a Galaxy tool, under the menu option "Specialized analyzis of tracks", and the submenu option" Cluster tracks based on genome level similarity", at the Genomic HyperBrowser server: http://hyperbrowser.uio.no/hb/.	[Rydbeck, Halfdan; Sandve, Geir Kjetil; Simovski, Boris; Hovig, Eivind] Univ Oslo, Dept Informat, N-0316 Oslo, Norway; [Rydbeck, Halfdan; Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Tumour Biol, Oslo, Norway; [Hovig, Eivind] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Med Informat, Oslo, Norway; [Ferkingstad, Egil] Norwegian Comp Ctr, Stat Innovat, N-0314 Oslo, Norway; [Ferkingstad, Egil] Univ Iceland, Inst Sci, IS-107 Reykjavik, Iceland; [Rye, Morten] Norwegian Univ Sci & Technol, Dept Canc Res & Mol Med, N-7034 Trondheim, Norway	University of Oslo; University of Oslo; University of Oslo; University of Iceland; Norwegian University of Science & Technology (NTNU)	Rydbeck, H (corresponding author), Univ Oslo, Dept Informat, N-0316 Oslo, Norway.	halfdanr@ifi.uio.no; geirksa@ifi.uio.no	Hovig, Eivind/H-2474-2011	Hovig, Eivind/0000-0002-9103-1077; Ferkingstad, Egil/0000-0001-8090-7988; Sandve, Geir Kjetil/0000-0002-4959-1409; rydbeck, halfdan/0000-0003-1606-3842	Statistics for Innovation, (sfi)2, one of the first 14 Norwegian centers for research-based innovation; Norwegian Radium Hospital Legacies	Statistics for Innovation, (sfi)2, one of the first 14 Norwegian centers for research-based innovation; Norwegian Radium Hospital Legacies	This work was funded in part by Statistics for Innovation, (sfi)2, one of the first 14 Norwegian centers for research-based innovation (HR, EF), and by the Norwegian Radium Hospital Legacies (HR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; [Anonymous], 2013, GALAXY PAGES DOCUMEN; [Anonymous], 2010, ENCODE; [Anonymous], 2009, DATABASE ANNOTATION; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bickel PJ, 2010, ANN APPL STAT, V4, P1660, DOI 10.1214/10-AOAS363; De S, 2011, NAT BIOTECHNOL, V29, P1103, DOI 10.1038/nbt.2030; De Vos KJ, 2003, MOL BIOL CELL, V14, P3636, DOI 10.1091/mbc.E02-10-0638; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fernando P, 2002, P NATL ACAD SCI USA, V99, P11025, DOI 10.1073/pnas.162172899; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Gerstein MB, 2010, SCIENCE, V330, P1775, DOI 10.1126/science.1196914; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Gundersen S, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-494; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/NMETH.1937, 10.1038/nmeth.1937]; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Johannes F, 2010, BIOINFORMATICS, DOI [10.1093/bioinformatics/btq087, DOI 10.1093/BI0INFORMATICS/BTQ087]; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kundaje A, 2012, GENOME RES, V22, P1735, DOI 10.1101/gr.136366.111; Larson JL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031414; Liu F, 2007, PLOS COMPUT BIOL, V3, P874, DOI 10.1371/journal.pcbi.0030093; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nielsen CB, 2012, GENOME RES, V22, P2262, DOI 10.1101/gr.140665.112; Nielsen FGG, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0028272, DOI 10.1371/JOURNAL.PONE.0028272]; Rosenbloom KR, 2013, NUCLEIC ACIDS RES, V41, pD56, DOI 10.1093/nar/gks1172; Sandve GK, 2013, NUCLEIC ACIDS RES, V41, pW133, DOI 10.1093/nar/gkt342; Sandve GK, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-r121; Saxton WM, 2012, J CELL SCI, V125, P2095, DOI 10.1242/jcs.053850; Song LY, 2011, GENOME RES, V21, P1757, DOI 10.1101/gr.121541.111; Yu HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036988	35	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123261	10.1371/journal.pone.0123261	http://dx.doi.org/10.1371/journal.pone.0123261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879845	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500044
J	Xu, L; Gu, SY; Feng, QJ; Liang, CH; Xin, SX				Xu, Li; Gu, Shiyong; Feng, Qianjin; Liang, Changhong; Xin, Sherman Xuegang			Quantitative Study of Liver Magnetic Resonance Spectroscopy Quality at 3T Using Body and Phased Array Coils with Physical Analysis and Clinical Evaluation	PLOS ONE			English	Article							PROTON MR SPECTROSCOPY; RADIOFREQUENCY COIL; HEPATIC STEATOSIS; BIRDCAGE COIL; B-1 FIELD; 3.0 TESLA; H-1 MRS; SAR; QUANTIFICATION; OVERWEIGHT	This study aims to investigate the quality difference of short echo time (TE) breathhold 1H magnetic resonance spectroscopy (MRS) of the liver at 3.0T using the body and phased array coils, respectively. In total, 20 pairs of single-voxel proton spectra of the liver were acquired at 3.0T using the phased array and body coils as receivers. Consecutive stacks of breathhold spectra were acquired using the point resolved spectroscopy (PRESS) technique at a short TE of 30 ms and a repetition time (TR) of 1500 ms. The first spectroscopy sequence was "copied" for the second acquisition to ensure identical voxel positioning. The MRS prescan adjustments of shimming and water suppression, signal-to noise ratio (SNR), and major liver quantitative information were compared between paired spectra. Theoretical calculation of the SNR and homogeneity of the region of interest (ROI, 2 cmx2 cmx2 cm) using different coils loaded with 3D liver electromagnetic model of real human body was implemented in the theoretical analysis. The theoretical analysis showed that, inside the ROI, the SNR of the phase array coil was 2.8387 times larger than that of body coil and the homogeneity of the phase array coil and body coil was 80.10% and 93.86%, respectively. The experimental results showed excellent correlations between the paired data (all r > 0.86). Compared with the body coil group, the phased array group had slightly worse shimming effect and better SNR (all P values <.01). The discrepancy of the line width because of the different coils was approximately 0.8 Hz (0.00625 ppm). No significant differences of the major liver quantitative information of Cho/Lip2 height, Cho/Lip2 area, and lipid content were observed (all P values > 0.05). The theoretical analysis and clinical experiment showed that the phased array coil was superior to the body coil with respect to 3.0T breathhold hepatic proton MRS.	[Xu, Li] Guangzhou Univ Tradit Chinese Med, Dept Radiol, Guangdong Prov Tradit Chinese Med Hosp, Guangzhou, Guangdong, Peoples R China; [Xu, Li] Guangzhou Univ Tradit Chinese Med, Postdoctoral Mobile Res Stn, Guangzhou, Guangdong, Peoples R China; [Gu, Shiyong; Feng, Qianjin; Xin, Sherman Xuegang] So Med Univ, Biomed Engn Sch, Guangzhou, Guangdong, Peoples R China; [Liang, Changhong] Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Xin, Sherman Xuegang] NYU, Sch Med, Bernard & Irene Schwartz Ctr Biomed Imaging, New York, NY USA	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Southern Medical University - China; Guangdong Academy of Medical Sciences & Guangdong General Hospital; New York University	Feng, QJ (corresponding author), So Med Univ, Biomed Engn Sch, Guangzhou, Guangdong, Peoples R China.	1271992826@qq.com; shermansheen@gmail.com	feng, qianjin/GNM-7856-2022; Liang, Chang Hong/L-1885-2016; Feng, Qianjin/Y-5438-2019	feng, qianjin/0000-0002-3830-5120; 	National Natural Science Foundation of China [61172034]; Science Foundation of Guangdong Province for Dr. Startup Project [S2012040006618]; Science and Technology Program of Guangzhou, China [2014J4100160]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Guangdong Province for Dr. Startup Project; Science and Technology Program of Guangzhou, China	This research was partially supported by the National Natural Science Foundation of China (No. 61172034), the Science Foundation of Guangdong Province for Dr. Startup Project (No. S2012040006618), and the Science and Technology Program of Guangzhou, China (No.2014J4100160).	Carlsson A, 2011, MAGN RESON MATER PHY, V24, P97, DOI 10.1007/s10334-010-0239-2; Chabanova E, 2013, ABDOM IMAGING, V38, P315, DOI 10.1007/s00261-012-9930-2; Collins CM, 2011, MAGN RESON MED, V65, P1470, DOI 10.1002/mrm.22845; Collins CM, 2001, MAGN RESON MED, V45, P684, DOI 10.1002/mrm.1091; Fischbach F, 2008, EUR RADIOL, V18, P2549, DOI 10.1007/s00330-008-1040-8; Fischbach F, 2008, LIVER INT, V28, P297, DOI 10.1111/j.1478-3231.2007.01647.x; Gambarota G, 2011, BIOL MED, V24, P339, DOI [10.1007/s10334-011-0278-3, DOI 10.1007/S10334-011-0278-3]; Ibrahim TS, 2001, PHYS MED BIOL, V46, P609, DOI 10.1088/0031-9155/46/2/324; Katz-Brull R, 2003, MAGNET RESON MED, V50, P461, DOI 10.1002/mrm.10560; Keong Li B, 2005, MAGN RESON MED, V53, P1251; Kreis R, 2004, NMR BIOMED, V17, P361, DOI 10.1002/nbm.891; Qayyum A, 2009, RADIOGRAPHICS, V29, P1653, DOI 10.1148/rg.296095520; Rial B, 2011, MAGN RESON MED, V66, P619, DOI 10.1002/mrm.23011; ROEMER PB, 1990, MAGNET RESON MED, V16, P192, DOI 10.1002/mrm.1910160203; Schonfeld G, 2003, J LIPID RES, V44, P470, DOI 10.1194/jlr.M200342-JLR200; Sharma P, 2009, J MAGN RESON IMAGING, V29, P629, DOI 10.1002/jmri.21682; Solga SF, 2008, LIVER INT, V28, P675, DOI 10.1111/j.1478-3231.2008.01705.x; Su TH, 2012, CLIN RADIOL, V67, P633, DOI 10.1016/j.crad.2011.05.018; Tang L, 2011, CONCEPT MAGN RESON B, V39B, P11, DOI 10.1002/cmr.b.20185; ter Voert EGW, 2011, WORLD J GASTROENTERO, V17, P5133, DOI 10.3748/wjg.v17.i47.5133; van Werven JR, 2009, J MAGN RESON IMAGING, V30, P444, DOI 10.1002/jmri.21837; Wang CS, 2006, J MAGN RESON IMAGING, V24, P439, DOI 10.1002/jmri.20635; Welker KM, 2001, RADIOLOGY, V221, P11, DOI 10.1148/radiol.2211001537; Xin SX, 2013, IEEE T MICROW THEORY, V61, P2146, DOI 10.1109/TMTT.2013.2247053; Xin XG, 2012, NMR BIOMED, V25, P909, DOI 10.1002/nbm.1811; Xu L, 2013, WORLD J GASTROENTERO, V19, P1472, DOI 10.3748/wjg.v19.i9.1472; Xu L, 2012, SCI WORLD J, DOI 10.1100/2012/804698; Xu L, 2010, ACAD RADIOL, V17, P1462, DOI 10.1016/j.acra.2010.07.005; Zhu YD, 2012, MAGN RESON MED, V67, P1367, DOI 10.1002/mrm.23126	29	4	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122999	10.1371/journal.pone.0122999	http://dx.doi.org/10.1371/journal.pone.0122999			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881016	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500034
J	Silva, AKSE; Torres, DDC; Gomes, FOD; Silva, BD; Ribeiro, EL; Oliveira, AC; dos Santos, LAM; de Lima, MDA; Pitta, ID; Peixoto, CA				Soares e Silva, Amanda Karolina; Cipriano Torres, Dilenia de Oliveira; dos Santos Gomes, Fabiana Oliveira; Silva, Bruna dos Santos; Ribeiro, Edlene Lima; Oliveira, Amanda Costa; Martins dos Santos, Laise Aline; Alves de Lima, Maria do Carmo; Pitta, Ivan da Rocha; Peixoto, Christina Alves			LPSF/GQ-02 Inhibits the Development of Hepatic Steatosis and Inflammation in a Mouse Model of Non-Alcoholic Fatty Liver Disease (NAFLD)	PLOS ONE			English	Article							NF-KAPPA-B; RECEPTOR-DEFICIENT MICE; NITRIC-OXIDE; ATHEROSCLEROTIC LESIONS; ACTIVATED RECEPTORS; GENE-EXPRESSION; ADIPOSE-TISSUE; PPAR-GAMMA; IN-VITRO; ALPHA	Non-alcoholic fatty liver disease (NAFLD) defines a wide spectrum of liver diseases that extends from simple steatosis to non-alcoholic steatohepatitis. Although the pathogenesis of NAFLD remains undefined, it is recognized that insulin resistance is present in almost all patients who develop this disease. Thiazolidinediones (TZDs) act as an insulin sensitizer and have been used in the treatment of patients with type 2 diabetes and other insulin-resistant conditions, including NAFLD. Hence, therapy of NAFLD with insulin-sensitizing drugs should ideally improve the key hepatic histological changes, while also reducing cardiometabolic and cancer risks. Controversially, TZDs are associated with the development of cardiovascular events and liver problems. Therefore, there is a need for the development of new therapeutic strategies to improve liver function in patients with chronic liver diseases. The aim of the present study was to assess the therapeutic effects of LPSF/GQ-02 on the liver of LDLR-/-mice after a high-fat diet. Eighty male mice were divided into 4 groups and two different experiments: 1-received a standard diet; 2-fed with a high-fat diet (HFD); 3-HFD+pioglitazone; 4-HFD+LPSF/GQ-02. The experiments were conducted for 10 or 12 weeks and in the last two or four weeks respectively, the drugs were administered daily by gavage. The results obtained with an NAFLD murine model indicated that LPSF/GQ-02 was effective in improving the hepatic architecture, decreasing fat accumulation, reducing the amount of collagen, decreasing inflammation by reducing IL-6, iNOS, COX-2 and F4/80, and increasing the protein expression of I kappa B alpha, cytoplasmic NF kappa B-65, eNOS and IRS-1 in mice LDLR -/-. These results suggest a direct action by LPSF/GQ-02 on the factors that affect inflammation, insulin resistance and fat accumulation in the liver of these animals. Further studies are being conducted in our laboratory to investigate the possible mechanism of action of LPSF/GQ-02 on hepatic lipid metabolism.	[Soares e Silva, Amanda Karolina; dos Santos Gomes, Fabiana Oliveira; Silva, Bruna dos Santos; Ribeiro, Edlene Lima; Oliveira, Amanda Costa; Martins dos Santos, Laise Aline; Peixoto, Christina Alves] Ctr Pesquisa Aggeu Magalhaes FIOCRUZ, Lab Ultraestrutura, Recife, PE, Brazil; [Cipriano Torres, Dilenia de Oliveira] Univ Pernambuco, Lab Anal Clin, Recife, PE, Brazil; [Alves de Lima, Maria do Carmo; Pitta, Ivan da Rocha] Univ Fed Pernambuco, Lab Planejamento & Sintese Farmacos, Recife, PE, Brazil	Fundacao Oswaldo Cruz; Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco	Silva, AKSE (corresponding author), Ctr Pesquisa Aggeu Magalhaes FIOCRUZ, Lab Ultraestrutura, Recife, PE, Brazil.	kls.amanda@gmail.com	PEIXOTO, CHRISTINA/AAD-9608-2019; Alves de Lima, Maria do carmo/H-3520-2015	PEIXOTO, CHRISTINA/0000-0002-7008-5930; 	Brazilian fostering agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Brazilian fostering agency Fundacao Oswaldo Cruz (FIOCRUZ); Brazilian fostering agency Instituto Nacional de Biologia Estrutural e Bioimagem (INBEB)	Brazilian fostering agency Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian fostering agency Fundacao Oswaldo Cruz (FIOCRUZ); Brazilian fostering agency Instituto Nacional de Biologia Estrutural e Bioimagem (INBEB)	The authors would like to thank the Brazilian fostering agencies Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Fundacao Oswaldo Cruz (FIOCRUZ) and Instituto Nacional de Biologia Estrutural e Bioimagem (INBEB) for their support in the development of the present study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, Ann N Y Acad Sci, V557, P1; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; Bedoucha M, 2001, J HEPATOL, V35, P17, DOI 10.1016/S0168-8278(01)00066-6; Bochem AE, 2013, EUR HEART J, V34, P286, DOI 10.1093/eurheartj/ehs376; Bradford MA, 1970, ANAL BIOCHEM, V72, P240; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Camp Heidi S, 2003, Curr Opin Investig Drugs, V4, P406; Chao L, 2000, J CLIN INVEST, V106, P1221, DOI 10.1172/JCI11245; Cheung O, 2010, CURR OPIN GASTROEN, V26, P202, DOI 10.1097/MOG.0b013e328337b0c4; Ciupinska-Kajor M, 2013, HEPATOL INT, V7, P233, DOI 10.1007/s12072-011-9320-9; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Leite LFCD, 2007, EUR J MED CHEM, V42, P1263, DOI 10.1016/j.ejmech.2007.02.015; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Dowman JK, 2011, DIABETES OBES METAB, V13, P692, DOI 10.1111/j.1463-1326.2011.01403.x; Esterson YB, 2013, J INVEST MED, V61, P1152, DOI 10.2310/JIM.0000000000000017; Game BA, 2007, ATHEROSCLEROSIS, V192, P85, DOI 10.1016/j.atherosclerosis.2006.06.025; GHOSH S, 1990, NATURE, V344, P678, DOI 10.1038/344678a0; Gilmore TD, 1999, ONCOGENE, V18, P6842, DOI 10.1038/sj.onc.1203237; Girard J, 2001, DIABETES METAB, V27, P271; Gonzalez FJ, 2008, TOXICOLOGY, V246, P2, DOI 10.1016/j.tox.2007.09.030; Grumbach IM, 2005, J MOL CELL CARDIOL, V39, P595, DOI 10.1016/j.yjmcc.2005.06.012; Gupte AA, 2010, HEPATOLOGY, V52, P2001, DOI 10.1002/hep.23941; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Iredale JP, 2003, BMJ-BRIT MED J, V327, P143, DOI 10.1136/bmj.327.7407.143; Kallwitz ER, 2008, WORLD J GASTROENTERO, V14, P22, DOI 10.3748/wjg.14.22; Karin M, 2000, SEMIN IMMUNOL, V12, P85, DOI 10.1006/smim.2000.0210; Keaney JF, 2003, ARTERIOSCL THROM VAS, V23, P434, DOI 10.1161/01.ATV.0000058402.34138.11; Kugelmas M, 2003, HEPATOLOGY, V38, P413, DOI 10.1053/jhep.2003.50316; Lalloyer F, 2011, ARTERIOSCL THROM VAS, V31, P1573, DOI 10.1161/ATVBAHA.110.220525; Langer DA, 2008, HEPATOLOGY, V47, P1983, DOI 10.1002/hep.22285; Larter CZ, 2012, J GASTROEN HEPATOL, V27, P341, DOI 10.1111/j.1440-1746.2011.06939.x; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li Z, 1997, MOL CELL BIOL, V17, P6184, DOI 10.1128/MCB.17.10.6184; Liu W, 2014, J GASTROEN HEPATOL, V29, P614, DOI 10.1111/jgh.12430; Lutchman G, 2007, HEPATOLOGY, V46, P424, DOI 10.1002/hep.21661; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; Memon RA, 2000, ENDOCRINOLOGY, V141, P4021, DOI 10.1210/en.141.11.4021; Mohapatra J, 2009, PHARMACOLOGY, V84, P203, DOI 10.1159/000235996; Montes GS, 1988, HISTOCHEMICAL LOCALI, P41; Moran-Salvador E, 2011, FASEB J, V25, P2538, DOI 10.1096/fj.10-173716; Mourao RH, 2005, EUR J MED CHEM, V40, P1129, DOI 10.1016/j.ejmech.2005.06.002; Muriel P, 2009, J APPL TOXICOL, V29, P91, DOI 10.1002/jat.1393; Napoli C, 2002, CIRCULATION, V105, P1360, DOI 10.1161/01.CIR.0000013090.96919.FA; Nasir GA, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-78; Nissen SE, 2007, NEW ENGL J MED, V356, P2457, DOI 10.1056/NEJMoa072761; Ozasa H, 2011, ATHEROSCLEROSIS, V219, P141, DOI 10.1016/j.atherosclerosis.2011.07.113; Ratziu V, 2008, GASTROENTEROLOGY, V135, P100, DOI 10.1053/j.gastro.2008.03.078; Rivera CA, 2007, J HEPATOL, V47, P571, DOI 10.1016/j.jhep.2007.04.019; Salamone F, 2012, TRANSL RES, V159, P477, DOI 10.1016/j.trsl.2011.12.003; Savage DB, 2010, CURR OPIN LIPIDOL, V21, P329, DOI 10.1097/MOL.0b013e32833b7782; Schalm SW, 1997, J HEPATOL, V27, P1118, DOI 10.1016/S0168-8278(97)80159-6; Scheen Andre J., 2001, Drug Safety, V24, P873, DOI 10.2165/00002018-200124120-00002; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Silva AKSE, 2013, CARDIOVASC PATHOL, V22, P81, DOI 10.1016/j.carpath.2012.05.006; Stienstra R, 2010, HEPATOLOGY, V51, P511, DOI 10.1002/hep.23337; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Szczepaniak LS, 2005, AM J PHYSIOL-ENDOC M, V288, pE462, DOI 10.1152/ajpendo.00064.2004; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tian F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083819; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Varas-Lorenzo C, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-129; Wang HN, 2008, WORLD J GASTROENTERO, V14, P7240, DOI 10.3748/wjg.14.7240; Watkins PB, 2005, HEPATOLOGY, V41, P229, DOI 10.1002/hep.20598; Wiest R, 2002, HEPATOLOGY, V35, P478, DOI 10.1053/jhep.2002.31432; Wilkins T, 2013, AM FAM PHYSICIAN, V88, P35; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; YANG LY, 1995, J LIPID RES, V36, P125; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yoneda M, 2009, HEPATOL RES, V39, P963, DOI 10.1111/j.1872-034X.2009.00539.x; Yu J, 2006, HEPATOLOGY, V43, P826, DOI 10.1002/hep.21108; Yudkin JS, 2000, ATHEROSCLEROSIS, V148, P209, DOI 10.1016/S0021-9150(99)00463-3; Zhang W, 2014, SCI WORLD J, DOI 10.1155/2014/603409	77	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123787	10.1371/journal.pone.0123787	http://dx.doi.org/10.1371/journal.pone.0123787			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875942	gold, Green Submitted, Green Published			2022-12-27	WOS:000353014700044
J	O'Reilly, JA; Fitzgerald, J; Fitzgerald, S; Kenny, D; Kay, EW; O'Kennedy, R; Kijanka, GS				O'Reilly, Julie-Ann; Fitzgerald, Jenny; Fitzgerald, Sean; Kenny, Dermot; Kay, Elaine W.; O'Kennedy, Richard; Kijanka, Gregor S.			Diagnostic Potential of Zinc Finger Protein-Specific Autoantibodies and Associated Linear B-Cell Epitopes in Colorectal Cancer	PLOS ONE			English	Article							OCCULT BLOOD-TEST; P53 AUTOANTIBODIES; BREAST-CANCER; BIOMARKERS; PROGRESSION; ANTIGENS; UTILITY; DOMAIN; TESTS	Colorectal cancer is one of the most common cancers worldwide with almost 700,000 deaths every year. Detection of colorectal cancer at an early stage significantly improves patient survival. Cancer-specific autoantibodies found in sera of cancer patients can be used for pre-symptomatic detection of the disease. In this study we assess the zinc finger proteins ZNF346, ZNF638, ZNF700 and ZNF768 as capture antigens for the detection of autoantibodies in colorectal cancer. Sera from 96 patients with colorectal cancer and 35 control patients with no evidence of cancer on colonoscopy were analysed for the presence of ZNF-specific autoantibodies using an indirect ELISA. Autoantibodies to individual ZNF proteins were detected in 10-20% of colorectal cancer patients and in 0-5.7% of controls. A panel of all four ZNF proteins resulted in an assay specificity of 91.4% and sensitivity of 41.7% for the detection of cancer patients in a cohort of non-cancer controls and colorectal cancer patients. Clinicopathological and survival analysis revealed that ZNF autoantibodies were independent of disease stage and did not correlate with disease outcome. Since ZNF autoantibodies were shared between patients and corresponding ZNF proteins showed similarities in their zinc finger motifs, we performed an in silico epitope sequence analysis. Zinc finger proteins ZNF700 and ZNF768 showed the highest sequence similarity with a bl2seq score of 262 (E-value 1E-81) and their classical C2H2 ZNF motifs were identified as potential epitopes contributing to their elevated immunogenic potential. Our findings show an enhanced and specific immunogenicity to zinc finger proteins, thereby providing a multiplexed autoantibody assay for minimally invasive detection of colorectal cancer.	[O'Reilly, Julie-Ann; Fitzgerald, Jenny; Fitzgerald, Sean; Kenny, Dermot; O'Kennedy, Richard; Kijanka, Gregor S.] Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland; [Fitzgerald, Sean; O'Kennedy, Richard] Dublin City Univ, Sch Biotechnol, Dublin 9, Ireland; [Kenny, Dermot] Royal Coll Surgeons Ireland, Mol & Cellular Therapeut, Dublin 2, Ireland; [Kay, Elaine W.] Royal Coll Surgeons Ireland, Dept Pathol, Dublin 2, Ireland; [Kay, Elaine W.] Beaumont Hosp, Dublin 9, Ireland	Dublin City University; Dublin City University; Royal College of Surgeons - Ireland; Royal College of Surgeons - Ireland	Kijanka, GS (corresponding author), Dublin City Univ, Biomed Diagnost Inst, Dublin 9, Ireland.	gregor.kijanka@dcu.ie	Kenny, Dermot/C-3898-2012; Kijanka, Gregor/O-4300-2014; Fitzgerald, Seán/AAW-3626-2020	Kenny, Dermot/0000-0001-5548-3263; Kijanka, Gregor/0000-0003-2557-234X; Fitzgerald, Seán/0000-0001-6634-092X	Irish Cancer Society [CRF10KIJ]; Science Foundation Ireland under CSET Grant [10/CE/B1821]	Irish Cancer Society; Science Foundation Ireland under CSET Grant(Science Foundation Ireland)	This material is based upon works supported by the Irish Cancer Society Research Fellowship Award CRF10KIJ to GSK (http://www.cancer.ie/) and the Science Foundation Ireland under CSET Grant no. 10/CE/B1821 (http://www.sfi.ie/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMAN DG, 1994, BRIT MED J, V308, P1552, DOI 10.1136/bmj.308.6943.1552; Anderson KS, 2010, CANCER EPIDEM BIOMAR, V19, P859, DOI 10.1158/1055-9965.EPI-09-0880; Bachelot T, 2006, BRIT J CANCER, V94, P1066, DOI 10.1038/sj.bjc.6603037; Backes C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-340; Bataller L, 2002, NEUROLOGY, V59, P1985, DOI 10.1212/01.WNL.0000038352.01415.CE; Bracci PM, 2012, CANCER-AM CANCER SOC, V118, P5384, DOI 10.1002/cncr.27538; Brenner H, 2013, EUR J CANCER, V49, P3049, DOI 10.1016/j.ejca.2013.04.023; Burch JA, 2007, J MED SCREEN, V14, P132, DOI 10.1258/096914107782066220; Chan CC, 2010, INT J CANCER, V126, P1683, DOI 10.1002/ijc.24912; Charpin C, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4255; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Ferlay J, 2013, GLOBOCAN 2012 V1 0 C; GETZOFF ED, 1988, ADV IMMUNOL, V43, P1; Ishikawa A, 2012, RHEUMATOLOGY, V51, P1181, DOI 10.1093/rheumatology/kes033; Johnson LDS, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/onci.29243; JUBY AG, 1994, BRIT J RHEUMATOL, V33, P1121; Kijanka G, 2010, GUT, V59, P69, DOI 10.1136/gut.2009.178574; Ladd JJ, 2013, CANCER RES, V73, P1502, DOI 10.1158/0008-5472.CAN-12-2560; Laity JH, 2001, CURR OPIN STRUC BIOL, V11, P39, DOI 10.1016/S0959-440X(00)00167-6; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Li YL, 2005, INT J CANCER, V114, P157, DOI 10.1002/ijc.20715; Liu W, 2009, SCAND J IMMUNOL, V69, P57, DOI 10.1111/j.1365-3083.2008.02195.x; Morris S, 2012, BRIT J CANCER, V107, P765, DOI 10.1038/bjc.2012.303; MULLER S, 1994, CLIN IMMUNOL IMMUNOP, V73, P187, DOI 10.1006/clin.1994.1187; Murphy MA, 2012, J PROTEOMICS, V75, P4668, DOI 10.1016/j.jprot.2012.02.031; Nolen BM, 2010, CANCER BIOMARK, V6, P229, DOI 10.3233/CBM-2009-0137; Oldstone MBA, 2005, CURR TOP MICROBIOL, V296, P1; Olsen DA, 2013, CLIN CHEM LAB MED, V51, P2325, DOI 10.1515/cclm-2013-0166; Pallasch CP, 2005, INT J CANCER, V117, P456, DOI 10.1002/ijc.20929; Pedersen JW, 2013, BRIT J CANCER, V108, P107, DOI 10.1038/bjc.2012.517; Pranay A, 2013, PROTEOM CLIN APPL, V7, P392, DOI 10.1002/prca.201200081; Reis BS, 2013, CLIN CANCER RES, V19, P6112, DOI 10.1158/1078-0432.CCR-12-3580; Routsias JG, 2004, J MED CHEM, V47, P4327, DOI 10.1021/jm049844+; Schmitt J, 2012, INT J CANCER, V131, P673, DOI 10.1002/ijc.26419; Selim MA, 2011, MELANOMA RES, V21, P323, DOI 10.1097/CMR.0b013e3283471042; Tan EM, 2008, IMMUNOL REV, V222, P328, DOI 10.1111/j.1600-065X.2008.00611.x; Tsai-Turton M, 2009, GYNECOL ONCOL, V114, P12, DOI 10.1016/j.ygyno.2009.03.028; Van Regenmortel MHV, 2009, METHODS MOL BIOL, V524, P3, DOI 10.1007/978-1-59745-450-6_1; Yanagidani A, 2000, J AUTOIMMUN, V15, P75, DOI 10.1006/jaut.2000.0385; Zaenker P, 2013, CANCER EPIDEM BIOMAR, V22, P2161, DOI 10.1158/1055-9965.EPI-13-0621; Zhang JY, 2003, CANCER EPIDEM BIOMAR, V12, P136	41	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123469	10.1371/journal.pone.0123469	http://dx.doi.org/10.1371/journal.pone.0123469			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875936	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100179
J	Sedlacek, J; Wheeler, JA; Cortes, AJ; Bossdorf, O; Hoch, G; Lexer, C; Wipf, S; Karrenberg, S; van Kleunen, M; Rixen, C				Sedlacek, Janosch; Wheeler, Julia A.; Cortes, Andres J.; Bossdorf, Oliver; Hoch, Guenter; Lexer, Christian; Wipf, Sonja; Karrenberg, Sophie; van Kleunen, Mark; Rixen, Christian			The Response of the Alpine Dwarf Shrub Salix herbacea to Altered Snowmelt Timing: Lessons from a Multi-Site Transplant Experiment	PLOS ONE			English	Article							HIGH-MOUNTAIN PLANTS; CLIMATE-CHANGE; PHENOTYPIC PLASTICITY; FLOWERING PHENOLOGY; LOCAL ADAPTATION; GENE FLOW; SEXUAL REPRODUCTION; GROWTH; RANGE; ALPS	Climate change is altering spring snowmelt patterns in alpine and arctic ecosystems, and these changes may alter plant phenology, growth and reproduction. To predict how alpine plants respond to shifts in snowmelt timing, we need to understand trait plasticity, its effects on growth and reproduction, and the degree to which plants experience a home-site advantage. We tested how the common, long-lived dwarf shrub Salix herbacea responded to changing spring snowmelt time by reciprocally transplanting turfs of S. herbacea between early-exposure ridge and late-exposure snowbed microhabitats. After the transplant, we monitored phenological, morphological and fitness traits, as well as leaf damage, during two growing seasons. Salix herbacea leafed out earlier, but had a longer development time and produced smaller leaves on ridges relative to snowbeds. Longer phenological development times and smaller leaves were associated with reduced sexual reproduction on ridges. On snowbeds, larger leaves and intermediate development times were associated with increased clonal reproduction. Clonal and sexual reproduction showed no response to altered snowmelt time. We found no home-site advantage in terms of sexual and clonal reproduction. Leaf damage probability depended on snowmelt and thus exposure period, but had no short-term effect on fitness traits. We conclude that the studied populations of S. herbacea can respond to shifts in snowmelt by plastic changes in phenology and leaf size, while maintaining levels of clonal and sexual reproduction. The lack of a home-site advantage suggests that S. herbacea may not be adapted to different microhabitats. The studied populations are thus unlikely to react to climate change by rapid adaptation, but their responses will also not be constrained by small-scale local adaptation. In the short term, snowbed plants may persist due to high stem densities. However, in the long term, reduction in leaf size and flowering, a longer phenological development time and increased exposure to damage may decrease overall performance of S. herbacea under earlier snowmelt.	[Sedlacek, Janosch; van Kleunen, Mark] Univ Konstanz, Dept Biol, Ecol, D-78457 Constance, Germany; [Wheeler, Julia A.; Wipf, Sonja; Rixen, Christian] WSL Inst Snow & Avalanche Res SLF, CH-7260 Davos, Switzerland; [Cortes, Andres J.; Karrenberg, Sophie] Uppsala Univ, Dept Ecol & Genet, S-75236 Uppsala, Sweden; [Bossdorf, Oliver] Univ Tubingen, Inst Evolut & Ecol, Plant Evolutionary Ecol, D-72076 Tubingen, Germany; [Wheeler, Julia A.; Hoch, Guenter] Univ Basel, Inst Bot, CH-4056 Basel, Switzerland; [Lexer, Christian] Univ Fribourg, Dept Biol, Unit Ecol & Evolut, CH-1700 Fribourg, Switzerland	University of Konstanz; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; Uppsala University; Eberhard Karls University of Tubingen; University of Basel; University of Fribourg	van Kleunen, M (corresponding author), Univ Konstanz, Dept Biol, Ecol, D-78457 Constance, Germany.	mark.vankleunen@uni-konstanz.de	van Kleunen, Mark/B-3769-2009; Hoch, Guenter/H-1505-2018; Wipf, Sonja/A-5075-2010; Bossdorf, Oliver/A-8328-2008	van Kleunen, Mark/0000-0002-2861-3701; Hoch, Guenter/0000-0003-0985-9746; Wipf, Sonja/0000-0002-3492-1399; Bossdorf, Oliver/0000-0001-7504-6511; Rixen, Christian/0000-0002-2486-9988; Lexer, Christian/0000-0002-7221-7482; Cortes, Andres J./0000-0003-4178-0675	Swiss National Science Foundation [CRSI33_130409/1]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This project was funded by a Sinergia grant (grant nr. CRSI33_130409/1) provided by the Swiss National Science Foundation (http://www.snf.ch/en/funding/Pages/default. aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Anderson JT, 2012, P ROY SOC B-BIOL SCI, V279, P3843, DOI 10.1098/rspb.2012.1051; Arft AM, 1999, ECOL MONOGR, V69, P491, DOI 10.1890/0012-9615(1999)069[0491:ROTPTE]2.0.CO;2; Bazzaz F. A., 1996, PLANTS CHANGING ENV; Beerling DJ, 1998, J ECOL, V86, P872, DOI 10.1046/j.1365-2745.1998.8650872.x; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Beniston M, 2003, THEOR APPL CLIMATOL, V76, P125, DOI 10.1007/s00704-003-0016-5; Bennington CC, 2012, J ECOL, V100, P841, DOI 10.1111/j.1365-2745.2012.01984.x; Blanquart F, 2013, ECOL LETT, V16, P1195, DOI 10.1111/ele.12150; Bradshaw WE, 2006, SCIENCE, V312, P1477, DOI 10.1126/science.1127000; Byars SG, 2007, EVOLUTION, V61, P2925, DOI 10.1111/j.1558-5646.2007.00248.x; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cortes AJ, 2014, HEREDITY, V113, P233, DOI 10.1038/hdy.2014.19; Defossez E, 2011, BIOL LETTERS, V7, P699, DOI 10.1098/rsbl.2011.0236; Dullinger S, 2012, NAT CLIM CHANGE, V2, P619, DOI 10.1038/NCLIMATE1514; Franks SJ, 2014, EVOL APPL, V7, P123, DOI 10.1111/eva.12112; Frei ER, 2014, GLOBAL CHANGE BIOL, V20, P441, DOI 10.1111/gcb.12403; GALEN C, 1991, AM J BOT, V78, P978, DOI 10.2307/2445177; GALEN C, 1993, ECOLOGY, V74, P1052, DOI 10.2307/1940475; Gerdol R, 2013, J VEG SCI, V24, P569, DOI 10.1111/j.1654-1103.2012.01472.x; Givnish T., 1979, Topics in plant population biology., P375; Gonzalo-Turpin H, 2009, J ECOL, V97, P742, DOI 10.1111/j.1365-2745.2009.01509.x; GRABHERR G, 1995, ECOL STU AN, V113, P167; Haggberg S, 2014, THESIS U UPPSALA UPP; Hoye TT, 2013, NAT CLIM CHANGE, V3, P759, DOI [10.1038/nclimate1909, 10.1038/NCLIMATE1909]; Hudson JMG, 2011, GLOBAL CHANGE BIOL, V17, P1013, DOI 10.1111/j.1365-2486.2010.02294.x; Huelber K, 2006, ARCT ANTARCT ALP RES, V38, P99, DOI 10.1657/1523-0430(2006)038[0099:PROSST]2.0.CO;2; Hulber K, 2010, FUNCT ECOL, V24, P245, DOI 10.1111/j.1365-2435.2009.01645.x; Inouye DW, 2008, ECOLOGY, V89, P353, DOI 10.1890/06-2128.1; Jump AS, 2005, ECOL LETT, V8, P1010, DOI 10.1111/j.1461-0248.2005.00796.x; Kawai Y, 2011, BOTANY, V89, P361, DOI [10.1139/B11-024, 10.1139/b11-024]; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kim E, 2013, J ECOL, V101, P796, DOI 10.1111/1365-2745.12077; KRAMER K, 1995, PLANT CELL ENVIRON, V18, P93, DOI 10.1111/j.1365-3040.1995.tb00356.x; Kudo G., 1999, POLAR BIOSCI, V12, P100; Ladinig U, 2013, OECOLOGIA, V171, P743, DOI 10.1007/s00442-012-2581-8; LANDE R, 1983, EVOLUTION, V37, P1210, DOI 10.1111/j.1558-5646.1983.tb00236.x; Little C, 2014, THESIS LUDWIG MAXIMI; Merila J, 2014, EVOL APPL, V7, P1, DOI 10.1111/eva.12137; Midgley GF, 2006, DIVERS DISTRIB, V12, P555, DOI 10.1111/j.1366-9516.2006.00273.x; Molau U, 2005, AM J BOT, V92, P422, DOI 10.3732/ajb.92.3.422; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; R Core Team, 2021, R LANGUAGE ENV STAT; Rasmann S, 2014, FUNCT ECOL, V28, P46, DOI 10.1111/1365-2435.12135; Rixen C, 2012, OIKOS, V121, P1532, DOI 10.1111/j.1600-0706.2011.20031.x; Roy BA, 2004, ECOLOGY, V85, P2570, DOI 10.1890/03-0182; Scheepens JF, 2013, OECOLOGIA, V171, P679, DOI 10.1007/s00442-012-2582-7; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schob C, 2009, PLANT ECOL, V200, P91, DOI 10.1007/s11258-008-9435-9; Schwaegerle KE, 2000, EVOLUTION, V54, P452; Sedlacek JF, 2014, BASIC APPL ECOL, V15, P305, DOI 10.1016/j.baae.2014.05.006; Skelly DK, 2007, CONSERV BIOL, V21, P1353, DOI 10.1111/j.1523-1739.2007.00764.x; SMITH WK, 1979, OECOLOGIA, V41, P109, DOI 10.1007/BF00344841; Stanton ML, 1997, AM NAT, V150, P143, DOI 10.1086/286061; Steger C, 2013, CLIM DYNAM, V41, P735, DOI 10.1007/s00382-012-1545-3; Stinson KA, 2004, AM J BOT, V91, P531, DOI 10.3732/ajb.91.4.531; Theurillat JP, 2001, CLIMATIC CHANGE, V50, P77, DOI 10.1023/A:1010632015572; van der Putten WH, 2013, J ECOL, V101, P265, DOI 10.1111/1365-2745.12054; van Grunsven RHA, 2007, J ECOL, V95, P1050, DOI 10.1111/j.1365-2745.2007.01282.x; van Kleunen M, 2005, NEW PHYTOL, V166, P49, DOI 10.1111/j.1469-8137.2004.01296.x; van Kleunen M, 2001, OIKOS, V94, P515, DOI 10.1034/j.1600-0706.2001.940313.x; WALKER MD, 1995, ECOLOGY, V76, P1067, DOI 10.2307/1940916; Wheeler JA, 2015, BASIC APPL ECOL, V16, P202, DOI 10.1016/j.baae.2015.02.004; Wheeler JA, 2014, OECOLOGIA, V175, P219, DOI 10.1007/s00442-013-2872-8; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Wipf S, 2010, PLANT ECOL, V207, P53, DOI 10.1007/s11258-009-9653-9; Wipf S, 2009, CLIMATIC CHANGE, V94, P105, DOI [10.1007/s10584-009-9546-x, 10.1007/s10584-009-9546-X]; Zuur Alain F., 2009, P1	69	54	55	3	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122395	10.1371/journal.pone.0122395	http://dx.doi.org/10.1371/journal.pone.0122395			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893438	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700014
J	Toth, A; Fodor, J; Vincze, J; Olah, T; Juhasz, T; Zakany, R; Csernoch, L; Zador, E				Toth, Adrienn; Fodor, Janos; Vincze, Janos; Olah, Tamas; Juhasz, Tamas; Zakany, Roza; Csernoch, Laszlo; Zador, Erno			The Effect of SERCA1b Silencing on the Differentiation and Calcium Homeostasis of C2C12 Skeletal Muscle Cells	PLOS ONE			English	Article							NOTEXIN-INDUCED NECROSIS; MESSENGER-RNA LEVELS; RAT SOLEUS MUSCLE; STROMAL INTERACTION MOLECULE-1; CYCLOSPORINE-A; SARCOPLASMIC-RETICULUM; CA-2+ ATPASE; EXPRESSION; ENTRY; CALCINEURIN	The sarcoplasmic/endoplasmic reticulum Ca2+ ATPases (SERCAs) are the main Ca2+ pumps which decrease the intracellular Ca2+ level by reaccumulating Ca2+ into the sarcoplasmic reticulum. The neonatal SERCA1b is the major Ca2+ pump in myotubes and young muscle fibers. To understand its role during skeletal muscle differentiation its synthesis has been interfered with specific shRNA sequence. Stably transfected clones showing significantly decreased SERCA1b expression (cloneC1) were selected for experiments. The expression of the regulatory proteins of skeletal muscle differentiation was examined either by Western-blot at the protein level for MyoD, STIM1, calsequestrin (CSQ), and calcineurin (CaN) or by RT-PCR for myostatin and MCIP1.4. Quantitative analysis revealed significant alterations in CSQ, STIM1, and CaN expression in cloneC1 as compared to control cells. To examine the functional consequences of the decreased expression of SERCA1b, repeated Ca2+-transients were evoked by applications of 120 mM KCl. The significantly higher [Ca2+]i measured at the 20th and 40th seconds after the beginning of KCl application (112 +/- 3 and 110 +/- 3 nMvs. 150 +/- 7 and 135 +/- 5 nM, in control and in cloneC1 cells, respectively) indicated a decreased Ca2+-uptake capability which was quantified by extracting the maximal pump rate (454 +/- 41 mu M/s vs. 144 +/- 24 mu M/s, in control and in cloneC1 cells). Furthermore, the rate of calcium release from the SR (610 +/- 60 vs. 377 +/- 64 mu M/s) and the amount of calcium released (843 +/- 75 mu M vs. 576 +/- 80 mu M) were also significantly suppressed. These changes were also accompanied by a reduced activity of CaN in cells with decreased SERCA1b. In parallel, cloneC1 cells showed inhibited cell proliferation and decreased myotube nuclear numbers. Moreover, while cyclosporineA treatment suppressed the proliferation of parental cultures it had no effect on cloneC1 cells. SERCA1b is thus considered to play an essential role in the regulation of [Ca2+]i and its ab ovo gene silencing results in decreased skeletal muscle differentiation.	[Toth, Adrienn; Fodor, Janos; Vincze, Janos; Olah, Tamas; Csernoch, Laszlo] Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary; [Juhasz, Tamas; Zakany, Roza] Univ Debrecen, Fac Med, Dept Anat Histol & Embryol, Debrecen, Hungary; [Zador, Erno] Univ Szeged, Fac Med, Dept Biochem, Szeged, Hungary	University of Debrecen; University of Debrecen; Szeged University	Csernoch, L (corresponding author), Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary.	csl@edu.unideb.hu	Juhasz, Tamas/M-6878-2019	Juhasz, Tamas/0000-0003-0489-5676; Olah, Tamas/0000-0002-3834-6272; Csernoch, Laszlo/0000-0002-2446-1456	Bolyai Research Scholarship of the Hungarian Academy of Sciences; TAMOP [4.2.4. A/2-11-1-2012-0001];  [OTKA NN-107765];  [TAMOP-4.2.1/B-09/1/KONV-2010-0007];  [TAMOP-4.2.2/B-10/1-2010-0024]	Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); TAMOP; ; ; 	This work was supported by grants: OTKA NN-107765, TAMOP-4.2.1/B-09/1/KONV-2010-0007 and TAMOP-4.2.2/B-10/1-2010-0024, Bolyai Research Scholarship of the Hungarian Academy of Sciences to JF, TAMOP 4.2.4. A/2-11-1-2012-0001 'National Excellence Program' to TO.	Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Aoki MS, 2006, BRAZ J MED BIOL RES, V39, P243, DOI 10.1590/S0100-879X2006000200011; BRANDL CJ, 1986, CELL, V44, P597, DOI 10.1016/0092-8674(86)90269-2; BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; BURK SE, 1989, J BIOL CHEM, V264, P18561; Choi YM, 2014, BIOCHEM BIOPH RES CO, V448, P182, DOI 10.1016/j.bbrc.2014.04.083; Collet C, 2004, BIOPHYS J, V87, P268, DOI 10.1529/biophysj.103.039305; Fenyvesi R, 2004, BIOCHEM BIOPH RES CO, V320, P599, DOI 10.1016/j.bbrc.2004.06.005; Fodor J, 2013, CELL CALCIUM, V54, P1, DOI 10.1016/j.ceca.2013.03.003; Froehlich JP, 2008, BIOCHEMISTRY-US, V47, P13150, DOI 10.1021/bi801925p; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Guglielmi V, 2013, MOL GENET METAB, V110, P162, DOI 10.1016/j.ymgme.2013.07.015; GUNTESKIHAMBLIN AM, 1988, J BIOL CHEM, V263, P15032; Gutierrez-Martin Y, 2005, BBA-BIOMEMBRANES, V1711, P33, DOI 10.1016/j.bbamem.2005.02.017; Horsley V, 2002, J CELL BIOL, V156, P771, DOI 10.1083/jcb.200111073; Juhasz T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091541; Kosa M, 2013, MOL BIOTECHNOL, V54, P220, DOI 10.1007/s12033-012-9555-2; Lee KJ, 2014, PFLUG ARCH EUR J PHY, V466, P987, DOI 10.1007/s00424-013-1361-6; Lipskaia L, 2005, CIRC RES, V97, P488, DOI 10.1161/01.RES.0000180663.42594.aa; Lipskaia L, 2009, PFLUG ARCH EUR J PHY, V457, P673, DOI 10.1007/s00424-007-0428-7; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Mendler L, 1998, J MUSCLE RES CELL M, V19, P777, DOI 10.1023/A:1005499304147; Michalak M, 2009, TRENDS CELL BIOL, V19, P253, DOI 10.1016/j.tcb.2009.03.006; MILLER JB, 1990, J CELL BIOL, V111, P1149, DOI 10.1083/jcb.111.3.1149; Olah T, 2011, CELL CALCIUM, V49, P415, DOI 10.1016/j.ceca.2011.03.012; Pan Y, 2003, J BIOL CHEM, V278, P13367, DOI 10.1074/jbc.M213228200; Porter GA, 2002, J BIOL CHEM, V277, P28942, DOI 10.1074/jbc.M203961200; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roberts-Wilson TK, 2010, BBA-MOL CELL RES, V1803, P960, DOI 10.1016/j.bbamcr.2010.03.019; Rosenberg P, 2004, P NATL ACAD SCI USA, V101, P9387, DOI 10.1073/pnas.0308179101; Rossi D, 2007, CELL CALCIUM, V41, P573, DOI 10.1016/j.ceca.2006.10.007; Sachewsky N, 2014, DIS MODEL MECH, V7, P953, DOI 10.1242/dmm.014480; Sakuma K, 2005, ACTA NEUROPATHOL, V110, P269, DOI 10.1007/s00401-005-1049-x; Seth M, 2012, DEV DYNAM, V241, P639, DOI 10.1002/dvdy.23760; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; Stiber JA, 2011, CELL CALCIUM, V49, P341, DOI 10.1016/j.ceca.2010.11.012; Sumbilla C, 1999, AM J PHYSIOL-HEART C, V277, pH2381, DOI 10.1152/ajpheart.1999.277.6.H2381; Szabo A, 2008, J HISTOCHEM CYTOCHEM, V56, P1013, DOI 10.1369/jhc.2008.951632; Szappanos H, 2004, J BIOCHEM BIOPH METH, V59, P89, DOI 10.1016/j.jbbm.2003.12.002; Sztretye M, 2014, 58 ANN M BIOPH SOC B; Sztretye M, 2007, J MUSCLE RES CELL M, V28, P421, DOI 10.1007/s10974-008-9135-z; Tam TTP, 2013, BIOCHEM BIOPH RES CO, V430, P722, DOI 10.1016/j.bbrc.2012.11.082; Trebak M, 2013, MICROCIRCULATION, V20, P330, DOI 10.1111/micc.12042; Vangheluwe P, 2006, BBA-MOL CELL RES, V1763, P1216, DOI 10.1016/j.bbamcr.2006.08.025; Vega AV, 2011, J PHYSIOL-LONDON, V589, P4649, DOI 10.1113/jphysiol.2011.210765; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61; Yeo H, 2007, BONE, V40, P1502, DOI 10.1016/j.bone.2007.02.017; Zador E, 1998, ACTA HISTOCHEM, V100, P355, DOI 10.1016/S0065-1281(98)80033-0; Zador E, 1999, J MUSCLE RES CELL M, V20, P395, DOI 10.1023/A:1005541522599; Zador E, 1996, BIOCHEM J, V320, P107, DOI 10.1042/bj3200107; Zador E, 2007, CELL CALCIUM, V41, P379, DOI 10.1016/j.ceca.2006.08.001; Zador E, 2011, HISTOCHEM CELL BIOL, V135, P11, DOI 10.1007/s00418-010-0766-y; Zakany R, 2005, EXP CELL RES, V305, P190, DOI 10.1016/j.yexcr.2004.12.016; ZHANG M, 1995, DEV DYNAM, V204, P168, DOI 10.1002/aja.1002040207	54	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123583	10.1371/journal.pone.0123583	http://dx.doi.org/10.1371/journal.pone.0123583			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893964	Green Accepted, gold, Green Published			2022-12-27	WOS:000353211700044
J	Yilmaz, V; Oflazer, P; Aysal, F; Durmus, H; Poulas, K; Yentur, SP; Gulsen-Parman, Y; Tzartos, S; Marx, A; Tuzun, E; Deymeer, F; Saruhan-Direskeneli, G				Yilmaz, Vuslat; Oflazer, Piraye; Aysal, Fikret; Durmus, Hacer; Poulas, Kostas; Yentur, Sibel P.; Gulsen-Parman, Yesim; Tzartos, Socrates; Marx, Alexander; Tuzun, Erdem; Deymeer, Feza; Saruhan-Direskeneli, Guher			Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK	PLOS ONE			English	Article							ACETYLCHOLINE-RECEPTOR ANTIBODY; MESSENGER-RNA EXPRESSION; BLOOD MONONUCLEAR-CELLS; REGULATORY T-CELLS; IGG4 PRODUCTION; SUBPOPULATIONS; AUTOANTIBODIES; SECRETION; RESPONSES; IL-10	Neuromuscular transmission failure in myasthenia gravis (MG) is most commonly elicited by autoantibodies (ab) to the acetylcholine receptor or the muscle-specific kinase, constituting AChR-MG and MuSK-MG. It is controversial whether these MG subtypes arise through different T helper (Th) 1, Th2 or Th17 polarized immune reactions and how these reactions are blunted by immunosuppression. To address these questions, plasma levels of cytokines related to various Th subtypes were determined in patients with AChR-MG, MuSK-MG and healthy controls (CON). Peripheral blood mononuclear cells (PBMC) were activated in vitro by anti-CD3, and cytokines were quantified in supernatants. In purified blood CD4(+) T cells, RNA of various cytokines, Th subtype specific transcription factors and the co-stimulatory molecule, CD40L, were quantified by qRT-PCR. Plasma levels of Th1, Th2 and Th17 related cytokines were overall not significantly different between MG subtypes and CON. By contrast, in vitro stimulated PBMC from MuSK-MG but not AChR-MG patients showed significantly increased secretion of the Th1, Th17 and T follicular helper cell related cytokines, IFN-gamma, IL-17A and IL-21. Stimulated expression of IL-4, IL-6, IL-10 and IL-13 was not significantly different. At the RNA level, expression of CD40L by CD4+ T cells was reduced in both AChR-MG and MuSK-MG patients while expression of Th subset related cytokines and transcription factors were normal. Immunosuppression treatment had two effects: First, it reduced levels of IL12p40 in the plasma of AChR-MG and MuSK-MG patients, leaving other cytokine levels unchanged; second, it reduced spontaneous secretion of IFN-. and increased secretion of IL-6 and IL-10 by cultured PBMC from AChR-MG, but not MuSK-MG patients. We conclude that Th1 and Th17 immune reactions play a role in MuSK-MG. Immunosuppression attenuates the Th1 response in AChR-MG and MuSK-MG, but otherwise modulates immune responses in AChR-MG and MuSK-MG patients differentially.	[Yilmaz, Vuslat; Yentur, Sibel P.; Saruhan-Direskeneli, Guher] Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey; [Oflazer, Piraye; Durmus, Hacer; Gulsen-Parman, Yesim; Deymeer, Feza] Istanbul Univ, Istanbul Fac Med, Dept Neurol, Istanbul, Turkey; [Aysal, Fikret] Bakirkoy Res & Training Hosp Psychiat & Neurol Di, Dept Neurol, Istanbul, Turkey; [Poulas, Kostas] Univ Patras, Sch Hlth Sci, Dept Pharm, Patras, Greece; [Tzartos, Socrates] Hellenic Pasteur Inst, Athens, Greece; [Marx, Alexander] Heidelberg Univ, Inst Pathol, Univ Med Ctr Mannheim, Mannheim, Germany; [Tuzun, Erdem] Istanbul Univ, Expt Med Res Inst, Dept Neurosci, Istanbul, Turkey	Istanbul University; Istanbul University; Istanbul Bakirkoy Mental Health & Neurology Training & Research Hospital; University of Patras; Ruprecht Karls University Heidelberg; Istanbul University	Saruhan-Direskeneli, G (corresponding author), Istanbul Univ, Istanbul Fac Med, Dept Physiol, Istanbul, Turkey.	gsaruhan@istanbul.edu.tr	Saruhan-Direskeneli, Guher/AAG-5657-2019; Tuzun, Erdem/AAH-9212-2019; YILMAZ, VUSLAT/AAB-9205-2020; Poulas, Konstantinos/L-4874-2018	Saruhan-Direskeneli, Guher/0000-0002-6903-7173; Poulas, Konstantinos/0000-0002-5397-1543; , Piraye/0000-0001-8202-5313	TUBITAK [106S223, 109S353, 110S297]; BMBF [01DL12027]; Istanbul University Research Fund (UDP and BYP)	TUBITAK(Turkiye Bilimsel ve Teknolojik Arastirma Kurumu (TUBITAK)); BMBF(Federal Ministry of Education & Research (BMBF)); Istanbul University Research Fund (UDP and BYP)(Istanbul University)	The work was supported by the following: TUBITAK (grant #: 106S223, 109S353 and 110S297 to VY ET FD GSD); and BMBF (grant # 01DL12027 to AM) Istanbul University Research Fund (UDP and BYP to VY SPY GSD).	Berrih-Aknin S, 2014, J AUTOIMMUN, V48-49, P143, DOI 10.1016/j.jaut.2014.01.003; deBoer BA, 1997, INFECT IMMUN, V65, P1122, DOI 10.1128/IAI.65.3.1122-1125.1997; Diaz-Manera J, 2012, NEUROLOGY, V78, P189, DOI 10.1212/WNL.0b013e3182407982; DRACHMAN DB, 1978, NEW ENGL J MED, V298, P1116, DOI 10.1056/NEJM197805182982004; DRACHMAN DB, 1994, NEW ENGL J MED, V330, P1797, DOI 10.1056/NEJM199406233302507; Higuchi O, 2011, ANN NEUROL, V69, P418, DOI 10.1002/ana.22312; Hoch W, 2001, NAT MED, V7, P365, DOI 10.1038/85520; Huang WX, 2000, EUR J NEUROL, V7, P195, DOI 10.1046/j.1468-1331.2000.00056.x; Im SH, 2001, J IMMUNOL, V166, P6893, DOI 10.4049/jimmunol.166.11.6893; Jeannin P, 1998, J IMMUNOL, V160, P3555; Leite MI, 2008, BRAIN, V131, P1940, DOI 10.1093/brain/awn092; Li X, 2008, CLIN IMMUNOL, V126, P180, DOI 10.1016/j.clim.2007.10.001; Li Y, 2014, NEUROL SCI, V35, P29, DOI 10.1007/s10072-013-1460-3; LINDSTROM JM, 1976, NEUROLOGY, V26, P1054, DOI 10.1212/WNL.26.11.1054; LINK J, 1994, NEUROLOGY, V44, P728, DOI 10.1212/WNL.44.4.728; Masuda M, 2010, EUR J PHARMACOL, V627, P325, DOI 10.1016/j.ejphar.2009.10.040; Milani M, 2003, ANN NY ACAD SCI, V998, P284, DOI 10.1196/annals.1254.032; Mu LL, 2009, IMMUNOLOGY, V128, pe826, DOI 10.1111/j.1365-2567.2009.03089.x; Neron S, 2005, IMMUNOLOGY, V116, P454, DOI 10.1111/j.1365-2567.2005.02244.x; Pevzner A, 2012, J NEUROL, V259, P427, DOI 10.1007/s00415-011-6194-7; Roche JC, 2011, MUSCLE NERVE, V44, P278, DOI 10.1002/mus.22070; RODGAARD A, 1987, CLIN EXP IMMUNOL, V67, P82; Sanders DB, 2003, NEUROLOGY, V60, P1978, DOI 10.1212/01.WNL.0000065882.63904.53; STEVENS TL, 1988, NATURE, V334, P255, DOI 10.1038/334255a0; Tanaka A, 2012, ARTHRITIS RHEUM-US, V64, P254, DOI 10.1002/art.33320; Teleshova N, 2000, MUSCLE NERVE, V23, P946, DOI 10.1002/(SICI)1097-4598(200006)23:6<946::AID-MUS16>3.0.CO;2-4; Tuzun E, 2011, J AUTOIMMUN, V37, P136, DOI 10.1016/j.jaut.2011.05.006; Ulusoy C, 2014, CLIN IMMUNOL, V151, P155, DOI 10.1016/j.clim.2014.02.012; Uzawa A, 2014, CLIN EXP IMMUNOL, V176, P232, DOI 10.1111/cei.12272; VINCENT A, 1985, J NEUROL NEUROSUR PS, V48, P1246, DOI 10.1136/jnnp.48.12.1246; Vincent A, 2001, LANCET, V357, P2122, DOI 10.1016/S0140-6736(00)05186-2; Vincent Angela, 2002, Adv Neurol, V88, P159; Wang Z, 2012, SCAND J IMMUNOL, V76, P54, DOI 10.1111/j.1365-3083.2012.02703.x; Wood N, 2004, CELL IMMUNOL, V231, P133, DOI 10.1016/j.cellimm.2005.01.001; Yeh JH, 2009, EUR J NEUROL, V16, P1318, DOI 10.1111/j.1468-1331.2009.02729.x; Yi JS, 2014, J AUTOIMMUN, V52, P130, DOI 10.1016/j.jaut.2013.12.005; YI Q, 1994, J NEUROIMMUNOL, V50, P177, DOI 10.1016/0165-5728(94)90044-2; Yilmaz V, 2014, AUTOIMMUNITY, V2014, P1, DOI [10.3109/08916934.2013.856006, DOI 10.3109/08916934.2013.856006]; Yoshikawa H, 2002, J CLIN NEUROSCI, V9, P133, DOI 10.1054/jocn.2001.1028; Zhang B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091816; Zhang B, 2012, ARCH NEUROL-CHICAGO, V69, P445, DOI 10.1001/archneurol.2011.2393; Zisimopoulou P, 2014, J AUTOIMMUN, V52, P139, DOI 10.1016/j.jaut.2013.12.004	42	31	31	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123546	10.1371/journal.pone.0123546	http://dx.doi.org/10.1371/journal.pone.0123546			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893403	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700040
J	Zhang, XY; Song, QB				Zhang, Xueying; Song, Qinbao			A Multi-Label Learning Based Kernel Automatic Recommendation Method for Support Vector Machine	PLOS ONE			English	Article							ALGORITHM SELECTION; PATTERN-RECOGNITION; MODEL SELECTION; CLASSIFICATION; VALIDATION; PREDICTION; ACCURACY	Choosing an appropriate kernel is very important and critical when classifying a new problem with Support Vector Machine. So far, more attention has been paid on constructing new kernels and choosing suitable parameter values for a specific kernel function, but less on kernel selection. Furthermore, most of current kernel selection methods focus on seeking a best kernel with the highest classification accuracy via cross-validation, they are time consuming and ignore the differences among the number of support vectors and the CPU time of SVM with different kernels. Considering the tradeoff between classification success ratio and CPU time, there may be multiple kernel functions performing equally well on the same classification problem. Aiming to automatically select those appropriate kernel functions for a given data set, we propose a multi-label learning based kernel recommendation method built on the data characteristics. For each data set, the meta-knowledge data base is first created by extracting the feature vector of data characteristics and identifying the corresponding applicable kernel set. Then the kernel recommendation model is constructed on the generated meta-knowledge data base with the multi-label classification method. Finally, the appropriate kernel functions are recommended to a new data set by the recommendation model according to the characteristics of the new data set. Extensive experiments over 132 UCI benchmark data sets, with five different types of data set characteristics, eleven typical kernels (Linear, Polynomial, Radial Basis Function, Sigmoidal function, Laplace, Multiquadric, Rational Quadratic, Spherical, Spline, Wave and Circular), and five multi-label classification methods demonstrate that, compared with the existing kernel selection methods and the most widely used RBF kernel function, SVM with the kernel function recommended by our proposed method achieved the highest classification performance.	[Zhang, Xueying; Song, Qinbao] Xi An Jiao Tong Univ, Dept Comp Sci & Technol, Xian 710049, Shaanxi, Peoples R China	Xi'an Jiaotong University	Song, QB (corresponding author), Xi An Jiao Tong Univ, Dept Comp Sci & Technol, 28 Xian Ning West Rd, Xian 710049, Shaanxi, Peoples R China.	qbsong@mail.xjtu.edu.cn			National Natural Science Foundation of China [61373046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China. The grant number is 61373046 and the URLs of the National Natural Science Foundation of China is http://www.nsfc.gov.cn/. XYZ and QBS received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S., 2005, SUPPORT VECTOR MACHI, V53; Akay MF, 2009, EXPERT SYST APPL, V36, P3240, DOI 10.1016/j.eswa.2008.01.009; Ali S, 2006, APPL SOFT COMPUT, V6, P119, DOI 10.1016/j.asoc.2004.12.002; Ali S, 2006, NEUROCOMPUTING, V70, P173, DOI 10.1016/j.neucom.2006.03.004; ARONSZAJN N, 1950, T AM MATH SOC, V68, P337, DOI 10.1090/s0002-9947-1950-0051437-7; Ayat NE, 2005, PATTERN RECOGN, V38, P1733, DOI 10.1016/j.patcog.2005.03.011; Bach F. R., 2004, P 21 INT C MACH LEAR, P41, DOI 10.1145/ 1015330.1015424; Bensusan H, 2000, LECT NOTES COMPUT<D>, V1910, P325; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Boutell MR, 2004, PATTERN RECOGN, V37, P1757, DOI 10.1016/j.patcog.2004.03.009; Bradford JR, 2005, BIOINFORMATICS, V21, P1487, DOI 10.1093/bioinformatics/bti242; Brazdil P., 1994, Machine Learning: ECML-94. European Conference on Machine Learning. Proceedings, P83; Brazdil PB, 2003, MACH LEARN, V50, P251, DOI 10.1023/A:1021713901879; Brereton RG, 2010, ANALYST, V135, P230, DOI 10.1039/b918972f; Brown MPS, 2000, P NATL ACAD SCI USA, V97, P262, DOI 10.1073/pnas.97.1.262; Byun H, 2002, LECT NOTES COMPUT SC, V2388, P213; Castiello C, 2005, LECT NOTES ARTIF INT, V3558, P457; Cawley GC, 2006, IEEE IJCNN, P1661; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Clare A., 2001, EUROPEAN C PRINCIPLE, V2168, P42; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Crammer K, 2003, J MACH LEARN RES, V3, P1025, DOI 10.1162/153244303322533188; Cybenko G., 1989, Mathematics of Control, Signals, and Systems, V2, P303, DOI 10.1007/BF02551274; Demsar J, 2006, J MACH LEARN RES, V7, P1; Duin RPW, 2004, INT C PATT RECOG, P140; Elisseeff A, 2002, ADV NEUR IN, V14, P681; Freund Y, 1997, J COMPUT SYST SCI, V55, P119, DOI 10.1006/jcss.1997.1504; Friedman M, 1937, J AM STAT ASSOC, V32, P675, DOI 10.2307/2279372; Friedman M, 1940, ANN MATH STAT, V11, P86, DOI 10.1214/aoms/1177731944; Furnkranz J, 2008, MACH LEARN, V73, P133, DOI 10.1007/s10994-008-5064-8; Furey TS, 2000, BIOINFORMATICS, V16, P906, DOI 10.1093/bioinformatics/16.10.906; Genton MG, 2002, J MACH LEARN RES, V2, P299, DOI 10.1162/15324430260185646; Godbole S, 2004, LECT NOTES ARTIF INT, V3056, P22; Gonen M, 2011, J MACH LEARN RES, V12, P2211; Gopal S, 2010, SIGIR 2010: PROCEEDINGS OF THE 33RD ANNUAL INTERNATIONAL ACM SIGIR CONFERENCE ON RESEARCH DEVELOPMENT IN INFORMATION RETRIEVAL, P315; Heckman N, 2012, STAT SURV, V6, P113, DOI 10.1214/12-SS101; Ho TK, 2002, IEEE T PATTERN ANAL, V24, P289, DOI 10.1109/34.990132; HOLM S, 1979, SCAND J STAT, V6, P65; Howley T, 2005, ARTIF INTELL REV, V24, P379, DOI 10.1007/s10462-005-9009-3; Hsu CW, 2002, IEEE T NEURAL NETWOR, V13, P415, DOI 10.1109/72.991427; Huang J, 2005, IEEE T KNOWL DATA EN, V17, P299, DOI 10.1109/TKDE.2005.50; Jensen DD, 2000, MACH LEARN, V38, P309, DOI 10.1023/A:1007631014630; Kalousis A, 2004, MACH LEARN, V54, P275, DOI 10.1023/B:MACH.0000015882.38031.85; Katakis I, 2008, P ECML PKDD 2008 DIS; KIRA K, 1992, MACHINE LEARNING /, P249; Leopold E, 2002, MACH LEARN, V46, P423, DOI 10.1023/A:1012491419635; Lin CJ, 2010, PRACTICAL GUIDE SUPP; Lindner G, 1999, LECT NOTES ARTIF INT, V1704, P418; Muller KR, 2001, IEEE T NEURAL NETWOR, V12, P181, DOI 10.1109/72.914517; Nakhaeizadeh G., 1997, Proceedings of the Third International Conference on Knowledge Discovery and Data Mining, P37; Nguyen Minh N, 2003, Genome Inform, V14, P218; Partridge M, 2000, NEURAL NETWORKS FOR SIGNAL PROCESSING X, VOLS 1 AND 2, PROCEEDINGS, P289, DOI 10.1109/NNSP.2000.889420; Peng Y., 2002, 2 ECML PKDD INT WORK, P111; Pfahringer Bernhard, 2000, P 17 INT C MACH LEAR, P743, DOI [10.5555/645529.658105, DOI 10.5555/645529.658105]; Qi G.-J., 2007, P 15 INT C MULT, P17, DOI DOI 10.1145/1291233.1291245; Rakotomamonjy A, 2008, J MACH LEARN RES, V9, P2491; Sapankevych NL, 2009, IEEE COMPUT INTELL M, V4, P24, DOI 10.1109/MCI.2009.932254; Schapire RE, 2000, MACH LEARN, V39, P135, DOI 10.1023/A:1007649029923; Shi ZW, 2007, IEEE T NEURAL NETWOR, V18, P359, DOI 10.1109/TNN.2006.885113; Smola AJ, 1998, ALGORITHMICA, V22, P211, DOI 10.1007/PL00013831; Song QB, 2012, PATTERN RECOGN, V45, P2672, DOI 10.1016/j.patcog.2011.12.025; Sonnenburg S, 2006, J MACH LEARN RES, V7, P1531; Staelin C., 2003, HPL2002354R1; Sullivan K, 2007, GECCO 2007: GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, VOL 1 AND 2, P1702; Thabtah FA, 2004, FOURTH IEEE INTERNATIONAL CONFERENCE ON DATA MINING, PROCEEDINGS, P217, DOI 10.1109/ICDM.2004.10117; Thadani K, 2007, 2006 INTERNATIONAL CONFERENCE ON ADVANCED COMPUTING AND COMMUNICATIONS, VOLS 1 AND 2, P18; Tong S, 2002, J MACH LEARN RES, V2, P45, DOI 10.1162/153244302760185243; Tsoumakas G., 2009, INT J DATA WAREHOUS, V3, P1, DOI DOI 10.4018/JDWM.2007070101; Tsoumakas G, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P667, DOI 10.1007/978-0-387-09823-4_34; Vapnik V, 2000, NEURAL COMPUT, V12, P2013, DOI 10.1162/089976600300015042; Vapnik V., 1998, STAT LEARNING THEORY, V3, DOI DOI 10.1007/978-1-4419-1428-6_5864; Vapnik V.N., 2006, ESTIMATION DEPENDENC, VVolume 40; VAPNIK VN, 1971, THEOR PROBAB APPL+, V16, P264, DOI 10.1137/1116025; Wang GT, 2014, ACM T KNOWL DISCOV D, V9, DOI 10.1145/2629474; Wang WJ, 2008, LECT NOTES ARTIF INT, V5009, P596, DOI 10.1007/978-3-540-79721-0_80; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wolpert DH, 1998, SUPPORT VECTOR MACHI; Yang S, 2007, IEEE T CIRC SYST VID, V17, P324, DOI 10.1109/TCSVT.2007.890829; Yang Y., 1997, P 14 INT C MACH LEAR, P412, DOI DOI 10.1016/J.ESWA.2008.05.026; Yu K., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P258, DOI 10.1145/1076034.1076080; Zhang DQ, 2006, IEEE DATA MINING, P1178; Zhang DQ, 2006, PATTERN RECOGN, V39, P133, DOI 10.1016/j.patcog.2005.08.001; Zhang ML, 2007, PATTERN RECOGN, V40, P2038, DOI 10.1016/j.patcog.2006.12.019; Zhang ML, 2014, IEEE T KNOWL DATA EN, V26, P1819, DOI 10.1109/TKDE.2013.39; Zhang W, 2008, KNOWL-BASED SYST, V21, P879, DOI 10.1016/j.knosys.2008.03.044; Zhu S., 2005, SIGIR 2005. Proceedings of the Twenty-Eighth Annual International ACM SIGIR Conference on Research and Development in Information Retrieval, P274, DOI 10.1145/1076034.1076082; Zien A., 2007, P 24 INT C MACH LEAR, P1191, DOI DOI 10.1145/1273496.1273646	88	12	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0120455	10.1371/journal.pone.0120455	http://dx.doi.org/10.1371/journal.pone.0120455			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893896	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700005
J	Barnhart, CD; Yang, DR; Lein, PJ				Barnhart, Christopher D.; Yang, Dongren; Lein, Pamela J.			Using the Morris Water Maze to Assess Spatial Learning and Memory in Weanling Mice	PLOS ONE			English	Article							POLYCHLORINATED BIPHENYL PCB; SYNAPTIC PLASTICITY; COGNITIVE FUNCTION; DENDRITIC SPINES; KNOCKOUT MICE; MOUSE MODEL; RATS; HIPPOCAMPAL; EXPRESSION; EXPOSURE	Mouse models have been indispensable for elucidating normal and pathological processes that influence learning and memory. A widely used method for assessing these cognitive processes in mice is the Morris water maze, a classic test for examining spatial learning and memory. However, Morris water maze studies with mice have principally been performed using adult animals, which preclude studies of critical neurodevelopmental periods when the cellular and molecular substrates of learning and memory are formed. While weanling rats have been successfully trained in the Morris water maze, there have been few attempts to test weanling mice in this behavioral paradigm even though mice offer significant experimental advantages because of the availability of many genetically modified strains. Here, we present experimental evidence that weanling mice can be trained in the Morris water maze beginning on postnatal day 24. Maze-trained weanling mice exhibit significant improvements in spatial learning over the training period and results of the probe trial indicate the development of spatial memory. There were no sex differences in the animals' performance in these tasks. In addition, molecular biomarkers of synaptic plasticity are upregulated in maze-trained mice at the transcript level. These findings demonstrate that the Morris water maze can be used to assess spatial learning and memory in weanling mice, providing a potentially powerful experimental approach for examining the influence of genes, environmental factors and their interactions on the development of learning and memory.	[Barnhart, Christopher D.; Yang, Dongren; Lein, Pamela J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA	University of California System; University of California Davis	Lein, PJ (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	pjlein@ucdavis.edu		Lein, Pamela/0000-0001-7665-7584	United States National Institutes of Health [R01 ES014901]; Achievement Rewards for College Scientists (ARCS) Foundation;  [P42 ES04699];  [T32 ES007059]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004699, T32ES007059, R01ES014901] Funding Source: NIH RePORTER	United States National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Achievement Rewards for College Scientists (ARCS) Foundation; ; ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the United States National Institutes of Health (grant R01 ES014901 to PJL); CDB was supported by predoctoral fellowships provided by grants P42 ES04699 and T32 ES007059 and by a scholarship from the Achievement Rewards for College Scientists (ARCS) Foundation (https://www.arcsfoundation.org/). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Akers KG, 2011, DEV PSYCHOBIOL, V53, P1, DOI 10.1002/dev.20480; Barone S, 2000, NEUROTOXICOLOGY, V21, P15; Bellinger DC, 2012, ENVIRON HEALTH PERSP, V120, P501, DOI 10.1289/ehp.1104170; Bloom Barbara, 2009, Vital Health Stat 10, P1; BRANDEIS R, 1989, INT J NEUROSCI, V48, P29, DOI 10.3109/00207458909002151; BUCCI DJ, 1995, BEHAV NEUROSCI, V109, P180, DOI 10.1037/0735-7044.109.1.180; Corey DA, 1996, GROWTH DEVELOP AGING, V60, P131; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; Ehman KD, 2006, NEUROTOXICOL TERATOL, V28, P144, DOI 10.1016/j.ntt.2005.12.002; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Florian C, 2004, BEHAV BRAIN RES, V154, P365, DOI 10.1016/j.bbr.2004.03.003; Frick KM, 2000, NEUROREPORT, V11, P3461, DOI 10.1097/00001756-200011090-00013; Gerstein H, 2012, NEUROBIOL LEARN MEM, V97, P17, DOI 10.1016/j.nlm.2011.08.009; GOODLETT CR, 1995, NEUROBIOL LEARN MEM, V64, P265, DOI 10.1006/nlme.1995.0009; Grandjean P, 2014, LANCET NEUROL, V13, P330, DOI 10.1016/S1474-4422(13)70278-3; Grandjean P, 2012, ENVIRON HEALTH PERSP, V120, pA452, DOI 10.1289/ehp.1206033; Green EL., 1966, BIOL LAB MOUSE; Hongpaisan J, 2007, P NATL ACAD SCI USA, V104, P19571, DOI 10.1073/pnas.0709311104; Hu XL, 2010, NEUROSCI LETT, V476, P79, DOI 10.1016/j.neulet.2010.04.007; Huang FL, 2006, J NEUROSCI, V26, P6230, DOI 10.1523/JNEUROSCI.1182-06.2006; Diez-Guerra FJ, 2010, IUBMB LIFE, V62, P597, DOI 10.1002/iub.357; Jeltsch H, 2001, NEUROBIOL LEARN MEM, V76, P81, DOI 10.1006/nlme.2000.3986; Jett DA, 1997, PHARMACOL BIOCHEM BE, V57, P271, DOI 10.1016/S0091-3057(96)00350-4; Jett DA, 2001, TOXICOL APPL PHARM, V174, P89, DOI 10.1006/taap.2001.9198; Jiang YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012278; Kolb B, 2000, NEUROPHARMACOLOGY, V39, P756, DOI 10.1016/S0028-3908(99)00260-9; Kvajo M, 2012, NEUROSCIENCE, V211, P136, DOI 10.1016/j.neuroscience.2011.07.051; Landrigan PJ, 2012, ENVIRON HEALTH PERSP, V120, pA258, DOI 10.1289/ehp.1104285; Leggio MG, 2000, P NATL ACAD SCI USA, V97, P2320, DOI 10.1073/pnas.040554297; Li W, 2009, PHYSIOL BEHAV, V96, P557, DOI 10.1016/j.physbeh.2008.12.004; Lipp HP, 1998, CURR OPIN NEUROBIOL, V8, P272, DOI 10.1016/S0959-4388(98)80151-7; Logue SE, 1997, BEHAV NEUROSCI, V111, P104, DOI 10.1037/0735-7044.111.1.104; Malenka RC, 2008, NEUROSCI RES, V61, pS1; Malleret G, 1999, J NEUROSCI, V19, P6157, DOI 10.1523/JNEUROSCI.19-14-06157.1999; MCNAMARA RK, 1993, BRAIN RES REV, V18, P33, DOI 10.1016/0165-0173(93)90006-L; Mines MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009706; Morris RGM, 1997, PHILOS T ROY SOC B, V352, P1489, DOI 10.1098/rstb.1997.0136; MOSER MB, 1994, P NATL ACAD SCI USA, V91, P12673, DOI 10.1073/pnas.91.26.12673; Na ES, 2012, J NEUROSCI, V32, P3109, DOI 10.1523/JNEUROSCI.6000-11.2012; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Provost TL, 1999, PROG NEURO-PSYCHOPH, V23, P915, DOI 10.1016/S0278-5846(99)00035-4; Rhodes JS, 2003, BEHAV NEUROSCI, V117, P1006, DOI 10.1037/0735-7044.117.5.1006; Ricceri L, 1999, BEHAV NEUROSCI, V113, P1204, DOI 10.1037/0735-7044.113.6.1204; Ricceri L, 2008, BEHAV PHARMACOL, V19, P501, DOI 10.1097/FBP.0b013e32830c3645; RUDY JW, 1987, BEHAV NEUROSCI, V101, P62, DOI 10.1037/0735-7044.101.1.62; Rutten A, 2002, EUR J NEUROSCI, V16, P501, DOI 10.1046/j.1460-9568.2002.02103.x; Sala C, 2003, J NEUROSCI, V23, P6327; Salmaso N, 2012, J NEUROSCI, V32, P8930, DOI 10.1523/JNEUROSCI.1398-12.2012; Save E, 2000, BEHAV BRAIN RES, V109, P195, DOI 10.1016/S0166-4328(99)00173-4; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Stamou M, 2014, DRUG METAB DISPOS, V42, P239, DOI 10.1124/dmd.113.054239; Ta TA, 2011, NEUROTOXICOL TERATOL, V33, P393, DOI 10.1016/j.ntt.2011.02.003; Trasande L, 2011, HEALTH AFFAIR, V30, P863, DOI 10.1377/hlthaff.2010.1239; Varvel SA, 2002, J PHARMACOL EXP THER, V301, P915, DOI 10.1124/jpet.301.3.915; Vazdarjanova A, 2002, J NEUROSCI, V22, P10067; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang Z, 2012, ADV MATER RES-SWITZ, V496, P3, DOI 10.4028/www.scientific.net/AMR.496.3; Woods R, 2012, HUM MOL GENET, V21, P2399, DOI 10.1093/hmg/dds046; Xiao B, 1998, NEURON, V21, P707, DOI 10.1016/S0896-6273(00)80588-7; Yang D, 2009, ENVIRON HEALTH PERSP, V117, P426, DOI 10.1289/ehp.11771; Yang XW, 2011, CURR OPIN NEUROL, V24, P114, DOI 10.1097/WCO.0b013e32834451fb; Yin MM, 2013, BEHAV BRAIN RES, V253, P297, DOI 10.1016/j.bbr.2013.07.040	64	126	137	10	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124521	10.1371/journal.pone.0124521	http://dx.doi.org/10.1371/journal.pone.0124521			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886563	Green Published, gold			2022-12-27	WOS:000353017000134
J	Lee, WR; Sacharidou, A; Behling-Kelly, E; Oltmann, SC; Zhu, WF; Ahmed, M; Gerard, RD; Hui, DY; Abe, JI; Shaul, PW; Mineo, C				Lee, Wan Ru; Sacharidou, Anastasia; Behling-Kelly, Erica; Oltmann, Sarah C.; Zhu, Weifei; Ahmed, Mohamed; Gerard, Robert D.; Hui, David Y.; Abe, Jun-ichi; Shaul, Philip W.; Mineo, Chieko			PDZK1 Prevents Neointima Formation via Suppression of Breakpoint Cluster Region Kinase in Vascular Smooth Muscle	PLOS ONE			English	Article							RECEPTOR CLASS-B; ADAPTER PROTEIN PDZK1; TANDEM AFFINITY PURIFICATION; NITRIC-OXIDE SYNTHASE; SR-BI; LIPOPROTEIN METABOLISM; TARGETED DISRUPTION; BCR GENE; IN-VIVO; ATHEROSCLEROSIS	Scavenger receptor class B, type I (SR-BI) and its adaptor protein PDZK1 mediate responses to HDL cholesterol in endothelium. Whether the receptor-adaptor protein tandem serves functions in other vascular cell types is unknown. The current work determined the roles of SR-BI and PDZK1 in vascular smooth muscle (VSM). To evaluate possible VSM functions of SR-BI and PDZK1 in vivo, neointima formation was assessed 21 days post-ligation in the carotid arteries of wild-type, SR-BI-/- or PDZK1(-/-) mice. Whereas neointima development was negligible in wild-type and SR-BI-/-, there was marked neointima formation in PDZK1(-/-) mice. PDZK1 expression was demonstrated in primary mouse VSM cells, and compared to wild-type cells, PDZK1(-/-) VSM displayed exaggerated proliferation and migration in response to platelet derived growth factor (PDGF). Tandem affinity purification-mass spectrometry revealed that PDZK1 interacts with breakpoint cluster region kinase (Bcr), which contains a C-terminal PDZ binding sequence and is known to enhance responses to PDGF in VSM. PDZK1 interaction with Bcr in VSM was demonstrated by pull-down and by coimmunoprecipitation, and the augmented proliferative response to PDGF in PDZK1(-/-) VSM was abrogated by Bcr depletion. Furthermore, compared with wild-type Bcr overexpression, the introduction of a Bcr mutant incapable of PDZK1 binding into VSM cells yielded an exaggerated proliferative response to PDGF. Thus, PDZK1 has novel SR-BI-independent function in VSM that affords protection from neointima formation, and this involves PDZK1 suppression of VSM cell proliferation via an inhibitory interaction with Bcr.	[Lee, Wan Ru; Sacharidou, Anastasia; Behling-Kelly, Erica; Oltmann, Sarah C.; Zhu, Weifei; Ahmed, Mohamed; Shaul, Philip W.; Mineo, Chieko] Univ Texas SW Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX 75390 USA; [Gerard, Robert D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Hui, David Y.] Univ Cincinnati, Coll Med, Dept Pathol, Metab Dis Inst, Cincinnati, OH USA; [Abe, Jun-ichi] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA; [Abe, Jun-ichi] Univ Rochester, Sch Med & Dent, Aab Cardiovasc Res Inst, Rochester, NY USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University System of Ohio; University of Cincinnati; University of Rochester; University of Rochester	Shaul, PW (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Ctr Pulm & Vasc Biol, Dallas, TX 75390 USA.	Philip.Shaul@utsouthwestern.edu; Chieko.Mineo@utsouthwestern.edu			NIH [HL058888]; Crystal Charity Ball Center for Pediatric Critical Care Research; Associates First Capital Corporation Distinguished Chair in Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058888] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crystal Charity Ball Center for Pediatric Critical Care Research; Associates First Capital Corporation Distinguished Chair in Pediatrics; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by NIH Grant HL058888 (PWS). Additional support was provided by the Crystal Charity Ball Center for Pediatric Critical Care Research and the Associates First Capital Corporation Distinguished Chair in Pediatrics (PWS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alexis JD, 2009, CIRC RES, V104, P69, DOI 10.1161/CIRCRESAHA.108.188409; Aoki K, 1999, MOL MED, V5, P224, DOI 10.1007/BF03402119; Assanasen C, 2005, J CLIN INVEST, V115, P969, DOI 10.1172/JCI23858; Basford JE, 2009, ARTERIOSCL THROM VAS, V29, P1772, DOI 10.1161/ATVBAHA.109.194357; BOGUSKI MS, 1993, NATURE, V366, P643, DOI 10.1038/366643a0; BRASELMANN S, 1995, EMBO J, V14, P4839, DOI 10.1002/j.1460-2075.1995.tb00165.x; Burckstummer T, 2006, NAT METHODS, V3, P1013, DOI 10.1038/nmeth968; Che W, 2001, CIRCULATION, V104, P1399, DOI 10.1161/hc3701.095581; De Meyer G R, 1997, Vasc Med, V2, P179; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Dzau VJ, 2002, NAT MED, V8, P1249, DOI 10.1038/nm1102-1249; Hui DY, 2008, CURR DRUG TARGETS, V9, P251, DOI 10.2174/138945008783755601; Kher N, 2004, SEMIN THROMB HEMOST, V30, P665, DOI 10.1055/s-2004-861509; Kocher O, 1998, LAB INVEST, V78, P117; Kocher O, 2003, J BIOL CHEM, V278, P52820, DOI 10.1074/jbc.M310482200; Kocher O, 2003, MOL CELL BIOL, V23, P1175, DOI 10.1128/MCB.23.4.1175-1180.2003; Kocher O, 2008, BBA-MOL BASIS DIS, V1782, P310, DOI 10.1016/j.bbadis.2008.02.004; Kocher O, 2009, CURR OPIN LIPIDOL, V20, P236, DOI 10.1097/MOL.0b013e32832aee82; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Laurent E, 2001, CANCER RES, V61, P2343; Malmberg EK, 2004, J CELL SCI, V117, P5535, DOI 10.1242/jcs.01472; Mardones P, 2003, J BIOL CHEM, V278, P7884, DOI 10.1074/jbc.M211627200; MARU Y, 1991, CELL, V67, P459, DOI 10.1016/0092-8674(91)90521-Y; Mineo C, 2003, J BIOL CHEM, V278, P9142, DOI 10.1074/jbc.M211394200; Mineo C, 2006, CIRC RES, V98, P1352, DOI 10.1161/01.RES.0000225982.01988.93; Mineo C, 2012, CURR OPIN LIPIDOL, V23, P487, DOI 10.1097/MOL.0b013e328357ba61; Nakamura T, 2005, P NATL ACAD SCI USA, V102, P13404, DOI 10.1073/pnas.0506679102; Niemeier A, 2009, ATHEROSCLEROSIS, V202, P169, DOI 10.1016/j.atherosclerosis.2008.04.018; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Resch ZT, 2006, ENDOCRINOLOGY, V147, P5634, DOI 10.1210/en.2006-0493; Schwartz R, 2007, CIRC RES, V100, P1452, DOI 10.1161/01.RES.0000267745.03488.47; Seetharam D, 2006, CIRC RES, V98, P63, DOI 10.1161/01.RES.0000199272.59432.5b; Tachibana K, 2008, FEBS LETT, V582, P3884, DOI 10.1016/j.febslet.2008.10.027; Walker G, 2007, GYNECOL ONCOL, V106, P461, DOI 10.1016/j.ygyno.2007.05.009; Yesilaltay A, 2005, CURR OPIN LIPIDOL, V16, P147, DOI 10.1097/01.mol.0000162319.54795.e5; Yesilaltay A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008103; Yuhanna IS, 2001, NAT MED, V7, P853, DOI 10.1038/89986; Zeng XY, 2003, INFECT IMMUN, V71, P1306, DOI 10.1128/IAI.71.3.1306-1315.2003; Zhu BH, 2000, AM J PATHOL, V157, P1839, DOI 10.1016/S0002-9440(10)64823-7; Zhu WF, 2008, CIRC RES, V102, P480, DOI 10.1161/CIRCRESAHA.107.159079	42	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124494	10.1371/journal.pone.0124494	http://dx.doi.org/10.1371/journal.pone.0124494			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886360	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000132
J	Chen, LP; Zhou, J; Zhang, YY; Chu, SS; He, WN; Li, Y; Su, XR				Chen, Liping; Zhou, Jun; Zhang, Yunyun; Chu, Shuangshuang; He, Weina; Li, Ye; Su, Xiurong			Preparation and Representation of Recombinant Mn-Ferritin Flower-Like Spherical Aggregates from Marine Invertebrates	PLOS ONE			English	Article							AMINO-ACID-SEQUENCE; PIG SPLEEN FERRITIN; AZOTOBACTER-VINELANDII; HORSE SPLEEN; H-CHAIN; IRON-BINDING; CDNA CLONING; MANGANESE; PHOSPHATE; RECONSTITUTION	Ferritin has important functions in the transition and storage of toxic metal ions, but its regulation and function in many invertebrate species are still largely unknown. In our previous work, the cDNA sequence of Sinonovacula constricta, Apostichopus japonicas and Acaudina leucoprocta were constructed and efficiently expressed in E. Coli BL21 under IPTG induction. In this follow-up study, the recombinant ferritins were exposed to heavy metal manganese. The manganese concentration levels in three recombinant ferritins were greater than horse spleen ferritin (HSF). Compared with HSF, the amount of manganese enrichment in the three recombinant ferritins was 1.75-fold, 3.25-fold and 2.42-fold increases in ScFER, AjFER, and AlFER, respectively. After phosphate stimulation, the concentration of manganese increased and was higher than the ordinary dialysis control groups. The ScFER was four times its baseline value. The AjFER and AlFER were 1.4- and 8-fold higher, respectively. The AlFER sample stimulated by phosphate was 22-fold that of HSF. The morphologies of the resulting Mn-Ferritin from different marine invertebrates were characterized with scanning electron microscopy. Surface morphologies were lamella flower-like and are consistent with changes in surface morphologies of the standard Mn-HSF. Invertebrate recombinant ferritin and HSF both can uptake manganese. We found that the structure of A. leucoproctarecombinant Mn-Ferritin aggregate changed over time. The surface formed lamella flower-like aggregate, but gradually merged to create a relatively uniform plate-like phase of aggregate spherically and fused without clear boundaries.	[Chen, Liping; Zhou, Jun; Zhang, Yunyun; Chu, Shuangshuang; He, Weina; Li, Ye; Su, Xiurong] Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China	Ningbo University	Zhou, J (corresponding author), Ningbo Univ, Sch Marine Sci, Ningbo 315211, Zhejiang, Peoples R China.	zhougundam@qq.com; suxiurong@nbu.edu.cn			National Natural Science Foundation of China [41176123, 40776075]; K. C. Wong Magna Fund at Ningbo University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K. C. Wong Magna Fund at Ningbo University	This work was financially supported by the National Natural Science Foundation of China (No. 41176123and No. 40776075), and K. C. Wong Magna Fund at Ningbo University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS SC, 1992, J INORG BIOCHEM, V47, P161, DOI 10.1016/0162-0134(92)84062-R; BAKKER GR, 1986, J BIOL CHEM, V261, P3182; Barbeau A, 1976, Adv Neurol, V14, P339; Brock SL, 1998, CHEM MATER, V10, P2619, DOI 10.1021/cm980227h; CHANDRA SV, 1981, CLIN TOXICOL, V18, P407, DOI 10.3109/15563658108990264; Chasteen ND, 1999, J STRUCT BIOL, V126, P182, DOI 10.1006/jsbi.1999.4118; d'Estaintot BL, 2004, J MOL BIOL, V340, P277, DOI 10.1016/j.jmb.2004.04.036; Douglas T, 1998, PROTEIN SCI, V7, P1083, DOI 10.1002/pro.5560070502; Feng Q, 1999, J MATER CHEM, V9, P319, DOI 10.1039/a805369c; FORD GC, 1984, PHILOS T R SOC B, V304, P551, DOI 10.1098/rstb.1984.0046; Gay D, 2003, WATER RES, V37, P2173, DOI 10.1016/S0043-1354(02)00622-X; Harrison PM, 1996, BBA-BIOENERGETICS, V1275, P161, DOI 10.1016/0005-2728(96)00022-9; Hempstead PD, 1997, J MOL BIOL, V268, P424, DOI 10.1006/jmbi.1997.0970; Hilton RJ, 2012, J INORG BIOCHEM, V108, P8, DOI 10.1016/j.jinorgbio.2011.12.004; Huang HQ, 2002, BIOPHYS CHEM, V97, P17, DOI 10.1016/S0301-4622(02)00007-8; Huang HQ, 1999, BIOELECTROCH BIOENER, V48, P87, DOI 10.1016/S0302-4598(98)00215-3; Huang HQ, 1999, J PROTEIN CHEM, V18, P497, DOI 10.1023/A:1020653028685; HUANG HQ, 1993, J INORG BIOCHEM, V52, P59, DOI 10.1016/0162-0134(93)85623-G; Huang TS, 1996, EUR J BIOCHEM, V236, P450, DOI 10.1111/j.1432-1033.1996.00450.x; Jiang YM, 2007, NEUROTOXICOLOGY, V28, P126, DOI 10.1016/j.neuro.2006.08.005; Khan N, 2014, FOOD CHEM, V158, P200, DOI 10.1016/j.foodchem.2014.02.103; Kim JW, 2007, J ELECTROANAL CHEM, V601, P8, DOI 10.1016/j.jelechem.2006.10.018; Laufberger V., 1937, B SOC CHIM BIOL, V19, P1575; Lawson DM, 1991, SOLVING STRUCTURE HU; Li C, 2012, ANN SURG ONCOL, V7, P7, DOI DOI 10.1504/IJHPCN.2012.046371; Li CR, 2009, BIOCHIMIE, V91, P1475, DOI 10.1016/j.biochi.2009.08.007; Li Cheng-Hua, 2011, Oceanologia et Limnologia Sinica, V42, P567; Li CH, 2011, FISH SHELLFISH IMMUN, V30, P1147, DOI 10.1016/j.fsi.2011.02.017; Li M, 2008, COMP BIOCHEM PHYS B, V150, P263, DOI 10.1016/j.cbpb.2008.03.014; Liu GD, 2007, ANAL CHEM, V79, P5614, DOI 10.1021/ac070086f; LOBREAUX S, 1992, BIOCHEM J, V288, P931, DOI 10.1042/bj2880931; MACKLE P, 1993, J AM CHEM SOC, V115, P8471, DOI 10.1021/ja00071a076; MATHEIS G, 1991, FOOD CHEM, V39, P13, DOI 10.1016/0308-8146(91)90081-X; MELDRUM FC, 1995, J INORG BIOCHEM, V58, P59, DOI 10.1016/0162-0134(94)00037-B; Morillo J, 2008, ECOTOX ENVIRON SAFE, V71, P851, DOI 10.1016/j.ecoenv.2008.01.016; Polanams J, 2005, INORG CHEM, V44, P3203, DOI 10.1021/ic048819r; Qiu GF, 2008, COMP BIOCHEM PHYS B, V150, P320, DOI 10.1016/j.cbpb.2008.03.016; Rakshit T, 2010, LANGMUIR, V26, P16005, DOI 10.1021/la101776m; Rakshit T, 2012, J COLLOID INTERF SCI, V388, P282, DOI 10.1016/j.jcis.2012.08.028; Rakshit T, 2011, LANGMUIR, V27, P9681, DOI 10.1021/la202045a; ROHRER JS, 1990, BIOCHEMISTRY-US, V29, P259, DOI 10.1021/bi00453a035; Sana B, 2012, CHEM COMMUN, V48, P862, DOI 10.1039/c1cc15189d; SANTAMBROGIO P, 1993, J BIOL CHEM, V268, P12744; SHEN YF, 1993, SCIENCE, V260, P511, DOI 10.1126/science.260.5107.511; Solomon EI, 1996, CHEM REV, V96, P2563, DOI 10.1021/cr950046o; SRISUCHART B, 1987, J TOXICOL ENV HEALTH, V22, P91, DOI 10.1080/15287398709531053; STRANGE R, 1993, BIOCHIM BIOPHYS ACTA, V1164, P331, DOI 10.1016/0167-4838(93)90267-U; Suib SL, 1998, CURR OPIN SOLID ST M, V3, P63, DOI 10.1016/S1359-0286(98)80067-3; Suib SL, 2000, CHEMINFORM, V31; Tebo BM, 2005, TRENDS MICROBIOL, V13, P421, DOI 10.1016/j.tim.2005.07.009; Toner B, 2005, APPL ENVIRON MICROB, V71, P1300, DOI 10.1128/AEM.71.3.1300-1310.2005; TREFFRY A, 1989, FEBS LETT, V247, P268, DOI 10.1016/0014-5793(89)81350-X; Treffry A, 1997, BIOCHEMISTRY-US, V36, P432, DOI 10.1021/bi961830l; Uchida M, 2010, BBA-GEN SUBJECTS, V1800, P834, DOI 10.1016/j.bbagen.2009.12.005; Uygun DA, 2011, BIOTECHNOL BIOPROC E, V16, P173, DOI 10.1007/s12257-009-0162-4; Vashchenko G, 2013, NUTRIENTS, V5, P2289, DOI 10.3390/nu5072289; VONDARL M, 1994, EUR J BIOCHEM, V222, P353; Wang D, 2009, COMP BIOCHEM PHYS B, V152, P20, DOI 10.1016/j.cbpb.2008.09.082; Wang WM, 2009, MICROBIOL-SGM, V155, P1989, DOI 10.1099/mic.0.024141-0; WATT GD, 1992, BIOCHEMISTRY-US, V31, P5672, DOI 10.1021/bi00139a035; WATT RK, 1992, BIOCHEMISTRY-US, V31, P9673, DOI 10.1021/bi00155a021; Yamashita I, 2010, BBA-GEN SUBJECTS, V1800, P846, DOI 10.1016/j.bbagen.2010.03.005; Yang XK, 2000, BIOPHYS J, V78, P2049, DOI 10.1016/S0006-3495(00)76752-X; Zhang Y, 2003, COMP BIOCHEM PHYS B, V135, P43, DOI 10.1016/S1096-4959(03)00050-2; [周君 Zhou Jun], 2012, [海洋与湖沼, Oceanologia et Limnologia Sinica], V43, P713	66	7	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0119427	10.1371/journal.pone.0119427	http://dx.doi.org/10.1371/journal.pone.0119427			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879665	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500002
J	Costa, M; Cruz, E; Oliveira, S; Benes, V; Ivacevic, T; Silva, MJ; Vieira, I; Dias, F; Fonseca, S; Goncalves, M; Lima, M; Leitao, C; Muckenthaler, MU; Pinto, J; Porto, G				Costa, Monica; Cruz, Eugenia; Oliveira, Susana; Benes, Vladimir; Ivacevic, Tomi; Silva, Maria Joao; Vieira, Ines; Dias, Francisco; Fonseca, Sonia; Goncalves, Marta; Lima, Margarida; Leitao, Catarina; Muckenthaler, Martina U.; Pinto, Jorge; Porto, Graca			Lymphocyte Gene Expression Signatures from Patients and Mouse Models of Hereditary Hemochromatosis Reveal a Function of HFE as a Negative Regulator of CD8(+) T-Lymphocyte Activation and Differentiation In Vivo	PLOS ONE			English	Article							IRON OVERLOAD; PERIPHERAL-BLOOD; HLA HAPLOTYPES; LOW NUMBERS; CELLS; MEMORY; APOPTOSIS; IMMUNITY; RECEPTORS; PHENOTYPE	Abnormally low CD8(+) T-lymphocyte numbers is characteristic of some patients with hereditary hemochromatosis (HH), a MHC-linked disorder of iron overload. Both environmental and genetic components are known to influence CD8(+) T-lymphocyte homeostasis but the role of the HH associated protein HFE is still insufficiently understood. Genome-wide expression profiling was performed in peripheral blood CD8(+) T lymphocytes from HH patients selected according to CD8(+) T-lymphocyte numbers and from Hfe(-/-)mice maintained either under normal or high iron diet conditions. In addition, T-lymphocyte apoptosis and cell cycle progression were analyzed by flow cytometry in HH patients. HH patients with low CD8(+) T-lymphocyte numbers show a differential expression of genes related to lymphocyte differentiation and maturation namely CCR7, LEF1, ACTN1, NAA50, P2RY8 and FOSL2, whose expression correlates with the relative proportions of naive, central and effector memory subsets. In addition, expression levels of LEF1 and P2RY8 in memory cells as well as the proportions of CD8(+) T cells in G2/M cell cycle phase are significantly different in HH patients compared to controls. Hfe(-/-) mice do not show alterations in CD8(+) T-lymphocyte numbers but differential gene response patterns. We found an increased expression of S100a8 and S100a9 that is most pronounced in high iron diet conditions. Similarly, CD8(+) T lymphocytes from HH patients display higher S100a9 expression both at the mRNA and protein level. Altogether, our results support a role for HFE as a negative regulator of CD8(+) T-lymphocyte activation. While the activation markers S100a8 and S100a9 are strongly increased in CD8(+) T cells from both, Hfe(-/-) mice and HH patients, a differential profile of genes related to differentiation/maturation of CD8(+) T memory cells is evident in HH patients only. This supports the notion that HFE contributes, at least in part, to the generation of low peripheral blood CD8(+) T lymphocytes in HH.	[Costa, Monica; Cruz, Eugenia; Oliveira, Susana; Vieira, Ines; Pinto, Jorge; Porto, Graca] Univ Porto, Inst Invest & Inovacao Saude I3S, P-4100 Oporto, Portugal; [Costa, Monica; Cruz, Eugenia; Oliveira, Susana; Vieira, Ines; Pinto, Jorge; Porto, Graca] Univ Porto, Inst Biol Mol & Celular, Basic & Clin Res Iron Biol, P-4100 Oporto, Portugal; [Costa, Monica] Univ Porto, Fac Med, Doctoral Program Biomed, P-4100 Oporto, Portugal; [Cruz, Eugenia; Silva, Maria Joao; Dias, Francisco; Fonseca, Sonia; Goncalves, Marta; Lima, Margarida; Porto, Graca] Santo Antonio Hosp Ctr Hosp Porto, Clin Hematol, Oporto, Portugal; [Benes, Vladimir; Ivacevic, Tomi] European Mol Biol Lab, Genom Core Facil, D-69012 Heidelberg, Germany; [Leitao, Catarina] Univ Porto, Inst Biol Mol & Celular, Adv Flow Cytometry Unit, P-4100 Oporto, Portugal; [Muckenthaler, Martina U.] Heidelberg Univ, Dept Pediat Hematol, Heidelberg, Germany; [Muckenthaler, Martina U.] Heidelberg Univ, Dept Oncol & Immunol, Heidelberg, Germany; [Muckenthaler, Martina U.] Mol Med Partnership Unit, Heidelberg, Germany; [Porto, Graca] Univ Porto, Mol Immunol & Pathol, Inst Cirncias Biomed Abel Salazar, P-4100 Oporto, Portugal	Universidade do Porto; i3S - Instituto de Investigacao e Inovacao em Saude, Universidade do Porto; Universidade do Porto; Universidade do Porto; European Molecular Biology Laboratory (EMBL); Universidade do Porto; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Universidade do Porto	Porto, G (corresponding author), Univ Porto, Inst Invest & Inovacao Saude I3S, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	gporto@ibmc.up.pt	Lima, Margarida/S-7466-2016; Porto, Graca/J-7939-2013	Lima, Margarida/0000-0001-9702-5260; Porto, Graca/0000-0002-1923-4638; Muckenthaler, Martina/0000-0002-3778-510X; Oliveira, Susana Joao/0000-0002-6834-8703; Cruz, Eugenia/0000-0002-4801-5047; Goncalves, Marta/0000-0002-3003-8734; Costa, Monica Isabel/0000-0002-6792-5687	FEDER funds through the Operational Competitiveness Programme - COMPETE; FCT -Fundacao para a Ciencia e a Tecnologia [FCOMP-01-0124-FEDER-008447 (PIC/IC/82785/2007), FCOMP-01-0124-FEDER-015823 (PTDC/SAU/MET/113011/2009)]; FEDER project [NORTE-07-0124-FEDER-000003]; program (ON.2 - O Novo Norte), under cover of Quadro de Referencia Estrategico Nacional (QREN); INOVA/APRF, USA; FCT [SFRH/BD/69186/2010]; Fundação para a Ciência e a Tecnologia [2021.05346.BD, PIC/IC/82785/2007] Funding Source: FCT	FEDER funds through the Operational Competitiveness Programme - COMPETE; FCT -Fundacao para a Ciencia e a Tecnologia(Portuguese Foundation for Science and Technology); FEDER project(European Commission); program (ON.2 - O Novo Norte), under cover of Quadro de Referencia Estrategico Nacional (QREN); INOVA/APRF, USA; FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); Fundação para a Ciência e a Tecnologia	This work was funded by: a) FEDER funds through the Operational Competitiveness Programme - COMPETE and by National Funds through FCT -Fundacao para a Ciencia e a Tecnologia under the projects: FCOMP-01-0124-FEDER-008447 (PIC/IC/82785/2007) and FCOMP-01-0124-FEDER-015823 (PTDC/SAU/MET/113011/2009); b) FEDER project - "NORTE-07-0124-FEDER-000003 - Cell Homeostasis Tissue Organization and Organism Biology" co-funded by the program (ON.2 - O Novo Norte), under cover of Quadro de Referencia Estrategico Nacional (QREN); c) INOVA/APRF, USA grant and d) Monica Costa is recipient of a FCT doctoral fellowship (SFRH/BD/69186/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrian K, 2000, BBA-GENE STRUCT EXPR, V1492, P127, DOI 10.1016/S0167-4781(00)00094-4; Arezes J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079870; Arosa FA, 1997, CLIN EXP IMMUNOL, V107, P548, DOI 10.1046/j.1365-2249.1997.d01-967.x; AROSA FA, 1994, SCAND J IMMUNOL, V39, P426, DOI 10.1111/j.1365-3083.1994.tb03396.x; Babich A, 2013, IMMUNOL REV, V256, P80, DOI 10.1111/imr.12123; Bahram S, 1999, P NATL ACAD SCI USA, V96, P13312, DOI 10.1073/pnas.96.23.13312; Bresgen N, 2007, J CELL PHYSIOL, V212, P157, DOI 10.1002/jcp.21009; Cardoso EM, 2002, BLOOD, V100, P4239, DOI 10.1182/blood-2002-05-1565; Cardoso EMP, 2001, EUR J CLIN INVEST, V31, P45, DOI 10.1046/j.1365-2362.2001.00744.x; Cesaro A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045478; Costa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079990; Cruz E, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-16; Cruz E, 2006, BLOOD CELL MOL DIS, V37, P33, DOI 10.1016/j.bcmd.2006.04.004; Cruz E, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-97; D'Alessio F, 2012, J HEPATOL, V57, P1052, DOI 10.1016/j.jhep.2012.06.015; DESOUSA M, 1988, ANN NY ACAD SCI, V526, P310; DESOUSA M, 1994, IMMUNOL LETT, V39, P105, DOI 10.1016/0165-2478(94)90094-9; DESOUSA M, 1991, CURR STUD HEMATOL BL, V58, P171; DESOUSA M, 1978, AM J PATHOL, V90, P497; Dhanji S, 2004, BLOOD, V104, P2116, DOI 10.1182/blood-2004-01-0150; Fabio G, 2002, J HEPATOL, V37, P753, DOI 10.1016/S0168-8278(02)00276-3; Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399; Gerstmayer B, 2003, GENOMICS, V81, P588, DOI 10.1016/S0888-7543(03)00070-3; Green A, 2011, EPIGENET CHROMATIN, V4, DOI 10.1186/1756-8935-4-15; HASKINS D, 1952, J CLIN INVEST, V31, P543, DOI 10.1172/JCI102639; Khammanivong A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069395; Lim SC, 2011, YONSEI MED J, V52, P581, DOI 10.3349/ymj.2011.52.4.581; Lima M, 2000, Blood Cells Mol Dis, V26, P634, DOI 10.1006/bcmd.2000.0342; Loser K, 2010, NAT MED, V16, P713, DOI 10.1038/nm.2150; Macedo MF, 2010, CLIN EXP IMMUNOL, V159, P363, DOI 10.1111/j.1365-2249.2009.04066.x; Mina-Osorio P, 2004, TRENDS IMMUNOL, V25, P529, DOI 10.1016/j.it.2004.08.008; Monteiro M, 2007, BLOOD, V109, P2863, DOI 10.1182/blood-2006-06-027060; Nakayama T, 2012, ANTICANCER RES, V32, P1367; Nielsen JS, 2012, SCAND J IMMUNOL, V75, P193, DOI 10.1111/j.1365-3083.2011.02613.x; Okhrimenko A, 2014, P NATL ACAD SCI USA, V111, P9229, DOI 10.1073/pnas.1318731111; Peixoto A, 2004, GENOME RES, V14, P1938, DOI 10.1101/gr.2890204; Peixoto A, 2007, J EXP MED, V204, P1193, DOI 10.1084/jem.20062349; Pinto JP, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00024; Porto B, 2009, MUTAT RES-GEN TOX EN, V673, P37, DOI 10.1016/j.mrgentox.2008.11.016; PORTO G, 1994, EUR J HAEMATOL, V52, P283; Porto G, 1997, HEPATOLOGY, V25, P397, DOI 10.1002/hep.510250223; Porto G, 2000, HEMOCHROMATOSIS: GENETICS, PATHOPHYSIOLOGY, DIAGNOSIS AND TREATMENT, P51; Porto G, 2007, WORLD J GASTROENTERO, V13, P4707, DOI 10.3748/wjg.v13.i35.4707; REIMAO R, 1991, CR ACAD SCI III-VIE, V313, P481; Reuben A, 2014, EUR J IMMUNOL, V44, P1604, DOI 10.1002/eji.201343955; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Saadeldien HM, 2012, ULTRASTRUCT PATHOL, V36, P89, DOI 10.3109/01913123.2011.630125; Sallusto F, 2009, EUR J IMMUNOL, V39, P2076, DOI 10.1002/eji.200939722; Schenkel JM, 2014, J IMMUNOL, V192, P2961, DOI 10.4049/jimmunol.1400003; Schroll A, 2012, EUR J IMMUNOL, V42, P3346, DOI 10.1002/eji.201142351; SIMON M, 1987, AM J HUM GENET, V41, P89; Starheim KK, 2009, MOL CELL BIOL, V29, P3569, DOI 10.1128/MCB.01909-08; Willinger T, 2006, J IMMUNOL, V176, P1439, DOI 10.4049/jimmunol.176.3.1439	54	17	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124246	10.1371/journal.pone.0124246	http://dx.doi.org/10.1371/journal.pone.0124246			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880808	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500092
J	Ferrieri, AP; Appel, HM; Schultz, JC				Ferrieri, Abigail P.; Appel, Heidi M.; Schultz, Jack C.			Plant Vascular Architecture Determines the Pattern of Herbivore-Induced Systemic Responses in Arabidopsis thaliana	PLOS ONE			English	Article							ACQUIRED-RESISTANCE; DEVELOPING LEAVES; OPTIMAL DEFENSE; WOUND RESPONSE; INDUCTION; ONTOGENY; PHLOEM; GROWTH; ACID; GENE	The induction of systemic responses in plants is associated with the connectivity between damaged and undamaged leaves, as determined by vascular architecture. Despite the widespread appreciation for studying variation in induced plant defense, few studies have characterized spatial variability of induction in the model species, Arabidopsis thaliana. Here we show that plant architecture generates fine scale spatial variation in the systemic induction of invertase and phenolic compounds. We examined whether the arrangement of leaves along the stem (phyllotaxy) produces predictable spatial patterns of cell-wall bound and soluble invertase activities, and downstream phenolic accumulation following feeding by the dietary specialist herbivore, Pieris rapae and the generalist, Spodoptera exigua. Responses were measured in leaves within and outside of the damaged orthostichy (leaves sharing direct vascular connections), and compared to those from plants where source-sink transport was disrupted by source leaf removal and by an insertional mutation in a sucrose transporter gene (suc2-1). Following herbivore damage to a single, middle-aged leaf, induction of cell-wall and soluble invertase was most pronounced in young and old leaves within the damaged orthostichy. The pattern of accumulation of phenolics was also predicted by these vascular connections and was, in part, dependent on the presence of source leaves and intact sucrose transporter function. Induction also occurred in leaves outside of the damaged orthostichy, suggesting that mechanisms may exist to overcome vascular constraints in this system. Our results demonstrate that systemic responses vary widely according to orthostichy, are often herbivore-specific, and partially rely on transport between source and sink leaves. We also provide evidence that patterns of induction are more integrated in A. thaliana than previously described. This work highlights the importance of plant vascular architecture in determining patterns of systemic induction, which is likely to be ecologically important to insect herbivores and plant pathogens.	[Ferrieri, Abigail P.] Max Planck Inst Chem Ecol, Root Herbivore Interact Grp, Jena, Germany; [Appel, Heidi M.; Schultz, Jack C.] Univ Missouri, Div Plant Sci, Bond Life Sci Ctr, Columbia, MO USA	Max Planck Society; University of Missouri System; University of Missouri Columbia	Ferrieri, AP (corresponding author), Max Planck Inst Chem Ecol, Root Herbivore Interact Grp, Jena, Germany.	aferrieri@ice.mpg.de	Schultz, Jack C./V-8661-2019		National Science Foundation [IOS-0805272]; University of Missouri Life Sciences Fellowship Program	National Science Foundation(National Science Foundation (NSF)); University of Missouri Life Sciences Fellowship Program	Research was supported by National Science Foundation grant IOS-0805272 to JCS and HMA, and the University of Missouri Life Sciences Fellowship Program, which supported APF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 1999, J CHEM ECOL, V25, P2285, DOI 10.1023/A:1020821823794; Appel HM, 2001, J CHEM ECOL, V27, P761, DOI 10.1023/A:1010306103643; Appel HM, 2014, FRONT PLANT IN PRESS; Arnold T, 2004, NEW PHYTOL, V164, P157, DOI 10.1111/j.1469-8137.2004.01157.x; Arnold TM, 2012, PLANT SIGNAL BEHAV, V7, P1498, DOI 10.4161/psb.21900; Arnold TM, 2002, OECOLOGIA, V130, P585, DOI 10.1007/s00442-001-0839-7; Barto EK, 2005, OECOLOGIA, V146, P169, DOI 10.1007/s00442-005-0207-0; Barton KE, 2010, AM NAT, V175, P481, DOI 10.1086/650722; Bowles D, 1998, PHILOS T R SOC B, V353, P1495, DOI 10.1098/rstb.1998.0305; CALLOS JD, 1994, PLANT J, V6, P1, DOI 10.1046/j.1365-313X.1994.6010001.x; Choi S, 2009, PLANT SCI, V176, P678, DOI 10.1016/j.plantsci.2009.02.010; Cipollini DF, 2000, J CHEM ECOL, V26, P1411, DOI 10.1023/A:1005540107957; DAVIS JM, 1991, P NATL ACAD SCI USA, V88, P2393, DOI 10.1073/pnas.88.6.2393; Diezel C, 2009, PLANT PHYSIOL, V150, P1576, DOI 10.1104/pp.109.139550; Ferrieri AP, 2013, PLANT PHYSIOL, V161, P692, DOI 10.1104/pp.112.208868; Ferrieri AP, 2012, NUCL MED BIOL, V39, P1152, DOI 10.1016/j.nucmedbio.2012.06.005; Frost CJ, 2007, ECOL LETT, V10, P490, DOI 10.1111/j.1461-0248.2007.01043.x; Fukumoto LR, 2000, J AGR FOOD CHEM, V48, P3597, DOI 10.1021/jf000220w; Gottwald JR, 2000, P NATL ACAD SCI USA, V97, P13979, DOI 10.1073/pnas.250473797; Halitschke R, 2001, PLANT PHYSIOL, V125, P711, DOI 10.1104/pp.125.2.711; Hanik N, 2010, J CHEM ECOL, V36, P1058, DOI 10.1007/s10886-010-9835-x; Haritatos E, 2000, PLANTA, V211, P105, DOI 10.1007/s004250000268; HARPER JL, 1989, OECOLOGIA, V80, P53, DOI 10.1007/BF00789931; Heil M, 2008, TRENDS PLANT SCI, V13, P264, DOI 10.1016/j.tplants.2008.03.005; Heil M, 2007, P NATL ACAD SCI USA, V104, P5467, DOI 10.1073/pnas.0610266104; Kearsley MJC, 1998, ECOLOGY, V79, P178, DOI 10.1890/0012-9658(1998)079[0178:TDSOCA]2.0.CO;2; Kiefer IW, 2003, PLANT PHYSIOL, V132, P840, DOI 10.1104/pp.103.021709; Kozlowski T.T., 1997, GROWTH CONTROL WOODY, P352; LARSON PR, 1973, PLANTA, V111, P95, DOI 10.1007/BF00386270; McCartney N., 2007, ANAL PIERIS RAPAE SP; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Ohnmeiss TE, 2000, ECOLOGY, V81, P1765, DOI 10.1890/0012-9658(2000)081[1765:ODTPTO]2.0.CO;2; Orians C, 2005, J CHEM ECOL, V31, P2231, DOI 10.1007/s10886-005-7099-7; Orians CM, 2000, J CHEM ECOL, V26, P471, DOI 10.1023/A:1005469724427; Orians CM, 2001, OIKOS, V94, P493, DOI 10.1034/j.1600-0706.2001.940311.x; Rehrig EM, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00407; Reymond P, 1998, CURR OPIN PLANT BIOL, V1, P404, DOI 10.1016/S1369-5266(98)80264-1; Rhodes JD, 1999, ANN BOT-LONDON, V84, P109, DOI 10.1006/anbo.1999.0900; Richard S, 2000, PLANT CELL PHYSIOL, V41, P982, DOI 10.1093/pcp/pcd017; Roberts K, 2007, NEW PHYTOL, V175, P707, DOI 10.1111/j.1469-8137.2007.02136.x; Ryan CA, 2000, BBA-PROTEIN STRUCT M, V1477, P112, DOI 10.1016/S0167-4838(99)00269-1; Schittko U, 2003, J CHEM ECOL, V29, P763, DOI 10.1023/A:1022833022672; Schultz J.C., 1983, P61; Schultz JC, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00324; SCHULTZ JC, 1982, SCIENCE, V217, P149, DOI 10.1126/science.217.4555.149; Shao L, 2008, FUNCT PLANT BIOL, V35, P714, DOI 10.1071/FP08069; SHULAEV V, 1995, PLANT CELL, V7, P1691, DOI 10.1105/tpc.7.10.1691; Stadler R, 1996, BOT ACTA, V109, P299, DOI 10.1111/j.1438-8677.1996.tb00577.x; Steinbrenner AD, 2011, J CHEM ECOL, V37, P1294, DOI 10.1007/s10886-011-0042-1; Stratmann JW, 2003, TRENDS PLANT SCI, V8, P247, DOI 10.1016/S1360-1385(03)00106-7; Thorpe Michael, 2005, P201, DOI 10.1016/B978-012088457-5/50012-5; Thorpe MR, 2007, PLANTA, V226, P541, DOI 10.1007/s00425-007-0503-5; Turgeon R, 2006, BIOSCIENCE, V56, P15, DOI 10.1641/0006-3568(2006)056[0015:PLHLGT]2.0.CO;2; Van Dam NM, 2001, J CHEM ECOL, V27, P547, DOI 10.1023/A:1010341022761; Viswanathan DV, 2004, J CHEM ECOL, V30, P531, DOI 10.1023/B:JOEC.0000018627.26420.e0; Whitham T.G., 1983, P15; WHITHAM TG, 1981, OECOLOGIA, V49, P287, DOI 10.1007/BF00347587	57	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123899	10.1371/journal.pone.0123899	http://dx.doi.org/10.1371/journal.pone.0123899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879926	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500065
J	Johnson, KA; Burrowes, E; Coull, JT				Johnson, Katherine A.; Burrowes, Emma; Coull, Jennifer T.			Children Can Implicitly, but Not Voluntarily, Direct Attention in Time	PLOS ONE			English	Article							AGE-RELATED-CHANGES; UNINTENTIONAL CONTRIBUTIONS; NONSPECIFIC PREPARATION; PREPARATORY INTERVAL; ORIENTING ATTENTION; TEMPORAL BISECTION; PERCEPTION; FOREPERIOD; INFANTS; DISSOCIATIONS	Children are able to use spatial cues to orient their attention to discrete locations in space from around 4 years of age. In contrast, no research has yet investigated the ability of children to use informative cues to voluntarily predict when an event will occur in time. The spatial and temporal attention task was used to determine whether children were able to voluntarily orient their attention in time, as well as in space: symbolic spatial and temporal cues predicted where or when an imperative target would appear. Thirty typically developing children (average age 11 yrs) and 32 adults (average age 27 yrs) took part. Confirming previous findings, adults made use of both spatial and temporal cues to optimise behaviour, and were significantly slower to respond to invalidly cued targets in either space or time. Children were also significantly slowed by invalid spatial cues, demonstrating their use of spatial cues to guide expectations. In contrast, children's responses were not slowed by invalid temporal cues, suggesting that they were not using the temporal cue to voluntarily orient attention through time. Children, as well as adults, did however demonstrate signs of more implicit forms of temporal expectation: RTs were faster for long versus short cue-target intervals (the variable foreperiod effect) and slower when the preceding trial's cue-target interval was longer than that on the current trial (sequential effects). Overall, our results suggest that although children implicitly made use of the temporally predictive information carried by the length of the current and previous trial's cue-target interval, they could not deliberately use symbolic temporal cues to speed responses. The developmental trajectory of the ability to voluntarily use symbolic temporal cues is therefore delayed, relative both to the use of symbolic (arrow) spatial cues, and to the use of implicit temporal information.	[Johnson, Katherine A.; Burrowes, Emma] Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia; [Coull, Jennifer T.] Aix Marseille Univ, Lab Neurosci Cognit, Marseille, France; [Coull, Jennifer T.] CNRS, Marseille, France	University of Melbourne; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Johnson, KA (corresponding author), Univ Melbourne, Sch Psychol Sci, Parkville, Vic 3052, Australia.	kajo@unimelb.edu.au	Coull, Jennifer T/M-4243-2015; Johnson, Katherine A/K-8469-2015	Coull, Jennifer T/0000-0002-8790-5835; Johnson, Katherine A/0000-0002-2029-163X				[Anonymous], 2012, COGNITIVE NEUROSCIEN; BAUMEIST.AA, 1969, J EXP PSYCHOL, V82, P393, DOI 10.1037/h0028119; Bayless SJ, 2013, BRAIN TOPOGR, V26, P616, DOI 10.1007/s10548-013-0279-9; Berwanger D, 2004, ACTA NEUROBIOL EXP, V64, P387; Besson M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00094; Bolger D, 2014, J COGNITIVE NEUROSCI, V26, P593, DOI 10.1162/jocn_a_00511; Brannon EM, 2007, DEVELOPMENTAL SCI, V10, P770, DOI 10.1111/j.1467-7687.2007.00635.x; Brannon EM, 2004, COGNITIVE BRAIN RES, V21, P227, DOI 10.1016/j.cogbrainres.2004.04.007; Breska A, 2014, J COGNITIVE NEUROSCI, V26, P1555, DOI 10.1162/jocn_a_00564; Cason N, 2012, NEUROPSYCHOLOGIA, V50, P2652, DOI 10.1016/j.neuropsychologia.2012.07.018; Colombo J, 2002, PSYCHOL SCI, V13, P475, DOI 10.1111/1467-9280.00484; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Cotti J, 2011, NEUROIMAGE, V54, P1221, DOI 10.1016/j.neuroimage.2010.09.038; Coull JT, 2013, NEUROPSYCHOLOGIA, V51, P309, DOI 10.1016/j.neuropsychologia.2012.08.017; Coull JT, 2011, PSYCHOPHARMACOLOGY, V218, P543, DOI 10.1007/s00213-011-2346-9; Coull JT, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.010.2008; Coull JT, 2000, NEUROPSYCHOLOGIA, V38, P808, DOI 10.1016/S0028-3932(99)00132-3; Coull JT, 2001, CEREB CORTEX, V11, P73, DOI 10.1093/cercor/11.1.73; Coull JT, 1998, J NEUROSCI, V18, P7426; Doherty JR, 2005, J NEUROSCI, V25, P8259, DOI 10.1523/JNEUROSCI.1821-05.2005; Droit-Volet S, 2001, J EXP CHILD PSYCHOL, V80, P271, DOI 10.1006/jecp.2001.2629; Droit-Volet S, 2001, J EXP CHILD PSYCHOL, V80, P142, DOI 10.1006/jecp.2001.2631; Droit-Volet S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071424; Droit-Volet S, 2013, NEUROPSYCHOLOGIA, V51, P220, DOI 10.1016/j.neuropsychologia.2012.09.023; ELLIOTT R, 1970, J EXP CHILD PSYCHOL, V9, P86, DOI 10.1016/0022-0965(70)90102-5; Fan J, 2002, J COGNITIVE NEUROSCI, V14, P340, DOI 10.1162/089892902317361886; Flaugnacco E, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00392; Greenwood PM., 1994, AGING NEUROPSYCHOL C, V1, P188, DOI [10.1080/13825589408256576, DOI 10.1080/13825589408256576]; Griffin IC, 2002, NEUROPSYCHOLOGIA, V40, P2325, DOI 10.1016/S0028-3932(02)00087-8; HARMAN C, 1994, CAN J EXP PSYCHOL, V48, P301, DOI 10.1037/1196-1961.48.2.301; Johnson KA, 2008, J CHILD PSYCHOL PSYC, V49, P1339, DOI 10.1111/j.1469-7610.2008.01936.x; KARLIN L, 1959, J EXP PSYCHOL, V58, P185, DOI 10.1037/h0049152; Khalil AK, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00564; Los SA, 2005, J EXP PSYCHOL GEN, V134, P52, DOI 10.1037/0096-3445.134.1.52; Los SA, 2001, J EXP PSYCHOL HUMAN, V27, P370, DOI 10.1037/0096-1523.27.2.370; Luce RD, 1986, RESPONSE TIMES THEIR; Marchant JL, 2013, CEREB CORTEX, V23, P1290, DOI 10.1093/cercor/bhs095; Mento G, 2015, J COGNITIVE NEUROSCI, V27, P425, DOI 10.1162/jocn_a_00715; MUIR DW, 1994, SPATIAL VISION, V8, P141, DOI 10.1163/156856894X00288; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; Nobre AC, 2004, COGNITIVE NEUROSCIEN, P157; Olk B, 2008, VIS COGN, V16, P979, DOI 10.1080/13506280701848921; Olk B, 2014, EXP BRAIN RES, V232, P3623, DOI 10.1007/s00221-014-4033-7; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; POSNER MI, 1980, Q J EXP PSYCHOL, V32, P3, DOI 10.1080/00335558008248231; Provasi J, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.01048; Provasi J, 2011, J EXP PSYCHOL ANIM B, V37, P108, DOI 10.1037/a0019976; Richards JE, 2000, DEV PSYCHOL, V36, P91, DOI 10.1037/0012-1649.36.1.91; Ristic J, 2002, PSYCHON B REV, V9, P507, DOI 10.3758/BF03196306; Ristic J, 2006, Q J EXP PSYCHOL, V59, P1921, DOI 10.1080/17470210500416367; Ristic J, 2009, DEVELOPMENTAL SCI, V12, P289, DOI 10.1111/j.1467-7687.2008.00756.x; Robertson SS, 2012, P NATL ACAD SCI USA, V109, P11460, DOI 10.1073/pnas.1203482109; Rohenkohl G, 2014, J VISION, V14, DOI 10.1167/14.4.8; Rohenkohl G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014620; Rueda MR, 2004, NEUROPSYCHOLOGIA, V42, P1029, DOI 10.1016/j.neuropsychologia.2003.12.012; Trainor LJ, 2012, INT J PSYCHOPHYSIOL, V83, P256, DOI 10.1016/j.ijpsycho.2011.12.008; TREHUB SE, 1989, CAN J PSYCHOL, V43, P217, DOI 10.1037/h0084223; Trivino M, 2011, NEUROPSYCHOLOGIA, V49, P3917, DOI 10.1016/j.neuropsychologia.2011.10.009; Vallesi A, 2007, J EXP PSYCHOL HUMAN, V33, P1377, DOI 10.1037/0096-1523.33.6.1377; Vallesi A, 2014, COGNITION, V130, P141, DOI 10.1016/j.cognition.2013.10.006; Vallesi A, 2013, COGNITION, V127, P22, DOI 10.1016/j.cognition.2012.11.011; Vallesi A, 2009, J COGNITIVE NEUROSCI, V21, P1116, DOI 10.1162/jocn.2009.21098; Vanmarle K, 2006, DEVELOPMENTAL SCI, V9, pF41, DOI 10.1111/j.1467-7687.2006.00508.x; Woodrow H, 1914, PSYCHOL MONOGR, V17, P1; Zanto TP, 2011, J NEUROSCI, V31, P12461, DOI 10.1523/JNEUROSCI.1149-11.2011; Zelanti PS, 2011, J EXP CHILD PSYCHOL, V109, P143, DOI 10.1016/j.jecp.2011.01.003	66	19	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123625	10.1371/journal.pone.0123625	http://dx.doi.org/10.1371/journal.pone.0123625			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25881188	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500057
J	Michalopoulos, LTM; Murray, LK; Kane, JC; van Wyk, SS; Chomba, E; Cohen, J; Imasiku, M; Semrau, K; Unick, J; Bolton, PA				Michalopoulos, Lynn T. M.; Murray, Laura K.; Kane, Jeremy C.; van Wyk, Stephanie Skavenski; Chomba, Elwyn; Cohen, Judith; Imasiku, Mwiya; Semrau, Katherine; Unick, Jay; Bolton, Paul A.			Testing the Validity and Reliability of the Shame Questionnaire among Sexually Abused Girls in Zambia	PLOS ONE			English	Article							HIV-POSITIVE ADULTS; POSTTRAUMATIC-STRESS; PSYCHOMETRIC PROPERTIES; RISK-FACTORS; CHILDREN; SYMPTOMS; PTSD; IMPACT; STUDENTS; HISTORY	Purpose The aim of the current study is to test the validity and reliability of the Shame Questionnaire among traumatized girls in Lusaka, Zambia. Methods The Shame Questionnaire was validated through both classical test and item response theory methods. Internal reliability, criterion validity and construct validity were examined among a sample of 325 female children living in Zambia. Sub-analyses were conducted to examine differences in construct validity among girls who reported sexual abuse and girls who did not. Results All girls in the sample were sexually abused, but only 61.5% endorsed or reported that sexual abuse had occurred. Internal consistency was very good among the sample with alpha = .87. Criterion validity was demonstrated through a significant difference of mean Shame Questionnaire scores between girls who experienced 0-1 trauma events and more than one traumatic event, with higher mean Shame Questionnaire scores among girls who had more than one traumatic event (p = .004 for 0-1 compared to 2 and 3 events and p = .016 for 0-1 compared to 4+ events). Girls who reported a history of witnessing or experiencing physical abuse had a significantly higher mean Shame Questionnaire score than girls who did not report a history of witnessing or experiencing physical abuse (p<.0001). There was no significant difference in mean Shame Questionnaire score between girls who reported a sexual abuse history and girls who did not. Exploratory factor analysis indicated a two-factor model of the Shame Questionnaire, with an experience of shame dimension and an active outcomes of shame dimension. Item response theory analysis indicated adequate overall item fit. Results also indicate potential differences in construct validity between girls who did and did not endorse sexual abuse. Conclusions This study suggests the general utility of the Shame Questionnaire among Zambian girls and demonstrates the need for more psychometric studies in low and middle income countries.	[Michalopoulos, Lynn T. M.] Columbia Univ, Sch Social Work, Social Intervent Grp, Global Hlth Res Ctr Cent Asia, New York, NY 10027 USA; [Murray, Laura K.; Bolton, Paul A.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Int Hlth, Ctr Refugee & Disaster Response, Baltimore, MD USA; [Kane, Jeremy C.; van Wyk, Stephanie Skavenski] Johns Hopkins Univ, Dept Mental Hlth, Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Chomba, Elwyn] Minist Community Dev Mother Child Hlth, Lusaka, Zambia; [Cohen, Judith] Drexel Univ, Coll Med, Allegheny Gen Hosp, Ctr Traumat Stress Children & Adolescents, Pittsburgh, PA USA; [Imasiku, Mwiya] Univ Zambia, Sch Med, Lusaka, Zambia; [Semrau, Katherine] Boston Univ, Sch Publ Hlth, Ctr Global Hlth & Dev, Boston, MA USA; [Unick, Jay] Univ Maryland, Sch Social Work, Baltimore, MD 21201 USA	Columbia University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Allegheny General Hospital; Drexel University; University of Zambia; Boston University; University System of Maryland; University of Maryland Baltimore	Michalopoulos, LTM (corresponding author), Columbia Univ, Sch Social Work, Social Intervent Grp, Global Hlth Res Ctr Cent Asia, New York, NY 10027 USA.	lm2996@columbia.edu	Imasiku, Liamunga Mwiya/H-2986-2019	Semrau, Katherine/0000-0002-8360-1391	National Institute of Mental Health (NIMH) [K23MH077532, K23]; Centers for Disease Control and Prevention in Zambia (CDC-Zambia); NIDA training grant in Drug Dependence Epidemiology [T32DA007292]; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH077532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007292] Funding Source: NIH RePORTER	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Centers for Disease Control and Prevention in Zambia (CDC-Zambia); NIDA training grant in Drug Dependence Epidemiology; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was funded by a K23 grant for LKM from the National Institute of Mental Health (NIMH: K23MH077532) and the Centers for Disease Control and Prevention in Zambia (CDC-Zambia). Mr. Kane's contribution was supported by a NIDA training grant in Drug Dependence Epidemiology (T32DA007292; PI: Furr-Holden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bass JK, 2007, LANCET, V370, P918, DOI 10.1016/S0140-6736(07)61426-3; Betancourt TS, 2009, SOC PSYCH PSYCH EPID, V44, P685, DOI 10.1007/s00127-008-0475-1; Bolton P, 2001, J NERV MENT DIS, V189, P238, DOI 10.1097/00005053-200104000-00005; Budden A, 2009, SOC SCI MED, V69, P1032, DOI 10.1016/j.socscimed.2009.07.032; Chen LP, 2010, MAYO CLIN PROC, V85, P618, DOI 10.4065/mcp.2009.0583; Chomba E, 2010, J TROP MED-US, V2010, DOI 10.1155/2010/864760; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; De Ayala R.J., 2009, THEORY PRACTICE ITEM; Deblinger E, 2006, J AM ACAD CHILD PSY, V45, P1474, DOI 10.1097/01.chi.0000240839.56114.bb; Dickerson SS, 2004, J PERS, V72, P1191, DOI 10.1111/j.1467-6494.2004.00295.x; Dorahy MJ, 2013, J AFFECT DISORDERS, V147, P72, DOI 10.1016/j.jad.2012.10.010; DWECK CS, 1988, PSYCHOL REV, V95, P256, DOI 10.1037/0033-295X.95.2.256; Embretson S. E., 2013, ITEM RESPONSE THEORY; Fawzi MCS, 1997, J TRAUMA STRESS, V10, P101, DOI 10.1002/jts.2490100109; Feiring C, 2005, CHILD MALTREATMENT, V10, P337, DOI 10.1177/1077559505276686; Feiring C, 2002, DEV PSYCHOL, V38, P79, DOI 10.1037//0012-1649.38.1.79; Feiring C., 1998, CHILD MALTREATMENT, V3, P129, DOI [DOI 10.1177/1077559598003002007, https://doi.org/10.1177/1077559598003002007]; Feiring C, 2007, CHILD MALTREATMENT, V12, P220, DOI 10.1177/1077559507301840; Gilbert R, 2009, LANCET, V373, P68, DOI 10.1016/S0140-6736(08)61706-7; Group AMHR, 2000, DIME PROGR RES MOD D; Hardt J, 2004, J CHILD PSYCHOL PSYC, V45, P260, DOI 10.1111/j.1469-7610.2004.00218.x; Hutcheson G. D., 1999, MULTIVARIATE SOCIAL; Kessler RC, 2010, BRIT J PSYCHIAT, V197, P378, DOI 10.1192/bjp.bp.110.080499; King DW, 1993, PSYCHOL ASSESSMENT, V5, P457, DOI DOI 10.1037/1040-3590.5.4.457; LaGreca AM, 1996, J CONSULT CLIN PSYCH, V64, P712, DOI 10.1037/0022-006X.64.4.712; Lalor K, 2004, CHILD ABUSE NEGLECT, V28, P439, DOI 10.1016/j.chiabu.2003.07.005; Laor N, 2002, J NERV MENT DIS, V190, P824, DOI 10.1097/00005053-200212000-00004; Leskela J, 2002, J TRAUMA STRESS, V15, P223, DOI 10.1023/A:1015255311837; Lewis M., 1995, SHAME EXPOSED SELF; LONIGAN CJ, 1994, J AM ACAD CHILD PSY, V33, P94, DOI 10.1097/00004583-199401000-00013; Madu SN, 2000, CHILD ABUSE NEGLECT, V24, P259, DOI 10.1016/S0145-2134(99)00128-3; McCrann D, 2006, CHILD ABUSE NEGLECT, V30, P1343, DOI 10.1016/j.chiabu.2006.05.009; Mels C, 2010, SOC PSYCH PSYCH EPID, V45, P899, DOI 10.1007/s00127-009-0128-z; Meursing K, 1995, SOC SCI MED, V41, P1693, DOI 10.1016/0277-9536(95)00130-Y; Montgomery E, 2006, INT J METH PSYCH RES, V15, P64, DOI 10.1002/mpr.186; Murray LK, 2006, J NERV MENT DIS, V194, P610, DOI 10.1097/01.nmd.0000230662.01953.bc; Murray LK, 2011, INT J MENT HEAL SYST, V5, P5; NADER KO, 1993, BRIT J CLIN PSYCHOL, V32, P407, DOI 10.1111/j.2044-8260.1993.tb01075.x; Neufeld SAS, 2012, AIDS BEHAV, V16, P1063, DOI 10.1007/s10461-011-0086-9; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Pereda N, 2009, CLIN PSYCHOL REV, V29, P328, DOI 10.1016/j.cpr.2009.02.007; Persons E, 2010, AIDS PATIENT CARE ST, V24, P571, DOI 10.1089/apc.2009.0209; Putnam FW, 2003, J AM ACAD CHILD PSY, V42, P269, DOI 10.1097/00004583-200303000-00006; Roth S, 1997, J TRAUMA STRESS, V10, P539, DOI 10.1002/jts.2490100403; Sack WH, 1998, PERS INDIV DIFFER, V25, P57, DOI 10.1016/S0191-8869(98)00030-0; Shaw JA, 2003, TERRORISM DISASTER I, P41; Sikkema KJ, 2009, ARCH SEX BEHAV, V38, P121, DOI 10.1007/s10508-007-9238-4; Steinberg Alan M, 2004, Curr Psychiatry Rep, V6, P96, DOI 10.1007/s11920-004-0048-2; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Stroebel SS, 2012, J CHILD SEX ABUS, V21, P176, DOI 10.1080/10538712.2012.654007; Talbot JA, 2004, J TRAUMA STRESS, V17, P445, DOI 10.1023/B:JOTS.0000048959.29766.ae; Tangney JP, 1996, BEHAV RES THER, V34, P741, DOI 10.1016/0005-7967(96)00034-4; Tangney June Price, 1995, P343; Tarakeshwar N, 2005, MENT HEALTH RELIG CU, V8, P179, DOI 10.1080/13694670500138908; TERESI JA, 2001, J MENTAL HLTH AGING, V7, P31; Unick GJ, 2010, SOC WORK RES, V34, P94, DOI 10.1093/swr/34.2.94; Vernberg EM, 1996, J ABNORM PSYCHOL, V105, P237, DOI 10.1037/0021-843X.105.2.237; Widom CS, 1997, PSYCHOL ASSESSMENT, V9, P34, DOI 10.1037/1040-3590.9.1.34; Wright BD., 1994, RASCH MEASUREMENT T, V8, P370, DOI DOI 10.1177/01461672012710004; Wu M, 2012, ACER CONQUEST VERSIO	60	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123820	10.1371/journal.pone.0123820	http://dx.doi.org/10.1371/journal.pone.0123820			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25879658	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500062
J	Schriever, TA				Schriever, Tiffany A.			Food Webs in Relation to Variation in the Environment and Species Assemblage: A Multivariate Approach	PLOS ONE			English	Article							STABLE-ISOTOPE RATIOS; COMMUNITY-WIDE MEASURES; CHAIN LENGTH; ECOSYSTEM SIZE; DELTA-N-15; HYDROPERIOD; TEMPERATURE; DISTURBANCE; MECHANISMS; ENRICHMENT	The abiotic environment has strong influences on the growth, survival, behavior, and ecology of aquatic organisms. Biotic interactions and species life histories interact with abiotic factors to structure the food web. One measure of food-web structure is food-chain length. Several hypotheses predict a linear relationship between one environmental variable (e.g., disturbance or ecosystem size) and food-chain length. However, many abiotic and biotic variables interact in diverse ways to structure a community, and may affect other measures of food web structure besides food-chain length. This study took a multivariate approach to test the influence of several important environmental variables on four food-web characteristics measured in nine ponds along a hydroperiod gradient over two years. This approach allowed for testing the ecosystem size and dynamic constraints hypotheses while in context of other possibly interacting environmental variables. The relationship between amphibian and invertebrate communities and pond habitat variables was assessed to understand the underlying food-web structure. Hydroperiod and pond area had a strong influence on amphibian and invertebrate communities, trophic diversity and delta N-15 range. The range in delta C-13 values responded strongly to dissolved oxygen. Food-chain length responded to multiple environmental variables. Invertebrate and amphibian communities were structured by pond hydroperiod which in turn influenced the trophic diversity of the food web. The results of this study suggest food-chain length is influenced by environmental variation and species assemblage and that a multivariate approach may allow us to better understand the dynamics within and across aquatic food webs.	[Schriever, Tiffany A.] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	Schriever, TA (corresponding author), Oregon State Univ, Dept Integrat Biol, Corvallis, OR 97331 USA.	tiffany.schriever@gmail.com			Natural Sciences and engineering research council of Canada; Center for Global Change Science at the University of Toronto; Chicago Herpetological Society	Natural Sciences and engineering research council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Center for Global Change Science at the University of Toronto; Chicago Herpetological Society	The author was supported by Ph.D. advisor (DD Williams, Natural Sciences and engineering research council of Canada Discovery Grant) from 2007 to 2011 to complete the research detailed in this study. TAS received small grants including a graduate student research award in 2009 from the Center for Global Change Science at the University of Toronto and a grant from the Chicago Herpetological Society in 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTIG R, 1984, HERPETOLOGICA, V40, P212; ALTIG R, 1970, Herpetologica, V26, P180; [Anonymous], 2010, SALAMANDERS US CANAD; Barber C., 2012, GEOMETRY MESH GENERA; Batzer DP, 1996, ANNU REV ENTOMOL, V41, P75, DOI 10.1146/annurev.en.41.010196.000451; Beveridge OS, 2010, J ANIM ECOL, V79, P693, DOI 10.1111/j.1365-2656.2010.01662.x; Blaustein L, 2001, ISR J ZOOL, V47, P303, DOI 10.1560/CKMU-Q2PM-HTGC-P9C8; Cabana G, 1996, P NATL ACAD SCI USA, V93, P10844, DOI 10.1073/pnas.93.20.10844; Caut S, 2009, J APPL ECOL, V46, P443, DOI 10.1111/j.1365-2664.2009.01620.x; Cornwell WK, 2006, ECOLOGY, V87, P1465, DOI 10.1890/0012-9658(2006)87[1465:ATTFHF]2.0.CO;2; FRY B, 1991, ECOLOGY, V72, P2293, DOI 10.2307/1941580; Gotelli NJ, 2013, ECOSIMR 1 00; Hecky RE, 1995, J N AM BENTHOL SOC, V14, P631, DOI 10.2307/1467546; Hoeinghaus DJ, 2008, ECOLOGY, V89, P2353, DOI 10.1890/07-1143.1; Hoekman D, 2010, ECOLOGY, V91, P2819, DOI 10.1890/10-0260.1; JACKSON DA, 1993, CAN J FISH AQUAT SCI, V50, P2641, DOI 10.1139/f93-287; Layman CA, 2007, ECOLOGY, V88, P42, DOI 10.1890/0012-9658(2007)88[42:CSIRPF]2.0.CO;2; Legendre P., 2012, NUMERICAL ECOLOGY; Magnusson AK, 2006, ARCH HYDROBIOL, V165, P537, DOI 10.1127/0003-9136/2006/0165-0537; Marshall SA, 2006, INSECTS NATURAL HIST; McCutchan JH, 2003, OIKOS, V102, P378, DOI 10.1034/j.1600-0706.2003.12098.x; Merritt R.W., 1996, INTRO AQUATIC INSECT; MINAGAWA M, 1984, GEOCHIM COSMOCHIM AC, V48, P1135, DOI 10.1016/0016-7037(84)90204-7; O'Neill BJ, 2014, FRESHWATER BIOL, V59, P1462, DOI 10.1111/fwb.12358; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Persson Lennart, 1996, P396; PETERSON BJ, 1987, ANNU REV ECOL SYST, V18, P293, DOI 10.1146/annurev.es.18.110187.001453; PIMM SL, 1977, NATURE, V268, P329, DOI 10.1038/268329a0; PIMM SL, 1982, FOOD WEBS; Post DM, 2007, OECOLOGIA, V152, P179, DOI 10.1007/s00442-006-0630-x; Post DM, 2007, OIKOS, V116, P775, DOI 10.1111/j.2007.0030-1299.15552.x; Post DM, 2002, ECOLOGY, V83, P703, DOI 10.2307/3071875; Post DM, 2000, NATURE, V405, P1047, DOI 10.1038/35016565; Post DM, 2002, TRENDS ECOL EVOL, V17, P269, DOI 10.1016/S0169-5347(02)02455-2; R Core Team, 2013, LANG ENV STAT COMP, DOI [DOI 10.3758/S13428-013-0330-5, 10.3758/s13428-013-0330-5]; Sabo JL, 2009, ANN NY ACAD SCI, V1162, P187, DOI 10.1111/j.1749-6632.2009.04445.x; Schmidt SN, 2007, ECOLOGY, V88, P2793, DOI 10.1890/07-0121.1; Schneider DW, 1996, J N AM BENTHOL SOC, V15, P64, DOI 10.2307/1467433; SCHOENER TW, 1989, ECOLOGY, V70, P1559, DOI 10.2307/1938088; Schriever TA, 2013, FRESHW SCI, V32, P964, DOI 10.1899/13-008.1; Snodgrass JW, 2000, CONSERV BIOL, V14, P414, DOI 10.1046/j.1523-1739.2000.99161.x; SYSTAT, 2007, MYSTAT; Takimoto G, 2012, ECOL RES, P1; Takimoto G, 2008, ECOLOGY, V89, P3001, DOI 10.1890/07-1990.1; Turner TF, 2010, ECOLOGY, V91, P2227, DOI 10.1890/09-1454.1; Vander Zanden MJ, 2007, OIKOS, V116, P1378, DOI 10.1111/j.2007.0030-1299.16036.x; Vander Zanden MJ, 1999, ECOLOGY, V80, P1395; Vander Zanden MJ, 2001, LIMNOL OCEANOGR, V46, P2061; Vander Zanden MJ, 1999, AM NAT, V154, P406, DOI 10.1086/303250; Vanderklift MA, 2003, OECOLOGIA, V136, P169, DOI 10.1007/s00442-003-1270-z; Walters AW, 2008, ECOLOGY, V89, P3261, DOI 10.1890/08-0273.1; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; Williams DD., 2006, BIOL TEMPORARY WATER; Winemiller KO, 2007, MAR ECOL PROG SER, V343, P63, DOI 10.3354/meps06884	54	12	12	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122719	10.1371/journal.pone.0122719	http://dx.doi.org/10.1371/journal.pone.0122719			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880079	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500026
J	Gouveia-Figueira, S; Nording, ML; Gaida, JE; Forsgren, S; Alfredson, H; Fowler, CJ				Gouveia-Figueira, Sandra; Nording, Malin L.; Gaida, Jamie E.; Forsgren, Sture; Alfredson, Hakan; Fowler, Christopher J.			Serum Levels of Oxylipins in Achilles Tendinopathy: An Exploratory Study	PLOS ONE			English	Article							LINOLEIC-ACID METABOLITES; GROWTH-FACTOR; TENDON TISSUE; PAIN; TRPV1; METABOLOMICS; CORRELATE; GLUTAMATE; OVERUSE; PLASMA	Background Linoleic acid-derived oxidation products are found in experimental pain models. However, little is known about the levels of such oxylipins in human pain. In consequence, in the present study, we have undertaken a lipidomic profiling of oxylipins in blood serum from patients with Achilles tendinopathy and controls. Methodology/Principal findings A total of 34 oxylipins were analysed in the serum samples. At a significance level of P < 0.00147 (<0.05/34), two linoleic acid-derived oxylipins, 13-hydroxy-10E, 12Z-octadecadienoic (13-HODE) and 12(13)-dihydroxy-9Z-octadecenoic acid (12,13-DiHOME) were present at significantly higher levels in the Achilles tendinopathy samples. This difference remained significant when the dataset was controlled for age, gender and body-mass index. In contrast, 0/21 of the arachidonic acid-and 0/4 of the dihomo-gamma-linolenic acid, eicosapentaenoic acid or docosahenaenoic acid-derived oxylipins were higher in the patient samples at this level of significance. The area under the Receiver-Operator Characteristic (ROC) curve for 12,13-DiHOME was 0.91 (P<0.0001). Levels of four N-acylethanolamines were also analysed and found not to be significantly different between the controls and the patients at the level of P<0.0125 (<0.05/4). Conclusions/Significance It is concluded from this exploratory study that abnormal levels of linoleic acid-derived oxylipins are seen in blood serum from patients with Achilles tendinopathy. Given the ability of two of these, 9-and 13-HODE to activate transient receptor potential vanilloid 1, it is possible that these changes may contribute to the symptoms seen in Achilles tendinopathy.	[Gouveia-Figueira, Sandra; Fowler, Christopher J.] Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden; [Gouveia-Figueira, Sandra; Nording, Malin L.] Umea Univ, Dept Chem, Umea, Sweden; [Gaida, Jamie E.] Univ Canberra, Discipline Physiotherapy, Bruce, ACT, Australia; [Gaida, Jamie E.] Monash Univ, Dept Physiotherapy, Melbourne, Vic 3004, Australia; [Forsgren, Sture] Umea Univ, Sect Anat, Dept Integrat Med Biol, Umea, Sweden; [Alfredson, Hakan] Umea Univ, Sports Med Unit, Dept Surg & Perioperat Sci, Umea, Sweden	Umea University; Umea University; University of Canberra; Monash University; Umea University; Umea University	Fowler, CJ (corresponding author), Umea Univ, Pharmacol Unit, Dept Pharmacol & Clin Neurosci, Umea, Sweden.	cf@pharm.umu.se	Fowler, Christopher J./M-6313-2019; Gaida, Jamie E/A-6062-2011	Fowler, Christopher J./0000-0002-6658-7874; Gaida, Jamie E/0000-0002-4504-9188; Nording, Malin/0000-0002-1732-8147	Swedish Research Council [12158]; Swedish Research Council Formas; Research Funds of the Medical Faculty, Umea University	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Research Funds of the Medical Faculty, Umea University	The authors thank the Swedish Research Council (Grant no. 12158, medicine), the Swedish Research Council Formas, and the Research Funds of the Medical Faculty, Umea University for financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfredson H, 1999, KNEE SURG SPORT TR A, V7, P378, DOI 10.1007/s001670050184; Alsalem M, 2013, BRIT J PHARMACOL, V168, P1961, DOI 10.1111/bph.12092; Andersson G, 2011, BRIT J SPORT MED, V45, P1017, DOI 10.1136/bjsm.2010.082750; Asplund CA, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f1262; Bagge J, 2011, SCAND J MED SCI SPOR, V21, pE430, DOI 10.1111/j.1600-0838.2011.01358.x; Battery L, 2011, SPORTS MED ARTHROSC, V19, P213, DOI 10.1097/JSA.0b013e31820e6a92; BEETENS JR, 1986, BIOCHEM PHARMACOL, V35, P883, DOI 10.1016/0006-2952(86)90072-9; Bring DKI, 2012, WOUND REPAIR REGEN, V20, P50, DOI 10.1111/j.1524-475X.2011.00755.x; Caligiuri SPB, 2014, EXP GERONTOL, V59, P51, DOI 10.1016/j.exger.2014.04.005; Dandona P, 2001, J CLIN ENDOCR METAB, V86, P355, DOI 10.1210/jc.86.1.355; Fischer JE, 2003, INTENS CARE MED, V29, P1043, DOI 10.1007/s00134-003-1761-8; Gaida JE, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-41; Gaida JE, 2009, MED SCI SPORT EXER, V41, P1194, DOI 10.1249/MSS.0b013e31819794c3; Ghafouri N, 2013, PAIN, V154, P1649, DOI 10.1016/j.pain.2013.05.002; Gibson W, 2009, EXP BRAIN RES, V194, P173, DOI 10.1007/s00221-008-1683-3; GLASGOW WC, 1992, J BIOL CHEM, V267, P10771; Gouveia-Figueira S, 2014, ANAL CHEM, V86, P1186, DOI 10.1021/ac403352e; Green DP, 2013, PAIN, V154, P2512, DOI 10.1016/j.pain.2013.07.040; Heinemeier K, 2003, J APPL PHYSIOL, V95, P2390, DOI 10.1152/japplphysiol.00403.2003; KOSAKA K, 1994, MOL CELL BIOCHEM, V139, P141, DOI 10.1007/BF01081737; Langberg H, 2001, J PHYSL, V542, P985; Nieman DC, 2014, AM J PHYSIOL-REG I, V307, pR68, DOI 10.1152/ajpregu.00092.2014; Patwardhan AM, 2010, J CLIN INVEST, V120, P1617, DOI 10.1172/JCI41678; Patwardhan AM, 2009, P NATL ACAD SCI USA, V106, P18820, DOI 10.1073/pnas.0905415106; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Ramsden CE, 2012, PROSTAG LEUKOTR ESS, V87, P135, DOI 10.1016/j.plefa.2012.08.004; Rees JD, 2014, BRIT J SPORT MED, V48, P1553, DOI 10.1136/bjsports-2012-091957; Riley G, 2008, NAT CLIN PRACT RHEUM, V4, P82, DOI 10.1038/ncprheum0700; Ruparel S, 2013, PAIN, V154, P2363, DOI 10.1016/j.pain.2013.07.011; Ruparel S, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-73; Schuchardt JP, 2014, PROSTAG OTH LIPID M, V109, P23, DOI 10.1016/j.prostaglandins.2014.03.001; Schuchardt JP, 2013, PROSTAG LEUKOTR ESS, V89, P19, DOI 10.1016/j.plefa.2013.04.001; Scott A, 2015, BRIT J SPORT MED, V49, P984, DOI 10.1136/bjsports-2014-093989; Sisignano M, 2014, PROG LIPID RES, V53, P93, DOI 10.1016/j.plipres.2013.11.002; Sisignano M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081228; STEINHILBER D, 1993, P NATL ACAD SCI USA, V90, P5984, DOI 10.1073/pnas.90.13.5984; Stevens T, 2012, PANCREAS, V41, P518, DOI 10.1097/MPA.0b013e31823ca306; Tam VC, 2013, SEMIN IMMUNOL, V25, P240, DOI 10.1016/j.smim.2013.08.006; van den Berg RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-142; Yang J, 2009, ANAL CHEM, V81, P8085, DOI 10.1021/ac901282n	41	18	18	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123114	10.1371/journal.pone.0123114	http://dx.doi.org/10.1371/journal.pone.0123114			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875933	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100135
J	Martinez, O; Miranda, E; Ramirez, M; Santos, S; Rivera, C; Vazquez, L; Sanchez, T; Tremblay, RL; Rios-Olivares, E; Otero, M				Martinez, Osmarie; Miranda, Eric; Ramirez, Maite; Santos, Saritza; Rivera, Carlos; Vazquez, Luis; Sanchez, Tomas; Tremblay, Raymond L.; Rios-Olivares, Eddy; Otero, Miguel			Immunomodulator-Based Enhancement of Anti Smallpox Immune Responses	PLOS ONE			English	Article							DNA VACCINE; INNATE IMMUNITY; VIRUS; RESIQUIMOD; IMIQUIMOD; IMMUNIZATION; ADJUVANTS; IMMUNOGENICITY; OPTIMIZATION; PROTEINS	Background The current live vaccinia virus vaccine used in the prevention of smallpox is contraindicated for millions of immune-compromised individuals. Although vaccination with the current smallpox vaccine produces protective immunity, it might result in mild to serious health complications for some vaccinees. Thus, there is a critical need for the production of a safe virus-free vaccine against smallpox that is available to everyone. For that reason, we investigated the impact of imiquimod and resiquimod (Toll-like receptors agonists), and the codon-usage optimization of the vaccinia virus A27L gene in the enhancement of the immune response, with intent of producing a safe, virus-free DNA vaccine coding for the A27 vaccinia virus protein. Methods We analyzed the cellular-immune response by measuring the IFN-gamma production of spleno-cytes by ELISPOT, the humoral-immune responses measuring total IgG and IgG2a/IgG1 ratios by ELISA, and the TH1 and TH2 cytokine profiles by ELISA, in mice immunized with our vaccine formulation. Results The proposed vaccine formulation enhanced the A27L vaccine-mediated production of IFN-gamma on mouse spleens, and increased the humoral immunity with a TH1-biased response. Also, our vaccine induced a TH1 cytokine milieu, which is important against viral infections. Conclusion These results support the efforts to find a new mechanism to enhance an immune response against smallpox, through the implementation of a safe, virus-free DNA vaccination platform.	[Martinez, Osmarie; Miranda, Eric; Ramirez, Maite; Santos, Saritza; Otero, Miguel] Univ Puerto Rico, Dept Microbiol, San Juan, PR 00936 USA; [Rivera, Carlos; Vazquez, Luis; Sanchez, Tomas] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Miranda, Eric; Rios-Olivares, Eddy] Univ Cent Caribe, Sch Med, Dept Microbiol, Bayamon, PR USA; [Tremblay, Raymond L.] Univ Puerto Rico, Dept Biol, Humacao, PR USA; [Tremblay, Raymond L.] Univ Puerto Rico, Dept Biol, San Juan, PR 00936 USA; [Tremblay, Raymond L.] Univ Puerto Rico, Ctr Appl Trop Ecol & Conservat, San Juan, PR 00936 USA	University of Puerto Rico; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Humacao; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Rio Piedras	Otero, M (corresponding author), Univ Puerto Rico, Dept Microbiol, Med Sci Campus, San Juan, PR 00936 USA.	miguel.otero2@upr.edu	Tremblay, Raymond L/Q-3763-2019	Tremblay, Raymond L/0000-0002-8588-4372; Martinez, Osmarie/0000-0002-3161-0210	National Institutes of Health [8P20GM103475]; National Center for Research Resources [G12RR003051, 5G12RR003035-27]; National Institute on Minority Health and Health Disparities [8G12MD007600, 8G12MD007583-27]; Minority Biomedical Research Support Research Initiative for Scientific Enhancement [R25GM061838]; Puerto Rico Science, Technology and Research Trust [2013-000022]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003035] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, P20GM103475] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600, G12MD007583] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Minority Biomedical Research Support Research Initiative for Scientific Enhancement; Puerto Rico Science, Technology and Research Trust; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	The Puerto Rico Alliance for the Advancement of Biomedical Research Excellence National Institutes of Health 8P20GM103475, National Center for Research Resources G12RR003051, 5G12RR003035-27, National Institute on Minority Health and Health Disparities 8G12MD007600, 8G12MD007583-27, and the Minority Biomedical Research Support Research Initiative for Scientific Enhancement R25GM061838. The Puerto Rico Science, Technology and Research Trust, 2013-000022. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson Peter D, 2012, J Pharm Pract, V25, P521; Andre S, 1998, J VIROL, V72, P1497; [Anonymous], 2009, P P IMMUNE SYSTEM; Auckland C, 2005, VACCINE, V23, P4185, DOI 10.1016/j.vaccine.2004.10.052; Bendelac A, 2002, J EXP MED, V195, pF19, DOI 10.1084/jem.20020073; Buck Henry W, 2003, J Low Genit Tract Dis, V7, P290, DOI 10.1097/00128360-200310000-00011; BULLER RML, 1991, MICROBIOL REV, V55, P80, DOI 10.1128/MMBR.55.1.80-122.1991; Calarota S, 1998, LANCET, V351, P1320, DOI 10.1016/S0140-6736(97)09440-3; Calarota SA, 1999, J IMMUNOL, V163, P2330; Coffman RL, 2010, IMMUNITY, V33, P492, DOI 10.1016/j.immuni.2010.10.002; Cohen AD, 1998, FASEB J, V12, P1611, DOI 10.1096/fasebj.12.15.1611; Kohn William G, 2003, MMWR Recomm Rep, V52, P1; DEMKOWICZ WE, 1992, J VIROL, V66, P386, DOI 10.1128/JVI.66.1.386-398.1992; Donnelly JJ, 1997, ANNU REV IMMUNOL, V15, P617, DOI 10.1146/annurev.immunol.15.1.617; Dropulic LK, 2003, CLIN INFECT DIS, V36, P786, DOI 10.1086/374716; Edghill-Smith Y, 2005, J INFECT DIS, V191, P372, DOI 10.1086/427265; Empig C, 2006, VACCINE, V24, P3686, DOI 10.1016/j.vaccine.2005.03.029; Fishman JA, 2003, AM J TRANSPLANT, V3, P786, DOI 10.1034/j.1600-6143.2003.00145.x; Gilbert J, 2001, ARCH DERMATOL, V137, P1015; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Hayden EC, 2011, NATURE, V477, P150, DOI 10.1038/477150a; Hemmi H, 2002, NAT IMMUNOL, V3, P196, DOI 10.1038/ni758; Henderson DA, 2011, VACCINE, V29, pD7, DOI 10.1016/j.vaccine.2011.06.080; Hooper JW, 2003, VIROLOGY, V306, P181, DOI 10.1016/S0042-6822(02)00038-7; Kemper Alex R, 2002, Eff Clin Pract, V5, P84; Kim JJ, 1997, VACCINE, V15, P879, DOI 10.1016/S0264-410X(96)00260-5; Klimpel G.R., 1996, MED MICROBIOLOGY; Ko HJ, 2005, INFECT IMMUN, V73, P5666, DOI 10.1128/IAI.73.9.5666-5674.2005; Kochan G, 2008, CELL MICROBIOL, V10, P149, DOI 10.1111/j.1462-5822.2007.01026.x; Liu MA, 2005, ADV GENET, V55, P25, DOI 10.1016/S0065-2660(05)55002-8; LVOV DK, 2008, VOP VIRUSOL, V53, P4; MacGregor RR, 1998, J INFECT DIS, V178, P92, DOI 10.1086/515613; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; McNeel DG, 2012, CURR CANCER THER REV, V8, P245, DOI 10.2174/1573394711208040245; Meyer T, 2013, EXPERT OPIN INV DRUG, V22, P149, DOI 10.1517/13543784.2013.749236; Miller RL, 1999, INT J IMMUNOPHARMACO, V21, P1, DOI 10.1016/S0192-0561(98)00068-X; Napolitano PG, 2004, AM J OBSTET GYNECOL, V191, P1863, DOI 10.1016/j.ajog.2004.07.014; Narum DL, 2001, INFECT IMMUN, V69, P7250, DOI 10.1128/IAI.69.12.7250-7253.2001; Otero M, 2004, VACCINE, V22, P1782, DOI 10.1016/j.vaccine.2004.01.037; Prins RM, 2006, J IMMUNOL, V176, P157, DOI 10.4049/jimmunol.176.1.157; Qutaishat Salah S, 2003, Clin Med Res, V1, P85; Reimann J, 2000, VOX SANG, V78, P57; RODRIGUEZ JF, 1985, J VIROL, V56, P482, DOI 10.1128/JVI.56.2.482-488.1985; Rudraraju R, 2010, VACCINE, V28, P4997, DOI 10.1016/j.vaccine.2010.05.023; Sauder DN, 2000, J AM ACAD DERMATOL, V43, pS6; Schirmbeck R, 2001, BIOL CHEM, V382, P543, DOI 10.1515/BC.2001.068; Spruance SL, 2001, J INFECT DIS, V184, P196, DOI 10.1086/322007; Tang J, 2006, J VIROL, V80, P10010, DOI 10.1128/JVI.00601-06; Thomsen LL, 2004, VACCINE, V22, P1799, DOI 10.1016/j.vaccine.2003.09.052; van Seters M, 2008, NEW ENGL J MED, V358, P1465, DOI 10.1056/NEJMoa072685; Weinstein RS, 2011, EMERG INFECT DIS, V17, P681, DOI 10.3201/eid1704.101865; Zajac AJ, 2008, ENCY VIROLOGY, V3, P70	52	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123113	10.1371/journal.pone.0123113	http://dx.doi.org/10.1371/journal.pone.0123113			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875833	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100134
J	Munoz, I; Henriques, D; Johnston, JS; Chavez-Galarza, J; Kryger, P; Pinto, MA				Munoz, Irene; Henriques, Dora; Johnston, J. Spencer; Chavez-Galarza, Julio; Kryger, Per; Pinto, M. Alice			Reduced SNP Panels for Genetic Identification and Introgression Analysis in the Dark Honey Bee (Apis mellifera mellifera)	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; ADMIXTURE PROPORTIONS; PROTECTED POPULATIONS; EVOLUTIONARY HISTORY; GENOME; ORIGIN; LOCI; HYBRIDIZATION; CONSERVATION; SIGNATURES	Beekeeping activities, especially queen trading, have shaped the distribution of honey bee (Apis mellifera) subspecies in Europe, and have resulted in extensive introductions of two eastern European C-lineage subspecies (A. m. ligustica and A. m. carnica) into the native range of the M-lineage A. m. mellifera subspecies in Western Europe. As a consequence, replacement and gene flow between native and commercial populations have occurred at varying levels across western European populations. Genetic identification and introgression analysis using molecular markers is an important tool for management and conservation of honey bee subspecies. Previous studies have monitored introgression by using microsatellite, PCR-RFLP markers and most recently, high density assays using single nucleotide polymorphism (SNP) markers. While the latter are almost prohibitively expensive, the information gained to date can be exploited to create a reduced panel containing the most ancestry-informative markers (AIMs) for those purposes with very little loss of information. The objective of this study was to design reduced panels of AIMs to verify the origin of A. m. mellifera individuals and to provide accurate estimates of the level of C-lineage introgression into their genome. The discriminant power of the SNPs using a variety of metrics and approaches including the Weir & Cockerham's F-ST, an F-ST-based outlier test, Delta, informativeness (I-n), and PCA was evaluated. This study shows that reduced AIMs panels assign individuals to the correct origin and calculates the admixture level with a high degree of accuracy. These panels provide an essential tool in Europe for genetic stock identification and estimation of admixture levels which can assist management strategies and monitor honey bee conservation programs.	[Munoz, Irene; Henriques, Dora; Chavez-Galarza, Julio; Pinto, M. Alice] Polytech Inst Braganca, Mt Res Ctr CIMO, P-5301855 Braganca, Portugal; [Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Kryger, Per] Aarhus Univ, Dept Agroecol, DK-4200 Slagelse, Denmark	Instituto Politecnico de Braganca; Texas A&M University System; Texas A&M University College Station; Aarhus University	Pinto, MA (corresponding author), Polytech Inst Braganca, Mt Res Ctr CIMO, Campus Sta Apol nia,Apartado 1172, P-5301855 Braganca, Portugal.	apinto@ipb.pt	Muñoz, Irene/G-6678-2017; Kryger, Per/H-4600-2019; Henriques, Dora/AAI-4556-2020; Pinto, Maria Alice/AAF-4226-2020; Kryger, Per/C-1773-2013	Muñoz, Irene/0000-0002-9234-3267; Kryger, Per/0000-0001-5306-3230; Kryger, Per/0000-0001-5306-3230; Pinto, Maria Alice/0000-0001-9663-8399; Henriques, Dora/0000-0001-7530-682X; Chavez Galarza, Julio Cesar/0000-0002-8899-2862	Fundacion Seneca (Murcia, Spain) [19149/PD/13-N]; Fundacao para a Ciencia e Tecnologia (Portugal) [SFRH/BD/84195/2012, SFRH/BD/68682/2010]; Fundacao para a Ciencia e Tecnologia; COMPETE/QREN/EU [PTDC/BIA-BEC/099640/2008, BiodivERsA/0002/2014]; University Libraries; Office of the Vice President for Research; Fundação para a Ciência e a Tecnologia [BiodivERsA/0002/2014, PTDC/BIA-BEC/099640/2008] Funding Source: FCT	Fundacion Seneca (Murcia, Spain)(Fundacion Seneca); Fundacao para a Ciencia e Tecnologia (Portugal)(Portuguese Foundation for Science and Technology); Fundacao para a Ciencia e Tecnologia(Portuguese Foundation for Science and TechnologyEuropean Commission); COMPETE/QREN/EU(European Commission); University Libraries; Office of the Vice President for Research; Fundação para a Ciência e a Tecnologia	Munoz was supported by Fundacion Seneca (Murcia, Spain) through the Post-doctoral fellowship 19149/PD/13-N whereas Dora Henriques and Julio Chavez-Galarza were supported by Fundacao para a Ciencia e Tecnologia (Portugal) through the PhD scholarships SFRH/BD/84195/2012 and SFRH/BD/68682/2010, respectively. This research was funded by Fundacao para a Ciencia e Tecnologia and COMPETE/QREN/EU through the projects PTDC/BIA-BEC/099640/2008 and BiodivERsA/0002/2014. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrechtsen A, 2010, MOL BIOL EVOL, V27, P2534, DOI 10.1093/molbev/msq148; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Pinto MA, 2014, J APICULT RES, V53, P269, DOI 10.3896/IBRA.1.53.2.08; Allendorf F., 2007, CONSERVATION GENETIC; Anderson EC, 2010, MOL ECOL RESOUR, V10, P701, DOI 10.1111/j.1755-0998.2010.02846.x; Arias MC, 1996, MOL PHYLOGENET EVOL, V5, P557, DOI 10.1006/mpev.1996.0050; Bertrand B, 2014, MOL ECOL RES; Buchler R, 2014, J APICULT RES, V53, P205, DOI 10.3896/IBRA.1.53.2.03; Chavez-Galarza J, 2013, MOL ECOL, V22, P5890, DOI 10.1111/mec.12537; Clark AG, 2005, GENOME RES, V15, P1496, DOI 10.1101/gr.4107905; Crane E., 1999, WORLD HIST BEEKEEPIN, DOI DOI 10.4324/9780203819937; De la Rua P, 2009, APIDOLOGIE, V40, P263, DOI 10.1051/apido/2009027; Dowling TE, 1997, ANNU REV ECOL SYST, V28, P593, DOI 10.1146/annurev.ecolsys.28.1.593; DREHER K, 1946, HESSISCHE BIENE, V81, P62; Engel Michael S., 1999, Journal of Hymenoptera Research, V8, P165; Falush D, 2003, GENETICS, V164, P1567; Foll M, 2008, GENETICS, V180, P977, DOI 10.1534/genetics.108.092221; Francis RM, 2014, J APICULT RES, V53, P188, DOI 10.3896/IBRA.1.53.2.02; Frantz AC, 2006, MOL ECOL, V15, P3191, DOI 10.1111/j.1365-294X.2006.03022.x; Galanter JM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002554; GARNERY L, 1993, EXPERIENTIA, V49, P1016, DOI 10.1007/BF02125651; Garnery L, 1992, MOL ECOL, V1, P145, DOI 10.1111/j.1365-294X.1992.tb00170.x; Garnery L, 1998, GENET SEL EVOL, V30, pS31, DOI 10.1051/gse:19980702; Garnery L, 1998, GENET SEL EVOL, V30, pS49, DOI 10.1051/gse:19980703; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Harpur BA, 2014, P NATL ACAD SCI USA, V111, P2614, DOI 10.1073/pnas.1315506111; Harpur BA, 2013, MOL ECOL, V22, P3211, DOI 10.1111/mec.12332; HEPBURN HR, 1998, HONEY BEES AFRICA; Hoggart CJ, 2004, AM J HUM GENET, V74, P965, DOI 10.1086/420855; Jensen AB, 2005, MOL ECOL, V14, P93, DOI 10.1111/j.1365-294X.2004.02399.x; JENSEN AB, 2005, BEEKEEPING CONSERVIN, P142; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Kosoy R, 2009, HUM MUTAT, V30, P69, DOI 10.1002/humu.20822; MAUL V, 1994, APIDOLOGIE, V25, P119, DOI 10.1051/apido:19940201; Meixner M. D., 2013, J APICULT RES, V52, P1, DOI [10.3896/IBRA.1.52.4.05, DOI 10.3896/IBRA.1.52.4.05]; Meixner MD, 2011, APIDOLOGIE, V42, P425, DOI 10.1007/s13592-011-0007-y; Meixner MD, 2010, J APICULT RES, V49, P85, DOI 10.3896/IBRA.1.49.1.12; Miguel I, 2007, APIDOLOGIE, V38, P141, DOI 10.1051/apido:2007007; Munoz I, 2009, APIDOLOGIE, V40, P617, DOI 10.1051/apido/2009041; Nedic N, 2014, J APICULT RES, V53, P303, DOI 10.3896/IBRA.1.53.2.12; Nolte AW, 2010, TRENDS GENET, V26, P54, DOI 10.1016/j.tig.2009.12.001; Oleksa A, 2011, J APICULT RES, V50, P116, DOI 10.3896/IBRA.1.50.2.03; Ozerov M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082434; Pardo-Seco J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-543; Parra EJ, 1998, AM J HUM GENET, V63, P1839, DOI 10.1086/302148; Paschou P, 2007, PLOS GENET, V3, P1672, DOI 10.1371/journal.pgen.0030160; Pinto MA, 2012, APIDOLOGIE, V43, P663, DOI 10.1007/s13592-012-0141-1; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rhymer JM, 1996, ANNU REV ECOL SYST, V27, P83, DOI 10.1146/annurev.ecolsys.27.1.83; Rortais A, 2011, CONSERV GENET RESOUR, V3, P383, DOI 10.1007/s12686-010-9351-x; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Ruttner F., 1988, BIOGEOGRAPHY TAXONOM, DOI [10.1007/978-3-642-72649-1, DOI 10.1007/978-3-642-72649-1]; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Sheppard WS, 2003, APIDOLOGIE, V34, P367, DOI 10.1051/apido:2003037; Soland-Reckeweg G, 2009, J INSECT CONSERV, V13, P317, DOI 10.1007/s10841-008-9175-0; Storer CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049018; Strange JP, 2008, J INSECT CONSERV, V12, P527, DOI 10.1007/s10841-007-9093-6; Uzunov A, 2014, J APICULT RES, V53, P288, DOI 10.3896/IBRA.1.53.2.10; vanEngelsdorp D, 2010, J INVERTEBR PATHOL, V103, pS80, DOI 10.1016/j.jip.2009.06.011; Wallberg A, 2014, NAT GENET, V46, P1081, DOI 10.1038/ng.3077; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitfield CW, 2006, SCIENCE, V314, P642, DOI 10.1126/science.1132772; Wilkinson S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-580; Wilkinson S, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-45; Wright S., 1978, EVOLUTION GENETICS P	68	42	44	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124365	10.1371/journal.pone.0124365	http://dx.doi.org/10.1371/journal.pone.0124365			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875986	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100254
J	Counts, CJ; Ho, PS; Donlin, MJ; Tavis, JE; Chen, CP				Counts, Christopher J.; Ho, P. Shing; Donlin, Maureen J.; Tavis, John E.; Chen, Chaoping			A Functional Interplay between Human Immunodeficiency Virus Type 1 Protease Residues 77 and 93 Involved in Differential Regulation of Precursor Autoprocessing and Mature Protease Activity	PLOS ONE			English	Article							HIV-1 PROTEASE; TRANSFRAME PROTEIN; DRUG-RESISTANCE; REVERSE-TRANSCRIPTASE; COORDINATED EVOLUTION; CORRELATED MUTATIONS; GAGPOL PRECURSOR; SUBTYPES B; P RNA; INHIBITION	HIV-1 protease (PR) is a viral enzyme vital to the production of infectious virions. It is initially synthesized as part of the Gag-Pol polyprotein precursor in the infected cell. The free mature PR is liberated as a result of precursor autoprocessing upon virion release. We previously described a model system to examine autoprocessing in transfected mammalian cells. Here, we report that a covariance analysis of miniprecursor (p6*-PR) sequences derived from drug naive patients identified a series of amino acid pairs that vary together across independent viral isolates. These covariance pairs were used to build the first topology map of the miniprecursor that suggests high levels of interaction between the p6* peptide and the mature PR. Additionally, several PR-PR covariance pairs are located far from each other (> 12 angstrom C alpha to C alpha) relative to their positions in the mature PR structure. Biochemical characterization of one such covariance pair (77-93) revealed that each residue shows distinct preference for one of three alkyl amino acids (V, I, and L) and that a polar or charged amino acid at either of these two positions abolishes precursor autoprocessing. The most commonly observed 77V is preferred by the most commonly observed 93I, but the 77I variant is preferred by other 93 variances (L, V, or M) in supporting precursor autoprocessing. Furthermore, the 77I93V covariant enhanced precursor autoprocessing and Gag polyprotein processing but decreased the mature PR activity. Therefore, both covariance and biochemical analyses support a functional association between residues 77 and 93, which are spatially distant from each other in the mature PR structure. Our data also suggests that these covariance pairs differentially regulate precursor autoprocessing and the mature protease activity.	[Counts, Christopher J.; Ho, P. Shing; Chen, Chaoping] Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA; [Donlin, Maureen J.; Tavis, John E.] St Louis Univ, Dept Mol Microbiol & Immunol, Sch Med, St Louis, MO 63103 USA; [Donlin, Maureen J.] St Louis Univ, Dept Biochem & Mol Biol, Sch Med, St Louis, MO 63103 USA; [Donlin, Maureen J.; Tavis, John E.] St Louis Univ, Ctr Liver, Sch Med, St Louis, MO 63103 USA	Colorado State University; Saint Louis University; Saint Louis University; Saint Louis University	Chen, CP (corresponding author), Colorado State Univ, Dept Biochem & Mol Biol, Ft Collins, CO 80523 USA.	Chaoping.Chen@colostate.edu	Donlin, Maureen J./M-4709-2019; Ho, Pui/AAF-8838-2020; Ho, Pui S/F-6186-2014	Ho, Pui/0000-0002-8082-4311; Ho, Pui S/0000-0002-8082-4311; Counts, Christopher/0000-0002-6524-4263; Donlin, Maureen/0000-0001-7312-079X; Chen, Chaoping/0000-0001-9387-6252	NIH NIAID [R21A1080351, R03AI108392-01A1]; NIH [CA126807]; NSF [CHE-1152494]; Colorado State University Libraries Open Access Research and Scholarship Fund; NATIONAL CANCER INSTITUTE [R01CA126807] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI108392] Funding Source: NIH RePORTER	NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Colorado State University Libraries Open Access Research and Scholarship Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was in part supported by NIH NIAID R21A1080351 and R03AI108392-01A1 to CC, by NIH CA126807 to MJD and JET, and NSF CHE-1152494 to PSH. Authors acknowledge the Colorado State University Libraries Open Access Research and Scholarship Fund for covering the publication cost. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Aurora R, 2009, J CLIN INVEST, V119, P225, DOI 10.1172/JCI37085; Brown JW, 1996, P NATL ACAD SCI USA, V93, P3001, DOI 10.1073/pnas.93.7.3001; Campo DS, 2008, P NATL ACAD SCI USA, V105, P9685, DOI 10.1073/pnas.0801774105; Chang MW, 2011, J MOL BIOL, V410, P756, DOI 10.1016/j.jmb.2011.03.038; Chen CP, 2003, J VIROL, V77, P10280, DOI 10.1128/JVI.77.19.10280-10287.2003; Cherry E, 1998, J MOL BIOL, V284, P43, DOI 10.1006/jmbi.1998.1968; Dautin N, 2003, J VIROL, V77, P8216, DOI 10.1128/JVI.77.15.8216-8226.2003; Davis DA, 2012, ANTIMICROB AGENTS CH, V56, P3620, DOI 10.1128/AAC.00055-12; Donlin MJ, 2012, J VIROL, V86, P3050, DOI 10.1128/JVI.06857-11; Dumans AT, 2009, INFECT GENET EVOL, V9, P62, DOI 10.1016/j.meegid.2008.10.002; Dvali N, 2012, J MED VIROL, V84, P1002, DOI 10.1002/jmv.23269; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223; Fabrini R, 2009, BIOCHEMISTRY-US, V48, P10473, DOI 10.1021/bi901238t; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Ghosh AK, 2007, BIOORG MED CHEM; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Harris JK, 2001, RNA, V7, P220, DOI 10.1017/S1355838201001777; Heaslet H, 2006, J MOL BIOL, V356, P967, DOI 10.1016/j.jmb.2005.11.094; Huang LQ, 2013, FUTURE MED CHEM, V5, P1215, DOI 10.4155/fmc.13.89; Huang LQ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-79; Huang LQ, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-27; Huang LQ, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-24; Huang LQ, 2009, J VIROL, V83, P7789, DOI 10.1128/JVI.00473-09; HUANG MJ, 1995, J VIROL, V69, P6810, DOI 10.1128/JVI.69.11.6810-6818.1995; KAPLAN AH, 1993, J VIROL, V67, P4050, DOI 10.1128/JVI.67.7.4050-4055.1993; KARACOSTAS V, 1993, VIROLOGY, V193, P661, DOI 10.1006/viro.1993.1174; Koh Y, 2003, ANTIMICROB AGENTS CH, V47, P3123, DOI 10.1128/AAC.47.10.3123-3129.2003; Koh Y, 2007, J BIOL CHEM, V282, P28709, DOI 10.1074/jbc.M703938200; KOHL NE, 1988, P NATL ACAD SCI USA, V85, P4686, DOI 10.1073/pnas.85.13.4686; Lara James, 2011, In Silico Biology, V11, P213, DOI 10.3233/ISB-2012-0456; Leiherer A, 2009, J VIROL, V83, P7210, DOI 10.1128/JVI.02603-08; Liu Y, 2008, BIOINFORMATICS, V24, P1243, DOI 10.1093/bioinformatics/btn110; LOEB DD, 1989, NATURE, V340, P397, DOI 10.1038/340397a0; Louis J M, 2000, Adv Pharmacol, V49, P111; LOUIS JM, 1994, P NATL ACAD SCI USA, V91, P7970, DOI 10.1073/pnas.91.17.7970; Louis JM, 1999, NAT STRUCT BIOL, V6, P868; Louis JM, 2007, ADV PHARMACOL, V55, P261, DOI 10.1016/S1054-3589(07)55008-8; Louis JM, 2011, P NATL ACAD SCI USA, V108, P9072, DOI 10.1073/pnas.1102278108; Ludwig C, 2008, J VIROL, V82, P4573, DOI 10.1128/JVI.02353-07; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Ohtaka H, 2003, BIOCHEMISTRY-US, V42, P13659, DOI 10.1021/bi0350405; OROSZLAN S, 1990, CURR TOP MICROBIOL, V157, P153; PARTIN K, 1991, P NATL ACAD SCI USA, V88, P4776, DOI 10.1073/pnas.88.11.4776; Pettit SC, 2005, J VIROL, V79, P10601, DOI 10.1128/JVI.79.16.10601-10607.2005; Pettit SC, 2004, J VIROL, V78, P8477, DOI 10.1128/JVI.78.16.8477-8485.2004; Rhee SY, 2007, PLOS COMPUT BIOL, V3, P836, DOI 10.1371/journal.pcbi.0030087; Rhee SY, 2003, NUCLEIC ACIDS RES, V31, P298, DOI 10.1093/nar/gkg100; ROSE JR, 1993, J BIOL CHEM, V268, P11939; Schvoerer E, 2013, J INFECT DIS, V207, P1306, DOI 10.1093/infdis/jit032; Shafer RW, 2006, J INFECT DIS, V194, pS51, DOI 10.1086/505356; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang C, 2008, NATURE, V455, P693, DOI 10.1038/nature07342; Tessmer U, 1998, J VIROL, V72, P3459, DOI 10.1128/JVI.72.4.3459-3463.1998; Westin MR, 2011, AIDS RES HUM RETROV, V27, P981, DOI 10.1089/aid.2010.0260; Wondrak EM, 1996, J BIOL CHEM, V271, P4477, DOI 10.1074/jbc.271.8.4477; Wu TD, 2003, J VIROL, V77, P4836, DOI 10.1128/JVI.77.8.4836-4847.2003	58	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123561	10.1371/journal.pone.0123561	http://dx.doi.org/10.1371/journal.pone.0123561			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893662	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700042
J	Gilbert, GS; Briggs, HM; Magarey, R				Gilbert, Gregory S.; Briggs, Heather M.; Magarey, Roger			The Impact of Plant Enemies Shows a Phylogenetic Signal	PLOS ONE			English	Article							HOST PHYLOGENY; TRAITS; TRANSMISSION; SPECIFICITY; SIMILARITY; HERBIVORES; COMPONENTS; RESISTANCE; DIVERSITY; EMERGENCE	The host ranges of plant pathogens and herbivores are phylogenetically constrained, so that closely related plant species are more likely to share pests and pathogens. Here we conducted a reanalysis of data from published experimental studies to test whether the severity of host-enemy interactions follows a similar phylogenetic signal. The impact of herbivores and pathogens on their host plants declined steadily with phylogenetic distance from the most severely affected focal hosts. The steepness of this phylogenetic signal was similar to that previously measured for binary-response host ranges. Enemy behavior and development showed similar, but weaker phylogenetic signal, with oviposition and growth rates declining with evolutionary distance from optimal hosts. Phylogenetic distance is an informative surrogate for estimating the likely impacts of a pest or pathogen on potential plant hosts, and may be particularly useful in early assessing risk from emergent plant pests, where critical decisions must be made with incomplete host records.	[Gilbert, Gregory S.; Briggs, Heather M.] Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA; [Gilbert, Gregory S.] Smithsonian Trop Res Inst, Balboa, Panama; [Magarey, Roger] N Carolina State Univ, Ctr Integrated Pest Management, Raleigh, NC 27695 USA	University of California System; University of California Santa Cruz; Smithsonian Institution; Smithsonian Tropical Research Institute; University of North Carolina; North Carolina State University	Gilbert, GS (corresponding author), Univ Calif Santa Cruz, Dept Environm Studies, Santa Cruz, CA 95064 USA.	ggilbert@ucsc.edu		Magarey, Roger/0000-0002-5651-5965	NSF [DEB-0842059, DEB-1136626]; University of California Santa Cruz; Direct For Biological Sciences [1136626] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); University of California Santa Cruz(University of California System); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by Cooperative Agreement between G. Gilbert and USDA-APHIS-PPQ-CPHST PERAL funded from Section 10201 of the Farm Bill, and by NSF grants DEB-0842059 and DEB-1136626 to G. Gilbert. Additional support was provided by the University of California Santa Cruz. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2007, TRENDS ECOL EVOL, V22, P103, DOI 10.1016/j.tree.2006.10.012; Agrawal AA, 2009, NEW PHYTOL, V183, P848, DOI 10.1111/j.1469-8137.2009.02897.x; Agrawal AA, 2009, EVOLUTION, V63, P663, DOI 10.1111/j.1558-5646.2008.00573.x; AMMAR ED, 1995, PLANT PATHOL, V44, P239, DOI 10.1111/j.1365-3059.1995.tb02774.x; Antonovics J, 2013, EVOLUTION, V67, P1, DOI 10.1111/j.1558-5646.2012.01793.x; Bagchi R, 2014, NATURE, V506, P85, DOI 10.1038/nature12911; Barrett LG, 2012, TRENDS PLANT SCI, V17, P282, DOI 10.1016/j.tplants.2012.02.009; Becerra JX, 1997, SCIENCE, V276, P253, DOI 10.1126/science.276.5310.253; Becker BJ, 2007, STAT SCI, V22, P414, DOI 10.1214/07-STS243; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; Boller T, ANN REV PLANT BIOL, V602009, P379; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Carmona D, 2011, FUNCT ECOL, V25, P358, DOI 10.1111/j.1365-2435.2010.01794.x; Chazdon RL, 2003, ECOL MONOGR, V73, P331, DOI 10.1890/02-4037; CONNELL J H, 1971, P298; CUNFER BM, 1988, EUPHYTICA, V37, P129, DOI 10.1007/BF00036850; DAS MK, 1993, EUPHYTICA, V68, P99, DOI 10.1007/BF00024159; Davies TJ, 2008, P ROY SOC B-BIOL SCI, V275, P1695, DOI 10.1098/rspb.2008.0284; de Vienne DM, 2009, J EVOLUTION BIOL, V22, P2532, DOI 10.1111/j.1420-9101.2009.01878.x; Desneux N, 2012, ECOL LETT, V15, P453, DOI 10.1111/j.1461-0248.2012.01754.x; Farrell MJ, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/1/015036; Gilbert GS, 2007, P NATL ACAD SCI USA, V104, P4979, DOI 10.1073/pnas.0607968104; Gilbert Gregory S, 2012, Evol Appl, V5, P869, DOI 10.1111/j.1752-4571.2012.00265.x; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; Jonsson AM, 2011, CLIMATIC CHANGE, V109, P695, DOI 10.1007/s10584-011-0038-4; Liu XB, 2012, ECOL LETT, V15, P111, DOI 10.1111/j.1461-0248.2011.01715.x; Loiola PP, 2012, J VEG SCI, V23, P1095, DOI 10.1111/j.1654-1103.2012.01424.x; Magarey RD, 2009, BIOSCIENCE, V59, P875, DOI 10.1525/bio.2009.59.10.9; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McEvoy PB, 1996, BIOSCIENCE, V46, P401, DOI 10.2307/1312873; Medeiros MCI, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2947; Parker IM, NATURE IN PRESS; Pearse IS, 2013, OIKOS, V122, P1554, DOI 10.1111/j.1600-0706.2013.00527.x; Pearse IS, 2009, P NATL ACAD SCI USA, V106, P18097, DOI 10.1073/pnas.0904867106; Pedersen AB, 2009, ECOHEALTH, V6, P496, DOI 10.1007/s10393-010-0284-3; Perlman SJ, 2003, EVOLUTION, V57, P544, DOI 10.1111/j.0014-3820.2003.tb01546.x; Pichersky E, 2011, ANNU REV PLANT BIOL, V62, P549, DOI 10.1146/annurev-arplant-042110-103814; Ronsted N, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-182; Schweizer D, 2013, FOREST ECOL MANAG, V297, P57, DOI 10.1016/j.foreco.2013.02.012; Sedio BE, 2013, ECOL LETT, V16, P995, DOI 10.1111/ele.12130; Streicker DG, 2010, SCIENCE, V329, P676, DOI 10.1126/science.1188836; Terborgh J, 2012, AM NAT, V179, P303, DOI 10.1086/664183; Vacher C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001740; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wink M, 2003, PHYTOCHEMISTRY, V64, P3, DOI 10.1016/S0031-9422(03)00300-5; Yguel B, 2011, ECOL LETT, V14, P1117, DOI 10.1111/j.1461-0248.2011.01680.x	46	40	40	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123758	10.1371/journal.pone.0123758	http://dx.doi.org/10.1371/journal.pone.0123758			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893581	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700054
J	Sumbele, IUN; Kimbi, HK; Ndamukong-Nyanga, JL; Nweboh, M; Anchang-Kimbi, JK; Lum, E; Nana, Y; Ndamukong, KKJ; Lehman, LG				Sumbele, Irene Ule Ngole; Kimbi, Helen Kuokuo; Ndamukong-Nyanga, Judith Lum; Nweboh, Malaika; Anchang-Kimbi, Judith Kuoh; Lum, Emmaculate; Nana, Yannick; Ndamukong, Kenneth K. J.; Lehman, Leopold G.			Malarial Anaemia and Anaemia Severity in Apparently Healthy Primary School Children in Urban and Rural Settings in the Mount Cameroon Area: Cross Sectional Survey	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM PARASITEMIA; HEMOGLOBIN CONCENTRATIONS; YOUNG-CHILDREN; WESTERN KENYA; TRANSMISSION; IMPACT; ERYTHROPOIESIS; MORBIDITY; RESPONSES; IMMUNITY	Background This study examines the relative importance of living in an urban versus rural setting and malaria in contributing to the public health problem of malarial anaemia (MA) and anaemia respectively in apparently healthy primary school children. Methods A cross-sectional study was conducted among 727 school children aged between four and 15 years living in an urban (302) and rural (425) settings in the Mount Cameroon area. Blood sample collected from each child was used for the preparation of blood films for detection of malaria parasites and assessment of malaria parasite density as well as full blood count determination using an automated haematology analyzer. Based on haemoglobin (Hb) measurements, children with malaria parasitaemia were stratified into MA (Hb<11g/dL); mild MA (Hb of 8-10.9g/dL); moderate MA (Hb of 6.1-7.9g/dL) and severe MA (Hb <= 6g/dL). Evaluation of potential determinants of MA and anaemia was performed by multinomial logistic-regression analysis and odds ratios used to evaluate risk factors. Results Out of the 727 children examined, 72 (9.9%) had MA. The prevalence of MA and anaemia were significantly higher (chi(2) = 36.5, P < 0.001; chi(2) = 16.19, P < 0.001 respectively) in children in the urban (17.9%; 26.8% respectively) than in the rural area (4.2%; 14.8% respectively). Majority of the MA cases were mild (88.9%), with moderate (5.6%) and severe MA (5.6%) occurring in the urban area only. The age group <= 6years was significantly (P < 0.05) associated with both MA and anaemia. In addition, low parasite density was associated with MA while malaria parasite negative and microcytosis were associated with anaemia. Conclusions Malarial anaemia and anaemia display heterogeneity and complexity that differ with the type of settlement. The presence of severe MA and the contributions of the age group <= 6 years, low parasite density and microcytosis to the public health problem of MA and anaemia are noteworthy.	[Sumbele, Irene Ule Ngole; Kimbi, Helen Kuokuo; Nweboh, Malaika; Anchang-Kimbi, Judith Kuoh; Lum, Emmaculate; Nana, Yannick; Ndamukong, Kenneth K. J.] Univ Buea, Fac Sci, Dept Zool & Anim Physiol, Buea, Cameroon; [Ndamukong-Nyanga, Judith Lum] Univ Yaounde I, Higher Teachers Training Coll, Dept Biol Sci, Yaounde, Cameroon; [Lehman, Leopold G.] Univ Douala, Fac Sci, Dept Biol Sci, Douala, Cameroon	University of Yaounde I	Sumbele, IUN (corresponding author), Univ Buea, Fac Sci, Dept Zool & Anim Physiol, Buea, Cameroon.	sumbelei@yahoo.co.uk	Anchang-Kimbi, Judith/AAE-9802-2020		government of Cameroon	government of Cameroon	This work was supported by the staff development grant and special fund for research and modernization given to authors by the government of Cameroon.	ABDALLA S, 1980, BRIT J HAEMATOL, V46, P171, DOI 10.1111/j.1365-2141.1980.tb05956.x; Achidi EA, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-215; ALLEN SJ, 1992, T ROY SOC TROP MED H, V86, P494, DOI 10.1016/0035-9203(92)90083-O; [Anonymous], 2012, J BACTERIOL PARASITO; BEADLE C, 1995, J INFECT DIS, V172, P1047, DOI 10.1093/infdis/172.4.1047; Benichou J, STAT METH MED RES, V110, P195; Bhawna Sethi, 2013, Iranian Journal of Pathology, V8, P1; Biemba G, 2000, TROP MED INT HEALTH, V5, P9, DOI 10.1046/j.1365-3156.2000.00506.x; Bjorkman A, 2002, INT J PARASITOL, V32, P1637, DOI 10.1016/S0020-7519(02)00192-3; Brabin BJ, 2001, J NUTR, V131, p636S; Bryan FJ., 1992, DESIGN ANAL RES STUD; Casals-Pascual C, 2006, BLOOD, V108, P2569, DOI 10.1182/blood-2006-05-018697; Chang KH, 2004, INT J PARASITOL, V34, P1501, DOI 10.1016/j.ijpara.2004.10.008; Cheesbrough M., 2009, DISTRICT LAB PRACT 2; Cheesbrough M, 2009, DISTRICT LAB PRACT 1; Cornet M, 1998, AM J TROP MED HYG, V58, P606, DOI 10.4269/ajtmh.1998.58.606; De Silva PM, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/819563; Desai MR, 2005, AM J TROP MED HYG, V72, P47, DOI 10.4269/ajtmh.2005.72.47; Deshmukh Pradeep R, 2013, Med J Armed Forces India, V69, P213, DOI 10.1016/j.mjafi.2012.10.004; Doolan DL, 2009, CLIN MICROBIOL REV, V22, P13, DOI 10.1128/CMR.00025-08; Ekvall H, 2003, CURR OPIN HEMATOL, V10, P108, DOI 10.1097/00062752-200303000-00002; Ekvall H, 2001, T ROY SOC TROP MED H, V95, P611, DOI 10.1016/S0035-9203(01)90095-1; Fernando SD, 2003, AM J TROP MED HYG, V69, P582, DOI 10.4269/ajtmh.2003.69.582; Fowkes FJI, 2008, PLOS MED, V5, P494, DOI 10.1371/journal.pmed.0050056; Geerligs PDP, 2003, B WORLD HEALTH ORGAN, V81, P205; Ghosh K, 2007, PARASITOL RES, V101, P1463, DOI 10.1007/s00436-007-0742-1; Gudo ES, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-244; Hay SI, 2005, NAT REV MICROBIOL, V3, P81, DOI 10.1038/nrmicro1069; Kimbi H K, 2006, East Afr Med J, V83, P602; Kimbi HK, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-193; Kitua AY, 1997, TROP MED INT HEALTH, V2, P325; Klinkenberg E, 2006, TROP MED INT HEALTH, V11, P578, DOI 10.1111/j.1365-3156.2006.01609.x; Korenromp EL, 2004, TROP MED INT HEALTH, V9, P1050, DOI 10.1111/j.1365-3156.2004.01317.x; Ladhani S, 2002, BRIT J HAEMATOL, V119, P839, DOI 10.1046/j.1365-2141.2002.03904.x; Lucien K. F. H., 2010, African Journal of Clinical and Experimental Microbiology, V11, P120; Luxemburger C, 1998, T ROY SOC TROP MED H, V92, P45, DOI 10.1016/S0035-9203(98)90950-6; Martorell R, 1992, HUMAN GROWTH BASIC C, P143; MCELROY PD, 1994, AM J TROP MED HYG, V51, P523, DOI 10.4269/ajtmh.1994.51.523; McElroy PD, 2000, AM J TROP MED HYG, V62, P504, DOI 10.4269/ajtmh.2000.62.504; Menendez C, 2000, PARASITOL TODAY, V16, P469, DOI 10.1016/S0169-4758(00)01774-9; Mockenhaupt FP, 1999, J INFECT DIS, V180, P925, DOI 10.1086/314959; Nkuo-Akenji T. K., 2008, African Journal of Food, Agriculture, Nutrition and Development, V8, P252; Novelli EM, 2010, BRIT J HAEMATOL, V149, P711, DOI 10.1111/j.1365-2141.2010.08147.x; Ong'echa JM, 2006, AM J TROP MED HYG, V74, P376, DOI 10.4269/ajtmh.2006.74.376; Perkins DJ, 2011, INT J BIOL SCI, V7, P1427, DOI 10.7150/ijbs.7.1427; Sumbele IUN., 2010, J CLI MED RES, V2, P143; Tatem AJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-133; Vitor-Silva S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-230; Wanji S, 2008, MALARIA J, V7, P9, DOI [10.1186/1475-2875-7-9, DOI 10.1186/1475-2875-7-9]; World Health Organization, WORLD MALARIA REPORT	50	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123549	10.1371/journal.pone.0123549	http://dx.doi.org/10.1371/journal.pone.0123549			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893500	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700041
J	Wen, W; Yamashita, A; Asama, H				Wen, Wen; Yamashita, Atsushi; Asama, Hajime			The Sense of Agency during Continuous Action: Performance Is More Important than Action-Feedback Association	PLOS ONE			English	Article							SELF; EXPERIENCE; AWARENESS; SCHIZOPHRENIA; ABNORMALITIES; CONSEQUENCES; INFERENCE; INTENTION	The sense of agency refers to the feeling that one is controlling events through one's own behavior. This study examined how task performance and the delay of events influence one's sense of agency during continuous action accompanied by a goal. The participants were instructed to direct a moving dot into a square as quickly as possible by pressing the left and right keys on a keyboard to control the direction in which the dot traveled. The interval between the key press and response of the dot (i.e., direction change) was manipulated to vary task difficulty. Moreover, in the assisted condition, the computer ignored participants' erroneous commands, resulting in improved task performance but a weaker association between the participants' commands and actual movements of the dot relative to the condition in which all of the participants' commands were executed (i.e., self-control condition). The results showed that participants' sense of agency increased with better performance in the assisted condition relative to the self-control condition, even though a large proportion of their commands were not executed. We concluded that, when the action-feedback association was uncertain, cognitive inference was more dominant relative to the process of comparing predicted and perceived information in the judgment of agency.	[Wen, Wen; Yamashita, Atsushi; Asama, Hajime] Univ Tokyo, Dept Precis Engn, Tokyo, Japan	University of Tokyo	Wen, W (corresponding author), Univ Tokyo, Dept Precis Engn, Tokyo, Japan.	wen@robot.t.u-tokyo.ac.jp		Wen, Wen/0000-0002-7593-1702	JSPS KAKENHI [26120005]; JST RISTEX Service Science, Solutions and Foundation Integrated Research Program; Grants-in-Aid for Scientific Research [15K16007] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST RISTEX Service Science, Solutions and Foundation Integrated Research Program; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI Grant Number 26120005 and the JST RISTEX Service Science, Solutions and Foundation Integrated Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarts H, 2005, CONSCIOUS COGN, V14, P439, DOI 10.1016/j.concog.2004.11.001; Bednark JG, 2014, EXP BRAIN RES, V232, P1117, DOI 10.1007/s00221-014-3821-4; Berberian B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034075; Blakemore SJ, 1998, NAT NEUROSCI, V1, P635, DOI 10.1038/2870; Blakemore SJ, 2002, TRENDS COGN SCI, V6, P237, DOI 10.1016/S1364-6613(02)01907-1; Blakemore SJ, 1999, J COGNITIVE NEUROSCI, V11, P551, DOI 10.1162/089892999563607; Chambon V, 2012, COGNITION, V125, P441, DOI 10.1016/j.cognition.2012.07.011; Ebert JP, 2010, CONSCIOUS COGN, V19, P481, DOI 10.1016/j.concog.2009.10.002; Farrer C, 2013, CONSCIOUS COGN, V22, P1431, DOI 10.1016/j.concog.2013.09.010; Frith C, 2005, CONSCIOUS COGN, V14, P752, DOI 10.1016/j.concog.2005.04.002; Frith CD, 2000, BRAIN RES REV, V31, P357, DOI 10.1016/S0165-0173(99)00052-1; Haggard P, 2005, TRENDS COGN SCI, V9, P290, DOI 10.1016/j.tics.2005.04.012; Haggard P, 2002, NAT NEUROSCI, V5, P382, DOI 10.1038/nn827; Haggard P, 2007, CONSCIOUS COGN, V16, P211, DOI 10.1016/j.concog.2006.07.002; Kawabe T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0991; Kawabe T, 2013, CONSCIOUS COGN, V22, P407, DOI 10.1016/j.concog.2013.01.006; Kuhn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028657; Lindner A, 2005, CURR BIOL, V15, P1119, DOI 10.1016/j.cub.2005.05.049; Linser K, 2007, COGNITION, V104, P459, DOI 10.1016/j.cognition.2006.07.009; Metcalfe J, 2007, J EXP PSYCHOL GEN, V136, P184, DOI 10.1037/0096-3445.136.2.184; Moore JW, 2012, CONSCIOUS COGN, V21, P59, DOI 10.1016/j.concog.2011.08.010; Moore J, 2008, CONSCIOUS COGN, V17, P136, DOI 10.1016/j.concog.2006.12.004; Moore JW, 2010, CONSCIOUS COGN, V19, P490, DOI 10.1016/j.concog.2009.11.007; Moore JW, 2009, CONSCIOUS COGN, V18, P1056, DOI 10.1016/j.concog.2009.05.004; Sato A, 2005, COGNITION, V94, P241, DOI 10.1016/j.cognition.2004.04.003; Shergill SS, 2005, AM J PSYCHIAT, V162, P2384, DOI 10.1176/appi.ajp.162.12.2384; Stenner MP, 2014, COGNITION, V130, P227, DOI 10.1016/j.cognition.2013.11.008; Synofzik M, 2008, CONSCIOUS COGN, V17, P219, DOI 10.1016/j.concog.2007.03.010; Tsakiris M, 2006, CONSCIOUS COGN, V15, P423, DOI 10.1016/j.concog.2005.09.004; van der Wel RPRD, 2012, CONSCIOUS COGN, V21, P1267, DOI 10.1016/j.concog.2012.04.001; Voss M, 2006, NAT NEUROSCI, V9, P26, DOI 10.1038/nn1592; Wegner DM, 2004, J PERS SOC PSYCHOL, V86, P838, DOI 10.1037/0022-3514.86.6.838; Wegner DM, 2003, TRENDS COGN SCI, V7, P65, DOI 10.1016/S1364-6613(03)00002-0; Wenke D, 2010, COGNITION, V115, P26, DOI 10.1016/j.cognition.2009.10.016; Wolpert DM, 2000, NAT NEUROSCI, V3, P1212, DOI 10.1038/81497; Wolpert DM, 2001, CURR BIOL, V11, pR729, DOI 10.1016/S0960-9822(01)00432-8; Yoshie M, 2013, CURR BIOL, V23, P2028, DOI 10.1016/j.cub.2013.08.034	37	44	44	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125226	10.1371/journal.pone.0125226	http://dx.doi.org/10.1371/journal.pone.0125226			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893992	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700135
J	Zhang, W; Pei, YL; Zhong, L; Wen, BQ; Cao, SY; Han, JY				Zhang, Wei; Pei, Yangli; Zhong, Liang; Wen, Bingqiang; Cao, Suying; Han, Jianyong			Pluripotent and Metabolic Features of Two Types of Porcine iPSCs Derived from Defined Mouse and Human ES Cell Culture Conditions	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; EARLY LINEAGE SEGREGATION; SELF-RENEWAL; EXPRESSION; NAIVE; INDUCTION; EPIBLAST; STATE; FGF; FIBROBLASTS	The domestic pig is an excellent animal model for stem cell research and clinical medicine. There is still no suitable culture condition to generate authentic porcine embryonic stem cells (pESCs) and high quality porcine induced pluripotent stem cells (piPSCs). In this study, we found that culture conditions affected pluripotent and metabolic features of piPSCs. Using defined human embryonic stem cell (hESC) and mouse ESC (mESC) culture conditions, we generated two types of piPSCs, one of which was morphologically similar to hESCs (here called hpiPSCs), the other resembled mESCs (here called mpiPSCs). Transcriptome analysis and signaling pathway inhibition results suggested that mpiPSCs shared more of mESC signaling pathways, such as the BMP pathway and JAK/STAT pathway and hpiPSCs shared more hESC signaling pathways, such as the FGF pathway. Importantly, the mpiPSCs performed embryonic chimera incorporation more efficiently than the hpiPSCs did. In addition, the mpiPSCs showed mitochondrial features of naive ESCs and lipid droplets accumulation. These evidences may facilitate understanding of the gene regulation network and metabolism in piPSCs and promote derivation of bona fide pESCs for translational medicine.	[Zhang, Wei; Pei, Yangli; Zhong, Liang; Wen, Bingqiang; Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China; [Cao, Suying] Beijing Agr Univ, Coll Anim Sci & Technol, Beijing 100094, Peoples R China	China Agricultural University; Beijing University of Agriculture	Han, JY (corresponding author), China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100094, Peoples R China.	hanjy@cau.edu.cn	Zhong, Liang/AAO-1379-2020; Wen, Bingqiang/ABF-4375-2021; zhang, wei/J-1685-2019		China National Basic Research Program [2011CBB01001, 2011CBA01102]; Beijing Natural Science Foundation [6152004]; National Thousand Talents Program of China; Program for New Century Excellent Talents in University [NCET-11-0482]; State Key Laboratory for Agrobiotechnology Foundation [2015SKLAB6-18]	China National Basic Research Program(National Basic Research Program of China); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Thousand Talents Program of China; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); State Key Laboratory for Agrobiotechnology Foundation	This study was supported by grants from the China National Basic Research Program (2011CBB01001, 2011CBA01102), Beijing Natural Science Foundation (6152004), the National Thousand Talents Program of China and the Program for New Century Excellent Talents in University (NCET-11-0482) and by State Key Laboratory for Agrobiotechnology Foundation (2015SKLAB6-18). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cao SY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-4; Cao ZB, 2014, THERIOGENOLOGY, V81, P496, DOI 10.1016/j.theriogenology.2013.10.025; Chan YS, 2013, CELL STEM CELL, V13, P663, DOI 10.1016/j.stem.2013.11.015; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Cheng D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051778; Ezashi T, 2009, P NATL ACAD SCI USA, V106, P10993, DOI 10.1073/pnas.0905284106; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Gu Q, 2014, PROTEIN CELL, V5, P338, DOI 10.1007/s13238-014-0043-2; Hall VJ, 2010, DEV DYNAM, V239, P2911, DOI 10.1002/dvdy.22424; Hall VJ, 2014, STEM CELLS DEV, V23, P2030, DOI 10.1089/scd.2013.0502; Henderson JK, 2002, STEM CELLS, V20, P329, DOI 10.1634/stemcells.20-4-329; Kikuchi K, 2002, ZYGOTE, V10, P355, DOI 10.1017/S0967199402004100; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li ZH, 2014, CURR BIOL, V24, P1485, DOI 10.1016/j.cub.2014.05.022; Li ZH, 2012, CURR BIOL, V22, P2104, DOI 10.1016/j.cub.2012.09.018; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Montserrat N, 2013, CELL STEM CELL, V13, P341, DOI 10.1016/j.stem.2013.06.019; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Park JK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052481; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Ruan WM, 2011, SCI CHINA LIFE SCI, V54, P553, DOI 10.1007/s11427-011-4179-5; Shu J, 2013, CELL, V153, P963, DOI 10.1016/j.cell.2013.05.001; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telugu BPVL, 2010, INT J DEV BIOL, V54, P1703, DOI 10.1387/ijdb.103200bt; Thomson AJ, 2012, CELL REPROGRAM, V14, P112, DOI 10.1089/cell.2011.0078; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; West FD, 2010, STEM CELLS DEV, V19, P1211, DOI 10.1089/scd.2009.0458; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang Shuangqing, 2014, ScientificWorldJournal, V2014, P217142, DOI 10.1155/2014/217142; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71	45	26	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124562	10.1371/journal.pone.0124562	http://dx.doi.org/10.1371/journal.pone.0124562			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893435	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700105
J	Bovet, J; Raymond, M				Bovet, Jeanne; Raymond, Michel			Preferred Women's Waist-to-Hip Ratio Variation over the Last 2,500 Years	PLOS ONE			English	Article							FEMALE PHYSICAL ATTRACTIVENESS; BODY-FAT DISTRIBUTION; SEXUAL ATTRACTIVENESS; MENS PREFERENCES; BEAUTY; BRITAIN; EYE; JUDGMENTS; STANDARD; WEIGHT	The ratio between the body circumference at the waist and the hips (or WHR) is a secondary sexual trait that is unique to humans and is well known to influence men's mate preferences. Because a woman's WHR also provides information about her age, health and fertility, men's preference concerning this physical feature may possibly be a cognitive adaptation selected in the human lineage. However, it is unclear whether the preferred WHR in western countries reflects a universal ideal, as geographic variation in non-western areas has been found, and discordances about its temporal consistency remain in the literature. We analyzed the WHR of women considered as ideally beautiful who were depicted in western artworks from 500 BCE to the present. These vestiges of the past feminine ideal were then compared to more recent symbols of beauty: Playboy models and winners of several Miss pageants from 1920 to 2014. We found that the ideal WHR has changed over time in western societies: it was constant during almost a millennium in antiquity (from 500 BCE to 400 CE) and has decreased from the 15th century to the present. Then, based on Playboy models and Miss pageants winners, this decrease appears to slow down or even reverse during the second half of the 20th century. The universality of an ideal WHR is thus challenged, and historical changes in western societies could have caused these variations in men's preferences. The potential adaptive explanations for these results are discussed.	[Bovet, Jeanne; Raymond, Michel] Univ Montpellier, Inst Evolutionary Sci, CNRS, IRD,EPHE, Montpellier, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Universite de Montpellier	Raymond, M (corresponding author), Univ Montpellier, Inst Evolutionary Sci, CNRS, IRD,EPHE, CC 065,Pl Eugene Bataillon, Montpellier, France.	michel.raymond@univ-montp2.fr	Bovet, Jeanne/I-8527-2019	Bovet, Jeanne/0000-0002-3997-8837; Raymond, Michel/0000-0002-1714-6984	Agence Nationale pour la Recherche, 'HUMANWAY' project [ANR- 12-BSV7-0008-01]	Agence Nationale pour la Recherche, 'HUMANWAY' project(French National Research Agency (ANR))	This work was supported by the following: Agence Nationale pour la Recherche (http://www.agence-nationale-recherche.fr/), 'HUMANWAY' project ANR- 12-BSV7-0008-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MM, 2013, J ADOLESCENCE, V36, P539, DOI 10.1016/j.adolescence.2013.03.010; Beugnot Arthur Auguste, 1835, HIST DESTRUCTION PAG; Buggio L, 2012, GYNECOL ENDOCRINOL, V28, P753, DOI 10.3109/09513590.2012.662545; Buss D.M., 2005, HDB EVOLUTIONARY PSY; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; DeBruine LM, 2010, P ROY SOC B-BIOL SCI, V277, P2405, DOI 10.1098/rspb.2009.2184; Dixson BJ, 2007, AM J HUM BIOL, V19, P88, DOI 10.1002/ajhb.20584; Dixson BJ, 2011, ARCH SEX BEHAV, V40, P43, DOI 10.1007/s10508-009-9523-5; Dixson BJ, 2010, AM J PHYS ANTHROPOL, V141, P620, DOI 10.1002/ajpa.21181; Freese J, 2002, J SEX RES, V39, P133, DOI 10.1080/00224490209552132; GARNER DM, 1980, PSYCHOL REP, V47, P483, DOI 10.2466/pr0.1980.47.2.483; Hayes AF, 2007, COMMUN METHODS MEAS, V1, P77, DOI 10.1080/19312450709336664; Henss R, 2000, PERS INDIV DIFFER, V28, P501, DOI 10.1016/S0191-8869(99)00115-4; Hong YJ, 2009, AESTHET PLAST SURG, V33, P185, DOI 10.1007/s00266-008-9200-4; Hudson MJ, 2007, ANTIQUITY, V81, P961, DOI 10.1017/S0003598X00096046; Hughes SM, 2003, EVOL HUM BEHAV, V24, P173, DOI 10.1016/S1090-5138(02)00149-6; Jasienska G, 2004, P ROY SOC B-BIOL SCI, V271, P1213, DOI 10.1098/rspb.2004.2712; Jennett K. D., 2008, FEMALE FIGURINES UPP; KAYE SA, 1990, INT J OBESITY, V14, P583; Lahti-Koski M, 2000, AM J CLIN NUTR, V72, P1436; Lissner L, 1998, INT J OBESITY, V22, P1116, DOI 10.1038/sj.ijo.0800760; Marcinkowska UM, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0850; Marlowe FW, 2005, EVOL HUM BEHAV, V26, P458, DOI 10.1016/j.evolhumbehav.2005.07.005; Marlowe FW, 2001, PERS INDIV DIFFER, V30, P481, DOI 10.1016/S0191-8869(00)00039-8; Massar K, 2009, PERS INDIV DIFFER, V46, P129, DOI 10.1016/j.paid.2008.09.016; Mazur Allan, 1986, J SEX RES, V22, P281, DOI 10.1080/00224498609551309; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pettijohn TF, 2004, PERS SOC PSYCHOL B, V30, P1186, DOI 10.1177/0146167204264078; Platek SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009042; RICE P C, 1981, Journal of Anthropological Research, V37, P402; Roser M, 2014, GDP GROWTH VERY LONG; Roser M, 2014, INCOME INEQUALITY; Roser M, 2014, LIF EXP; Roser M, 2014, FOOD PER PERSON; SILVERSTEIN B, 1986, SEX ROLES, V14, P519, DOI 10.1007/BF00287452; SINGH D, 1993, J PERS SOC PSYCHOL, V65, P293, DOI 10.1037/0022-3514.65.2.293; SINGH D, 1993, HUM NATURE-INT BIOS, V4, P297, DOI 10.1007/BF02692203; Singh D, 2007, PERS INDIV DIFFER, V43, P329, DOI 10.1016/j.paid.2006.12.003; Singh D, 2007, P R SOC B, V274, P891, DOI 10.1098/rspb.2006.0239; Singh D, 2006, CLIN PLAST SURG, V33, P359, DOI 10.1016/j.cps.2006.05.007; Singh Devendra, 2002, Neuro Endocrinol Lett, V23 Suppl 4, P81; Singh D, 2011, SEX ROLES, V64, P723, DOI 10.1007/s11199-011-9938-z; Singh D, 2010, EVOL HUM BEHAV, V31, P176, DOI 10.1016/j.evolhumbehav.2009.09.001; Sorokowski P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105468; Sorokowski P, 2012, ARCH SEX BEHAV, V41, P1209, DOI 10.1007/s10508-012-9906-x; Sorokowski P, 2010, PERCEPTION, V39, P1427, DOI 10.1068/p6621; Sugiyama LS, 2004, EVOL HUM BEHAV, V25, P51, DOI 10.1016/S1090-5138(03)00083-7; Swami V, 2006, EUR J PERSONALITY, V20, P69, DOI 10.1002/per.568; Swami V., 2007, IMAGINATION COGNITIO, V26, P139; Swami V, 2007, BODY IMAGE, V4, P391, DOI 10.1016/j.bodyim.2007.07.002; Swami V, 2010, PERS SOC PSYCHOL B, V36, P309, DOI 10.1177/0146167209359702; Swami V, 2009, BRIT J PSYCHOL, V100, P313, DOI 10.1348/000712608X329525; Todorov T, 2000, ELOGE INDIVIDU ESSAI; World Health Organization, 2008, WAIST CIRCUMFERENCE; Yu DW, 1998, NATURE, V396, P321, DOI 10.1038/24512; ZAADSTRA BM, 1993, BRIT MED J, V306, P484, DOI 10.1136/bmj.306.6876.484	56	14	14	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123284	10.1371/journal.pone.0123284	http://dx.doi.org/10.1371/journal.pone.0123284			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886537	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000353017000054
J	Holthoff, VA; Marschner, K; Scharf, M; Steding, J; Meyer, S; Koch, R; Donix, M				Holthoff, Vjera A.; Marschner, Kira; Scharf, Maria; Steding, Julius; Meyer, Shirin; Koch, Rainer; Donix, Markus			Effects of Physical Activity Training in Patients with Alzheimer's Dementia: Results of a Pilot RCT Study	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; OLDER-ADULTS; NEUROTROPHIC FACTOR; EXECUTIVE FUNCTIONS; AEROBIC EXERCISE; DISEASE; RISK; INTERVENTIONS; PROGRAM; WALKING	Background There is evidence that physical activity (PA) is of cognitive benefit to the ageing brain, but little is known on the effect in patients with Alzheimer's disease (AD). The present pilot study assessed the effect of a home-based PA training on clinical symptoms, functional abilities, and caregiver burden after 12 and 24 weeks. Methods In an RCT thirty patients (aged 72.4 +/- 4.3 years) with AD (MMSE: 20.6 +/- 6.5 points) and their family caregivers were allocated to a home-based 12-week PA intervention program or the usual care group. The program changed between passive, motor-assisted or active resistive leg training and changes in direction on a movement trainer in order to combine physical and cognitive stimuli. Results Analysis of activities of daily living in the patients (ADCS ADL total score) revealed a significant group x time interaction effect (95% CI of the difference between both groups at T2: 5.01-10.51). The control group experienced decreases in ADL performance at week 12 and 24 whereas patients in the intervention group remained stable. Analyses of executive function and language ability revealed considerable effects for semantic word fluency with a group x time interaction (95% CI of the difference between both groups at T2: 0.18-4.02). Patients in the intervention group improved during the intervention and returned to initial performance at week 12 whereas the controls revealed continuous worsening. Analyses of reaction time, hand-eye quickness and attention revealed improvement only in the intervention group. Caregiver burden remained stable in the intervention group but worsened in the control group. Conclusions This study suggests that PA in a home-based setting might be an effective and intrinsically attractive way to promote PA training in AD and modulate caregiver burden. The results demonstrate transfer benefits to ADL, cognitive and physical skill in patients with AD.	[Holthoff, Vjera A.; Steding, Julius; Meyer, Shirin; Koch, Rainer; Donix, Markus] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Psychiat & Psychotherapy, Div Old Age Psychiat & Cognit Neuropsychiat, D-01307 Dresden, Germany; [Holthoff, Vjera A.; Marschner, Kira; Scharf, Maria; Donix, Markus] German Ctr Neurodegenerat Dis, DZNE, Dresden, Germany	Technische Universitat Dresden; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technische Universitat Dresden	Holthoff, VA (corresponding author), Tech Univ Dresden, Fac Med Carl Gustav Carus, Dept Psychiat & Psychotherapy, Div Old Age Psychiat & Cognit Neuropsychiat, D-01307 Dresden, Germany.	v.holthoff-detto@alexius.de		Holthoff, Vjera/0000-0001-7803-1091; Hennig (born Steding), Julius/0000-0002-4558-0323	RECK-Technik GmbH & Co. KG (Betzenweiler, Germany)	RECK-Technik GmbH & Co. KG (Betzenweiler, Germany)	Sponsor: RECK-Technik GmbH & Co. KG (Betzenweiler, Germany) provided all movement trainers (ReckMOTOmed viva2 (R)), technical support and delivery to and from the participants' homes. There was no financial sponsoring or scientific contribution by the sponsor. The sponsor is acknowledged in the manuscript. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other current funding sources for this study.	Anderson-Hanley C, 2012, AM J PREV MED, V42, P109, DOI 10.1016/j.amepre.2011.10.016; Baker LD, 2010, ARCH NEUROL-CHICAGO, V67, P71, DOI 10.1001/archneurol.2009.307; Bherer L., 2013, J AGING RES, V2013, DOI [10.1155/2013/657508., 10.1155/2013/657508]; Boyle PA, 2003, AM J GERIAT PSYCHIAT, V11, P214, DOI 10.1176/appi.ajgp.11.2.214; BRODATY H, 1993, ARCH NEUROL-CHICAGO, V50, P643, DOI 10.1001/archneur.1993.00540060073021; Cheng ST, 2014, AM J GERIAT PSYCHIAT, V22, P63, DOI 10.1016/j.jagp.2013.01.060; Davis B., 2000, PHYS ED STUDY SPORT; Coelho FGD, 2014, J ALZHEIMERS DIS, V39, P401, DOI 10.3233/JAD-131073; Forbes D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006489.pub3; Herholz SC, 2013, EXPERT REV NEUROTHER, V13, P1235, DOI 10.1586/14737175.2013.845086; Kemoun G, 2010, DEMENT GERIATR COGN, V29, P109, DOI 10.1159/000272435; Kempermann G, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00189; Lam LCW, 2011, INT J GERIATR PSYCH, V26, P733, DOI 10.1002/gps.2602; Lautenschlager NT, 2008, JAMA-J AM MED ASSOC, V300, P1027, DOI 10.1001/jama.300.9.1027; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Razani J, 2007, APPL NEUROPSYCHOL, V14, P208, DOI 10.1080/09084280701509125; Scherder EJA, 2005, AGING MENT HEALTH, V9, P272, DOI 10.1080/13607860500089930; Schneider N, 2013, J NUTR HEALTH AGING, V17, P252, DOI 10.1007/s12603-012-0402-8; Stubbs B, 2014, ARCH GERONTOL GERIAT, V59, P195, DOI 10.1016/j.archger.2014.06.006; Tak E, 2013, AGEING RES REV, V12, P329, DOI 10.1016/j.arr.2012.10.001; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Tudor-Locke C, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-79; van Uffelen JGZ, 2008, BRIT J SPORT MED, V42, DOI 10.1136/bjsm.2007.044735; Vreugdenhil A, 2012, SCAND J CARING SCI, V26, P12, DOI 10.1111/j.1471-6712.2011.00895.x; Weinstein G, 2014, JAMA NEUROL, V71, P55, DOI 10.1001/jamaneurol.2013.4781; Yaguez L, 2011, INT J GERIATR PSYCH, V26, P173, DOI 10.1002/gps.2510	27	68	72	1	72	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121478	10.1371/journal.pone.0121478	http://dx.doi.org/10.1371/journal.pone.0121478			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884637	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000019
J	Hosoda, M; Tokonami, S; Omori, Y; Sahoo, SK; Akiba, S; Sorimachi, A; Ishikawa, T; Nair, RR; Jayalekshmi, PA; Sebastian, P; Iwaoka, K; Akata, N; Kudo, H				Hosoda, Masahiro; Tokonami, Shinji; Omori, Yasutaka; Sahoo, Sarata Kumar; Akiba, Suminori; Sorimachi, Atsuyuki; Ishikawa, Tetsuo; Nair, Raghu Ram; Jayalekshmi, Padmavathy Amma; Sebastian, Paul; Iwaoka, Kazuki; Akata, Naofumi; Kudo, Hiromi			Estimation of External Dose by Car-Borne Survey in Kerala, India	PLOS ONE			English	Article							TERRESTRIAL GAMMA-RADIATION; BACKGROUND-RADIATION	A car-borne survey was carried out in Kerala, India to estimate external dose. Measurements were made with a 3-in x 3-in NaI(Tl) scintillation spectrometer from September 23 to 27, 2013. The routes were selected from 12 Panchayats in Karunagappally Taluk which were classified into high level, mid-level and low level high background radiation (HBR) areas. A heterogeneous distribution of air kerma rates was seen in the dose rate distribution map. The maximum air kerma rate, 2.1 mu Gy/h, was observed on a beach sand surface. Th-232 activity concentration for the beach sand was higher than that for soil and grass surfaces, and the range of activity concentration was estimated to be 0.7-2.3 kBq/kg. The contribution of 232Th to air kerma rate was over 70% at the measurement points with values larger than 0.34 mu Gy/h. The maximum value of the annual effective dose in Karunagappally Taluk was observed around coastal areas, and it was estimated to be 13 mSv/y. More than 30% of all the annual effective doses obtained in this survey exceeded 1 mSv/y.	[Hosoda, Masahiro; Kudo, Hiromi] Hirosaki Univ, Grad Sch Hlth Sci, Aomori, Japan; [Tokonami, Shinji; Iwaoka, Kazuki] Hirosaki Univ, Inst Radiat Emergency Med, Aomori, Japan; [Omori, Yasutaka; Sorimachi, Atsuyuki; Ishikawa, Tetsuo] Fukushima Med Univ, Fukushima, Japan; [Sahoo, Sarata Kumar] Natl Inst Radiol Sci, Chiba 260, Japan; [Akiba, Suminori] Kagoshima Univ, Grad Sch Med & Dent Sci, Kagoshima 890, Japan; [Nair, Raghu Ram; Sebastian, Paul] Reg Canc Ctr, Neendakara, Kerala, India; [Jayalekshmi, Padmavathy Amma] Nat Background Radiat Canc Registry, Neendakara, Kerala, India; [Akata, Naofumi] Natl Inst Fus Sci, Gifu, Japan	Hirosaki University; Hirosaki University; Fukushima Medical University; National Institutes for Quantum Science & Technology; Kagoshima University; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Fusion Science (NIFS) - Japan	Tokonami, S (corresponding author), Hirosaki Univ, Inst Radiat Emergency Med, Aomori, Japan.	tokonami@hirosaki-u.ac.jp	Omori, Yasutaka/AAF-8203-2021; Tokonami, Shinji/AAH-6042-2020	Omori, Yasutaka/0000-0003-3629-8761; Tokonami, Shinji/0000-0002-6617-7402	Japanese Ministry of the Environment	Japanese Ministry of the Environment(Ministry of the Environment, Japan)	This work was conducted for the grant-in-aid "Dosimetric Studies of Residents in High Natural Background Radiation Areas in India and China" financially supported from the Japanese Ministry of the Environment.	Akahane K, 2013, SCI REP-UK, V3, DOI 10.1038/srep01670; Beck H.L., 1972, HASL258 US AT EN COM; Beck HL, 1972, HASL262 US AT EN COM; Chougaonkar MP, 2004, J ENVIRON RADIOACTIV, V71, P275, DOI 10.1016/S0265-931X(03)00174-7; Christa EP, 2012, RADIAT PROT DOSIM, V148, P482, DOI 10.1093/rpd/ncr198; Derin MT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050468; Hosoda M, 2013, SCI REP-UK, V3, DOI 10.1038/srep02283; Ishikawa T., 2014, RAD EMERGENCY MED, V3, P21; Matsuda H., 1982, Reports of the Government Industrial Research Institute, Nagoya, V31, P132; Matsuda Hideharu, 2002, Radioisotopes, V51, P42; MINATO S, 1970, J NUCL SCI TECHNOL-T, V7, P401, DOI 10.3327/jnst.7.401; Minato S., 2001, Radioisotopes, V50, P463, DOI 10.3769/radioisotopes.50.10_463; MINATO S, 1971, J NUCL SCI TECHNOL-T, V8, P342, DOI 10.3327/jnst.8.342; Minato S., 1995, Reports of the National Industrial Research Institute of Nagoya, V44, P609; Minato S., 1977, Reports of the Government Industrial Research Institute, Nagoya, V26, P190; Minato S, 2012, RAD EMERG MED, V1, P108; Minato S., 1978, REP GOV IND RES I NA, V27, P384; Minato S., 1980, J JPN HLTH PHYS, V15, P19; Moller AP, 2013, BIOL REV, V88, P226, DOI 10.1111/j.1469-185X.2012.00249.x; Nair RRK, 2009, HEALTH PHYS, V96, P55, DOI 10.1097/01.HP.0000327646.54923.11; Nambi KSV, 1986, 130 BHABH AT RES CTR; Tokonami S, 2012, SCI REP-UK, V2, DOI 10.1038/srep00507; United Nations Scientific Committee on the Effects of Atomic Radiation, 2014, UNSCEAR 2013 REP GEN; United Nations Scientific Committee on the Effects of Atomic Radiation (UNSCEAR), 2000, SOURC EFF LON RAD; Wessel P, 1991, EOS T AM GEOPHYS UN, V72, P445, DOI [10.1029/90EO00319, DOI 10.1029/90EO00319, DOI 10.1029/90E000319]	25	31	32	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124433	10.1371/journal.pone.0124433	http://dx.doi.org/10.1371/journal.pone.0124433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885680	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000127
J	Nogueira, A; Rey, PJ; Alcantara, JM; Feitosa, RM; Lohmann, LG				Nogueira, Anselmo; Rey, Pedro J.; Alcantara, Julio M.; Feitosa, Rodrigo M.; Lohmann, Lucia G.			Geographic Mosaic of Plant Evolution: Extrafloral Nectary Variation Mediated by Ant and Herbivore Assemblages	PLOS ONE			English	Article							HELLEBORUS-FOETIDUS; BODY-SIZE; CHAMAECRISTA-FASCICULATA; FRUIT-SET; SELECTION; MUTUALISM; DISPERSAL; TRAITS; DISRUPTION; HERB	Herbivory is an ecological process that is known to generate different patterns of selection on defensive plant traits across populations. Studies on this topic could greatly benefit from the general framework of the Geographic Mosaic Theory of Coevolution (GMT). Here, we hypothesize that herbivory represents a strong pressure for extrafloral nectary (EFN) bearing plants, with differences in herbivore and ant visitor assemblages leading to different evolutionary pressures among localities and ultimately to differences in EFN abundance and function. In this study, we investigate this hypothesis by analyzing 10 populations of Anemopaegma album (30 individuals per population) distributed through ca. 600 km of Neotropical savanna and covering most of the geographic range of this plant species. A common garden experiment revealed a phenotypic differentiation in EFN abundance, in which field and experimental plants showed a similar pattern of EFN variation among populations. We also did not find significant correlations between EFN traits and ant abundance, herbivory and plant performance across localities. Instead, a more complex pattern of ant-EFN variation, a geographic mosaic, emerged throughout the geographical range of A. album. We modeled the functional relationship between EFNs and ant traits across ant species and extended this phenotypic interface to characterize local situations of phenotypic matching and mismatching at the population level. Two distinct types of phenotypic matching emerged throughout populations: (1) a population with smaller ants (Crematogaster crinosa) matched with low abundance of EFNs; and (2) seven populations with bigger ants (Camponotus species) matched with higher EFN abundances. Three matched populations showed the highest plant performance and narrower variance of EFN abundance, representing potential plant evolutionary hotspots. Cases of mismatched and matched populations with the lowest performance were associated with abundant and highly detrimental herbivores. Our findings provide insights on the ecology and evolution of plant-ant guarding systems, and suggest new directions to research on facultative mutualistic interactions at wide geographic scales.	[Nogueira, Anselmo; Lohmann, Lucia G.] Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil; [Rey, Pedro J.; Alcantara, Julio M.] Univ Jaen, Dept Biol Anim Biol Vegetal & Ecol, Fac Ciencias Expt, Jaen, Andalucia, Spain; [Feitosa, Rodrigo M.] Univ Fed Parana, Dept Zool, Setor Ciencias Biol, BR-80060000 Curitiba, Parana, Brazil	Universidade de Sao Paulo; Universidad de Jaen; Universidade Federal do Parana	Nogueira, A (corresponding author), Univ Sao Paulo, Inst Biociencias, Dept Bot, Sao Paulo, SP, Brazil.	anselmoeco@yahoo.com.br; prey@ujaen.es; jmalcan@ujaen.es; rsmfeitosa@gmail.com; llohmann@usp.br	Lohmann, Lucia G./AAF-7259-2021; Feitosa, Rodrigo Machado/D-2171-2012; Alcantara, Julio M./O-4400-2017; Rey, Pedro J./I-2165-2015; Nogueira, Anselmo/C-3465-2013	Lohmann, Lucia G./0000-0003-4960-0587; Feitosa, Rodrigo Machado/0000-0001-9042-0129; Alcantara, Julio M./0000-0002-8003-7844; Rey, Pedro J./0000-0001-5550-0393; Nogueira, Anselmo/0000-0002-8232-4636	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [AN 2012/02110-5, AN 2013/04591-3]; FAPESP grant [LGL 2007/55433-8]; Pq-1C grant from the CNPq; CAPES/PROEX	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP grant(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Pq-1C grant from the CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES/PROEX(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This project was funded by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP Fellowships to AN 2012/02110-5 and AN 2013/04591-3, and FAPESP grant to LGL 2007/55433-8), a Pq-1C grant from the CNPq to LGL, and CAPES/PROEX.	Alcantara JM, 2007, EVOL ECOL, V21, P411, DOI 10.1007/s10682-006-9110-3; Baker-Meio B, 2012, J ECOL, V100, P242, DOI 10.1111/j.1365-2745.2011.01892.x; Beattie A. J., 1985, EVOLUTIONARY ECOLOGY; Beattie Andrew J., 2002, P211; Benkman CW, 1999, AM NAT, V153, pS75, DOI 10.1086/303213; Bluthgen N, 2004, ECOLOGY, V85, P1479, DOI 10.1890/03-0430; Bronstein JL, 1998, BIOTROPICA, V30, P150, DOI 10.1111/j.1744-7429.1998.tb00050.x; BRONSTEIN JL, 1994, TRENDS ECOL EVOL, V9, P214, DOI 10.1016/0169-5347(94)90246-1; Chamberlain SA, 2009, ECOLOGY, V90, P2384, DOI 10.1890/08-1490.1; Davidson DW, 2004, OECOLOGIA, V139, P255, DOI 10.1007/s00442-004-1508-4; DelClaro K, 1996, J TROP ECOL, V12, P887, DOI 10.1017/S0266467400010142; Denno R.F., 1983, VARIABLE PLANTS HERB; Diaz-Castelazo C, 2005, ANN BOT-LONDON, V96, P1175, DOI 10.1093/aob/mci270; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Elias T. S., 1983, The biology of nectaries, P174; Garrido JL, 2002, J ECOL, V90, P446, DOI 10.1046/j.1365-2745.2002.00675.x; GENTRY AH, 1974, ANN MO BOT GARD, V61, P728, DOI 10.2307/2395026; Godoy BS, 2013, BIOTA NEOTROP, V13, P91, DOI 10.1590/S1676-06032013000100010; Gomez JM, 2009, ECOL MONOGR, V79, P245, DOI 10.1890/08-0511.1; Hanifin CT, 2008, PLOS BIOL, V6, P471, DOI 10.1371/journal.pbio.0060060; Heil M, 2003, ANNU REV ECOL EVOL S, V34, P425, DOI 10.1146/annurev.ecolsys.34.011802.132410; Herrera C.M., 2006, ECOLOGY EVOLUTION FL, P278; Hijmans R. J., 2014, GEOSPHERE SPHERICAL; Hurlbert AH, 2008, ECOL ENTOMOL, V33, P144, DOI 10.1111/j.1365-2311.2007.00962.x; Jones CG, 2007, J VEG SCI, V18, P771; Kersch MF, 2005, ECOLOGY, V86, P2117, DOI 10.1890/04-1916; Korndorfer AP, 2006, BIOTROPICA, V38, P786, DOI 10.1111/j.1744-7429.2006.00200.x; Kostyshak S, 2014, BOOTSTRAP R PACKAGE; Legendre P., 2012, NUMERICAL ECOLOGY; Liere H, 2010, OIKOS, V119, P1394, DOI 10.1111/j.1600-0706.2010.17985.x; Loe G, 2007, OIKOS, V116, P134, DOI 10.1111/j.2006.0030-1299.15022.x; Manly B., 1998, RANDOMIZATION BOOTST; Manzaneda AJ, 2008, ECOGRAPHY, V31, P583, DOI 10.1111/j.0906-7590.2008.05345.x; Manzaneda AJ, 2007, BIOL J LINN SOC, V92, P135, DOI 10.1111/j.1095-8312.2007.00831.x; Manzaneda AJ, 2012, ECOGRAPHY, V35, P322, DOI 10.1111/j.1600-0587.2011.06923.x; Manzaneda AJ, 2009, ECOLOGY, V90, P3009, DOI 10.1890/08-2274.1; Mezquida ET, 2005, J EVOLUTION BIOL, V18, P348, DOI 10.1111/j.1420-9101.2004.00846.x; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Mooney KA, 2006, ECOLOGY, V87, P1805, DOI 10.1890/0012-9658(2006)87[1805:TDOAAM]2.0.CO;2; Nascimento EA, 2010, FLORA, V205, P754, DOI 10.1016/j.flora.2009.12.040; Ness JH, 2006, ECOLOGY, V87, P912, DOI 10.1890/0012-9658(2006)87[912:IQAQOM]2.0.CO;2; Ness JH, 2003, OECOLOGIA, V134, P210, DOI 10.1007/s00442-002-1110-6; Nogueira A, 2012, J EVOLUTION BIOL, V25, P2325, DOI 10.1111/j.1420-9101.2012.02615.x; Nogueira A, 2013, ANN BOT-LONDON, V112, P1331, DOI 10.1093/aob/mct201; Nogueira A, 2012, PLANT ECOL, V213, P289, DOI 10.1007/s11258-011-9974-3; Nowbahari E, 1999, AGGRESSIVE BEHAV, V25, P369, DOI 10.1002/(SICI)1098-2337(1999)25:5<369::AID-AB5>3.0.CO;2-C; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Oliveira PS, 1997, FUNCT ECOL, V11, P323, DOI 10.1046/j.1365-2435.1997.00087.x; Oliveira PS, 2004, NATURWISSENSCHAFTEN, V91, P557, DOI 10.1007/s00114-004-0585-x; R Development Core Team, 2014, R LANG ENV STAT COMP; Rey P.J., 2009, CONSERVACION INTERAC, P113; Rey PJ, 2007, J ECOL, V95, P1381, DOI 10.1111/j.1365-2745.2007.01293.x; Rey PJ, 2006, J EVOLUTION BIOL, V19, P21, DOI 10.1111/j.1420-9101.2005.00992.x; Ribas CR, 2002, OECOLOGIA, V131, P606, DOI 10.1007/s00442-002-0912-x; Rico-Gray V, 1998, BIOTROPICA, V30, P190, DOI 10.1111/j.1744-7429.1998.tb00054.x; Rico-Gray V., 2008, ECOLOGY EVOLUTION AN, DOI DOI 10.7208/CHICAGO/9780226713540.001.0001; Rios RS, 2008, OECOLOGIA, V156, P577, DOI 10.1007/s00442-008-1024-z; Rodriguez-Cabal MA, 2012, BIOL INVASIONS, V14, P557, DOI 10.1007/s10530-011-0097-5; Rudgers JA, 2004, P ROY SOC B-BIOL SCI, V271, P2481, DOI 10.1098/rspb.2004.2900; Rudgers JA, 2004, ECOLOGY, V85, P192, DOI 10.1890/02-0625; Rutter MT, 2004, EVOLUTION, V58, P2657, DOI 10.1111/j.0014-3820.2004.tb01619.x; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schoereder Jose H., 2010, Terrestrial Arthropod Reviews, V3, P3, DOI 10.1163/187498310X487785; Sendoya SF, 2009, AM NAT, V174, P134, DOI 10.1086/599302; STEPHENSON AG, 1982, ECOLOGY, V63, P663, DOI 10.2307/1936786; Stinchcombe JR, 2002, P ROY SOC B-BIOL SCI, V269, P1241, DOI 10.1098/rspb.2002.2015; Thompson J., 2013, RELENTLESS EVOLUTION, DOI DOI 10.7208/CHICAGO/9780226018898.001.0001; Thompson J. N., 2005, INTERSPEC INTERACT; Thompson JD., 1994, COEVOLUTIONARY PROCE; Thompson JN, 1997, ECOLOGY, V78, P1619; Thompson JN, 1999, AM NAT, V153, pS1, DOI 10.1086/303208; Weber MG, 2013, ANN BOT-LONDON, V111, P1251, DOI 10.1093/aob/mcs225; Zangerl AR, 2003, EVOLUTION, V57, P806, DOI 10.1111/j.0014-3820.2003.tb00292.x	73	18	18	0	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123806	10.1371/journal.pone.0123806	http://dx.doi.org/10.1371/journal.pone.0123806			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885221	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000083
J	Vogelstein, JT; Conroy, JM; Lyzinski, V; Podrazik, LJ; Kratzer, SG; Harley, ET; Fishkind, DE; Vogelstein, RJ; Priebe, CE				Vogelstein, Joshua T.; Conroy, John M.; Lyzinski, Vince; Podrazik, Louis J.; Kratzer, Steven G.; Harley, Eric T.; Fishkind, Donnie E.; Vogelstein, R. Jacob; Priebe, Carey E.			Fast Approximate Quadratic Programming for Graph Matching	PLOS ONE			English	Article							ALGORITHM	Quadratic assignment problems arise in a wide variety of domains, spanning operations research, graph theory, computer vision, and neuroscience, to name a few. The graph matching problem is a special case of the quadratic assignment problem, and graph matching is increasingly important as graph-valued data is becoming more prominent. With the aim of efficiently and accurately matching the large graphs common in big data, we present our graph matching algorithm, the Fast Approximate Quadratic assignment algorithm. We empirically demonstrate that our algorithm is faster and achieves a lower objective value on over 80% of the QAPLIB benchmark library, compared with the previous state-of-the-art. Applying our algorithm to our motivating example, matching C. elegans connectomes (brain-graphs), we find that it efficiently achieves performance.	[Vogelstein, Joshua T.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA; [Conroy, John M.; Podrazik, Louis J.; Kratzer, Steven G.] Inst Def Analyses, Ctr Comp Sci, Bowie, MD USA; [Lyzinski, Vince] Johns Hopkins Univ, Human Language Technol Ctr Excellence, Baltimore, MD USA; [Harley, Eric T.; Fishkind, Donnie E.; Priebe, Carey E.] Johns Hopkins Univ, Dept Appl Math & Stat, Baltimore, MD USA; [Vogelstein, R. Jacob] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD 21218 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory	Vogelstein, JT (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	jovo@jhu.edu	Vogelstein, Joshua/AAG-5489-2019	Vogelstein, Joshua/0000-0003-2487-6237	Research Program in Applied Neuroscience; National Security Science and Engineering Faculty Fellowship; Johns Hopkins University Human Language Technology Center of Excellence; XDATA program of the Defense Advanced Research Projects Agency; Air Force Research Laboratory [FA8750-12-2-0303]	Research Program in Applied Neuroscience; National Security Science and Engineering Faculty Fellowship; Johns Hopkins University Human Language Technology Center of Excellence; XDATA program of the Defense Advanced Research Projects Agency; Air Force Research Laboratory	This work was partially supported by the Research Program in Applied Neuroscience (JV, RJV, CEP, http://www.jhuapl.edu/ourwork/red/an/), a National Security Science and Engineering Faculty Fellowship (CEP, http://www.acq.osd.mil/rd/basic_research/program_info/nsseff.html), Johns Hopkins University Human Language Technology Center of Excellence (DEF, JV, CEP, VL, http://hltcoe.jhu.edu/), and the XDATA program of the Defense Advanced Research Projects Agency (CEP, http://www.darpa.mil/Our_Work/I2O/Programs/XDATA.aspx) administered through Air Force Research Laboratory contract FA8750-12-2-0303. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstreicher KM, 2001, MATH PROGRAM, V89, P341, DOI 10.1007/PL00011402; Anstreicher KM, 2003, SIAM J OPTIMIZ, V97, P27; Babai L., 1981, Fundamentals of Computation Theory. Proceedings of the 1981 International FCT-Conference, P34; BABAI L, 1980, SIAM J COMPUT, V9, P628, DOI 10.1137/0209047; Bazaraa M.S., 2013, NONLINEAR PROGRAMMIN, Vthird; Boyd S., 2004, CONVEX OPTIMIZATION; Bradley SP, 1977, APPL MATH PROGRAMMIN; Brixius NW, 2000, MANAGEMENT, P1; Burkard R. E., 2013, HDB COMBINATORIAL OP, P2741, DOI DOI 10.1007/978-1-4419-7997-1_22; Burkard RE, 1997, J GLOBAL OPTIM, V10, P391, DOI 10.1023/A:1008293323270; Calhoun Vince D, 2011, Front Psychiatry, V2, P75, DOI 10.3389/fpsyt.2011.00075; CHEN JN, 1994, SIAM J DISCRETE MATH, V7, P614, DOI 10.1137/S0895480191196769; Conte D, 2004, INT J PATTERN RECOGN, V18, P265, DOI 10.1142/S0218001404003228; Csernansky JG, 2004, NEUROIMAGE, V23, pS56, DOI 10.1016/j.neuroimage.2004.07.025; Escolano F, 2011, COMPUTER VISION PATT; Fornito A, 2012, NEUROIMAGE, V62, P2296, DOI 10.1016/j.neuroimage.2011.12.090; Fornito Alex, 2012, Front Psychiatry, V3, P32, DOI 10.3389/fpsyt.2012.00032; Fortin S, 1996, TECHNICAL REPORT; Frank M., 1956, NAV RES LOGIST Q, V3, P95, DOI 10.1002/nav.3800030109; Gold S, 1996, IEEE T PATTERN ANAL, V18, P377, DOI 10.1109/34.491619; Gray Roncal W., 2013, GLOB C SIGN INF PROC; HAGMANN P, 2005, THESIS I TRAITEMENT; Herculano-Houzel S, 2012, P NATL ACAD SCI USA, V109, P10661, DOI 10.1073/pnas.1201895109; JONKER R, 1987, COMPUTING, V38, P325, DOI 10.1007/BF02278710; Kolaczyk ED, 2009, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-88146-1_1; KOOPMANS TC, 1957, ECONOMETRICA, V25, P53, DOI 10.2307/1907742; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Leordeanu M., 2009, ADV NEURAL INFORM PR, P1114; Liu ZY, 2012, IEEE T PATTERN ANAL, V34, P1451, DOI 10.1109/TPAMI.2012.45; Lyzinski V, 2013, 13101297 ARXIV; Lyzinski V, 2014, J MACHINE L IN PRESS; Lyzinski V, 2014, ARXIV14053133; Papadimitriou C.H., 1998, COMBINATORIAL OPTIMI, VUnabridged edition; Priebe CE, 2013, COMMUN STAT-THEOR M, V42, P3455, DOI 10.1080/03610926.2011.630768; Schellewald C., 2001, Pattern Recognition. 23rd DAGM Symposium. Proceedings (Lecture Notes in Computer Science Vol.2191), P361; Singh R, 2007, LECT NOTES COMPUT SC, V4453, P16; SINKHORN R, 1964, ANN MATH STAT, V35, P876, DOI 10.1214/aoms/1177703591; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; UMEYAMA S, 1988, IEEE T PATTERN ANAL, V10, P695, DOI 10.1109/34.6778; Varshney LR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001066; Vogelstein JT, 2014, J CLASSIFIC IN PRESS; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Zaslavskiy M, 2010, LECT NOTES ARTIF INT, V6323, P515, DOI 10.1007/978-3-642-15939-8_33; Zaslavskiy M, 2009, IEEE T PATTERN ANAL, V31, P2227, DOI 10.1109/TPAMI.2008.245	45	60	61	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121002	10.1371/journal.pone.0121002	http://dx.doi.org/10.1371/journal.pone.0121002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886624	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000015
J	Bartlett, D; Boyle, GM; Ziman, M; Medic, S				Bartlett, Danielle; Boyle, Glen M.; Ziman, Mel; Medic, Sandra			Mechanisms Contributing to Differential Regulation of PAX3 Downstream Target Genes in Normal Human Epidermal Melanocytes versus Melanoma Cells	PLOS ONE			English	Article							NORMAL SKIN MELANOCYTES; ALTERNATIVE ISOFORMS; EXPRESSION; PROTEIN; PHOSPHORYLATION; LINES; IDENTIFICATION; MELANOBLAST; MIGRATION; NO	Melanoma is a highly aggressive and drug resistant form of skin cancer. It arises from melanocytes, the pigment producing cells of the skin. The formation of these melanocytes is driven by the transcription factor PAX3 early during embryonic development. As a result of alternative splicing, the PAX3 gene gives rise to eight different transcripts which encode isoforms that have different structures and activate different downstream target genes involved in pathways of cell proliferation, migration, differentiation and survival. Furthermore, post-translational modifications have also been shown to alter the functions of PAX3. We previously identified PAX3 downstream target genes in melanocytes and melanoma cells. Here we assessed the effects of PAX3 down-regulation on this panel of target genes in primary melanocytes versus melanoma cells. We show that PAX3 differentially regulates various downstream target genes involved in cell proliferation in melanoma cells compared to melanocytes. To determine mechanisms behind this differential downstream target gene regulation, we performed immunoprecipitation to assess post-translational modifications of the PAX3 protein as well as RNAseq to determine PAX3 transcript expression profiles in melanocytes compared to melanoma cells. Although PAX3 was found to be post-translationally modified, there was no qualitative difference in phosphorylation and ubiquitination between melanocytes and melanoma cells, while acetylation of PAX3 was reduced in melanoma cells. Additionally, there were differences in PAX3 transcript expression profiles between melanocytes and melanoma cells. In particular the PAX3E transcript, responsible for reducing melanocyte proliferation and increasing apoptosis, was found to be down-regulated in melanoma cells compared to melanocytes. These results suggest that alternate transcript expression profiles activate different downstream target genes leading to the melanoma phenotype.	[Bartlett, Danielle; Ziman, Mel; Medic, Sandra] Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia; [Boyle, Glen M.] QIMR Berghofer Med Res Inst, Div Canc & Cell Biol, Canc Drug Mech Grp, Brisbane, Qld, Australia; [Ziman, Mel] Univ Western Australia, Sch Pathol & Lab Med, Perth, WA 6009, Australia; [Medic, Sandra] Curtin Univ, Curtin Hlth Innovat Res Inst Ageing & Chron Dis, Perth, WA 6845, Australia	Edith Cowan University; QIMR Berghofer Medical Research Institute; University of Western Australia; Curtin University	Ziman, M (corresponding author), Edith Cowan Univ, Sch Med Sci, Perth, WA, Australia.	m.ziman@ecu.edu.au	Boyle, Glen/G-1347-2013	Boyle, Glen/0000-0002-1385-529X; Ziman, Mel/0000-0001-7527-3538; Bartlett, Danielle/0000-0002-6096-3760	Cancer Council Western Australia; Edith Cowan University	Cancer Council Western Australia(Cancer Council Western Australia); Edith Cowan University	Funding was provided by Cancer Council Western Australia Early Career Investigators Grant, SM MZ; Edith Cowan University Early Career Researchers Grant SM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBINO AP, 1994, MELANOMA RES, V4, P35, DOI 10.1097/00008390-199402000-00006; ALILECHE A, 1993, ONCOGENE, V8, P1791; Balch CM, 2009, J CLIN ONCOL, V27, P6199, DOI 10.1200/JCO.2009.23.4799; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Berlin I, 2012, MOL CELL BIOL, V32, P1237, DOI 10.1128/MCB.06257-11; Blake JA, 2005, DEV GROWTH DIFFER, V47, P627; Bonvin E, 2012, MOL CELL BIOL, V32, P4674, DOI 10.1128/MCB.01067-12; Boutet SC, 2007, CELL, V130, P349, DOI 10.1016/j.cell.2007.05.044; Boutet SC, 2010, MOL CELL, V40, P749, DOI 10.1016/j.molcel.2010.09.029; Boyle GM, 2011, PIGM CELL MELANOMA R, V24, P525, DOI 10.1111/j.1755-148X.2011.00849.x; CHENEVIXTRENCH G, 1990, ONCOGENE, V5, P1187; Dietz KN, 2011, INT J BIOCHEM CELL B, V43, P936, DOI 10.1016/j.biocel.2011.03.010; FABRICANT RN, 1977, P NATL ACAD SCI USA, V74, P565, DOI 10.1073/pnas.74.2.565; FOGH J, 1977, J NATL CANCER I, V58, P209, DOI 10.1093/jnci/58.2.209; Goodall J, 2008, CANCER RES, V68, P7788, DOI 10.1158/0008-5472.CAN-08-1053; He SJ, 2010, J INVEST DERMATOL, V130, P1465, DOI 10.1038/jid.2009.434; He SJ, 2005, MOL CANCER THER, V4, P996, DOI 10.1158/1535-7163.MCT-04-0252; Hoek KS, 2006, PIGM CELL RES, V19, P290, DOI 10.1111/j.1600-0749.2006.00322.x; Ichi S, 2011, MOL BIOL CELL, V22, P503, DOI 10.1091/mbc.E10-06-0541; Kaiser P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-233; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lowen M, 2001, J BIOL CHEM, V276, P42565, DOI 10.1074/jbc.M106536200; Medic S, 2011, BIOCHEM BIOPH RES CO, V411, P832, DOI 10.1016/j.bbrc.2011.07.053; Medic S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009977; Medic S, 2009, CRIT REV BIOCHEM MOL, V44, P85, DOI 10.1080/10409230902755056; Miller PJ, 2008, PROTEIN SCI, V17, P1979, DOI 10.1110/ps.035956.108; Miller PJ, 2007, BBA-GEN SUBJECTS, V1770, P1450, DOI 10.1016/j.bbagen.2007.06.016; Philippidou D, 2010, CANCER RES, V70, P4163, DOI 10.1158/0008-5472.CAN-09-4512; Pinner S, 2009, CANCER RES, V69, P7969, DOI 10.1158/0008-5472.CAN-09-0781; Poulikakos PI, 2011, CANCER CELL, V19, P11, DOI 10.1016/j.ccr.2011.01.008; Russowsky D, 2006, BIOORG CHEM, V34, P173, DOI 10.1016/j.bioorg.2006.04.003; Sparrow L E, 1999, Australas J Dermatol, V40, P19, DOI 10.1046/j.1440-0960.1999.00310.x; Tucker MA, 2009, HEMATOL ONCOL CLIN N, V23, P383, DOI 10.1016/j.hoc.2009.03.010; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Wang QY, 2007, INT J CANCER, V120, P1223, DOI 10.1002/ijc.22316; Wang QY, 2006, CANCER RES, V66, P8574, DOI 10.1158/0008-5472.CAN-06-0947; White CA, 1998, INT J CANCER, V75, P590; Zhang XD, 1999, CANCER RES, V59, P2747	38	7	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124154	10.1371/journal.pone.0124154	http://dx.doi.org/10.1371/journal.pone.0124154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880082	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500086
J	Patarroyo, ME; Bermudez, A; Alba, MP; Vanegas, M; Moreno-Vranich, A; Poloche, LA; Patarroyo, MA				Elkin Patarroyo, Manuel; Bermudez, Adriana; Patricia Alba, Martha; Vanegas, Magnolia; Moreno-Vranich, Armando; Antonio Poloche, Luis; Alfonso Patarroyo, Manuel			IMPIPS: The Immune Protection-Inducing Protein Structure Concept in the Search for Steric-Electron and Topochemical Principles for Complete Fully-Protective Chemically Synthesised Vaccine Development	PLOS ONE			English	Article							T-CELL-RECEPTOR; MHC CLASS-II; PLASMODIUM-FALCIPARUM MALARIA; MAJOR HISTOCOMPATIBILITY COMPLEX; CRYSTAL-STRUCTURE; FIELD TRIAL; HLA-DR4 DRA-ASTERISK-0101; HEMAGGLUTININ PEPTIDE; SYNTHETIC VACCINE; HOST-CELLS	Determining immune protection-inducing protein structures (IMPIPS) involves defining the stereo-electron and topochemical characteristics which are essential in MHC-p-TCR complex formation. Modified high activity binding peptides (mHABP) were thus synthesised to produce a large panel of IMPIPS measuring 26.5 +/- 3.5 angstrom between the farthest atoms fitting into Pockets 1 to 9 of HLA-DR beta 1* structures. They displayed a polyproline II-like (PPIIL) structure with their backbone O and N atoms orientated to establish H-bonds with specific residues from HLA-DR beta 1*- peptide binding regions (PBR). Residues having specific charge and gauche(+) orientation regarding p3x1, p5x2, and p7x1 angles determined appropriate rotamer orientation for perfectly fitting into the TCR to induce an appropriate immune response. Immunological assays in Aotus monkeys involving IMPIPS mixtures led to promising results; taken together with the aforementioned physicochemical principles, non-interfering, long-lasting, protection-inducing, multi-epitope, multistage, minimal subunit-based chemically-synthesised peptides can be designed against diseases scourging humankind.	[Elkin Patarroyo, Manuel; Bermudez, Adriana; Patricia Alba, Martha; Vanegas, Magnolia; Moreno-Vranich, Armando; Antonio Poloche, Luis; Alfonso Patarroyo, Manuel] FIDIC, Bogota, Colombia; [Elkin Patarroyo, Manuel] Univ Nacl Colombia, Bogota, Colombia; [Bermudez, Adriana; Patricia Alba, Martha; Vanegas, Magnolia; Alfonso Patarroyo, Manuel] Univ Rosario, Bogota, Colombia	Universidad Nacional de Colombia; Universidad del Rosario	Patarroyo, ME (corresponding author), FIDIC, Bogota, Colombia.	mepatarr@gmail.com	Vanegas, Magnolia/I-7968-2016; Murillo, Manuel Elkin M.E Patarroyo/S-1422-2017; Bermudez, Adriana/I-7935-2016; Patarroyo, Manuel A/I-8046-2016	Vanegas, Magnolia/0000-0001-7722-4115; Murillo, Manuel Elkin M.E Patarroyo/0000-0002-1119-6040; Bermudez, Adriana/0000-0003-2669-7259; Patarroyo, Manuel A/0000-0002-4751-2500; Alba, Martha patricia/0000-0003-0641-5162	The Colombian Science, Technology and Innovation Department (Colciencias) [709-2013]	The Colombian Science, Technology and Innovation Department (Colciencias)(Departamento Administrativo de Ciencia, Tecnologia e Innovacion Colciencias)	This work was financed by the "The Colombian Science, Technology and Innovation Department (Colciencias)" (Grant 709-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JJ, 2011, IMMUNITY, V35, P681, DOI 10.1016/j.immuni.2011.09.013; ADZHUBEI AA, 1993, J MOL BIOL, V229, P472, DOI 10.1006/jmbi.1993.1047; ALONSO PL, 1994, LANCET, V344, P1175, DOI 10.1016/S0140-6736(94)90505-3; Arastu-Kapur S, 2008, NAT CHEM BIOL, V4, P203, DOI 10.1038/nchembio.70; Armstrong KM, 2008, BIOCHEM J, V415, P183, DOI 10.1042/BJ20080850; Balbin A, 2006, BIOCHIMIE, V88, P1307, DOI 10.1016/j.biochi.2006.05.009; Bejon P, 2013, LANCET INFECT DIS, V13, P319, DOI 10.1016/S1473-3099(13)70005-7; Bermudez A, 2014, VACCINE, V32, P2117, DOI 10.1016/j.vaccine.2014.02.003; Bermudez A, 2008, VACCINE, V26, P6908, DOI 10.1016/j.vaccine.2008.09.071; Best RB, 2004, J AM CHEM SOC, V126, P7734, DOI 10.1021/ja049078w; Bromley SK, 2001, ANNU REV IMMUNOL, V19, P375, DOI 10.1146/annurev.immunol.19.1.375; Cardenas C, 2005, J STRUCT BIOL, V149, P38, DOI 10.1016/j.jsb.2004.08.003; Cardenas C, 2004, BIOCHEM BIOPH RES CO, V323, P1265, DOI 10.1016/j.bbrc.2004.08.225; Cardenas C, 2002, COMPUT CHEM, V26, P667, DOI 10.1016/S0097-8485(02)00052-9; Cardenas C, 2007, J MOL GRAPH MODEL, V25, P605, DOI 10.1016/j.jmgm.2006.04.005; Chellgren BW, 2004, BIOCHEMISTRY-US, V43, P5864, DOI 10.1021/bi049922v; Chen K, 2005, J AM CHEM SOC, V127, P10146, DOI 10.1021/ja052094o; Choudhary A, 2009, J AM CHEM SOC, V131, P7244, DOI 10.1021/ja901188y; Creamer TP, 2002, ADV PROTEIN CHEM, V62, P263; Creamer TP, 1998, PROTEINS, V33, P218, DOI 10.1002/(SICI)1097-0134(19981101)33:2<218::AID-PROT6>3.0.CO;2-E; Curtidor H, 2011, CURR MED CHEM, V18, P4470, DOI 10.2174/092986711797287575; Daeffler KNM, 2012, J AM CHEM SOC, V134, P14890, DOI 10.1021/ja304560x; Davis IW, 2006, STRUCTURE, V14, P265, DOI 10.1016/j.str.2005.10.007; Deng L, 2012, P NATL ACAD SCI USA, V109, P14960, DOI 10.1073/pnas.1207186109; Dessen A, 1997, IMMUNITY, V7, P473, DOI 10.1016/S1074-7613(00)80369-6; Diaz D, 2000, IMMUNOGENETICS, V51, P528, DOI 10.1007/s002510000189; Diaz OL, 2000, IMMUNOGENETICS, V51, P212, DOI 10.1007/s002510050034; Donermeyer DL, 2006, J IMMUNOL, V177, P6911, DOI 10.4049/jimmunol.177.10.6911; Drobnak I, 2013, J AM CHEM SOC, V135, P1288, DOI 10.1021/ja305081b; DUNBRACK RL, 1993, J MOL BIOL, V230, P543, DOI 10.1006/jmbi.1993.1170; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; Patarroyo ME, 2011, CHEM REV, V111, P3459, DOI 10.1021/cr100223m; Epstein JE, 2011, SCIENCE, V334, P475, DOI 10.1126/science.1211548; Fattom A, 1999, VACCINE, V17, P126, DOI 10.1016/S0264-410X(98)00162-5; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GHOSH P, 1995, NATURE, V378, P457, DOI 10.1038/378457a0; Hennecke J, 2002, J EXP MED, V195, P571, DOI 10.1084/jem.20011194; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Horng JC, 2006, PROTEIN SCI, V15, P74, DOI 10.1110/ps.051779806; HUNT JD, 1994, VACCINE, V12, P457, DOI 10.1016/0264-410X(94)90125-2; Jakobsche CE, 2010, J AM CHEM SOC, V132, P6651, DOI 10.1021/ja100931y; JANIN J, 1978, J MOL BIOL, V125, P357, DOI 10.1016/0022-2836(78)90408-4; Jardetzky TS, 1996, P NATL ACAD SCI USA, V93, P734, DOI 10.1073/pnas.93.2.734; JARDETZKY TS, 1990, EMBO J, V9, P1797, DOI 10.1002/j.1460-2075.1990.tb08304.x; Koch O, 2009, PROTEINS, V74, P353, DOI 10.1002/prot.22185; Kuemin M, 2009, J AM CHEM SOC, V131, P15474, DOI 10.1021/ja906466q; Lee MCS, 2008, NAT CHEM BIOL, V4, P161, DOI 10.1038/nchembio0308-161; Lopez C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096973; Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.0.CO;2-2; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Marrack P, 2008, ANNU REV IMMUNOL, V26, P171, DOI 10.1146/annurev.immunol.26.021607.090421; Mian-McCarthy S, 2012, NEW ENGL J MED, V367, P2284, DOI 10.1056/NEJMoa1208394; MORENO A, 1993, J IMMUNOL, V151, P489; Mota MM, 2002, BIOESSAYS, V24, P149, DOI 10.1002/bies.10050; Mota MM, 2002, NAT MED, V8, P1318, DOI 10.1038/nm785; Mota MM, 2001, SCIENCE, V291, P141, DOI 10.1126/science.291.5501.141; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Nino-Vasquez JJ, 2000, IMMUNOGENETICS, V51, P219, DOI 10.1007/s002510050035; Nosten F, 1996, LANCET, V348, P701, DOI 10.1016/S0140-6736(96)04465-0; NOYA O, 1994, J INFECT DIS, V170, P396, DOI 10.1093/infdis/170.2.396; Pappu RV, 2002, PROTEIN SCI, V11, P2437, DOI 10.1110/ps.0217402; Parra-Lopez C, 2006, J BIOL CHEM, V281, P14907, DOI 10.1074/jbc.M511571200; Patarroyo MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009771; Patarroyo ME, 2008, INT J BIOCHEM CELL B, V40, P543, DOI 10.1016/j.biocel.2007.09.005; Patarroyo ME, 2008, ACCOUNTS CHEM RES, V41, P377, DOI 10.1021/ar700120t; Patarroyo ME, 2012, BIOCHEM BIOPH RES CO, V429, P75, DOI 10.1016/j.bbrc.2012.10.089; Patarroyo ME, 2012, BIOCHEM BIOPH RES CO, V429, P81, DOI 10.1016/j.bbrc.2012.10.088; PATARROYO ME, 1987, NATURE, V328, P629, DOI 10.1038/328629a0; PATARROYO ME, 1988, NATURE, V332, P158, DOI 10.1038/332158a0; Pico de Coana Y, 2004, CYTOKINE, V27, P129, DOI 10.1016/j.cyto.2004.04.004; Pizzanelli S, 2010, J PHYS CHEM B, V114, P3965, DOI 10.1021/jp907502n; Porter LL, 2011, P NATL ACAD SCI USA, V108, P109, DOI 10.1073/pnas.1014674107; Pos W, 2012, CELL, V151, P1557, DOI 10.1016/j.cell.2012.11.025; Rath A, 2005, BIOPOLYMERS, V80, P179, DOI 10.1002/bip.20227; Robinson J, 2013, NUCLEIC ACIDS RES, V41, pD1222, DOI 10.1093/nar/gks949; Rodriguez LE, 2008, CHEM REV, V108, P3656, DOI 10.1021/cr068407v; Rossmeisl J, 2003, J AM CHEM SOC, V125, P16383, DOI 10.1021/ja0359658; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Salazar LM, 2004, BIOCHEM BIOPH RES CO, V322, P119, DOI 10.1016/j.bbrc.2004.07.086; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Schuldt NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024147; Scott DR, 2011, J MOL BIOL, V414, P385, DOI 10.1016/j.jmb.2011.10.006; Sedegah M, 2004, GENE THER, V11, P448, DOI 10.1038/sj.gt.3302139; Seder RA, 2013, SCIENCE, V341, P1359, DOI 10.1126/science.1241800; SEMPERTEGUI F, 1994, VACCINE, V12, P337, DOI 10.1016/0264-410X(94)90098-1; Shapovalov MV, 2007, PROTEINS, V66, P279, DOI 10.1002/prot.21150; Shi ZS, 2006, CHEM REV, V106, P1877, DOI 10.1021/cr040433a; Smith KJ, 1998, J EXP MED, V188, P1511, DOI 10.1084/jem.188.8.1511; Stapley BJ, 1999, PROTEIN SCI, V8, P587; STERN LJ, 1994, NATURE, V368, P215, DOI 10.1038/368215a0; Suarez CF, 2006, IMMUNOGENETICS, V58, P542, DOI 10.1007/s00251-006-0127-0; Tamminga C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025868; Thera MA, 2011, NEW ENGL J MED, V365, P1004, DOI 10.1056/NEJMoa1008115; Tolia NH, 2005, CELL, V122, P183, DOI 10.1016/j.cell.2005.05.033; VALERO MV, 1993, LANCET, V341, P705, DOI 10.1016/0140-6736(93)90483-W; Valero MV, 1996, VACCINE, V14, P1466, DOI 10.1016/S0264-410X(96)00070-9; Vogel G, 2012, SCIENCE, V338, P871, DOI 10.1126/science.338.6109.871; Wang RB, 2005, INFECT IMMUN, V73, P2863, DOI 10.1128/IAI.73.5.2863-2872.2005; Wilson-Davis K, 1999, PHARMACOEPIDEM DR S, V8, P58, DOI 10.1002/(SICI)1099-1557(199901/02)8:1<58::AID-PDS390>3.0.CO;2-5; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhang XC, 2008, J MOL BIOL, V379, P105, DOI 10.1016/j.jmb.2008.03.039	102	24	24	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123249	10.1371/journal.pone.0123249	http://dx.doi.org/10.1371/journal.pone.0123249			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879751	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500043
J	Huang, H; Li, S; Sun, LZ; Zhou, GH				Huang, Huan; Li, Shuo; Sun, Lizhou; Zhou, Guohua			Digital Detection of Multiple Minority Mutants and Expression Levels of Multiple Colorectal Cancer-Related Genes Using Digital-PCR Coupled with Bead-Array	PLOS ONE			English	Article							DNA; MUTATIONS; TISSUE; STOOL; KRAS; RAS	To simultaneously analyze mutations and expression levels of multiple genes on one detection platform, we proposed a method termed "multiplex ligation-dependent probe amplification-digital amplification coupled with hydrogel bead-array" (MLPA-DABA) and applied it to diagnose colorectal cancer (CRC). CRC cells and tissues were sampled to extract nucleic acid, perform MLPA with sequence-tagged probes, perform digital emulsion polymerase chain reaction (PCR), and produce a hydrogel bead-array to immobilize beads and form a single bead layer on the array. After hybridization with fluorescent probes, the number of colored beads, which reflects the abundance of expressed genes and the mutation rate, was counted for diagnosis. Only red or green beads occurred on the chips in the mixed samples, indicating the success of single-molecule PCR. When a one-source sample was analyzed using mixed MLPA probes, beads of only one color occurred, suggesting the high specificity of the method in analyzing CRC mutation and gene expression. In gene expression analysis of a CRC tissue from one CRC patient, the mutant percentage was 3.1%, and the expression levels of CRC-related genes were much higher than those of normal tissue. The highly sensitive MLPA-DABA succeeds in the relative quantification of mutations and gene expressions of exfoliated cells in stool samples of CRC patients on the same chip platform. MLPA-DABA coupled with hydrogel bead-array is a promising method in the non-invasive diagnosis of CRC.	[Huang, Huan; Sun, Lizhou] Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Li, Shuo] Nanjing Xiaozhuang Univ, Nanjing, Jiangsu, Peoples R China; [Zhou, Guohua] Nanjing Univ, Sch Med, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Xiaozhuang University; Nanjing University	Huang, H (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China.	huanghuan@njmu.edu.cn		Zhou, Guohua/0000-0001-6675-4452	National Science Foundation of China [21305069, 21275161]; Training project of Young talents in Jiangsu Province Maternal and Child Health Hospital [FRC201302]; Jiangsu Province's Clinical Science & Technology Special Project [SBL2012061]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Training project of Young talents in Jiangsu Province Maternal and Child Health Hospital; Jiangsu Province's Clinical Science & Technology Special Project	The National Science Foundation of China (Grant No. 21305069 and 21275161) provided funding for the decision to publish and preparation of the manuscript. The Training project of Young talents in Jiangsu Province Maternal and Child Health Hospital (FRC201302) provided funding for data collection and analysis. Jiangsu Province's Clinical Science & Technology Special Project (SBL2012061) provided funding for study design.	Armaghany T, 2012, GASTROINTEST CANC RE, V5, P19; BARELI M, 1989, BLOOD, V73, P281; Church TR, 2005, J NATL CANCER I, V97, P328, DOI 10.1093/jnci/dji078; Deng LL, 2012, ANAL CHEM, V84, P5645, DOI 10.1021/ac3008016; Diehl F, 2008, GASTROENTEROLOGY, V135, P489, DOI 10.1053/j.gastro.2008.05.039; Dressman D, 2003, P NATL ACAD SCI USA, V100, P8817, DOI 10.1073/pnas.1133470100; Hsieh JS, 2005, AM SURGEON, V71, P336; Huang H, 2009, CHEM COMMUN, P4094, DOI 10.1039/b902196e; Huang JM, 2002, ONCOGENE, V21, P1909, DOI 10.1038/sj.onc.1205109; Kalmar A, 2013, METHODS, V59, pS16, DOI 10.1016/j.ymeth.2012.09.011; Kheirelseid EAH, 2013, J GASTROINTEST ONCOL, V4, P144, DOI 10.3978/j.issn.2078-6891.2013.010; Lee RDW, 2013, GENE, V512, P16, DOI 10.1016/j.gene.2012.10.001; Mao C, 2013, CANCER-AM CANCER SOC, V119, P714, DOI 10.1002/cncr.27804; Mouliere F, 2013, TRANSL ONCOL, V6, P319, DOI 10.1593/tlo.12445; Pincas H, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh150; Qi ZT, 2011, ANALYST, V136, P2252, DOI 10.1039/c0an00976h; Sinha R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060142; Xiao PF, 2007, ELECTROPHORESIS, V28, P1903, DOI 10.1002/elps.200600794	18	2	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123420	10.1371/journal.pone.0123420	http://dx.doi.org/10.1371/journal.pone.0123420			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880764	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500052
J	Tsai, J; Grant, AM; Beckman, MG; Grosse, SD; Yusuf, HR; Richardson, LC				Tsai, James; Grant, Althea M.; Beckman, Michele G.; Grosse, Scott D.; Yusuf, Hussain R.; Richardson, Lisa C.			Determinants of Venous Thromboembolism among Hospitalizations of US Adults: A Multilevel Analysis	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; QUALITY-OF-CARE; RISK-FACTORS; PULMONARY-EMBOLISM; AMERICAN-COLLEGE; MEDICAL PATIENTS; HEALTH; PROPHYLAXIS; THROMBOPROPHYLAXIS; PREVENTION	Background Venous thromboembolism (VTE) is a significant clinical and public health concern. We evaluated a variety of multilevel factors-demographics, clinical and insurance status, preexisting comorbid conditions, and hospital characteristics-for VTE diagnosis among hospitalizations of US adults. Methods We generated adjusted odds ratios with 95% confidence intervals (CIs) and determined sources of outcome variation by conducting multilevel logistic regression analysis of data from the 2011 Nationwide Inpatient Sample that included 6,710,066 hospitalizations of US adults nested within 1,039 hospitals. Results Among hospitalizations of adults, age, sex, race or ethnicity, total days of hospital stay, status of health insurance, and operating room procedure were important determinants of VTE diagnosis; each of the following preexisting comorbid conditions-acquired immune deficiency syndrome, anemia, arthritis, congestive heart failure, coagulopathy, hypertension, lymphoma, metastatic cancer, other neurological disorders, obesity, paralysis, pulmonary circulation disorders, renal failure, solid tumor without metastasis, and weight loss-was associated independently with 1.04 (95% CI: 1.02-1.06) to 2.91 (95% CI: 2.81-3.00) times increased likelihood of VTE diagnosis than among hospitalizations of adults without any of these corresponding conditions. The presence of 2 or more of such conditions was associated a 180%-450% increased likelihood of a VTE diagnosis. Hospitalizations of adults who were treated in urban hospitals were associated with a 14%-15% increased likelihood of having a VTE diagnosis than those treated in rural hospitals. Approximately 7.4% of the total variation in VTE diagnosis occurred between hospitals. Conclusion The presence of certain comorbidities and hospital contextual factors is associated with significantly elevated likelihood of VTE diagnosis among hospitalizations of adults. The findings of this study underscore the importance of clinical risk assessment and adherence to evidence-based clinical practice guidelines in preventing VTE, as well as the need to evaluate potential contextual factors that might modify the risk of VTE among hospitalized patients.	[Tsai, James; Grant, Althea M.; Beckman, Michele G.; Grosse, Scott D.; Yusuf, Hussain R.; Richardson, Lisa C.] Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tsai, J (corresponding author), Ctr Dis Control & Prevent, Div Blood Disorders, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA.	jxt9@cdc.gov		Tsai, James/0000-0002-3114-124X; Grosse, Scott/0000-0003-1078-6855; Richardson, Lisa/0000-0002-9555-7674				Ageno W, 2008, CIRCULATION, V117, P93, DOI 10.1161/CIRCULATIONAHA.107.709204; AHRQ, 2013, OV NAT INP SAMPL NIS; AHRQ, 2012, COM SOFTW VERS 3 7; AHRQ, 2012, PROC CLASS 2012; AHRQ, 2012, MAJ OP ROOM PROC IND; Bibas M, 2011, MEDITERR J HEMATOL I, V3, DOI 10.4084/MJHID.2011.030; Carle AC, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-49; Chandra D, 2009, ANN INTERN MED, V151, P180, DOI 10.7326/0003-4819-151-3-200908040-00129; Cohen AT, 2005, THROMB HAEMOSTASIS, V94, P750, DOI 10.1160/TH05-06-0385; Dabbagh O, 2010, CHEST, V137, P1145, DOI 10.1378/chest.09-2177; Dean Steven M, 2010, Congest Heart Fail, V16, P164, DOI 10.1111/j.1751-7133.2010.00148.x; DHHS, 2008, SURG GEN CALL ACT PR; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Folsom AR, 2007, J GERONTOL A-BIOL, V62, P79, DOI 10.1093/gerona/62.1.79; Franchini M, 2008, ANN HEMATOL, V87, P167, DOI 10.1007/s00277-007-0416-1; Guyatt GH, 2012, CHEST, V141, p7S, DOI 10.1378/chest.1412S3; Heit JA, 2000, ARCH INTERN MED, V160, P809, DOI 10.1001/archinte.160.6.809; Heit JA, 2001, MAYO CLIN PROC, V76, P1102, DOI 10.4065/76.11.1102; Houchens R, 2007, HCUP METHODS SERIES, V2007-01; Huseynova K, 2009, J AM COLL SURGEONS, V208, P547, DOI 10.1016/j.jamcollsurg.2009.01.002; Introduction to the HCUP nationwide inpatient sample (NIS), 2011, HEALTHC COST UT PROJ; Kaboli Peter J, 2005, Cleve Clin J Med, V72 Suppl 1, pS7; Keenan CR, 2007, CURR OPIN PULM MED, V13, P377, DOI 10.1097/MCP.0b013e3281eb8ef0; Kim SC, 2013, ARTHRIT CARE RES, V65, P1600, DOI 10.1002/acr.22039; Lopes Antonio Augusto, 2006, Cardiovascular & Hematological Agents in Medicinal Chemistry, V4, P53, DOI 10.2174/187152506775268794; Lyman GH, 2011, CANCER-AM CANCER SOC, V117, P1334, DOI 10.1002/cncr.25714; Maynard GA, 2010, AHRQ PUBLICATION, V08-0075; Papanikolaou PN, 2006, PLOS MED, V3, P1603, DOI 10.1371/journal.pmed.0030341; Piazza G, 2007, CHEST, V132, P554, DOI 10.1378/chest.07-0430; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Qaseem A, 2011, ANN INTERN MED, V155, P625, DOI 10.7326/0003-4819-155-9-201111010-00011; Ruppert Andras, 2011, J Med Econ, V14, P65, DOI 10.3111/13696998.2010.546465; Sarrazin MSV, 2012, JAMA-J AM MED ASSOC, V307, P1433, DOI 10.1001/jama.2012.404; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Spencer FA, 2007, ARCH INTERN MED, V167, P1471, DOI 10.1001/archinte.167.14.1471; Streiff MB, 2012, HEMATOL-AM SOC HEMAT, P631, DOI 10.1182/asheducation-2012.1.631; Sundstrom A, 2009, BJOG-INT J OBSTET GY, V116, P91, DOI 10.1111/j.1471-0528.2008.01926.x; Tapson VF, 2007, CHEST, V132, P936, DOI 10.1378/chest.06-2993; Thornlow DK, 2006, MED CARE, V44, P265, DOI 10.1097/01.mlr.0000199668.42261.a3; Tsai J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070061; Tsai J, 2013, INT J MED SCI, V10, P1352, DOI 10.7150/ijms.6714; Tveit DP, 2002, AM J KIDNEY DIS, V39, P1011, DOI 10.1053/ajkd.2002.32774; Valderas JM, 2009, ANN FAM MED, V7, P357, DOI 10.1370/afm.983; Vogeli C, 2009, MED CARE, V47, P591, DOI 10.1097/MLR.0b013e31819432cd; Wattanakit K, 2008, J AM SOC NEPHROL, V19, P135, DOI 10.1681/ASN.2007030308; White RH, 2012, CIRCULATION, V125, P2051, DOI 10.1161/CIRCULATIONAHA.112.102814; Wolberg AS, 2012, ANESTH ANALG, V114, P275, DOI 10.1213/ANE.0b013e31823a088c; Yusuf HR, 2013, CLIN APPL THROM 0627	49	18	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123842	10.1371/journal.pone.0123842	http://dx.doi.org/10.1371/journal.pone.0123842			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879844	gold, Green Published			2022-12-27	WOS:000353016500064
J	Uppu, DSSM; Manjunath, GB; Yarlagadda, V; Kaviyil, JE; Paramanandham, K				Uppu, D. S. S. M.; Manjunath, G. B.; Yarlagadda, V; Kaviyil, J. E.; Paramanandham, K.			Membrane-Active Macromolecules Resensitize NDM-1 Gram-Negative Clinical Isolates to Tetracycline Antibiotics (vol 10, e0119422, 2015)	PLOS ONE			English	Correction														Uppu, Divakara SSM/0000-0002-7271-9538; Yarlagadda, Venkateswarlu/0000-0001-7476-0078				Uppu DSSM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119422	1	1	1	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0126757	10.1371/journal.pone.0126757	http://dx.doi.org/10.1371/journal.pone.0126757			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879927	Green Published, gold			2022-12-27	WOS:000353016500125
J	Vultaggio, A; Virgili, G; Gaeta, F; Romano, A; Maggi, E; Matucci, A				Vultaggio, Alessandra; Virgili, Gianni; Gaeta, Francesco; Romano, Antonino; Maggi, Enrico; Matucci, Andrea			High Serum beta-Lactams Specific/Total IgE Ratio Is Associated with Immediate Reactions to beta-Lactams Antibiotics	PLOS ONE			English	Article							IMMUNOGLOBULIN-E; DIAGNOSIS; MARKERS; DISEASE	Total serum IgE result from the combination of specific and non-specific pools. High specific/total IgE ratio may reflect high level of allergen-specific IgE on mast cells. No data regarding its applications to drug allergies is available. One hundred seventy-one patients with a history of immediate reactions to beta-lactams, confirmed by positive skin testing, and 122 control subjects tolerant to beta-lactams, were studied. CAP System was used for the detection of serum total and specific IgE antibodies. The specific/total IgE ratio was tested for diagnostic accuracy compared with conventional criteria. We finally performed a simulation study to expand our investigation of the performance of the specific/total IgE ratio index in a scenario in which the new CAP detection threshold is lowered further. Specific/total IgE ratio values >= 0.002 were observed more frequently in reactive than in controls. Seventy-four of 80 subjects with values >= 0.002 were allergic to beta-lactams, yielding a positive predictive value of 92.5%. The application of specific/total IgE ratio significantly improves the positive likelihood ratio and the overall diagnostic performance. In addition, we showed the capability of this new criterion to identify true reactive patients even among subjects with high levels of total IgE (>200 kU/L). Significant increase in both receiver operator characteristic (ROC) curve and sensitivity were observed in imputed case of the simulation study. The beta-lactams-specific/total IgE ratio may be an additional index compared to the common criterion of positivity to a single hapten in the allergological work-up of patients with beta-lactams immediate adverse reactions.	[Vultaggio, Alessandra; Matucci, Andrea] Policlin Careggi, Immunoallergol Unit, Dept Biomed, Florence, Italy; [Virgili, Gianni] Univ Florence, Dept Specialised Surg Sci, Florence, Italy; [Gaeta, Francesco; Romano, Antonino] Complesso Integrato Columbus, Allergy Unit, Rome, Italy; [Maggi, Enrico] Univ Florence, Ctr Res Transfer & High Educ DENOTHE, Florence, Italy	University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Florence	Matucci, A (corresponding author), Policlin Careggi, Immunoallergol Unit, Dept Biomed, Florence, Italy.	andrea.matucci@unifi.it	Maggi, Enrico/AAA-8045-2019; Gaeta, Francesco/AAC-7107-2020; Romano, Antonino/D-3102-2017; Alessandra, Vultaggio/K-3201-2014; Virgili, Gianni/P-6607-2014	Maggi, Enrico/0000-0002-1824-3583; Gaeta, Francesco/0000-0003-2942-7633; Romano, Antonino/0000-0001-9742-9898; Virgili, Gianni/0000-0002-9960-2989	EU [FP6-LSBH-CT-2006-018861]	EU(European Commission)	This study was supported by the EU Project SENS-IT-IV (FP6-LSBH-CT-2006-018861).	Di Lorenzo G, 2009, J ALLERGY CLIN IMMUN, V123, P1103, DOI 10.1016/j.jaci.2009.02.012; Federly TJ, 2013, ANN ALLERG ASTHMA IM, V111, P20, DOI 10.1016/j.anai.2013.05.012; Hayen A, 2010, J CLIN EPIDEMIOL, V63, P883, DOI 10.1016/j.jclinepi.2009.08.024; ISHIZAKA T, 1984, FED PROC, V43, P2840; Jackola DR, 2004, HUM IMMUNOL, V65, P20, DOI 10.1016/j.humimm.2003.10.012; Janes H, 2008, AM J EPIDEMIOL, V168, P89, DOI 10.1093/aje/kwn099; Johansson SGO, 2013, J ALLERGY CLIN IMMUN, V132, P235, DOI 10.1016/j.jaci.2012.11.017; Johansson SGO, 2009, ALLERGY, V64, P1472, DOI 10.1111/j.1398-9995.2009.02051.x; Kerkhof M, 2003, ALLERGY, V58, P905, DOI 10.1034/j.1398-9995.2003.00230.x; Khan DA, 2010, J ALLERGY CLIN IMMUN, V125, pS126, DOI 10.1016/j.jaci.2009.10.028; Matricardi PM, 2009, ALLERGY, V64, P1093, DOI 10.1111/j.1398-9995.2009.02055.x; Pencina MJ, 2012, AM J EPIDEMIOL, V176, P473, DOI 10.1093/aje/kws207; Rutjes AWS, 2005, CLIN CHEM, V51, P1335, DOI 10.1373/clinchem.2005.048595; Torres MJ, 2003, ALLERGY, V58, P961, DOI 10.1034/j.1398-9995.2003.00280.x; Vultaggio A, 2009, CLIN EXP ALLERGY, V39, P838, DOI 10.1111/j.1365-2222.2009.03219.x; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067	16	40	41	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121857	10.1371/journal.pone.0121857	http://dx.doi.org/10.1371/journal.pone.0121857			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880869	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500013
J	Wang, RY; Ng, CN				Wang, Raymond Yu; Ng, Cho Nam			Can Centralized Sanctioning Promote Trust in Social Dilemmas? A Two-Level Trust Game with Incomplete Information	PLOS ONE			English	Article							ALTRUISTIC PUNISHMENT; POLITICAL TRUST; COOPERATION; RECIPROCITY; GOVERNANCE	The problem of trust is a paradigmatic social dilemma. Previous literature has paid much academic attention on effects of peer punishment and altruistic third-party punishment on trust and human cooperation in dyadic interactions. However, the effects of centralized sanctioning institutions on decentralized reciprocity in hierarchical interactions remain to be further explored. This paper presents a formal two-level trust game with incomplete information which adds an authority as a strategic purposive actor into the traditional trust game. This model allows scholars to examine the problem of trust in more complex game theoretic configurations. The analysis demonstrates how the centralized institutions might change the dynamics of reciprocity between the trustor and the trustee. Findings suggest that the sequential equilibria of the newly proposed two-level model simultaneously include the risk of placing trust for the trustor and the temptation of short-term defection for the trustee. Moreover, they have shown that even a slight uncertainty about the type of the newly introduced authority might facilitate the establishment of trust and reciprocity in social dilemmas.	[Wang, Raymond Yu] Univ Hong Kong, Fac Social Sci, Hong Kong, Hong Kong, Peoples R China; [Ng, Cho Nam] Univ Hong Kong, Dept Geog, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Wang, RY (corresponding author), Univ Hong Kong, Fac Social Sci, Hong Kong, Hong Kong, Peoples R China.	wangyuray@connect.hku.hk	Wang, Raymond Yu/AAL-2328-2020; Wang, Raymond Yu/AAV-8653-2021	Wang, Raymond Yu/0000-0003-0634-9492; 				Anderhub V, 2002, J ECON BEHAV ORGAN, V48, P197, DOI 10.1016/S0167-2681(01)00216-5; Arrow K., 1970, ANAL PUBLIC OUTPUT; Arrow K. J., 1974, LIMITS ORG; Bachmann R, 2001, ORGAN STUD, V22, P337, DOI 10.1177/0170840601222007; Baldassarri D, 2011, P NATL ACAD SCI USA, V108, P11023, DOI 10.1073/pnas.1105456108; Berg L, 2004, APPETITE, V42, P21, DOI 10.1016/S0195-6663(03)00112-0; Bernhard H, 2006, NATURE, V442, P912, DOI 10.1038/nature04981; Bolton GE, 2000, AM ECON REV, V90, P166, DOI 10.1257/aer.90.1.166; Bower AG, 1997, INT J IND ORGAN, V15, P165, DOI 10.1016/0167-7187(95)00495-5; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Boyd R, 2010, SCIENCE, V328, P617, DOI 10.1126/science.1183665; Buskens V, 1998, SOC NETWORKS, V20, P265, DOI 10.1016/S0378-8733(98)00005-7; Buskens V, 2000, RATION SOC, V12, P227, DOI 10.1177/104346300012002004; Buskens V, 2003, GAME ECON BEHAV, V42, P235, DOI 10.1016/S0899-8256(02)00563-8; Buskens V., 2002, SOCIAL NETWORKS TRUS, V30; Buskens V., 2002, GROUP COHESION TRUST, V19, P167, DOI [DOI 10.1016/S0882-6145(02)19007-2, 10.1016/S0882-6145(02)19007-2]; Buskens V, 2013, HDB RATIONAL CHOICE; Buskens V, 2010, SOC NETWORKS, V32, P301, DOI 10.1016/j.socnet.2010.05.001; CAMERER C, 1988, ECONOMETRICA, V56, P1, DOI 10.2307/1911840; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; Coleman J., 1990, FDN SOCIAL THEORY; Cook KS, 2003, RUSSELL SAGE TRUST, V6, P209; Dasgupta P., 1988, TRUST MAKING BREAKIN, P49; Edelenbos J, 2012, ADMIN SOC, V44, P647, DOI 10.1177/0095399711413876; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fehr E, 1999, Q J ECON, V114, P817, DOI 10.1162/003355399556151; Fowler JH, 2005, P NATL ACAD SCI USA, V102, P7047, DOI 10.1073/pnas.0500938102; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Janssen MA, 2014, ECOLOGY SOC, P19; KREPS DM, 1982, ECONOMETRICA, V50, P863, DOI 10.2307/1912767; Kreps DM, 1990, PERSPECTIVES POSITIV, P90, DOI [DOI 10.1017/CBO9780511571657.006, 10.1017/CBO9780511571657.006]; Kurzban R, 2007, EVOL HUM BEHAV, V28, P75, DOI 10.1016/j.evolhumbehav.2006.06.001; Lane C., 1998, TRUST ORG CONCEPTUAL; Levi M, 2000, ANNU REV POLIT SCI, V3, P475, DOI 10.1146/annurev.polisci.3.1.475; Li LJ, 2013, MOD CHINA, V39, P3, DOI 10.1177/0097700412450661; Lindgreen A., 2003, British Food Journal, V105, P310, DOI 10.1108/00070700310481694; Lorenz EH, 1988, TRUST MAKING BREAKIN, P194; Mishler W, 2001, COMP POLIT STUD, V34, P30, DOI 10.1177/0010414001034001002; Ng CN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073793; Nooteboom B, 1997, ACAD MANAGE J, V40, P308, DOI 10.2307/256885; Norris P., 2002, DEMOCRATIC PHOENIX R; O'Gorman R, 2009, P ROY SOC B-BIOL SCI, V276, P323, DOI 10.1098/rspb.2008.1082; Ostrom E, 1998, AM POLIT SCI REV, V92, P1, DOI 10.2307/2585925; OUCHI WG, 1980, ADMIN SCI QUART, V25, P129, DOI 10.2307/2392231; Pedersen E. J., 2013, P ROYAL SOC B, V280; Poteete AR, 2010, WORKING TOGETHER: COLLECTIVE ACTION, THE COMMONS, AND MULTIPLE METHODS IN PRACTICE, P1; Putnam R.D., 1994, MAKING DEMOCRACY WOR, DOI DOI 10.2307/206637; Ratnasingam P, 2003, INTERORGANIZATIONAL; RING PS, 1992, STRATEGIC MANAGE J, V13, P483, DOI 10.1002/smj.4250130702; Rockenbach B, 2006, NATURE, V444, P718, DOI 10.1038/nature05229; Rothstein Bo, 2005, SOCIAL TRAPS PROBLEM; Sethi R, 2003, J ECON BEHAV ORGAN, V50, P1, DOI 10.1016/S0167-2681(02)00032-X; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Snijders C, 1996, TRUST COMMITMENTS; Traulsen A, 2012, P ROY SOC B-BIOL SCI, V279, P3716, DOI 10.1098/rspb.2012.0937; Uslaner E., 2002, MORAL FDN TRUST; Woolthuis RK, 1999, SLEEPING ENEMY TRUST; Zucker L., 1986, RES ORGAN BEHAV, V8, P1840, DOI DOI 10.1023/A	63	3	3	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124513	10.1371/journal.pone.0124513	http://dx.doi.org/10.1371/journal.pone.0124513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25879752	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500103
J	Madeo, A; Piras, P; Re, F; Gabriele, S; Nardinocchi, P; Teresi, L; Torromeo, C; Chialastri, C; Schiariti, M; Giura, G; Evangelista, A; Dominici, T; Varano, V; Zachara, E; Puddu, PE				Madeo, Andrea; Piras, Paolo; Re, Federica; Gabriele, Stefano; Nardinocchi, Paola; Teresi, Luciano; Torromeo, Concetta; Chialastri, Claudia; Schiariti, Michele; Giura, Geltrude; Evangelista, Antonietta; Dominici, Tania; Varano, Valerio; Zachara, Elisabetta; Puddu, Paolo Emilio			A New 4D Trajectory-Based Approach Unveils Abnormal LV Revolution Dynamics in Hypertrophic Cardiomyopathy	PLOS ONE			English	Article							VENTRICULAR ROTATIONAL MECHANICS; EUROPEAN-SOCIETY; ECHOCARDIOGRAPHY; GENOTYPE; STRAIN; QUANTIFICATION; ASSOCIATION; GUIDELINES	The assessment of left ventricular shape changes during cardiac revolution may be a new step in clinical cardiology to ease early diagnosis and treatment. To quantify these changes, only point registration was adopted and neither Generalized Procrustes Analysis nor Principal Component Analysis were applied as we did previously to study a group of healthy subjects. Here, we extend to patients affected by hypertrophic cardiomyopathy the original approach and preliminarily include genotype positive/phenotype negative individuals to explore the potential that incumbent pathology might also be detected. Using 3D Speckle Tracking Echocardiography, we recorded left ventricular shape of 48 healthy subjects, 24 patients affected by hypertrophic cardiomyopathy and 3 genotype positive/phenotype negative individuals. We then applied Generalized Procrustes Analysis and Principal Component Analysis and inter-individual differences were cleaned by Parallel Transport performed on the tangent space, along the horizontal geodesic, between the per- subject consensuses and the grand mean. Endocardial and epicardial layers were evaluated separately, different from many ecocardiographic applications. Under a common Principal Component Analysis, we then evaluated left ventricle morphological changes (at both layers) explained by first Principal Component scores. Trajectories' shape and orientation were investigated and contrasted. Logistic regression and Receiver Operating Characteristic curves were used to compare these morphometric indicators with traditional 3D Speckle Tracking Echocardiography global parameters. Geometric morphometrics indicators performed better than 3D Speckle Tracking Echocardiography global parameters in recognizing pathology both in systole and diastole. Genotype positive/phenotype negative individuals clustered with patients affected by hypertrophic cardiomyopathy during diastole, suggesting that incumbent pathology may indeed be foreseen by these methods. Left ventricle deformation in patients affected by hypertrophic cardiomyopathy compared to healthy subjects may be assessed by modern shape analysis better than by traditional 3D Speckle Tracking Echocardiography global parameters. Hypertrophic cardiomyopathy pathophysiology was unveiled in a new manner whereby also diastolic phase abnormalities are evident which is more difficult to investigate by traditional ecocardiographic techniques.	[Madeo, Andrea; Piras, Paolo; Torromeo, Concetta; Schiariti, Michele; Giura, Geltrude; Dominici, Tania; Puddu, Paolo Emilio] Univ Roma La Sapienza, Dipartimento Sci Cardiovasc Resp Nefrol Anestesio, I-00185 Rome, Italy; [Madeo, Andrea; Re, Federica; Chialastri, Claudia; Zachara, Elisabetta] Osped S Camillo Forlanini, Ctr Cardiomiopatie, Rome, Italy; [Piras, Paolo] Univ Rome Tre, Dipartimento Sci, I-00146 Rome, Italy; [Piras, Paolo] Ctr Evolut Ecol, Rome, Italy; [Piras, Paolo; Nardinocchi, Paola] Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, I-00100 Rome, Italy; [Gabriele, Stefano] Univ Rome Tre, LaMS Modeling & Simulat Lab, Dipartimento Architettura, I-00146 Rome, Italy; [Teresi, Luciano; Varano, Valerio] Univ Rome Tre, LaMS Modeling & Simulat Lab, Dipartimento Matemat & Fis, I-00146 Rome, Italy; [Evangelista, Antonietta] Osped San Giovanni Calibita Fatebenefratelli Isol, Rome, Italy	Sapienza University Rome; Azienda Ospedaliera San Camillo-Forlanini; Roma Tre University; Sapienza University Rome; Roma Tre University; Roma Tre University	Piras, P (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Strutturale & Geotecn, Via Eudossiana 18, I-00100 Rome, Italy.	ppiras@uniroma3.it	schiariti, michele/W-4393-2018; Puddu, Paolo Emilio/G-6180-2012; Madeo, Andrea/AIC-5118-2022; Gabriele, Stefano/J-1091-2019; Gabriele, Stefano/G-5280-2010; nardinocchi, paola/C-9454-2009	schiariti, michele/0000-0001-5077-8134; Puddu, Paolo Emilio/0000-0002-6191-7838; Madeo, Andrea/0000-0002-5320-6796; Gabriele, Stefano/0000-0001-8264-2792; Gabriele, Stefano/0000-0001-8264-2792; TORROMEO, Concetta/0000-0003-0936-2780; Teresi, Luciano/0000-0002-5178-8120; Piras, Paolo/0000-0001-9832-2742; Nardinocchi, Paola/0000-0002-9972-1662; Varano, Valerio/0000-0003-0298-6398				Abate E, 2014, J AM SOC ECHOCARDIOG, V27, P239, DOI 10.1016/j.echo.2013.12.009; Adams DC, 2004, ITAL J ZOOL, V71, P5, DOI 10.1080/11250000409356545; Adams DC, 2009, EVOLUTION, V63, P1143, DOI 10.1111/j.1558-5646.2009.00649.x; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Bertini M, 2010, HEART, V96, P1737, DOI 10.1136/hrt.2010.197533; Campbell SG, 2011, J R SOC INTERFACE, V8, P1550, DOI 10.1098/rsif.2011.0184; Collyer ML, 2015, HEREDITY, V115, P357, DOI 10.1038/hdy.2014.75; Collyer ML, 2013, HYSTRIX, V24, P75, DOI 10.4404/hystrix-24.1-6298; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Dryden IL, 1998, STAT SHAPE ANAL, DOI DOI 10.5555/1046920.1088707; Elliott PM, 2014, EUR HEART J, V35, P2733, DOI 10.1093/eurheartj/ehu284; Evangelista A, 2015, J BIOMECH, V48, P465, DOI 10.1016/j.jbiomech.2014.12.028; Evangelista A, 2011, PROG BIOPHYS MOL BIO, V107, P112, DOI 10.1016/j.pbiomolbio.2011.07.008; Goffinet C, 2009, EUR HEART J, V30, P608, DOI 10.1093/eurheartj/ehn511; Gruner C, 2013, CIRC-CARDIOVASC GENE, V6, P19, DOI 10.1161/CIRCGENETICS.112.963363; Hillis DM, 1994, HOMOLOGY HIERARCHICA; Ho CY, 2002, CIRCULATION, V105, P2992, DOI 10.1161/01.CIR.0000019070.70491.6D; Kuhl HP, 2004, J AM COLL CARDIOL, V43, P2083, DOI 10.1016/j.jacc.2004.01.037; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Leitman M, 2010, J AM SOC ECHOCARDIOG, V23, P64, DOI 10.1016/j.echo.2009.10.004; Maron BJ, 2013, LANCET, V381, P242, DOI 10.1016/S0140-6736(12)60397-3; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Maron BJ, 2011, AM J CARDIOL, V107, P604, DOI 10.1016/j.amjcard.2010.10.022; Maron BJ, 2014, GUIDE HYPERTROPHIC C, V3rd; Martinez-Legazpi P, 2014, J AM COLL CARDIOL, V64, P1711, DOI 10.1016/j.jacc.2014.06.1205; Piras P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086896; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Seo Y, 2009, CIRC-CARDIOVASC IMAG, V2, P451, DOI 10.1161/CIRCIMAGING.109.858480; Serri K, 2006, J AM COLL CARDIOL, V47, P1175, DOI 10.1016/j.jacc.2005.10.061; Sugeng L, 2003, HEART, V89, P29; van Dalen BM, 2013, LEFT VENTRICULAR TWI; Yang Y, 2008, INT J AP MAT COM-POL, V18, P399, DOI 10.2478/v10006-008-0036-5; Zheng Y, 2007, P 11 IEEE INT C COMP	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122376	10.1371/journal.pone.0122376	http://dx.doi.org/10.1371/journal.pone.0122376			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875818	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100069
J	Gabor, CR; Fisher, MC; Bosch, J				Gabor, Caitlin R.; Fisher, Matthew C.; Bosch, Jaime			Elevated Corticosterone Levels and Changes in Amphibian Behavior Are Associated with Batrachochytrium dendrobatidis (Bd) Infection and Bd Lineage	PLOS ONE			English	Article							POPULATION DECLINES; CHYTRIDIOMYCOSIS; STRESS; SUSCEPTIBILITY; TEMPERATURE; PREVALENCE; RESPONSES; DISEASE; GLUCOCORTICOIDS; HORMONE	Few studies have examined the role hormones play in mediating clinical changes associated with infection by the parasite Batrachochytrium dendrobatidis (Bd). Glucocorticoid (GC) hormones such as corticosteroids (CORT) regulate homeostasis and likely play a key role in response to infection in amphibians. We explore the relationship between CORT release rates and Bd infection in tadpoles of the common midwife toad, Alytes obstetricians, using a non-invasive water-borne hormone collection method across seven populations. We further examined whether tadpoles of A. muletensis infected with a hypervirulent lineage of Bd, BdGPL, had greater CORT release rates than those infected with a hypovirulent lineage, BdCAPE. Finally, we examined the relationship between righting reflex and CORT release rates in infected metamorphic toads of A. obstetricans. We found an interaction between elevation and Bd infection status confirming that altitude is associated with the overall severity of infection. In tandem, increasing elevation was associated with increasing CORT release rates. Tadpoles infected with the hypervirulent BdGPL had significantly higher CORT release rates than tadpoles infected with BdCAPE showing that more aggressive infections lead to increased CORT release rates. Infected metamorphs with higher CORT levels had an impaired righting reflex, our defined experimental endpoint. These results provide evidence that CORT is associated with an amphibian's vulnerability to Bd infection, and that CORT is also affected by the aggressiveness of infection by Bd. Together these results indicate that CORT is a viable biomarker of amphibian stress.	[Gabor, Caitlin R.] Texas State Univ, Dept Biol, San Marcos, TX USA; [Fisher, Matthew C.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, London, England; [Bosch, Jaime] CSIC, Museo Nacl Ciencias Nat, E-28006 Madrid, Spain	Texas State University System; Texas State University San Marcos; Imperial College London; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN)	Fisher, MC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, Norfolk Pl, London, England.	matthew.fisher@imperial.ac.uk	Fisher, Matthew/B-9094-2011; Bosch, Jaime/H-3042-2011; Gabor, Caitlin/AAK-8369-2020	Fisher, Matthew/0000-0002-1862-6402; Bosch, Jaime/0000-0002-0099-7934; 	Fundacion General CSIC; Biodiversa Project RACE; UK Natural Environmental Research Council NERC; Banco Santander (Zero Project); NERC [NE/K014455/1] Funding Source: UKRI; Natural Environment Research Council [NE/K014455/1] Funding Source: researchfish	Fundacion General CSIC; Biodiversa Project RACE; UK Natural Environmental Research Council NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Banco Santander (Zero Project); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Funding was provided by the Fundacion General CSIC and Banco Santander (Zero Project, PI: J. Bosch), the Biodiversa Project RACE (PI: M. C. Fisher) and the UK Natural Environmental Research Council NERC (PI: M. C. Fisher). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berger L, 1998, P NATL ACAD SCI USA, V95, P9031, DOI 10.1073/pnas.95.15.9031; Bielby J, 2008, CONSERV LETT, V1, P82, DOI 10.1111/j.1755-263X.2008.00015.x; Blaustein AR, 2012, PHILOS T R SOC B, V367, P1688, DOI 10.1098/rstb.2012.0011; Blaustein AR, 2005, CONSERV BIOL, V19, P1460, DOI 10.1111/j.1523-1739.2005.00195.x; Bosch J, 2001, BIOL CONSERV, V97, P331, DOI 10.1016/S0006-3207(00)00132-4; Bosch J, 2007, P ROY SOC B-BIOL SCI, V274, P253, DOI 10.1098/rspb.2006.3713; Boyle DG, 2004, DIS AQUAT ORGAN, V60, P141, DOI 10.3354/dao060141; Davis A. K., 2010, Comparative Clinical Pathology, V19, P49, DOI 10.1007/s00580-009-0914-8; Doddington BJ, 2013, ECOLOGY, V94, P1795, DOI 10.1890/12-1270.1; DuRant SE, 2008, GEN COMP ENDOCR, V156, P126, DOI 10.1016/j.ygcen.2007.12.004; Eikenaar C, 2012, AM NAT, V180, P642, DOI 10.1086/667891; Farrer RA, 2011, P NATL ACAD SCI USA, V108, P18732, DOI 10.1073/pnas.1111915108; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Gabor CR, 2013, AMPHIBIA-REPTILIA, V34, P151, DOI 10.1163/15685381-00002877; Gabor CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056054; Garner TWJ, 2011, GLOBAL CHANGE BIOL, V17, P667, DOI 10.1111/j.1365-2486.2010.02272.x; Garner TWJ, 2009, OIKOS, V118, P783, DOI 10.1111/j.1600-0706.2008.17202.x; Gosner K. L., 1960, Herpetologica, V16, P183; Graham CM, 2013, GEN COMP ENDOCR, V191, P24, DOI 10.1016/j.ygcen.2013.05.012; Homan RN, 2003, GEN COMP ENDOCR, V130, P165, DOI 10.1016/S0016-6480(02)00578-6; Janin A, 2012, CONSERV BIOL, V26, P923, DOI 10.1111/j.1523-1739.2012.01910.x; Janin A, 2011, BIOL CONSERV, V144, P1008, DOI 10.1016/j.biocon.2010.12.009; Kindermann C, 2012, COMP BIOCHEM PHYS A, V162, P171, DOI 10.1016/j.cbpa.2012.02.018; Knapp RA, 2011, ECOSPHERE, V2, DOI 10.1890/ES11-00028.1; Kriger KM, 2008, AUSTRAL ECOL, V33, P1022, DOI 10.1111/j.1442-9993.2008.01872.x; Kriger KM, 2007, CONSERV BIOL, V21, P1280, DOI 10.1111/j.1523-1739.2007.00777.x; Landys MM, 2006, GEN COMP ENDOCR, V148, P132, DOI 10.1016/j.ygcen.2006.02.013; Lips KR, 2003, CONSERV BIOL, V17, P1078, DOI 10.1046/j.1523-1739.2003.01623.x; Narayan EJ, 2012, GEN COMP ENDOCR, V178, P301, DOI 10.1016/j.ygcen.2012.06.014; Pearl CA, 2009, ECOHEALTH, V6, P209, DOI 10.1007/s10393-009-0237-x; Peterson JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062146; Pounds JA, 2006, NATURE, V439, P161, DOI 10.1038/nature04246; Raffel TR, 2006, FUNCT ECOL, V20, P819, DOI 10.1111/j.1365-2435.2006.01159.x; Ribas L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008408; Rollins-Smith LA, 2011, INTEGR COMP BIOL, V51, P552, DOI 10.1093/icb/icr095; Rosenblum EB, 2013, P NATL ACAD SCI USA, V110, P9385, DOI 10.1073/pnas.1300130110; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sapsford SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082425; Searle CL, 2014, J EXP ZOOL PART A, V321, P243, DOI 10.1002/jez.1855; Tobler U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034667; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wack CL, 2012, COMP BIOCHEM PHYS A, V161, P153, DOI 10.1016/j.cbpa.2011.10.017; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Warne RW, 2011, FUNCT ECOL, V25, P139, DOI 10.1111/j.1365-2435.2010.01793.x	44	36	36	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122685	10.1371/journal.pone.0122685	http://dx.doi.org/10.1371/journal.pone.0122685			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893675	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700015
J	Leoni, GG; Palmerini, MG; Satta, V; Succu, S; Pasciu, V; Zinellu, A; Carru, C; Macchiarelli, G; Nottola, SA; Naitana, S; Berlinguer, F				Leoni, Giovanni Giuseppe; Palmerini, Maria Grazia; Satta, Valentina; Succu, Sara; Pasciu, Valeria; Zinellu, Angelo; Carru, Ciriaco; Macchiarelli, Guido; Nottola, Stefania Annarita; Naitana, Salvatore; Berlinguer, Fiammetta			Differences in the Kinetic of the First Meiotic Division and in Active Mitochondrial Distribution between Prepubertal and Adult Oocytes Mirror Differences in their Developmental Competence in a Sheep Model	PLOS ONE			English	Article							IN-VITRO MATURATION; PROMOTING FACTOR ACTIVITY; EARLY EMBRYO DEVELOPMENT; BOVINE OOCYTES; MATURE OOCYTES; PREIMPLANTATION EMBRYOS; ADENOSINE-TRIPHOSPHATE; AGGREGATION PATTERNS; PROTEIN-SYNTHESIS; GENE-EXPRESSION	Our aim is to verify if oocyte developmental potential is related to the timing of meiotic progression and to mitochondrial distribution and activity using prepubertal and adult oocytes as models of low and high developmental capacity respectively. Prepubertal and adult oocytes were incorporated in an in vitro maturation system to determine meiotic and developmental competence and to assess at different time points kinetic of meiotic maturation, 2D protein electrophoresis patterns, ATP content and mitochondria distribution. Maturation and fertilization rates did not differ between prepubertal and adult oocytes (95.1% vs 96.7% and 66.73% vs 70.62% respectively for prepubertal and adult oocytes). Compared to adults, prepubertal oocytes showed higher parthenogenesis (17.38% vs 2.08% respectively in prepubertals and adults; P<0.01) and polispermy (14.30% vs 2.21% respectively in prepubertals and adults; P<0.01), lower cleavage rates (60.00% vs 67.08% respectively in prepubertals and adults; P<0.05) and blastocyst output (11.94% vs 34.% respectively in prepubertals and adults; P<0.01). Prepubertal oocytes reached MI stage 1 hr later than adults and this delay grows as the first meiotic division proceeds. Simultaneously, the protein pattern was altered since in prepubertal oocytes it fluctuates, dropping and rising to levels similar to adults only at 24 hrs. In prepubertal oocytes ATP rise is delayed and did not reach levels comparable to adult ones. CLSM observations revealed that at MII, in the majority of prepubertal oocytes, the active mitochondria are homogenously distributed, while in adults they are aggregated in big clusters. Our work demonstrates that mitochondria and their functional aggregation during maturation play an active role to provide energy in terms of ATP. The oocyte ATP content determines the timing of the meiotic cycle and the acquisition of developmental competence. Taken together our data suggest that oocytes with low developmental competence have a slowed down energetic metabolism which delays later development.	[Leoni, Giovanni Giuseppe; Satta, Valentina; Succu, Sara; Pasciu, Valeria; Naitana, Salvatore; Berlinguer, Fiammetta] Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy; [Leoni, Giovanni Giuseppe; Naitana, Salvatore; Berlinguer, Fiammetta] CCBA, Sardinian Anim Biodivers Ctr, Sassari, Italy; [Palmerini, Maria Grazia; Macchiarelli, Guido] Univ Aquila, Dept Life Hlth & Environm Sci, I-67100 Laquila, Italy; [Zinellu, Angelo; Carru, Ciriaco] Univ Sassari, Dept Biomed Sci, I-07100 Sassari, Italy; [Nottola, Stefania Annarita] Univ Roma La Sapienza, Dept Anat Histol Forens Med & Orthopaed, I-00185 Rome, Italy	University of Sassari; University of L'Aquila; University of Sassari; Sapienza University Rome	Leoni, GG (corresponding author), Univ Sassari, Dept Vet Med, I-07100 Sassari, Italy.	gioleoni@uniss.it	Pasciu, Valeria/ABP-1843-2022; Carru, Ciriaco/AAI-9996-2021; Palmerini, Maria Grazia/N-7424-2017; Berlinguer, Fiammetta/Y-1757-2019; Macchiarelli, Guido/N-1771-2016	Palmerini, Maria Grazia/0000-0002-3985-0112; Berlinguer, Fiammetta/0000-0002-2500-8063; Macchiarelli, Guido/0000-0002-9182-0586; Carru, Ciriaco/0000-0002-6985-4907; Zinellu, Angelo/0000-0002-8396-0968	Fondazione Banco di Sardegna; Sardinian Region Council	Fondazione Banco di Sardegna(Fondazione Banco di Sardegna); Sardinian Region Council	This study was supported by the Fondazione Banco di Sardegna (www.fondazionebancodisardegna.it) and the Sardinian Region Council (www.regione.sardegna.it). SS received a grant from the Fondazione Banco di Sardegna (www.fondazionebancodisardegna. it). The Sardinian Region Council (www.regione.sardegna.it) gave a grant to VS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bebbere D, 2009, REPROD FERT DEVELOP, V21, P187, DOI 10.1071/RDv21n1Ab177; Bettegowda A, 2008, REPROD FERT DEVELOP, V20, P45, DOI 10.1071/RD07156; Brevini TAL, 2005, BIOL REPROD, V72, P1218, DOI 10.1095/biolreprod.104.038141; CALARCO PG, 1995, DEV GENET, V16, P36, DOI 10.1002/dvg.1020160108; Catala MG, 2012, FERTIL STERIL, V97, P1004, DOI 10.1016/j.fertnstert.2011.12.043; Dal Canto M, 2012, REPROD BIOMED ONLINE, V25, P474, DOI 10.1016/j.rbmo.2012.07.016; Dang-Nguyen TQ, 2010, J REPROD DEVELOP, V56, P593, DOI 10.1262/jrd.10-038M; De los Reyes M, 2011, THERIOGENOLOGY, V75, P346, DOI 10.1016/j.theriogenology.2010.09.005; Dell'Aquila ME, 2009, FERTIL STERIL, V91, P249, DOI 10.1016/j.fertnstert.2007.10.042; Dominko T, 1997, MOL REPROD DEV, V47, P456, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;456::AID-MRD13&gt;3.0.CO;2-U; Dumollard R, 2007, CURR TOP DEV BIOL, V77, P21, DOI 10.1016/S0070-2153(06)77002-8; EARL CR, 1998, GAMETES DEV FUNCTION, P115; Eichenlaub-Ritter U, 2004, REPROD BIOMED ONLINE, V8, P45, DOI 10.1016/S1472-6483(10)60497-X; EPPIG JJ, 1982, DEV BIOL, V89, P268, DOI 10.1016/0012-1606(82)90314-1; Escrich L, 2012, FERTIL STERIL, V98, P1147, DOI 10.1016/j.fertnstert.2012.07.1116; Fenwick J, 2002, HUM REPROD, V17, P407, DOI 10.1093/humrep/17.2.407; Ferreira EM, 2009, THERIOGENOLOGY, V71, P836, DOI 10.1016/j.theriogenology.2008.10.023; Gardner DK, 2005, REPROD FERT DEVELOP, V17, P361, DOI 10.1071/RD04103; Catala MG, 2011, REPRODUCTION, V142, P517, DOI 10.1530/REP-10-0528; Khalili MA, 2012, EUR J HISTOCHEM, V56, P236, DOI 10.4081/ejh.2012.e38; Kochhar HPS, 2002, REPROD DOMEST ANIM, V37, P19, DOI 10.1046/j.1439-0531.2002.00326.x; Ledda S, 1997, J REPROD FERTIL, V109, P73, DOI 10.1530/jrf.0.1090073; Ledda S, 1996, ZYGOTE, V4, P343, DOI 10.1017/S0967199400003361; Ledda S, 2001, BIOL REPROD, V65, P247, DOI 10.1095/biolreprod65.1.247; LEDDA S, 1998, GAMETES DEV FUNCTION, P101; Leoni GG, 2007, REPROD DOMEST ANIM, V42, P299, DOI 10.1111/j.1439-0531.2006.00783.x; Leoni GG, 2007, MOL REPROD DEV, V74, P249, DOI 10.1002/mrd.20442; Leoni GG, 2006, ANIM REPROD SCI, V92, P373, DOI 10.1016/j.anireprosci.2005.05.027; Liu S, 2010, FERTIL STERIL, V93, P1550, DOI 10.1016/j.fertnstert.2009.03.050; Lonergan P, 2008, THERIOGENOLOGY, V69, P17, DOI 10.1016/j.theriogenology.2007.09.007; Lonergan P, 2000, MOL REPROD DEV, V57, P146, DOI 10.1002/1098-2795(200010)57:2&lt;146::AID-MRD5&gt;3.0.CO;2-2; Morton KM, 2008, REPROD DOMEST ANIM, V43, P137, DOI 10.1111/j.1439-0531.2008.01153.x; Nagano M, 2006, ZYGOTE, V14, P299, DOI 10.1017/S0967199406003807; Nottola SA, 2009, REPROD BIOMED ONLINE, V19, P17, DOI 10.1016/S1472-6483(10)60280-5; OBrien JK, 1996, REPROD FERT DEVELOP, V8, P1029, DOI 10.1071/RD9961029; Palmerini MG, 2014, REPROD BIOL ENDOCRIN, V12, DOI 10.1186/1477-7827-12-115; Ptak G, 1999, BIOL REPROD, V61, P1568, DOI 10.1095/biolreprod61.6.1568; Ptak G, 2006, HUM REPROD, V21, P2228, DOI 10.1093/humrep/del184; Santos TA, 2006, FERTIL STERIL, V85, P584, DOI 10.1016/j.fertnstert.2005.09.017; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Somfai T, 2010, J REPROD DEVELOP, V56, P200, DOI 10.1262/jrd.09-097A; Stojkovic M, 2001, BIOL REPROD, V64, P904, DOI 10.1095/biolreprod64.3.904; Tarazona AM, 2006, REPROD DOMEST ANIM, V41, P5, DOI 10.1111/j.1439-0531.2006.00615.x; Tomek W, 2002, REPROD DOMEST ANIM, V37, P86, DOI 10.1046/j.1439-0531.2002.00336.x; Torner H, 2007, REPROD DOMEST ANIM, V42, P176, DOI 10.1111/j.1439-0531.2006.00749.x; Torner H, 2004, THERIOGENOLOGY, V61, P1675, DOI 10.1016/j.theriogenology.2003.09.013; Urrego R, 2014, EPIGENETICS, V9, DOI [10.4161/epi.28790, DOI 10.4161/EPI.28790]; Valentini L, 2010, ANIM REPROD SCI, V117, P166, DOI 10.1016/j.anireprosci.2009.03.008; Van Blerkom J, 2008, MOL HUM REPROD, V14, P431, DOI 10.1093/molehr/gan037; Van Blerkom J, 2011, MITOCHONDRION, V11, P797, DOI 10.1016/j.mito.2010.09.012; VANBLERKOM J, 1995, HUM REPROD, V10, P415, DOI 10.1093/oxfordjournals.humrep.a135954; VANBLERKOM J, 1984, AM J ANAT, V171, P335, DOI 10.1002/aja.1001710309; Velilla E, 2006, MOL REPROD DEV, V73, P617, DOI 10.1002/mrd.20426; Wilding M, 2001, HUM REPROD, V16, P909, DOI 10.1093/humrep/16.5.909; Yin H, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-14; Zinellu A, 2010, ANAL BIOANAL CHEM, V398, P2109, DOI 10.1007/s00216-010-4186-6	56	53	54	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124911	10.1371/journal.pone.0124911	http://dx.doi.org/10.1371/journal.pone.0124911			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893245	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700130
J	Littnerova, S; Kala, P; Jarkovsky, J; Kubkova, L; Prymusova, K; Kubena, P; Tesak, M; Toman, O; Poloczek, M; Spinar, J; Dusek, L; Parenica, J				Littnerova, Simona; Kala, Petr; Jarkovsky, Jiri; Kubkova, Lenka; Prymusova, Krystyna; Kubena, Petr; Tesak, Martin; Toman, Ondrej; Poloczek, Martin; Spinar, Jindrich; Dusek, Ladislav; Parenica, Jiri			GRACE Score among Six Risk Scoring Systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) Demonstrated the Best Predictive Value for Prediction of Long-Term Mortality in Patients with ST-Elevation Myocardial Infarction	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; OUTCOMES; REGISTRY; THERAPY; MODEL	Aim To compare the prognostic accuracy of six scoring models for up to three-year mortality and rates of hospitalisation due to acute decompensated heart failure (ADHF) in STEMI patients. Methods and Results A total of 593 patients treated with primary PCI were evaluated. Prospective follow-up of patients was >= 3 years. Thirty-day, one-year, two-year, and three-year mortality rates were 4.0%, 7.3%, 8.9%, and 10.6%, respectively. Six risk scores-the TIMI score and derived dynamic TIMI, CADILLAC, PAMI, Zwolle, and GRACE-showed a high predictive accuracy for six- and 12-month mortality with area under the receiver operating characteristic curve (AUC) values of 0.73-0.85. The best predictive values for long-term mortality were obtained by GRACE. The next best-performing scores were CADILLAC, Zwolle, and Dynamic TIMI. All risk scores had a lower prediction accuracy for repeat hospitalisation due to ADHF, except Zwolle with the discriminatory capacity for hospitalisation up to two years (AUC, 0.80-0.83). Conclusions All tested models showed a high predictive value for the estimation of one-year mortality, but GRACE appears to be the most suitable for the prediction for a longer follow-up period. The tested models exhibited an ability to predict the risk of ADHF, especially the Zwolle model.	[Littnerova, Simona; Jarkovsky, Jiri; Dusek, Ladislav] Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic; [Kala, Petr; Kubkova, Lenka; Prymusova, Krystyna; Kubena, Petr; Tesak, Martin; Toman, Ondrej; Poloczek, Martin; Spinar, Jindrich; Parenica, Jiri] Univ Hosp Brno, Dept Cardiol, Brno, Czech Republic; [Kala, Petr; Kubkova, Lenka; Kubena, Petr; Poloczek, Martin; Spinar, Jindrich; Parenica, Jiri] Masaryk Univ, Fac Med, Brno, Czech Republic; [Kubkova, Lenka; Toman, Ondrej; Spinar, Jindrich; Parenica, Jiri] St Annes Univ Hosp, Int Clin Res Ctr, Dept Cardiovasc Dis, Brno, Czech Republic; [Prymusova, Krystyna] Hosp Podlesi AS, Trinec, Czech Republic; [Tesak, Martin] Hosp Trebic, Trebic, Czech Republic	Institute of Biostatistics & Analyses; Masaryk University Brno; University Hospital Brno; Masaryk University Brno; St Anne's University Hospital Brno (FNUSA-ICRC)	Jarkovsky, J (corresponding author), Masaryk Univ, Inst Biostat & Anal, Brno, Czech Republic.	jarkovsky@iba.muni.cz	Dušek, Ladislav/G-8794-2013; Jarkovsky, Jiri/G-5494-2017	Dusek, Ladislav/0000-0002-8589-4378	MH CZ - DRO (FNBr) [65269705]; European Regional Development Fund - Project FNUSA-ICRC [CZ.1.05/1.1.00/02.0123]; Ministry of Education Youth and Sports of the Czech Republic [MUNI/A/1012/2013]	MH CZ - DRO (FNBr); European Regional Development Fund - Project FNUSA-ICRC; Ministry of Education Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the MH CZ - DRO (FNBr, 65269705), by the European Regional Development Fund - Project FNUSA-ICRC (CZ.1.05/1.1.00/02.0123), the Grant of Ministry of Education Youth and Sports of the Czech Republic (MUNI/A/1012/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addala S, 2004, AM J CARDIOL, V93, P629, DOI 10.1016/j.amjcard.2003.11.036; Amin ST, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.003269; De Bruyne B, 2012, NEW ENGL J MED, V367, P991, DOI 10.1056/NEJMoa1205361; De Luca G, 2004, CIRCULATION, V109, P2737, DOI 10.1161/01.CIR.0000131765.73959.87; Eagle KA, 2004, JAMA-J AM MED ASSOC, V291, P2727, DOI 10.1001/jama.291.22.2727; Fox KAA, 2006, BMJ-BRIT MED J, V333, P1091, DOI 10.1136/bmj.38985.646481.55; Garg S, 2011, JACC-CARDIOVASC INTE, V4, P66, DOI 10.1016/j.jcin.2010.09.017; Granger CB, 2003, ARCH INTERN MED, V163, P2345, DOI 10.1001/archinte.163.19.2345; Halkin A, 2005, J AM COLL CARDIOL, V45, P1397, DOI 10.1016/j.jacc.2005.01.041; Kozieradzka A, 2011, INT J CARDIOL, V148, P70, DOI 10.1016/j.ijcard.2009.10.026; Lev EI, 2008, AM J CARDIOL, V102, P6, DOI 10.1016/j.amjcard.2008.02.088; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Morrow DA, 2001, JAMA-J AM MED ASSOC, V286, P1356, DOI 10.1001/jama.286.11.1356; Stebbins A, 2010, CIRC-CARDIOVASC INTE, V3, P414, DOI 10.1161/CIRCINTERVENTIONS.109.925180; Steg PG, 2012, EUR HEART J, V33, P2569, DOI 10.1093/eurheartj/ehs215; Widimsky P, 2010, EUR HEART J, V31, P943, DOI 10.1093/eurheartj/ehp492	16	38	46	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123215	10.1371/journal.pone.0123215	http://dx.doi.org/10.1371/journal.pone.0123215			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893501	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700028
J	Wang, JG; Zheng, R; Bai, SL; Gao, XM; Liu, M; Yan, W				Wang, Jugang; Zheng, Rong; Bai, Shulan; Gao, Xiaomin; Liu, Min; Yan, Wei			Mongolian Almond (Prunus mongolica Maxim): The Morpho-Physiological, Biochemical and Transcriptomic Response to Drought Stress	PLOS ONE			English	Article							GENE-EXPRESSION; WEB TOOL; AQUAPORINS; MEMBRANE; RESISTANCE; DATABASE; FAMILY; IDENTIFICATION; PERSPECTIVE; ANTIOXIDANT	Prunus mongolica Maxim, which is widely established in the Gobi Desert, shows extreme tolerance to drought. However, there is a lack of available transcriptomic resources for this species related to its response to water deficiency. To investigate the mechanisms that allow P. mongolica to maintain growth in extremely arid environments, the response of P. mongolica seedlings to drought stress was analyzed using morphological, physiological, biochemical and high-throughput sequencing approaches. We generated 28,713,735 and 26,650,133 raw reads from no-stress control and drought-stressed P. mongolica seedlings, respectively. In total, we obtained 67,352 transcripts with an average length of 874.44 bp. Compared with the no-stress control, 3,365 transcripts were differentially expressed in the drought-stressed seedlings, including 55.75% (1,876 transcripts) up-regulated and 44.25% (1,489 transcripts) down-regulated transcripts. The photosynthesis response showed a decreasing tendency under drought stress, but the changes in the levels of hormones (auxins, cytokinins and abscisic acid) resulted in the closing of stomata and decreased cell enlargement and division; these changes were effective for promoting P. mongolica survival in Gobi Desert. Next, we analyzed the aquaporin and superoxide dismutase gene families due to their importance in plant resistance to drought stress. We found that all of the plasma membrane intrinsic protein transcripts were down-regulated in the drought-stressed treatment, whereas drought did not affect the expression of nodulin intrinsic protein or small basic intrinsic protein transcripts in P. mongolica seedlings. In addition, activation of iron superoxide dismutase transcription and enhanced transcription of manganese superoxide dismutase were observed in P. mongolica to promote tolerance of drought stress. This study identified drought response genes in P. mongolica seedlings. Our results provide a significant contribution to the understanding of how P. mongolica responds to drought stress at the transcriptome level, which may help to elucidate molecular mechanisms associated with the drought response of almond plants.	[Wang, Jugang; Zheng, Rong; Bai, Shulan; Liu, Min] Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Inner Mongolia, Peoples R China; [Zheng, Rong] Inner Mongolia Normal Univ, Coll Life Sci & Technol, Hohhot, Inner Mongolia, Peoples R China; [Gao, Xiaomin] Inner Mongolia Agr Univ, Coll Agr, Hohhot, Inner Mongolia, Peoples R China; [Yan, Wei] Inst Forestry Sci Ordos, Ordos, Inner Mongolia, Peoples R China	Inner Mongolia Agricultural University; Inner Mongolia Normal University; Inner Mongolia Agricultural University	Bai, SL (corresponding author), Inner Mongolia Agr Univ, Coll Forestry, Hohhot, Inner Mongolia, Peoples R China.	baishulan2004@163.com		Wang, Ju-Gang/0000-0002-4616-8007	National Natural Science Foundation of China [31060110, 30860225]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Nos. 31060110 and 30860225). URL: http://www.nsfc.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajithkumar IP, 2014, CELL BIOCHEM BIOPHYS, V68, P587, DOI 10.1007/s12013-013-9746-x; Alimohammadi A, 2013, SCI HORTIC-AMSTERDAM, V159, P19, DOI 10.1016/j.scienta.2013.04.023; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alvarez M, 2009, TREE PHYSIOL; Arias R, 2014, WATER-SUI, V6, P3049, DOI 10.3390/w6103049; Arshad M, 2014, TREES-STRUCT FUNCT, V28, P531, DOI 10.1007/s00468-013-0969-7; Bhoomika K, 2013, PLANT GROWTH REGUL, V71, P235, DOI 10.1007/s10725-013-9824-5; Blankenship R. E., 2014, MOL MECH PHOTOSYNTHE; Chaumont F, 2001, PLANT PHYSIOL, V125, P1206, DOI 10.1104/pp.125.3.1206; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Chen JH, 2013, PLANT MOL BIOL REP, V31, P946, DOI 10.1007/s11105-013-0563-6; Davies P.J., 2004, PLANT HORMONES BIOSY; Dong YP, 2014, INT J MOL SCI, V15, P4583, DOI 10.3390/ijms15034583; Eilmann B, 2013, ANN FOREST SCI, V70, P685, DOI 10.1007/s13595-013-0310-z; Eldem V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050298; Fan XD, 2013, GENE, V512, P392, DOI 10.1016/j.gene.2012.09.100; Gale EM, 2010, INORG CHEM, V49, P7080, DOI 10.1021/ic1009187; Golldack D, 2011, PLANT CELL REP, V30, P1383, DOI 10.1007/s00299-011-1068-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gross SM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-563; Gupta S, 2012, FUNCT INTEGR GENOMIC, V12, P543, DOI 10.1007/s10142-012-0277-0; Hancock JT, 2011, PLANT SCI, V181, P555, DOI 10.1016/j.plantsci.2011.03.017; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ishikawa F, 2005, FEBS LETT, V579, P5814, DOI 10.1016/j.febslet.2005.09.076; Jain M, 2009, PLANT SCI, V176, P702, DOI 10.1016/j.plantsci.2009.02.001; Jang JY, 2004, PLANT MOL BIOL, V54, P713, DOI 10.1023/B:PLAN.0000040900.61345.a6; Jayanthi H, 2013, INT J DISAST RISK RE, V4, P71, DOI 10.1016/j.ijdrr.2013.02.001; Jiang JL, 2013, BIOLOGIA, V68, P231, DOI 10.2478/s11756-013-0003-y; Kanehisa M, 2006, NUCLEIC ACIDS RES, V34, pD354, DOI 10.1093/nar/gkj102; Keppel-Aleks G, 2014, GLOBAL BIOGEOCHEM CY, V28, P1295, DOI 10.1002/2014GB004890; Lamesch P, 2012, NUCLEIC ACIDS RES, V40, pD1202, DOI 10.1093/nar/gkr1090; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2010, BIOINFORMATICS, V26, P493, DOI 10.1093/bioinformatics/btp692; Liu TM, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-130; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TT, 2010, GENOME RES, V20, P1238, DOI 10.1101/gr.106120.110; Manea A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091046; Maurel C, 2008, ANNU REV PLANT BIOL, V59, P595, DOI 10.1146/annurev.arplant.59.032607.092734; Mousavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104541; Muller T, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-673; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Nadzirin N, 2012, INT J MOL SCI, V13, P12761, DOI 10.3390/ijms131012761; Nakashima K, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00170; Nuruzzaman M, 2014, J PLANT PHYSIOL, V171, P2, DOI 10.1016/j.jplph.2013.09.010; Okay S, 2014, MOL GENET GENOMICS, V289, P765, DOI 10.1007/s00438-014-0849-x; Peng SM, 2012, TREE PHYSIOL, V32, P1541, DOI 10.1093/treephys/tps110; Polozov R, 2014, J BIOMOLECULAR STRUC, P1; Pou A, 2013, PLANT CELL ENVIRON, V36, P828, DOI 10.1111/pce.12019; Raney J. A., 2014, American Journal of Plant Sciences, V5, P338; Robertson G, 2010, NAT METHODS, V7, P909, DOI 10.1038/nmeth.1517; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Sarda X, 1997, PLANT J, V12, P1103, DOI 10.1046/j.1365-313X.1997.12051103.x; SCALABRIN S, 2011, CATALOG MOL DIVERSIT, P169; Shiran B, 2007, SCI HORTIC-AMSTERDAM, V111, P280, DOI 10.1016/j.scienta.2006.10.024; Signorelli S, 2013, PLANT PHYSIOL BIOCH, V70, P195, DOI 10.1016/j.plaphy.2013.05.028; Song LH, 2013, PHYSIOL PLANTARUM, V148, P322, DOI 10.1111/ppl.12013; Tang S, 2013, PLANT MOL BIOL, V83, P539, DOI 10.1007/s11103-013-0107-3; Tarkowska D., 2014, PLANTA, P1; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Tian FX, 2013, J EXP BOT, V64, P1509, DOI 10.1093/jxb/ert004; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Utsumi Y, 2012, DNA RES, V19, P335, DOI 10.1093/dnares/dss016; Varshney RK, 2012, J BIOSCIENCES, V37, P811, DOI 10.1007/s12038-012-9228-0; Vencio RZN, 2003, BIOINFORMATICS, V19, P2461, DOI 10.1093/bioinformatics/btg357; Verde I, 2013, NAT GENET, V45, P487, DOI 10.1038/ng.2586; Verkman AS, 2013, CURR BIOL, V23, pR52, DOI 10.1016/j.cub.2012.11.025; Xangsayasane P, 2014, FIELD CROP RES, V156, P281, DOI 10.1016/j.fcr.2013.10.017; Yan F, 2014, GENETICS MOL RES GMR, P13; Yazbek MM, 2014, GENETIC RESOURCES CR, P1; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zadworny M, 2014, FOREST ECOL MANAG, V318, P133, DOI 10.1016/j.foreco.2014.01.017; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	74	9	14	2	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124442	10.1371/journal.pone.0124442	http://dx.doi.org/10.1371/journal.pone.0124442			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893685	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700094
J	Bhawna; Chaduvula, PK; Bonthala, VS; Manjusha, V; Siddiq, EA; Polumetla, AK; Prasad, GMNV				Bhawna; Chaduvula, Pavan K.; Bonthala, Venkata S.; Manjusha, Verma; Siddiq, Ebrahimali A.; Polumetla, Ananda K.; Prasad, Gajula M. N. V.			CmMDb: A Versatile Database for Cucumis melo Microsatellite Markers and Other Horticulture Crop Research	PLOS ONE			English	Article							SSR MARKERS; GENOME; IDENTIFICATION; SEQUENCES	Cucumis melo L. that belongs to Cucurbitaceae family ranks among one of the highest valued horticulture crops being cultivated across the globe. Besides its economical and medicinal importance, Cucumis melo L. is a valuable resource and model system for the evolutionary studies of cucurbit family. However, very limited numbers of molecular markers were reported for Cucumis melo L. so far that limits the pace of functional genomic research in melon and other similar horticulture crops. We developed the first whole genome based microsatellite DNA marker database of Cucumis melo L. and comprehensive web resource that aids in variety identification and physical mapping of Cucurbitaceae family. The Cucumis melo L. microsatellite database (CmMDb: http://65.181.125.102/cmmdb2/index.html) encompasses 39,072 SSR markers along with its motif repeat, motif length, motif sequence, marker ID, motif type and chromosomal locations. The database is featured with novel automated primer designing facility to meet the needs of wet lab researchers. CmMDb is a freely available web resource that facilitates the researchers to select the most appropriate markers for marker-assisted selection in melons and to improve breeding strategies.	[Bhawna; Manjusha, Verma] Natl Bur Plant Genet Resources, Genom Resources Div, New Delhi 12, India; [Chaduvula, Pavan K.] Natl Res Ctr Plant Biotechnol, New Delhi 110012, India; [Bonthala, Venkata S.; Siddiq, Ebrahimali A.; Polumetla, Ananda K.; Prasad, Gajula M. N. V.] PJTSAU, Inst Biotechnol, Hyderabad 500030, Andhra Pradesh, India	Indian Council of Agricultural Research (ICAR); ICAR - National Bureau of Plant Genetics Resources; Indian Council of Agricultural Research (ICAR); ICAR - National Institute For Plant Biotechnology (NIPB)	Prasad, GMNV (corresponding author), PJTSAU, Inst Biotechnol, Hyderabad 500030, Andhra Pradesh, India.	gajulaibt@grnail.com	Bonthala, Venkata Suresh/G-9852-2013	Bonthala, Venkata Suresh/0000-0001-6550-1648; Bonthala, Bhawna/0000-0003-2839-1691	Department of Science and Technology, Govt. of India; Ramanujan Fellowship grant [SRN/S2/RJN-22/2011]	Department of Science and Technology, Govt. of India; Ramanujan Fellowship grant	This work was supported by the Department of Science and Technology, Govt. of India; Ramanujan Fellowship grant award no. SRN/S2/RJN-22/2011. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Arumuganathan K, 1991, PLANT MOL BIOL REP, V9, P208, DOI DOI 10.1007/BF02672069; Bhawna, 2014, APPL BIOCH BIOTECHNO; Cavagnaro PF, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-569; Clepet C, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-252; DELSENY M, 1983, BIOCHEM BIOPH RES CO, V116, P113, DOI 10.1016/0006-291X(83)90388-1; Diaz A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-111; Ferreira ME., 1998, INTRO USE MOL MARKER, V2, P220; Garcia-Mas J, 2012, P NATL ACAD SCI USA, V109, P11872, DOI 10.1073/pnas.1205415109; Gonzalez VM, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-339; Gonzalez-Ibeas D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-306; Gupta S, 2012, PLANT CELL REP, V31, P323, DOI 10.1007/s00299-011-1168-x; Harel-Beja R, 2010, THEOR APPL GENET, V121, P511, DOI 10.1007/s00122-010-1327-4; Karakousis A, 2003, AUST J AGR RES, V54, P1197, DOI 10.1071/AR02178; KAWCHUK LM, 1990, MOL PLANT MICROBE IN, V3, P301, DOI 10.1094/MPMI-3-301; Kumari K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067742; Lin HS, 2011, INT J MOL SCI, V12, P7835, DOI 10.3390/ijms12117835; Manigbas N. L., 2004, Philippine Journal of Crop Science, V29, P23; Mascarell-Creus A, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-467; MICCOLIS V, 1991, J AM SOC HORTIC SCI, V116, P1025, DOI 10.21273/JASHS.116.6.1025; Nunez-Palenius HG, 2008, CRIT REV BIOTECHNOL, V28, P13, DOI [10.1080/07388550801891111, 10.1080/07388550801891111 ]; Ophir R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-269; Pandey G, 2013, DNA RES, V20, P197, DOI 10.1093/dnares/dst002; Parida SK, 2006, THEOR APPL GENET, V112, P808, DOI 10.1007/s00122-005-0182-1; Parida SK, 2010, GENOME, V53, P55, DOI [10.1139/G09-084, 10.1139/g09-084]; Parida SK, 2009, THEOR APPL GENET, V118, P327, DOI 10.1007/s00122-008-0902-4; Ren Y, 2014, BMC PLANT BIOL, V14, DOI 10.1186/1471-2229-14-33; Ritschel Patricia Silva, 2004, BMC Plant Biology, V4, P9, DOI 10.1186/1471-2229-4-9; Shirasawa K, 2013, MOL BREEDING, V31, P101, DOI 10.1007/s11032-012-9774-z; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; Suresh BV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086387; TAUTZ D, 1984, NUCLEIC ACIDS RES, V12, P4127, DOI 10.1093/nar/12.10.4127; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Venkata SB, 2013, PLOS ONE, V8, DOI [10.1371/journal, DOI 10.1371/JOURNAL]; Youens-Clark K, 2009, BIOINFORMATICS, V25, P3040, DOI 10.1093/bioinformatics/btp458	35	6	7	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0118630	10.1371/journal.pone.0118630	http://dx.doi.org/10.1371/journal.pone.0118630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885062	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000003
J	Lupianez-Perez, I; Uttumchandani, SK; Morilla-Herrera, J; Martin-Santos, FJ; Fernandez-Gallego, MC; Navarro-Moya, FJ; Lupianez-Perez, Y; Contreras-Fernandez, E; Morales-Asencio, JM				Lupianez-Perez, Inmaculada; Kaknani Uttumchandani, Shakira; Carlos Morilla-Herrera, Juan; Javier Martin-Santos, Francisco; Cuevas Fernandez-Gallego, Magdalena; Javier Navarro-Moya, Francisco; Lupianez-Perez, Yolanda; Contreras-Fernandez, Eugenio; Miguel Morales-Asencio, Jose			Topical Olive Oil Is Not Inferior to Hyperoxygenated Fatty Aids to Prevent Pressure Ulcers in High-Risk Immobilised Patients in Home Care. Results of a Multicentre Randomised Triple-Blind Controlled Non-Inferiority Trial	PLOS ONE			English	Article							PREVALENCE; HOSPITALS	Pressure ulcers represent a major current health problem and produce an important economic impact on the healthcare system. Most of studies to prevent pressure ulcers have been carried out in hospital contexts, with respect to the use of hyperoxygenated fatty acids and to date, no studies have specifically examined the use of olive oil-based substances. Methods and Design Main objective: To assess the effectiveness of the use of olive oil, comparing it with hyperoxygenated fatty acids, for immobilised home-care patients at risk of suffering pressure ulcers. Design: Non-inferiority, triple-blind, parallel, multicentre, randomised clinical trial. Scope: Population attending Primary Healthcare Centres in Andalusia (Spain). Sample: 831 immobilised patients at risk of suffering pressure ulcers. Results The follow-up period was 16 weeks. Groups were similar after randomization. In the per protocol analysis, none of the body areas evaluated presented risk differences for pressure ulcers incidence that exceeded the 10% delta value established. Sacrum: Olive Oil 8 (2.55%) vs HOFA 8 (3.08%), ARR 0.53 (-2.2 to 3.26) Right heel: Olive Oil 4 (1.27%) vs HOFA 5 (1.92)%, ARR0.65 (-1.43 to 2.73). Left heel: Olive Oil 3 (0.96%) vs HOFA 3 (1.15%), ARR0.2 (-1.49 to 1.88). Right trochanter: Olive Oil 0 (0%) vs HOFA 4 (1.54%), ARR1.54 (0.04 to 3.03). Left trochanter: Olive Oil 1 (0.32%) vs HOFA 1 (0.38%), ARR0.07 (-0.91 to 1.04). In the intention to treat analysis the lower limit of the established confidence interval was never exceeded. Discussion The results obtained confirmed that the use of topical extra-virgin olive oil to prevent PU in the home environment, for immobilised patients at high risk, is not inferior to the use of HOFA. Further studies are needed to investigate the mechanism by which olive oil achieves this outcome.	[Lupianez-Perez, Inmaculada; Carlos Morilla-Herrera, Juan; Javier Martin-Santos, Francisco; Cuevas Fernandez-Gallego, Magdalena; Javier Navarro-Moya, Francisco] Malaga Guadalhorce Primary Healthcare Dist, Andalusian Hlth Serv, Malaga, Spain; [Kaknani Uttumchandani, Shakira; Miguel Morales-Asencio, Jose] Univ Malaga, Fac Hlth Sci, E-29071 Malaga, Spain; [Lupianez-Perez, Yolanda] Virgen de la Victoria Univ Hosp, Malaga, Spain; [Lupianez-Perez, Yolanda] Carlos Haya Reg Hosp, Malaga, Spain; [Contreras-Fernandez, Eugenio] Costa Sol Primary Healthcare Dist, Andalusian Hlth Serv, Malaga, Spain	Universidad de Malaga; Hospital Virgen de la Victoria	Lupianez-Perez, I (corresponding author), Malaga Guadalhorce Primary Healthcare Dist, Andalusian Hlth Serv, Malaga, Spain.	ilupianeperez@gmail.com	MORALES-ASENCIO, JOSE MIGUEL/B-4996-2008	MORALES-ASENCIO, JOSE MIGUEL/0000-0001-7911-7487; Morilla Herrera, Juan Carlos/0000-0003-3814-4440	Spanish Ministry of Health, Social Policy and Equality [EC11-526]	Spanish Ministry of Health, Social Policy and Equality	This research was undertaken pursuant to the Independent Clinical Calls and Proposals managed by the Spanish Ministry of Health, Social Policy and Equality (EC11-526). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoiz Linares JI, 2003, ATEN PRIM, V31, P473, DOI 10.1157/13047722; Beauchamp GK, 2005, NATURE, V437, P45, DOI 10.1038/437045a; Candela-Zamora MD, 2010, ENFERM CLIN, V20, P10, DOI 10.1016/j.enfcli.2009.07.013; Coleman S, 2014, J ADV NURS, V70, P2222, DOI 10.1111/jan.12405; Coleman S, 2013, INT J NURS STUD, V50, P974, DOI 10.1016/j.ijnurstu.2012.11.019; Defloor T, 2006, J ADV NURS, V54, P189, DOI 10.1111/j.1365-2648.2006.03801.x; Delmore B, 2011, J WOUND OSTOMY CONT, V38, P505, DOI 10.1097/WON.0b013e31822ad2ab; Escudero MC, 2001, ENFERM CLIN, V11, P91; Gallart E, 2001, ENFERM CLIN, V11, P179, DOI [10.1016/s1130, DOI 10.1016/S1130, 10.1016/j.medin.2014.09.004, DOI 10.1016/J.MEDIN.2014.09.004]; Gorecki C, 2009, J AM GERIATR SOC, V57, P1175, DOI 10.1111/j.1532-5415.2009.02307.x; Hanson D, 2010, ADV SKIN WOUND CARE, V23, P21, DOI 10.1097/01.ASW.0000363489.38996.13; Home care across Europe, 2014, CURR STRUCT FUT CHAL; James J, 2010, INT WOUND J, V7, P147, DOI 10.1111/j.1742-481X.2010.00665.x; Kottner Jan, 2010, Pflege Z, V63, P228; Lamura G, 2008, GERONTOLOGIST, V48, P752, DOI 10.1093/geront/48.6.752; Lee TT, 2012, CIN-COMPUT INFORM NU, V30, P489, DOI 10.1097/NXN.0b013e3182573aec; Lupianez-Perez I, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-348; Martínez Cuervo F., 2009, Gerokomos, V20, P41, DOI 10.4321/s1134-928x2009000100006; Morilla Herrera JC, 2004, GUIA PRACTICA CLIN M; NICE, 2014, PRESS ULC PREV DRAFT; Owen R W, 2000, Lancet Oncol, V1, P107, DOI 10.1016/S1470-2045(00)00015-2; Park-Lee E, 2009, NCHS DATA BRIEF, P1; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Salcido R, 2011, ADV SKIN WOUND CARE, V24, P374, DOI [10.1097/01.ASW.0000403251.92754.27, 10.1097/01.ASW.0000403250.85131.b9]; Segovia Gomez T, 2001, Rev Enferm, V24, P18; Soldevilla Agreda J., 2007, GEROKOMOS, V18, P201, DOI DOI 10.4321/S1134-928X2007000400007; Soldevilla Agreda J. Javier, 2006, Gerokomos, V17, P154, DOI 10.4321/s1134-928x2006000300006; Soldevilla Agreda JJ, 2011, GEROKOMOS, V22, P77; Torra i Bou J E, 2005, J Wound Care, V14, P117; Torra i Bou Joan-Enric, 2003, Rev Enferm, V26, P54; Tubaishat A, 2011, J TISSUE VIABILITY, V20, P14, DOI 10.1016/j.jtv.2010.08.001; White-Chu EF, 2011, CLIN GERIATR MED, V27, P241, DOI 10.1016/j.cger.2011.02.001; Wilborn D, 2010, GESUNDHEITSWESEN, V72, P240, DOI 10.1055/s-0029-1220757; Yamamoto Y, 2010, J EVAL CLIN PRACT, V16, P585, DOI 10.1111/j.1365-2753.2009.01171.x	34	18	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122238	10.1371/journal.pone.0122238	http://dx.doi.org/10.1371/journal.pone.0122238			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886152	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000030
J	Ndase, P; Celum, C; Kidoguchi, L; Ronald, A; Fife, KH; Bukusi, E; Donnell, D; Baeten, JM				Ndase, Patrick; Celum, Connie; Kidoguchi, Lara; Ronald, Allan; Fife, Kenneth H.; Bukusi, Elizabeth; Donnell, Deborah; Baeten, Jared M.		Partners PrEP Study Team	Frequency of False Positive Rapid HIV Serologic Tests in African Men and Women Receiving PrEP for HIV Prevention: Implications for Programmatic Roll-Out of Biomedical Interventions	PLOS ONE			English	Article							ANTIRETROVIRAL PROPHYLAXIS; INFECTION	Background Rapid HIV assays are the mainstay of HIV testing globally. Delivery of effective biomedical HIV prevention strategies such as antiretroviral pre-exposure prophylaxis (PrEP) requires periodic HIV testing. Because rapid tests have high (> 95%) but imperfect specificity, they are expected to generate some false positive results. Methods We assessed the frequency of true and false positive rapid results in the Partners PrEP Study, a randomized, placebo-controlled trial of PrEP. HIV testing was performed monthly using 2 rapid tests done in parallel with HIV enzyme immunoassay (EIA) confirmation following all positive rapid tests. Results A total of 99,009 monthly HIV tests were performed; 98,743 (99.7%) were dual-rapid HIV negative. Of the 266 visits with >= 1 positive rapid result, 99 (37.2%) had confirmatory positive EIA results (true positives), 155 (58.3%) had negative EIA results (false positives), and 12 (4.5%) had discordant EIA results. In the active PrEP arms, over two-thirds of visits with positive rapid test results were false positive results (69.2%, 110 of 159), although false positive results occurred at < 1% (110/65,945) of total visits. Conclusions When HIV prevalence or incidence is low due to effective HIV prevention interventions, rapid HIV tests result in a high number of false relative to true positive results, although the absolute number of false results will be low. Program roll-out for effective interventions should plan for quality assurance of HIV testing, mechanisms for confirmatory HIV testing, and counseling strategies for persons with positive rapid test results.	[Ndase, Patrick; Celum, Connie; Kidoguchi, Lara; Bukusi, Elizabeth; Donnell, Deborah; Baeten, Jared M.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Med, Seattle, WA USA; [Celum, Connie; Baeten, Jared M.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Ronald, Allan] Univ Manitoba, Dept Med, Winnipeg, MB, Canada; [Ronald, Allan] Makerere Univ, Infect Dis Inst, Kampala, Uganda; [Fife, Kenneth H.] Indiana Univ, Dept Med, Indianapolis, IN USA; [Bukusi, Elizabeth] Univ Nairobi, Dept Obstet & Gynecol, Nairobi, Kenya; [Bukusi, Elizabeth] Kenyatta Natl Hosp, Nairobi, Kenya; [Bukusi, Elizabeth] Kenya Govt Med Res Ctr, Ctr Microbiol Res, Nairobi, Kenya; [Bukusi, Elizabeth] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Donnell, Deborah] Fred Hutchinson Canc Res Ctr, Stat Ctr HIV AIDS Res & Prevent, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Manitoba; Makerere University; Indiana University System; Indiana University-Purdue University Indianapolis; University of Nairobi; Kenyatta National Hospital; Kenya Medical Research Institute; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center	Baeten, JM (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	jbaeten@u.washington.edu	Hendrix, Craig W/G-4182-2014	Hendrix, Craig W/0000-0002-5696-8665; Were, Edwin/0000-0002-4783-0795; Ronald, Allan/0000-0002-5746-3490; Donnell, Deborah/0000-0002-0587-7480	Bill and Melinda Gates Foundation [OPP47674]; National Institute of Mental Health of the US National Institutes of Health [R01 MH095507]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH095507] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institute of Mental Health of the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by The Bill and Melinda Gates Foundation (grant OPP47674) and the National Institute of Mental Health of the US National Institutes of Health (grant R01 MH095507).	Baeten JM, 2012, NEW ENGL J MED, V367, P399, DOI 10.1056/NEJMoa1108524; Baveewo Steven, 2012, BMC Res Notes, V5, P154, DOI 10.1186/1756-0500-5-154; Choopanya K, 2013, LANCET, V381, P2083, DOI 10.1016/S0140-6736(13)61127-7; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Crucitti T, 2011, CLIN VACCINE IMMUNOL, V18, P1480, DOI 10.1128/CVI.05069-11; Grant RM, 2010, NEW ENGL J MED, V363, P2587, DOI 10.1056/NEJMoa1011205; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Moodley D, 2008, SAMJ S AFR MED J, V98, P707; Thigpen MC, 2012, NEW ENGL J MED, V367, P423, DOI 10.1056/NEJMoa1110711; von Knorring N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030728; Wolpaw BJ, 2010, BMC HEALTH SERV RES, V10, DOI 10.1186/1472-6963-10-73; World Health Organization, 2004, RAP HIV TESTS GUID U	12	13	13	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123005	10.1371/journal.pone.0123005	http://dx.doi.org/10.1371/journal.pone.0123005			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885664	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000047
J	Rothhammer, F; Fuentes-Guajardo, M; Chakraborty, R; Bermejo, JL; Dittmar, M				Rothhammer, Francisco; Fuentes-Guajardo, Macarena; Chakraborty, Ranajit; Bermejo, Justo Lorenzo; Dittmar, Manuela			Neonatal Variables, Altitude of Residence and Aymara Ancestry in Northern Chile	PLOS ONE			English	Article							GAMMA-GLOBIN-GENE; BIRTH-WEIGHT; PHENOTYPIC PLASTICITY; OXYGEN DELIVERY; ADAPTATION; FETAL; POPULATIONS; REDUCTIONS; DELETION; HYPOXIA	Studies performed in the Andean plateau, one of the highest inhabited areas in the world, have reported that reduced availability of oxygen is associated to fetal growth retardation and lower birth weight, which are established predictors of morbidity and mortality during the first year of life. To test this hypothesis, perinatal variables of neonates born at the Juan Noe Hospital of Arica, Chile, were analyzed in relation to altitude of residence and Aymara ancestry of their mothers. The study population comprised the offspring of 5,295 mothers born between February 2004 and August 2010. Information included birth weight, height, head circumference, gestational age, altitude of residence and socioeconomic status, and was obtained from medical records. Mother's ancestry was assessed based on surnames which were linked to percentages of Aymara admixture estimates relying on 40 selected ancestry informative markers. After correcting for the effect of multicollinearity among predictor variables, neonates born to mothers with an increased component of Aymara ancestry showed significantly higher birth weight and height at sea level, a marginally significant (p-value 0.06) decrease of birth weight and a significant decrease of height with altitude in comparison with the offspring of mothers with low Aymara ancestry. Since observed tendencies are suggestive of a possible genetic adaptation to hypoxia of the Chilean Aymara, we discuss briefly preliminary evidence related to fetal oxygen transport, particularly polymorphisms in the promoters of the HBG1 and HBG2 genes that are modulators of HbF synthesis, obtained in this ethnic group.	[Rothhammer, Francisco] Univ Tarapaca, Inst Alta Invest, Arica, Chile; [Rothhammer, Francisco] Ctr Invest Hombre Desierto CIHDE, Arica, Chile; [Chakraborty, Ranajit] Univ N Texas, Hlth Sci Ctr, Ctr Computat Genom, Inst Appl Genet, Ft Worth, TX USA; [Bermejo, Justo Lorenzo] Heidelberg Univ, Inst Med Biometry & Informat, Heidelberg, Germany; [Dittmar, Manuela] Univ Kiel, Inst Zool, Dept Human Biol, D-24098 Kiel, Germany; [Fuentes-Guajardo, Macarena] Univ Tarapaca, Fac Ciencias Salud, Dept Tecnol Med, Arica, Chile	Universidad de Tarapaca; University of North Texas System; University of North Texas Health Science Center; Ruprecht Karls University Heidelberg; University of Kiel; Universidad de Tarapaca	Rothhammer, F (corresponding author), Univ Tarapaca, Inst Alta Invest, Arica, Chile.	frothham@med.uchile.cl		Lorenzo Bermejo, Justo/0000-0002-6568-5333	University of Tarapaca	University of Tarapaca	Funding was provided by University of Tarapaca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beall CM, 2010, P NATL ACAD SCI USA, V107, P11459, DOI 10.1073/pnas.1002443107; Bennett A, 2008, AM J HUM BIOL, V20, P592, DOI 10.1002/ajhb.20784; Bigham A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001116; Bigham AW, 2014, PHYSIOL GENOMICS, V46, P687, DOI 10.1152/physiolgenomics.00063.2014; Bigham AW, 2013, AM J HUM BIOL, V25, P190, DOI 10.1002/ajhb.22358; Capriles JM, 2013, QUATERN INT, V301, P46, DOI 10.1016/j.quaint.2012.06.012; COLEMAN MB, 1991, BLOOD, V78, P2473; Eichstaedt CA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093314; FRISANCHO AR, 1995, AM J PHYS ANTHROPOL, V96, P431, DOI 10.1002/ajpa.1330960408; Fuentes M, 2014, REV MED CHILE, V142, P281, DOI 10.4067/S0034-98872014000300001; GILMAN JG, 1985, BLOOD, V66, P783; GILMAN JG, 1988, BRIT J HAEMATOL, V68, P455; Hammond KA, 2001, J EXP BIOL, V204, P1991; Hartinger S, 2006, INT J GYNECOL OBSTET, V93, P275, DOI 10.1016/j.ijgo.2006.02.023; Huerta-Sanchez E, 2014, NATURE, V512, P194, DOI 10.1038/nature13408; Johnson L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019918; Julian CG, 2007, ARCH DIS CHILD-FETAL, V92, P372, DOI 10.1136/adc.2006.109579; Julian CG, 2011, CLIN CHEST MED, V32, P21, DOI 10.1016/j.ccm.2010.10.008; Julian CG, 2009, AM J HUM BIOL, V21, P614, DOI 10.1002/ajhb.20900; Julian CG, 2009, AM J PHYSIOL-REG I, V296, pR1564, DOI 10.1152/ajpregu.90945.2008; Lomaglio D, 2005, ANTROPOL, V9, P61; MANCA L, 1991, BRIT J HAEMATOL, V78, P105, DOI 10.1111/j.1365-2141.1991.tb04390.x; Manriquez G, 2011, CHUNGARA, V43, P283, DOI 10.4067/S0717-73562011000200009; Mazzi E, 1985, REV SOC BOLIV PEDIAT, V24, P43; McAuliffe F, 2001, BRIT J OBSTET GYNAEC, V108, P980, DOI 10.1111/j.1471-0528.2001.00225.x; Moore LG, 2001, HIGH ALT MED BIOL, V2, P257, DOI 10.1089/152702901750265341; Moraga M, 2005, AM J PHYS ANTHROPOL, V127, P170, DOI 10.1002/ajpa.10438; Moreno S, 2003, OBSERV MEDIOAMB, V6, P161; Munoz I., 1993, ACHA 2 ORIGENES POBL; Peng Y, 2011, MOL BIOL EVOL, V28, P1075, DOI 10.1093/molbev/msq290; Postigo L, 2009, J PHYSIOL-LONDON, V587, P693, DOI 10.1113/jphysiol.2008.163634; Rothhammer F, 2009, ANN HUM GENET, V73, P540, DOI 10.1111/j.1469-1809.2009.00537.x; Rottgardt I, 2010, ANTHROPOL SCI, V118, P41, DOI 10.1537/ase.090402; Rupert JL, 2001, HIGH ALT MED BIOL, V2, P235, DOI 10.1089/152702901750265332; Rupert JL, 2001, J EXP BIOL, V204, P3151; Scheinfeldt LB, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-133; Schull WJ, 1990, AYMARA STRATEGIES HU; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Soria R, 2013, PEDIATR RES, V74, P633, DOI 10.1038/pr.2013.150; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Stuber T, 2010, PROG CARDIOVASC DIS, V52, P534, DOI 10.1016/j.pcad.2010.02.009; Wang B, 2011, PLOS ONE, V9; Xu SH, 2011, MOL BIOL EVOL, V28, P1003, DOI 10.1093/molbev/msq277	43	9	9	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121834	10.1371/journal.pone.0121834	http://dx.doi.org/10.1371/journal.pone.0121834			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885573	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000026
J	Wang, GQ; Wang, R; Strulovici-Barel, Y; Salit, J; Staudt, MR; Ahmed, J; Tilley, AE; Yee-Levin, J; Hollmann, C; Harvey, BG; Kaner, RJ; Mezey, JG; Sridhar, S; Pillai, SG; Hilton, H; Wolff, G; Bitter, H; Visvanathan, S; Fine, JS; Stevenson, CS; Crystal, RG				Wang, Guoqing; Wang, Rui; Strulovici-Barel, Yael; Salit, Jacqueline; Staudt, Michelle R.; Ahmed, Joumana; Tilley, Ann E.; Yee-Levin, Jenny; Hollmann, Charleen; Harvey, Ben-Gary; Kaner, Robert J.; Mezey, Jason G.; Sridhar, Sriram; Pillai, Sreekumar G.; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay S.; Stevenson, Christopher S.; Crystal, Ronald G.			Persistence of Smoking-Induced Dysregulation of MiRNA Expression in the Small Airway Epithelium Despite Smoking Cessation	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; CIGARETTE-SMOKE; GENE-EXPRESSION; LUNG-FUNCTION; BRONCHIAL EPITHELIUM; MICRORNAS; CANCER; INFLAMMATION; MODULATION; EXPOSURE	Even after quitting smoking, the risk of the development of chronic obstructive pulmonary disease (COPD) and lung cancer remains significantly higher compared to healthy nonsmokers. Based on the knowledge that COPD and most lung cancers start in the small airway epithelium (SAE), we hypothesized that smoking modulates miRNA expression in the SAE linked to the pathogenesis of smoking-induced airway disease, and that some of these changes persist after smoking cessation. SAE was collected from 10th to 12th order bronchi using fiberoptic bronchoscopy. Affymetrix miRNA 2.0 arrays were used to assess miRNA expression in the SAE from 9 healthy nonsmokers and 10 healthy smokers, before and after they quit smoking for 3 months. Smoking status was determined by urine nicotine and cotinine measurement. There were significant differences in the expression of 34 miRNAs between healthy smokers and healthy nonsmokers (p<0.01, fold-change >1.5), with functions associated with lung development, airway epithelium differentiation, inflammation and cancer. After quitting smoking for 3 months, 12 out of the 34 miRNAs did not return to normal levels, with Wnt/beta-catenin signaling pathway being the top identified enriched pathway of the target genes of the persistent dysregulated miRNAs. In the context that many of these persistent smoking-dependent miRNAs are associated with differentiation, inflammatory diseases or lung cancer, it is likely that persistent smoking-related changes in SAE miRNAs play a role in the subsequent development of these disorders.	[Wang, Guoqing; Wang, Rui; Strulovici-Barel, Yael; Salit, Jacqueline; Staudt, Michelle R.; Ahmed, Joumana; Tilley, Ann E.; Yee-Levin, Jenny; Hollmann, Charleen; Harvey, Ben-Gary; Kaner, Robert J.; Mezey, Jason G.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Tilley, Ann E.; Harvey, Ben-Gary; Kaner, Robert J.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med, Div Pulm & Crit Care Med, New York, NY USA; [Mezey, Jason G.] Cornell Univ, Dept Biol Stat & Computat Biol, Ithaca, NY USA; [Sridhar, Sriram; Pillai, Sreekumar G.; Hilton, Holly; Wolff, Gerhard; Bitter, Hans; Visvanathan, Sudha; Fine, Jay S.; Stevenson, Christopher S.] Hoffmann La Roche Inc, Nutley, NJ 07110 USA	Cornell University; Cornell University; Cornell University; Roche Holding	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Wolff MD|PhD, Gerhard/0000-0002-4458-0700; Staudt, Michelle/0000-0002-3364-0894	JP Smith Clinical Scholar; Hoffmann-La Roche, Inc, Nutley;  [1R01HL107882];  [P20 HL113443];  [1K23 HL103837];  [UL1-RR024996];  [UL1-RR024143];  [P50 HL084936]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000457, UL1TR002384] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024143, UL1RR024996] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL084936, P20HL113443, R01HL107882, K23HL103837] Funding Source: NIH RePORTER	JP Smith Clinical Scholar; Hoffmann-La Roche, Inc, Nutley; ; ; ; ; ; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by 1R01HL107882, P20 HL113443, 1K23 HL103837, UL1-RR024996, UL1-RR024143, and P50 HL084936. RJK and BGH were supported in part by "JP Smith Clinical Scholar." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This study was also supported by Hoffmann-La Roche, Inc, Nutley, who provided support in the form of salaries for authors SS, SGP, HH, GW, HB, SV, JSF, and CSS, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions section.	Anthonisen NR, 2002, AM J RESP CRIT CARE, V166, P675, DOI 10.1164/rccm.2112096; AUERBACH O, 1961, NEW ENGL J MED, V265, P253, DOI 10.1056/NEJM196108102650601; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Beane J, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r201; Bhaskaran M, 2009, PHYSIOL GENOMICS, V37, P268, DOI 10.1152/physiolgenomics.90268.2008; Boldin MP, 2012, IMMUNOL REV, V246, P205, DOI 10.1111/j.1600-065X.2011.01089.x; Brody JS, 2011, ANNU REV PHYSIOL, V73, P437, DOI 10.1146/annurev-physiol-012110-142219; Buro-Auriemma LJ, 2013, HUM MOL GENET, V22, P4726, DOI 10.1093/hmg/ddt326; Chari R, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-297; Davidson MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012560; Davis-Dusenbery BN, 2011, J BIOL CHEM, V286, P28097, DOI 10.1074/jbc.M111.236950; Dong J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010854; Duan MC, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/350727; Ezzie ME, 2012, THORAX, V67, P122, DOI 10.1136/thoraxjnl-2011-200089; Gillen AE, 2011, BIOCHEM J, V438, P25, DOI 10.1042/BJ20110672; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hackett NR, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-82; HALPERN MT, 1993, JNCI-J NATL CANCER I, V85, P457, DOI 10.1093/jnci/85.6.457; Harvey BG, 2007, J MOL MED, V85, P39, DOI 10.1007/s00109-006-0103-z; Hecht SS, 2003, NAT REV CANCER, V3, P733, DOI 10.1038/nrc1190; Heijink IH, 2013, THORAX, V68, P709, DOI 10.1136/thoraxjnl-2012-201667; HOGG JC, 1968, NEW ENGL J MED, V278, P1355, DOI 10.1056/NEJM196806202782501; Janssen HLA, 2013, NEW ENGL J MED, V368, P1685, DOI 10.1056/NEJMoa1209026; Konigshoff M, 2010, AM J RESP CELL MOL, V42, P21, DOI 10.1165/rcmb.2008-0485TR; Lapperre TS, 2007, RESP RES, V8, DOI 10.1186/1465-9921-8-85; Lee YS, 2009, ANNU REV PATHOL-MECH, V4, P199, DOI 10.1146/annurev.pathol.4.110807.092222; Lee YB, 2009, NUCLEIC ACIDS RES, V37, P123, DOI 10.1093/nar/gkn920; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; MacNee W, 2001, EUR J PHARMACOL, V429, P195, DOI 10.1016/S0014-2999(01)01320-6; Marcet B, 2011, NAT CELL BIOL, V13, P693, DOI 10.1038/ncb2241; Milosevic J, 2012, AM J RESP CELL MOL, V47, P879, DOI 10.1165/rcmb.2011-0377OC; Mizuno S, 2012, CHEST, V142, P663, DOI 10.1378/chest.11-2746; Morissette MC, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-49; Nana-Sinkam SP, 2009, AM J RESP CRIT CARE, V179, P4, DOI 10.1164/rccm.200807-1042PP; Nohata N, 2012, ONCOTARGET, V3, P9; Peto R, 2000, BRIT MED J, V321, P323, DOI 10.1136/bmj.321.7257.323; Punturieri A, 2009, JNCI-J NATL CANCER I, V101, P554, DOI 10.1093/jnci/djp023; Qin W, 2012, ONCOGENE, V31, P4067, DOI 10.1038/onc.2011.561; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; ROSADODECHRISTENSON ML, 1994, RADIOGRAPHICS, V14, P429, DOI 10.1148/radiographics.14.2.8190965; Sato T, 2010, AM J RESP CRIT CARE, V182, P1020, DOI 10.1164/rccm.201001-0055OC; Schembri F, 2009, P NATL ACAD SCI USA, V106, P2319, DOI 10.1073/pnas.0806383106; Solberg OD, 2012, AM J RESP CRIT CARE; Spira A, 2004, P NATL ACAD SCI USA, V101, P10143, DOI 10.1073/pnas.0401422101; Steiling K, 2013, AM J RESP CRIT CARE, V187, P933, DOI 10.1164/rccm.201208-1449OC; Sun XH, 2014, TRENDS CARDIOVAS MED, V24, P105, DOI 10.1016/j.tcm.2013.09.002; Tilley AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022798; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Willemse BWM, 2004, EUR RESPIR J, V23, P464, DOI 10.1183/09031936.04.00012704; Williams AE, 2007, DEV DYNAM, V236, P572, DOI 10.1002/dvdy.21047; Xi SC, 2013, J CLIN INVEST, V123, P1241, DOI 10.1172/JCI61271; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yoshida T, 2007, PHYSIOL REV, V87, P1047, DOI 10.1152/physrev.00048.2006; Zhang Y, 2011, EMBO REP, V12, P811, DOI 10.1038/embor.2011.98	55	53	54	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120824	10.1371/journal.pone.0120824	http://dx.doi.org/10.1371/journal.pone.0120824			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886353	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000012
J	Wu, N; Tong, SF; Xiang, Y; Wu, L; Xu, B; Zhang, Y; Ma, XY; Li, YF; Song, ZY; Zhong, L				Wu, Na; Tong, Shifei; Xiang, Ying; Wu, Long; Xu, Bin; Zhang, Yao; Ma, Xiangyu; Li, Yafei; Song, Zhiyuan; Zhong, Li			Association of Hemostatic Markers with Atrial Fibrillation: A Meta-Analysis and Meta-Regression	PLOS ONE			English	Article							MEAN PLATELET VOLUME; SOLUBLE P-SELECTIN; VON-WILLEBRAND-FACTOR; C-REACTIVE PROTEIN; FIBRIN D-DIMER; PROTHROMBOTIC STATE; HYPERCOAGULABLE STATE; BETA-THROMBOGLOBULIN; RISK-FACTOR; ENDOTHELIAL DYSFUNCTION	Background There is growing evidence that indicates the presence of a prothrombotic state in atrial fibrillation (AF). However, the role of hemostatic markers in AF remains inconclusive. Methods We conducted a meta-analysis of observational studies to evaluate the association between hemostatic markers and AF. A meta-regression was performed to explore potential sources of heterogeneity. Results A total of 59 studies met our inclusion criteria for the meta-analysis. For platelet activation, increased circulating platelet factor-4, beta-thromboglobulin (BTG) and P-selectin were significantly higher in AF cases compared with controls (standardized mean difference [SMD] [95% confidence interval (CI)]: 1.72[0.96-2.49], 1.61[1.03-2.19] and 0.50[0.23-0.77], respectively). For coagulation activation, increased levels of plasma D-dimer, fibrinogen, thrombin-antithrombin, prothrombin fragment 1+2, and antithrombin-III were significantly associated with AF (SMD[95% CI]: 1.82[1.38-2.26], 0.72[0.55-0.89], 0.42[0.13-0.72], 1.00 [0.00-1.99] and 1.38[0.16-2.60], respectively). For fibrinolytic function, tissue-type plasminogen activator and plasminogen activator inhibitor-1 were significantly increased in AF cases compared with controls (SMD[95% CI]: 0.86[0.04-1.67] and 0.87[0.28-1.47], respectively) but the associations became nonsignificant after performing subgroup analysis by anticoagulants treatment status. For endothelial function, increased von Willebrand factor was significantly associated with AF (SMD, 0.79; 95% CI, 0.60-0.99); however, no association was observed for soluble thrombomodulin (SMD, 0.60; 95% CI, -0.13-1.33). Conclusions Increased circulating hemostatic factors (PF-4, BTG, P-selectin, D-dimer, fibrinogen, TAT, F1+2, AT-III, and vWf) are significantly associated with AF. Future research is necessary to elucidate the precise mechanism of the prothrombotic state and how hemostatic markers promote thromboembolism in AF.	[Wu, Na; Xiang, Ying; Wu, Long; Xu, Bin; Zhang, Yao; Ma, Xiangyu; Li, Yafei] Third Mil Med Univ, Dept Epidemiol, Coll Prevent Med, Chongqing, Peoples R China; [Xiang, Ying; Wu, Long; Xu, Bin; Zhang, Yao; Ma, Xiangyu; Li, Yafei] Third Mil Med Univ, Evidence Based Med & Clin Epidemiol Ctr, Chongqing, Peoples R China; [Tong, Shifei; Song, Zhiyuan; Zhong, Li] Third Mil Med Univ, Dept Cardiol, Southwest Hosp, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Song, ZY (corresponding author), Third Mil Med Univ, Dept Cardiol, Southwest Hosp, Chongqing, Peoples R China.	zysong2010@126.com; zhongli28@hotmail.com	翔宇, 马/ABH-3164-2021	翔宇, 马/0000-0001-7967-3950				Acevedo M, 2012, J THROMB THROMBOLYS, V128, pe113; Adamsson Eryd S, 2011, EUR J EPIDEMIOL, V26, P449, DOI 10.1007/s10654-011-9565-6; Akar JG, 2008, J AM COLL CARDIOL, V51, P1790, DOI 10.1016/j.jacc.2007.11.083; Alberti S, 2009, PLATELETS, V20, P235, DOI 10.1080/09537100902954370; Alonso A, 2012, INT J CARDIOL, V155, P217, DOI 10.1016/j.ijcard.2010.09.051; Atalar E, 2003, PLATELETS, V14, P407, DOI 10.1080/09537100310001638814; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Blann AD, 2008, INT J CARDIOL, V127, P135, DOI 10.1016/j.ijcard.2007.04.028; Brotman DJ, 2004, SOUTH MED J, V97, P213, DOI 10.1097/01.SMJ.0000105663.01648.25; Cecchi E, 2006, AM J CARDIOL, V97, P1745, DOI 10.1016/j.amjcard.2006.01.034; Choudhury A, 2003, PATHOPHYSIOL HAEMO T, V33, P282, DOI 10.1159/000083815; Choudhury A, 2008, CHEST, V134, P574, DOI 10.1378/chest.07-2745; Chung NAY, 2002, STROKE, V33, P2187, DOI 10.1161/01.STR.0000023889.84649.3D; Colkesen Y, 2008, BLOOD COAGUL FIBRIN, V19, P411, DOI 10.1097/MBC.0b013e3283049697; Colman R.W., 2006, HEMOSTASIS THROMBOSI; Conway DSG, 2004, AM J CARDIOL, V93, P1368, DOI 10.1016/j.amjcard.2004.02.032; Conway DSG, 2004, J AM COLL CARDIOL, V43, P2075, DOI 10.1016/j.jacc.2003.11.062; Conway DSG, 2003, STROKE, V34, P413, DOI 10.1161/01.STR.0000051728.85133.32; Das UN, 2005, MED SCI MONITOR, V11, pRA155; Feng C, 2013, HEART LUNG CIRC, V22, P43, DOI 10.1016/j.hlc.2012.08.052; Feng DL, 2001, AM J CARDIOL, V87, P168, DOI 10.1016/S0002-9149(00)01310-2; Fu RB, 2011, EUROPACE, V13, P31, DOI 10.1093/europace/euq346; Fuster V, 2011, J AM COLL CARDIOL, V57, pE101, DOI 10.1016/j.jacc.2010.09.013; Gartner W, 2008, CLIN BIOCHEM, V41, P1434, DOI 10.1016/j.clinbiochem.2008.09.096; Giansante C, 2000, AM HEART J, V140, P423, DOI 10.1067/mhj.2000.108520; Guo YT, 2012, J AM COLL CARDIOL, V60, P2263, DOI 10.1016/j.jacc.2012.04.063; GUSTAFSSON C, 1990, STROKE, V21, P47, DOI 10.1161/01.STR.21.1.47; Ha SI, 2011, PLATELETS, V22, P408, DOI 10.3109/09537104.2011.560306; Hatzinikolaou-Kotsakou E, 2003, J THROMB THROMBOLYS, V16, P155, DOI 10.1023/B:THRO.0000024053.45693.fc; Hayashi M, 2011, THROMB RES, V128, pE113, DOI 10.1016/j.thromres.2011.07.013; Heeringa J, 2006, J THROMB HAEMOST, V4, P1944, DOI 10.1111/j.1538-7836.2006.02115.x; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hou JP, 2010, CLIN BIOCHEM, V43, P1212, DOI 10.1016/j.clinbiochem.2010.07.013; Hozo SP., 2005, BMC MED RES METHODOL, V5, P1, DOI [10.1186/1471-2288-5-13, DOI 10.1186/1471-2288-5-13]; Inoue H, 2004, CHEST, V126, P687, DOI 10.1378/chest.126.3.687; Kahn SR, 1997, CAN MED ASSOC J, V157, P673; Kamath S, 2003, HEART, V89, P1093, DOI 10.1136/heart.89.9.1093; Kamath S, 2002, BLOOD COAGUL FIBRIN, V13, P627, DOI 10.1097/00001721-200210000-00008; Kamath S, 2002, EUR HEART J, V23, P1788, DOI 10.1053/euhj.2002.3259; Kamath S, 2002, STROKE, V33, P1237, DOI 10.1161/01.STR.0000013739.82306.7F; KUMAGAI K, 1990, J AM COLL CARDIOL, V16, P377, DOI 10.1016/0735-1097(90)90589-H; Li-Saw-Hee FL, 1999, AM J CARDIOL, V83, P1206, DOI 10.1016/S0002-9149(99)00060-0; Li-Saw-Hee FL, 2001, EUR HEART J, V22, P1741, DOI 10.1053/euhj.2000.2531; Li-Saw-Hee FL, 2000, J AM COLL CARDIOL, V35, P1926, DOI 10.1016/S0735-1097(00)00627-6; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; LIP GYH, 1995, LANCET, V346, P1313, DOI 10.1016/S0140-6736(95)92339-X; LIP GYH, 1995, BRIT HEART J, V73, P527; Lip GYH, 1996, CIRCULATION, V94, P425, DOI 10.1161/01.CIR.94.3.425; Lip GYH, 1996, AM HEART J, V131, P724, DOI 10.1016/S0002-8703(96)90278-1; Little J, 2002, AM J EPIDEMIOL, V156, P300, DOI 10.1093/oxfordjournals.aje.a000179; Liu T, 2007, J AM COLL CARDIOL, V49, P1642, DOI 10.1016/j.jacc.2006.12.042; Marcus GM, 2008, AM HEART J, V155, P303, DOI 10.1016/j.ahj.2007.09.006; Marin F, 2003, THROMB RES, V109, P233, DOI 10.1016/S0049-3848(03)00259-7; Marin F, 2003, STROKE, V34, P1181, DOI 10.1161/01.STR.0000065431.76788.D9; Marin F, 1999, AM J CARDIOL, V84, P862, DOI 10.1016/S0002-9149(99)00453-1; Marin V, 2004, HEART, V90, P1162, DOI 10.1136/hrt.2003.024521; Minamino T, 1997, ARTERIOSCL THROM VAS, V17, P3191, DOI 10.1161/01.ATV.17.11.3191; Minamino T, 1999, AM J CARDIOL, V83, P194, DOI 10.1016/S0002-9149(98)00823-6; Mitusch R, 1996, THROMB HAEMOSTASIS, V75, P219; Mondillo S, 2000, INT J CARDIOL, V75, P227, DOI 10.1016/S0167-5273(00)00336-3; NAGAO T, 1995, STROKE, V26, P1365, DOI 10.1161/01.STR.26.8.1365; Roldan V, 2005, AM J CARDIOL, V95, P881, DOI 10.1016/j.amjcard.2004.12.016; Roldan V, 1998, AM HEART J, V136, P956, DOI 10.1016/S0002-8703(98)70149-8; Roldan V, 2011, J AM COLL CARDIOL, V57, P2496, DOI 10.1016/j.jacc.2010.12.033; Schnabel RB, 2010, CIRCULATION, V121, P200, DOI 10.1161/CIRCULATIONAHA.109.882241; Shiroshita-Takeshita A, 2005, J INTERV CARD ELECTR, V13, P181, DOI 10.1007/s10840-005-2362-y; Sohara H, 1997, J AM COLL CARDIOL, V29, P106, DOI 10.1016/S0735-1097(96)00427-5; SOHARA H, 1994, JPN CIRC J, V58, P821, DOI 10.1253/jcj.58.821; Targonski R, 2008, KARDIOL POL, V66, P729; Thompson SG, 1999, STAT MED, V18, P2693, DOI 10.1002/(SICI)1097-0258(19991030)18:20<2693::AID-SIM235>3.0.CO;2-V; Topaloglu S, 2007, ANGIOLOGY, V58, P85, DOI 10.1177/0003319706297917; Topcuoglu MA, 2000, NEUROL SCI, V21, P235, DOI 10.1007/s100720070082; Tsai LM, 1998, AM J CARDIOL, V81, P1249, DOI 10.1016/S0002-9149(98)00131-3; Turgut N, 2006, CLIN APPL THROMB-HEM, V12, P15, DOI 10.1177/107602960601200104; Turgut O, 2013, PLATELETS, V24, P493, DOI 10.3109/09537104.2012.725876; Vene N, 2003, THROMB HAEMOSTASIS, V90, P1163, DOI 10.1160/TH03-06-0363; Wang TD, 2001, J CARDIOVASC ELECTR, V12, P877, DOI 10.1046/j.1540-8167.2001.00877.x; Watson T, 2009, LANCET, V373, P155, DOI 10.1016/S0140-6736(09)60040-4; Wells GASB, 2011, THE NEWCASTLE OTTAWA; Wu N, 2013, INT J CARDIOL, V169, P62, DOI 10.1016/j.ijcard.2013.08.078; YAMAUCHI K, 1986, JPN HEART J, V27, P481; Yip HK, 2006, INT HEART J, V47, P371, DOI 10.1536/ihj.47.371; Zorlu A, 2012, J THROMB THROMBOLYS, V33, P343, DOI 10.1007/s11239-011-0656-8	83	29	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124716	10.1371/journal.pone.0124716	http://dx.doi.org/10.1371/journal.pone.0124716			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884835	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000141
J	Zhe, C; Yu, F; Tian, J; Zheng, SG				Zhe, Cheng; Yu, Fan; Tian, Ju; Zheng, Shuguo			Trps1 Regulates Biliary Epithelial-Mesenchymal Transition and Has Roles during Biliary Fibrosis in Liver Grafts: A Preliminary Study	PLOS ONE			English	Article							COLD PRESERVATION; CANCER; TRANSPLANTATION; EXPRESSION; CELLS; DIFFERENTIATION; FIBROGENESIS; MECHANISMS; ISCHEMIA; KIDNEY	Objectives To investigate the role(s) of Trps1 in non-anastomotic biliary stricture (NABS) following liver transplantation. Methods Immunohistochemical and histological techniques were used to detect Trps1, E-cadherin, CK19, vimentin, alpha-SMA, and collagen deposition. Human intrahepatic biliary epithelial cells (HIBECs) were infected with a Trps1 adenovirus, or transfected with Trps1 short-interfering RNAs (siRNAs). Reverse transcription polymerase chain reaction (RT-PCR) assays and western blotting were used to determine expression levels of epithelial and mesenchymal markers, and Trps1 in HIBECs. Results Expression of Trps1 and epithelial markers was down-regulated or absent in NABS liver samples. Mesenchymal markers were seen in biliary epithelial cells (BECs), with collagen deposited around the bile duct. Trps1 expression positively correlated with epithelial markers. Expression of epithelial marker mRNAs and proteins in HIBECs decreased with prolonged cold preservation (CP), while mesenchymal marker expression increased. A 12-h CP period led to increased Trps1 mRNA and protein levels. Expression of E-cadherin was increased in HIBECs following Trps1 adenovirus infection and CP/reperfusion injury (CPRI), with vimentin expression levels reduced and CPRI-mediated epithelial-mesenchymal transition (EMT) inhibited. Transfection of HIBECs with Trps1 siRNAs in conjunction with CPRI revealed that E-cadherin expression was decreased, vimentin expression was increased, and CPRI-mediated EMT was promoted. Conclusion Trps1 is involved in NABS pathogenesis following liver transplantation and negatively correlates with BEC EMT and biliary fibrosis in liver grafts. Trps1 demonstrates antagonistic effects that could reverse EMT.	[Zhe, Cheng; Yu, Fan; Tian, Ju; Zheng, Shuguo] Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, Chongqing 400038, Peoples R China	Army Medical University	Zheng, SG (corresponding author), Third Mil Med Univ, Inst Hepatobiliary Surg, Southwest Hosp, 29 Gaotanyan Rd, Chongqing 400038, Peoples R China.	shuguozh@gmail.com			National Science Foundation of China [30972948]	National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Science Foundation of China (No: 30972948).	Chen Jie Qing, 2011, Hormones & Cancer, V2, P132, DOI 10.1007/s12672-011-0067-5; Dooley S, 2008, GASTROENTEROLOGY, V135, P642, DOI 10.1053/j.gastro.2008.04.038; Gai ZB, 2011, HISTOL HISTOPATHOL, V26, P915, DOI 10.14670/HH-26.915; Gai ZB, 2010, J AM SOC NEPHROL, V21, P1468, DOI 10.1681/ASN.2009121201; Gai ZB, 2009, J AM SOC NEPHROL, V20, P2403, DOI 10.1681/ASN.2008091020; Hong J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/454085; Huang Kun, 2012, J 3 MILITARY MED U, V34, P1158; Huang WY, 2009, J BIOL CHEM, V284, P9426, DOI 10.1074/jbc.M900039200; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Liang H, 2012, GENOME RES, V22, P2120, DOI 10.1101/gr.137596.112; Lin VC, 2014, ARCH TOXICOL, V88, P901, DOI 10.1007/s00204-014-1196-8; Liu XW, 2012, HEPATOL RES, V42, P1024, DOI 10.1111/j.1872-034X.2012.01011.x; Malik TH, 2002, MOL CELL BIOL, V22, P8592, DOI 10.1128/MCB.22.24.8592-8600.2002; Malik TH, 2001, EMBO J, V20, P1715, DOI 10.1093/emboj/20.7.1715; Park JB, 2008, TRANSPLANTATION, V86, P1536, DOI 10.1097/TP.0b013e31818b2316; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Que XY, 2004, J SURG RES, V116, P262, DOI 10.1016/j.jss.2003.07.005; Rauen U, 1997, FREE RADICAL BIO MED, V23, P392, DOI 10.1016/S0891-5849(96)00618-1; Robertson H, 2007, HEPATOLOGY, V45, P977, DOI 10.1002/hep.21624; Rygiel KA, 2008, LAB INVEST, V88, P112, DOI 10.1038/labinvest.3700704; SANCHEZURDAZPAL L, 1992, HEPATOLOGY, V16, P49, DOI 10.1002/hep.1840160110; Stinson S, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002258; Su AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071309; Wendt MK, 2012, CELL TISSUE RES, V347, P85, DOI 10.1007/s00441-011-1199-1; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Yanagita M, 2012, NEPHROL DIAL TRANSPL, V27, P3686, DOI 10.1093/ndt/gfs381; Zhao LJ, 2011, J SURG RES, V171, P819, DOI 10.1016/j.jss.2010.04.059; Zheng S, 2008, TRANSPL P, V40, P1629, DOI 10.1016/j.transproceed.2008.01.072	29	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123233	10.1371/journal.pone.0123233	http://dx.doi.org/10.1371/journal.pone.0123233			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886207	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000051
J	de Melo, SCCS; Gavena, AAF; Silva, FTR; Moreira, RC; Scodro, RBD; Cardoso, RF; Siqueira, VLD; de Padua, RAF; Carvalho, MDD; Pelloso, SM				Castanho Sabaini de Melo, Simone Cristina; Franca Gavena, Angela Andreia; Ribeiro Silva, Flavia Teixeira; Moreira, Ricardo Castanho; de Lima Scodro, Regiane Bertin; Cardoso, Rosilene Fressatti; Dias Siqueira, Vera Lucia; Faleiros de Padua, Rubia Andreia; de Barros Carvalho, Maria Dalva; Pelloso, Sandra Marisa			Performance of Hitchens-Pike-Todd-Hewitt Medium for Group B Streptococcus Screening in Pregnant Women	PLOS ONE			English	Article							DISEASE; PREVENTION; AGALACTIAE; PCR	Group B streptococcus (GBS), which commonly colonizes the female genital tract and rectum, can cause infections in newborns with varying severity, possibly leading to death. The aim of the present study was to evaluate Hitchens-Pike-Todd-Hewitt (HPTH) medium performance for GBS screening in pregnant women. A descriptive analytical cross-sectional study was performed with 556 pregnant women, of which 496 were at 35-37 weeks of gestation and 60 were at >= 38 weeks of gestation. The study was conducted from September 2011 to March 2014 in northern Parana, Brazil. Vaginal and anorectal clinical specimens from each pregnant woman were plated on sheep blood agar (SBA) and seeded on HPTH medium and Todd-Hewitt enrichment broth. Of the 496 pregnant women at 35-37 weeks of gestation, 141 (28.4%) were positive for GBS, based on the combination of the three culture media and clinical specimens. The GBS colonization rates that were detected by each medium were 22.2% for HPTH medium, 21.2% for SBA, and 13.1% for Todd-Hewitt enrichment broth. Of the 60 pregnant women at >= 38 weeks of gestation, seven (11.7%) were positive for GBS. These results demonstrate that HPTH medium and SBA were more sensitive than Todd-Hewitt enrichment broth for GBS screening in pregnant women and good GBS recovery in culture, indicating that the two media should be used together for vaginal and anorectal specimens.	[Castanho Sabaini de Melo, Simone Cristina; Franca Gavena, Angela Andreia; Pelloso, Sandra Marisa] Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil; [Castanho Sabaini de Melo, Simone Cristina; Ribeiro Silva, Flavia Teixeira; Moreira, Ricardo Castanho] State Univ Northern Parana, Nursing Sect, Bandeirantes, Parana, Brazil; [de Lima Scodro, Regiane Bertin; Cardoso, Rosilene Fressatti; Dias Siqueira, Vera Lucia; Faleiros de Padua, Rubia Andreia] Univ Estadual Maringa, Dept Clin Anal & Biomed, Maringa, Parana, Brazil; [de Barros Carvalho, Maria Dalva] Univ Estadual Maringa, Dept Med, Maringa, Parana, Brazil; [Pelloso, Sandra Marisa] Univ Estadual Maringa, Dept Nursing, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual do Norte do Parana (UENP); Universidade Estadual de Maringa; Universidade Estadual de Maringa; Universidade Estadual de Maringa	de Melo, SCCS (corresponding author), Univ Estadual Maringa, Postgrad Program Hlth Sci, Maringa, Parana, Brazil.	simonecastanho@uenp.edu.br	Carvalho, Maria Dalva/AAK-8411-2021; Cardoso, Rosilene Fressatti/AAX-9166-2021; Cardoso, Rosilene F/J-4796-2015; de Lima Scodro, Regiane Bertin/Y-9234-2019	Carvalho, Maria Dalva/0000-0002-1377-3331; Cardoso, Rosilene Fressatti/0000-0001-6228-4780; Cardoso, Rosilene F/0000-0001-6228-4780; de Lima Scodro, Regiane Bertin/0000-0002-9129-2445				Cortes JIA, 2013, ENFERM INFEC MICR CL, V31, P159, DOI 10.1016/j.eimc.2012.03.013; [Anonymous], 2013, C D REV ELETRONICA F; Beraldo Cláudio, 2004, Rev. Bras. Ginecol. Obstet., V26, P543, DOI 10.1590/S0100-72032004000700006; Berg BR, 2013, J CLIN MICROBIOL, V51, P1253, DOI 10.1128/JCM.02780-12; Chaves Jr M, 2007, THESIS STATE U MARIN; Chaves M, 2010, J CLIN LAB ANAL, V24, P403, DOI 10.1002/jcla.20419; Choi SJ, 2012, ANN LAB MED, V32, P194, DOI 10.3343/alm.2012.32.3.194; Dagnew AF, 2012, CLIN INFECT DIS, V55, P91, DOI 10.1093/cid/cis395; Feuerschuette OM, 2012, ARCH GYNECOL OBSTET, V286, P1437, DOI 10.1007/s00404-012-2498-9; Funcao JM, 2013, REV ESC ENFERM USP, V47, P22, DOI 10.1590/S0080-62342013000100003; Hamedi Abdolkarim, 2012, Acta Med Iran, V50, P805; Kiss FS, 2013, SCI MED, V23, P169; Melin P, 2011, CLIN MICROBIOL INFEC, V17, P1294, DOI 10.1111/j.1469-0691.2011.03576.x; Mocelin CO, 1995, REV BRAS GINECOL OBS, V105, P915; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Verhoeven PO, 2014, J CLIN MICROBIOL, V52, P991, DOI 10.1128/JCM.02926-13	16	2	2	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123988	10.1371/journal.pone.0123988	http://dx.doi.org/10.1371/journal.pone.0123988			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881083	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500075
J	Tavares, R; Pathak, SK				Tavares, Raquel; Pathak, Sushil Kumar			Helicobacter pylori Protein JHP0290 Exhibits Proliferative and Anti-Apoptotic Effects in Gastric Epithelial Cells	PLOS ONE			English	Article							CANCER; MUCOSA; CYCLE; PHOSPHORYLATION; PROGRESSION; ACTIVATION; EXPRESSION; INFECTION; TURNOVER; KINETICS	The influence of Helicobacter pylori infection on gastric epithelial cell proliferation, apoptosis and signaling pathways contributes to the development of infection-associated diseases. Here we report that JHP0290, which is a poorly functionally characterized protein from H. pylori, regulates multiple responses in human gastric epithelial cells. The differential expression and release of JHP0290 homologues was observed among H. pylori strains. JHP0290 existed in monomeric and dimeric forms in H. pylori cell extracts and culture broth. Recombinant purified JHP0290 (rJHP0290) also showed monomeric and dimeric forms, whereas the rJHP0290 C162A mutant exhibited only a monomeric form. The dimeric form of the protein was found to bind more efficiently to gastric epithelial cells than the monomeric form. The exposure of gastric epithelial cells to rJHP0290 induced proliferation in a dose-dependent manner. Faster progression into the cell cycle was observed in rJHP0290-challenged gastric epithelial cells. Furthermore, we detected an anti-apoptotic effect of rJHP0290 in gastric epithelial cells when the cells were treated with rJHP0290 in combination with Camptothecin (CPT), which is an inducer of apoptosis. CPT-induced caspase 3 activation was significantly reduced in the presence of rJHP0290. In addition, the activation of ERK MAPK and the transcription factor NF kappa B was observed in rJHP0290-challenged gastric epithelial cells lines. Our results suggest that JHP0290 may affect H. pylori-induced gastric diseases via the regulation of gastric epithelial cell proliferation and anti-apoptotic pathways.	[Tavares, Raquel; Pathak, Sushil Kumar] Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden	Stockholm University	Pathak, SK (corresponding author), Stockholm Univ, Dept Mol Biosci, Wenner Gren Inst, S-10691 Stockholm, Sweden.	sushil.pathak@su.se			Swedish Research Council; Ake Wiberg Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wiberg Foundation	This work was supported by the Swedish Research Council (www.vr.se) and the Ake Wiberg Foundation (http://www.ake-wiberg.com). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A, 2000, MICROBES INFECT, V2, P1159, DOI 10.1016/S1286-4579(00)01270-3; Anti M, 1998, GUT, V43, pS27, DOI 10.1136/gut.43.2008.S27; Basak C, 2005, J IMMUNOL, V174, P5672, DOI 10.4049/jimmunol.174.9.5672; Basmarke-Wehelie R, 2011, GASTROENTEROLOGY, V141, P918, DOI 10.1053/j.gastro.2011.05.009; Cahill RJ, 1996, GUT, V38, P177, DOI 10.1136/gut.38.2.177; Chaturvedi MM, 2011, ONCOGENE, V30, P1615, DOI 10.1038/onc.2010.566; Chen YC, 2006, WORLD J GASTROENTERO, V12, P5972, DOI 10.3748/wjg.v12.i37.5972; Correa P, 1997, J NATL CANCER I, V89, P836, DOI 10.1093/jnci/89.12.836; Correa P, 1998, BRIT MED BULL, V54, P151; De Luca A, 2003, CANCER RES, V63, P6350; Devi S, 2014, HELICOBACTER, V19, P26, DOI 10.1111/hel.12100; Ding SZ, 2008, J GASTROEN HEPATOL, V23, pE67, DOI 10.1111/j.1440-1746.2007.04912.x; Epplein M, 2013, CANCER EPIDEM BIOMAR, V22, P1964, DOI 10.1158/1055-9965.EPI-13-0702; Epplein M, 2012, CANCER EPIDEM BIOMAR, V21, P2185, DOI 10.1158/1055-9965.EPI-12-0792-T; Fan XG, 1996, GUT, V38, P19, DOI 10.1136/gut.38.1.19; Haas G, 2002, PROTEOMICS, V2, P313, DOI 10.1002/1615-9861(200203)2:3<313::AID-PROT313>3.0.CO;2-7; Hennig EE, 2004, INFECT IMMUN, V72, P3429, DOI 10.1128/IAI.72.6.3429-3435.2004; Hirata Y, 2001, INFECT IMMUN, V69, P3965, DOI 10.1128/IAI.69.6.3965-3971.2001; Holck S, 2007, FEMS IMMUNOL MED MIC, V50, P206, DOI 10.1111/j.1574-695X.2007.00254.x; Jang TJ, 2000, J GASTROENTEROL, V35, P265, DOI 10.1007/s005350050344; Jones NL, 1997, AM J PATHOL, V151, P1695; Kalali B, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/426309; Kang D, 2013, HELICOBACTER, V18, P347, DOI 10.1111/hel.12057; Kim N, 2002, J BACTERIOL, V184, P6155, DOI 10.1128/JB.184.22.6155-6162.2002; Lamb A, 2013, J CELL BIOCHEM, V114, P491, DOI 10.1002/jcb.24389; Lamb A, 2010, GUT MICROBES, V1, P109, DOI 10.4161/gmic.1.2.11587; LYNCH DAF, 1995, GUT, V36, P346, DOI 10.1136/gut.36.3.346; Maeda S, 2002, J CLIN PATHOL-MOL PA, V55, P286, DOI 10.1136/mp.55.5.286; Maeda S, 2002, GUT, V50, P771, DOI 10.1136/gut.50.6.771; Masato S, 2009, CELL HOST MICROBE; Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005; Nagy TA, 2009, J INFECT DIS, V199, P641, DOI 10.1086/596660; Nozawa Y, 2002, BIOCHEM PHARMACOL, V64, P21, DOI 10.1016/S0006-2952(02)01030-4; Oldani A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000603; Pathak SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077872; Peek RM, 1999, CANCER RES, V59, P6124; Peek RM, 1997, JNCI-J NATL CANCER I, V89, P863, DOI 10.1093/jnci/89.12.863; Shibata W, 2010, GASTROENTEROLOGY, V138, P1022, DOI 10.1053/j.gastro.2009.11.054; Shiotani A, 2005, J GASTROENTEROL, V40, P337, DOI 10.1007/s00535-004-1549-9; Shirin H, 1999, CANCER RES, V59, P2277; Smith MF, 2003, J BIOL CHEM, V278, P32552, DOI 10.1074/jbc.M305536200; Sommi P, 2002, EXP CELL RES, V281, P128, DOI 10.1006/excr.2002.5629; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Suganuma M, 2005, J CANCER RES CLIN, V131, P305, DOI 10.1007/s00432-004-0652-x; Sugiyama Toshiro, 2004, Medical Electron Microscopy, V37, P149; Suzuki M, 2009, CELL HOST MICROBE, V5, P23, DOI 10.1016/j.chom.2008.11.010; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Wroblewski LE, 2010, CLIN MICROBIOL REV, V23, P713, DOI 10.1128/CMR.00011-10; Yanai A, 2003, J INFECT DIS, V188, P1741, DOI 10.1086/379629; Yokota S, 2010, INFECT IMMUN, V78, P468, DOI 10.1128/IAI.00903-09	50	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124407	10.1371/journal.pone.0124407	http://dx.doi.org/10.1371/journal.pone.0124407			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879227	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500099
J	Rodriguez-Ramilo, ST; Fernandez, J; Toro, MA; Hernandez, D; Villanueva, B				Teresa Rodriguez-Ramilo, Silvia; Fernandez, Jesus; Angel Toro, Miguel; Hernandez, Delfino; Villanueva, Beatriz			Genome-Wide Estimates of Coancestry, Inbreeding and Effective Population Size in the Spanish Holstein Population	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; SELECTION; PEDIGREE; CATTLE; PREDICTION; INFORMATION; DEFICIENCY; DEPRESSION; STRATEGIES; DIVERSITY	Estimates of effective population size in the Holstein cattle breed have usually been low despite the large number of animals that constitute this breed. Effective population size is inversely related to the rates at which coancestry and inbreeding increase and these rates have been high as a consequence of intense and accurate selection. Traditionally, coancestry and inbreeding coefficients have been calculated from pedigree data. However, the development of genome-wide single nucleotide polymorphisms has increased the interest of calculating these coefficients from molecular data in order to improve their accuracy. In this study, genomic estimates of coancestry, inbreeding and effective population size were obtained in the Spanish Holstein population and then compared with pedigree-based estimates. A total of 11,135 animals genotyped with the Illumina BovineSNP50 BeadChip were available for the study. After applying filtering criteria, the final genomic dataset included 36,693 autosomal SNPs and 10,569 animals. Pedigree data from those genotyped animals included 31,203 animals. These individuals represented only the last five generations in order to homogenise the amount of pedigree information across animals. Genomic estimates of coancestry and inbreeding were obtained from identity by descent segments (coancestry) or runs of homozygosity (inbreeding). The results indicate that the percentage of variance of pedigree-based coancestry estimates explained by genomic coancestry estimates was higher than that for inbreeding. Estimates of effective population size obtained from genome-wide and pedigree information were consistent and ranged from about 66 to 79. These low values emphasize the need of controlling the rate of increase of coancestry and inbreeding in Holstein selection programmes.	[Teresa Rodriguez-Ramilo, Silvia; Fernandez, Jesus; Villanueva, Beatriz] INIA, Dept Mejora Genet Anim, Madrid, Spain; [Angel Toro, Miguel] Escuela Tecn Super Ingenieros Agonomos, Dept Anim Prod, Madrid, Spain; [Hernandez, Delfino] Dept Tecnico Conafe, Madrid, Spain		Rodriguez-Ramilo, ST (corresponding author), INIA, Dept Mejora Genet Anim, Madrid, Spain.	rodriguez.silvia@inia.es	Ramilo, Silvia Teresa Rodriguez/AAC-2843-2021; Toro, Miguel Angel Angel/H-9370-2015; Toro, Miguel Angel/AAA-1309-2019; Fernandez, Jesus/H-4894-2015	Ramilo, Silvia Teresa Rodriguez/0000-0001-7150-0692; Toro, Miguel Angel Angel/0000-0001-7460-2483; Toro, Miguel Angel/0000-0001-7460-2483; Fernandez, Jesus/0000-0001-8269-1893	Ministerio de Economia y Competitividad, Spain [CGL2012-39861-C02-02]	Ministerio de Economia y Competitividad, Spain	This study was supported by the Ministerio de Economia y Competitividad, Spain (grant CGL2012-39861-C02-02).	Avendano S, 2003, J ANIM SCI, V81, P2964; Bjelland DW, 2013, J DAIRY SCI, V96, P4697, DOI 10.3168/jds.2012-6435; Boichard D, 2002, P 7 WORLD C GEN APPL; Brotherstone S, 2005, PHILOS T R SOC B, V360, P1479, DOI 10.1098/rstb.2005.1668; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; CABALLERO A, 1994, HEREDITY, V73, P657, DOI 10.1038/hdy.1994.174; Charlier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043085; Daetwyler HD, 2007, J ANIM BREED GENET, V124, P369, DOI 10.1111/j.1439-0388.2007.00693.x; de Roos APW, 2011, J DAIRY SCI, V94, P1559, DOI 10.3168/jds.2010-3354; Falconer D. S., 1996, INTRO QUANTITATIVE G; Ferencakovic M, 2013, J ANIM BREED GENET, V130, P286, DOI 10.1111/jbg.12012; Ferencakovic M, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-42; Forni S, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-1; Gomez-Romano F, 2014, P 10 WORLD C GEN APP; Gomez-Romano F, 2013, GENET SEL EVOL, V45, DOI 10.1186/1297-9686-45-38; Gonzalez-Recio O, 2007, J DAIRY SCI, V90, P5744, DOI 10.3168/jds.2007-0203; Grundy B, 1998, GENET RES, V72, P159, DOI 10.1017/S0016672398003474; Gutierrez JP, 2005, J ANIM BREED GENET, V122, P172, DOI 10.1111/j.1439-0388.2005.00512.x; Hayes BJ, 2003, GENOME RES, V13, P635, DOI 10.1101/gr.387103; Hill WG, 2010, PHILOS T R SOC B, V365, P73, DOI 10.1098/rstb.2009.0203; Kearney JF, 2004, J DAIRY SCI, V87, P3503, DOI 10.3168/jds.S0022-0302(04)73485-2; KEHRLI ME, 1990, AM J VET RES, V51, P1826; Keller MC, 2011, GENETICS, V189, P237, DOI 10.1534/genetics.111.130922; Li MH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026256; Luan T, 2014, GENET SEL EVOL, V46, DOI 10.1186/s12711-014-0064-6; Lund MS, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-43; MacLeod I. M., 2013, Proceedings of the Twentieth Conference of the Association for the Advancement of Animal Breeding and Genetics, Translating Science into Action, Napier, New Zealand, 20th-23rd October 2013, P215; Malecot G., 1948, MATH HEREDITE; Meuwissen THE, 2011, J ANIM BREED GENET, V128, P429, DOI 10.1111/j.1439-0388.2011.00966.x; MEUWISSEN THE, 1992, GENET SEL EVOL, V24, P305, DOI 10.1051/gse:19920402; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Meuwissen THE, 2001, GENETICS, V157, P1819; Miglior F., 2008, PHENOTYPIC ANAL INBR; Pryce JE, 2012, J DAIRY SCI, V95, P377, DOI 10.3168/jds.2011-4254; Purfield DC, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-70; de Cara MAR, 2013, MOL ECOL, V22, P6091, DOI 10.1111/mec.12560; Rodriguez-Ramilo ST, 2007, AQUACULTURE, V273, P434, DOI 10.1016/j.aquaculture.2007.10.036; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Saura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078314; Schaeffer LR, 2006, J ANIM BREED GENET, V123, P218, DOI 10.1111/j.1439-0388.2006.00595.x; Schutz E, 2008, J DAIRY SCI, V91, P4854, DOI 10.3168/jds.2008-1154; SHANKS RD, 1984, J HERED, V75, P337, DOI 10.1093/oxfordjournals.jhered.a109951; Silio L, 2013, J ANIM BREED GENET, V130, P349, DOI 10.1111/jbg.12031; Sonesson AK, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-27; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Su G, 2012, J DAIRY SCI, V95, P4657, DOI 10.3168/jds.2012-5379; Sun C, 2013, J DAIRY SCI, V96, P8014, DOI 10.3168/jds.2013-6969; Rodriguez-Ramilo ST, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093424; Toro M, 2002, CONSERV GENET, V3, P309, DOI 10.1023/A:1019921131171; Toro MA, 2014, LIVEST SCI, V166, P48, DOI 10.1016/j.livsci.2014.04.020; Toro MA, 2011, GENET SEL EVOL, V43, DOI 10.1186/1297-9686-43-27; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2011, J DAIRY SCI, V94, P5673, DOI 10.3168/jds.2011-4500; VanRaden PM., 2007, INTERBULL B, V37, P33; Weigel K. A., 2001, Journal of Dairy Science, V84, pE177, DOI 10.3168/jds.S0022-0302(01)70213-5; Weigel KA, 2002, J DAIRY SCI, V85, P2376, DOI 10.3168/jds.S0022-0302(02)74318-X; Wiggans GR, 2011, J DAIRY SCI, V94, P3202, DOI 10.3168/jds.2010-3866; Zimin AV, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r42	58	34	34	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124157	10.1371/journal.pone.0124157	http://dx.doi.org/10.1371/journal.pone.0124157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880228	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000353016500087
J	Wakasa, K; Kawabata, R; Nakao, S; Hattori, H; Taguchi, K; Uchida, J; Yamanaka, T; Maehara, Y; Fukushima, M; Oda, S				Wakasa, Kentaro; Kawabata, Rumi; Nakao, Seiki; Hattori, Hiroyoshi; Taguchi, Kenichi; Uchida, Junji; Yamanaka, Takeharu; Maehara, Yoshihiko; Fukushima, Masakazu; Oda, Shinya			Dynamic Modulation of Thymidylate Synthase Gene Expression and Fluorouracil Sensitivity in Human Colorectal Cancer Cells	PLOS ONE			English	Article							DIHYDROPYRIMIDINE DEHYDROGENASE; MAMMALIAN-CELLS; 5-FLUOROURACIL; LINES; INHIBITION; SYNTHETASE; MECHANISM; RESISTANT	Biomarkers have revolutionized cancer chemotherapy. However, many biomarker candidates are still in debate. In addition to clinical studies, a priori experimental approaches are needed. Thymidylate synthase (TS) expression is a long-standing candidate as a biomarker for 5-fluorouracil (5-FU) treatment of cancer patients. Using the Tet-OFF system and a human colorectal cancer cell line, DLD-1, we first constructed an in vitro system in which TS expression is dynamically controllable. Quantitative assays have elucidated that TS expression in the transformant was widely modulated, and that the dynamic range covered 15-fold of the basal level. 5-FU sensitivity of the transformant cells significantly increased in response to downregulated TS expression, although being not examined in the full dynamic range because of the doxycycline toxicity. Intriguingly, our in vitro data suggest that there is a linear relationship between TS expression and the 5-FU sensitivity in cells. Data obtained in a mouse model using transformant xenografts were highly parallel to those obtained in vitro. Thus, our in vitro and in vivo observations suggest that TS expression is a determinant of 5-FU sensitivity in cells, at least in this specific genetic background, and, therefore, support the possibility of TS expression as a biomarker for 5-FU-based cancer chemotherapy.	[Wakasa, Kentaro; Nakao, Seiki; Taguchi, Kenichi; Fukushima, Masakazu; Oda, Shinya] Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan; [Kawabata, Rumi; Uchida, Junji] Taiho Pharmaceut Co Ltd, Tokushima Res Ctr, Tokushima, Japan; [Hattori, Hiroyoshi] Nagoya Med Ctr, Clin Res Ctr, Nagoya, Aichi, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; [Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Taiho Pharmaceutical; Nagoya Medical Center; Yokohama City University; Kyushu University	Wakasa, K (corresponding author), Kyushu Natl Canc Ctr, Clin Res Inst, Fukuoka, Japan.	soda@nk-cc.go.jp			Ministry of Health, Labour and Welfare; Ministry of Education, Science, Sports and Culture of Japan; Taiho Pharmaceutical Co., Ltd.	Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Taiho Pharmaceutical Co., Ltd.	This study was funded by grants from the Ministry of Health, Labour and Welfare and the Ministry of Education, Science, Sports and Culture of Japan and also partly supported by the Taiho Pharmaceutical Co., Ltd. (SO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript, except that the in vivo experiments were done in the laboratories of the Taiho Pharmaceutical Co., Ltd. Co-authors RK and JU are employed by Taiho Pharmaceutical Co., Ltd. Taiho Pharmaceutical Co., Ltd. provided support in the form of salaries for authors RK and JU and in vivo experiments were done in the laboratories of the Taiho Pharmaceutical Co., Ltd., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	AYUSAWA D, 1984, J BIOL CHEM, V259, P4361; Bissoon-Haqqani S, 2006, J HISTOCHEM CYTOCHEM, V54, P19, DOI 10.1369/jhc.5A6642.2005; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burcin Mark M., 1998, Frontiers in Bioscience, V3, pC1; Ciaparrone M, 2006, ONCOLOGY-BASEL, V70, P366, DOI 10.1159/000098110; DUNLAP RB, 1971, BIOCHEMISTRY-US, V10, P88, DOI 10.1021/bi00777a014; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; GOSSEN M, 1995, SCIENCE, V268, P1766, DOI 10.1126/science.7792603; Grem JL, 2001, CLIN CANCER RES, V7, P999; Koci L, 2012, ONCOL LETT, V3, P913, DOI 10.3892/ol.2012.593; Koopman M, 2009, EUR J CANCER, V45, P1935, DOI 10.1016/j.ejca.2009.04.023; KOZAK M, 1987, MOL CELL BIOL, V7, P3438, DOI 10.1128/MCB.7.10.3438; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Longley DB, 2001, CLIN CANCER RES, V7, P3533; Morris EJ, 2006, PLOS GENET, V2, P1834, DOI 10.1371/journal.pgen.0020196; NEWMAN EM, 1988, BIOCHEM PHARMACOL, V37, P443, DOI 10.1016/0006-2952(88)90212-2; Okabe H, 2000, INT J MOL MED, V5, P133; Schiffer CA, 1995, BIOCHEMISTRY-US, V34, P16279, DOI 10.1021/bi00050a007; Shirasaka T, 1996, ANTI-CANCER DRUG, V7, P548, DOI 10.1097/00001813-199607000-00010; SPEARS CP, 1982, CANCER RES, V42, P450; Sprowl JA, 2012, DRUG RESIST UPDATE, V15, P5, DOI 10.1016/j.drup.2012.01.009; Tokunaga E, 2000, EUR J CANCER, V36, P1998, DOI 10.1016/S0959-8049(00)00200-8; YOSHIOKA A, 1987, J BIOL CHEM, V262, P8235	23	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123076	10.1371/journal.pone.0123076	http://dx.doi.org/10.1371/journal.pone.0123076			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881233	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500037
J	Kozica, S; Lombard, C; Teede, H; Ilic, D; Murphy, K; Harrison, C				Kozica, Samantha; Lombard, Catherine; Teede, Helena; Ilic, Dragan; Murphy, Kerry; Harrison, Cheryce			Initiating and Continuing Behaviour Change within a Weight Gain Prevention Trial: A Qualitative Investigation	PLOS ONE			English	Article							PRETREATMENT PREDICTORS; OBESITY; INTERVENTIONS; MAINTENANCE; MANAGEMENT; PROGRAMS; EFFICACY; WOMEN	Background Preventing obesity is an international health priority. In Australia, young women who live in rural communities are at high risk of unhealthy weight gain. Interventions which engage young women and support sustainable behaviour change are needed and comprehensive evaluation of such interventions generates knowledge for population scale-up. This qualitative sub-study aims to identify enablers and barriers to behaviour change initiation and continuation within a community weight gain prevention program. Methods In-depth semi-structured interviews were conducted with program participants 6 months after baseline. All interviews were audio-taped and transcribed verbatim. Transcripts were analysed independently by two investigators via thematic analysis. Participants A total of 28 women with a mean age of 39.9 +/- 6.2years and a BMI of 28.6 +/- 5.2kg/m(2) were purposively recruited from the larger cohort (n = 649) that participated in the prevention trial. Results Four behaviour change groups emerged were identified from participant interviews: (i) no change, (ii) relapse, (iii) intermittent and (iv) continued change. Factors influencing behaviour change initiation and continuation included realistic program expectations and the participant's ability to apply the core program elements including: setting small, achievable behaviour change goals, problem solving and using self-management techniques. Personal knowledge, skills, motivation, self-efficacy, accountability and perceived social and environmental barriers also affected behaviour change. Satisfaction with personal program progress and the perceived amount of program supports required to achieve ongoing behaviour change varied amongst participants. Women who relapsed expressed a desire for more intensive and regular support from health professionals, identified more barriers unrelated to the program, anticipated significant weight loss and had lower satisfaction with their progress. Conclusion Initiating and continuing behaviour change is a complex process. Our findings elucidate that initiation and continuation of behaviour change in women undertaking a weight gain prevention program may be facilitated by accurate and realistic understanding of program expectation, the ability to apply the core program messages, higher internal motivation, self-efficacy and minimal social and environmental barriers.	[Kozica, Samantha; Lombard, Catherine; Teede, Helena; Harrison, Cheryce] Monash Univ, Sch Publ Hlth & Prevent Med, MCHRI, Clayton, Vic 3168, Australia; [Teede, Helena] Monash Hlth, Diabet & Vasc Med Unit, Clayton, Vic 3168, Australia; [Ilic, Dragan; Murphy, Kerry] Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia	Monash University; Monash University	Harrison, C (corresponding author), Monash Univ, Sch Publ Hlth & Prevent Med, MCHRI, Clayton, Vic 3168, Australia.	cheryce.harrison@monash.edu	Harrison, Cheryce/AAC-3675-2019; Ilic, Dragan/I-2437-2014	Harrison, Cheryce/0000-0002-3154-4946; Lombard, Catherine/0000-0001-9091-8090; Kozica-Olenski, Samantha/0000-0001-9116-0293; Ilic, Dragan/0000-0001-5127-9185; Teede, Helena/0000-0001-7609-577X	National Health and Medical Research Council (NMHRC) [1025249]	National Health and Medical Research Council (NMHRC)(National Health and Medical Research Council (NHMRC) of Australia)	This study is supported by a National Health and Medical Research Council (NMHRC) project grant (1025249). http://www.nhmrc.gov.au/.	[Anonymous], 2020, AUSTR HEALTH COUNTR; Australian Bureau of Statistics, 2011, SOC EC IND AR INF PA; Australian Institute of Health and Welfare, HLTH PRIOR AR; Backholer K, 2010, AM J PUBLIC HEALTH, V100, P2033, DOI 10.2105/AJPH.2010.200337; BANDURA A, 1986, J SOC CLIN PSYCHOL, V4, P359, DOI 10.1521/jscp.1986.4.3.359; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brown T, 2007, OBES REV, V8, P127, DOI 10.1111/j.1467-789X.2007.00331.x; Byrne S, 2003, INT J OBESITY, V27, P955, DOI 10.1038/sj.ijo.0802305; Deci E. L., 1985, SELF DETERMINATION; Elfhag K, 2005, OBES REV, V6, P67, DOI 10.1111/j.1467-789X.2005.00170.x; Glasgow RE, 1999, AM J PUBLIC HEALTH, V89, P1322, DOI 10.2105/AJPH.89.9.1322; Glasgow RE, 2001, PATIENT EDUC COUNS, V44, P119, DOI 10.1016/S0738-3991(00)00186-5; Glenny AM, 1997, INT J OBESITY, V21, P715, DOI 10.1038/sj.ijo.0800495; Hammarstrom A, 2014, BMC WOMENS HEALTH, V14, DOI 10.1186/1472-6874-14-59; Hardeman W, 2000, INT J OBESITY, P24; Jeffery RW, 1998, J CONSULT CLIN PSYCH, V66, P641, DOI 10.1037/0022-006X.66.4.641; King L, 2011, OBES REV, V12, P329, DOI 10.1111/j.1467-789X.2010.00798.x; Klem ML, 2000, INT J OBESITY, V24, P219, DOI 10.1038/sj.ijo.0801117; Kremers S, 2010, OBES REV, V11, P371, DOI 10.1111/j.1467-789X.2009.00598.x; Lemmens VEPP, 2008, OBES REV, V9, P446, DOI 10.1111/j.1467-789X.2008.00468.x; Lombard C, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c3215; Lombard CB, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-608; Lombard CB, 2009, PUBLIC HEALTH NUTR, V12, P2236, DOI 10.1017/S1368980009990577; Lutes LD, 2008, ANN BEHAV MED, V35, P351, DOI 10.1007/s12160-008-9033-z; Mathison, 2004, ENCY EVALUATION; Mycroft H, 2008, J HEALTH PSYCHOL, V13, P1040, DOI 10.1177/1359105308097969; Oldenburg B, 2011, TRANSL BEHAV MED, V1, P252, DOI 10.1007/s13142-011-0051-1; Pope C, 2000, BMJ-BRIT MED J, V320, P114, DOI 10.1136/bmj.320.7227.114; Ritchie LD, 2006, J AM DIET ASSOC, V106, P925, DOI 10.1016/j.jada.2006.03.001; Strauss A., 1990, BASICS QUALITATIVE R; Teixeira PJ, 2005, OBES REV, V6, P43, DOI 10.1111/j.1467-789X.2005.00166.x; Teixeira PJ, 2004, INT J OBESITY, V28, P1124, DOI 10.1038/sj.ijo.0802727; Thomas SL, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-34; Tsai AG, 2005, ANN INTERN MED, V142, P56, DOI 10.7326/0003-4819-142-1-200501040-00012; Wilson AM, 2010, PUBLIC HEALTH NUTR, V13, P1262, DOI 10.1017/S1368980009991807; Wing RR, 2001, DIABETES CARE, V24, P117, DOI 10.2337/diacare.24.1.117	36	17	17	4	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119773	10.1371/journal.pone.0119773	http://dx.doi.org/10.1371/journal.pone.0119773			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875943	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800008
J	Maity, J; Honcharenko, D; Stromberg, R				Maity, Jyotirmoy; Honcharenko, Dmytro; Stromberg, Roger			Synthesis of Triamino Acid Building Blocks with Different Lipophilicities	PLOS ONE			English	Article							SOLID-PHASE SYNTHESIS; ALPHA-AMINO ALDEHYDES; CYSTEINE; INHIBITORS; REDUCTION; BEARING; DESIGN	To obtain different amino acids with varying lipophilicity and that can carry up to three positive charges we have developed a number of new triamino acid building blocks. One set of building blocks was achieved by aminoethyl extension, via reductive amination, of the side chain of ortnithine, diaminopropanoic and diaminobutanoic acid. A second set of triamino acids with the aminoethyl extension having hydrocarbon side chains was synthesized from diaminobutanoic acid. The aldehydes needed for the extension by reductive amination were synthesized from the corresponding Fmoc-L-2-amino fatty acids in two steps. Reductive amination of these compounds with Boc-L-Dab-OH gave the C4-C8 alkyl-branched triamino acids. All triamino acids were subsequently Boc-protected at the formed secondary amine to make the monomers appropriate for the N-terminus position when performing Fmoc-based solid-phase peptide synthesis.	[Maity, Jyotirmoy; Honcharenko, Dmytro; Stromberg, Roger] Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden	Karolinska Institutet	Stromberg, R (corresponding author), Karolinska Inst, Dept Biosci & Nutr, Stockholm, Sweden.	Roger.Stromberg@ki.se			Swedish Research Council	Swedish Research Council(Swedish Research CouncilEuropean Commission)	We gratefully acknowledge financial support from the Swedish Research Council. We also thank Prof. Goran Widmalm and Wangchuk Rabten at Stockholm University for assistance with the polarimeter.	Bandyopadhyay A, 2010, ORG BIOMOL CHEM, V8, P4855, DOI 10.1039/c0ob00199f; Bhattacharya S, 2009, CHEM COMMUN, P4632, DOI 10.1039/b900666b; Bondebjerg J, 2002, J AM CHEM SOC, V124, P11046, DOI 10.1021/ja0123913; Brown ZZ, 2010, ORG LETT, V12, P1436, DOI 10.1021/ol100048g; Chhabra SR, 2002, J ORG CHEM, V67, P4017, DOI 10.1021/jo010456e; Chhabra SR, 1999, TETRAHEDRON LETT, V40, P4905, DOI 10.1016/S0040-4039(99)00909-0; Clausen JD, 2012, AMINO ACIDS, V43, P1633, DOI 10.1007/s00726-012-1239-5; Cochrane SA, 2014, J MED CHEM, V57, P1127, DOI 10.1021/jm401779d; Debaene F, 2004, TETRAHEDRON, V60, P8677, DOI 10.1016/j.tet.2004.05.107; Debaene F, 2007, TETRAHEDRON, V63, P6577, DOI 10.1016/j.tet.2007.03.033; FEHRENTZ JA, 1994, TETRAHEDRON LETT, V35, P9031, DOI 10.1016/0040-4039(94)88419-6; Flodin NW, 1997, J AM COLL NUTR, V16, P7, DOI 10.1080/07315724.1997.10718644; FUKUYAMA T, 1990, J AM CHEM SOC, V112, P7050, DOI 10.1021/ja00175a043; GRIFFITH RS, 1978, DERMATOLOGICA, V156, P257, DOI 10.1159/000250926; Gros L, 2006, J MED CHEM, V49, P6094, DOI 10.1021/jm060290f; HO PT, 1993, J ORG CHEM, V58, P2313, DOI 10.1021/jo00060a056; Honcharenko D, 2014, ORG BIOMOL CHEM, V12, P6684, DOI 10.1039/c4ob00959b; Lawton GR, 2004, J AM CHEM SOC, V126, P12762, DOI 10.1021/ja046436m; Lee JT, 2009, BIOORG MED CHEM LETT, V19, P5086, DOI 10.1016/j.bmcl.2009.07.045; Lehmann TJ, 2001, BIOORGAN MED CHEM, V9, P1827, DOI 10.1016/S0968-0896(01)00079-7; Liberska A, 2011, CHEM COMMUN, V47, P12774, DOI 10.1039/c1cc15805h; Liu XL, 2011, PHARM RES-DORDR, V28, P962, DOI 10.1007/s11095-010-0303-7; MACKELLAR C, 1992, NUCLEIC ACIDS RES, V20, P3411, DOI 10.1093/nar/20.13.3411; Maity J, 2014, MOLBANK, DOI 10.3390/M833; Mandal PK, 2009, J MED CHEM, V52, P6126, DOI 10.1021/jm901105k; MAREK M, 1970, COMP BIOCHEM PHYSIOL, V35, P737, DOI 10.1016/0010-406X(70)90992-8; Mariani R, 2005, BIOORG MED CHEM LETT, V15, P3748, DOI 10.1016/j.bmcl.2005.05.060; Matsumori N, 2004, CHEM BIODIVERS, V1, P346, DOI 10.1002/cbdv.200490030; MCCORD TJ, 1964, ARCH BIOCHEM BIOPHYS, V105, P349, DOI 10.1016/0003-9861(64)90018-9; NEISES B, 1978, ANGEW CHEM INT EDIT, V17, P522, DOI 10.1002/anie.197805221; Smriga M, 2003, P NATL ACAD SCI USA, V100, P15370, DOI 10.1073/pnas.2436556100; Tedeschi T, 2008, TETRAHEDRON LETT, V49, P4958, DOI 10.1016/j.tetlet.2008.05.114; Tokuyama H, 2002, SYNTHESIS-STUTTGART, P1121; Tripathi RP, 2008, CURR ORG CHEM, V12, P1093, DOI 10.2174/138527208785740283; Wang G, 2003, ORG LETT, V5, P737, DOI 10.1021/ol0275567; Wen JJ, 1998, TETRAHEDRON-ASYMMETR, V9, P1855, DOI 10.1016/S0957-4166(98)00183-9; Xu XD, 2012, POLYM CHEM-UK, V3, P2479, DOI 10.1039/c2py20299a; Zhang L, WO 2013/142088 A1, Patent No. 2013142088	38	2	2	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124046	10.1371/journal.pone.0124046	http://dx.doi.org/10.1371/journal.pone.0124046			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25876040	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700054
J	Munoz-Rodriguez, JL; Vrba, L; Futscher, BW; Hu, CC; Komenaka, IK; Meza-Montenegro, MM; Gutierrez-Millan, LE; Daneri-Navarro, A; Thompson, PA; Martinez, ME				Munoz-Rodriguez, Jose L.; Vrba, Lukas; Futscher, Bernard W.; Hu, Chengcheng; Komenaka, Ian K.; Mercedes Meza-Montenegro, Maria; Enrique Gutierrez-Millan, Luis; Daneri-Navarro, Adrian; Thompson, Patricia A.; Martinez, Maria Elena			Differentially Expressed MicroRNAs in Postpartum Breast Cancer in Hispanic Women	PLOS ONE			English	Article							DNA METHYLATION; TRANSIENT INCREASE; PREGNANCY; RISK; GENE; AGE; INACTIVATION; PROGRESSION; METASTASIS; SIGNATURE	The risk of breast cancer transiently increases immediately following pregnancy; peaking between 3-7 years. The biology that underlies this risk window and the effect on the natural history of the disease is unknown. MicroRNAs (miRNAs) are small non-coding RNAs that have been shown to be dysregulated in breast cancer. We conducted miRNA profiling of 56 tumors from a case series of multiparous Hispanic women and assessed the pattern of expression by time since last full-term pregnancy. A data-driven splitting analysis on the pattern of 355 miRNAs separated the case series into two groups: a) an early group representing women diagnosed with breast cancer <= 5.2 years postpartum (n = 12), and b) a late group representing women diagnosed with breast cancer >= 5.3 years postpartum (n = 44). We identified 15 miRNAs with significant differential expression between the early and late postpartum groups; 60% of these miRNAs are encoded on the X chromosome. Ten miRNAs had a two-fold or higher difference in expression with miR-138, miR-660, miR-31, miR-135b, miR-17, miR-454, and miR-934 overexpressed in the early versus the late group; while miR-892a, miR-199a-5p, and miR-542-5p were underexpressed in the early versus the late postpartum group. The DNA methylation of three out of five tested miRNAs (miR-31, miR-135b, and miR-138) was lower in the early versus late postpartum group, and negatively correlated with miRNA expression. Here we show that miRNAs are differentially expressed and differentially methylated between tumors of the early versus late postpartum, suggesting that potential differences in epigenetic dysfunction may be operative in postpartum breast cancers.	[Munoz-Rodriguez, Jose L.; Vrba, Lukas; Futscher, Bernard W.] Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA; [Munoz-Rodriguez, Jose L.; Futscher, Bernard W.] Univ Arizona, Coll Pharm, Dept Pharmacol & Toxicol, Tucson, AZ 85721 USA; [Hu, Chengcheng] Univ Arizona, Dept Epidemiol & Biostat, Mel & Enid Zuckerman Coll Publ Hlth, Tucson, AZ USA; [Komenaka, Ian K.] Maricopa Cty Gen Hosp, Dept Surg, Phoenix, AZ USA; [Mercedes Meza-Montenegro, Maria] Inst Tecnol Sonora, Obregon, Mexico; [Enrique Gutierrez-Millan, Luis] Univ Sonora, Dept Invest Cient & Tecnol, Hermosillo 83000, Sonora, Mexico; [Daneri-Navarro, Adrian] Univ Guadalajara, Dept Fisiol, Ctr Univ Ciencias Salud, Guadalajara 44430, Jalisco, Mexico; [Thompson, Patricia A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Martinez, Maria Elena] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA	University of Arizona; University of Arizona; University of Arizona; Maricopa County General Hospital; Universidad de Sonora; Universidad de Guadalajara; University of Arizona; University of California System; University of California San Diego	Futscher, BW (corresponding author), Univ Arizona, Ctr Canc, Tucson, AZ 85721 USA.	bfutscher@uacc.arizona.edu	Komenaka, Ian/ABC-5161-2021; Daneri-Navarro, Adrian/C-1935-2013; Rodríguez, Jose Manuel JMMR Muñoz/A-7323-2016; Vrba, Lukas/J-9268-2015; Hu, Chengcheng/A-8391-2017	Daneri-Navarro, Adrian/0000-0002-8206-749X; Rodríguez, Jose Manuel JMMR Muñoz/0000-0002-4688-6420; Vrba, Lukas/0000-0003-3042-6275; Hu, Chengcheng/0000-0001-8525-0356; Meza-Montenegro, Maria Mercedes/0000-0002-1199-9310	National Cancer Institute [3U01CA153086-01, 3U01CA153086-02S1]; NATIONAL CANCER INSTITUTE [U01CA153086] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The project described was supported by Grant Number 3U01CA153086-01 from the National Cancer Institute. JLMR also received support under the Research Supplements to Promote Diversity in Health-Related Research Program, Grant Number 3U01CA153086-02S1 from the National Cancer Institute. The content of this study is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrektsen G, 2005, BRIT J CANCER, V92, P167, DOI 10.1038/sj.bjc.6602302; ALBREKTSEN G, 1995, BRIT J CANCER, V72, P480, DOI 10.1038/bjc.1995.359; Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; American Cancer Society, 2012, CANC FACTS FIG HISP; American Cancer Society, 2014, BREAST CANC FACTS; [Anonymous], 2014, R LANG ENV STAT COMP; Arigoni M, 2013, AM J PATHOL, V182, P2058, DOI 10.1016/j.ajpath.2013.02.046; Aure MR, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r126; Ben Gacem R, 2014, TUMOR BIOL, V35, P4047, DOI 10.1007/s13277-013-1530-4; Berletch JB, 2011, HUM GENET, V130, P237, DOI 10.1007/s00439-011-1011-z; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Caldas C, 2005, NAT MED, V11, P712, DOI 10.1038/nm0705-712; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Callihan EB, 2013, BREAST CANCER RES TR, V138, P549, DOI 10.1007/s10549-013-2437-x; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chaligne R, 2014, FEBS LETT, V588, P2514, DOI 10.1016/j.febslet.2014.06.023; Chie WC, 2000, AM J EPIDEMIOL, V151, P715, DOI 10.1093/oxfordjournals.aje.a010266; Demicheli R, 2007, CANCER-AM CANCER SOC, V110, P1880, DOI 10.1002/cncr.22998; Ferlay J, 2013, IARC CANC BASE; Friend KE, 2012, AM SURGEON, V78, P819; Fury Wen, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P5531; Garbe JC, 2009, CANCER RES, V69, P7557, DOI 10.1158/0008-5472.CAN-09-0270; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/782490; Jinda S, 2014, BREAST CANCER RES, V16, DOI 10.1186/bcr3633; Key TJ, 2001, LANCET ONCOL, V2, P133, DOI 10.1016/S1470-2045(00)00254-0; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; LAMBE M, 1994, NEW ENGL J MED, V331, P5, DOI 10.1056/NEJM199407073310102; Laurila EM, 2013, GENE CHROMOSOME CANC, V52, P1103, DOI 10.1002/gcc.22107; Lee YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052979; Liu Q, 2002, CANCER CAUSE CONTROL, V13, P299, DOI 10.1023/A:1015287208222; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Liu XQ, 2011, BIOCHEM J, V440, P23, DOI 10.1042/BJ20111006; Lowery AJ, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2257; Lujambio A, 2008, P NATL ACAD SCI USA, V105, P13556, DOI 10.1073/pnas.0803055105; Luo DY, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-57; Lyons TR, 2009, J MAMMARY GLAND BIOL, V14, P87, DOI 10.1007/s10911-009-9119-7; Martinez ME, 2010, HEALTH, V2, P1040, DOI DOI 10.4236/HEALTH.2010.29153; Morita S, 2012, INT J MOL SCI, V13, P8259, DOI 10.3390/ijms13078259; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Novak P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052299; Novak P, 2009, CANCER RES, V69, P5251, DOI 10.1158/0008-5472.CAN-08-4977; O'Day E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2484; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Risendal B, 2008, CANCER CAUSE CONTROL, V19, P1349, DOI 10.1007/s10552-008-9206-x; Schaap-Oziemlak AM, 2010, STEM CELLS DEV, V19, P877, DOI 10.1089/scd.2009.0112; Schedin P, 2006, NAT REV CANCER, V6, P281, DOI 10.1038/nrc1839; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; Vrba L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054398; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Vrba L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008697; Yuan JH, 2003, CANCER RES, V63, P4174	55	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124340	10.1371/journal.pone.0124340	http://dx.doi.org/10.1371/journal.pone.0124340			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875827	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100251
J	Proches, S; Forest, F; Jose, S; De Dominicis, M; Ramdhani, S; Wiggill, T				Proches, Serban; Forest, Felix; Jose, Sarah; De Dominicis, Michela; Ramdhani, Syd; Wiggill, Timothy			How Do Alien Plants Fit in the Space-Phylogeny Matrix?	PLOS ONE			English	Article							SOUTH-AFRICA; MANTEL TEST; COMMUNITIES; RELATEDNESS; INVASIVENESS; EVOLUTION; INVASION; ECOLOGY; PATTERN; SCALES	Recent advances in the field of plant community phylogenetics and invasion phylogenetics are mostly based on plot-level data, which do not take into consideration the spatial arrangement of individual plants within the plot. Here we use within-plot plant coordinates to investigate the link between the physical distance separating plants, and their phylogenetic relatedness. We look at two vegetation types (forest and grassland, similar in species richness and in the proportion of alien invasive plants) in subtropical coastal KwaZulu-Natal, South Africa. The relationship between phylogenetic distance and physical distance is weak in grassland (characterised by higher plant densities and low phylogenetic diversity), and varies substantially in forest vegetation (variable plant density, higher phylogenetic diversity). There is no significant relationship between the proportion of alien plants in the plots and the strength of the physical-phylogenetic distance relationship, suggesting that alien plants are well integrated in the local spatial-phylogenetic landscape.	[Proches, Serban; De Dominicis, Michela; Wiggill, Timothy] Univ KwaZulu Natal, Discipline Geog, Durban, South Africa; [Forest, Felix; Jose, Sarah] Royal Bot Gardens, Jodrell Lab, Richmond TW9 3DS, Surrey, England; [Ramdhani, Syd] Univ KwaZulu Natal, Sch Life Sci, Durban, South Africa	University of Kwazulu Natal; Royal Botanic Gardens, Kew; University of Kwazulu Natal	Proches, S (corresponding author), Univ KwaZulu Natal, Discipline Geog, Westville Campus,Private Bag X54001, Durban, South Africa.	setapion@gmail.com	Procheş, Şerban/A-2044-2008; Ramdhani, Syd/AFQ-0706-2022	Procheş, Şerban/0000-0002-3415-6930; Ramdhani, Syd/0000-0003-1988-5438; Jose, Sarah/0000-0003-2737-6473	National Research Foundation; Royal Botanic Gardens, Kew Phylogenetic analysis	National Research Foundation; Royal Botanic Gardens, Kew Phylogenetic analysis	This work was supported by the following sources of funding: National Research Foundation (http://www.nrf.ac.za/) Incentive Funding for Rated Researchers SP Postdoctoral Grant SR; Royal Botanic Gardens, Kew (http://www.kew.org/) Phylogenetic analysis FF SJ.	[Anonymous], 2010, R LANG ENV STAT COMP; Carvallo GO, 2014, AUSTRAL ECOL, V39, P304, DOI 10.1111/aec.12079; Cavender-Bares J, 2004, AM NAT, V163, P823, DOI 10.1086/386375; Daehler CC, 2001, AM NAT, V158, P324, DOI 10.1086/321316; Dale MRT, 2001, J VEG SCI, V12, P597, DOI 10.2307/3236899; Davies KF, 2011, DIVERS DISTRIB, V17, P35, DOI 10.1111/j.1472-4642.2010.00721.x; Dawson W, 2009, J ECOL, V97, P657, DOI 10.1111/j.1365-2745.2009.01519.x; Diniz JAF, 2013, GENET MOL BIOL, V36, P475, DOI 10.1590/S1415-47572013000400002; Dostal P, 2011, AM NAT, V177, P655, DOI 10.1086/659060; Duncan RP, 2002, NATURE, V417, P608, DOI 10.1038/417608a; Eccles NS, 1999, PLANT ECOL, V142, P71, DOI 10.1023/A:1009857824912; Escobedo VM, 2011, REV CHIL HIST NAT, V84, P543, DOI 10.4067/S0716-078X2011000400007; ESRI, 2008, ARCGIS VERS 9 3; eThekwini Municipality, 2010, FRAM STRAT CONTR INV; Forest F, 2007, NATURE, V445, P757, DOI 10.1038/nature05587; Germishuizen G., 2003, PLANTS SO AFRICA ANN; Gray L, 2009, FOREST ECOL MANAG, V259, P98, DOI 10.1016/j.foreco.2009.09.048; Greene BT, 2012, BIOL INVASIONS, V14, P139, DOI 10.1007/s10530-011-9990-1; Jones EI, 2013, P NATL ACAD SCI USA, V110, P20627, DOI 10.1073/pnas.1310247110; Legendre P, 2010, MOL ECOL RESOUR, V10, P831, DOI 10.1111/j.1755-0998.2010.02866.x; Oksanen J, 2022, COMMUNITY ECOLOGY PA; Padayachi Y, 2014, ARTHROPOD-PLANT INTE, V8, P135, DOI 10.1007/s11829-014-9295-2; Pellock S, 2013, COMMUNITY ECOL, V14, P172, DOI 10.1556/ComEc.14.2013.2.7; Pooley E, 2005, AIELD FUIDE WILD FLO; Pooley E. S., 2003, COMPLETE FIELD GUIDE; Prinzing A, 2001, P ROY SOC LOND B BIO, V268, P1, DOI DOI 10.1098/RSPB.2000.1322; Prinzing A, 2008, ECOL LETT, V11, P809, DOI 10.1111/j.1461-0248.2008.01189.x; Proches S, 2006, P R SOC B, V273, P1143, DOI 10.1098/rspb.2005.3427; Proches S, 2008, GLOBAL ECOL BIOGEOGR, V17, P5, DOI 10.1111/j.1466-8238.2007.00333.x; Pysek Petr, 2007, V193, P97; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Shen GC, 2013, METHODS ECOL EVOL, V4, P1132, DOI 10.1111/2041-210X.12119; Silvertown J, 2006, P ROY SOC B-BIOL SCI, V273, P39, DOI 10.1098/rspb.2005.3288; Slingsby JA, 2006, AM NAT, V168, P14, DOI 10.1086/505158; SOLTIS DE, 1998, MOL SYSTEMATICS PLAN, V2, P1; Strauss SY, 2006, P NATL ACAD SCI USA, V103, P5841, DOI 10.1073/pnas.0508073103; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thuiller W, 2011, DIVERS DISTRIB, V16, P471; Vila M, 2015, GLOBAL ECOL BIOGEOGR, V24, P139, DOI 10.1111/geb.12249; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Zachariades C, 2000, P 5 INT WORKSH BIOL	41	4	4	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123238	10.1371/journal.pone.0123238	http://dx.doi.org/10.1371/journal.pone.0123238			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893962	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700031
J	Tencerova, M; Kracmerova, J; Krauzova, E; Mallsova, L; Kovacova, Z; Wedellova, Z; Siklova, M; Stich, V; Rossmeislova, L				Tencerova, Michaela; Kracmerova, Jana; Krauzova, Eva; Malisova, Lucia; Kovacova, Zuzana; Wedellova, Zuzana; Siklova, Michaela; Stich, Vladimir; Rossmeislova, Lenka			Experimental Hyperglycemia Induces an Increase of Monocyte and T-Lymphocyte Content in Adipose Tissue of Healthy Obese Women	PLOS ONE			English	Article							INSULIN-RESISTANCE; GENE-EXPRESSION; OXIDATIVE STRESS; INFLAMMATION; MACROPHAGES; CELLS; INTERVENTION; INFILTRATION; ACTIVATION; CYTOKINE	Background/Objectives Hyperglycemia represents one of possible mediators for activation of immune system and may contribute to worsening of inflammatory state associated with obesity. The aim of our study was to investigate the effect of a short-term hyperglycemia (HG) on the phenotype and relative content of immune cells in circulation and subcutaneous abdominal adipose tissue (SAAT) in obese women without metabolic complications. Subjects/Methods Three hour HG clamp with infusion of octreotide and control investigations with infusion of octreotide or saline were performed in three groups of obese women (Group1: HG, Group 2: Octreotide, Group 3: Saline, n=10 per group). Before and at the end of the interventions, samples of SAAT and blood were obtained. The relative content of immune cells in blood and SAAT was determined by flow cytometry. Gene expression analysis of immunity-related markers in SAAT was performed by quantitative real-time PCR. Results In blood, no changes in analysed immune cell population were observed in response to HG. In SAAT, HG induced an increase in the content of CD206 negative monocytes/macrophages (p<0.05) and T lymphocytes (both T helper and T cytotoxic lymphocytes, p<0.01). Further, HG promoted an increase of mRNA levels of immune response markers (CCL2, TLR4, TNF alpha) and lymphocyte markers (CD3g, CD4, CD8a, TBX21, GATA3, FoxP3) in SAAT p<0.05 and 0.01). Under both control infusions, none of these changes were observed. Conclusions Acute HG significantly increased the content of monocytes and lymphocytes in SAAT of healthy obese women. This result suggests that the short-term HG can modulate an immune status of AT in obese subjects.	[Tencerova, Michaela; Kracmerova, Jana; Krauzova, Eva; Malisova, Lucia; Kovacova, Zuzana; Wedellova, Zuzana; Siklova, Michaela; Stich, Vladimir; Rossmeislova, Lenka] Charles Univ Prague, Fac Med 3, Franco Czech Lab Clin Res Obes, CZ-10000 Prague 10, Czech Republic; [Tencerova, Michaela; Kracmerova, Jana; Krauzova, Eva; Malisova, Lucia; Kovacova, Zuzana; Wedellova, Zuzana; Siklova, Michaela; Stich, Vladimir; Rossmeislova, Lenka] Charles Univ Prague, Fac Med 3, Dept Sport Med, CZ-10000 Prague, Czech Republic; [Wedellova, Zuzana] Vinohrady Teaching Hosp, Internal Med Dept 2, Prague, Czech Republic	Charles University Prague; Charles University Prague; University Hospital Vinohrady	Tencerova, M (corresponding author), Charles Univ Prague, Fac Med 3, Franco Czech Lab Clin Res Obes, CZ-10000 Prague 10, Czech Republic.	mtencerova@health.sdu.dk	Siklova, Michaela/G-6939-2015; Rossmeislová, Lenka/D-1931-2013; Krauzová, Eva/T-1921-2017; Tencerova, Michaela/G-8089-2017	Siklova, Michaela/0000-0003-0489-1069; Rossmeislová, Lenka/0000-0002-7611-7585; Krauzová, Eva/0000-0003-2007-8414; Tencerova, Michaela/0000-0001-8670-425X; Neubert, Jana/0000-0002-2159-7139	Ministry of Health [IGA NT 144 86]; Charles University [HEALTH-F2-2008-201100, PRVOUK 204015]; Grant Agency of the Czech Republic [GAP301/11/0748]	Ministry of Health; Charles University; Grant Agency of the Czech Republic(Grant Agency of the Czech Republic)	This work was supported by grant IGA NT 144 86 of Ministry of Health, Collaborative Project ADAPT (www.adapt-eu.net) Contract No. HEALTH-F2-2008-201100, PRVOUK 204015 of Charles University and by grant GAP301/11/0748 of the Grant Agency of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Amano SU, 2014, CELL METAB, V19, P162, DOI 10.1016/j.cmet.2013.11.017; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Bes-Houtmann S, 2007, HISTOCHEM CELL BIOL, V127, P131, DOI 10.1007/s00418-006-0230-1; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chen H, 2006, PHARMACOL RES, V53, P469, DOI 10.1016/j.phrs.2006.03.003; Curat CA, 2004, DIABETES, V53, P1285, DOI 10.2337/diabetes.53.5.1285; Dasu MR, 2008, DIABETES, V57, P3090, DOI 10.2337/db08-0564; Dasu MR, 2010, DIABETES CARE, V33, P861, DOI 10.2337/dc09-1799; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Duffaut C, 2009, ARTERIOSCL THROM VAS, V29, P1608, DOI 10.1161/ATVBAHA.109.192583; Duffaut C, 2009, BIOCHEM BIOPH RES CO, V384, P482, DOI 10.1016/j.bbrc.2009.05.002; Elbein SC, 2011, DIABETES, V60, P1019, DOI 10.2337/db10-1270; Elgazar-Carmon V, 2008, J LIPID RES, V49, P1894, DOI 10.1194/jlr.M800132-JLR200; Esposito K, 2002, CIRCULATION, V106, P2067, DOI 10.1161/01.CIR.0000034509.14906.AE; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; Faraj A, 2008, DIABETES METAB, V34, P334, DOI 10.1016/j.diabet.2008.01.014; Goossens GH, 2012, MOL IMMUNOL, V50, P142, DOI 10.1016/j.molimm.2012.01.005; Hardy OT, 2011, SURG OBES RELAT DIS, V7, P60, DOI 10.1016/j.soard.2010.05.013; Heilbronn LK, 2008, CURR PHARM DESIGN, V14, P1225, DOI 10.2174/138161208784246153; Hofmann MA, 1998, DIABETES CARE, V21, P1310, DOI 10.2337/diacare.21.8.1310; Jones BW, 2001, ANN RHEUM DIS, V60, pIII6; Kashiwagi M, 2012, ATHEROSCLEROSIS, V221, P249, DOI 10.1016/j.atherosclerosis.2011.12.030; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Klimcakova E, 2006, J CLIN ENDOCR METAB, V91, P5107, DOI 10.1210/jc.2006-0382; Klimcakova E, 2011, DIABETOLOGIA, V54, P876, DOI 10.1007/s00125-010-2014-3; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kovacikova M, 2011, INT J OBESITY, V35, P91, DOI 10.1038/ijo.2010.112; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; McLaughlin T, 2008, DIABETOLOGIA, V51, P2303, DOI 10.1007/s00125-008-1148-z; Meugnier E, 2007, DIABETES, V56, P992, DOI 10.2337/db06-1242; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Mudaliar H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108844; Murdolo G, 2007, J CLIN ENDOCR METAB, V92, P2688, DOI 10.1210/jc.2006-2814; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Parker LC, 2004, J IMMUNOL, V172, P4977, DOI 10.4049/jimmunol.172.8.4977; Rocha VZ, 2008, CIRC RES, V103, P467, DOI 10.1161/CIRCRESAHA.108.177105; Sell H, 2010, CURR OPIN CLIN NUTR, V13, P366, DOI 10.1097/MCO.0b013e32833aab7f; Snyder-Cappione JE, 2013, MOL ASPECTS MED, V34, P30, DOI 10.1016/j.mam.2012.10.003; Stentz FB, 2003, CURR DRUG TARGETS, V4, P493, DOI 10.2174/1389450033490966; Sultan A, 2009, CIRC RES, V104, P961, DOI 10.1161/CIRCRESAHA.108.190280; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Weyer C, 1999, J CLIN INVEST, V104, P787, DOI 10.1172/JCI7231; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Zhang WY, 2008, ARTERIOSCL THROM VAS, V28, P2312, DOI 10.1161/ATVBAHA.108.175687	45	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122872	10.1371/journal.pone.0122872	http://dx.doi.org/10.1371/journal.pone.0122872			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894202	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700018
J	Busconi, M; Colli, L; Sanchez, RA; Santaella, M; Pascual, MD; Santana, O; Roldan, M; Fernandez, JA				Busconi, Matteo; Colli, Licia; Ana Sanchez, Rosa; Santaella, Marcela; De-Los-Mozos Pascual, Marcelino; Santana, Omar; Roldan, Marta; Fernandez, Jose-Antonio			AFLP and MS-AFLP Analysis of the Variation within Saffron Crocus (Crocus sativus L.) Germplasm	PLOS ONE			English	Article							DNA METHYLATION; STRATEGIES; GENOTYPE	The presence and extent of genetic variation in saffron crocus are still debated, as testified by several contradictory articles providing contrasting results about the monomorphism or less of the species. Remarkably, phenotypic variations have been frequently observed in the field, such variations are usually unstable and can change from one growing season to another. Considering that gene expression can be influenced both by genetic and epigenetic changes, epigenetics could be a plausible cause of the alternative phenotypes. In order to obtain new insights into this issue, we carried out a molecular marker analysis of 112 accessions from the World Saffron and Crocus Collection. The accessions were grown for at least three years in the same open field conditions. The same samples were analysed using Amplified Fragment Length Polymorphism (AFLP) and Methyl Sensitive AFLP in order to search for variation at the genetic (DNA sequence) and epigenetic (cytosine methylation) level. While the genetic variability was low (4.23% polymorphic peaks and twelve (12) effective different genotypes), the methyl sensitive analysis showed the presence of high epigenetic variability (33.57% polymorphic peaks and twenty eight (28) different effective epigenotypes). The pattern obtained by Factorial Correspondence Analysis of AFLP and, in particular, of MS-AFLP data was consistent with the geographical provenance of the accessions. Very interestingly, by focusing on Spanish accessions, it was observed that the distribution of the accessions in the Factorial Correspondence Analysis is not random but tends to reflect the geographical origin. Two clearly defined clusters grouping accessions from the West (Toledo and Ciudad Real) and accessions from the East (Cuenca and Teruel) were clearly recognised.	[Busconi, Matteo; Colli, Licia] Univ Cattolica Sacro Cuore, Fac Agr Food & Environm Sci, Piacenza, Italy; [Busconi, Matteo; Colli, Licia] Univ Cattolica Sacro Cuore, BioDNA, Ctr Ric Biodiversita & DNA Ant, Piacenza, Italy; [Ana Sanchez, Rosa; Santaella, Marcela; Roldan, Marta; Fernandez, Jose-Antonio] Univ Castilla La Mancha, IDR Biotechnol, Albacete, Spain; [Santaella, Marcela; De-Los-Mozos Pascual, Marcelino; Santana, Omar] Consejeria Agr Castilla La Mancha, Ctr Invest Agr Albaladejito, Cuenca, Spain	Catholic University of the Sacred Heart; Catholic University of the Sacred Heart; Universidad de Castilla-La Mancha	Busconi, M (corresponding author), Univ Cattolica Sacro Cuore, Fac Agr Food & Environm Sci, Piacenza, Italy.	matteo.busconi@unicatt.it; JoseAntonio.FPerez@uclm.es	Colli, Licia/AAC-2985-2021; Fernández, José Antonio/R-9082-2019	Fernández, José Antonio/0000-0002-9913-4978; SANTANA MERIDAS, OMAR/0000-0003-0352-5921; Busconi, Matteo/0000-0002-7824-3446	Creacion de la coleccion espanola de azafran y especies afines [RF2004-00032]; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Coleccion espanola de germoplasma de azafran y especies afines [RF2008-00012]; Avances en la estrategia de conservacion, multiplicacion y caracterizacion de la coleccion espanola de germoplasma de azafran y especies afines [RF2011-00005]; European commission; Genetic resources of saffron and allies [AGRI-2006-0265]; European Cooperation in Science and Technology; Omics technologies for crop improvement, traceability, determination of authenticity, adulteration and origin in saffron, COST action [FA1101]	Creacion de la coleccion espanola de azafran y especies afines; Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Coleccion espanola de germoplasma de azafran y especies afines; Avances en la estrategia de conservacion, multiplicacion y caracterizacion de la coleccion espanola de germoplasma de azafran y especies afines; European commission(European CommissionEuropean Commission Joint Research Centre); Genetic resources of saffron and allies; European Cooperation in Science and Technology(European Cooperation in Science and Technology (COST)); Omics technologies for crop improvement, traceability, determination of authenticity, adulteration and origin in saffron, COST action	This work was supported by: 1) Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Creacion de la coleccion espanola de azafran y especies afines, grant number RF2004-00032; URL: http://www.inia.es/IniaPortal/verPresentacion.action; grant holder MDM; 2) Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Coleccion espanola de germoplasma de azafran y especies afines, grant number RF2008-00012; URL: http://www.inia.es/IniaPortal/verPresentacion.action; grant holder MDM; 3) Instituto Nacional de Investigacion y Tecnologia Agraria y Alimentaria (ES); Avances en la estrategia de conservacion, multiplicacion y caracterizacion de la coleccion espanola de germoplasma de azafran y especies afines, grant number RF2011-00005; URL: http://www.inia.es/IniaPortal/verPresentacion.action; grant holder MDM; 4) European commission; Genetic resources of saffron and allies (crocus spp.): Crocusbank, grant number AGRI-2006-0265; URL: http://ec.europa.eu/; grant holder JAF; 5) European Cooperation in Science and Technology; Omics technologies for crop improvement, traceability, determination of authenticity, adulteration and origin in saffron, COST action FA1101; URL: http://www.cost.eu/; grant holder MR.	Agayev YMO, 2009, EUPHYTICA, V169, P81, DOI 10.1007/s10681-009-9946-z; BELKHIR K., 2004, LOGICIEL WINDOWS GEN; Benjak A, 2006, VITIS, V45, P15; BENZECRI J.-P, 1973, LANALYSE DONNEES; Bonasio R, 2010, SCIENCE, V330, P612, DOI 10.1126/science.1191078; Brautigam K, 2013, ECOL EVOL, V3, P399, DOI 10.1002/ece3.461; Brandizzi F, 1998, PLANT SYST EVOL, V211, P149, DOI 10.1007/BF00985356; BRIGHTON C A, 1973, Kew Bulletin, V28, P451, DOI 10.2307/4108890; Caiola MG, 2004, ACTA HORTIC, P25; Chinnusamy V, 2009, CURR OPIN PLANT BIOL, V12, P133, DOI 10.1016/j.pbi.2008.12.006; De-Los-Mozos-Pascual M, 2010, ACTA HORTIC, V850, P35, DOI 10.17660/ActaHortic.2010.850.3; Erol O, 2014, TURK J BIOL, V38, P48, DOI 10.3906/biy-1305-14; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fernandez JA, 2004, RECENT RES DEV PLANT, V2, P127; Fernandez JA, 2011, GENET RESOUR CROP EV, V58, P125, DOI 10.1007/s10722-010-9601-5; Fluch S, 2010, ACTA HORTIC, V850, P41, DOI 10.17660/ActaHortic.2010.850.4; Herrera CM, 2013, BOT J LINN SOC, V171, P441, DOI 10.1111/boj.12007; Lisch D, 2011, INT REV CEL MOL BIO, V292, P119, DOI 10.1016/B978-0-12-386033-0.00003-7; Lu GY, 2007, J INTEGR PLANT BIOL, V49, P1599, DOI 10.1111/j.1774-7909.2007.00566.x; Luo M, 2012, BBA-GENE REGUL MECH, V1819, P129, DOI 10.1016/j.bbagrm.2011.06.008; Marconi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075597; Meirmans PG, 2004, MOL ECOL NOTES, V4, P792, DOI 10.1111/j.1471-8286.2004.00770.x; Montana G, 2006, BRIEF BIOINFORM, V7, P297, DOI 10.1093/bib/bbl028; Myles S, 2011, P NATL ACAD SCI USA, V108, P3530, DOI 10.1073/pnas.1009363108; Nei M., 1987, MOL EVOLUTIONARY GEN; Nemati Z, 2014, SPAN J AGRIC RES, V12, P753, DOI 10.5424/sjar/2014123-5564; Paszkowski J, 2011, CURR OPIN PLANT BIOL, V14, P195, DOI 10.1016/j.pbi.2011.01.002; Ranieri E, 2013, P 57 IT SOC AGR GEN; Richards EJ, 2011, CURR OPIN PLANT BIOL, V14, P204, DOI 10.1016/j.pbi.2011.03.009; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rubio-Moraga Angela, 2009, BMC Res Notes, V2, P189, DOI 10.1186/1756-0500-2-189; Saze H, 2012, PLANT CELL PHYSIOL, V53, P766, DOI 10.1093/pcp/pcs008; Schmidt T, 1998, TRENDS PLANT SCI, V3, P195, DOI 10.1016/S1360-1385(98)01223-0; Siracusa L, 2013, GENET RESOUR CROP EV, V60, P711, DOI 10.1007/s10722-012-9868-9; Tenaillon MI, 2010, TRENDS PLANT SCI, V15, P471, DOI 10.1016/j.tplants.2010.05.003; Zhang ChangQing, 2013, Plant Breeding and Biotechnology, V1, P307, DOI 10.9787/PBB.2013.1.4.307	38	28	29	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123434	10.1371/journal.pone.0123434	http://dx.doi.org/10.1371/journal.pone.0123434			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885113	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000063
J	Cao, LH; Tong, HY; Xu, GX; Liu, P; Meng, HT; Wang, JH; Zhao, XY; Tang, YM; Jin, J				Cao, Lihong; Tong, Hongyan; Xu, Gaixiang; Liu, Ping; Meng, Haitao; Wang, Jinghan; Zhao, Xiaoying; Tang, Yongmin; Jin, Jie			Systemic Lupus Erythematous and Malignancy Risk: A Meta-Analysis	PLOS ONE			English	Article							NON-HODGKINS-LYMPHOMA; CANCER INCIDENCE; CLINICAL-TRIALS; HEPATITIS-B; FOLLOW-UP; COHORT; ASSOCIATION; CELL; CLASSIFICATION; CARCINOMA	Background Pilot studies have estimated cancer incidence in patients with systemic lupus erythematous (SLE). However, the results have been inconclusive. To ascertain the correlation between SLE and malignancy more comprehensively and precisely, we conducted a meta-analysis. Methods PubMed, the Cochrane Library and Embase databases through June 2014, were searched to identify observational studies evaluating the association between SLE and malignancy. The outcomes from these studies were measured as relative risks (RRs). A random or fixed effects model was chosen to calculate the pooled RR according to heterogeneity test. Between- study heterogeneity was assessed by estimating.2 index. Publication bias was assessed by Egger's test. Results A total of 16 papers, including 59,662 SLE patients, were suitable for the meta-analysis. Of these papers, 15 reported RRs for overall malignancy, 12 for non-Hodgkin lymphoma (NHL) and lung cancer, 7 for bladder cancer, 6 for Hodgkin lymphoma (HL) and leukemia, 5 for skin melanoma, and liver and thyroid cancers, 4 for multiple myeloma (MM), and esophageal and vaginal/vulvar cancers and 3 for laryngeal and non-melanoma skin cancers. The pooled RRs were 1.28 (95% CI, 1.17-1.41) for overall cancer, 5.40 (95% CI, 3.75-7.77) for NHL, 3.26(95% CI, 2.17-4.88) for HL, 2.01(95% CI, 1.61-2.52) for leukemia, 1.45(95% CI, 1.04-2.03) for MM, 4.19(95% CI, 1.98-8.87) for laryngeal cancer, 1.59 (95% CI, 1.44-1.76) for lung cancer, 1.86(95% CI, 1.21-2.88) for esophageal cancer, 3.21(95% CI, 1.70-6.05) for liver cancer, 3.67(95% CI, 2.80-4.81) for vaginal/ vulvar cancer, 2.11 (95% CI, 1.12-3.99) for bladder cancer, 1.51(95% CI, 1.12-2.03) for non-melanoma skin cancer, 1.78(95% CI, 1.35-2.33) for thyroid cancer, and 0.65(95% CI, 0.50-0.85) for skin melanoma. Only the meta-analyses of overall malignancy, NHL, and liver and bladder cancers produced substantial heterogeneity (I-2, 57.6% vs 74.3% vs 67.7% vs 82.3%). No apparent publication bias was detected except for NHL studies. Conclusions Our data support an association between SLE and malignancy, not only demonstrating an increased risk for NHL, HL, leukemia, and some non-hematologic malignancies, including laryngeal, lung, liver, vaginal/vulvar, and thyroid malignancies, but also a reduced risk for skin melanoma. Although an increased risk of MM, and esophageal, bladder and non-melanoma skin cancers was identified from the accumulated data in these studies, this observation requires confirmation.	[Cao, Lihong; Tong, Hongyan; Xu, Gaixiang; Meng, Haitao; Wang, Jinghan; Jin, Jie] Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Cao, Lihong; Tong, Hongyan; Xu, Gaixiang; Meng, Haitao; Wang, Jinghan; Jin, Jie] Zhejiang Univ, Sch Med, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Liu, Ping] Univ Western Australia, Sch Populat Hlth, Perth, WA 6009, Australia; [Zhao, Xiaoying] Zhejiang Univ, Affiliated Hosp 2, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Tang, Yongmin] Zhejiang Univ, Affiliated Childrens Hosp, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; University of Western Australia; Zhejiang University; Zhejiang University	Jin, J (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Dept Hematol, Hangzhou 310003, Zhejiang, Peoples R China.	zjuhematology@163.com	cao, lihong/HDM-0128-2022	cao, lihong/0000-0002-7818-9937	Program for Zhejiang Leading Team of ST Innovation [2011R50015]	Program for Zhejiang Leading Team of ST Innovation	This work was supported by the Program for Zhejiang Leading Team of S&T Innovation (grant number 2011R50015, http://www.zjkjt.gov.cn/html/node05/detail150408/2010/15040802_18629.html.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott Iain J, 2009, J Med Case Rep, V3, P7289, DOI 10.4076/1752-1947-3-7289; Abu-Shakra M, 2002, LUPUS, V11, P137, DOI 10.1191/0961203302lu182rr; AbuShakra M, 1996, ARTHRITIS RHEUM, V39, P1050, DOI 10.1002/art.1780390625; Agmon-Levin N, 2009, LUPUS, V18, P1181, DOI 10.1177/0961203309346653; Amissah-Arthur MB, 2010, THER ADV CHRONIC DIS, V1, P163, DOI 10.1177/2040622310380100; Antonelli A, 2010, METABOLISM, V59, P896, DOI 10.1016/j.metabol.2009.10.010; Azizi G, 2011, ENDOCR PRACT, V17, P201, DOI 10.4158/EP10123.OR; Bernatsky S, 2005, ANN RHEUM DIS, V64, P1507, DOI 10.1136/ard.2004.034504; Bernatsky S, 2013, J AUTOIMMUN, V42, P130, DOI 10.1016/j.jaut.2012.12.009; Bernatsky Sasha, 2002, Curr Rheumatol Rep, V4, P351, DOI 10.1007/s11926-002-0045-6; Bjornadal L, 2002, SCAND J RHEUMATOL, V31, P66; Bourre-Tessier J, 2013, ARTHRIT CARE RES, V65, P1275, DOI 10.1002/acr.21966; Bugelski PJ, 2010, INT J TOXICOL, V29, P435, DOI 10.1177/1091581810374654; Chun BC, 2005, LUPUS, V14, P635, DOI 10.1191/0961203305lu2180xx; Cibere J, 2001, LUPUS, V10, P394, DOI 10.1191/096120301678646128; D'Cruz DP, 2007, LANCET, V369, P587, DOI 10.1016/S0140-6736(07)60279-7; Daniels CE, 2005, CURR OPIN PULM MED, V11, P431, DOI 10.1097/01.mcp.0000170521.71497.ba; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dias C, 2011, NAT REV RHEUMATOL, V7, P360, DOI 10.1038/nrrheum.2011.62; Dreyer L, 2011, ARTHRITIS RHEUM-US, V63, P3032, DOI 10.1002/art.30483; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekblom-Kullberg S, 2013, CLIN RHEUMATOL, V32, P1219, DOI 10.1007/s10067-013-2224-4; English DR, 1998, INT J CANCER, V76, P628, DOI 10.1002/(SICI)1097-0215(19980529)76:5<628::AID-IJC3>3.0.CO;2-S; GALBRAITH RF, 1988, STAT MED, V7, P889, DOI 10.1002/sim.4780070807; Gokce M, 2012, LUPUS, V21, P910, DOI 10.1177/0961203312436859; Gordon C, 2002, RHEUMATOLOGY, V41, P1095, DOI 10.1093/rheumatology/41.10.1095; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Huang HB, 2014, J CANCER RES CLIN, V140, P1067, DOI 10.1007/s00432-014-1604-8; Kang KY, 2010, CLIN RHEUMATOL, V29, P381, DOI 10.1007/s10067-009-1332-7; KASSAN SS, 1978, ANN INTERN MED, V89, P888, DOI 10.7326/0003-4819-89-6-888; Kiss E, 2010, AUTOIMMUN REV, V9, P195, DOI 10.1016/j.autrev.2009.07.004; Mellemkjaer L, 1997, ARTHRITIS RHEUM-US, V40, P761, DOI 10.1002/art.1780400424; Ni J, 2014, LUPUS, V23, P284, DOI 10.1177/0961203313520060; Nived O, 2001, LUPUS, V10, P500, DOI 10.1191/096120301678416079; Ott G, 2008, HAEMATOL-HEMATOL J, V93, P1773, DOI 10.3324/haematol.2008.001495; Parikh-Patel A, 2008, CANCER CAUSE CONTROL, V19, P887, DOI 10.1007/s10552-008-9151-8; PASSAS CM, 1985, ARTHRITIS RHEUM, V28, P620, DOI 10.1002/art.1780280604; PETTERSSON T, 1992, ANN RHEUM DIS, V51, P437, DOI 10.1136/ard.51.4.437; Ragnarsson O, 2003, LUPUS, V12, P687, DOI 10.1191/0961203303lu443oa; Ramsey-Goldman R, 1998, J INVEST MED, V46, P217; RUIZ J, 1992, HEPATOLOGY, V16, P637, DOI 10.1002/hep.1840160305; Saurit V, 2003, MEDICINA-BUENOS AIRE, V63, P283; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Sultan SM, 2000, RHEUMATOLOGY, V39, P1147, DOI 10.1093/rheumatology/39.10.1147; SWEENEY DM, 1995, J RHEUMATOL, V22, P1478; Tam LS, 2004, ARTHRITIS RHEUM-US, V50, P3619, DOI 10.1002/art.20616; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; Tarr T, 2007, ANN NY ACAD SCI, V1108, P76, DOI 10.1196/annals.1422.008; THOMAS RHM, 1985, J AM ACAD DERMATOL, V13, P832, DOI 10.1016/S0190-9622(85)80407-2; Wang ZL, 2012, J RHEUMATOL, V39, P974, DOI 10.3899/jrheum.111107; Zanetti R, 1996, BRIT J CANCER, V73, P1440, DOI 10.1038/bjc.1996.274; Zintzaras E, 2005, ARCH INTERN MED, V165, P2337, DOI 10.1001/archinte.165.20.2337	52	50	54	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122964	10.1371/journal.pone.0122964	http://dx.doi.org/10.1371/journal.pone.0122964			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885411	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000045
J	Houston, DR; Yen, LH; Pettit, S; Walkinshaw, MD				Houston, Douglas R.; Yen, Li-Hsuan; Pettit, Simon; Walkinshaw, Malcolm D.			Structure- and Ligand-Based Virtual Screening Identifies New Scaffolds for Inhibitors of the Oncoprotein MDM2	PLOS ONE			English	Article							SMALL-MOLECULE RITA; PROTEIN-PROTEIN INTERACTIONS; SCORING FUNCTIONS; P53 FUNCTION; TARGETING MDM2; DOCKING; DISCOVERY; RESTORATION; PREDICTION; WEIGHT	A major challenge in the field of ligand discovery is to identify chemically useful fragments that can be developed into inhibitors of specific protein-protein interactions. Low molecular weight fragments (with molecular weight less than 250 Da) are likely to bind weakly to a protein's surface. Here we use a new virtual screening procedure which uses a combination of similarity searching and docking to identify chemically tractable scaffolds that bind to the p53-interaction site of MDM2. The binding has been verified using capillary electrophoresis which has proven to be an excellent screening method for such small, weakly binding ligands.	[Houston, Douglas R.; Yen, Li-Hsuan; Walkinshaw, Malcolm D.] Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland; [Pettit, Simon] Selcia Ltd, Ongar, Essex, England	University of Edinburgh	Houston, DR (corresponding author), Univ Edinburgh, Inst Struct & Mol Biol, Edinburgh, Midlothian, Scotland.	DouglasR.Houston@ed.ac.uk	walkinshaw, malcolm/AAB-7497-2019	walkinshaw, malcolm/0000-0001-5955-9325; Houston, Douglas/0000-0002-3469-1546	BBSRC-Biotechnology and Biological Sciences Research Council (Industrial CASE Award)	BBSRC-Biotechnology and Biological Sciences Research Council (Industrial CASE Award)	BBSRC-Biotechnology and Biological Sciences Research Council (Industrial CASE Award). MDW and LHY received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer E, 1999, MACH LEARN, V36, P105, DOI 10.1023/A:1007515423169; Benaliouche H, 2014, SCI WORLD J, DOI 10.1155/2014/829369; Bixby D, 2008, CELL CYCLE, V7, P971, DOI 10.4161/cc.7.8.5754; Blackburn TJ, 2013, MEDCHEMCOMM, V4, P1297, DOI 10.1039/c3md00161j; Brennan RC, 2011, CANCER RES, V71, P4205, DOI 10.1158/0008-5472.CAN-11-0058; Cheng TJ, 2009, J CHEM INF MODEL, V49, P1079, DOI 10.1021/ci9000053; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; de Winter H., SILICOS IT CHEMOINFO; Ding QJ, 2013, J MED CHEM, V56, P5979, DOI 10.1021/jm400487c; Domling A, 2008, CURR OPIN CHEM BIOL, V12, P281, DOI 10.1016/j.cbpa.2008.04.603; Dolinsky TJ, 2007, NUCLEIC ACIDS RES, V35, pW522, DOI 10.1093/nar/gkm276; Donehower LA, 2009, NAT REV CANCER, V9, P830, DOI 10.1038/nrc2731; Espinoza-Fonseca LM, 2005, THEOR BIOL MED MODEL, V2, DOI 10.1186/1742-4682-2-38; Genheden S, 2010, J COMPUT CHEM, V31, P837, DOI 10.1002/jcc.21366; Gohlke H, 2000, J MOL BIOL, V295, P337, DOI 10.1006/jmbi.1999.3371; Goodsell DS, 1996, J MOL RECOGNIT, V9, P1, DOI 10.1002/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6; Grant JA, 1996, J COMPUT CHEM, V17, P1653, DOI 10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K; Hann MM, 2004, CURR OPIN CHEM BIOL, V8, P255, DOI 10.1016/j.cbpa.2004.04.003; Hann MM, 2001, J CHEM INF COMP SCI, V41, P856, DOI 10.1021/ci000403i; Hardcastle IR, 2011, J MED CHEM, V54, P1233, DOI 10.1021/jm1011929; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hipp Jason, 2011, J Pathol Inform, V2, P25, DOI 10.4103/2153-3539.82050; Hopkins AL, 2006, CURR OPIN STRUC BIOL, V16, P127, DOI 10.1016/j.sbi.2006.01.013; Houston DR, 2013, J CHEM INF MODEL, V53, P384, DOI 10.1021/ci300399w; Huang SY, 2010, PHYS CHEM CHEM PHYS, V12, P12899, DOI 10.1039/c0cp00151a; Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634; Irwin JJ, 2005, BIOCHEMISTRY-US, V44, P12316, DOI 10.1021/bi050801k; Issaeva N, 2004, NAT MED, V10, P1321, DOI 10.1038/nm1146; Kasparov G., CHESS METAPHORS ARTI, P232; Krajewski M, 2005, NAT MED, V11, P1135, DOI 10.1038/nm1105-1135; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kuenemann MA, 2014, J CHEM INF MODEL; Kukol A, 2011, EUR J MED CHEM, V46, P4661, DOI 10.1016/j.ejmech.2011.05.026; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Labbe CM, 2013, DRUG DISCOV TODAY, V18, P958, DOI 10.1016/j.drudis.2013.05.003; Laura R., 2014, 19 INT COMM CONTR RE; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li Y, 2014, J CHEM INF MODEL, V54, P1717, DOI 10.1021/ci500081m; Little James N., 1999, American Biotechnology Laboratory, V17, P36; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Marx J, 2007, SCIENCE, V315, P1211, DOI 10.1126/science.315.5816.1211; MOMAND J, 1992, CELL, V69, P1237, DOI 10.1016/0092-8674(92)90644-R; Mpamhanga CP, 2009, J MED CHEM, V52, P4454, DOI 10.1021/jm900414x; Murray JK, 2007, BIOPOLYMERS, V88, P657, DOI 10.1002/bip.20741; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Pan YP, 2003, J CHEM INF COMP SCI, V43, P267, DOI 10.1021/ci020055f; Patil S.P., 2014, NUCLEIC ACIDS RES, V28, P89, DOI DOI 10.1093/NAR/GKQ786; PEARLMAN RS, CONCORD; Pierceall William E, 2004, Methods Mol Biol, V261, P187; Popowicz GM, 2010, CELL CYCLE, V9, P1104, DOI 10.4161/cc.9.6.10956; Rella M, 2006, J CHEM INF MODEL, V46, P708, DOI 10.1021/ci0503614; Renner S, 2005, CHEMBIOCHEM, V6, P1119, DOI 10.1002/cbic.200400376; Rew Y, 2014, J MED CHEM, V57, P6332, DOI 10.1021/jm500627s; Roh JL, 2012, CANCER LETT, V325, P35, DOI 10.1016/j.canlet.2012.05.020; Rouvray D., 2002, TOPOLOGY CHEM, V2002, P16, DOI [10.1533/9780857099617.16, DOI 10.1533/9780857099617.16]; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; Santana L, 2006, J MED CHEM, V49, P1149, DOI 10.1021/jm0509849; Sauton N, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-184; Schuster D, 2006, J MED CHEM, V49, P3454, DOI 10.1021/jm0600794; Seifert MHJ, 2008, MINI-REV MED CHEM, V8, P63, DOI 10.2174/138955708783331540; Shangary S, 2008, CLIN CANCER RES, V14, P5318, DOI 10.1158/1078-0432.CCR-07-5136; Shangary S, 2008, P NATL ACAD SCI USA, V105, P3933, DOI 10.1073/pnas.0708917105; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Shave S.R., 2010, DEV HIGH PERFORMANCE; Taylor P, 2008, BRIT J PHARMACOL, V153, pS55, DOI 10.1038/sj.bjp.0707532; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tuccinardi T, 2014, J CHEM INF MODEL, V54, P2980, DOI 10.1021/ci500424n; Tuccinardi T, 2009, COMB CHEM HIGH T SCR, V12, P303, DOI 10.2174/138620709787581666; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Villoutreix BO, 2009, COMB CHEM HIGH T SCR, V12, P1000, DOI 10.2174/138620709789824682; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Vu B, 2013, ACS MED CHEM LETT, V4, P466, DOI 10.1021/ml4000657; Wade M, 2009, MOL CANCER RES, V7, P1, DOI 10.1158/1541-7786.MCR-08-0423; Wang RX, 2001, J CHEM INF COMP SCI, V41, P1422, DOI 10.1021/ci010025x; Wang RX, 2002, J COMPUT AID MOL DES, V16, P11, DOI 10.1023/A:1016357811882; Wang YX, 2011, J CLIN INVEST, V121, P893, DOI 10.1172/JCI44504; WIENER H, 1947, J AM CHEM SOC, V69, P17, DOI 10.1021/ja01193a005; Willett P, 2013, COMPUT STRUCT BIOTEC, V5, DOI 10.5936/csbj.201302002; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhong SJ, 2010, CURR OPIN DRUG DISC, V13, P326	82	10	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121424	10.1371/journal.pone.0121424	http://dx.doi.org/10.1371/journal.pone.0121424			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884407	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000017
J	Hua, YJ; Stojanovic, A; Utheim, TP; Chen, XJ; Raeder, S; Huang, JH; Wang, QM				Hua, Yanjun; Stojanovic, Aleksander; Utheim, Tor Paaske; Chen, Xiangjun; Raeder, Sten; Huang, Jinhai; Wang, Qinmei			Keratometric Index Obtained by Fourier-Domain Optical Coherence Tomography	PLOS ONE			English	Article							LENS POWER CALCULATION; CORNEAL POWER; ORBSCAN-II; POSTERIOR SURFACE; ANTERIOR SEGMENT; PENTACAM; CURVATURE; SURGERY; EYES; VIDEOKERATOGRAPHY	Purpose To determine the keratometric indices calculated based on parameters obtained by Fourier-domain optical coherence tomography (FD-OCT). Methods The ratio of anterior corneal curvature to posterior corneal curvature (Ratio) and keratometric index (N) were calculated within central 3 mm zone with the RTVue FD-OCT (RTVue, Optovue, Inc.) in 186 untreated eyes, 60 post-LASIK/PRK eyes, and 39 keratoconus eyes. The total corneal powers were calculated using different keratometric indices: K-cal based on the mean calculated keratometric index, K1.3315 calculated by the keratometric index of 1.3315, and K1.3375 calculated by the keratometric index of 1.3375. In addition, the total corneal powers based on Gaussian optics formula (K-actual) were calculated. Results The means for Ratio in untreated controls, post-LASIK/PRK group and keratoconus group were 1.176 +/- 0.022 (95% confidence interval (CI), 1.172-1.179), 1.314 +/- 0.042 (95% CI, 1.303-1.325) and 1.229 +/- 0.118 (95% CI, 1.191-1.267), respectively. And the mean calculated keratometric index in untreated controls, post-LASIK/PRK group and keratoconus group were 1.3299 +/- 0.00085 (95% CI, 1.3272-1.3308), 1.3242 +/- 0.00171 (95% CI, 1.3238-1.3246) and 1.3277 +/- 0.0046 (95% CI, 1.3263-1.3292), respectively. All the parameters were normally distributed. The differences between Kcal and Kactual, K1.3315 and Kactual, and K1.3375 and Kactual were 0.00 +/- 0.11 D, 0.21 +/- 0.11 D and 0.99 +/- 0.12 D, respectively, in untreated controls; -0.01 +/- 0.20 D, 0.85 +/- 0.18 D and 1.56 +/- 0.16 D, respectively, in postLASIK/PRK group; and 0.03 +/- 0.67 D, 0.56 +/- 0.70 D and 1.40 +/- 0.76 D, respectively, in keratoconus group. Conclusion The calculated keratometric index is negatively related to the ratio of anterior corneal curvature to posterior corneal curvature in untreated, post-LASIK/PRK, and keratoconus eyes, respectively. Using the calculated keratometric index may improve the prediction accuracies of total corneal powers in untreated controls, but not in post-LASIK/PRK and keratoconus eyes.	[Hua, Yanjun] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Ophthalmol, Shanghai 200233, Peoples R China; [Stojanovic, Aleksander] Univ Hosp North Norway, Dept Ophthalmol, Tromso, Norway; [Stojanovic, Aleksander; Chen, Xiangjun; Raeder, Sten] SynsLaser Kirurgi AS, Tromso, Norway; [Utheim, Tor Paaske] Oslo Univ Hosp, Dept Med Biochem, N-0450 Oslo, Norway; [Huang, Jinhai; Wang, Qinmei] Wenzhou Med Univ, Sch Optometry & Ophthalmol, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China; [Huang, Jinhai; Wang, Qinmei] Wenzhou Med Univ, Hosp Eye, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China	Shanghai Jiao Tong University; UiT The Arctic University of Tromso; University Hospital of North Norway; University of Oslo; Wenzhou Medical University; Wenzhou Medical University	Huang, JH (corresponding author), Wenzhou Med Univ, Sch Optometry & Ophthalmol, Key Lab Vis Sci, Minist Hlth Peoples Republ China, Wenzhou, Zhejiang, Peoples R China.	1278034009@qq.com; wqm6@mail.eye.ac.en	Huang, Jinhai/ABH-4519-2020	HUA, YANJUN/0000-0001-6461-3576	National Natural Science Foundation of China [81300807]; Foundation of Wenzhou City Science & Technology Bureau [Y20120176, Y20130118]; National Science and Technology Ministry [2012BAI08B04]; Health Bureau of Zhejiang Province [2012KYB135]; Science Research Fund of Zhejiang Provincial Education Department [Y201223147]; SynsLaser Kirurgi AS	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation of Wenzhou City Science & Technology Bureau; National Science and Technology Ministry; Health Bureau of Zhejiang Province; Science Research Fund of Zhejiang Provincial Education Department; SynsLaser Kirurgi AS	This study was supported in part by the National Natural Science Foundation of China (81300807); Foundation of Wenzhou City Science & Technology Bureau (Y20120176, Y20130118); the National Science and Technology Ministry (2012BAI08B04); the Health Bureau of Zhejiang Province (2012KYB135); and the Science Research Fund of Zhejiang Provincial Education Department (Y201223147). Authors AS, XC and SR are employed by SynsLaser Kirurgi AS. SynsLaser Kirurgi AS provided support in the form of salaries for authors AS, XC and SR, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Ang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101483; Arce CG, 2007, J CATARACT REFR SURG, V33, P1348, DOI 10.1016/j.jcrs.2007.03.062; Borasio E, 2006, J CATARACT REFR SURG, V32, P2004, DOI 10.1016/j.jcrs.2006.08.037; Cheng ACK, 2009, J REFRACT SURG, V25, P221, DOI 10.3928/1081597X-20090201-08; Dubbelman M, 2006, VISION RES, V46, P993, DOI 10.1016/j.visres.2005.09.021; Falavarjani KG, 2010, CLIN EXP OPHTHALMOL, V38, P341, DOI 10.1111/j.1442-9071.2010.02286.x; Fam HB, 2007, J CATARACT REFR SURG, V33, P686, DOI 10.1016/j.jcrs.2006.11.023; Garner LF, 1997, OPTOMETRY VISION SCI, V74, P496, DOI 10.1097/00006324-199707000-00016; Goss DA, 2002, INTRO OPTICS EYE, P113; Ho JD, 2008, J CATARACT REFR SURG, V34, P137, DOI 10.1016/j.jcrs.2007.09.033; Hua Y, 2013, CHINESE J OPTOMETRY, V15, P150, DOI [10.1016/j.optom.2013.06.002, DOI 10.1016/J.0PT0M.2013.06.002]; [华焱军 Hua Yanjun], 2013, [中华实验眼科杂志, Chinese Journal of Experimental Ophthalmology], V31, P177; Jin HY, 2012, J CATARACT REFR SURG, V38, P1749, DOI 10.1016/j.jcrs.2012.06.048; Leyland M, 2004, EYE, V18, P357, DOI 10.1038/sj.eye.6700659; Lim KL, 2006, J CATARACT REFR SURG, V32, P1814, DOI 10.1016/j.jcrs.2006.08.022; McAlinden C, 2011, INVEST OPHTH VIS SCI, V52, P7731, DOI 10.1167/iovs.10-7093; OLSEN T, 1986, BRIT J OPHTHALMOL, V70, P152, DOI 10.1136/bjo.70.2.152; Ortiz S, 2011, BIOMED OPT EXPRESS, V2, P3232, DOI 10.1364/BOE.2.003232; Savini G, 2009, J REFRACT SURG, V25, P534, DOI 10.3928/1081597X-20090512-07; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Tang ML, 2006, J CATARACT REFR SURG, V32, P1843, DOI 10.1016/j.jcrs.2006.04.046; Tang ML, 2012, J CATARACT REFR SURG, V38, P589, DOI 10.1016/j.jcrs.2011.11.025; Tang ML, 2010, J CATARACT REFR SURG, V36, P2115, DOI 10.1016/j.jcrs.2010.07.018; Wang L, 2011, INVEST OPHTH VIS SCI, V52, P1716, DOI 10.1167/iovs.09-4982; Wang QM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045607	25	3	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122441	10.1371/journal.pone.0122441	http://dx.doi.org/10.1371/journal.pone.0122441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886489	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000033
J	Stanifer, JW; Maro, V; Egger, J; Karia, F; Thielman, N; Turner, EL; Shimbi, D; Kilaweh, H; Matemu, O; Patel, UD				Stanifer, John W.; Maro, Venance; Egger, Joseph; Karia, Francis; Thielman, Nathan; Turner, Elizabeth L.; Shimbi, Dionis; Kilaweh, Humphrey; Matemu, Oliver; Patel, Uptal D.			The Epidemiology of Chronic Kidney Disease in Northern Tanzania: A Population-Based Survey	PLOS ONE			English	Article							PREVALENCE; BURDEN; ADULTS; RISK	Background In sub-Saharan Africa, kidney failure has a high morbidity and mortality. Despite this, population-based estimates of prevalence, potential etiologies, and awareness are not available. Methods Between January and June 2014, we conducted a household survey of randomly-selected adults in Northern Tanzania. To estimate prevalence we screened for CKD, which was defined as an estimated glomerular filtration rate <= 60 ml/min/1.73m2 and/or persistent albuminuria. We also screened for human immunodeficiency virus (HIV), diabetes, hypertension, obesity, and lifestyle practices including alcohol, tobacco, and traditional medicine use. Awareness was defined as a self-reported disease history and subsequently testing positive. We used population-based age-and gender-weights in estimating prevalence, and we used generalized linear models to explore potential risk factors associated with CKD, including living in an urban environment. Results We enrolled 481 adults from 346 households with a median age of 45 years. The community-based prevalence of CKD was 7.0% (95% CI 3.8-12.3), and awareness was low at 10.5% (4.7-22.0). The urban prevalence of CKD was 15.2% (9.6-23.3) while the rural prevalence was 2.0% (0.5-6.9). Half of the cases of CKD (49.1%) were not associated with any of the measured risk factors of hypertension, diabetes, or HIV. Living in an urban environment had the strongest crude (5.40; 95% CI 2.05-14.2) and adjusted prevalence risk ratio (4.80; 1.70-13.6) for CKD, and the majority (79%) of this increased risk was not explained by demographics, traditional medicine use, socioeconomic status, or co-morbid non-communicable diseases (NCDs). Conclusions We observed a high burden of CKD in Northern Tanzania that was associated with low awareness. Although demographic, lifestyle practices including traditional medicine use, socioeconomic factors, and NCDs accounted for some of the excess CKD risk observed with urban residence, much of the increased urban prevalence remained unexplained and will further study as demographic shifts reshape sub-Saharan Africa.	[Stanifer, John W.; Thielman, Nathan; Patel, Uptal D.] Duke Univ, Dept Med, Durham, NC 27708 USA; [Stanifer, John W.; Egger, Joseph; Thielman, Nathan; Turner, Elizabeth L.] Duke Univ, Duke Global Hlth Inst, Durham, NC USA; [Maro, Venance; Karia, Francis; Shimbi, Dionis; Kilaweh, Humphrey; Matemu, Oliver] Kilimanjaro Christian Med Coll, Moshi, Tanzania; [Turner, Elizabeth L.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Patel, Uptal D.] Duke Univ, Duke Clin Res Inst, Durham, NC USA	Duke University; Duke University; Duke University; Duke University	Stanifer, JW (corresponding author), Duke Univ, Dept Med, Durham, NC 27708 USA.	john.stanifer@duke.edu	Thielman, Nathan/R-5142-2019	Thielman, Nathan/0000-0001-8152-2879	NIH - Fogarty International Center [R25 TW009337]; National Institute of Mental Health; Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Master's of Science research stipend from Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER [R25TW009337] Funding Source: NIH RePORTER	NIH - Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Research and Prevention Grant - International Society of Nephrology Global Outreach Committee; Master's of Science research stipend from Duke Global Health Institute; FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	This study was supported by an NIH Research Training Grant (#R25 TW009337) funded by the Fogarty International Center and the National Institute of Mental Health; a Research and Prevention Grant funded by the International Society of Nephrology Global Outreach Committee; and a Master's of Science research stipend from the Duke Global Health Institute. There was no involvement by the funding source in the design, analysis, or writing of this study. All authors had full access to the data and had final responsibility for the decision to publish.	Agarwal SK, 2005, NEPHROL DIAL TRANSPL, V20, P1638, DOI 10.1093/ndt/gfh855; Agyei-Mensah S, 2010, J URBAN HEALTH, V87, P879, DOI 10.1007/s11524-010-9492-y; Boutayeb Abdesslam, 2005, Int J Equity Health, V4, P2, DOI 10.1186/1475-9276-4-2; Central Census Office and National Bureau of Statistics, 2013, UN REP TANZ 2012 POP; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Demographic and Health Surveys, 2013, UN REP TANZ HIV AIDS; DONNER A, 1980, BIOMETRIKA, V67, P719; Eastwood JB, 2010, NEPHROL DIAL TRANSPL, V25, P2178, DOI 10.1093/ndt/gfp765; Education Sector Development Committee, 2013, UN REP TANZ ED SECT; Fuster V, 2006, NAT CLIN PRACT CARD, V3, P401, DOI 10.1038/ncpcardio0630; Hall V, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-564; Hendriks ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032638; Hove M, 2013, STABILITY, V2, DOI 10.5334/sta.ap; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Krenzke T, 2006, P AM SOC ASS SURV RE; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mbanya JCN, 2010, LANCET, V375, P2254, DOI 10.1016/S0140-6736(10)60550-8; Naicker S, 2013, KIDNEY INT SUPPL, V3, P161, DOI 10.1038/kisup.2013.4; National AIDS Control Programme, 2005, NAT GUID VOL TEST CO; Seck SM, 2014, IRAN J KIDNEY DIS, V8, P286; Sharma SK, 2010, AM J KIDNEY DIS, V56, P915, DOI 10.1053/j.ajkd.2010.06.022; Singh AK, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-114; Stanifer JW, 2014, LANCET GLOB HEALTH, V2, pE174, DOI 10.1016/S2214-109X(14)70002-6; Sumaili EK, 2009, NEPHROL DIAL TRANSPL, V24, P117, DOI 10.1093/ndt/gfn469; Sumaili EK, 2008, NEPHRON CLIN PRACT, V110, pC220, DOI 10.1159/000167869; United Nations Office of the Secretary General, 2011, REP PREV CONTR NONC; United Nations Programme on HIV/AIDS, 2013, GETTING ZERO HIV E S; Wu S, 2012, CONTEMP CLIN TRIALS, V33, P869, DOI 10.1016/j.cct.2012.05.004; Wyatt CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069601	31	52	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124506	10.1371/journal.pone.0124506	http://dx.doi.org/10.1371/journal.pone.0124506			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886472	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000133
J	Xiang, YX; Yan, H; Zhou, J; Zhang, Q; Hanley, G; Caudle, Y; LeSage, G; Zhang, XM; Yin, DL				Xiang, Yanxiao; Yan, Hui; Zhou, Jun; Zhang, Qi; Hanley, Gregory; Caudle, Yi; LeSage, Gene; Zhang, Xiumei; Yin, Deling			The Role of Toll-Like Receptor 9 in Chronic Stress-Induced Apoptosis in Macrophage	PLOS ONE			English	Article							IN-VIVO; KINASE; EXPRESSION; IMMUNITY; PHOSPHORYLATION; PROGRESSION; INHIBITION; PATHWAYS; MORPHINE; GAMMA	Emerging evidence implied that chronic stress has been exerting detrimental impact on immune system functions in both humans and animals. Toll-like receptors (TLRs) have been shown to play an essential role in modulating immune responses and cell survival. We have recently shown that TLR9 deficiency protects against lymphocyte apoptosis induced by chronic stress. However, the exact role of TLR9 in stress-mediated change of macrophage function remains unclear. The results of the current study showed that when BALB/c mice were treated with restraint stress (12 h daily for 2 days), the number of macrophages recruited to the peritoneal cavity was obviously increased. Results also demonstrated that the sustained effects of stress elevated cytokine IL-1 beta, TNF-alpha and IL-10 production yet diminished IFN-gamma production from macrophage, which led to apoptotic cell death. However, TLR9 deficiency prevented the chronic stress-mediated accumulation of macrophages. In addition, knocking out TLR9 significantly abolished the chronic stress-induced imbalance of cytokine levels and apoptosis in macrophage. TLR9 deficiency was also found to reverse elevation of plasma IL-1 beta, IL-10 and IL-17 levels and decrease of plasma IFN-. level under the condition of chronic stress. These results indicated that TLR9-mediated macrophage responses were required for chronic stress-induced immunosuppression. Further exploration showed that TLR9 deficiency prevented the increment of p38 MAPK phosphorylation and reduction of Akt/Gsk-3 beta phosphorylation; TLR9 deficiency also attenuated the release of mitochondrial cytochrome c into cytoplasm, caused upregulation of Bcl-2/Bax protein ratio, downregulation of cleavage of caspase-3 and PARP, as well as decreased TUNEL-positive cells in macrophage of stressed mice. Collectively, our studies demonstrated that deficiency of TLR9 maintained macrophage function by modulating macrophage accumulation and attenuating macrophage apoptosis, thus preventing immunosuppression in restraint-stressed mice.	[Xiang, Yanxiao; Yan, Hui; Zhang, Qi; Caudle, Yi; LeSage, Gene; Yin, Deling] E Tennessee State Univ, Dept Internal Med, Coll Med, Johnson City, TN 37614 USA; [Xiang, Yanxiao; Zhang, Xiumei] Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Peoples R China; [Zhou, Jun] Shanghai Univ Tradit Chinese Med, Dept Radiol, Shuguang Hosp, Shanghai, Peoples R China; [Hanley, Gregory] E Tennessee State Univ, Coll Med, Lab Anim Resources, Johnson City, TN 37614 USA	East Tennessee State University; Shandong University; Shanghai University of Traditional Chinese Medicine; East Tennessee State University	Zhang, XM (corresponding author), Shandong Univ, Dept Pharmacol, Sch Med, Jinan 250100, Peoples R China.	zhangxm@sdu.edu.cn; yin@etsu.edu		Yan, Hui/0000-0002-6990-2526	NIH [NIGMS94740]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by research grant NIGMS94740 from NIH to D. Yin.	Andjelkovic M, 1997, J BIOL CHEM, V272, P31515, DOI 10.1074/jbc.272.50.31515; Beutler B, 2004, MOL IMMUNOL, V40, P845, DOI 10.1016/j.molimm.2003.10.005; Chang CW, 2009, J BIOL CHEM, V284, P33195, DOI 10.1074/jbc.M109.020586; Chen L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009205; Cheng MG, 1998, P NATL ACAD SCI USA, V95, P1091, DOI 10.1073/pnas.95.3.1091; Deveraux QL, 1998, EMBO J, V17, P2215, DOI 10.1093/emboj/17.8.2215; Dhabhar FS, 1997, BRAIN BEHAV IMMUN, V11, P286, DOI 10.1006/brbi.1997.0508; Dominguez-Gerpe L, 2001, BMC Immunol, V2, P7, DOI 10.1186/1471-2172-2-7; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; ELIAS JA, 1985, J IMMUNOL, V135, P3198; Gowda NM, 2012, J IMMUNOL, V188, P5073, DOI 10.4049/jimmunol.1102143; He L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018190; Hu D, 2014, BRAIN BEHAV IMMUN, V36, P118, DOI 10.1016/j.bbi.2013.10.016; Hu D, 2013, CELL IMMUNOL, V283, P18, DOI 10.1016/j.cellimm.2013.05.007; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kour K, 2011, NEUROPHARMACOLOGY, V60, P852, DOI 10.1016/j.neuropharm.2011.01.001; Li H., 2010, MODERN MED J, V3, P003; Li HX, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-143; Li H, 2011, J NEUROIMMUNOL, V233, P73, DOI 10.1016/j.jneuroim.2010.11.015; Liang XQ, 2010, BLOOD, V115, P5041, DOI 10.1182/blood-2009-03-213363; Maes M, 2001, CLIN SCI, V101, P193, DOI 10.1042/CS20010157; Martin M, 2005, NAT IMMUNOL, V6, P777, DOI 10.1038/ni1221; Maus U, 2002, AM J RESP CRIT CARE, V165, P95, DOI 10.1164/ajrccm.165.1.2106148; Moon DO, 2007, ACTA PHARMACOL SIN, V28, P1205, DOI 10.1111/j.1745-7254.2007.00615.x; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Nilsson EM, 2010, EXP CELL RES, V316, P800, DOI 10.1016/j.yexcr.2009.11.019; Palermo-Neto J, 2003, BRAIN BEHAV IMMUN, V17, P43, DOI 10.1016/S0889-1591(02)00057-0; Ponferrada A, 2007, GASTROENTEROLOGY, V132, P1791, DOI 10.1053/j.gastro.2007.02.032; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reiche EMV, 2004, LANCET ONCOL, V5, P617, DOI 10.1016/S1470-2045(04)01597-9; Riquelme P, 2013, MOL THER, V21, P409, DOI 10.1038/mt.2012.168; Ropert C, 2001, J IMMUNOL, V166, P3423, DOI 10.4049/jimmunol.166.5.3423; Sarkar DK, 2012, CANCER RES, V72, P836, DOI 10.1158/0008-5472.CAN-11-3292; Shan M, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003041; Shi YF, 2003, BRAIN BEHAV IMMUN, V17, pS18; Singhal PC, 2002, J IMMUNOL, V168, P4025, DOI 10.4049/jimmunol.168.8.4025; Sun XM, 1999, J BIOL CHEM, V274, P5053, DOI 10.1074/jbc.274.8.5053; Thirunavukkarasu S, 2013, VET IMMUNOL IMMUNOP, V156, P20, DOI 10.1016/j.vetimm.2013.08.008; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zhang Y, 2008, J NEUROIMMUNOL, V200, P71, DOI 10.1016/j.jneuroim.2008.06.014; Zhang Y, 2008, J NEUROIMMUNOL, V194, P115, DOI 10.1016/j.jneuroim.2007.12.002; Zhang Y, 2008, J NEUROIMMUNOL, V204, P13, DOI 10.1016/j.jneuroim.2008.08.011	43	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123447	10.1371/journal.pone.0123447	http://dx.doi.org/10.1371/journal.pone.0123447			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885582	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000066
J	Liu, L; Li, XS; Yuan, R; Zhang, HH; Qiang, LX; Shen, JL; Jin, SD				Liu, Li; Li, Xiangshun; Yuan, Rui; Zhang, Honghong; Qiang, Lixia; Shen, Jingling; Jin, Shoude			Associations of ABHD2 Genetic Variations with Risks for Chronic Obstructive Pulmonary Disease in a Chinese Han Population	PLOS ONE			English	Article							MICE LACKING; COPD; BURDEN; EPIDEMIOLOGY; EXPRESSION; MANAGEMENT; SMOKING	The human alpha/beta hydrolase domain-containing protein 2 gene (ABHD2) plays a critical role in pulmonary emphysema, a major subset of the clinical entity known as chronic obstructive pulmonary disease (COPD). Here, we evaluated genetic variation in the ABHD2 gene in a Chinese Han population of 286 COPD patients and 326 control subjects. The rs12442260 CT/CC genotype was associated with COPD (P < 0.001) under a dominant model. In the former-smoker group, the rs12442260 TT genotype was associated with a decreased risk of developing COPD after adjusting for age, gender and pack-years (P = 0.012). Rs12442260 was also associated with pre-FEV1 (the predicted bronchodilator forced expiratory volume in the first second) in controls (P = 0.027), but with FEV1/forced vital capacity (FVC) ratios only in COPD patients (P = 0.012) under a dominant model. Results from the current study suggest that ABHD2 gene polymorphisms contribute to COPD susceptibility in the Chinese Han population.	[Liu, Li; Yuan, Rui; Zhang, Honghong; Shen, Jingling] Harbin Med Univ, Dept Histol & Embryol, Harbin 150001, Heilongjiang Pr, Peoples R China; [Li, Xiangshun; Qiang, Lixia; Jin, Shoude] Harbin Med Univ, Hosp 4, Div Resp Dis, Harbin 150001, Heilongjiang Pr, Peoples R China	Harbin Medical University; Harbin Medical University	Liu, L (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin 150001, Heilongjiang Pr, Peoples R China.	shenjingling@rocketmail.com; jinshoude@163.com			National Natural Science Foundation of China [30900413]; Science Foundation of Heilongjiang Province of China [LC201024]; National Basic Science Research Program of China (973 Program) [2012CBA01303]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of Heilongjiang Province of China; National Basic Science Research Program of China (973 Program)(National Basic Research Program of China)	This study was funded by the National Natural Science Foundation of China (30900413), Science Foundation of Heilongjiang Province of China (LC201024), the National Basic Science Research Program of China (973 Program) (grant no. 2012CBA01303).	Anto JM, 2001, EUR RESPIR J, V17, P982, DOI 10.1183/09031936.01.17509820; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; BURCHFIEL CM, 1995, AM J RESP CRIT CARE, V151, P1778, DOI 10.1164/ajrccm.151.6.7767520; Castaldi PJ, 2010, HUM MOL GENET, V19, P526, DOI 10.1093/hmg/ddp519; Celli BR, 2008, CHEST, V133, P1451, DOI 10.1378/chest.07-2061; Chen YX, 2006, BIOCHEM BIOPH RES CO, V340, P758, DOI 10.1016/j.bbrc.2005.12.068; Edgar AJ, 2002, BIOCHEM BIOPH RES CO, V292, P617, DOI 10.1006/bbrc.2002.6692; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FLETCHER C, 1977, BMJ-BRIT MED J, V1, P1645, DOI 10.1136/bmj.1.6077.1645; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Hogg JC, 2009, ANNU REV PATHOL-MECH, V4, P435, DOI 10.1146/annurev.pathol.4.110807.092145; Ito K, 2009, CHEST, V135, P173, DOI 10.1378/chest.08-1419; Jin S, 2009, BIOCHEM BIOPH RES CO, V380, P419, DOI 10.1016/j.bbrc.2009.01.098; Lokke A, 2006, THORAX, V61, P935, DOI 10.1136/thx.2006.062802; Lopez AD, 2006, EUR RESPIR J, V27, P397, DOI 10.1183/09031936.06.00025805; Mannino David M, 2002, MMWR Surveill Summ, V51, P1; Miyata K, 2005, BIOCHEM BIOPH RES CO, V329, P296, DOI 10.1016/j.bbrc.2005.01.127; Miyata K, 2008, BIOCHEM BIOPH RES CO, V365, P207, DOI 10.1016/j.bbrc.2007.10.127; Nakamura Hidetoshi, 2011, Allergology International, V60, P253, DOI 10.2332/allergolint.11-RAI-0326; Parikh I, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-32; Pauwels RA, 2004, LANCET, V364, P613, DOI 10.1016/S0140-6736(04)16855-4; Pauwels Romain A., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1256; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Rennard SI, 2004, LANCET, V364, P791, DOI 10.1016/S0140-6736(04)16941-9; Sandford AJ, 2002, THORAX, V57, P736, DOI 10.1136/thorax.57.8.736; Sethi JM, 2000, CLIN CHEST MED, V21, P67, DOI 10.1016/S0272-5231(05)70008-3; Shahdoust M, 2013, ASIAN PAC J CANCER P, V14, P111, DOI 10.7314/APJCP.2013.14.1.111; Shi YY, 2005, CELL RES, V15, P97, DOI 10.1038/sj.cr.7290272; Silverman EK, 2002, CHEST, V121, p1S, DOI 10.1378/chest.121.3_suppl.1S-a; Trajkov D, 2009, IRAN J ALLERGY ASTHM, V8, P31, DOI 08.01/ijaai.3142; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; Wang XJ, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-275; Yoshida T, 2010, CANCER INFORM, V9, P147	34	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123929	10.1371/journal.pone.0123929	http://dx.doi.org/10.1371/journal.pone.0123929			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880496	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500069
J	Macianskiene, R; Martisiene, I; Navalinskas, A; Vosyliute, R; Treinys, R; Vaidelyte, B; Benetis, R; Jurevicius, J				Macianskiene, Regina; Martisiene, Irma; Navalinskas, Antanas; Vosyliute, Ruta; Treinys, Rimantas; Vaidelyte, Birute; Benetis, Rimantas; Jurevicius, Jonas			Evaluation of Excitation Propagation in the Rabbit Heart: Optical Mapping and Transmural Microelectrode Recordings	PLOS ONE			English	Article							VENTRICULAR-FIBRILLATION; PHOTON SCATTERING; CARDIAC-MUSCLE; SIGNALS; LIGHT	Background Because of the optical features of heart tissue, optical and electrical action potentials are only moderately associated, especially when near-infrared dyes are used in optical mapping (OM) studies. Objective By simultaneously recording transmural electrical action potentials (APs) and optical action potentials (OAPs), we aimed to evaluate the contributions of both electrical and optical influences to the shape of the OAP upstroke. Methods and Results A standard glass microelectrode and OM, using an near-infrared fluorescent dye (di-4-ANBDQBS), were used to simultaneously record transmural APs and OAPs in a Langendorff-perfused rabbit heart during atrial, endocardial, and epicardial pacing. The actual profile of the transmural AP upstroke across the LV wall, together with the OAP upstroke, allowed for calculations of the probing-depth constant (k similar to 2.1 mm, n = 24) of the fluorescence measurements. In addition, the transmural AP recordings aided the quantitative evaluation of the influences of depth-weighted and lateral-scattering components on the OAP upstroke. These components correspond to the components of the propagating electrical wave that are transmural and parallel to the epicardium. The calculated mean values for the depth-weighted and lateral-scattering components, whose sum comprises the OAP upstroke, were (in ms) 10.18 +/- 0.62 and 0.0 +/- 0.56 for atrial stimulation, 9.37 +/- 1.12 and 3.01 +/- 1.30 for endocardial stimulation, and 6.09 +/- 0.79 and 8.16 +/- 0.98 for epicardial stimulation; (n = 8 for each). For this dye, 90% of the collected fluorescence originated up to 4.83 +/- 0.18 mm (n = 24) from the epicardium. Conclusions The co-registration of OM and transmural microelectrode APs enabled the probing depth of fluorescence measurements to be calculated and the OAP upstroke to be divided into two components (depth-weighted and lateral-scattering), and it also allowed the relative strengths of their effects on the shape of the OAP upstroke to be evaluated.	[Macianskiene, Regina; Martisiene, Irma; Navalinskas, Antanas; Vosyliute, Ruta; Treinys, Rimantas; Vaidelyte, Birute; Benetis, Rimantas; Jurevicius, Jonas] Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania	Lithuanian University of Health Sciences	Macianskiene, R (corresponding author), Lithuanian Univ Hlth Sci, Inst Cardiol, Kaunas, Lithuania.	jonas.jurevicius@lsmuni.lt		Treinys, Rimantas/0000-0002-7590-7606	European Social Fund under the Global Grant measure	European Social Fund under the Global Grant measure	This research was funded by the European Social Fund under the Global Grant measure. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter WT, 2001, BIOPHYS J, V80, P516, DOI 10.1016/S0006-3495(01)76034-1; Bishop MJ, 2007, BIOPHYS J, V93, P3714, DOI 10.1529/biophysj.107.110981; Bishop MJ, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00338; Bishop MJ, 2006, BIOPHYS J, V90, P2938, DOI 10.1529/biophysj.105.076505; Ding L, 2001, IEEE T BIO-MED ENG, V48, P1098, DOI 10.1109/10.951512; Efimov IR, 1998, CIRCULATION, V98, P54, DOI 10.1161/01.CIR.98.1.54; EFIMOV IR, 1994, CIRCULATION, V90, P1469, DOI 10.1161/01.CIR.90.3.1469; Fedorov VV, 2007, HEART RHYTHM, V4, P619, DOI 10.1016/j.hrthm.2006.12.047; Gardner CM, 1996, LASER SURG MED, V18, P129; GILMOUR RF, 1984, AM J PHYSIOL, V247, pH303, DOI 10.1152/ajpheart.1984.247.2.H303; Girouard SD, 1996, J CARDIOVASC ELECTR, V7, P1024, DOI 10.1111/j.1540-8167.1996.tb00478.x; Hyatt CJ, 2005, CIRC RES, V97, P277, DOI 10.1161/01.RES.0000176022.74579.47; Hyatt CJ, 2003, BIOPHYS J, V85, P2673, DOI 10.1016/S0006-3495(03)74690-6; Kanaporis G, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.9.096007; Kelly A, 2013, CIRC-ARRHYTHMIA ELEC, V6, P809, DOI 10.1161/CIRCEP.113.000334; KNISLEY SB, 1995, CIRC RES, V77, P1229, DOI 10.1161/01.RES.77.6.1229; Knisley SB, 2003, ANN BIOMED ENG, V31, P32, DOI 10.1114/1.1535413; Kong W, 2012, AM J PHYSIOL-HEART C, V302, pH1294, DOI 10.1152/ajpheart.00426.2011; Masse S, 2007, AM J PHYSIOL-HEART C, V292, pH2589, DOI 10.1152/ajpheart.01336.2006; Mitrea BG, 2009, IEEE ENG MED BIO, P4194, DOI 10.1109/IEMBS.2009.5334048; Nanthakumar K, 2007, AM J PHYSIOL-HEART C, V293, pH875, DOI 10.1152/ajpheart.01415.2006; Spach MS, 1998, CIRC RES, V83, P1144, DOI 10.1161/01.RES.83.11.1144; Svaasand L O, 1984, Prog Clin Biol Res, V170, P91; Walton RD, 2012, BIOPHYS J, V102, P30, DOI 10.1016/j.bpj.2011.10.036; Walton RD, 2009, IEEE ENG MED BIO, P4523, DOI 10.1109/IEMBS.2009.5334106; Warren M, 2010, AM J PHYSIOL-HEART C, V299, pH1271, DOI 10.1152/ajpheart.00248.2010; Welch AJ, 1997, LASER SURG MED, V21, P166, DOI 10.1002/(SICI)1096-9101(1997)21:2<166::AID-LSM8>3.3.CO;2-Q	28	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123050	10.1371/journal.pone.0123050	http://dx.doi.org/10.1371/journal.pone.0123050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881157	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500036
J	Mutimura, E; Hoover, DR; Shi, QH; Dusingize, JC; Sinayobye, JD; Cohen, M; Anastos, K				Mutimura, Eugene; Hoover, Donald R.; Shi, Qiuhu; Dusingize, Jean Claude; Sinayobye, Jean D'Amour; Cohen, Mardge; Anastos, Kathryn			Insulin Resistance Change and Antiretroviral Therapy Exposure in HIV-Infected and Uninfected Rwandan Women: A Longitudinal Analysis	PLOS ONE			English	Article							HOMEOSTASIS MODEL ASSESSMENT; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; DATA-COLLECTION; ADVERSE EVENTS; SENSITIVITY; COHORT; RISK; PREVALENCE; HEART	Background We longitudinally assessed predictors of insulin resistance (IR) change among HIV-uninfected and HIV-infected (ART-initiators and ART-non-initiators) Rwandan women. Methodology HIV-infected (HIV+) and uninfected (HIV-) women provided demographic and clinical measures: age, body mass index (BMI) in Kg/(height in meters)(2), Fat-Mass (FMI) and Fat-FreeMass (FFMI) index, fasting serum glucose and insulin. Homeostasis Model Assessment (HOMA) was calculated to estimate IR change over time in log(10) transformed HOMA measured at study enrollment or prior to ART initiation in 3 groups: HIV-(n = 194), HIV+ART-non- initiators (n= 95) and HIV+ART-initiators (n= 371). ANCOVA linear regression models of change in log(10)-HOMA were fit with all models included the first log10 HOMA as a predictor. Results Mean +/- SD log(10)-HOMA was -0.18 +/- 0.39 at the 1st and -0.21 +/- 0.41 at the 2nd measure, with mean change of 0.03 +/- 0.44. In the final model (all women) BMI at 1st HOMA measure (0.014; 95% CI= 0.006-0.021 per kg/m(2); p<0.001) and change in BMI from 1st to 2nd measure (0.024; 95% CI= 0.013-0.035 per kg/ m(2); p<0.001) predicted HOMA change. When restricted to subjects with FMI measures, FMI at 1st HOMA measure (0.020; 95% CI=0.0100.030 per kg/ m(2); p<0.001) and change in FMI from 1st to 2nd measure (0.032; 95% CI=0.020-0.043 per kg/m2; p<0.0001) predicted change in HOMA. While ART use did not predict change in log(10)-HOMA, untreated HIV+women had a significant decline in IR over time. Use or duration of AZT, d4T and EFV was not associated with HOMA change in HIV+women. Conclusions Baseline BMI and change in BMI, and in particular fat mass and change in fat mass predicted insulin resistance change over similar to 3 years in HIV-infected and uninfected Rwandan women. Exposure to specific ART (d4T, AZT, EFV) did not predict insulin resistance change in ART-treated HIV-infected Rwandan women.	[Mutimura, Eugene; Dusingize, Jean Claude; Sinayobye, Jean D'Amour] Reg Alliance Sustainable Dev RASD Rwanda Kigali, Kigali, Rwanda; [Hoover, Donald R.] SUNY, New Brunswick, NJ USA; [Shi, Qiuhu] New York Med Coll, Sch Hlth Sci & Practice, New York, NY USA; [Cohen, Mardge] Stroger Hosp, Dept Med, Chicago, IL USA; [Anastos, Kathryn] Albert Einstein Coll Med, Bronx, NY 10467 USA; [Anastos, Kathryn] Montefiore Med Ctr, Bronx, NY 10467 USA	New York Medical College; John H Stroger Junior Hospital Cook County; Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine	Mutimura, E (corresponding author), Reg Alliance Sustainable Dev RASD Rwanda Kigali, Kigali, Rwanda.	eugene.mutimura@gmail.com		Dusingize, Jean Claude/0000-0001-5721-100X	National Institute of Allergy and Infectious [UO1-AI-35004]; Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center - National Institutes of Health [NIH AI-51519]; Fogarty International Center of the National Institutes of Health [D71TW009618]; Central Africa International Epidemiological Databases (IeDEA) to evaluate AIDS [5U01-AI-096299]; AIDS International Training and Research Program (Fogarty International Center) [NIH D43-TW001403]; FOGARTY INTERNATIONAL CENTER [D71TW009618, D43TW001403] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001073] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI096299, U01AI035004] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center - National Institutes of Health; Fogarty International Center of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Central Africa International Epidemiological Databases (IeDEA) to evaluate AIDS; AIDS International Training and Research Program (Fogarty International Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was supported by supplements from the National Institute of Allergy and Infectious Diseases to the Bronx/Manhattan Women's Interagency HIV Study (WIHS), which is funded by the National Institute of Allergy and Infectious (UO1-AI-35004). The study was also supported in part by the Center for AIDS Research of the Albert Einstein College of Medicine and Montefiore Medical Center funded by the National Institutes of Health (NIH AI-51519) and by the Fogarty International Center of the National Institutes of Health under Award Number D71TW009618, and the Central Africa International Epidemiological Databases (IeDEA) to evaluate AIDS (5U01-AI-096299). Additional support was provided by the AIDS International Training and Research Program (Fogarty International Center, NIH D43-TW001403).	Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Boufassa F, 2012, ANTIVIR THER, V17, P91, DOI 10.3851/IMP1916; Brar I, 2007, JAIDS-J ACQ IMM DEF, V45, P66, DOI 10.1097/QAI.0b013e318031d7e3; Brown TT, 2005, ARCH INTERN MED, V165, P1179, DOI 10.1001/archinte.165.10.1179; Butt AA, 2009, AIDS, V23, P1227, DOI 10.1097/QAD.0b013e32832bd7af; Capeau J, 2012, AIDS, V26, P303, DOI 10.1097/QAD.0b013e32834e8776; Danoff A, 2005, JAIDS-J ACQ IMM DEF, V39, P55, DOI 10.1097/01.qai.0000147659.80642.5a; Dave JA, 2011, JAIDS-J ACQ IMM DEF, V57, P284, DOI 10.1097/QAI.0b013e318221863f; De Wit S, 2008, DIABETES CARE, V31, P1224, DOI 10.2337/dc07-2013; Dusingize JC, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003879; Dusingize JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035079; Hanson RL, 2000, AM J EPIDEMIOL, V151, P190; Henderson M, 2011, DIABETES METAB, V37, P72, DOI 10.1016/j.diabet.2010.06.008; Idiculla J, 2011, INT J GEN MED, V4, P73, DOI 10.2147/IJGM.S15818; Justman JE, 2003, JAIDS-J ACQ IMM DEF, V32, P298, DOI 10.1097/00126334-200303010-00009; Kalra S, 2013, CURR DIABETES REP, V13, P419, DOI 10.1007/s11892-013-0369-9; Kiage JN, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-50; Kiefer E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029625; Kotler Donald P., 1996, American Journal of Clinical Nutrition, V64, p489S, DOI 10.1093/ajcn/64.3.489S; Ledergerber B, 2007, CLIN INFECT DIS, V45, P111, DOI 10.1086/518619; Maruthur NM, 2013, CURR DIABETES REP, V13, P786, DOI 10.1007/s11892-013-0426-4; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menezes CN, 2014, HIV MED, V15, P3, DOI 10.1111/hiv.12074; Petoumenos K, 2012, J INT AIDS SOC, V15, DOI 10.7448/IAS.15.2.17426; Senn S, 2006, STAT MED, V25, P4334, DOI 10.1002/sim.2682; Shao YM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007187; Thienemann F, 2013, EUR HEART J, V34, P3538, DOI 10.1093/eurheartj/eht388; Tien PC, 2008, JAIDS-J ACQ IMM DEF, V49, P369, DOI 10.1097/QAI.0b013e318189a780; UNAIDS, 2010, UNAIDS REP GLOB AIDS; Worm SW, 2009, CIRCULATION, V119, P805, DOI 10.1161/CIRCULATIONAHA.108.790857	30	6	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123936	10.1371/journal.pone.0123936	http://dx.doi.org/10.1371/journal.pone.0123936			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880634	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500070
J	Wu, Q; Jiang, D; Huang, CJ; van Dyk, LF; Li, LW; Chu, HW				Wu, Qun; Jiang, Di; Huang, Chunjian; van Dyk, Linda F.; Li, Liwu; Chu, Hong Wei			Trehalose-Mediated Autophagy Impairs the Anti-Viral Function of Human Primary Airway Epithelial Cells	PLOS ONE			English	Article							C VIRUS-INFECTION; RHINOVIRUS INFECTION; VIRAL-INFECTIONS; DENDRITIC CELLS; INNATE IMMUNITY; KINASE M; INDUCTION; ASTHMA; MECHANISM; ALPHA	Human rhinovirus (HRV) is the most common cause of acute exacerbations of chronic lung diseases including asthma. Impaired anti-viral IFN-.1 production and increased HRV replication in human asthmatic airway epithelial cells may be one of the underlying mechanisms leading to asthma exacerbations. Increased autophagy has been shown in asthmatic airway epithelium, but the role of autophagy in anti-HRV response remains uncertain. Trehalose, a natural glucose disaccharide, has been recognized as an effective autophagy inducer in mammalian cells. In the current study, we used trehalose to induce autophagy in normal human primary airway epithelial cells in order to determine if autophagy directly regulates the anti-viral response against HRV. We found that trehalose-induced autophagy significantly impaired IFN-lambda 1 expression and increased HRV-16 load. Inhibition of autophagy via knockdown of autophagy-related gene 5 (ATG5) effectively rescued the impaired IFN-lambda 1 expression by trehalose and subsequently reduced HRV-16 load. Mechanistically, ATG5 protein interacted with retinoic acid-inducible gene I (RIG-I) and IFN-beta promoter stimulator 1 (IPS-1), two critical molecules involved in the expression of anti-viral interferons. Our results suggest that induction of autophagy in human primary airway epithelial cells inhibits the anti-viral IFN-lambda 1 expression and facilitates HRV infection. Intervention of excessive autophagy in chronic lung diseases may provide a novel approach to attenuate viral infections and associated disease exacerbations.	[Wu, Qun; Jiang, Di; Huang, Chunjian; Chu, Hong Wei] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [van Dyk, Linda F.] Univ Colorado Denver, Denver Sch Med, Dept Immunol & Microbiol, Aurora, CO USA; [Li, Liwu] Virginia Polytech Inst & State Univ, Dept Biol Sci, Blacksburg, VA 24061 USA	National Jewish Health; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Virginia Polytechnic Institute & State University	Chu, HW (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.	chuhw@njhealth.org		Li, Liwu/0000-0001-8870-5299; van Dyk, Linda/0000-0003-2662-5554	National Institutes of Health [R01AI106287, R01HL122321]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122321] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grants R01AI106287 and R01HL122321. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Byrd CM, 2013, ANTIMICROB AGENTS CH, V57, P1902, DOI 10.1128/AAC.02251-12; Contoli M, 2009, MINERVA MED, V100, P467; Contoli M, 2006, NAT MED, V12, P1023, DOI 10.1038/nm1462; Delgado M, 2009, IMMUNOL REV, V227, P189, DOI 10.1111/j.1600-065X.2008.00725.x; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Guevin C, 2010, VIROLOGY, V405, P1, DOI 10.1016/j.virol.2010.05.032; Hao WD, 2012, J VIROL, V86, P13524, DOI 10.1128/JVI.02094-12; Henault J, 2012, IMMUNITY, V37, P986, DOI 10.1016/j.immuni.2012.09.014; Hermant P, 2014, J INNATE IMMUN, V6, P563, DOI 10.1159/000360084; Horikawa I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5706; Ioannidis I, 2013, J VIROL, V87, P3261, DOI 10.1128/JVI.01956-12; Jounai N, 2007, P NATL ACAD SCI USA, V104, P14050, DOI 10.1073/pnas.0704014104; Ke PY, 2011, J CLIN INVEST, V121, P37, DOI 10.1172/JCI41474; Khaitov MR, 2009, ALLERGY, V64, P375, DOI 10.1111/j.1398-9995.2008.01826.x; Martin LJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033454; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; Minutoli L, 2007, SHOCK, V27, P91, DOI 10.1097/01.shk.0000235092.76292.bc; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mo RH, 2012, MOL BIOTECHNOL, V51, P1, DOI 10.1007/s12033-011-9422-6; Mosser AG, 2005, AM J RESP CRIT CARE, V171, P645, DOI 10.1164/rccm.200407-970OC; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Newcomb DC, 2008, AM J RESP CRIT CARE, V177, P1111, DOI 10.1164/rccm.200708-1243OC; Nobre A, 2014, MICROBIOL-SGM, V160, P1547, DOI 10.1099/mic.0.075895-0; Okamoto M, 2014, J IMMUNOL, V192, P2770, DOI 10.4049/jimmunol.1301459; Onoguchi K, 2007, J BIOL CHEM, V282, P7576, DOI 10.1074/jbc.M608618200; Papadopoulos NG, 2000, J INFECT DIS, V181, P1875, DOI 10.1086/315513; Poon AH, 2012, J ALLERGY CLIN IMMUN, V129, P569, DOI 10.1016/j.jaci.2011.09.035; Reikine S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00342; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Stock Ingo, 2014, Med Monatsschr Pharm, V37, P44; Suarez AL, 2011, J VIROL, V85, P6293, DOI 10.1128/JVI.00001-11; Sykes A, 2014, THORAX, V69, P240, DOI 10.1136/thoraxjnl-2012-202909; Takeshita F, 2008, AUTOPHAGY, V4, P67, DOI 10.4161/auto.5055; Wat D, 2008, J CYST FIBROS, V7, P320, DOI 10.1016/j.jcf.2007.12.002; Wu Q, 2013, VIROLOGY, V446, P199, DOI 10.1016/j.virol.2013.08.005; Wu Q, 2012, J ALLERGY CLIN IMMUN, V129, P825, DOI 10.1016/j.jaci.2011.10.043; Yordy B, 2013, INT IMMUNOL, V25, P1, DOI 10.1093/intimm/dxs101; Zaru M, 2007, EUR J PHARM BIOPHARM, V67, P655, DOI 10.1016/j.ejpb.2007.04.005; Zhang XJ, 2014, AUTOPHAGY, V10, P588, DOI 10.4161/auto.27710; Zhou DJ, 2012, J INFECT DIS, V205, P1258, DOI 10.1093/infdis/jis187	40	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124524	10.1371/journal.pone.0124524	http://dx.doi.org/10.1371/journal.pone.0124524			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879848	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500104
J	Fuller, T; Pearson, M; Peters, J; Anderson, R				Fuller, Thomas; Pearson, Mark; Peters, Jaime; Anderson, Rob			What Affects Authors' and Editors' Use of Reporting Guidelines? Findings from an Online Survey and Qualitative Interviews	PLOS ONE			English	Article							MEDICAL JOURNAL EDITORS; HEALTH RESEARCH; PUBLICATION GUIDELINES; ACCESS; TRANSPARENT; EXPERIENCE; ACCURATE; POLICIES; SCIENCE	Objectives To identify and understand, through data from multiple sources, some of the factors that affect authors' and editors' decisions to use reporting guidelines in the publication of health research. Design Mixed methods study comprising an online survey and semi-structured interviews with a sample of authors (online survey: n = 56; response rate = 32%; semi-structured interviews: n = 5) and journal editors (online survey: n = 43; response rate = 27%; semi-structured interviews: n = 6) involved in publishing health and medical research. Participants were recruited from an earlier study examining the effectiveness of the TREND reporting guideline. Results Four types of factors interacted to affect authors' and editors' likelihood of reporting guideline use; individual (e.g. having multiple reasons for use of reporting guidelines); the professional culture in which people work; environmental (e.g. policies of journals); and, practical (e.g. having time to use reporting guidelines). Having multiple reasons for using reporting guidelines was a particularly salient factor in facilitating reporting guidelines use for both groups of participants. Conclusions Improving the completeness and consistency of reporting of research studies is critical to the integrity and synthesis of health research. The use of reporting guidelines offers one potentially efficient and effective means for achieving this, but decisions to use (or not use) reporting guidelines take many factors into account. These findings could be used to inform future studies that might, for example, test the factors that we have identified within a wider theoretical framework for understanding changes in professional practices. The use of reporting guidelines by senior professionals appears to shape the expectations of what constitutes best practice and can be assimilated into the culture of a field or discipline. Without evidence of effectiveness of reporting guidelines, and sustained, multifaceted efforts to improve reporting, little progress seems likely to be made.	[Fuller, Thomas; Pearson, Mark; Anderson, Rob] Univ Exeter, Sch Med, Collaborat Leadership Appl Hlth Res & Care CLAHRC, Exeter, Devon, England; [Pearson, Mark; Peters, Jaime; Anderson, Rob] Univ Exeter, Sch Med, Evidence Synth & Modelling Hlth Improvement ESMI, Exeter, Devon, England	University of Exeter; University of Exeter	Fuller, T (corresponding author), Maastricht Univ, Fac Psychol & Neurosci, Dept Clin Psychol Sci, NL-6200 MD Maastricht, Limburg, Netherlands.	thomas.fuller@maastrichtuniversity.nl	Pearson, Mark/ABH-8108-2020	Fuller, Thomas/0000-0001-7909-9805; Peters, Judith/0000-0003-0979-1016	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula	National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula	This report presents independent research funded by the National Institute for Health Research (NIHR) Collaboration for Leadership in Applied Health Research and Care (CLAHRC) for the South West Peninsula (http://clahrc-peninsula.nihr.ac.uk/). The views expressed in this publication are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health in England. PenCLAHRC has the scope to appraise and fund projects consistent with its aims, as in the case of the project investigating factors affecting the uptake and impact of reporting guidelines. The project was subject to internal and external peer review in considering its value to PenCLAHRC but does not have a specific grant number. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2010, J ANTIMICROB CHEMOTH, V65, P1, DOI 10.1093/jac/dkp410; Bossuyt PM, 2003, CLIN CHEM, V49, P1, DOI 10.1373/49.1.1; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burford BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075122; Chan AW, 2005, BMJ-BRIT MED J, V330, P753, DOI 10.1136/bmj.38356.424606.8F; Cook C, 2000, EDUC PSYCHOL MEAS, V60, P821, DOI 10.1177/00131640021970934; Cozzarelli NR, 2004, P NATL ACAD SCI USA, V101, P1111, DOI 10.1073/pnas.0307315101; da Costa BR, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2010-000048; Davidoff F, 2008, QUAL SAF HEALTH CARE, V17, P3, DOI 10.1136/qshc.2008.029066; Des Jarlais DC, 2004, AM J PUBLIC HEALTH, V94, P361, DOI 10.2105/AJPH.94.3.361; EQUATOR, 2013, REP GUID LIB; Eysenbach G, 2004, J MED INTERNET RES, V6, P12, DOI 10.2196/jmir.6.3.e34; Freda MC, 2005, J NURS SCHOLARSHIP, V37, P87, DOI 10.1111/j.1547-5069.2005.00006.x; Fuller T, 2012, EQUATOR S, P49; Fuller T, 2012, BMJ OPEN, P2; Fuller T, 2014, AM J PUBLIC HEALTH, V104, pE110, DOI 10.2105/AJPH.2014.302195; Garrow J, 1998, JAMA-J AM MED ASSOC, V280, P286, DOI 10.1001/jama.280.3.286; Good CD, 1999, S AFR MED J, V89, P397; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Higgins JPT, 2022, COCHRANE HDB SYSTEMA, DOI DOI 10.1002/9781119536604; Hopewell S, 2008, TRIALS, V9, DOI 10.1186/1745-6215-9-20; Keen A, 2007, NURS EDUC TODAY, V27, P382, DOI 10.1016/j.nedt.2006.05.019; Larson EL, 2012, J CLIN EPIDEMIOL, V65, P239, DOI 10.1016/j.jclinepi.2011.07.008; Macleod MR, 2014, LANCET, V383, P101, DOI 10.1016/S0140-6736(13)62329-6; Marusic A, 2003, ACAD MED, V78, P1235, DOI 10.1097/00001888-200312000-00007; Marusic A, 2013, MED TEACH, V35, P609, DOI 10.3109/0142159X.2013.772969; May C, 2013, IMPLEMENT SCI, V8, DOI 10.1186/1748-5908-8-18; McShane LM, 2005, BRIT J CANCER, V93, P387, DOI 10.1038/sj.bjc.6602678; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moher D, 2011, J CLIN EPIDEMIOL, V64, P718, DOI 10.1016/j.jclinepi.2010.09.013; Pullenayegum EM, 2012, J STAT ED, V20, pn1; Roberts J, 2013, SUCCESSFUL IMPLEMENT; Roberts J, 2012, POTENTIAL BARRIERS J; Roberts J, 2010, HEADACHE, V50, P345, DOI 10.1111/j.1526-4610.2010.01612.x; Schroter S, 2006, J ROY SOC MED, V99, P141, DOI 10.1258/jrsm.99.3.141; Schroter S, 2006, BRIT MED J, V332, P394, DOI 10.1136/bmj.38705.490961.55; Schulz KF, 2010, BMC MED, V8, DOI [10.1186/1741-7015-8-18, 10.1136/bmj.c332]; Shamseer L, 2013, 7 INT C PEER REV BIO; Simera I, 2008, PLOS MED, V5, P869, DOI 10.1371/journal.pmed.0050139; Smyth RMD, 2011, BRIT MED J, V342; Stevens A, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g3804; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; To MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084779; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Turner L, 2012, SYST REV-LONDON, V1, DOI 10.1186/2046-4053-1-60; von Elm E, 2007, LANCET, V370, P1453, DOI 10.1016/S0140-6736(07)61602-X; Wager E, 2009, J MED ETHICS, V35, P348, DOI 10.1136/jme.2008.028324; WILKES MS, 1995, J GEN INTERN MED, V10, P443, DOI 10.1007/BF02599916; Wong VSS, 2012, J CLIN EPIDEMIOL, V65, P247, DOI 10.1016/j.jclinepi.2011.08.003	49	23	24	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121585	10.1371/journal.pone.0121585	http://dx.doi.org/10.1371/journal.pone.0121585			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875918	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800024
J	Felsmann, K; Baudis, M; Gimbel, K; Kayler, ZE; Ellerbrock, R; Bruehlheide, H; Bruckhoff, J; Welk, E; Puhlmann, H; Weiler, M; Gessler, A; Ulrich, A				Felsmann, Katja; Baudis, Mathias; Gimbel, Katharina; Kayler, Zachary E.; Ellerbrock, Ruth; Bruehlheide, Helge; Bruckhoff, Johannes; Welk, Erik; Puhlmann, Heike; Weiler, Markus; Gessler, Arthur; Ulrich, Andreas			Soil Bacterial Community Structure Responses to Precipitation Reduction and Forest Management in Forest Ecosystems across Germany	PLOS ONE			English	Article							INDUCED TREE MORTALITY; MICROBIAL COMMUNITY; RIBOSOMAL-RNA; HERBACEOUS-LAYER; CLIMATE-CHANGE; DROUGHT; CARBON; DIVERSITY; GROWTH; WATER	Soil microbial communities play an important role in forest ecosystem functioning, but how climate change will affect the community composition and consequently bacterial functions is poorly understood. We assessed the effects of reduced precipitation with the aim of simulating realistic future drought conditions for one growing season on the bacterial community and its relation to soil properties and forest management. We manipulated precipitation in beech and conifer forest plots managed at different levels of intensity in three different regions across Germany. The precipitation reduction decreased soil water content across the growing season by between 2 to 8% depending on plot and region. T-RFLP analysis and pyrosequencing of the 16S rRNA gene were used to study the total soil bacterial community and its active members after six months of precipitation reduction. The effect of reduced precipitation on the total bacterial community structure was negligible while significant effects could be observed for the active bacteria. However, the effect was secondary to the stronger influence of specific soil characteristics across the three regions and management selection of overstorey tree species and their respective understorey vegetation. The impact of reduced precipitation differed between the studied plots; however, we could not determine the particular parameters being able to modify the response of the active bacterial community among plots. We conclude that the moderate drought induced by the precipitation manipulation treatment started to affect the active but not the total bacterial community, which points to an adequate resistance of the soil microbial system over one growing season.	[Felsmann, Katja; Kayler, Zachary E.; Ellerbrock, Ruth; Bruckhoff, Johannes; Gessler, Arthur; Ulrich, Andreas] Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany; [Baudis, Mathias; Bruehlheide, Helge; Welk, Erik] Univ Halle Wittenberg, Inst Biology Geobot & Bot Garden, D-06108 Halle, Germany; [Gimbel, Katharina; Puhlmann, Heike; Weiler, Markus] Univ Freiburg, Fac Environm & Nat Resources, D-79106 Freiburg, Germany; [Puhlmann, Heike] Forest Res Inst Baden Wurttemberg, Dept Soils & Environm, Freiburg, Germany; [Gessler, Arthur] Berlin Brandenburg Inst Adv Biodivers Res BBIB, Berlin, Germany; [Gessler, Arthur] Swiss Fed Inst Forest Snow & Landscape Res WSL, Birmensdorf, Switzerland	Leibniz Zentrum fur Agrarlandschaftsforschung (ZALF); Martin Luther University Halle Wittenberg; University of Freiburg; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Ulrich, A (corresponding author), Leibniz Ctr Agr Landscape Res ZALF, Inst Landscape Biogeochem, Muncheberg, Germany.	aulrich@zalf.de	Weiler, Markus/F-5584-2011; Gessler, Arthur/C-7121-2008; Gimbel, Katharina/M-6279-2015; Ulrich, Andreas/G-3956-2012; WELK, Erik/AGL-4971-2022	Weiler, Markus/0000-0001-6245-6917; Gessler, Arthur/0000-0002-1910-9589; Gimbel, Katharina/0000-0003-4555-1773; Ulrich, Andreas/0000-0003-3854-9608; Kayler, Zachary/0000-0003-0090-7537	DFG [GE1090/11-1, BR1698/16-1, WE4598/3-1]	DFG(German Research Foundation (DFG))	The work has been funded by the DFG Priority Program 1374 "Infrastructure-Biodiversity-Exploratories" (DFG-Refno.WE4598/3-1, GE1090/11-1, and BR1698/16-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen CD, 2010, FOREST ECOL MANAG, V259, P660, DOI 10.1016/j.foreco.2009.09.001; Anderegg WRL, 2012, P NATL ACAD SCI USA, V109, P233, DOI 10.1073/pnas.1107891109; [Anonymous], 1994, 10694 DIN ISO; Bachmair S, 2009, J HYDROL, V369, P241, DOI 10.1016/j.jhydrol.2009.02.031; Baldrian P, 2012, ISME J, V6, P248, DOI 10.1038/ismej.2011.95; Barnard RL, 2013, ISME J, V7, P2229, DOI 10.1038/ismej.2013.104; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baudis M, 2014, FOREST ECOL MANAG, V330, P283, DOI 10.1016/j.foreco.2014.07.012; Blazewicz SJ, 2013, ISME J, V7, P2061, DOI 10.1038/ismej.2013.102; Bouskill NJ, 2013, ISME J, V7, P384, DOI 10.1038/ismej.2012.113; Breda N, 2006, ANN FOREST SCI, V63, P625, DOI 10.1051/forest:2006042; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Cregger MA, 2012, APPL ENVIRON MICROB, V78, P8587, DOI 10.1128/AEM.02050-12; Crowther TW, 2014, GLOBAL CHANGE BIOL, V20, P2983, DOI 10.1111/gcb.12565; Dimitriu PA, 2010, MICROB ECOL, V59, P563, DOI 10.1007/s00248-009-9590-0; Dunbar J, 2001, APPL ENVIRON MICROB, V67, P190, DOI 10.1128/AEM.67.1.190-197.2001; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Evans SE, 2014, ECOLOGY, V95, P110, DOI 10.1890/13-0500.1; Field C. B., 2012, SPECIAL REPORT WORKI, P1, DOI DOI 10.1017/CBO9781139177245; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2005, APPL ENVIRON MICROB, V71, P4117, DOI 10.1128/AEM.71.7.4117-4120.2005; Fischer M, 2010, BASIC APPL ECOL, V11, P473, DOI 10.1016/j.baae.2010.07.009; Foster D, 2003, BIOSCIENCE, V53, P77, DOI 10.1641/0006-3568(2003)053[0077:TIOLUL]2.0.CO;2; Fuchslueger L, 2014, NEW PHYTOL, V201, P916, DOI 10.1111/nph.12569; Gessler A, 2004, PLANT BIOLOGY, V6, P289, DOI 10.1055/s-2004-820878; Gilliam FS, 2007, BIOSCIENCE, V57, P845, DOI 10.1641/B571007; GILLIAM FS, 1995, ECOL APPL, V5, P947, DOI 10.2307/2269345; Goransson H, 2013, SOIL BIOL BIOCHEM, V57, P477, DOI [10.1016/j.soilbio2012.08.031, 10.1016/j.soilbio.2012.08.031]; Griffiths BS, 2013, FEMS MICROBIOL REV, V37, P112, DOI 10.1111/j.1574-6976.2012.00343.x; Hammel K., 2001, CHARAKTERISIERUNG AN, P185; Holden SR, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00163; Hommel R, 2014, PHYSIOL PLANTARUM, V152, P98, DOI 10.1111/ppl.12160; Huse SM, 2010, ENVIRON MICROBIOL, V12, P1889, DOI 10.1111/j.1462-2920.2010.02193.x; Iovieno P, 2008, FEMS MICROBIOL ECOL, V65, P400, DOI 10.1111/j.1574-6941.2008.00524.x; Kandeler E, 2000, BIOL FERT SOILS, V32, P390, DOI 10.1007/s003740000268; Keitel C, 2003, PLANT CELL ENVIRON, V26, P1157, DOI 10.1046/j.1365-3040.2003.01040.x; Krebs CJ., 1999, ECOLOGICAL METHODOLO; Kreuzwieser J, 2010, TREE PHYSIOL, V30, P1221, DOI 10.1093/treephys/tpq055; Landesman WJ, 2010, SOIL BIOL BIOCHEM, V42, P1751, DOI 10.1016/j.soilbio.2010.06.012; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lorenz K, 2001, J PLANT NUTR SOIL SC, V164, P9, DOI 10.1002/1522-2624(200102)164:1<9::AID-JPLN9>3.0.CO;2-Q; Manzoni S, 2014, SOIL BIOL BIOCHEM, V73, P69, DOI 10.1016/j.soilbio.2014.02.008; McCune B., 2011, PC ORD MULTIVARIATE; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mielke P. W., 2001, PERMUTATION METHODS; Molin S, 1999, ENVIRON MICROBIOL, V1, P383, DOI 10.1046/j.1462-2920.1999.00056.x; Moore-Kucera J, 2008, MICROB ECOL, V55, P500, DOI 10.1007/s00248-007-9295-1; Morales VL, 2010, J HYDROL, V393, P29, DOI 10.1016/j.jhydrol.2009.12.048; Nacke H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017000; Nicotra AB, 1999, ECOLOGY, V80, P1908, DOI 10.1890/0012-9658(1999)080[1908:SHOLAW]2.0.CO;2; OLSEN RA, 1987, MICROB ECOL, V13, P59, DOI 10.1007/BF02014963; Pailler A, 2014, SOIL BIOL BIOCHEM, V70, P1, DOI 10.1016/j.soilbio.2013.12.003; Pinheiro J, 2020, R PACKAGE VERSION 31; Prescott CE, 2002, TREE PHYSIOL, V22, P1193, DOI 10.1093/treephys/22.15-16.1193; Prescott CE, 2013, FOREST ECOL MANAG, V309, P19, DOI 10.1016/j.foreco.2013.02.034; Puhlmann H, WALDOKOL LANDSCHAFTS, V12, P61; Royer-Tardif S, 2010, SOIL BIOL BIOCHEM, V42, P813, DOI 10.1016/j.soilbio.2010.01.018; Ruehr NK, 2009, NEW PHYTOL, V184, P950, DOI 10.1111/j.1469-8137.2009.03044.x; Sala A, 2012, TREE PHYSIOL, V32, P764, DOI 10.1093/treephys/tpr143; Sala A, 2010, NEW PHYTOL, V186, P274, DOI 10.1111/j.1469-8137.2009.03167.x; Scheller RM, 2002, ECOL APPL, V12, P1329, DOI 10.1890/1051-0761(2002)012[1329:USPADI]2.0.CO;2; Schimel JP, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00348; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmidt M., 2007, Forstarchiv, V78, P205; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoning I, 2013, PLANT SOIL, V370, P625, DOI 10.1007/s11104-013-1654-8; SHUTTLEWORTH WJ, 1985, Q J ROY METEOR SOC, V111, P839, DOI 10.1256/smsqj.46909; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Sukenik A, 2012, ISME J, V6, P670, DOI 10.1038/ismej.2011.128; Sun H, 2014, APPL SOIL ECOL, V74, P37, DOI 10.1016/j.apsoil.2013.09.010; Thoms C, 2013, SOIL BIOL BIOCHEM, V66, P239, DOI 10.1016/j.soilbio.2013.05.018; Tian J, 2012, EUR J SOIL BIOL, V52, P67, DOI 10.1016/j.ejsobi.2012.07.002; Towe S, 2011, J MICROBIOL METH, V84, P406, DOI 10.1016/j.mimet.2010.12.028; Ulrich A, 2006, FEMS MICROBIOL ECOL, V56, P430, DOI 10.1111/j.1574-6941.2006.00085.x; Vos M, 2013, FEMS MICROBIOL REV, V37, P936, DOI 10.1111/1574-6976.12023; Wang Y, 2012, MICROBES ENVIRON, V27, P111, DOI 10.1264/jsme2.ME11304; Will C, 2010, APPL ENVIRON MICROB, V76, P6751, DOI 10.1128/AEM.01063-10; Willerslev E, 2004, CURR BIOL, V14, pR9, DOI 10.1016/j.cub.2003.12.012; Wolf AB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083661; World Reference Base for Soil Resources (WRB), 2006, FRAM INT CLASS CORR; Wubet T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047500; Zumsteg A, 2013, SOIL BIOL BIOCHEM, V61, P121, DOI 10.1016/j.soilbio.2013.02.017	83	38	39	2	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122539	10.1371/journal.pone.0122539	http://dx.doi.org/10.1371/journal.pone.0122539			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875835	Green Published, gold			2022-12-27	WOS:000353014700019
J	Gil-Jimenez, E; Villamuelas, M; Serrano, E; Delibes, M; Fernandez, N				Gil-Jimenez, Esperanza; Villamuelas, Miriam; Serrano, Emmanuel; Delibes, Miguel; Fernandez, Nestor			Fecal Nitrogen Concentration as a Nutritional Quality Indicator for European Rabbit Ecological Studies	PLOS ONE			English	Article							INFRARED REFLECTANCE SPECTROSCOPY; DEER CAPREOLUS-CAPREOLUS; DIET QUALITY; ORYCTOLAGUS-CUNICULUS; MAMMALIAN HERBIVORES; CHEMICAL-COMPOSITION; IBERIAN PENINSULA; STOMACH CONTENTS; COMPOUND FEEDS; NATIONAL-PARK	Measuring the quality of the nutritional resources available to wild herbivores is critical to understanding trophic regulation processes. However, the direct assessment of dietary nutritional characteristics is usually difficult, which hampers monitoring nutritional constraints in natural populations. The feeding ecology of ruminant herbivores has been often assessed by analyzing fecal nitrogen (FN) concentrations, although this method has been less evaluated in other taxa. This study analyzed the suitability of FN as an indicator of ingesta quality in the European rabbit (Oryctolagus cuniculus), which is a keystone lagomorph species in Mediterranean ecosystems and of great conservation interest. Firstly, domestic O. cuniculus were used to evaluate under experimental conditions the accuracy of total FN and the metabolic FN as diet quality indicators of forages with characteristics similar to those available under natural conditions. Secondly, the accuracy of Near-Infrared Spectroscopy (NIRS) to calculate FN was tested using partial least squares regression. Thirdly, a pilot field study was conducted to monitor FN dynamics from wild O. cuniculus in three different habitats during wet and drought periods. A strong association was found between diet type and total FN and metabolic FN (Pseudo-R-2 >= 0.89). It was also found that NIRS calibrations were accurate for depicting nitrogen concentrations (R-2 > 0.98 between NIRS and chemical results). Finally, the seasonal FN dynamics measured in the field were consistent with current knowledge on vegetation dynamics and forage limitations in the three habitats. The results support the use of NIRS methods and FN indices as a reliable and affordable approach to monitoring the nutritional quality of rabbit habitats. Potential applications include the assessment of the mechanistic relationships between resource limitations and population abundance, e.g., in relation to natural drought cycles and to habitat interventions aimed at reinforcing rabbit populations.	[Gil-Jimenez, Esperanza; Delibes, Miguel; Fernandez, Nestor] Spanish Council Sci Res CSIC, Dept Conservat Biol, Estn Biol, Seville, Spain; [Villamuelas, Miriam; Serrano, Emmanuel] Univ Autonoma Barcelona, Dept Med & Cirugia Anim, Serv Ecopatol Fauna Salvatge, Bellaterra, Barcelona, Spain; [Serrano, Emmanuel] Univ Aveiro, CESAM, Dept Biol, P-3800 Aveiro, Portugal	Consejo Superior de Investigaciones Cientificas (CSIC); Autonomous University of Barcelona; Universidade de Aveiro	Fernandez, N (corresponding author), Spanish Council Sci Res CSIC, Dept Conservat Biol, Estn Biol, Seville, Spain.	nestor@ebd.csic.es	Fernández, Néstor/AAA-3523-2020; SERRANO-FERRON, Emmanuel/J-4489-2013; Gil-Jiménez, Esperanza/C-6108-2015; Fernández, Néstor/N-5802-2014; Delibes, Miguel/K-2744-2014	SERRANO-FERRON, Emmanuel/0000-0002-9799-9804; Gil-Jiménez, Esperanza/0000-0002-6808-9967; Fernández, Néstor/0000-0002-9645-8571; Delibes, Miguel/0000-0002-3569-567X	Consejeria de Economia, Innovacion, Ciencia y Empleo of Junta de Andalucia [RNM-6685]; Fundaxao para a Ciencia ea Tecnologia, Portugal [SFRH/BPD/96637/2013]	Consejeria de Economia, Innovacion, Ciencia y Empleo of Junta de Andalucia; Fundaxao para a Ciencia ea Tecnologia, Portugal	Funding was provided by Consejeria de Economia, Innovacion, Ciencia y Empleo of Junta de Andalucia, Excellence Project #RNM-6685; ES was supported by the postdoctoral program (SFRH/BPD/96637/2013) of the Fundaxao para a Ciencia ea Tecnologia, Portugal. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2006, OFFICIAL METHODS ANA; BARNES RJ, 1989, APPL SPECTROSC, V43, P772, DOI 10.1366/0003702894202201; Barton K., 2014, R PACKAGE VERSION; BERGERON JM, 1994, CAN J ZOOL, V72, P183, DOI 10.1139/z94-023; Bjornhag Goran, 1999, Mitteilungen aus dem Museum fuer Naturkunde in Berlin Zoologische Reihe, V75, P275; Blanchard P, 2003, J WILDLIFE MANAGE, V67, P477, DOI 10.2307/3802705; Carneiro M, 2011, MOL BIOL EVOL, V28, P1801, DOI 10.1093/molbev/msr003; Cen HY, 2007, TRENDS FOOD SCI TECH, V18, P72, DOI 10.1016/j.tifs.2006.09.003; Clark JE, 2003, J MAMMAL, V84, P1399, DOI 10.1644/BRG-105; Delibes M., 1979, P WORLD LAGOMORPH C, P614, DOI DOI 10.1007/BF00275171; Delibes-Mateos M, 2008, CONSERV BIOL, V22, P1106, DOI 10.1111/j.1523-1739.2008.00993.x; Delibes-Mateos M, 2009, MAMMAL REV, V39, P124, DOI 10.1111/j.1365-2907.2009.00140.x; Dixon R, 2009, J NEAR INFRARED SPEC, V17, P1, DOI 10.1255/jnirs.822; Duffy JP, 2012, AFR J ECOL, V50, P455, DOI 10.1111/j.1365-2028.2012.01340.x; Etheridge RD, 1998, ANIM FEED SCI TECH, V73, P21, DOI 10.1016/S0377-8401(98)00136-9; Fernandez N, 2005, LANDSCAPE ECOL, V20, P897, DOI 10.1007/s10980-004-3976-7; Fernandez N, 2003, ECOL APPL, V13, P1310, DOI 10.1890/02-5081; Fernandez N, 2010, REMOTE SENS ENVIRON, V114, P211, DOI 10.1016/j.rse.2009.09.001; Ferreira C, 2014, MAMMAL REV, V44, P30, DOI 10.1111/mam.12006; Foley WJ, 1998, OECOLOGIA, V116, P293, DOI 10.1007/s004420050591; Franz R, 2011, J ANIM PHYSIOL AN N, V95, P564, DOI 10.1111/j.1439-0396.2010.01084.x; Galvez- Ceron A, 2013, EUR J WILDLIFE RES, P59; Garel M, 2011, J MAMMAL, V92, P1112, DOI 10.1644/10-MAMM-A-056.1; GELADI P, 1985, APPL SPECTROSC, V39, P491, DOI 10.1366/0003702854248656; Giorgi F, 2008, GLOBAL PLANET CHANGE, V63, P90, DOI 10.1016/j.gloplacha.2007.09.005; Gislum R, 2004, FIELD CROP RES, V88, P269, DOI 10.1016/j.fcr.2004.01.021; Hirakawa H, 2001, MAMMAL REV, V31, P61, DOI 10.1046/j.1365-2907.2001.00079.x; HOBBS NT, 1987, J WILDLIFE MANAGE, V51, P317, DOI 10.2307/3801008; Hopcraft JGC, 2010, TRENDS ECOL EVOL, V25, P119, DOI 10.1016/j.tree.2009.08.001; Janova E, 2015, EUR J WILDLIFE RES, V61, P57, DOI 10.1007/s10344-014-0873-5; Kamler J, 2005, FOLIA ZOOL, V54, P89; Kamler J, 2004, WILDLIFE BIOL, V10, P235, DOI 10.2981/wlb.2004.021; Leslie DM, 2008, J WILDLIFE MANAGE, V72, P1420, DOI 10.2193/2007-404; LESLIE DM, 1987, J WILDLIFE MANAGE, V51, P321, DOI 10.2307/3801009; Lombardi L, 2003, J MAMMAL, V84, P26, DOI 10.1644/1545-1542(2003)084<0026:HRDIRO>2.0.CO;2; Lombardi L, 2007, BASIC APPL ECOL, V8, P453, DOI 10.1016/j.baae.2006.09.004; Marco A, 2002, TALANTA, V57, P1019, DOI 10.1016/S0039-9140(02)00136-4; MATTSON WJ, 1980, ANNU REV ECOL SYST, V11, P119, DOI 10.1146/annurev.es.11.110180.001003; Meineri G, 2009, ITAL J ANIM SCI, V8, P75, DOI 10.4081/ijas.2009.75; Mesochina P, 1998, GRASS FORAGE SCI, V53, P189, DOI 10.1046/j.1365-2494.1998.5320189.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nunez-Sanchez N, 2012, LIVEST SCI, V150, P386, DOI 10.1016/j.livsci.2012.07.030; Parker KL, 2009, FUNCT ECOL, V23, P57, DOI 10.1111/j.1365-2435.2009.01528.x; Pettorelli N, 2009, AM NAT, V173, P698, DOI 10.1086/597379; Pinheiro J, 2014, TEAM RC NLME LINEAR; PLUMPTRE AJ, 1995, J ZOOL, V235, P323; R Core Team, 2014, LANG ENV STAT COMP; Robbins C.T., 1983, WILDLIFE FEEDING NUT; ROBBINS CT, 1987, ECOLOGY, V68, P98, DOI 10.2307/1938809; Rothman JM, 2008, AM J PRIMATOL, V70, P690, DOI 10.1002/ajp.20540; Rothman JM, 2006, AM J PRIMATOL, V68, P675, DOI 10.1002/ajp.20243; Sacconi F, 2007, ITAL J ANIM SCI, V6, P862, DOI 10.4081/ijas.2007.1s.862; Sader A. P. O., 2004, Archives of Veterinary Science, V9, P73; Sakaguchi Ei, 2003, Animal Science Journal, V74, P327, DOI 10.1046/j.1344-3941.2003.00124.x; Schwarm A, 2009, J ANIM PHYSIOL AN N, V93, P596, DOI 10.1111/j.1439-0396.2008.00842.x; Shenk J. S., 1995, ROUTINE OPERATION CA; Shenk J.S., 1996, NEAR INFRARED SPECTR, P198; Showers SE, 2006, RANGELAND ECOL MANAG, V59, P300, DOI 10.2111/04-069.1; Stott P, 2008, MAMM BIOL, V73, P276, DOI 10.1016/j.mambio.2007.07.002; Stuth J, 2003, FIELD CROP RES, V84, P45, DOI 10.1016/S0378-4290(03)00140-0; van der Waal C, 2003, S AFR J WILDL RES, V33, P33; Van Soest P.J., 1994, NUTR ECOLOGY RUMINAN; Verheyden H, 2011, WILDLIFE BIOL, V17, P166, DOI 10.2981/10-111; Villafuerte R, 1997, REV ECOL-TERRE VIE, V52, P345; Vogel KP, 1999, CROP SCI, V39, P276, DOI 10.2135/cropsci1999.0011183X003900010042x; Williams P. C., 2001, NEAR INFRARED TECHNO, V2, P145; Williams PC, 1996, NEAR INFRARED SPECTR, P185; Windley HR, 2013, OECOLOGIA, V173, P203, DOI 10.1007/s00442-013-2616-9; Xiccato G, 1999, ANIM FEED SCI TECH, V77, P201, DOI 10.1016/S0377-8401(98)00253-3; Xiccato G, 2003, ANIM FEED SCI TECH, V104, P153, DOI 10.1016/S0377-8401(02)00294-8	70	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125190	10.1371/journal.pone.0125190	http://dx.doi.org/10.1371/journal.pone.0125190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893872	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700134
J	Gu, YD; Mei, QC; Fernandez, J; Li, JS; Ren, XJ; Feng, N				Gu, Yaodong; Mei, Qichang; Fernandez, Justin; Li, Jianshe; Ren, Xuejun; Feng, Neng			Foot Loading Characteristics of Chinese Bound Feet Women: A Comparative Analysis	PLOS ONE			English	Article							PLANTAR PRESSURE; BINDING; WALKING	The custom of bound feet among Chinese women has existed for almost a century. This practice has influenced the daily life of Chinese women, especially during everyday locomotion. The primary aim of this study is to analyze the loading patterns of bound feet. Specifically, the plantar pressure and center of pressure were analyzed for peak pressure, contact area, force time integral, center of pressure displacement velocity and trajectory in the anterior-posterior direction via a comparison with normal feet. The key outcomes from this work were that the forefoot and rearfoot of bound feet bear the whole loading during stance phase. The center of pressure displacement velocity of bound feet was also greatly reduced with the shortening of trajectories. This suggests that the proprioceptive system adjusts motor function to adapt to new loading patterns while maintaining locomotive stability. A biomechanical understanding of bound feet may assist with prevention, treatment and rehabilitation of bound feet disorders.	[Gu, Yaodong; Mei, Qichang; Li, Jianshe] Ningbo Univ, Fac Sports Sci, Ningbo 315211, Zhejiang, Peoples R China; [Fernandez, Justin] Univ Auckland, Dept Engn Sci, Auckland, New Zealand; [Fernandez, Justin] Univ Auckland, Auckland Bioengn Inst, Auckland 1, New Zealand; [Ren, Xuejun] Liverpool John Moores Univ, Sch Engn, Liverpool L3 5UX, Merseyside, England; [Feng, Neng] Ningbo Ninth Hosp, Rehabil Ctr, Ningbo, Zhejiang, Peoples R China	Ningbo University; University of Auckland; University of Auckland; Liverpool John Moores University	Gu, YD (corresponding author), Ningbo Univ, Fac Sports Sci, Ningbo 315211, Zhejiang, Peoples R China.	guyaodong@hotmail.com	Gu, Yaodong/AAJ-4148-2020; Gu, Yaodong/AAH-7551-2020; Mei, Qichang/AAF-2467-2019; Mei, Qichang/AAN-4052-2020	Mei, Qichang/0000-0003-1113-877X; gu, yaodong/0000-0003-2187-9440; Ren, James/0000-0001-6132-1228	National Natural Science Foundation of China [81301600]; K.C. Wong Magna Fund in Ningbo University; Ningbo Natural Science Foundation [2013A610262]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); K.C. Wong Magna Fund in Ningbo University; Ningbo Natural Science Foundation	The study sponsored by National Natural Science Foundation of China (81301600), K.C. Wong Magna Fund in Ningbo University, and Ningbo Natural Science Foundation (2013A610262).	Alfuth M, 2011, NEUROSCI LETT, V503, P58, DOI 10.1016/j.neulet.2011.08.010; Bergstra SA, J SCI MED S IN PRESS; BLAKE CD, 1994, SIGNS, V19, P676, DOI 10.1086/494917; Chuckpaiwong B, 2008, GAIT POSTURE, V28, P405, DOI 10.1016/j.gaitpost.2008.01.012; De Cock A, 2008, GAIT POSTURE, V27, P669, DOI 10.1016/j.gaitpost.2007.08.013; Gates H, 2008, HIST FAM, V13, P58, DOI 10.1016/j.hisfam.2007.11.001; GREENHALGH SUSAN, 1977, FRONTIERS, V2, P7, DOI DOI 10.2307/3346103; Grouios G., 2004, FOOT, V14, P175, DOI DOI 10.1016/J.FOOT.2004.07.005; Gu YD, 2014, HUM MOVEMENT SCI, V36, P46, DOI 10.1016/j.humov.2014.04.008; Gu YD, 2014, J MECH MED BIOL, V14, DOI 10.1142/S0219519414500080; Hafer JF, 2013, GAIT POSTURE, V38, P544, DOI 10.1016/j.gaitpost.2013.01.028; Howard R, 2010, JCR-J CLIN RHEUMATOL, V16, P408, DOI 10.1097/RHU.0b013e3182005c7c; JACKSON R, 1990, INT J DERMATOL, V29, P322, DOI 10.1111/j.1365-4362.1990.tb04751.x; Ma JB, 2013, INT J BIOMED ENG TEC, V13, P147, DOI 10.1504/IJBET.2013.057927; McGeoch PD, 2007, MED HYPOTHESES, V69, P938, DOI 10.1016/j.mehy.2007.01.071; Mei QC, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415500141; Munk PL, 1996, AM J ROENTGENOL, V167, P1216, DOI 10.2214/ajr.167.5.8911183; NACHBAUER W, 1992, MED SCI SPORT EXER, V24, P1264; Reischl U, 2008, COLLEGIUM ANTROPOL, V32, P629; Stone PK, 2012, INT J PALEOPATHOL, V2, P53, DOI 10.1016/j.ijpp.2012.09.008; Wilson AM, 2013, J GENDER STUD, V22, P17, DOI 10.1080/09589236.2012.681182; Zhang XY, 2014, GAIT POSTURE, V39, P1012, DOI 10.1016/j.gaitpost.2013.12.025; Zhang Y., 2014, J BIOMIMETICS BIOMAT, V19, P120, DOI [DOI 10.4172/1662-100X.1000120, 10.4172/1662-100X.1000120]	23	8	8	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121695	10.1371/journal.pone.0121695	http://dx.doi.org/10.1371/journal.pone.0121695			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884982	Green Submitted, gold, Green Published, Green Accepted			2022-12-27	WOS:000353017000022
J	D'Ambrosio, A; Agricola, E; Russo, L; Gesualdo, F; Pandolfi, E; Bortolus, R; Castellani, C; Lalatta, F; Mastroiacovo, P; Tozzi, AE				D'Ambrosio, Angelo; Agricola, Eleonora; Russo, Luisa; Gesualdo, Francesco; Pandolfi, Elisabetta; Bortolus, Renata; Castellani, Carlo; Lalatta, Faustina; Mastroiacovo, Pierpaolo; Tozzi, Alberto Eugenio			Web-Based Surveillance of Public Information Needs for Informing Preconception Interventions	PLOS ONE			English	Article							HEALTH-PROMOTION; FOLIC-ACID; INTERNET; CARE; RECOMMENDATIONS; MOTHERS; WOMEN	Background The risk of adverse pregnancy outcomes can be minimized through the adoption of healthy lifestyles before pregnancy by women of childbearing age. Initiatives for promotion of preconception health may be difficult to implement. Internet can be used to build tailored health interventions through identification of the public's information needs. To this aim, we developed a semi-automatic web-based system for monitoring Google searches, web pages and activity on social networks, regarding preconception health. Methods Based on the American College of Obstetricians and Gynecologists guidelines and on the actual search behaviors of Italian Internet users, we defined a set of keywords targeting preconception care topics. Using these keywords, we analyzed the usage of Google search engine and identified web pages containing preconception care recommendations. We also monitored how the selected web pages were shared on social networks. We analyzed discrepancies between searched and published information and the sharing pattern of the topics. Results We identified 1,807 Google search queries which generated a total of 1,995,030 searches during the study period. Less than 10% of the reviewed pages contained preconception care information and in 42.8% information was consistent with ACOG guidelines. Facebook was the most used social network for sharing. Nutrition, Chronic Diseases and Infectious Diseases were the most published and searched topics. Regarding Genetic Risk and Folic Acid, a high search volume was not associated to a high web page production, while Medication pages were more frequently published than searched. Vaccinations elicited high sharing although web page production was low; this effect was quite variable in time. Conclusion Our study represent a resource to prioritize communication on specific topics on the web, to address misconceptions, and to tailor interventions to specific populations.	[D'Ambrosio, Angelo; Agricola, Eleonora; Russo, Luisa; Gesualdo, Francesco; Pandolfi, Elisabetta; Tozzi, Alberto Eugenio] Bambino Gesu Pediat Hosp, IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy; [Bortolus, Renata] Verona Univ Hosp, Dept Hosp Management & Pharm, Off Res Promot, Verona, Italy; [Castellani, Carlo] Verona Univ Hosp, Cyst Fibrosis Ctr, Verona, Italy; [Lalatta, Faustina] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Clin Genet Unit, Milan, Italy; [Mastroiacovo, Pierpaolo] Alessandra Lisi Int Ctr Birth Defects & Prematur, Rome, Italy	IRCCS Bambino Gesu; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; University of Verona; Azienda Ospedaliera Universitaria Integrata Verona; IRCCS Ca Granda Ospedale Maggiore Policlinico	D'Ambrosio, A (corresponding author), Bambino Gesu Pediat Hosp, IRCCS, Multifactorial Dis & Complex Phenotype Res Area, Rome, Italy.	bakaburg1@gmail.com	D'Ambrosio, Angelo/Y-1798-2018; Castellani, Carlo/AAB-3847-2019; Bortolus, Renata/K-6396-2016; Gesualdo, Francesco/H-9221-2012; Tozzi, Alberto Eugenio/F-9494-2012; Pandolfi, Elisabetta/K-5173-2016	D'Ambrosio, Angelo/0000-0002-2045-5155; Bortolus, Renata/0000-0003-3857-4133; Gesualdo, Francesco/0000-0002-9087-4398; Tozzi, Alberto Eugenio/0000-0002-6884-984X; Pandolfi, Elisabetta/0000-0003-2424-2736	Centro nazionale per la prevenzione e il controllo delle malattie (CCM)-Italian Ministry of Health [201301X003129]	Centro nazionale per la prevenzione e il controllo delle malattie (CCM)-Italian Ministry of Health	Centro nazionale per la prevenzione e il controllo delle malattie (CCM)-Italian Ministry of Health. (Grant n. 201301X003129) (http://www.ccmnetwork.it/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agricola E, 2013, BMC MED INFORM DECIS, V13, DOI 10.1186/1472-6947-13-14; American College of Obstetricians and Gynecologists, 2005, Obstet Gynecol, V106, P665; Amitai Y, 2004, PREV MED, V39, P731, DOI 10.1016/j.ypmed.2004.02.042; [Anonymous], 2011, Obstet Gynecol, V117, P747, DOI 10.1097/AOG.0b013e318214780e; Atrash H, 2008, AM J OBSTET GYNECOL, V199, pS259, DOI 10.1016/j.ajog.2008.08.059; Ayers JW, 2013, AM J PREV MED, V44, P520, DOI 10.1016/j.amepre.2013.01.012; Bhutta ZA, 2014, LANCET, V384, P347, DOI 10.1016/S0140-6736(14)60792-3; Bock BC, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.989; Botto LD, 1999, NEW ENGL J MED, V341, P1509, DOI 10.1056/NEJM199911113412006; Brigo F, 2014, EPILEPSY BEHAV, V31, P67, DOI 10.1016/j.yebeh.2013.11.020; Chunara R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061373; Chung M, 2012, J PEDIATR-US, V161, P1080, DOI 10.1016/j.jpeds.2012.06.004; Committee on Obstetric Practice, 2012, Obstet Gynecol, V120, P416, DOI 10.1097/AOG.0b013e31826804e8; Corchia C, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-68; Cugelman B, 2011, J MED INTERNET RES, V13, P84, DOI 10.2196/jmir.1367; Dehkordy SF, 2014, ACAD RADIOL, V21, P1172, DOI 10.1016/j.acra.2014.05.005; Delvoye P, 2009, EUR J CONTRACEP REPR, V14, P307, DOI 10.1080/13625180903056123; Gesualdo F, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-561; Gosselin P, 2008, J MED INTERNET RES, V10, DOI 10.2196/jmir.1127; Helander E, 2014, J MED INTERNET RES, V16, P52, DOI 10.2196/jmir.3084; Jack BW, 2008, AM J OBSTET GYNECOL, V199, pS266, DOI 10.1016/j.ajog.2008.07.067; Larsson M, 2009, MIDWIFERY, V25, P14, DOI 10.1016/j.midw.2007.01.010; Linkov F, 2014, SURG OBES RELAT DIS, V10, P533, DOI 10.1016/j.soard.2013.10.007; Merchant Gina, 2014, J Med Internet Res, V16, pe158, DOI 10.2196/jmir.3267; National Institute of Statistics (ISTAT), 2010, CITT NUOV TECN; Neuhauser L, 2003, J HEALTH PSYCHOL, V8, P7, DOI 10.1177/1359105303008001426; Nicholson L, 2014, BR J OPHTHALMOL, V98; Patton LL, 2014, OR SURG OR MED OR PA, V118, P78, DOI 10.1016/j.oooo.2014.03.019; Plunkett KS, 2002, OBSTET GYN CLIN N AM, V29, P265, DOI 10.1016/S0889-8545(02)00003-7; Shannon GD, 2014, MATERN CHILD HLTH J, V18, P1354, DOI 10.1007/s10995-013-1370-2; Simmering JE, 2014, RES SOC ADMIN PHARM, V10, P896, DOI 10.1016/j.sapharm.2014.01.003; Squiers L, 2013, AM J HEALTH PROMOT, V27, pS10, DOI 10.4278/ajhp.120217-QUAL-95; Stephenson J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103085; Tafuri S, 2014, HUM VACCIN IMMUNOTHE, V10; Tian H, 2009, J MED INTERNET RES, V11, DOI 10.2196/jmir.1278; van der Pal-de Bruin KM, 2000, PAEDIATR PERINAT EP, V14, P111; Vance K, 2009, DERMATOL CLIN, V27, P133, DOI 10.1016/j.det.2008.11.010; Weymann N, 2014, HLTH PROMOT INT	38	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122551	10.1371/journal.pone.0122551	http://dx.doi.org/10.1371/journal.pone.0122551			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879682	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500022
J	Deng, K; Yang, L; Hu, B; Wu, H; Zhu, H; Tang, CW				Deng, Kai; Yang, Li; Hu, Bing; Wu, Hao; Zhu, Hong; Tang, Chengwei			The Prognostic Significance of Pretreatment Serum CEA Levels in Gastric Cancer: A Meta-Analysis Including 14651 Patients	PLOS ONE			English	Article							PREOPERATIVE CARCINOEMBRYONIC ANTIGEN; LYMPH-NODE METASTASIS; LONG-TERM SURVIVAL; CA 72-4; CLINICAL-SIGNIFICANCE; TUMOR-MARKERS; CA-19-9; CARCINOMA; ASSOCIATION; RECURRENCE	Background Carcinoembryonic antigen (CEA) is commonly used as a serum tumor marker in clinical practice; however, its prognostic value for gastric cancer patients remains uncertain. This meta-analysis was performed to assess the prognostic value of CEA and investigate CEA as a tumor marker. Methods PubMed, EMBASE and other databases were searched for potentially eligible studies. Forty-one studies reporting the prognostic effect of pretreatment serum CEA expression in gastric cancer patients were selected. Data on 14651 eligible patients were retrieved for the meta-analysis. Based on the data extracted from the available literature, the hazard ratio (HR) and 95% confidence interval (CI) for an adverse prognosis were estimated for gastric cancer patients with elevated pretreatment serum levels of CEA (CEA+) relative to patients with normal pretreatment CEA levels (CEA). Results The CEA+ patients had a significantly poorer prognosis than the CEA-patients in terms of overall survival (OS: HR 1.716, 95% CI 1.594 - 1.848, P < 0.001), disease-specific survival (DSS: HR 1.940, 95% CI 1.563 - 2.408, P < 0.001), and disease-free survival (DFS: HR 2.275, 95% CI 1.836 - 2.818, P < 0.001). Publication bias and an influence of different cut-off values were not observed (all P > 0.05). In the pooled analyses of multivariate-adjusted HRs, the results suggested that pretreatment serum CEA may be an independent prognostic factor in gastric cancer (OS: HR 1.681, 95% CI 1.425 - 1.982; DSS: HR 1.900, 95% CI 1.441 - 2.505; DFS: HR 2.579, 95% CI 1.935 - 3.436). Conclusion/Significance The meta-analysis based on the available literature supported the association of elevated pretreatment serum CEA levels with a poor prognosis for gastric cancer and a nearly doubled risk of mortality in gastric cancer patients. CEA may be an independent prognostic factor for gastric cancer patients and may aid in determining appropriate treatment which may preferentially benefit the CEA+ patients.	[Deng, Kai; Yang, Li; Hu, Bing; Wu, Hao; Tang, Chengwei] Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Sichuan, Peoples R China; [Zhu, Hong] Sichuan Univ, West China Hosp, Dept Abdominal Canc, Chengdu 610064, Sichuan, Peoples R China	Sichuan University; Sichuan University	Tang, CW (corresponding author), Sichuan Univ, West China Hosp, Dept Gastroenterol, Chengdu 610064, Sichuan, Peoples R China.	ChengweiTang@126.com		Hu, Bing/0000-0002-9898-8656	National Natural Science Foundation of China [81170413, 81301962]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The research was supported by the National Natural Science Foundation of China [81170413] and [81301962].	Ahn HS, 2011, BRIT J SURG, V98, P255, DOI 10.1002/bjs.7310; Aloe S, 2003, INT J BIOL MARKER, V18, P21, DOI 10.1177/172460080301800104; BENCHIMOL S, 1989, CELL, V57, P327, DOI 10.1016/0092-8674(89)90970-7; BOGENSCHUTZ O, 1986, J SURG ONCOL, V32, P165, DOI 10.1002/jso.2930320310; Cetin B, 2005, SURG TODAY, V35, P919, DOI 10.1007/s00595-005-3057-9; Chan ACO, 2003, J CLIN ONCOL, V21, P2288, DOI 10.1200/JCO.2003.08.078; Chapman MAS, 1998, BRIT J CANCER, V78, P1346, DOI 10.1038/bjc.1998.682; COX DR, 1972, J R STAT SOC B, V34, P187; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dilege E, 2010, HEPATO-GASTROENTEROL, V57, P674; Duraker N, 2002, EUR J SURG ONCOL, V28, P844, DOI 10.1053/ejso.2002.1295; Duraker N, 2001, J SURG ONCOL, V76, P266, DOI 10.1002/jso.1044; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fong Y, 1999, ANN SURG, V230, P309, DOI 10.1097/00000658-199909000-00004; Gaspar MJ, 2001, TUMOR BIOL, V22, P318, DOI 10.1159/000050633; GOLD P, 1965, J EXP MED, V121, P439, DOI 10.1084/jem.121.3.439; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Ikeguchi M, 2009, GASTRIC CANCER, V12, P95, DOI 10.1007/s10120-009-0509-8; Ishigami S, 2001, J CLIN GASTROENTEROL, V32, P41, DOI 10.1097/00004836-200101000-00010; Jiang X, 2012, BRIT J CANCER, V107, P275, DOI 10.1038/bjc.2012.262; Kanetaka K, 2013, SURGERY, V154, P563, DOI 10.1016/j.surg.2013.03.005; Kim DH, 2011, J SURG ONCOL, V104, P585, DOI 10.1002/jso.21919; Kim DY, 2000, J SURG ONCOL, V74, P185, DOI 10.1002/1096-9098(200007)74:3<185::AID-JSO4>3.3.CO;2-S; Kim J, 2013, SPACE, P78; Kim YJ, 2014, EUROPEAN J IN PRESS; Kochi Mitsugu, 2000, Gastric Cancer, V3, P177, DOI 10.1007/PL00011715; Kodera Y, 1996, AM J GASTROENTEROL, V91, P49; KOGA T, 1987, JPN J SURG, V17, P342, DOI 10.1007/BF02470632; Konstantopoulos K, 2009, ANNU REV BIOMED ENG, V11, P177, DOI 10.1146/annurev-bioeng-061008-124949; Lau J, 1997, ANN INTERN MED, V127, P820, DOI 10.7326/0003-4819-127-9-199711010-00008; Li FX, 2013, BIOMARKERS, V18, P632, DOI 10.3109/1354750X.2013.840800; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Liu XW, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-68; Louhimo J, 2004, INT J CANCER, V111, P929, DOI 10.1002/ijc.20321; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marrelli D, 1999, ONCOLOGY-BASEL, V57, P55, DOI 10.1159/000012001; Migita K, 2013, ANN SURG ONCOL, V20, P2647, DOI 10.1245/s10434-013-2926-5; Mihmanli M, 2004, HEPATO-GASTROENTEROL, V51, P1544; Nakagoe T, 2002, J CLIN GASTROENTEROL, V34, P408, DOI 10.1097/00004836-200204000-00005; Nakajima K, 1998, TUMOR BIOL, V19, P464, DOI 10.1159/000030038; NAKANE Y, 1994, CANCER-AM CANCER SOC, V73, P2703, DOI 10.1002/1097-0142(19940601)73:11<2703::AID-CNCR2820731109>3.0.CO;2-X; Nakata B, 1998, BRIT J CANCER, V77, P1820, DOI 10.1038/bjc.1998.302; OGOSHI K, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P355; Park HS, 2011, ONCOLOGY-BASEL, V80, P142, DOI 10.1159/000328507; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Reiter W, 2000, ANTICANCER RES, V20, P5195; Reiter W, 1997, ANTICANCER RES, V17, P2903; Shimada H, 2014, GASTRIC CANCER, V17, P26, DOI 10.1007/s10120-013-0259-5; Shimizu Keiji, 2005, Gastric Cancer, V8, P214, DOI 10.1007/s10120-005-0337-4; STAAB HJ, 1982, BRIT J CANCER, V45, P718, DOI 10.1038/bjc.1982.113; Tachibana M, 1998, J AM COLL SURGEONS, V187, P64, DOI 10.1016/S1072-7515(98)00133-1; TAKAHASHI I, 1994, BRIT J CANCER, V69, P163, DOI 10.1038/bjc.1994.27; Thomas SN, 2008, J BIOL CHEM, V283, P15647, DOI 10.1074/jbc.M800543200; Thomas SN, 2009, BIORHEOLOGY, V46, P207, DOI 10.3233/BIR-2009-0534; Ucar E, 2008, ADV THER, V25, P1075, DOI 10.1007/s12325-008-0100-4; Vallbohmer D, 2009, J SURG ONCOL, V99, P409, DOI 10.1002/jso.21271; Victorzon M, 1995, Eur J Surg Oncol, V21, P379, DOI 10.1016/S0748-7983(95)92450-7; Wang Chia-Siu, 2002, Chang Gung Med J, V25, P216; Wells G., 2012, THE NEWCASTLE OTTAWA; Xia HHX, 2009, CANCER-AM CANCER SOC, V115, P5441, DOI 10.1002/cncr.24609; Yamashita K, 2008, ANTICANCER RES, V28, P435; Yamashita K, 2007, ANTICANCER RES, V27, P4381; Ychou M, 2000, DIS MARKERS, V16, P105, DOI 10.1155/2000/595492; Ye XT, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0061-1; Zhang YH, 2009, HEPATO-GASTROENTEROL, V56, P1750; Zhou F, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0726-1	66	55	58	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124151	10.1371/journal.pone.0124151	http://dx.doi.org/10.1371/journal.pone.0124151			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879931	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500085
J	Faber, BW; Kadir, KA; Rodriguez-Garcia, R; Remarque, EJ; Saul, FA; Vulliez-Le Normand, B; Bentley, GA; Kocken, CHM; Singh, B				Faber, Bart W.; Kadir, Khamisah Abdul; Rodriguez-Garcia, Roberto; Remarque, Edmond J.; Saul, Frederick A.; Vulliez-Le Normand, Brigitte; Bentley, Graham A.; Kocken, Clemens H. M.; Singh, Balbir			Low Levels of Polymorphisms and No Evidence for Diversifying Selection on the Plasmodium knowlesi Apical Membrane Antigen 1 Gene	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; FALCIPARUM; TRANSMISSION; IMMUNIZATION; SPECIFICITY; FREQUENCY; VIVAX; AMA1	Infection with Plasmodium knowlesi, a zoonotic primate malaria, is a growing human health problem in Southeast Asia. P. knowlesi is being used in malaria vaccine studies, and a number of proteins are being considered as candidate malaria vaccine antigens, including the Apical Membrane Antigen 1 (AMA1). In order to determine genetic diversity of the ama1 gene and to identify epitopes of AMA1 under strongest immune selection, the ama1 gene of 52 P. knowlesi isolates derived from human infections was sequenced. Sequence analysis of isolates from two geographically isolated regions in Sarawak showed that polymorphism in the protein is low compared to that of AMA1 of the major human malaria parasites, P. falciparum and P. vivax. Although the number of haplotypes was 27, the frequency of mutations at the majority of the polymorphic positions was low, and only six positions had a variance frequency higher than 10%. Only two positions had more than one alternative amino acid. Interestingly, three of the high-frequency polymorphic sites correspond to invariant sites in PfAMA1 or PvAMA1. Statistically significant differences in the quantity of three of the six high frequency mutations were observed between the two regions. These analyses suggest that the pkama1 gene is not under balancing selection, as observed for pfama1 and pvama1, and that the PkAMA1 protein is not a primary target for protective humoral immune responses in their reservoir macaque hosts, unlike PfAMA1 and PvAMA1 in humans. The low level of polymorphism justifies the development of a single allele PkAMA1-based vaccine.	[Faber, Bart W.; Rodriguez-Garcia, Roberto; Remarque, Edmond J.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Kadir, Khamisah Abdul; Singh, Balbir] Univ Malaysia Sarawak, Fac Med & Hlth Sci, Malaria Res Ctr, Kuching, Sarawak, Malaysia; [Saul, Frederick A.; Vulliez-Le Normand, Brigitte; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Dept Biol Struct & Chim, Paris, France; [Saul, Frederick A.; Vulliez-Le Normand, Brigitte; Bentley, Graham A.] CNRS, URA 2185, Paris, France	University of Malaysia Sarawak; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Faber, BW (corresponding author), Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands.	faber@bprc.nl; bskhaira55@gmail.com	Remarque, Ed/AAE-8643-2020; Singh, Balbir/A-3610-2009	Kocken, Clemens/0000-0002-4784-1734; Singh, Balbir/0000-0002-9143-3965; Faber, Bart/0000-0001-6808-1204	European Commission EUROMALVAC2 [QLK2-CT-2002-01197]; Centre National de la Recherche Scientifique; Universiti Malaysia Sarawak [01(TD03)/1003/2013(01)]; European Commission EMVDA [LSHP-CT-2007-037506]; E(M)VI, European (Malaria) Vaccine Initiative; Universiti of Sarawak [E14054/F05/54/PKI/09/2012(01)]	European Commission EUROMALVAC2; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universiti Malaysia Sarawak; European Commission EMVDA; E(M)VI, European (Malaria) Vaccine Initiative; Universiti of Sarawak	This work was supported by: European Commission EUROMALVAC2 (contract QLK2-CT-2002-01197), The Centre National de la Recherche Scientifique, The Universiti Malaysia Sarawak (grant number 01(TD03)/1003/2013(01)), European Commission EMVDA grant LSHP-CT-2007-037506, E(M)VI, The European (Malaria) Vaccine Initiative, and Universiti of Sarawak: Grant E14054/F05/54/PKI/09/2012(01); www.emvda.org; www.euvaccine.eu; www.evimalar.org; ec.europa.eu/research/health/infectious-diseases/poverty-diseases/projects/71_en.htm. The external funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; CHIN W, 1968, AM J TROP MED HYG, V17, P355, DOI 10.4269/ajtmh.1968.17.355; COLLINS WE, 1967, J PARASITOL, V53, P841, DOI 10.2307/3276783; Dutta S, 2007, P NATL ACAD SCI USA, V104, P12488, DOI 10.1073/pnas.0701464104; Dutta S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003840; EDESON JFB, 1953, T ROY SOC TROP MED H, V47, P399, DOI 10.1016/S0035-9203(53)80020-9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FU YX, 1993, GENETICS, V133, P693; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Howell SA, 2003, J BIOL CHEM, V278, P23890, DOI 10.1074/jbc.M302160200; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-182; Kusi KA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015391; Kusi KA, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-40; Kusi KA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008110; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lee KS, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002015; Lee KS, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-73; Lee KS, 2009, INT J PARASITOL, V39, P1125, DOI 10.1016/j.ijpara.2009.03.003; Midega JT, 2007, J MED ENTOMOL, V44, P923, DOI 10.1603/0022-2585(2007)44[923:EDASOA]2.0.CO;2; Miura K, 2013, INFECT IMMUN, V81, P1491, DOI 10.1128/IAI.01414-12; Ord RL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003366; Pacheco MA, 2012, INFECT GENET EVOL, V12, P978, DOI 10.1016/j.meegid.2012.02.009; Pacheco MA, 2010, INFECT GENET EVOL, V10, P655, DOI 10.1016/j.meegid.2010.03.013; Polley SD, 2003, GENETICS, V165, P555; Polley SD, 2001, GENETICS, V158, P1505; Putaporntip C, 2013, INFECT GENET EVOL, V18, P213, DOI 10.1016/j.meegid.2013.05.019; Remarque EJ, 2008, INFECT IMMUN, V76, P2660, DOI 10.1128/IAI.00170-08; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Rozas J, 1999, BIOINFORMATICS, V15, P174, DOI 10.1093/bioinformatics/15.2.174; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; TAJIMA F, 1989, GENETICS, V123, P597; Vulliez-Le Normand B, 2015, PLOS ONE IN PRESS; WHARTON RH, 1961, SCIENCE, V134, P279, DOI 10.1126/science.134.3474.279; William T, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-390	36	14	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124400	10.1371/journal.pone.0124400	http://dx.doi.org/10.1371/journal.pone.0124400			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881166	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000353016500096
J	Han, M; Kim, K; Jang, SJ; Cho, HS; Bouma, BE; Oh, WY; Ryu, S				Han, Myounghee; Kim, Kyunghun; Jang, Sun-Joo; Cho, Han Saem; Bouma, Brett E.; Oh, Wang-Yuhl; Ryu, Sukyoung			GPU-Accelerated Framework for Intracoronary Optical Coherence Tomography Imaging at the Push of a Button	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; INCOMPLETE STENT APPOSITION; DRUG-ELUTING STENTS; MYOCARDIAL-INFARCTION; INSIGHTS; OCT; CPU	Frequency domain optical coherence tomography (FD-OCT) has become one of the important clinical tools for intracoronary imaging to diagnose and monitor coronary artery disease, which has been one of the leading causes of death. To help more accurate diagnosis and monitoring of the disease, many researchers have recently worked on visualization of various coronary microscopic features including stent struts by constructing three-dimensional (3D) volumetric rendering from series of cross-sectional intracoronary FD-OCT images. In this paper, we present the first, to our knowledge, "push-of-a-button" graphics processing unit (GPU)-accelerated framework for intracoronary OCT imaging. Our framework visualizes 3D microstructures of the vessel wall with stent struts from raw binary OCT data acquired by the system digitizer as one seamless process. The framework reports the state-of-the-art performance; from raw OCT data, it takes 4.7 seconds to provide 3D visualization of a 5-cm-long coronary artery (of size 1600 samples x 1024 A-lines x 260 frames) with stent struts and detection of malapposition automatically at the single push of a button.	[Han, Myounghee; Kim, Kyunghun; Ryu, Sukyoung] Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea; [Jang, Sun-Joo; Cho, Han Saem; Oh, Wang-Yuhl] Korea Adv Inst Sci & Technol, Dept Mech Engn, Taejon 305701, South Korea; [Jang, Sun-Joo] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Taejon 305701, South Korea; [Bouma, Brett E.] Harvard Univ, Sch Med, Boston, MA USA; [Bouma, Brett E.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital	Ryu, S (corresponding author), Korea Adv Inst Sci & Technol, Dept Comp Sci, Taejon 305701, South Korea.	sryu.cs@kaist.ac.kr	Ryu, Sukyoung/C-2080-2011; Ryu, Sukyoung/A-8543-2015; Jang, Sun-Joo/AAI-9828-2021	Ryu, Sukyoung/0000-0002-0019-9772; Jang, Sun-Joo/0000-0002-4311-4855; Kim, Kyunghun/0000-0002-2902-8811	National Research Foundation of Korea [NRF-2010-0017465, NRF-2014R1A2A2A01003235, NRF-2008-0062609]; Ministry of Science, ICT and Future Planning of Korea [GFP/CISS-2012M3A6A6054200, NIPA-2013-H0401-13-1007]; National Institute of Health [P41 EB015903]	National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT and Future Planning of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was funded in part by the National Research Foundation of Korea to WO (NRF-2010-0017465) and SR (NRF-2014R1A2A2A01003235, NRF-2008-0062609), by the Ministry of Science, ICT and Future Planning of Korea (GFP/CISS-2012M3A6A6054200, NIPA-2013-H0401-13-1007) to WO, and by the National Institute of Health (P41 EB015903) to BEB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonnema GT, 2008, PHYS MED BIOL, V53, P3083, DOI 10.1088/0031-9155/53/12/001; Bradski G., 2000, DOBBS J SOFTWARE TOO; Brezinski ME, 1996, AM J CARDIOL, V77, P92, DOI 10.1016/S0002-9149(97)89143-6; Chieffo A, 2014, EUROINTERVENTION, V10, P916, DOI 10.4244/EIJY14M06_10; Cho HS, 2014, BIOMED OPT EXPRESS, V5, P223, DOI 10.1364/BOE.5.000223; CUDA N, 2011, CUDA C PROGR GUID V4; CUDA N, 2011, NVIDIA CUDA CUFFT LI; de Boer JF, 2001, APPL OPTICS, V40, P5787, DOI 10.1364/AO.40.005787; Farooq V, 2013, EUR HEART J, V34, P875, DOI 10.1093/eurheartj/ehr409; Farooq V, 2011, JACC-CARDIOVASC INTE, V4, P921, DOI 10.1016/j.jcin.2011.06.004; Gonzalez R.C., 2008, DIGITAL IMAGE PROCES, V3, P627; Gonzalo N, 2008, Minerva Cardioangiol, V56, P511; Gonzalo N, 2009, JACC-CARDIOVASC INTE, V2, P445, DOI 10.1016/j.jcin.2009.01.012; Grundeken MJ, 2014, EUROINTERVENTION; Han M, 2013, PROC SPIE, V8565, DOI 10.1117/12.2004335; Hoyert DL, 2012, NATL VITAL STAT REPO, P61; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Jablin TB, 2011, ACM SIGPLAN NOTICES, V46, P142, DOI 10.1145/1993316.1993516; Jian Y, FDOCT GPU OPEN SOURC; Jian YF, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.2.026002; Kauffmann C, 2010, IEEE T MED IMAGING, V29, P807, DOI 10.1109/TMI.2009.2037755; Kubo T, 2012, CIRC J, V76, P2076, DOI 10.1253/circj.CJ-12-0828; Lee KKC, 2012, BIOMED OPT EXPRESS, V3, P1557, DOI 10.1364/BOE.3.001557; Lee VW, 2010, CONF PROC INT SYMP C, P451, DOI 10.1145/1816038.1816021; Li J, 2011, APPL OPTICS, V50, P1832, DOI 10.1364/AO.50.001832; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; Lu H, 2012, BIOMED OPT EXPRESS, V3, P2809, DOI 10.1364/BOE.3.002809; Nakazawa G, 2008, CIRCULATION, V118, P1138, DOI 10.1161/CIRCULATIONAHA.107.762047; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Ozaki Y, 2010, EUR HEART J, V31, P1470, DOI 10.1093/eurheartj/ehq066; Rasakanthan J, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3548153; Reiber JHC, 2011, CARDIOVASC DIAGN THE, V1, P57, DOI 10.3978/j.issn.2223-3652.2011.09.03; ROSENFEL.A, 1966, J ACM, V13, P471; Tearney GJ, 1996, CIRCULATION, V94, P3013, DOI 10.1161/01.CIR.94.11.3013; Tearney GJ, 2012, J AM COLL CARDIOL, V59, P1058, DOI 10.1016/j.jacc.2011.09.079; Tearney GJ, 2008, JACC-CARDIOVASC IMAG, V1, P752, DOI 10.1016/j.jcmg.2008.06.007; Ughi Giovanni J, 2012, Biomed Opt Express, V3, P3291, DOI 10.1364/BOE.3.003291; Watanabe Y, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3275463; Yang PS, 2015, J CARDIOL, V65, P305, DOI 10.1016/j.jjcc.2014.12.004; Yun SH, 2004, OPT EXPRESS, V12, P4822, DOI 10.1364/OPEX.12.004822; Zhang K, 2012, IEEE J SEL TOP QUANT, V18, P1270, DOI 10.1109/JSTQE.2011.2164517	41	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124192	10.1371/journal.pone.0124192	http://dx.doi.org/10.1371/journal.pone.0124192			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880375	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500088
J	Jiang, TS; Mandal, RK; Wideman, RF; Khatiwara, A; Pevzner, I; Kwon, YM				Jiang, Tieshan; Mandal, Rabindra K.; Wideman, Robert F., Jr.; Khatiwara, Anita; Pevzner, Igal; Kwon, Young Min			Molecular Survey of Bacterial Communities Associated with Bacterial Chondronecrosis with Osteomyelitis (BCO) in Broilers	PLOS ONE			English	Article							FEMORAL-HEAD NECROSIS; STAPHYLOCOCCUS-AUREUS; LEG WEAKNESS; PAIRED-END; CHICKENS; LAMENESS; IDENTIFICATION; GENERATION; INFECTION; REVEALS	Bacterial chondronecrosis with osteomyelitis (BCO) is recognized as an important cause of lameness in commercial broiler chickens (meat-type chickens). Relatively little is known about the microbial communities associated with BCO. This study was conducted to increase our understanding of the microbial factors associated with BCO using a culture-independent approach. Using Illumina sequencing of the hyper-variable region V6 in the 16S rRNA gene, we characterized the bacterial communities in 97 femoral or tibial heads from normal and lame broilers carefully selected to represent diverse variations in age, line, lesion type, floor type, clinical status and bone type. Our in-depth survey based on 14 million assembled sequence reads revealed that complex bacterial communities exist in all samples, including macroscopically normal bones from clinically healthy birds. Overall, Proteobacteria (mean 90.9%) comprised the most common phylum, followed by Firmicutes (6.1%) and Actinobacteria (2.6%), accounting for more than 99% of all reads. Statistical analyses demonstrated that there are differences in bacterial communities in different types of bones (femur vs. tibia), lesion types (macroscopically normal femora or tibiae vs. those with pathognomonic BCO lesions), and among individual birds. This analysis also showed that BCO samples overrepresented genera Staphylococcus, whose species have been frequently isolated in BCO samples in previous studies. Rarefaction analysis demonstrated the general tendency that increased severities of BCO lesions were associated with reduced species diversity in both femoral and tibial samples when compared to macroscopically normal samples. These observations suggest that certain bacterial subgroups are preferentially selected in association with the development of BCO lesions. Understanding the microbial species associated with BCO will identify opportunities for understanding and modulating the pathogenesis of this form of lameness in broilers.	[Jiang, Tieshan; Mandal, Rabindra K.; Wideman, Robert F., Jr.; Kwon, Young Min] Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA; [Wideman, Robert F., Jr.; Khatiwara, Anita; Kwon, Young Min] Univ Arkansas, Cell & Mol Biol Program, Fayetteville, AR 72701 USA; [Pevzner, Igal] Cobb Vantress Inc, Siloam Springs, AR USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Jiang, TS (corresponding author), Univ Arkansas, Dept Poultry Sci, Fayetteville, AR 72701 USA.	txj001@uark.edu			Cobb-Vantress Inc., Siloam Springs, Arkansas, USA	Cobb-Vantress Inc., Siloam Springs, Arkansas, USA	Funding for this project was provided by Cobb-Vantress Inc., Siloam Springs, Arkansas, USA. The funder provided support in the form of a salary for author IP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ANDREASEN JR, 1993, AVIAN DIS, V37, P284, DOI 10.2307/1591650; Bartram AK, 2011, APPL ENVIRON MICROB, V77, P3846, DOI 10.1128/AEM.02772-10; Bradshaw RH, 2002, AVIAN POULT BIOL REV, V13, P45, DOI 10.3184/147020602783698421; Butterworth A, 1999, WORLD POULTRY SCI J, V55, P327, DOI 10.1079/WPS19990024; Cabral JPS, 2010, INT J ENV RES PUB HE, V7, P3657, DOI 10.3390/ijerph7103657; Cai H, 2003, J VET DIAGN INVEST, V15, P465, DOI 10.1177/104063870301500511; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; CARRERO P, 1995, J CLIN MICROBIOL, V33, P275, DOI 10.1128/JCM.33.2.275-276.1995; Cephas KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023503; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Danzeisen JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027949; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dimitriu PA, 2005, INT J SYST EVOL MICR, V55, P2273, DOI 10.1099/ijs.0.63647-0; Dinev I, 2009, BRIT POULTRY SCI, V50, P284, DOI 10.1080/00071660902942783; DUFF SRI, 1987, RES VET SCI, V42, P17, DOI 10.1016/S0034-5288(18)30650-7; Dumas MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024785; Durairaj V, 2009, AVIAN DIS, V53, P21, DOI 10.1637/8367-051908-Reg.1; El-Lethey H, 2003, VET IMMUNOL IMMUNOP, V95, P91, DOI 10.1016/S0165-2427(02)00308-2; Ernebjerg M, 2012, APPL ENVIRON MICROB, V78, P1345, DOI 10.1128/AEM.06585-11; Fierer N, 2010, P NATL ACAD SCI USA, V107, P6477, DOI 10.1073/pnas.1000162107; Gloor GB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015406; Grohskopf LA, 2001, NEW ENGL J MED, V344, P1491, DOI 10.1056/NEJM200105173442001; Harris L. G., 2002, European Cells & Materials, V4, P39; Hong PY, 2010, APPL ENVIRON MICROB, V76, P5631, DOI 10.1128/AEM.00281-10; Hume E, 2004, Arch Soc Esp Oftalmol, V79, P475; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Joiner KS, 2005, VET PATHOL, V42, P275, DOI 10.1354/vp.42-3-275; Julie G, 2009, KNEE, V16, P512, DOI 10.1016/j.knee.2009.02.008; Kip N, 2011, ENV MICROBIOL REP, V3, P667, DOI 10.1111/j.1758-2229.2011.00260.x; Lang KS, 2010, APPL ENVIRON MICROB, V76, P5321, DOI 10.1128/AEM.00323-10; Laufer AS, 2011, MBIO, V2, DOI 10.1128/mBio.00245-10; Luo CW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030087; McNamee PT, 1998, VET REC, V143, P131, DOI 10.1136/vr.143.5.131; McNamee PT, 1999, AVIAN PATHOL, V28, P26, DOI 10.1080/03079459995019; McNamee PT, 2000, AVIAN PATHOL, V29, P253, DOI 10.1080/03079450050118386; Moya A, 2008, NAT REV GENET, V9, P218, DOI 10.1038/nrg2319; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; NRC, 1994, NUTR REQ POULTR; Pattison M, 1992, BONE BIOL SKELETAL D, P329; Petrosino JF, 2009, CLIN CHEM, V55, P856, DOI 10.1373/clinchem.2008.107565; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Smeltzer MS, 2000, POULTRY SCI, V79, P1042, DOI 10.1093/ps/79.7.1042; Smith DR, 2008, GENOME RES, V18, P1638, DOI 10.1101/gr.077776.108; SPEERS DJ, 1985, INFECT IMMUN, V49, P443, DOI 10.1128/IAI.49.2.443-446.1985; Stalker MJ, 2010, J VET DIAGN INVEST, V22, P643, DOI 10.1177/104063871002200426; THORP BH, 1993, AVIAN PATHOL, V22, P325, DOI 10.1080/03079459308418924; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ursua PR, 1996, J CLIN MICROBIOL, V34, P216, DOI 10.1128/JCM.34.1.216-217.1996; Vahjen W, 2010, APPL ENVIRON MICROB, V76, P6689, DOI 10.1128/AEM.03075-09; van Kessel MAHJ, 2011, AMB EXPRESS, V1, DOI 10.1186/2191-0855-1-41; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Werner JJ, 2012, ISME J, V6, P1273, DOI 10.1038/ismej.2011.186; Whiteford N, 2009, BIOINFORMATICS, V25, P2194, DOI 10.1093/bioinformatics/btp383; Wideman RF, 2012, POULTRY SCI, V91, P2464, DOI 10.3382/ps.2012-02386; Wideman RF, 2012, POULTRY SCI, V91, P870, DOI 10.3382/ps.2011-01907; Wideman Robert F, 2012, Front Endocrinol (Lausanne), V3, P183, DOI 10.3389/fendo.2012.00183; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160	59	23	23	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124403	10.1371/journal.pone.0124403	http://dx.doi.org/10.1371/journal.pone.0124403			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881241	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500097
J	Rudenick, PA; Bijnens, BH; Segers, P; Garcia-Dorado, D; Evangelista, A				Rudenick, Paula A.; Bijnens, Bart H.; Segers, Patrick; Garcia-Dorado, David; Evangelista, Arturo			Assessment of Wall Elasticity Variations on Intraluminal Haemodynamics in Descending Aortic Dissections Using a Lumped-Parameter Model	PLOS ONE			English	Article							IN-VITRO PHANTOM; BLOOD-FLOW; TRUE-LUMEN; TEAR SIZE; MANAGEMENT; SIMULATIONS; DIAGNOSIS; IMPEDANCE; PATTERNS; ANALOG	Descending aortic dissection (DAD) is associated with high morbidity and mortality rates. Aortic wall stiffness is a variable often altered in DAD patients and potentially involved in long-term outcome. However, its relevance is still mostly unknown. To gain more detailed knowledge of how wall elasticity (compliance) might influence intraluminal haemodynamics in DAD, a lumped-parameter model was developed based on experimental data from a pulsatile hydraulic circuit and validated for 8 clinical scenarios. Next, the variations of intraluminal pressures and flows were assessed as a function of wall elasticity. In comparison with the most rigid-wall case, an increase in elasticity to physiological values was associated with a decrease in systolic and increase in diastolic pressures of up to 33% and 63% respectively, with a subsequent decrease in the pressure wave amplitude of up to 86%. Moreover, it was related to an increase in multidirectional intraluminal flows and transition of behaviour as 2 parallel vessels towards a vessel with a side-chamber. The model supports the extremely important role of wall elasticity as determinant of intraluminal pressures and flow patterns for DAD, and thus, the relevance of considering it during clinical assessment and computational modelling of the disease.	[Rudenick, Paula A.; Garcia-Dorado, David; Evangelista, Arturo] Univ Autonoma Barcelona, Univ Hosp, E-08193 Barcelona, Spain; [Rudenick, Paula A.; Garcia-Dorado, David; Evangelista, Arturo] Univ Autonoma Barcelona, Res Inst Vall dHebron, E-08193 Barcelona, Spain; [Rudenick, Paula A.; Bijnens, Bart H.] Univ Pompeu Fabra, DTIC, Physense, Barcelona, Spain; [Bijnens, Bart H.] ICREA, Barcelona, Spain; [Segers, Patrick] Univ Ghent, Inst Biomed Technol, Biofluid Tissue & Solid Mech Med Applicat, B-9000 Ghent, Belgium	Autonomous University of Barcelona; Autonomous University of Barcelona; Pompeu Fabra University; ICREA; Ghent University	Rudenick, PA (corresponding author), Univ Autonoma Barcelona, Univ Hosp, E-08193 Barcelona, Spain.	paula.rudenick@upf.edu	Bijnens, Bart H/C-2955-2008; Bijnens, Bart/AAE-7186-2021; Segers, Patrick/AAA-7844-2020	Bijnens, Bart H/0000-0003-3130-6937; Bijnens, Bart/0000-0003-3130-6937; Segers, Patrick/0000-0003-3870-3409	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain [PI108/0608, PI11/01709]; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU [611823]; ICREA Funding Source: Custom	Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain; Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR), Spain; EU(European Commission); ICREA(ICREA)	This study was partially supported by the Subprograma de Proyectos de Investigacion en Salud (FIS), Instituto de Salud Carlos III, Spain (ref. PI108/0608, PI11/01709); the Programa de ayudas destinadas a universidades, centros de investigacion y fundaciones hospitalarias para la contratacion de personal investigador novel (FI-DGR 2011), Spain; and the EU FP7 for research, technological development and demonstration under grant agreement VP2HF (no 611823).	Cheng Z, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000964; Cheng Z, 2013, J VASC SURG, V57, p35S, DOI 10.1016/j.jvs.2012.07.061; Chung JW, 2000, RADIOLOGY, V214, P87, DOI 10.1148/radiology.214.1.r00ja3287; Erbel R, 2001, EUR HEART J, V22, P1642, DOI 10.1053/euhj.2001.2782; Evangelista A, 2006, THORACIC AORTIC DIS, P33; Evangelista A, 2012, CIRCULATION, V125, P3133, DOI 10.1161/CIRCULATIONAHA.111.090266; Francois CJ, 2013, J THORAC CARDIOV SUR, V145, P1359, DOI 10.1016/j.jtcvs.2012.07.019; JAGER GN, 1965, CIRC RES, V16, P121, DOI 10.1161/01.RES.16.2.121; Karmonik C, 2013, MAGN RESON MED, V69, P1438, DOI 10.1002/mrm.24376; Khan IA, 2002, CHEST, V122, P311, DOI 10.1378/chest.122.1.311; LePage MA, 2001, AM J ROENTGENOL, V177, P207, DOI 10.2214/ajr.177.1.1770207; Milisic V, 2004, ESAIM-MATH MODEL NUM, V38, P613, DOI 10.1051/m2an:2004036; MURGO JP, 1980, CIRCULATION, V62, P105, DOI 10.1161/01.CIR.62.1.105; Nienaber CA, 2003, CIRCULATION, V108, P772, DOI 10.1161/01.CIR.0000087400.48663.19; Nienaber CA, 2006, ESC TXB CARDIOVASCUL, P993; Quint LE, 2003, J ENDOVASC THER, V10, P505, DOI 10.1583/1545-1550(2003)010<0505:AITDWS>2.0.CO;2; Reymond P, 2013, MED ENG PHYS, V35, P784, DOI 10.1016/j.medengphy.2012.08.009; Roccabianca S, 2014, J MECH BEHAV BIOMED, V29, P618, DOI 10.1016/j.jmbbm.2013.01.026; Rubin Sylvain, 2006, Interact Cardiovasc Thorac Surg, V5, P746, DOI 10.1510/icvts.2006.134957; Rudenick PA, 2013, LECT NOTES COMPUTER, V7746, P375; Rudenick PA, 2013, J VASC SURG, V57, P464, DOI 10.1016/j.jvs.2012.07.008; Rudenick PA, 2010, LECT NOTES COMPUT SC, V6364, P114, DOI 10.1007/978-3-642-15835-3_12; Shi YB, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-33; Soudah E, 2015, COMPUT METHOD BIOMEC, V18, P805, DOI 10.1080/10255842.2013.847095; Tan FPP, 2009, INT J APPL MECH, V1, P179, DOI 10.1142/S1758825109000095; Taylor M, 2011, MCDONALD'S BLOOD FLOW IN ARTERIES: THEORETICAL, EXPERIMENTAL AND CLINICAL PRINCIPLES, 6TH EDITION, P77; Trimarchi S, 2014, ANN CARDIOTHORAC SUR, V3, P285, DOI 10.3978/j.issn.2225-319X.2014.05.01; Tsai TT, 2006, CIRCULATION, V114, P2226, DOI 10.1161/CIRCULATIONAHA.106.622340; Tse KM, 2011, J BIOMECH, V44, P827, DOI 10.1016/j.jbiomech.2010.12.014; WESTERHOF N, 1969, J BIOMECH, V2, P121, DOI 10.1016/0021-9290(69)90024-4; Williams D M, 1993, J Vasc Interv Radiol, V4, P75, DOI 10.1016/S1051-0443(93)71824-2; Williams DM, 1997, RADIOLOGY, V203, P23, DOI 10.1148/radiology.203.1.9122399; Wu D, 2013, J SURG RES, V184, P907, DOI 10.1016/j.jss.2013.06.007	33	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124011	10.1371/journal.pone.0124011	http://dx.doi.org/10.1371/journal.pone.0124011			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881158	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500076
J	Zitzmann-Roth, EM; von Sonnenburg, F; de la Motte, S; Arndtz-Wiedemann, N; von Krempelhuber, A; Uebler, N; Vollmar, J; Virgin, G; Chaplin, P				Zitzmann-Roth, Eva-Maria; von Sonnenburg, Frank; de la Motte, Stephan; Arndtz-Wiedemann, Nathaly; von Krempelhuber, Alfred; Uebler, Nadine; Vollmar, Jens; Virgin, Garth; Chaplin, Paul			Cardiac Safety of Modified Vaccinia Ankara for Vaccination against Smallpox in a Young, Healthy Study Population	PLOS ONE			English	Article							UNITED-STATES; TROPONIN-I; FOLLOW-UP; COMPLICATIONS; MYOPERICARDITIS; IMMUNOGENICITY; ELECTROCARDIOGRAPHY; ABNORMALITIES; MYOCARDITIS; CIVILIANS	Background Conventional smallpox vaccines based on replicating vaccinia virus (VV) strains (e.g. Lister Elstree, NYCBOH) are associated with a high incidence of myo-/pericarditis, a severe inflammatory cardiac complication. A new smallpox vaccine candidate based on a nonreplicating Modified Vaccinia Ankara (MVA) poxvirus has been assessed for cardiac safety in a large placebo-controlled clinical trial. Methods Cardiac safety of one and two doses of MVA compared to placebo was assessed in 745 healthy subjects. Vaccinia-naive subjects received either one dose of MVA and one dose of placebo, two doses of MVA, or two doses of placebo by subcutaneous injection four weeks apart; vaccinia-experienced subjects received a single dose of MVA. Solicited and unsolicited adverse events (AE) and cardiac safety parameters (recorded as Adverse Events of Special Interest, AESI) were monitored after each injection. Results A total of 5 possibly related AESI (3 cases of palpitations, 2 of tachycardia) were reported during the study. No case of myo- or pericarditis occurred. One possibly related serious AE (SAE) was reported during the 6-month follow-up period (sarcoidosis). The most frequently observed AEs were injection site reactions. Conclusions Vaccination with MVA was safe and well tolerated and did not increase the risk for development of myo-/pericarditis.	[Zitzmann-Roth, Eva-Maria] Praxis Zitzmann Roth, Munich, Germany; [von Sonnenburg, Frank] Univ Munich, Dept Trop Med & Infect Dis, Sect Int Med & Publ Hlth, Munich, Germany; [de la Motte, Stephan] Harrison Clin Res GmbH, Munich, Germany; [Arndtz-Wiedemann, Nathaly; von Krempelhuber, Alfred; Uebler, Nadine; Vollmar, Jens; Virgin, Garth; Chaplin, Paul] Bavarian Nord GmbH, Martinsried, Germany	University of Munich; Bavarian Nordic	Arndtz-Wiedemann, N (corresponding author), Bavarian Nord GmbH, Martinsried, Germany.	nathaly.arndtz@bavarian-nordic.com			NIAID [N01-Al-40072]; Bavarian Nordic	NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Bavarian Nordic	The study was funded by NIAID contract # N01-Al-40072. The study sponsor was Bavarian Nordic. All authors except for those employed by Bavarian Nordic received research grants from Bavarian Nordic to support the conduct of this trial. AK, JV, NU and GV were employees of Bavarian Nordic at the time of the study conduct. NA and PC are employees of Bavarian Nordic, at the time of study conduct and still currently. The funder provided support in the form of salaries for authors AK, JV, NU, GV, NA and PC, but did not have and additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acambis, 2007, ACAM2000 SMALLP VACC; Arness MK, 2004, AM J EPIDEMIOL, V160, P642, DOI 10.1093/aje/kwh269; Cassimatis DC, 2004, J AM COLL CARDIOL, V43, P1503, DOI 10.1016/j.jacc.2003.11.053; Eckart RE, 2005, AM J CARDIOL, V95, P1252, DOI 10.1016/j.amjcard.2005.01.061; Eckart RE, 2004, J AM COLL CARDIOL, V44, P201, DOI 10.1016/j.jacc.2004.05.004; Eijsvogels T, 2010, AM J CARDIOL, V105, P267, DOI 10.1016/j.amjcard.2009.08.679; Elizaga ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054407; Food and Drug Administration HHS, 2005, Fed Regist, V70, P61134; Frey SE, 2007, VACCINE, V25, P8562, DOI 10.1016/j.vaccine.2007.10.017; Frey SE, 2013, VACCINE, V31, P3025, DOI 10.1016/j.vaccine.2013.04.050; Grabenstein JD, 2003, JAMA-J AM MED ASSOC, V289, P3278, DOI 10.1001/jama.289.24.3278; Greenberg RN, 2013, J INFECT DIS, V207, P749, DOI 10.1093/infdis/jis753; Halsell JS, 2003, JAMA-J AM MED ASSOC, V289, P3283, DOI 10.1001/jama.289.24.3283; Hingorani P, 2012, INDIAN J MED RES, V135, P322; Hiss RG, 1962, CIRCULATION, V25; Kennedy JS, 2009, EXPERT REV VACCINES, V8, P13, DOI 10.1586/14760584.8.1.13; Kobza R, 2012, HEART RHYTHM, V9, P2018, DOI 10.1016/j.hrthm.2012.08.034; LANE JM, 1970, J INFECT DIS, V122, P303, DOI 10.1093/infdis/122.4.303; LANE JM, 1969, NEW ENGL J MED, V281, P1201, DOI 10.1056/NEJM196911272812201; MAYR A, 1964, ZENTBL BAKTERIOLOG P, V195, P24; Mayr A., 1975, INFECTION, V3, P6, DOI [10.1007/BF01641272, DOI 10.1007/BF01641272]; MMWR, 2003, MMWR MORB MORTAL WKL, V52, P444; Mora LF, 2009, SOUTH MED J, V102, P615, DOI 10.1097/SMJ.0b013e31819fe55b; Morgan J, 2008, CLIN INFECT DIS, V46, pS242, DOI 10.1086/524747; Neff J, 2008, CLIN INFECT DIS, V46, pS258, DOI 10.1086/524749; Neumayr G, 2001, AM J CARDIOL, V87, P369, DOI 10.1016/S0002-9149(00)01382-5; Nosanchuk JS, 1999, CLIN CHEM, V45, P714; Sano J, 2009, AM J MED, V122, P79, DOI 10.1016/j.amjmed.2008.07.025; Sharma Umesh, 2011, WMJ, V110, P291; Sniadack MM, 2008, CLIN INFECT DIS, V46, pS251, DOI 10.1086/524741; STICKL H, 1974, DEUT MED WOCHENSCHR, V99, P2386, DOI 10.1055/s-0028-1108143; Suter M, VACCINE; Vollmar J, 2006, VACCINE, V24, P2065, DOI 10.1016/j.vaccine.2005.11.022; von Krempelhuber A, 2010, VACCINE, V28, P1209, DOI 10.1016/j.vaccine.2009.11.030; Wu AHB, 1999, CLIN CHEM, V45, P1104	35	23	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122653	10.1371/journal.pone.0122653	http://dx.doi.org/10.1371/journal.pone.0122653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879867	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500024
J	Lee, A; Ratnarajah, N; Tuan, TA; Chen, SHA; Qiu, AQ				Lee, Annie; Ratnarajah, Nagulan; Tuan, Ta Anh; Chen, Shen-Hsing Annabel; Qiu, Anqi			Adaptation of Brain Functional and Structural Networks in Aging	PLOS ONE			English	Article							AGE-RELATED-CHANGES; DEFAULT MODE NETWORK; WORKING-MEMORY; SPONTANEOUS FLUCTUATIONS; NEURAL SPECIALIZATION; CEREBRAL-CORTEX; TEMPORAL-LOBE; CONNECTIVITY; OLDER; FMRI	The human brain, especially the prefrontal cortex (PFC), is functionally and anatomically reorganized in order to adapt to neuronal challenges in aging. This study employed structural MRI, resting-state fMRI (rs-fMRI), and high angular resolution diffusion imaging (HARDI), and examined the functional and structural reorganization of the PFC in aging using a Chinese sample of 173 subjects aged from 21 years and above. We found age-related increases in the structural connectivity between the PFC and posterior brain regions. Such findings were partially mediated by age-related increases in the structural connectivity of the occipital lobe within the posterior brain. Based on our findings, it is thought that the PFC reorganization in aging could be partly due to the adaptation to age-related changes in the structural reorganization of the posterior brain. This thus supports the idea derived from task-based fMRI that the PFC reorganization in aging may be adapted to the need of compensation for resolving less distinctive stimulus information from the posterior brain regions. In addition, we found that the structural connectivity of the PFC with the temporal lobe was fully mediated by the temporal cortical thickness, suggesting that the brain morphology plays an important role in the functional and structural reorganization with aging.	[Lee, Annie; Ratnarajah, Nagulan; Tuan, Ta Anh; Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore 117576, Singapore; [Chen, Shen-Hsing Annabel] Nanyang Technol Univ, Div Psychol, Singapore 637332, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore 117456, Singapore; [Qiu, Anqi] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore 117609, Singapore	National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS)	Qiu, AQ (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore 117576, Singapore.	bieqa@nus.edu.sg	Chen, SH Annabel/F-3742-2011; Qiu, Anqi/H-2267-2011	Chen, SH Annabel/0000-0002-1540-5516; Qiu, Anqi/0000-0002-0215-6338; Ratnarajah, Nagulan/0000-0003-1758-9969	Young Investigator Award at the National University of Singapore [NUSYIA FY10 P07]; Singapore Ministry of Education Academic Research Fund Tier 2 [MOE2012-T2-2-130]	Young Investigator Award at the National University of Singapore(National University of Singapore); Singapore Ministry of Education Academic Research Fund Tier 2(Ministry of Education, Singapore)	The work was supported by grants from the Young Investigator Award at the National University of Singapore (NUSYIA FY10 P07) and the Singapore Ministry of Education Academic Research Fund Tier 2 (MOE2012-T2-2-130).	Batouli AH, 2009, IRAN J RADIOL, V6, P153; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bluhm RL, 2008, NEUROREPORT, V19, P887, DOI 10.1097/WNR.0b013e328300ebbf; Bookheimer S, 2007, NEUROPSYCHOL REV, V17, P145, DOI 10.1007/s11065-007-9026-x; Cabeza R, 1997, NEUROREPORT, V8, P3479, DOI 10.1097/00001756-199711100-00013; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Cheng H, 2012, NEUROIMAGE, V61, P1153, DOI 10.1016/j.neuroimage.2012.03.036; CONVIT A, 1995, PSYCHIAT QUART, V66, P343, DOI 10.1007/BF02238754; Damoiseaux JS, 2008, CEREB CORTEX, V18, P1856, DOI 10.1093/cercor/bhm207; Daselaar SM, 2006, CEREB CORTEX, V16, P1771, DOI 10.1093/cercor/bhj112; Daselaar SM, 2003, BRAIN, V126, P43, DOI 10.1093/brain/awg005; Davis SW, 2008, CEREB CORTEX, V18, P1201, DOI 10.1093/cercor/bhm155; Dennis NA, 2008, J EXP PSYCHOL LEARN, V34, P791, DOI 10.1037/0278-7393.34.4.791; Du J, 2011, NEUROIMAGE, V56, P162, DOI 10.1016/j.neuroimage.2011.01.067; Duverne S, 2009, CEREB CORTEX, V19, P733, DOI 10.1093/cercor/bhn122; Esposito F, 2008, MAGN RESON IMAGING, V26, P905, DOI 10.1016/j.mri.2008.01.045; Eyler LT, 2011, BIOL PSYCHIAT, V70, P115, DOI 10.1016/j.biopsych.2010.12.032; Fischer FU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086258; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Ford JH, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00307; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frey S, 2000, P NATL ACAD SCI USA, V97, P8723, DOI 10.1073/pnas.140543497; Friman O, 2006, IEEE T MED IMAGING, V25, P965, DOI 10.1109/TMI.2006.877093; Goh JO, 2010, NEUROIMAGE, V51, P336, DOI 10.1016/j.neuroimage.2010.01.107; Goh JOS, 2011, AGING DIS, V2, P30; Gong GL, 2009, J NEUROSCI, V29, P15684, DOI 10.1523/JNEUROSCI.2308-09.2009; Grady CL, 2008, CEREB CORTEX, V18, P189, DOI 10.1093/cercor/bhm045; Grady CL, 2000, BIOL PSYCHOL, V54, P259, DOI 10.1016/S0301-0511(00)00059-4; Grady CL, 2002, PSYCHOL AGING, V17, P7, DOI 10.1037//0882-7974.17.1.7; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gunning-Dixon FM, 2009, INT J GERIATR PSYCH, V24, P109, DOI 10.1002/gps.2087; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Heuninckx S, 2008, J NEUROSCI, V28, P91, DOI 10.1523/JNEUROSCI.3300-07.2008; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Hugenschmidt CE, 2009, BRAIN TOPOGR, V21, P241, DOI 10.1007/s10548-009-0098-1; Iidaka T, 2001, COGNITIVE BRAIN RES, V11, P1, DOI 10.1016/S0926-6410(00)00058-6; Johnson SC, 2000, NEUROIMAGE, V11, P179, DOI 10.1006/nimg.1999.0530; KAPUR S, 1994, P NATL ACAD SCI USA, V91, P2008, DOI 10.1073/pnas.91.6.2008; Koch W, 2010, NEUROIMAGE, V51, P280, DOI 10.1016/j.neuroimage.2009.12.008; Lee Y, 2011, J COGNITIVE NEUROSCI, V23, P3433, DOI 10.1162/jocn_a_00026; Leergaard TB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008595; Levine BK, 2000, NEUROBIOL AGING, V21, P577, DOI 10.1016/S0197-4580(00)00144-5; Meunier D, 2009, NEUROIMAGE, V44, P715, DOI 10.1016/j.neuroimage.2008.09.062; Mevel K, 2013, NEUROBIOL AGING, V34, P1292, DOI 10.1016/j.neurobiolaging.2012.08.018; Ng TP, 2007, AM J GERIAT PSYCHIAT, V15, P130, DOI 10.1097/01.JGP.0000235710.17450.9a; Nyberg L, 2003, P NATL ACAD SCI USA, V100, P13728, DOI 10.1073/pnas.1735487100; Park DC, 2004, P NATL ACAD SCI USA, V101, P13091, DOI 10.1073/pnas.0405148101; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Payer D, 2006, NEUROREPORT, V17, P487, DOI 10.1097/01.wnr.0000209005.40481.31; Persson J, 2004, NEUROIMAGE, V23, P1382, DOI 10.1016/j.neuroimage.2004.08.004; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Rajah MN, 2010, CORTEX, V46, P535, DOI 10.1016/j.cortex.2009.07.006; Raz N, 2004, NEUROLOGY, V62, P433, DOI 10.1212/01.WNL.0000106466.09835.46; Razlighi QR, 2014, BRAIN BEHAV, V4, P143, DOI 10.1002/brb3.202; Reuter-Lorenz PA, 2000, J COGNITIVE NEUROSCI, V12, P174, DOI 10.1162/089892900561814; Reuter-Lorenz PA, 2010, J GERONTOL B-PSYCHOL, V65, P405, DOI 10.1093/geronb/gbq035; Rusinek H, 2003, RADIOLOGY, V229, P691, DOI 10.1148/radiol.2293021299; Rypma B, 2000, NAT NEUROSCI, V3, P509, DOI 10.1038/74889; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; Shimony JS, 2009, ACAD RADIOL, V16, P578, DOI 10.1016/j.acra.2009.02.001; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; Supekar K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000157; Takeuchi H, 2012, HUMAN BRAIN MAPPING; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Uddin LQ, 2013, TRENDS COGN SCI, V17, P600, DOI 10.1016/j.tics.2013.09.011; Voss MW, 2008, BRAIN RES, V1244, P121, DOI 10.1016/j.brainres.2008.09.051; Wagner AD, 1998, SCIENCE, V281, P1188, DOI 10.1126/science.281.5380.1188; Weissman-Fogel I, 2010, HUM BRAIN MAPP, V31, P1713, DOI 10.1002/hbm.20968; Yan CG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005743; Ziegler G, 2012, HUM BRAIN MAPP, V33, P2377, DOI 10.1002/hbm.21374	75	14	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123462	10.1371/journal.pone.0123462	http://dx.doi.org/10.1371/journal.pone.0123462			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875816	Green Published, gold			2022-12-27	WOS:000353015800100
J	Sarveswaran, S; Ghosh, R; Morisetty, S; Ghosh, J				Sarveswaran, Sivalokanathan; Ghosh, Ritisha; Morisetty, Shravan; Ghosh, Jagadananda			MK591, a Second Generation Leukotriene Biosynthesis Inhibitor, Prevents Invasion and Induces Apoptosis in the Bone-Invading C4-2B Human Prostate Cancer Cells: Implications for the Treatment of Castration-Resistant, Bone-Metastatic Prostate Cancer	PLOS ONE			English	Article							ARACHIDONATE 5-LIPOXYGENASE; SIGNALING PATHWAY; FATTY-ACIDS; DIETARY-FAT; MYC; GROWTH; ACTIVATION; PROMOTER; BINDING; STRESS	Castration-resistant prostate cancer (CRPC) is a major clinical challenge for which no cure is currently available primarily because of the lack of proper understanding about appropriate molecular target(s). Previously we observed that inhibition of 5-lipoxygenase (5-Lox) activity induces apoptosis in some types of prostate cancer cells, suggesting an important role of 5-Lox in the viability of prostate cancer cells. However, nothing is known about the role of 5-Lox in the survival of castration-resistant, metastatic prostate cancer cells. Thus, we tested the effects of MK591, a second-generation, specific inhibitor of 5-Lox activity, on the viability and metastatic characteristics of CRPC cells. We observed that MK591 effectively kills the bone-invading C4-2B human prostate cancer cells (which bear characteristics of CRPC), but does not affect normal, non-cancer fibroblasts (which do not express 5-Lox) in the same experimental conditions. We also observed that MK591 dramatically inhibits the in vitro invasion and soft-agar colony formation of C4-2B cells. Interestingly, we found that treatment with MK591 dramatically down-regulates the expression of c-Myc and its targets at sub-lethal doses. In light of frequent over-activation of c-Myc in a spectrum of aggressive cancers (including CRPC), and the challenges associated with inhibition of c-Myc (because of its non-enzymatic nature), our novel findings of selective killing, and blockade of invasive and soft-agar colony-forming abilities of the castration-resistant, bone-metastatic C4-2B prostate cancer cells by MK591, open up a new avenue to attack CRPC cells for better management of advanced prostate cancer while sparing normal, non-cancer body cells.	[Sarveswaran, Sivalokanathan; Ghosh, Ritisha; Morisetty, Shravan; Ghosh, Jagadananda] Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA; [Ghosh, Jagadananda] Henry Ford Hlth Syst, Josephine Ford Canc Ctr, Detroit, MI 48202 USA	Henry Ford Health System; Henry Ford Hospital; Henry Ford Health System; Henry Ford Hospital	Ghosh, J (corresponding author), Henry Ford Hlth Syst, Dept Urol, Detroit, MI 48202 USA.	jghosh1@hfhs.org			National Cancer Institute of the National Institutes of Health [RO1 CA152334]; United States Department of Defense Prostate Cancer Research Program [W81-XWH-05-1-0022]; Henry Ford Health System internal research grant [A10203]; NATIONAL CANCER INSTITUTE [R01CA152334] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); United States Department of Defense Prostate Cancer Research Program(United States Department of Defense); Henry Ford Health System internal research grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Research reported in this publication was supported by the National Cancer Institute of the National Institutes of Health under award number RO1 CA152334, the United States Department of Defense Prostate Cancer Research Program W81-XWH-05-1-0022, and the Henry Ford Health System internal research grant A10203 to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Anderson KM, 1998, PROSTATE, V37, P161, DOI 10.1002/(SICI)1097-0045(19981101)37:3<161::AID-PROS5>3.0.CO;2-D; Attard G, 2006, BRIT J CANCER, V95, P767, DOI 10.1038/sj.bjc.6603223; Carson JP, 1999, CANCER RES, V59, P1449; Civenni G, 2013, CANCER RES, V73, P6816, DOI 10.1158/0008-5472.CAN-13-0615; CRAWFORD ED, 1989, NEW ENGL J MED, V321, P419, DOI 10.1056/NEJM198908173210702; DEPRE M, 1994, CLIN PHARMACOL THER, V56, P22, DOI 10.1038/clpt.1994.96; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Engelman JA, 2006, NAT REV GENET, V7, P606, DOI 10.1038/nrg1879; Evans JF, 2008, TRENDS PHARMACOL SCI, V29, P72, DOI 10.1016/j.tips.2007.11.006; Ferguson AD, 2007, SCIENCE, V317, P510, DOI 10.1126/science.1144346; Fleshner Neil, 2004, Journal of Urology, V171, pS19, DOI 10.1097/01.ju.0000107838.33623.19; GANN PH, 1994, J NATL CANCER I, V86, P281, DOI 10.1093/jnci/86.4.281; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Ghosh J, 2003, BIOCHEM BIOPH RES CO, V307, P342, DOI 10.1016/S0006-291X(03)01201-4; Ghosh J, 1997, BIOCHEM BIOPH RES CO, V235, P418, DOI 10.1006/bbrc.1997.6799; Ghosh J, 1999, ADV EXP MED BIOL, V469, P577; Ghosh J., 2008, CURR ENZYME INHIB, V4, P18, DOI DOI 10.2174/157340808783502540; GIOVANNUCCI E, 1993, J NATL CANCER I, V85, P1571, DOI 10.1093/jnci/85.19.1571; Gupta S, 2001, CANCER-AM CANCER SOC, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; Harris WP, 2009, NAT CLIN PRACT UROL, V6, P76, DOI 10.1038/ncpuro1296; Hawksworth D, 2010, PROSTATE CANCER P D, V13, P311, DOI 10.1038/pcan.2010.31; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Kanno T, 2006, J LIPID RES, V47, P1146, DOI 10.1194/jlr.M500329-JLR200; Kharbanda S, 2000, J BIOL CHEM, V275, P322, DOI 10.1074/jbc.275.1.322; Khew-Goodall Y, 2010, NAT CELL BIOL, V12, P209, DOI 10.1038/ncb0310-209; Klan N, 2003, BIOL CHEM, V384, P777, DOI 10.1515/BC.2003.086; Koh CM, 2011, AM J PATHOL, V178, P1824, DOI 10.1016/j.ajpath.2010.12.040; Koh Cheryl M, 2010, Genes Cancer, V1, P617, DOI 10.1177/1947601910379132; Kolonel LN, 1999, JNCI-J NATL CANCER I, V91, P414, DOI 10.1093/jnci/91.5.414; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Kyriakis JM, 1996, J BIOL CHEM, V271, P24313, DOI 10.1074/jbc.271.40.24313; Lin DL, 2001, PROSTATE, V47, P212, DOI 10.1002/pros.1065; Ma L, 2010, NAT CELL BIOL, V12, P247, DOI 10.1038/ncb2024; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Maroney AC, 1999, J NEUROCHEM, V73, P1901; Marques RB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013500; Marte BM, 1997, TRENDS BIOCHEM SCI, V22, P355, DOI 10.1016/S0968-0004(97)01097-9; Maundrell K, 1997, J BIOL CHEM, V272, P25238, DOI 10.1074/jbc.272.40.25238; Nadeau PJ, 2009, MOL BIOL CELL, V20, P3628, DOI 10.1091/mbc.E09-03-0211; PRASIT P, 1993, J LIPID MEDIATOR, V6, P239; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Radmark O, 2010, BIOCHEM BIOPH RES CO, V396, P105, DOI 10.1016/j.bbrc.2010.02.173; Roberts WG, 1997, GASTROENTEROLOGY, V112, P725, DOI 10.1053/gast.1997.v112.pm9041233; Rose DP, 1997, AM J CLIN NUTR, V66, P1513; Ryan CJ, 2005, J CLIN ONCOL, V23, P8242, DOI 10.1200/JCO.2005.03.3092; Sarveswaran S, 2013, CANCER LETT, V336, P185, DOI 10.1016/j.canlet.2013.04.027; Sarveswaran S, 2011, BBA-MOL CELL RES, V1813, P2108, DOI 10.1016/j.bbamcr.2011.07.015; Sarveswaran S, 2010, CANCER LETT, V291, P167, DOI 10.1016/j.canlet.2009.10.008; Shaw GL, 2007, BJU INT, V99, P1056, DOI 10.1111/j.1464-410X.2007.06770.x; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sorg BL, 2006, BBA-MOL CELL BIOL L, V1761, P686, DOI 10.1016/j.bbalip.2006.04.005; Tanaka A, 2003, BIOORG MED CHEM LETT, V13, P1037, DOI 10.1016/S0960-894X(03)00089-1; THALMANN GN, 1994, CANCER RES, V54, P2577; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; Wang DZ, 2010, NAT REV CANCER, V10, P181, DOI 10.1038/nrc2809; WANG Y, 1995, J NATL CANCER I, V87, P1456, DOI 10.1093/jnci/87.19.1456; Werz O, 2006, PHARMACOL THERAPEUT, V112, P701, DOI 10.1016/j.pharmthera.2006.05.009; WEST DW, 1991, CANCER CAUSE CONTROL, V2, P85, DOI 10.1007/BF00053126; Wolfer A, 2011, CANCER RES, V71, P2034, DOI 10.1158/0008-5472.CAN-10-3776; Wolfer A, 2010, CELL CYCLE, V9, P3639, DOI 10.4161/cc.9.18.13220; Wolfer A, 2010, P NATL ACAD SCI USA, V107, P3698, DOI 10.1073/pnas.0914203107; WYNDER EL, 1994, NUTR CANCER, V22, P1, DOI 10.1080/01635589409514327; Yamamura S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029722	65	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122805	10.1371/journal.pone.0122805	http://dx.doi.org/10.1371/journal.pone.0122805			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875826	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800076
J	Sur, A; Pradhan, B; Banerjee, A; Aich, P				Sur, Abhinav; Pradhan, Biswaranjan; Banerjee, Arka; Aich, Palok			Immune Activation Efficacy of Indolicidin Is Enhanced upon Conjugation with Carbon Nanotubes and Gold Nanoparticles	PLOS ONE			English	Article							CATIONIC ANTIMICROBIAL PEPTIDES; HOST-DEFENSE PEPTIDES; MODULATION; RESISTANCE; DELIVERY; BINDING; PROTEIN; MICE	Antibiotic resistance is concern of today's world. Search for alternative molecules, for treatment and immune stimulation, remains at the forefront. One such group of biomolecules with promise, along the line of immune stimulation or therapy, is host defense peptide ( HDP). These molecules, however, are required at a higher dose to be effective which leads to high cost. To alleviate such problems, an aid can be used to achieve similar efficacy but at a smaller effective dose of the immune stimulant. We hypothesised that by conjugating HDPs with carbon nanotubes and/or gold nanoparticles, it would be possible to stimulate a protective immune response in host system at a lower dosage of HDP. In this report, we characterized, using biophysical methodologies, conjugation of Indolicidin, as a representative of HDP. We further established efficacy of peptide-nanomaterial conjugates in activating innate immunity and protecting against pathogen infection in vitro at a significantly small dose.	[Sur, Abhinav; Pradhan, Biswaranjan; Banerjee, Arka; Aich, Palok] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Orissa, India	National Institute of Science Education & Research (NISER)	Aich, P (corresponding author), Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Orissa, India.	palok.aich@niser.ac.in	Sur, Abhinav/GXZ-4996-2022; Aich, Palok/A-3605-2010; Pradhan, Biswaranjan/AAW-5511-2020	Aich, Palok/0000-0003-4927-7812; Pradhan, Biswaranjan/0000-0002-8337-7748; Sur, Abhinav/0000-0003-2236-1459	Department of Science & Technology, India [SR/NM/NS-58/2010]	Department of Science & Technology, India(Department of Science & Technology (India))	Funding is through Nanomission project of Department of Science & Technology, India with DST # SR/NM/NS-58/2010. Funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AJ, 2013, ACS NANO, V7, P1108, DOI 10.1021/nn3055175; Andres E, 2004, REV MED INTERNE, V25, P629, DOI 10.1016/j.revmed.2004.02.025; Bianco Alberto, 2005, Current Drug Delivery, V2, P253, DOI 10.2174/1567201054367959; Boehr DD, 2003, CHEM BIOL, V10, P189, DOI 10.1016/S1074-5521(03)00026-7; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Chakravarthy KV, 2010, P NATL ACAD SCI USA, V107, P10172, DOI 10.1073/pnas.0914561107; Chen RJ, 2001, J AM CHEM SOC, V123, P3838, DOI 10.1021/ja010172b; Davies SA, 2009, GEN COMP ENDOCR, V162, P113, DOI 10.1016/j.ygcen.2008.09.012; Diamond G, 2009, CURR PHARM DESIGN, V15, P2377, DOI 10.2174/138161209788682325; Doss M, 2010, J LEUKOCYTE BIOL, V87, P79, DOI 10.1189/jlb.0609382; Easton DM, 2009, TRENDS BIOTECHNOL, V27, P582, DOI 10.1016/j.tibtech.2009.07.004; Harrison C J, 2009, Minerva Pediatr, V61, P503; Hilchie AL, 2013, NAT CHEM BIOL, V9, P761, DOI [10.1038/NCHEMBIO.1393, 10.1038/nchembio.1393]; Kotagiri N, 2014, INT J NANOMED, V9, P85, DOI 10.2147/IJN.S51854; Kovacs-Nolan J, 2009, VACCINE, V27, P2055, DOI 10.1016/j.vaccine.2009.01.118; Lacerda L, 2006, ADV DRUG DELIVER REV, V58, P1460, DOI 10.1016/j.addr.2006.09.015; Marchand C, 2006, NUCLEIC ACIDS RES, V34, P5157, DOI 10.1093/nar/gkl667; Minati L, 2012, LANGMUIR, V28, P15900, DOI 10.1021/la303298u; Mookherjee N, 2006, J IMMUNOL, V176, P2455, DOI 10.4049/jimmunol.176.4.2455; Nijnik A, 2009, J IMMUNOL, V183, P5788, DOI 10.4049/jimmunol.0901491; Okuyama-Nishida Y, 2009, ANTIMICROB AGENTS CH, V53, P2510, DOI 10.1128/AAC.00863-08; Pompilio A, 2011, PEPTIDES, V32, P1807, DOI 10.1016/j.peptides.2011.08.002; Riehemann K, 2009, ANGEW CHEM INT EDIT, V48, P872, DOI 10.1002/anie.200802585; Scott MG, 2000, J IMMUNOL, V164, P549, DOI 10.4049/jimmunol.164.2.549; Steinstraesser L, 2009, INT J MOL SCI, V10, P3951, DOI 10.3390/ijms10093951; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; Watari F, 2009, J R SOC INTERFACE, V6, pS371, DOI 10.1098/rsif.2008.0488.focus; Wheeler DS, 2009, RECENT PATENTS INFLA, V3, P96, DOI 10.2174/187221309788489779; Wiesner J, 2010, VIRULENCE, V1, P440, DOI 10.4161/viru.1.5.12983	29	22	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123905	10.1371/journal.pone.0123905	http://dx.doi.org/10.1371/journal.pone.0123905			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876153	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800122
J	Vaz, S; Falkmer, M; Ciccarelli, M; Passmore, A; Parsons, R; Tan, T; Falkmer, T				Vaz, Sharmila; Falkmer, Marita; Ciccarelli, Marina; Passmore, Anne; Parsons, Richard; Tan, Tele; Falkmer, Torbjorn			The Personal and Contextual Contributors to School Belongingness among Primary School Students	PLOS ONE			English	Article							MIDDLE-SCHOOL; DIFFICULTIES-QUESTIONNAIRE; PARENTAL INVOLVEMENT; MENTAL-HEALTH; MULTIDIMENSIONAL SCALE; COMMUNITY-SERVICE; PEER REJECTION; ADOLESCENTS; CONNECTEDNESS; FAMILY	School belongingness has gained currency among educators and school health professionals as an important determinant of adolescent health. The current cross-sectional study presents the 15 most significant personal and contextual factors that collectively explain 66.4% (two-thirds) of the variability in 12-year old students' perceptions of belongingness in primary school. The study is part of a larger longitudinal study investigating the factors associated with student adjustment in the transition from primary to secondary school. The study found that girls and students with disabilities had higher school belongingness scores than boys, and their typically developing counterparts respectively; and explained 2.5% of the variability in school belongingness. The majority (47.1% out of 66.4%) of the variability in school belongingness was explained by student personal factors, such as social acceptance, physical appearance competence, coping skills, and social affiliation motivation; followed by parental expectations (3% out of 66.4%), and school-based factors (13.9% out of 66.4%) such as, classroom involvement, task-goal structure, autonomy provision, cultural pluralism, and absence of bullying. Each of the identified contributors of primary school belongingness can be shaped through interventions, system changes, or policy reforms.	[Vaz, Sharmila; Falkmer, Marita; Ciccarelli, Marina; Passmore, Anne; Parsons, Richard; Falkmer, Torbjorn] Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia; [Falkmer, Marita] Jonkoping Univ, Inst Disabil Res, CHILD Programme, Sch Educ & Commun, Jonkoping, Sweden; [Parsons, Richard] Curtin Univ, Sch Pharm, Perth, WA 6845, Australia; [Tan, Tele] Curtin Univ, Dept Mech Engn, Perth, WA 6845, Australia; [Falkmer, Torbjorn] Linkoping Univ, Rehabil Med, Dept Med & Hlth Sci IMH, Fac Hlth Sci, Linkoping, Sweden; [Falkmer, Torbjorn] Cty Council, UHL, Pain & Rehabil Ctr, Linkoping, Sweden	Curtin University; Jonkoping University; Curtin University; Curtin University; Linkoping University	Vaz, S (corresponding author), Curtin Univ, Sch Occupat Therapy & Social Work, Perth, WA 6845, Australia.	s.vaz@curtin.edu.au		Vaz, Sharmila/0000-0003-1003-9593; Tan, Tele/0000-0003-3195-3480	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University, Perth, Australia; Healthway Australia	Centre for Research into Disability and Society; School of Occupational Therapy and Social Work, Curtin University, Perth, Australia; Healthway Australia	This project was funded by a Doctoral scholarship provided by the Centre for Research into Disability and Society and the School of Occupational Therapy and Social Work, Curtin University, Perth, Australia. It was part of a larger study that was awarded the 2007 Social Determinants for Health Research award by Healthway Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABS, 2003, AUSTR DEM STAT; Alexander KL, 2001, EDUC EVAL POLICY AN, V23, P171, DOI 10.3102/01623737023002171; Ali J., 2005, AARE 2005 INT ED C S; Ames C., 1992, STUDENT PERCEPTIONS, P327; Anderman EM, 2002, J EDUC PSYCHOL, V94, P795, DOI 10.1037//0022-0663.94.4.795; Anderman L., 2004, ADV MOTIVATION ACHIE, V13, P27, DOI DOI 10.1016/S0749-7423(03)13002-6; Anderman LH, 2003, J EXP EDUC, V72, P5, DOI 10.1080/00220970309600877; [Anonymous], 2004, J SCHOOL HEALTH, V74, P233; [Anonymous], 2002, HDB SELF DETERMINATI; Australian Bureau of Statistics, 2009, ANZSCO AUSTR NZ STAN; Australian Bureau of Statistics [ABS], 2001, ABS 2001 CENS DIC; Barber BK, 1997, J ADOLESCENT RES, V12, P287, DOI 10.1177/0743554897122008; Battistich V, 1997, EDUC PSYCHOL-US, V32, P137, DOI 10.1207/s15326985ep3203_1; BAUMEISTER RF, 1995, PSYCHOL BULL, V117, P497, DOI 10.1037/0033-2909.117.3.497; Billingsley F, 1996, SPECIAL ED LEADERSHI, V3, P43; Black R., 2007, ENGAGING STUDENTS SC; Blum RW, 2005, EDUC LEADERSHIP, V62, P16; Blum RW, 2004, J SCHOOL HEALTH, V74, P231, DOI 10.1111/j.1746-1561.2004.tb08278.x; Bond L, 2007, J ADOLESCENT HEALTH, V40, DOI DOI 10.1016/J.JADOHEALTH.2006.10.013; Buhs ES, 2001, DEV PSYCHOL, V37, P550, DOI 10.1037//0012-1649.37.4.550; Bukowski W.M., 1989, PEER RELATIONSHIPS C, P15; BYLES J, 1988, FAM PROCESS, V27, P97, DOI 10.1111/j.1545-5300.1988.00097.x; Catalano RF, 2004, J SCHOOL HEALTH, V74, P252, DOI 10.1111/j.1746-1561.2004.tb08281.x; CERNKOVICH SA, 1992, CRIMINOLOGY, V30, P261, DOI 10.1111/j.1745-9125.1992.tb01105.x; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Connell JP, 1990, SELF TRANSISTION INF; Cooley C. H., 1902, HUMAN NATURE SOCIAL; Cormack P., 1996, ALIENATION ENGAGEMEN; COWEN EL, 1994, AM J COMMUN PSYCHOL, V22, P149, DOI 10.1007/BF02506861; Crick N.R., 1999, CHILDRENS LONELINESS, P153; Cross D, 2002, FRIENDLY SCH FAMILIE; DECI EL, 1991, EDUC PSYCHOL-US, V26, P325, DOI 10.1207/s15326985ep2603&4_6; Deci LM, 1985, INTRINSIC MOTIVATION; Despa S, 2007, STATNEWS 70 QUANTILE; Eccles JS, 1997, J ADOLESCENT RES, V12, P263, DOI 10.1177/0743554897122007; Elliott ES, 1998, J PERSONALITY ASSESS, V54; Emerson E, 2005, J INTELLECT DEV DIS, V30, P14, DOI 10.1080/13668250500033169; ENTWISLE DR, 1983, DEV PSYCHOL, V19, P200, DOI 10.1037/0012-1649.19.2.200; EPSTEIN NB, 1983, J MARITAL FAM THER, V9, P171, DOI 10.1111/j.1752-0606.1983.tb01497.x; EVERTSON CM, 1992, EDUC LEADERSHIP, V49, P74; Faircloth BS, 2005, J YOUTH ADOLESCENCE, V34, P293, DOI 10.1007/s10964-005-5752-7; FELNER RD, 1985, AM J COMMUN PSYCHOL, V13, P365, DOI 10.1007/BF00911214; Felner RD, 2001, J SCHOOL PSYCHOL, V39, P177, DOI 10.1016/S0022-4405(01)00057-7; Felner RD, 1989, PRIMARY PREVENTION P, P13; Field A., 2006, DISCOVERING STAT USI; FINN JD, 1989, REV EDUC RES, V59, P117, DOI 10.3102/00346543059002117; Frederickson N, 2007, BRIT J SPEC EDUC, V34, P105, DOI 10.1111/j.1467-8578.2007.00463.x; Frydenberg E., 1999, J PSYCHOL COUNS SCH, V9, P19, DOI [10.1017/S1037291100002971, DOI 10.1017/S1037291100002971]; Frydenberg E., 1993, ADOLESCENT COPING SC; Fullarton S., 2003, PATTERNS PARTICIPATI; Furrer CJ, 2003, J ED PSYCHOL, V95; Gill S, 1999, J SCHOOL PSYCHOL, V37, P403, DOI 10.1016/S0022-4405(99)00027-8; GOODENOW C, 1993, PSYCHOL SCHOOLS, V30, P79, DOI 10.1002/1520-6807(199301)30:1<79::AID-PITS2310300113>3.0.CO;2-X; GOODENOW C, 1993, J EXP EDUC, V62, P60, DOI 10.1080/00220973.1993.9943831; Goodenow C., 1993, J EARLY ADOLESCENCE, V13, P21, DOI [10. 1177/0272431693013001002, DOI 10.1177/0272431693013001002]; Gorard S., 2006, COMPREHENSIVE ED EVO; Gottfredson G.D., 1985, VICTIMIZATION SCH; Gottfredson GD, 2005, J RES CRIME DELINQ, V42, P412, DOI 10.1177/0022427804271931; HAGBORG WJ, 1994, J PSYCHOEDUC ASSESS, V12, P312, DOI 10.1177/073428299401200401; Hagborg WJ, 2001, SCH MEMBERSHIP MIDDL; Hammer A.L., 1998, MANUAL COPING RESOUR; Hardre PL, 2003, J EDUC PSYCHOL, V95, P347, DOI 10.1037/0022-0663.95.2.347; Hargreaves A., 1986, 2 CULTURES SCH CASE; HARTER S, 1982, CHILD DEV, V53, P87, DOI 10.1111/j.1467-8624.1982.tb01295.x; Harter S, 1998, AM EDUC RES J, V35, P653, DOI 10.2307/1163462; Harter S., 1983, HDB CHILD DEV, P275; Harter S, 1989, PERCEPTIONS COMPETEN, P67; Harter S., 1999, CONSTRUCTION SELF; Hartley SL, 2006, J INTELL DISABIL RES, V50, P813, DOI 10.1111/j.1365-2788.2006.00844.x; Hartup W. W., 1986, SOCIAL BEHAVIOUR AUT, P61; Hine P, 2001, THESIS CURTIN U TECH, P1; Hoover-Dempsey KV, 1997, REV ED RES, V67; Jacobson KC, 1999, DEV PSYCHOL, V35, P926, DOI 10.1037/0012-1649.35.4.926; Jeynes WH, 2005, URBAN EDUC, V40, P237, DOI 10.1177/0042085905274540; Johnson SL, 2009, J SCHOOL HEALTH, V79, P451, DOI 10.1111/j.1746-1561.2009.00435.x; Kaptein S, 2008, J INTELL DISABIL RES, V52, P125, DOI 10.1111/j.1365-2788.2007.00978.x; Koenker R, 2001, J ECON PERSPECT, V15, P143, DOI 10.1038/s41592-019-0406-y; Kuperminc GP, 2001, J SCHOOL PSYCHOL, V39, P141, DOI 10.1016/S0022-4405(01)00059-0; Lamb S, 2000, NONCOMPLETION SCH AU; Lamb S., 2004, STAYING SCH IMPROVIN; Larson RW, 2000, AM PSYCHOL, V55, P170, DOI 10.1037/0003-066X.55.1.170; Lenerz K, 1987, BIOL PSYCHOL INTERAC, P212; Libbey HP, 2004, J SCHOOL HEALTH, V74, P274, DOI 10.1111/j.1746-1561.2004.tb08284.x; Lodge J, 2007, ENHANCING WELLBEING; Ma X, 2003, J EDUC RES, V96, P340, DOI 10.1080/00220670309596617; Manz PH, 2004, J SCHOOL PSYCHOL, V42, P461, DOI 10.1016/j.jsp.2004.08.002; MARSH HW, 1989, J EDUC PSYCHOL, V81, P417, DOI 10.1037/0022-0663.81.3.417; Mathai J, 2008, ADV MENT HEALTH, V7, P200, DOI 10.5172/jamh.7.3.200; McInerney D M, 2001, J Appl Meas, V2, P135; McInerney D. M., 2006, EDUC PSYCHOL-UK, V26, P717, DOI [10.1080/01443410500342559, DOI 10.1080/01443410500342559]; McInerney Dennis M, 2003, J Appl Meas, V4, P335; McInerney DM, 2003, ADOLESCENT MOTIVATIO, P25; McKnight P, 2007, MISSING DATA GENTLE; McMahon SD, 2008, PSYCHOL SCH, V45, P26; McNeal RB, 1999, SOC FORCES, V78, P117, DOI 10.1093/sf/78.1.117; McNeely CA, 2002, J SCHOOL HEALTH, V72, P138, DOI 10.1111/j.1746-1561.2002.tb06533.x; Mellor D, 2005, AUST PSYCHOL, V40, P215, DOI 10.1080/00050060500243475; Meyers L. S., 2006, APPL MULTIVARIATE RE; Midgley C, 2001, J EDUC PSYCHOL, V93, P77, DOI 10.1037//0022-0663.93.1.77; Morrison GM, 2003, CALIFORNIA SCH PSYCH, V8; National Research Council & the Institute of Medicine, 2004, ENG SCH FOST HIGH SC; NCSS, 1996, PASS 6 0 US GUID; Neill L, 1996, ETHNICITY GENDER SEL; Nichols SL, 2008, J EXP EDUC, V76, P145, DOI 10.3200/JEXE.76.2.145-169; Norman K, 1998, SCI EDUC, V82, P127, DOI 10.1002/(SICI)1098-237X(199804)82:2<127::AID-SCE1>3.0.CO;2-G; O'Dea JA, 2000, INT J EAT DISORDER, V28, P43, DOI 10.1002/(SICI)1098-108X(200007)28:1<43::AID-EAT6>3.0.CO;2-D; Organisation for Economic Co-operation and Development [OECD], 2003, SCH FACT REL QUAL EQ; Osterman KF, 2000, REV EDUC RES, V70, P323, DOI 10.2307/1170786; PARKER JG, 1993, DEV PSYCHOL, V29, P611, DOI 10.1037/0012-1649.29.4.611; PARKHURST JT, 1992, DEV PSYCHOL, V28, P231, DOI 10.1037/0012-1649.28.2.231; Passmore A, 1998, RELATIONSHIP LEISURE; Pellegrini AD, 2000, AM EDUC RES J, V37, P699, DOI 10.3102/00028312037003699; Perkins EA., 2007, J POLICY PRACT INTEL, V4, P1, DOI DOI 10.HTTP://DX.D0I.0RG/10.1111/J.1741-1130.2006.00092.X; Petrocelli JV, 2003, MEAS EVAL COUNS DEV, V36, P9, DOI 10.1080/07481756.2003.12069076; Pintrich PR, 2000, CONTEMP EDUC PSYCHOL, V25, P92, DOI 10.1006/ceps.1999.1017; Resnick MD, 1997, JAMA-J AM MED ASSOC, V278, P823, DOI 10.1001/jama.278.10.823; Rigby K., 2002, NEW PERSPECTIVES BUL; Rigby K, 2003, CAN J PSYCHIAT, V48, P583, DOI 10.1177/070674370304800904; Roeser RW, 1996, J EDUC PSYCHOL, V88, P408, DOI 10.1037/0022-0663.88.3.408; RUMBERGER RW, 1990, SOCIOL EDUC, V63, P283, DOI 10.2307/2112876; Shochet IM, 2006, J CLIN CHILD ADOLESC, V35, P170, DOI 10.1207/s15374424jccp3502_1; Simpson KB, 2004, 3 BIENN C SELF RES B; Soodak LC, 1998, J SPEC EDUC, V31, P480, DOI 10.1177/002246699803100405; Tabachnick B.G., 2007, USING MULTIVARIATE S, VVolume 5, P481; Ungar M, 2004, FAM PROCESS, V43, P23, DOI 10.1111/j.1545-5300.2004.04301004.x; Vaz S, 2010, FACTORS AFFECTING ST; Vaz S, 2014, PLOS ONE; Vaz S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089874; Vieno A, 2005, AM J COMMUN PSYCHOL, V36, P327, DOI 10.1007/s10464-005-8629-8; Walker JMT, 2005, ELEM SCHOOL J, V106, P85, DOI 10.1086/499193; Warnock M., 2005, SPECIAL ED NEEDS NEW; Wehlage G. G., 1989, REDUCING RISK SCH CO; Wentzel KR, 1998, J EDUC PSYCHOL, V90, P202, DOI 10.1037/0022-0663.90.2.202; Wentzel KR, 1999, J EARLY ADOLESCENCE, V19, P114, DOI 10.1177/0272431699019001006; Williams LJ, 1998, J ASSOC PERS SEVERE, V23, P98, DOI 10.2511/rpsd.23.2.98; Woolley ME, 2007, FAM RELAT, V56, P92, DOI 10.1111/j.1741-3729.2007.00442.x; Youniss J, 1999, J ADOLESCENT RES, V14, P248, DOI 10.1177/0743558499142006; Youniss J, 1997, J ADOLESCENT RES, V12, P245, DOI 10.1177/0743554897122006; ZIMET GD, 1990, J PERS ASSESS, V55, P610, DOI 10.1207/s15327752jpa5503&4_17; ZIMET GD, 1988, J PERS ASSESS, V52, P30, DOI 10.1207/s15327752jpa5201_2; Zubrick S, 1993, FIELD INSTRUMENT DEV; Zubrick S, 2000, INDICATORS SOCIAL FA	142	11	11	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123353	10.1371/journal.pone.0123353	http://dx.doi.org/10.1371/journal.pone.0123353			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25876074	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800095
J	Huang, C; Liu, W; Hu, Y; Zou, ZJ; Zhao, ZH; Shen, L; Weschler, LB; Sundell, J				Huang, Chen; Liu, Wei; Hu, Yu; Zou, Zhijun; Zhao, Zhuohui; Shen, Li; Weschler, Louise B.; Sundell, Jan			Updated Prevalences of Asthma, Allergy, and Airway Symptoms, and a Systematic Review of Trends over Time for Childhood Asthma in Shanghai, China	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; BUILDING CHARACTERISTICS; ENVIRONMENTAL-FACTORS; RESPIRATORY SYMPTOMS; HOME DAMPNESS; RISK-FACTORS; PHASE-III; HEALTH; ASSOCIATIONS; RHINITIS	Background The prevalence of asthma among Shanghai children has increased over time. This increase might be associated with changes in environmental exposures. Investigation of the timetrend of asthma and current prevalences is essential to understanding the causes. Objective To estimate the current prevalences of asthma, allergies and other respiratory symptoms among Shanghai preschool children, and to investigate the time-trend of childhood asthma prevalence of from 1990 to 2011. Methods From April 2011 to April 2012, the CCHH (China, Children, Homes, Health) cross-sectional study was conducted in Shanghai. Questionnaires were distributed to 17,898 parents or guardians of preschool children from 72 kindergartens in 5 districts. Previous similar studies were also summarized by a systematic literature review. Results From a total of 14,884 questionnaires for 3-7 year old children, prevalences of the following diseases and symptoms were calculated: asthma 10.2%, wheeze (ever) 28.1%, pneumonia (ever) 33.5%, otitis media 11.0%, rhinitis (ever) 54.1%, hay fever 12.2%, eczema (ever) 22.7%, and food allergy 15.7%. Urban children had higher prevalences of most symptoms than suburban children. The prevalence of asthma has increased significantly, almost five-fold, from 2.1% in 1990 to 10.2% in the present study. The prevalence of asthma in boys was higher than in girls in the present study and in all reviewed studies. Conclusions Asthma, allergy and airway symptoms are common among preschool children in Shanghai. The prevalence of childhood asthma in Shanghai has increased rapidly from 1990 to 2011.	[Huang, Chen; Liu, Wei; Zou, Zhijun; Shen, Li] Univ Shanghai Sci & Technol, Dept Bldg Environm & Energy Engn, Sch Environm & Architecture, Shanghai, Peoples R China; [Hu, Yu] Tongji Architectural Design Grp Co Ltd TJAD, Shanghai, Peoples R China; [Zhao, Zhuohui] Fudan Univ, Dept Environm Hlth, Sch Publ Hlth, Key Lab Publ Hlth Safety,Minist Educ, Shanghai 200433, Peoples R China; [Sundell, Jan] Tsinghua Univ, Sch Architecture, Dept Bldg Sci, Beijing 100084, Peoples R China	University of Shanghai for Science & Technology; Fudan University; Tsinghua University	Huang, C (corresponding author), Univ Shanghai Sci & Technol, Dept Bldg Environm & Energy Engn, Sch Environm & Architecture, Shanghai, Peoples R China.	hcyhyywj@163.com	Liu, Wei/E-3097-2015	Liu, Wei/0000-0001-9863-4332	National Natural Science Foundation of China [51278302]; Innovation Program of Shanghai Municipal Education Commission [14ZZ132]; Hujiang Foundation of China [D14003]; Innovation Fund Project for Graduate Student of Shanghai [JWCXSL1401]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission); Hujiang Foundation of China; Innovation Fund Project for Graduate Student of Shanghai	This study is financially supported by National Natural Science Foundation of China (51278302), Innovation Program of Shanghai Municipal Education Commission (14ZZ132), Hujiang Foundation of China (D14003), and The Innovation Fund Project for Graduate Student of Shanghai (JWCXSL1401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Khaled N, 2009, ALLERGY, V64, P123, DOI 10.1111/j.1398-9995.2008.01884.x; Almqvist C, 2008, ALLERGY, V63, P47, DOI 10.1111/j.1398-9995.2007.01524.x; Anderson HR, 2007, THORAX, V62, P85, DOI 10.1136/thx.2006.066407; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Asher MI, 1998, EUR RESPIR J, V12, P315; ASHER MI, 1995, EUR RESPIR J, V8, P483, DOI 10.1183/09031936.95.08030483; Bjerg A, 2010, ALLERGY, V65, P48, DOI 10.1111/j.1398-9995.2009.02105.x; Bjorksten B, 2008, PEDIAT ALLERG IMM-UK, V19, P110, DOI 10.1111/j.1399-3038.2007.00601.x; Bornehag CG, 2004, INDOOR AIR, V14, P59, DOI 10.1111/j.1600-0668.2004.00274.x; BURNEY PGJ, 1994, EUR RESPIR J, V7, P954, DOI 10.1183/09031936.94.07050954; Castro-Rodriguez JA, 2011, CURR OPIN ALLERGY CL, V11, P157, DOI 10.1097/ACI.0b013e3283464c4a; CEPSY China electricity council, 2013, CHIN EL POW STAT YB; Chen Yu-zhi, 2004, Zhonghua Jiehe He Huxi Zazhi, V27, P112; Chen YZ., 1998, CHIN J PEDIAT, V36, P352; Choi J, 2014, BUILD ENVIRON, V75, P176, DOI 10.1016/j.buildenv.2014.01.019; de Marco R, 2000, AM J RESP CRIT CARE, V162, P68, DOI 10.1164/ajrccm.162.1.9907008; Deckers IAG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039803; Dong GH, 2008, RESPIRATION, V76, P82, DOI 10.1159/000121370; [董蔚 Dong Wei], 2012, [临床儿科杂志, Journal of Chinical Pediatrics], V30, P1139; Duggan EM, 2012, PEDIAT ALLERG IMM-UK, V23, P464, DOI 10.1111/j.1399-3038.2012.01291.x; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; Grize L, 2006, ALLERGY, V61, P556, DOI 10.1111/j.1398-9995.2006.01030.x; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; Guilbert TW, 2004, J ALLERGY CLIN IMMUN, V114, P1282, DOI 10.1016/j.jaci.2004.09.020; Hong Soyoung, 2012, Environ Health Toxicol, V27, pe2012006, DOI 10.5620/eht.2012.27.e2012006; Hu Y, 2014, INDOOR AIR, V24, P450, DOI 10.1111/ina.12104; Huang C, 2013, CHINESE SCI BULL, V58, P4203, DOI 10.1007/s11434-013-5679-4; Li F, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-437; Liu W, 2014, INDOOR BUILT ENVIRON, V23, P270, DOI 10.1177/1420326X13516970; Liu W, 2013, CHINESE SCI BULL, V58, P4211, DOI 10.1007/s11434-013-5728-z; Mallol J, 2013, ALLERGOL IMMUNOPATH, V41, P73, DOI 10.1016/j.aller.2012.03.001; Mi YH, 2006, INDOOR AIR, V16, P454, DOI 10.1111/j.1600-0668.2006.00439.x; Naydenov K, 2008, BUILD ENVIRON, V43, P1840, DOI 10.1016/j.buildenv.2007.10.020; Niu C., 2010, CHIN J SCH HEAL, V31, P708; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; Postma DS, 2007, GENDER MED, V4, pS133, DOI 10.1016/S1550-8579(07)80054-4; Poulos Leanne M, 2005, Paediatr Respir Rev, V6, P20, DOI 10.1016/j.prrv.2004.11.004; Qian JJ, 2011, J INTER MED CON PRAC, V6, P121; Qu F, 2013, CHINESE SCI BULL, V58, P4190, DOI 10.1007/s11434-013-5790-6; Shanghai Municipal Bureau of Statistics, 2012, SHANGH STAT YB 2012; Shi YM., 2010, CHIN J GEN PRACTICE, V11, P1436; Song DP, 2008, CHIN J PRI MED PHAR, V15, P1421; The Cooperation Group on Childhood Asthma of Shanghai Medical Association, 1994, J CLIN PEDIAT, V12, P107; The Cooperation Group on Childhood Asthma of Shanghai Medical Association, 2002, J CLIN PEDIAT, V12, P144; Weschler CJ, 2009, ATMOS ENVIRON, V43, P153, DOI 10.1016/j.atmosenv.2008.09.044; Williams H, 1999, J ALLERGY CLIN IMMUN, V103, P125, DOI 10.1016/S0091-6749(99)70536-1; WILSON NM, 1995, EUR RESPIR J, V8, P364, DOI 10.1183/09031936.95.08030364; Wu JinGai, 2010, Journal of Environment and Health, V27, P127; Yangzong YZ, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-860; Yuan Dong, 2007, Journal of Environmental & Occupational Medicine, V24, P573; Zhang YP, 2013, CHINESE SCI BULL, V58, P4182, DOI 10.1007/s11434-013-5914-z; Zhang YP, 2013, ENVIRON HEALTH PERSP, V121, P751, DOI 10.1289/ehp.1205983; [张玉娥 Zhang Yue], 2012, [临床儿科杂志, Journal of Chinical Pediatrics], V30, P339; [张玉娥 ZHANG Yue], 2010, [临床儿科杂志, Journal of Chinical Pediatrics], V28, P149; Zhao J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-551; Zollner IK, 2005, THORAX, V60, P545, DOI 10.1136/thx.2004.029561; 杭晶卿, 2002, [中国实用内科杂志, Chinese Journal of Practical Internal Medicine], V22, P616	58	74	79	6	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121577	10.1371/journal.pone.0121577	http://dx.doi.org/10.1371/journal.pone.0121577			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875829	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100043
J	Ji, C; Miao, Z; He, XL				Ji, Cong; Miao, Zong; He, Xionglei			A Simple Strategy for Reducing False Negatives in Calling Variants from Single-Cell Sequencing Data	PLOS ONE			English	Article							MULTIPLE DISPLACEMENT AMPLIFICATION; GENETIC-VARIATION; SOMATIC MUTATION; GENOME; CANCER; NUCLEOTIDE; EVOLUTION; EMBRYO; TUMOR	Due to the growth of interest in single-cell genomics, computational methods for distinguishing true variants from artifacts are highly desirable. While special attention has been paid to false positives in variant or mutation calling from single-cell sequencing data, an equally important but often neglected issue is that of false negatives derived from allele dropout during the amplification of single cell genomes. In this paper, we propose a simple strategy to reduce the false negatives in single-cell sequencing data analysis. Simulation results show that this method is highly reliable, with an error rate of 4.94x10(-5), which is orders of magnitude lower than the expected false negative rate (similar to 34%) estimated from a single-cell exome dataset, though the method is limited by the low SNP density in the human genome. We applied this method to analyze the exome data of a few dozen single tumor cells generated in previous studies, and extracted cell specific mutation information for a small set of sites. Interestingly, we found that there are difficulties in using the classical clonal model of tumor cell growth to explain the mutation patterns observed in some tumor cells.	[Ji, Cong; Miao, Zong; He, Xionglei] Sun Yat Sen Univ, Coll Ecol & Evolut, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Ji, C (corresponding author), Sun Yat Sen Univ, Coll Ecol & Evolut, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	jicong2015@outlook.com			Marine Fisheries Science and Technology Promotion Project of Guangdong Province [A201301C09]; Science and Technology Planning Project of Guangdong Province [2012A080202006]	Marine Fisheries Science and Technology Promotion Project of Guangdong Province; Science and Technology Planning Project of Guangdong Province	This work is supported by the Marine Fisheries Science and Technology Promotion Project of Guangdong Province (no. A201301C09) and the Science and Technology Planning Project of Guangdong Province (no. 2012A080202006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Burlet P, 2006, MOL HUM REPROD, V12, P647, DOI 10.1093/molehr/gal069; Caldas C, 2012, NAT BIOTECHNOL, V30, P408, DOI 10.1038/nbt.2213; Davis EE, 2014, CLIN GENET, V85, P359, DOI 10.1111/cge.12189; Evrony GD, 2012, CELL, V151, P483, DOI 10.1016/j.cell.2012.09.035; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Guo Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-194; Heinmoller E, 2002, LAB INVEST, V82, P443, DOI 10.1038/labinvest.3780437; Hou Y, 2012, CELL, V148, P873, DOI 10.1016/j.cell.2012.02.028; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lu SJ, 2012, SCIENCE, V338, P1627, DOI 10.1126/science.1229112; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Murray JI, 2012, GENOME RES, V22, P1282, DOI 10.1101/gr.131920.111; Renwick P, 2006, REPROD BIOMED ONLINE, V13, P110, DOI 10.1016/S1472-6483(10)62024-X; Shapiro E, 2013, NAT REV GENET, V14, P618, DOI 10.1038/nrg3542; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; Spits C, 2006, NAT PROTOC, V1, P1965, DOI 10.1038/nprot.2006.326; STRACHAN T, 2010, HUMAN MOL GENETICS; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Xu X, 2012, CELL, V148, P886, DOI 10.1016/j.cell.2012.02.025; Zong CH, 2012, SCIENCE, V338, P1622, DOI 10.1126/science.1229164	24	0	0	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123789	10.1371/journal.pone.0123789	http://dx.doi.org/10.1371/journal.pone.0123789			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876174	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100214
J	Larmarange, J; Mossong, J; Barnighausen, T; Newell, ML				Larmarange, Joseph; Mossong, Joel; Barnighausen, Till; Newell, Marie Louise			Participation Dynamics in Population-Based Longitudinal HIV Surveillance in Rural South Africa	PLOS ONE			English	Article							OPTIMAL MATCHING METHODS; ANTIRETROVIRAL TREATMENT; SEQUENCE-ANALYSIS; LIFE EXPECTANCY; HIGH-PREVALENCE; SCALE-UP; INFECTION; SEROPREVALENCE; MORTALITY; COMMUNITY	Population-based HIV surveillance is crucial to inform understanding of the HIV pandemic and evaluate HIV interventions, but little is known about longitudinal participation patterns in such settings. We investigated the dynamics of longitudinal participation patterns in a high HIV prevalence surveillance setting in rural South Africa between 2003 and 2012, taking into account demographic dynamics. At any given survey round, 22,708 to 30,495 persons were eligible. Although the yearly participation rates were relatively modest (26% to 46%), cumulative rates increased substantially with multiple recruitment opportunities: 68% of eligible persons participated at least once, 48% at least twice and 31% at least three times after five survey rounds. We identified two types of study fatigue: at the individual level, contact and consent rates decreased with multiple recruitment opportunities and, at the population level, these rates also decreased over calendar time, independently of multiple recruitment opportunities. Using sequence analysis and hierarchical clustering, we identified three broad individual participation profiles: consenters (20%), switchers (43%) and refusers (37%). Men were over represented among refusers, women among consenters, and temporary non-residents among switchers. The specific subgroup of persons who were systemically not contacted or refusers constitutes a challenge for population-based surveillance and interventions.	[Larmarange, Joseph] Ctr Populat & Dev, Inst Rech Dev, UMR Paris Descartes Ined IRD 196, Paris, France; [Larmarange, Joseph; Mossong, Joel; Barnighausen, Till; Newell, Marie Louise] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Mtubatuba, South Africa; [Mossong, Joel] Lab Natl St, Surveillance & Epidemiol Infect Dis, Luxembourg, Luxembourg; [Barnighausen, Till] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA; [Newell, Marie Louise] Univ Southampton, Fac Med, Fac Social & Human Sci, Southampton SO9 5NH, Hants, England	UDICE-French Research Universities; Universite Paris Cite; Institut de Recherche pour le Developpement (IRD); University of Kwazulu Natal; Harvard University; Harvard T.H. Chan School of Public Health; University of Southampton	Larmarange, J (corresponding author), Ctr Populat & Dev, Inst Rech Dev, UMR Paris Descartes Ined IRD 196, Paris, France.	joseph.larmarange@ceped.org	Mossong, Joël/D-4998-2009; Larmarange, Joseph/I-5889-2015; Bärnighausen, Till/Y-2388-2019; Newell, Marie-Louise/AAE-8222-2019	Mossong, Joël/0000-0003-0717-9835; Larmarange, Joseph/0000-0001-7097-700X; Newell, Marie-Louise/0000-0002-1074-7699	Wellcome Trust, UK [065377/2/01/B, 082384/Z/07/Z]; Institut de Recherche pour le Developpement (IRD); German government through the Centre for International Migration and Development (CIM); Wellcome Trust; NIH; National Institute of Child Health and Human Development [1R01-HD058482-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058482, R01HD084233] Funding Source: NIH RePORTER	Wellcome Trust, UK(Wellcome Trust); Institut de Recherche pour le Developpement (IRD); German government through the Centre for International Migration and Development (CIM); Wellcome Trust(Wellcome TrustEuropean Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding for the Africa Centre's Demographic Surveillance Information System and Population-based HIV Survey was received from the Wellcome Trust, UK (grants 065377/2/01/B and 082384/Z/07/Z). JL was supported by the Institut de Recherche pour le Developpement (IRD) and JM received partial financial support from the German government through the Centre for International Migration and Development (CIM). TB has been supported by the Wellcome Trust and by NIH and by grant 1R01-HD058482-01 from the National Institute of Child Health and Human Development.	ABBOTT A, 1986, J INTERDISCIPL HIST, V16, P471, DOI 10.2307/204500; Abbott A, 2000, SOCIOL METHOD RES, V29, P3, DOI 10.1177/0049124100029001001; Aisenbrey S, 2010, SOCIOL METHOD RES, V38, P420, DOI 10.1177/0049124109357532; Asiki G, 2013, INT J EPIDEMIOL; Barnighausen T, 2012, TROP MED INT HEALTH, V17, pe103, DOI 10.1111/j.1365-3156.2012.02928.x; Barnighausen T, 2011, EPIDEMIOLOGY, V22, P27, DOI 10.1097/EDE.0b013e3181ffa201; Barnighausen T, 2009, AIDS RES HUM RETROV, V25, P405, DOI 10.1089/aid.2008.0211; Barnighausen T, 2008, AIDS, V22, P139, DOI 10.1097/QAD.0b013e3282f2ef43; Boerma JT, 1999, AIDS, V13, P1233, DOI 10.1097/00002030-199907090-00013; Bor J, 2013, SCIENCE, V339, P961, DOI 10.1126/science.1230413; Camlin CS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011539; Camlin CS, 2013, POPUL SPACE PLACE; Elzinga CH, 2014, SOCIOL METHOD RES; French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS), 2011, IMP IMM VERS WHO REC; Gabadinho A, 2011, ANAL VISUALIZING STA; Giordano K, 2012, JHASE, V4, P1; Glynn JR, 2001, AIDS, V15, P2025, DOI 10.1097/00002030-200110190-00016; Granich R, 2010, CURR OPIN HIV AIDS, V5, P298, DOI 10.1097/COH.0b013e32833a6c32; Helleringer S, 2012, AIDS BEHAV; Herbst AJ, 2009, B WORLD HEALTH ORGAN, V87, P754, DOI 10.2471/BLT.08.058982; HIV Prevention Trials Network, 2013, POP EFF ANT THER RED; HULL HF, 1988, JAMA-J AM MED ASSOC, V260, P935, DOI 10.1001/jama.260.7.935; Husson F., 2010, EXPLORATORY MULTIVAR, DOI DOI 10.1201/B10345; Iwuji C, 2014, 20 INT AIDS C; Iwuji CC, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-230; Jahn A, 2008, LANCET, V371, P1603, DOI 10.1016/S0140-6736(08)60693-5; JENUM P, 1988, NIPH (National Institute of Public Health) Annals (Oslo), V11, P53; Johnson LF, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001418; Le S, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i01; Maher D, 2013, B WORLD HEALTH ORGAN, V91, P950, DOI 10.2471/BLT.13.117309; Marston M, 2008, SEX TRANSM INFECT, V84, pI71, DOI 10.1136/sti.2008.030353; Michael D, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.21783; Mills EJ, 2011, ANN INTERN MED, V155, P209, DOI 10.7326/0003-4819-155-4-201108160-00358; Mossong J, 2013, AIDS, V27, P2471, DOI 10.1097/01.aids.0000432475.14992.da; Muhwava W, 2010, AFRICAN POPULATION S, V24, P259; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reniers G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-163; Reniers G, 2009, AIDS, V23, P621, DOI 10.1097/QAD.0b013e3283269e13; Reynolds L, 2012, SOC SCI MED; Robette N., 2012, B DE LELO TT ME THOD, V116, P5, DOI [DOI 10.1177/0759106312454635, 10.1177/0759106312454635]; Sakarovitch C, 2007, STAT MED, V26, P320, DOI 10.1002/sim.2540; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; Tanser F, 2008, INT J EPIDEMIOL, V37, P956, DOI 10.1093/ije/dym211; Tanser F, 2013, SCIENCE, V339, P966, DOI 10.1126/science.1228160; Tanser F, 2011, LANCET, V378, P247, DOI 10.1016/S0140-6736(11)60779-4; University of California San Francisco, 2013, SUST E AFR RES COMM; Welaga P, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-193; Welz T, 2007, AIDS, V21, P1467, DOI 10.1097/QAD.0b013e3280ef6af2; Zuch M, 2012, BMC INT HEALTH HUM R, V12, DOI 10.1186/1472-698X-12-3	49	35	35	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123345	10.1371/journal.pone.0123345	http://dx.doi.org/10.1371/journal.pone.0123345			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CF8XK	25875851	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100165
J	Abuya, T; Warren, CE; Miller, N; Njuki, R; Ndwiga, C; Maranga, A; Mbehero, F; Njeru, A; Bellows, B				Abuya, Timothy; Warren, Charlotte E.; Miller, Nora; Njuki, Rebecca; Ndwiga, Charity; Maranga, Alice; Mbehero, Faith; Njeru, Anne; Bellows, Ben			Exploring the Prevalence of Disrespect and Abuse during Childbirth in Kenya	PLOS ONE			English	Article							DOMESTIC VIOLENCE; MATERNITY SERVICES; RISK-FACTORS; HEALTH; CARE; TANZANIA; WOMEN; EXPERIENCES; DELIVERY; ACCOUNTS	Background Poor quality of care including fear of disrespect and abuse (D&A) perpetuated by health workers influences women's decisions to seek maternity care. Key manifestations of D&A include: physical abuse, non-consented care, non-confidential care, non-dignified care, discrimination, abandonment, and detention in facilities. This paper describes manifestations of D&A experienced in Kenya and measures their prevalence. Methods This paper is based on baseline data collected during a before-and-after study designed to measure the effect of a package of interventions to reduce the prevalence of D&A experienced by women during labor and delivery in thirteen Kenyan health facilities. Data were collected through an exit survey of 641 women discharged from postnatal wards. We present percentages of D&A manifestations and odds ratios of its relationship with demographic characteristics using a multivariate fixed effects logistic regression model. Results Twenty percent of women reported any form of D&A. Manifestations of D&A includes: non-confidential care (8.5%), non-dignified care (18%), neglect or abandonment (14.3%), Non-consensual care (4.3%) physical abuse (4.2%) and, detainment for non-payment of fees (8.1). Women aged 20-29 years were less likely to experience non-confidential care compared to those under 19; OR: [0.6 95% CI (0.36, 0.90); p= 0.017]. Clients with no companion during delivery were less likely to experience inappropriate demands for payment; OR: [0.49 (0.26, 0.95); p= 0.037]; while women with higher parities were three times more likely to be detained for lack of payment and five times more likely to be bribed compared to those experiencing there first birth. Conclusion One out of five women experienced feeling humiliated during labor and delivery. Six categories of D&A during childbirth in Kenya were reported. Understanding the prevalence of D&A is critical in developing interventions at national, health facility and community levels to address the factors and drivers that influence D&A in facilities and to encourage clients' future facility utilization.	[Abuya, Timothy; Ndwiga, Charity; Bellows, Ben] Populat Council, Nairobi, Kenya; [Warren, Charlotte E.] Populat Council, Washington, DC 20008 USA; [Miller, Nora] Woman Care Global, San Diego, CA 92130 USA; [Njuki, Rebecca] Ctr Populat Hlth Res & Management, Nairobi, Kenya; [Maranga, Alice] Federat Women Lawyers, Nairobi, Kenya; [Mbehero, Faith] Natl Nurses Assoc Kenya, Nairobi 4942200100, Kenya; [Njeru, Anne] Minist Hlth, Div Reprod Hlth, Nairobi, Kenya	Population Council	Abuya, T (corresponding author), Populat Council, POB 17643-00500, Nairobi, Kenya.	tabuya@popcouncil.org	Abuya, Timothy/AAH-5479-2020	Bellows, Ben/0000-0001-9205-6623	United States Agency for International Development under USAID [GHS-A-00-09-00015-00]	United States Agency for International Development under USAID(United States Agency for International Development (USAID))	The project is funded by the United States Agency for International Development under USAID Cooperative Agreement No. GHS-A-00-09-00015-00. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, MILL DEV GOALS REP; Audo M O, 2005, East Afr Med J, V82, P547; Bowser D, 2010, ECPLORING EVIDENCE D; Bryce J, 2010, TRACKING PROGR MATER; D'Ambruoso L, 2005, BMC PUBLIC HEALTH, V5, DOI 10.1186/1471-2458-5-140; FCI, 2005, FCI 2005 SKILL CAR I; FIDA Kenya and Centre for Reproductive Rights, 2007, FAILURE DELIVER VIOL; FINKELHOR D, 1994, CHILD ABUSE NEGLECT, V18, P409, DOI 10.1016/0145-2134(94)90026-4; Freedman LP, 2014, B WORLD HEALTH ORGAN, V92, P915, DOI 10.2471/BLT.14.137869; Garcia-Moreno CH, 2011, WHO MULTCOUNTRY STUD; Garcia-Moreno C, 2006, LANCET, V368, P1260, DOI 10.1016/S0140-6736(06)69523-8; Goverment of Kenya, 2002, STAND MAT CAR KENY; Hindin Michelle J., 2008, INTIMATE PARTNER VIO; Jewkes R, 1998, SOC SCI MED, V47, P1781, DOI 10.1016/S0277-9536(98)00240-8; Jewkes R, 2002, SOC SCI MED, V55, P1603, DOI 10.1016/S0277-9536(01)00294-5; Kenya national Bureau of statistics (KNBS) and ICF macro, 2010, KEN DEM HLTH SURV 20; Koenig MA, 2003, B WORLD HEALTH ORGAN, V81, P53; Kruk ME, 2009, AM J PUBLIC HEALTH, V99, P1666, DOI 10.2105/AJPH.2008.146209; Kyomuhendo GB, 2003, REPROD HEALTH MATTER, V11, P16, DOI 10.1016/S0968-8080(03)02176-1; McMahon SA, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-268; Mselle LT, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-174; Muhajarine N, 1999, CAN MED ASSOC J, V160, P1007; National Cordinating Agency for Population and Development (NCAPD) [Kenya] [Kenya] MoMSM [Kenya] MoPHaSM Kenya National Bureau of Statistics (KNBS) [Kenya] IM, 2011, KEN NAT BUR STAT KNS; Schroll AM, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-74; Sunita K, 2004, PROFILING DOMESTIC V; Warren C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-177; Warren CE, 2013, BMC PREGNANCY CHILDB, V13, DOI [10.1186/1471-2393-13-21, 10.1186/1471-2393-13-150]; WHO UNICEF, 2010, COUNTD 2015 DEC REP	28	170	171	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123606	10.1371/journal.pone.0123606	http://dx.doi.org/10.1371/journal.pone.0123606			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884566	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000078
J	Greenlee, JE; Clawson, SA; Hill, KE; Wood, B; Clardy, SL; Tsunoda, I; Carlson, NG				Greenlee, John E.; Clawson, Susan A.; Hill, Kenneth E.; Wood, Blair; Clardy, Stacey L.; Tsunoda, Ikuo; Carlson, Noel G.			Anti-Yo Antibody Uptake and Interaction with Its Intracellular Target Antigen Causes Purkinje Cell Death in Rat Cerebellar Slice Cultures: A Possible Mechanism for Paraneoplastic Cerebellar Degeneration in Humans with Gynecological or Breast Cancers	PLOS ONE			English	Article							ULTRASTRUCTURAL-LOCALIZATION; NEUROLOGICAL DISEASE; BINDING SITES; IMMUNOREACTIVITY; DIFFERENTIATION; NEURONS; CLONING; SERA	Anti-Yo antibodies are immunoglobulin G (IgG) autoantibodies reactive with a 62 kDa Purkinje cell cytoplasmic protein. These antibodies are closely associated with paraneoplastic cerebellar degeneration in the setting of gynecological and breast malignancies. We have previously demonstrated that incubation of rat cerebellar slice cultures with patient sera and cerebrospinal fluid containing anti-Yo antibodies resulted in Purkinje cell death. The present study addressed three fundamental questions regarding the role of anti-Yo antibodies in disease pathogenesis: 1) Whether the Purkinje cell cytotoxicity required binding of anti-Yo antibody to its intraneuronal 62 kDa target antigen; 2) whether Purkinje cell death might be initiated by antibody-dependent cellular cytotoxicity rather than intracellular antibody binding; and 3) whether Purkinje cell death might simply be a more general result of intracellular antibody accumulation, rather than of specific antibody-antigen interaction. In our study, incubation of rat cerebellar slice cultures with anti-Yo IgG resulted in intracellular antibody binding, and cell death. Infiltration of the Purkinje cell layer by cells of macrophage/microglia lineage was not observed until extensive cell death was already present. Adsorption of anti-Yo IgG with its 62 kDa target antigen abolished both antibody accumulation and cytotoxicity. Antibodies to other intracellular Purkinje cell proteins were also taken up by Purkinje cells and accumulated intracellularly; these included calbindin, calmodulin, PCP-2, and patient anti-Purkinje cell antibodies not reactive with the 62 kDa Yo antigen. However, intracellular accumulation of these antibodies did not affect Purkinje cell viability. The present study is the first to demonstrate that anti-Yo antibodies cause Purkinje cell death by binding to the intracellular 62 kDa Yo antigen. Anti-Yo antibody cytotoxicity did not involve other antibodies or factors present in patient serum and was not initiated by brain mononuclear cells. Purkinje cell death was not simply due to intraneuronal antibody accumulation.	[Greenlee, John E.; Clardy, Stacey L.] George E Wahlen Vet Affairs Hlth Care Syst, Neurol Serv, Salt Lake City, UT 84148 USA; [Greenlee, John E.; Clawson, Susan A.; Hill, Kenneth E.; Wood, Blair; Clardy, Stacey L.; Carlson, Noel G.] Univ Utah, Sch Med, Dept Neurol, Salt Lake City, UT USA; [Tsunoda, Ikuo] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol & Immunol, CMTV, Shreveport, LA 71105 USA; [Carlson, Noel G.] George E Wahlen Vet Affairs Hlth Care Syst, GRECC, Salt Lake City, UT USA; [Carlson, Noel G.] George E Wahlen Vet Affairs Hlth Care Syst, Res Serv, Salt Lake City, UT USA; [Carlson, Noel G.] Univ Utah, Sch Med, Dept Neurobiol & Anat, Salt Lake City, UT USA	US Department of Veterans Affairs; Utah System of Higher Education; University of Utah; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; US Department of Veterans Affairs; Utah System of Higher Education; University of Utah	Greenlee, JE (corresponding author), George E Wahlen Vet Affairs Hlth Care Syst, Neurol Serv, Salt Lake City, UT 84148 USA.	john.greenlee@hsc.utah.edu	Carlson, Noel/W-2734-2019; Tsunoda, Ikuo/B-4722-2008	Tsunoda, Ikuo/0000-0003-1798-714X; Clardy, Stacey/0000-0001-6600-9428	Merit Review Research Award from the United States Department of Veterans Affairs; Western Institute for Biomedical Research; National Institute of Neurological Disorders and Stroke of the National Institutes of Health [R21NS059724]; COBRE Center from the National Institute of General Medical Sciences of the NIH [8P20GM103433]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110703, P20GM103433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS059724] Funding Source: NIH RePORTER	Merit Review Research Award from the United States Department of Veterans Affairs; Western Institute for Biomedical Research; National Institute of Neurological Disorders and Stroke of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); COBRE Center from the National Institute of General Medical Sciences of the NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was funded by a Merit Review Research Award from the United States Department of Veterans Affairs and by a research award from the Western Institute for Biomedical Research. Dr. Tsunoda is supported by grant R21NS059724 from the National Institute of Neurological Disorders and Stroke of the National Institutes of Health and by COBRE Center grant 8P20GM103433 from the National Institute of General Medical Sciences of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMENTA F, 1994, NEUROSCI LETT, V178, P131, DOI 10.1016/0304-3940(94)90307-7; BERREBI AS, 1992, J CHEM NEUROANAT, V5, P235, DOI 10.1016/0891-0618(92)90048-U; BRASHEAR HR, 1989, NEUROLOGY, V39, P1605, DOI 10.1212/WNL.39.12.1605; Dalmau J, 2008, LANCET NEUROL, V7, P327, DOI 10.1016/S1474-4422(08)70060-7; DROPCHO EJ, 1987, P NATL ACAD SCI USA, V84, P4552, DOI 10.1073/pnas.84.13.4552; FATHALLAHSHAYKH H, 1991, P NATL ACAD SCI USA, V88, P3451, DOI 10.1073/pnas.88.8.3451; FURNEAUX HF, 1990, NEUROLOGY, V40, P1085, DOI 10.1212/WNL.40.7.1085; FURNEAUX HM, 1990, NEW ENGL J MED, V322, P1844, DOI 10.1056/NEJM199006283222604; Graus F, 2010, J NEUROL, V257, P509, DOI 10.1007/s00415-009-5431-9; GREENLEE JE, 1988, J NEUROPATH EXP NEUR, V47, P561, DOI 10.1097/00005072-198809000-00007; GREENLEE JE, 1993, NEUROLOGY, V43, P2049, DOI 10.1212/WNL.43.10.2049; GREENLEE JE, 1983, ANN NEUROL, V14, P609, DOI 10.1002/ana.410140603; Greenlee JE, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0160-0; Greenlee JE, 2010, J NEUROPATH EXP NEUR, V69, P997, DOI 10.1097/NEN.0b013e3181f0c82b; Gu JP, 2013, J BIOL CHEM, V288, P33081, DOI 10.1074/jbc.M113.494922; Guan JZ, 2005, BIOCHEM J, V392, P389, DOI 10.1042/BJ20042102; HENSON RA, 1982, CANCER NERVOUS SYSTE, P346; HIDA C, 1994, ARCH NEUROL-CHICAGO, V51, P555, DOI 10.1001/archneur.1994.00540180033010; Hill KE, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-31; King MA, 2000, J IMMUNOL METHODS, V243, P155, DOI 10.1016/S0022-1759(00)00232-5; LIN CT, 1980, J CELL BIOL, V85, P473, DOI 10.1083/jcb.85.2.473; MOLL JWB, 1995, NEUROLOGY, V45, P1937, DOI 10.1212/WNL.45.10.1937; Nag TC, 1999, J CHEM NEUROANAT, V17, P1, DOI 10.1016/S0891-0618(99)00016-2; RODRIGUEZ M, 1988, NEUROLOGY, V38, P1380, DOI 10.1212/WNL.38.9.1380; ROTHSTEIN JD, 1993, P NATL ACAD SCI USA, V90, P6591, DOI 10.1073/pnas.90.14.6591; Tauer U, 1996, NEUROPATH APPL NEURO, V22, P361, DOI 10.1111/j.1365-2990.1996.tb01115.x	26	35	35	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123446	10.1371/journal.pone.0123446	http://dx.doi.org/10.1371/journal.pone.0123446			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885452	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000065
J	Lee, JS; Chiou, MJ; Teng, FL; See, LC				Lee, Jiahn-Shing; Chiou, Meng-Jiun; Teng, Feng-Ling; See, Lai-Chu			The Role of Principal and Secondary Diagnoses of Hospitalized Eye Trauma: A Nationwide Cohort in Taiwan, 1996-2010	PLOS ONE			English	Article							OCULAR TRAUMA; INJURY; POPULATION	Purpose To estimate the rate of hospitalized eye trauma in Taiwan and investigate the role between principal and secondary diagnoses of such trauma. Methods Nationwide fixed cohort study of 1,000,000 beneficiaries from the Taiwan Longitudinal Health Database was used and 4819 patients who were hospitalized for eye trauma during 1996-2010 were analyzed. Results During 1996-2010, the incidence rates of hospitalized eye trauma (per 100 000 person-years) were 35.0 (95% confidence interval (CI), 34.0 to 36.0) for total diagnosis, 9.8 (95% CI, 9.3 to 10.3) for a principal diagnosis, and 25.3 (95% CI, 24.4 to 26.1) for a secondary diagnosis. The sex risk ratio was 3.1 for a principal diagnosis and 2.1 for a secondary diagnosis. The main causes of eye trauma were traffic accident, work accident, assault (among males < 60 years of age), and falls (among elderly men and women). The proportion admitted to an ophthalmic department among those with a principal diagnosis of eye trauma (64.8%) was significantly higher than among those with a secondary diagnosis (2.3%) (p<. 0001). Patients with a principal diagnosis of eye trauma had shorter hospital stays (7.1 +/- 10.2 days) and lower fatality (0.07%) than those with a secondary diagnosis of eye trauma (10.0 +/- 31.6 days and 0.3%, respectively). Conclusion Data only from ophthalmic admissions tends to underestimate the true incidence rate of hospitalized eye trauma. Patients with a principal diagnosis of eye trauma had less severe injuries than did those with a secondary diagnosis.	[Lee, Jiahn-Shing] Chang Gung Mem Hosp, Dept Ophthalmol, Taoyuan, Taiwan; [Lee, Jiahn-Shing] Chang Gung Univ, Taoyuan, Taiwan; [Chiou, Meng-Jiun; See, Lai-Chu] Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan, Taiwan; [Teng, Feng-Ling] Chang Gung Univ Sci & Technol, Dept Nursing, Taoyuan, Taiwan; [See, Lai-Chu] Chang Gung Univ, Biostat Core Lab, Mol Med Res Ctr, Taoyuan, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung University of Science & Technology; Chang Gung University	See, LC (corresponding author), Chang Gung Univ, Dept Publ Hlth, Coll Med, Taoyuan, Taiwan.	lichu@mail.cgu.edu.tw		Lee, Jiahn-Shing/0000-0001-7007-939X; See, Lai-Chu/0000-0002-1379-8969				Ahmad OB, 2001, AGE STANDARDIZATION, V31, P10; Baker R S, 1999, Ophthalmic Epidemiol, V6, P159, DOI 10.1076/opep.6.3.159.1505; Cao HX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049884; Chang CH, 2008, GRAEF ARCH CLIN EXP, V246, P223, DOI 10.1007/s00417-007-0733-z; Cillino S, 2008, BMC OPHTHALMOL, V8, DOI 10.1186/1471-2415-8-6; Desai P, 1996, BRIT J OPHTHALMOL, V80, P592, DOI 10.1136/bjo.80.7.592; Huang SK, 2014, J FORMOS MED ASSOC, V113, P1, DOI 10.1016/j.jfma.2013.08.010; KLOPFER J, 1992, ARCH OPHTHALMOL-CHIC, V110, P838, DOI 10.1001/archopht.1992.01080180110037; Lai MS, 2012, J FORMOS MED ASSOC, V111, P587, DOI 10.1016/j.jfma.2012.08.016; Mela EK, 2005, OPHTHAL EPIDEMIOL, V12, P185, DOI 10.1080/09286580590964801; *NAT HLTH RES I, INTR NAT HLTH INS RE; National Health Research Institutes Taiwan, 2012, UN HLTH COV TAIW UPD; Negrel A D, 1998, Ophthalmic Epidemiol, V5, P143, DOI 10.1076/opep.5.3.143.8364; Rothman K, 1986, MODERN EPIDEMIOLOGY; Saeed A, 2010, INJURY, V41, P86, DOI 10.1016/j.injury.2009.01.118; SNIEZEK JE, 1989, JAMA-J AM MED ASSOC, V262, P2270, DOI 10.1001/jama.262.16.2270; TIELSCH JM, 1989, ARCH OPHTHALMOL-CHIC, V107, P519, DOI 10.1001/archopht.1989.01070010533025; Wong TY, 1999, AM J OPHTHALMOL, V128, P345, DOI 10.1016/S0002-9394(99)00167-1	18	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123348	10.1371/journal.pone.0123348	http://dx.doi.org/10.1371/journal.pone.0123348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884507	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000058
J	Mendez, F; de Garay, T; Rodriguez, D; Rodriguez, JF				Mendez, Fernando; de Garay, Tomas; Rodriguez, Dolores; Rodriguez, Jose F.			Infectious Bursal Disease Virus VP5 Polypeptide: A Phosphoinositide-Binding Protein Required for Efficient Cell-to-Cell Virus Dissemination	PLOS ONE			English	Article							TRANSMEMBRANE TOPOLOGY; PLASMA-MEMBRANE; LIPIDS; EXPRESSION; APOPTOSIS; GENE	Infectious bursal disease virus (IBDV), a member of the Birnaviridae family, is a major avian pathogen responsible for an immunosuppressive disease affecting juvenile chickens. The IBDV genome is formed by two dsRNA segments. The largest one harbors two partially overlapping open reading frames encoding a non-structural polypeptide, known as VP5, and a large polyprotein, respectively. VP5 is non-essential for virus replication. However, it plays a major role in IBDV pathogenesis. VP5 accumulates at the plasma membrane (PM) of IBDV-infected cells. We have analyzed the mechanism underlying the VP5 PM targeting. Updated topological prediction algorithm servers fail to identify a transmembrane domain within the VP5 sequence. However, the VP5 polycationic C-terminal region, harboring three closely spaced patches formed by two or three consecutive basic amino acid residues (lysine or arginine), might account for its PM tropism. We have found that mutations, either C-terminal VP5 deletions or replacement of basic amino acids by alanine residues, that reduce the electropositive charge of the VP5 C-terminus abolish PM targeting. Lipid overlay assays performed with an affinity-purified Flag-tagged VP5 (FVP5) protein version show that this polypeptide binds several phosphoinositides (PIP), exhibiting a clear preference for monophosphate species. Experiments performed with FVP5 mutant proteins lacking the polycationic domain demonstrate that this region is essential for PIP binding. Data gathered with IBDV mutants expressing C-terminal deleted VP5 polypeptides generated by reverse genetics demonstrate that the VP5-PIP binding domain is required both for its PM targeting in infected cells, and for efficient virus dissemination. Data presented here lead us to hypothesize that IBDV might use a non-lytic VP5-dependent cell-to-cell spreading mechanism.	[Mendez, Fernando; de Garay, Tomas; Rodriguez, Dolores; Rodriguez, Jose F.] Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid 28049, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Rodriguez, JF (corresponding author), Ctr Nacl Biotecnol CSIC, Dept Mol & Cellular Biol, Madrid 28049, Spain.	jfrodrig@cnb.csic.es	Rodríguez, José F/T-8500-2017; Rodriguez, Dolores/ABF-9855-2020	Rodríguez, José F/0000-0001-7944-5341; Rodriguez, Dolores/0000-0001-6365-4501	Spanish Ministry of Economy and Competitiveness [AGL2011-24758, AGL2010-15495]	Spanish Ministry of Economy and Competitiveness(Spanish Government)	This study was supported by grant AGL2011-24758, Spanish Ministry of Economy and Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/); grant AGL2010-15495, Spanish Ministry of Economy and Competitiveness (http://www.idi.mineco.gob.es/portal/site/MICINN/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Bird SW, 2014, P NATL ACAD SCI USA, V111, P13081, DOI 10.1073/pnas.1401437111; CLAROS MG, 1994, COMPUT APPL BIOSCI, V10, P685; Cserzo M, 2002, PROTEIN ENG, V15, P745, DOI 10.1093/protein/15.9.745; Feng ZD, 2013, NATURE, V496, P367, DOI 10.1038/nature12029; Fernandez-Arias A, 1998, J GEN VIROL, V79, P1047, DOI 10.1099/0022-1317-79-5-1047; Goldenberg NM, 2010, CANCER RES, V70, P1277, DOI 10.1158/0008-5472.CAN-09-2905; Harlow E., 1988, ANTIBODIES LAB MANUA; Heo WD, 2006, SCIENCE, V314, P1458, DOI 10.1126/science.1134389; Hernandez M, 2010, VIRUS GENES, V41, P59, DOI 10.1007/s11262-010-0485-4; HOFMANN K, 1993, BIOL CHEM HOPPESEYLE, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Ingrao F, 2013, DEV COMP IMMUNOL, V41, P429, DOI 10.1016/j.dci.2013.03.017; Irigoyen N, 2009, J BIOL CHEM, V284, P8064, DOI 10.1074/jbc.M808942200; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kutateladze TG, 2010, NAT CHEM BIOL, V6, P507, DOI [10.1038/NCHEMBIO.390, 10.1038/nchembio.390]; LEMON SM, 1985, NEW ENGL J MED, V313, P1059, DOI 10.1056/NEJM198510243131706; Li F, 2006, ANNU REV MICROBIOL, V60, P503, DOI 10.1146/annurev.micro.60.080805.142205; Li ZH, 2012, J VIROL, V86, P1328, DOI 10.1128/JVI.06104-11; Liu MH, 2006, J VIROL, V80, P3369, DOI 10.1128/JVI.80.7.3369-3377.2006; Lombardo E, 2000, VIROLOGY, V277, P345, DOI 10.1006/viro.2000.0595; Lorizate M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004820; Luque D, 2009, J MOL BIOL, V386, P891, DOI 10.1016/j.jmb.2008.11.029; Mahgoub HA, 2012, ARCH VIROL, V157, P2047, DOI 10.1007/s00705-012-1377-9; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Meier C, 2006, STRUCTURE, V14, P1157, DOI 10.1016/j.str.2006.05.012; Moss SE, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002839; Mundt E, 1997, J VIROL, V71, P5647, DOI 10.1128/JVI.71.7.5647-5651.1997; MUNDT E, 1995, J GEN VIROL, V76, P437, DOI 10.1099/0022-1317-76-2-437; Paloheimo O, 2011, J VIROL, V85, P6714, DOI 10.1128/JVI.00247-10; Payrastre Bernard, 2012, Subcell Biochem, V59, P363, DOI 10.1007/978-94-007-3015-1_12; Qin LT, 2010, VACCINE, V28, P3735, DOI 10.1016/j.vaccine.2010.02.102; Rancurel C, 2009, J VIROL, V83, P10719, DOI 10.1128/JVI.00595-09; Roussarie JP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001331; Stenmark H, 1999, J CELL SCI, V112, P4175; Tusnady GE, 2001, BIOINFORMATICS, V17, P849, DOI 10.1093/bioinformatics/17.9.849; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Viklund H, 2008, BIOINFORMATICS, V24, P2928, DOI 10.1093/bioinformatics/btn550; WARD GA, 1995, P NATL ACAD SCI USA, V92, P6773, DOI 10.1073/pnas.92.15.6773; Wei L, 2011, VIROLOGY, V417, P211, DOI 10.1016/j.virol.2011.03.003; Wu YP, 2009, ARCH VIROL, V154, P1873, DOI 10.1007/s00705-009-0524-4; Yao K, 1998, J VIROL, V72, P2647, DOI 10.1128/JVI.72.4.2647-2654.1998	41	17	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123470	10.1371/journal.pone.0123470	http://dx.doi.org/10.1371/journal.pone.0123470			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886023	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000069
J	Charron, L; Geffard, O; Chaumot, A; Coulaud, R; Jaffal, A; Gaillet, V; Dedourge-Geffard, O; Geffard, A				Charron, Laetitia; Geffard, Olivier; Chaumot, Arnaud; Coulaud, Romain; Jaffal, Ali; Gaillet, Veronique; Dedourge-Geffard, Odile; Geffard, Alain			Consequences of Lower Food Intake on the Digestive Enzymes Activities, the Energy Reserves and the Reproductive Outcome in Gammarus fossarum	PLOS ONE			English	Article							SITU FEEDING ASSAY; DAPHNIA-MAGNA; WATER-QUALITY; ENVIRONMENTAL ASSESSMENT; CONFOUNDING FACTORS; RAPID-DETERMINATION; SPP. CRUSTACEA; GROWTH ASSAY; PULEX; BIOMARKERS	Digestive enzyme activity is often used as a sensitive response to environmental pollution. However, only little is known about the negative effects of stress on digestive capacities and their consequences on energy reserves and reproduction, although these parameters are important for the maintenance of populations. To highlight if changes in biochemical responses (digestive enzymes and reserves) led to impairments at an individual level (fertility), Gammarus fossarum were submitted to a lower food intake throughout a complete female reproductive cycle (i.e. from ovogenesis to offspring production). For both males and females, amylase activity was inhibited by the diet stress, whereas trypsin activity was not influenced. These results underline similar sensitivity of males and females concerning their digestive capacity. Energy reserves decreased with food starvation in females, and remained stable in males. The number of embryos per female decreased with food starvation. Lower digestive activity in males and females therefore appears as an early response. These results underline the ecological relevance of digestive markers, as they make it possible to anticipate upcoming consequences on reproduction in females, a key biological variable for population dynamics.	[Charron, Laetitia; Jaffal, Ali; Gaillet, Veronique; Dedourge-Geffard, Odile; Geffard, Alain] Univ Reims, Unite Format & Rech Sci Exactes & Nat, Unite Mixte Rech Ineris UMR Stress Environm & Bio, Reims 2, France; [Geffard, Olivier; Chaumot, Arnaud; Coulaud, Romain] Inst Natl Rech Sci & Technol Environm & Agr, Unite Rech Milieux Aquat Ecol & Pollut, Villeurbanne, France	Universite de Reims Champagne-Ardenne; INRAE	Geffard, A (corresponding author), Univ Reims, Unite Format & Rech Sci Exactes & Nat, Unite Mixte Rech Ineris UMR Stress Environm & Bio, Moulin Housse, Reims 2, France.	alain.geffard@univ-reims.fr		Geffard, Alain/0000-0001-9236-2890; Olsen, Jennifer/0000-0001-6547-8791; chaumot, arnaud/0000-0001-9132-3419; Geffard, olivier/0000-0001-7760-4644; Dedourge-Geffard, Odile/0000-0001-6308-2080	National Research Agency; CESA program [GAMMA 021 02]; PIREN-Seine Program	National Research Agency(French National Research Agency (ANR)); CESA program; PIREN-Seine Program	This research program was financially supported by the National Research Agency, CESA program GAMMA 021 02 "Variability-adaptation-diversity and Ecotoxicology in gammarids" (2012-2015), and the PIREN-Seine Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amiard-Triquet C., 2013, ECOLOGICAL BIOMARKER; [Anonymous], STATISTICA; Baillieul M, 2005, COMP BIOCHEM PHYS C, V140, P364, DOI 10.1016/j.cca.2005.03.007; Baillieul M, 1996, FUNCT ECOL, V10, P227, DOI 10.2307/2389847; BARLOCHE.F, 1973, OIKOS, V24, P295, DOI 10.2307/3543888; Besse JP, 2013, WATER RES, V47, P650, DOI 10.1016/j.watres.2012.10.024; Boldina-Cosqueric I, 2010, ECOTOX ENVIRON SAFE, V73, P1733, DOI 10.1016/j.ecoenv.2010.08.008; Bourgeault A, 2010, ENVIRON TOXICOL, V25, P468, DOI 10.1002/tox.20591; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Charron L, 2013, ENVIRON SCI POLLUT R, V20, P9044, DOI 10.1007/s11356-013-1921-5; Charron L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096393; Coulaud R, 2011, WATER RES, V45, P6417, DOI 10.1016/j.watres.2011.09.035; De Coen W. M., 1997, Journal of Aquatic Ecosystem Stress and Recovery, V6, P43, DOI 10.1023/A:1008228517955; De Coen WM, 2003, ENVIRON TOXICOL CHEM, V22, P1632, DOI [10.1897/1551-5028(2003)22&lt;1632:TMBLRB&gt;2.0.CO;2, 10.1002/etc.5620220727]; De Coen WM, 1998, HYDROBIOLOGIA, V367, P199, DOI 10.1023/A:1003240502946; Dedourge-Geffard O, 2013, ECOTOX ENVIRON SAFE, V97, P139, DOI 10.1016/j.ecoenv.2013.07.016; DEPLEDGE MH, 1994, ECOTOXICOLOGY, V3, P161, DOI 10.1007/BF00117081; Dick JTA, 2005, MAR ECOL PROG SER, V291, P151, DOI 10.3354/meps291151; Duquesne S, 2006, ECOTOX ENVIRON SAFE, V65, P145, DOI 10.1016/j.ecoenv.2006.01.008; Dutra BK, 2009, COMP BIOCHEM PHYS C, V149, P640, DOI 10.1016/j.cbpc.2009.01.005; Felten V, 2008, FUND APPL LIMNOL, V170, P303, DOI 10.1127/1863-9135/2008/0170-0303; Forbes VE, 2006, ENVIRON TOXICOL CHEM, V25, P272, DOI 10.1897/05-257R.1; Foucreau N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077242; Garcia-Esquivel Z, 2002, COMP BIOCHEM PHYS A, V133, P63, DOI 10.1016/S1095-6433(02)00112-5; GARCIACARRENO FL, 1993, J FOOD BIOCHEM, V17, P97, DOI 10.1111/j.1745-4514.1993.tb00864.x; Geffard O, 2010, ENVIRON TOXICOL CHEM, V29, P2249, DOI 10.1002/etc.268; Gismondi E, 2012, ENVIRON POLLUT, V160, P17, DOI 10.1016/j.envpol.2011.09.021; Handy RD, 1999, ECOTOXICOLOGY, V8, P329, DOI 10.1023/A:1008930404461; Hervant F, 1997, COMP BIOCHEM PHYS A, V118, P1277, DOI 10.1016/S0300-9629(97)00047-9; Kalman J, 2009, MAR ECOL PROG SER, V393, P55, DOI 10.3354/meps08239; Kelly DW, 2002, HYDROBIOLOGIA, V485, P199, DOI 10.1023/A:1021370405349; Koop JHE, 2008, LIMNOLOGICA, V38, P378, DOI 10.1016/j.limno.2008.05.004; Lacaze E, 2011, ENVIRON RES, V111, P626, DOI 10.1016/j.envres.2011.03.012; Maazouzi C, 2009, FUND APPL LIMNOL, V175, P327, DOI 10.1127/1863-9135/2009/0175-0327; MacNeil C, 1997, BIOL REV, V72, P349, DOI 10.1017/S0006323196005038; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; MALTBY L, 1990, FUNCT ECOL, V4, P393, DOI 10.2307/2389601; MALTBY L, 1990, ECOTOX ENVIRON SAFE, V19, P292, DOI 10.1016/0147-6513(90)90031-Y; Maltby L, 2002, ENVIRON TOXICOL CHEM, V21, P361, DOI 10.1897/1551-5028(2002)021<0361:EOTGPI>2.0.CO;2; Maltby L, 1994, WATER QUALITY STRESS, V4, P98; Meier GM, 2000, ARCH HYDROBIOL, V147, P447; Mezek T, 2010, AQUAT ECOL, V44, P397, DOI 10.1007/s10452-009-9299-7; Muyssen BTA, 2002, AQUAT TOXICOL, V56, P69, DOI 10.1016/S0166-445X(01)00206-5; NAYLOR C, 1990, WATER RES, V24, P757, DOI 10.1016/0043-1354(90)90032-2; NAYLOR C, 1989, HYDROBIOLOGIA, V188, P517, DOI 10.1007/BF00027819; Olsen GH, 2008, MAR ENVIRON RES, V66, P215, DOI 10.1016/j.marenvres.2008.02.063; Palais F, 2010, MOLLUSCAN RES, V30, P29; Plaistow SJ, 2003, ANIM BEHAV, V65, P683, DOI 10.1006/anbe.2003.2116; POCKL M, 1992, FRESHWATER BIOL, V27, P211, DOI 10.1111/j.1365-2427.1992.tb00534.x; Sroda S, 2011, CHEMOSPHERE, V83, P538, DOI 10.1016/j.chemosphere.2010.12.023; Sutcliffe D.W., 1992, Freshwater Forum, V2, P102; Tankoua OF, 2012, AQUAT TOXICOL, V114, P96, DOI 10.1016/j.aquatox.2012.02.016; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P302; Wang T, 2006, ANNU REV PHYSIOL, V68, P223, DOI 10.1146/annurev.physiol.68.040104.105739; WILLOUGHBY LG, 1976, FRESHWATER BIOL, V6, P577, DOI 10.1111/j.1365-2427.1976.tb01647.x; Xuereb B, 2009, AQUAT TOXICOL, V94, P114, DOI 10.1016/j.aquatox.2009.06.010	57	82	82	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125154	10.1371/journal.pone.0125154	http://dx.doi.org/10.1371/journal.pone.0125154			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880985	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500114
J	Gerxhani, K; Bruggeman, J				Gerxhani, Klarita; Bruggeman, Jeroen			Time Lag and Communication in Changing Unpopular Norms	PLOS ONE			English	Article							SPACES; MODEL	Humans often coordinate their social lives through norms. When a large majority of people are dissatisfied with an existing norm, it seems obvious that they will change it. Often, however, this does not occur. We investigate how a time lag between individual support of a norm change and the change itself hinders such change, related to the critical mass of supporters needed to effectuate the change, and the (im)possibility of communicating about it. To isolate these factors, we utilize a laboratory experiment. As predicted, we find unambiguous effects of time lag on precluding norm change; a higher threshold for a critical mass does so as well. Communication facilitates choosing superior norms but it does not necessarily lead to norm change when the uncertainty on whether there will be a norm change in the future is high. Communication seems to help coordination on actions at the present but not the future. Hence, the uncertainty driven by time lag makes individuals choose the status quo, here the unpopular norm.	[Gerxhani, Klarita; Bruggeman, Jeroen] Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands	University of Amsterdam	Gerxhani, K (corresponding author), Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands.	k.gerxhani@uva.nl	Gerxhani, Klarita/K-2446-2018	Gerxhani, Klarita/0000-0002-9056-4920				BANERJEE AV, 1992, Q J ECON, V107, P797, DOI 10.2307/2118364; Berns GS, 2007, TRENDS COGN SCI, V11, P482, DOI 10.1016/j.tics.2007.08.011; Bicchieri C., 1999, BUS ETHICS Q, V9, P127, DOI DOI 10.2307/3857639; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Boyd R, 2010, PHILOS T R SOC B, V365, P3787, DOI 10.1098/rstb.2010.0046; Centola D, 2005, AM J SOCIOL, V110, P1009, DOI 10.1086/427321; Easley D, 2010, NETWORKS CROWDS MARK; Elster Jon, 2007, EXPLAINING SOCIAL BE; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Grantham J, 2012, NATURE, V491, P303, DOI 10.1038/491303a; Hannan H, 2007, LOGICS ORG THEORY AU; HARDIN G, 1968, SCIENCE, V162, P1243, DOI 10.1126/science.162.3859.1243; Horne C., 2001, SOCIAL NORMS, P3; Janis IL, 1982, GROUPTHINK PSYCHOL S; Kellogg KC, 2009, AM J SOCIOL, V115, P657, DOI 10.1086/603535; Knight J, 1998, NEW I SOCIOLOGY, P105; Ledyard JO, 1996, HDB EXPT EC, P111; Lorenz J, 2011, P NATL ACAD SCI USA, V108, P9020, DOI 10.1073/pnas.1008636108; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Ostrom E, 2010, AM ECON REV, V100, P641, DOI 10.1257/aer.100.3.641; Polletta F, 1999, THEOR SOC, V28, P1, DOI 10.1023/A:1006941408302; Richerson P. J, 2005, NOT GENES ALONE; ROGERS AR, 1990, AM NAT, V135, P398, DOI 10.1086/285053; Schelling T.C., 1960, STRATEGY CONFLICT; Willer R, 2009, AM J SOCIOL, V115, P451, DOI 10.1086/599250; Wills T.A., 1991, SOCIAL COMP CONT THE, P287; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110	28	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124715	10.1371/journal.pone.0124715	http://dx.doi.org/10.1371/journal.pone.0124715			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25880200	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500107
J	Naganathan, A; Wood, MP; Moore, SD				Naganathan, Anusha; Wood, Matthew P.; Moore, Sean D.			The Large Ribosomal Subunit Protein L9 Enables the Growth of EF-P Deficient Cells and Enhances Small Subunit Maturation	PLOS ONE			English	Article							ELONGATION-FACTOR-P; ESCHERICHIA-COLI; TRANSLATION ELONGATION; QUALITY-CONTROL; STRUCTURAL INSIGHTS; CRYSTAL-STRUCTURE; INITIATION-FACTOR; ESSENTIAL GTPASE; MESSENGER-RNAS; PEPTIDE-BOND	The loss of the large ribosomal protein L9 causes a reduction in translation fidelity by an unknown mechanism. To identify pathways affected by L9, we identified mutants of E. coli that require L9 for fitness. In a prior study, we characterized L9-dependent mutations in the essential GTPase Der (EngA). Here, we describe a second class of L9-dependent mutations that either compromise or inactivate elongation factor P (EF-P, eIF5A in eukaryotes). Without L9, Delta efp cells are practically inviable. Cell fractionation studies revealed that, in both the Der and EF-P mutant cases, L9's activity reduces immature 16S rRNA in 30S particles and partially restores the abundance of monosomes. Inspired by these findings, we discovered that L9 also enhances 16S maturation in wild-type cells. Surprisingly, although the amount of immature 16S in 30S particles was found to be elevated in Delta rplI cells, the amount in polysomes was low and inversely correlated with the immature 16S abundance. These findings provide an explanation for the observed fitness increases afforded by L9 in these mutants and reveal particular physiological conditions in which L9 becomes critical. Additionally, L9 may affect the partitioning of small subunits containing immature 16S rRNA.	[Naganathan, Anusha; Moore, Sean D.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA; [Wood, Matthew P.] Seattle Biomed, Seattle, WA 98109 USA; [Wood, Matthew P.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	State University System of Florida; University of Central Florida; Center for Infectious Disease Research; University of Washington; University of Washington Seattle	Moore, SD (corresponding author), Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL 32816 USA.	sean.moore@ucf.edu		Wood, Matthew/0000-0001-6741-0088	National Institutes of Health [R15 GM102714-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM102714] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grant R15 GM102714-01 from the National Institutes of Health: http://www.nigms.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamski FM, 1996, J MOL BIOL, V261, P357, DOI 10.1006/jmbi.1996.0469; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailly M, 2010, BIOL DIRECT, V5, DOI 10.1186/1745-6150-5-3; Behshad E, 2006, BIOCHEMISTRY-US, V45, P12639, DOI 10.1021/bi061328t; Belotserkovsky JM, 2011, FEBS J, V278, P3508, DOI 10.1111/j.1742-4658.2011.08272.x; Berk V, 2006, P NATL ACAD SCI USA, V103, P15830, DOI 10.1073/pnas.0607541103; Bernhardt TG, 2004, MOL MICROBIOL, V52, P1255, DOI 10.1111/j.1365-2958.2004.04063.x; Bharat A, 2006, J BACTERIOL, V188, P7992, DOI 10.1128/JB.00959-06; Blaha G, 2009, SCIENCE, V325, P966, DOI 10.1126/science.1175800; Bullwinkle TJ, 2013, J BIOL CHEM, V288, P4416, DOI 10.1074/jbc.M112.438879; Carr AC, 2012, J BACTERIOL, V194, P5932, DOI 10.1128/JB.00913-12; Carr AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037640; Chomczynski P, 2006, NAT PROTOC, V1, P581, DOI 10.1038/nprot.2006.83; Connolly K, 2013, MOL MICROBIOL, V87, P968, DOI 10.1111/mmi.12145; Connolly K, 2008, MOL MICROBIOL, V70, P1062, DOI 10.1111/j.1365-2958.2008.06485.x; Cougot N, 2013, J MOL BIOL; Demirci H, 2010, RNA, V16, P2319, DOI 10.1261/rna.2357210; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; Dunkle JA, 2011, SCIENCE, V332, P981, DOI 10.1126/science.1202692; Dunkle JA, 2010, P NATL ACAD SCI USA, V107, P17152, DOI 10.1073/pnas.1007988107; Frazier AD, 2012, ARCH MICROBIOL, V194, P1033, DOI 10.1007/s00203-012-0839-5; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Gupta N, 2014, NAT STRUCT MOL BIOL; HERBST KL, 1994, P NATL ACAD SCI USA, V91, P12525, DOI 10.1073/pnas.91.26.12525; HEROLD M, 1987, J BIOL CHEM, V262, P8826; Herr AJ, 2000, EMBO J, V19, P2671, DOI 10.1093/emboj/19.11.2671; Hersch SJ, 2014, J BIOL CHEM, V289, P28160, DOI 10.1074/jbc.M114.593277; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; HOFFMAN DW, 1994, EMBO J, V13, P205, DOI 10.1002/j.1460-2075.1994.tb06250.x; Hwang J, 2001, J BIOL CHEM, V276, P31415, DOI 10.1074/jbc.M104455200; Hwang J, 2006, MOL MICROBIOL, V61, P1660, DOI 10.1111/j.1365-2958.2006.05348.x; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Jomaa A, 2011, RNA, V17, P697, DOI 10.1261/rna.2509811; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Korepanov AP, 2012, NUCLEIC ACIDS RES, V40, P9153, DOI 10.1093/nar/gks676; Kurata T, 2015, J MOL BIOL, V427, P955, DOI 10.1016/j.jmb.2014.12.013; Lebaron S, 2012, NAT STRUCT MOL BIOL, V19, P744, DOI 10.1038/nsmb.2308; Leipuviene R, 2007, J BACTERIOL, V189, P7024, DOI 10.1128/JB.00710-07; Li GW, 2012, NATURE, V484, P538, DOI 10.1038/nature10965; Lieberman KR, 2000, J MOL BIOL, V297, P1129, DOI 10.1006/jmbi.2000.3621; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; MANGIAROTTI G, 1974, NATURE, V247, P147, DOI 10.1038/247147a0; MODOLELL J, 1969, NATURE, V224, P345, DOI 10.1038/224345a0; Moore SD, 2008, P NATL ACAD SCI USA, V105, P11685, DOI 10.1073/pnas.0805633105; Naganathan A, 2013, J BACTERIOL, V195, P3682, DOI 10.1128/JB.00464-13; Nakatogawa H, 2004, CURR OPIN MICROBIOL, V7, P145, DOI 10.1016/j.mib.2004.01.001; Navarre WW, 2010, MOL CELL, V39, P209, DOI 10.1016/j.molcel.2010.06.021; Ogle JM, 2005, ANNU REV BIOCHEM, V74, P129, DOI 10.1146/annurev.biochem.74.061903.155440; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Park MH, 2010, AMINO ACIDS, V38, P491, DOI 10.1007/s00726-009-0408-7; Peil L, 2012, NAT CHEM BIOL; Peil L, 2013, P NATL ACAD SCI USA, V110, P15265, DOI 10.1073/pnas.1310642110; Rodnina MV, 2001, ANNU REV BIOCHEM, V70, P415, DOI 10.1146/annurev.biochem.70.1.415; Roy H, 2011, NAT CHEM BIOL, V7, P667, DOI [10.1038/NCHEMBIO.632, 10.1038/nchembio.632]; Roy-Chaudhuri B, 2008, MOL MICROBIOL, V68, P1547, DOI 10.1111/j.1365-2958.2008.06252.x; Roy-Chaudhuri B, 2010, P NATL ACAD SCI USA, V107, P4567, DOI 10.1073/pnas.0912305107; Samatova E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5459; Schaefer L, 2006, J BACTERIOL, V188, P8252, DOI 10.1128/JB.01213-06; Schifano JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4538; Schmeing TM, 2009, SCIENCE, V326, P688, DOI 10.1126/science.1179700; Seidman JS, 2011, J BIOL CHEM, V286, P31105, DOI 10.1074/jbc.M111.268201; Selmer M, 2012, ACTA CRYSTALLOGR D, V68, P578, DOI 10.1107/S0907444912006348; Shimizu Y, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00170; Song W, 2014, NUCLEIC ACIDS RES, V42, P4669, DOI 10.1093/nar/gku093; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Vesper O, 2011, CELL, V147, P147, DOI 10.1016/j.cell.2011.07.047; Yanagisawa T, 2010, NAT STRUCT MOL BIOL, V17, P1136, DOI 10.1038/nsmb.1889; Yang ZX, 2014, PROTEIN CELL, V5, P394, DOI 10.1007/s13238-014-0044-1; Zaher HS, 2011, CELL, V147, P396, DOI 10.1016/j.cell.2011.08.045; Zaher HS, 2009, NATURE, V457, P161, DOI 10.1038/nature07582; Zhang X, 2014, NUCL ACIDS RES; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7	74	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120060	10.1371/journal.pone.0120060	http://dx.doi.org/10.1371/journal.pone.0120060			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879934	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500005
J	Vondrackova, S; Szakova, J; Drabek, O; Tejnecky, V; Hejcman, M; Mullerova, V; Tlustos, P				Vondrackova, Stanislava; Szakova, Jirina; Drabek, Ondrej; Tejnecky, Vaclav; Hejcman, Michal; Muellerova, Vladimira; Tlustos, Pavel			Aluminium Uptake and Translocation in Al Hyperaccumulator Rumex obtusifolius Is Affected by Low-Molecular-Weight Organic Acids Content and Soil pH	PLOS ONE			English	Article							ENVIRONMENTAL-SAMPLES; EXTRACTION PROCEDURES; FAGOPYRUM-ESCULENTUM; CONTAMINATED SOILS; ALKALINE SOILS; FOREST SOILS; HEAVY-METALS; OXALIC-ACID; PLANT; RESISTANCE	Background and Aims High Al resistance of Rumex obtusifolius together with its ability to accumulate Al has never been studied in weakly acidic conditions (pH > 5.8) and is not sufficiently described in real soil conditions. The potential elucidation of the role of organic acids in plant can explain the Al tolerance mechanism. Methods We established a pot experiment with R. obtusifolius planted in slightly acidic and alkaline soils. For the manipulation of Al availability, both soils were untreated and treated by lime and superphosphate. We determined mobile Al concentrations in soils and concentrations of Al and organic acids in organs. Results Al availability correlated positively to the extraction of organic acids (citric acid < oxalic acid) in soils. Monovalent Al cations were the most abundant mobile Al forms with positive charge in soils. Liming and superphosphate application were ambiguous measures for changing Al mobility in soils. Elevated transport of total Al from belowground organs into leaves was recorded in both lime-treated soils and in superphosphate-treated alkaline soil as a result of sufficient amount of Ca available from soil solution as well as from superphosphate that can probably modify distribution of total Al in R. obtusifolius as a representative of "oxalate plants." The highest concentrations of Al and organic acids were recorded in the leaves, followed by the stem and belowground organ infusions. Conclusions In alkaline soil, R. obtusifolius is an Al-hyperaccumulator with the highest concentrations of oxalate in leaves, of malate in stems, and of citrate in belowground organs. These organic acids form strong complexes with Al that can play a key role in internal Al tolerance but the used methods did not allow us to distinguish the proportion of total Al-organic complexes to the free organic acids.	[Vondrackova, Stanislava; Szakova, Jirina; Tlustos, Pavel] Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Agroenvironm Chem & Plant Nutr, Prague 16521 6, Suchdol, Czech Republic; [Drabek, Ondrej; Tejnecky, Vaclav] Czech Univ Life Sci, Dept Soil Sci & Soil Protect, Fac Agrobiol Food & Nat Resources, Prague 16521 6, Suchdol, Czech Republic; [Hejcman, Michal; Muellerova, Vladimira] Czech Univ Life Sci, Fac Environm Sci, Dept Ecol, Prague 16521 6, Suchdol, Czech Republic	Czech University of Life Sciences Prague; Czech University of Life Sciences Prague; Czech University of Life Sciences Prague	Vondrackova, S (corresponding author), Czech Univ Life Sci, Fac Agrobiol Food & Nat Resources, Dept Agroenvironm Chem & Plant Nutr, Kamycka 129, Prague 16521 6, Suchdol, Czech Republic.	vondrackovas@af.czu.cz	Kroulikova, Stanislava/GRF-3434-2022; Tejnecký, Václav/K-9043-2013; Tlustos, Pavel/L-5312-2019; Drábek, Ondřej/AAU-3496-2021; MÃllerovÃ, VladimÃra/ABI-6294-2020; Száková, Jiřina/K-6296-2019	Kroulikova, Stanislava/0000-0003-4721-1158; Tejnecký, Václav/0000-0003-0296-4981; Tlustos, Pavel/0000-0003-1274-0658; Száková, Jiřina/0000-0002-3390-6365; Hejcman, Michal/0000-0002-3513-2017; Jurasova, Vladimira/0000-0003-2293-6566	Czech University of Life Sciences in Prague [CIGA 20124205, CIGA 20142027]	Czech University of Life Sciences in Prague	This study was supported by the Czech University of Life Sciences in Prague (CIGA 20124205, CIGA 20142027). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez E, 2005, FOREST ECOL MANAG, V211, P227, DOI 10.1016/j.foreco.2005.02.044; Arunakumara KKIU, 2013, J KOREAN SOC APPL BI, V56, P1, DOI 10.1007/s13765-012-2314-z; Barcelo J, 2002, ENVIRON EXP BOT, V48, P75, DOI 10.1016/S0098-8472(02)00013-8; Brautigan DJ, 2012, PLANT SOIL, V360, P187, DOI 10.1007/s11104-012-1232-5; Drabek O, 2005, J INORG BIOCHEM, V99, P1788, DOI 10.1016/j.jinorgbio.2005.06.024; Ettler V, 2009, J HAZARD MATER, V170, P1264, DOI 10.1016/j.jhazmat.2009.05.068; Gleyzes C, 2002, TRAC-TREND ANAL CHEM, V21, P451, DOI 10.1016/S0165-9936(02)00603-9; HARRISON WJ, 1992, GEOCHIM COSMOCHIM AC, V56, P565, DOI 10.1016/0016-7037(92)90082-T; Hejcman M, 2014, PLANT SOIL ENVIRON, V60, P489, DOI 10.17221/414/2014-PSE; Hejcman M, 2012, PLANT SOIL ENVIRON, V58, P561, DOI 10.17221/612/2012-PSE; Huang J, 2009, WASTE MANAGE RES, V27, P668, DOI 10.1177/0734242X09103835; HUE NV, 1986, SOIL SCI SOC AM J, V50, P28, DOI 10.2136/sssaj1986.03615995005000010006x; Inostroza-Blancheteau C, 2012, MOL BIOL REP, V39, P2069, DOI 10.1007/s11033-011-0954-4; Jones DL, 1998, PLANT SOIL, V205, P25, DOI 10.1023/A:1004356007312; Kassaye YA, 2013, ACTA PHYSIOL PLANT, V35, P1749, DOI 10.1007/s11738-012-1212-7; KINRAIDE TB, 1990, PLANT PHYSIOL, V93, P1620, DOI 10.1104/pp.93.4.1620; KOCHIAN LV, 1995, ANNU REV PLANT PHYS, V46, P237, DOI 10.1146/annurev.pp.46.060195.001321; Koopmans GF, 2005, J ENVIRON QUAL, V34, P1446, DOI 10.2134/jeq2005.0028; Kubova J, 2005, ANAL CHIM ACTA, V547, P119, DOI 10.1016/j.aca.2004.12.014; Li JY, 2006, APPL GEOCHEM, V21, P1750, DOI 10.1016/j.apgeochem.2006.06.013; Ma JF, 2001, TRENDS PLANT SCI, V6, P273, DOI 10.1016/S1360-1385(01)01961-6; Ma JF, 2005, CRIT REV PLANT SCI, V24, P267, DOI 10.1080/07352680500196017; Ma JF, 1998, PLANT PHYSIOL, V117, P753, DOI 10.1104/pp.117.3.753; Malik J, 2008, FOOD CHEM, V111, P520, DOI 10.1016/j.foodchem.2008.04.009; Malik J, 2013, FOOD CHEM, V139, P728, DOI 10.1016/j.foodchem.2013.02.013; MARSCHNER H, 1991, PLANT SOIL, V134, P1, DOI 10.1007/BF00010712; Matus P, 2009, J INORG BIOCHEM, V103, P1473, DOI 10.1016/j.jinorgbio.2009.08.004; MCCOLL JG, 1986, WATER AIR SOIL POLL, V31, P917, DOI 10.1007/BF00284237; Miyagi A, 2013, WEED RES, V53, P30, DOI 10.1111/j.1365-3180.2012.00949.x; Miyagi A, 2010, METABOLOMICS, V6, P146, DOI 10.1007/s11306-009-0186-y; Mucha AP, 2005, ESTUAR COAST SHELF S, V65, P191, DOI 10.1016/j.ecss.2005.06.007; Namiesnik J, 2010, CRIT REV ANAL CHEM, V40, P68, DOI 10.1080/10408340903153234; Peters RW, 1999, J HAZARD MATER, V66, P151, DOI 10.1016/S0304-3894(99)00010-2; Poschenrieder C, 2008, SCI TOTAL ENVIRON, V400, P356, DOI 10.1016/j.scitotenv.2008.06.003; Quevauviller P, 1998, TRAC-TREND ANAL CHEM, V17, P289, DOI 10.1016/S0165-9936(97)00119-2; Reyna-Llorens I, 2015, ENVIRON EXP BOT, V111, P74, DOI 10.1016/j.envexpbot.2014.11.005; Scancar J, 2006, ANAL BIOANAL CHEM, V386, P999, DOI 10.1007/s00216-006-0422-5; Schottelndreier M, 2001, ANN BOT-LONDON, V87, P769, DOI 10.1006/anbo.2001.1405; Schwertfeger DM, 2009, SOIL SCI SOC AM J, V73, P737, DOI 10.2136/sssaj2008.0009; Shen RF, 2001, J EXP BOT, V52, P1683, DOI 10.1093/jexbot/52.361.1683; SIMS JR, 1971, SOIL SCI, V112, P137, DOI 10.1097/00010694-197108000-00007; Singh D, 2011, CURR SCI INDIA, V100, P1509; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Strom L, 2005, SOIL BIOL BIOCHEM, V37, P2046, DOI 10.1016/j.soilbio.2005.03.009; Tejnecky V, 2010, BIOGEOCHEMISTRY, V101, P151, DOI 10.1007/s10533-010-9450-5; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; TLUSTOS P, 1994, ROST VYROBA, V40, P1107; Tolra R, 2011, J PLANT RES, V124, P165, DOI 10.1007/s10265-010-0344-3; Tolra RP, 2005, ENVIRON EXP BOT, V54, P231, DOI 10.1016/j.envexpbot.2004.07.006; Trichopoulou A, 2000, FOOD CHEM, V70, P319, DOI 10.1016/S0308-8146(00)00091-1; TYLER G, 1994, EXPERIENTIA, V50, P701, DOI 10.1007/BF01952878; van Hees PAW, 2000, GEODERMA, V94, P201, DOI 10.1016/S0016-7061(98)00139-6; Vardavas CI, 2006, FOOD CHEM, V99, P813, DOI 10.1016/j.foodchem.2005.08.057; Vondrackova S, 2014, PLANT SOIL, V379, P231, DOI 10.1007/s11104-014-2058-0; Watanabe T, 2002, COMMUN SOIL SCI PLAN, V33, P1247, DOI 10.1081/CSS-120003885; White PJ, 2003, ANN BOT-LONDON, V92, P487, DOI 10.1093/aob/mcg164; Wuana RA, 2010, INT J ENVIRON SCI TE, V7, P485, DOI 10.1007/BF03326158; Zheng SJ, 1998, PLANT PHYSIOL, V117, P745, DOI 10.1104/pp.117.3.745	58	10	12	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123351	10.1371/journal.pone.0123351	http://dx.doi.org/10.1371/journal.pone.0123351			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880431	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500049
J	Wen, ZZT; Bitoun, JP; Liao, SM				Wen, Zezhang T.; Bitoun, Jacob P.; Liao, Sumei			PBP1a-Deficiency Causes Major Defects in Cell Division, Growth and Biofilm Formation by Streptococcus mutans	PLOS ONE			English	Article							PENICILLIN-BINDING PROTEINS; STRESS RESPONSES; PNEUMONIAE; RESISTANCE; GENES; ACID; GLUCOSYLTRANSFERASES; HYDROXYAPATITE; TRANSFORMATION; TOLERANCE	Streptococcus mutans, a key etiological agent of human dental caries, lives almost exclusively on the tooth surface in plaque biofilms and is known for its ability to survive and respond to various environmental insults, including low pH, and antimicrobial agents from other microbes and oral care products. In this study, a penicillin-binding protein (PBP1a)-deficient mutant, strain JB467, was generated by allelic replacement mutagenesis and analyzed for the effects of such a deficiency on S. mutans' stress tolerance response and biofilm formation. Our results so far have shown that PBP1a-deficiency in S. mutans affects growth of the deficient mutant, especially at acidic and alkaline pHs. As compared to the wild-type, UA159, the PBP1a-deficient mutant, JB467, had a reduced growth rate at pH 6.2 and did not grow at all at pH 8.2. Unlike the wild-type, the inclusion of paraquat in growth medium, especially at 2 mM or above, significantly reduced the growth rate of the mutant. Acid killing assays showed that the mutant was 15-fold more sensitive to pH 2.8 than the wild-type after 30 minutes. In a hydrogen peroxide killing assay, the mutant was 16-fold more susceptible to hydrogen peroxide (0.2%, w/v) after 90 minutes than the wild-type. Relative to the wild-type, the mutant also had an aberrant autolysis rate, indicative of compromises in cell envelope integrity. As analyzed using on 96-well plate model and spectrophotometry, biofilm formation by the mutant was decreased significantly, as compared to the wild-type. Consistently, Field Emission-SEM analysis also showed that the PBP1a-deficient mutant had limited capacity to form biofilms. TEM analysis showed that PBP1a mutant existed primarily in long rod-like cells and cells with multiple septa, as compared to the coccal wild-type. The results presented here highlight the importance of pbp1a in cell morphology, stress tolerance, and biofilm formation in S. mutans.	[Wen, Zezhang T.; Bitoun, Jacob P.; Liao, Sumei] Louisiana State Univ, Hlth Sci Ctr, Dept Comprehens Dent & Biomat, New Orleans, LA 70112 USA; [Wen, Zezhang T.; Bitoun, Jacob P.; Liao, Sumei] Louisiana State Univ, Hlth Sci Ctr, Ctr Oral & Craniofacial Biol, New Orleans, LA 70112 USA; [Wen, Zezhang T.] Louisiana State Univ, Hlth Sci Ctr, Dept Microbiol Immunol & Parasitol, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Wen, ZZT (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Comprehens Dent & Biomat, New Orleans, LA 70112 USA.	zwen@lsuhsc.edu	Liao, Sumei/E-6589-2015		National Institute for Dental and Craniofacial Research, United States of America [DE19452]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE019452] Funding Source: NIH RePORTER	National Institute for Dental and Craniofacial Research, United States of America; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported in part by R01 grant DE19452 from the National Institute for Dental and Craniofacial Research, United States of America (http://www.nidcr.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajdic D, 2002, P NATL ACAD SCI USA, V99, P14434, DOI 10.1073/pnas.172501299; Banas JA, 2003, CRIT REV ORAL BIOL M, V14, P89, DOI 10.1177/154411130301400203; Banzhaf M, 2012, MOL MICROBIOL, V85, P179, DOI 10.1111/j.1365-2958.2012.08103.x; BELLI WA, 1991, APPL ENVIRON MICROB, V57, P1134, DOI 10.1128/AEM.57.4.1134-1138.1991; Berg KH, 2013, J BACTERIOL, V195, P4342, DOI 10.1128/JB.00184-13; Bitoun JP, 2012, APPL ENVIRON MICROB, V78, P2914, DOI 10.1128/AEM.07823-11; Bitoun JP, 2011, FEMS MICROBIOL LETT, V320, P110, DOI 10.1111/j.1574-6968.2011.02293.x; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Crowley PJ, 1999, INFECT IMMUN, V67, P1201, DOI 10.1128/IAI.67.3.1201-1206.1999; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; Egan AJF, 2013, ANN NY ACAD SCI, V1277, P8, DOI 10.1111/j.1749-6632.2012.06818.x; Evans KL, 2013, J BACTERIOL, V195, P4415, DOI 10.1128/JB.00596-13; Fani F, 2014, ANTIMICROB AGENTS CH, V58, P1397, DOI 10.1128/AAC.01311-13; Grebe T, 1996, ANTIMICROB AGENTS CH, V40, P829, DOI 10.1128/AAC.40.4.829; Gregoire S, 2011, APPL ENVIRON MICROB, V77, P6357, DOI 10.1128/AEM.05203-11; Hamilton A, 2006, INFECT IMMUN, V74, P6179, DOI 10.1128/IAI.00895-06; Hu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051905; Hughes HV, 2013, MOL MICROBIOL, V90, P1162, DOI 10.1111/mmi.12422; Job V, 2008, J BIOL CHEM, V283, P4886, DOI 10.1074/jbc.M706181200; Koksharova OA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P963, DOI 10.1134/S0006297913090010; Koo H, 2003, J ANTIMICROB CHEMOTH, V52, P782, DOI 10.1093/jac/dkg449; Lau PCY, 2002, J MICROBIOL METH, V49, P193, DOI 10.1016/S0167-7012(01)00369-4; LeBanc D., 1991, GENETICS MOL BIOL ST, P235; Lemos JAC, 2001, J BACTERIOL, V183, P6074, DOI 10.1128/JB.183.20.6074-6084.2001; Li YH, 2002, J BACTERIOL, V184, P6333, DOI 10.1128/JB.184.22.6333-6342.2002; Li YH, 2001, J BACTERIOL, V183, P897, DOI 10.1128/JB.183.3.897-908.2001; Liao SM, 2014, J BACTERIOL, V196, P2355, DOI 10.1128/JB.01493-14; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; MARTIN C, 1992, EMBO J, V11, P3831, DOI 10.1002/j.1460-2075.1992.tb05475.x; MARTIN C, 1992, J BACTERIOL, V174, P4517, DOI 10.1128/JB.174.13.4517-4523.1992; Massidda O, 2013, ENVIRON MICROBIOL, V15, P3133, DOI 10.1111/1462-2920.12189; Navarre WW, 1999, MICROBIOL MOL BIOL R, V63, P174, DOI 10.1128/MMBR.63.1.174-229.1999; Nguyen UT, 2014, ANTIMICROB AGENTS CH, V58, P6508, DOI 10.1128/AAC.03671-14; Oli MW, 2012, MICROBIOL-SGM, V158, P2903, DOI 10.1099/mic.0.060855-0; Otero LH, 2013, P NATL ACAD SCI USA, V110, P16808, DOI 10.1073/pnas.1300118110; Perry JA, 2009, FEMS MICROBIOL LETT, V299, P261, DOI 10.1111/j.1574-6968.2009.01758.x; Priyadarshini R, 2006, J BACTERIOL, V188, P5345, DOI 10.1128/JB.00476-06; Reichmann P, 1997, J INFECT DIS, V176, P1001, DOI 10.1086/516532; Sauvage E, 2008, FEMS MICROBIOL REV, V32, P234, DOI 10.1111/j.1574-6976.2008.00105.x; Silhavy TJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000414; TAO L, 1988, J BACTERIOL, V170, P3752, DOI 10.1128/jb.170.8.3752-3755.1988; Vacca-Smith AM, 1998, ARCH ORAL BIOL, V43, P103, DOI 10.1016/S0003-9969(97)00111-8; Vijayan S, 2014, CURR MICROBIOL, V68, P174, DOI 10.1007/s00284-013-0453-z; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P259, DOI 10.1111/j.1574-6976.2007.00099.x; Wen ZT, 2004, J BACTERIOL, V186, P2682, DOI 10.1128/JB.186.9.2682-2691.2004; Wen ZT, 2002, APPL ENVIRON MICROB, V68, P1196, DOI 10.1128/AEM.68.3.1196-1203.2002; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; Zeng L, 2006, MOL MICROBIOL, V62, P187, DOI 10.1111/j.1365-2958.2006.05359.x	48	12	12	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124319	10.1371/journal.pone.0124319	http://dx.doi.org/10.1371/journal.pone.0124319			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880908	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500093
J	Largeron, C; Mougel, PN; Rabbany, R; Zaiane, OR				Largeron, Christine; Mougel, Pierre-Nicolas; Rabbany, Reihaneh; Zaiane, Osmar R.			Generating Attributed Networks with Communities	PLOS ONE			English	Article							MODEL	In many modern applications data is represented in the form of nodes and their relationships, forming an information network. When nodes are described with a set of attributes we have an attributed network. Nodes and their relationships tend to naturally form into communities or clusters, and discovering these communities is paramount to many applications. Evaluating algorithms or comparing algorithms for automatic discovery of communities requires networks with known structures. Synthetic generators of networks have been proposed for this task but most solely focus on connectivity and their properties and overlook attribute values and the network properties vis-a-vis these attributes. In this paper, we propose a new generator for attributed networks with community structure that dependably follows the properties of real world networks.	[Largeron, Christine; Mougel, Pierre-Nicolas] Univ Lyon, Hubert Curien Lab, St Etienne, France; [Rabbany, Reihaneh; Zaiane, Osmar R.] Univ Alberta, Dept Comp Sci, Edmonton, AB, Canada	University of Alberta	Largeron, C (corresponding author), Univ Lyon, Hubert Curien Lab, St Etienne, France.	Christine.Largeron@univ-st-etienne.fr			Universite Jean Monnet; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Centre for Machine Learning	Universite Jean Monnet; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Centre for Machine Learning	Funding provided by Universite Jean Monnet, Natural Sciences and Engineering Research Council of Canada, and Alberta Innovates Centre for Machine Learning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akoglu L, 2009, DATA MIN KNOWL DISC, V19, P194, DOI 10.1007/s10618-009-0140-7; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Benson AR, 2014, PROCEEDINGS OF THE 20TH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING (KDD'14), P1326, DOI 10.1145/2623330.2623718; Dang T. N. L., 2012, THESIS; Easley D, 2010, NETWORKS CROWDS MARK, P85; ERDOS P, 1960, B INT STATIST INST, V38, P343; Fortunato S., 2012, COMPUT COMPLEX THEOR, P490, DOI [10.1007/978-1-4614-1800-9_33, DOI 10.1007/978-1-4614-1800-9_33]; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goldenberg A, 2010, FOUND TRENDS MACH LE, V2, P129, DOI 10.1561/2200000005; Gustafsson M, 2006, PHYSICA A, V367, P559, DOI 10.1016/j.physa.2005.12.017; Kaufman L., 1987, Statistical Data Analysis Based on the L1-Norm and Related Methods. First International Conference, P405; Kim M, 2010, LECT NOTES COMPUT SC, V6516, P62, DOI 10.1007/978-3-642-18009-5_7; Kolda TG, 2013, CORR; Lancichinetti A., 2013, DYNAMICS COMPLEX NET, V2, P143; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.056117; Lancichinetti A, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.016118; Lancichinetti A, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.046110; Lazarsfeld P. F., 1954, FREEDOM CONTROL MOD, V18, P18, DOI DOI 10.1111/J.1467-8705.2012.02056_3.X; Leskovec J., 2008, P 14 ACM SIGKDD INT, P462, DOI DOI 10.1145/1401890.1401948; Leskovec J., 2005, P 11 ACM SIGKDD INT, P177, DOI 10.1145/1081870.1081893; Leskovec J, 2010, J MACH LEARN RES, V11, P985; Leskovec J, 2007, ACM T WEB, V1, DOI 10.1145/1232722.1232727; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; MILGRAM S, 1967, PSYCHOL TODAY, V1, P61; Moussiades L, 2009, INT CONF RES CHAL, P197, DOI 10.1109/RCIS.2009.5089283; Newman MEJ, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.036104; Newman M.E.J., 2010, NETWORKS INTRO; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Newman MEJ, 2002, P NATL ACAD SCI USA, V99, P2566, DOI 10.1073/pnas.012582999; Orman Gunce Keziban, 2013, International Journal of Web Based Communities, V9, P349; Orman GK, 2009, LECT NOTES ARTIF INT, V5808, P242, DOI 10.1007/978-3-642-04747-3_20; Orman GK, 2010, 2010 INTERNATIONAL CONFERENCE ON ADVANCES IN SOCIAL NETWORKS ANALYSIS AND MINING (ASONAM 2010), P301, DOI 10.1109/ASONAM.2010.70; Orman GK, 2011, COMM COM INF SC, V167, P265; Palla G, 2010, P NATL ACAD SCI USA, V107, P7640, DOI 10.1073/pnas.0912983107; Palla K., 2012, P 29 INT C MACH LEAR, P1607; Poncela J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002449; Seshadhri C, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.056109; Vazquez A, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.056104; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wong LH, 2006, PHYSICA A, V360, P99, DOI 10.1016/j.physa.2005.04.029; Yang J, 2013, IEEE DATA MINING, P1151, DOI 10.1109/ICDM.2013.167; Zhou Y., 2009, PVLDB, V2, P718, DOI DOI 10.14778/1687627.1687709	47	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122777	10.1371/journal.pone.0122777	http://dx.doi.org/10.1371/journal.pone.0122777			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893834	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700016
J	Ziegler, D; Strom, A; Strassburger, K; Nowotny, B; Zahiragic, L; Nowotny, PJ; Carstensen-Kirberg, M; Herder, C; Szendroedi, J; Roden, M				Ziegler, Dan; Strom, Alexander; Strassburger, Klaus; Nowotny, Bettina; Zahiragic, Lejla; Nowotny, Peter J.; Carstensen-Kirberg, Maren; Herder, Christian; Szendroedi, Julia; Roden, Michael			Differential Patterns and Determinants of Cardiac Autonomic Nerve Dysfunction during Endotoxemia and Oral Fat Load in Humans	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; GLUCAGON-LIKE PEPTIDE-1; INFLAMMATORY RESPONSE; SYSTEMIC INFLAMMATION; INSULIN-RESISTANCE; VAGUS NERVE; ONSET; LIPOPOLYSACCHARIDE; ACTIVATION; TONE	The autonomic nervous system(ANS) plays an important role in regulating the metabolic homeostasis and controlling immune function. ANS alterations can be detected by reduced heart rate variability (HRV) in conditions like diabetes and sepsis. We determined the effects of experimental conditions mimicking inflammation and hyperlipidemia on HRV and heart rate (HR) in relation to the immune, metabolic, and hormonal responses resulting from these interventions. Sixteen lean healthy subjects received intravenous (i.v.) low-dose endotoxin (lipopolysaccharide [LPS]), i.v. fat, oral fat, and i.v. glycerol (control) for 6 hours, during which immune, metabolic, hormonal, and five HRV parameters (pNN50, RMSSD, low-frequency (LF) and high-frequency (HF) power, and LF/HF ratio) were monitored and energy metabolism and insulin sensitivity (M-value) were assessed. LPS infusion induced an increase (AUC) in HR and LF/HF ratio and decline in pNN50 and RMSSD, while oral fat resulted in elevated HR and a transient (hours 1-2) decrease in pNN50, RMSSD, and HF power. During LPS infusion, Delta IL-1ra levels and Delta IL-1ra and Delta IL-1 beta gene expression correlated positively with Delta LF/HF ratio and inversely with Delta RMSSD. During oral fat intake, Delta GLP-1 tended to correlate positively with Delta HR and inversely with Delta pNN50 and Delta RMSSD. Following LPS infusion, lipid oxidation correlated positively with HR and inversely with pNN50 and RMSSD, whereas HRV was not related to M-value. In conclusion, suppression of vagal tone and sympathetic predominance during endotoxemia are linked to anti-inflammatory processes and lipid oxidation but not to insulin resistance, while weaker HRV changes in relation to the GLP-1 response are noted during oral fat load.	[Ziegler, Dan; Strom, Alexander; Nowotny, Bettina; Zahiragic, Lejla; Nowotny, Peter J.; Carstensen-Kirberg, Maren; Herder, Christian; Szendroedi, Julia; Roden, Michael] Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany; [Ziegler, Dan; Zahiragic, Lejla; Szendroedi, Julia; Roden, Michael] Univ Hosp, Dept Endocrinol & Diabetol, Dusseldorf, Germany; [Ziegler, Dan; Strom, Alexander; Carstensen-Kirberg, Maren; Herder, Christian; Szendroedi, Julia; Roden, Michael] German Ctr Diabet Res DZD, Dusseldorf, Germany; [Strassburger, Klaus] Univ Dusseldorf, Inst Biometr & Epidemiol, German Diabet Ctr, Leibniz Ctr Diabet Res, Dusseldorf, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf; Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Ziegler, D (corresponding author), Univ Dusseldorf, Leibniz Ctr Diabet Res, German Diabet Ctr, Inst Clin Diabetol, Dusseldorf, Germany.	dan.ziegler@ddz.uni-duesseldorf.de	Roden, Michael/AAD-3843-2019	Nowotny, Bettina/0000-0002-0671-9644	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); European Foundation for the Study of Diabetes (EFSD Clinical Research Grant in the Field of Diabetes); German Research Foundation (Deutsche Forschungsgemeinschaft) [SFB 575]; German Diabetes Association ("Fett & Immunregulation"); German Center for Diabetes Research (DZD e.V.); National Institutes of Health [DK-49230, DK-085638, DK-45735]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK085638, R01DK049230, P30DK045735] Funding Source: NIH RePORTER	Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW); German Federal Ministry of Health (BMG); European Foundation for the Study of Diabetes (EFSD Clinical Research Grant in the Field of Diabetes); German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Diabetes Association ("Fett & Immunregulation"); German Center for Diabetes Research (DZD e.V.); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Ministry of Science and Research of the State of North Rhine-Westphalia (MIWF NRW) and the German Federal Ministry of Health (BMG) and in part by the European Foundation for the Study of Diabetes (EFSD Clinical Research Grant in the Field of Diabetes 2010), the German Research Foundation (Deutsche Forschungsgemeinschaft, SFB 575), the German Diabetes Association ("Fett & Immunregulation"), the German Center for Diabetes Research (DZD e.V.), and grants from the National Institutes of Health (DK-49230, DK-085638, and DK-45735). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006642; Alvarez SM, 2007, J ENDOTOXIN RES, V13, P358, DOI 10.1177/0968051907086465; Andreasen AS, 2008, CURR MED CHEM, V15, P1697, DOI 10.2174/092986708784872393; Annane D, 1999, AM J RESP CRIT CARE, V160, P458, DOI 10.1164/ajrccm.160.2.9810073; Bergman BC, 2009, AM J PHYSIOL-ENDOC M, V296, pE358, DOI 10.1152/ajpendo.90747.2008; Berkelaar M, 2013, DIABETOLOGIA, V56, P1436, DOI 10.1007/s00125-013-2848-6; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Camm AJ, 1996, CIRCULATION, V93, P1043; Czura CJ, 2005, J INTERN MED, V257, P156, DOI 10.1111/j.1365-2796.2004.01442.x; DRAKEHOLLAND AJ, 1984, TRANSPLANTATION, V38, P454, DOI 10.1097/00007890-198411000-00002; DRAKEHOLLAND AJ, 1989, CIRCULATION, V80, P1476, DOI 10.1161/01.CIR.80.5.1476; Elenkov IJ, 2000, PHARMACOL REV, V52, P595; Flanagan DE, 1999, J CLIN ENDOCR METAB, V84, P1263, DOI 10.1210/jc.84.4.1263; Griffioen KJ, 2011, CARDIOVASC RES, V89, P72, DOI 10.1093/cvr/cvq271; Herder C, 2013, DIABETES CARE, V36, P3663, DOI 10.2337/dc13-0382; Jan BU, 2010, SHOCK, V33, P363, DOI 10.1097/SHK.0b013e3181b66bf4; Jan BU, 2009, ANN SURG, V249, P750, DOI 10.1097/SLA.0b013e3181a40193; Kox M, 2014, P NATL ACAD SCI USA, V111, P7379, DOI 10.1073/pnas.1322174111; Kox M, 2011, SHOCK, V36, P115, DOI 10.1097/SHK.0b013e31821c2330; Kumar A, 2005, CRIT CARE MED, V33, P331, DOI 10.1097/01.CCM.0000152229.69180.2; Lindmark S, 2005, OBES RES, V13, P717, DOI 10.1038/oby.2005.81; Marsland AL, 2007, PSYCHOSOM MED, V69, P709, DOI 10.1097/PSY.0b013e3181576118; Michaeli B, 2012, CRIT CARE, V16, DOI 10.1186/cc11444; Molina-Holgado F, 2000, J NEUROIMMUNOL, V111, P1, DOI 10.1016/S0165-5728(00)00344-1; Murakami M, 2009, J NEUROSCI RES, V87, P2095, DOI 10.1002/jnr.22036; Nowotny B, 2013, DIABETES, V62, P2240, DOI 10.2337/db12-1179; Pagani M, 2012, EXP PHYSIOL, V97, P1141, DOI 10.1113/expphysiol.2012.066977; Pannacciulli N, 2006, AM J CLIN NUTR, V84, P556, DOI 10.1093/ajcn/84.3.556; Paolisso G, 2000, CLIN SCI, V98, P129, DOI 10.1042/cs0980129; Paolisso G, 2000, AM J CLIN NUTR, V72, P723; Pavlov VA, 2003, MOL MED, V9, P125, DOI 10.1007/BF03402177; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Sayk F, 2008, AM J PHYSIOL-REG I, V295, pR891, DOI 10.1152/ajpregu.90444.2008; Schirra J, 2000, GUT, V46, P622, DOI 10.1136/gut.46.5.622; Schmidt H, 2005, CRIT CARE MED, V33, P1994, DOI 10.1097/01.CCM.0000178181.91250.99; Schulte A, 2014, J SURG RES, V188, P480, DOI 10.1016/j.jss.2014.01.022; Stuckey MI, 2014, DIABETES-METAB RES, V30, P784, DOI 10.1002/dmrr.2555; Tateishi Y, 2007, SHOCK, V28, P549, DOI 10.1097/shk.0b013e3180638d1; Tracey KJ, 2007, J CLIN INVEST, V117, P289, DOI 10.1172/JCI30555; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Valensi P, 2013, DIABETOLOGIA, V56, P1196, DOI 10.1007/s00125-013-2909-x; van der Vusse GJ, 1998, CARDIOVASC RES, V37, P160, DOI 10.1016/S0008-6363(97)00220-4; vanderPoll T, 1996, J CLIN INVEST, V97, P713, DOI 10.1172/JCI118469; Vimercati C, 2012, J PHYSIOL-LONDON, V590, P6065, DOI 10.1113/jphysiol.2012.241943; Vinik AI, 2007, CIRCULATION, V115, P387, DOI 10.1161/CIRCULATIONAHA.106.634949	45	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124242	10.1371/journal.pone.0124242	http://dx.doi.org/10.1371/journal.pone.0124242			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893426	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700079
J	Chen, YB; Yang, WQ; Long, JY; Zhang, YH; Feng, JY; Li, YQ; Huang, BA				Chen, Yongbin; Yang, Wanqun; Long, Jinyi; Zhang, Yuhu; Feng, Jieying; Li, Yuanqing; Huang, Biao			Discriminative Analysis of Parkinson's Disease Based on Whole-Brain Functional Connectivity	PLOS ONE			English	Article							ALPHA-SYNUCLEIN LEVELS; PERMUTATION TESTS; MRI; FMRI; CLASSIFICATION; DIAGNOSIS; PATTERNS; NUCLEUS; SCHIZOPHRENIA; STIMULATION	Recently, there has been an increasing emphasis on applications of pattern recognition and neuroimaging techniques in the effective and accurate diagnosis of psychiatric or neurological disorders. In the present study, we investigated the whole-brain resting-state functional connectivity patterns of Parkinson's disease (PD), which are expected to provide additional information for the clinical diagnosis and treatment of this disease. First, we computed the functional connectivity between each pair of 116 regions of interest derived from a prior atlas. The most discriminative features based on Kendall tau correlation coefficient were then selected. A support vector machine classifier was employed to classify 21 PD patients with 26 demographically matched healthy controls. This method achieved a classification accuracy of 93.62% using leave-one-out cross-validation, with a sensitivity of 90.47% and a specificity of 96.15%. The majority of the most discriminative functional connections were located within or across the default mode, cingulo-opercular and frontal-parietal networks and the cerebellum. These disease-related resting-state network alterations might play important roles in the pathophysiology of this disease. Our results suggest that analyses of whole-brain resting-state functional connectivity patterns have the potential to improve the clinical diagnosis and treatment evaluation of PD.	[Chen, Yongbin; Long, Jinyi; Li, Yuanqing] S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou 510641, Guangdong, Peoples R China; [Yang, Wanqun; Feng, Jieying; Huang, Biao] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Radiol, Guangzhou, Guangdong, Peoples R China; [Zhang, Yuhu] Guangdong Acad Med Sci, Guangdong Gen Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China	South China University of Technology; Guangdong Academy of Medical Sciences & Guangdong General Hospital; Guangdong Academy of Medical Sciences & Guangdong General Hospital	Li, YQ (corresponding author), S China Univ Technol, Ctr Brain Comp Interfaces & Brain Informat Proc, Guangzhou 510641, Guangdong, Peoples R China.	auyqli@scut.edu.cn; cjr.huangbiao@vip.163.com			863 Program of China [2012AA011601]; National Foundation of Natural Science of China [91120305, 81471654]; Guangdong Province Science Foundation for Research Team Program	863 Program of China(National High Technology Research and Development Program of China); National Foundation of Natural Science of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science Foundation for Research Team Program	This work was supported by 863 Program of China (2012AA011601), the National Foundation of Natural Science of China (91120305 and 81471654), and the Guangdong Province Science Foundation for Research Team Program.	Abe O, 2010, PSYCHIAT RES-NEUROIM, V181, P64, DOI 10.1016/j.pscychresns.2009.07.007; Acton PD, 2006, PHYS MED BIOL, V51, P3057, DOI 10.1088/0031-9155/51/12/004; BENABID AL, 1991, LANCET, V337, P403, DOI 10.1016/0140-6736(91)91175-T; Benninger DH, 2009, J NEUROL, V256, P256, DOI 10.1007/s00415-009-0092-2; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Borghammer P, 2010, EUR J NEUROL, V17, P314, DOI 10.1111/j.1468-1331.2009.02807.x; Brefel-Courbon C, 2005, MOVEMENT DISORD, V20, P1557, DOI 10.1002/mds.20629; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Dosenbach NUF, 2008, TRENDS COGN SCI, V12, P99, DOI 10.1016/j.tics.2008.01.001; Dosenbach NUF, 2007, P NATL ACAD SCI USA, V104, P11073, DOI 10.1073/pnas.0704320104; Dosenbach NUF, 2010, SCIENCE, V329, P1358, DOI 10.1126/science.1194144; Ecker C, 2010, NEUROIMAGE, V49, P44, DOI 10.1016/j.neuroimage.2009.08.024; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Gottlich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077336; Golland P, 2003, LECT NOTES COMPUT SC, V2732, P330; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Hacker CD, 2012, BRAIN, V135, P3699, DOI 10.1093/brain/aws281; Imabayashi E, 2013, BRAIN BEHAV, V3, P487, DOI 10.1002/brb3.146; Jankovic J, 2008, J NEUROL NEUROSUR PS, V79, P368, DOI 10.1136/jnnp.2007.131045; Klement S, 2008, LECT NOTES COMPUT SC, V5163, P41, DOI 10.1007/978-3-540-87536-9_5; Liu H, 2013, PSYCHIAT RES-NEUROIM, V211, P64, DOI 10.1016/j.pscychresns.2012.10.007; Long D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047714; Lowe MJ, 1998, NEUROIMAGE, V7, P119, DOI 10.1006/nimg.1997.0315; Luo CY, 2014, NEUROBIOL AGING, V35, P431, DOI 10.1016/j.neurobiolaging.2013.08.018; Mourao-Miranda J, 2006, NEUROIMAGE, V33, P1055, DOI 10.1016/j.neuroimage.2006.08.016; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Ojala M, 2010, J MACH LEARN RES, V11, P1833; OWEN AM, 1992, BRAIN, V115, P1727, DOI 10.1093/brain/115.6.1727; Papapetropoulos S, 2007, PARKINSONISM RELAT D, V13, P308, DOI 10.1016/j.parkreldis.2006.06.009; Payoux P, 2004, ARCH NEUROL-CHICAGO, V61, P1307, DOI 10.1001/archneur.61.8.1307; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Salvatore C, 2014, J NEUROSCI METH, V222, P230, DOI 10.1016/j.jneumeth.2013.11.016; Sandrone S, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00261; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Shen H, 2010, NEUROIMAGE, V49, P3110, DOI 10.1016/j.neuroimage.2009.11.011; Singh S, 2014, NEURORADIOLOGY, V56, P413, DOI 10.1007/s00234-014-1325-3; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Szewczyk-Krolikowski K, 2014, NEUROLOGY, V83, P208, DOI 10.1212/WNL.0000000000000592; Tessitore A, 2012, NEUROLOGY, V79, P2226, DOI 10.1212/WNL.0b013e31827689d6; Van Dijk KRA, 2012, NEUROIMAGE, V59, P431, DOI 10.1016/j.neuroimage.2011.07.044; Westerlund M, 2008, FASEB J, V22, P3509, DOI 10.1096/fj.08-110148; Weygandt M, 2012, NEUROIMAGE, V60, P1186, DOI 10.1016/j.neuroimage.2012.01.064; Wu T, 2013, BRAIN, V136, P696, DOI 10.1093/brain/aws360; Wu T, 2012, NEUROSCI LETT, V524, P55, DOI 10.1016/j.neulet.2012.07.012; Xia MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068910; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Yu RJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059717; Zeng LL, 2014, HUM BRAIN MAPP, V35, P1630, DOI 10.1002/hbm.22278; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhu CZ, 2008, NEUROIMAGE, V40, P110, DOI 10.1016/j.neuroimage.2007.11.029	53	22	25	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124153	10.1371/journal.pone.0124153	http://dx.doi.org/10.1371/journal.pone.0124153			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885059	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000103
J	Deiteren, A; van der Linden, L; de Wit, A; Ceuleers, H; Buckinx, R; Timmermans, JP; Moreels, TG; Pelckmans, PA; De Man, JG; De Winter, BY				Deiteren, Annemie; van der Linden, Laura; de Wit, Anouk; Ceuleers, Hannah; Buckinx, Roeland; Timmermans, Jean-Pierre; Moreels, Tom G.; Pelckmans, Paul A.; De Man, Joris G.; De Winter, Benedicte Y.			P2X(3) Receptors Mediate Visceral Hypersensitivity during Acute Chemically-Induced Colitis and in the Post-Inflammatory Phase via Different Mechanisms of Sensitization	PLOS ONE			English	Article							RAT MODEL; NEUROPATHIC PAIN; MECHANOSENSORY TRANSDUCTION; COLORECTAL DISTENSION; ANTAGONIST; MICE; ATP; HYPERALGESIA; CONSTRICTION; A-317491	Objectives Experiments using P2X(3) knock-out mice or more general P2X receptor antagonists suggest that P2X(3) receptors contribute to visceral hypersensitivity. We aimed to investigate the effect of the selective P2X(3) antagonist A-317491 on visceral sensitivity under physiological conditions, during acute colitis and in the post-inflammatory phase of colitis. Methods Trinitrobenzene sulphonic-acid colitis was monitored by colonoscopy: on day 3 to confirm the presence of colitis and then every 4 days, starting from day 10, to monitor convalescence and determine the exact timepoint of endoscopic healing in each rat. Visceral sensitivity was assessed by quantifying visceromotor responses to colorectal distension in controls, rats with acute colitis and post-colitis rats. A-317491 was administered 30 min prior to visceral sensitivity testing. Expression of P2X(3) receptors (RT-PCR and immunohistochemistry) and the intracellular signalling molecules cdk5, csk and CASK (RT-PCR) were quantified in colonic tissue and dorsal root ganglia. ATP release in response to colorectal distension was measured by luminiscence. Results Rats with acute TNBS-colitis displayed significant visceral hypersensitivity that was dose-dependently, but not fully, reversed by A-317491. Hypersenstivity was accompanied by an increased colonic release of ATP. Post-colitis rats also displayed visceral hypersensitivity that was dose-dependently reduced and fully normalized by A-317491 without increased release of ATP. A-317491 did not modify visceral sensitivity in controls. P2X(3) mRNA and protein expression in the colon and dorsal root ganglia were similar in control, acute colitis and post-colitis groups, while colonic mRNA expression of cdk5, csk and CASK was increased in the post-colitis group only. Conclusions These findings indicate that P2X(3) receptors are not involved in sensory signaling under physiological conditions whereas they modulate visceral hypersensitivity during acute TNBS-colitis and even more so in the post-inflammatory phase, albeit via different mechanisms of sensitization, validating P2X(3) receptors as potential new targets in the treatment of abdominal pain syndromes.	[Deiteren, Annemie; van der Linden, Laura; de Wit, Anouk; Ceuleers, Hannah; Moreels, Tom G.; Pelckmans, Paul A.; De Man, Joris G.; De Winter, Benedicte Y.] Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium; [Buckinx, Roeland; Timmermans, Jean-Pierre] Univ Antwerp, Lab Cell Biol & Histol, B-2020 Antwerp, Belgium; [Moreels, Tom G.; Pelckmans, Paul A.] Univ Antwerp Hosp, Dept Gastroenterol & Hepatol, Antwerp, Belgium	University of Antwerp; University of Antwerp; University of Antwerp	De Winter, BY (corresponding author), Univ Antwerp, Div Gastroenterol, Lab Expt Med & Pediat, B-2020 Antwerp, Belgium.	benedicte.dewinter@uantwerpen.be	Buckinx, Roeland/G-9482-2011; De Winter, Benedicte Y/G-2616-2011; Deiteren, Annemie/J-4487-2014	Buckinx, Roeland/0000-0001-9976-2889; De Winter, Benedicte Y/0000-0003-0327-6304; Deiteren, Annemie/0000-0002-3841-8731; Ceuleers, Hannah/0000-0003-0477-150X; Timmermans, Jean-Pierre/0000-0003-2506-6252	Fund for Scientific Research Flanders [G.0341.13, G.0249.09N]; Fund for Scientific Research Flanders Community "Gastrointestinal regulatory mechanisms"	Fund for Scientific Research Flanders(FWO); Fund for Scientific Research Flanders Community "Gastrointestinal regulatory mechanisms"	AD is an aspirant of the Fund for Scientific Research Flanders (http://www.fwo.be). This work was supported financially by the Fund for Scientific Research Flanders G.0341.13 and G.0249.09N to BYDW and by the Fund for Scientific Research Flanders Community "Gastrointestinal regulatory mechanisms" (BYDW and JPT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad C, 2005, INFLAMM BOWEL DIS, V11, P674, DOI 10.1097/01.MIB.0000171872.70738.58; Bian XC, 2003, J PHYSIOL-LONDON, V551, P309, DOI 10.1113/jphysiol.2003.044172; Burnstock G, 2001, TRENDS PHARMACOL SCI, V22, P182, DOI 10.1016/S0165-6147(00)01643-6; Burnstock Geoffrey, 2009, Handb Exp Pharmacol, P333, DOI 10.1007/978-3-540-79090-7_10; Cauwels A, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.70; Cavaliere F, 2007, J PHARMACOL EXP THER, V323, P70, DOI 10.1124/jpet.106.119024; Cockayne DA, 2005, J PHYSIOL-LONDON, V567, P621, DOI 10.1113/jphysiol.2005.088435; De Schepper HU, 2008, ALIMENT PHARM THER, V27, P621, DOI 10.1111/j.1365-2036.2008.03624.x; Deiteren A, 2014, GUT, V63, P1873, DOI 10.1136/gutjnl-2013-305870; Deiteren A, 2014, STRESS, V17, P431, DOI 10.3109/10253890.2014.951034; Ford AP, 2012, PURINERG SIGNAL, V8, pS3, DOI 10.1007/s11302-011-9271-6; Ford APDW, 2006, BRIT J PHARMACOL, V147, pS132, DOI 10.1038/sj.bjp.0706637; Galligan JJ, 2004, BRIT J PHARMACOL, V141, P1294, DOI 10.1038/sj.bjp.0705761; Honore P, 2002, PAIN, V96, P99, DOI 10.1016/S0304-3959(01)00434-1; Hsieh YL, 2012, EXP NEUROL, V235, P316, DOI 10.1016/j.expneurol.2012.02.013; Jarvis MF, 2002, P NATL ACAD SCI USA, V99, P17179, DOI 10.1073/pnas.252537299; Jones RCW, 2005, J NEUROSCI, V25, P10981, DOI 10.1523/JNEUROSCI.0703-05.2005; Kreis ME, 1998, AM J PHYSIOL-GASTR L, V275, pG675, DOI 10.1152/ajpgi.1998.275.4.G675; Longstreth GF, 2006, GASTROENTEROLOGY, V130, P1480, DOI 10.1053/j.gastro.2005.11.061; Ma B, 2011, PURINERG SIGNAL, V7, P73, DOI 10.1007/s11302-010-9212-9; Matricon J, 2013, NEUROGASTROENT MOTIL, V25, pE740, DOI 10.1111/nmo.12199; NESS TJ, 1988, BRAIN RES, V450, P153, DOI 10.1016/0006-8993(88)91555-7; Noma N, 2013, J DENT RES, V92, P456, DOI 10.1177/0022034513483770; Robinson DR, 2004, NEUROGASTROENT MOTIL, V16, P113, DOI 10.1046/j.1365-2982.2003.00456.x; Rong W, 2009, NEUROGASTROENT MOTIL, V21, DOI 10.1111/j.1365-2982.2008.01259.x; Sharp CJ, 2006, BRIT J PHARMACOL, V148, P845, DOI 10.1038/sj.bjp.0706790; Shinoda M, 2010, J NEUROPHYSIOL, V104, P3113, DOI 10.1152/jn.00560.2010; Shinoda M, 2009, GASTROENTEROLOGY, V137, P2096, DOI 10.1053/j.gastro.2009.06.048; Spiller R, 2009, GASTROENTEROLOGY, V136, P1979, DOI 10.1053/j.gastro.2009.02.074; Van Crombruggen K, 2007, NEUROPHARMACOLOGY, V53, P257, DOI 10.1016/j.neuropharm.2007.05.010; Vermeulen W, 2011, ACTA GASTRO-ENT BELG, V74, P304; Vermeulen W, 2014, WORLD J GASTROENTERO, V20, P1005, DOI 10.3748/wjg.v20.i4.1005; Vermeulen W, 2013, EUR J PHARMACOL, V698, P404, DOI 10.1016/j.ejphar.2012.10.014; Volonte C, 2013, J NEUROCHEM, V126, P1, DOI 10.1111/jnc.12282; WALLACE JL, 1990, AM J PHYSIOL, V258, pG527, DOI 10.1152/ajpgi.1990.258.4.G527; Wu G, 2004, EUR J PHARMACOL, V504, P45, DOI 10.1016/j.ejphar.2004.09.056; Wynn G, 2004, AM J PHYSIOL-GASTR L, V287, pG647, DOI 10.1152/ajpgi.00020.2004; Wynn G, 2003, GASTROENTEROLOGY, V125, P1398, DOI 10.1016/j.gastro.2003.07.008; Wynn Gregory, 2006, Purinergic Signal, V2, P517, DOI 10.1007/s11302-005-5305-2; Xu GY, 2008, GUT, V57, P1230, DOI 10.1136/gut.2007.134221; Yiangou Y, 2001, NEUROGASTROENT MOTIL, V13, P365, DOI 10.1046/j.1365-2982.2001.00276.x; Yiangou YG, 2001, EUR J GASTROEN HEPAT, V13, P891, DOI 10.1097/00042737-200108000-00003	42	40	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123810	10.1371/journal.pone.0123810	http://dx.doi.org/10.1371/journal.pone.0123810			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885345	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000084
J	Denrell, J; Kovacs, B				Denrell, Jerker; Kovacs, Balazs			The Effect of Selection Bias in Studies of Fads and Fashions	PLOS ONE			English	Article							DIFFUSION; MODEL	Most studies of fashion and fads focus on objects and practices that once were popular. We argue that limiting the sample to such trajectories generates a selection bias that obscures the underlying process and generates biased estimates. Through simulations and the analysis of a data set that has previously not been used to analyze the rise and fall of cultural practices, the New York Times text archive, we show that studying a whole range of cultural objects, both popular and less popular, is essential for understanding the drivers of popularity. In particular, we show that estimates of statistical models of the drivers of popularity will be biased if researchers use only trajectories of those practices that once were popular.	[Denrell, Jerker] Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England; [Kovacs, Balazs] Univ Svizzera Italiana, Inst Management, Lugano, Switzerland	University of Warwick; Universita della Svizzera Italiana	Denrell, J (corresponding author), Univ Warwick, Warwick Business Sch, Coventry CV4 7AL, W Midlands, England.	Jerker.Denrell@wbs.ac.uk; kovacsb@usi.ch		Denrell, Jerker/0000-0001-9628-1924				Abrahamson E, 1996, ACAD MANAGE REV, V21, P254, DOI 10.2307/258636; Abrahamson E, 2008, ADMIN SCI QUART, V53, P719, DOI 10.2189/asqu.53.4.719; Acerbi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032541; Bailey NTJ, 1957, MATH THEORY EPIDEMIC; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; BASS FM, 1969, MANAGE SCI, V15, P215, DOI 10.1287/mnsc.15.5.215; BECKER GS, 1991, J POLIT ECON, V99, P1109, DOI 10.1086/261791; Berger J, 2009, P NATL ACAD SCI USA, V106, P8146, DOI 10.1073/pnas.0812647106; BIKHCHANDANI S, 1992, J POLIT ECON, V100, P992, DOI 10.1086/261849; Bourdieu P., 1984, DISTINCTION SOCIAL C; BREWER MB, 1991, PERS SOC PSYCHOL B, V17, P475, DOI 10.1177/0146167291175001; Cadavid L, 2014, ADV INTELL SYST, V229, P73, DOI 10.1007/978-3-642-39829-2_7; Carroll G., 2000, DEMOGRAPHY CORPORATI; CHANDLER A.D., 1962, STRATEGY STRUCTURE; Cojocaru MG, 2013, ENVIRON MODELL SOFTW, V50, P169, DOI 10.1016/j.envsoft.2013.06.008; Coleman J. S., 1964, INTRO MATH SOCIOLOGY; Cowan R, 2004, CAN J ECON, V37, P149, DOI 10.1111/j.0008-4085.2004.008_1.x; David RJ, 2006, ACAD MANAGE J, V49, P215, DOI 10.2307/20159761; Denrell J, 2008, ADMIN SCI QUART, V53, P109, DOI 10.2189/asqu.53.1.109; DEUTSCH MORTON, 1955, JOUR ABNORMAL AND SOCIAL PSYCHOL, V51-31, P629, DOI 10.1037/h0046408; Etzion D, 2013, ORGAN SCI, V25, P420; Fast NJ, 2009, PSYCHOL SCI, V20, P904, DOI 10.1111/j.1467-9280.2009.02387.x; Festinger L, 1963, SOCIAL PRESSURES INF; GRANOVETTER M, 1978, AM J SOCIOL, V83, P1420, DOI 10.1086/226707; Gureckis TM, 2009, TOP COGN SCI, V1, P651, DOI 10.1111/j.1756-8765.2009.01046.x; Hamer, 1906, MILROY LECT EPIDEMIC; Hedstrom P., 2005, DISSECTING SOCIAL; Holtz G, 2014, JASSS-J ARTIF SOC S, V17, DOI 10.18564/jasss.2333; Jonsson S, 2009, ORGAN SCI, V20, P172, DOI 10.1287/orsc.1080.0370; Lieberson S., 2000, MATTER TASTE NAMES F; Lomi A, 2005, MANAGE SCI, V51, P882, DOI 10.1287/mnsc.1050.0364; Mahajan V., 1985, MODELS INNOVATION DI; MILLER CM, 1993, J MARKETING RES, V30, P142, DOI 10.2307/3172824; NAUS JI, 1966, J AM STAT ASSOC, V61, P1191, DOI 10.2307/2283208; ROBINSON DE, 1976, AM J SOCIOL, V81, P1133, DOI 10.1086/226188; Rogers E.M., 2003, DIFFUSION INNOVATION, V5th ed; Ruef M, 2004, IND CORP CHANGE, V13, P61, DOI 10.1093/icc/13.1.61; Saavedra S, 2008, P NATL ACAD SCI USA, V105, P16466, DOI 10.1073/pnas.0804740105; Schelling T., 1978, MICROMOTIVES MACROBE; Sterman J.D., 2000, BUSINESS DYNAMICS, DOI DOI 10.4324/9781351152723-7; Strang D, 1998, ANNU REV SOCIOL, V24, P265, DOI 10.1146/annurev.soc.24.1.265; Strang D, 2001, AM J SOCIOL, V107, P147, DOI 10.1086/323039; Veblen Thorstein., 1912, THEORY LEISURE CLASS; WALLENSTEIN S, 1980, AM J EPIDEMIOL, V111, P367, DOI 10.1093/oxfordjournals.aje.a112908; Watts DJ, 2002, P NATL ACAD SCI USA, V99, P5766, DOI 10.1073/pnas.082090499; Weng L., 2012, SCI REPORTS, V2; Wood W, 2000, ANNU REV PSYCHOL, V51, P539, DOI 10.1146/annurev.psych.51.1.539; Zipf G. K., 1949, HUMAN BEHAV PRINCIPL	48	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123471	10.1371/journal.pone.0123471	http://dx.doi.org/10.1371/journal.pone.0123471			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886158	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000070
J	Iglesias, V; Krause, TR; Whitlock, C				Iglesias, Virginia; Krause, Teresa R.; Whitlock, Cathy			Complex Response of White Pines to Past Environmental Variability Increases Understanding of Future Vulnerability	PLOS ONE			English	Article							SUB-ALPINE FORESTS; YELLOWSTONE-NATIONAL-PARK; WIND RIVER RANGE; CLIMATE-CHANGE; MODERN POLLEN; VEGETATION; HOLOCENE; RECORDS; CONSERVATION; DISTURBANCE	Ecological niche models predict plant responses to climate change by circumscribing species distributions within a multivariate environmental framework. Most projections based on modern bioclimatic correlations imply that high-elevation species are likely to be extirpated from their current ranges as a result of rising growing-season temperatures in the coming decades. Paleoecological data spanning the last 15,000 years from the Greater Yellow-stone region describe the response of vegetation to past climate variability and suggest that white pines, a taxon of special concern in the region, have been surprisingly resilient to high summer temperature and fire activity in the past. Moreover, the fossil record suggests that winter conditions and biotic interactions have been critical limiting variables for high-elevation conifers in the past and will likely be so in the future. This long-term perspective offers insights on species responses to a broader range of climate and associated ecosystem changes than can be observed at present and should be part of resource management and conservation planning for the future.	[Iglesias, Virginia; Whitlock, Cathy] Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA; [Krause, Teresa R.; Whitlock, Cathy] Montana State Univ, Dept Earth Sci, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Iglesias, V (corresponding author), Montana State Univ, Montana Inst Ecosyst, Bozeman, MT 59717 USA.	virginia.iglesias@msu.montana.edu		Iglesias, Virginia/0000-0001-5732-3714	National Science Foundation [0818467, 0966472]; Yellowstone National Park; United States Geological Survey North-Central Climate Science Center; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Yellowstone National Park; United States Geological Survey North-Central Climate Science Center; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	Funding for the research came from the National Science Foundation (http://www.nsf.gov, grant numbers 0818467 and 0966472), Yellowstone National Park (http://www.yellowstonenationalpark.com), and United States Geological Survey North-Central Climate Science Center (https://nccwsc.usgs.gov/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Akima H., 1978, ACM Transactions on Mathematical Software, V4, P148, DOI 10.1145/355780.355786; Alder J, 2014, CLIM PAST DISCUSS, V10, P2925; [Anonymous], 2014, R LANG ENV STAT COMP; Arno S, 1986, WEST J APPL FOR, V1, P92, DOI DOI 10.1093/WJAF/1.3.92; Baker R, 1976, 279E US GEOL SURV; Bennett KD, 2001, TRACKING ENV CHANGE, V3, P5, DOI DOI 10.1007/0-306-47668-1_2; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Blarquez O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065852; Brunelle A, 2008, FOREST ECOL MANAG, V255, P836, DOI 10.1016/j.foreco.2007.10.008; Burnham KP, 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.1007/978-1-4757-2917-7, DOI 10.1007/978-1-4757-2917-7]; Callaway RM, 1998, OIKOS, V82, P561, DOI 10.2307/3546376; Chang T, PLOS ONE; Davis MB, 2000, ANNU REV EARTH PL SC, V28, P1, DOI 10.1146/annurev.earth.28.1.1; Dawson TP, 2011, SCIENCE, V332, P53, DOI 10.1126/science.1200303; FALL PL, 1994, ARCTIC ALPINE RES, V26, P383, DOI 10.2307/1551800; Genries A, 2009, ECOSCIENCE, V16, P13, DOI 10.2980/16-1-3180; Greater Yellowstone Coordinating Committee Whitebark Pine Subcommi.ttee, 2011, WHIT PIN STRAT GREAT; Higuera PE, 2014, J ECOL, V102, P1429, DOI 10.1111/1365-2745.12296; Higuera PE, 2011, HOLOCENE, V21, P327, DOI 10.1177/0959683610374882; Huerta MA, 2009, PALAEOGEOGR PALAEOCL, V271, P170, DOI 10.1016/j.palaeo.2008.10.015; HUTCHINSON GE, 1957, COLD SPRING HARB SYM, V22, P415, DOI 10.1101/SQB.1957.022.01.039; Iglesias V, 2014, P NATL ACAD SCI US; Jewett JT, 2011, FOREST SCI, V57, P320; Johnson K.A., 2001, FIRE EFFECTS INFORM; Keane R.E., 2001, WHITEBARK PINE COMMU, P89; Kendall C, 1995, STATUS TRENDS NATION; Kendall K, 1996, NUTCRACKER NOTES, V7, P23; Krause T, PALAEOGEOG PALAEOCLI; Krause TR, 2013, QUATERNARY RES, V79, P391, DOI 10.1016/j.yqres.2013.01.005; Leung LR, 2004, CLIMATIC CHANGE, V62, P75, DOI 10.1023/B:CLIM.0000013692.50640.55; Logan JA, 1999, ENVIRON ENTOMOL, V28, P924, DOI 10.1093/ee/28.6.924; Logan JA, 2010, ECOL APPL, V20, P895, DOI 10.1890/09-0655.1; Lotan J.E., 1990, SILVICS N AM, V654, P302, DOI DOI 10.2307/j.ctt1ffjhpb.19; Lynch EA, 1998, ECOLOGY, V79, P1320, DOI 10.1890/0012-9658(1998)079[1320:OOAPFV]2.0.CO;2; MARKGRAF V, 1980, Grana, V19, P127; Marlon J. R., 2012, P NATL ACAD SCI USA, V109, P3203; Millspaugh S, 1997, THESIS U OREGON; Minckley TA, 2008, QUATERNARY SCI REV, V27, P1962, DOI 10.1016/j.quascirev.2008.07.006; Minore D, 1979, PNW87 USFS; Mote P, 2013, US NATL CLIMATE ASSE; Mote PW, 2006, J CLIMATE, V19, P6209, DOI 10.1175/JCLI3971.1; Ortu E, 2006, J QUATERNARY SCI, V21, P615, DOI 10.1002/jqs.998; PRENTICE IC, 1985, QUATERNARY RES, V23, P76, DOI 10.1016/0033-5894(85)90073-0; Ryan WBF, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2008GC002332; Schrag AM, 2008, J BIOGEOGR, V35, P698, DOI 10.1111/j.1365-2699.2007.01815.x; Steele R, 1990, SILVICS N AM, V1, P699; Swetnam TW, 1998, J CLIMATE, V11, P3128, DOI 10.1175/1520-0442(1998)011<3128:MDAERT>2.0.CO;2; Temperli C, 2013, ECOL MONOGR, V83, P383, DOI 10.1890/12-1503.1; Tomback D. F., 1986, MADRONO, V33, P100; Westerling AL, 2011, P NATL ACAD SCI USA, V108, P13165, DOI 10.1073/pnas.1110199108; WHITLOCK C, 1993, QUATERNARY RES, V39, P231, DOI 10.1006/qres.1993.1026; WHITLOCK C, 1993, ECOL MONOGR, V63, P173, DOI 10.2307/2937179; Whitlock C, 2001, TRACKING ENV CHANGE, P75, DOI DOI 10.1007/0-306-47668-1_5; Whitlock C, 2012, PALAEOGEOGR PALAEOCL, V331, P90, DOI 10.1016/j.palaeo.2012.03.001; Wood SN, 2011, J R STAT SOC B, V73, P3, DOI 10.1111/j.1467-9868.2010.00749.x	56	17	17	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124439	10.1371/journal.pone.0124439	http://dx.doi.org/10.1371/journal.pone.0124439			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885810	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000128
J	Ma, TT; Wang, H; Wang, C; Chang, DY; Zhao, MH; Chen, M				Ma, Tian-Tian; Wang, Huan; Wang, Chen; Chang, Dong-Yuan; Zhao, Ming-Hui; Chen, Min			Urinary Levels of High Mobility Group Box-1 Are Associated with Disease Activity in Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis	PLOS ONE			English	Article							CHROMATIN PROTEIN; HMGB1; INFLAMMATION; CLASSIFICATION; RECEPTOR; MARKER	Background High mobility group box-1 (HMGB1), a kind of pro-inflammatory mediator, is associated with inflammatory conditions and tissue damage. Our previous study demonstrated that the circulating levels of HMGB1 correlated with disease activity of antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). In the current study, we aimed to measure urinary levels of HMGB1 in AAV patients, correlated them to clinical activity index and analysed the immunohistochemical HMGB1 staining in kidney specimens. Methods 50 patients with AAV in active stage and 56 patients with AAV in remission were recruited. The urinary levels of HMGB1 were determined by enzyme-linked immunosorbent assay. Moreover, renal biopsy specimens from 27 patients with active AAV were randomly collected to evaluate the deposition of HMGB1. Results Urinary HMGB1 levels in AAV patients in active stage were significantly higher than those in AAV patients in remission and healthy controls (1.46 [0.56-3.43] versus 0.38 [0.10-1.35] mg/mu molCr, P= 0.001; 1.46 [0.56-3.43] versus 0.48 [0.40-0.60] mg/mu molCr, P= 0.000, respectively). Further analysis found that urinary levels of HMGB1 correlated with erythrocyte sedimentation rate (r=0.354, p=0.012), C-reactive protein (r=0.289, p=0.042), and Birmingham Vasculitis Activity Score (r=0.350, p=0.013). Renal tissue of active AAV patients showed HMGB1 was mainly expressed in the cytoplasm and the extracellular space. The percentage of HMGB1-negative nuclei in renal tissue of patients with active AAV was significantly higher than that in normal controls (60.6 +/- 20.2 % versus 2.7 +/- 0.6 %, p<0.01). Conclusion Urinary levels of HMGB1 may be associated with the disease activity in AAV patients.	[Ma, Tian-Tian; Wang, Huan; Wang, Chen; Chang, Dong-Yuan; Zhao, Ming-Hui; Chen, Min] Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China	Peking University	Chen, M (corresponding author), Peking Univ, Div Renal, Dept Med, Hosp 1, Beijing 100871, Peoples R China.	chenmin74@sina.com			Chinese 973 project [2012CB517702]; Research Fund for the Doctoral Program of Higher Education of China [20120001110018]; National Natural Science Fund [81425008, 81321064, 81300599]; "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China [2011BAI10B04]	Chinese 973 project(National Basic Research Program of China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Natural Science Fund(National Natural Science Foundation of China (NSFC)); "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China	This study is supported by a grant of Chinese 973 project (No. 2012CB517702), the Research Fund for the Doctoral Program of Higher Education of China (No. 20120001110018), three grants of the National Natural Science Fund (No. 81425008, No. 81321064 and No. 81300599), and the "National Key Technology Research and Development (R&D) Program" of the Ministry of Science and Technology of China (No. 2011BAI10B04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdulahad DA, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar4015; Bajema IM, 1999, KIDNEY INT, V56, P1751, DOI 10.1046/j.1523-1755.1999.00758.x; Berden AE, 2010, J AM SOC NEPHROL, V21, P1628, DOI 10.1681/ASN.2010050477; Bruchfeld A, 2011, MOL MED, V17, P29, DOI 10.2119/molmed.2010.00132; Chen Y, 2013, RHEUMATOLOGY, V52, P1739, DOI 10.1093/rheumatology/ket134; de Souza AWS, 2014, CLIN EXP IMMUNOL, V178, P270, DOI 10.1111/cei.12422; Degryse B, 2001, J CELL BIOL, V152, P1197, DOI 10.1083/jcb.152.6.1197; Harris HE, 2004, EUR J IMMUNOL, V34, P1503, DOI 10.1002/eji.200424916; Hauer HA, 2002, KIDNEY INT, V61, P80, DOI 10.1046/j.1523-1755.2002.00089.x; Hellmich B, 2007, ANN RHEUM DIS, V66, P605, DOI 10.1136/ard.2006.062711; Henes FO, 2011, ANN RHEUM DIS, V70, P1926, DOI 10.1136/ard.2010.146456; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Jayne D, 2009, NEPHROLOGY, V14, P42, DOI 10.1111/j.1440-1797.2009.01101.x; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; LUQMANI RA, 1994, Q J MED, V87, P671; Muller S, 2001, EMBO J, V20, P4337, DOI 10.1093/emboj/20.16.4337; Park JS, 2004, J BIOL CHEM, V279, P7370, DOI 10.1074/jbc.M306793200; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; de Souza AWS, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4284; Urbonaviciute V, 2011, J INTERN MED, V270, P309, DOI 10.1111/j.1365-2796.2011.02432.x; Vitali R, 2011, AM J GASTROENTEROL, V106, P2029, DOI 10.1038/ajg.2011.231; Wang C, 2013, ARTHRIT CARE RES, V65, P1828, DOI 10.1002/acr.22187	24	11	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123586	10.1371/journal.pone.0123586	http://dx.doi.org/10.1371/journal.pone.0123586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884225	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000076
J	Ruiz, MA; Feng, B; Chakrabarti, S				Ruiz, Michael Anthony; Feng, Biao; Chakrabarti, Subrata			Polycomb Repressive Complex 2 Regulates MiR-200b in Retinal Endothelial Cells: Potential Relevance in Diabetic Retinopathy	PLOS ONE			English	Article							ZESTE HOMOLOG 2; OXIDATIVE STRESS; VASCULAR COMPLICATIONS; EPIGENETIC REGULATION; SUPPRESSOR MICRORNAS; HISTONE METHYLATION; EZH2; GLUCOSE; GENES; EXPRESSION	Glucose-induced augmented vascular endothelial growth factor (VEGF) production is a key event in diabetic retinopathy. We have previously demonstrated that downregulation of miR-200b increases VEGF, mediating structural and functional changes in the retina in diabetes. However, mechanisms regulating miR-200b in diabetes are not known. Histone methyltransferase complex, Polycomb Repressive Complex 2 (PRC2), has been shown to repress miRNAs in neoplastic process. We hypothesized that, in diabetes, PRC2 represses miR-200b through its histone H3 lysine-27 trimethylation mark. We show that human retinal microvascular endothelial cells exposed to high levels of glucose regulate miR-200b repression through histone methylation and that inhibition of PRC2 increases miR-200b while reducing VEGF. Furthermore, retinal tissue from animal models of diabetes showed increased expression of major PRC2 components, demonstrating in vivo relevance. This research established a repressive relationship between PRC2 and miR-200b, providing evidence of a novel mechanism of miRNA regulation through histone methylation.	[Ruiz, Michael Anthony; Feng, Biao; Chakrabarti, Subrata] Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada	Western University (University of Western Ontario)	Chakrabarti, S (corresponding author), Univ Western Ontario, Dept Pathol & Lab Med, London, ON, Canada.	subrata.chakrabarti@lhsc.on.ca		Chakrabarti, Subrata/0000-0002-0208-1401	Canadian Diabetes Association; Heart and Stroke Foundation of Ontario	Canadian Diabetes Association; Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario)	This research was supported in parts by grants from the Canadian Diabetes Association (Operating Grant 2010-2013) and the Heart and Stroke Foundation of Ontario (Grant-in-Aid competition 2013/2014). Specifically, these grants were received by SC to carry out the experiments in this research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of manuscript.	Aiello LP, 2014, DIABETES CARE, V37, P17, DOI 10.2337/dc13-2251; American Diabetes Association, 2002, DIABETES CARE, V25, pS28, DOI [10.2337/diacare.25.2007.S28, DOI 10.2337/DIACARE.25.2007.S28]; Au SLK, 2012, HEPATOLOGY, V56, P622, DOI 10.1002/hep.25679; Bao B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043726; Bao B, 2012, CANCER RES, V72, P335, DOI 10.1158/0008-5472.CAN-11-2182; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chadwick BP, 2003, DEV CELL, V4, P445, DOI 10.1016/S1534-5807(03)00097-2; Chang CJ, 2012, BRIT J CANCER, V106, P243, DOI 10.1038/bjc.2011.551; Cheng XD, 2010, BIOCHEMISTRY-US, V49, P2999, DOI 10.1021/bi100213t; Chistiakov DA, 2011, DIABETES METAB SYND, V5, P165, DOI 10.1016/j.dsx.2012.02.025; Chronopoulos A, 2011, CURR EYE RES, V36, P747, DOI 10.3109/02713683.2011.585735; Davidson JA, 2007, ENDOCRINE, V32, P107, DOI 10.1007/s12020-007-0040-9; Deb G, 2013, EPIGENETICS-US, V8, P464, DOI 10.4161/epi.24532; Di Croce L, 2013, NAT STRUCT MOL BIOL, V20, P1147, DOI 10.1038/nsmb.2669; Dreger H, 2012, HYPERTENSION, V60, P1176, DOI 10.1161/HYPERTENSIONAHA.112.191098; Evans JL, 2003, DIABETES, V52, P1, DOI 10.2337/diabetes.52.1.1; Feng BA, 2011, DIABETES, V60, P2975, DOI 10.2337/db11-0478; Feng B, 2012, BIOMED PHARMACOTHER, V66, P397, DOI 10.1016/j.biopha.2012.06.002; Schoof CRG, 2012, AM J CANCER RES, V2, P414; Giacco F, 2010, CIRC RES, V107, P1058, DOI 10.1161/CIRCRESAHA.110.223545; Ho L, 2008, CELL STEM CELL, V3, P577, DOI 10.1016/j.stem.2008.11.007; Huang A, 2012, DIABETES, V61, P3181, DOI 10.2337/db12-0559; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kotake Y, 2011, ONCOGENE, V30, P1956, DOI 10.1038/onc.2010.568; Kumar M, 2012, PROTEIN CELL, V3, P726, DOI 10.1007/s13238-012-2055-0; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lu CH, 2010, CANCER CELL, V18, P185, DOI 10.1016/j.ccr.2010.06.016; Ma EB, 2012, J MOL BIOL, V422, P466, DOI 10.1016/j.jmb.2012.06.009; McArthur K, 2011, DIABETES, V60, P1314, DOI 10.2337/db10-1557; Miranda TB, 2009, MOL CANCER THER, V8, P1579, DOI 10.1158/1535-7163.MCT-09-0013; MUECKLER M, 1994, EUR J BIOCHEM, V219, P713, DOI 10.1111/j.1432-1033.1994.tb18550.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Okabe J, 2012, CIRC RES, V110, P1067, DOI 10.1161/CIRCRESAHA.112.266171; RUDNEY HARRY, 1940, SCIENCE, V92, P112, DOI 10.1126/science.92.2379.112; Ruiz MA, 2013, CAN J DIABETES, V37, P339, DOI 10.1016/j.jcjd.2013.07.003; Son SM, 2012, DIABETES METAB J, V36, P190, DOI 10.4093/dmj.2012.36.3.190; Syreeni A, 2011, DIABETES, V60, P3073, DOI 10.2337/db11-0073; Tan JZ, 2014, ACTA PHARMACOL SIN, V35, P161, DOI 10.1038/aps.2013.161; Tousoulis Dimitris, 2011, Recent Pat Cardiovasc Drug Discov, V6, P103; Villeneuve LM, 2008, P NATL ACAD SCI USA, V105, P9047, DOI 10.1073/pnas.0803623105; Vrba L, 2011, GENOME RES, V21, P2026, DOI 10.1101/gr.123935.111; Yamagishi S, 2009, THER APHER DIAL, V13, P534, DOI 10.1111/j.1744-9987.2009.00775.x; Yan JQ, 2012, CELL MOL LIFE SCI, V69, P115, DOI 10.1007/s00018-011-0731-5; Zourek M, 2008, PHYSIOL RES, V57, P531, DOI 10.33549/physiolres.931255	48	58	60	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123987	10.1371/journal.pone.0123987	http://dx.doi.org/10.1371/journal.pone.0123987			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884496	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000098
J	Satirapoj, B; Tassanasorn, S; Charoenpitakchai, M; Supasyndh, O				Satirapoj, Bancha; Tassanasorn, Surat; Charoenpitakchai, Mongkon; Supasyndh, Ouppatham			Periostin as a Tissue and Urinary Biomarker of Renal Injury in Type 2 Diabetes Mellitus	PLOS ONE			English	Article							MESENCHYMAL TRANSITION; DISEASE; BETA	Background Improving the early detection of diabetic nephropathy remains a great challenge in disease management. Periostin is a marker of renal tubular injury and related to progressive kidney injury in animal models of chronic kidney disease. The clinical implications of urinary periostin activities in patients with type 2 diabetes have not been evaluated. Methods Urine samples were obtained from 30 healthy volunteers and 328 type 2 diabetic patients with normoalbuminuria (n=114), microalbuminuria (n=100) and macroalbuminuria (n=114). The excretion levels of urinary periostin were quantified with enzyme-linked immunosorbent assay. Immunohistochemical periostin expression was determined in kidney tissues from overt diabetic nephropathy. Results Increased periostin expression in glomeruli and tubular epithelium in diabetic renal pathology was observed. Urinary periostin levels were significantly elevated in the patients of the normoalbuminuria [3.06 (IQR: 1.12, 6.77) ng/mgCr], microalbuminuria [8.71 (IQR: 5.09, 19.29) ng/mgCr] and macroalbuminuria [13.58 (IQR: 3.99, 16.19) ng/mgCr] compared with healthy controls [1.15 (IQR: 0.60, 1.63) ng/mgCr] (P<0.01). Increased urine periostin level significantly correlated with aging, high albuminuria and decline of GFR. Urine periostin ELISA also demonstrated high performance for the diagnosis of established normoalbuminuric, microalbuminuric and macroalbuminuric type 2 diabetes (AUC 0.78 (95%CI, 0.71 to associated renal derangement in patients with established diabetic nephropathy and it may be used as an early marker of diabetic renal injury.0.86), 0.99 (95%CI, 0.98 to 1.00) and 0.95 (95%CI, 0.91 to 0.98), respectively). Conclusion The study indicates that increased urine periostin levels can be detected in patients with type 2 diabetes before the onset of significant albuminuria. Urinary periostin is an associated renal derangement in patients with established diabetic nephropathy and it may be used as an early marker of diabetic renal injury.	[Satirapoj, Bancha; Tassanasorn, Surat; Supasyndh, Ouppatham] Phramongkutklao Hosp & Coll Med, Dept Med, Div Nephrol, Bangkok, Thailand; [Charoenpitakchai, Mongkon] Ph ramongkutklao Hosp & Coll Med, Dept Pathol, Bangkok, Thailand	Phramongkutklao College of Medicine; Phramongkutklao Hospital; Phramongkutklao Hospital	Satirapoj, B (corresponding author), Phramongkutklao Hosp & Coll Med, Dept Med, Div Nephrol, Bangkok, Thailand.	satirapoj@yahoo.com			Phramongkutklao Hospital; College of Medicine; National Science and Technology Development Agency (NSTDA), Thailand [P-13-00505]	Phramongkutklao Hospital; College of Medicine; National Science and Technology Development Agency (NSTDA), Thailand	The authors are grateful for grant support from Phramongkutklao Hospital and College of Medicine and the National Science and Technology Development Agency (NSTDA, P-13-00505), Thailand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER S, 1986, AM J PATHOL, V123, P553; Bitzer M, 1998, KIDNEY BLOOD PRESS R, V21, P1, DOI 10.1159/000025837; FIORETTO P, 1995, KIDNEY INT, V48, P1929, DOI 10.1038/ki.1995.493; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Gordon ED, 2012, CLIN EXP ALLERGY, V42, P144, DOI 10.1111/j.1365-2222.2011.03840.x; Guerrot D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031974; Hills CE, 2010, AM J NEPHROL, V31, P68, DOI 10.1159/000256659; Hong CY, 1998, J DIABETES COMPLICAT, V12, P43, DOI 10.1016/S1056-8727(97)00045-7; Ito T, 2002, KIDNEY INT, V62, P763, DOI 10.1046/j.1523-1755.2002.00533.x; Levin A, 2013, KIDNEY INT SUPPL, V3, P5, DOI 10.1038/kisup.2012.77; Mael-Ainin M, 2014, J AM SOC NEPHROL, V25, P1724, DOI 10.1681/ASN.2013060664; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; Oku E, 2008, INT J HEMATOL, V88, P57, DOI 10.1007/s12185-008-0095-2; PFLEIDERER S, 1993, CLIN INVESTIGATOR, V71, P972; Reidy K, 2009, AM J KIDNEY DIS, V54, P590, DOI 10.1053/j.ajkd.2009.07.003; Satirapoj B, 2014, TRANSPL P, V46, P135, DOI 10.1016/j.transproceed.2013.07.069; Satirapoj B, 2014, KIDNEY RES CLIN PRAC, V33, P121, DOI 10.1016/j.krcp.2014.08.001; Satirapoj B, 2013, ADV EXP MED BIOL, V771, P107; Satirapoj B, 2012, NEPHROL DIAL TRANSPL, V27, P2702, DOI 10.1093/ndt/gfr670; Satirapoj B, 2012, ADV CHRONIC KIDNEY D, V19, P93, DOI 10.1053/j.ackd.2011.12.001; Sen K, 2011, AM J PATHOL, V179, P1756, DOI 10.1016/j.ajpath.2011.06.002; Tabaei BP, 2001, DIABETES CARE, V24, P1560, DOI 10.2337/diacare.24.9.1560; Takayama G, 2006, J ALLERGY CLIN IMMUN, V118, P98, DOI 10.1016/j.jaci.2006.02.046; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B	24	40	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124055	10.1371/journal.pone.0124055	http://dx.doi.org/10.1371/journal.pone.0124055			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884625	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000099
J	Sato, H; Tanabe, AS; Toju, H				Sato, Hirotoshi; Tanabe, Akifumi S.; Toju, Hirokazu			Contrasting Diversity and Host Association of Ectomycorrhizal Basidiomycetes versus Root-Associated Ascomycetes in a Dipterocarp Rainforest	PLOS ONE			English	Article							DARK SEPTATE ENDOPHYTES; FUNGAL DIVERSITY; COMMUNITY COMPOSITION; GENUS STROBILOMYCES; MYCORRHIZAL FUNGI; SEEDLING SURVIVAL; PLANT; BIODIVERSITY; NETWORKS; EVOLUTION	Root-associated fungi, including ectomycorrhizal and root-endophytic fungi, are among the most diverse and important belowground plant symbionts in dipterocarp rainforests. Our study aimed to reveal the biodiversity, host association, and community structure of ectomycorrhizal Basidiomycota and root-associated Ascomycota (including root-endophytic Ascomycota) in a lowland dipterocarp rainforest in Southeast Asia. The host plant chloroplast ribulose-1,5-bisphosphate carboxylase/oxygenase large subunit (rbcL) region and fungal internal transcribed spacer 2 (ITS2) region were sequenced using tag-encoded, massively parallel 454 pyrosequencing to identify host plant and root-associated fungal taxa in root samples. In total, 1245 ascomycetous and 127 putative ectomycorrhizal basidiomycetous taxa were detected from 442 root samples. The putative ectomycorrhizal Basidiomycota were likely to be associated with closely related dipterocarp taxa to greater or lesser extents, whereas host association patterns of the root-associated Ascomycota were much less distinct. The community structure of the putative ectomycorrhizal Basidiomycota was possibly more influenced by host genetic distances than was that of the root-associated Ascomycota. This study also indicated that in dipterocarp rainforests, root-associated Ascomycota were characterized by high biodiversity and indistinct host association patterns, whereas ectomycorrhizal Basidiomycota showed less biodiversity and a strong host phylogenetic preference for dipterocarp trees. Our findings lead to the working hypothesis that root-associated Ascomycota, which might be mainly represented by root-endophytic fungi, have biodiversity hotspots in the tropics, whereas biodiversity of ectomycorrhizal Basidiomycota increases with host genetic diversity.	[Sato, Hirotoshi] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga 5202113, Japan; [Tanabe, Akifumi S.] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa 2368648, Japan; [Tanabe, Akifumi S.] Kyoto Univ, Grad Sch Global Environm Studies, Sakyo Ku, Kyoto 6068501, Japan; [Toju, Hirokazu] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ku, Kyoto 6068501, Japan	Kyoto University; Japan Fisheries Research & Education Agency (FRA); Kyoto University; Kyoto University	Sato, H (corresponding author), Kyoto Univ, Ctr Ecol Res, 509-3,2 Chome, Otsu, Shiga 5202113, Japan.	h-sato@sys.bot.kyoto-u.ac.jp	Toju, Hirokazu/T-7355-2019; Toju, Hirokazu/S-7307-2017; Tanabe, Akifumi/P-9381-2015	Toju, Hirokazu/0000-0002-3362-3285; Tanabe, Akifumi/0000-0003-1017-6504	Funding Program for Next Generation World-Leading Researchers of Cabinet Office; Japanese Government [GS014];  [24870017];  [26711026]; Grants-in-Aid for Scientific Research [26840128] Funding Source: KAKEN	Funding Program for Next Generation World-Leading Researchers of Cabinet Office; Japanese Government; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Grant-in Aid for Scientific Research (24870017) to H.S.; and by the Funding Program for Next Generation World-Leading Researchers of Cabinet Office, the Japanese Government (GS014) and the Grant-in Aid for Scientific Research (26711026) to H.T.	Addy HD, 2005, CAN J BOT, V83, P1, DOI [10.1139/B04-171, 10.1139/b04-171]; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnold AE, 2000, ECOL LETT, V3, P267, DOI 10.1046/j.1461-0248.2000.00159.x; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chase JM, 2011, ECOSPHERE, V2, DOI 10.1890/ES10-00117.1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Dickie IA, 2008, NEW PHYTOL, V180, P263, DOI 10.1111/j.1469-8137.2008.02635.x; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Gao C, 2013, MOL ECOL, V22, P3403, DOI 10.1111/mec.12297; Gelman A., 1992, STAT SCI, V7, P457, DOI [10.1214/ss/1177011136, DOI 10.1214/SS/1177011136]; GIELLY L, 1994, MOL BIOL EVOL, V11, P769; Gilbert GS, 2002, ANNU REV PHYTOPATHOL, V40, P13, DOI 10.1146/annurev.phyto.40.021202.110417; Grunig CR, 2008, BOTANY, V86, P1355, DOI 10.1139/B08-108; Halling RE., 2005, COMMON MUSHROOMS TAL; Hamady M, 2008, NAT METHODS, V5, P235, DOI 10.1038/NMETH.1184; Hawksworth DL, 2001, MYCOL RES, V105, P1422, DOI 10.1017/S0953756201004725; Henkel TW, 2005, NEW PHYTOL, V167, P543, DOI 10.1111/j.1469-8137.2005.01431.x; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; Hogberg P, 2001, NATURE, V411, P789, DOI 10.1038/35081058; Huson DH, 2007, GENOME RES, V17, P377, DOI 10.1101/gr.5969107; Ishida TA, 2007, NEW PHYTOL, V174, P430, DOI 10.1111/j.1469-8137.2007.02016.x; Jumpponen A, 1998, NEW PHYTOL, V140, P295, DOI 10.1046/j.1469-8137.1998.00265.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kernaghan G, 2011, MICROB ECOL, V62, P460, DOI 10.1007/s00248-011-9851-6; Leake JR, 2004, CAN J BOT, V82, P1016, DOI [10.1139/B04-060, 10.1139/b04-060]; Lee H. S., 2002, Journal of Tropical Forest Science, V14, P379; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mandyam K, 2005, STUD MYCOL, P173; Mangan SA, 2010, NATURE, V466, P752, DOI 10.1038/nature09273; McGuire KL, 2007, ECOLOGY, V88, P567, DOI 10.1890/05-1173; Moyersoen B, 2006, NEW PHYTOL, V172, P753, DOI 10.1111/j.1469-8137.2006.01860.x; Newsham KK, 2011, NEW PHYTOL, V190, P783, DOI 10.1111/j.1469-8137.2010.03611.x; Oksanen J, R PACKAGE VERSION; Onguene NA, 2002, MYCORRHIZA, V12, P13, DOI 10.1007/s00572-001-0140-y; Peay KG, 2010, NEW PHYTOL, V185, P529, DOI 10.1111/j.1469-8137.2009.03075.x; Peterson R. L., 2004, Mycorrhizas: anatomy and cell biology; Phosri C, 2012, BIODIVERS CONSERV, V21, P2287, DOI 10.1007/s10531-012-0250-1; Raaijmakers JM, 2009, PLANT SOIL, V321, P341, DOI 10.1007/s11104-008-9568-6; Read D, 1997, NATURE, V388, P517, DOI 10.1038/41426; Read DJ, 2004, CAN J BOT, V82, P1243, DOI [10.1139/b04-123, 10.1139/B04-123]; Rodriguez RJ, 2009, NEW PHYTOL, V182, P314, DOI 10.1111/j.1469-8137.2009.02773.x; Sato H, 2008, MOL PHYLOGENET EVOL, V48, P326, DOI 10.1016/j.ympev.2008.01.033; Sato H, 2007, AM J BOT, V94, P1630, DOI 10.3732/ajb.94.10.1630; Simard SW, 2004, CAN J BOT, V82, P1140, DOI [10.1139/b04-116, 10.1139/B04-116]; Smith ME, 2011, NEW PHYTOL, V192, P699, DOI 10.1111/j.1469-8137.2011.03844.x; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Sommer DD, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-64; Stone JK, 2000, BOOK SOIL P, P3; Swofford DL, 2002, PHYLOGENETIC ANAL US; Tanabe AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076910; Tanabe AS, 2013, ASSAMS V0 1 2013 01; Tedersoo L, 2008, NEW PHYTOL, V180, P479, DOI 10.1111/j.1469-8137.2008.02561.x; Tedersoo L, 2013, NEW PHYTOL, V199, P822, DOI 10.1111/nph.12328; Tedersoo L, 2012, MOL ECOL, V21, P4160, DOI 10.1111/j.1365-294X.2012.05602.x; Tedersoo L, 2010, ISME J, V4, P465, DOI 10.1038/ismej.2009.131; Tedersoo L, 2010, MYCORRHIZA, V20, P217, DOI 10.1007/s00572-009-0274-x; Tedersoo L, 2010, NEW PHYTOL, V185, P351, DOI 10.1111/j.1469-8137.2009.03134.x; Tedersoo L, 2009, ENVIRON MICROBIOL, V11, P3166, DOI 10.1111/j.1462-2920.2009.02020.x; Toju H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078248; Toju H, 2013, ECOL EVOL, V3, P3112, DOI 10.1002/ece3.706; Toju H, 2013, ECOL EVOL, V3, P1281, DOI 10.1002/ece3.546; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Tsumura Y, 1996, THEOR APPL GENET, V93, P22, DOI 10.1007/BF00225722; van der Heijden MGA, 2008, ECOL LETT, V11, P296, DOI 10.1111/j.1461-0248.2007.01139.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; Wang B, 2006, MYCORRHIZA, V16, P299, DOI 10.1007/s00572-005-0033-6; WILSON D, 1995, OIKOS, V73, P274, DOI 10.2307/3545919	70	19	20	0	58	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125550	10.1371/journal.pone.0125550	http://dx.doi.org/10.1371/journal.pone.0125550			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884708	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000160
J	van Hees, NJM; Giltay, EJ; Tielemans, SMAJ; Geleijnse, JM; Puvill, T; Janssen, N; van der Does, W				van Hees, Nathalie J. M.; Giltay, Erik J.; Tielemans, Susanne M. A. J.; Geleijnse, Johanna M.; Puvill, Thomas; Janssen, Nadine; van der Does, Willem			Essential Amino Acids in the Gluten-Free Diet and Serum in Relation to Depression in Patients with Celiac Disease	PLOS ONE			English	Article							FOOD-FREQUENCY QUESTIONNAIRE; BRANCHED-CHAIN AMINO; TRYPTOPHAN-METABOLISM; FIBER; MOOD; ASSOCIATION; ADOLESCENTS; DISORDERS; DEPLETION; SYMPTOMS	Introduction Celiac disease (CD) is associated with an increased risk of major depressive disorder, possibly due to deficiencies in micronutrients in the gluten-free diet. We aimed to investigate whether essential amino acids (i.e., the precursors of serotonin, dopamine and other neurotransmitters) are depleted in the diet and serum of CD patients with major depressive disorder. Methods In a cross-sectional study we assessed dietary intake of amino acids and serum levels of amino acids, in 77 CD patients on a gluten-free diet and in 33 healthy controls. Major depressive disorder was assessed with structured interviews (using the Mini International Neuropsychiatric Interview Plus). Dietary intake was assessed using a 203-item food frequency questionnaire. Results Participants had a mean age of 55 years and 74% were women. The intake of vegetable protein was significantly lower in CD patients than in healthy controls (mean difference of 7.8 g/d; 95% CI: 4.7-10.8), as were serum concentrations of tyrosine, phenylalanine and tryptophan (all p < 0.005). However, within the CD patient group, the presence of major depressive disorder (n = 42) was not associated with intake or serum levels of essential amino acids. Conclusions Patients with CD on a long-term gluten-free diet, with good adherence, consume significantly less vegetable protein than controls, and their serum levels of several essential amino acids were also lower. Despite its potential adverse effect, intake and serum levels of essential amino acids were not related to major depression.	[van Hees, Nathalie J. M.; Janssen, Nadine; van der Does, Willem] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Giltay, Erik J.; van der Does, Willem] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [Tielemans, Susanne M. A. J.; Geleijnse, Johanna M.] Wageningen Univ, Div Human Nutr, NL-6700 AP Wageningen, Netherlands; [Puvill, Thomas] Leyden Acad Vital & Ageing, Leiden, Netherlands	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Wageningen University & Research	van Hees, NJM (corresponding author), Leiden Univ, Inst Psychol, Leiden, Netherlands.	heesnjmvan@fsw.ledenuniv.nl	Giltay, Erik J./AAL-9948-2021; Van der Does, Willem/B-1465-2008; Geleijnse, Johanna Marianna M/B-5749-2012	Van der Does, Willem/0000-0002-9753-2454; Geleijnse, Johanna Marianna M/0000-0001-7638-0589; /0000-0001-6716-0023; Giltay, Erik/0000-0001-8874-2292	Netherlands Science Foundation (N.W.OMaGW Vici grant) [453-06-005]; Leiden University Fund (LUF); Gratama foundation [08.10]	Netherlands Science Foundation (N.W.OMaGW Vici grant); Leiden University Fund (LUF); Gratama foundation	This project was funded by a grant from the Netherlands Science Foundation (N.W.OMaGW Vici grant # 453-06-005 to WVdD), http://www.nwo.nl/en, and grants from the Leiden University Fund (LUF) and Gratama foundation # 08.10, http://www.luf.nl/subsidies/information-in-english. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addolorato G, 2008, INT J CLIN PRACT, V62, P1063, DOI 10.1111/j.1742-1241.2008.01763.x; Addolorato G, 1996, HEPATO-GASTROENTEROL, V43, P1513; Addolorato G, 2008, DIGEST DIS, V26, P140, DOI 10.1159/000116772; American Psychiatric Association APATFoDSMIV, 2000, DIAGN STAT MAN MENT; [Anonymous], 2006, DUTCH FOOD COMP TABL; Beirao EM, BRAZILIAN J INFECT D; Booij L, 2003, MOL PSYCHIATR, V8, P951, DOI 10.1038/sj.mp.4001423; Carta MG, 2002, J PSYCHOSOM RES, V53, P789, DOI 10.1016/S0022-3999(02)00328-8; [FAO] FaAO, 1993, MAIZ HUM NUTR; FAO/WHO/UNU (Expert Consultation), 2007, WHO TECHN REP SER, V935; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Fernstrom JD, 2012, J NUTR, V142, p2236S, DOI 10.3945/jn.111.157065; FEUNEKES GIJ, 1993, AM J CLIN NUTR, V58, P489, DOI 10.1093/ajcn/58.4.489; Geleijnse JM, 2010, AM HEART J, V159, P539, DOI 10.1016/j.ahj.2009.12.033; HALLERT C, 1983, PSYCHOL MED, V13, P267, DOI 10.1017/S003329170005087X; HALLERT C, 1982, SCAND J GASTROENTERO, V17, P17, DOI 10.3109/00365528209181037; HALLERT C, 1982, SCAND J GASTROENTERO, V17, P87, DOI 10.3109/00365528209181049; HERNANZ A, 1991, GUT, V32, P1478, DOI 10.1136/gut.32.12.1478; HUTSON SM, 1981, AM J CLIN NUTR, V34, P173, DOI 10.1093/ajcn/34.2.173; Kalia M, 2005, METABOLISM, V54, P24, DOI 10.1016/j.metabol.2005.01.009; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Leffler DA, 2009, CLIN GASTROENTEROL H, V7, P530, DOI 10.1016/j.cgh.2008.12.032; Matthews DE, 2005, J NUTR, V135, p1580S, DOI 10.1093/jn/135.6.1580S; Merens W, 2005, BRIT J NUTR, V94, P415, DOI 10.1079/BJN20051492; Nutt DJ, 2007, J CLIN PSYCHIAT, V68, P42; Ocke MC, 1997, INT J EPIDEMIOL, V26, pS49, DOI 10.1093/ije/26.suppl_1.S49; Pynnonen PA, 2002, PSYCHOSOMATICS, V43, P331, DOI 10.1176/appi.psy.43.4.331; Pynnonen PA, 2005, BMC PSYCHIATRY, V5, DOI 10.1186/1471-244X-5-14; Rostom A, 2006, GASTROENTEROLOGY, V131, P1981, DOI 10.1053/j.gastro.2006.10.004; Rubio-Tapia A, 2010, AM J GASTROENTEROL, V105, P1412, DOI 10.1038/ajg.2010.10; Sainio EL, 1996, AMINO ACIDS, V10, P21, DOI 10.1007/BF00806091; Schulte-van Maaren YWM, 2013, J EVAL CLIN PRACT, V19, P342, DOI 10.1111/j.1365-2753.2012.01830.x; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solanto MV, 2002, BEHAV BRAIN RES, V130, P65, DOI 10.1016/S0166-4328(01)00431-4; Thompson T, 2000, J AM DIET ASSOC, V100, P1389, DOI 10.1016/S0002-8223(00)00386-2; Thompson T, 2005, J HUM NUTR DIET, V18, P163, DOI 10.1111/j.1365-277X.2005.00607.x; Tommasini A, 2004, ARCH DIS CHILD, V89, P512, DOI 10.1136/adc.2003.029603; Torres MI, 2007, CLIN EXP IMMUNOL, V148, P419, DOI 10.1111/j.1365-2249.2007.03365.x; van Hees NJM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097778; van Hees NJM, 2013, J PSYCHOSOM RES, V74, P155, DOI 10.1016/j.jpsychores.2012.11.007; van Vliet I M, 2007, Tijdschr Psychiatr, V49, P393; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4; Wild D, 2010, ALIMENT PHARM THER, V32, P573, DOI 10.1111/j.1365-2036.2010.04386.x; Wood PB, 2007, EUR J NEUROSCI, V25, P3576, DOI 10.1111/j.1460-9568.2007.05623.x; Young SN, 2002, PHARMACOL BIOCHEM BE, V71, P857, DOI 10.1016/S0091-3057(01)00670-0; YOUNG SN, 1985, PSYCHOPHARMACOLOGY, V87, P173, DOI 10.1007/BF00431803	46	15	15	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122619	10.1371/journal.pone.0122619	http://dx.doi.org/10.1371/journal.pone.0122619			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884227	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000036
J	Benevento, E; Djebbari, A; Keshavarz-Motamed, Z; Cecere, R; Kadem, L				Benevento, Emilia; Djebbari, Abdelghani; Keshavarz-Motamed, Zahra; Cecere, Renzo; Kadem, Lyes			Hemodynamic Changes following Aortic Valve Bypass: A Mathematical Approach	PLOS ONE			English	Article							AMERICAN-HEART-ASSOCIATION; APICOAORTIC CONDUIT; MAGNETIC-RESONANCE; STENOSIS; SURGERY; OUTCOMES; ECHOCARDIOGRAPHY; IMPLANTATION; REPLACEMENT; CARDIOLOGY	Aortic valve bypass (AVB) has been shown to be a viable solution for patients with severe aortic stenosis (AS). Under this circumstance, the left ventricle (LV) has a double outlet. The objective was to develop a mathematical model capable of evaluating the hemodynamic performance following the AVB surgery. A mathematical model that captures the interaction between LV, AS, arterial system, and AVB was developed. This model uses a limited number of parameters that all can be non-invasively measured using patient data. The model was validated using in vivo data from the literature. The model was used to determine the effect of different AVB and AS configurations on flow proportion and pressure of the aortic valve and the AVB. Results showed that the AVB leads to a significant reduction in transvalvular pressure gradient. The percentage of flow through the AVB can range from 55.47% to 69.43% following AVB with a severe AS. LV stroke work was also significantly reduced following the AVB surgery and reached a value of around 1.2 J for several AS severities. Findings of this study suggest: 1) the AVB leads to a significant reduction in transvalvular pressure gradients; 2) flow distribution between the AS and the AVB is significantly affected by the conduit valve size; 3) the AVB leads to a significant reduction in LV stroke work; and 4) hemodynamic performance variations can be estimated using the model.	[Benevento, Emilia; Keshavarz-Motamed, Zahra; Kadem, Lyes] Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada; [Djebbari, Abdelghani] Univ Abou Bekr Belkaid Tlemcen, Tilimsen, Algeria; [Keshavarz-Motamed, Zahra] MIT, Inst Med Engn & Sci, Cambridge, MA 02139 USA; [Keshavarz-Motamed, Zahra] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Keshavarz-Motamed, Zahra] Univ Laval, Dept Med, Quebec City, PQ G1K 7P4, Canada; [Cecere, Renzo] McGill Univ, Dept Surg, Div Cardiac Surg, Montreal, PQ H3A 2T5, Canada	Concordia University - Canada; Universite Abou Bekr Belkaid; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Laval University; McGill University	Keshavarz-Motamed, Z (corresponding author), Concordia Univ, Dept Mech & Ind Engn, Montreal, PQ, Canada.	lcfd@encs.concordia.ca	Djebbari, Abdelghani/H-5717-2011	Djebbari, Abdelghani/0000-0001-7330-5188	Fonds de recherche du Quebec - Nature et technologies [176048]	Fonds de recherche du Quebec - Nature et technologies	The work was supported by Fonds de recherche du Quebec - Nature et technologies, 176048 (ZKM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asimakopoulos G, 1997, CIRCULATION, V96, P3403; Balaras E, 2009, J THORAC CARDIOV SUR, V137, P680, DOI 10.1016/j.jtcvs.2008.08.032; Carrel A, 1910, ANN SURG, V52, P83, DOI 10.1097/00000658-191007000-00009; Charlson E, 2006, J HEART VALVE DIS, V15, P312; Cooley DA, 2000, ANN THORAC SURG, V69, P1511, DOI 10.1016/S0003-4975(00)01242-X; Elmistekawy E, 2010, J SAUDI HEART ASSOC, V22, P187, DOI 10.1016/j.jsha.2010.06.003; Gammie JS, 2008, CIRCULATION, V118, P1460, DOI 10.1161/CIRCULATIONAHA.108.790030; Garcia D, 2005, J BIOMECH, V38, P1303, DOI 10.1016/j.jbiomech.2004.06.018; Garcia J, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-25; Keshavarz-Motamed Z, 2011, J BIOMECH, V44, P2817, DOI 10.1016/j.jbiomech.2011.08.001; Keshavarz-Motamed Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086793; Kotani S, 2010, INTERACT CARDIOV TH, V10, P486, DOI 10.1510/icvts.2009.220707; Lund JT, 2013, INTERACT CARDIOV TH, V17, P79, DOI 10.1093/icvts/ivt087; Palacios IF, 2012, CIRCULATION, V125, P3233, DOI 10.1161/CIRCULATIONAHA.112.093104; Pibarot P, 2009, CIRCULATION, V119, P1034, DOI 10.1161/CIRCULATIONAHA.108.778886; Reuthebuch O, 2013, INTERACT CARDIOV TH, V16, P482, DOI 10.1093/icvts/ivs513; Rosengart TK, 2008, CIRCULATION, V117, P1750, DOI 10.1161/CIRCULATIONAHA.107.188525; SARNOFF SJ, 1955, CIRCULATION, V11, P564, DOI 10.1161/01.CIR.11.4.564; Senzaki H, 1996, CIRCULATION, V94, P2497, DOI 10.1161/01.CIR.94.10.2497; SHANEBROOK JR, 1979, CARDIOVASC DIS, V6, P425; Stauffer CE, 2011, ANN THORAC SURG, V92, P1332, DOI 10.1016/j.athoracsur.2011.04.069; SUGA H, 1973, CIRC RES, V32, P314, DOI 10.1161/01.RES.32.3.314; To A, 2011, J AM COLL CARDIOL, V58, P0735; Varadarajan P, 2006, EUR J CARDIO-THORAC, V30, P722, DOI 10.1016/j.ejcts.2006.07.028; Vliek CJ, 2010, ANN THORAC SURG, V90, P136, DOI 10.1016/j.athoracsur.2010.03.046; Wijesinghe N, 2010, JACC-CARDIOVASC INTE, V3, P1122, DOI 10.1016/j.jcin.2010.08.016; Zoghbi WA, 2009, J AM SOC ECHOCARDIOG, V22, P975, DOI 10.1016/j.echo.2009.07.013	27	14	14	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123000	10.1371/journal.pone.0123000	http://dx.doi.org/10.1371/journal.pone.0123000			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881082	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500035
J	Hagopian, K; Tomilov, AA; Kim, K; Cortopassi, GA; Ramsey, JJ				Hagopian, Kevork; Tomilov, Alexey A.; Kim, Kyoungmi; Cortopassi, Gino A.; Ramsey, Jon J.			Key Glycolytic Enzyme Activities of Skeletal Muscle Are Decreased under Fed and Fasted States in Mice with Knocked Down Levels of Shc Proteins	PLOS ONE			English	Article							PYRUVATE-DEHYDROGENASE; CALORIC RESTRICTION; GENE-EXPRESSION; KINASE; INSULIN; METABOLISM; PHOSPHOFRUCTOKINASE; HEXOKINASE; INCREASES; PHOSPHORYLATION	Shc proteins interact with the insulin receptor, indicating a role in regulating glycolysis. To investigate this idea, the activities of key glycolytic regulatory enzymes and metabolites levels were measured in skeletal muscle from mice with low levels of Shc proteins (ShcKO) and wild-type (WT) controls. The activities of hexokinase, phosphofructokinase-1 and pyruvate kinase were decreased in ShcKO versusWT mice under both fed and fasted conditions. Increased alanine transaminase and branched-chain amino acid transaminase activities were also observed in ShcKO mice under both fed and fasting conditions. Protein expression of glycolytic enzymes was unchanged in the ShcKO and WT mice, indicating that decreased activities were not due to changes in their transcription. Changes in metabolite levels were consistent with the observed changes in enzyme activities. In particular, the levels of fructose-2,6-bisphosphate, a potent activator of phosphofructokinase-1, were consistently decreased in the ShcKO mice. Furthermore, the levels of lactate (inhibitor of hexokinase and phosphofructokinase-1) and citrate (inhibitor of phosphofructokinase-1 and pyruvate kinase) were increased in fed and fasted ShcKO versus WT mice. Pyruvate dehydrogenase activity was lower in ShcKO versusWT mice under fed conditions, and showed inhibition under fasting conditions in both ShcKO and WT mice, with ShcKO mice showing less inhibition than the WT mice. Pyruvate dehydrogenase kinase 4 levels were unchanged under fed conditions but were lower in the ShcKO mice under fasting conditions. These studies indicate that decreased levels of Shc proteins in skeletal muscle lead to a decreased glycolytic capacity in both fed and fasted states.	[Hagopian, Kevork; Tomilov, Alexey A.; Cortopassi, Gino A.; Ramsey, Jon J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Kim, Kyoungmi] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA	University of California System; University of California Davis; University of California System; University of California Davis	Hagopian, K (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA.	khagopian@ucdavis.edu			National Institutes of Health [P01 AG025532]; UC Davis MMPC [NIH DKO92993]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993, U2CDK092993] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UC Davis MMPC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institutes of Health grant P01 AG025532 (GAC, JJR). The authors also thank UC Davis MMPC (Grant NIH DKO92993) for performing the triglyceride analysis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADIBI SA, 1976, METABOLISM, V25, P1287, DOI 10.1016/S0026-0495(76)80012-1; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Burgering B, 2008, ONCOGENE, V27, P2258, DOI 10.1038/onc.2008.29; CAHILL GF, 1966, J CLIN INVEST, V45, P1751, DOI 10.1172/JCI105481; Cai GZ, 1997, BIOPHYS CHEM, V64, P199, DOI 10.1016/S0301-4622(96)02232-6; Cheng ZY, 2011, ANTIOXID REDOX SIGN, V14, P649, DOI 10.1089/ars.2010.3370; COORE HG, 1971, BIOCHEM J, V125, P115, DOI 10.1042/bj1250115; Depre C, 1998, EUR J BIOCHEM, V258, P277, DOI 10.1046/j.1432-1327.1998.2580277.x; Dieni CA, 2011, COMP BIOCHEM PHYS B, V159, P236, DOI 10.1016/j.cbpb.2011.05.003; DUNAWAY GA, 1983, MOL CELL BIOCHEM, V52, P75; FOE LG, 1982, J BIOL CHEM, V257, P6368; FOLCH J, 1957, J BIOL CHEM, V226, P497; Furuyama T, 2003, BIOCHEM J, V375, P365, DOI 10.1042/BJ20030022; Furuyama T, 2002, MICROSC RES TECHNIQ, V59, P331, DOI 10.1002/jemt.10213; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Guan KL, 2011, TRENDS BIOCHEM SCI, V36, P108, DOI 10.1016/j.tibs.2010.09.003; Hagopian K, 2003, EXP GERONTOL, V38, P267, DOI 10.1016/S0531-5565(02)00202-4; Hagopian K, 2012, METABOLISM, V61, P1703, DOI 10.1016/j.metabol.2012.05.007; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Holness MJ, 2003, BIOCHEM SOC T, V31, P1143; HUE L, 1987, BIOCHEM J, V245, P313, DOI 10.1042/bj2450313; JACOBSON K, 1961, J BIOL CHEM, V236, P343; Keppler D., 1984, METHOD ENZYMAT AN, V6, P11; Leite TC, 2011, FEBS LETT, V585, P92, DOI 10.1016/j.febslet.2010.11.009; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Mollering H, 1985, METHOD ENZYMAT AN, P2; Munday MR, 2002, BIOCHEM SOC T, V30, P1059, DOI 10.1042/bst0301059; Natalicchio A, 2009, AM J PHYSIOL-ENDOC M, V296, pE228, DOI 10.1152/ajpendo.90347.2008; Nelson D.L., 2017, LEHNINGER PRINCIPLES, V7th; ODESSEY R, 1979, BIOCHEM J, V178, P475, DOI 10.1042/bj1780475; PELICCI G, 1992, CELL, V70, P93, DOI 10.1016/0092-8674(92)90536-L; RANDLE PJ, 1986, BIOCHEM SOC T, V14, P799, DOI 10.1042/bst0140799; Ranieri SC, 2010, P NATL ACAD SCI USA, V107, P13420, DOI 10.1073/pnas.1008647107; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Roberts DJ, 2013, J BIOL CHEM, V288, P23798, DOI 10.1074/jbc.M113.482026; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Robey RB, 2009, SEMIN CANCER BIOL, V19, P25, DOI 10.1016/j.semcancer.2008.11.010; ROUSSEAU GG, 1993, PROG NUCLEIC ACID RE, V45, P99, DOI 10.1016/S0079-6603(08)60868-5; Sasaoka T, 2000, ENDOCR J, V47, P373, DOI 10.1507/endocrj.47.373; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Sola-Penna M, 2010, IUBMB LIFE, V62, P791, DOI 10.1002/iub.393; SOLING HD, 1981, CURR TOP CELL REGUL, V20, P107; Stiles BL, 2009, ADV DRUG DELIVER REV, V61, P1276, DOI 10.1016/j.addr.2009.07.017; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; SUGDEN MC, 1993, ADV ENZYME REGUL, V33, P71; Thompson AL, 2000, DIABETES, V49, P1761, DOI 10.2337/diabetes.49.11.1761; Thomson DM, 2009, ACTA PHYSIOL, V196, P147, DOI 10.1111/j.1748-1716.2009.01973.x; Tomilov AA, 2011, AGING CELL, V10, P55, DOI 10.1111/j.1474-9726.2010.00641.x; Usenik A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015447; VANSCHAFTINGEN E, 1987, ADV ENZYMOL RAMB, V59, P315; Ventura A, 2002, J BIOL CHEM, V277, P22370, DOI 10.1074/jbc.M200280200; VILLARPA.C, 1970, ANNU REV BIOCHEM, V39, P639, DOI 10.1146/annurev.bi.39.070170.003231; Whiteman EL, 2002, TRENDS ENDOCRIN MET, V13, P444, DOI 10.1016/S1043-2760(02)00662-8; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu PF, 2000, ARCH BIOCHEM BIOPHYS, V381, P1, DOI 10.1006/abbi.2000.1946; Xiong Y, 2011, COLD SH Q B, V76, P285, DOI 10.1101/sqb.2011.76.010942	58	12	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124204	10.1371/journal.pone.0124204	http://dx.doi.org/10.1371/journal.pone.0124204			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880638	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500090
J	Huang, YF; Chang, CT; Muo, CH; Tsai, CH; Shen, YF; Wu, CZ				Huang, Yi Fang; Chang, Chung Ta; Muo, Chih Hsin; Tsai, Chun Hao; Shen, Yu Fu; Wu, Ching Zong			Impact of Bisphosphonate-related Osteonecrosis of the Jaw on Osteoporotic Patients after Dental Extraction: A Population-Based Cohort Study	PLOS ONE			English	Article							CLINICAL-FEATURES; RISK; EPIDEMIOLOGY; PREVENTION	Background and Aims Little is currently known about the risk of developing bisphosphonate-related osteonecrosis of the jaw (BRONJ). This study sought to determine the incidence of BRONJ in osteoporotic patients. We also sought to identify the nature and types of risk factors of osteonecrosis of jaw (ONJ) related to the use of oral bisphosphonates (BPs). Materials and Methods Data from the National Health Insurance system of Taiwan. This cohort study included 19,399 adult osteoporosis patients received dental extraction in 2000-2010 (osteoporosis cohort) and 38,669 age and gender matched comparisons selected from dental extraction people without osteoporosis and osteonecrosis history (comparison cohort). All study subjects were followed from the date of their dental extraction (index date) to the development of ONJ and were included in the study up to 2011 or were lost to the study, whichever occurred first. Cox proportional hazard regression was used to estimate the hazard ratio and 95% confidence intervals for the two cohorts. Results Patients with osteoporosis had a significantly higher risk to develop ONJ than healthy persons (adjusted HR, 2.05; 95% confidence interval, 1.58-2.65). The risk of ONJ increased with the severity of osteoporosis, no matter whether patient with cancer or not. A cumulative effect of dental extraction frequency may increase the risk of ONJ. Conclusions We concluded that ONJ is caused by a number of factors. Osteoporosis and past dental history play the very important roles, while BPs play the synergistic effect.	[Huang, Yi Fang; Shen, Yu Fu] Chang Gung Mem Hosp, Dept Gen Dent, Linkou, Taiwan; [Huang, Yi Fang; Chang, Chung Ta; Wu, Ching Zong] Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan; [Chang, Chung Ta] Far Eastern Mem Hosp, Dept Emergency Med, Taipei, Taiwan; [Muo, Chih Hsin] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Tsai, Chun Hao] China Med Univ Hosp, Dept Orthoped, Taichung, Taiwan; [Tsai, Chun Hao] China Med Univ, Grad Inst Clin Med, Taichung, Taiwan; [Wu, Ching Zong] Taipei Med Univ Hosp, Dept Dent, Taipei, Taiwan; [Wu, Ching Zong] Lotung PohAi Hosp, Dept Dent, Yilan, Taiwan	Chang Gung Memorial Hospital; Taipei Medical University; Far Eastern Memorial Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital	Wu, CZ (corresponding author), Taipei Med Univ, Sch Dent, Coll Oral Med, Taipei, Taiwan.	chinaowu@tmu.edu.tw	Huang, Yi-Fang/ABB-5777-2021; Chang, Chung-Ta/ABB-5600-2021; Tsai, Chun-Hao/H-3140-2013	Chang, Chung-Ta/0000-0002-9211-1407; Tsai, Chun-Hao/0000-0002-4428-3132; Huang, Yi-Fang/0000-0003-2569-999X	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW103-TDU-B-212-113002]; China Medical University Hospital [1MS1]	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; China Medical University Hospital	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW103-TDU-B-212-113002) and China Medical University Hospital (1MS1). The funders had no role in study design, data collection and analysis, decision to publication, or preparation of the manuscript.	AAOMS, 2007, J ORAL MAXIL SURG, V65, P369, DOI 10.1016/j.joms.2006.11.003; American Dental Association Council on Scientific Affairs, 2006, J Am Dent Assoc, V137, P1144; Assael LA, 2009, J ORAL MAXIL SURG, V67, P35, DOI 10.1016/j.joms.2009.01.003; Badros A, 2006, J CLIN ONCOL, V24, P945, DOI 10.1200/JCO.2005.04.2465; Bedogni A, 2012, ORAL DIS, V18, P621, DOI 10.1111/j.1601-0825.2012.01903.x; Bilezikian JP, 2006, NEW ENGL J MED, V355, P2278, DOI 10.1056/NEJMp068157; Durie BGM, 2005, NEW ENGL J MED, V353, P99; Edwards BJ, 2008, J AM DENT ASSOC, V139, P545, DOI 10.14219/jada.archive.2008.0214; Font RG, 2008, MED ORAL PATOL ORAL, V13, pE318; Khan AA, 2011, J RHEUMATOL, V38, P1396, DOI 10.3899/jrheum.100221; Khosla S, 2007, J BONE MINER RES, V22, P1479, DOI 10.1359/JBMR.0707ONJ; King AE, 2008, PHARMACOTHERAPY, V28, P667, DOI 10.1592/phco.28.5.667; Kotecha RS, 2010, PEDIATR BLOOD CANCER, V54, P934, DOI 10.1002/pbc.22428; Krueger CD, 2007, ANN PHARMACOTHER, V41, P276, DOI 10.1345/aph.1H521; Kruger TB, 2013, ACTA ODONTOL SCAND, V71, P1386, DOI 10.3109/00016357.2013.764007; Kuehn BM, 2005, JAMA-J AM MED ASSOC, V293, P2458, DOI 10.1001/jama.293.20.2458; Lin TC, 2014, OSTEOPOROSIS INT, V25, P1503, DOI 10.1007/s00198-014-2624-6; Lin TC, 2011, CLIN PHARMACOL THER, V90, P109, DOI 10.1038/clpt.2011.62; Loukota RA, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e5988; Marx RE, 2005, J ORAL MAXIL SURG, V63, P1567, DOI 10.1016/j.joms.2005.07.010; Marx RE, 2003, J ORAL MAXIL SURG, V61, P1115, DOI 10.1016/S0278-2391(03)00720-1; Migliorati CA, 2005, J AM DENT ASSOC, V136, P1658, DOI 10.14219/jada.archive.2005.0108; Migliorati Cesar Augusto, 2007, J Evid Based Dent Pract, V7, P77, DOI 10.1016/j.jebdp.2007.03.015; Miksad RA, 2011, ONCOLOGIST, V16, P121, DOI 10.1634/theoncologist.2010-0183; Reid IR, 2012, NAT REV RHEUMATOL, V8, P90, DOI 10.1038/nrrheum.2011.181; Scully Crispian, 2006, Implant Dent, V15, P212, DOI 10.1097/01.id.0000236120.22719.02; Solomon DH, 2013, OSTEOPOROSIS INT, V24, P237, DOI 10.1007/s00198-012-2042-6; Van den Wyngaert T, 2006, ANN ONCOL, V17, P1197, DOI 10.1093/annonc/mdl294; Weitzman R, 2007, CRIT REV ONCOL HEMAT, V62, P148, DOI 10.1016/j.critrevonc.2006.12.005; Woo SB, 2006, ANN INTERN MED, V144, P753, DOI 10.7326/0003-4819-144-10-200605160-00009; Yarom N, 2007, OSTEOPOROSIS INT, V18, P1363, DOI 10.1007/s00198-007-0384-2; Yuh DY, 2014, J DENT, V42, P1343, DOI 10.1016/j.jdent.2014.05.001	32	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120756	10.1371/journal.pone.0120756	http://dx.doi.org/10.1371/journal.pone.0120756			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880208	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500007
J	Maeda, M; Hayashi, T; Mizuno, N; Hattori, Y; Kuzuya, M				Maeda, Morihiko; Hayashi, Toshio; Mizuno, Natsumi; Hattori, Yuichi; Kuzuya, Masafumi			Intermittent High Glucose Implements Stress-Induced Senescence in Human Vascular Endothelial Cells: Role of Superoxide Production by NADPH Oxidase	PLOS ONE			English	Article							PROTEIN-KINASE-C; NITRIC-OXIDE; OXIDATIVE STRESS; CELLULAR SENESCENCE; ENHANCES APOPTOSIS; EXPRESSION; ACTIVATION; SYNTHASE; HYPERGLYCEMIA; FLUCTUATIONS	Impaired glucose tolerance characterized by postprandial hyperglycemia, which occurs frequently in elderly persons and represents an important preliminary step in diabetes mellitus, poses an independent risk factor for the development of atherosclerosis. Endothelial cellular senescence is reported to precede atherosclerosis. We reported that continuous high glucose stimulus causes endothelial senescence more markedly than hypertension or dyslipidemia stimulus. In the present study, we evaluated the effect of fluctuating glucose levels on human endothelial senescence. Constant high glucose increased senescence-associated-beta-galactosidase(SA-beta-gal) activity, a widely used marker for cellular senescence. Interestingly, in intermittent high glucose, this effect was more pronounced as well as increase of p21 and p 16(INK4a), senescence related proteins with DNA damage. However, telomerase was not activated and telomere length was not shortened, thus stress-induced senescence was shown. However, constant high glucose activated telomerase and shortened telomere length, which suggested replicative senescence. Intermittent but not constant high glucose strikingly up-regulated the expression of p22(phox), an NADPH oxidase component, increasing superoxide. The small interfering RNA of p22(pho)x undermined the increase in SA-beta-gal activity induced by intermittent high glucose. Conclusively, intermittent high glucose can promote vascular endothelial senescence more than constant high glucose, which is in partially dependent on superoxide overproduction.	[Maeda, Morihiko; Hayashi, Toshio; Kuzuya, Masafumi] Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan; [Mizuno, Natsumi; Hattori, Yuichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Mol & Med Pharmacol, Toyama 9300194, Japan	Nagoya University; University of Toyama	Maeda, M (corresponding author), Nagoya Univ, Grad Sch Med, Dept Geriatr, Nagoya, Aichi 4668550, Japan.	hayashi@med.nagoya-u.ac.jp	Kuzuya, Masafumi/I-1583-2012; Hayashi, Toshio/I-7346-2014	Hayashi, Toshio/0000-0002-7711-2700; Mizuno, Natsumi/0000-0001-7161-266X	Ministry of Education, Culture, Sports, Science and Technology of Japan [24590881]; Grants-in-Aid for Scientific Research [24590881] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan No. 24590881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Wanschel ACBA, 2014, NITRIC OXIDE-BIOL CH, V36, P58, DOI 10.1016/j.niox.2013.12.003; Ceriello A, 1998, DIABETIC MED, V15, P188; Chait A, 2009, J LIPID RES, V50, pS335, DOI 10.1194/jlr.R800059-JLR200; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Christ M, 2002, DIABETES, V51, P2648, DOI 10.2337/diabetes.51.8.2648; Erusalimsky JD, 2008, EXP PHYSIOL, V94.3, P299; Erusalimsky JD, 2009, J APPL PHYSIOL, V106, P326, DOI 10.1152/japplphysiol.91353.2008; Esaki T, 1997, ATHEROSCLEROSIS, V128, P39, DOI 10.1016/S0021-9150(96)05976-X; Guo X, 2000, ACTA PHARMACOL SIN, V21, P325; Han J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086539; Hayashi T, 2007, BBA-MOL BASIS DIS, V1772, P364, DOI 10.1016/j.bbadis.2006.11.011; Hayashi T, 2006, P NATL ACAD SCI USA, V103, P17018, DOI 10.1073/pnas.0607873103; Hayashi T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088391; Hayashi T, 2014, P NATL ACAD SCI USA, V111, P1168, DOI 10.1073/pnas.1322153111; Hayashi T, 2008, PHARMACOL THERAPEUT, V120, P333, DOI 10.1016/j.pharmthera.2008.09.002; Herrera M, 2009, J BIOL CHEM, V284, P1454, DOI 10.1074/jbc.M804322200; Hunt Michelle A, 2010, J Biomol Tech, V21, P66; Liu XJ, 2013, EXP THER MED, V6, P361, DOI 10.3892/etm.2013.1166; Matsui-Hirai H, 2011, J PHARMACOL EXP THER, V337, P591, DOI 10.1124/jpet.110.177584; Minamino T, 2007, CIRC RES, V100, P15, DOI 10.1161/01.RES.0000256837.40544.4a; Monnier L, 2006, JAMA-J AM MED ASSOC, V295, P1681, DOI 10.1001/jama.295.14.1681; Nabzdyk CS, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-48; Nolly MB, 2014, J MOL CELL CARDIOL, V67, P60, DOI 10.1016/j.yjmcc.2013.12.004; Park MH, 2014, APPL BIOCHEM BIOTECH, V174, P632, DOI 10.1007/s12010-014-1099-4; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Quagliaro L, 2003, DIABETES, V52, P2795, DOI 10.2337/diabetes.52.11.2795; Risso A, 2001, AM J PHYSIOL-ENDOC M, V281, pE924, DOI 10.1152/ajpendo.2001.281.5.E924; Salminen A, 2011, CELL SIGNAL, V23, P747, DOI 10.1016/j.cellsig.2010.10.012; Sena CM, 2013, BBA-MOL BASIS DIS, V1832, P2216, DOI 10.1016/j.bbadis.2013.08.006; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Sun JZ, 2009, MOL CELL ENDOCRINOL, V313, P64, DOI 10.1016/j.mce.2009.08.019; Taguchi K, 2014, J PHARMACOL EXP THER, V349, P199, DOI 10.1124/jpet.113.211854; TAKEUCHI A, 1995, AM J PHYSIOL-RENAL, V268, pF13, DOI 10.1152/ajprenal.1995.268.1.F13; Torimoto K, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-1; Yokoi T, 2006, DIABETES, V55, P1660, DOI 10.2337/db05-1607; Zalli A, 2014, P NATL ACAD SCI USA, V111, P4519, DOI 10.1073/pnas.1322145111; Zhang X, 2014, NITRIC OXIDE-BIOL CH, V40, P10, DOI 10.1016/j.niox.2014.05.001	38	56	60	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123169	10.1371/journal.pone.0123169	http://dx.doi.org/10.1371/journal.pone.0123169			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879533	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500041
J	Rivest, EB; Gouhier, TC				Rivest, E. B.; Gouhier, T. C.			Complex Environmental Forcing across the Biogeographical Range of Coral Populations (vol 10, e0121742, 2015)	PLOS ONE			English	Correction														Gouhier, Tarik/0000-0002-9537-7358	Division of Computing and Communication Foundations [1442728] Funding Source: National Science Foundation	Division of Computing and Communication Foundations(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Rivest EB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121742	1	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0126756	10.1371/journal.pone.0126756	http://dx.doi.org/10.1371/journal.pone.0126756			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879832	Green Published, gold			2022-12-27	WOS:000353016500124
J	Wang, C; Zhang, QF				Wang, Cheng; Zhang, Qingfang			Phonological Codes Constrain Output of Orthographic Codes via Sublexical and Lexical Routes in Chinese Written Production	PLOS ONE			English	Article							VISUAL WORD RECOGNITION; SYLLABLE-FREQUENCY; HOMOPHONE DENSITY; SPOKEN; REGULARITY; RETRIEVAL; ACTIVATION; ACCESS; INTERFERENCE; INFORMATION	To what extent do phonological codes constrain orthographic output in handwritten production? We investigated how phonological codes constrain the selection of orthographic codes via sublexical and lexical routes in Chinese written production. Participants wrote down picture names in a picture-naming task in Experiment 1or response words in a symbol-word associative writing task in Experiment 2. A sublexical phonological property of picture names (phonetic regularity: regular vs. irregular) in Experiment 1and a lexical phonological property of response words (homophone density: dense vs. sparse) in Experiment 2, as well as word frequency of the targets in both experiments, were manipulated. A facilitatory effect of word frequency was found in both experiments, in which words with high frequency were produced faster than those with low frequency. More importantly, we observed an inhibitory phonetic regularity effect, in which low-frequency picture names with regular first characters were slower to write than those with irregular ones, and an inhibitory homophone density effect, in which characters with dense homophone density were produced more slowly than those with sparse homophone density. Results suggested that phonological codes constrained handwritten production via lexical and sublexical routes.	[Wang, Cheng; Zhang, Qingfang] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Zhang, Qingfang] Renmin Univ China, Dept Psychol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Renmin University of China	Zhang, QF (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	qingfang.zhang@ruc.edu.cn		Wang, Cheng/0000-0003-3070-6664	National Natural Science Foundation of China [31170977, 31471074]; Fundamental Research funds for the Central Univsersities; Renmin University of China [14NXLF12]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research funds for the Central Univsersities; Renmin University of China	This research was supported by Grants from the National Natural Science Foundation of China (31170977, 31471074), the Fundamental Research funds for the Central Univsersities, and the Research Funds of Renmin University of China (No. 14NXLF12) to Qingfang Zhang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonso O, 2011, J EXP PSYCHOL LEARN, V37, P1474, DOI 10.1037/a0024515; Aitchison J., 1982, LANGUAGE COGNITIVE S, P180; Alario FX, 2003, BRAIN LANG, V84, P372, DOI 10.1016/S0093-934X(02)00556-4; [Anonymous], 1986, MODERN CHINESE FREQU; Baayen RH, 2008, J MEM LANG, V59, P390, DOI 10.1016/j.jml.2007.12.005; Barber H, 2004, NEUROREPORT, V15, P545, DOI 10.1097/00001756-200403010-00032; BASSO A, 1978, J NEUROL NEUROSUR PS, V41, P556, DOI 10.1136/jnnp.41.6.556; Bates D, 2005, FITTING LINEAR MIXED, V5; Bien H, 2005, P NATL ACAD SCI USA, V102, P17876, DOI 10.1073/pnas.0508431102; Bonin P, 1998, INT J PSYCHOL, V33, P269, DOI 10.1080/002075998400312; Bonin P, 1998, ACTA PSYCHOL, V99, P311, DOI 10.1016/S0001-6918(98)00017-1; Bonin P, 2001, J MEM LANG, V45, P688, DOI 10.1006/jmla.2000.2786; Bonin P, 2002, EUR J COGN PSYCHOL, V14, P289, DOI 10.1080/09541440143000078; CARAMAZZA A, 1990, COGNITION, V37, P243, DOI 10.1016/0010-0277(90)90047-N; CARAMAZZA A, 1990, CORTEX, V26, P95, DOI 10.1016/S0010-9452(13)80077-9; Carreiras M, 2004, BRAIN LANG, V90, P393, DOI 10.1016/j.bandl.2003.12.003; CARREIRAS M, 1993, J MEM LANG, V32, P766, DOI 10.1006/jmla.1993.1038; Chen HC, 2009, LANG COGNITIVE PROC, V24, P967, DOI 10.1080/01690960902804515; Cholin J, 2006, COGNITION, V99, P205, DOI 10.1016/j.cognition.2005.01.009; Coltheart M, 2001, PSYCHOL REV, V108, P204, DOI 10.1037//0033-295X.108.1.204; Conrad M, 2008, LANG COGNITIVE PROC, V23, P296, DOI 10.1080/01690960701571570; Conrad M, 2006, PSYCHON B REV, V13, P339, DOI 10.3758/BF03193854; Damian MF, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00765; Damian MF, 2011, J EXP PSYCHOL LEARN, V37, P813, DOI 10.1037/a0023260; Damian MF, 1999, J EXP PSYCHOL LEARN, V25, P345, DOI 10.1037/0278-7393.25.2.345; Delattre M, 2006, J EXP PSYCHOL LEARN, V32, P1330, DOI 10.1037/0278-7393.32.6.1330; DELL GS, 1986, PSYCHOL REV, V93, P283, DOI 10.1037/0033-295X.93.3.283; DELL GS, 1988, J MEM LANG, V27, P124, DOI 10.1016/0749-596X(88)90070-8; Ellis A.W., 1982, NORMALITY PATHOLOGY; Ellis A. W., 1988, LANG COGNITIVE PROC, V3, P99, DOI DOI 10.1080/01690968808402084; Farrell MT, 2014, Q J EXP PSYCHOL, V67, P525, DOI 10.1080/17470218.2013.820763; Farrell MT, 2011, J EXP PSYCHOL LEARN, V37, P277, DOI 10.1037/a0021328; Hotopf W. H. N., 1980, COGNITIVE PROCESS, P287; Hue C-W., 1992, ADV PSYCHOL, V90, P93, DOI [DOI 10.1016/S0166-4115(08)61888-9, 10.1016/S0166-4115(08)61888-9]; Hutzler F, 2004, NEUROSCI LETT, V372, P179, DOI 10.1016/j.neulet.2004.07.050; Jared D, 2002, J MEM LANG, V46, P723, DOI 10.1006/jmla.2001.2827; JESCHENIAK JD, 1994, J EXP PSYCHOL LEARN, V20, P824, DOI 10.1037/0278-7393.20.4.824; Kandel S, 2006, LANG COGNITIVE PROC, V21, P432, DOI 10.1080/01690960400018378; Kandel S, 2006, J EXP PSYCHOL HUMAN, V32, P18, DOI 10.1037/0096-1523.32.1.18; Kandel S, 2011, J EXP PSYCHOL HUMAN, V37, P1310, DOI 10.1037/a0023094; Kandel S, 2009, COGNITION, V110, P440, DOI 10.1016/j.cognition.2008.12.001; Laganaro M, 2006, J MEM LANG, V55, P178, DOI 10.1016/j.jml.2006.05.001; Lambert E, 2008, READ WRIT, V21, P859, DOI 10.1007/s11145-007-9095-5; Lambert E, 2011, CAN J EXP PSYCHOL, V65, P141, DOI 10.1037/a0022538; Lee C.-Y., 2005, LANGUAGE LINGUISTICS, V6, P75; Levelt WJM, 1999, BEHAV BRAIN SCI, V22, P1; LEVELT WJM, 1994, COGNITION, V50, P239, DOI 10.1016/0010-0277(94)90030-2; Liu Y., 1990, DICT USAGE FREQUENCY; Luce PA, 1998, EAR HEARING, V19, P1, DOI 10.1097/00003446-199802000-00001; Miceli G, 1999, COGNITIVE NEUROPSYCH, V16, P557, DOI 10.1080/026432999380726; Perea M, 1998, J EXP PSYCHOL HUMAN, V24, P134, DOI 10.1037/0096-1523.24.1.134; Qu QQ, 2011, PSYCHOL SCI, V22, P1107, DOI 10.1177/0956797611417001; R Core Team, 2020, R LANG ENV STAT COMP; Rapp B, 1997, COGNITIVE NEUROPSYCH, V14, P71, DOI 10.1080/026432997381628; Rapp B, 1997, BRAIN LANG, V56, P248, DOI 10.1006/brln.1997.1735; Roux S, 2013, COGNITION, V127, P235, DOI 10.1016/j.cognition.2012.12.009; SEIDENBERG MS, 1985, COGNITION, V19, P1, DOI 10.1016/0010-0277(85)90029-0; SEIDENBERG MS, 1984, J VERB LEARN VERB BE, V23, P383, DOI 10.1016/S0022-5371(84)90270-6; Shen XR, 2013, J MEM LANG, V68, P69, DOI 10.1016/j.jml.2012.10.003; SNOWLING M, 1994, Q J EXP PSYCHOL-A, V47, P895, DOI 10.1080/14640749408401101; STARREVELD PA, 1995, J EXP PSYCHOL LEARN, V21, P686, DOI 10.1037/0278-7393.21.3.686; STERNBERG S, 1969, AM SCI, V57, P421; Taler V, 2010, J GERONTOL B-PSYCHOL, V65, P551, DOI 10.1093/geronb/gbq039; Tan LH, 2001, NEUROREPORT, V12, P83, DOI 10.1097/00001756-200101220-00024; Vitevitch MS, 2008, LANG SPEECH, V51, P361, DOI 10.1177/0023830908099070; Wang WN, 2012, NEUROSCI LETT, V516, P67, DOI 10.1016/j.neulet.2012.03.059; Yip MCW, 2000, PSYCHOLOGIA, V43, P135; Yum YN, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00315; [张清芳 Zhang Qingfang], 2003, [心理学报, Acta Psychologica Sinica], V35, P447; Zhang QF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00120; Zhang QF, 2010, MEM COGNITION, V38, P519, DOI 10.3758/MC.38.4.519; [周海燕 Zhou Haiyan], 2008, [心理科学, Psychological Science], V31, P852; Zhou Y, 1978, ZHONGGUO YUWEN, V146, P172; Ziegler JC, 2003, PSYCHON B REV, V10, P947, DOI 10.3758/BF03196556; Ziegler JC, 2000, PSYCHOL SCI, V11, P234, DOI 10.1111/1467-9280.00247; Zolfonoun Ehsan, 2015, CLIN CHEM LAB MED, V103, P835, DOI [10.1515/ract-2015-2466, DOI 10.1515/CCLM-2022-0965]	76	10	10	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124470	10.1371/journal.pone.0124470	http://dx.doi.org/10.1371/journal.pone.0124470			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25879662	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500102
J	Warren, CR; Kassir, E; Spurlin, J; Martinez, J; Putnam, NH; Farach-Carson, MC				Warren, Curtis R.; Kassir, Elias; Spurlin, James; Martinez, Jerahme; Putnam, Nicholas H.; Farach-Carson, Mary C.			Evolution of the Perlecan/HSPG2 Gene and Its Activation in Regenerating Nematostella vectensis	PLOS ONE			English	Article							HEPARAN-SULFATE PROTEOGLYCAN; GENOME REVEALS; CELL; PROTEIN; EXPRESSION; FEATURES; ORIGIN; SYSTEM; GROWTH	The heparan sulfate proteoglycan 2 (HSPG2)/perlecan gene is ancient and conserved in all triploblastic species. Its presence maintains critical cell boundaries in tissue and its large (up to similar to 900 kDa) modular structure has prompted speculation about the evolutionary origin of the gene. The gene's conservation amongst basal metazoans is unclear. After the recent sequencing of their genomes, the cnidarian Nematostella vectensis and the placozoan Trichoplax adhaerens have become favorite models for studying tissue regeneration and the evolution of multicellularity. More ancient basal metazoan phyla include the poriferan and ctenophore, whose evolutionary relationship has been clarified recently. Our in silico and PCR-based methods indicate that the HSPG2 gene is conserved in both the placozoan and cnidarian genomes, but not in those of the ctenophores and only partly in poriferan genomes. HSPG2 also is absent from published ctenophore and Capsaspora owczarzaki genomes. The gene in T. adhaerens is encoded as two separate but genetically juxtaposed genes that house all of the constituent pieces of the mammalian HSPG2 gene in tandem. These genetic constituents are found in isolated genes of various poriferan species, indicating a possible intronic recombinatory mechanism for assembly of the HSPG2 gene. Perlecan's expression during wound healing and boundary formation is conserved, as expression of the gene was activated during tissue regeneration and reformation of the basement membrane of N. vectensis. These data indicate that the complex HSPG2 gene evolved concurrently in a common ancestor of placozoans, cnidarians and bilaterians, likely along with the development of differentiated cell types separated by acellular matrices, and is activated to reestablish these tissue borders during wound healing.	[Warren, Curtis R.; Kassir, Elias; Spurlin, James; Martinez, Jerahme; Putnam, Nicholas H.; Farach-Carson, Mary C.] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Farach-Carson, Mary C.] Rice Univ, Dept Bioengn, Houston, TX USA	Rice University; Rice University	Farach-Carson, MC (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.	farachca@rice.edu	; Putnam, Nicholas/B-9968-2008	Farach-Carson, Mary/0000-0002-4526-3088; Putnam, Nicholas/0000-0002-1315-782X	National Institutes of Health/National Cancer Institute Program Project - MCFC Project 2 PI [P01CA098912]; National Science Foundation Research Experiences for Undergraduates program - EMK [DBI1004853]; NATIONAL CANCER INSTITUTE [P01CA098912] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute Program Project - MCFC Project 2 PI; National Science Foundation Research Experiences for Undergraduates program - EMK; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by P01CA098912 National Institutes of Health/National Cancer Institute Program Project - MCFC Project 2 PI (http://www.cancer.gov/) and DBI1004853 National Science Foundation Research Experiences for Undergraduates program - EMK (http://www.nsf.gov/div/index.jsp?div=DBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arikawa-Hirasawa E, 2001, NAT GENET, V27, P431, DOI 10.1038/86941; BORK P, 1995, PROTEIN SCI, V4, P1421, DOI 10.1002/pro.5560040716; Bossert PE, 2013, DEV DYNAM, V242, P1320, DOI 10.1002/dvdy.24021; Carr M, 2008, P NATL ACAD SCI USA, V105, P16641, DOI 10.1073/pnas.0801667105; DATTA S, 1992, GENETICS, V130, P523; Dohrmann M, 2013, INTEGR COMP BIOL, V53, P503, DOI 10.1093/icb/ict008; Dubuc TQ, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-24; Etchevers HC, 2001, DEVELOPMENT, V128, P1059; Farach-Carson MC, 2007, GLYCOBIOLOGY, V17, P897, DOI 10.1093/glycob/cwm043; Farach-Carson MC, 2014, MATRIX BIOL, V34, P64, DOI 10.1016/j.matbio.2013.08.004; Feta A, 2009, BIOCHEM J, V419, P585, DOI 10.1042/BJ20082081; Govindasamy N, 2014, BIOL OPEN; Hynes RO, 2012, J CELL BIOL, V196, P671, DOI 10.1083/jcb.201109041; King N, 2008, NATURE, V451, P783, DOI 10.1038/nature06617; Moroz LL, 2014, NATURE, V510, P109, DOI 10.1038/nature13400; MURDOCH AD, 1992, J BIOL CHEM, V267, P8544; Ozbek S, 2010, MOL BIOL CELL, V21, P4300, DOI 10.1091/mbc.E10-03-0251; Ojeda AF, 2013, GENE EXPR PATTERNS, V13, P303, DOI 10.1016/j.gep.2013.05.006; Passamaneck YJ, 2012, BMC DEV BIOL, V12, DOI 10.1186/1471-213X-12-34; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel A, 2006, INVERTEBRATE BIOLOGY, V126, P99; Riesgo A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-376; Ringrose JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2424; ROGALSKI TM, 1993, GENE DEV, V7, P1471, DOI 10.1101/gad.7.8.1471; Ryan JF, 2013, SCIENCE, V342, P1336, DOI 10.1126/science.1242592; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Srivastava M, 2010, NATURE, V466, P720, DOI 10.1038/nature09201; Stefanik DJ, 2013, NAT PROTOC, V8, P892, DOI 10.1038/nprot.2012.151; Suga H, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3325; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tucker RP, 2011, INVERTEBR BIOL, V130, P11, DOI 10.1111/j.1744-7410.2010.00219.x; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yamazaki M, 2004, J ORAL PATHOL MED, V33, P177, DOI 10.1111/j.0904-2512.2004.00087.x; Zhou ZJ, 2004, CANCER RES, V64, P4699, DOI 10.1158/0008-5472.CAN-04-0810	34	13	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124578	10.1371/journal.pone.0124578	http://dx.doi.org/10.1371/journal.pone.0124578			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876075	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800145
J	Gonzalez, M; Rojas, S; Avila, P; Cabrera, L; Villalobos, R; Palma, C; Aguayo, C; Pena, E; Gallardo, V; Guzman-Gutierrez, E; Saaz, T; Salsoso, R; Sanhueza, C; Pardo, F; Leiva, A; Sobrevia, L				Gonzalez, Marcelo; Rojas, Susana; Avila, Pia; Cabrera, Lissette; Villalobos, Roberto; Palma, Carlos; Aguayo, Claudio; Pena, Eduardo; Gallardo, Victoria; Guzman-Gutierrez, Enrique; Saez, Tamara; Salsoso, Rocio; Sanhueza, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis			Insulin Reverses D-Glucose-Increased Nitric Oxide and Reactive Oxygen Species Generation in Human Umbilical Vein Endothelial Cells	PLOS ONE			English	Article							L-ARGININE TRANSPORT; SLC29A1 PROMOTER ACTIVITY; ADENOSINE TRANSPORT; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; DIABETES-MELLITUS; EXPRESSION; DYSFUNCTION; SYNTHASE; CAT-1	Vascular tone is controlled by the L-arginine/nitric oxide (NO) pathway, and NO bioavailability is strongly affected by hyperglycaemia-induced oxidative stress. Insulin leads to high expression and activity of human cationic amino acid transporter 1 (hCAT-1), NO synthesis and vasodilation; thus, a protective role of insulin on high D-glucose-alterations in endothelial function is likely. Vascular reactivity to U46619 (thromboxane A(2) mimetic) and calcitonin gene related peptide (CGRP) was measured in KCl preconstricted human umbilical vein rings (wire myography) incubated in normal (5 mmol/L) or high (25 mmol/L) D-glucose. hCAT-1, endothelial NO synthase (eNOS), 42 and 44 kDa mitogen-activated protein kinases (p42/44(mapk)), protein kinase B/Akt (Akt) expression and activity were determined by western blotting and qRT-PCR, tetrahydrobiopterin (BH4) level was determined by HPLC, and L-arginine transport (0-1000 mu mol/L) was measured in response to 5-25 mmol/L D-glucose (0-36 hours) in passage 2 human umbilical vein endothelial cells (HUVECs). Assays were in the absence or presence of insulin and/or apocynin (nicotinamide adenine dinucleotide phosphate-oxidase [NADPH oxidase] inhibitor), tempol or Mn(III) TMPyP (SOD mimetics). High D-glucose increased hCAT-1 expression and activity, which was biphasic (peaks: 6 and 24 hours of incubation). High D-glucose-increased maximal transport velocity was blocked by insulin and correlated with lower hCAT-1 expression and SLC7A1 gene promoter activity. High D-glucose-increased transport parallels higher reactive oxygen species (ROS) and superoxide anion (O-2(center dot-)) generation, and increased U46619-contraction and reduced CGRP-dilation of vein rings. Insulin and apocynin attenuate ROS and O-2(center dot-) generation, and restored vascular reactivity to U46619 and CGRP. Insulin, but not apocynin or tempol reversed high D-glucose-increased NO synthesis; however, tempol and Mn(III) TMPyP reversed the high D- glucose-reduced BH4 level. Insulin and tempol blocked the high D-glucose-increased p42/44(mapk) phosphorylation. Vascular dysfunction caused by high D- glucose is likely attenuated by insulin through the L-arginine/NO and O-2(center dot-)/NADPH oxidase pathways. These findings are of interest for better understanding vascular dysfunction in states of foetal insulin resistance and hyperglycaemia.	[Gonzalez, Marcelo; Rojas, Susana; Avila, Pia; Cabrera, Lissette; Palma, Carlos] Univ Concepcion, Fac Biol Sci, Dept Physiol, Vasc Physiol Lab, Concepcion 4070386, Chile; [Pena, Eduardo; Gallardo, Victoria] Univ Concepcion, Fac Biol Sci, Dept Physiopathol, Concepcion 4070386, Chile; [Aguayo, Claudio] Univ Concepcion, Fac Pharm, Dept Clin Biochem & Immunol, Concepcion 4070386, Chile; [Cabrera, Lissette] Univ Diego Port, Fac Med, Dept Morphophysiol, Santiago 8370076, Chile; [Aguayo, Claudio; Guzman-Gutierrez, Enrique] Grp Res & Innovat Vasc Hlth GRIVAS Hlth, Chillan 3800708, Chile; [Guzman-Gutierrez, Enrique] Univ San Sebastian, Fac Hlth Sci, Concepcion 4080871, Chile; [Sobrevia, Luis] Univ Queensland, Fac Med & Biomed Sci, UQCCR, Herston, Qld 4029, Australia; [Sobrevia, Luis] Univ Seville, Fac Pharm, Dept Physiol, E-41012 Seville, Spain; [Saez, Tamara; Salsoso, Rocio; Sanhueza, Carlos; Pardo, Fabian; Leiva, Andrea; Sobrevia, Luis] Pontificia Univ Catolica Chile, CMPL, Div Obstet & Gynaecol, Sch Med,Fac Med, Santiago 8330024, Chile	Universidad de Concepcion; Universidad de Concepcion; Universidad de Concepcion; University Diego Portales; Universidad San Sebastian; University of Queensland; University of Sevilla; Pontificia Universidad Catolica de Chile	Gonzalez, M (corresponding author), Univ Concepcion, Fac Biol Sci, Dept Physiol, Vasc Physiol Lab, POB 160-C, Concepcion 4070386, Chile.	mgonzalezo@udec.cl; sobrevia@med.puc.cl; aaleiva@uc.cl	Sobrevia, Luis/H-9608-2016; Palma, Carlos/ABB-6084-2020; Rodriguez, Maria/AAB-1401-2021; Aguayo, Claudio/AAX-7364-2020; Gonzalez, Marcelo/O-4416-2016; Guzman-Gutierrez, Enrique/H-3536-2016	Palma, Carlos/0000-0001-6182-7501; Gonzalez, Marcelo/0000-0002-0521-3633; Guzman-Gutierrez, Enrique/0000-0001-6589-5667	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile [1110977, 11100192, 11110059, 3130583, 3140516]; International NETWORK program (CONICYT), Chile [130102]; Direccion de Investigacion, Universidad de Concepcion (DIUC), Chile [210.033.103-1.0]; Faculty of Medicine, Pontificia Universidad Catolica de Chile-PhD fellowship; Universidad de Concepcion-MSc (Chile) fellowships	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT), Chile(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); International NETWORK program (CONICYT), Chile; Direccion de Investigacion, Universidad de Concepcion (DIUC), Chile; Faculty of Medicine, Pontificia Universidad Catolica de Chile-PhD fellowship; Universidad de Concepcion-MSc (Chile) fellowships	The work was supported by the following: Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) (grant numbers 1110977, 11100192, 11110059, 3130583, 3140516), Chile; International NETWORK program (CONICYT) (grant number 130102), Chile; and Direccion de Investigacion, Universidad de Concepcion (DIUC) (grant number 210.033.103-1.0), Chile. RS is recipient of a Faculty of Medicine, Pontificia Universidad Catolica de Chile-PhD fellowship; TS and RS hold CONICYT-PhD (Chile) fellowships; PA and LC held Universidad de Concepcion-MSc (Chile) fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akamine EH, 2006, J VASC RES, V43, P309, DOI 10.1159/000093196; Banerjee M, 2006, NAT CLIN PRACT CARD, V3, P596, DOI 10.1038/ncpcardio0683; Brewster S, 2013, J AM COLL CARDIOL, V62, P677, DOI 10.1016/j.jacc.2013.01.080; Coustan DR, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2010.04.006; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; De Vriese AS, 2000, BRIT J PHARMACOL, V130, P963, DOI 10.1038/sj.bjp.0703393; Farias M, 2010, CARDIOVASC RES, V86, P45, DOI 10.1093/cvr/cvp410; Felice F, 2010, MICROVASC RES, V80, P332, DOI 10.1016/j.mvr.2010.05.004; Fernandez J, 2003, J BIOL CHEM, V278, P50000, DOI 10.1074/jbc.M305903200; Fukushima T, 1980, Methods Enzymol, V66, P429; Gonzalez M, 2004, PFLUG ARCH EUR J PHY, V448, P383; Gonzalez M, 2011, J CELL PHYSIOL, V226, P2916, DOI 10.1002/jcp.22635; GRIENDLING KK, 1994, CIRC RES, V74, P1141, DOI 10.1161/01.RES.74.6.1141; Guzman-Gutierrez E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041705; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Hayward CE, 2013, PLACENTA, V34, P281, DOI 10.1016/j.placenta.2013.01.001; Huang CC, 2009, J BIOL CHEM, V284, P32312, DOI 10.1074/jbc.M109.024471; Jayakumar T, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/403703; Kaneto H, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/453892; Karbach S, 2012, J DIABETES COMPLICAT, V26, P155, DOI 10.1016/j.jdiacomp.2012.03.011; Kohlhaas CF, 2011, BIOCHEM BIOPH RES CO, V412, P747, DOI 10.1016/j.bbrc.2011.08.048; Lindsay RS, 2007, CLIN ENDOCRINOL, V66, P322, DOI 10.1111/j.1365-2265.2006.02719.x; Liu J, 1998, AMINO ACIDS, V15, P321, DOI 10.1007/BF01320897; Pepine CJ, 2009, AM J MED, V122, P10, DOI 10.1016/j.amjmed.2009.03.003; Potdar S, 2009, MICROVASC RES, V78, P191, DOI 10.1016/j.mvr.2009.04.001; Puebla C, 2008, J CELL PHYSIOL, V215, P645, DOI 10.1002/jcp.21347; Quagliaro L, 2005, ATHEROSCLEROSIS, V183, P259, DOI 10.1016/j.atherosclerosis.2005.03.015; Roe ND, 2011, DIABETES OBES METAB, V13, P465, DOI 10.1111/j.1463-1326.2011.01369.x; Roe ND, 2012, VASC PHARMACOL, V57, P168, DOI 10.1016/j.vph.2012.02.004; Salomon C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040578; Salsoso R, 2015, PLACENTA, V36, P287, DOI 10.1016/j.placenta.2014.12.007; Sarwar N, 2010, LANCET, V375, P2215, DOI 10.1016/S0140-6736(10)60484-9; Schneider S, 2012, J PERINAT MED, V40, P511, DOI 10.1515/jpm-2012-0015; Shin S, 2011, BIOCHEM BIOPH RES CO, V414, P660, DOI 10.1016/j.bbrc.2011.09.112; Sobrevia L, 1996, J PHYSIOL-LONDON, V490, P775, DOI 10.1113/jphysiol.1996.sp021185; Sobrevia L, 2015, EXP PHYSIOL, V100, P231, DOI 10.1113/expphysiol.2014.082743; Sobrevia L, 2009, CURR VASC PHARMACOL, V7, P467, DOI 10.2174/157016109789043919; Solomon SS, 2008, LIFE SCI, V83, P305, DOI 10.1016/j.lfs.2008.06.024; Steinberger J, 2003, CIRCULATION, V107, P1448, DOI 10.1161/01.CIR.0000060923.07573.F2; Taye A, 2010, EUR J PHARMACOL, V627, P42, DOI 10.1016/j.ejphar.2009.10.045; Westermeier F, 2015, FASEB J, V29, P37, DOI 10.1096/fj.14-254219; Westgate JA, 2006, DIABETES CARE, V29, P1345, DOI 10.2337/dc05-1677; Yano M, 2004, REDOX REP, V9, P111, DOI 10.1179/135100004225004779; Zhou ZW, 2012, EUR J PHARMACOL, V697, P97, DOI 10.1016/j.ejphar.2012.09.051	44	37	38	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0122398	10.1371/journal.pone.0122398	http://dx.doi.org/10.1371/journal.pone.0122398			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875935	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700014
J	Tao, GY; Hua, J; Chen, JL				Tao, Guoyu; Hua, Jennifer; Chen, Jessica L.			Understanding Sexual Activity and Chlamydia Testing Rate Based on Linked National Survey and Medicaid Claims Data	PLOS ONE			English	Article							CARE-EFFECTIVENESS-DATA; UNITED-STATES; COVERAGE; WOMEN; CHILDREN	Background Monitoring adherence to national recommendations for annual chlamydia screening of female adolescents and young adult women is important for targeting quality improvement interventions to improve low screening rates. However, accurate measurement of rates may vary depending on the data source used to determine eligible sexually-active women. Methods The 2001-2004 NHANES data linked with Medicaid administrative data by respondent's unique identifier, the 2011-2012 NHANES data, and the 2004 and 2010 Medicaid data were used in this cross-sectional analysis. We defined self-reported sexual activity by self-reported sexual behaviors, claim-identified sexual activity by reproductive-related claims among women who had >= one healthcare claim, HEDIS-defined sexual activity by reproductive-related claims among women who were enrolled in Medicaid for >= 330 days and had >= one healthcare claim, and chlamydia tests by claims submitted in the 12 months prior to the survey interview. Results Of Medicaid women aged 18-25 years, 91.5% self-reported to be sexually-active. Of self-reported sexually-active women aged 18-25 years, 92.0% had >= one healthcare claim in the 12 months prior to the survey interview; of this subpopulation, only 58.8% were enrolled in Medicaid for >= 330 days in the 12 months prior to the survey interview; of this further subpopulation, 74.1% had healthcare claims identifying them as sexually-active in the 12 months prior to the survey interview. Of HEDIS-defined sexually-active women, 42.4% had chlamydia testing. Conclusion Our study suggests that the number of sexually-active women aged 18-25 years used as the denominator in the chlamydia testing measure could be significantly different, depending upon the definition applied and the data used. Our data highlight the limited representativeness of Medicaid population in the current HEDIS measure on chlamydia testing when a high proportion of women who were enrolled in Medicaid for <330 days had been excluded from the measure. The interventions that can improve the proportion of women who were enrolled in Medicaid for >= 330 days among all young Medicaid women are needed not only for improving health care services, but also for measuring quality of healthcare.	[Tao, Guoyu; Hua, Jennifer; Chen, Jessica L.] Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Tao, GY (corresponding author), Ctr Dis Control & Prevent, Div STD Prevent, Natl Ctr HIV AIDS Viral Hepatitis STD & TB Preven, Atlanta, GA 30333 USA.	gat3@cdc.gov	Tao, Guoyu/AAV-9345-2021					[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P362; [Anonymous], 2011, NATL HLTH STAT REPOR; Berlan ED, 2014, PEDIATRICS; Broad JM, 2013, SEX TRANSM DIS, V40, P292, DOI 10.1097/OLQ.0b013e3182809776; Centers forDisease Control and Prevention (CDC), 2012, SEX TRANSM DIS SURV; Datta SD, 2007, ANN INTERN MED, V147, P89, DOI 10.7326/0003-4819-147-2-200707170-00007; Fairbrother G, 2011, ACAD PEDIATR, V11, P318, DOI 10.1016/j.acap.2011.05.004; Khosropour CM, 2014, SEX TRANSM DIS, V41, P665, DOI 10.1097/OLQ.0000000000000186; Ku L, 2013, HEALTH AFFAIR, V32, P1576, DOI 10.1377/hlthaff.2013.0362; Lefevre ML, 2014, ANN INTERN MED; Mangione-Smith R, 2000, ARCH PEDIAT ADOL MED, V154, P1108, DOI 10.1001/archpedi.154.11.1108; Medicine CoAaSfAHa, 2014, PEDIATRICS, V134, pe302; Mirel Lisa B, 2014, Natl Health Stat Report, P1; NCQA, 2013, HEDIS 2013 TECHNICAL; Physicians. AAoF, 2014, PHYSICIANS; Tao GY, 2007, SEX TRANSM DIS, V34, P180, DOI 10.1097/01.olq.0000230437.79119.31; Tao Guoyu, 2002, Jt Comm J Qual Improv, V28, P435; Tao GY, 2012, SEX TRANSM DIS, V39, P605, DOI 10.1097/OLQ.0b013e318254c837; Wei F, 2003, AM J MANAG CARE, V9, P585; Workowski Kimberly A, 2010, MMWR Recomm Rep, V59, P1	20	4	4	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122927	10.1371/journal.pone.0122927	http://dx.doi.org/10.1371/journal.pone.0122927			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875858	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100119
J	Cueto, JA; Rodriguez, C; Vega, IA; Castro-Vazquez, A				Cueto, Juan A.; Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo			Immune Defenses of the Invasive Apple Snail Pomacea canaliculata (Caenogastropoda, Ampullariidae): Phagocytic Hemocytes in the Circulation and the Kidney	PLOS ONE			English	Article							FRESH-WATER SNAIL; VIVIPARUS-ATER GASTROPODA; ANGIOSTRONGYLUS-CANTONENSIS; BIOMPHALARIA-GLABRATA; MERCENARIA-MERCENARIA; LYMNAEA-STAGNALIS; CELLS; PROSOBRANCHIA; HEMATOPOIESIS; GRANULOCYTES	Hemocytes in the circulation and kidney islets, as well as their phagocytic responses to microorganisms and fluorescent beads, have been studied in Pomacea canaliculata, using flow cytometry, light microscopy (including confocal laser scanning microscopy) and transmission electron microscopy (TEM). Three circulating hemocyte types (hyalinocytes, agranulocytes and granulocytes) were distinguished by phase contrast microscopy of living cells and after light and electron microscopy of fixed material. Also, three different populations of circulating hemocytes were separated by flow cytometry, which corresponded to the three hemocyte types. Hyalinocytes showed a low nucleus/cytoplasm ratio, and no apparent granules in stained material, but showed granules of moderate electron density under TEM (L granules) and at least some L granules appear acidic when labeled with LysoTracker Red. Both phagocytic and non-phagocytic hyalinocytes lose most (if not all) L granules when exposed to microorganisms in vitro. The phagosomes formed differed whether hyalinocytes were exposed to yeasts or to Gram positive or Gram negative bacteria. Agranulocytes showed a large nucleus/cytoplasm ratio and few or no granules. Granulocytes showed a low nucleus/cytoplasm ratio and numerous eosinophilic granules after staining. These granules are electron dense and rod-shaped under TEM (R granules). Granulocytes may show merging of R granules into gigantic ones, particularly when exposed to microorganisms. Fluorescent bead exposure of sorted hemocytes showed phagocytic activity in hyalinocytes, agranulocytes and granulocytes, but the phagocytic index was significantly higher in hyalinocytes. Extensive hemocyte aggregates ('islets') occupy most renal hemocoelic spaces and hyalinocyte-like cells are the most frequent component in them. Presumptive glycogen deposits were observed in most hyalinocytes in renal islets (they also occur in the circulation but less frequently) and may mean that hyalinocytes participate in the storage and circulation of this compound. Injection of microorganisms in the foot results in phagocytosis by hemocytes in the islets, and the different phagosomes formed are similar to those in circulating hyalinocytes. Dispersed hemocytes were obtained after kidney collagenase digestion and cell sorting, and they were able to phagocytize fluorescent beads. A role for the kidney as an immune barrier is proposed for this snail.	[Cueto, Juan A.; Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo] Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina; [Cueto, Juan A.; Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo] Consejo Nacl Invest Cient & Tecn, Inst Histol Embriol Dr Mario H Burgos, Mendoza, Argentina; [Rodriguez, Cristian; Vega, Israel A.; Castro-Vazquez, Alfredo] Univ Nacl Cuyo, Fac Ciencias Exactas & Nat, Area Biol, RA-5500 Mendoza, Argentina	University Nacional Cuyo Mendoza; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University Nacional Cuyo Mendoza	Castro-Vazquez, A (corresponding author), Univ Nacl Cuyo, Fac Ciencias Med, Inst Fisiol, RA-5500 Mendoza, Argentina.	acastrovazquez@gmail.com		Rodriguez, Cristian/0000-0003-3289-4187	Agencia Nacional de Promocion Cientifica y Tecnologica; Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional de Cuyo; Malacological Society of London	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cuyo; Malacological Society of London	This paper was funded by grants from Agencia Nacional de Promocion Cientifica y Tecnologica (www.agencia.mincyt.gob.ar), Consejo Nacional de Investigaciones Cientificas y Tecnicas (www.conicet.gov.ar) and Universidad Nacional de Cuyo (www.uncu.edu.ar) to ACV and IAV, and a grant from the Malacological Society of London to JAC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accorsi A, 2013, FISH SHELLFISH IMMUN, V34, P1260, DOI 10.1016/j.fsi.2013.02.008; ADEMA CM, 1992, J INVERTEBR PATHOL, V59, P24, DOI 10.1016/0022-2011(92)90107-F; Andrews E. B., 1965, Journal of Zoology London, V146, P70; ANDREWS EB, 1981, J MOLLUS STUD, V47, P248; Bayne C.J., 1983, P407; Cerenius L, 2010, ADV EXP MED BIOL, V708, P239; Cheng T.C., 1981, INVERTEBRATE BLOOD C, V1, P233; CHENG TC, 1975, J INVERTEBR PATHOL, V25, P261, DOI 10.1016/0022-2011(75)90076-2; CHENG TC, 1975, ANN NY ACAD SCI, V266, P343, DOI 10.1111/j.1749-6632.1975.tb35116.x; CHENG TC, 1977, J INVERTEBR PATHOL, V30, P119, DOI 10.1016/0022-2011(77)90052-0; Ciacci C, 2009, COMP BIOCHEM PHYS B, V153, P365, DOI 10.1016/j.cbpb.2009.04.007; Cowie Robert H, 2013, Hawaii J Med Public Health, V72, P3; Crozatier M, 2011, DIS MODEL MECH, V4, P439, DOI 10.1242/dmm.007351; Cueto JA, 2013, FISH SHELLFISH IMMUN, V34, P443, DOI 10.1016/j.fsi.2012.11.035; Cueto JA, 2011, MOLLUSCAN RES, V31, P57; Fisher W.S., 1986, P25; FOLEY DA, 1977, J INVERTEBR PATHOL, V29, P321, DOI 10.1016/S0022-2011(77)80037-2; FRANCHINI A, 1990, J INVERTEBR PATHOL, V55, P28, DOI 10.1016/0022-2011(90)90028-5; Franchini A, 2000, TISSUE CELL, V32, P312, DOI 10.1054/tice.2000.0118; Giraud-Billoud M, 2013, J EXP BIOL, V216, P614, DOI 10.1242/jeb.075655; Giraud-Billoud M, 2011, COMP BIOCHEM PHYS A, V158, P506, DOI 10.1016/j.cbpa.2010.12.012; Godoy A, 1997, MEM I OSWALDO CRUZ, V92, P121, DOI 10.1590/S0074-02761997000100026; Hayes KA, 2008, DIVERS DISTRIB, V14, P701, DOI 10.1111/j.1472-4642.2008.00483.x; Hayes KA, 2012, ZOOL J LINN SOC-LOND, V166, P723, DOI 10.1111/j.1096-3642.2012.00867.x; Hyman L., 1967, INVERTEBRATES; Lemos QT, 2001, MEM I OSWALDO CRUZ, V96, P719, DOI 10.1590/S0074-02762001000500025; Loker ES, 2010, ADV EXP MED BIOL, V708, P17; Lv S, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000368; Mahilini HM, 2008, J INVERTEBR PATHOL, V97, P20, DOI 10.1016/j.jip.2007.07.007; Martin GG, 2007, J MOLLUS STUD, V73, P355, DOI 10.1093/mollus/eym032; MOHANDAS A, 1985, J INVERTEBR PATHOL, V46, P189, DOI 10.1016/0022-2011(85)90148-X; Morassutti AL, 2014, MEM I OSWALDO CRUZ, V109, P399, DOI 10.1590/0074-0276140023; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; OTTAVIANI E, 1983, DEV COMP IMMUNOL, V7, P209, DOI 10.1016/0145-305X(83)90002-2; OTTAVIANI E, 1992, CELL MOL NEUROBIOL, V12, P455, DOI 10.1007/BF00711546; Ottaviani E, 1996, PROG NEUROBIOL, V48, P421, DOI 10.1016/0301-0082(95)00049-6; OTTAVIANI E, 1988, ACTA ZOOL-STOCKHOLM, V69, P157, DOI 10.1111/j.1463-6395.1988.tb00912.x; OTTAVIANI E, 1991, TISSUE CELL, V23, P317, DOI 10.1016/0040-8166(91)90049-Y; Pickett JA, 2006, TRAFFIC, V7, P109, DOI 10.1111/j.1600-0854.2005.00372.x; Ray M, 2013, FISH SHELLFISH IMMUN, V34, P244, DOI 10.1016/j.fsi.2012.11.006; Rebelo MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057384; REVEL JP, 1960, J BIOPHYS BIOCHEM CY, V8, P575, DOI 10.1083/jcb.8.3.575; RODRIGUEZ C., 2012, BIOCELL, V36, pA113; SAKHAROV DA, 1989, ACTA BIOL HUNG, V40, P329; Scott M. I. H., 1958, Revista del Museo Argentino de las Ciencias Naturales Zool, V3, P233; SHOZAWA A, 1990, DEV COMP IMMUNOL, V14, P175, DOI 10.1016/0145-305X(90)90089-W; SMINIA T, 1974, CELL TISSUE RES, V153, P307, DOI 10.1007/BF00229161; Sminia T, 1972, CELL TISSUE RES, V130, P497; Sminia T, 1981, INVERTEBRATE BLOOD C, P191; Soderhall I, 2003, DEV COMP IMMUNOL, V27, P661, DOI 10.1016/S0145-305X(03)00039-9; Thiengo Silvana Carvalho, 2013, Hawaii J Med Public Health, V72, P18; Travers MA, 2008, FISH SHELLFISH IMMUN, V24, P400, DOI 10.1016/j.fsi.2007.10.001; YOUSIF F, 1980, Z PARASITENKD, V62, P179, DOI 10.1007/BF00927863	54	40	40	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123964	10.1371/journal.pone.0123964	http://dx.doi.org/10.1371/journal.pone.0123964			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893243	gold, Green Submitted, Green Published			2022-12-27	WOS:000353211700065
J	Li, XT; Li, XQ; Hu, XM; Qiu, XY				Li, Xian-Tao; Li, Xiao-Qing; Hu, Xi-Mu; Qiu, Xiao-Yue			The Inhibitory Effects of Ca2+ Channel Blocker Nifedipine on Rat Kv2.1 Potassium Channels	PLOS ONE			English	Article							SHAKER K+ CHANNEL; DELAYED RECTIFIER; TRANSIENT OUTWARD; VOLTAGE SENSOR; MESSENGER-RNA; HUMAN HEART; CURRENTS; EXPRESSION; INACTIVATION; MECHANISMS	It is well documented that nifedipine, a commonly used dihydropyridine Ca2+ channel blocker, has also significant interactions with voltage-gated K+ (Kv) channels. But to date, little is known whether nifedipine exerted an action on Kv2.1 channels, a member of the Shab subfamily with slow inactivation. In the present study, we explored the effects of nifedipine on rat Kv2.1 channels expressed in HEK293 cells. Data from whole-cell recording showed that nifedipine substantially reduced Kv2.1 currents with the IC50 value of 37.5 +/- 5.7 mu M and delayed the time course of activation without effects on the activation curve. Moreover, this drug also significantly shortened the duration of inactivation and deactivation of Kv2.1 currents in a voltage-dependent manner. Interestingly, the half-maximum inactivation potential (V1/2) of Kv2.1 currents was -11.4 +/- 0.9 mV in control and became -38.5 +/- 0.4 mV after application of 50 mu M nifedipine. The large hyperpolarizing shift (27 mV) of the inactivation curve has not been reported previously and may result in more inactivation for outward delayed rectifier K+ currents mediated by Kv2.1 channels at repolarization phases. The Y380R mutant significantly increased the binding affinity of nifedipine to Kv2.1 channels, suggesting an interaction of nifedipine with the outer mouth region of this channel. The data present here will be helpful to understand the diverse effects exerted by nifedipine on various Kv channels.	[Li, Xian-Tao; Li, Xiao-Qing] South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan, Peoples R China; [Hu, Xi-Mu; Qiu, Xiao-Yue] South Cent Univ Nationalities, Wuhan, Peoples R China	South Central Minzu University; South Central Minzu University	Li, XT (corresponding author), South Cent Univ Nationalities, Coll Life Sci, Dept Neurosci, Wuhan, Peoples R China.	xiantaoli@outlook.com						BARRY DM, 1995, CIRC RES, V77, P361, DOI 10.1161/01.RES.77.2.361; Bett GCL, 2006, BIOCHEM BIOPH RES CO, V340, P1167, DOI 10.1016/j.bbrc.2005.12.135; Bezanilla F, 2002, J GEN PHYSIOL, V120, P465, DOI 10.1085/jgp.20028660; Brahmajothi MV, 1996, CIRC RES, V78, P1083, DOI 10.1161/01.RES.78.6.1083; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; Cheng YM, 2011, BIOPHYS J, V101, P651, DOI 10.1016/j.bpj.2011.06.025; De Leeuw PW, 2002, BLOOD PRESSURE, V11, P71; Dixon JE, 1996, EUR J NEUROSCI, V8, P183, DOI 10.1111/j.1460-9568.1996.tb01179.x; DREWE JA, 1992, J NEUROSCI, V12, P538; Du J, 2000, J PHYSIOL-LONDON, V522, P19, DOI 10.1111/j.1469-7793.2000.t01-2-00019.xm; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Feng JL, 1997, J PHARMACOL EXP THER, V281, P384; Frolov RV, 2010, BRIT J PHARMACOL, V159, P405, DOI 10.1111/j.1476-5381.2009.00539.x; Gandhi CS, 2002, J GEN PHYSIOL, V120, P455, DOI 10.1085/jgp.20028678; Gao Z, 2005, BRIT J PHARMACOL, V144, P595, DOI 10.1038/sj.bjp.0706113; GOTOH Y, 1991, AM J PHYSIOL, V260, pH1737, DOI 10.1152/ajpheart.1991.260.5.H1737; GRISSMER S, 1994, MOL PHARMACOL, V45, P1227; JACOBS ER, 1990, J PHARMACOL EXP THER, V255, P459; JAHNEL U, 1994, N-S ARCH PHARMACOL, V349, P87; Kerschensteiner D, 2003, J BIOL CHEM, V278, P18154, DOI 10.1074/jbc.M213117200; Klemic KG, 1998, BIOPHYS J, V74, P1779, DOI 10.1016/S0006-3495(98)77888-9; Kodirov SA, 2004, AM J PHYSIOL-HEART C, V286, pH368, DOI 10.1152/ajpheart.00303.2003; Koidl B, 1997, EUR J PHARMACOL, V322, P243, DOI 10.1016/S0014-2999(96)00995-8; Kumar S, 2003, DRUG AGING, V20, P805, DOI 10.2165/00002512-200320110-00002; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin S, 2001, AM J PHYSIOL-HEART C, V280, pH1160, DOI 10.1152/ajpheart.2001.280.3.H1160; Malin SA, 2002, J NEUROSCI, V22, P10094; Milligan CJ, 2000, BIOPHYS J, V78, P1852, DOI 10.1016/S0006-3495(00)76734-8; Milnes JT, 2003, FEBS LETT, V547, P20, DOI 10.1016/S0014-5793(03)00662-8; Misonou H, 2005, NEUROTOXICOLOGY, V26, P743, DOI 10.1016/j.neuro.2005.02.003; Mohapatra DP, 2006, J NEUROSCI, V26, P685, DOI 10.1523/JNEUROSCI.4620-05.2006; Nerbonne JM, 2001, CIRC RES, V89, P944, DOI 10.1161/hh2301.100349; Rasmusson RL, 1998, CIRC RES, V82, P739, DOI 10.1161/01.RES.82.7.739; RODEN DM, 1993, AM J CARDIOL, V72, pB44, DOI 10.1016/0002-9149(93)90040-J; SANGUINETTI MC, 1990, J GEN PHYSIOL, V96, P195, DOI 10.1085/jgp.96.1.195; Scholle A, 2004, BIOPHYS J, V87, P873, DOI 10.1529/biophysj.104.040550; SLAWSKY MT, 1994, J PHARMACOL EXP THER, V269, P66; Starace DM, 1997, NEURON, V19, P1319, DOI 10.1016/S0896-6273(00)80422-5; TAMKUN MM, 1991, FASEB J, V5, P331, DOI 10.1096/fasebj.5.3.2001794; Tammaro P, 2005, EUR BIOPHYS J BIOPHY, V34, P42, DOI 10.1007/s00249-004-0423-2; TRIMMER JS, 1993, FEBS LETT, V324, P205, DOI 10.1016/0014-5793(93)81394-F; UEHARA A, 1985, J GEN PHYSIOL, V85, P621, DOI 10.1085/jgp.85.5.621; VANDONGEN AMJ, 1990, NEURON, V5, P433, DOI 10.1016/0896-6273(90)90082-Q; Vega-Saenz de Miera E, 2004, MOL BRAIN RES, V123, P91, DOI 10.1016/j.molbrainres.2004.01.004; Wang SM, 2003, J PHYSIOL-LONDON, V546, P387, DOI 10.1113/jphysiol.2002.029512; White William B, 2003, Clin Cardiol, V26, pII7; Xu HD, 1999, CIRC RES, V85, P623, DOI 10.1161/01.RES.85.7.623; Yellen G, 2002, NATURE, V419, P35, DOI 10.1038/nature00978; Yi BA, 2001, P NATL ACAD SCI USA, V98, P11016, DOI 10.1073/pnas.191351798; Zhang ST, 1999, CIRC RES, V84, P989, DOI 10.1161/01.RES.84.9.989; Zhang X, 1997, J PHARMACOL EXP THER, V281, P1247; Zhang XL, 2009, NEUROSCIENCE, V161, P184, DOI 10.1016/j.neuroscience.2009.03.012	53	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124602	10.1371/journal.pone.0124602	http://dx.doi.org/10.1371/journal.pone.0124602			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893973	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700108
J	Reddycherla, AV; Meinert, I; Reinhold, A; Reinhold, D; Schraven, B; Simeonil, L				Reddycherla, Amarendra V.; Meinert, Ines; Reinhold, Annegret; Reinhold, Dirk; Schraven, Burkhart; Simeonil, Luca			miR-20a Inhibits TCR-Mediated Signaling and Cytokine Production in Human Naive CD4(+) T Cells	PLOS ONE			English	Article							MIR-17-92 CLUSTER; MIR-17-SIMILAR-TO-92 FAMILY; ACTIVATION KINETICS; REGULATES EFFECTOR; MAP KINASE; RESPONSES; MICRORNAS; DIFFERENTIATION; INTERLEUKIN-6; EXPRESSION	Upon TCR stimulation by peptide-MHC complexes, CD4(+) T cells undergo activation and proliferation. This process will ultimately culminate in T-cell differentiation and the acquisition of effector functions. The production of specific cytokines by differentiated CD4(+) T cells is crucial for the generation of the appropriate immune response. Altered CD4(+) T-cell activation and cytokine production result in chronic inflammatory conditions and autoimmune disorders. miRNAs have been shown to be important regulators of T-cell biology. In this study, we have focused our investigation on miR-20a, a member of the miR-17-92 cluster, whose expression is decreased in patients suffering from multiple sclerosis. We have found that miR-20a is rapidly induced upon TCR-triggering in primary human naive CD4(+) T cells and that its transcription is regulated in a Erk-, NF-kappa B-, and Ca++-dependent manner. We have further shown that overexpression of miR-20a inhibits TCR-mediated signaling but not the proliferation of primary human naive CD4(+) T cells. However, miR-20a overexpression strongly suppresses IL-10 secretion and moderately decreases IL-2, IL-6 and IL8 production, which are crucial regulators of inflammatory responses. Our study suggests that miR-20a is a new player in the regulation of TCR signaling strength and cytokine production.	[Reddycherla, Amarendra V.; Meinert, Ines; Reinhold, Annegret; Reinhold, Dirk; Schraven, Burkhart; Simeonil, Luca] Otto Von Guericke Univ, Inst Mol & Clin Immunol, Magdeburg, Germany; [Schraven, Burkhart] Helmholtz Ctr Infect Res, Dept Immune Control, Braunschweig, Germany	Otto von Guericke University; Helmholtz Association; Helmholtz-Center for Infection Research	Simeonil, L (corresponding author), Otto Von Guericke Univ, Inst Mol & Clin Immunol, Leipziger Str 44, Magdeburg, Germany.	Iuca.simeoni@med.ovgu.de	Simeoni, Luca/G-2121-2013		Deutsche Forschung Gemeinschaft (DFG) [GRK1167/TP12, SFB854/TP19]	Deutsche Forschung Gemeinschaft (DFG)(German Research Foundation (DFG))	The work was supported by grants from the Deutsche Forschung Gemeinschaft (DFG) to LS and BS (GRK1167/TP12), and to LS (SFB854/TP19). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Arndt B, 2013, J IMMUNOL METHODS, V387, P276, DOI 10.1016/j.jim.2012.11.006; Assier E, 2010, JOINT BONE SPINE, V77, P532, DOI 10.1016/j.jbspin.2010.07.007; Baumjohann D, 2013, NAT IMMUNOL, V14, P840, DOI 10.1038/ni.2642; Buckler JL, 2008, IMMUNOL REV, V224, P239, DOI 10.1111/j.1600-065X.2008.00650.x; Cebrian M, 1998, J EXP MED, V28, P1621; Cox MB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012132; Dodeller F, 2005, EUR J IMMUNOL, V35, P3631, DOI 10.1002/eji.200535029; Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798; Dumont FJ, 1998, J IMMUNOL, V160, P2579; Ebisuya M, 2005, J CELL SCI, V118, P2997, DOI 10.1242/jcs.02505; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Graves Paul, 2012, Genomics Proteomics & Bioinformatics, V10, P239, DOI 10.1016/j.gpb.2012.06.004; Hutchins AP, 2013, BRIEF FUNCT GENOMICS, V12, P489, DOI 10.1093/bfgp/elt028; Jiang S, 2011, BLOOD, V118, P5487, DOI 10.1182/blood-2011-05-355644; Kang SG, 2013, NAT IMMUNOL, V14, P849, DOI 10.1038/ni.2648; Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008; Liston A, 2012, CELL MOL LIFE SCI, V69, P3533, DOI 10.1007/s00018-012-1124-0; Liu SQ, 2014, J BIOL CHEM, V289, P12446, DOI 10.1074/jbc.M114.550723; LOPEZCABRERA M, 1993, J EXP MED, V178, P537, DOI 10.1084/jem.178.2.537; Lu LF, 2009, IMMUNITY, V30, P80, DOI 10.1016/j.immuni.2008.11.010; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Milner JD, 2010, J IMMUNOL, V184, P6569, DOI 10.4049/jimmunol.1000674; Ng THS, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00129; NUNES J, 1991, MOL IMMUNOL, V28, P427, DOI 10.1016/0161-5890(91)90156-E; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; OPPENHEIM JJ, 1991, ANNU REV IMMUNOL, V9, P617, DOI 10.1146/annurev.iy.09.040191.003153; Poltorak M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-4; Psathas JN, 2013, BLOOD, V122, P4220, DOI 10.1182/blood-2012-12-473090; Rincon M, 2012, TRENDS IMMUNOL, V33, P571, DOI 10.1016/j.it.2012.07.003; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; Saraiva M, 2009, IMMUNITY, V31, P209, DOI 10.1016/j.immuni.2009.05.012; Skinner JPJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088997; Sloan DD, 2007, J VIROL, V81, P12504, DOI 10.1128/JVI.01111-07; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Stittrich AB, 2010, NAT IMMUNOL, V11, P1057, DOI 10.1038/ni.1945; Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200; Tanaka T, 2014, SEMIN IMMUNOL, V26, P88, DOI 10.1016/j.smim.2014.01.009; Taub DD, 1996, J CLIN INVEST, V97, P1931, DOI 10.1172/JCI118625; Trompeter HI, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016138; van Haaften G, 2010, GENE DEV, V24, P1, DOI 10.1101/gad.1887110; van Panhuys N, 2014, IMMUNITY, V41, P63, DOI 10.1016/j.immuni.2014.06.003; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; WEISS A, 1994, CELL, V76, P263, DOI 10.1016/0092-8674(94)90334-4; Wu TQ, 2012, P NATL ACAD SCI USA, V109, P9965, DOI 10.1073/pnas.1207327109; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Xue F, 2013, GENES IMMUN, V14, P1, DOI [10.1038/gene.2012.54, DOI 10.1038/GENE.2012.54]; Yamane H, 2013, IMMUNOL REV, V252, P12, DOI 10.1111/imr.12032; Yu ZR, 2010, P NATL ACAD SCI USA, V107, P8231, DOI 10.1073/pnas.1002080107; Zhang MM, 2011, J IMMUNOL, V186, P4716, DOI 10.4049/jimmunol.1002989; Zhu DH, 2013, J ALLERGY CLIN IMMUN, V132, P426, DOI 10.1016/j.jaci.2013.02.005	55	21	22	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125311	10.1371/journal.pone.0125311	http://dx.doi.org/10.1371/journal.pone.0125311			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884400	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000157
J	Shen, M; Zhao, DK; Qiao, Q; Liu, L; Wang, JL; Cao, GH; Li, T; Zhao, ZW				Shen, Mi; Zhao, Da-Ke; Qiao, Qin; Liu, Lei; Wang, Jun-Ling; Cao, Guan-Hua; Li, Tao; Zhao, Zhi-Wei			Identification of Glutathione S-Transferase (GST) Genes from a Dark Septate Endophytic Fungus (Exophiala pisciphila) and Their Expression Patterns under Varied Metals Stress	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; HEAVY-METAL; PHANEROCHAETE-CHRYSOSPORIUM; SUPERGENE FAMILY; IN-VITRO; TOLERANCE; EVOLUTION; DSE; SUPERFAMILY; TOXICITY	Glutathione S-transferases (GSTs) compose a family of multifunctional enzymes that play important roles in the detoxification of xenobiotics and the oxidative stress response. In the present study, twenty four GST genes from the transcriptome of ametal-tolerant dark septate endophyte (DSE), Exophiala pisciphila, were identified based on sequence homology, and their responses to various heavy metal exposures were also analyzed. Phylogenetic analysis showed that the 24 GST genes from E. pisciphila (EpGSTs) were divided into eight distinct classes, including seven cytosolic classes and one mitochondrial metaxin 1-like class. Moreover, the variable expression patterns of these EpGSTs were observed under different heavy metal stresses at their effective concentrations for inhibiting growth by 50%(EC50). Lead (Pb) exposure caused the up-regulation of all EpGSTs, while cadmium (Cd), copper (Cu) and zinc (Zn) treatments led to the significant up-regulation of most of the EpGSTs (p < 0.05 to p < 0.001). Furthermore, although heavy metal-specific differences in performance were observed under various heavy metals in Escherichia coli BL21 (DE3) transformed with EpGSTN-31, the overexpression of this gene was able to enhance the heavy metal tolerance of the host cells. These results indicate that E. Pisciphilaharbored a diverse of GST genes and the up-regulated EpGSTs are closely related to the heavy metal tolerance of E. pisciphila. The study represents the first investigation of the GST family in E. pisciphila and provides a primary interpretation of heavymetal detoxification for E. pisciphila.	[Shen, Mi; Zhao, Da-Ke; Wang, Jun-Ling; Cao, Guan-Hua; Li, Tao; Zhao, Zhi-Wei] Yunnan Univ, Key Lab Conservat & Utilizat Bioresources, Kunming, Yunnan, Peoples R China; [Shen, Mi; Zhao, Da-Ke; Wang, Jun-Ling; Cao, Guan-Hua; Li, Tao; Zhao, Zhi-Wei] Yunnan Univ, Key Lab Microbial Divers Southwest China, Minist Educ, Kunming, Yunnan, Peoples R China; [Zhao, Da-Ke; Qiao, Qin; Zhao, Zhi-Wei] Yunnan Univ, Sch Agr, Kunming, Yunnan, Peoples R China; [Liu, Lei] Yunnan Univ, Sch Life Sci, Kunming, Yunnan, Peoples R China	Yunnan University; Yunnan University; Yunnan University; Yunnan University	Zhao, ZW (corresponding author), Yunnan Univ, Key Lab Conservat & Utilizat Bioresources, Cuihu North Rd 2, Kunming, Yunnan, Peoples R China.	zhaozhw@ynu.edu.cn		Jun-Ling, Wang/0000-0002-1067-3300	National Natural Science Foundation of China [31160009, 31460114, 41161083, 41461073]; Key Project of Applied Basic Research of Yunnan [2013FA001]; Postdoctoral Sustentation Fund through Yunnan University; Young Academic and Technical Leader Raising Foundation of Yunnan Province [2012HB006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Project of Applied Basic Research of Yunnan; Postdoctoral Sustentation Fund through Yunnan University; Young Academic and Technical Leader Raising Foundation of Yunnan Province	This work was supported by the National Natural Science Foundation of China (31160009, ZWZ; 31460114, ZWZ; 41161083, TL; 41461073, TL, http://npd.nsfc.gov.cn/fundingProjectSearchAction.action!search.action). The funders had the role in study design, data collection and analysis, and decision to publish. This work was also supported by the Key Project of Applied Basic Research of Yunnan (2013FA001, ZWZ) the Postdoctoral Sustentation Fund supported through Yunnan University and the Young Academic and Technical Leader Raising Foundation of Yunnan Province (2012HB006, D KZ), who had the role in preparation of the manuscript.	Armstrong LC, 1997, J BIOL CHEM, V272, P6510, DOI 10.1074/jbc.272.10.6510; Basantani M, 2007, CAN J BOT, V85, P443, DOI 10.1139/B07-033; Baudin-Baillieu A, 2003, MOL BIOL CELL, V14, P3449, DOI 10.1091/mbc.e03-01-0007; Dixit P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016360; Edwards R, 2005, METHOD ENZYMOL, V401, P169, DOI 10.1016/S0076-6879(05)01011-6; Foley V, 1998, BIOCHEM J, V333, P839, DOI 10.1042/bj3330839; Frova C, 2006, BIOMOL ENG, V23, P149, DOI 10.1016/j.bioeng.2006.05.020; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; Garcera A, 2010, FEMS YEAST RES, V10, P422, DOI 10.1111/j.1567-1364.2010.00613.x; Gonzalez-Guerrero Manuel, 2009, P107, DOI 10.1007/978-3-540-87978-7_8; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Hyde KD, 2008, FUNGAL DIVERS, V33, P163; Jain M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-73; Jeppesen MG, 2003, J BIOL CHEM, V278, P47190, DOI 10.1074/jbc.M306630200; Kumar S, 2013, PLANT MOL BIOL REP, V31, P569, DOI 10.1007/s11105-012-0524-5; Kumar S, 2013, J HAZARD MATER, V248, P228, DOI 10.1016/j.jhazmat.2013.01.004; Lan T, 2009, PLANT CELL, V21, P3749, DOI 10.1105/tpc.109.070219; Lee KW, 2008, AQUAT TOXICOL, V89, P158, DOI 10.1016/j.aquatox.2008.06.011; Li T, 2011, SCI TOTAL ENVIRON, V409, P1069, DOI 10.1016/j.scitotenv.2010.12.012; Liu D, 2013, MOL BIOL+, V47, P515, DOI 10.1134/S0026893313040109; Liu YJ, 2013, PLANT PHYSIOL, V161, P773, DOI 10.1104/pp.112.205815; Mannervik B, 2012, J BIOL CHEM, V287, P6072, DOI 10.1074/jbc.X112.342675; Mariani D, 2008, REDOX REP, V13, P246, DOI 10.1179/135100008X309028; Mathieu Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080298; McGoldrick S, 2005, FEMS MICROBIOL LETT, V242, P1, DOI 10.1016/j.femsle.2004.10.033; Morel M, 2013, MICROB BIOTECHNOL, V6, P248, DOI 10.1111/1751-7915.12015; Morel M, 2009, CELL MOL LIFE SCI, V66, P3711, DOI 10.1007/s00018-009-0104-5; Nair PMG, 2011, AQUAT TOXICOL, V101, P550, DOI 10.1016/j.aquatox.2010.12.006; Ovecka M, 2014, BIOTECHNOL ADV, V32, P73, DOI 10.1016/j.biotechadv.2013.11.011; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; Regvar M, 2010, PLANT SOIL, V330, P345, DOI 10.1007/s11104-009-0207-7; Rojas-Loria CC, 2014, ACTA PHYSIOL PLANT, V36, P2501, DOI 10.1007/s11738-014-1623-8; Sato I, 2009, J BIOL CHEM, V284, P8042, DOI 10.1074/jbc.M807771200; Sawicki R, 2003, BIOCHEM J, V370, P661, DOI 10.1042/BJ20021287; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Thuillier A, 2013, FEBS LETT, V587, P2125, DOI 10.1016/j.febslet.2013.05.031; Thuillier Anne, 2011, Int J Evol Biol, V2011, P938308, DOI 10.4061/2011/938308; Winer J, 1999, ANAL BIOCHEM, V270, P41, DOI 10.1006/abio.1999.4085; Wymelenberg AV, 2011, APPL ENVIRON MICROB, V77, P4499, DOI 10.1128/AEM.00508-11; Wysocki R, 2010, FEMS MICROBIOL REV, V34, P925, DOI 10.1111/j.1574-6976.2010.00217.x; Yu XL, 2012, COMP BIOCHEM PHYS B, V161, P356, DOI 10.1016/j.cbpb.2011.12.009; Zhang LB, 2012, COMP BIOCHEM PHYS C, V155, P517, DOI 10.1016/j.cbpc.2012.01.002; Zhang WW, 2013, J HAZARD MATER, V261, P646, DOI 10.1016/j.jhazmat.2013.08.023; Zhang Y, 2013, SOIL SEDIMENT CONTAM, V22, P532, DOI 10.1080/15320383.2013.750267; Zhang YJ, 2008, J MICROBIOL, V46, P624, DOI 10.1007/s12275-008-0163-6; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhao D, 2015, MICROBIOL RES, V170, P27, DOI 10.1016/j.micres.2014.09.005; Zhou WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056604	48	38	41	5	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123418	10.1371/journal.pone.0123418	http://dx.doi.org/10.1371/journal.pone.0123418			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884726	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000060
J	Speiser, JL; Lee, WM; Karvellas, CJ				Speiser, Jaime Lynn; Lee, William M.; Karvellas, Constantine J.		US Acute Liver Failure Study Grp	Predicting Outcome on Admission and Post-Admission for Acetaminophen-Induced Acute Liver Failure Using Classification and Regression Tree Models	PLOS ONE			English	Article							TRANSPLANTATION; SURVIVAL	Background/Aim Assessing prognosis for acetaminophen-induced acute liver failure (APAP-ALF) patients often presents significant challenges. King's College (KCC) has been validated on hospital admission, but little has been published on later phases of illness. We aimed to improve determinations of prognosis both at the time of and following admission for APAP-ALF using Classification and Regression Tree (CART) models. Methods CART models were applied to US ALFSG registry data to predict 21-day death or liver transplant early (on admission) and post-admission (days 3-7) for 803 APAP-ALF patients enrolled 01/1998-09/2013. Accuracy in prediction of outcome (AC), sensitivity (SN), specificity (SP), and area under receiver-operating curve (AUROC) were compared between 3 models: KCC (INR, creatinine, coma grade, pH), CART analysis using only KCC variables (KCC-CART) and a CART model using new variables (NEW-CART). Results Traditional KCC yielded 69% AC, 90% SP, 27% SN, and 0.58 AUROC on admission, with similar performance post-admission. KCC-CART at admission offered predictive 66% AC, 65% SP, 67% SN, and 0.74 AUROC. Post-admission, KCC-CART had predictive 82% AC, 86% SP, 46% SN and 0.81 AUROC. NEW-CART models using MELD (Model for end stage liver disease), lactate and mechanical ventilation on admission yielded predictive 72% AC, 71% SP, 77% SN and AUROC 0.79. For later stages, NEW-CART (MELD, lactate, coma grade) offered predictive AC 86%, SP 91%, SN 46%, AUROC 0.73. Conclusion CARTs offer simple prognostic models for APAP-ALF patients, which have higher AUROC and SN than KCC, with similar AC and negligibly worse SP. Admission and post-admission predictions were developed.	[Speiser, Jaime Lynn] Med Univ S Carolina, Dept Publ Hlth Sci, Charleston, SC 29425 USA; [Lee, William M.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Digest & Liver Dis, Dallas, TX 75390 USA; [Karvellas, Constantine J.] Univ Alberta, Div Hepatol & Crit Care Med, Edmonton, AB, Canada	Medical University of South Carolina; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Alberta	Karvellas, CJ (corresponding author), Univ Alberta, Div Hepatol & Crit Care Med, Edmonton, AB, Canada.	dean.karvellas@ualberta.ca		Karvellas, Constantine/0000-0002-1555-1089	National Institutes of Health (from National Institute of Diabetes and Digestive and Kidney Diseases) [U-01 58369]	National Institutes of Health (from National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was sponsored by the National Institutes of Health grant U-01 58369 (from National Institute of Diabetes and Digestive and Kidney Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguiar FS, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-40; Antoniades CG, 2008, J HEPATOL, V49, P845, DOI 10.1016/j.jhep.2008.08.009; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Audimoolam VK, 2014, CRIT CARE MED, V42, P592, DOI 10.1097/01.ccm.0000435666.15070.d5; Bernal W, 2002, LANCET, V359, P558, DOI 10.1016/S0140-6736(02)07743-7; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Bernuau J, 1990, Rev Prat, V40, P1652; Breiman L, 1984, CLASSIFICATION AND R; Clemmesen JO, 1999, HEPATOLOGY, V29, P648, DOI 10.1002/hep.510290309; Fagan E, 1996, BRIT MED J, V313, P1417, DOI 10.1136/bmj.313.7070.1417; Garzotto M, 2005, J CLIN ONCOL, V23, P4322, DOI 10.1200/JCO.2005.11.136; GORDON L, 1985, CANCER TREAT REP, V69, P1065; Hubbard AE, 2010, EPIDEMIOLOGY, V21, P467, DOI 10.1097/EDE.0b013e3181caeb90; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Karvellas CJ, 2010, LIVER INT, V30, P826, DOI 10.1111/j.1478-3231.2010.02243.x; Koch DG, 2012, HEPATOLOGY, V56, p964A; Larson AM, 2005, HEPATOLOGY, V42, P1364, DOI 10.1002/hep.20948; Nakayama N, 2012, J GASTROENTEROL, V47, P664, DOI 10.1007/s00535-012-0529-8; OGRADY JG, 1993, LANCET, V342, P273; OGRADY JG, 1989, GASTROENTEROLOGY, V97, P439, DOI 10.1016/0016-5085(89)90081-4; PAUWELS A, 1993, J HEPATOL, V17, P124, DOI 10.1016/S0168-8278(05)80532-X; Reddy KR, 2012, HEPATOLOGY, V56, p246A; Schmidt LE, 2007, HEPATOLOGY, V45, P789, DOI 10.1002/hep.21503; Schmidt LE, 2002, HEPATOLOGY, V36, P659, DOI 10.1053/jhep.2002.35069; Shakil AO, 2000, LIVER TRANSPLANT, V6, P163, DOI 10.1016/S1527-6465(00)80005-2; Simpson KJ, 2009, LIVER TRANSPLANT, V15, P600, DOI 10.1002/lt.21681; Sing T., 2005, BIOINFORMATICS, V21; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Team RDC, 2019, R LANG ENV STAT COMP; Therneau TM., 2015, INTRO RECURSIVE PART	30	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122929	10.1371/journal.pone.0122929	http://dx.doi.org/10.1371/journal.pone.0122929			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885260	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000044
J	Zhang, CJ; Hou, YQ; Hao, QN; Chen, HF; Chen, LM; Yuan, SL; Shan, ZH; Zhang, XJ; Yang, ZL; Qiu, DZ; Zhou, XA; Huang, WJ				Zhang, Chanjuan; Hou, Yuqing; Hao, Qingnan; Chen, Haifeng; Chen, Limiao; Yuan, Songli; Shan, Zhihui; Zhang, Xiaojuan; Yang, Zhonglu; Qiu, Dezhen; Zhou, Xinan; Huang, Wenjun			Genome-Wide Survey of the Soybean GATA Transcription Factor Gene Family and Expression Analysis under Low Nitrogen Stress	PLOS ONE			English	Article							ZINC-FINGER PROTEIN; CHLOROPHYLL BIOSYNTHESIS; MEDIATED TRANSFORMATION; CHLOROPLAST DEVELOPMENT; REGULATORY ELEMENTS; NEUROSPORA-CRASSA; REDUCTASE GENE; ARABIDOPSIS; LIGHT; PATTERNS	GATA transcription factors are transcriptional regulatory proteins that contain a characteristic type-IV zinc finger DNA-binding domain and recognize the conserved GATA motif in the promoter sequence of target genes. Previous studies demonstrated that plant GATA factors possess critical functions in developmental control and responses to the environment. To date, the GATA factors in soybean (Glycine max) have yet to be characterized. Thus, this study identified 64 putative GATA factors from the entire soybean genomic sequence. The chromosomal distributions, gene structures, duplication patterns, phylogenetic tree, tissue expression patterns, and response to low nitrogen stress of the 64 GATA factors in soybean were analyzed to further investigate the functions of these factors. Results indicated that segmental duplication predominantly contributed to the expansion of the GATA factor gene family in soybean. These GATA proteins were phylogenetically clustered into four distinct subfamilies, wherein their gene structure and motif compositions were considerably conserved. A comparative phylogenetic analysis of the GATA factor zinc finger domain sequences in soybean, Arabidopsis (Arabidopsis thaliana), and rice (Oryza sativa) revealed four major classes. The GATA factors in soybean exhibited expression diversity among different tissues; some of these factors showed tissue-specific expression patterns. Numerous GATA factors displayed upregulation or downregulation in soybean leaf in response to low nitrogen stress, and two GATA factors GATA44 and GATA58 were likely to be involved in the regulation of nitrogen metabolism in soybean. Overexpression of GmGATA44 complemented the reduced chlorophyll phenotype of the Arabidopsis ortholog AtGATA21 mutant, implying that GmGATA44 played an important role in modulating chlorophyll biosynthesis. Overall, our study provides useful information for the further analysis of the biological functions of GATA factors in soybean and other crops.	[Zhang, Chanjuan; Hou, Yuqing; Hao, Qingnan; Chen, Haifeng; Chen, Limiao; Yuan, Songli; Shan, Zhihui; Zhang, Xiaojuan; Yang, Zhonglu; Qiu, Dezhen; Zhou, Xinan] Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China; [Huang, Wenjun] Chinese Acad Sci, Key Lab Plant Germplasm Enhancement & Specialty A, Wuhan Bot Garden, Wuhan, Peoples R China	Chinese Academy of Agricultural Sciences; Oil Crops Research Institute, CAAS; Ministry of Agriculture & Rural Affairs; Chinese Academy of Sciences; Wuhan Botanical Garden, CAS	Zhou, XA (corresponding author), Chinese Acad Agr Sci, Key Lab Oil Crop Biol, Minist Agr, Oil Crops Res Inst, Wuhan, Peoples R China.	zhouxinan@caas.cn; wjhuang@wbgcas.cn	HUANG, WENJUN/GXM-9167-2022	Yuan, Songli/0000-0001-8558-1454	National Transgenic Project [2014ZX08004-005]; Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China [31201153]	National Transgenic Project; Agricultural Science and Technology Innovation Program; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from the National Transgenic Project (No. 2014ZX08004-005), Agricultural Science and Technology Innovation Program, and National Natural Science Foundation of China (No. 31201153). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amarasinghe BHRR, 1998, PLANTA, V206, P44, DOI 10.1007/s004250050372; Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198; Bi YM, 2005, PLANT J, V44, P680, DOI 10.1111/j.1365-313X.2005.02568.x; BUZBY JS, 1990, PLANT CELL, V2, P805, DOI 10.1105/tpc.2.8.805; Cannon Ethalinda K S, 2011, Int J Plant Genomics, V2011, P373875, DOI 10.1155/2011/373875; Carre IA, 1995, PLANT CELL, V7, P2039, DOI 10.2307/3870149; CASTRESANA C, 1988, EMBO J, V7, P1929, DOI 10.1002/j.1460-2075.1988.tb03030.x; Chiang YH, 2012, PLANT PHYSIOL, V160, P332, DOI 10.1104/pp.112.198705; DANIELVEDELE F, 1993, MOL GEN GENET, V240, P365, DOI 10.1007/BF00280388; Eckhardt U, 2004, PLANT MOL BIOL, V56, P1, DOI 10.1007/s11103-004-2331-3; FU YH, 1990, MOL CELL BIOL, V10, P1056, DOI 10.1128/MCB.10.3.1056; GIULIANO G, 1988, P NATL ACAD SCI USA, V85, P7089, DOI 10.1073/pnas.85.19.7089; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Guo Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076809; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hao QN, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-525; Hudson D, 2013, PLANT PHYSIOL, V162, P132, DOI 10.1104/pp.113.217265; Hudson D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026765; JARAI G, 1992, CURR GENET, V21, P37, DOI 10.1007/BF00318652; Jeong MJ, 2003, BIOCHEM BIOPH RES CO, V300, P555, DOI 10.1016/S0006-291X(02)02892-9; Kereszt A, 2007, NAT PROTOC, V2, P948, DOI 10.1038/nprot.2007.141; Kim S, 2013, PLANT CELL, V25, P4984, DOI 10.1105/tpc.113.119172; Kong H, 2007, PLANT J, V50, P873, DOI 10.1111/j.1365-313X.2007.03097.x; LAM E, 1990, PLANT CELL, V2, P857, DOI 10.1105/tpc.2.9.857; Li XX, 2014, APPL MICROBIOL BIOT, V98, P2805, DOI 10.1007/s00253-013-5240-z; Libault M, 2009, PLANT PHYSIOL, V151, P1207, DOI 10.1104/pp.109.144030; Liu PP, 2005, PLANT J, V44, P960, DOI 10.1111/j.1365-313X.2005.02588.x; Lowry JA, 2000, J MOL EVOL, V50, P103, DOI 10.1007/s002399910012; Luo XM, 2010, DEV CELL, V19, P872, DOI 10.1016/j.devcel.2010.10.023; Manfield IW, 2007, PLANT PHYSIOL, V143, P941, DOI 10.1104/pp.106.090761; Mara CD, 2008, PLANT PHYSIOL, V147, P707, DOI 10.1104/pp.107.115634; Meyer LJ, 2012, PLANT PHYSIOL, V159, P517, DOI 10.1104/pp.111.191700; Nishii A, 2000, BIOSCI BIOTECH BIOCH, V64, P1402, DOI 10.1271/bbb.64.1402; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Ortega JL, 2001, PLANT PHYSIOL, V126, P109, DOI 10.1104/pp.126.1.109; Patient RK, 2002, CURR OPIN GENET DEV, V12, P416, DOI 10.1016/S0959-437X(02)00319-2; Rastogi R, 1997, PLANT MOL BIOL, V34, P465, DOI 10.1023/A:1005842812321; Reyes JC, 2004, PLANT PHYSIOL, V134, P1718, DOI 10.1104/pp.103.037788; Richter R, 2010, GENE DEV, V24, P2093, DOI 10.1101/gad.594910; Robson F, 2001, PLANT J, V28, P619, DOI 10.1046/j.1365-313x.2001.01163.x; Scazzocchio C, 2000, CURR OPIN MICROBIOL, V3, P126, DOI 10.1016/S1369-5274(00)00063-1; Scheible WR, 2004, PLANT PHYSIOL, V136, P2483, DOI 10.1104/pp.104.047019; Schmutz J, 2010, NATURE, V463, P178, DOI 10.1038/nature08670; Shikata M, 2004, J EXP BOT, V55, P631, DOI 10.1093/jxb/erh078; Shoichet SA, 2000, P NATL ACAD SCI USA, V97, P4076, DOI 10.1073/pnas.97.8.4076; Strayer C, 2000, SCIENCE, V289, P768, DOI 10.1126/science.289.5480.768; Teakle GR, 2002, PLANT MOL BIOL, V50, P43, DOI 10.1023/A:1016062325584; Teakle GR, 1995, PLANT MOL BIOL, V29, P1253, DOI 10.1007/BF00020466; Teakle GR, 1998, TRENDS BIOCHEM SCI, V23, P100, DOI 10.1016/S0968-0004(98)01174-8; Vanholme B, 2007, TRENDS PLANT SCI, V12, P239, DOI 10.1016/j.tplants.2007.04.004; Wang LP, 2009, CELL RES, V19, P598, DOI 10.1038/cr.2009.36; WELLBURN AR, 1994, J PLANT PHYSIOL, V144, P307, DOI 10.1016/S0176-1617(11)81192-2; Wu SC, 1995, PLANT MOL BIOL, V29, P491, DOI 10.1007/BF00020980; YANG WC, 1993, PLANT J, V3, P573, DOI 10.1046/j.1365-313X.1993.03040573.x; Zhang XR, 2006, NAT PROTOC, V1, P641, DOI 10.1038/nprot.2006.97; Zhao YX, 2004, PLANT CELL, V16, P2586, DOI 10.1105/tpc.104.024869	56	50	50	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125174	10.1371/journal.pone.0125174	http://dx.doi.org/10.1371/journal.pone.0125174			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886477	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000153
J	Li, LR; Wang, DJ; Zhou, J; Cheng, Y; Liang, T; Zhang, GM				Li, Liru; Wang, Dejun; Zhou, Jun; Cheng, Yan; Liang, Tian; Zhang, Guangmei			Characteristics of Human Amniotic Fluid Mesenchymal Stem Cells and Their Tropism to Human Ovarian Cancer	PLOS ONE			English	Article							DELIVERY VEHICLES; GENE-THERAPY; BRAIN; BLADDER	The mesenchymal stem cells (MSCs) derived from amniotic fluid (AF) have become an attractive stem cells source for cell-based therapy because they can be harvested at low cost and avoid ethical disputes. In human research, stem cells derived from AF gradually became a hot research direction for disease treatment, specifically for their plasticity, their reduced immunogenicity and their tumor tropism regardless of the tumor size, location and source. Our work aimed to obtain and characterize human amniotic fluid mesenchymal stem cells (AFMSCs) and detect their ovarian cancer tropsim in nude mice model. Ten milliliters of twenty independent amniotic fluid samples were collected from 16-20 week pregnant women who underwent amniocentesis for fetal genetic determination in routine prenatal diagnosis in the first affiliated hospital of Harbin medical university. We successfully isolated the AFMSCs from thirteen of twenty amniotic fluid samples. AFMSCs presented a fibroblastic-like morphology during the culture. Flow cytometry analyses showed that the cells were positive for specific stem cell markers CD73, CD90, CD105, CD166 and HLA-ABC (MHC class I), but negative for CD 45, CD40, CD34, CD14 and HLA-DR (MHC class II). RT-PCR results showed that the AFMSCs expressed stem cell marker OCT4. AFMSCs could differentiate into bone cells, fat cells and chondrocytes under certain conditions. AFMSCs had the high motility to migrate to ovarian cancer site but didn't have the tumorigenicity. This study enhances the possibility of AFMSCs as drug carrier in human cell-based therapy. Meanwhile, the research emphasis in the future can also put in targeting therapy of ovarian cancer.	[Li, Liru; Wang, Dejun; Zhou, Jun; Cheng, Yan; Liang, Tian; Zhang, Guangmei] Harbin Med Univ, Dept Genecol & Obstet, Harbin, Heilongjiang, Peoples R China	Harbin Medical University	Li, LR (corresponding author), Harbin Med Univ, Dept Genecol & Obstet, Harbin, Heilongjiang, Peoples R China.	guangmeizhang@126.com			National Natural Science Foundation [81242092]; Heilongjiang innovation experiment program [201310226045]; State Key Basic Research and Development Project of China [2012CB526700]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Heilongjiang innovation experiment program; State Key Basic Research and Development Project of China(State Key Development Program for Basic Research of China)	This work was supported by the National Natural Science Foundation (NO. 81242092) URL: http://www.nsfc.gov.cn/, Heilongjiang innovation experiment program (NO.201310226045) URL:http://125.223.1.200/hljgj/, and State Key Basic Research and Development Project of China (2012CB526700) URL: http://www.most.gov.cn/.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Barry Frank P., 2003, Birth Defects Research, V69, P250, DOI 10.1002/bdrc.10021; Bexell D, 2010, MOL THER, V18, P1067, DOI 10.1038/mt.2010.58; Bitsika V, 2012, STEM CELLS DEV, V21, P1097, DOI 10.1089/scd.2011.0151; Cananz iM, 2009, ETHICS BIOSCI LIFE, V4, P17; Chen X, 2008, MOL THER, V16, P749, DOI 10.1038/mt.2008.3; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; De Coppi P, 2007, J UROLOGY, V177, P369, DOI 10.1016/j.juro.2006.09.103; De Coppi P, 2007, NAT BIOTECHNOL, V25, P100, DOI 10.1038/nbt1274; Gregory CA, 2005, EXP CELL RES, V306, P330, DOI 10.1016/j.yexcr.2005.03.018; Komarova S, 2006, MOL CANCER THER, V5, P755, DOI 10.1158/1535-7163.MCT-05-0334; Kucerova L, 2007, CANCER RES, V67, P6304, DOI 10.1158/0008-5472.CAN-06-4024; Lee DH, 2009, CLIN CANCER RES, V15, P4925, DOI 10.1158/1078-0432.CCR-08-3076; Nakamizo A, 2005, CANCER RES, V65, P3307, DOI 10.1158/0008-5472.CAN-04-1874; Pappa KI, 2009, REGEN MED, V4, P423, DOI 10.2217/RME.09.12; Prusa AR, 2003, HUM REPROD, V18, P1489, DOI 10.1093/humrep/deg279; Rachakatla RS, 2007, CANCER GENE THER, V14, P828, DOI 10.1038/sj.cgt.7701077; Rennie K, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/721538; Roubelakis MG, 2007, STEM CELLS DEV, V16, P931, DOI 10.1089/scd.2007.0036; Roubelakis MG, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/107836; Serakinci N, 2011, CANCER BIOTHER RADIO, V26, P767, DOI 10.1089/cbr.2011.1024; Sessarego N, 2008, HAEMATOLOGICA, V93, P339, DOI 10.3324/haematol.11869; Siegel N, 2007, STEM CELL REV, V3, P256, DOI 10.1007/s12015-007-9003-z; Studeny M, 2004, JNCI-J NATL CANCER I, V96, P1593, DOI 10.1093/jnci/djh299; Tsai MS, 2004, HUM REPROD, V19, P1450, DOI 10.1093/humrep/deh279	25	19	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123350	10.1371/journal.pone.0123350	http://dx.doi.org/10.1371/journal.pone.0123350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880317	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500048
J	Sejersen, MHJ; Frost, P; Hansen, TB; Deutch, SR; Svendsen, SW				Sejersen, Maria Hee Jung; Frost, Poul; Hansen, Torben Baek; Deutch, Soren Rasmussen; Svendsen, Susanne Wulff			Proteomics Perspectives in Rotator Cuff Research: A Systematic Review of Gene Expression and Protein Composition in Human Tendinopathy	PLOS ONE			English	Article							HUMAN ACHILLES-TENDON; ENDOTHELIAL GROWTH-FACTOR; TENASCIN-C EXPRESSION; MESSENGER-RNA LEVELS; MATRIX-METALLOPROTEINASE; MASS-SPECTROMETRY; SHOULDER PAIN; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; IMPINGEMENT SYNDROME	Background Rotator cuff tendinopathy including tears is a cause of significant morbidity. The molecular pathogenesis of the disorder is largely unknown. This review aimed to present an overview of the literature on gene expression and protein composition in human rotator cuff tendinopathy and other tendinopathies, and to evaluate perspectives of proteomics - the comprehensive study of protein composition - in tendon research. Materials and Methods We conducted a systematic search of the literature published between 1 January 1990 and 18 December 2012 in PubMed, Embase, and Web of Science. We included studies on objectively quantified differential gene expression and/or protein composition in human rotator cuff tendinopathy and other tendinopathies as compared to control tissue. Results We identified 2199 studies, of which 54 were included; 25 studies focussed on rotator cuff or biceps tendinopathy. Most of the included studies quantified prespecified mRNA molecules and proteins using polymerase chain reactions and immunoassays, respectively. There was a tendency towards an increase of collagen I (11 of 15 studies) and III (13 of 14), metalloproteinase (MMP)-1 (6 of 12), -9 (7 of 7), -13 (4 of 7), tissue inhibitor of metalloproteinase (TIMP)-1 (4 of 7), and vascular endothelial growth factor (4 of 7), and a decrease in MMP-3 (10 of 12). Fourteen proteomics studies of tendon tissues/cells failed inclusion, mostly because they were conducted in animals or in vitro. Conclusions Based on methods, which only allowed simultaneous quantification of a limited number of prespecified mRNA molecules or proteins, several proteins appeared to be differentially expressed/represented in rotator cuff tendinopathy and other tendinopathies. No proteomics studies fulfilled our inclusion criteria, although proteomics technologies may be a way to identify protein profiles (including non-prespecified proteins) that characterise specific tendon disorders or stages of tendinopathy. Thus, our results suggested an untapped potential for proteomics in tendon research.	[Sejersen, Maria Hee Jung; Svendsen, Susanne Wulff] Univ Res Clin, Reg Hosp West Jutland, Dept Occupat Med, Danish Ramazzini Ctr, Herning, Denmark; [Frost, Poul] Aarhus Univ Hosp, Dept Occupat Med, Danish Ramazzini Ctr, DK-8000 Aarhus, Denmark; [Hansen, Torben Baek] Holstebro Reg Hosp, Res Unit Orthopaed, Holstebro, Denmark; [Hansen, Torben Baek] Aarhus Univ, Inst Clin Med, Fac Hlth Sci, Aarhus, Denmark; [Deutch, Soren Rasmussen] Randers Reg Hosp, Dept Orthopaed Surg, Randers, Denmark	Aarhus University; Aarhus University; Aarhus University; Aarhus University	Svendsen, SW (corresponding author), Univ Res Clin, Reg Hosp West Jutland, Dept Occupat Med, Danish Ramazzini Ctr, Herning, Denmark.	susasven@rm.dk	Hansen, Torben Bæk/O-2455-2019; Hansen, Torben Bæk/C-2686-2014	Hansen, Torben Bæk/0000-0003-1678-3612; Hansen, Torben Bæk/0000-0003-1678-3612; Frausing, Maria Hee Jung Park/0000-0003-2026-1032				Abate M, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2723; Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511; Alfredson H, 2003, J ORTHOPAED RES, V21, P970, DOI 10.1016/S0736-0266(03)00107-4; Alfredson H, 2006, EUR J SPORT SCI, V6, P81, DOI 10.1080/17461390600617808; Ali M, 2005, SEMIN ARTHRITIS RHEU, V35, P67, DOI 10.1016/j.semarthrit.2005.07.002; Backman LJ, 2011, J MUSCULOSKEL NEURON, V11, P133; Bagge J, 2011, SCAND J MED SCI SPOR, V21, pE430, DOI 10.1111/j.1600-0838.2011.01358.x; Bank RA, 1998, BIOCHEM J, V330, P345, DOI 10.1042/bj3300345; Bank RA, 1999, ANN RHEUM DIS, V58, P35, DOI 10.1136/ard.58.1.35; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2012, ANAL BIOANAL CHEM, V404, P939, DOI 10.1007/s00216-012-6203-4; Battery L, 2011, SPORTS MED ARTHROSC, V19, P213, DOI 10.1097/JSA.0b013e31820e6a92; Bedi A, 2012, J SHOULDER ELB SURG, V21, P218, DOI 10.1016/j.jse.2011.09.020; Benjamin M, 1998, J ANAT, V193, P481, DOI 10.1046/j.1469-7580.1998.19340481.x; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Benson RT, 2010, J BONE JOINT SURG BR, V92B, P448, DOI 10.1302/0301-620X.92B3.23074; Benson RT, 2009, J BONE JOINT SURG BR, V91B, P119, DOI 10.1302/0301-620X.91B1.21058; Berenson MC, 1996, J ORTHOP RES, V14, P518, DOI 10.1002/jor.1100140404; Birch HL, 2007, INT J EXP PATHOL, V88, P241, DOI 10.1111/j.1365-2613.2007.00552.x; Bjorklund E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024731; Bridgeman JT, 2010, FOOT ANKLE INT, V31, P1081, DOI 10.3113/FAI.2010.1081; Chaudhury S, 2011, J BONE JOINT SURG BR, V93B, P370, DOI 10.1302/0301-620X.93B3.25470; Chaudhury S, 2012, J SHOULDER ELB SURG, V21, P191, DOI 10.1016/j.jse.2011.10.022; Chen CH, 2008, J HAND SURG-AM, V33A, P1834, DOI 10.1016/j.jhsa.2008.07.003; CHIQUETEHRISMANN R, 1994, J CELL BIOL, V127, P2093, DOI 10.1083/jcb.127.6.2093; Cook JL, 2009, BRIT J SPORT MED, V43, P409, DOI 10.1136/bjsm.2008.051193; Corps AN, 2006, RHEUMATOLOGY, V45, P291, DOI 10.1093/rheumatology/kei152; Corps AN, 2004, RHEUMATOLOGY, V43, P969, DOI 10.1093/rheumatology/keh222; Corps AN, 2008, MATRIX BIOL, V27, P393, DOI 10.1016/j.matbio.2008.02.002; Corps AN, 2012, ANN RHEUM DIS, V71, P746, DOI 10.1136/annrheumdis-2011-200391; Couppe C, 2009, J APPL PHYSIOL, V107, P880, DOI 10.1152/japplphysiol.00291.2009; Danielson P, 2006, KNEE SURG SPORT TR A, V14, P125, DOI 10.1007/s00167-005-0636-7; de Hoog CL, 2004, ANNU REV GENOM HUM G, V5, P267, DOI 10.1146/annurev.genom.4.070802.110305; de Mos M, 2007, AM J SPORT MED, V35, P1549, DOI 10.1177/0363546507301885; Dean BJF, 2012, BONE JOINT RES, V1, P158, DOI 10.1302/2046-3758.17.2000115; Del Buono A, 2012, J SHOULDER ELB SURG, V21, P200, DOI 10.1016/j.jse.2011.10.020; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Eriksen HA, 2002, J ORTHOPAED RES, V20, P1352, DOI 10.1016/S0736-0266(02)00064-5; Evans CH, 1999, SPORTS MED, V28, P71, DOI 10.2165/00007256-199928020-00001; Fenwick SA, 2001, J ANAT, V199, P231, DOI 10.1046/j.1469-7580.2001.19930231.x; Fredberg U, 2008, SCAND J MED SCI SPOR, V18, P3, DOI 10.1111/j.1600-0838.2007.00746.x; Fu SC, 2007, CLIN J SPORT MED, V17, P129, DOI 10.1097/JSM.0b013e318037998f; Fu SC, 2002, ACTA ORTHOP SCAND, V73, P658, DOI 10.3109/17453670209178031; Fu SC, 2002, CLIN ORTHOP RELAT R, P174; Garofalo R, 2011, SPORTS MED ARTHROSC, V19, P207, DOI 10.1097/JSA.0b013e318227b07b; Gobezie R, 2006, J AM ACAD ORTHOP SUR, V14, P325, DOI 10.5435/00124635-200606000-00002; Goncalves-Neto J, 2002, JOINT BONE SPINE, V69, P189, DOI 10.1016/S1297-319X(02)00369-X; Gotoh M, 2001, RHEUMATOLOGY, V40, P995, DOI 10.1093/rheumatology/40.9.995; Hakimi O, 2012, OSTEOARTHR CARTILAGE, V20, pS262, DOI 10.1016/j.joca.2012.02.441; Hamada K, 1997, J ORTHOPAED RES, V15, P24, DOI 10.1002/jor.1100150105; Hammer E, 2011, J PROTEOME RES, V10, P2161, DOI 10.1021/pr1008042; Harris RD, 2003, BIOMED SCI INSTRUM, V39, P493; HIJIOKA A, 1993, ARCH ORTHOP TRAUM SU, V112, P61, DOI 10.1007/BF00420255; Holmes MV, 2009, GENOME MED, V1, DOI 10.1186/gm104; Ireland D, 2001, MATRIX BIOL, V20, P159, DOI 10.1016/S0945-053X(01)00128-7; Jarvinen TAH, 1999, J CELL SCI, V112, P3157; Jarvinen TAH, 2003, J CELL SCI, V116, P857, DOI 10.1242/jcs.00303; Jarvinen TAH, 2000, SCAND J MED SCI SPOR, V10, P376, DOI 10.1034/j.1600-0838.2000.010006376.x; Jelinsky SA, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-86; Jiang YK, 2011, BIOMATERIALS, V32, P4085, DOI 10.1016/j.biomaterials.2011.02.033; Jielile J, 2011, APPL BIOCHEM BIOTECH, V165, P1092, DOI 10.1007/s12010-011-9327-7; Johnson MT, 2009, FRONT BIOSCI-LANDMRK, V14, P1505, DOI 10.2741/3321; Jones GC, 2006, ARTHRITIS RHEUM-US, V54, P832, DOI 10.1002/art.21672; Joseph M, 2009, J ORTHOP RES, V27, P1379, DOI 10.1002/jor.20868; Junge K, 2004, LANGENBECK ARCH SURG, V389, P17, DOI 10.1007/s00423-003-0429-8; Karousou E, 2008, CLIN ORTHOP RELAT R, V466, P1577, DOI 10.1007/s11999-008-0255-y; Kim B, 2010, ARCH BIOCHEM BIOPHYS, V501, P221, DOI 10.1016/j.abb.2010.06.017; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Kmet LM, 2004, STAND QUAL ASS CRIT; Lakemeier S, 2011, KNEE SURG SPORT TR A, V19, P1760, DOI 10.1007/s00167-010-1367-y; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-271; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-230; Lakemeier S, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-191; Legerlotz K, 2013, SCAND J MED SCI SPOR, V23, P31, DOI 10.1111/j.1600-0838.2011.01410.x; Legerlotz K, 2012, RHEUMATOLOGY, V51, P1161, DOI 10.1093/rheumatology/kes002; Lehman Christopher, 1995, Bulletin Hospital for Joint Diseases, V54, P30; Lin TW, 2006, J BIOMECH, V39, P61, DOI 10.1016/j.jbiomech.2004.11.009; Lo IKY, 2005, ARTHROSCOPY, V21, P645, DOI 10.1016/j.arthro.2005.03.008; Lo IKY, 2004, AM J SPORT MED, V32, P1223, DOI 10.1177/0363546503262200; Lundgreen K, 2011, BRIT J SPORT MED, V45, P1035, DOI 10.1136/bjsm.2010.083188; MacIej ML, 2011, EUR CELLS MATER, V22, P64; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Magra M, 2005, BRIT J SPORT MED, V39, P789, DOI 10.1136/bjsm.2005.017855; Malila S, 2011, GENET MOL RES, V10, P4158, DOI 10.4238/2011.October.31.1; Martin JA, 2003, BIORHEOLOGY, V40, P321; Matuszewski PE, 2012, CONNECT TISSUE RES, V53, P343, DOI 10.3109/03008207.2012.654866; Mehr D, 2000, J ORTHOPAED RES, V18, P537, DOI 10.1002/jor.1100180405; Millar NL, 2009, J BONE JOINT SURG BR, V91B, P417, DOI 10.1302/0301-620X.91B3.21652; Millar NL, 2008, CLIN ORTHOP RELAT R, V466, P1569, DOI 10.1007/s11999-008-0265-9; Millar NL, 2012, ANN RHEUM DIS, V71, P302, DOI 10.1136/ard.2011.154229; Miller BF, 2005, J PHYSIOL-LONDON, V567, P1021, DOI 10.1113/jphysiol.2005.093690; Miranda H, 2005, AM J EPIDEMIOL, V161, P847, DOI 10.1093/aje/kwi112; Mokone GG, 2006, SCAND J MED SCI SPOR, V16, P19, DOI 10.1111/j.1600-0838.2005.00439.x; Mokone GG, 2005, AM J SPORT MED, V33, P1016, DOI 10.1177/0363546504271986; Neer CS, 2005, J BONE JOINT SURG AM, V87A, P1399, DOI 10.2106/JBJS.8706.cl; Nordqvist Anders, 2007, Lakartidningen, V104, P1492; Ohlendieck Kay, 2011, Muscles Ligaments Tendons J, V1, P119; Oliva F, 2009, BIOCHEM BIOPH RES CO, V379, P887, DOI 10.1016/j.bbrc.2008.12.188; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Pajala A, 2009, HISTOL HISTOPATHOL, V24, P1207, DOI 10.14670/HH-24.1207; Parkinson J, 2010, ARTHRITIS RHEUM-US, V62, P3028, DOI 10.1002/art.27587; Pasternak B, 2009, ACTA ORTHOP, V80, P693, DOI 10.3109/17453670903448257; Patel L, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-164; Pingel J, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-53; Pufe T, 2001, VIRCHOWS ARCH, V439, P579, DOI 10.1007/s004280100422; Qi J, 2012, J APPL PHYSIOL, V113, P861, DOI 10.1152/japplphysiol.00198.2012; Raleigh SM, 2009, BRIT J SPORT MED, V43, P514, DOI 10.1136/bjsm.2008.053892; Riley G, 2004, RHEUMATOLOGY, V43, P131, DOI 10.1093/rheumatology/keg448; RILEY GP, 1994, ANN RHEUM DIS, V53, P367, DOI 10.1136/ard.53.6.367; Riley GP, 2005, SCAND J MED SCI SPOR, V15, P241, DOI 10.1111/j.1600-0838.2005.00456.x; Riley GP, 2002, MATRIX BIOL, V21, P185, DOI 10.1016/S0945-053X(01)00196-2; RILEY GP, 1994, ANN RHEUM DIS, V53, P359, DOI 10.1136/ard.53.6.359; Riley GP, 1994, INT J EXP PATHOL, V75, pA29; Ritter SY, 2013, ARTHRITIS RHEUM-US, V65, P981, DOI 10.1002/art.37823; Robbins JR, 1997, ARCH BIOCHEM BIOPHYS, V342, P203, DOI 10.1006/abbi.1997.0102; Rodriguez D, 2010, BBA-MOL CELL RES, V1803, P39, DOI 10.1016/j.bbamcr.2009.09.015; Rolf CG, 2001, RHEUMATOLOGY, V40, P256, DOI 10.1093/rheumatology/40.3.256; Roquelaure Y, 2011, SCAND J WORK ENV HEA, V37, P502, DOI 10.5271/sjweh.3179; Samiric T, 2009, MATRIX BIOL, V28, P230, DOI 10.1016/j.matbio.2009.04.001; Sato N, 2012, CONNECT TISSUE RES, V53, P59; Schizas N, 2010, SCAND J MED SCI SPOR, V20, P208, DOI 10.1111/j.1600-0838.2009.00913.x; Schizas N, 2012, J ORTHOP RES, V30, P1447, DOI 10.1002/jor.22094; Schubert TEO, 2005, ANN RHEUM DIS, V64, P1083, DOI 10.1136/ard.2004.029876; Scott A, 2008, SCAND J MED SCI SPOR, V18, P427, DOI 10.1111/j.1600-0838.2007.00735.x; Scott A, 2008, CLIN ORTHOP RELAT R, V466, P1598, DOI 10.1007/s11999-008-0272-x; Scott A, 2008, J ORTHOP RES, V26, P685, DOI 10.1002/jor.20536; Seitz AL, 2011, CLIN BIOMECH, V26, P1, DOI 10.1016/j.clinbiomech.2010.08.001; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Shindle MK, 2011, J SHOULDER ELB SURG, V20, P917, DOI 10.1016/j.jse.2011.02.015; Shirachi I, 2011, ARTHROSCOPY, V27, P1173, DOI 10.1016/j.arthro.2011.03.078; Shiri R, 2007, J RHEUMATOL, V34, P1076; Singaraju VM, 2008, J SHOULDER ELB SURG, V17, P898, DOI 10.1016/j.jse.2008.05.044; Sodersten F, 2006, CONNECT TISSUE RES, V47, P85, DOI 10.1080/03008200600584124; Svendsen SW, 2012, SCAND J RHEUMATOL, V41, P59, DOI 10.3109/03009742.2011.595375; Svendsen SW, 2004, OCCUP ENVIRON MED, V61, P844, DOI 10.1136/oem.2003.010637; Tillander B, 2002, J ORTHOP RES, V20, P1358, DOI 10.1016/S0736-0266(02)00057-8; TODHUNTER RJ, 1994, AM J VET RES, V55, P425; Tomonaga Akihito, 2000, Tokai Journal of Experimental and Clinical Medicine, V25, P125; Tsuzaki M, 2003, J ORTHOP RES, V21, P256, DOI 10.1016/S0736-0266(02)00141-9; van Rijn RM, 2010, SCAND J WORK ENV HEA, V36, P189, DOI 10.5271/sjweh.2895; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Vitale MA, 2010, J BONE JOINT SURG AM, V92A, P1842, DOI 10.2106/JBJS.I.01003; Vlaanderen J, 2010, OCCUP ENVIRON MED, V67, P136, DOI 10.1136/oem.2008.042788; Voloshin I, 2005, ARTHROSCOPY, V21, P1076, DOI 10.1016/j.arthro.2005.05.017; Wang MX, 2001, BIOCHEM BIOPH RES CO, V284, P667, DOI 10.1006/bbrc.2001.4991; Williams A, 2011, FRONT BIOSCI-LANDMRK, V16, P2622, DOI 10.2741/3876; Wren TAL, 2003, ANN BIOMED ENG, V31, P710, DOI 10.1114/1.1569267; Xia W, 2006, INFLAMM RES, V55, P40, DOI 10.1007/s00011-005-0006-4; Yamaguchi K, 2006, J BONE JOINT SURG AM, V88A, P1699, DOI 10.2106/JBJS.E.00835; Yamamoto A, 2010, J SHOULDER ELB SURG, V19, P116, DOI 10.1016/j.jse.2009.04.006; Yoon JH, 2004, ARCH TOXICOL, V78, P599, DOI 10.1007/s00204-004-0574-z; Yoon JH, 2004, CELL BIOL TOXICOL, V20, P41, DOI 10.1023/B:CBTO.0000021154.01035.f9; Yuan J, 2003, CLIN SPORT MED, V22, P693, DOI 10.1016/S0278-5919(03)00049-8; Zhao YC, 2009, EXPERT REV PROTEOMIC, V6, P115, DOI [10.1586/epr.09.8, 10.1586/EPR.09.8]	154	16	17	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0119974	10.1371/journal.pone.0119974	http://dx.doi.org/10.1371/journal.pone.0119974			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879758	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500003
J	Wei, T; Zhang, P; Wang, K; Ding, RX; Yang, BP; Nie, JF; Jia, ZK; Han, QF				Wei, Ting; Zhang, Peng; Wang, Ke; Ding, Ruixia; Yang, Baoping; Nie, Junfeng; Jia, Zhikuan; Han, Qingfang			Effects of Wheat Straw Incorporation on the Availability of Soil Nutrients and Enzyme Activities in Semiarid Areas	PLOS ONE			English	Article							CROP RESIDUE MANAGEMENT; ORGANIC-MATTER; CARBON SEQUESTRATION; NITROGEN MANAGEMENT; AGGREGATE STABILITY; TILLAGE PRACTICES; RED SOIL; RICE; CHINA; FERTILITY	Soil infertility is the main barrier to dryland agricultural production in China. To provide a basis for the establishment of a soil amelioration technical system for rainfed fields in the semiarid area of northwest China, we conducted a four-year (2007-2011) field experiment to determine the effects of wheat straw incorporation on the arid soil nutrient levels of crop-land cultivated with winter wheat after different straw incorporation levels. Three wheat straw incorporation levels were tested (H: 9000 kg hm(-2), M: 6000 kg hm(-2), and L: 3000 kg hm(-2)) and no straw incorporation was used as the control (CK). The levels of soil nutrients, soil organic carbon (SOC), soil labile organic carbon (LOC), and enzyme activities were analyzed each year after the wheat harvest. After straw incorporation for four years, the results showed that variable straw amounts had different effects on the soil fertility indices, where treatment H had the greatest effect. Compared with CK, the average soil available N, available P, available K, SOC, and LOC levels were higher in the 0-40 cm soil layers after straw incorporation treatments, i.e., 9.1-30.5%, 9.8-69.5%, 10.3-27.3%, 0.7-23.4%, and 44.4-49.4% higher, respectively. On average, the urease, phosphatase, and invertase levels in the 0-40 cm soil layers were 24.4-31.3%, 9.9-36.4%, and 42.9-65.3% higher, respectively. Higher yields coupled with higher nutrient contents were achieved with H, M and L compared with CK, where these treatments increased the crop yields by 26.75%, 21.51%, and 7.15%, respectively.	[Wei, Ting; Zhang, Peng; Wang, Ke; Ding, Ruixia; Nie, Junfeng; Jia, Zhikuan; Han, Qingfang] Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China; [Wei, Ting; Zhang, Peng; Wang, Ke; Ding, Ruixia; Yang, Baoping; Nie, Junfeng; Jia, Zhikuan; Han, Qingfang] Northwest A&F Univ, Minist Agr, Key Lab Crop Physiecol & Tillage Sci Northwest Lo, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Jia, ZK (corresponding author), Northwest A&F Univ, Chinese Inst Water Saving Agr, Yangling 712100, Shaanxi, Peoples R China.	jiazhk@126.com; hanqf88@nwsuaf.edu.cn			China Support Program for Dryland Farming in the 11th 5-year plan period [2006BAD29B03]; National High Technology Research and Development Program of China [2013AA102902-5]; China Support Program for Dryland Farming in the 12th 5-year plan period [2012BAD09B03, 2011AA100504, 2011BAD29B09]; Program of Introducing Talents of Discipline to Universities [B12007]; Youth Project of National Natural Science Fund [31201156]; Basic Science Research Fund in Northwest AF University [QN2013005]	China Support Program for Dryland Farming in the 11th 5-year plan period; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); China Support Program for Dryland Farming in the 12th 5-year plan period; Program of Introducing Talents of Discipline to Universities; Youth Project of National Natural Science Fund; Basic Science Research Fund in Northwest AF University	This study was sponsored by the China Support Program (2006BAD29B03) for Dryland Farming in the 11th 5-year plan period, by the National High Technology Research and Development Program of China (Project No. 2013AA102902-5), by the China Support Program (2012BAD09B03, 2011AA100504, and 2011BAD29B09) for Dryland Farming in the 12th 5-year plan period, by the Program of Introducing Talents of Discipline to Universities (No. B12007), by the Youth Project of National Natural Science Fund (31201156), and by the Basic Science Research Fund in Northwest A&F University (QN2013005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulakh MS, 2001, SOIL SCI SOC AM J, V65, P820, DOI 10.2136/sssaj2001.653820x; Bakht J, 2009, SOIL TILL RES, V104, P233, DOI 10.1016/j.still.2009.02.006; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; BHATNAGAR VK, 1983, SOIL TILL RES, V3, P27, DOI 10.1016/0167-1987(83)90014-4; Chen CR, 2005, FOREST ECOL MANAG, V206, P237, DOI 10.1016/j.foreco.2004.11.005; DICK RP, 1996, SSSA SPECIAL PUBLICA, V49, P247, DOI DOI 10.2136/SS-SASPECPUB49.C15.IN:D0RAN; Dick RP, 1988, SOIL BIOL BIOCHEM, V6, pl59, DOI DOI 10.1007/BF00257667; Dolan MS, 2006, SOIL TILL RES, V89, P221, DOI 10.1016/j.still.2005.07.015; Dong WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044504; DORICH RA, 1984, SOIL SCI SOC AM J, V48, P72, DOI 10.2136/sssaj1984.03615995004800010013x; Frankenberger Jr Johanson J, 1983, PLANT SOIL, V74, P301; Fuentes M, 2009, EUR J AGRON, V30, P228, DOI 10.1016/j.eja.2008.10.005; Gangwar KS, 2006, SOIL TILL RES, V88, P242, DOI 10.1016/j.still.2005.06.015; Garg S, 2008, BIORESOURCE TECHNOL, V99, P5773, DOI 10.1016/j.biortech.2007.10.063; Gong W, 2009, GEODERMA, V149, P318, DOI 10.1016/j.geoderma.2008.12.010; Haynes RJ, 1997, SOIL BIOL BIOCHEM, V29, P1647, DOI 10.1016/S0038-0717(97)00078-3; Hu KeLin, 1999, Transactions of the Chinese Society of Agricultural Engineering, V15, P33; Jin K, 2009, SOIL TILL RES, V104, P115, DOI 10.1016/j.still.2009.02.004; Jin XC, 2005, SCI CHINA SER C, V48, P948, DOI 10.1360/062005-286; Karami A, 2012, AGR ECOSYST ENVIRON, V148, P22, DOI 10.1016/j.agee.2011.10.021; Knudsen D, 1982, MONOGR, V2, P225, DOI DOI 10.2134/AGR0NM0N0GR9.2.2ED.C13; Lao XiuRong, 2002, Transactions of the Chinese Society of Agricultural Engineering, V18, P49; Lee J, 2010, SCI HORTIC-AMSTERDAM, V124, P299, DOI 10.1016/j.scienta.2010.01.004; LI LM, 2006, SOILS, V38, P422; Li ZP, 2010, SOIL TILL RES, V106, P268, DOI 10.1016/j.still.2009.12.008; Liu EK, 2010, GEODERMA, V158, P173, DOI 10.1016/j.geoderma.2010.04.029; Loginow W, 1987, POL J SOIL SCI, P20; Lou YL, 2011, SOIL TILL RES, V113, P70, DOI 10.1016/j.still.2011.01.007; Mandal KG, 2004, J FOOD AGRIC ENVIRON, V2, P224; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; MARTENS DA, 1992, SOIL SCI, V153, P53, DOI 10.1097/00010694-199201000-00008; MAURYA PR, 1981, FIELD CROP RES, V4, P33, DOI 10.1016/0378-4290(81)90052-6; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; Mupangwa W, 2008, PHYS CHEM EARTH, V33, P762, DOI 10.1016/j.pce.2008.06.049; Olsen S.R., 1982, PHOSPHORUS METHODS S; Pinheiro EFM, 2004, SOIL TILL RES, V77, P79, DOI 10.1016/j.still.2003.11.005; Plaza C, 2004, SOIL BIOL BIOCHEM, V36, P1577, DOI 10.1016/j.soilbio.2004.07.017; Power JF, 1998, SOIL SCI SOC AM J, V62, P1393, DOI 10.2136/sssaj1998.03615995006200050035x; Roldan A, 2005, APPL SOIL ECOL, V30, P11, DOI 10.1016/j.apsoil.2005.01.004; Roldan A, 2003, SOIL TILL RES, V72, P65, DOI 10.1016/S0167-1987(03)00051-5; Sa JCD, 2009, SOIL TILL RES, V103, P46, DOI 10.1016/j.still.2008.09.003; Saroa GS, 2003, LAND DEGRAD DEV, V14, P481, DOI 10.1002/ldr.569; Shah Z, 2003, FIELD CROP RES, V83, P1, DOI 10.1016/S0378-4290(03)00005-4; Six J, 2000, SOIL SCI SOC AM J, V64, P681, DOI 10.2136/sssaj2000.642681x; Smith J. L., 1992, Soil microbial ecology: applications in agricultural and environmental management., P65; Surekha K, 2003, NUTR CYCL AGROECOSYS, V67, P145, DOI 10.1023/A:1025543810663; Tabatabai M.A., 1994, METHODS SOIL ANAL 2, V5, P775; Tan DeShui, 2007, Scientia Agricultura Sinica, V40, P133, DOI 10.1016/S1671-2927(07)60035-2; Tong XG, 2014, CATENA, V113, P251, DOI 10.1016/j.catena.2013.08.005; Tripathy R, 2004, J PLANT NUTR SOIL SC, V167, P216, DOI 10.1002/jpln.200321175; Uhlen G, 1996, NORW J AGR SCI, P9; UTOMO M, 1990, AGRON J, V82, P979, DOI 10.2134/agronj1990.00021962008200050028x; Wagner S, 2007, J PLANT NUTR SOIL SC, V170, P173, DOI 10.1002/jpln.200521732; [王灿 Wang Can], 2008, [生态环境, Ecology and Environment], V17, P688; Wang SQ, 2003, TELLUS B, V55, P416, DOI 10.1034/j.1600-0889.2003.00039.x; Yang YS, 2009, PLANT SOIL, V323, P153, DOI 10.1007/s11104-009-9921-4; Zhang P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092839; Zhang WJ, 2009, NUTR CYCL AGROECOSYS, V84, P59, DOI 10.1007/s10705-008-9226-7; Zhao YC, 2009, EUR J AGRON, V31, P36, DOI 10.1016/j.eja.2009.03.001; Zhou J., 2002, CHINESE AGR SCI B, V4; Zhu HH, 2010, PLANT SOIL, V331, P427, DOI 10.1007/s11104-009-0263-z	61	97	107	8	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120994	10.1371/journal.pone.0120994	http://dx.doi.org/10.1371/journal.pone.0120994			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880452	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500009
J	Ciarloni, L; Hosseinian, S; Monnier-Benoit, S; Imaizumi, N; Dorta, G; Ruegg, C				Ciarloni, Laura; Hosseinian, Sahar; Monnier-Benoit, Sylvain; Imaizumi, Natsuko; Dorta, Gian; Ruegg, Curzio		DGNP-COL-Study Grp	Discovery of a 29-Gene Panel in Peripheral Blood Mononuclear Cells for the Detection of Colorectal Cancer and Adenomas Using High Throughput Real-Time PCR	PLOS ONE			English	Article							BREAST-CANCER; INFLAMMATION; PROGRAM; PROFILES; OUTCOMES; MODELS; MOUSE	Colorectal cancer (CRC) is the second leading cause of cancer-related death in developed countries. Early detection of CRC leads to decreased CRC mortality. A blood-based CRC screening test is highly desirable due to limited invasiveness and high acceptance rate among patients compared to currently used fecal occult blood testing and colonoscopy. Here we describe the discovery and validation of a 29-gene panel in peripheral blood mononuclear cells (PBMC) for the detection of CRC and adenomatous polyps (AP). Blood samples were prospectively collected from a multicenter, case-control clinical study. First, we profiled 93 samples with 667 candidate and 3 reference genes by high throughput real-time PCR (OpenArray system). After analysis, 160 genes were retained and tested again on 51 additional samples. Low expressed and unstable genes were discarded resulting in a final dataset of 144 samples profiled with 140 genes. To define which genes, alone or in combinations had the highest potential to discriminate AP and/or CRC from controls, data were analyzed by a combination of univariate and multivariate methods. A list of 29 potentially discriminant genes was compiled and evaluated for its predictive accuracy by penalized logistic regression and bootstrap. This method discriminated AP >1cm and CRC from controls with a sensitivity of 59% and 75%, respectively, with 91% specificity. The behavior of the 29-gene panel was validated with a LightCycler 480 real-time PCR platform, commonly adopted by clinical laboratories. In this work we identified a 29-gene panel expressed in PBMC that can be used for developing a novel minimally-invasive test for accurate detection of AP and CRC using a standard real-time PCR platform.	[Ciarloni, Laura; Hosseinian, Sahar; Monnier-Benoit, Sylvain; Imaizumi, Natsuko] Diagnoplex SA, Epalinges, Switzerland; [Ciarloni, Laura; Hosseinian, Sahar; Monnier-Benoit, Sylvain; Ruegg, Curzio] Novigenix SA, Epalinges, Switzerland; [Imaizumi, Natsuko; Ruegg, Curzio] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res ISREC, Natl Ctr Competence Res, Mol Oncol, Lausanne, Switzerland; [Dorta, Gian] CHU Vaudois, Dept Gastroenterol & Hepatol, CH-1011 Lausanne, Switzerland; [Dorta, Gian] Univ Lausanne, Lausanne, Switzerland; [Ruegg, Curzio] Univ Fribourg, Dept Med, Fac Sci, CH-1700 Fribourg, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; University of Fribourg	Ruegg, C (corresponding author), Novigenix SA, Epalinges, Switzerland.	curzio.ruegg@unifr.ch		Ciarloni, Laura/0000-0003-4185-016X	Diagnoplex SA	Diagnoplex SA	This study was supported by Diagnoplex SA. The funder provided support in the form of salaries for authors LC, NI, SMB, SH, but did not have any additional role in data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contributions' section.	Henriquez-Hernandez LA, 2013, BIOLOGICALS, V41, P424, DOI 10.1016/j.biologicals.2013.09.006; Bernard PS, 2002, CLIN CHEM, V48, P1178; Bilinski C, 2012, ANN CLIN LAB SCI, V42, P266; Brown JR, 2005, J CLIN ONCOL, V23, P2840, DOI 10.1200/JCO.2005.09.051; Burczynski ME, 2005, CLIN CANCER RES, V11, P1181; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Espinosa E, 2006, EUR J CANCER, V42, P598, DOI 10.1016/j.ejca.2005.11.021; Friedman J, 2010, J STAT SOFTW, V33, P1, DOI 10.18637/jss.v033.i01; Galamb O, 2010, BRIT J CANCER, V102, P765, DOI 10.1038/sj.bjc.6605515; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Grivennikov SI, 2013, SEMIN IMMUNOPATHOL, V35, P229, DOI 10.1007/s00281-012-0352-6; Han M, 2008, CLIN CANCER RES, V14, P455, DOI 10.1158/1078-0432.CCR-07-1801; Masao H, 2010, BIOCHEM BIOPH RES CO, V400, P7, DOI 10.1016/j.bbrc.2010.07.123; Jean-Jacques M, 2012, ANN FAM MED, V10, P412, DOI 10.1370/afm.1381; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kuonen F, 2012, CLIN CANCER RES, V18, P4365, DOI 10.1158/1078-0432.CCR-11-3028; Laurent J, 2011, CANCER RES, V71, P3781, DOI 10.1158/0008-5472.CAN-10-3684; Levin B, 2008, GASTROENTEROLOGY, V134, P1570, DOI 10.1053/j.gastro.2008.02.002; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Marshall KW, 2010, INT J CANCER, V126, P1177, DOI 10.1002/ijc.24910; Nichita C, 2014, ALIMENT PHARM THER, V39, P507, DOI 10.1111/apt.12618; Oshima M, 2001, CANCER RES, V61, P1733; Osman I, 2006, CLIN CANCER RES, V12, P3374, DOI 10.1158/1078-0432.CCR-05-2081; Parente F, 2013, ENDOSCOPY, V45, P27, DOI 10.1055/s-0032-1325800; Park MY, 2007, J ROY STAT SOC B, V69, P659, DOI 10.1111/j.1467-9868.2007.00607.x; Popovici V, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-42; Quackenbush J, 2006, NEW ENGL J MED, V354, P2463, DOI 10.1056/NEJMra042342; Rasmussen R, 2001, RAPID CYCLE REAL TIM, P21, DOI [10.1007/978-3-642-59524-0_3, DOI 10.1007/978-3-642-59524-0_3]; Sharma P, 2005, BREAST CANCER RES, V7, pR634, DOI 10.1186/bcr1203; Showe MK, 2009, CANCER RES, V69, P9202, DOI 10.1158/0008-5472.CAN-09-1378; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tan AC, 2005, BIOINFORMATICS, V21, P3896, DOI 10.1093/bioinformatics/bti631; Twine NC, 2003, CANCER RES, V63, P6069; von Karsa L, 2013, ENDOSCOPY, V45, P51, DOI 10.1055/s-0032-1325997; von Wagner C, 2011, INT J EPIDEMIOL, V40, P712, DOI 10.1093/ije/dyr008; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Xuan JK, 2013, CANCER LETT, V340, P284, DOI 10.1016/j.canlet.2012.11.025	38	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123904	10.1371/journal.pone.0123904	http://dx.doi.org/10.1371/journal.pone.0123904			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876024	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100222
J	Ferre, ER; Walther, LE; Haggard, P				Ferre, Elisa Raffaella; Walther, Leif Erik; Haggard, Patrick			Multisensory Interactions between Vestibular, Visual and Somatosensory Signals	PLOS ONE			English	Article							VENTRAL INTRAPARIETAL AREA; SELF-MOTION; SUPERIOR COLLICULUS; EQUILIBRIUM ORGAN; STIMULATION; INTEGRATION; CORTEX; RESPONSES; INFORMATION; MODULATION	Vestibular inputs are constantly processed and integrated with signals from other sensory modalities, such as vision and touch. The multiply-connected nature of vestibular cortical anatomy led us to investigate whether vestibular signals could participate in a multi-way interaction with visual and somatosensory perception. We used signal detection methods to identify whether vestibular stimulation might interact with both visual and somatosensory events in a detection task. Participants were instructed to detect near-threshold somatosensory stimuli that were delivered to the left index finger in one half of experimental trials. A visual signal occurred close to the finger in half of the trials, independent of somatosensory stimuli. A novel Near infrared caloric vestibular stimulus (NirCVS) was used to artificially activate the vestibular organs. Sham stimulations were used to control for non-specific effects of NirCVS. We found that both visual and vestibular events increased somatosensory sensitivity. Critically, we found no evidence for supra-additive multisensory enhancement when both visual and vestibular signals were administered together: in fact, we found a trend towards sub-additive interaction. The results are compatible with a vestibular role in somatosensory gain regulation.	[Ferre, Elisa Raffaella; Haggard, Patrick] UCL, Inst Cognit Neurosci, London, England; [Walther, Leif Erik] Heidelberg Univ, Univ Med Mannheim, Dept Otorhinolaryngol & Head & Neck Surg, Mannheim, Germany	University of London; University College London; Ruprecht Karls University Heidelberg	Ferre, ER (corresponding author), UCL, Inst Cognit Neurosci, London, England.	e.ferre@ucl.ac.uk		Ferre, Elisa Raffaella/0000-0002-0643-848X; Haggard, Patrick/0000-0001-7798-793X	EU Project VERE Workpackage 1; ESRC; ERC Advanced Grant HUMVOL; ESRC [ES/J023140/1] Funding Source: UKRI; Economic and Social Research Council [ES/J023140/1] Funding Source: researchfish	EU Project VERE Workpackage 1; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ERC Advanced Grant HUMVOL; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	ERF and PH were supported by EU Project VERE Workpackage 1. PH was additionally supported by a Professorial Fellowship from ESRC and by ERC Advanced Grant HUMVOL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avillac M, 2007, J NEUROSCI, V27, P1922, DOI 10.1523/JNEUROSCI.2646-06.2007; Beauchamp MS, 2005, CURR OPIN NEUROBIOL, V15, P145, DOI 10.1016/j.conb.2005.03.011; Bense S, 2001, J NEUROPHYSIOL, V85, P886, DOI 10.1152/jn.2001.85.2.886; BOTTINI G, 1995, NATURE, V376, P778, DOI 10.1038/376778a0; Brandt T, 1998, BRAIN, V121, P1749, DOI 10.1093/brain/121.9.1749; Bremmer F, 2002, EUR J NEUROSCI, V16, P1569, DOI 10.1046/j.1460-9568.2002.02206.x; Brown RJ, 2010, J PSYCHOSOM RES, V69, P241, DOI 10.1016/j.jpsychores.2009.11.010; Butler JS, 2010, J VISION, V10, DOI 10.1167/10.11.23; BUTTNER U, 1978, BRAIN RES, V153, P392, DOI 10.1016/0006-8993(78)90421-3; Chen AH, 2010, J NEUROSCI, V30, P3022, DOI 10.1523/JNEUROSCI.4029-09.2010; Deutschlander A, 2002, HUM BRAIN MAPP, V16, P92, DOI 10.1002/hbm.10030; Dienes Z, 2011, PERSPECT PSYCHOL SCI, V6, P274, DOI 10.1177/1745691611406920; Dieterich M, 2003, CEREB CORTEX, V13, P994, DOI 10.1093/cercor/13.9.994; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Eulenburg PZ, 2012, NEUROIMAGE, V60, P162, DOI 10.1016/j.neuroimage.2011.12.032; Ferre ER, 2013, NEUROSCI LETT, V550, P35, DOI 10.1016/j.neulet.2013.06.046; Ferre ER, 2011, EUR J NEUROSCI, V34, P1337, DOI 10.1111/j.1460-9568.2011.07859.x; Ferre ER, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086379; Fetsch CR, 2013, NAT REV NEUROSCI, V14, P429, DOI 10.1038/nrn3503; Fetsch CR, 2009, J NEUROSCI, V29, P15601, DOI 10.1523/JNEUROSCI.2574-09.2009; Gallistel CR, 2009, PSYCHOL REV, V116, P439, DOI 10.1037/a0015251; Garcia-Marques L, 2003, PSYCHON B REV, P1; Goodman SN, 1999, ANN INTERN MED, V130, P995, DOI 10.7326/0003-4819-130-12-199906150-00008; GRUSSER OJ, 1990, J PHYSIOL-LONDON, V430, P537; Guldin WO, 1998, TRENDS NEUROSCI, V21, P254, DOI 10.1016/S0166-2236(97)01211-3; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Helbig HB, 2007, EXP BRAIN RES, V179, P595, DOI 10.1007/s00221-006-0814-y; Hillis JM, 2002, SCIENCE, V298, P1627, DOI 10.1126/science.1075396; Johnson RM, 2006, BRAIN RES, V1073, P398, DOI 10.1016/j.brainres.2005.12.025; Klam F, 2003, EUR J NEUROSCI, V18, P995, DOI 10.1046/j.1460-9568.2003.02813.x; Klam F, 2006, J PHYSIOL-LONDON, V574, P367, DOI 10.1113/jphysiol.2005.103697; Konen CS, 2014, CEREB CORTEX, V24, P501, DOI 10.1093/cercor/bhs331; Kruschke JK, 2011, PERSPECT PSYCHOL SCI, V6, P299, DOI 10.1177/1745691611406925; LOFTUS GR, 1978, MEM COGNITION, V6, P312, DOI 10.3758/BF03197461; Lopez C, 2012, NEUROSCIENCE, V212, P159, DOI 10.1016/j.neuroscience.2012.03.028; Lopez C, 2011, BRAIN RES REV, V67, P119, DOI 10.1016/j.brainresrev.2010.12.002; Macmillan N. A., 2004, DETECTION THEORY USE; McKenzie KJ, 2010, PERCEPTION, V39, P839, DOI 10.1068/p6401; MEREDITH MA, 1983, SCIENCE, V221, P389, DOI 10.1126/science.6867718; MEREDITH MA, 1986, J NEUROPHYSIOL, V56, P640, DOI 10.1152/jn.1986.56.3.640; Mirams L, 2010, EXP BRAIN RES, V202, P787, DOI 10.1007/s00221-010-2185-7; Naito Y, 2003, BRAIN, V126, P1562, DOI 10.1093/brain/awg165; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Prsa M, 2012, J NEUROPHYSIOL, V108, P2282, DOI 10.1152/jn.00439.2012; Schlack A, 2005, J NEUROSCI, V25, P4616, DOI 10.1523/JNEUROSCI.0455-05.2005; Sripati AP, 2006, J NEUROSCI, V26, P2101, DOI 10.1523/JNEUROSCI.3720-05.2006; Stanford TR, 2007, NEUROREPORT, V18, P787, DOI 10.1097/WNR.0b013e3280c1e315; Stein BE, 2011, PROG BRAIN RES, V191, P145, DOI 10.1016/B978-0-444-53752-2.00007-2; Stein BE, 1996, J COGNITIVE NEUROSCI, V8, P497, DOI 10.1162/jocn.1996.8.6.497; VALLAR G, 1993, BRAIN, V116, P71, DOI 10.1093/brain/116.1.71; VALLAR G, 1990, CORTEX, V26, P123, DOI 10.1016/S0010-9452(13)80078-0; Vega-Bermudez F, 1999, J NEUROPHYSIOL, V81, P2711, DOI 10.1152/jn.1999.81.6.2711; Wallace MT, 1998, J NEUROPHYSIOL, V80, P1006, DOI 10.1152/jn.1998.80.2.1006; Walther LE, 2011, ACTA OTORHINOLARYNGO, V31, P90; Walther LE, 2004, HNO, V52, P525, DOI 10.1007/s00106-003-0935-6; Walther LE, 2004, LARYNGO RHINO OTOL, V83, P88, DOI 10.1055/s-2004-814238; Walther LE, 2003, LARYNGO RHINO OTOL, V82, P687; Wenzel R, 1996, BRAIN, V119, P101, DOI 10.1093/brain/119.1.101; Zhou YD, 2014, PNAS, V97, P9777	59	24	26	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124573	10.1371/journal.pone.0124573	http://dx.doi.org/10.1371/journal.pone.0124573			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875819	Green Published, gold, Green Accepted			2022-12-27	WOS:000352845100266
J	Zago, CE; Silva, S; Sanita, PV; Barbugli, PA; Dias, CMI; Lordello, VB; Vergani, CE				Zago, Chaiene Evelin; Silva, Sonia; Sanita, Paula Volpato; Barbugli, Paula Aboud; Improta Dias, Carla Maria; Lordello, Virginia Barreto; Vergani, Carlos Eduardo			Dynamics of Biofilm Formation and the Interaction between Candida albicans and Methicillin-Susceptible (MSSA) and -Resistant Staphylococcus aureus (MRSA)	PLOS ONE			English	Article							ENZYMATIC-ACTIVITY PROFILE; IN-VITRO EVALUATION; VIRULENCE; QUANTIFICATION; SPP.; PHOSPHOLIPASES; FLUCONAZOLE; PREVALENCE; DAPTOMYCIN; EXPRESSION	Polymicrobial biofilms are an understudied and a clinically relevant problem. This study evaluates the interaction between C. albicans, and methicillin-susceptible (MSSA) and resistant (MRSA) S. aureus growing in single-and dual-species biofilms. Single and dual species adhesion (90 min) and biofilms (12, 24, and 48 h) were evaluated by complementary methods: counting colony-forming units (CFU mL(-1)), XTT-reduction, and crystal violet staining (CV). The secretion of hydrolytic enzymes by the 48 h biofilms was also evaluated using fluorimetric kits. Scanning electron microscopy (SEM) was used to assess biofilm structure. The results from quantification assays were compared using two-way ANOVAs with Tukey post-hoc tests, while data from enzymatic activities were analyzed by one-way Welch-ANOVA followed by Games-Howell post hoc test (alpha = 0.05). C. albicans, MSSA and MRSA were able to adhere and to form biofilm in both single or mixed cultures. In general, all microorganisms in both growth conditions showed a gradual increase in the number of cells and metabolic activity over time, reaching peak values between 12 h and 48 h (rho<0.05). C. albicans single-and dual-biofilms had significantly higher total biomass values (rho<0.05) than single biofilms of bacteria. Except for single MRSA biofilms, all microorganisms in both growth conditions secreted proteinase and phospholipase-C. SEM images revealed extensive adherence of bacteria to hyphal elements of C. albicans. C. albicans, MSSA, and MRSA can co-exist in biofilms without antagonism and in an apparent synergistic effect, with bacteria cells preferentially associated to C. albicans hyphal forms.	[Zago, Chaiene Evelin; Sanita, Paula Volpato; Barbugli, Paula Aboud; Improta Dias, Carla Maria; Lordello, Virginia Barreto; Vergani, Carlos Eduardo] Univ Estadual Paulista, UNESP, Dept Dent Mat & Prosthodont, Araraquara Dent Sch, Sao Paulo, Brazil; [Silva, Sonia] Univ Minho, IBB, Ctr Biol Engn, Braga, Portugal	Universidade Estadual Paulista; Universidade do Minho	Vergani, CE (corresponding author), Univ Estadual Paulista, UNESP, Dept Dent Mat & Prosthodont, Araraquara Dent Sch, Sao Paulo, Brazil.	vergani@foar.unesp.br	Barbugli, Paula/AAK-8605-2021; Sanitá, Paula/A-7777-2015; Barbugli, Paula/D-7148-2013; Zago, Chaiene Evelin/D-9530-2013; Vergani, Carlos E/A-3043-2008; Silva, Sónia/F-1190-2013; FAPESP, CDMF/J-3591-2015	Vergani, Carlos E/0000-0002-7375-4714; Silva, Sónia/0000-0003-0000-7387; FAPESP, CDMF/0000-0002-4464-0937; Barbugli, Paula/0000-0002-0078-1172; Barreto Lordello, Virginia/0000-0002-8199-0151	CAPES (Coordination for the Improvement of Higher Level Personnel); CNPq (Council for Technical and Scientific Development) [400658/2012-7]; Fundacao para a Ciencia e Tecnologia (FCT), Portugal [SFRH/BPD/71076/2010]	CAPES (Coordination for the Improvement of Higher Level Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq (Council for Technical and Scientific Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao para a Ciencia e Tecnologia (FCT), Portugal(Portuguese Foundation for Science and Technology)	This work was supported by CAPES (Coordination for the Improvement of Higher Level Personnel), CNPq (Council for Technical and Scientific Development) (Grant 400658/2012-7) and Fundacao para a Ciencia e Tecnologia (FCT), Portugal (SFRH/BPD/71076/2010). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe S, 2001, ARCH GERONTOL GERIAT, V32, P45, DOI 10.1016/S0167-4943(00)00091-1; Al-Fattani MA, 2006, J MED MICROBIOL, V55, P999, DOI 10.1099/jmm.0.46569-0; Altieri KT, 2012, J AM DENT ASSOC, V143, P270, DOI 10.14219/jada.archive.2012.0152; Baena-Morroy T, 2004, ORAL MED PATHOLOGY, V10, P27; Bamford CV, 2009, INFECT IMMUN, V77, P3696, DOI 10.1128/IAI.00438-09; Bosco Vera Lucia, 2003, Pesqui Odontol Bras, V17, P217, DOI 10.1590/S1517-74912003000300004; Calderone RA, 2001, TRENDS MICROBIOL, V9, P327, DOI 10.1016/S0966-842X(01)02094-7; CARLSON E, 1983, INFECT IMMUN, V42, P285, DOI 10.1128/IAI.42.1.285-292.1983; CARLSON E, 1985, INFECT IMMUN, V50, P655, DOI 10.1128/IAI.50.3.655-659.1985; Chadwick PR, 1999, INT J ANTIMICROB AG, V11, P89, DOI 10.1016/S0924-8579(98)00103-4; Chandra J, 2001, J DENT RES, V80, P903, DOI 10.1177/00220345010800031101; Colombo AL, 1999, DIAGN MICR INFEC DIS, V34, P281; Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318; D'Eca A, 2011, REV SOC BRAS MED TRO, V44, P334, DOI 10.1590/S0037-86822011005000036; El-Azizi MA, 2004, J APPL MICROBIOL, V96, P1067, DOI 10.1111/j.1365-2672.2004.02213.x; Faix R G, 1989, J Perinatol, V9, P131; Gerberding J, 1999, AM J INFECT CONTROL, V27, P520; Ghannoum MA, 2000, CLIN MICROBIOL REV, V13, P122, DOI 10.1128/CMR.13.1.122-143.2000; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Harriott MM, 2010, ANTIMICROB AGENTS CH, V54, P3746, DOI 10.1128/AAC.00573-10; Harriott MM, 2009, ANTIMICROB AGENTS CH, V53, P3914, DOI 10.1128/AAC.00657-09; Hua X, 2009, MOL VIS, V15, P1476; Hube B, 1996, Curr Top Med Mycol, V7, P55; Ibarra-Trujillo C, 2012, REV IBEROAM MICOL, V29, P214, DOI 10.1016/j.riam.2012.02.003; KAMINISHI H, 1995, INFECT IMMUN, V63, P984, DOI 10.1128/IAI.63.3.984-988.1995; Klotz SA, 2007, DIAGN MICR INFEC DIS, V59, P401, DOI 10.1016/j.diagmicrobio.2007.07.001; Kuramitsu HK, 2007, MICROBIOL MOL BIOL R, V71, P653, DOI 10.1128/MMBR.00024-07; Lyon JP, 2006, ORAL SURG ORAL MED O, V102, P632, DOI 10.1016/j.tripleo.2005.12.015; Manfredi M, 2006, ORAL MICROBIOL IMMUN, V21, P183, DOI 10.1111/j.1399-302X.2006.00275.x; Mylotte JM, 2002, CLIN INFECT DIS, V35, P1205, DOI 10.1086/344281; Naglik JR, 1999, INFECT IMMUN, V67, P2482, DOI 10.1128/IAI.67.5.2482-2490.1999; Negri M, 2010, MYCOPATHOLOGIA, V169, P175, DOI 10.1007/s11046-009-9246-0; O'Day DM, 2000, INVEST OPHTH VIS SCI, V41, P1116; Palavecino E, 2004, CLIN LAB MED, V24, P403, DOI 10.1016/j.cll.2004.03.007; Pande M, 2006, J AGR FOOD CHEM, V54, P10141, DOI 10.1021/jf062206a; Pereira CA, 2011, LASER MED SCI, V26, P341, DOI 10.1007/s10103-010-0852-3; Peters BM, 2013, INFECT IMMUN, V81, P2178, DOI 10.1128/IAI.00265-13; Peters BM, 2012, MICROBIOL-SGM, V158, P2975, DOI 10.1099/mic.0.062109-0; Peters BM, 2010, FEMS IMMUNOL MED MIC, V59, P493, DOI 10.1111/j.1574-695X.2010.00710.x; Pinto E, 2008, J ORAL PATHOL MED, V37, P587, DOI 10.1111/j.1600-0714.2008.00687.x; Rajendran R, 2010, MYCOPATHOLOGIA, V170, P229, DOI 10.1007/s11046-010-9319-0; Ramage G, 2002, FEMS MICROBIOL LETT, V214, P95, DOI 10.1111/j.1574-6968.2002.tb11330.x; Roveta S, 2008, INT J ANTIMICROB AG, V31, P321, DOI 10.1016/j.ijantimicag.2007.11.012; SALYERS AA, 1994, BACTERIAL PATHOGENES; Sanita PV, 2014, OR SURG OR MED OR PA, V118, P84, DOI 10.1016/j.oooo.2014.03.020; Sanita PV, 2014, MYCOSES, V57, P351, DOI 10.1111/myc.12162; Sanita PV, 2011, ORAL SURG ORAL MED O, V111, P726, DOI 10.1016/j.tripleo.2011.02.033; Schlecht LM, 2015, MICROBIOL-SGM, V161, P168, DOI 10.1099/mic.0.083485-0; Shirtliff ME, 2009, FEMS MICROBIOL LETT, V299, P1, DOI 10.1111/j.1574-6968.2009.01668.x; Silva S, 2010, CURR MICROBIOL, V61, P534, DOI 10.1007/s00284-010-9649-7; Silva S, 2009, MED MYCOL, V47, P681, DOI 10.3109/13693780802549594; Smith AJ, 2003, J HOSP INFECT, V55, P184, DOI 10.1016/j.jhin.2003.08.004; Smith K, 2009, INT J ANTIMICROB AG, V33, P374, DOI 10.1016/j.ijantimicag.2008.08.029; Stepanovic S, 2000, J MICROBIOL METH, V40, P175, DOI 10.1016/S0167-7012(00)00122-6; Taniguchi L, 2009, J MICROBIOL METH, V78, P171, DOI 10.1016/j.mimet.2009.05.012; Terpenning MS, 2001, J AM GERIATR SOC, V49, P557, DOI 10.1046/j.1532-5415.2001.49113.x; Thein ZM, 2006, ARCH ORAL BIOL, V51, P672, DOI 10.1016/j.archoralbio.2006.02.005	57	94	97	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123206	10.1371/journal.pone.0123206	http://dx.doi.org/10.1371/journal.pone.0123206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875834	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100152
J	Hao, RJ; Adoligbe, C; Jiang, BJ; Zhao, XL; Gui, LS; Qu, KX; Wu, S; Zan, LS				Hao, Ruijie; Adoligbe, Camus; Jiang, Bijie; Zhao, Xianlin; Gui, Linsheng; Qu, Kaixing; Wu, Sen; Zan, Linsen			An Optimized Trichloroacetic Acid/Acetone Precipitation Method for Two-Dimensional Gel Electrophoresis Analysis of Qinchuan Cattle Longissimus Dorsi Muscle Containing High Proportion of Marbling	PLOS ONE			English	Article							PROTEIN EXTRACTION; SAMPLE PREPARATION; MASS-SPECTROMETRY; PLANT-TISSUES; PROTEOMICS; RESOLUTION; SOLUBILIZATION; COMPATIBILITY; IMPROVEMENTS; MEMBRANE	Longissimus dorsi muscle (LD) proteomics provides a novel opportunity to reveal the molecular mechanism behind intramuscular fat deposition. Unfortunately, the vast amounts of lipids and nucleic acids in this tissue hampered LD proteomics analysis. Trichloroacetic acid (TCA)/acetone precipitation is a widely used method to remove contaminants from protein samples. However, the high speed centrifugation employed in this method produces hard precipitates, which restrict contaminant elimination and protein re-dissolution. To address the problem, the centrifugation precipitates were first grinded with a glass tissue grinder and then washed with 90% acetone (TCA/acetone-G-W) in the present study. According to our result, the treatment for solid precipitate facilitated non-protein contaminant removal and protein re-dissolution, ultimately improving two-dimensional gel electrophoresis (2-DE) analysis. Additionally, we also evaluated the effect of sample drying on 2-DE profile as well as protein yield. It was found that 30 min air-drying did not result in significant protein loss, but reduced horizontal streaking and smearing on 2-DE gel compared to 10 min. In summary, we developed an optimized TCA/acetone precipitation method for protein extraction of LD, in which the modifications improved the effectiveness of TCA/acetone method.	[Hao, Ruijie; Adoligbe, Camus; Jiang, Bijie; Zhao, Xianlin; Gui, Linsheng; Qu, Kaixing; Wu, Sen; Zan, Linsen] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China; [Zan, Linsen] Northwest A&F Univ, Natl Beef Cattle Improvement Ctr, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China	Zan, LS (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling, Shaanxi, Peoples R China.	zanlinsen@163.com	开兴, 亐/AAG-4304-2020	Wu, Sen/0000-0001-5244-4293	National 863 Program of China [2013AA102505, 2011AA100307-02]; National Natural Science Foundation [31272411]; National Beef and Yak Industrial Technology System [CARS-38]; National Science-technology Support Plan Projects [2012BAD28B04-03]; Major Projects for New Varieties of Genetically Modified Organisms of China [2011ZX08007-002]; Technical Innovation Engineering Project of Shaanxi Province [2014KTZB02-02-01]	National 863 Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National Beef and Yak Industrial Technology System; National Science-technology Support Plan Projects; Major Projects for New Varieties of Genetically Modified Organisms of China; Technical Innovation Engineering Project of Shaanxi Province	This work was supported by National 863 Program of China (#2013AA102505 & #2011AA100307-02) http://www.863.gov.on/, National Natural Science Foundation (#31272411) http://www.nsfc.gov.on/, National Beef and Yak Industrial Technology System (#CARS-38) http://www.moa.gov.on/, National Science-technology Support Plan Projects (#2012BAD28B04-03) http://www.most.gov.on/, Major Projects for New Varieties of Genetically Modified Organisms of China (#2011ZX08007-002) http://www.most.gov.on/kjjh/, and Technical Innovation Engineering Project of Shaanxi Province (#2014KTZB02-02-01) http://www.sninfo.gov.on: 8083/initSnFirstPageList. do?method = initSnFirstPageList. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry R, 2004, PROTEOMICS, V4, P3717, DOI 10.1002/pmic.200300877; Bjarnadottir SG, 2010, J AGR FOOD CHEM, V58, P7408, DOI 10.1021/jf100697h; Bodzon-Kulakowska A, 2007, J CHROMATOGR B, V849, P1, DOI 10.1016/j.jchromb.2006.10.040; Bouley J, 2004, PROTEOMICS, V4, P1811, DOI 10.1002/pmic.200300688; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Canas B, 2007, J CHROMATOGR A, V1153, P235, DOI 10.1016/j.chroma.2007.01.045; Carpentier SC, 2005, PROTEOMICS, V5, P2497, DOI 10.1002/pmic.200401222; Chaze T, 2008, PROTEOMICS, V8, P4236, DOI 10.1002/pmic.200701101; Chromy BA, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-10; DAMERVAL C, 1986, ELECTROPHORESIS, V7, P52, DOI 10.1002/elps.1150070108; DESFRANCS CC, 1985, PLANT PHYSIOL, V78, P178, DOI 10.1104/pp.78.1.178; Garbis S, 2005, J CHROMATOGR A, V1077, P1, DOI 10.1016/j.chroma.2005.04.059; Giavalisco P, 2003, ELECTROPHORESIS, V24, P207, DOI 10.1002/elps.200390016; Gorg A, 1998, ELECTROPHORESIS, V19, P1516, DOI 10.1002/elps.1150190850; Gorg A, 2004, PROTEOMICS, V4, P3665, DOI 10.1002/pmic.200401031; GORG A, 1988, ELECTROPHORESIS, V9, P681, DOI 10.1002/elps.1150091103; Herbert BR, 1998, ELECTROPHORESIS, V19, P845, DOI 10.1002/elps.1150190540; HOCHSTRASSER DF, 1988, ANAL BIOCHEM, V173, P424, DOI 10.1016/0003-2697(88)90209-6; Islam N, 2004, PROTEOMICS, V4, P1903, DOI 10.1002/pmic.200300816; Jiang L, 2004, J CHROMATOGR A, V1023, P317, DOI 10.1016/j.chroma.2003.10.029; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Lametsch R, 2003, J AGR FOOD CHEM, V51, P6992, DOI 10.1021/jf034083p; Lametsch R, 2001, J AGR FOOD CHEM, V49, P4531, DOI 10.1021/jf010103g; Laville E, 2009, J AGR FOOD CHEM, V57, P10755, DOI 10.1021/jf901949r; Lee H, 2010, FOOD SCI BIOTECHNOL, V19, P1107, DOI 10.1007/s10068-010-0157-0; Li AN, 2013, MAMM GENOME, V24, P72, DOI 10.1007/s00335-012-9440-0; Lin JF, 2008, ANAL BIOANAL CHEM, V390, P1765, DOI 10.1007/s00216-008-1910-6; Liu JS, 2009, J AGR FOOD CHEM, V57, P3808, DOI 10.1021/jf8033144; Luque-Garcia JL, 2007, J CHROMATOGR A, V1153, P259, DOI 10.1016/j.chroma.2006.11.054; MACGILLIVRAY AJ, 1974, EUR J BIOCHEM, V41, P181, DOI 10.1111/j.1432-1033.1974.tb03258.x; Maldonado AM, 2008, J PROTEOMICS, V71, P461, DOI 10.1016/j.jprot.2008.06.012; Marino R, 2013, MEAT SCI, V95, P281, DOI 10.1016/j.meatsci.2013.04.009; Millioni R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030911; Nandakumar MP, 2003, J PROTEOME RES, V2, P89, DOI 10.1021/pr025541x; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Ohlendieck K, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-6; Pomastowski P, 2014, TRAC-TREND ANAL CHEM, V53, P167, DOI 10.1016/j.trac.2013.09.010; Rabilloud T, 1997, ELECTROPHORESIS, V18, P307, DOI 10.1002/elps.1150180303; Rabilloud T, 2011, J PROTEOMICS, V74, P1829, DOI 10.1016/j.jprot.2011.05.040; Rabilloud T, 2010, J PROTEOMICS, V73, P2064, DOI 10.1016/j.jprot.2010.05.016; Rodriguez-Pineiro AM, 2007, J CHROMATOGR B, V849, P251, DOI 10.1016/j.jchromb.2006.09.021; Roe MR, 2006, PROTEOMICS, V6, P4678, DOI 10.1002/pmic.200500876; Ruan YS, 2007, ELECTROPHORESIS, V28, P3333, DOI 10.1002/elps.200700035; Saravanan RS, 2004, PROTEOMICS, V4, P2522, DOI 10.1002/pmic.200300789; Sheoran IS, 2009, PLANT SCI, V176, P99, DOI 10.1016/j.plantsci.2008.09.015; Song YF, 2012, PLANT MOL BIOL REP, V30, P1204, DOI 10.1007/s11105-012-0442-6; Tang SH, 2002, J AGR FOOD CHEM, V50, P7444, DOI 10.1021/jf025771w; Taylor CM, 2003, PROTEOMICS, V3, P1303, DOI 10.1002/pmic.200300451; Wang SB, 2003, J APPL PHYCOL, V15, P485, DOI 10.1023/B:JAPH.0000004324.88897.b2; Wilkins M, 2009, EXPERT REV PROTEOMIC, V6, P599, DOI [10.1586/epr.09.81, 10.1586/EPR.09.81]; Wu BY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097286; Wu XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050497; Wu YP, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-38; Zhang Q, 2010, MEAT SCI, V86, P814, DOI 10.1016/j.meatsci.2010.07.002	54	14	15	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124723	10.1371/journal.pone.0124723	http://dx.doi.org/10.1371/journal.pone.0124723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893432	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700118
J	Pozniak, B; Grabowski, T; Motykiewicz-Pers, K; Bobrek, K; Rak, L; Bobusia, K; Gawel, A; Switala, M				Pozniak, Blazej; Grabowski, Tomasz; Motykiewicz-Pers, Karolina; Bobrek, Kamila; Rak, Lech; Bobusia, Katarzyna; Gawel, Andrzej; Switala, Marcin			Pharmacokinetics of Repeated Sodium Salicylate Administration to Laying Hens: Evidence for Time Dependent Increase in Drug Elimination from Plasma and Eggs	PLOS ONE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DIETARY ACETYLSALICYLIC-ACID; INDUCTION; CHICKENS; ASPIRIN	Salicylates were the first non-steroid anti-inflammatory drugs (NSAIDs) to be used in any species and are still widely used in humans and livestock. However, the data on their pharmacokinetics in animals is limited, especially after repeated administration. Evidence exist that in chickens (Gallus gallus) salicylate (SA) may induce its own elimination. The aim of this study was to investigate salicylate pharmacokinetics and egg residues during repeated administration of sodium salicylate (SS) to laying hens. Pharmacokinetics of SA was assessed during 14 d oral administration of SS at daily doses of 50 mg/kg and 200 mg/kg body weight to laying hens. On the 1st, 7th and 14th d a 24 h-long pharmacokinetic study was carried out, whereas eggs were collected daily. Salicylate concentrations in plasma and eggs were determined using high-performance liquid chromatography with ultraviolet detection and pharmacokinetic variables were calculated using a non-compartmental model. Mean residence time (MRT), minimal plasma concentration (C-min, C-16h) and elimination half-life (T-1/2el) of SA showed gradual decrease in layers administered with a lower dose. Total body clearance (CIB) increased. Layers administered with the higher dose showed a decrease only in the T-1/2el. In the low dose group, SA was found only in the egg white and was low throughout the experiment. Egg whites from the higher dose group showed initially high SA levels which significantly decreased during the experiment. Yolk SA levels were lower and showed longer periods of accumulation and elimination. Repeated administration of SS induces SA elimination, although this effect may differ depending on the dose and production type of a chicken. Decreased plasma drug concentration may have clinical implications during prolonged SS treatment.	[Pozniak, Blazej; Motykiewicz-Pers, Karolina; Switala, Marcin] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biochem Pharmacol & Toxicol, Wroclaw, Poland; [Grabowski, Tomasz] Polpharma Biol, Gdansk, Poland; [Bobrek, Kamila; Bobusia, Katarzyna; Gawel, Andrzej] Wroclaw Univ Environm & Life Sci, Dept Epizootiol, Fac Vet Med, Wroclaw, Poland; [Bobrek, Kamila; Bobusia, Katarzyna; Gawel, Andrzej] Wroclaw Univ Environm & Life Sci, Clin Birds & Exot Anim, Fac Vet Med, Wroclaw, Poland; [Rak, Lech] Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Food Hyg & Consumer Hlth Protect, Wroclaw, Poland	Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences; Wroclaw University of Environmental & Life Sciences	Pozniak, B (corresponding author), Wroclaw Univ Environm & Life Sci, Fac Vet Med, Dept Biochem Pharmacol & Toxicol, Wroclaw, Poland.	blazej.pozniak@up.wroc.pl	Świtała, Marcin/ABB-4761-2021; Grabowski, Tomasz/GPT-2033-2022; Grabowski, Tomasz/AAE-6300-2020; Poźniak, Błażej/ABB-4032-2021; Bobrek, Kamila/X-2745-2018	Grabowski, Tomasz/0000-0002-3077-9698; Grabowski, Tomasz/0000-0002-3077-9698; Poźniak, Błażej/0000-0002-5813-1404; Gawel, Andrzej/0000-0002-5595-8852; Switala, Marcin/0000-0001-7356-1333; Bobrek, Kamila/0000-0001-7214-073X	Fundamental Research Fund for the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences [WdW/ 312/99/2010]; Wroclaw Centre of Biotechnology, programme: the Leading National Research Centre (KNOW); Polpharma Biologics	Fundamental Research Fund for the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences; Wroclaw Centre of Biotechnology, programme: the Leading National Research Centre (KNOW); Polpharma Biologics	This research was supported by the Fundamental Research Fund for the Faculty of Veterinary Medicine, Wroclaw University of Environmental and Life Sciences (WdW/ 312/99/2010). Publication supported by Wroclaw Centre of Biotechnology, programme: the Leading National Research Centre (KNOW) for years 2014-2018. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Co-author TG is employed by Polpharma Biologics. Polpharma Biologics provided support in the form of salary for author TG, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	Baenkler H, 2008, DTSCH ARZTEBL INT, V105, P137, DOI 10.3238/arztebl.2008.0137; Baert K, 2004, J VET PHARMACOL THER, V27, P123, DOI 10.1111/j.1365-2885.2004.00554.x; Baert K, 2003, COMP BIOCHEM PHYS C, V134, P25, DOI 10.1016/S1532-0456(02)00184-9; Baert K, 2002, J VET PHARMACOL THER, V25, P449, DOI 10.1046/j.1365-2885.2002.00441.x; Balog JM, 2000, POULTRY SCI, V79, P1101, DOI 10.1093/ps/79.8.1101; BALOG JM, 1991, POULTRY SCI, V70, P624, DOI 10.3382/ps.0700624; Boulianne M., 1990, Proceedings of the thirty-ninth Western Poultry Disease Conference, March 4-6, 1990, Sacramento, California., P89; Damme B, 1996, TOXICOLOGY, V106, P99, DOI 10.1016/0300-483X(95)03168-F; de Boever S, 2010, J VET PHARMACOL THER, V33, P564, DOI 10.1111/j.1365-2885.2010.01184.x; Donoghue DJ, 2000, BRIT POULTRY SCI, V41, P174, DOI 10.1080/713654912; Dupont I, 1999, DRUG METAB DISPOS, V27, P322; Johnson A.L., 2000, P569, DOI 10.1016/B978-012747605-6/50023-7; JOUGLAR JY, 1992, RECL MED VET, V168, P745; LEES P, 1991, J SMALL ANIM PRACT, V32, P183, DOI 10.1111/j.1748-5827.1991.tb00541.x; Liu JH, 1996, J CHROMATOGR B, V675, P61; Machin KL, 2005, SEMIN AVIAN EXOT PET, V14, P236, DOI 10.1053/j.saep.2005.09.004; MCDANIEL CD, 1993, POULTRY SCI, V72, P1109, DOI 10.3382/ps.0721109; Mohammad FK, 2012, VET MED-CZECH, V57, P121, DOI 10.17221/5851-VETMED; Mohammed A.A., 2010, INT J POULTRY SCI, V9, P382; Nebbia C, 2003, VET J, V165, P53, DOI 10.1016/S1090-0233(02)00174-0; Pozniak B, 2013, BRIT POULTRY SCI, V54, P538, DOI 10.1080/00071668.2013.809403; Pozniak B, 2012, BRIT POULTRY SCI, V53, P777, DOI 10.1080/00071668.2012.745929; Sampson HA, 1999, J ALLERGY CLIN IMMUN, V103, P717, DOI 10.1016/S0091-6749(99)70411-2; Xu CJ, 2005, ARCH PHARM RES, V28, P249, DOI 10.1007/BF02977789	24	8	9	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123526	10.1371/journal.pone.0123526	http://dx.doi.org/10.1371/journal.pone.0123526			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893240	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700039
J	Cui, J; Li, XL; Duan, ZG; Xue, WQ; Wang, Z; Lu, S; Lin, RZ; Liu, MF; Zhu, GX; Huang, JD				Cui, Ju; Li, Xiuling; Duan, Zhigang; Xue, Wenqian; Wang, Zai; Lu, Song; Lin, Raozhou; Liu, Mengfei; Zhu, Guixia; Huang, Jian-Dong			Analysis of Kif5b Expression during Mouse Kidney Development	PLOS ONE			English	Article							KINESIN HEAVY-CHAIN; PANCREATIC BETA-CELLS; THICK ASCENDING LIMB; CONVENTIONAL KINESIN; TARGETED DISRUPTION; DISTAL NEPHRON; TRANSPORT; JUNCTIONS; MICE; LOCALIZATION	Recent studies showed that kidney-specific inactivation of Kif3a produces kidney cysts and renal failure, suggesting that kinesin-mediated intracellular transportation is important for the establishement and maintenance of renal epithelial cell polarity and normal nephron functions. Kif5b, one of the most conserved kinesin heavy chain, is the mouse homologue of the human ubiquitous Kinesin Heavy Chain (uKHC). In order to elucidate the role of Kif5b in kidney development and function, it is essential to establish its expression profile within the organ. Therefore, in this study, we examined the expression pattern of Kif5b in mouse kidney. Kidneys from embryonic (E) 12.5-, 16.5-dpc (days post coitus) mouse fetuses, from postnatal (P) day 0, 10, 20 pups and from adult mice were collected. The distribution of Kif5b was analyzed by immunostaining. The possible involvement of Kif5b in kidney development was investigated in conditional mutant mice by using a Cre-LoxP strategy. This study showed that the distribution of Kif5b displayed spatiotemporal changes during postnatal kidney development. In kidneys of new born mice, Kif5b was strongly expressed in all developing tubules and in the ureteric bud, but not in the glomerulus or in other early-developing structures, such as the cap mesenchyme, the comma-shaped body, and the S-shaped body. In kidneys of postnatal day 20 or of older mice, however, Kif5b was localized selectively in the basolateral domain of epithelial cells of the thick ascending loop of Henle, as well as of the distal convoluted tubule, with little expression being observed in the proximal tubule or in the collecting duct. Conditional knock-down of Kif5b in mouse kidney did not result in detectable morphological defects, but it did lead to a decrease in cell proliferation rate and also to a misloalization of Na+/K+/-ATPase, indicating that although Kif5b is non-essential for kidney morphogenesis, it is important for nephron maturation.	[Cui, Ju] Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China; [Cui, Ju] Minist Hlth, Beijing Inst Geriatr, Beijing, Peoples R China; [Cui, Ju; Li, Xiuling; Xue, Wenqian; Wang, Zai; Lu, Song; Lin, Raozhou; Liu, Mengfei; Zhu, Guixia; Huang, Jian-Dong] Univ Hong Kong, LKS Fac Med, Dept Biochem, Hong Kong, Hong Kong, Peoples R China; [Duan, Zhigang] Univ Hong Kong, LKS Fac Med, Dept Anat, Hong Kong, Hong Kong, Peoples R China; [Wang, Zai] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Huang, Jian-Dong] Shenzhen Inst Adv Technol, Ctr Synthet Biol Engn Res, Shenzhen, Peoples R China	Beijing Hospital; University of Hong Kong; University of Hong Kong; China-Japan Friendship Hospital; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Cui, J (corresponding author), Beijing Hosp, Key Lab Geriatr, Beijing, Peoples R China.	juzi.cui@gmail.com; jdhuang@hku.hk	Lin, Raozhou/ABG-3533-2021; /C-4277-2009	Lin, Raozhou/0000-0002-1066-8464; /0000-0001-7531-2816	Hong Kong Research Grants Council [HKU 768113M, HKU 767012]; Ph.D. Scientific Research Foundation of Beijing Hospital [BJ-2012-187]; National Natural Science Foundation of China [31400995]	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Ph.D. Scientific Research Foundation of Beijing Hospital; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Hong Kong Research Grants Council (HKU 768113M, HKU 767012) to J.D.H., a Ph.D. Scientific Research Foundation of Beijing Hospital (BJ-2012-187) and a grant from National Natural Science Foundation of China (31400995) to J.C.. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachmann S, 1999, ANAT EMBRYOL, V200, P447, DOI 10.1007/s004290050294; Cardoso CMP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004424; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; CHAMBERLIN ME, 1984, AM J PHYSIOL, V247, pF955, DOI 10.1152/ajprenal.1984.247.6.F955; Chen XY, 2003, J CELL BIOL, V163, P547, DOI 10.1083/jcb.200305137; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Gamba G, 1999, KIDNEY INT, V56, P1606, DOI 10.1046/j.1523-1755.1999.00712.x; Grigoriev I, 2007, DEV CELL, V13, P305, DOI 10.1016/j.devcel.2007.06.010; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Hebert SC, 2004, KIDNEY INT, V66, pS28, DOI 10.1111/j.1523-1755.2004.09105.x; HIROKAWA N, 1989, CELL, V56, P867, DOI 10.1016/0092-8674(89)90691-0; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Ichimura T, 2002, BIOCHEMISTRY-US, V41, P5566, DOI 10.1021/bi015946f; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Jaulin F, 2007, DEV CELL, V13, P511, DOI 10.1016/j.devcel.2007.08.001; Joost HG, 2001, MOL MEMBR BIOL, V18, P247, DOI 10.1080/09687680110090456; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KATZ AI, 1979, AM J PHYSIOL, V237, pF114, DOI 10.1152/ajprenal.1979.237.2.F114; Lin FM, 2003, P NATL ACAD SCI USA, V100, P5286, DOI 10.1073/pnas.0836980100; MARPLES D, 1995, AM J PHYSIOL-CELL PH, V269, pC655, DOI 10.1152/ajpcell.1995.269.3.C655; Meng YX, 1997, ENDOCRINOLOGY, V138, P1979, DOI 10.1210/en.138.5.1979; Naesens Maarten, 2004, Nephron Physiol, V96, pp65, DOI 10.1159/000076752; Nekrasova OE, 2011, J CELL BIOL, V195, P1185, DOI 10.1083/jcb.201106057; Noda Y, 2001, J CELL BIOL, V155, P77, DOI 10.1083/jcb.200108042; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Palm F, 2005, INT J BIOCHEM CELL B, V37, P1554, DOI 10.1016/j.biocel.2005.02.007; Palm F, 2004, DIABETOLOGIA, V47, P1223, DOI 10.1007/s00125-004-1434-3; Palm F, 2003, DIABETOLOGIA, V46, P1153, DOI 10.1007/s00125-003-1155-z; Patel V, 2008, HUM MOL GENET, V17, P1578, DOI 10.1093/hmg/ddn045; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Tanaka Y, 1998, CELL, V93, P1147, DOI 10.1016/S0092-8674(00)81459-2; Trejo HE, 2010, FASEB J, V24, P374, DOI 10.1096/fj.09-137802; Vainio S, 2002, NAT REV GENET, V3, P533, DOI 10.1038/nrg842; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang Z, 2013, DEVELOPMENT, V140, P617, DOI 10.1242/dev.085969; Xia CH, 2003, J CELL BIOL, V161, P55, DOI 10.1083/jcb.200301026; Xue XX, 2010, J CELL SCI, V123, P1732, DOI 10.1242/jcs.056366	40	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0126002	10.1371/journal.pone.0126002	http://dx.doi.org/10.1371/journal.pone.0126002			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885434	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000165
J	Makino, K; Takeichi, O; Hatori, K; Imai, K; Ochiai, K; Ogiso, B				Makino, Kosuke; Takeichi, Osamu; Hatori, Keisuke; Imai, Kenichi; Ochiai, Kuniyasu; Ogiso, Bunnai			Epstein-Barr Virus Infection in Chronically Inflamed Periapical Granulomas	PLOS ONE			English	Article							CYTOKINE EXPRESSION; APICAL PERIODONTITIS; GASTRIC-CARCINOMA; T-LYMPHOCYTE; CELLS; CYTOMEGALOVIRUS; THERAPY; LESIONS; GROWTH; IL-10	Periapical granulomas are lesions around the apex of a tooth caused by a polymicrobial infection. Treatment with antibacterial agents is normally performed to eliminate bacteria from root canals; however, loss of the supporting alveolar bone is typically observed, and tooth extraction is often selected if root canal treatment does not work well. Therefore, bacteria and other microorganisms could be involved in this disease. To understand the pathogenesis of periapical granulomas more precisely, we focused on the association with Epstein-Barr virus (EBV) using surgically removed periapical granulomas (n = 32). EBV DNA was detected in 25 of 32 periapical granulomas (78.1%) by real-time PCR, and the median number of EBV DNA copies was approximately 8,688.01/mu g total DNA. In contrast, EBV DNA was not detected in healthy gingival tissues (n = 10); the difference was statistically significant according to the Mann-Whitney U test (p = 0.0001). Paraffin sections were also analyzed by in situ hybridization to detect EBV-encoded small RNA (EBER)-expressing cells. EBER was detected in the cytoplasm and nuclei of B cells and plasma cells in six of nine periapical granulomas, but not in healthy gingival tissues. In addition, immunohistochemical analysis for latent membrane protein 1 (LMP-1) of EBV using serial tissue sections showed that LMP-1-expressing cells were localized to the same areas as EBER-expressing cells. These data suggest that B cells and plasma cells in inflamed granulomas are a major source of EBV infection, and that EBV could play a pivotal role in controlling immune cell responses in periapical granulomas.	[Makino, Kosuke; Takeichi, Osamu; Hatori, Keisuke; Ogiso, Bunnai] Nihon Univ, Sch Dent, Dept Endodont, Chiyoda Ku, Tokyo 101, Japan; [Imai, Kenichi; Ochiai, Kuniyasu] Nihon Univ, Sch Dent, Dept Microbiol, Chiyoda Ku, Tokyo 101, Japan	Nihon University; Nihon University	Takeichi, O (corresponding author), Nihon Univ, Sch Dent, Dept Endodont, Chiyoda Ku, Tokyo 101, Japan.	takeichi.osamu@nihon-u.ac.jp			 [23592811];  [26462897]	; 	OT: Grant-in-AId for Scientific Research (http://www.jsps.go.jp/j-grantsinaid/index.html) for 2013 (23592811) and 2014 (26462897). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altmann M, 2005, PLOS BIOL, V3, P2148, DOI 10.1371/journal.pbio.0030404; Chang K L, 1992, Diagn Mol Pathol, V1, P246, DOI 10.1097/00019606-199203000-00037; Chen V, 2009, J ENDODONT, V35, P182, DOI 10.1016/j.joen.2008.11.018; Chong JM, 2002, J VIROL, V76, P6825, DOI 10.1128/JVI.76.13.6825-6831.2002; Endo LH, 2001, INT J PEDIATR OTORHI, V58, P9, DOI 10.1016/S0165-5876(00)00446-8; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FURNARI FB, 1992, J VIROL, V66, P2837, DOI 10.1128/JVI.66.5.2837-2845.1992; Glaser R, 2006, VIROLOGY, V346, P205, DOI 10.1016/j.virol.2005.10.034; Guilherme BPS, 2011, ORAL SURG ORAL MED O, V112, P678, DOI 10.1016/j.tripleo.2011.05.003; Hren NI, 2009, ARCH ORAL BIOL, V54, P156, DOI 10.1016/j.archoralbio.2008.09.014; Iwakiri D, 2005, ONCOGENE, V24, P1767, DOI 10.1038/sj.onc.1208357; Iwakiri D, 2009, J EXP MED, V206, P2091, DOI 10.1084/jem.20081761; Jungermann GB, 2011, J ENDODONT, V37, P1337, DOI 10.1016/j.joen.2011.06.028; Kivity S, 2014, J AUTOIMMUN, V51, P17, DOI 10.1016/j.jaut.2014.02.008; Kuppers R, 2003, NAT REV IMMUNOL, V3, P801, DOI 10.1038/nri1201; Nair PNR, 2004, CRIT REV ORAL BIOL M, V15, P348, DOI 10.1177/154411130401500604; Nakai H, 2012, MICROBIOL IMMUNOL, V56, P93, DOI 10.1111/j.1348-0421.2011.00410.x; de Brito LCN, 2012, J ENDODONT, V38, P481, DOI 10.1016/j.joen.2011.12.010; Sabeti M, 2003, ORAL MICROBIOL IMMUN, V18, P327, DOI 10.1034/j.1399-302X.2003.00079.x; Sabeti M, 2012, J ENDODONT, V38, P47, DOI 10.1016/j.joen.2011.09.026; Samanta M, 2008, ONCOGENE, V27, P4150, DOI 10.1038/onc.2008.75; Sawada S, 2007, AUTOIMMUN REV, V6, P126, DOI 10.1016/j.autrev.2006.08.014; SCHWEMMLE M, 1992, P NATL ACAD SCI USA, V89, P10292, DOI 10.1073/pnas.89.21.10292; Sin SH, 2012, J INTERF CYTOK RES, V32, P53, DOI 10.1089/jir.2011.0083; Siqueira JF, 2009, J DENT RES, V88, P969, DOI 10.1177/0022034509346549; Siqueira Jose F Jr, 2009, J Oral Microbiol, V1, DOI 10.3402/jom.v1i0.2009; Sunde PT, 2008, J CLIN VIROL, V42, P176, DOI 10.1016/j.jcv.2008.01.007; Szkaradkiewicz A, 2006, VIRUS RES, V118, P115, DOI 10.1016/j.virusres.2005.12.001; Takeichi O, 1998, IMMUNOLOGY, V93, P275; Windley W, 2005, J ENDODONT, V31, P439, DOI 10.1097/01.don.0000148143.80283.ea; Yang LX, 2004, CANCER RES, V64, P5332, DOI 10.1158/0008-5472.CAN-04-0733	31	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121548	10.1371/journal.pone.0121548	http://dx.doi.org/10.1371/journal.pone.0121548			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884725	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000020
J	Parham, GP; Mwanahamuntu, MH; Kapambwe, S; Muwonge, R; Bateman, AC; Blevins, M; Chibwesha, CJ; Pfaendler, KS; Mudenda, V; Shibemba, AL; Chisele, S; Mkumba, G; Vwalika, B; Hicks, ML; Vermund, SH; Chi, BH; Stringer, JSA; Sankaranarayanan, R; Sahasrabuddhe, VV				Parham, Groesbeck P.; Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Muwonge, Richard; Bateman, Allen C.; Blevins, Meridith; Chibwesha, Carla J.; Pfaendler, Krista S.; Mudenda, Victor; Shibemba, Aaron L.; Chisele, Samson; Mkumba, Gracilia; Vwalika, Bellington; Hicks, Michael L.; Vermund, Sten H.; Chi, Benjamin H.; Stringer, Jeffrey S. A.; Sankaranarayanan, Rengaswamy; Sahasrabuddhe, Vikrant V.			Population-Level Scale-Up of Cervical Cancer Prevention Services in a Low-Resource Setting: Development, Implementation, and Evaluation of the Cervical Cancer Prevention Program in Zambia	PLOS ONE			English	Article							HIV-INFECTED WOMEN; VISUAL INSPECTION; ACETIC-ACID; MORTALITY; INDIA; CARE	Background Very few efforts have been undertaken to scale-up low-cost approaches to cervical cancer prevention in low-resource countries. Methods In a public sector cervical cancer prevention program in Zambia, nurses provided visual-inspection with acetic acid (VIA) and cryotherapy in clinics co-housed with HIV/AIDS programs, and referred women with complex lesions for histopathologic evaluation. Low-cost technological adaptations were deployed for improving VIA detection, facilitating expert physician opinion, and ensuring quality assurance. Key process and outcome indicators were derived by analyzing electronic medical records to evaluate program expansion efforts. Findings Between 2006-2013, screening services were expanded from 2 to 12 clinics in Lusaka, the most-populous province in Zambia, through which 102,942 women were screened. The majority (71.7%) were in the target age-range of 25-49 years; 28% were HIV-positive. Out of 101,867 with evaluable data, 20,419 (20%) were VIA positive, of whom 11,508 (56.4%) were treated with cryotherapy, and 8,911 (43.6%) were referred for histopathologic evaluation. Most women (87%, 86,301 of 98,961 evaluable) received same-day services (including 5% undergoing same-visit cryotherapy and 82% screening VIA-negative). The proportion of women with cervical intraepithelial neoplasia grade 2 and worse (CIN2+) among those referred for histopathologic evaluation was 44.1% (1,735/3,938 with histopathology results). Detection rates for CIN2+ and invasive cervical cancer were 17 and 7 per 1,000 women screened, respectively. Women with HIV were more likely to screen positive, to be referred for histopathologic evaluation, and to have cervical precancer and cancer than HIV-negative women. Interpretation We creatively disrupted the 'no screening' status quo prevailing in Zambia and addressed the heavy burden of cervical disease among previously unscreened women by establishing and scaling-up public-sector screening and treatment services at a population level. Key determinants for successful expansion included leveraging HIV/AIDS program investments, and context-specific information technology applications for quality assurance and filling human resource gaps.	[Parham, Groesbeck P.; Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Bateman, Allen C.; Chibwesha, Carla J.; Pfaendler, Krista S.; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Ctr Infect Dis Res Zambia, Lusaka, Zambia; [Parham, Groesbeck P.; Mwanahamuntu, Mulindi H.; Kapambwe, Sharon; Mudenda, Victor; Shibemba, Aaron L.; Chisele, Samson; Mkumba, Gracilia; Vwalika, Bellington] Univ Zambia, Lusaka, Zambia; [Parham, Groesbeck P.; Bateman, Allen C.; Chibwesha, Carla J.; Chi, Benjamin H.; Stringer, Jeffrey S. A.] Univ N Carolina, Chapel Hill, NC USA; [Parham, Groesbeck P.; Muwonge, Richard; Sankaranarayanan, Rengaswamy] Int Agcy Res Canc, F-69372 Lyon, France; [Blevins, Meridith; Vermund, Sten H.; Sahasrabuddhe, Vikrant V.] Vanderbilt Univ, Nashville, TN 37235 USA; [Hicks, Michael L.] Michigan Canc Inst, Pontiac, MI USA; [Sahasrabuddhe, Vikrant V.] NCI, Bethesda, MD 20892 USA; [Pfaendler, Krista S.] Univ Calif Irvine, Irvine, CA USA	University of Zambia; University of North Carolina; University of North Carolina Chapel Hill; World Health Organization; International Agency for Research on Cancer (IARC); Vanderbilt University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of California System; University of California Irvine	Parham, GP (corresponding author), Ctr Infect Dis Res Zambia, Lusaka, Zambia.	professorparham@gmail.com	Stringer, Jeffrey S. A./AAU-2342-2021; Vermund, Sten/AAD-3592-2020; Muwonge, Richard/P-6375-2015	Vermund, Sten/0000-0001-7289-8698; Stringer, Jeffrey/0000-0002-9590-7216	Government of the Republic of Zambia's Ministry of Health; Ministry of Community Development, Mother and Child Health; United States Government through the President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC); United States National Institutes of Health (NIH) [D43CA153784, D43TW001035, R24TW007988]; FOGARTY INTERNATIONAL CENTER [R24TW007988, D43TW001035] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA060396, D43CA153784] Funding Source: NIH RePORTER	Government of the Republic of Zambia's Ministry of Health; Ministry of Community Development, Mother and Child Health; United States Government through the President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC); United States National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The program was supported by funding from the Government of the Republic of Zambia's Ministry of Health and Ministry of Community Development, Mother and Child Health, as well as from the United States Government through the President's Emergency Plan for AIDS Relief (PEPFAR) program through the United States Centers for Disease Control and Prevention (CDC). Support for technical assistance and training for program personnel was received from the United States National Institutes of Health (NIH) grants to the University of North Carolina at Chapel Hill (grant number D43CA153784) and Vanderbilt University (grant numbers D43TW001035 and R24TW007988). Dr. Groesbeck Parham serves as a Senior Visiting Scientist at the International Agency for Research on Cancer (IARC)-World Health Organization (WHO), which also provided technical assistance for this evaluation. Dr. Parham had full access to all the data in the study and had final responsibility for the decision to submit for publication. The sponsors of this study had no role in study design, data collection, data analysis, data interpretation, writing of the report, or in the decision to submit the report for publication.	[Anonymous], CANC INCIDENCE 5 CON; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bendavid E, 2012, JAMA-J AM MED ASSOC, V307, P2060, DOI 10.1001/jama.2012.2001; Chirwa Susan, 2010, Glob Health Promot, V17, P47, DOI 10.1177/1757975910363938; Editorial, 2012, LANCET, V380, P1622, DOI [10.1016/S0140-6736(12)61931-X, DOI 10.1016/S0140-6736(12)61931-X]; Ferlay J, 2012, IARC CANCERBASE; Gaffikin L, 1999, LANCET, V353, P869; Gaffikin L, 2003, LANCET, V361, P814, DOI 10.1016/S0140-6736(03)12707-9; Murillo R, 2008, VACCINE, V26, pL37, DOI 10.1016/j.vaccine.2008.06.013; Muwonge R, 2010, INT J GYNECOL OBSTET, V111, P68, DOI 10.1016/j.ijgo.2010.04.024; Mwanahamuntu MH, 2014, INT J GYNECOL OBSTET, V126, P88, DOI 10.1016/j.ijgo.2014.01.006; Mwanahamuntu MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074607; Mwanahamuntu MH, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001032; Mwanahamuntu MH, 2009, AIDS, V23, pN1, DOI 10.1097/QAD.0b013e3283236e11; Ngoma T, 2010, INT J GYNECOL OBSTET, V109, P100, DOI 10.1016/j.ijgo.2009.11.025; Parham GP, 2006, GYNECOL ONCOL, V103, P1017, DOI 10.1016/j.ygyno.2006.06.015; Parham GP, 2010, J LOW GENIT TRACT DI, V14, P167, DOI 10.1097/LGT.0b013e3181cd6d5e; Pfaendler KS, 2008, GYNECOL ONCOL, V110, P402, DOI 10.1016/j.ygyno.2008.04.031; Ronco G, 2014, LANCET, V383, P524, DOI 10.1016/S0140-6736(13)62218-7; Sahasrabuddhe VV, 2012, CANCER PREV RES, V5, P11, DOI 10.1158/1940-6207.CAPR-11-0540; Sankaranarayanan R, 2007, LANCET, V370, P398, DOI 10.1016/S0140-6736(07)61195-7; Sankaranarayanan R, 2012, BEST PRACT RES CL OB, V26, P221, DOI 10.1016/j.bpobgyn.2011.08.003; Sankaranarayanan R, 2009, NEW ENGL J MED, V360, P1385, DOI 10.1056/NEJMoa0808516; Sellors J. W., 2003, COLPOSCOPY TREATMENT; Shastri SS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju009; Szarewski A, 2007, LANCET, V370, P365, DOI 10.1016/S0140-6736(07)61171-4; Ullrich A, 2011, LANCET, V377, P639, DOI 10.1016/S0140-6736(11)60233-X; WHO, 2013, WHO GUID SCREEN TREA	28	92	93	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122169	10.1371/journal.pone.0122169	http://dx.doi.org/10.1371/journal.pone.0122169			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885821	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000028
J	Paudel, S; Zacharioudakis, IM; Zervou, FN; Ziakas, PD; Mylonakis, E				Paudel, Suresh; Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Ziakas, Panayiotis D.; Mylonakis, Eleftherios			Prevalence of Clostridium difficile Infection among Solid Organ Transplant Recipients: A Meta-Analysis of Published Studies	PLOS ONE			English	Article							RISK-FACTORS; LIVER-TRANSPLANTATION; UNITED-STATES; PANCREAS TRANSPLANTATION; LUNG TRANSPLANTATION; COLITIS; OUTCOMES; EPIDEMIOLOGY; DIARRHEA; KIDNEY	Several factors including antibiotic use, immunosuppression and frequent hospitalizations make solid organ transplant (SOT) recipients vulnerable to Clostridium difficile infection (CDI). We conducted a meta-analysis of published studies from 1991-2014 to estimate the prevalence of CDI in this patient population. We searched PubMed, EMBASE and Google Scholar databases. Among the 75,940 retrieved citations, we found 30 studies coded from 35 articles that were relevant to our study. Based on these studies, we estimated the prevalence of CDI among 21,683 patients who underwent transplantation of kidney, liver, lungs, heart, pancreas, intestine or more than one organ and stratified each study based on the type of transplanted organ, place of the study conduction, and size of patient population. The overall estimated prevalence in SOT recipients was 7.4% [95% CI, (5.6-9.5%)] and it varied based on the type of organ transplant. The prevalence was 12.7%[95% CI, (6.4%-20.9%)] among patients who underwent transplantation for more than one organ. The prevalence among other SOT recipients was: lung 10.8% [95% CI, (5.5%-17.7%)], liver 9.1 % [95% CI, (5.8%-13.2%)], intestine 8% [95% CI, (2.6%-15.9%)], heart 5.2% [95% CI, (1.8%-10.2%)], kidney 4.7% [95% CI, (2.6%-7.3%)], and pancreas 3.2% [95% CI, (0.5%-7.9%)]. Among the studies that reported relevant data, the estimated prevalence of severe CDI was 5.3% [95% CI (2.3%-9.3%)] and the overall recurrence rate was 19.7% [95% CI, (13.7%-26.6%)]. In summary, CDI is a significant complication after SOT and preventive strategies are important in order to reduce the CDI related morbidity and mortality.	[Paudel, Suresh; Zacharioudakis, Ioannis M.; Zervou, Fainareti N.; Ziakas, Panayiotis D.; Mylonakis, Eleftherios] Brown Univ, Rhode Isl Hosp, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02903 USA	Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	Mylonakis, E (corresponding author), Brown Univ, Rhode Isl Hosp, Div Infect Dis, Warren Alpert Med Sch, Providence, RI 02903 USA.	emylonakis@lifespan.org		Ziakas, Panayiotis/0000-0002-5943-8635				Abid S, 2011, AM J TRANSPLANT, V11, P324; Albright JB, 2007, TRANSPL INT, V20, P856, DOI 10.1111/j.1432-2277.2007.00530.x; Berger N, 2006, TRANSPL INT, V19, P549, DOI 10.1111/j.1432-2277.2006.00293.x; Boutros M, 2012, TRANSPLANTATION, V93, P1051, DOI 10.1097/TP.0b013e31824d34de; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Coltart IC, 2009, GUT, V58, pA69; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Deshmukh A. A, 2015, P INT C EL COMP COMM, P1; Deshpande A, 2013, INFECT DIS CLIN PRAC, V21, P292, DOI DOI 10.1097/IPC.0b013e31828d7231; Dorschner P, 2014, AM J TRANSPLANT, V14, P776; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Esfeh JM, 2014, LIVER TRANSPLANT, V20, P544, DOI 10.1002/lt.23845; Garg S, 2014, GASTROENTEROLOGY, V146, pS942; Gellad ZF, 2007, TRANSPL INFECT DIS, V9, P276, DOI 10.1111/j.1399-3062.2007.00255.x; GEORGE DL, 1991, REV INFECT DIS, V13, P387; Goudarzi M, 2014, SCIENTIFICA, V2014, DOI 10.1155/2014/916826; Gunderson CC, 2008, TRANSPL INFECT DIS, V10, P245, DOI 10.1111/j.1399-3062.2008.00305.x; Halabi WJ, 2013, J AM COLL SURGEONS, V217, P802, DOI 10.1016/j.jamcollsurg.2013.05.028; Hall AJ, 2012, CLIN INFECT DIS, V55, P216, DOI 10.1093/cid/cis386; Hashimoto M, 2007, WORLD J GASTROENTERO, V13, P2072, DOI 10.3748/wjg.v13.i14.2072; Honda H, 2014, CURR OPIN INFECT DIS, V27, P336, DOI 10.1097/QCO.0000000000000075; Hsu JL, 2014, CLIN TRANSPLANT, V28, P267, DOI 10.1111/ctr.12309; Johnson S, 2009, J INFECTION, V58, P403, DOI 10.1016/j.jinf.2009.03.010; Keven K, 2004, Transpl Infect Dis, V6, P10, DOI 10.1111/j.1399-3062.2004.00040.x; Kittleson M, 2013, J HEART LUNG TRANSPL, V32, pS131, DOI 10.1016/j.healun.2013.01.290; Lee JT, 2013, J HEART LUNG TRANSPL, V32, P1020, DOI 10.1016/j.healun.2013.06.012; Lee JT, 2013, J SURG RES, V184, P599, DOI 10.1016/j.jss.2013.03.041; Lee JT, 2013, CLIN TRANSPLANT, V27, P303, DOI 10.1111/ctr.12064; Len O, 2012, TRANSPL INT, V25, P1275, DOI 10.1111/j.1432-2277.2012.01568.x; Loinaz C, 2003, TRANSPLANT P, V35, P1929, DOI 10.1016/S0041-1345(03)00728-0; Longo WE, 2004, DIS COLON RECTUM, V47, P1620, DOI 10.1007/s10350-004-0672-2; Louie TJ, 2011, NEW ENGL J MED, V364, P422, DOI 10.1056/NEJMoa0910812; Michalak G, 2005, TRANSPL P, V37, P3560, DOI 10.1016/j.transproceed.2005.09.078; Miller BA, 2011, INFECT CONT HOSP EP, V32, P387, DOI 10.1086/659156; Mittal C, 2014, AM J TRANSPLANT, V14, P1901, DOI 10.1111/ajt.12798; Mitu-Pretorian OM, 2010, TRANSPL P, V42, P2631, DOI 10.1016/j.transproceed.2010.04.057; Munoz P, 2007, J HEART LUNG TRANSPL, V26, P907, DOI 10.1016/j.healun.2007.07.010; Neofytos D, 2013, TRANSPL INFECT DIS, V15, P134, DOI 10.1111/tid.12030; Ott E, 2011, CLIN MICROBIOL INFEC, V17, pS774; Pant C, 2012, TRANSPL INFECT DIS, V14, P540, DOI 10.1111/j.1399-3062.2012.00761.x; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Puli SR, 2014, CAN J GASTROENTEROL, V28, P50, DOI 10.1155/2014/539783; Riddle DJ, 2009, INFECT DIS CLIN N AM, V23, P727, DOI 10.1016/j.idc.2009.04.011; Rosen JB, 2010, PEDIATR TRANSPLANT, V14, P651, DOI 10.1111/j.1399-3046.2010.01314.x; Rostambeigi N, 2010, TRANSPLANTATION, V89, P1126, DOI 10.1097/TP.0b013e3181d54bb9; Rucker G, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-79; Shah SA, 2013, TRANSPL INFECT DIS, V15, P502, DOI 10.1111/tid.12113; Stelzmueller I, 2007, DIGEST DIS SCI, V52, P3231, DOI 10.1007/s10620-007-9770-z; Stelzmueller I, 2007, J GASTROINTEST SURG, V11, P911, DOI 10.1007/s11605-007-0134-y; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Theunissen C, 2008, TRANSPL INFECT DIS, V10, P240, DOI 10.1111/j.1399-3062.2007.00269.x; Tsapepas DS, 2014, DIAGN MICROBIOL INFE; Wallia A, 2010, TRANSPLANTATION, V89, P222, DOI 10.1097/TP.0b013e3181c3c2ff; Wells G. A., 2009, NEWCASTLE OTTAWA SCA; West M, 1999, CLIN TRANSPLANT, V13, P318, DOI 10.1034/j.1399-0012.1999.130407.x; Wheeler M, 2013, AM J TRANSPLANT, V13, P344; Wysowski DK, 2006, PUBLIC HEALTH REP, V121, P361; Zacharioudakis Ioannis M, 2014, Biol Blood Marrow Transplant, V20, P1650, DOI 10.1016/j.bbmt.2014.06.001; Ziakas PD, 2014, AM J TRANSPLANT, V14, P1887, DOI 10.1111/ajt.12784; Zilberberg MD, 2008, EMERG INFECT DIS, V14, P929, DOI 10.3201/eid1406.071447; Ziring D, 2005, TRANSPLANTATION, V79, P702, DOI 10.1097/01.TP.0000154911.15693.80	63	65	66	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124483	10.1371/journal.pone.0124483	http://dx.doi.org/10.1371/journal.pone.0124483			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886133	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000130
J	Schumak, B; Klocke, K; Kuepper, JM; Biswas, A; Djie-Maletz, A; Limmer, A; van Rooijen, N; Mack, M; Hoerauf, A; Dunay, IR				Schumak, Beatrix; Klocke, Katrin; Kuepper, Janina M.; Biswas, Aindrila; Djie-Maletz, Andrea; Limmer, Andreas; van Rooijen, Nico; Mack, Matthias; Hoerauf, Achim; Dunay, Ildiko Rita			Specific Depletion of Ly6C(hi) Inflammatory Monocytes Prevents Immunopathology in Experimental Cerebral Malaria	PLOS ONE			English	Article							T-CELL RESPONSES; CHEMOKINE RECEPTOR CCR2; BLOOD-BRAIN-BARRIER; CD8(+) T; PLASMODIUM-BERGHEI; TOXOPLASMA-GONDII; DENDRITIC CELLS; INBRED STRAINS; BONE-MARROW; INFECTION	Plasmodium berghei ANKA (PbA) infection of C57BL/6 mice leads to experimental cerebral malaria (ECM) that is commonly associated with serious T cell mediated damage. In other parasitic infection models, inflammatory monocytes have been shown to regulate Th1 responses but their role in ECM remains poorly defined, whereas neutrophils are reported to contribute to ECM immune pathology. Making use of the recent development of specific monoclonal antibodies (mAb), we depleted in vivo Ly6C(hi) inflammatory monocytes (by anti-CCR2), Ly6G(+) neutrophils (by anti-Ly6G) or both cell types (by anti-Gr1) during infection with Ovalbumin-transgenic PbA parasites (PbTg). Notably, the application of anti-Gr1 or anti-CCR2 but not anti-Ly6G antibodies into PbTg-infected mice prevented ECM development. In addition, depletion of Ly6Chi inflammatory monocytes but not neutrophils led to decreased IFN gamma levels and IFN gamma(+)CD8(+) T effector cells in the brain. Importantly, anti-CCR2 mAb injection did not prevent the generation of PbTg-specific T cell responses in the periphery, whereas anti-Gr1 mAb injection strongly diminished T cell frequencies and CTL responses. In conclusion, the specific depletion of Ly6Chi inflammatory monocytes attenuated brain inflammation and immune cell recruitment to the CNS, which prevented ECM following Plasmodium infection, pointing out a substantial role of Ly6C(+) monocytes in ECM inflammatory processes.	[Schumak, Beatrix; Klocke, Katrin; Kuepper, Janina M.; Hoerauf, Achim] Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany; [Biswas, Aindrila; Dunay, Ildiko Rita] Univ Magdeburg, Inst Med Microbiol, D-39106 Magdeburg, Germany; [Djie-Maletz, Andrea] Univ Freiburg, Dept Neurosurg, D-79106 Freiburg, Germany; [Limmer, Andreas] Univ Bonn, Inst Mol Med, Bonn, Germany; [Limmer, Andreas] Univ Bonn, Inst Expt Immunol, Bonn, Germany; [van Rooijen, Nico] Vrije Univ, Fac Med, VUMC Dept Mol Cell Biol, Amsterdam, Netherlands; [Mack, Matthias] Univ Hosp Regensburg, Dept Internal Med 2, Regensburg, Germany	University of Bonn; Otto von Guericke University; University of Freiburg; University of Bonn; University of Bonn; Vrije Universiteit Amsterdam; University of Regensburg	Schumak, B (corresponding author), Univ Bonn, Inst Med Microbiol Immunol & Parasitol, Bonn, Germany.	bschumak@uni-bonn.de; ildikodunay@gmail.com	Van Rooijen, Nico/Z-1578-2019	Kuehlwein, Janina M./0000-0003-3648-2649	German Research Foundation Excellence Cluster Immunosensation (DFG) [EXC 1023]; BONFOR intramural funding scheme of the Medical Faculty at Bonn University [2012-1-22, 2013-1-29]; German Research Foundation [DU1112/3-1]	German Research Foundation Excellence Cluster Immunosensation (DFG); BONFOR intramural funding scheme of the Medical Faculty at Bonn University; German Research Foundation(German Research Foundation (DFG))	This study received financial support from the German Research Foundation Excellence Cluster Immunosensation (DFG, EXC 1023), through an award to BS to establish a research group (http://www.immunosensation.de). AH is a steering committee member of the EXC 1023 and also of the German Center for Infection Research, DZIF (www.dzif.de). BS and JMK are supported by the BONFOR intramural funding scheme of the Medical Faculty at Bonn University (grants 2012-1-22, 2013-1-29) (www.ukb.unibonn.de/bonfor/). IRD is supported by the German Research Foundation (DU1112/3-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amante FH, 2007, AM J PATHOL, V171, P548, DOI 10.2353/ajpath.2007.061033; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Belnoue E, 2002, J IMMUNOL, V169, P6369, DOI 10.4049/jimmunol.169.11.6369; Belnoue E, 2008, PARASITE IMMUNOL, V30, P544, DOI 10.1111/j.1365-3024.2008.01053.x; Belnoue E, 2003, INFECT IMMUN, V71, P3648, DOI 10.1128/IAI.71.6.3648-3651.2003; Biswas A, 2015, J IMMUNOL, V194, P3223, DOI 10.4049/jimmunol.1402037; Bruhl H, 2007, ARTHRITIS RHEUM, V56, P2975, DOI 10.1002/art.22854; Chen L, 2000, CLIN EXP IMMUNOL, V120, P125, DOI 10.1046/j.1365-2249.2000.01196.x; Daley JM, 2008, J LEUKOCYTE BIOL, V83, P64, DOI 10.1189/jlb.0407247; Dunay IR, 2008, IMMUNITY, V29, P306, DOI 10.1016/j.immuni.2008.05.019; Dunay IR, 2010, CURR OPIN IMMUNOL, V22, P461, DOI 10.1016/j.coi.2010.04.008; Dunay IR, 2010, INFECT IMMUN, V78, P1564, DOI 10.1128/IAI.00472-09; Feuerer M, 2003, NAT MED, V9, P1151, DOI 10.1038/nm914; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Geissmann F, 2008, IMMUNOL CELL BIOL, V86, P398, DOI 10.1038/icb.2008.19; GREENBERG J, 1957, J PARASITOL, V43, P413, DOI 10.2307/3274665; GREENBERG J, 1957, J PARASITOL, V43, P420, DOI 10.2307/3274666; Helk E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003096; Hohl TM, 2009, CELL HOST MICROBE, V6, P470, DOI 10.1016/j.chom.2009.10.007; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Hunt NH, 2006, INT J PARASITOL, V36, P569, DOI 10.1016/j.ijpara.2006.02.016; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Karlmark KR, 2012, EUR J MICROBIOL IMMU, V2, P97, DOI 10.1556/EuJMI.2.2012.2.1; Lundie RJ, 2008, P NATL ACAD SCI USA, V105, P14509, DOI 10.1073/pnas.0806727105; Mack M, 2001, J IMMUNOL, V166, P4697, DOI 10.4049/jimmunol.166.7.4697; Maffei M, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-87; Mohle L, 2014, EUR J MICROBIOL IMMU, V4, P65, DOI 10.1556/EuJMI.4.2014.1.6; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; Naert G, 2013, J MOL CELL BIOL, V5, P284, DOI 10.1093/jmcb/mjt028; Naert G, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00051; Ribes S, 2013, INFECT IMMUN, V81, P1810, DOI 10.1128/IAI.01349-12; Schenk M, 2007, SEMIN IMMUNOL, V19, P84, DOI 10.1016/j.smim.2006.09.002; Schmidt KE, 2011, MICROBES INFECT, V13, P828, DOI 10.1016/j.micinf.2011.04.006; Serbina NV, 2006, NAT IMMUNOL, V7, P311, DOI 10.1038/ni1309; Sheel M, 2012, TRENDS PARASITOL, V28, P408, DOI 10.1016/j.pt.2012.07.008; Soudja SM, 2012, IMMUNITY, V37, P549, DOI 10.1016/j.immuni.2012.05.029; Sponaas AM, 2009, BLOOD, V114, P5522, DOI 10.1182/blood-2009-04-217489; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Wang BM, 2012, CELL IMMUNOL, V278, P103, DOI 10.1016/j.cellimm.2012.07.005; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Wojtasiak M, 2010, J GEN VIROL, V91, P2158, DOI 10.1099/vir.0.021915-0; Yanez DM, 1996, J IMMUNOL, V157, P1620	43	44	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124080	10.1371/journal.pone.0124080	http://dx.doi.org/10.1371/journal.pone.0124080			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884830	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000101
J	Vazquez, AI; Klimentidis, YC; Dhurandhar, EJ; Veturi, YC; Paerez-Rodriguez, P				Vazquez, Ana I.; Klimentidis, Yann C.; Dhurandhar, Emily J.; Veturi, Yogasudha C.; Paerez-Rodriguez, Paulino			Assessment of Whole-Genome Regression for Type II Diabetes	PLOS ONE			English	Article							GENETIC-RELATIONSHIP INFORMATION; MISSING HERITABILITY; SUSCEPTIBILITY LOCI; CLINICAL MASTITIS; PREDICTION; SELECTION; POPULATION; MELLITUS; IMPACT; ARCHITECTURE	Lifestyle and genetic factors play a large role in the development of Type 2 Diabetes (T2D). Despite the important role of genetic factors, genetic information is not incorporated into the clinical assessment of T2D risk. We assessed and compared Whole Genome Regression methods to predict the T2D status of 5,245 subjects from the Framingham Heart Study. For evaluating each method we constructed the following set of regression models: A clinical baseline model (CBM) which included non-genetic covariates only. CBM was extended by adding the first two marker-derived principal components and 65 SNPs identified by a recent GWAS consortium for T2D (M-65SNPs). Subsequently, it was further extended by adding 249,798 genome-wide SNPs from a high-density array. The Bayesian models used to incorporate genome-wide marker information as predictors were: Bayes A, Bayes C Pi, Bayesian LASSO (BL), and the Genomic Best Linear Unbiased Prediction (G-BLUP). Results included estimates of the genetic variance and heritability, genetic scores for T2D, and predictive ability evaluated in a 10-fold cross-validation. The predictive AUC estimates for CBM and M-65SNPs were: 0.668 and 0.684, respectively. We found evidence of contribution of genetic effects in T2D, as reflected in the genomic heritability estimates (0.492 +/- 0.066). The highest predictive AUC among the genome-wide marker Bayesian models was 0.681 for the Bayesian LASSO. Overall, the improvement in predictive ability was moderate and did not differ greatly among models that included genetic information. Approximately 58% of the total number of genetic variants was found to contribute to the overall genetic variation, indicating a complex genetic architecture for T2D. Our results suggest that the Bayes C Pi and the G-BLUP models with a large set of genome-wide markers could be used for predicting risk to T2D, as an alternative to using high-density arrays when selected markers from large consortiums for a given complex trait or disease are unavailable.	[Vazquez, Ana I.] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Klimentidis, Yann C.] Univ Arizona, Mel & Enid Zuckerman Coll Publ Hlth, Div Epidemiol & Biostat, Tucson, AZ USA; [Dhurandhar, Emily J.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Hlth Behav, Birmingham, AL 35294 USA; [Veturi, Yogasudha C.] Univ Alabama Birmingham, Sch Publ Hlth, Dept Biostat, Birmingham, AL 35294 USA; [Paerez-Rodriguez, Paulino] Colegio Postgrad, Montecillo, Edo De Mexico, Mexico	Michigan State University; University of Arizona; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Colegio de Postgraduados - Mexico	Vazquez, AI (corresponding author), Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA.	avazquez@uab.edu	Klimentidis, Yann/B-2348-2015	Klimentidis, Yann/0000-0002-6065-4044	National Heart, Lung, and Blood Institute (NHLBI); Boston University [N01-HC-25195]; NHLBI [N02-HL-64278]; National Institute of Health grant, from National Institute of Diabetes and Digestive and Kidney [7-R01-DK-062148-10]; NIH [K01DK095032, R01GM099992, R01GM101219]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL064278] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK062710, R01DK062148, P30DK079626, K01DK095032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099992, R01GM101219] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Health grant, from National Institute of Diabetes and Digestive and Kidney; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The Framingham Heart Study is conducted and supported by the National Heart, Lung, and Blood Institute (NHLBI) in collaboration with Boston University (Contract No. N01-HC-25195). This manuscript was not prepared in collaboration with investigators of the Framingham Heart Study and does not necessarily reflect the opinions or views of the Framingham Heart Study, Boston University, or NHLBI. Funding for SHARe Affymetrix genotyping was provided by NHLBI Contract N02-HL-64278. SHARe Illumina genotyping was provided under an agreement between Illumina and Boston University. AIV acknowledges National Institute of Health grant, from National Institute of Diabetes and Digestive and Kidney, Research Supplement to 7-R01-DK-062148-10, for their financial support. YCK acknowledges support from NIH grant K01DK095032. PPR had financial support from NIH Grants R01GM099992 AND R01GM101219. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aslibekyan Stella, 2014, BMC Proc, V8, pS102, DOI 10.1186/1753-6561-8-S1-S102; Avendano S, 2010, 9 WORLD C GEN APPL L; Cowie CC, 1995, DIABETES AM, P85; Crossa J, 2010, GENETICS, V186, P713, DOI 10.1534/genetics.110.118521; Daetwyler HD, 2013, GENETICS, V193, P347, DOI 10.1534/genetics.112.147983; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DAWBER TR, 1963, ANN NY ACAD SCI, V107, P539, DOI 10.1111/j.1749-6632.1963.tb13299.x; De los Campos G, 2013, BGLR BAYESIAN GEN LI; de los Campos G, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003608; de los Campos G, 2013, GENETICS, V193, P327, DOI 10.1534/genetics.112.143313; de los Campos G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040964; de los Campos G, 2010, NAT REV GENET, V11, P880, DOI 10.1038/nrg2898; de los Campos G, 2009, GENETICS, V182, P375, DOI 10.1534/genetics.109.101501; Drineas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011892; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; GARCIA MJ, 1974, DIABETES, V23, P105, DOI 10.2337/diab.23.2.105; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Goddard M, 2009, GENETICA, V136, P245, DOI 10.1007/s10709-008-9308-0; Govindaraju DR, 2008, ADV GENET, V62, P33, DOI 10.1016/S0065-2660(08)00602-0; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2010, GENET SEL EVOL, V42, DOI 10.1186/1297-9686-42-5; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Howie B, 2011, G3-GENES GENOM GENET, V1, P457, DOI 10.1534/g3.111.001198; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ishwaran H, 2005, ANN STAT, V33, P730, DOI 10.1214/009053604000001147; KAPRIO J, 1992, DIABETOLOGIA, V35, P1060, DOI 10.1007/BF02221682; Klimentidis Yann C., 2013, Frontiers in Genetics, V4, P174, DOI 10.3389/fgene.2013.00174; Kuo L., 1998, SANKHYA, V60, P65, DOI DOI 10.1186/1471-2105-12-186; Maher B, 2008, NATURE, V456, P18, DOI 10.1038/456018a; Makowsky R, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002051; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Meuwissen THE, 2001, GENETICS, V157, P1819; Mills GW, 2004, DIABETOLOGIA, V47, P732, DOI 10.1007/s00125-004-1338-2; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Perez P, 2014, GENETICS, V198, P483, DOI 10.1534/genetics.114.164442; Perez-Cabal M, 2010, P 9 WORLD C GEN APPL, P150; Poulsen P, 1999, DIABETOLOGIA, V42, P139, DOI 10.1007/s001250051131; Purcell SM, 2009, NATURE, V460, P748, DOI 10.1038/nature08185; R Development Core Team R Core Team, 2010, R LANG ENV STAT COMP; Resende MDV, 2012, NEW PHYTOL, V194, P116, DOI 10.1111/j.1469-8137.2011.04038.x; Shaw JE, 2010, DIABETES RES CLIN PR, V87, P4, DOI 10.1016/j.diabres.2009.10.007; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Vazquez AI, 2010, J DAIRY SCI, V93, P5942, DOI 10.3168/jds.2010-3335; Vazquez AI, 2009, J DAIRY SCI, V92, P5239, DOI 10.3168/jds.2009-2085; Vazquez AI, 2009, J DAIRY SCI, V92, P739, DOI 10.3168/jds.2008-1325; Vazquez AI, 2012, GENETICS, V192, P1493, DOI 10.1534/genetics.112.141705; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Zaitlen N, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003520; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120	60	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123818	10.1371/journal.pone.0123818	http://dx.doi.org/10.1371/journal.pone.0123818			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885636	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000086
J	Zuo, HD; Jiang, LX; Qu, N; Wang, JH; Cui, XJ; Yao, WW				Zuo, Houdong; Jiang, Lingxia; Qu, Nan; Wang, Jianhua; Cui, Xiaojiang; Yao, Weiwu			The Biomarkers Changes in Serum and the Correlation with Quantitative MRI Markers by Histopathologic Evaluation of the Cartilage in Surgically-Induced Osteoarthritis Rabbit Model	PLOS ONE			English	Article							HUMAN ARTICULAR-CARTILAGE; MATRIX PROTEIN COMP; BONE MORPHOGENETIC PROTEIN-2; C-TELOPEPTIDE LEVELS; URINARY CTX-II; KNEE OSTEOARTHRITIS; 3 T; HYALINE CARTILAGE; SPATIAL VARIATION; SYNOVIAL-FLUID	Purpose To investigate the biomarkers change in serum and the correlation with quantitative MRI markers by histopathologic evaluation of the cartilage in surgically-induced osteoarthritis (OA) rabbit model. Materials and Methods Thirty-six mature New Zealand rabbits were used. Eighteen rabbits were divided into six groups randomly and equally and subjected to surgery using the improved Hulth method. The other eighteen rabbits were also allocated into six groups randomly and equally which served as the control. At multiple time points after surgery, the BMP-2, CTX-II and COMP levels in the serum were analyzed by ELISA, and quantitative MRI was performed. Histopathology was examined with HE, and Mankin scores were assessed. The changes in the biochemical biomarkers and imaging markers in the OA groups were compared with those in the control groups using paired-samples T tests. The correlation of quantitative MRI markers with biomarkers and Mankin scores were analyzed. The analysis of Mankin scores was conducted with non-parametric wilcoxon signed rank tests. Results The BMP-2 levels were increased at various times after surgery, and significant differences were observed between the OA and control groups (all the P values < 0.001). CTX-II levels were significantly elevated at several intervals after surgery, including W2, W8, W12, W16 and W20 (P=0.019, 0.004, 0.007, <0.001 and 0.016 respectively), but not at W4 (P=0.764). Significant differences in the COMP levels from W2 to W20 were observed between the OA and the control groups (P<0.001, <0.001, <0.001, <0.001, =0.002 and =0.004 respectively). The T2 values increased at W8 post-surgery and were significantly different between the OA and control groups (P=0.001, <0.001, <0.001 and <0.001 respectively). T2* values increased from W2 to W20 and were significantly different between the control and OA groups (P=0.002, =0.001, <0.001, <0.001, =0.001 and <0.001 respectively). T2 values had significant correlation with BMP-2 and CTX-II (P<0.001 and =0.014), except COMP (P=0.305)., while the correlation of T2* values with BMP-2, CTX-II and COMP was significant (P=0.043, 0.005 and 0.025 respectively). In addition, a positive correlation of T2 values and Mankin scores was observed (P<0.001). Conclusion With the relevance of the multiple time point analysis of the serum biomarkers and imaging markers compared with histological findings, BMP-2, CTX-II and COMP combined with T2 and T2* can be used to reflect and monitor OA progression potentially.	[Zuo, Houdong; Qu, Nan; Yao, Weiwu] Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China; [Jiang, Lingxia] Tongji Univ, Dept Radiol, Peoples Hosp 10, Shanghai 200092, Peoples R China; [Wang, Jianhua] Shanghai Jiao Tong Univ, Sch Med, Dept Orthoped, Xin Hua Hosp, Shanghai 200030, Peoples R China; [Cui, Xiaojiang] Cedars Sinai Med Ctr, Dept Surg, Samuel Oschin Comprehens Canc Inst, Los Angeles, CA 90048 USA	Shanghai Jiao Tong University; Tongji University; Shanghai Jiao Tong University; Cedars Sinai Medical Center	Yao, WW (corresponding author), Shanghai Jiao Tong Univ, Dept Radiol, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	Xiaojiang.cui@cshs.org; yaoweiwu@yahoo.com			National Natural Science Foundation of China [81171312]; NATIONAL CANCER INSTITUTE [R01CA151610] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by a grant from the National Natural Science Foundation of China (No. 81171312). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakker AC, 2001, OSTEOARTHR CARTILAGE, V9, P128, DOI 10.1053/joca.2000.0368; BELLAMY N, 1988, J RHEUMATOL, V15, P1833; Bender AL, 2010, CLIN CHEM LAB MED, V48, P569, DOI 10.1515/CCLM.2010.081; Charni-Ben Tabassi Nadine, 2007, Curr Rheumatol Rep, V9, P16; Chmielewski TL, 2012, OSTEOARTHR CARTILAGE, V20, P1294, DOI 10.1016/j.joca.2012.07.014; Clark AG, 1999, ARTHRITIS RHEUM, V42, P2356, DOI 10.1002/1529-0131(199911)42:11<2356::AID-ANR14>3.0.CO;2-R; Dardzinski BJ, 1997, RADIOLOGY, V205, P546, DOI 10.1148/radiology.205.2.9356643; Davidson ENB, 2006, ANN RHEUM DIS, V65, P1414, DOI 10.1136/ard.2005.045971; Disler DG, 1996, AM J ROENTGENOL, V167, P127, DOI 10.2214/ajr.167.1.8659356; Duclos ME, 2010, OSTEOARTHR CARTILAGE, V18, P1467, DOI 10.1016/j.joca.2010.07.007; EHRLICH MG, 1978, ARTHRITIS RHEUM-US, V21, P761, DOI 10.1002/art.1780210704; El-Arman Mohammed M, 2010, HSS J, V6, P171, DOI 10.1007/s11420-010-9157-0; EYRE DR, 1995, J RHEUMATOL, V22, P82; Freeman TA, 2010, FIBROGENESIS TISSUE, V3, DOI 10.1186/1755-1536-3-17; Fukin N, 2003, J BONE JOINT SURG AM, V85, P59; Garnero P, 2003, ANN RHEUM DIS, V62, P939, DOI 10.1136/ard.62.10.939; Gelse K, 2008, OSTEOARTHR CARTILAGE, V16, P1457, DOI 10.1016/j.joca.2008.04.006; Henrotin Y, 2007, CURR OPIN RHEUMATOL, V19, P444, DOI 10.1097/BOR.0b013e32829fb3b5; HULTH A, 1970, ACTA ORTHOP SCAND, V41, P522, DOI 10.3109/17453677008991540; Jordan KM, 2006, ANN RHEUM DIS, V65, P871, DOI 10.1136/ard.2005.042895; Kalai E, 2012, CLIN LAB, V58, P209; Kim T, 2014, SKELETAL RADIOL, V43, P947, DOI 10.1007/s00256-014-1872-z; Lee SY, 2010, ACTA RADIOL, V51, P455, DOI 10.3109/02841851003662772; Li X, 2013, OSTEOARTHR CARTILAGE, V21, P1567, DOI 10.1016/j.joca.2013.06.006; Lindhorst E, 2005, OSTEOARTHR CARTILAGE, V13, P139, DOI 10.1016/j.joca.2004.10.017; Lohmander LS, 2003, ARTHRITIS RHEUM, V48, P3130, DOI 10.1002/art.11326; Mamisch TC, 2012, SKELETAL RADIOL, V41, P287, DOI 10.1007/s00256-011-1171-x; MANKIN HJ, 1971, J BONE JOINT SURG AM, VA 53, P523, DOI 10.2106/00004623-197153030-00009; Marik W, 2012, EUR J RADIOL, V81, P923, DOI 10.1016/j.ejrad.2011.01.124; Matyas JR, 2004, ARTHRITIS RHEUM-US, V50, P543, DOI 10.1002/art.20027; Mazzuca SA, 2006, ANN RHEUM DIS, V65, P1055, DOI 10.1136/ard.2005.041582; MILLER AJ, 1993, MAGN RESON IMAGING, V11, P1051, DOI 10.1016/0730-725X(93)90225-3; Mosher TJ, 2000, RADIOLOGY, V214, P259, DOI 10.1148/radiology.214.1.r00ja15259; Murata M, 2003, CLIN ORTHOP RELAT R, P285, DOI 10.1097/01.blo.0000059582.08469.ac; Papathanasiou I, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3805; Peterfy CG, 2004, OSTEOARTHR CARTILAGE, V12, P177, DOI 10.1016/j.joca.2003.11.003; Petersson IF, 1998, OSTEOARTHR CARTILAGE, V6, P33, DOI 10.1053/joca.1997.0090; Petersson IF, 1998, BRIT J RHEUMATOL, V37, P46; Pfitzner T, 2012, KNEE SURG SPORT TR A, V20, P1803, DOI 10.1007/s00167-011-1774-8; Reijman M, 2004, ARTHRITIS RHEUM-US, V50, P2471, DOI 10.1002/art.20332; Reyes R, 2014, J BIOMED MATER RES A, V102, P1110, DOI 10.1002/jbma.34769; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Rogart JN, 1999, OSTEOARTHR CARTILAGE, V7, P539, DOI 10.1053/joca.1999.0258; Salzmanni GM, 2009, OSTEOARTHR CARTILAGE, V17, P1576, DOI 10.1016/j.joca.2009.07.010; Sowers MF, 2009, OSTEOARTHR CARTILAGE, V17, P1609, DOI 10.1016/j.joca.2009.06.001; Thomas E, 2014, RHEUMATOLOGY, V53, P338, DOI 10.1093/rheumatology/ket346; URIST M R, 1965, J Bone Joint Surg Br, V47, P304; Verma P, 2013, J ORTHOP RES, V31, P999, DOI 10.1002/jor.22324; Vilim V, 2002, OSTEOARTHR CARTILAGE, V10, P707, DOI 10.1053/joca.2002.0819; Vos LM, 2013, J ORAL MAXIL SURG, V71, P1659, DOI 10.1016/j.joms.2013.06.201; Welsch GH, 2008, RADIOLOGY, V247, P154, DOI 10.1148/radiol.2471070688; Welsch GH, 2010, EUR RADIOL, V20, P1515, DOI 10.1007/s00330-009-1669-y; Welsch GH, 2010, AM J SPORT MED, V38, P934, DOI 10.1177/0363546509354971	53	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124717	10.1371/journal.pone.0124717	http://dx.doi.org/10.1371/journal.pone.0124717			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884951	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000142
J	Ornellas, F; Souza-Mello, V; Mandarim-de-Lacerda, CA; Aguila, MB				Ornellas, Fernanda; Souza-Mello, Vanessa; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa			Programming of Obesity and Comorbidities in the Progeny: Lessons from a Model of Diet-Induced Obese Parents	PLOS ONE			English	Article							HIGH-FAT DIET; ANTHROPOMETRIC RELATIONSHIPS; INSULIN; GLUCOSE; MICE; DYSFUNCTION; MECHANISMS; EXPRESSION; OXIDATION; C57BL/6J	Aim To determine the impact of paternal obesity, maternal obesity or the combination of two obese parents on markers of adult offspring metabolism, with a focus on body mass (BM), lipid and carbohydrate, components of lipogenesis and beta-oxidation in the liver, sex dimorphism in the offspring that received a SC diet during the postnatal period. Materials and Methods Male and female C57BL/6 mice were fed a high-fat diet (HF; 49% lipids) or standard chow (SC; 17% lipids) for 8 weeks before mating until lactation. The offspring were labeled according to sex, maternal diet (first letters), paternal diet (second letters), and received a SCdiet until 12-weeks of age when they were sacrificed. BM, eating behavior, glucose tolerance, plasma analysis, gene and protein expression of the components of lipogenesis and beta-oxidation in the liver of offspring were evaluated. Results HF diet-fed mothers and fathers were overweight, hyperglycemic and glucose intolerant and had a deteriorating lipid profile. The adult male and female offspring of HF-mothers were overweight, with an increased adiposity index, hyperphagic, had an impaired glucose metabolism, increased total cholesterol and triacylglycerol levels, increased lipogenesis concomitant with decreased beta-oxidation resulting in liver steatosis. The male and female offspring of HF-father had impaired glucose metabolism, exacerbated lipogenesis without influencing beta-oxidation and enhanced hepatic steatosis. These findings are independent of BM. Male and female offspring of a mother and father that received a HF diet demonstrated these effects most prominently in adult life. Conclusion Paternal obesity leads to alterations in glucose metabolism, increase in components of lipogenesis and liver steatosis. In contrast, maternal obesity leads to overweight and changes in the metabolic profile and liver resulting from activation of hepatic lipogenesis with impaired beta-oxidation. When both parents are obese, the effects observed in the male and female offspring are exacerbated.	[Ornellas, Fernanda; Souza-Mello, Vanessa; Mandarim-de-Lacerda, Carlos Alberto; Aguila, Marcia Barbosa] State Univ Rio Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil	Universidade do Estado do Rio de Janeiro	Aguila, MB (corresponding author), State Univ Rio Janeiro, Inst Biol, Biomed Ctr, Lab Morphometry Metab & Cardiovasc Dis, Rio De Janeiro, Brazil.	marciaguila@gmail.com	Mandarim-de-Lacerda, Carlos Alberto/P-2360-2019; Aguila, Marcia/P-2349-2019; Souza-Mello, Vanessa/D-5092-2013; Souza-Mello, Vanessa/E-3463-2014; Aguila, Marcia Barbosa/ABF-6505-2020; Mandarim-de-Lacerda, Carlos A/F-7125-2012	Mandarim-de-Lacerda, Carlos Alberto/0000-0003-4134-7978; Souza-Mello, Vanessa/0000-0002-2510-9569; Aguila, Marcia Barbosa/0000-0003-3994-4589; 	Conselho Nacional de Ciencia e Tecnologia from Brazil [302.154/2011-6]; Fundacao do Amparo a Pesquisa do Rio de Janeiro from Rio de Janeiro State [E-26/102.944/2011]	Conselho Nacional de Ciencia e Tecnologia from Brazil; Fundacao do Amparo a Pesquisa do Rio de Janeiro from Rio de Janeiro State	This research was supported by grants from the Conselho Nacional de Ciencia e Tecnologia from Brazil (grant # 302.154/2011-6, to CML), and Fundacao do Amparo a Pesquisa do Rio de Janeiro from Rio de Janeiro State (grant # E-26/102.944/2011, to CML). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbasi A, 2011, J INTERN MED, V270, P388, DOI 10.1111/j.1365-2796.2011.02347.x; Aguila M, 2003, LIVER INT, V23, P363, DOI 10.1034/j.1478-3231.2003.00858.x; Anderson LM, 2006, NUTRITION, V22, P327, DOI 10.1016/j.nut.2005.09.006; Barbosa-da-Silva S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039837; BARKER DJP, 1995, MOL MED TODAY, V1, P418, DOI 10.1016/S1357-4310(95)90793-9; Berge JM, 2014, HEALTH PLACE, V26, P69, DOI 10.1016/j.healthplace.2013.11.007; Binder NK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052304; Borengasser SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024068; Botton J, 2010, EARLY HUM DEV, V86, P445, DOI 10.1016/j.earlhumdev.2010.06.001; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Catta-Preta M, 2011, VIRCHOWS ARCH, V459, P477, DOI 10.1007/s00428-011-1147-1; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Curley JP, 2011, HORM BEHAV, V59, P306, DOI 10.1016/j.yhbeh.2010.06.018; Dake BL, 2015, OBESITY, V23, P623, DOI 10.1002/oby.21009; de Onis M, 2000, AM J CLIN NUTR, V72, P1032; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Entringer S, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/632548; Fields DA, 2012, PEDIATR OBES, V7, P304, DOI 10.1111/j.2047-6310.2012.00059.x; Fullston T, 2013, FASEB J, V27, P4226, DOI 10.1096/fj.12-224048; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goodman ZD, 2014, CLIN LIVER DIS, V18, P33, DOI 10.1016/j.cld.2013.09.010; Gregorio BM, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.06.042; Guan HP, 2014, PROG MOL BIOL TRANSL, V121, P165, DOI 10.1016/B978-0-12-800101-1.00006-5; Hammond RA, 2010, DIABETES METAB SYNDR, V3, P285, DOI [10.2147/DMSOTT.S7384, 10.2147/DMSO.S7384]; Heude B, 2005, INT J OBESITY, V29, P1222, DOI 10.1038/sj.ijo.0802920; Koo SH, 2013, CLIN MOL HEPATOL, V19, P210, DOI 10.3350/cmh.2013.19.3.210; Lionetti L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092753; Long NM, 2012, J ANIM SCI, V90, P2201, DOI 10.2527/jas.2011-4343; Magliano DC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064258; Meigs JB, 2000, DIABETES, V49, P2201, DOI 10.2337/diabetes.49.12.2201; Muoio DM, 2008, DIABETES, V57, P1455, DOI 10.2337/db08-0281; Muoio DM, 2008, NAT REV MOL CELL BIO, V9, P193, DOI 10.1038/nrm2327; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Ornellas F, 2013, LIFE SCI, V93, P454, DOI 10.1016/j.lfs.2013.08.005; Pembrey ME, 2006, EUR J HUM GENET, V14, P159, DOI 10.1038/sj.ejhg.5201538; Penesova A, 2010, DIABETES CARE, V33, P1823, DOI 10.2337/dc10-0664; Rao MS, 2004, HEPATOLOGY, V40, P783, DOI 10.1002/hep.20453; Rasmussen BB, 2002, J CLIN INVEST, V110, P1687, DOI 10.1172/JCI200215715; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Robinson K, 2011, CRIT CARE, V15, DOI 10.1186/cc10021; Ruiz R, 2014, J BIOL CHEM, V289, P5510, DOI 10.1074/jbc.M113.541110; Safer DL, 2001, INT J OBESITY, V25, P1532, DOI 10.1038/sj.ijo.0801786; Serviddio G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024084; SURWIT RS, 1995, METABOLISM, V44, P645, DOI 10.1016/0026-0495(95)90123-X; Tschanz SA, 2011, J MICROSC-OXFORD, V243, P47, DOI 10.1111/j.1365-2818.2010.03481.x; Watkins AJ, 2014, AM J PHYSIOL-HEART C, V306, DOI 10.1152/ajpheart.00981.2013	48	47	47	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124737	10.1371/journal.pone.0124737	http://dx.doi.org/10.1371/journal.pone.0124737			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880318	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500108
J	Song, D; Heo, JH; Kim, DI; Kim, DJ; Kim, BM; Lee, K; Yoo, J; Lee, HS; Nam, HS; Kim, YD				Song, Dongbeom; Heo, Ji Hoe; Kim, Dong Ik; Kim, Dong Joon; Kim, Byung Moon; Lee, Kijeong; Yoo, Joonsang; Lee, Hye Sun; Nam, Hyo Suk; Kim, Young Dae			Impact of Temporary Opening Using a Stent Retriever on Clinical Outcome in Acute Ischemic Stroke	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; ENDOVASCULAR THERAPY; MECHANICAL RECANALIZATION; FLOW RESTORATION; THROMBOLYSIS; REVASCULARIZATION; TRIAL; TIME	Background Stent retriever has a distinct ability to restore blood flow temporarily before achieving final reperfusion. There has been a limited report regarding the clinical impact of it. We investigated if temporary opening of occluded vessels using a stent retriever before final reperfusion might improve clinical outcome in acute ischemic stroke patients who received the endovascular reperfusion treatment. Methods We enrolled consecutive ischemic stroke patients who had an initial occlusive lesion in the anterior circulation and achieved final reperfusion (Thrombolysis In Cerebral Infarction [TICI] >= 2) by endovascular treatment. Temporary opening was defined as the presence of ante grade flow (TICI >= 2) during deployment of a stent retriever. Favorable outcome was defined as a modified Rankin scale score <= 2 at 90 day. Results A total of 98 patients were included in the study and temporary opening was achieved in 49 (50%). Temporary opening was associated with favorable outcome (odds ratio, 7.825; 95% confidence interval, 1.592-38.461; p = 0.011) in the multivariate analysis. The probability of having a favorable outcome tended to decrease as time from onset to final reperfusion increased in patients without temporary opening. However, this trend was not evident in the patient with temporary opening. The beneficial effect of temporary opening on clinical outcome seemed to be present in patients with good collaterals but not in patients with poor collaterals. Conclusions Temporary opening of occluded vessel using a stent retriever may be beneficial for improving clinical outcome in acute ischemic stroke patients.	[Song, Dongbeom; Heo, Ji Hoe; Lee, Kijeong; Yoo, Joonsang; Nam, Hyo Suk; Kim, Young Dae] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kim, Dong Ik; Kim, Dong Joon; Kim, Byung Moon] Yonsei Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Lee, Hye Sun] Yonsei Univ, Coll Med, Dept Biostat, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Kim, YD (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	neuro05@yuhs.ac	Kim, Dong Joon/AAH-2257-2021; Lee, Hye Sun/J-2154-2015	Kim, Dong Joon/0000-0002-7035-087X; Kim, Byung Moon/0000-0001-8593-6841; Kim, Young Dae/0000-0001-5750-2616; NAM, HYO SUK/0000-0002-4415-3995; Heo, Ji Hoe/0000-0001-9898-3321; Yoo, Joonsang/0000-0003-1169-6798; Lee, Hye Sun/0000-0001-6328-6948	Korea Healthcare Technology R&D Project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI10C2020]; Yonsei University College of Medicine [2013-32-0023]	Korea Healthcare Technology R&D Project through the Korean Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Yonsei University College of Medicine(General Electric)	This work was supported by a grant of the Korea Healthcare Technology R&D Project through the Korean Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (HI10C2020) and by a new faculty research seed money grant of Yonsei University College of Medicine for 2013-32-0023.	Arnold M, 2005, J NEUROL NEUROSUR PS, V76, P1373, DOI 10.1136/jnnp.2004.055160; ASTRUP J, 1981, STROKE, V12, P723, DOI 10.1161/01.STR.12.6.723; Berkhemer OA, 2015, NEW ENGL J MED, V372, P11, DOI 10.1056/NEJMoa1411587; Broderick JP, 2013, NEW ENGL J MED, V368, P893, DOI 10.1056/NEJMoa1214300; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Ciccone A, 2013, NEW ENGL J MED, V368, P904, DOI 10.1056/NEJMoa1213701; Ellis JA, 2011, INT J STROKE, V6, P511, DOI 10.1111/j.1747-4949.2011.00670.x; Fargen KM, 2013, J NEUROINTERV SURG, V5, P506, DOI 10.1136/neurintsurg-2012-010541; Fields JD, 2011, AM J NEURORADIOL, V32, P2170, DOI 10.3174/ajnr.A2709; Fischer U, 2013, EUR J NEUROL, V20, P1017, DOI 10.1111/ene.12094; Goyal M, 2015, N ENGL J MED; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Higashida RT, 2003, STROKE, V34, pE109, DOI 10.1161/01.STR.0000082721.62796.09; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2009, NEUROLOGY, V73, P1066, DOI 10.1212/WNL.0b013e3181b9c847; Lee KY, 2004, AM J NEURORADIOL, V25, P1470; Machi P, 2012, J NEUROINTERV SURG, V4, P62, DOI 10.1136/jnis.2010.004051; MARLER JR, 1995, NEW ENGL J MED, V333, P1581, DOI 10.1056/nejm199512143332401; Mazighi M, 2009, LANCET NEUROL, V8, P802, DOI 10.1016/S1474-4422(09)70182-6; Nogueira RG, 2012, LANCET, V380, P1231, DOI 10.1016/S0140-6736(12)61299-9; Papanagiotou P, 2010, CIRCULATION, V121, P2605, DOI 10.1161/CIRCULATIONAHA.110.948166; Puetz V, 2009, INT J STROKE, V4, P354, DOI 10.1111/j.1747-4949.2009.00337.x; Ribo M, 2009, J NEUROIMAGING, V19, P188, DOI 10.1111/j.1552-6569.2008.00253.x; Roth C, 2010, STROKE, V41, P2559, DOI 10.1161/STROKEAHA.110.592071; Roth C, 2013, JACC-CARDIOVASC INTE, V6, P386, DOI 10.1016/j.jcin.2012.11.013; Rouchaud A, 2011, STROKE, V42, P1289, DOI 10.1161/STROKEAHA.110.599399; Saver JL, 2012, LANCET, V380, P1241, DOI 10.1016/S0140-6736(12)61384-1; Song D, 2014, EUR J NEUROL, V21, P779, DOI 10.1111/ene.12391	28	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124551	10.1371/journal.pone.0124551	http://dx.doi.org/10.1371/journal.pone.0124551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879929	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500105
J	Villeponteau, B; Matsagas, K; Nobles, AC; Rizza, C; Horwitz, M; Benford, G; Mockett, RJ				Villeponteau, Bryant; Matsagas, Kennedy; Nobles, Amber C.; Rizza, Cristina; Horwitz, Marc; Benford, Gregory; Mockett, Robin J.			Herbal Supplement Extends Life Span Under Some Environmental Conditions and Boosts Stress Resistance	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; DROSOPHILA-MELANOGASTER; C. ELEGANS; CAENORHABDITIS-ELEGANS; PTEROCARPUS-MARSUPIUM; ALZHEIMERS-DISEASE; VEGF LEVELS; LONGEVITY; RESVERATROL; MORTALITY	Genetic studies indicate that aging is modulated by a great number of genetic pathways. We have used Drosophila longevity and stress assays to test a multipath intervention strategy. To carry out this strategy, we supplemented the flies with herbal extracts (SC100) that are predicted to modulate the expression of many genes involved in aging and stress resistance, such as mTOR, NOS, NF-KappaB, and VEGF. When flies were housed in large cages with SC100 added, daily mortality rates of both male and female flies were greatly diminished in mid to late life. Surprisingly, SC100 also stabilized midlife mortality rate increases so as to extend the maximum life span substantially beyond the limits previously reported for D. melanogaster. Under these conditions, SC100 also promoted robust resistance to partial starvation stress and to heat stress. Fertility was the same initially in both treated and control flies, but it became significantly higher in treated flies at older ages as the fertility of control flies declined. Mean and maximum life spans of flies in vials at the same test site were also extended by SC100, but the life spans were short in absolute terms. In contrast, at an independent test site where stress was minimized, the flies exhibited much longer mean life spans, but the survival curves became highly rectangular and the effects of SC100 on both mean and maximum life spans declined greatly or were abolished. The data indicate that SC100 is a novel herbal mix with striking effects on enhancing Drosophila stress resistance and life span in some environments, while minimizing mid to late life mortality rates. They also show that the environment and other factors can have transformative effects on both the length and distribution of survivorship, and on the ability of SC100 to extend the life span.	[Villeponteau, Bryant; Matsagas, Kennedy; Rizza, Cristina; Horwitz, Marc; Benford, Gregory] Genescient Inc, Fountain Valley, CA 92708 USA; [Benford, Gregory] Univ Calif Irvine, Irvine, CA USA; [Nobles, Amber C.; Mockett, Robin J.] Univ S Alabama, Mobile, AL 36688 USA	University of California System; University of California Irvine; University of South Alabama	Villeponteau, B (corresponding author), Genescient Inc, Fountain Valley, CA 92708 USA.	bvillepo@san.rr.com			Genescient Corporation	Genescient Corporation	The California part of this study was funded by Genescient Corporation. The authors recommended and received approval for publication from the Genescient Board of Directors. Gregory Benford is on the Board. The funder provided support in the form of salaries for all authors, but did not have any additional role in the study design, data collection and analysis, or preparation of the manuscript. Studies conducted at the University of South Alabama were funded by donations from Mr. Douglas R. Arends and an anonymous donor. The authors are not aware of any competing interests with the anonymous donor. The specific roles of these authors are articulated in the 'author contributions' section.	Austad S, 2010, AGING CELL, V9, P297, DOI 10.1111/j.1474-9726.2010.00565.x; Auyeung KKW, 2010, INT J MOL MED, V26, P341, DOI 10.3892/ijmm_00000471; Ayyadevara S, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00211; Bass TM, 2007, MECH AGEING DEV, V128, P546, DOI 10.1016/j.mad.2007.07.007; Borroni B, 2008, REJUV RES, V11, P773, DOI 10.1089/rej.2008.0711; Borroni B, 2010, J ALZHEIMERS DIS, V21, P87, DOI 10.3233/JAD-2010-091615; Burnett C, 2011, NATURE, V477, P482, DOI 10.1038/nature10296; Carvalho GB, 2005, NAT METHODS, V2, P813, DOI 10.1038/NMETH798; Cesarone MR, 2010, PHYTOMEDICINE, V17, P835, DOI 10.1016/j.phymed.2010.04.009; Chang J, 2012, NEUROBIOL AGING, V33, P2062, DOI 10.1016/j.neurobiolaging.2011.08.015; Cho HS, 2008, NEUROTOXICOLOGY, V29, P656, DOI 10.1016/j.neuro.2008.03.004; Cho WCS, 2009, CANCER INVEST, V27, P334, DOI 10.1080/07357900802392683; Di X, 2010, NEUROSCIENCE, V168, P778, DOI 10.1016/j.neuroscience.2010.04.019; Dong Li-hua, 2007, Sichuan Da Xue Xue Bao Yi Xue Ban, V38, P417; Easton DM, 2008, AGE, V30, P311, DOI 10.1007/s11357-008-9073-0; Egashira N, 2007, J PHARMACOL SCI, V105, P211, DOI 10.1254/jphs.SCZ070901; Epel ES, 2014, J GERONTOL A-BIOL, V69, pS10, DOI 10.1093/gerona/glu055; Grandison RC, 2009, NATURE, V462, P1061, DOI 10.1038/nature08619; Grimm Tanja, 2006, J Inflamm (Lond), V3, P1, DOI 10.1186/1476-9255-3-1; Iemitsu M, 2006, AM J PHYSIOL-HEART C, V291, pH1290, DOI 10.1152/ajpheart.00820.2005; JAHROMI MAF, 1993, J NAT PROD, V56, P989, DOI 10.1021/np50097a001; Joseph JA, 2008, J AGR FOOD CHEM, V56, P10544, DOI 10.1021/jf802279h; Joshi A, 1996, EXP GERONTOL, V31, P533, DOI 10.1016/0531-5565(96)00003-4; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kumar S, 2005, CHRONOBIOL INT, V22, P641, DOI 10.1080/07420520500179423; Kumsta C, 2014, AGING CELL, V13, P419, DOI 10.1111/acel.12189; Kwak CJ, 2009, J HYPERTENS, V27, P92, DOI 10.1097/HJH.0b013e3283186994; Li X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060338; Mair W, 2005, PLOS BIOL, V3, P1305, DOI 10.1371/journal.pbio.0030223; Manickam M, 1997, J NAT PROD, V60, P609, DOI 10.1021/np9607013; Mateo I, 2007, ACTA NEUROL SCAND, V116, P56, DOI 10.1111/j.1600-0404.2006.00775.x; Matsagas K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006578; Mockett RJ, 2006, BIOGERONTOLOGY, V7, P157, DOI 10.1007/s10522-006-9004-3; Mockett RJ, 2006, EXP GERONTOL, V41, P566, DOI 10.1016/j.exger.2006.03.015; Mockett RJ, 2013, J GERONTOL A-BIOL, V68, P1157, DOI 10.1093/gerona/glt031; Moskalev AA, 2014, CELL CYCLE, V13, P1063, DOI 10.4161/cc.28433; Mueller LD, 1995, EXP GERONTOL, V30, P553, DOI 10.1016/0531-5565(95)00029-1; Mueller LD, 1996, P NATL ACAD SCI USA, V93, P15249, DOI 10.1073/pnas.93.26.15249; Nusbaum TJ, 1996, EXP GERONTOL, V31, P507, DOI 10.1016/0531-5565(96)00002-2; Orr WC, 2003, J BIOL CHEM, V278, P26418, DOI 10.1074/jbc.M303095200; Paul S, 2010, CARCINOGENESIS, V31, P1272, DOI 10.1093/carcin/bgq004; Pinheiro J, 2001, MIXED EFFECTS MODELS; Prowse N, 1997, J INSECT PHYSIOL, V43, P501, DOI 10.1016/S0022-1910(97)00014-0; Robine JM, 2001, EXP GERONTOL, V36, P915, DOI 10.1016/S0531-5565(00)00250-3; Rohdewald P, 2002, INT J CLIN PHARM TH, V40, P158; Rose MR, 2002, EVOLUTION, V56, P1982; Savory FR, 2014, ECOL EVOL, V4, P1176, DOI 10.1002/ece3.1013; Shahrestani Parvin, 2009, Curr Aging Sci, V2, P3; Shen Bin, 2011, Zhongguo Gu Shang, V24, P652; Takeda A, 2011, CELL MOL NEUROBIOL, V31, P1079, DOI 10.1007/s10571-011-9707-0; Toivonen JM, 2007, PLOS GENET, V3, P973, DOI 10.1371/journal.pgen.0030095; Tomada N, 2010, J SEX MED, V7, P1410, DOI 10.1111/j.1743-6109.2009.01648.x; Unno K, 2011, FREE RADICAL RES, V45, P966, DOI 10.3109/10715762.2011.566869; Villar-Cheda B, 2009, J CEREBR BLOOD F MET, V29, P230, DOI 10.1038/jcbfm.2008.127; Wang YY, 2014, COMPLEMENT THER MED, V22, P826, DOI 10.1016/j.ctim.2014.06.004; Wang ZD, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/268963; WILSON DL, 1994, MECH AGEING DEV, V74, P15, DOI 10.1016/0047-6374(94)90095-7; Xu Chun-jiao, 2007, Hua Xi Kou Qiang Yi Xue Za Zhi, V25, P432; Xu Chun-jiao, 2006, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V31, P512; Xu J, 2014, AGING CELL, V13, P19, DOI 10.1111/acel.12145; Yaguchi Y, 2014, EUR J NUTR; Yu Qin, 2010, Zhongguo Zhong Xi Yi Jie He Za Zhi, V30, P393; Zhang L, 2011, PHARMAZIE, V66, P144, DOI 10.1691/ph.2011.0738; Zhang MM, 2004, WORLD J GASTROENTERO, V10, P3500; Zimmerman SM, 2014, AGING CELL, V13, P329, DOI 10.1111/acel.12179	65	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0119068	10.1371/journal.pone.0119068	http://dx.doi.org/10.1371/journal.pone.0119068			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879540	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500001
J	Wardle, SL; Bailey, MES; Kilikevicius, A; Malkova, D; Wilson, RH; Venckunas, T; Moran, CN				Wardle, Sophie L.; Bailey, Mark E. S.; Kilikevicius, Audrius; Malkova, Dalia; Wilson, Richard H.; Venckunas, Tomas; Moran, Colin N.			Plasma MicroRNA Levels Differ between Endurance and Strength Athletes	PLOS ONE			English	Article							SKELETAL-MUSCLE; CIRCULATING MICRORNAS; EXERCISE; CANCER; CELLS; BIOMARKERS; MARKERS; MIRNAS; SERUM; YOUNG	Aim MicroRNAs (miRNAs) are stable in the circulation and are likely to function in inter-organ communication during a variety of metabolic responses that involve changes in gene expression, including exercise training. However, it is unknown whether differences in circulating-miRNA (c-miRNA) levels are characteristic of training modality. Methods We investigated whether levels of candidate c-miRNAs differ between elite male athletes of two different training modalities (n = 10 per group) -endurance (END) and strength (STR) - and between these groups and untrained controls (CON; n = 10). Fasted, non-exercised, morning plasma samples were analysed for 14 c-miRNAs (miR-1, miR-16-2, miR-20a-1, miR-21, miR-93, miR-103a, miR-133a, miR-146a, miR-192, miR-206, miR-221, miR-222, miR-451, miR-499). Moreover, we investigated whether c-miRNA levels were associated with quantitative performance-related phenotypes within and between groups. Results miR-222 was present at different levels in the three participant groups (p = 0.028) with the highest levels being observed in END and the lowest in STR. A number of other c-miRNAs were present at higher levels in END than in STR (relative to STR, +/- 1 SEM; miR-222: 1.94 fold (1.73-2.18), p = 0.011; miR-21: 1.56 fold (1.39-1.74), p = 0.013; miR-146a: 1.50 fold (1.38-1.64), p = 0.019; miR-221: 1.51 fold (1.34-1.70), p = 0.026). Regression analyses revealed several associations between candidate c-miRNA levels and strength-related performance measures before and after adjustment for muscle or fat mass, but not following adjustment for group. Conclusion Certain c-miRNAs (miR-222, miR-21, miR-146a and miR-221) differ between endurance- and resistance-trained athletes and thus have potential as useful biomarkers of exercise training and / or play a role in exercise mode-specific training adaptations. However, levels of these c-miRNAs are probably unrelated to muscle bulk or fat reserves.	[Wardle, Sophie L.; Moran, Colin N.] Univ Stirling, Hlth & Exercise Sci Res Grp, Stirling FK9 4LA, Scotland; [Bailey, Mark E. S.; Wilson, Richard H.] Univ Glasgow, Coll Med Vet & Life Sci, Sch Life Sci, Glasgow, Lanark, Scotland; [Kilikevicius, Audrius; Venckunas, Tomas] Lithuanian Sports Univ, Kaunas, Lithuania; [Malkova, Dalia] Univ Glasgow, Coll Med Vet & Life Sci, Sch Med, Glasgow, Lanark, Scotland	University of Stirling; University of Glasgow; Lithuanian Sports University; University of Glasgow	Venckunas, T (corresponding author), Lithuanian Sports Univ, Kaunas, Lithuania.	tomas.venckunas@lsu.lt	Moran, Colin/F-5416-2011	Moran, Colin/0000-0001-6226-8131; Bailey, Mark E. S./0000-0002-9788-2278				Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Aoi W, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00080; Baggish AL, 2014, J APPL PHYSIOL, V116, P522, DOI 10.1152/japplphysiol.01141.2013; Baggish AL, 2011, J PHYSIOL-LONDON, V589, P3983, DOI 10.1113/jphysiol.2011.213363; Banzet S, 2013, J APPL PHYSIOL, V115, P1237, DOI 10.1152/japplphysiol.00075.2013; Beneke R, 2002, EUR J APPL PHYSIOL, V87, P388, DOI 10.1007/s00421-002-0622-4; Beuvink I, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1118; Bye A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057496; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Clark DA, 1998, INT J BIOCHEM CELL B, V30, P293, DOI 10.1016/S1357-2725(97)00128-3; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Coffey VG, 2007, SPORTS MED, V37, P737, DOI 10.2165/00007256-200737090-00001; Davidsen PK, 2011, J APPL PHYSIOL, V110, P309, DOI 10.1152/japplphysiol.00901.2010; DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; Holloszy JO, 2005, J APPL PHYSIOL, V99, P338, DOI 10.1152/japplphysiol.00123.2005; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; Iglewicz B, 1993, DETECT HANDLE OUTLIE, V16; John Bino, 2006, V342, P101, DOI 10.1385/1-59745-123-1:101; Kraemer W J, 1996, Exerc Sport Sci Rev, V24, P363; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu TP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042390; MARTIN AD, 1990, MED SCI SPORT EXER, V22, P729, DOI 10.1249/00005768-199010000-00027; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Mooren FC, 2014, AM J PHYSIOL-HEART C, V306, pH557, DOI 10.1152/ajpheart.00711.2013; Nielsen S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087308; Pedersen BK, 2006, ESSAYS BIOCHEM, V42, P105, DOI 10.1042/bse0420105; Reid G, 2011, CRIT REV ONCOL HEMAT, V80, P193, DOI 10.1016/j.critrevonc.2010.11.004; Roberts MD, 2011, APPL PHYSIOL NUTR ME, V36, P96, DOI 10.1139/H10-090; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Sawada S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070823; Tsui NBY, 2002, CLIN CHEM, V48, P1647; Turchinovich A., 2013, Frontiers in Genetics, V4, P119, DOI 10.3389/fgene.2013.00119; Wolfarth B, 2014, MED SCI SPORT EXER, V46, P851, DOI 10.1249/MSS.0000000000000300; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zhu K, 2013, CARCINOGENESIS, V34, P2071, DOI 10.1093/carcin/bgt160	40	57	62	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122107	10.1371/journal.pone.0122107	http://dx.doi.org/10.1371/journal.pone.0122107			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881132	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000353016500016
J	Gonzalez-Ortega, I; Alberich, S; Echeburua, E; Aizpuru, F; Millan, E; Vieta, E; Matute, C; Gonzalez-Pinto, A				Gonzalez-Ortega, Itxaso; Alberich, Susana; Echeburua, Enrique; Aizpuru, Felipe; Millan, Eduardo; Vieta, Eduard; Matute, Carlos; Gonzalez-Pinto, Ana			Subclinical Depressive Symptoms and Continued Cannabis Use: Predictors of Negative Outcomes in First Episode Psychosis	PLOS ONE			English	Article							SUBSTANCE USE DISORDERS; PSYCHIATRIC-DISORDERS; SELF-MEDICATION; AXIS I; SCHIZOPHRENIA; ASSOCIATION; DEPENDENCE; SEVERITY; TRIAL; SCALE	Background Although depressive symptoms in first episode psychosis have been associated with cannabis abuse, their influence on the long-term functional course of FEP patients who abuse cannabis is unknown. The aims of the study were to examine the influence of subclinical depressive symptoms on the long-term outcome in first episode-psychosis patients who were cannabis users and to assess the influence of these subclinical depressive symptoms on the ability to quit cannabis use. Methods 64 FEP patients who were cannabis users at baseline were followed-up for 5 years. Two groups were defined: (a) patients with subclinical depressive symptoms at least once during follow-up (DPG), and (b) patients without subclinical depressive symptoms during follow-up (NDPG). Psychotic symptoms were measured using the Positive and Negative Syndrome Scale (PANSS), depressive symptoms using the Hamilton Depression Rating Scale (HDRS)-17, and psychosocial functioning was assessed using the Global Assessment of Functioning (GAF). A linear mixed-effects model was used to analyze the combined influence of cannabis use and subclinical depressive symptomatology on the clinical outcome. Results Subclinical depressive symptoms were associated with continued abuse of cannabis during follow-up (beta=4.45; 95% confidence interval [CI]: 1.78 to 11.17; P=.001) and with worse functioning (beta=-5.50; 95% CI: -9.02 to -0.33; P=.009). Conclusions Subclinical depressive symptoms and continued cannabis abuse during follow-up could be predictors of negative outcomes in FEP patients.	[Gonzalez-Ortega, Itxaso; Alberich, Susana; Echeburua, Enrique; Gonzalez-Pinto, Ana] Univ Basque Country, Univ Hosp Alava Santiago, CIBERSAM, Dept Psychiat, Vitoria, Spain; [Aizpuru, Felipe] Osakidetza, Araba Res Unit, Vitoria, Spain; [Millan, Eduardo] Osakidetza, Direcc Asistencia Sanit, Vitoria, Spain; [Vieta, Eduard] Univ Barcelona, Hosp Clin, IDIBAPS, CIBERSAM,Inst Biosci,Bipolar Disorders Program, Barcelona, Spain; [Matute, Carlos] Univ Basque Country, Achucarro Basque Ctr Neurosci, CIBERNED, Leioa, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Basque Country; CIBER - Centro de Investigacion Biomedica en Red; CIBERSAM; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; CIBERNED; University of Basque Country	Gonzalez-Ortega, I (corresponding author), Univ Basque Country, Univ Hosp Alava Santiago, CIBERSAM, Dept Psychiat, Vitoria, Spain.	itxaso.gonzalezortega@osakidetza.net	Echeburua, Enrique/F-9033-2010; Vieta, Eduard/Y-2919-2019; Matute, Carlos/N-5559-2014	Echeburua, Enrique/0000-0001-7654-0781; Vieta, Eduard/0000-0002-0548-0053; Matute, Carlos/0000-0001-8672-711X; Gonzalez-Pinto, Ana Maria/0000-0002-2568-5179; Alberich, Susana/0000-0002-4945-3428; Gonzalez-Ortega, Itxaso/0000-0001-7074-4353	Spanish Government [PS09/02002, EC10-333, PI10/01430, PI10/01746, PI11/01977, PI11/02708, 2011/1064, 11-BI-01, 1677-DJ-030, EC10-220]; European Regional Development Funds; Basque Country Government [2008111010, 2009111047, 2010111170, 2010112009, 2011111110, 2011111113, SAIO10-PC10BF01, SAIO11-PE11BF006, SAIO11-PE11BF007, SAIO10-PR10BF01, GIC 10/80, KRONIK 11/010]; Basque Foundation for Health Innovation and Research (BIOEF) [BIO09/EM/010]; Spanish Clinical Research Network (CAIBER) [1392-D-079]; University of the Basque Country [GIC10/80, US10/08, EHU08/54]; Stanley Research Foundation [03-RC-003]	Spanish Government(Spanish GovernmentEuropean Commission); European Regional Development Funds(European Commission); Basque Country Government(Basque Government); Basque Foundation for Health Innovation and Research (BIOEF); Spanish Clinical Research Network (CAIBER); University of the Basque Country; Stanley Research Foundation	This work was supported by health research funds from the Spanish Government (PS09/02002 CIBER Network; EC10-333, PI10/01430, PI10/01746, PI11/01977, PI11/02708, 2011/1064, 11-BI-01, 1677-DJ-030, and EC10-220); European Regional Development Funds, and local grants from the Basque Country Government (2008111010, 2009111047, 2010111170, 2010112009, 2011111110, 2011111113, SAIO10-PC10BF01, SAIO11-PE11BF006, SAIO11-PE11BF007, SAIO10-PR10BF01, GIC 10/80, and KRONIK 11/010); the Basque Foundation for Health Innovation and Research (BIOEF; BIO09/EM/010); the Spanish Clinical Research Network (CAIBER; 1392-D-079) and the University of the Basque Country (GIC10/80, US10/08, and EHU08/54). The psychiatric research department in University Hospital of Alava-Santiago is supported by the Stanley Research Foundation (03-RC-003). These institutions had no further role in the study design, data collection, analysis or interpretation, writing of the report, or in the decision to submit the paper for publication.	Allsop DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044864; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Arendt M, 2007, PSYCHOL MED, V37, P935, DOI 10.1017/S0033291706009688; Barrigon ML, 2010, J PSYCHIATR RES, V44, P413, DOI 10.1016/j.jpsychires.2009.10.004; Barrowclough C, 2013, SCHIZOPHRENIA BULL, V39, P339, DOI 10.1093/schbul/sbr152; Birchwood M, 2005, EUR ARCH PSY CLIN N, V255, P202, DOI 10.1007/s00406-005-0588-4; Bobes J. G, 2002, BANCO INSTRUMENTOS B; Bossong MG, 2013, EUR NEUROPSYCHOPHARM, V23, P1687, DOI 10.1016/j.euroneuro.2013.06.009; Campos AC, 2012, PHILOS T R SOC B, V367, P3364, DOI 10.1098/rstb.2011.0389; Chen RQ, 2013, CELL, V155, P1154, DOI 10.1016/j.cell.2013.10.042; Clausen L, 2014, PSYCHOL MED, V44, P117, DOI 10.1017/S0033291713000433; Cotton SM, 2012, SCHIZOPHR RES, V134, P20, DOI 10.1016/j.schres.2011.08.018; D'Souza DC, 2005, BIOL PSYCHIAT, V57, P594, DOI 10.1016/j.biopsych.2004.12.006; Degenhardt L, 2003, ADDICTION, V98, P1493, DOI 10.1046/j.1360-0443.2003.00437.x; Degenhardt L, 2007, ADDICTION, V102, P1076, DOI 10.1111/j.1360-0443.2007.01839.x; Denson TF, 2006, ADDICT BEHAV, V31, P738, DOI 10.1016/j.addbeh.2005.05.052; ENDICOTT J, 1976, ARCH GEN PSYCHIAT, V33, P766; First M. B., 1997, STRUCTURED CLIN INTE; Gonzalez-Pinto A, 2008, J CLIN PSYCHIAT, V69, P1210, DOI 10.4088/JCP.v69n0802; Gonzalez-Pinto A, 2011, SCHIZOPHRENIA BULL, V37, P631, DOI 10.1093/schbul/sbp126; Gregg L, 2014, PSYCHOL ADDICT BEHAV, V28, P247, DOI 10.1037/a0034761; Hall W, 2009, LANCET, V374, P1383, DOI 10.1016/S0140-6736(09)61037-0; HAMILTON M, 1967, BRIT J SOC CLIN PSYC, V6, P278; Hartley S, 2013, ACTA PSYCHIAT SCAND, V128, P327, DOI 10.1111/acps.12080; Hjorthoj CR, 2013, SCHIZOPHR RES, V151, P191, DOI 10.1016/j.schres.2013.10.014; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kokkevi A., 1995, EUR ADDICT RES, V1, P208, DOI [10.1159/000259089, DOI 10.1159/000259089]; Kuepper R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070378; Lev-Ran S, 2014, PSYCHOL MED, V44, P797, DOI 10.1017/S0033291713001438; Lynskey MT, 2004, ARCH GEN PSYCHIAT, V61, P1026, DOI 10.1001/archpsyc.61.10.1026; Madigan K, 2013, SCHIZOPHR RES, V143, P138, DOI 10.1016/j.schres.2012.10.018; MCLELLAN AT, 1992, J SUBST ABUSE TREAT, V9, P199, DOI 10.1016/0740-5472(92)90062-S; Moore THM, 2007, LANCET, V370, P319, DOI 10.1016/S0140-6736(07)61162-3; National Institute for Health and Clinical Excellence, 2009, DEPR AD CHRON PHYS H; Otten R, 2013, ADDICT BIOL, V18, P826, DOI 10.1111/j.1369-1600.2011.00380.x; Peralta MV, 1994, ACTAS LUSO-ESP NEUR, V22, P171; R Development Core Team, R LANG ENV STAT COMP; Ramos-Brieva J A, 1986, Actas Luso Esp Neurol Psiquiatr Cienc Afines, V14, P324; Riedel M, 2012, WORLD J BIOL PSYCHIA, V13, P30, DOI 10.3109/15622975.2011.552633; Romm KL, 2010, J NERV MENT DIS, V198, P67, DOI 10.1097/NMD.0b013e3181c81fc0; Ruiz-Veguilla M, 2013, J PSYCHIATR RES, V47, P1036, DOI 10.1016/j.jpsychires.2013.03.003; Schofield D, 2006, AUST NZ J PSYCHIAT, V40, P570, DOI 10.1111/j.1440-1614.2006.01840.x; Secora AM, 2010, J ADDICT DIS, V29, P325, DOI 10.1080/10550887.2010.489444; Sonmez N, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-106; Stone JM, 2014, PSYCHOL MED, V44, P499, DOI 10.1017/S0033291713000883; Tomlinson KL, 2006, ADDICT BEHAV, V31, P461, DOI 10.1016/j.addbeh.2005.05.028; Tosato S, 2013, J PSYCHIATR RES, V47, P438, DOI 10.1016/j.jpsychires.2012.11.009; Upthegrove R, 2010, ACTA PSYCHIAT SCAND, V122, P211, DOI 10.1111/j.1600-0447.2009.01506.x; van Gastel WA, 2013, PSYCHOL MED, V43, P1849, DOI 10.1017/S0033291712002723; Wu LT, 2013, J PSYCHIATR RES, V47, P1940, DOI 10.1016/j.jpsychires.2013.08.022; Wu LT, 2011, J PSYCHIATR RES, V45, P1453, DOI 10.1016/j.jpsychires.2011.06.012; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	52	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123707	10.1371/journal.pone.0123707	http://dx.doi.org/10.1371/journal.pone.0123707			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875862	Green Published, gold			2022-12-27	WOS:000353015800111
J	Starha, P; Travnicek, Z; Dvorak, Z; Radosova-Muchova, T; Pracharova, J; Vanco, J; Kasparkova, J				Starha, Pavel; Travnicek, Zdenek; Dvorak, Zdenek; Radosova-Muchova, Tereza; Pracharova, Jitka; Vanco, Jan; Kasparkova, Jan			Potentiating Effect of UVA Irradiation on Anticancer Activity of Carboplatin Derivatives Involving 7-Azaindoles	PLOS ONE			English	Article							INTERSTRAND CROSS-LINKS; PLATINUM(II) COMPLEXES; DNA; CISPLATIN; ADDUCTS; CIS-DIAMMINEDICHLOROPLATINUM(II); CYTOTOXICITY; RECOGNITION; HYDROLYSIS; RESISTANCE	The moderate-to-high in vitro cytotoxicity against ovarian A2780 (IC50 = 4.7-14.4 mu M), prostate LNCaP (IC50 = 18.7-30.8 mu M) and prostate PC-3 (IC50 = 17.6-42.3 mu M) human cancer cell lines of the platinum(II) cyclobutane-1,1'-dicarboxylato complexes [Pt(cbdc)(naza)2] (1-6; cbdc = cyclobutane-1,1'-dicarboxylate(2-); naza = halogeno-substituted 7-azaindoles), derived from the anticancer metallodrug carboplatin, are reported. The complexes containing the chloro-and bromo-substituted 7-azaindoles (1, 2, and 4-6) showed a significantly higher (p < 0.05) cytotoxicity against A2780 cell line as compared to cisplatin used as a reference drug. Addition of the non-toxic concentration (5.0 mu M) of L-buthionine sulfoximine (L-BSO, an effective inhibitor of.-glutamylcysteine synthase) markedly increases the in vitro cytotoxicity of the selected complex 3 against A2780 cancer cell line by a factor of about 4.4. The cytotoxicity against A2780 and LNCaP cells, as well as the DNA platination, were effectively enhanced by UVA light irradiation (lambda(max) = 365 nm) of the complexes, with the highest phototoxicity determined for compound 3, resulting in a 4-fold decline in the A2780 cells viability from 25.1% to 6.1%. The H-1 NMR and ESI-MS experiments suggested that the complexes did not interact with glutathione as well as their ability to interact with guanosine monophosphate. The studies also confirmed UVA light induced the formation of the cis [Pt(H2O)(2)(cbdc')(naza)] intermediate, where cbdc' represents monodentate-coordinated cbdc ligand, which is thought to be responsible for the enhanced cytotoxicity. This is further supported by the results of transcription mapping experiments showing that the studied complexes preferentially form the bifunctional adducts with DNA under UVA irradiation, in contrast to the formation of the less effective monofunctional adducts in dark.	[Starha, Pavel; Travnicek, Zdenek; Dvorak, Zdenek; Vanco, Jan] Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic; [Starha, Pavel; Travnicek, Zdenek; Vanco, Jan] Palacky Univ, Fac Sci, Dept Inorgan Chem, CR-77147 Olomouc, Czech Republic; [Dvorak, Zdenek] Palacky Univ, Fac Sci, Dept Cell Biol & Genet, CR-77147 Olomouc, Czech Republic; [Radosova-Muchova, Tereza] Palacky Univ, Fac Sci, Ctr Reg Hana Biotechnol & Agr Res, CR-77147 Olomouc, Czech Republic; [Radosova-Muchova, Tereza; Pracharova, Jitka; Kasparkova, Jan] Palacky Univ, Fac Sci, Dept Biophys, CR-77147 Olomouc, Czech Republic	Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc; Palacky University Olomouc	Travnicek, Z (corresponding author), Palacky Univ, Fac Sci, Reg Ctr Adv Technol & Mat, CR-77147 Olomouc, Czech Republic.	zdenek.travnicek@upol.cz	Starha, Pavel/H-3902-2016; Vanco, Jan/H-2705-2013	Vanco, Jan/0000-0003-3351-1192; Travnicek, Zdenek/0000-0002-5890-7874; Dvorak, Zdenek/0000-0002-3938-3585	Czech Science Foundation [GACR P207/11/0841]; National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic [LO1204, LO1305]; Palacky University in Olomouc [IGA_PrF_2014009, IGA_PrF_2014029]	Czech Science Foundation(Grant Agency of the Czech Republic); National Program of Sustainability I of the Ministry of Education, Youth and Sports of the Czech Republic; Palacky University in Olomouc	Support was provided by the Czech Science Foundation (GACR P207/11/0841), [www.gacr.cz] to ZT and PS; the National Program of Sustainability I (LO1204 and LO1305) of the Ministry of Education, Youth and Sports of the Czech Republic, [www.msmt.cz] to ZT, PS, JV, ZD, TR, JP and JK; Palacky University in Olomouc (IGA_PrF_2014009 and IGA_PrF_2014029), [www.upol.cz] to ZT, PS, TR, JP and JK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barry NPE, 2013, CHEM COMMUN, V49, P5106, DOI 10.1039/c3cc41143e; BRABEC V, 1993, P NATL ACAD SCI USA, V90, P5345, DOI 10.1073/pnas.90.11.5345; BRABEC V, 1994, BIOCHEMISTRY-US, V33, P1316, DOI 10.1021/bi00172a005; Brabec V, 2002, PROG NUCLEIC ACID RE, V71, P1, DOI 10.1016/S0079-6603(02)71040-4; BUTOUR JL, 1977, EUR J BIOCHEM, V78, P455, DOI 10.1111/j.1432-1033.1977.tb11758.x; BUTOUR JL, 1991, EUR J BIOCHEM, V202, P975, DOI 10.1111/j.1432-1033.1991.tb16458.x; Dhara S. C., 1970, IND J CHEM, P193; Dvorak L, 2010, EUR J INORG CHEM, P3441, DOI 10.1002/ejic.201000322; EASTMAN A, 1987, PHARMACOL THERAPEUT, V34, P155, DOI 10.1016/0163-7258(87)90009-X; FARRELL N, 1990, BIOCHEMISTRY-US, V29, P9522, DOI 10.1021/bi00493a005; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; FREY U, 1993, INORG CHEM, V32, P1333, DOI 10.1021/ic00060a005; Hay RW, 1998, POLYHEDRON, V17, P2337, DOI 10.1016/S0277-5387(97)00477-4; Jamieson ER, 1999, CHEM REV, V99, P2467, DOI 10.1021/cr980421n; Jansen BAJ, 2002, J INORG BIOCHEM, V89, P197, DOI 10.1016/S0162-0134(02)00381-1; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kelland LR, 2000, PLATINUM BASED DRUGS; LEMAIRE MA, 1991, P NATL ACAD SCI USA, V88, P1982, DOI 10.1073/pnas.88.5.1982; Mackay FS, 2007, P NATL ACAD SCI USA, V104, P20743, DOI 10.1073/pnas.0707742105; Mlcouskova J, 2012, J BIOL INORG CHEM, V17, P891, DOI 10.1007/s00775-012-0906-z; Muchova T, 2013, J BIOL INORG CHEM, V18, P579, DOI 10.1007/s00775-013-1003-7; New EJ, 2009, J INORG BIOCHEM, V103, P1120, DOI 10.1016/j.jinorgbio.2009.05.005; Pavelka M, 2007, CHEM-EUR J, V13, P10108, DOI 10.1002/chem.200700887; Ramos-Lima FJ, 2006, J MED CHEM, V49, P2640, DOI 10.1021/jm0602514; Romero-Canelon I, 2013, J MED CHEM, V56, P1291, DOI 10.1021/jm3017442; ROSENBERG B, 1965, NATURE, V205, P698, DOI 10.1038/205698a0; Siddik ZH, 2003, ONCOGENE, V22, P7265, DOI 10.1038/sj.onc.1206933; Smith NA, 2013, PHILOS T R SOC A, V371, DOI 10.1098/rsta.2012.0519; Starha P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090341; Starha P, 2012, J INORG BIOCHEM, V115, P57, DOI 10.1016/j.jinorgbio.2012.05.006; Starha P, 2012, POLYHEDRON, V33, P404, DOI 10.1016/j.poly.2011.11.059; Zamora A, 2013, J INORG BIOCHEM, V128, P48, DOI 10.1016/j.jinorgbio.2013.07.010; Zhao J, 2012, INORG CHEM, V51, P10317, DOI 10.1021/ic301374z; Zhao Y, 2013, CHEM-EUR J, V19, P9578, DOI 10.1002/chem.201300374	34	14	14	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123595	10.1371/journal.pone.0123595	http://dx.doi.org/10.1371/journal.pone.0123595			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875850	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800106
J	Yadav, CB; Bhareti, P; Muthamilarasan, M; Mukherjee, M; Khan, Y; Rathi, P; Prasad, M				Yadav, Chandra Bhan; Bhareti, Priyanka; Muthamilarasan, Mehanathan; Mukherjee, Minakshi; Khan, Yusuf; Rathi, Pushpendra; Prasad, Manoj			Genome-Wide SNP Identification and Characterization in Two Soybean Cultivars with Contrasting Mungbean Yellow Mosaic India Virus Disease Resistance Traits	PLOS ONE			English	Article							SOFTWARE; TOOL; TM4	Mungbean yellow mosaic India virus (MYMIV) is a bipartite Geminivirus, which causes severe yield loss in soybean (Glycine max). Considering this, the present study was conducted to develop large-scale genome-wide single nucleotide polymorphism (SNP) markers and identify potential markers linked with known disease resistance loci for their effective use in genomics-assisted breeding to impart durable MYMIV tolerance. The whole-genome re-sequencing of MYMIV resistant cultivar 'UPSM-534' and susceptible Indian cultivar 'JS335' was performed to identify high-quality SNPs and InDels (insertion and deletions). Approximately 234 and 255 million of 100-bp paired-end reads were generated from 'UPSM-534 and JS-335, respectively, which provided similar to 98% coverage of reference soybean genome. A total of 3083987 SNPs (1559556 in UPSM-534 and 1524431 in JS-335) and 562858 InDels (281958 in UPSM-534 and 280900 in JS-335) were identified. Of these, 1514 SNPs were found to be present in 564 candidate disease resistance genes. Among these, 829 non-synonymous and 671 synonymous SNPs were detected in 266 and 286 defence-related genes, respectively. Noteworthy, a non-synonymous SNP (in chromosome 18, named 18-1861613) at the 149th base-pair of LEUCINE-RICH REPEAT RECEPTOR-LIKE PROTEIN KINASE gene responsible for a G/C transversion [ proline (CCC) to alanine (GCC)] was identified and validated in a set of 12 soybean cultivars. Taken together, the present study generated a large-scale genomic resource such as, SNPs and InDels at a genome-wide scale that will facilitate the dissection of various complex traits through construction of high-density linkage maps and fine mapping. In the present scenario, these markers can be effectively used to design high-density SNP arrays for their large-scale validation and high-throughput genotyping in diverse natural and mapping populations, which could accelerate genomics-assisted MYMIV disease resistance breeding in soybean.	[Yadav, Chandra Bhan; Muthamilarasan, Mehanathan; Mukherjee, Minakshi; Khan, Yusuf; Prasad, Manoj] Natl Inst Plant Genome Res, New Delhi, India; [Bhareti, Priyanka; Rathi, Pushpendra] Govind Ballabh Pant Univ Agr & Technol, Dept Genet & Plant Breeding, Pantnagar 263145, Uttarakhand, India	Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR); Govind Ballabh Pant University of Agriculture Technology	Prasad, M (corresponding author), Natl Inst Plant Genome Res, New Delhi, India.	manoj_prasad@nipgr.ac.in	khan, yusuf/AAQ-9470-2021; Muthamilarasan, Mehanathan/H-9340-2017; Prasad, Manoj/AAE-8540-2019; Khan, Yusuf/E-6726-2015	Muthamilarasan, Mehanathan/0000-0001-7589-6372; Prasad, Manoj/0000-0003-0691-0163; Yadav, Chandra Bhan/0000-0001-9613-2232; Khan, Yusuf/0000-0001-6986-4657	Department of Biotechnology, Ministry of Science and Technology, Government of India, India [BT/PR14302/AGR/02/736/2010]; National Institute of Plant Genome Research, Government of India, India; University Grants Commission, New Delhi, India	Department of Biotechnology, Ministry of Science and Technology, Government of India, India; National Institute of Plant Genome Research, Government of India, India; University Grants Commission, New Delhi, India(University Grants Commission, India)	This work was financially supported by the Department of Biotechnology, Ministry of Science and Technology, Government of India, India (Grant no. BT/PR14302/AGR/02/736/2010) and core grant of National Institute of Plant Genome Research, Government of India, India. MuM is the recipient of research fellowship from University Grants Commission, New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhattacharyya PK, 1999, EUPHYTICA, V108, P157, DOI 10.1023/A:1003620713110; Bhupender Kumar, 2014, Australian Journal of Crop Science, V8, P27; Chung WH, 2014, DNA RES, V21, P153, DOI 10.1093/dnares/dst047; Concibido VC, 2004, CROP SCI, V44, P1121, DOI 10.2135/cropsci2004.1121; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Finn RD, 2011, NUCLEIC ACIDS RES, V39, pW29, DOI 10.1093/nar/gkr367; Gutierrez C, 1999, CELL MOL LIFE SCI, V56, P313, DOI 10.1007/s000180050433; Hanley-Bowdoin L, 2000, CRIT REV BIOCHEM MOL, V35, P105; Jain M, 2014, PLANT BIOTECHNOL J, V12, P253, DOI 10.1111/pbi.12133; Kang YJ, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-139; Karangula UB, 2009, CURR ISSUES MOL BIOL, V11, pI73; KOBAYASHI M, 2014, PLANT CELL PHYSIOL, V55, P445, DOI DOI 10.1093/pcp/pct181; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lal SK, 2005, SOYBEAN GENET NEWS L, V1, P32; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; LI YJ, 2013, J INEQUAL APPL, DOI DOI 10.1186/1471-2164-14-579; Marone D, 2013, INT J MOL SCI, V14, P7302, DOI 10.3390/ijms14047302; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; Nene YL, 1972, INDIAN J RES B, V4, P191; Qiu LJ, 2013, PLANT MOL BIOL, V83, P41, DOI 10.1007/s11103-013-0076-6; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sahu PP, 2014, FUNCT INTEGR GENOMIC, V14, P47, DOI 10.1007/s10142-013-0346-z; Sahu PP, 2010, MOL PLANT PATHOL, V11, P531, DOI [10.1111/J.1364-3703.2010.00630.X, 10.1111/j.1364-3703.2010.00630.x]; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Xu XY, 2013, P NATL ACAD SCI USA, V110, P13469, DOI 10.1073/pnas.1222368110; Yadav RK, 2009, VIRUS RES, V144, P89, DOI 10.1016/j.virusres.2009.04.011; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Yuan J, 2002, CROP SCI, V42, P271, DOI 10.2135/cropsci2002.0271	29	23	23	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123897	10.1371/journal.pone.0123897	http://dx.doi.org/10.1371/journal.pone.0123897			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875830	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100221
J	Sommerfelt, RM; Feuerherm, AJ; Skuland, T; Johansen, B				Sommerfelt, Randi M.; Feuerherm, Astrid J.; Skuland, Trine; Johansen, Berit			Cytosolic Phospholipase A2 Modulates TLR2 Signaling in Synoviocytes	PLOS ONE			English	Article							FIBROBLAST-LIKE SYNOVIOCYTES; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; GROUP-V; SYNOVIAL FIBROBLASTS; ARACHIDONIC-ACID; BACTERIAL PEPTIDOGLYCANS; CHRONIC INFLAMMATION; IMMUNE-RESPONSES; A(2) INHIBITOR	Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic synovitis leading to destruction of cartilage and bone. PLA2 enzymes are key players in inflammation regulating the release of unsaturated fatty acids such as arachidonic acid (AA), a precursor of pro-inflammatory eicosanoids. Several lines of evidence point to toll-like receptors (TLRs) as drivers of synovitis and joint destruction in RA. However, few studies have addressed the implication of PLA2 activity downstream TLR activation in the synovium. Here, we aimed to characterize PLA2 enzyme involvement in TLR2-induced signaling in synovial fibroblast-like cells. TLRs1-7 and a range of sPLA2, iPLA2 and cPLA2 enzymes were found to be transcriptionally expressed in cultured synoviocytes. Activation of TLR2/1 and TLR2/6 led to phosphorylation of cPLA2 alpha at Ser(505), and induced AA release and PGE(2) production; effects that were attenuated by cPLA2 alpha inhibitors. In contrast, sPLA2 inhibitors did not affect AA or PGE(2) release. cPLA2 alpha inhibitors furthermore attenuated TLR-induced expression of IL-6, IL-8 and COX2. COX1/2 inhibitors attenuated TLR2/6-induced IL-6 transcription and protein production comparable to cPLA2 alpha inhibition. Moreover, exogenously PGE(2) added alone induced IL-6 production and completely rescued IL-6 transcription when added simultaneously with FSL-1 in the presence of a cPLA2 alpha inhibitor. Our results demonstrate for the first time that cPLA2 alpha is involved in TLR2/1-and TLR2/6-induced AA release, PGE(2) production and pro-inflammatory cytokine expression in synoviocytes, possibly through COX/PGE(2)-dependent pathways. These findings expand our understanding of cPLA2 alpha as a modulator of inflammatory molecular mechanisms in chronic diseases such as RA.	[Sommerfelt, Randi M.; Feuerherm, Astrid J.; Skuland, Trine; Johansen, Berit] Norwegian Univ Sci & Technol, Lipid Signaling Grp, Dept Biol, N-7034 Trondheim, Norway	Norwegian University of Science & Technology (NTNU)	Johansen, B (corresponding author), Norwegian Univ Sci & Technol, Lipid Signaling Grp, Dept Biol, N-7034 Trondheim, Norway.	berit.johansen@ntnu.no	Skuland, Trine/HGC-9078-2022		Norwegian Research Council, BIA program; Health Region Mid-Norway; Avexxin AS	Norwegian Research Council, BIA program; Health Region Mid-Norway; Avexxin AS	This work was supported by the Norwegian Research Council, BIA program; Health Region Mid-Norway and Avexxin AS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have read	Alonzi T, 1998, J EXP MED, V187, P461, DOI 10.1084/jem.187.4.461; Anthonsen MW, 2001, J BIOL CHEM, V276, P30527, DOI 10.1074/jbc.M008481200; Anthonsen MW, 2001, J BIOL CHEM, V276, P35344, DOI 10.1074/jbc.M105264200; Antonopoulou G, 2008, BIOORGAN MED CHEM, V16, P10257, DOI 10.1016/j.bmc.2008.10.046; Balsinde J, 1998, P NATL ACAD SCI USA, V95, P7951, DOI 10.1073/pnas.95.14.7951; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Buckley CD, 2011, IMMUNOL LETT, V138, P12, DOI 10.1016/j.imlet.2011.02.010; Chi PL, 2011, ARTHRITIS RHEUM-US, V63, P2905, DOI 10.1002/art.30504; Crofford LJ, 2002, CURR OPIN RHEUMATOL, V14, P225, DOI 10.1097/00002281-200205000-00005; Dayer JM, 2010, RHEUMATOLOGY, V49, P15, DOI 10.1093/rheumatology/kep329; DELEURAN B, 1994, SCAND J RHEUMATOL, V23, P2, DOI 10.3109/03009749409102126; Dennis EA, 2011, CHEM REV, V111, P6130, DOI 10.1021/cr200085w; Dieter P, 2002, CELL SIGNAL, V14, P199, DOI 10.1016/S0898-6568(01)00243-1; Fraser H, 2009, J CARDIOVASC PHARM, V53, P60, DOI 10.1097/FJC.0b013e318195bfbc; Goh FG, 2012, RHEUMATOLOGY, V51, P7, DOI 10.1093/rheumatology/ker257; Harizi H, 2008, TRENDS MOL MED, V14, P461, DOI 10.1016/j.molmed.2008.08.005; Hayashida K, 2001, ARTHRITIS RES, V3, P118, DOI 10.1186/ar149; Hegen M, 2003, J EXP MED, V197, P1297, DOI 10.1084/jem.20030016; Honda T, 2006, J EXP MED, V203, P325, DOI 10.1084/jem.20051310; Huang QQ, 2009, J IMMUNOL, V182, P4965, DOI 10.4049/jimmunol.0801563; HULKOWER KI, 1992, BIOCHEM BIOPH RES CO, V184, P712, DOI 10.1016/0006-291X(92)90648-5; HUSBY G, 1977, ARTHRITIS RHEUM, V20, P785, DOI 10.1002/art.1780200304; Huwiler A, 2012, BRIT J PHARMACOL, V167, P1691, DOI 10.1111/j.1476-5381.2012.02114.x; Inoue H, 2002, BRIT J PHARMACOL, V136, P287, DOI 10.1038/sj.bjp.0704705; Johansen B, 2000, PROSTAG OTH LIPID M, V60, P119, DOI 10.1016/S0090-6980(99)00057-X; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kawashima M, 2013, J ORAL PATHOL MED, V42, P499, DOI 10.1111/jop.12045; Kikawada E, 2007, BLOOD, V110, P561, DOI 10.1182/blood-2006-10-052258; Koch AE, 2001, ARTHRITIS RHEUM-US, V44, P31, DOI 10.1002/1529-0131(200101)44:1<31::AID-ANR5>3.0.CO;2-4; Kokotos G, 2014, J MED CHEM, V57, P7523, DOI 10.1021/jm500192s; Kunisch E, 2009, J IMMUNOL, V183, P1328, DOI 10.4049/jimmunol.0900801; Kyburz D, 2003, ARTHRITIS RHEUM-US, V48, P642, DOI 10.1002/art.10848; Levi M, 2013, J CLIN PHARMACOL, V53, P151, DOI [10.1177/0091270012437585, 10.1177/0091270011437585]; Lindner SC, 2009, J LEUKOCYTE BIOL, V86, P389, DOI 10.1189/jlb.1008591; Lio YC, 1998, BBA-LIPID LIPID MET, V1392, P320, DOI 10.1016/S0005-2760(98)00049-6; Ludwig J, 2006, J MED CHEM, V49, P2611, DOI 10.1021/jm051243a; Maini RN, 2006, ARTHRITIS RHEUM-US, V54, P2817, DOI 10.1002/art.22033; Malaviya R, 2006, EUR J PHARMACOL, V539, P195, DOI 10.1016/j.ejphar.2006.03.018; Masuda S, 2005, FEBS J, V272, P655, DOI 10.1111/j.1742-4658.2004.04489.x; Matsushita K, 2009, NATURE, V458, P1185, DOI 10.1038/nature07924; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Mosher AA, 2014, REPROD SCI; Murakami M, 2011, EXP ANIM TOKYO, V60, P7, DOI 10.1538/expanim.60.7; Murakami M, 2011, PROG LIPID RES, V50, P152, DOI 10.1016/j.plipres.2010.12.001; Nagase T, 2000, NAT IMMUNOL, V1, P42, DOI 10.1038/76897; Nagase T, 2002, NAT MED, V8, P480, DOI 10.1038/nm0502-480; Ohto T, 2005, J BIOL CHEM, V280, P24576, DOI 10.1074/jbc.M413711200; Okamoto H, 1997, ARTHRITIS RHEUM, V40, P1096, DOI 10.1002/art.1780400614; Pawliczak R, 2004, J BIOL CHEM, V279, P48550, DOI 10.1074/jbc.M408926200; Philippe L, 2012, J IMMUNOL, V188, P454, DOI 10.4049/jimmunol.1102348; Raichel L, 2008, EUR J IMMUNOL, V38, P2905, DOI 10.1002/eji.200838545; Ruijter JM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp045; Ruiperez V, 2009, J IMMUNOL, V182, P3877, DOI 10.4049/jimmunol.0804003; Sacre SM, 2007, AM J PATHOL, V170, P518, DOI 10.2353/ajpath.2007.060657; Sasai M, 1999, ARTHRITIS RHEUM, V42, P1635, DOI 10.1002/1529-0131(199908)42:8<1635::AID-ANR11>3.0.CO;2-Q; Schett G, 1998, J CLIN INVEST, V102, P302, DOI 10.1172/JCI2465; Seibl R, 2003, AM J PATHOL, V162, P1221, DOI 10.1016/S0002-9440(10)63918-1; Singer AG, 2002, J BIOL CHEM, V277, P48535, DOI 10.1074/jbc.M205855200; Snyder DW, 1999, J PHARMACOL EXP THER, V288, P1117; Sommerfelt RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083555; STREET IP, 1993, BIOCHEMISTRY-US, V32, P5935, DOI 10.1021/bi00074a003; SUNDLER R, 1994, BIOCHEM J, V301, P455, DOI 10.1042/bj3010455; Tai N, 2010, INFLAMM RES, V59, P53, DOI 10.1007/s00011-009-0069-8; Takagi N, 1998, ARTHRITIS RHEUM, V41, P2117, DOI 10.1002/1529-0131(199812)41:12<2117::AID-ART6>3.3.CO;2-G; Takahashi Y, 1999, TOHOKU J EXP MED, V188, P75, DOI 10.1620/tjem.188.75; Tamaki Y, 2011, J RHEUMATOL, V38, P810, DOI 10.3899/jrheum.100732; Uozumi N, 1997, NATURE, V390, P618, DOI 10.1038/37622; Uson J, 1997, J RHEUMATOL, V24, P2069; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; Varastehpour A, 2006, J CLIN ENDOCR METAB, V91, P248, DOI 10.1210/jc.2005-0873; Winstead MV, 2000, BBA-MOL CELL BIOL L, V1488, P28, DOI 10.1016/S1388-1981(00)00107-4	72	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119088	10.1371/journal.pone.0119088	http://dx.doi.org/10.1371/journal.pone.0119088			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893499	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700002
J	Ahronian, LG; Driscoll, DR; Klimstra, DS; Lewis, BC				Ahronian, Leanne G.; Driscoll, David R.; Klimstra, David S.; Lewis, Brian C.			The p53(R172H) Mutant Does Not Enhance Hepatocellular Carcinoma Development and Progression	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; MOUSE MODEL; P53 GAIN; P73; MUTATION; METASTASIS; EXPRESSION; TP53; P63; TRANSCRIPTION	Hepatocellular carcinoma is a highly deadly malignancy, accounting for approximately 800,000 deaths worldwide every year. Mutation of the p53 tumor suppressor gene is a common genetic change in HCC, present in 30% of cases. p53(R175H) (corresponding to p53(R172H) in mice) is a hotspot for mutation that demonstrates "prometastatic" gain-of-function in other cancer models. Since the frequency of p53 mutation increases with tumor grade in HCC, we hypothesized that p53(R172H) is a gain-of-function mutation in HCC that contributes to a decrease in tumor-free survival and an increase in metastasis. In an HCC mouse model, we found that p53(R172H/flox) mice do not have decreased survival, increased tumor incidence, or increased metastasis, relative to p53(flox/flox) littermates. Analysis of cell lines derived from both genotypes indicated that there are no differences in anchorage-independent growth and cell migration. However, shRNA-mediated knockdown of mutant p53 in p53(R172H)-expressing HCC cell lines resulted in decreased cell migration and anchorage-independent growth. Thus, although p53 mutant-expressing cells and tumors do not have enhanced properties relative to their p53 null counterparts, p53(R172H)-expressing HCC cells depend on this mutant for their transformation. p53 mutants have been previously shown to bind and inhibit the p53 family proteins p63 and p73. Interestingly, we find that the levels of p63 and p73 target genes are similar in p53 mutant and p53 null HCC cells. These data suggest that pathways regulated by these p53 family members are similarly impacted by p53(R172H) in mutant expressing cells, and by alternate mechanisms in p53 null cells, resulting in equivalent phenotypes. Consistent with this, we find that p53 null HCC cell lines display lower levels of the TA isoforms of p63 and p73 and higher levels of Delta Np63. Taken together these data point to the importance of p63 and p73 in constraining HCC progression.	[Ahronian, Leanne G.; Driscoll, David R.; Lewis, Brian C.] Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA; [Klimstra, David S.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA USA; [Lewis, Brian C.] Univ Massachusetts, Sch Med, Ctr Canc, Worcester, MA USA	University of Massachusetts System; University of Massachusetts Worcester; Memorial Sloan Kettering Cancer Center; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Lewis, BC (corresponding author), Univ Massachusetts, Sch Med, Dept Mol Cell & Canc Biol, Worcester, MA 01605 USA.	Brian.Lewis@umassmed.edu			National Institutes of Health [R01CA121171]; NATIONAL CANCER INSTITUTE [R01CA121171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by National Institutes of Health grant R01CA121171 to BCL [http://www.nih.gov/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benard J, 2003, HUM MUTAT, V21, P182, DOI 10.1002/humu.10172; Buendia MA, 2000, SEMIN CANCER BIOL, V10, P185; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Cucchetti A, 2012, WORLD J GASTROENTERO, V18, P6398, DOI 10.3748/wjg.v18.i44.6398; Cucchetti A, 2011, ANN SURG ONCOL, V18, P1630, DOI 10.1245/s10434-010-1463-8; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gouas DA, 2010, CARCINOGENESIS, V31, P1475, DOI 10.1093/carcin/bgq118; Harms K, 2004, CELL MOL LIFE SCI, V61, P822, DOI 10.1007/s00018-003-3304-4; Herath NI, 2000, HEPATOLOGY, V31, P601, DOI 10.1002/hep.510310309; HOLLSTEIN M, 1991, SCIENCE, V253, P49, DOI 10.1126/science.1905840; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; KERN SE, 1992, SCIENCE, V256, P827, DOI 10.1126/science.1589764; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lee MK, 2012, CANCER CELL, V22, P751, DOI 10.1016/j.ccr.2012.10.022; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; Lin YL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000680; Liu G, 2000, P NATL ACAD SCI USA, V97, P4174, DOI 10.1073/pnas.97.8.4174; Liu JB, 2012, EUR J CANCER, V48, P2328, DOI 10.1016/j.ejca.2012.03.001; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet Josep M, 2004, Liver Transpl, V10, pS115, DOI 10.1002/lt.20034; Lu X, 2012, ONCOGENE; Morton JP, 2010, P NATL ACAD SCI USA, V107, P246, DOI 10.1073/pnas.0908428107; ODA T, 1992, CANCER RES, V52, P6358; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; ORY K, 1994, EMBO J, V13, P3496, DOI 10.1002/j.1460-2075.1994.tb06656.x; Pan HC, 2002, ACTA ONCOL, V41, P550; Petitjean A, 2005, ONCOGENE, V24, P512, DOI 10.1038/sj.onc.1208215; Sayan AE, 2001, ONCOGENE, V20, P5111, DOI 10.1038/sj.onc.1204669; Schilling T, 2010, BIOCHEM BIOPH RES CO, V394, P817, DOI 10.1016/j.bbrc.2010.03.082; Sigal A, 2000, CANCER RES, V60, P6788; Stiewe T, 2004, CLIN CANCER RES, V10, P626, DOI 10.1158/1078-0432.CCR-0153-03; Tannapfel A, 1999, J NATL CANCER I, V91, P1154, DOI 10.1093/jnci/91.13.1154; Tannapfel A, 2008, CARCINOGENESIS, V29, P211, DOI 10.1093/carcin/bgm236; UNGER T, 1992, EMBO J, V11, P1383, DOI 10.1002/j.1460-2075.1992.tb05183.x; Venkatanarayan A, 2014, NATURE; Wijnhoven SWP, 2007, CANCER RES, V67, P4648, DOI 10.1158/0008-5472.CAN-06-4681; Woo HG, 2011, GASTROENTEROLOGY, V140, P1063, DOI 10.1053/j.gastro.2010.11.034	41	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123816	10.1371/journal.pone.0123816	http://dx.doi.org/10.1371/journal.pone.0123816			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885474	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000085
J	Capela, NA; Lemaire, ED; Baddour, N				Capela, Nicole A.; Lemaire, Edward D.; Baddour, Natalie			Feature Selection for Wearable Smartphone-Based Human Activity Recognition with Able bodied, Elderly, and Stroke Patients	PLOS ONE			English	Article							CLASSIFICATION; ACCELEROMETRY; POSTURES; SENSORS; PEOPLE	Human activity recognition (HAR), using wearable sensors, is a growing area with the potential to provide valuable information on patient mobility to rehabilitation specialists. Smartphones with accelerometer and gyroscope sensors are a convenient, minimally invasive, and low cost approach for mobility monitoring. HAR systems typically pre-process raw signals, segment the signals, and then extract features to be used in a classifier. Feature selection is a crucial step in the process to reduce potentially large data dimensionality and provide viable parameters to enable activity classification. Most HAR systems are customized to an individual research group, including a unique data set, classes, algorithms, and signal features. These data sets are obtained predominantly from able-bodied participants. In this paper, smartphone accelerometer and gyroscope sensor data were collected from populations that can benefit from human activity recognition: able-bodied, elderly, and stroke patients. Data from a consecutive sequence of 41 mobility tasks (18 different tasks) were collected for a total of 44 participants. Seventy-six signal features were calculated and subsets of these features were selected using three filter-based, classifier-independent, feature selection methods (Relief-F, Correlation-based Feature Selection, Fast Correlation Based Filter). The feature subsets were then evaluated using three generic classifiers (Naive Bayes, Support Vector Machine, j48 Decision Tree). Common features were identified for all three populations, although the stroke population subset had some differences from both able-bodied and elderly sets. Evaluation with the three classifiers showed that the feature subsets produced similar or better accuracies than classification with the entire feature set. Therefore, since these feature subsets are classifier-independent, they should be useful for developing and improving HAR systems across and within populations.	[Capela, Nicole A.; Lemaire, Edward D.] Ottawa Hosp, Res Inst, Ottawa, ON, Canada; [Lemaire, Edward D.] Univ Ottawa, Fac Med, Ottawa, ON, Canada; [Capela, Nicole A.; Baddour, Natalie] Univ Ottawa, Dept Mech Engn, Ottawa, ON K1N 6N5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa; University of Ottawa	Capela, NA (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	ncape055@uottawa.ca	Baddour, Natalie/A-4018-2008	Baddour, Natalie/0000-0002-7025-7501; Lemaire, Edward/0000-0003-4693-2623	Natural Sciences and Engineering Research Council of Canada; BlackBerry [CRDPJ 408109]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); BlackBerry	This project was funded by the Natural Sciences and Engineering Research Council of Canada Collaborative Research and Development Grants and BlackBerry (formerly Research in Motion) (CRDPJ 408109, www.nserc-crsng.gc.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen FR, 2006, PHYSIOL MEAS, V27, P935, DOI 10.1088/0967-3334/27/10/001; Atallah L., 2010, BODY SENSOR NETWORKS, DOI DOI 10.1109/BSN.2010.23; Avci A., 2010, 23 INT C ARCH COMP S; Barra J, 2009, NEUROLOGY, V72, P1582, DOI 10.1212/WNL.0b013e3181a4123a; Bidargaddi N, 2007, PROCEEDINGS OF THE 2007 INTERNATIONAL CONFERENCE ON INTELLIGENT SENSORS, SENSOR NETWORKS AND INFORMATION PROCESSING, P555; Cheung VH, 2011, ARCH PHYS MED REHAB, V92, P998, DOI 10.1016/j.apmr.2010.12.040; Del Rosario MB, 2014, PHYSIOL MEAS, V35, P2269, DOI 10.1088/0967-3334/35/11/2269; Dijkstra B, 2010, AGE AGEING, V39, P259, DOI 10.1093/ageing/afp249; Feng YQ, 2003, 2003 INTERNATIONAL CONFERENCE ON MACHINE LEARNING AND CYBERNETICS, VOLS 1-5, PROCEEDINGS, P2085, DOI 10.1109/ICMLC.2003.1259848; Fish B, 2012, INT CONF ACOUST SPEE, P1729, DOI 10.1109/ICASSP.2012.6288232; Fulk GD, 2011, TOP STROKE REHABIL, V18, P746, DOI 10.1310/tsr1806-746; Hache G, 2011, IEEE T INSTRUM MEAS, V60, P3153, DOI 10.1109/TIM.2011.2122490; Hristijan Gjoreski SK, 2014, USING MULTIPLE CONTE, DOI [10.3233/978-1-61499-419-0-1015, DOI 10.3233/978-1-61499-419-0-1015]; Incel OD, 2013, BIONANOSCIENCE, V3, P145, DOI 10.1007/s12668-013-0088-3; Khan AM, 2014, INT J DISTRIB SENS N, DOI 10.1155/2014/503291; Kozina S, 2013, J MED BIOL ENG, V33, P406, DOI 10.5405/jmbe.1321; Lau S.L., 2010, P FUT NETW MOB SUMM, P1; Liu H, 2008, CH CRC DATA MIN KNOW, P3; Mark A, 1999, FEATURE SELECTION FO, P235; Maurer U, 2006, BSN 2006: INTERNATIONAL WORKSHOP ON WEARABLE AND IMPLANTABLE BODY SENSOR NETWORKS, PROCEEDINGS, P113; Mizuike C, 2009, GAIT POSTURE, V30, P60, DOI 10.1016/j.gaitpost.2009.02.017; Nicole A, 2014, 36 ANN INT C IEEE EN; Nuno Cruz Silva JMM, 2013, FEATURES SELECTION H; Pantelopoulos A, 2010, IEEE T SYST MAN CY C, V40, P1, DOI 10.1109/TSMCC.2009.2032660; Patel S, 2010, P IEEE, V98, P450, DOI 10.1109/JPROC.2009.2038727; Ravi N., 2005, P 17 C INN APPL ART, P1541, DOI DOI 10.1007/978-3-642-02481-8_120; Steele BC, 2003, J REHABIL RES DEV, V40, P45, DOI 10.1682/JRRD.2003.10.0045; Tundo MD, 2013, IEEE INT SYM MED MEA, P58, DOI 10.1109/MeMeA.2013.6549706; Zhang M., 2011, BODYNETS, P92; Zhang M, 2012, UBICOMP'12: PROCEEDINGS OF THE 2012 ACM INTERNATIONAL CONFERENCE ON UBIQUITOUS COMPUTING, P1036; Zhao Z., ADV FEATURE SELECTIO	31	100	103	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124414	10.1371/journal.pone.0124414	http://dx.doi.org/10.1371/journal.pone.0124414			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885272	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000124
J	Ernst, JB; Becker, T; Kuhn, J; Gummert, JF; Zittermann, A				Ernst, Jana B.; Becker, Tobias; Kuhn, Joachim; Gummert, Jan F.; Zittermann, Armin			Independent Association of Circulating Vitamin D Metabolites with Anemia Risk in Patients Scheduled for Cardiac Surgery	PLOS ONE			English	Article							CORONARY-ARTERY-BYPASS; CHRONIC KIDNEY-DISEASE; RED-BLOOD-CELL; HEMODIALYSIS-PATIENTS; PREOPERATIVE ANEMIA; D DEFICIENCY; INTRAVENOUS CALCITRIOL; D SUPPLEMENTATION; HEMOGLOBIN LEVEL; TRANSFUSION	Background Preoperative anemia is considered an independent risk factor of poor clinical outcome in cardiac surgical patients. Low vitamin D status may increase anemia risk. Methods We investigated 3,615 consecutive patients scheduled for cardiac surgery to determine the association between preoperative anemia (hemoglobin [Hb] < 12.5 g/dL) and circulating levels of the vitamin D metabolites 25-hydroxyvitamin D (25OHD) and 1,25-dihydroxyvitamin D (1,25[OH](2)D). Results Of the study cohort, 27.8% met the criteria for anemia. In patients with deficient 25OHD levels (<30 nmol/l) mean Hb concentrations were 0.5 g/dL lower than in patients with adequate 25OHD levels (50.0-125 nmol/l; P<0.001). Regarding 1,25(OH)(2)D, mean Hb concentrations were 1.2 g/dL lower in the lowest 1,25(OH)(2)D category (<40 pmol/l) than in the highest 1,25(OH)(2)D category (>70 pmol/l; P<0.001). In multivariable-adjusted logistic regression analyses, the odds ratios for anemia of the lowest categories of 25OHD and 1,25(OH)(2)D were 1.48 (95% CI: 1.19-1.83) and 2.35 (95% CI: 1.86-2.97), compared with patients who had adequate 25OHD levels and 1,25(OH)(2)D values in the highest category, respectively. Anemia risk was greatest in patients with dual deficiency of 25OHD and 1,25(OH)(2)D (multivariable-adjusted OR = 3.60 (95% CI: 2.40-5.40). Prevalence of deficient 25OHD levels was highest in anemia of nutrient deficiency, whereas low 1,25(OH)(2)D levels were most frequent in anemia of chronic kidney disease. Conclusion This cross-sectional study demonstrates an independent inverse association between vitamin D status and anemia risk. If confirmed in clinical trials, preoperative administration of vitamin D or activated vitamin D (in case of chronic kidney disease) would be a promising strategy to prevent anemia in patients scheduled for cardiac surgery.	[Ernst, Jana B.; Becker, Tobias; Gummert, Jan F.; Zittermann, Armin] Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany; [Kuhn, Joachim] Ruhr Univ Bochum, Inst Lab & Transfus Med, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany	Ruhr University Bochum; Ruhr University Bochum	Zittermann, A (corresponding author), Ruhr Univ Bochum, Clin Thorac & Cardiovasc Surg, Heart & Diabet Ctr North Rhine Westphalia, Bad Oeynhausen, Germany.	azittermann@hdz-nrw.de						Atkinson MA, 2014, J PEDIATR-US, V164, P153, DOI 10.1016/j.jpeds.2013.08.060; Aucella F, 2003, NEPHRON CLIN PRACT, V95, pC121, DOI 10.1159/000074837; Baron DM, 2014, BRIT J ANAESTH, V113, P416, DOI 10.1093/bja/aeu098; Ben Alon D, 2002, EXP HEMATOL, V30, P403, DOI 10.1016/S0301-472X(02)00789-0; Bilgin YM, 2004, CIRCULATION, V109, P2755, DOI 10.1161/01.CIR.0000130162.11925.21; Blanco-Rojo R, 2013, EUR J NUTR, V52, P695, DOI 10.1007/s00394-012-0375-8; Carrascal Y, 2010, INTERACT CARDIOV TH, V10, P249, DOI 10.1510/icvts.2009.220160; Eloranta JJ, 2009, MOL PHARMACOL, V76, P1062, DOI 10.1124/mol.109.055392; Engoren M, 2014, ANN THORAC SURG, V97, P514, DOI 10.1016/j.athoracsur.2013.09.019; Galas FRBG, 2013, J CARDIOTHORAC SURG, V8, DOI 10.1186/1749-8090-8-54; Goicoechea M, 1998, NEPHRON, V78, P23, DOI 10.1159/000044877; Harskamp RE, 2014, ANN THORAC SURG, V97, P824, DOI 10.1016/j.athoracsur.2013.09.099; Healthcare Cost and Utilization Project, 2013, MOST FREQ PROC PERF; Hung M, 2011, ANAESTHESIA, V66, P812, DOI 10.1111/j.1365-2044.2011.06819.x; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P3799, DOI 10.1093/ndt/gfp370; Jones G, 1998, PHYSIOL REV, V78, P1193, DOI 10.1152/physrev.1998.78.4.1193; Karkouti K, 2008, CIRCULATION, V117, P478, DOI 10.1161/CIRCULATIONAHA.107.718353; Kendrick J, 2009, AM J NEPHROL, V30, P64, DOI 10.1159/000202632; Kim C, 2014, PERFUSION IN PRESS; Kiss Z, 2011, NEPHRON CLIN PRACT, V117, pC373, DOI 10.1159/000321521; Koch CG, 2006, CRIT CARE MED, V34, P1608, DOI 10.1097/01.CCM.0000217920.48559.D8; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Kumar VA, 2011, J NEPHROL, V24, P98, DOI 10.5301/JN.2010.1830; Lac PT, 2010, CLIN NEPHROL, V74, P25; Lawson M, 1999, BRIT MED J, V318, P28, DOI 10.1136/bmj.318.7175.28; Leal-Noval SM, 2001, CHEST, V119, P1461, DOI 10.1378/chest.119.5.1461; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; MASUHARA T, 1963, J NUTR, V80, P332, DOI 10.1093/jn/80.3.332; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Mehta S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008770; Murphy GJ, 2007, CIRCULATION, V116, P2544, DOI 10.1161/CIRCULATIONAHA.107.698977; Nazem A. K., 1997, International Urology and Nephrology, V29, P119, DOI 10.1007/BF02551427; Neumeister B, 2009, KLINIKLEITFADEN LABO; Neves PL, 2006, INT UROL NEPHROL, V38, P175, DOI 10.1007/s11255-004-1563-0; Paone G, 2014, ANN THORAC SURG, V97, P87, DOI 10.1016/j.athoracsur.2013.07.020; Patel NM, 2010, KIDNEY INT, V77, P715, DOI 10.1038/ki.2009.551; Perlstein TS, 2011, BLOOD, V117, P2800, DOI 10.1182/blood-2010-09-309708; Petkovich M, 2011, CURR OPIN NEPHROL HY, V20, P337, DOI 10.1097/MNH.0b013e3283477a7b; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Saab G, 2007, NEPHRON CLIN PRACT, V105, P132, DOI 10.1159/000098645; Shavit L, 2014, CLIN J AM SOC NEPHRO, V9, P1536, DOI 10.2215/CJN.00110114; Shin JY, 2013, CLIN CHIM ACTA, V421, P177, DOI 10.1016/j.cca.2013.02.025; Sim JJ, 2010, ANN HEMATOL, V89, P447, DOI 10.1007/s00277-009-0850-3; Spahn DR, 2013, LANCET, V381, P1855, DOI 10.1016/S0140-6736(13)60808-9; Surgenor SD, 2009, ANESTH ANALG, V108, P1741, DOI 10.1213/ane.0b013e3181a2a696; Whitson BA, 2010, J SURG RES, V158, P20, DOI 10.1016/j.jss.2008.10.015; Williams ML, 2013, ANN THORAC SURG, V96, P1628, DOI 10.1016/j.athoracsur.2013.06.030; Zittermann A, 2013, INT J LAB H IN PRESS; Zittermann A, 2015, J CLIN ENDOCR METAB, V100, P72, DOI 10.1210/jc.2014-3013; Zittermann A, 2011, CLIN RES CARDIOL, V100, P781, DOI 10.1007/s00392-011-0312-5; Zittermann A, 2009, CLIN CHEM, V55, P1163, DOI 10.1373/clinchem.2008.120006	51	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124751	10.1371/journal.pone.0124751	http://dx.doi.org/10.1371/journal.pone.0124751			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885271	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000144
J	Jing, YP; Wu, KW; Liu, JS; Ai, Q; Ge, P; Dai, J; Jiang, R; Zhou, D; Che, Q; Wan, JY; Zhang, L				Jing, Yuping; Wu, Kunwei; Liu, Jiashuo; Ai, Qing; Ge, Pu; Dai, Jie; Jiang, Rong; Zhou, Dan; Che, Qian; Wan, Jingyuan; Zhang, Li			Aminotriazole Alleviates Acetaminophen Poisoning via Downregulating P450 2E1 and Suppressing Inflammation	PLOS ONE			English	Article							INDUCED LIVER-INJURY; CARBON-TETRACHLORIDE; OXIDANT STRESS; CELL-DEATH; INDUCED HEPATOTOXICITY; NEUTROPHIL ACTIVATION; ACATALASEMIC MICE; HYDROGEN-PEROXIDE; CATALASE ACTIVITY; TERMINAL KINASE	Aminotriazole (ATZ) is commonly used as a catalase (CAT) inhibitor. We previously found ATZ attenuated oxidative liver injury, but the underlying mechanisms remain unknown. Acetaminophen (APAP) overdose frequently induces life-threatening oxidative hepatitis. In the present study, the potential hepatoprotective effects of ATZ on oxidative liver injury and the underlying mechanisms were further investigated in a mouse model with APAP poisoning. The experimental data indicated that pretreatment with ATZ dose-and time-dependently suppressed the elevation of plasma aminotransferases in APAP exposed mice, these effects were accompanied with alleviated histological abnormality and improved survival rate of APAP-challenged mice. In mice exposed to APAP, ATZ pretreatment decreased the CAT activities, hydrogen peroxide (H2O2) levels, malondialdehyde (MDA) contents, myeloperoxidase (MPO) levels in liver and reduced TNF-a levels in plasma. Pretreatment with ATZ also downregulated APAP-induced cytochrome P450 2E1 (CYP2E1) expression and JNK phosphorylation. In addition, posttreatment with ATZ after APAP challenge decreased the levels of plasma aminotransferases and increased the survival rate of experimental animals. Posttreatment with ATZ had no effects on CYP2E1 expression or JNK phosphorylation, but it significantly decreased the levels of plasma TNF-alpha. Our data indicated that the LD50 of ATZ in mice was 5367.4 mg/kg body weight, which is much higher than the therapeutic dose of ATZ in the present study. These data suggested that ATZ might be effective and safe in protect mice against APAP-induced hepatotoxicity, the beneficial effects might resulted from downregulation of CYP2E1 and inhibiton of inflammation.	[Jing, Yuping; Wu, Kunwei; Liu, Jiashuo; Ge, Pu; Zhou, Dan; Che, Qian; Zhang, Li] Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China; [Ai, Qing] Chongqing Med Univ, Dept Physiol, Chongqing, Peoples R China; [Dai, Jie] Hosp Chongqing Univ Arts & Sci, Chongqing, Peoples R China; [Jiang, Rong] Chongqing Med Univ, Lab Stem Cell & Tissue Engn, Chongqing, Peoples R China; [Wan, Jingyuan] Chongqing Med Univ, Dept Pharmacol, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Zhang, L (corresponding author), Chongqing Med Univ, Dept Pathophysiol, Chongqing, Peoples R China.	zhangli@cqmu.edu.cn	Wu, Kunwei/AAY-8111-2021	Wu, Kunwei/0000-0003-4074-0567	National Nature Science Foundation of China [81370179]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from the National Nature Science Foundation of China (No. 81370179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmegeed MA, 2010, BIOCHEM PHARMACOL, V79, P57, DOI 10.1016/j.bcp.2009.07.016; Antoniades CG, 2014, HEPATOLOGY, V59, P1564, DOI 10.1002/hep.26933; Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Bajt ML, 2011, TOXICOL SCI, V122, P598, DOI 10.1093/toxsci/kfr116; Bateman DN, 2014, LANCET, V383, P697, DOI 10.1016/S0140-6736(13)62062-0; Bernal W, 2010, LANCET, V376, P190, DOI 10.1016/S0140-6736(10)60274-7; Brenner C, 2013, J HEPATOL, V59, P583, DOI 10.1016/j.jhep.2013.03.033; Cesaratto Laura, 2004, Ann Hepatol, V3, P86; Chaudhuri S, 2012, TOXICOL APPL PHARM, V264, P192, DOI 10.1016/j.taap.2012.08.001; Chen X, 2009, WORLD J GASTROENTERO, V15, P1829, DOI 10.3748/wjg.15.1829; Chen XL, 2004, ARCH BIOCHEM BIOPHYS, V422, P197, DOI 10.1016/j.abb.2003.12.023; Cheung C, 2005, DRUG METAB DISPOS, V33, P449, DOI 10.1124/dmd.104.002402; Deng XY, 2012, FOOD CHEM TOXICOL, V50, P3073, DOI 10.1016/j.fct.2012.05.052; Fukuoka N, 2008, AM J NEPHROL, V28, P661, DOI 10.1159/000121357; Gandhi A, 2010, J TOXICOL SCI, V35, P163, DOI 10.2131/jts.35.163; Han D., 2010, HDB EXP PHARM, V196, P267, DOI DOI 10.1007/978-3-642-00663-0_10; Hanawa N, 2008, J BIOL CHEM, V283, P13565, DOI 10.1074/jbc.M708916200; Henderson NC, 2007, GUT, V56, P982, DOI 10.1136/gut.2006.104372; Jaeschke H, 2006, TOXICOL SCI, V89, P31, DOI 10.1093/toxsci/kfi336; Jaeschke H, 2003, TOXICOL LETT, V144, P279, DOI 10.1016/S0378-4274(03)00239-X; Jaeschke H, 2012, DRUG METAB REV, V44, P88, DOI 10.3109/03602532.2011.602688; Jaeschke H, 2012, LIVER INT, V32, P8, DOI 10.1111/j.1478-3231.2011.02501.x; Josephy PD, 2005, DRUG METAB REV, V37, P581, DOI 10.1080/03602530500205200; Jozwiak-Bebenista M, 2014, ACTA POL PHARM, V71, P11; Kim ND, 1997, BIOCHEM PHARMACOL, V53, P261, DOI 10.1016/S0006-2952(96)00647-8; Kim SN, 2007, DRUG METAB DISPOS, V35, P1754, DOI 10.1124/dmd.107.015545; Lee SST, 1996, J BIOL CHEM, V271, P12063, DOI 10.1074/jbc.271.20.12063; Li JX, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.241; Ma HP, 2011, J BIOL CHEM, V286, P32444, DOI 10.1074/jbc.M111.254102; Maddrey WC, 2005, J CLIN GASTROENTEROL, V39, pS83, DOI 10.1097/01.mcg.0000155548.91524.6e; Miller L, 2013, TOXICOL SCI, V134, P400, DOI 10.1093/toxsci/kft122; Milton NGN, 2001, NEUROTOXICOLOGY, V22, P767, DOI 10.1016/S0161-813X(01)00064-X; Ozer J, 2008, TOXICOLOGY, V245, P194, DOI 10.1016/j.tox.2007.11.021; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Sen P, 2003, MUTAT RES-FUND MOL M, V529, P87, DOI 10.1016/S0027-5107(03)00106-4; Sinclair J, 1998, BIOCHEM PHARMACOL, V55, P1557; Smith C, 2000, EXP MOL PATHOL, V69, P223, DOI 10.1006/exmp.2000.2328; Dao VTV, 2011, J CELL MOL MED, V15, P2326, DOI 10.1111/j.1582-4934.2010.01227.x; Wang DH, 1996, ARCH TOXICOL, V70, P189, DOI 10.1007/s002040050259; Weber LWD, 2003, CRIT REV TOXICOL, V33, P105, DOI 10.1080/713611034; Williams CD, 2014, TOXICOL APPL PHARM, V275, P122, DOI 10.1016/j.taap.2014.01.004; Zamocky M, 2008, ANTIOXID REDOX SIGN, V10, P1527, DOI 10.1089/ars.2008.2046; Zmijewski JW, 2009, AM J RESP CRIT CARE, V179, P694, DOI 10.1164/rccm.200806-851OC	43	10	10	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122781	10.1371/journal.pone.0122781	http://dx.doi.org/10.1371/journal.pone.0122781			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884831	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000041
J	Kusch, A; Schmidt, M; Gurgen, D; Postpieszala, D; Catar, R; Hegner, B; Davidson, MM; Mahmoodzadeh, S; Dragun, D				Kusch, Angelika; Schmidt, Maria; Guergen, Dennis; Postpieszala, Daniel; Catar, Rusan; Hegner, Bjoern; Davidson, Merci M.; Mahmoodzadeh, Shokoufeh; Dragun, Duska			17 beta- Estradiol Regulates mTORC2 Sensitivity to Rapamycin in Adaptive Cardiac Remodeling	PLOS ONE			English	Article							COMPLEX INTEGRITY; INHIBITS MTORC2; PROTEIN-KINASE; UP-REGULATION; AKT; ESTROGEN; PHOSPHORYLATION; HYPERTROPHY; PATHWAY; ACTIVATION	Adaptive cardiac remodeling is characterized by enhanced signaling of mTORC2 downstream kinase Akt. In females, 17 beta-estradiol (E2), as well as Akt contribute essentially to sex-related premenopausal cardioprotection. Pharmacologic mTOR targeting with rapamycin is increasingly used for various clinical indications, yet burdened with clinical heterogeneity in therapy responses. The drug inhibits mTORC1 and less-so mTORC2. In male rodents, rapamycin decreases maladaptive cardiac hypertrophy whereas it leads to detrimental dilative cardiomyopathy in females. We hypothesized that mTOR inhibition could interfere with 17 beta-estradiol (E2)-mediated sexual dimorphism and adaptive cell growth and tested responses in murine female hearts and cultured female cardiomyocytes. Under physiological in vivo conditions, rapamycin compromised mTORC2 function only in female, but not in male murine hearts. In cultured female cardiomyocytes, rapamycin impaired simultaneously IGF-1 induced activation of both mTOR signaling branches, mTORC1 and mTORC2 only in presence of E2. Use of specific estrogen receptor (ER)alpha- and ER beta-ago-nists indicated involvement of both estrogen receptors (ER) in rapamycin effects on mTORC1 and mTORC2. Classical feedback mechanisms common in tumour cells with upregulation of PI3K signaling were not involved. E2 effect on Akt-pS473 downregulation by rapamycin was independent of ERK as shown by sequential mTOR and MEK-inhibition. Furthermore, regulatory mTORC2 complex defining component rictor phosphorylation at Ser1235, known to interfere with Akt-substrate binding to mTORC2, was not altered. Functionally, rapamycin significantly reduced trophic effect of E2 on cell size. In addition, cardiomyocytes with reduced Akt-pS473 under rapamycin treatment displayed decreased SERCA2A mRNA and protein expression suggesting negative functional consequences on cardiomyocyte contractility. Rictor silencing confirmed regulation of SERCA2A expression by mTORC2 in E2-cultured female cardiomyocytes. These data highlight a novel modulatory function of E2 on rapamycin effect on mTORC2 in female cardiomyocytes and regulation of SERCA2A expression by mTORC2. Conceivably, rapamycin abrogates the premenopausal "female advantage".	[Kusch, Angelika; Schmidt, Maria; Guergen, Dennis; Postpieszala, Daniel; Catar, Rusan; Hegner, Bjoern; Dragun, Duska] Charite, Charite Campus Virchow Klinikum, Dept Nephrol & Intens Care Med, D-13353 Berlin, Germany; [Kusch, Angelika; Guergen, Dennis; Catar, Rusan; Hegner, Bjoern; Mahmoodzadeh, Shokoufeh; Dragun, Duska] Charite, Ctr Cardiovasc Res, D-13353 Berlin, Germany; [Davidson, Merci M.] Columbia Univ, Dept Neurol, Coll Phys & Surg, New York, NY USA; [Mahmoodzadeh, Shokoufeh] Max Delbruck Ctr Mol Med, Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Columbia University; Helmholtz Association; Max Delbruck Center for Molecular Medicine	Kusch, A (corresponding author), Charite, Charite Campus Virchow Klinikum, Dept Nephrol & Intens Care Med, D-13353 Berlin, Germany.	angelika.kusch@charite.de	Schmidt, Maria/V-3196-2019; Catar, Rusan Ali/I-3948-2019; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022	Catar, Rusan Ali/0000-0002-7000-7860; Schmidt, Maria Inês/0000-0002-3837-0731; Mahmoodzadeh, Shokoufeh/0000-0002-3094-7874; Hegner, Bjorn/0000-0003-3524-1165; Dragun, Duska/0000-0002-0310-9269	Deutsche Forschungsgemeinschaft DFG [DR 498/1-2 - FOR1054]	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	Funding was provided by Deutsche Forschungsgemeinschaft DFG - DR 498/1-2 - FOR1054, http://www.dfg.de/en/, DD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Arias-Loza PA, 2008, GENDER MED, V5, pS34, DOI 10.1016/j.genm.2008.03.005; Aryal B, 2014, P NATL ACAD SCI USA, V111, P2011, DOI 10.1073/pnas.1321783111; Ashraf MI, 2014, CELL COMMUN SIGNAL, V12, DOI 10.1186/1478-811X-12-6; Baselga J, 2012, NEW ENGL J MED, V366, P520, DOI 10.1056/NEJMoa1109653; Bueno OF, 2000, EMBO J, V19, P6341, DOI 10.1093/emboj/19.23.6341; Buss SJ, 2012, AM J PHYSIOL-HEART C, V302, pH420, DOI 10.1152/ajpheart.00211.2011; Camper-Kirby D, 2001, CIRC RES, V88, P1020, DOI 10.1161/hh1001.090858; Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]; Chen CH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001731; Chen SN, 2014, CIRC RES, V114, P454, DOI 10.1161/CIRCRESAHA.114.302810; Chen XG, 2010, MOL CARCINOGEN, V49, P603, DOI 10.1002/mc.20628; Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979; Cong BH, 2014, MOL CELL ENDOCRINOL, V382, P17, DOI 10.1016/j.mce.2013.09.002; Davidson MM, 2005, J MOL CELL CARDIOL, V39, P133, DOI 10.1016/j.yjmcc.2005.03.003; DeBosch B, 2006, CIRCULATION, V113, P2097, DOI 10.1161/CIRCULATIONAHA.105.595231; Dworatzek E, 2014, CARDIOVASC RES, V102, P418, DOI 10.1093/cvr/cvu065; Fox EM, 2009, STEROIDS, V74, P622, DOI 10.1016/j.steroids.2008.10.014; Gabardi S, 2010, PHARMACOTHERAPY, V30, P1044, DOI 10.1592/phco.30.10.1044; Gan XQ, 2011, J BIOL CHEM, V286, P10998, DOI 10.1074/jbc.M110.195016; Garcia-Segura LM, 2006, NEUROENDOCRINOLOGY, V84, P275, DOI 10.1159/000097485; Gurgen D, 2013, HYPERTENSION, V61, P730, DOI 10.1161/HYPERTENSIONAHA.111.00276; Gurgen D, 2011, HYPERTENSION, V57, P648, DOI 10.1161/HYPERTENSIONAHA.110.166157; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Hayward CS, 2000, CARDIOVASC RES, V46, P28, DOI 10.1016/S0008-6363(00)00005-5; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huang JX, 2009, BIOCHEM SOC T, V37, P217, DOI 10.1042/BST0370217; Inoki K, 2006, TRENDS CELL BIOL, V16, P206, DOI 10.1016/j.tcb.2006.02.002; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jeanes HL, 2008, J ENDOCRINOL, V197, P493, DOI 10.1677/JOE-08-0071; Jesmin S, 2010, EUR J PHARMACOL, V641, P168, DOI 10.1016/j.ejphar.2010.05.020; Juhaszova M, 2009, CIRC RES, V104, P1240, DOI 10.1161/CIRCRESAHA.109.197996; Kemi OJ, 2008, J CELL PHYSIOL, V214, P316, DOI 10.1002/jcp.21197; Kim KH, 2009, MOL CELL ENDOCRINOL, V308, P3, DOI 10.1016/j.mce.2009.03.025; Kim SJ, 2008, AM J PHYSIOL-HEART C, V295, pH130, DOI 10.1152/ajpheart.00298.2008; Kushwaha SS, 2008, EUR HEART J, V29, P2742, DOI 10.1093/eurheartj/ehn407; Lipskaia L, 2010, EXPERT OPIN BIOL TH, V10, P29, DOI 10.1517/14712590903321462; Liu CG, 2007, CLIN EXP PHARMACOL P, V34, P998, DOI 10.1111/j.1440-1681.2007.04675.x; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lorenz K, 2009, INT J BIOCHEM CELL B, V41, P2351, DOI 10.1016/j.biocel.2009.08.002; Maillet M, 2013, NAT REV MOL CELL BIO, V14, P38, DOI 10.1038/nrm3495; Marks AR, 2013, J CLIN INVEST, V123, P46, DOI 10.1172/JCI62834; McMullen JR, 2004, CIRCULATION, V109, P3050, DOI 10.1161/01.CIR.0000130641.08705.45; McMullen JR, 2004, MOL CELL BIOL, V24, P6231, DOI 10.1128/MCB.24.14.6231-6240.2004; Miyamoto S, 2009, CARDIOVASC RES, V82, P272, DOI 10.1093/cvr/cvp087; Molkentin JD, 2004, CARDIOVASC RES, V63, P467, DOI 10.1016/j.cardiores.2004.01.021; Neff F, 2013, J CLIN INVEST, V123, P3272, DOI 10.1172/JCI67674; Piro M, 2010, J AM COLL CARDIOL, V55, P1057, DOI 10.1016/j.jacc.2009.09.065; Prossnitz ER, 2014, MOL CELL ENDOCRINOL, V389, P71, DOI 10.1016/j.mce.2014.02.002; Sarbassov DD, 2005, CURR OPIN CELL BIOL, V17, P596, DOI 10.1016/j.ceb.2005.09.009; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Shende P, 2011, CIRCULATION, V123, P1073, DOI 10.1161/CIRCULATIONAHA.110.977066; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; Shioi T, 2003, CIRCULATION, V107, P1664, DOI 10.1161/01.CIR.0000057979.36322.88; Siedlecki AM, 2009, KIDNEY INT, V75, P800, DOI 10.1038/ki.2008.690; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Voelkers M, 2013, CIRCULATION, V128, P2132, DOI 10.1161/CIRCULATIONAHA.113.003638; Wallace EL, 2012, AM J CARDIOL, V109, P932, DOI 10.1016/j.amjcard.2011.11.021; White SM, 2004, AM J PHYSIOL-HEART C, V286, pH823, DOI 10.1152/ajpheart.00986.2003; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yano N, 2008, AM J PHYSIOL-HEART C, V295, pH1690, DOI 10.1152/ajpheart.00531.2008; Yip CK, 2010, MOL CELL, V38, P768, DOI 10.1016/j.molcel.2010.05.017; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao CY, 2010, J BIOL CHEM, V285, P39575, DOI 10.1074/jbc.R110.180109; Zimmermann S, 1999, SCIENCE, V286, P1741, DOI 10.1126/science.286.5445.1741	70	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123385	10.1371/journal.pone.0123385	http://dx.doi.org/10.1371/journal.pone.0123385			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880554	Green Submitted, Green Accepted, Green Published, gold			2022-12-27	WOS:000353016500050
J	Munseri, PJ; Kroidl, A; Nilsson, C; Joachim, A; Geldmacher, C; Mann, P; Moshiro, C; Aboud, S; Lyamuya, E; Maboko, L; Missanga, M; Kaluwa, B; Mfinanga, S; Podola, L; Bauer, A; Godoy-Ramirez, K; Marovich, M; Moss, B; Hoelscher, M; Gotch, F; Stohr, W; Stout, R; McCormack, S; Wahren, B; Mhalu, F; Robb, ML; Biberfeld, G; Sandstrom, E; Bakari, M				Munseri, Patricia. J.; Kroidl, Arne; Nilsson, Charlotta; Joachim, Agricola; Geldmacher, Christof; Mann, Philipp; Moshiro, Candida; Aboud, Said; Lyamuya, Eligius; Maboko, Leonard; Missanga, Marco; Kaluwa, Bahati; Mfinanga, Sayoki; Podola, Lilly; Bauer, Asli; Godoy-Ramirez, Karina; Marovich, Mary; Moss, Bernard; Hoelscher, Michael; Gotch, Frances; Stoehr, Wolfgang; Stout, Richard; McCormack, Sheena; Wahren, Britta; Mhalu, Fred; Robb, Merlin L.; Biberfeld, Gunnel; Sandstrom, Eric; Bakari, Muhammad			Priming with a Simplified Intradermal HIV-1 DNA Vaccine Regimen followed by Boosting with Recombinant HIV-1 MVA Vaccine Is Safe and Immunogenic: A Phase IIa Randomized Clinical Trial	PLOS ONE			English	Article							HUMORAL IMMUNE-RESPONSES; VIRUS ANKARA; BROAD; PREVENTION; INFECTION; MULTIGENE	Background Intradermal priming with HIV-1 DNA plasmids followed by HIV-1MVA boosting induces strong and broad cellular and humoral immune responses. In our previous HIVIS-03 trial, we used 5 injections with 2 pools of HIV-DNA at separate sites for each priming immunization. The present study explores whether HIV-DNA priming can be simplified by reducing the number of DNA injections and administration of combined versus separated plasmid pools. Methods In this phase IIa, randomized trial, priming was performed using 5 injections of HIV-DNA, 1000 mu g total dose, (3 Env and 2 Gag encoding plasmids) compared to two "simplified" regimens of 2 injections of HIV-DNA, 600 mu g total dose, of Env- and Gag-encoding plasmid pools with each pool either administered separately or combined. HIV-DNA immunizations were given intradermally at weeks 0, 4, and 12. Boosting was performed intramuscularly with 10(8) pfu HIV-MVA at weeks 30 and 46. Results 129 healthy Tanzanian participants were enrolled. There were no differences in adverse events between the groups. The proportion of IFN-gamma ELISpot responders to Gag and/or Env peptides after the second HIV-MVA boost did not differ significantly between the groups primed with 2 injections of combined HIV-DNA pools, 2 injections with separated pools, and 5 injections with separated pools (90%, 97% and 97%). There were no significant differences in the magnitude of Gag and/or Env IFN-gamma ELISpot responses, in CD4+ and CD8+ T cell responses measured as IFN-gamma/IL-2 production by intracellular cytokine staining (ICS) or in response rates and median titers for binding antibodies to Env gp160 between study groups. Conclusions A simplified intradermal vaccination regimen with 2 injections of a total of 600 mu g with combined HIV-DNA plasmids primed cellular responses as efficiently as the standard regimen of 5 injections of a total of 1000 mu g with separated plasmid pools after boosting twice with HIV-MVA.	[Munseri, Patricia. J.; Bakari, Muhammad] MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania; [Munseri, Patricia. J.; Sandstrom, Eric] Karolinska Inst, Stockholm, Sweden; [Kroidl, Arne; Mann, Philipp; Maboko, Leonard; Missanga, Marco; Kaluwa, Bahati; Podola, Lilly; Bauer, Asli; Hoelscher, Michael] Mbeya Med Res Ctr, Natl Inst Med Research, Mbeya, Tanzania; [Kroidl, Arne; Geldmacher, Christof; Mann, Philipp; Podola, Lilly; Bauer, Asli; Hoelscher, Michael] Klinikum Univ Munich, Dept Infect Dis & Trop Med, Munich, Germany; [Kroidl, Arne; Geldmacher, Christof; Hoelscher, Michael] German Ctr Infect Res DZIF, Munich, Germany; [Nilsson, Charlotta; Godoy-Ramirez, Karina; Biberfeld, Gunnel] Publ Hlth Agcy Sweden, Solna, Sweden; [Nilsson, Charlotta; Wahren, Britta; Biberfeld, Gunnel] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Nilsson, Charlotta] Karolinska Inst, Dept Lab Med, Huddinge, Sweden; [Joachim, Agricola; Aboud, Said; Lyamuya, Eligius; Mhalu, Fred] MUHAS, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Moshiro, Candida] MUHAS, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Mfinanga, Sayoki] Muhimbili Med Res Ctr, Natl Inst Med Res, Dar Es Salaam, Tanzania; [Marovich, Mary; Robb, Merlin L.] WRAIR, Rockville, MD USA; [Marovich, Mary; Robb, Merlin L.] Henry M Jackson Fdn, Rockville, MD USA; [Moss, Bernard] NIAID, Viral Dis Lab, NIH, Bethesda, MD 20892 USA; [Gotch, Frances] Univ London Imperial Coll Sci Technol & Med, London, England; [Stoehr, Wolfgang; McCormack, Sheena] UCL, MRC, Clin Trials Unit, London, England; [Stout, Richard] Bioject Med Technol, Tigard, OR USA	Muhimbili University of Health & Allied Sciences; Karolinska Institutet; University of Munich; German Center for Infection Research; Public Health Agency of Sweden; Karolinska Institutet; Karolinska Institutet; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; National Institute of Medical Research; Walter Reed Army Institute of Research (WRAIR); Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Imperial College London; Medical Research Council Clinical Trials Unit; University of London; University College London	Munseri, PJ (corresponding author), MUHAS, Dept Internal Med, Dar Es Salaam, Tanzania.	pmunseri@yahoo.com	Hoelscher, Michael/D-3436-2012	Moss, Bernard/0000-0002-2154-8564; Stohr, Wolfgang/0000-0002-6533-2888; Moshiro, Candida/0000-0001-7606-2361; Mann, Philipp/0000-0001-8130-2032	European and Developing Countries Clinical Trials Partnership (EDCTP) [CT.2006.33111.007]; Swedish International Development Cooperation Agency (Sida), in Tanzania; Regional HIV/AIDS Team for Africa at the Embassy of Sweden in Lusaka; German Ministry of Education and Research (BMBF), The Division of Intramural Research, NIAID; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. [W81XWH-07-2-0067]; U.S. Department of Defense (DOD) [W81XWH-07-2-0067]; MRC [MC_U122861400] Funding Source: UKRI; Medical Research Council [MC_U122861400, MC_UU_12023/23] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000416] Funding Source: NIH RePORTER	European and Developing Countries Clinical Trials Partnership (EDCTP); Swedish International Development Cooperation Agency (Sida), in Tanzania; Regional HIV/AIDS Team for Africa at the Embassy of Sweden in Lusaka; German Ministry of Education and Research (BMBF), The Division of Intramural Research, NIAID; Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.; U.S. Department of Defense (DOD)(United States Department of Defense); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work has been supported by the European and Developing Countries Clinical Trials Partnership (EDCTP) Grant CT.2006.33111.007, the Swedish International Development Cooperation Agency (Sida), in Tanzania and the Regional HIV/AIDS Team for Africa at the Embassy of Sweden in Lusaka jointly funded by Sweden and Norway, the German Ministry of Education and Research (BMBF), The Division of Intramural Research, NIAID, and by a cooperative agreement (W81XWH-07-2-0067) between the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., and the U.S. Department of Defense (DOD). The views expressed are those of the authors and should not be construed to represent the positions of the U.S. Army or the DOD. None of these organizations had any influence in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, 2013 UNAIDS REP GLOB; Bakari M, 2011, VACCINE, V29, P8417, DOI 10.1016/j.vaccine.2011.08.001; Barouch DH, 2012, NATURE, V482, P89, DOI 10.1038/nature10766; Brave A, 2005, MOL THER, V12, P1197, DOI 10.1016/j.ymthe.2005.06.473; Brave A, 2006, VACCINE, V24, P4524, DOI 10.1016/j.vaccine.2005.08.018; Cicconi Paola, 2013, J Int AIDS Soc, V16, P18591, DOI 10.7448/IAS.16.1.18591; Currier JR, 2002, J IMMUNOL METHODS, V260, P157, DOI 10.1016/S0022-1759(01)00535-X; DAIDS, 2004, DIV AIDS TABL GRAD S; Earl PL, 2009, VACCINE, V27, P5885, DOI 10.1016/j.vaccine.2009.07.039; Eller LA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003919; Excler JL, 2013, CURR OPIN HIV AIDS, V8, P421, DOI 10.1097/COH.0b013e3283632c26; Fauci AS, 2014, CLIN INFECT DIS, V59, pS80, DOI 10.1093/cid/ciu420; Fauci AS, 2014, NEW ENGL J MED, V370, P495, DOI 10.1056/NEJMp1313771; Freel SA, 2011, IMMUNOL RES, V49, P135, DOI 10.1007/s12026-010-8177-7; Goepfert PA, 2011, J INFECT DIS, V203, P610, DOI 10.1093/infdis/jiq105; Haddy TB, 1999, J LAB CLIN MED, V133, P15, DOI 10.1053/lc.1999.v133.a94931; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Joint United Nations Programme on HIV/AIDS, 2014, FAST TRACK ENDING AI; Karim QA, 2010, SCIENCE, V329, P1168, DOI 10.1126/science.1193748; Kibaya RS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003327; Kim JH, 2010, CURR OPIN HIV AIDS, V5, P428, DOI 10.1097/COH.0b013e32833d17ac; Lai LL, 2011, J INFECT DIS, V204, P164, DOI 10.1093/infdis/jir199; Letvin NL, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002351; Mehendale S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055831; Nilsson C, 2014, AIDS RES HUM RETROV, V30, P299, DOI [10.1089/aid.2013.0149, 10.1089/AID.2013.0149]; O'Connell RJ, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a007351; Ratto-Kim S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045840; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; Saunders KO, 2012, AIDS, V26, P1293, DOI 10.1097/QAD.0b013e32835474d2; Soghoian DZ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003165; Vermund SH, 2013, JAIDS-J ACQ IMM DEF, V63, pS12, DOI 10.1097/QAI.0b013e31829202a2; Walker BD, 2011, NAT MED, V17, P1194, DOI 10.1038/nm.2529	33	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119629	10.1371/journal.pone.0119629	http://dx.doi.org/10.1371/journal.pone.0119629			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875843	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800007
J	Norambuena, F; Hermon, K; Skrzypczyk, V; Emery, JA; Sharon, Y; Beard, A; Turchini, GM				Norambuena, Fernando; Hermon, Karen; Skrzypczyk, Vanessa; Emery, James A.; Sharon, Yoni; Beard, Alastair; Turchini, Giovanni M.			Algae in Fish Feed: Performances and Fatty Acid Metabolism in Juvenile Atlantic Salmon	PLOS ONE			English	Article							TILAPIA OREOCHROMIS-NILOTICUS; ULVA MEAL SUPPLEMENTATION; BODY-COMPOSITION; RAINBOW-TROUT; NILE TILAPIA; AMINO-ACID; GROWTH-PERFORMANCE; LIPID-METABOLISM; EDIBLE SEAWEED; DIETARY FIBER	Algae are at the base of the aquatic food chain, producing the food resources that fish are adapted to consume. Previous studies have proven that the inclusion of small amounts (<10% of the diet) of algae in fish feed (aquafeed) resulted in positive effects in growth performance and feed utilisation efficiency. Marine algae have also been shown to possess functional activities, helping in the mediation of lipid metabolism, and therefore are increasingly studied in human and animal nutrition. The aim of this study was to assess the potentials of two commercially available algae derived products (dry algae meal), Verdemin (derived from Ulva ohnoi) and Rosamin (derived from diatom Entomoneis spp.) for their possible inclusion into diet of Atlantic Salmon (Salmo salar). Fish performances, feed efficiency, lipid metabolism and final product quality were assessed to investigated the potential of the two algae products (in isolation at two inclusion levels, 2.5% and 5%, or in combination), in experimental diets specifically formulated with low fish meal and fish oil content. The results indicate that inclusion of algae product Verdemin and Rosamin at level of 2.5 and 5.0% did not cause any major positive, nor negative, effect in Atlantic Salmon growth and feed efficiency. An increase in the omega-3 long-chain polyunsaturated fatty acid (n-3 LC-PUFA) content in whole body of fish fed 5% Rosamin was observed.	[Norambuena, Fernando; Hermon, Karen; Skrzypczyk, Vanessa; Emery, James A.; Turchini, Giovanni M.] Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia; [Sharon, Yoni; Beard, Alastair] MBD Energy Ltd, Melbourne, Vic, Australia	Deakin University	Norambuena, F (corresponding author), Deakin Univ, Sch Life & Environm Sci, Warrnambool, Vic, Australia.	f.norambuena@deakin.edu.au		Turchini, Giovanni/0000-0003-0694-4283	MBD energy; MBD Energy Ltd.	MBD energy; MBD Energy Ltd.	This project was funded by MBD energy, whose products are featured in this study; their support was greatly appreciated. Co-authors Yoni Sharon and Alastair Beard are employed by MBD Energy Ltd. MBD Energy Ltd. provided support in the form of salaries for authors YS and AB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Airanthi MKWA, 2011, J AGR FOOD CHEM, V59, P4156, DOI 10.1021/jf104643b; Aki T, 2014, LIPIDS, V49, P133, DOI 10.1007/s11745-013-3856-5; AOAC, 2005, AN FEED OFF METH AN, P52; ATKINSON JL, 1984, CAN J FISH AQUAT SCI, V41, P1384, DOI 10.1139/f84-170; Azaza MS, 2008, J APPL ICHTHYOL, V24, P202, DOI 10.1111/j.1439-0426.2007.01017.x; Cyrus MD, 2014, AQUAC NUTR, P1; D'Orazio N, 2012, MAR DRUGS, V10, P604, DOI 10.3390/md10030604; Dawczynski C, 2007, FOOD CHEM, V103, P891, DOI 10.1016/j.foodchem.2006.09.041; de Oliveira MN, 2009, FOOD CHEM, V115, P254, DOI 10.1016/j.foodchem.2008.12.004; Diler I., 2007, J BIOL SCI, V7, P305, DOI [10.3923/jbs.2007.305.308, DOI 10.3923/JBS.2007.305.308]; Ergun S, 2009, AQUACULT INT, V17, P355, DOI 10.1007/s10499-008-9207-5; Fleurence J, 1999, TRENDS FOOD SCI TECH, V10, P25, DOI 10.1016/S0924-2244(99)00015-1; FOLCH J, 1957, J BIOL CHEM, V226, P497; Francis DS, 2007, J AGR FOOD CHEM, V55, P1582, DOI 10.1021/jf062153x; Francis DS, 2006, AQUACULTURE, V253, P547, DOI 10.1016/j.aquaculture.2005.08.008; Grammes F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083213; Guroy B, 2012, AQUAC INT, P1; Guroy BK, 2007, TURK J VET ANIM SCI, V31, P91; Guroy D, 2011, J ANIM PHYSIOL AN N, V95, P320, DOI 10.1111/j.1439-0396.2010.01057.x; HASHIM R, 1992, AQUACULTURE, V108, P299, DOI 10.1016/0044-8486(92)90114-Z; Hidalgo MC, 1999, AQUACULTURE, V170, P267, DOI 10.1016/S0044-8486(98)00413-X; Jones AC, 2014, FISH FISH, P1; Kim SK, 2011, ADV FOOD NUTR RES, V64, P191, DOI 10.1016/B978-0-12-387669-0.00014-4; Li P, 2009, AMINO ACIDS, V37, P43, DOI 10.1007/s00726-008-0171-1; Maeda H, 2005, BIOCHEM BIOPH RES CO, V332, P392, DOI 10.1016/j.bbrc.2005.05.002; MONTGOMERY WL, 1980, ENVIRON BIOL FISH, V5, P143, DOI 10.1007/BF02391621; Mustafa MG, 1995, ISR J AQUACULT-BAMID, V47, P155; NAKAGAWA H, 1987, AQUACULTURE, V62, P109, DOI 10.1016/0044-8486(87)90315-2; Nakagawa H, 1997, BIOMED PHARMACOTHER, V51, P345, DOI 10.1016/S0753-3322(97)88053-5; Nakagawa Heisuke, 1993, Asian Fisheries Science, V6, P139; Norambuena F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081705; Ortiz J, 2006, FOOD CHEM, V99, P98, DOI 10.1016/j.foodchem.2005.07.027; Peng J, 2011, MAR DRUGS, V9, P1806, DOI 10.3390/md9101806; ROSELL KG, 1985, J PHYCOL, V21, P304, DOI 10.1111/j.0022-3646.1985.00304.x; SATOH K, 1987, NIPPON SUISAN GAKK, V53, P1115; Shpigel M, 1999, J SHELLFISH RES, V18, P227; STANLEY JG, 1976, AQUACULTURE, V7, P219, DOI 10.1016/0044-8486(76)90140-X; Tacon AGJ, 2008, AQUACULTURE, V285, P146, DOI 10.1016/j.aquaculture.2008.08.015; Tsukui T, 2007, J AGR FOOD CHEM, V55, P5025, DOI 10.1021/jf070110q; Turchini GM, 2007, LIPIDS, V42, P1065, DOI 10.1007/s11745-007-3105-x; Turchini GM, 2009, REV AQUACULT, V1, P10, DOI 10.1111/j.1753-5131.2008.01001.x; Turchini GM, 2009, BRIT J NUTR, V102, P69, DOI 10.1017/S0007114508137874; Valente LMP, 2006, AQUACULTURE, V252, P85, DOI 10.1016/j.aquaculture.2005.11.052; Wahbeh MI, 1997, AQUACULTURE, V159, P101, DOI 10.1016/S0044-8486(97)00183-X; Wassef E.A., 2005, EGYPT J AQUAT RES, V31, P321; Wilke T, 2014, EUR J LIPID SCI TECH, P1; Yildirim O, 2009, KAFKAS UNIV VET FAK, V15, P455; Yuan YV, 2006, FOOD CHEM TOXICOL, V44, P1144, DOI 10.1016/j.fct.2006.02.002	48	88	90	4	93	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124042	10.1371/journal.pone.0124042	http://dx.doi.org/10.1371/journal.pone.0124042			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875839	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800129
J	Andrew, EVW; Pell, C; Angwin, A; Auwun, A; Daniels, J; Mueller, I; Phuanukoonnon, S; Pool, R				Andrew, Erin V. W.; Pell, Christopher; Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat; Pool, Robert			Knowledge, Attitudes, and Practices Concerning Malaria in Pregnancy: Results from a Qualitative Study in Madang, Papua New Guinea	PLOS ONE			English	Article							EAST SEPIK PROVINCE; MUKONO DISTRICT; VACCINE TRIALS; ANTENATAL CARE; VIVAX MALARIA; WOSERA AREA; RURAL WOMEN; EPIDEMIOLOGY; HEALTH; PERCEPTIONS	Background Malaria is the leading cause of illness and death in Papua New Guinea (PNG). Infection during pregnancy with falciparum or vivax malaria, as occurs in PNG, has health implications for mother and child, causing complications such as maternal anemia, low birth weight and miscarriage. This article explores knowledge, attitudes and practices concerning malaria during pregnancy and it's prevention in Madang, PNG, a high prevalence area. Methods As part of a qualitative study in Madang, exploring MiP, participatory techniques (free-listing and sorting) were conducted along with focus group discussions, in-depth interviews (with pregnant women, health staff and other community members) and observations in the local community and health facilities. Results The main themes explored were attitudes towards and knowledge of MiP, its risks, and prevention. Although there was a general awareness of the term "malaria", it was often conflated with general sickness or with pregnancy-related symptoms. Moreover, many preventive methods for MiP were related to practices of general healthy living. Indeed, varied messages from health staff about the risks of MiP were observed. In addition to ideas about the seriousness and risk of MiP, other factors influenced the uptake of interventions: availability and perceived comfort of sleeping under insecticide-treated mosquito nets were important determinants of usage, and women's heavy workload influenced Chloroquine adherence. Conclusion The non-specific symptoms of MiP and its resultant conflation with symptoms of pregnancy that are perceived as normal have implications for MiP prevention and control. However, in Madang, PNG, this was compounded by the inadequacy of health staff's message about MiP.	[Andrew, Erin V. W.; Pell, Christopher; Mueller, Ivo; Pool, Robert] Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain; [Andrew, Erin V. W.] San Francisco Dept Publ Hlth, Bridge HIV, San Francisco, CA USA; [Pell, Christopher; Pool, Robert] Univ Amsterdam, Ctr Social Sci & Global Hlth, Amsterdam, Netherlands; [Angwin, Angeline; Auwun, Alma; Daniels, Job; Mueller, Ivo; Phuanukoonnon, Suparat] Papua New Guinea Inst Med Res, Madang, Papua N Guinea; [Mueller, Ivo] Walter & Eliza Hall Inst Med Res, Infect & Immun Div, Parkville, Vic, Australia	ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; San Francisco Department of Public Health; University of Amsterdam; PNG Institute Of Medical Research; Walter & Eliza Hall Institute	Andrew, EVW (corresponding author), Univ Barcelona, Hosp Clin, CRESIB, Barcelona Ctr Int Hlth Res, Barcelona, Spain.	erinvwandrew@gmail.com		Pell, Christopher/0000-0001-9405-5851	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation [OPP46099]	Malaria in Pregnancy (MiP) Consortium - Bill and Melinda Gates Foundation	This research was supported and endorsed by the Malaria in Pregnancy (MiP) Consortium, which is funded by a grant from the Bill and Melinda Gates Foundation (www.gatesfoundation.org), Grant OPP46099. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins AD, 2005, BMJ-BRIT MED J, V331, P737, DOI 10.1136/bmj.331.7519.737; Allen SJ, 1998, ARCH DIS CHILD-FETAL, V79, pF135, DOI 10.1136/fn.79.2.F135; [Anonymous], 2009, WHO WORLD MAL REP; Anya Samuel E, 2008, BMC Pregnancy Childbirth, V8, P9, DOI 10.1186/1471-2393-8-9; Benet A, 2006, AM J TROP MED HYG, V75, P597, DOI 10.4269/ajtmh.2006.75.597; BRABIN BJ, 1990, ANN TROP MED PARASIT, V84, P1; CATTANI JA, 1986, AM J TROP MED HYG, V35, P3, DOI 10.4269/ajtmh.1986.35.3; Cochran PAL, 2008, AM J PUBLIC HEALTH, V98, P22, DOI 10.2105/AJPH.2006.093641; Davy C, 2009, PRIMARY HLTH CARE KN; Davy CP, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-268; Dellicour S, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000221; Department of Health Papua New Guinea, 2007, NAT POL TRAD MED, P17; Erhun W, 2006, AFRICAN J BIOMEDICAL, V8, P25; GENTON B, 1995, ANN TROP MED PARASIT, V89, P377, DOI 10.1080/00034983.1995.11812966; GENTON B, 1995, ANN TROP MED PARASIT, V89, P359, DOI 10.1080/00034983.1995.11812965; Government of Papua New Guinea, 2010, NAT HLTH PLAN 2011 2; Heggenhougen K, 2003, TDRSTRSEBVOL031 UNDP; Hill Z, 2007, PUBLIC HEALTH NUTR, V10, P827, DOI 10.1017/S1368980007382554; Hinton R, 2011, ASIA PAC VIEWP, V52, P178, DOI 10.1111/j.1467-8373.2011.01449.x; Hinton R, 2010, HEALTH SOCIOL REV, V19, P5, DOI 10.5172/hesr.2010.19.1.005; Hinton R, 2010, WOMEN STUD INT FORUM, V33, P180, DOI 10.1016/j.wsif.2009.12.006; Jahn A, 2000, TROP MED INT HEALTH, V5, P657, DOI 10.1046/j.1365-3156.2000.00611.x; Kazura JW, 2012, ACTA TROP, V121, P274, DOI 10.1016/j.actatropica.2011.08.002; KENGEYAKAYONDO JF, 1994, ACTA TROP, V58, P267, DOI 10.1016/0001-706X(94)90020-5; Launiala A, 2006, ACTA TROP, V98, P111, DOI 10.1016/j.actatropica.2005.12.008; Mbonye AK, 2006, J BIOSOC SCI, V38, P221, DOI 10.1017/S0021932005007108; Mbonye AK, 2006, HEALTH POLICY PLANN, V21, P17, DOI 10.1093/heapol/czj002; McGready R, 2012, LANCET INFECT DIS, V12, P388, DOI 10.1016/S1473-3099(11)70339-5; Menaca A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-257; Menendez C, 2000, J INFECT DIS, V181, P1740, DOI 10.1086/315449; Muela SH, 2002, SOC SCI MED, V55, P403; Mueller Ivo, 2008, Papua New Guinea Medical Journal, V51, P12; Muller I, 2003, TRENDS PARASITOL, V19, P253, DOI 10.1016/S1471-4922(03)00091-6; Ndyomugyenyi R, 1998, HEALTH POLICY PLANN, V13, P94, DOI 10.1093/heapol/13.1.94; Nosten F, 2004, TRENDS PARASITOL, V20, P425, DOI 10.1016/j.pt.2004.06.007; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Pell C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022452; Pell C, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-369; Pulford J, 2012, SOCIAL SCI MED; Reilley B, 2002, TROP MED INT HEALTH, V7, P744, DOI 10.1046/j.1365-3156.2002.00919.x; Rijken MJ, 2012, LANCET INFECT DIS, V12, P75, DOI 10.1016/S1473-3099(11)70315-2; Rogerson SJ, 2007, LANCET INFECT DIS, V7, P105, DOI 10.1016/S1473-3099(07)70022-1; Schlagenhauf P, 2011, MALARIA J, V10; Shulman CE, 1999, LANCET, V353, P632, DOI 10.1016/S0140-6736(98)07318-8; Strauss A, 1997, GROUNDED THEORY PRAC; Telfer Michelle L, 2002, Afr J Reprod Health, V6, P74, DOI 10.2307/3583148; Villar J, 2001, LANCET, V357, P1551, DOI 10.1016/S0140-6736(00)04722-X; Welsch RL, 1983, ANTHR MED CULTURE ME, P32; Winch PJ, 1996, SOC SCI MED, V42, P1057, DOI 10.1016/0277-9536(95)00293-6; Wood J W, 1985, J Biosoc Sci Suppl, V9, P159; World Health Organization, 2002, ANT CAR RAND TRIAL M; World Health Organization, 2005, WHO PAP NEW GUIN COU	52	16	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119077	10.1371/journal.pone.0119077	http://dx.doi.org/10.1371/journal.pone.0119077			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893405	Green Published, gold			2022-12-27	WOS:000353211700001
J	Ghouri, N; Purves, D; Deans, KA; Logan, G; McConnachie, A; Wilson, J; Gill, JMR; Sattar, N				Ghouri, Nazim; Purves, David; Deans, Kevin A.; Logan, Greig; McConnachie, Alex; Wilson, John; Gill, Jason M. R.; Sattar, Naveed			An Investigation of Two-Dimensional Ultrasound Carotid Plaque Presence and Intima Media Thickness in Middle-Aged South Asian and European Men Living in the United Kingdom	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; INCREASED INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; RISK-FACTORS; MYOCARDIAL-INFARCTION; VASCULAR-DISEASE; FOLLOW-UP; ATHEROSCLEROSIS; UK	Objectives Ultrasound studies of carotid intima media thickness (cIMT) and plaques are limited in South Asians, a group at elevated cardiovascular disease (CVD) risk. We determined whether South Asians have a difference in these ultrasound markers compared to Europeans living in the United Kingdom and whether measured risk factor(s) could account for any such differences. Methods One hundred South Asian men, aged 40 to 70 years and 100 European men of similar age and BMI, without diagnosed CVD or diabetes, underwent carotid ultrasound for measurement of cIMT and carotid plaque presence. Physical activity, cardiorespiratory fitness, anthropometry and blood pressure were assessed, fasted blood taken for measurement of cardiometabolic risk factors and demographic and lifestyle factors recorded. Results Age-adjusted mean (SD) cIMT was similar in South Asians and Europeans (0.64 (0.16) mm v 0.65 (0.12) mm, p = 0.64). Plaque was present in 48 South Asians and 37 Europeans and overall, there was no age-adjusted difference between South Asian and Europeans for plaque score(odds ratio 1.49, 95% CI, 0.86-2.80, p = 0.16), however, South Asians appeared to have more plaques at a younger age than Europeans; at age 40-50 years the odds of South Asians having plaques was 2.63 (95% CI, 1.16-5.93) times that for Europeans. Conclusions cIMT is similar between healthy South Asian and European men. Whilst there was no overall difference in plaque presence in South Asians, there is an indication of greater plaque prevalence at younger ages - an observation requiring further investigation. Prospective studies linking plaques to CVD outcomes in South Asians are needed to investigate whether these measures help improve CVD risk prediction.	[Ghouri, Nazim; Logan, Greig; Wilson, John; Gill, Jason M. R.; Sattar, Naveed] Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland; [Purves, David; McConnachie, Alex] Univ Glasgow, Inst Hlth & Wellbeing, Robertson Ctr Biostat, Glasgow G12 8QA, Lanark, Scotland; [Deans, Kevin A.] Aberdeen Royal Infirm, Dept Clin Biochem, Aberdeen AB25 2ZN, Scotland; [Logan, Greig] AUT Univ, Human Potential Ctr, Auckland 1142, New Zealand	University of Glasgow; University of Glasgow; University of Aberdeen; Auckland University of Technology	Ghouri, N (corresponding author), Univ Glasgow, BHF Glasgow Cardiovasc Res Ctr, Inst Cardiovasc & Med Sci, Coll Med Vet & Life Sci, Glasgow G12 8TA, Lanark, Scotland.	nazim.ghouri@glasgow.ac.uk; jason.gill@glasgow.ac.uk; naveed.sattar@glasgow.ac.uk		Sattar, Naveed/0000-0002-1604-2593; Ghouri, Noushima/0000-0002-8202-3913	Chest, Heart and Stroke Scotland	Chest, Heart and Stroke Scotland	NG was supported by a Fellowship from Chest, Heart and Stroke Scotland.	ADAMS MR, 1995, CIRCULATION, V92, P2127, DOI 10.1161/01.CIR.92.8.2127; Agyemang C, 2002, J HUM HYPERTENS, V16, P739, DOI 10.1038/sj.jhh.1001488; Anand SS, 2000, LANCET, V356, P279, DOI 10.1016/S0140-6736(00)02502-2; [Anonymous], 2006, HLTH MIN ETHN GROUPS; BALARAJAN R, 1984, BRIT MED J, V289, P1185, DOI 10.1136/bmj.289.6453.1185; Baldassarre D, 2012, J AM COLL CARDIOL, V60, P1489, DOI 10.1016/j.jacc.2012.06.034; Barnett PA, 1997, J HYPERTENS, V15, P49, DOI 10.1097/00004872-199715010-00004; Chandalia M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000812; Chaturvedi N, 2007, ATHEROSCLEROSIS, V193, P204, DOI 10.1016/j.atherosclerosis.2006.06.017; Deans KA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4170; Forouhi NG, 2006, DIABETOLOGIA, V49, P2580, DOI 10.1007/s00125-006-0393-2; Ghouri N, 2013, DIABETOLOGIA, V56, P2238, DOI 10.1007/s00125-013-2969-y; Gill JMR, 2011, DIABETES CARE, V34, P1214, DOI 10.2337/dc10-2313; Hall LML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014197; Hall LML, 2008, FUTURE LIPIDOL, V3, P411, DOI 10.2217/17460875.3.4.411; Hippisley-Cox J, 2008, BMJ-BRIT MED J, V336, P1475, DOI 10.1136/bmj.39609.449676.25; Hollander M, 2003, STROKE, V34, P2367, DOI 10.1161/01.STR.0000091393.32060.0E; Jose PO, 2014, J AM COLL CARDIOL, V64, P2486, DOI 10.1016/j.jacc.2014.08.048; Koulaouzidis G, 2013, INT J CARDIOL; Koulaouzidis G, 2012, INT J CARDIOL; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Makris GC, 2011, ATHEROSCLEROSIS, V219, P377, DOI 10.1016/j.atherosclerosis.2011.05.006; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; MCKEIGUE PM, 1993, CIRCULATION, V87, P152, DOI 10.1161/01.CIR.87.1.152; MCKEIGUE PM, 1989, J CLIN EPIDEMIOL, V42, P597, DOI 10.1016/0895-4356(89)90002-4; Mukhopadhyay B, 2006, DIABETIC MED, V23, P94, DOI 10.1111/j.1464-5491.2005.01735.x; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Ntuk UE, 2014, DIABETES CARE, V37, P2500, DOI 10.2337/dc13-2966; R Core Team RFfSCVA, 2014, R LANG ENV STAT COMP; ROMAN MJ, 1992, CIRCULATION, V86, P1909, DOI 10.1161/01.CIR.86.6.1909; Simon A, 2007, EUR HEART J, V28, P2967, DOI 10.1093/eurheartj/ehm487; Stein JH, 2008, J AM SOC ECHOCARDIOG, V21, P93, DOI 10.1016/j.echo.2007.11.011; Stein JH, 2005, J AM SOC ECHOCARDIOG, V18, P244, DOI 10.1016/j.echo.2004.12.002; Tillin T, 2008, INT J CARDIOL, V129, P406, DOI 10.1016/j.ijcard.2007.07.129; Touboul PJ, 2007, CEREBROVASC DIS, V23, P75, DOI 10.1159/000097034; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Wendelhag I, 1997, STROKE, V28, P2195, DOI 10.1161/01.STR.28.11.2195; Whincup PH, 2012, STROKE, V43, P1747, DOI 10.1161/STROKEAHA.111.644955; Wild SH, 2007, J PUBLIC HEALTH-UK, V29, P191, DOI 10.1093/pubmed/fdm010; Williams E.D., 2010, J EPIDEMIOL COMMUNIT; Yamada K, 2009, CEREBROVASC DIS, V28, P417, DOI 10.1159/000235746; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	42	8	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123317	10.1371/journal.pone.0123317	http://dx.doi.org/10.1371/journal.pone.0123317			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884221	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000353017000056
J	Gomez-Sanchez, L; Garcia-Ortiz, L; Recio-Rodriguez, JI; Patino-Alonso, MC; Agudo-Conde, C; Rigo, F; Ramos, R; Marti, R; Gomez-Marcos, MA				Gomez-Sanchez, Leticia; Garcia-Ortiz, Luis; Recio-Rodriguez, Jose I.; Patino-Alonso, Maria C.; Agudo-Conde, Cristina; Rigo, Fernando; Ramos, Rafe; Marti, Ruth; Gomez-Marcos, Manuel A.		MARK Grp	Leukocyte Subtype Counts and Its Association with Vascular Structure and Function in Adults with Intermediate Cardiovascular Risk. MARK Study	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; PULSE-WAVE VELOCITY; C-REACTIVE PROTEIN; BLOOD-CELL COUNT; MOBIL-O-GRAPH; ARTERIAL STIFFNESS; HYPERTENSIVE PATIENTS; MONOCYTE COUNT; INDEX CAVI	Objectives We investigated the relationship between leukocyte subtype counts and vascular structure and function based on carotid intima-media thickness, pulse wave velocity, central augmentation index and cardio-ankle vascular index by gender in intermediate cardiovascular risk patients. Methods This study analyzed 500 subjects who were included in the MARK study, aged 35 to 74 years (mean: 60.3 +/- 8.4), 45.6% women. Measurement: Brachial ankle Pulse Wave Velocity (ba-PWV) estimate by equation, Cardio-AnkleVascular Index (CAVI) using the VaSera device and Carotid ultrasound was used to measure carotid Intima Media Thickness (IMT). The Mobil-O-Graph was used to measure the Central Augmentation Index (CAIx). Results Total leukocyte, neutrophil and monocyte counts were positively correlated with IMT (p < 0.01) in men. Monocyte count was positively correlated with CAIx in women (p < 0.01). In a multiple linear regression analysis, the IMT mean maintained a positive association with the neutrophil count (beta = 1.500, p = 0.007) in men. CAIx maintained a positive association with the monocyte count (beta = 2.445, p = 0.022) in women. Conclusion The results of this study suggest that the relationship between subtype circulating leukocyte counts and vascular structure and function, although small, may be different by gender. In men, the neutrophil count was positively correlated with IMT and in women, the monocyte count with CAIx, in a large sample of intermediate-risk patients. These association were maintained after adjusting for age and other confounders.	[Gomez-Sanchez, Leticia; Garcia-Ortiz, Luis; Recio-Rodriguez, Jose I.; Patino-Alonso, Maria C.; Agudo-Conde, Cristina; Gomez-Marcos, Manuel A.] Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain; [Garcia-Ortiz, Luis; Recio-Rodriguez, Jose I.; Patino-Alonso, Maria C.; Agudo-Conde, Cristina; Gomez-Marcos, Manuel A.] Biomed Res Inst Salamanca IBSAL, Castilla & Leon Hlth Serv SACyL, Salamanca, Spain; [Garcia-Ortiz, Luis; Gomez-Marcos, Manuel A.] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain; [Patino-Alonso, Maria C.] Univ Salamanca, Dept Stat, E-37008 Salamanca, Spain; [Rigo, Fernando] Isles Baleares Hlth Serv IBSALUT, San Agustin Hlth Ctr, Palma De Mallorca, Spain; [Ramos, Rafe; Marti, Ruth] Jordi Gol Inst Primary Care Res IDIAP Jordi Gol, Res Unit Family Med, Girona, Spain; [Ramos, Rafe] Univ Girona, Sch Med, Dept Med Sci, Translab Res Grp, Girona, Spain; [Ramos, Rafe; Marti, Ruth] Dr Trueta Univ Hosp, Girona Biomed Res Inst IDIBGI, Girona, Spain; [MARK Grp] Res Network Prevent Act & Hlth Promot RedIAPP, MARK Grp, Girona, Spain	University of Salamanca; University of Salamanca; Atencio Primaria de Mallorca; Universitat de Girona; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI)	Gomez-Marcos, MA (corresponding author), Alamedilla Hlth Ctr, Primary Care Res Unit, Salamanca, Spain.	magomez@usal.es	Patino-Alonso, Carmen/I-4608-2014; Recio-Rodriguez, Jose I/AAA-8588-2020; Ramos, Rafel/D-9627-2016; Martí, Ruth/H-8198-2014; Ramos, Rafel/P-2083-2019; Rodríguez-Sánchez, Emiliano/N-5582-2014; Stefanadis, Christodoulos/ABH-2232-2020; Maderuelo-Fernandez, Jose-Angel/R-8868-2018	Patino-Alonso, Carmen/0000-0001-8232-6685; Ramos, Rafel/0000-0001-7970-5537; Martí, Ruth/0000-0002-7320-9521; Ramos, Rafel/0000-0001-7970-5537; Rodríguez-Sánchez, Emiliano/0000-0003-3667-7155; Stefanadis, Christodoulos/0000-0001-5974-6454; Garcia-Ortiz, Luis/0000-0001-6555-8302; Maderuelo-Fernandez, Jose-Angel/0000-0001-7544-8684; Quesada Sabate, Miquel/0000-0002-0469-3866; Pages Cadena, Nuria/0000-0002-7424-752X; Recio-Rodriguez, Jose I/0000-0002-3772-8746; Gomez-Marcos, Manuel A/0000-0003-0133-6123; Parramon, Didac/0000-0001-6833-7345; DE CABO-LASO, ANGELA/0000-0003-1449-282X	Spanish Ministry of Science and Innovation (MICINN); Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) (Red RedIAPP) [RD06/0018, RD06/0018/2009, RD06/0018/0045, RD06/0018/0027]; Health Research Fund(FIS) [PI10/01088, PI10/02077, PI10/02043]; Regional Health Management of the Castilla and Leon [GRS 635/A/11]	Spanish Ministry of Science and Innovation (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) (Red RedIAPP); Health Research Fund(FIS)(Instituto de Salud Carlos III); Regional Health Management of the Castilla and Leon	This work was supported by grants funded by the Spanish Ministry of Science and Innovation (MICINN) and Carlos III Health Institute/European Regional Development Fund (ERDF) (MICINN, ISCIII/FEDER) (Red RedIAPP RD06/0018, Research Groups: RD06/0018/2009, RD06/0018/0045/RD06/0018/0027) and by the Health Research Fund(FIS PI10/01088, PI10/02077, PI10/02043) and Regional Health Management of the Castilla and Leon(GRS 635/A/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anoop S, 2014, J DIABETES COMPLICAT; Chapman CML, 2004, STROKE, V35, P1619, DOI 10.1161/01.STR.0000130857.19423.ad; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Franssen PML, 2010, BLOOD PRESS MONIT, V15, P229, DOI 10.1097/MBP.0b013e328339be38; Gomez-Marcos MA, 2012, BMC CARDIOVASC DISOR, V12, DOI 10.1186/1471-2261-12-37; Gomez-Marcos MA, 2012, AM J HYPERTENS, V25, P955, DOI 10.1038/ajh.2012.72; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Johnsen SH, 2005, STROKE, V36, P715, DOI 10.1161/01.STR.0000158909.07634.83; Kavousi M, 2012, ANN INTERN MED, V156, P438, DOI 10.7326/0003-4819-156-6-201203200-00006; Kawai T, 2013, J ATHEROSCLER THROMB, V20, P391, DOI 10.5551/jat.15040; Korkmaz L, 2012, ANATOL J CARDIOL, V12, P102, DOI 10.5152/akd.2012.034; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Kuo Wen-Kai, 2012, Acta Neurol Taiwan, V21, P158; Lau KK, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-101; Laurent S, 2006, EUR HEART J, V27, P2588, DOI 10.1093/eurheartj/ehl254; Li CR, 2010, ATHEROSCLEROSIS, V209, P545, DOI 10.1016/j.atherosclerosis.2009.09.029; Loimaala A, 2006, ATHEROSCLEROSIS, V188, P363, DOI 10.1016/j.atherosclerosis.2005.11.021; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Marlatt KL, 2013, J CLIN ULTRASOUND, V41, P340, DOI 10.1002/jcu.22015; Marrugat J, 2003, J EPIDEMIOL COMMUN H, V57, P634, DOI 10.1136/jech.57.8.634; Marti R, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-61; Matsumura T, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-177; Mattace-Raso FUS, 2006, CIRCULATION, V113, P657, DOI 10.1161/CIRCULATIONAHA.105.555235; McEniery CM, 2010, HYPERTENSION, V56, P591, DOI 10.1161/HYPERTENSIONAHA.110.156950; McEniery CM, 2005, J AM COLL CARDIOL, V46, P1753, DOI 10.1016/j.jacc.2005.07.037; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Nozawa N, 2010, CIRC J, V74, P1384, DOI 10.1253/circj.CJ-09-0779; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Ortega E, 2012, ATHEROSCLEROSIS, V221, P275, DOI 10.1016/j.atherosclerosis.2011.12.038; Phillips AC, 2012, J HUM HYPERTENS, V26, P485, DOI 10.1038/jhh.2011.58; Protogerou AD, 2012, AM J HYPERTENS, V25, P876, DOI 10.1038/ajh.2012.63; Rossi P, 2011, J HYPERTENS, V29, P1023, DOI 10.1097/HJH.0b013e328344da5e; Sekitani Y, 2010, BIOMARKERS, V15, P454, DOI 10.3109/1354750X.2010.486870; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101, DOI 10.5551/jat.13.101; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P924; Shirai K, 2011, J ATHEROSCLER THROMB, V18, P49, DOI 10.5551/jat.3582; Soehnlein O, 2012, CIRC RES, V110, P875, DOI 10.1161/CIRCRESAHA.111.257535; Takaki A, 2008, HYPERTENS RES, V31, P1347, DOI 10.1291/hypres.31.1347; Takaki A, 2007, CIRC J, V71, P1710, DOI 10.1253/circj.71.1710; Tuttolomondo A, 2012, CURR PHARM DESIGN, V18, P4266, DOI 10.2174/138161212802481237; Vermeersch SJ, 2008, J HYPERTENS, V26, P1411, DOI 10.1097/HJH.0b013e3282ffac00; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Wassertheurer S, 2010, J HUM HYPERTENS, V24, P498, DOI 10.1038/jhh.2010.27; Weiss W, 2012, BLOOD PRESS MONIT, V17, P128, DOI 10.1097/MBP.0b013e328353ff63; Weiss W, 2010, BLOOD PRESS MONIT, V15, P225, DOI 10.1097/MBP.0b013e328338892f; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; Yasmin, 1999, QJM-INT J MED, V92, P595, DOI 10.1093/qjmed/92.10.595; Yeboah J, 2012, JAMA-J AM MED ASSOC, V308, P788, DOI 10.1001/jama.2012.9624; Zhang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014525; Zhu JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046551	51	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119963	10.1371/journal.pone.0119963	http://dx.doi.org/10.1371/journal.pone.0119963			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885665	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000007
J	Kim, H; Song, KD; Kim, HJ; Park, W; Kim, J; Lee, T; Shin, DH; Kwak, W; Kwon, YJ; Sung, S; Moon, S; Lee, KT; Kim, N; Hong, JK; Eo, KY; Seo, KS; Kim, G; Park, S; Yun, CH; Kim, H; Choi, K; Kim, J; Lee, WK; Kim, DK; Oh, JD; Kim, ES; Ch, S; Lee, HK; Kim, TH; Kim, H				Kim, Hyeongmin; Song, Ki Duk; Kim, Hyeon Jeong; Park, WonCheoul; Kim, Jaemin; Lee, Taeheon; Shin, Dong-Hyun; Kwak, Woori; Kwon, Young-jun; Sung, Samsun; Moon, Sunjin; Lee, Kyung-Tai; Kim, Namshin; Hong, Joon Ki; Eo, Kyung Yeon; Seo, Kang Seok; Kim, Girak; Park, Sungmoo; Yun, Cheol-Heui; Kim, Hyunil; Choi, Kimyung; Kim, Jiho; Lee, Woon Kyu; Kim, Duk-Kyung; Oh, Jae-Don; Kim, Eui-Soo; Ch, Seoae; Lee, Hak-Kyo; Kim, Tae-Hun; Kim, Heebal			Exploring the Genetic Signature of Body Size in Yucatan Miniature Pig	PLOS ONE			English	Article							RECENT POSITIVE SELECTION; GENOME; LECTIN; BETA; ASSOCIATIONS; FRAMEWORK; FORMAT; SWEEPS; DUROC; SWINE	Since being domesticated about 10,000-12,000 years ago, domestic pigs (Sus scrofa domesticus) have been selected for traits of economic importance, in particular large body size. However, Yucatan miniature pigs have been selected for small body size to withstand high temperature environment and for laboratory use. This renders the Yucatan miniature pig a valuable model for understanding the evolution of body size. We investigate the genetic signature for selection of body size in the Yucatan miniature pig. Phylogenetic distance of Yucatan miniature pig was compared to other large swine breeds (Yorkshire, Landrace, Duroc and wild boar). By estimating the XP-EHH statistic using re-sequencing data derived from 70 pigs, we were able to unravel the signatures of selection of body size. We found that both selections at the level of organism, and at the cellular level have occurred. Selection at the higher levels include feed intake, regulation of body weight and increase in mass while selection at the molecular level includes cell cycle and cell proliferation. Positively selected genes probed by XP-EHH may provide insight into the docile character and innate immunity as well as body size of Yucatan miniature pig.	[Kim, Hyeongmin; Park, WonCheoul; Lee, Taeheon; Shin, Dong-Hyun; Moon, Sunjin; Kim, Girak; Park, Sungmoo; Yun, Cheol-Heui; Kim, Heebal] Seoul Natl Univ, Dept Agr Biotechnol, Anim Biotechnol Major, Seoul 151921, South Korea; [Kim, Hyeongmin; Park, WonCheoul; Lee, Taeheon; Shin, Dong-Hyun; Moon, Sunjin; Kim, Girak; Park, Sungmoo; Yun, Cheol-Heui; Kim, Heebal] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Song, Ki Duk; Kim, Duk-Kyung; Oh, Jae-Don; Lee, Hak-Kyo] Hankyong Natl Univ, Genom Informat Ctr, Ansong 456749, South Korea; [Kim, Hyeon Jeong; Sung, Samsun; Ch, Seoae; Kim, Heebal] Seoul Natl Univ, CHO & KIM Genom, Seoul 151919, South Korea; [Kim, Jaemin; Kwak, Woori; Kwon, Young-jun] Seoul Natl Univ, Interdisciplinary Program Bioinformat, Seoul 151742, South Korea; [Lee, Kyung-Tai; Kim, Tae-Hun] Natl Inst Anim Sci, RDA, Suwon 441706, South Korea; [Kim, Namshin] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon 305806, South Korea; [Hong, Joon Ki] Natl Inst Anim Sci, RDA, Swine Sci Div, Cheonan 331801, South Korea; [Eo, Kyung Yeon] Seoul Zoo, Anim Res Div, Seoul 427702, South Korea; [Seo, Kang Seok] Sunchon Natl Univ, Dept Anim Sci & Technol, Coll Life Sci & Nat Resources, Sunchon 540950, South Korea; [Kim, Hyunil; Choi, Kimyung; Kim, Jiho] Optipharm Inc, Chengwon Gun 363954, Chungcheongbuk, South Korea; [Lee, Woon Kyu] Inha Univ, Coll Med, Lab Dev Genet, Inchon 400103, South Korea; [Kim, Eui-Soo] Iowa State Univ, Dept Anim Sci, Ames, IA 50011 USA	Seoul National University (SNU); Seoul National University (SNU); Hankyong National University; Seoul National University (SNU); Seoul National University (SNU); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Korea Research Institute of Bioscience & Biotechnology (KRIBB); National Institute of Animal Science, Republic of Korea; Rural Development Administration (RDA), Republic of Korea; Sunchon National University; Inha University; Iowa State University	Lee, HK (corresponding author), Hankyong Natl Univ, Genom Informat Ctr, Ansong 456749, South Korea.	breedlee@empas.com; thkim63@korea.kr; heebal@snu.ac.kr	Kim, Heebal/A-8889-2016; YUN, Cheol-Heui/AAR-2775-2020; Kim, Namshin/Q-6491-2017; Sung, Samsun/AAP-1325-2020	Kim, Heebal/0000-0003-3064-1303; YUN, Cheol-Heui/0000-0002-0041-2887; Kim, Namshin/0000-0001-6361-274X; KIM, Girak/0000-0003-2613-1140; Park, WonCheoul/0000-0003-3140-5628; Moon, Sunjin/0000-0002-3803-6354	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea [PJ01104401, PJ01110901, PJ00811602]; Optipharm, Inc	Next-Generation BioGreen 21 Program, Rural Development Administration, Republic of Korea; Optipharm, Inc	This work was supported by a grant from the Next-Generation BioGreen 21 Program [No. PJ01104401, PJ01110901 and PJ00811602], Rural Development Administration, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Optipharm, Inc provided support in the form of salaries for authors [Hyunil Kim, KC and Jiho Kim], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adachi Y, 2004, INFECT IMMUN, V72, P4159, DOI 10.1128/IAI.72.7.4159-4171.2004; Alterovitz G., 2011, KNOWL BAS BIOINF AN; Andersson L, 2012, J INTERN MED, V271, P1, DOI 10.1111/j.1365-2796.2011.02450.x; [Anonymous], 1991, MICROLIVESTOCK LITTL; Barbosa MTP, 2007, FASEB J, V21, P3629, DOI 10.1096/fj.07-8290com; Browning BL, 2009, AM J HUM GENET, V85, P847, DOI 10.1016/j.ajhg.2009.11.004; Chakrama FZ, 2010, AUTOPHAGY, V6, P495, DOI 10.4161/auto.6.4.11819; CROW J F, 1970, P591, DOI 10.1093/bioinformatics/btr330; Delneste Y, 2002, IMMUNITY, V17, P353, DOI 10.1016/S1074-7613(02)00388-6; Deng CJ, 2010, GENET MOL BIOL, V33, P266, DOI 10.1590/S1415-47572010005000034; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Fan B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014726; Fang XD, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-16; Galione A, 2000, SCI STKE, V2000, ppe1; Granka JM, 2012, GENETICS, V192, P1049, DOI 10.1534/genetics.112.144071; HAENSLY WE, 1968, J GERONTOL, V23, P53, DOI 10.1093/geronj/23.1.53; Hayashida K, 2002, FEBS LETT, V511, P133, DOI 10.1016/S0014-5793(01)03297-5; Hogan A, 2004, J BIOL CHEM, V279, P53717, DOI 10.1074/jbc.M410654200; HORTON GMJ, 1991, CAN J ANIM SCI, V71, P607, DOI 10.4141/cjas91-075; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Kim TH, 2005, J ANIM SCI, V83, P2255; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Lawrence DA, 1996, EUR CYTOKINE NETW, V7, P363; Lee H-J, 2014, GENOME BIOL EVOLUTIO, pevu102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Li H, 2010, BIOINFORMATICS, V26, P589, DOI 10.1093/bioinformatics/btp698; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Maglott D, 2011, NUCLEIC ACIDS RES, V39, pD52, DOI 10.1093/nar/gkq1237; Magowan E, 2009, EFFECT SIRE LINE BRE, P1; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miah SMS, 2004, GENES CELLS, V9, P993, DOI 10.1111/j.1365-2443.2004.00784.x; PANEPINTO LM, 1986, LAB ANIM SCI, V36, P344; Pickrell JK, 2009, GENOME RES, V19, P826, DOI 10.1101/gr.087577.108; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Pritchard JK, 2000, GENETICS, V155, P945; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rambaut A, 2012, FIGTREE; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Smith DM, 2005, XENOTRANSPLANTATION, V12, P481, DOI 10.1111/j.1399-3089.2005.00252.x; Smith JM, 2007, GENET RES, V89, P391, DOI [10.1017/S0016672308009579, 10.1017/S0016672300014634]; Sola-Oriol D, 2009, J ANIM SCI, V87, P562, DOI 10.2527/jas.2008-0949; Sutter NB, 2007, SCIENCE, V316, P112, DOI 10.1126/science.1137045; Suzuki K, 2005, J ANIM SCI, V83, P2058; Suzuki K, 2003, MEAT SCI, V64, P35, DOI 10.1016/S0309-1740(02)00134-1; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Tsuji S, 2001, J BIOL CHEM, V276, P23456, DOI 10.1074/jbc.M103162200; van Heemst D, 2005, AGING CELL, V4, P79, DOI 10.1111/j.1474-9728.2005.00148.x; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Walsh S, 2007, J APPL PHYSIOL, V102, P2142, DOI 10.1152/japplphysiol.01322.2006; Wang J, 1999, ENDOCRINOLOGY, V140, P3391, DOI 10.1210/en.140.7.3391; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X	55	26	26	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121732	10.1371/journal.pone.0121732	http://dx.doi.org/10.1371/journal.pone.0121732			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885114	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000023
J	Palayret, M; Armes, H; Basu, S; Watson, AT; Herbert, A; Lando, D; Etheridge, TJ; Endesfelder, U; Heilemann, M; Laue, E; Carr, AM; Klenerman, D; Lee, SF				Palayret, Matthieu; Armes, Helen; Basu, Srinjan; Watson, Adam T.; Herbert, Alex; Lando, David; Etheridge, Thomas J.; Endesfelder, Ulrike; Heilemann, Mike; Laue, Ernest; Carr, Antony M.; Klenerman, David; Lee, Steven F.			Virtual-'Light-Sheet' Single-Molecule Localisation Microscopy Enables Quantitative Optical Sectioning for Super-Resolution Imaging	PLOS ONE			English	Article							FLUORESCENCE MICROSCOPY; DIFFRACTION-LIMIT	Single-molecule super-resolution microscopy allows imaging of fluorescently-tagged proteins in live cells with a precision well below that of the diffraction limit. Here, we demonstrate 3D sectioning with single-molecule super-resolution microscopy by making use of the fitting information that is usually discarded to reject fluorophores that emit from above or below a virtual-'light-sheet', a thin volume centred on the focal plane of the microscope. We describe an easy-to-use routine (implemented as an open-source ImageJ plug-in) to quickly analyse a calibration sample to define and use such a virtual light-sheet. In addition, the plug-in is easily usable on almost any existing 2D super-resolution instrumentation. This optical sectioning of super-resolution images is achieved by applying well-characterised width and amplitude thresholds to diffraction-limited spots that can be used to tune the thickness of the virtual light-sheet. This allows qualitative and quantitative imaging improvements: by rejecting out-of-focus fluorophores, the super-resolution image gains contrast and local features may be revealed; by retaining only fluorophores close to the focal plane, virtual-'light-sheet' single-molecule localisation microscopy improves the probability that all emitting fluorophores will be detected, fitted and quantitatively evaluated.	[Palayret, Matthieu; Armes, Helen; Klenerman, David; Lee, Steven F.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Armes, Helen; Watson, Adam T.; Herbert, Alex; Etheridge, Thomas J.; Carr, Antony M.] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England; [Basu, Srinjan; Lando, David; Laue, Ernest] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England; [Endesfelder, Ulrike; Heilemann, Mike] Goethe Univ Frankfurt, Inst Phys & Theoret Chem, D-60438 Frankfurt, Germany	University of Cambridge; University of Sussex; University of Cambridge; Goethe University Frankfurt	Lee, SF (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.	sl591@cam.ac.uk	Basu, Srinjan/AGQ-3666-2022; Basu, Srinjan/M-7835-2016; Lando, David/AAH-3052-2019	Basu, Srinjan/0000-0002-1080-979X; Basu, Srinjan/0000-0002-1080-979X; Lando, David/0000-0001-5783-8769; Carr, Antony Michael/0000-0002-2028-2389; Klenerman, David/0000-0001-7116-6954; Etheridge, Thomas/0000-0001-8144-6917; Endesfelder, Ulrike/0000-0002-7801-6278; Palayret, Matthieu/0000-0002-5343-8378; Heilemann, Mike/0000-0002-9821-3578; Laue, Ernest/0000-0002-7476-4148; Watson, Adam/0000-0002-8140-8205	Wellcome Trust [093756/B/10/Z, 082010/Z/07/Z]; Royal Society [UF120277]; German Science Foundation [EXC 115, SFB 902]; BBSRC [BB/K013726/1]; European Commission [EC FP7 CP 277899]; ERC [268788-SMI-DDR]; MRC [MR/K015850/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K013726/1] Funding Source: researchfish; Medical Research Council [MR/K015850/1] Funding Source: researchfish	Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); German Science Foundation(German Research Foundation (DFG)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank the Wellcome Trust for the PhD studentship of MP (093756/B/10/Z), and the Royal Society for the University Research Fellowship of SFL (UF120277). The work by SB and DL was also funded by the Wellcome Trust (082010/Z/07/Z). UE and MH acknowledge funding by the German Science Foundation (grants EXC 115 and SFB 902). SB is funded by a BBSRC grant (BB/K013726/1). The authors also thank the European Commission for support through the 4DCellFate project (EC FP7 CP 277899). AMC acknowledges ERC Award 268788-SMI-DDR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/ BF02956173, DOI 10.1007/BF02956173]; Abraham AV, 2009, OPT EXPRESS, V17, P23352, DOI 10.1364/OE.17.023352; AMBROSE EJ, 1956, NATURE, V178, P1194, DOI 10.1038/1781194a0; Backlund MP, 2014, CHEMPHYSCHEM, V15, P587, DOI 10.1002/cphc.201300880; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bone N, 1998, CURR BIOL, V8, P135, DOI 10.1016/S0960-9822(98)00060-8; Chen XD, 2011, APPL OPTICS, V50, P5524, DOI 10.1364/AO.50.005524; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Henriques R, 2010, NAT METHODS, V7, P339, DOI 10.1038/nmeth0510-339; Herbert A, 2014, PEAK FIT SINGLE MOLE; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Horrocks MH, 2014, HISTOCHEM CELL BIOL, V141, P577, DOI 10.1007/s00418-014-1186-1; Hu YS, 2014, CHEMPHYSCHEM, V15, P577, DOI 10.1002/cphc.201300732; Huang B, 2008, SCIENCE, V319, P810, DOI 10.1126/science.1153529; Huang F, 2013, NAT METHODS, V10, P653, DOI [10.1038/NMETH.2488, 10.1038/nmeth.2488]; Huisken J, 2004, SCIENCE, V305, P1007, DOI 10.1126/science.1100035; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Lando D, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120078; Mortensen KI, 2010, NAT METHODS, V7, P377, DOI [10.1038/nmeth.1447, 10.1038/NMETH.1447]; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Ovesny M, 2014, BIOINFORMATICS, V30, P2389, DOI 10.1093/bioinformatics/btu202; Pavani SRP, 2009, P NATL ACAD SCI USA, V106, P2995, DOI 10.1073/pnas.0900245106; Rowland DJ, 2014, CHEMPHYSCHEM, V15, P712, DOI 10.1002/cphc.201300774; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shtengel G, 2009, P NATL ACAD SCI USA, V106, P3125, DOI 10.1073/pnas.0813131106; Starr R, 2012, OPT LETT, V37, P413, DOI 10.1364/OL.37.000413; Strack RL, 2009, BIOCHEMISTRY-US, V48, P8279, DOI 10.1021/bi900870u; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Wolter S, 2012, NAT METHODS, V9, P1040, DOI 10.1038/nmeth.2224; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Zanacchi FC, 2011, NAT METHODS, V8, P1047, DOI [10.1038/NMETH.1744, 10.1038/nmeth.1744]; Zhang MS, 2012, NAT METHODS, V9, P727, DOI [10.1038/NMETH.2021, 10.1038/nmeth.2021]	37	11	11	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125438	10.1371/journal.pone.0125438	http://dx.doi.org/10.1371/journal.pone.0125438			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884495	Green Published, gold, Green Accepted			2022-12-27	WOS:000353017000158
J	Reichert, M; Lutz, A; Deuschle, M; Gilles, M; Hill, H; Limberger, MF; Ebner-Priemer, UW				Reichert, Markus; Lutz, Alexander; Deuschle, Michael; Gilles, Maria; Hill, Holger; Limberger, Matthias F.; Ebner-Priemer, Ulrich W.			Improving Motor Activity Assessment in Depression: Which Sensor Placement, Analytic Strategy and Diurnal Time Frame Are Most Powerful in Distinguishing Patients from Controls and Monitoring Treatment Effects	PLOS ONE			English	Article							ANTIDEPRESSANT THERAPY; PHYSICAL-ACTIVITY; GAIT PATTERNS; EMBODIMENT; UNIPOLAR; POSTURE; DAYTIME; SLEEP	Background Abnormalities in motor activity represent a central feature in major depressive disorder. However, measurement issues are poorly understood, limiting the use of objective measurement of motor activity for diagnostics and treatment monitoring. Methods To improve measurement issues, especially sensor placement, analytic strategies and diurnal effects, we assessed motor activity in depressed patients at the beginning (MD; n=27) and after anti-depressive treatment (MD-post; n=18) as well as in healthy controls (HC; n=16) using wrist-and chest-worn accelerometers. We performed multiple analyses regarding sensor placements, extracted features, diurnal variation, motion patterns and posture to clarify which parameters are most powerful in distinguishing patients from controls and monitoring treatment effects. Results Whereas most feature-placement combinations revealed significant differences between groups, acceleration (wrist) distinguished MD from HC (d=1.39) best. Frequency (vertical axis chest) additionally differentiated groups in a logistic regression model (R-2=0.54). Accordingly, both amplitude (d=1.16) and frequency (d=1.04) showed alterations, indicating reduced and decelerated motor activity. Differences between MD and HC in gestures (d=0.97) and walking (d=1.53) were found by data analysis from the wrist sensor. Comparison of motor activity at the beginning and after MD-treatment largely confirms our findings. Limitations Sample size was small, but sufficient for the given effect sizes. Comparison of depressed in-patients with non-hospitalized controls might have limited motor activity differences between groups. Conclusions Measurement of wrist-acceleration can be recommended as a basic technique to capture motor activity in depressed patients as it records whole body movement and gestures. Detailed analyses showed differences in amplitude and frequency denoting that depressed patients walked less and slower.	[Reichert, Markus; Hill, Holger; Limberger, Matthias F.; Ebner-Priemer, Ulrich W.] Karlsruhe Inst Technol, Dept Sports & Sports Sci, Baden, Switzerland; [Reichert, Markus] Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Baden Wuerttemb, Germany; [Lutz, Alexander; Deuschle, Michael; Gilles, Maria] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Dept Psychiat & Psychotherapy, Mannheim, Baden Wuerttemb, Germany; [Limberger, Matthias F.; Ebner-Priemer, Ulrich W.] Cent Inst Mental Hlth, Dept Psychosomat Med & Psychotherapy, Mannheim, Baden Wuerttemb, Germany	Central Institute of Mental Health; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; Central Institute of Mental Health	Ebner-Priemer, UW (corresponding author), Karlsruhe Inst Technol, Dept Sports & Sports Sci, Baden, Switzerland.	ulrich.ebner-priemer@kit.edu	Reichert, Markus/AAB-3696-2021; Stevens, David/F-4683-2015	Reichert, Markus/0000-0003-3290-0962; Limberger, Matthias F./0000-0002-6332-397X				aan het Rot M, 2012, CLIN PSYCHOL REV, V32, P510, DOI 10.1016/j.cpr.2012.05.007; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Baune BT, 2007, HUM PSYCHOPHARM CLIN, V22, P1, DOI 10.1002/hup.817; Berle Jan O, 2010, BMC Res Notes, V3, P149, DOI 10.1186/1756-0500-3-149; BRAMER G R, 1988, World Health Statistics Quarterly, V41, P32; Burton C, 2013, J AFFECT DISORDERS, V145, P21, DOI 10.1016/j.jad.2012.07.001; Bussmann JBJ, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00463; Bussmann JBJ, 2009, EUR PSYCHOL, V14, P142, DOI 10.1027/1016-9040.14.2.142; Ebner-Priemer U.W., 2012, FRONT PSYCHOL, V3, P596, DOI [10.3389/fpsyg.2012.00596, DOI 10.3389/FPSYG.2012.00596]; Ebner-Priemer UW, 2007, EUR J PSYCHOL ASSESS, V23, P214, DOI 10.1027/1015-5759.23.4.214; Faurholt-Jepsen M, 2012, J AFFECT DISORDERS, V141, P457, DOI 10.1016/j.jad.2012.02.020; Germain A, 2008, HUM PSYCHOPHARM CLIN, V23, P571, DOI 10.1002/hup.964; Hauge ER, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016291; Help4Mood Consortium, HELP4MOOD COMP DISTR; ICT4 Depression Consortium, ICT4 DEPR CONS; Lemke MR, 2000, J PSYCHIATR RES, V34, P277, DOI 10.1016/S0022-3956(00)00017-0; Matthews CE, 2012, MED SCI SPORT EXER, V44, pS68, DOI 10.1249/MSS.0b013e3182399e5b; Michalak J, 2014, CLIN PSYCHOL PSYCHOT, V21, P519, DOI 10.1002/cpp.1890; Michalak J, 2012, MINDFULNESS, V3, P190, DOI 10.1007/s12671-012-0107-4; Michalak J, 2011, J COGN BEHAV PSYCHOT, V11, P13; Michalak J, 2009, PSYCHOSOM MED, V71, P580, DOI 10.1097/PSY.0b013e3181a2515c; Myrtek M, 2001, FREIBURGER MONITORIN; Myrtek M, 2004, HEART EMOTION AMBULA; Nakamura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002050; Optimi Consortium, ONL PRED TOOLS INT M; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; RAOUX N, 1994, PSYCHIAT RES, V52, P85, DOI 10.1016/0165-1781(94)90122-8; Robillard R, 2013, J AFFECT DISORDERS, V145, P260, DOI 10.1016/j.jad.2012.06.006; Scharnholz B, 2014, PSYCHONEUROENDOCRINO, V39, P104, DOI 10.1016/j.psyneuen.2013.09.030; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Sobin C, 1997, AM J PSYCHIAT, V154, P4; Tabachnick BG., 2013, USING MULTIVARIATE S, V6th; Todder D, 2009, WORLD J BIOL PSYCHIA, V10, P276, DOI 10.3109/15622970701403081; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Trull TJ, 2013, ANNU REV CLIN PSYCHO, V9, P151, DOI 10.1146/annurev-clinpsy-050212-185510; Volkers AC, 2003, J AFFECT DISORDERS, V76, P23, DOI 10.1016/S0165-0327(02)00066-6; Volkers AC, 2002, EUR NEUROPSYCHOPHARM, V12, P273, DOI 10.1016/S0924-977X(02)00019-6; Wichers M, 2011, ACTA PSYCHIAT SCAND, V124, P262, DOI 10.1111/j.1600-0447.2011.01749.x	38	16	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124231	10.1371/journal.pone.0124231	http://dx.doi.org/10.1371/journal.pone.0124231			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25885258	gold, Green Published			2022-12-27	WOS:000353017000104
J	Bock, M; Heijnen, I; Trendelenburg, M				Bock, Merete; Heijnen, Ingmar; Trendelenburg, Marten			Anti-C1q Antibodies as a Follow-Up Marker in SLE Patients	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; HEREDITARY C1Q DEFICIENCY; DISEASE-ACTIVITY; IGG AUTOANTIBODIES; PREDICTIVE-VALUE; NEPHRITIS; COMPLEMENT; HYPOCOMPLEMENTEMIA; MANIFESTATIONS; IMMUNOLOGY	In cross-sectional studies autoantibodies against complement C1q (anti-C1q) were found to be highly associated with active lupus nephritis. The aim of this retrospective study was to determine the value of anti-C1q as follow-up marker of disease activity and renal involvement in patients with systemic lupus erythematosus (SLE). Fifty-two patients with SLE and a minimum of three anti-C1q measurements during follow-up were analyzed. Anti-C1q levels correlated with global disease activity scores. In subgroup analyses, patients without renal involvement did not show a significant correlation between anti-C1q levels and disease activity. In contrast, in patients with renal involvement, anti-C1q levels correlated well with global disease activity. In addition, a positive correlation with the urine protein-to-creatinine ratio and anti-dsDNA antibody levels as well as a negative correlation with complement levels was observed. Anti-C1q antibodies were found to strongly correlate with parameters of SLE disease activity during follow-up, in particular with regard to renal involvement.	[Bock, Merete; Trendelenburg, Marten] Univ Basel Hosp, Div Internal Med, CH-4031 Basel, Switzerland; [Heijnen, Ingmar] Univ Basel Hosp, Dept Lab Med, Div Med Immunol, CH-4031 Basel, Switzerland	University of Basel; University of Basel	Bock, M (corresponding author), Univ Basel Hosp, Div Internal Med, CH-4031 Basel, Switzerland.	Merete_Bock@gmx.de	Trendelenburg, Marten/AAM-1626-2020	Trendelenburg, Marten/0000-0001-7036-8386	Swiss National Science foundation [32003B_152674/1]	Swiss National Science foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by a grant from the Swiss National Science foundation (32003B_152674/1). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhter E, 2011, LUPUS, V20, P1267, DOI 10.1177/0961203311411597; BOMBARDIER C, 1992, ARTHRITIS RHEUM, V35, P630, DOI 10.1002/art.1780350606; BOWNESS P, 1994, Q J MED, V87, P455; Cameron JS, 1999, J AM SOC NEPHROL, V10, P413; Cervera R, 2003, MEDICINE, V82, P299, DOI 10.1097/01.md.0000091181.93122.55; COREMANS IEM, 1995, AM J KIDNEY DIS, V26, P595, DOI 10.1016/0272-6386(95)90595-2; FremeauxBacchi V, 1996, LUPUS, V5, P216, DOI 10.1177/096120339600500309; Giles I, 2008, LUPUS, V17, P241, DOI 10.1177/0961203307088248; Gilliam BE, 2012, SEMIN ARTHRITIS RHEU, V41, P840, DOI 10.1016/j.semarthrit.2011.09.009; Hochberg MC, 1997, ARTHRITIS RHEUM, V40, P1725, DOI 10.1002/art.1780400928; Horvath L, 2001, CLIN EXP RHEUMATOL, V19, P667; Katsumata Y, 2011, ARTHRITIS RHEUM-US, V63, P2436, DOI 10.1002/art.30401; Kozyro I, 2006, PEDIATRICS, V117, P1663, DOI 10.1542/peds.2005-1148; Liang MH, 2004, ARTHRITIS RHEUM-US, V50, P3418, DOI 10.1002/art.20628; Manson JJ, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-6; Marto N, 2005, ANN RHEUM DIS, V64, P444, DOI 10.1136/ard.2004.024943; Mayer M.M., 1961, EXPT IMMUNOCHEMISTRY, P133; Moroni G, 2009, ANN RHEUM DIS, V68, P234, DOI 10.1136/ard.2008.094508; Pickering M C, 2000, Adv Immunol, V76, P227; Potlukova E, 2008, SCAND J IMMUNOL, V67, P423, DOI 10.1111/j.1365-3083.2008.02089.x; Schejbel L, 2011, GENES IMMUN, V12, P626, DOI 10.1038/gene.2011.39; SIEGERT C, 1991, J RHEUMATOL, V18, P230; SIEGERT CEH, 1993, ANN RHEUM DIS, V52, P851, DOI 10.1136/ard.52.12.851; Sinico RA, 2009, ANN NY ACAD SCI, V1173, P47, DOI 10.1111/j.1749-6632.2009.04746.x; SMEENK RJT, 1991, RHEUMATOL INT, V11, P101, DOI 10.1007/BF00304496; Trendelenburg M, 1999, AM J KIDNEY DIS, V34, P745, DOI 10.1016/S0272-6386(99)70402-6; Trendelenburg M, 2005, SPRINGER SEMIN IMMUN, V27, P276, DOI 10.1007/s00281-005-0007-y; Trendelenburg M, 1999, ARTHRITIS RHEUM, V42, P187, DOI 10.1002/1529-0131(199901)42:1<187::AID-ANR24>3.0.CO;2-U; Trendelenburg M, 2006, NEPHROL DIAL TRANSPL, V21, P3115, DOI 10.1093/ndt/gfl436; Walport MJ, 2002, ARTHRITIS RES THER, V4, pS279, DOI 10.1186/ar586; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506	32	37	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123572	10.1371/journal.pone.0123572	http://dx.doi.org/10.1371/journal.pone.0123572			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881125	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500056
J	Reinhold, AK; Batti, L; Bilbao, D; Buness, A; Rittner, HL; Heppenstall, PA				Reinhold, A. K.; Batti, L.; Bilbao, D.; Buness, A.; Rittner, H. L.; Heppenstall, P. A.			Differential Transcriptional Profiling of Damaged and Intact Adjacent Dorsal Root Ganglia Neurons in Neuropathic Pain	PLOS ONE			English	Article							CORTICOTROPIN-RELEASING-FACTOR; SENSORY NEURONS; SPINAL-CORD; RAT; EXPRESSION; RECEPTORS; INVOLVEMENT; INHIBITION; INJURY; ALPHA	Neuropathic pain, caused by a lesion in the somatosensory system, is a severely impairing mostly chronic disease. While its underlying molecular mechanisms are not thoroughly understood, neuroimmune interactions as well as changes in the pain pathway such as sensitization of nociceptors have been implicated. It has been shown that not only are different cell types involved in generation and maintenance of neuropathic pain, like neurons, immune and glial cells, but, also, intact adjacent neurons are relevant to the process. Here, we describe an experimental approach to discriminate damaged from intact adjacent neurons in the same dorsal root ganglion (DRG) using differential fluorescent neuronal labelling and fluorescence-activated cell sorting (FACS). Two fluorescent tracers, Fluoroemerald (FE) and 1-dioctadecyl-3,3,3,3-tetramethylindocarbocyanine perchlorate (DiI), were used, whose properties allow us to distinguish between damaged and intact neurons. Subsequent sorting permitted transcriptional analysis of both groups. Results and qPCR validation show a strong regulation in damaged neurons versus contralateral controls as well as a moderate regulation in adjacent neurons. Data for damaged neurons reveal an mRNA expression pattern consistent with established upregulated genes like galanin, which supports our approach. Moreover, novel genes were found strongly regulated such as corticotropinreleasing hormone (CRH), providing novel targets for further research. Differential fluorescent neuronal labelling and sorting allows for a clear distinction between primarily damaged neuropathic neurons and "bystanders," thereby facilitating a more detailed understanding of their respective roles in neuropathic processes in the DRG.	[Reinhold, A. K.; Batti, L.; Bilbao, D.; Buness, A.; Heppenstall, P. A.] European Mol Biol Lab, Monterotondo, Italy; [Reinhold, A. K.; Rittner, H. L.] Univ Hosp, Dept Anaesthesiol, Wurzburg, Germany	European Molecular Biology Laboratory (EMBL); University of Wurzburg	Reinhold, AK (corresponding author), European Mol Biol Lab, Monterotondo, Italy.	paul.heppenstall@embl.de	RIttner, Heike/AAC-6523-2019	RIttner, Heike/0000-0003-4867-0188; Reinhold, Ann Kristin/0000-0002-0269-462X; Bilbao Cortes, Daniel/0000-0003-1630-8811; Batti, Laura/0000-0003-3717-8470	project "ncRNAPain" under the European Union's 7th framework programme [602133]; EMBL Monterotondo Flow cytometry facility; EMBL Genomics Core Facility	project "ncRNAPain" under the European Union's 7th framework programme; EMBL Monterotondo Flow cytometry facility; EMBL Genomics Core Facility	This study was technically supported by EMBL Monterotondo Flow cytometry facility and EMBL Genomics Core Facility. The study has received funding from the project "ncRNAPain" under the European Union's 7th framework programme (Grant no. 602133).	Aguilera G, 2012, FRONT NEUROENDOCRIN, V33, P67, DOI 10.1016/j.yfrne.2011.08.002; Ali Z, 1999, J NEUROPHYSIOL, V81, P455, DOI 10.1152/jn.1999.81.2.455; BENNETT GJ, 1988, PAIN, V33, P87, DOI 10.1016/0304-3959(88)90209-6; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Choi D, 2002, J NEUROSCI METH, V117, P167, DOI 10.1016/S0165-0270(02)00098-5; Finnerup NB, 2010, PAIN, V150, P573, DOI 10.1016/j.pain.2010.06.019; FRITZSCH B, 1991, J NEUROSCI METH, V39, P9, DOI 10.1016/0165-0270(91)90088-H; HONIG MG, 1986, J CELL BIOL, V103, P171, DOI 10.1083/jcb.103.1.171; Hudson LJ, 2001, EUR J NEUROSCI, V13, P2105, DOI 10.1046/j.0953-816x.2001.01591.x; Hughes JP, 2012, ANN NY ACAD SCI, V1255, P30, DOI 10.1111/j.1749-6632.2012.06561.x; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Kim DS, 2009, PAIN, V143, P114, DOI 10.1016/j.pain.2009.02.006; Kim EH, 2011, ANAT CELL BIOL, V44, P60, DOI 10.5115/acb.2011.44.1.60; Labuz D, 2009, J CLIN INVEST, V119, P278, DOI [10.1172/JCI36246, 10.1172/JCI36246C1]; Ma W, 1997, NEUROSCIENCE, V79, P1183, DOI 10.1016/S0306-4522(97)00088-2; Mechaly I, 2006, MOL CELL NEUROSCI, V32, P217, DOI 10.1016/j.mcn.2006.04.004; Mousa SA, 2003, PAIN, V106, P297, DOI 10.1016/S0304-3959(03)00302-6; Mousa SA, 2007, NEUROPSYCHOPHARMACOL, V32, P2530, DOI 10.1038/sj.npp.1301393; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Ng KY, 2010, NEURON GLIA BIOL, V6, P19, DOI 10.1017/S1740925X09990433; Parkitna JR, 2006, J PHYSIOL PHARMACOL, V57, P401; Pecorelli A, 2015, BBA-MOL BASIS DIS, V1852, P507, DOI 10.1016/j.bbadis.2014.11.016; Rountree RB, 2010, J INVEST DERMATOL, V130, P102, DOI 10.1038/jid.2009.223; Sarantopoulos C, 2002, REGION ANESTH PAIN M, V27, P47, DOI 10.1053/rapm.2002.29124; SATO J, 1991, SCIENCE, V251, P1608, DOI 10.1126/science.2011742; Schafers M, 2003, EUR J NEUROSCI, V17, P791, DOI 10.1046/j.1460-9568.2003.02504.x; SKOFITSCH G, 1985, PEPTIDES, V6, P307, DOI 10.1016/0196-9781(85)90057-9; Van Steenwinckel J, 2011, J NEUROSCI, V31, P5865, DOI 10.1523/JNEUROSCI.5986-10.2011; VIDALSANZ M, 1988, EXP NEUROL, V102, P92, DOI 10.1016/0014-4886(88)90081-7; von Hehn CA, 2012, NEURON, V73, P638, DOI 10.1016/j.neuron.2012.02.008; White FA, 2005, P NATL ACAD SCI USA, V102, P14092, DOI 10.1073/pnas.0503496102; Xiao HS, 2002, P NATL ACAD SCI USA, V99, P8360, DOI 10.1073/pnas.122231899; Yuan H, 2010, SPINAL CORD, V48, P850, DOI 10.1038/sc.2010.47	33	27	27	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123342	10.1371/journal.pone.0123342	http://dx.doi.org/10.1371/journal.pone.0123342			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880204	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500047
J	Kim, Y; Bae, JM; Li, G; Cho, NY; Kang, GH				Kim, Younghoon; Bae, Jeong Mo; Li, Gang; Cho, Nam Yun; Kang, Gyeong Hoon			Image Analyzer-Based Assessment of Tumor-Infiltrating T Cell Subsets and Their Prognostic Values in Colorectal Carcinomas	PLOS ONE			English	Article							COLON-CANCER PATIENTS; GENETIC ALTERATIONS; CLINICAL IMPACT; INVASION FRONT; LYMPHOCYTES; SURVIVAL; CD8(+); IMMUNOLOGY; MARKERS	To find useful tools to evaluate the prognosis in colorectal carcinoma (CRC) patients, we investigated the prognostic values of tumor-infiltrating T lymphocyte subsets according to intratumoral subsites as well as clinical or molecular characteristics. Immunohistochemistry for CD8, CD45RO, and FOXP3 was performed, and densities of the T cell subsets in each tissue microarray core (cells/mm(2)) were measured by image analysis. In the training set (n = 218) of CRC, T cell subset densities in the invasion front were more strongly associated with patient outcome than those in the tumor center. In the validation set (n = 549), T cell subset densities in the invasion front were evaluated. Univariate analysis showed that all three T cell subset densities were significantly associated with longer progression free survival and overall survival time (p < 0.001). In multivariate analysis, a high CD45RO density correlated independently with longer progression free survival (p = 0.011) and overall survival time (p = 0.007) in CRC patients, regardless of tumor location or adjuvant chemotherapy status. Our results showed that CD45RO density in the invasion front was the only independent prognostic factor regarding CRC. However, CD8 and FOXP3 densities were also independent prognostic factors in certain clinical settings. Thus, image analysis of tissue microarray cores in the invasion front of CRC could be used as a valid method for evaluating the prognostic significance of T cell subset densities.	[Kim, Younghoon; Li, Gang; Kang, Gyeong Hoon] Seoul Natl Univ Coll Med, Dept Pathol, Seoul, South Korea; [Bae, Jeong Mo; Cho, Nam Yun; Kang, Gyeong Hoon] Seoul Natl Univ Coll Med, Lab Epigenet, Canc Res Inst, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Kang, GH (corresponding author), Seoul Natl Univ Coll Med, Dept Pathol, Seoul, South Korea.	ghkang@snu.ac.kr	Kang, Gyeong Hoon/F-1051-2010	Kang, Gyeong Hoon/0000-0003-2380-6675; Kim, Younghoon/0000-0003-4656-0188	National Research Foundation of Korea (NRF) - Ministry of Education [2013R1A1A2059080]; Ministry of Health Welfare [HI13C1804, HI14C1277]; NRF - Ministry of Science, ICT and Future Planning (MSIP) [2011-0030049]	National Research Foundation of Korea (NRF) - Ministry of Education; Ministry of Health Welfare; NRF - Ministry of Science, ICT and Future Planning (MSIP)	This study was supported by a grant from Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2013R1A1A2059080), a grant from the Korean Health Technology R&D Project, Ministry of Health & Welfare (HI13C1804 & HI14C1277), and the NRF grant funded by the Ministry of Science, ICT and Future Planning (MSIP) (2011-0030049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2000, J SURG ONCOL, V74, P249, DOI 10.1002/1096-9098(200008)74:4<249::AID-JSO2>3.0.CO;2-S; BOON T, 1994, ANNU REV IMMUNOL, V12, P337, DOI 10.1146/annurev.immunol.12.1.337; Chang SC, 2006, INT J CANCER, V118, P1721, DOI 10.1002/ijc.21563; Correale P, 2010, J IMMUNOTHER, V33, P435, DOI 10.1097/CJI.0b013e3181d32f01; Dalerba P, 2003, CRIT REV ONCOL HEMAT, V46, P33, DOI 10.1016/S1040-8428(02)00159-2; De Wever O, 2008, HISTOCHEM CELL BIOL, V130, P481, DOI 10.1007/s00418-008-0464-1; deLeeuw RJ, 2012, CLIN CANCER RES, V18, P3022, DOI 10.1158/1078-0432.CCR-11-3216; Deschoolmeester V, 2010, BMC IMMUNOL, V11, DOI 10.1186/1471-2172-11-19; Frey DM, 2010, INT J CANCER, V126, P2635, DOI 10.1002/ijc.24989; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Hojo S, 2007, CANCER RES, V67, P4725, DOI 10.1158/0008-5472.CAN-06-3424; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kahlert C, 2011, CLIN CANCER RES, V17, P7654, DOI 10.1158/1078-0432.CCR-10-2816; Kim JH, 2009, VIRCHOWS ARCH, V455, P485, DOI 10.1007/s00428-009-0857-0; Ladoire S, 2011, CANCER IMMUNOL IMMUN, V60, P909, DOI 10.1007/s00262-011-1046-y; Lee DW, 2015, ANN SURG ONCOL, V22, P187, DOI 10.1245/s10434-014-3826-z; Lee WS, 2010, CANCER-AM CANCER SOC, V116, P5188, DOI 10.1002/cncr.25293; Ling A, 2014, BRIT J CANCER, V110, P2551, DOI 10.1038/bjc.2014.161; Mackay CR, 1999, NATURE, V401, P659, DOI 10.1038/44309; Mahmoud SMA, 2011, J CLIN ONCOL, V29, P1949, DOI 10.1200/JCO.2010.30.5037; Mei Z, 2014, BRIT J CANCER, V110, P1595, DOI 10.1038/bjc.2014.46; Nosho K, 2010, J PATHOL, V222, P350, DOI 10.1002/path.2774; Ormandy LA, 2005, CANCER RES, V65, P2457, DOI 10.1158/0008-5472.CAN-04-3232; OSTENSTAD B, 1994, GUT, V35, P382, DOI 10.1136/gut.35.3.382; Pages F, 2005, NEW ENGL J MED, V353, P2654, DOI 10.1056/NEJMoa051424; Pages F, 2009, J CLIN ONCOL, V27, P5944, DOI 10.1200/JCO.2008.19.6147; Park SY, 2007, ARCH PATHOL LAB MED, V131, P1561; Petersen RP, 2006, CANCER-AM CANCER SOC, V107, P2866, DOI 10.1002/cncr.22282; Salama P, 2009, J CLIN ONCOL, V27, P186, DOI 10.1200/JCO.2008.18.7229; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sinicrope FA, 2009, GASTROENTEROLOGY, V137, P1270, DOI 10.1053/j.gastro.2009.06.053; Sugai T, 2006, J MOL DIAGN, V8, P193, DOI 10.2353/jmoldx.2006.050052; Suzuki H, 2010, CANCER IMMUNOL IMMUN, V59, P653, DOI 10.1007/s00262-009-0781-9; Titu LV, 2002, CANCER IMMUNOL IMMUN, V51, P235, DOI 10.1007/s00262-002-0276-4; Tosolini M, 2011, CANCER RES, V71, P1263, DOI 10.1158/0008-5472.CAN-10-2907; Xu W, 2013, J CANCER RES CLIN, V139, P1845, DOI 10.1007/s00432-013-1500-7; Yoon HH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042274; Yuen ST, 2002, CANCER RES, V62, P6451	39	18	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122183	10.1371/journal.pone.0122183	http://dx.doi.org/10.1371/journal.pone.0122183			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875774	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800044
J	Obana-Koshino, A; Ono, H; Miura, J; Sakai, M; Uchida, H; Nakamura, W; Nohara, K; Maruyama, Y; Hattori, A; Sakai, T				Obana-Koshino, Aya; Ono, Hitomi; Miura, Jiro; Sakai, Manabu; Uchida, Hitoshi; Nakamura, Wataru; Nohara, Kanji; Maruyama, Yusuke; Hattori, Atsuhiko; Sakai, Takayoshi			Melatonin Inhibits Embryonic Salivary Gland Branching Morphogenesis by Regulating Both Epithelial Cell Adhesion and Morphology	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; IN-VITRO; IMMUNE-SYSTEM; MOUSE; CANCER; RHYTHM; EXPRESSION; MICE; PINEALECTOMY; ACTIVATION	Many organs, including salivary glands, lung, and kidney, are formed by epithelial branching during embryonic development. Branching morphogenesis occurs via either local outgrowths or the formation of clefts that subdivide epithelia into buds. This process is promoted by various factors, but the mechanism of branching morphogenesis is not fully understood. Here we have defined melatonin as a potential negative regulator or "brake" of branching morphogenesis, shown that the levels of it and its receptors decline when branching morphogenesis begins, and identified the process that it regulates. Melatonin has various physiological functions, including circadian rhythm regulation, free-radical scavenging, and gonadal development. Furthermore, melatonin is present in saliva and may have an important physiological role in the oral cavity. In this study, we found that the melatonin receptor is highly expressed on the acinar epithelium of the embryonic submandibular gland. We also found that exogenous melatonin reduces salivary gland size and inhibits branching morphogenesis. We suggest that this inhibition does not depend on changes in either proliferation or apoptosis, but rather relates to changes in epithelial cell adhesion and morphology. In summary, we have demonstrated a novel function of melatonin in organ formation during embryonic development.	[Obana-Koshino, Aya; Ono, Hitomi; Uchida, Hitoshi; Nohara, Kanji; Sakai, Takayoshi] Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka, Japan; [Miura, Jiro] Osaka Univ, Grad Sch Dent, Div Interdisciplinary Dent, Suita, Osaka, Japan; [Sakai, Manabu] Osaka Univ, Dent Hosp, Clin Lab, Suita, Osaka, Japan; [Uchida, Hitoshi; Nakamura, Wataru] Osaka Univ, Grad Sch Dent, Lab Oral Chronobiol, Suita, Osaka, Japan; [Maruyama, Yusuke; Hattori, Atsuhiko] Tokyo Med & Dent Univ, Dept Biol, Ichikawa, Chiba, Japan	Osaka University; Osaka University; Osaka University; Osaka University; Tokyo Medical & Dental University (TMDU)	Sakai, T (corresponding author), Osaka Univ, Grad Sch Dent, Dept Oral Facial Disorders, Suita, Osaka, Japan.	sakai@dent.osaka-u.ac.jp	Sakai, Takayoshi/L-1456-2019; 学, 酒井/GXF-6076-2022; Miura, Jiro/AAF-8083-2021	Sakai, Takayoshi/0000-0003-4348-4896; 学, 酒井/0000-0003-0403-6994; Miura, Jiro/0000-0002-0000-025X	JSPS [24390452, 24570068]; Grants-in-Aid for Scientific Research [24659890, 24390452] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors would like to thank Yuichi Kadoya for helpful discussion. This work was supported in part by grants to T.S. (Grant-in-Aid for Scientific Research [B] 24390452 by the JSPS) and to A.H. (Grant-in-Aid for Scientific Research [C] 24570068 by the JSPS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batmanabane M, 1996, ANAT RECORD, V245, P519; Carrillo-Vico A, 2004, FASEB J, V18, P537, DOI 10.1096/fj.03-0694fje; Carrillo-Vico A, 2003, CELL MOL LIFE SCI, V60, P2272, DOI 10.1007/s00018-003-3207-4; Cos S, 1998, CANCER RES, V58, P4383; DOLLINS AB, 1994, P NATL ACAD SCI USA, V91, P1824, DOI 10.1073/pnas.91.5.1824; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Garcia-Maurino S, 2000, J PINEAL RES, V29, P129, DOI 10.1034/j.1600-079X.2000.290301.x; Gomez-Corvera A, 2009, J PINEAL RES, V47, P15, DOI 10.1111/j.1600-079X.2009.00683.x; Hieda Y, 1997, DEV GROWTH DIFFER, V39, P1; Hsu JCF, 2010, INT J ORAL SCI, V2, P117, DOI 10.4248/IJOS10042; ITOH MT, 1995, MOL CELL ENDOCRINOL, V115, P59, DOI 10.1016/0303-7207(95)03670-3; Jung-Hynes B, 2011, J PINEAL RES, V50, P140, DOI 10.1111/j.1600-079X.2010.00823.x; Kasahara T, 2010, P NATL ACAD SCI USA, V107, P6412, DOI 10.1073/pnas.0914399107; Kennaway DJ, 1998, J CLIN ENDOCR METAB, V83, P1013, DOI 10.1210/jc.83.3.1013; Koyama H, 2002, J BONE MINER RES, V17, P1219, DOI 10.1359/jbmr.2002.17.7.1219; Kumasaka S, 2010, HISTOCHEM CELL BIOL, V133, P577, DOI 10.1007/s00418-010-0698-6; Leon J, 2005, J PINEAL RES, V38, P1, DOI 10.1111/j.1600-079X.2004.00181.x; Martinez-Campa C, 2006, J PINEAL RES, V40, P291, DOI 10.1111/j.1600-079X.2006.00315.x; Metzger RJ, 1999, SCIENCE, V284, P1635, DOI 10.1126/science.284.5420.1635; Mima J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061653; Miyajima H, 2011, BIOMATERIALS, V32, P6754, DOI 10.1016/j.biomaterials.2011.05.072; Naji L, 2004, LIFE SCI, V74, P2227, DOI 10.1016/j.lfs.2003.08.046; Nakahara D, 2003, P NATL ACAD SCI USA, V100, P9584, DOI 10.1073/pnas.1631069100; Onodera T, 2010, SCIENCE, V329, P562, DOI 10.1126/science.1191880; Picoli LC, 2011, MICROSC RES TECHNIQ, V74, P1154, DOI 10.1002/jemt.21008; Poirel VJ, 2003, NEUROENDOCRINOL LETT, V24, P33; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; REPPERT SM, 1995, P NATL ACAD SCI USA, V92, P8734, DOI 10.1073/pnas.92.19.8734; REPPERT SM, 1994, NEURON, V13, P1177, DOI 10.1016/0896-6273(94)90055-8; Sack RL, 2000, NEW ENGL J MED, V343, P1070, DOI 10.1056/NEJM200010123431503; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sakai T, 2009, J MED INVESTIG, V56, P234, DOI 10.2152/jmi.56.234; Sanchez-Barcelo EJ, 2003, ENDOCR-RELAT CANCER, V10, P153, DOI 10.1677/erc.0.0100153; Satomura K, 2007, J PINEAL RES, V42, P231, DOI 10.1111/j.1600-079X.2006.00410.x; Shimozuma M, 2011, HISTOCHEM CELL BIOL, V135, P389, DOI 10.1007/s00418-011-0800-8; Torres-Farfan C, 2006, J PINEAL RES, V41, P58, DOI 10.1111/j.1600-079X.2006.00331.x; UBEDA A, 1995, CANCER LETT, V91, P241, DOI 10.1016/0304-3835(95)03736-G; VAKKURI O, 1985, J ENDOCRINOL, V105, P263, DOI 10.1677/joe.0.1050263; VAKKURI O, 1985, ACTA PHYSIOL SCAND, V124, P409, DOI 10.1111/j.1748-1716.1985.tb07676.x; VAKKURI O, 1985, LIFE SCI, V37, P489, DOI 10.1016/0024-3205(85)90412-6; Vivien-Roels B, 1998, J BIOL RHYTHM, V13, P403, DOI 10.1177/074873098129000228; YELLON SM, 1988, BIOL REPROD, V39, P1093, DOI 10.1095/biolreprod39.5.1093; Yonei Y., 2010, ANTIAGEING MED, V7, P85	43	6	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0119960	10.1371/journal.pone.0119960	http://dx.doi.org/10.1371/journal.pone.0119960			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876057	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800009
J	Olivarius, ND; Siersma, VD; Koster-Rasmussen, R; Heitmann, BL; Waldorff, FB				Olivarius, Niels de Fine; Siersma, Volkert Dirk; Koster-Rasmussen, Rasmus; Heitmann, Berit Lilienthal; Waldorff, Frans Boch			Weight Changes following the Diagnosis of Type 2 Diabetes: The Impact of Recent and Past Weight History before Diagnosis. Results from the Danish Diabetes Care in General Practice (DCGP) Study	PLOS ONE			English	Article							LIFE-STYLE INTERVENTION; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; RISK-FACTORS; GLUCOSE; ACCURACY; AGE; COMPLICATIONS; OBESITY; 4-YEAR	Aims The association between recent and more distant weight changes before and after the diagnosis of type 2 diabetes has been little researched. The aim of this study is to determine the influence of patients' weight history before diabetes diagnosis on the observed 6-year weight changes after diagnosis. Methods A clinical cohort study combined with self-reported past weight history. In total 885 patients aged >= 40 years and newly diagnosed with clinical type 2 diabetes were included. Body weight was measured immediately after diabetes diagnosis and again at the 6-year follow up examination (median, 5.7 years). At diagnosis patients reported their weight 1 year and 10 years previously, and also at the age of 20. Multivariate linear regression analyses controlled for 20 baseline patient characteristics. Results The median (interquartile range) age at diagnosis was 63.2 (53.9; 71.4) years. Median body weight was 80.0 (72.0; 90.0) kg 10 years before diagnosis, 85.0 (75.0; 95.0) kg 1 year before diagnosis, 82.4 (72.0; 94.0) kg at diagnosis, and 80.0 (70.0; 91.1) kg at 6-year follow up. Each kg of weight gain during the year preceding the diagnosis was associated with a weight change (95% CI) of -0.20 (-0.28; -0.13) kg during the follow up period. In all models age and body mass index at diagnosis predicted future weight changes, while the weight at age 20 (-0.01 (-0.06; 0.03) kg/kg), and the weight change from 10 years to 1 year before diagnosis (-0.01 (-0.06; 0.04) kg/kg), did not predict weight change after diagnosis. Conclusions During the first on average 5.7 years after diagnosis of type 2 diabetes, patients generally follow a course of declining average weight, and these weight developments are related primarily to recent weight changes, body mass index, and age, but not to the more distant weight history.	[Olivarius, Niels de Fine; Siersma, Volkert Dirk; Koster-Rasmussen, Rasmus; Waldorff, Frans Boch] Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark; [Olivarius, Niels de Fine; Siersma, Volkert Dirk; Koster-Rasmussen, Rasmus; Waldorff, Frans Boch] Univ Copenhagen, Dept Publ Hlth, Sect Gen Practice, Copenhagen, Denmark; [Heitmann, Berit Lilienthal] Frederiksberg Univ Hosp, Res Unit Dietary Studies, Inst Prevent Med, Frederiksberg, Denmark	University of Copenhagen; University of Copenhagen	Olivarius, ND (corresponding author), Univ Copenhagen, Dept Publ Hlth, Res Unit Gen Practice, Copenhagen, Denmark.	olivarius@sund.ku.dk	Siersma, Volkert D/G-6867-2016; Waldorff, Frans Boch/P-7845-2015; de Fine Olivarius, Niels/K-6832-2015	Siersma, Volkert D/0000-0003-1941-2681; de Fine Olivarius, Niels/0000-0001-6465-3615; Waldorff, Frans Boch/0000-0002-7859-633X; Koster-Rasmussen, Rasmus/0000-0002-6452-1839; Heitmann, Berit Lilienthal/0000-0002-6809-4504	Danish Medical Research Council; Danish Research Foundation for General Practice; Health Insurance Foundation; Danish Ministry of Health; Novo Nordisk Farmaka Denmark Ltd.; Pharmacy Foundation; Foundation for General Practice in Copenhagen, Frederiksberg, Tarnby and Dragor; Doctor Sofus Carl Emil Friis and his Wife Olga Doris Friis Trust; Danish Medical Association; Velux Foundation; Rockwool Foundation; Novo Nordisk Ltd.; Danish Diabetes Association; Oda and Hans Svenningsen's Fund; A P Moller Foundation for the Advancement of Medical Science; Captain Axel Viggo Morch and his Wife's Trust; Danish Eye Health Society; Mogens and Jenny Vissing's Trust; Bernhard and Marie Klein's Trust	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Danish Research Foundation for General Practice; Health Insurance Foundation; Danish Ministry of Health; Novo Nordisk Farmaka Denmark Ltd.(Novo Nordisk); Pharmacy Foundation; Foundation for General Practice in Copenhagen, Frederiksberg, Tarnby and Dragor; Doctor Sofus Carl Emil Friis and his Wife Olga Doris Friis Trust; Danish Medical Association; Velux Foundation(Velux Fonden); Rockwool Foundation; Novo Nordisk Ltd.(Novo Nordisk); Danish Diabetes Association; Oda and Hans Svenningsen's Fund; A P Moller Foundation for the Advancement of Medical Science; Captain Axel Viggo Morch and his Wife's Trust; Danish Eye Health Society; Mogens and Jenny Vissing's Trust; Bernhard and Marie Klein's Trust	The work was supported by the Danish Medical Research Council, The Danish Research Foundation for General Practice, The Health Insurance Foundation, The Danish Ministry of Health, Novo Nordisk Farmaka Denmark Ltd., The Pharmacy Foundation, The Foundation for General Practice in Copenhagen, Frederiksberg, Tarnby and Dragor, The Doctor Sofus Carl Emil Friis and his Wife Olga Doris Friis Trust, The Danish Medical Association Research Fund, The Velux Foundation, The Rockwool Foundation, Novo Nordisk Ltd., The Danish Diabetes Association, Oda and Hans Svenningsen's Fund, The A P Moller Foundation for the Advancement of Medical Science, Captain Axel Viggo Morch and his Wife's Trust, The Danish Eye Health Society, Mogens and Jenny Vissing's Trust, and Bernhard and Marie Klein's Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone BB, 2006, OBESITY, V14, P902, DOI 10.1038/oby.2006.104; Black E, 2005, DIABETIC MED, V22, P1199, DOI 10.1111/j.1464-5491.2005.01615.x; CHAN JM, 1994, DIABETES CARE, V17, P961, DOI 10.2337/diacare.17.9.961; Chaudhry ZW, 2006, DIABETES CARE, V29, P493, DOI 10.2337/diacare.29.03.06.dc05-1703; Dahl AK, 2013, OBESITY, V21, P1293, DOI 10.1002/oby.20299; de Fine Olivarius N, 2006, DIABETOLOGIA, V49, P2058, DOI 10.1007/s00125-006-0328-y; Drivsholm T, 2005, DIABETOLOGIA, V48, P210, DOI 10.1007/s00125-004-1625-y; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ekelund U, 2006, PUBLIC HEALTH NUTR, V9, P258, DOI 10.1079/PHN2005840; Eriksen L, 2011, SCAND J PUBLIC HEALT, V39, P203, DOI 10.1177/1403494810393557; Espeland M, 2007, DIABETES CARE, V30, P1374; Gaede P, 2003, NEW ENGL J MED, V348, P383, DOI 10.1056/NEJMoa021778; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Griffin SJ, 2011, LANCET, V378, P156, DOI 10.1016/S0140-6736(11)60698-3; GUARE JC, 1995, OBES RES, V3, P329, DOI 10.1002/j.1550-8528.1995.tb00158.x; Janssen I, 2005, J NUTR HEALTH AGING, V9, P408; Keenan PS, 2009, ARCH INTERN MED, V169, P237, DOI 10.1001/archinternmed.2008.557; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Kroke A, 2002, INT J OBESITY, V26, P403, DOI 10.1038/sj.ijo.0801920; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Looker HC, 2001, DIABETES CARE, V24, P1917, DOI 10.2337/diacare.24.11.1917; Haheim LL, 2006, QJM-INT J MED, V99, P665, DOI 10.1093/qjmed/hcl090; Lustig RH, 2006, NAT CLIN PRACT ENDOC, V2, P447, DOI 10.1038/ncpendmet0220; Morrison JA, 2008, AM J CLIN NUTR, V88, P778, DOI 10.1093/ajcn/88.3.778; Olivarius ND, 2008, DIABETIC MED, V25, P933, DOI 10.1111/j.1464-5491.2008.02472.x; Olivarius ND, 1997, INT J OBESITY, V21, P67, DOI 10.1038/sj.ijo.0800365; Olivarius ND, 2004, DIABETES METAB, V30, P269, DOI 10.1016/S1262-3636(07)70118-0; Olivarius ND, 2001, BMJ-BRIT MED J, V323, P970, DOI 10.1136/bmj.323.7319.970; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Stevens J, 2006, INT J OBESITY, V30, P391, DOI 10.1038/sj.ijo.0803175; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Teh BH, 1996, INT J OBESITY, V20, P683; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Wadden TA, 2011, OBESITY, V19, P1987, DOI 10.1038/oby.2011.230; Wing R, 2013, NEW ENGL J MED, V369, P145, DOI 10.1056/NEJMoa1212914; Yoong SL, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-38	37	15	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122219	10.1371/journal.pone.0122219	http://dx.doi.org/10.1371/journal.pone.0122219			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876061	gold, Green Published			2022-12-27	WOS:000353015800046
J	Lee, S; Jeong, SJ; Il Hwang, S; Hong, SK; Lee, HJ; Byun, SS; Choe, G; Lee, SE				Lee, Sangchul; Jeong, Seong Jin; Il Hwang, Sung; Hong, Sung Kyu; Lee, Hak Jong; Byun, Seok Soo; Choe, Gheeyoung; Lee, Sang Eun			Clinical Value of Core Length in Contemporary Multicore Prostate Biopsy	PLOS ONE			English	Article							CANCER-DETECTION RATE; RADICAL PROSTATECTOMY; SPECIMENS; QUALITY; SIZE; MEN	Objectives There is little data about the clinical value of core length for prostate biopsy (PBx). We investigated the clinical values of various clinicopathological biopsy-related parameters, including core length, in the contemporary multi-core PBx. Patients and Methods Medical records of 5,243 consecutive patients who received PBx at our institution were reviewed. Among them, 3,479 patients with prostate-specific antigen (PSA) <= 10ng/ml level who received transrectal ultrasound (TRUS)-guided multi (>= 12)-core PBx at our institution were analyzed for prostate cancer (PCa). Gleason score upgrading (GSU) was analyzed in 339 patients who were diagnosed with low-risk PCa and received radical prostatectomy. Multivariate logistic regression analyses for PCa detection and prediction of GSU were performed. Results The mean age and PSA of the entire cohort were 63.5 years and 5.4ng/ml, respectively. The overall cancer detection rate was 28.5%. There was no statistical difference in core length between patients diagnosed with PCa and those without PCa (16.1 +/- 1.8 vs 16.1 +/- 1.9mm, P = 0.945). The core length was also not significantly different (16.4 +/- 1.7 vs 16.4 +/- 1.6mm, P = 0.889) between the GSU group and non-GSU group. Multivariate logistic regression analyses demonstrated that the core length of PBx did not affect PCa detection in TRUS-guided multi-core PBx (P = 0.923) and was not prognostic for GSU in patients with low-risk PCa (P = 0.356). Conclusions In patients undergoing contemporary multi-core PBx, core length may not have significant impact on PCa detection and also GSU following radical prostatectomy among low-risk PCa group.	[Lee, Sangchul; Jeong, Seong Jin; Hong, Sung Kyu; Byun, Seok Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea; [Il Hwang, Sung; Lee, Hak Jong] Seoul Natl Univ, Bundang Hosp, Dept Radiol, Seongnam, South Korea; [Choe, Gheeyoung] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Seongnam, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU)	Hong, SK (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Seongnam, South Korea.	skhong@snubh.org		Hwang, Sung Il/0000-0001-7516-5369				Beauval JB, 2012, UROLOGY, V80, P656, DOI 10.1016/j.urology.2012.04.051; Bill-Axelson A, 2011, NEW ENGL J MED, V364, P1708, DOI 10.1056/NEJMoa1011967; Boccon-Gibod L, 2004, EUR UROL, V46, P177, DOI 10.1016/j.eururo.2004.04.006; Chun FKH, 2010, EUR UROL, V58, P851, DOI 10.1016/j.eururo.2010.08.041; Cicione A, 2012, UROL INT, V89, P57, DOI 10.1159/000339250; Dogan HS, 2005, EUR UROL, V47, P297, DOI 10.1016/j.eururo.2004.09.004; Eggener SE, 2011, J UROLOGY, V185, P869, DOI 10.1016/j.juro.2010.10.057; Eichler K, 2006, J UROLOGY, V175, P1605, DOI 10.1016/S0022-5347(05)00957-2; EPSTEIN JI, 1994, JAMA-J AM MED ASSOC, V271, P368, DOI 10.1001/jama.271.5.368; Ficarra V, 2006, EUR UROL, V50, P266, DOI 10.1016/j.eururo.2005.12.057; Fiset PO, 2013, CAN J UROL, V20, P6848; Guichard G, 2007, EUR UROL, V52, P430, DOI 10.1016/j.eururo.2007.02.062; Iczkowski KA, 2002, UROLOGY, V59, P698, DOI 10.1016/S0090-4295(02)01515-7; Inal GH, 2008, PROSTATE CANCER P D, V11, P270, DOI 10.1038/pcan.2008.34; Iremashvili V, 2012, CANCER-AM CANCER SOC, V118, P378, DOI 10.1002/cncr.26306; Jiang XK, 2013, EUR UROL, V63, P1031, DOI 10.1016/j.eururo.2013.01.035; Miller DC, 2006, JNCI-J NATL CANCER I, V98, P1134, DOI 10.1093/jnci/djj308; Mullins JK, 2012, J UROLOGY, V187, P1620, DOI 10.1016/j.juro.2011.12.072; Obek C, 2012, J UROLOGY, V187, P2051, DOI 10.1016/j.juro.2012.01.075; Rogatsch H, 2000, HUM PATHOL, V31, P1102, DOI 10.1053/hupa.2000.9837; Shariat Shahrokh F, 2008, Rev Urol, V10, P262; van der Kwast TH, 2003, J CLIN PATHOL, V56, P336, DOI 10.1136/jcp.56.5.336; Wilt TJ, 2012, NEW ENGL J MED, V367, P203, DOI 10.1056/NEJMoa1113162	23	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123704	10.1371/journal.pone.0123704	http://dx.doi.org/10.1371/journal.pone.0123704			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875823	Green Published, gold, Green Submitted			2022-12-27	WOS:000353014700039
J	Adegbija, O; Hoy, W; Wang, ZQ				Adegbija, Odewumi; Hoy, Wendy; Wang, Zhiqiang			Predicting Absolute Risk of Type 2 Diabetes Using Age and Waist Circumference Values in an Aboriginal Australian Community	PLOS ONE			English	Article							BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; POPULATION; OBESITY; PEOPLE; TOOL	Objectives To predict in an Australian Aboriginal community, the 10-year absolute risk of type 2 diabetes associated with waist circumference and age on baseline examination. Method A sample of 803 diabetes-free adults (82.3% of the age-eligible population) from baseline data of participants collected from 1992 to 1998 were followed-up for up to 20 years till 2012. The Cox-proportional hazard model was used to estimate the effects of waist circumference and other risk factors, including age, smoking and alcohol consumption status, of males and females on prediction of type 2 diabetes, identified through subsequent hospitalisation data during the follow-up period. The Weibull regression model was used to calculate the absolute risk estimates of type 2 diabetes with waist circumference and age as predictors. Results Of 803 participants, 110 were recorded as having developed type 2 diabetes, in subsequent hospitalizations over a follow-up of 12633.4 person-years. Waist circumference was strongly associated with subsequent diagnosis of type 2 diabetes with P<0.0001 for both genders and remained statistically significant after adjusting for confounding factors. Hazard ratios of type 2 diabetes associated with 1 standard deviation increase in waist circumference were 1.7 (95%CI 1.3 to 2.2) for males and 2.1 (95%CI 1.7 to 2.6) for females. At 45 years of age with baseline waist circumference of 100 cm, a male had an absolute diabetic risk of 10.9%, while a female had a 14.3% risk of the disease. Conclusions The constructed model predicts the 10-year absolute diabetes risk in an Aboriginal Australian community. It is simple and easily understood and will help identify individuals at risk of diabetes in relation to waist circumference values. Our findings on the relationship between waist circumference and diabetes on gender will be useful for clinical consultation, public health education and establishing WC cut-off points for Aboriginal Australians.	[Adegbija, Odewumi; Hoy, Wendy; Wang, Zhiqiang] Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia	University of Queensland	Adegbija, O (corresponding author), Univ Queensland, Sch Med, Ctr Chron Dis, Brisbane, Qld, Australia.	o.adegbija@uq.edu.au	Adegbija, Odewumi/N-1434-2019; Wang, Zhiqiang/A-5835-2010; Hoy, Wendy E/A-7325-2010	Wang, Zhiqiang/0000-0002-5839-743X; Hoy, Wendy E/0000-0002-8405-1539; Adegbija, Odewumi/0000-0001-6517-3795	National Health and Medical Research Council of Australia [APP1025350]; National Health and Medical Research Council of Australia grant [320860]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia grant(National Health and Medical Research Council (NHMRC) of Australia)	This project was supported by National Health and Medical Research Council of Australia APP1025350). The baseline screening was supported by National Health and Medical Research Council of Australia grant (320860). Dr Wendy Hoy's National Health and Medical Research Council of Australia Australia Research Fellowship (#511081). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Government, 2013, AB TORR STRAIT ISL D; Australian Government Department of Health, 2010, AUSTR TYP 2 DAIB RIS; Baker IDI Heart & Biabetes Institure Diabetes Australia, 2012, DIAB AUSTR DIAB SIL; Bambrick HJ, 2005, AUSTR INDIGENOUS HLT, V5, P1; Bergman RN, 2000, TRENDS ENDOCRIN MET, V11, P351, DOI 10.1016/S1043-2760(00)00323-4; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; Burke V, 2007, DIABETES RES CLIN PR, V78, P360, DOI 10.1016/j.diabres.2007.04.007; Chen L, 2010, MED J AUSTRALIA, V192, P197, DOI 10.5694/j.1326-5377.2010.tb03478.x; Chien K, 2009, DIABETOLOGIA, V52, P443, DOI 10.1007/s00125-008-1232-4; Chittleborough CR, 2007, PUBLIC HEALTH, V121, P92, DOI 10.1016/j.puhe.2006.09.017; Daniel M, 1999, DIABETES CARE, V22, P1993, DOI 10.2337/diacare.22.12.1993; Diabetes Australia Guideline Development Consortium, 2009, NAT EV BAS GUID CAW, V2009, P1; Hearst News Service, 1908, HEARST NEWS SER 0507, P1; Hoy WE, 2000, MED J AUSTRALIA, V172, P473, DOI 10.5694/j.1326-5377.2000.tb124070.x; Janiszewski PM, 2007, DIABETES CARE, V30, P3105, DOI 10.2337/dc07-0945; Kondalsamy-Chennakesavan S, 2008, AM J HUM BIOL, V20, P317, DOI 10.1002/ajhb.20729; Lindstrom J, 2003, DIABETES CARE, V26, P725, DOI 10.2337/diacare.26.3.725; McDermott RA, 2010, MED J AUSTRALIA, V192, P562, DOI 10.5694/j.1326-5377.2010.tb03636.x; O'Dea K., 1987, P NUTR SOC AUST, V12, P56; Schmidt MI, 2005, DIABETES CARE, V28, P2013, DOI 10.2337/diacare.28.8.2013; StataCorp, 2011, STAT STAT SOFTW REL, P173; Wang YF, 2005, AM J CLIN NUTR, V81, P555; Wang Z, 2004, INT J OBESITY, V28, P1580, DOI 10.1038/sj.ijo.0802771; Wang Z, 2004, EUR J CLIN NUTR, V58, P888, DOI 10.1038/sj.ejcn.1601891; Wang Z, 2010, BMC EMERG MED, V10, DOI [10.1186/1471-227X-10-1, 10.1186/1471-2458-10-487]; Wang ZQ, 2003, ETHNIC DIS, V13, P324	26	8	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123788	10.1371/journal.pone.0123788	http://dx.doi.org/10.1371/journal.pone.0123788			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876058	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100213
J	Chen, CC; Chang, MW; Chang, CP; Chang, WY; Chang, SC; Lin, MT; Yang, CL				Chen, Chi-Chun; Chang, Ming-Wen; Chang, Ching-Ping; Chang, Wen-Ying; Chang, Shin-Chieh; Lin, Mao-Tsun; Yang, Chin-Lung			Improved Infrared-Sensing Running Wheel Systems with an Effective Exercise Activity Indicator	PLOS ONE			English	Article							CEREBRAL-ARTERY OCCLUSION; REGIONAL ANGIOGENESIS; PHYSICAL-ACTIVITY; FORCED EXERCISE; ISCHEMIA; BRAIN; MODEL; RATS; VOLUNTARY; NEUROGENESIS	This paper describes an infrared-sensing running wheel (ISRW) system for the quantitative measurement of effective exercise activity in rats. The ISRW system provides superior exercise training compared with commercially available traditional animal running platforms. Four infrared (IR) light-emitting diode/detector pairs embedded around the rim of the wheel detect the rat's real-time position; the acrylic wheel has a diameter of 55 cm and a thickness of 15 cm, that is, it is larger and thicker than traditional exercise wheels, and it is equipped with a rubber track. The acrylic wheel hangs virtually frictionless, and a DC motor with an axially mounted rubber wheel, which has a diameter of 10 cm, drives the acrylic wheel from the outer edge. The system can automatically train rats to run persistently. The proposed system can determine effective exercise activity (EEA), with the IR sensors (which are connected to a conventional PC) recording the rat exercise behavior. A prototype of the system was verified by a hospital research group performing ischemic stroke experiments on rats by considering middle cerebral artery occlusion. The experimental data demonstrated that the proposed system provides greater neuroprotection in an animal stroke model compared with a conventional treadmill and a motorized running wheel for a given exercise intensity. The quantitative exercise effectiveness indicator showed a 92% correlation between an increase in the EEA and a decrease in the infarct volume. This indicator can be used as a noninvasive and objective reference in clinical animal exercise experiments.	[Chen, Chi-Chun; Chang, Shin-Chieh] Natl Chin Yi Univ Technol, Dept Elect Engn, Taichung, Taiwan; [Chang, Ming-Wen] South Taiwan Univ Sci & Technol, Dept Elect Engn, Tainan, Taiwan; [Chang, Ching-Ping] South Taiwan Univ Sci & Technol, Tainan, Taiwan; [Chang, Wen-Ying; Yang, Chin-Lung] Natl Cheng Kung Univ, Dept Elect Engn, Tainan 70101, Taiwan; [Lin, Mao-Tsun] ChiMei Med Ctr, Dept Med Res, Tainan, Taiwan	National Chin-Yi University of Technology; National Cheng Kung University	Yang, CL (corresponding author), Natl Cheng Kung Univ, Dept Elect Engn, 1 Univ Rd, Tainan 70101, Taiwan.	cyang@mail.ncku.edu.tw	Yang, Chin-Lung/D-4008-2015	Yang, Chin-Lung/0000-0002-5542-7576; Chang, Ching-Ping/0000-0003-0890-9414				Adlard PA, 2005, J NEUROSCI, V25, P4217, DOI 10.1523/JNEUROSCI.0496-05.2005; Arida RM, 2004, NEUROSCI LETT, V364, P135, DOI 10.1016/j.neulet.2004.03.086; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; BEDERSON JB, 1986, STROKE, V17, P472, DOI 10.1161/01.STR.17.3.472; Belayev L, 1996, STROKE, V27, P1616, DOI 10.1161/01.STR.27.9.1616; Brown DA, 2007, J APPL PHYSIOL, V103, P1979, DOI 10.1152/japplphysiol.00706.2007; Buchheit M, 2013, SPORTS MED, V43, P927, DOI 10.1007/s40279-013-0066-5; Caton SJ, 2012, PHYSIOL BEHAV, V106, P185, DOI 10.1016/j.physbeh.2012.02.003; Chang MW, 2008, J NEUROSCI METH, V168, P186, DOI 10.1016/j.jneumeth.2007.09.013; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Dalleck LC, 2013, PREV MED, V57, P392, DOI 10.1016/j.ypmed.2013.06.002; Demirel HA, 1998, MED SCI SPORT EXER, V30, P1211, DOI 10.1097/00005768-199808000-00005; Ding Y, 2004, NEUROSCIENCE, V124, P583, DOI 10.1016/j.neuroscience.2003.12.029; Ding YC, 2003, STROKE, V34, P240; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fantegrossi WE, 2013, J NEUROSCI METH, V212, P338, DOI 10.1016/j.jneumeth.2012.10.020; FORDYCE DE, 1991, BEHAV BRAIN RES, V46, P123, DOI 10.1016/S0166-4328(05)80105-6; Frasier CR, 2011, J APPL PHYSIOL, V111, P905, DOI 10.1152/japplphysiol.00004.2011; Gartshore G, 1997, EXP NEUROL, V147, P353, DOI 10.1006/exnr.1997.6635; Greenwood BN, 2013, EUR J NEUROSCI, V37, P469, DOI 10.1111/ejn.12044; Hayes K, 2008, ACTA NEUROPATHOL, V115, P289, DOI 10.1007/s00401-008-0340-z; Hillman CH, 2008, BE SMART EXERCISE YO; Jin J, 2010, BRAIN INJURY, V24, P533, DOI 10.3109/02699051003610458; Ke Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016643; Kennard JA, 2012, PHYSIOL BEHAV, V106, P423, DOI 10.1016/j.physbeh.2012.02.023; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Leasure JL, 2008, NEUROSCIENCE, V156, P456, DOI 10.1016/j.neuroscience.2008.07.041; Li J, 2004, NEUROL RES, V26, P404, DOI 10.1179/016164104225016038; Liebetanz D, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-168; LIN TN, 1993, STROKE, V24, P117, DOI 10.1161/01.STR.24.1.117; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Moraska A, 2000, AM J PHYSIOL-REG I, V279, pR1321, DOI 10.1152/ajpregu.2000.279.4.R1321; Peng CW, 2011, J MED BIOL ENG, V31, P1, DOI 10.5405/jmbe.718; Raichlen DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020601; ROGERS RL, 1990, J AM GERIATR SOC, V38, P123, DOI 10.1111/j.1532-5415.1990.tb03472.x; Schmidt-Kassow M, 2012, NEUROREPORT, V23, P889, DOI 10.1097/WNR.0b013e32835946ca; Smith AD, 2003, EXP NEUROL, V184, P31, DOI 10.1016/j.expneurol.2003.08.017; Symons JD, 2003, J APPL PHYSIOL, V95, P1638, DOI 10.1152/japplphysiol.01168.2002; Todoroki K, 2004, JPN J PHYS FIT SPORT, V53, P537, DOI 10.7600/jspfsm1949.53.537; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Vancini RL, 2013, EPILEPSY BEHAV, V29, P431, DOI 10.1016/j.yebeh.2013.08.023; Wang RY, 2001, BRAIN RES, V922, P140, DOI 10.1016/S0006-8993(01)03154-7; Waters RP, 2008, PHYSIOL BEHAV, V93, P1044, DOI 10.1016/j.physbeh.2008.01.013; Yanagita S, 2007, LIFE SCI, V80, P356, DOI 10.1016/j.lfs.2006.09.027; Zhang F, 2011, NEUROSCIENCE, V177, P170, DOI 10.1016/j.neuroscience.2011.01.018	49	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122394	10.1371/journal.pone.0122394	http://dx.doi.org/10.1371/journal.pone.0122394			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875841	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100070
J	Noble, C; Nilsson, AN; Freitag, C; Beech, JP; Tegenfeldt, JO; Ambjornsson, T				Noble, Charleston; Nilsson, Adam N.; Freitag, Camilla; Beech, Jason P.; Tegenfeldt, Jonas O.; Ambjornsson, Tobias			A Fast and Scalable Kymograph Alignment Algorithm for Nanochannel-Based Optical DNA Mappings	PLOS ONE			English	Article							ORDERED RESTRICTION MAPS; SINGLE-MOLECULE APPROACH; AXONAL-TRANSPORT; DYNAMICS; SEQUENCE	Optical mapping by direct visualization of individual DNA molecules, stretched in nanochannels with sequence-specific fluorescent labeling, represents a promising tool for disease diagnostics and genomics. An important challenge for this technique is thermal motion of the DNA as it undergoes imaging; this blurs fluorescent patterns along the DNA and results in information loss. Correcting for this effect (a process referred to as kymograph alignment) is a common preprocessing step in nanochannel-based optical mapping workflows, and we present here a highly efficient algorithm to accomplish this via pattern recognition. We compare our method with the one previous approach, and we find that our method is orders of magnitude faster while producing data of similar quality. We demonstrate proof of principle of our approach on experimental data consisting of melt mapped bacteriophage DNA.	[Noble, Charleston; Nilsson, Adam N.; Ambjornsson, Tobias] Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden; [Noble, Charleston; Freitag, Camilla; Beech, Jason P.; Tegenfeldt, Jonas O.] Lund Univ, Dept Phys, Div Solid State Phys, S-22362 Lund, Sweden; [Freitag, Camilla] Gothenburg Univ, Dept Phys, Gothenburg, Sweden	Lund University; Lund University; University of Gothenburg	Ambjornsson, T (corresponding author), Lund Univ, Dept Astron & Theoret Phys, Lund, Sweden.	tobias.ambjornsson@thep.lu.se	beech, jason/A-5831-2010; Tegenfeldt, Jonas/B-9506-2008	beech, jason/0000-0002-1347-4657; Tegenfeldt, Jonas/0000-0002-3695-6886; Ambjornsson, Tobias/0000-0002-6439-8842; Kinos, Adam/0000-0002-1472-0100	Swedish Research Council [2009-2924, 2007-584]; VINNOVA [P35735-1]; Carl Tryggers Foundation [12: 13]; Hasselblad Foundation	Swedish Research Council(Swedish Research CouncilEuropean Commission); VINNOVA(Vinnova); Carl Tryggers Foundation; Hasselblad Foundation	TA, Swedish Research Council, grant no. 2009-2924, http://www.vr.se/ Funding provided to JOT, 2007-584, Swedish Research Council, grant no. 2007-584, http://www.vr.se/, JOT, VINNOVA, grant number P35735-1, http://www.vinnova.se/en/, TA, The Carl Tryggers Foundation grant no. 12: 13 http://www.carltryggersstiftelse.se/, and JOT, The Hasselblad Foundation http://www.hasselbladfoundation.org/news. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ananiev GE, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-68; Aston C, 1999, TRENDS BIOTECHNOL, V17, P297, DOI 10.1016/S0167-7799(99)01326-8; Baday M, 2012, NANO LETT, V12, P3861, DOI 10.1021/nl302069q; BENSIMON A, 1994, SCIENCE, V265, P2096, DOI 10.1126/science.7522347; CAI WW, 1995, P NATL ACAD SCI USA, V92, P5164, DOI 10.1073/pnas.92.11.5164; Cai WW, 1998, P NATL ACAD SCI USA, V95, P3390, DOI 10.1073/pnas.95.7.3390; Chetta J, 2011, J NEUROSCI METH, V199, P230, DOI 10.1016/j.jneumeth.2011.05.013; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cormen Thomas H., 2009, INTRO ALGORITHMS; Cover TM, 1991, ELEMENTS INFORM THEO, P12, DOI [10.1002/0471200611.ch2, DOI 10.1002/0471200611.CH2]; Das SK, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq673; de Gennes P. G., 1979, SCALING CONCEPTS POL; Douville N, 2008, ANAL BIOANAL CHEM, V391, P2395, DOI 10.1007/s00216-008-1995-y; Haghnia M, 2007, MOL BIOL CELL, V18, P2081, DOI 10.1091/mbc.E06-08-0695; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Huang KM, 2008, 2008 IEEE SOUTHWEST SYMPOSIUM ON IMAGE ANALYSIS & INTERPRETATION, P29, DOI 10.1109/SSIAI.2008.4512277; Jing JP, 1998, P NATL ACAD SCI USA, V95, P8046, DOI 10.1073/pnas.95.14.8046; Jo K, 2007, P NATL ACAD SCI USA, V104, P2673, DOI 10.1073/pnas.0611151104; Kotewicz ML, 2007, MICROBIOL-SGM, V153, P1720, DOI 10.1099/mic.0.2006/004507-0; Lim SF, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3613671; Marie R, 2013, P NATL ACAD SCI USA, V110, P4893, DOI 10.1073/pnas.1214570110; MENG X, 1995, NAT GENET, V9, P432, DOI 10.1038/ng0495-432; Miller KE, 2004, J CELL SCI, V117, P2791, DOI 10.1242/jcs.01130; Neely RK, 2011, BIOPOLYMERS, V95, P298, DOI 10.1002/bip.21579; Neely RK, 2010, CHEM SCI, V1, P453, DOI 10.1039/c0sc00277a; Nilsson AN, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku556; Nyberg LK, 2012, BIOCHEM BIOPH RES CO, V417, P404, DOI 10.1016/j.bbrc.2011.11.128; Obashi K, 2013, EUR J NEUROSCI, V38, P2350, DOI 10.1111/ejn.12263; Persson F, 2010, CHEM SOC REV, V39, P985, DOI 10.1039/b912918a; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reisner W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.196101; Reisner W, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/10/106601; Reisner W, 2010, P NATL ACAD SCI USA, V107, P13294, DOI 10.1073/pnas.1007081107; SAMAD A, 1995, GENOME RES, V5, P1, DOI 10.1101/gr.5.1.1; SCHWARTZ DC, 1993, SCIENCE, V262, P110, DOI 10.1126/science.8211116; Shukla SK, 2009, J BACTERIOL, V191, P5717, DOI 10.1128/JB.00325-09; Tegenfeldt JO, 2004, P NATL ACAD SCI USA, V101, P10979, DOI 10.1073/pnas.0403849101; Tsibidis GD, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-86; Valouev A, 2006, J COMPUT BIOL, V13, P442, DOI 10.1089/cmb.2006.13.442; Valouev A, 2006, P NATL ACAD SCI USA, V103, P15770, DOI 10.1073/pnas.0604040103; Welch RA, 2002, P NATL ACAD SCI USA, V99, P17020, DOI 10.1073/pnas.252529799; Xiao M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1044; Zhou HM, 2001, J NEUROSCI, V21, P3749, DOI 10.1523/JNEUROSCI.21-11-03749.2001; Zhou S, 2004, J BACTERIOL, V186, P7773, DOI 10.1128/JB.186.22.7773-7782.2004; Zhou SG, 2002, APPL ENVIRON MICROB, V68, P6321, DOI 10.1128/AEM.68.12.6321-6331.2002	46	6	7	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121905	10.1371/journal.pone.0121905	http://dx.doi.org/10.1371/journal.pone.0121905			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875920	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100052
J	Schrimpf, C; Gillmann, HJ; Sahlmann, B; Meinders, A; Larmann, J; Wilhelmi, M; Aper, T; Rustum, S; Lichtinghagen, R; Theilmeier, G; Teebken, OE				Schrimpf, Claudia; Gillmann, Hans-Joerg; Sahlmann, Bianca; Meinders, Antje; Larmann, Jan; Wilhelmi, Mathias; Aper, Thomas; Rustum, Saad; Lichtinghagen, Ralf; Theilmeier, Gregor; Teebken, Omke E.			Renal Function Interferes with Copeptin in Prediction of Major Adverse Cardiac Events in Patients Undergoing Vascular Surgery	PLOS ONE			English	Article							CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; VASOPRESSIN; TROPONIN; RULE; BIOMARKERS; ISCHEMIA; SYSTEM; RISK	Objective Precise perioperative risk stratification is important in vascular surgery patients who are at high risk for major adverse cardiovascular events (MACE) peri- and postoperatively. In clinical practice, the patient's perioperative risk is predicted by various indicators, e.g. revised cardiac index (RCRI) or modifications thereof. Patients suffering from chronic kidney disease (CKD) are stratified into a higher risk category. We hypothesized that Copeptin as a novel biomarker for hemodynamic stress could help to improve the prediction of perioperative cardiovascular events in patients undergoing vascular surgery including patients with chronic kidney disease. Methods 477 consecutive patients undergoing abdominal aortic, peripheral arterial or carotid surgery from June 2007 to October 2012 were prospectively enrolled. Primary endpoint was 30-day postoperative major adverse cardiovascular events (MACE). Results 41 patients reached the primary endpoint, including 63.4% aortic, 26.8% carotid, and 9.8% peripheral surgeries. Linear regression analysis showed that RCRI (P<.001), pre(P<.001), postoperative Copeptin (P<.001) and Copeptin level change (P=.001) were associated with perioperative MACE, but CKD remained independently associated with MACE and Copeptin levels. Multivariate regression showed that increased Copeptin levels added risk predictive information to the RCRI (P=.003). Especially in the intermediate RCRI categories was Copeptin significantly associated with the occurrence of MACE. (P<.05 Kruskal Wallis test). Subdivision of the study cohort into CKD stages revealed that preoperative Copeptin was significantly associated with CKD stages (P<.0001) and preoperative Copeptin measurements could not predict MACE in patients with more severe CKD stages. Conclusion Preoperative Copeptin loses its risk predictive potential for perioperative MACE in patients with chronic kidney disease undergoing vascular surgery.	[Schrimpf, Claudia; Wilhelmi, Mathias; Aper, Thomas; Rustum, Saad; Teebken, Omke E.] Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Div Vasc & Endovasc Surg, Hannover, Germany; [Gillmann, Hans-Joerg; Sahlmann, Bianca; Meinders, Antje; Larmann, Jan; Theilmeier, Gregor] Hannover Med Sch, Dept Anesthesiol & Intens Care Med, Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Dept Clin Chem, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Teebken, OE (corresponding author), Hannover Med Sch, Dept Cardiothorac Transplantat & Vasc Surg, Div Vasc & Endovasc Surg, Hannover, Germany.	teebken.omke@mh-hannover.de	; Larmann, Jan/B-4034-2011	Aper, Thomas/0000-0001-9549-0249; Larmann, Jan/0000-0003-3365-4572				Abbasi A, 2012, DIABETOLOGIA, V55, P1963, DOI 10.1007/s00125-012-2545-x; Bertges DJ, 2010, J VASC SURG, V52, P674, DOI 10.1016/j.jvs.2010.03.031; Bottiger BW, 2004, ANAESTHESIA, V59, P1083, DOI 10.1111/j.1365-2044.2004.03960.x; Botto F, 2014, ANESTHESIOLOGY, V120, P564, DOI 10.1097/ALN.0000000000000113; Charpentier S, 2012, ACAD EMERG MED, V19, P517, DOI 10.1111/j.1553-2712.2012.01350.x; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Fenske W, 2011, J AM SOC NEPHROL, V22, P782, DOI 10.1681/ASN.2010070691; Gillmann HJ, 2014, CRIT CARE MED, V42, P1498, DOI 10.1097/CCM.0000000000000249; Hoeks SE, 2009, AM J MED, V122, P559, DOI 10.1016/j.amjmed.2008.10.041; Holmes CL, 2004, CRIT CARE, V8, P15, DOI 10.1186/cc2338; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Jarai R, 2011, AM J CARDIOL, V108, P1188, DOI 10.1016/j.amjcard.2011.06.024; Jochberger S, 2009, CRIT CARE MED, V37, P476, DOI 10.1097/CCM.0b013e3181957532; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Lin S, 2012, RESUSCITATION, V83, P684, DOI 10.1016/j.resuscitation.2011.12.015; Luyt CE, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.12.009; Maravic-Stojkovic V, 2014, ANGIOLOGY, V65, P122, DOI 10.1177/0003319712473637; Morgenthaler NG, 2008, TRENDS ENDOCRIN MET, V19, P43, DOI 10.1016/j.tem.2007.11.001; Ray P, 2012, AM J EMERG MED, V30, P440, DOI 10.1016/j.ajem.2011.12.008; Reichlin T, 2009, J AM COLL CARDIOL, V54, P60, DOI 10.1016/j.jacc.2009.01.076; Sutton R, 2002, BRIT J SURG, V89, P763, DOI 10.1046/j.1365-2168.2002.02080.x; Thygesen K, 2012, J AM COLL CARDIOL, V60, P1581, DOI 10.1016/j.jacc.2012.08.001; Vondrakova D, 2011, INT J CARDIOL, V150, P343, DOI 10.1016/j.ijcard.2011.05.029	23	17	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123093	10.1371/journal.pone.0123093	http://dx.doi.org/10.1371/journal.pone.0123093			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	VK4RY	25875814	gold, Green Published, Green Submitted			2022-12-27	WOS:000703335300001
J	Sreedhar, RV; Kumari, P; Rupwate, SD; Rajasekharan, R; Srinivasan, M				Sreedhar, R. V.; Kumari, Priya; Rupwate, Sunny D.; Rajasekharan, Ram; Srinivasan, Malathi			Exploring Triacylglycerol Biosynthetic Pathway in Developing Seeds of Chia (Salvia hispanica L.): A Transcriptomic Approach	PLOS ONE			English	Article							MONOACYLGLYCEROL ACYLTRANSFERASE; DIACYLGLYCEROL ACYLTRANSFERASE; BIFUNCTIONAL ENZYME; RNA-SEQ; EXPRESSION; ALIGNMENT; GENOME; LIPIDS; GENES	Chia (Salvia hispanica L.), a member of the mint family (Lamiaceae), is a rediscovered crop with great importance in health and nutrition and is also the highest known terrestrial plant source of heart-healthy omega-3 fatty acid, alpha linolenic acid (ALA). At present, there is no public genomic information or database available for this crop, hindering research on its genetic improvement through genomics-assisted breeding programs. The first comprehensive analysis of the global transcriptome profile of developing Salvia hispanica L. seeds, with special reference to lipid biosynthesis is presented in this study. RNA from five different stages of seed development was extracted and sequenced separately using the Illumina GAIIx platform. De novo assembly of processed reads in the pooled transcriptome using Trinity yielded 76,014 transcripts. The total transcript length was 66,944,462 bases (66.9 Mb), with an average length of approximately 880 bases. In the molecular functions category of Gene Ontology (GO) terms, ATP binding and nucleotide binding were found to be the most abundant and in the biological processes category, the metabolic process and the regulation of transcription-DNA-dependent and oxidation-reduction process were abundant. From the EuKaryotic Orthologous Groups of proteins (KOG) classification, the major category was "Metabolism" (31.97%), of which the most prominent class was 'carbohydrate metabolism and transport' (5.81% of total KOG classifications) followed by 'secondary metabolite biosynthesis transport and catabolism' (5.34%) and 'lipid metabolism' (4.57%). A majority of the candidate genes involved in lipid biosynthesis and oil accumulation were identified. Furthermore, 5596 simple sequence repeats (SSRs) were identified. The transcriptome data was further validated through confirmative PCR and qRT-PCR for select lipid genes. Our study provides insight into the complex transcriptome and will contribute to further genome-wide research and understanding of chia. The identified novel UniGenes will facilitate gene discovery and creation of genomic resource for this crop.	[Sreedhar, R. V.; Kumari, Priya; Srinivasan, Malathi] CSIR, CFTRI, LIPIC, Resource Ctr,Lipidomic Ctr, Bangalore 560065, Karnataka, India; [Rupwate, Sunny D.; Rajasekharan, Ram] CSIR, CFTRI, LIPIC, Lipid Ctr, Mysore 570020, Karnataka, India; [Srinivasan, Malathi] CSIR, Acad Sci & Innovat Res, New Delhi 110025, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India	Srinivasan, M (corresponding author), CSIR, CFTRI, LIPIC, Resource Ctr,Lipidomic Ctr, Bangalore 560065, Karnataka, India.	m.srinivasan@cftri.res.in	Rajasekharan, Ram/R-2257-2019	Ram, Rajasekharan/0000-0002-4114-0654	Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project LIPIC [BSC0401]	Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project LIPIC	This work was financially supported by Council of Scientific and Industrial Research (CSIR), INDIA through 12th Five year plan project LIPIC (BSC0401). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; [Anonymous], 2013, OFFICIAL J EUROPEA L, V21; Apweiler R, 2013, NUCLEIC ACIDS RES, V41, pD43, DOI 10.1093/nar/gks1068; Ayerza(h) Ricardo, 2008, P377, DOI 10.1007/978-1-59745-330-1_26; Ayerza R, 2011, IND CROP PROD, V34, P1366, DOI 10.1016/j.indcrop.2010.12.007; Bates PD, 2012, PLANT PHYSIOL, V160, P1530, DOI 10.1104/pp.112.204438; Blake JA, 2012, NUCLEIC ACIDS RES, V40, pD559, DOI 10.1093/nar/gkr1028; Bourre J M, 2004, J Nutr Health Aging, V8, P163; Bozhko M, 2003, MOL ECOL, V12, P3147, DOI 10.1046/j.1365-294X.2003.01983.x; Compeau PEC, 2011, NAT BIOTECHNOL, V29, P987, DOI 10.1038/nbt.2023; Ge XX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087693; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haslam RP, 2013, PLANT BIOTECHNOL J, V11, P157, DOI 10.1111/pbi.12012; Huima, 2013, BMC PLANT BIOL, V13, P152, DOI [10.1186/1471-2229-13-152, DOI 10.1186/1471-2229-13-152]; Jako C, 2001, PLANT PHYSIOL, V126, P861, DOI 10.1104/pp.126.2.861; KENNEDY EP, 1961, FED PROC, V20, P934; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Legrand S, 2010, GENE, V450, P55, DOI 10.1016/j.gene.2009.10.004; Li MY, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.10; Monsanto Company, 2009, STEAR SDA OM 3 SOYB; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz LA, 2013, FOOD REV INT, V29, P394, DOI 10.1080/87559129.2013.818014; Nykiforuk CL, 2012, TRANSGENIC RES, V21, P367, DOI 10.1007/s11248-011-9543-5; OHLROGGE JB, 1991, BIOCHIM BIOPHYS ACTA, V1082, P1, DOI 10.1016/0005-2760(91)90294-R; Park YH, 2005, MOL GENET GENOMICS, V274, P428, DOI 10.1007/s00438-005-0037-0; Parthibane V, 2012, J BIOL CHEM, V287, P1946, DOI 10.1074/jbc.M111.309955; Patel RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030619; Reyes-Caudillo E, 2008, FOOD CHEM, V107, P656, DOI 10.1016/j.foodchem.2007.08.062; Rupwate SD, 2012, FEBS LETT, V586, P1555, DOI 10.1016/j.febslet.2012.04.022; Saha S, 2006, PLANT PHYSIOL, V141, P1533, DOI 10.1104/pp.106.082198; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Small Ernest, 2011, Biodiversity (Ottawa), V12, P49, DOI 10.1080/14888386.2011.575104; USDA, 2011, MILK NAT NUTR DAT ST; Varshney RK, 2009, TRENDS BIOTECHNOL, V27, P522, DOI 10.1016/j.tibtech.2009.05.006; Vijayaraj P, 2012, PLANT PHYSIOL, V160, P667, DOI 10.1104/pp.112.202135; Wang HW, 2007, PLANT J, V52, P716, DOI 10.1111/j.1365-313X.2007.03268.x; Wang LP, 2012, PLANT CELL, V24, P4652, DOI 10.1105/tpc.112.104604; Wei L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084105; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080464; Zhang J, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-228	40	28	29	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123580	10.1371/journal.pone.0123580	http://dx.doi.org/10.1371/journal.pone.0123580			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875809	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100191
J	Stroo, I; Claessen, N; Teske, GJD; Butter, LM; Florquin, S; Leemans, JC				Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Butter, Loes M.; Florquin, Sandrine; Leemans, Jaklien C.			Deficiency for the Chemokine Monocyte Chemoattractant Protein-1 Aggravates Tubular Damage after Renal Ischemia/Reperfusion Injury	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; EPITHELIAL-CELLS; ISCHAEMIA/REPERFUSION INJURY; INDUCED APOPTOSIS; OXIDATIVE STRESS; KAPPA-B; EXPRESSION; KIDNEY; REPAIR; GROWTH	Temporal expression of chemokines is a crucial factor in the regulation of renal ischemia/reperfusion (I/R) injury and repair. Beside their role in the migration and activation of inflammatory cells to sites of injury, chemokines are also involved in other processes such as angiogenesis, development and migration of stem cells. In the present study we investigated the role of the chemokine MCP-1 (monocyte chemoattractant protein-1 or CCL2), the main chemoattractant for monocytes, during renal I/R injury. MCP-1 expression peaks several days after inducing renal I/R injury coinciding with macrophage accumulation. However, MCP-1 deficient mice had a significant decreased survival and increased renal damage within the first two days, i.e. the acute inflammatory response, after renal I/R injury with no evidence of altered macrophage accumulation. Kidneys and primary tubular epithelial cells from MCP-1 deficient mice showed increased apoptosis after ischemia. Taken together, MCP-1 protects the kidney during the acute inflammatory response following renal I/R injury.	[Stroo, Ingrid; Claessen, Nike; Teske, Gwendoline J. D.; Butter, Loes M.; Florquin, Sandrine; Leemans, Jaklien C.] Univ Amsterdam, Acad Med Ctr, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Stroo, I (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Pathol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	I.Stroo@amc.uva.nl	Leemans, Jaklien/AAM-4958-2020		Dutch Kidney Foundation (NSN) [2059]	Dutch Kidney Foundation (NSN)	This work was supported by a grant from the Dutch Kidney Foundation (NSN#2059) (IS/JCL) (http://www.nierstichting.nl/asset/voor-professionals/biomedisch-onderzoek/report-bwo-proj-groups-20feb12.pdf). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnhold J, 2010, ARCH BIOCHEM BIOPHYS, V500, P92, DOI 10.1016/j.abb.2010.04.008; Bolignano D, 2008, AM J KIDNEY DIS, V52, P595, DOI 10.1053/j.ajkd.2008.01.020; Buckley S, 2008, AM J PHYSIOL-LUNG C, V294, pL739, DOI 10.1152/ajplung.00294.2007; Dessing MC, 2014, KIDNEY INT; Dewald O, 2005, CIRC RES, V96, P881, DOI 10.1161/01.RES.0000163017.13772.3a; Diaz-Guerra E, 2007, J IMMUNOL, V179, P7352, DOI 10.4049/jimmunol.179.11.7352; Eugenin EA, 2003, J NEUROCHEM, V85, P1299, DOI 10.1046/j.1471-4159.2003.01775.x; Fridlender ZG, 2011, AM J RESP CELL MOL, V44, P230, DOI 10.1165/rcmb.2010-0080OC; Furuichi K, 2003, J AM SOC NEPHROL, V14, P1066, DOI 10.1097/01.ASN.0000059339.14780.E4; Furuichi K, 2003, J AM SOC NEPHROL, V14, P2503, DOI 10.1097/01.ASN.0000089563.63641.A8; Guan QN, 2010, TRANSPLANTATION, V89, P1320, DOI 10.1097/TP.0b013e3181d8e9dc; JIANG YL, 1992, J IMMUNOL, V148, P2423; Ko GJ, 2010, AM J PHYSIOL-RENAL, V298, pF1472, DOI 10.1152/ajprenal.00619.2009; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Leemans JC, 2005, J CLIN INVEST, V115, P2894, DOI 10.1172/JCI22832; Lu B, 1998, J EXP MED, V187, P601, DOI 10.1084/jem.187.4.601; Mantovani A, 2009, ARTERIOSCL THROM VAS, V29, P1419, DOI 10.1161/ATVBAHA.108.180497; Miura M, 2001, AM J PATHOL, V159, P2137, DOI 10.1016/S0002-9440(10)63065-9; Morimoto H, 2008, CARDIOVASC RES, V78, P554, DOI 10.1093/cvr/cvn035; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; PRODJOSUDJADI W, 1995, KIDNEY INT, V48, P1477, DOI 10.1038/ki.1995.437; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Rice JC, 2002, RENAL FAILURE, V24, P703, DOI 10.1081/JDI-120015673; Roca H, 2009, J BIOL CHEM, V284, P34342, DOI 10.1074/jbc.M109.042671; Rozen S, 2000, Methods Mol Biol, V132, P365; SAFIRSTEIN R, 1991, AM J PHYSIOL, V261, pF1095, DOI 10.1152/ajprenal.1991.261.6.F1095; Schecter AD, 2004, J LEUKOCYTE BIOL, V75, P1079, DOI 10.1189/jlb.0903421; SCHMOUDER RL, 1993, KIDNEY INT, V44, P43, DOI 10.1038/ki.1993.211; Segerer S, 2000, J AM SOC NEPHROL, V11, P152, DOI 10.1681/ASN.V111152; Shin I, 2001, MOL BIOL CELL, V12, P3328, DOI 10.1091/mbc.12.11.3328; Shirernan PK, 2007, J LEUKOCYTE BIOL, V81, P775, DOI 10.1189/jlb.0506356; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Stokman G, 2010, NEPHROL DIAL TRANSPL, V25, P3852, DOI 10.1093/ndt/gfq311; Stroo I, 2010, INT IMMUNOL, V22, P433, DOI 10.1093/intimm/dxq025; Sung FL, 2002, KIDNEY INT, V62, P1160, DOI 10.1111/j.1523-1755.2002.kid577.x; Tarzami ST, 2005, BIOCHEM BIOPH RES CO, V335, P1008, DOI 10.1016/j.bbrc.2005.07.168; Vaidya VS, 2006, AM J PHYSIOL-RENAL, V290, pF517, DOI 10.1152/ajprenal.00291.2005; Viedt C, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000015609.31253.7F; Voskuil M, 2004, VASC MED, V9, P287, DOI 10.1191/1358863x04vm571oa; WUTHRICH RP, 1990, KIDNEY INT, V37, P783, DOI 10.1038/ki.1990.46; Zamara E, 2007, J HEPATOL, V46, P230, DOI 10.1016/j.jhep.2006.09.007	43	17	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123203	10.1371/journal.pone.0123203	http://dx.doi.org/10.1371/journal.pone.0123203			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875776	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100150
J	Yu, Y; Zhao, W; Zhu, CP; Kong, ZP; Xu, Y; Liu, GZ; Gao, XG				Yu, Yao; Zhao, Wei; Zhu, Chunpeng; Kong, Zhiping; Xu, Yan; Liu, Guangzhi; Gao, Xuguang			The Clinical Effect of Deferoxamine Mesylate on Edema after Intracerebral Hemorrhage	PLOS ONE			English	Article							PERIHEMATOMAL EDEMA; BRAIN-INJURY; IRON ACCUMULATION; NATURAL-HISTORY; NEURONAL DEATH; RAT MODEL; STROKE	Background and Purpose It has been shown that 3 days of 62 mg/kg/day deferoxamine infusion (maximum dose not to exceed 6000 mg/day) is safe and tolerated by intracerebral hemorrhage (ICH) patients. The aim of this study was to investigate the efficacy of deferoxamine mesylate for edema resolution and hematoma absorption after ICH. Methods From February 2013 to May 2014, spontaneous ICH patients diagnosed by computed tomography (CT) within 18 hours of onset were evaluated. Patients were randomly divided into two groups: an experimental group and a control group. The treatment of the two groups was similar except that the experimental group received deferoxamine mesylate. Patients were evaluated by CT and neurology scale at the time of admission, and on the fourth, eighth, and fifteenth day (or at discharge) after admission. Patients were followed up for the first 30 days and clinical data of the two groups were compared. Results Forty-two patients completed 30 days of follow-up by May 2014; 21 cases in the experimental group and 21 cases in the control group. The control group's relative edema volume on the fifteenth day (or discharge) was 10.26 +/- 17.54, which was higher than the experimental group (1.91 +/- 1.94; P < 0.05). The control group's 1-8 day and 8-15 day relative hematoma absorption were greater than the experimental group (P < 0.05). The control group's relative edema volume on the fourth, eighth, and fifteenth day (or discharge) was higher than the experimental group (P < 0.05). Neurological scores between the two groups were not statistically different on the fifteenth day (or discharge) or on the thirtieth day. Conclusions Deferoxamine mesylate may slow hematoma absorption and inhibit edema after ICH, although further investigation is required to form definitive conclusions.	[Yu, Yao; Xu, Yan; Liu, Guangzhi; Gao, Xuguang] Peking Univ, Peoples Hosp, Dept Neurol, Beijing 100871, Peoples R China; [Zhao, Wei; Zhu, Chunpeng; Kong, Zhiping] Mancheng Country Hosp, Dept Internal Med, Baoding, Peoples R China	Peking University	Gao, XG (corresponding author), Peking Univ, Peoples Hosp, Dept Neurol, Beijing 100871, Peoples R China.	gxg56@tom.com						Anderson C, 2014, J NEUROSCI RURAL PRA, V5, P1, DOI 10.4103/0976-3147.127859; Arima H, 2009, NEUROLOGY, V73, P1963, DOI 10.1212/WNL.0b013e3181c55ed3; Arthur AS, 1997, NEUROSURGERY, V41, P1385, DOI 10.1097/00006123-199712000-00028; Barber M, 2004, POSTGRAD MED J, V80, P89, DOI 10.1136/pmj.2003.010967; Cabantchik ZI, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00167; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Chiuen CC, 2001, PEDIATR NEURO, V125, P138; Chun HJ, 2012, NEUROL SCI, V33, P289, DOI 10.1007/s10072-011-0733-y; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Freeman WD, 2008, NEUROCRIT CARE, V9, P307, DOI 10.1007/s12028-008-9089-4; Gebel JM, 2002, STROKE, V33, P2631, DOI 10.1161/01.STR.0000035284.12699.84; Goldstein L, 2003, J NEUROSCI RES, V73, P113, DOI 10.1002/jnr.10633; Gu YX, 2011, ACTA NEUROCHIR SUPPL, V111, P123, DOI 10.1007/978-3-7091-0693-8_20; Gu YX, 2009, STROKE, V40, P2241, DOI 10.1161/STROKEAHA.108.539536; Hatakeyama T, 2013, TRANSL STROKE RES, V4, P546, DOI 10.1007/s12975-013-0270-5; HURN PD, 1995, STROKE, V26, P688, DOI 10.1161/01.STR.26.4.688; Hwang BY, 2011, CEREBROVASC DIS, V31, P211, DOI 10.1159/000321870; KEBERLE H, 1964, ANN NY ACAD SCI, V119, P758; Lou M, 2009, CEREBROVASC DIS, V27, P266, DOI 10.1159/000199464; Okauchi M, 2010, STROKE, V41, P375, DOI 10.1161/STROKEAHA.109.569830; Okauchi M, 2009, STROKE, V40, P1858, DOI 10.1161/STROKEAHA.108.535765; PALMER C, 1994, STROKE, V25, P1039, DOI 10.1161/01.STR.25.5.1039; Qing WG, 2009, J NEUROSURG, V110, P462, DOI 10.3171/2008.4.JNS17512; Quinn TJ, 2007, CRIT CARE, V11, DOI 10.1186/cc5731; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Sansing LH, 2011, NEUROCRIT CARE, V14, P395, DOI 10.1007/s12028-010-9498-z; Selim M, 2011, STROKE, V42, P3067, DOI 10.1161/STROKEAHA.111.617589; Selim M, 2009, STROKE, V40, pS90, DOI 10.1161/STROKEAHA.108.533125; Tanaka Y, 2009, BRAIN RES BULL, V78, P158, DOI 10.1016/j.brainresbull.2008.10.012; Venkatasubramanian C, 2011, STROKE, V42, P73, DOI 10.1161/STROKEAHA.110.590646; Xi GH, 2006, LANCET NEUROL, V5, P53, DOI 10.1016/S1474-4422(05)70283-0	33	36	36	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122371	10.1371/journal.pone.0122371	http://dx.doi.org/10.1371/journal.pone.0122371			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875777	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100068
J	Brinkworth, AJ; Hammer, CH; Olano, LR; Kobayashi, SD; Chen, L; Kreiswirth, BN; Deleo, FR				Brinkworth, Amanda J.; Hammer, Carl H.; Olano, L. Renee; Kobayashi, Scott D.; Chen, Liang; Kreiswirth, Barry N.; DeLeo, Frank R.			Identification of Outer Membrane and Exoproteins of Carbapenem-Resistant Multilocus Sequence Type 258 Klebsiella pneumoniae	PLOS ONE			English	Article							IRON-ACQUISITION-SYSTEMS; BETA-LACTAMASE; ESCHERICHIA-COLI; UNITED-STATES; PROTEIN; IMPACT; COMBINATION; INFECTIONS; EPIDEMIOLOGY; PREVALENCE	Carbapenem-resistant Klebsiella pneumoniae strains have emerged as a cause of life-threatening infections in susceptible individuals (e.g., transplant recipients and critically ill patients). Strains classified as multilocus sequence type (ST) 258 are among the most prominent causes of carbapenem-resistant K. pneumoniae infections worldwide, but the basis for the success of this lineage remains incompletely determined. To gain a more comprehensive view of the molecules potentially involved in the success of ST258, we used a proteomics approach to identify surface-associated and culture supernatant proteins produced by ST258. Protein samples were prepared from varied culture conditions in vitro, and were analyzed by a combination of two-dimensional electrophoresis and liquid chromatography followed by tandem mass spectrometry (LC-MS/MS). We identified a total of 193 proteins in outer membrane preparations from bacteria cultured in Luria-Bertani broth (LB) or RPMI 1640 tissue culture media (RPMI). Compared with LB, several iron-acquisition proteins, including IutA, HmuR, HmuS, CirA, FepA, FitA, FoxA, FhuD, and YfeX, were more highly expressed in RPMI. Of the 177 proteins identified in spent media, only the fimbrial subunit, MrkA, was predicted to be extracellular, a finding that suggests few proteins (or a limited quantity) are freely secreted by ST258. Notably, we discovered 203 proteins not reported in previous K. pneumoniaeproteome studies. In silico modeling of proteins with unknown function revealed several proteins with beta-barrel transmembrane structures typical of porins, as well as possible host-interacting proteins. Taken together, these findings contribute several new targets for the mechanistic study of drug-resistance and pathogenesis by ST258 K. pneumoniaeisolates.	[Brinkworth, Amanda J.; Kobayashi, Scott D.; DeLeo, Frank R.] NIAID, Rocky Mt Lab, Lab Human Bacterial Pathogens, NIH, Hamilton, MT 59840 USA; [Hammer, Carl H.; Olano, L. Renee] NIAID, Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Chen, Liang; Kreiswirth, Barry N.] Rutgers State Univ, New Jersey Med Sch, Publ Hlth Res Inst TB Ctr, Newark, NJ 07102 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Deleo, FR (corresponding author), NIAID, Rocky Mt Lab, Lab Human Bacterial Pathogens, NIH, Hamilton, MT 59840 USA.	fdeleo@niaid.nih.gov	Chen, Liang/Q-5337-2019	Chen, Liang/0000-0001-5845-2235; Kobayashi, Scott/0000-0002-5705-1381; Brinkworth, Amanda/0000-0003-3340-8494; DeLeo, Frank/0000-0003-3150-2516	Intramural Research Program of the National Institute of Allergy and Infectious Diseases; National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001195, ZICAI001051] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported in part by the Intramural Research Program of the National Institute of Allergy and Infectious Diseases, National Institutes of Health.	Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Clancy CJ, 2013, ANTIMICROB AGENTS CH, V57, P5258, DOI 10.1128/AAC.01069-13; Climent N, 1997, RES MICROBIOL, V148, P133, DOI 10.1016/S0923-2508(97)87644-9; Cuzon G, 2010, EMERG INFECT DIS, V16, P1349, DOI 10.3201/eid1609.091389; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; DELORENZO V, 1984, J GEN MICROBIOL, V130, P391; Endimiani A, 2009, J ANTIMICROB CHEMOTH, V64, P1102, DOI 10.1093/jac/dkp327; Frirdich E, 2005, J BIOL CHEM, V280, P27604, DOI 10.1074/jbc.M504987200; Gona F, 2014, CLIN MICROBIOL INFEC, V20, pO633, DOI 10.1111/1469-0691.12577; Hong JH, 2013, ANTIMICROB AGENTS CH, V57, P2147, DOI 10.1128/AAC.02411-12; Hsieh PF, 2008, J INFECT DIS, V197, P1717, DOI 10.1086/588383; Huang SH, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-148; Jacob JT, 2013, MMWR-MORBID MORTAL W, V62, P165; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kitchel B, 2009, ANTIMICROB AGENTS CH, V53, P3365, DOI 10.1128/AAC.00126-09; Kurupati P, 2006, PROTEOMICS, V6, P836, DOI 10.1002/pmic.200500214; Larrie-Bagha SM, 2013, IRAN J MICROBIOL, V5, P113; Lee CH, 1999, ANAL BIOCHEM, V267, P161, DOI 10.1006/abio.1998.2961; Lee GC, 2012, ANN CLIN MICROB ANTI, V11, DOI 10.1186/1476-0711-11-32; Lee JC, 2012, FEMS MICROBIOL LETT, V331, P17, DOI 10.1111/j.1574-6968.2012.02549.x; Lin CT, 2011, MICROBIOL-SGM, V157, P419, DOI 10.1099/mic.0.044065-0; Lundberg U, 2013, HUM VACC IMMUNOTHER, V9, P497, DOI 10.4161/hv.23225; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; MartinezMartinez L, 1996, ANTIMICROB AGENTS CH, V40, P342, DOI 10.1128/AAC.40.2.342; Mathers AJ, 2011, MBIO, V2, DOI 10.1128/mBio.00204-11; Molloy MP, 2000, EUR J BIOCHEM, V267, P2871, DOI 10.1046/j.1432-1327.2000.01296.x; Molloy MP, 2001, ELECTROPHORESIS, V22, P1686, DOI 10.1002/1522-2683(200105)22:9<1686::AID-ELPS1686>3.0.CO;2-L; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Patel G, 2008, INFECT CONT HOSP EP, V29, P1099, DOI 10.1086/592412; Pitout JDD, 2008, LANCET INFECT DIS, V8, P159, DOI 10.1016/S1473-3099(08)70041-0; PUGSLEY AP, 1986, J BACTERIOL, V166, P1083, DOI 10.1128/jb.166.3.1083-1088.1986; Qureshi ZA, 2012, ANTIMICROB AGENTS CH, V56, P2108, DOI 10.1128/AAC.06268-11; Rey S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-162; Russo TA, 2014, INFECT IMMUN, V82, P2356, DOI 10.1128/IAI.01667-13; SADER HS, 1994, DIAGN MICR INFEC DIS, V20, P203, DOI 10.1016/0732-8893(94)90004-3; Satheshkumar PS, 2013, J VIROL, V87, P10710, DOI 10.1128/JVI.01261-13; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Trishin A. V., 2005, Vestnik Rossiiskoi Akademii Meditsinskikh Nauk, P43; Trishin A. V., 2008, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P46; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Tusnady GE, 2005, BIOINFORMATICS, V21, P1276, DOI 10.1093/bioinformatics/bti121; Wang Wei, 2003, Proteome Sci, V1, P6, DOI 10.1186/1477-5956-1-6; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Wright MS, 2014, ANTIMICROB AGENTS CH, V58, P4961, DOI 10.1128/AAC.00125-14; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zarkotou O, 2011, CLIN MICROBIOL INFEC, V17, P1798, DOI 10.1111/j.1469-0691.2011.03514.x	47	15	15	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123219	10.1371/journal.pone.0123219	http://dx.doi.org/10.1371/journal.pone.0123219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893665	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700029
J	Choi, H; Gillespie, DL; Berg, S; Rice, C; Couldwell, S; Gu, J; Colman, H; Jensen, RL; Huang, LE				Choi, Hyunsung; Gillespie, David L.; Berg, Shauna; Rice, Christopher; Couldwell, Sandrine; Gu, Jie; Colman, Howard; Jensen, Randy L.; Huang, L. Eric			Intermittent Induction of HIF-1 alpha Produces Lasting Effects on Malignant Progression Independent of Its Continued Expression	PLOS ONE			English	Article							INDUCIBLE FACTOR-I; HIF-ALPHA; C-MYC; HYPOXIA; CELL; ACTIVATION; CANCER; GROWTH; STABILIZATION; HIF-2-ALPHA	Dysregulation of hypoxia-inducible transcription factors HIF-1 alpha and HIF-2 alpha correlates with poor prognosis in human cancers; yet, divergent and sometimes opposing activities of these factors in cancer biology have been observed. Adding to this complexity is that HIF-1 alpha apparently possesses tumor-suppressing activities, as indicated by the loss-of-function mutations or even homozygous deletion of HIF1A in certain human cancers. As a step towards understanding this complexity, we employed 8-week intermittent induction of a stable HIF-1 alpha variant, HIF1 alpha(PP), in various cancer cell lines and examined the effects on malignant progression in xenografts of immunocompromised mice in comparison to those of HIF2 alpha(PP). Although 8-week treatment led to eventual loss of HIF1 alpha(PP) expression, treated osteosarcoma U-2 OS cells acquired tumorigenicity in the subcutaneous tissue. Furthermore, the prior treatment resulted in widespread invasion of malignant glioma U-87 MG cells in the mouse brain and sustained growth of U-118 MG glioma cells. The lasting effects of HIF-1 alpha on malignant progression are specific because neither HIF2 alpha(PP) nor beta-galactosidase yielded similar effects. By contrast, transient expression of HIF1 alpha(PP) in U-87MG cells or constitutive expression of HIF1 alpha(PP) but not HIF2 alpha(PP) in a patient-derived glioma sphere culture inhibited tumor growth and spread. Our results indicate that intermittent induction of HIF-1 alpha produces lasting effects on malignant progression even at its own expense.	[Choi, Hyunsung; Gillespie, David L.; Berg, Shauna; Rice, Christopher; Couldwell, Sandrine; Gu, Jie; Colman, Howard; Jensen, Randy L.; Huang, L. Eric] Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA; [Huang, L. Eric] Univ Utah, Huntsman Canc Inst, Dept Oncol Sci, Salt Lake City, UT USA	Utah System of Higher Education; University of Utah; Huntsman Cancer Institute; Utah System of Higher Education; University of Utah	Choi, H (corresponding author), Univ Utah, Clin Neurosci Ctr, Dept Neurosurg, Salt Lake City, UT 84112 USA.	eric.huang@hsc.utah.edu	Colman, Howard/L-5433-2019; Couldwell, Sandrine/GNH-4078-2022	Gillespie, David/0000-0002-7375-0262; Huang, Eric/0000-0002-6444-1708	NIH Grant from the National Cancer Institute [CA084563]; Department of Neurosurgery at the University of Utah; NATIONAL CANCER INSTITUTE [K22CA084563] Funding Source: NIH RePORTER	NIH Grant from the National Cancer Institute; Department of Neurosurgery at the University of Utah; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by an NIH Grant CA084563 from the National Cancer Institute and by the Department of Neurosurgery at the University of Utah. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker T, 2005, CANCER CELL, V8, P131, DOI 10.1016/j.ccr.2005.07.003; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bhat KPL, 2011, GENE DEV, V25, P2594, DOI 10.1101/gad.176800.111; Cairns RA, 2001, CANCER RES, V61, P8903; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; Ema M, 1999, EMBO J, V18, P1905, DOI 10.1093/emboj/18.7.1905; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Hayashi M, 2011, CELL CYCLE, V10, P2364, DOI 10.4161/cc.10.14.16313; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Huang LE, 2008, CELL DEATH DIFFER, V15, P672, DOI 10.1038/sj.cdd.4402302; Huang LE, 2013, SCIENCE, V339, P1285, DOI 10.1126/science.1236966; Huang LE, 1996, J BIOL CHEM, V271, P32253, DOI 10.1074/jbc.271.50.32253; Huang LE, 2004, DRUG DISCOV TODAY, V9, P869, DOI 10.1016/S1359-6446(04)03227-1; Huang LE, 1998, P NATL ACAD SCI USA, V95, P7987, DOI 10.1073/pnas.95.14.7987; Hubbi ME, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003417; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jensen RL, 2006, NEUROSURG FOCUS, V20, pE24, DOI DOI 10.3171/foc.2006.20.4.16; Kaelin WG, 2007, ANNU REV PATHOL-MECH, V2, P145, DOI 10.1146/annurev.pathol.2.010506.092049; Kageyama Y, 2004, FASEB J, V18, P1028, DOI 10.1096/fj.03-1233fje; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Ku BM, 2011, INT J CANCER, V128, P1316, DOI 10.1002/ijc.25466; Lee CG, 2011, ANNU REV PHYSIOL, V73, P479, DOI 10.1146/annurev-physiol-012110-142250; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mack FA, 2005, MOL CELL BIOL, V25, P4565, DOI 10.1128/MCB.25.11.4565-4578.2005; Martinive P, 2006, CANCER RES, V66, P11736, DOI 10.1158/0008-5472.CAN-06-2056; Maxwell PH, 2001, CURR OPIN GENET DEV, V11, P293, DOI 10.1016/S0959-437X(00)00193-3; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mazure NM, 1996, CANCER RES, V56, P3436; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ohh M, 2000, NAT CELL BIOL, V2, P423, DOI 10.1038/35017054; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Pugh CW, 1997, J BIOL CHEM, V272, P11205; Purdue MP, 2011, NAT GENET, V43, P60, DOI 10.1038/ng.723; Rankin EB, 2008, CELL DEATH DIFFER, V15, P678, DOI 10.1038/cdd.2008.21; Rapisarda A, 2012, NAT REV CLIN ONCOL, V9, P378, DOI 10.1038/nrclinonc.2012.64; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rice Christopher, 2010, Cancer Manag Res, V3, P9, DOI 10.2147/CMR.S14812; Rofstad EK, 1999, BRIT J CANCER, V80, P1697, DOI 10.1038/sj.bjc.6690586; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; SEMENZA GL, 1991, P NATL ACAD SCI USA, V88, P5680, DOI 10.1073/pnas.88.13.5680; SEMENZA GL, 1994, J BIOL CHEM, V269, P23757; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Shen C, 2011, CANCER DISCOV, V1, P222, DOI 10.1158/2159-8290.CD-11-0098; Sun HX, 2013, HEPATOLOGY, V57, P1088, DOI 10.1002/hep.26188; Tanimoto K, 2000, EMBO J, V19, P4298, DOI 10.1093/emboj/19.16.4298; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; Tiburcio PD, 2014, HYPOXIA, V2, P59, DOI 10.2147/HP.S50651; Toffoli S, 2008, FEBS J, V275, P2991, DOI 10.1111/j.1742-4658.2008.06454.x; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang V, 2005, CANCER RES, V65, P3299, DOI 10.1158/0008-5472.CAN-04-4130; Young RM, 2012, NAT MED, V18, P1024, DOI 10.1038/nm.2865; YOUNG SD, 1988, P NATL ACAD SCI USA, V85, P9533, DOI 10.1073/pnas.85.24.9533; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119	64	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125125	10.1371/journal.pone.0125125	http://dx.doi.org/10.1371/journal.pone.0125125			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893706	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700133
J	El Alaoui, S; Ljotsson, B; Hedman, E; Kaldo, V; Andersson, E; Ruck, C; Andersson, G; Lindefors, N				El Alaoui, Samir; Ljotsson, Brjann; Hedman, Erik; Kaldo, Viktor; Andersson, Evelyn; Ruck, Christian; Andersson, Gerhard; Lindefors, Nils			Predictors of Symptomatic Change and Adherence in Internet-Based Cognitive Behaviour Therapy for Social Anxiety Disorder in Routine Psychiatric Care	PLOS ONE			English	Article							UNGUIDED SELF-HELP; PSYCHOMETRIC PROPERTIES; IDENTIFICATION TEST; DSM-IV; SCALE; PHOBIA; INTERVENTIONS; DEPRESSION; MEDIATORS	Objective A central goal of health care is to improve patient outcomes. Although several studies have demonstrated the effectiveness of therapist guided internet-based cognitive behaviour therapy (ICBT) for social anxiety disorder (SAD), a significant proportion of patients do not respond to treatment. Consequently, the aim of this study was to identify individual characteristics and treatment program related factors that could help clinicians predict treatment outcomes and adherence for individuals with SAD. Method The sample comprised longitudinal data collected during a 4-year period of adult individuals (N = 764) treated for SAD at a public service psychiatric clinic. Weekly self-rated Liebowitz Social Anxiety Scale (LSAS-SR) scores were provided. Rates of symptomatic change during treatment and adherence levels were analysed using multilevel modelling. The following domains of prognostic variables were examined: (a) socio-demographic variables; (b) clinical characteristics; (c) family history of mental illness; and (d) treatment-related factors. Results Higher treatment credibility and adherence predicted a faster rate of improvement during treatment, whereas higher overall functioning level evidenced a slower rate of improvement. Treatment credibility was the strongest predictor of greater adherence. Having a family history of SAD-like symptoms was also associated with greater adherence, whereas Attention-Deficit/Hyperactivity Disorder (ADHD)-like symptoms, male gender, and family history of minor depression predicted lower adherence. Also, the amount of therapist time spent per treatment module was negatively associated with adherence. Conclusions Results from a large clinical sample indicate that the credibility of ICBT is the strongest prognostic factor explaining individual differences in both adherence level and symptomatic improvement. Early screening of ADHD-like symptoms may help clinicians identify patients who might need extra support or an adjusted treatment. Therapist behaviours that promote adherence may be important for treatment response, although more research is needed in order to determine what type of support would be most beneficial.	[El Alaoui, Samir; Ljotsson, Brjann; Hedman, Erik; Kaldo, Viktor; Andersson, Evelyn; Ruck, Christian; Andersson, Gerhard; Lindefors, Nils] Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden; [Hedman, Erik] Karolinska Inst, Osher Ctr Integrat Med, Dept Clin Neurosci, Stockholm, Sweden; [Ljotsson, Brjann; Hedman, Erik] Karolinska Inst, Div Psychol, Dept Clin Neurosci, Stockholm, Sweden; [Andersson, Gerhard] Linkoping Univ, Dept Behav Sci & Learning, Linkoping, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Linkoping University	El Alaoui, S (corresponding author), Karolinska Inst, Div Psychiat, Dept Clin Neurosci, Stockholm, Sweden.	samir.el.alaoui@ki.se	Andersson, Gerhard/J-8529-2012; El Alaoui, Samir/I-3504-2012	Andersson, Gerhard/0000-0003-4753-6745; El Alaoui, Samir/0000-0002-6590-1606; Kaldo, Viktor/0000-0002-6443-5279; Ruck, Christian/0000-0002-8742-0168; Hedman-Lagerlof, Erik/0000-0002-7939-9848	Stockholm County Council	Stockholm County Council(Stockholm County Council)	This study was supported by research grants from Stockholm County Council (Nils Lindefors). The main funding organization is a public institution, and neither of the funding organizations had any role in the design and conduct of the study; in the collection, management, and analysis of the data; or in the preparation, review, and approval of the manuscript.	Allen JP, 2001, PREV MED, V33, P428, DOI 10.1006/pmed.2001.0910; Amir N, 2011, J CONSULT CLIN PSYCH, V79, P533, DOI 10.1037/a0023808; Andersson G, 2006, J CONSULT CLIN PSYCH, V74, P677, DOI 10.1037/0022-006X.74.4.677; Andersson G, 2014, WILEY BLACKWELL HANDBOOK OF SOCIAL ANXIETY DISORDER, P569; Andersson G, 2014, WORLD PSYCHIATRY, V13, P4, DOI 10.1002/wps.20083; Andersson G, 2013, VERHALTENSTHERAPIE, V23, P140, DOI 10.1159/000354779; Aydos L, 2009, AUSTRALAS PSYCHIATRY, V17, P488, DOI 10.1080/10398560903284943; Baker SL, 2002, BEHAV RES THER, V40, P701, DOI 10.1016/S0005-7967(01)00060-2; Berger T, 2011, BEHAV RES THER, V49, P158, DOI 10.1016/j.brat.2010.12.007; Berman AH, 2005, EUR ADDICT RES, V11, P22, DOI 10.1159/000081413; BORKOVEC TD, 1972, J BEHAV THER EXP PSY, V3, P257, DOI 10.1016/0005-7916(72)90045-6; Mululo SCC, 2012, REV BRAS PSIQUIATR, V34, P92, DOI 10.1590/S1516-44462012000100016; Cassell J, 2002, J MED ETHICS, V28, P315; Chambless DL, 1997, J ANXIETY DISORD, V11, P221, DOI 10.1016/S0887-6185(97)00008-X; Clark AM, 2004, NEW ENGL J MED, V351, P612; Clark D. M., 1995, SOCIAL PHOBIA DIAGNO; Erwin BA, 2002, BEHAV RES THER, V40, P19, DOI 10.1016/S0005-7967(00)00114-5; Fournier JC, 2009, J CONSULT CLIN PSYCH, V77, P775, DOI 10.1037/a0015401; Fresco DM, 2001, PSYCHOL MED, V31, P1025, DOI 10.1017/S0033291701004056; Furmark T, 2009, BRIT J PSYCHIAT, V195, P440, DOI 10.1192/bjp.bp.108.060996; Geraghty AWA, 2010, SOC SCI MED, V71, P30, DOI 10.1016/j.socscimed.2010.03.007; Guy W, 1976, ECDEU ASSESSMENT MAN, P217; Heck R.H., 2013, MULTILEVEL LONGITUDI, V2nd Edn; Hedman E, 2012, ACTA PSYCHIAT SCAND, V126, P126, DOI 10.1111/j.1600-0447.2012.01834.x; Hedman E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018001; Hedman E, 2010, COMPUT HUM BEHAV, V26, P736, DOI 10.1016/j.chb.2010.01.010; Heimberg RG, 1999, PSYCHOL MED, V29, P199, DOI 10.1017/S0033291798007879; Hilvert-Bruce Z, 2012, BEHAV RES THER, V50, P463, DOI 10.1016/j.brat.2012.04.001; Hofmann SG, 2000, CLIN PSYCHOL-SCI PR, V7, P3, DOI 10.1093/clipsy/7.1.3; Hofmann SG, 2008, J CLIN PSYCHIAT, V69, P621, DOI 10.4088/jcp.v69n0415; Kazdin AE, 2008, AM PSYCHOL, V63, P146, DOI 10.1037/0003-066X.63.3.146; Kessler RC, 2005, PSYCHOL MED, V35, P245, DOI 10.1017/S0033291704002892; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kraemer HC, 2002, ARCH GEN PSYCHIAT, V59, P877, DOI 10.1001/archpsyc.59.10.877; Ledley DR, 2005, DEPRESS ANXIETY, V22, P161, DOI 10.1002/da.20121; McEvoy PM, 2012, BEHAV RES THER, V50, P258, DOI 10.1016/j.brat.2012.01.009; Mennin DS, 2002, J ANXIETY DISORD, V16, P661, DOI 10.1016/S0887-6185(02)00134-2; Mewton L, 2014, PSYCHOL RES BEHAV MA, V7, P37, DOI 10.2147/PRBM.S40879; Nordgreen T, 2012, BEHAV RES THER, V50, P13, DOI 10.1016/j.brat.2011.10.009; Rapee RM, 2007, BRIT J PSYCHIAT, V191, P246, DOI 10.1192/bjp.bp.106.028167; Raudenbush SW, 2002, HIEARCHIAL LINEAR MO; Rodebaugh TL, 2004, CLIN PSYCHOL REV, V24, P883, DOI 10.1016/j.cpr.2004.07.007; Rytwinski NK, 2009, DEPRESS ANXIETY, V26, P34, DOI 10.1002/da.20503; Schibbye P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100614; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; SHERER M, 1982, PSYCHOL REP, V51, P663, DOI 10.2466/pr0.1982.51.2.663; Singer J.D., 2003, APPL LONGITUDINAL DA, DOI 10.1093/acprof:oso/9780195152968.001.0001; Smits JAJ, 2013, J CONSULT CLIN PSYCH, V81, P1100, DOI 10.1037/a0034120; Spek V, 2007, PSYCHOL MED, V37, P319, DOI 10.1017/S0033291706008944; Sprich SE, 2010, COGN BEHAV PRACT, V17, P9, DOI 10.1016/j.cbpra.2009.09.002; Stein MB, 2008, LANCET, V371, P1115, DOI 10.1016/S0140-6736(08)60488-2; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; Titov N, 2008, AUST NZ J PSYCHIAT, V42, P1030, DOI 10.1080/00048670802512107; Turner SM, 1996, BEHAV RES THER, V34, P795, DOI 10.1016/0005-7967(96)00028-9	54	51	51	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124258	10.1371/journal.pone.0124258	http://dx.doi.org/10.1371/journal.pone.0124258			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893687	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700081
J	Lu, L; Cheng, HG; Liu, XL; Xie, J; Li, Q; Zhou, T				Lu, Lu; Cheng, Hongguang; Liu, Xuelian; Xie, Jing; Li, Qian; Zhou, Tan			Assessment of Regional Human Health Risks from Lead Contamination in Yunnan Province, Southwestern China	PLOS ONE			English	Article							MODEL; EMISSIONS; EXPOSURE	Identification and management the 'critical risk areas' where hotspot lead exposures are a potential risk to human health, become a major focus of public health efforts in China. But the knowledge of health risk assessment of lead pollution at regional and national scales is still limited in China. In this paper, under the guidance of 'sources-pathways-receptors' framework, regional human health risk assessment model for lead contamination was developed to calculate the population health risk in Yunnan province. And the cluster and AHP (analytic hierarchy process) analysis was taken to classify and calculate regional health risk and the decomposition of the regional health risk in the greatest health risk region, respectively. The results showed that Yunnan province can be divided into three areas. The highest health risk levels, located in northeastern Yunnan, including Kunming, Qujing, Zhaotong region. In those regions, lead is present at high levels in air, food, water and soil, and high population density which pose a high potential population risk to the public. The current study also reveals that most regional health risk was derived from the child receptors (age above 3 years) 4.3 times than the child receptors (age under 3years), and ingestion of lead-contaminated rice was found to be the most significant contributor to the health risk (accounting for more than 49% health risk of total). This study can provide a framework for regional risk assessment in China and highlighted some indicators and uncertainties.	[Lu, Lu; Cheng, Hongguang; Liu, Xuelian; Xie, Jing] Beijing Normal Univ, Sch Environm, Beijing 100875, Peoples R China; [Li, Qian] Standardizat Tech Res Ctr, Shandong Inst Standardizat, Jinan, Shandong, Peoples R China; [Zhou, Tan] Texas A&M Univ, Spatial Sci Lab, College Stn, TX USA	Beijing Normal University; Texas A&M University System; Texas A&M University College Station	Cheng, HG (corresponding author), Beijing Normal Univ, Sch Environm, Beijing 100875, Peoples R China.	chg@bnu.edu.cn	Zhou, Tan/U-3953-2019	Zhou, Tan/0000-0002-9193-5113	National Natural Science Foundation of China [40930740, 41171384]; Special Environmental Research Funds for Public Welfare [2010467046]; program of the "Twelfth Five-year Plan" for Sci & Tech Research of China [2012BAD15B05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Environmental Research Funds for Public Welfare; program of the "Twelfth Five-year Plan" for Sci & Tech Research of China	This research work was funded by the National Natural Science Foundation of China (key project 40930740 and general project 41171384) and Special Environmental Research Funds for Public Welfare (No. 2010467046). The authors are also grateful for financial support from the program of the "Twelfth Five-year Plan" for Sci & Tech Research of China (2012BAD15B05). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BOGEN KT, 1987, RISK ANAL, V7, P427, DOI 10.1111/j.1539-6924.1987.tb00480.x; Caudeville J, 2012, SCI TOTAL ENVIRON, V432, P297, DOI 10.1016/j.scitotenv.2012.06.001; Chen JM, 2005, ATMOS ENVIRON, V39, P1245, DOI 10.1016/j.atmosenv.2004.10.041; Cheng SY, 2012, ATMOS ENVIRON, V60, P613, DOI 10.1016/j.atmosenv.2012.07.056; Cohen JE, 2012, HLTH HUMAN RIGHTS IN, V14; Dong ZM, 2012, ENVIRON SCI TECHNOL, V46, P1144, DOI 10.1021/es202800z; Duzgoren-Aydin NS, 2007, SCI TOTAL ENVIRON, V385, P182, DOI 10.1016/j.scitotenv.2007.06.047; Feng JF, 2011, J ENVIRON SCI-CHINA, V23, P1158, DOI 10.1016/S1001-0742(10)60529-3; Gumus AT, 2009, EXPERT SYST APPL, V36, P4067, DOI 10.1016/j.eswa.2008.03.013; He KM, 2009, SCI TOTAL ENVIRON, V407, P3986, DOI 10.1016/j.scitotenv.2009.03.018; Kayal T, 2011, TECHNOL ECON DEV ECO, V17, P313, DOI 10.3846/20294913.2011.583727; LEGGETT RW, 1993, ENVIRON HEALTH PERSP, V101, P598, DOI 10.2307/3431645; Li Q, 2012, ATMOSPHERIC ENV; Ma HW, 2012, ENVIRON SCI TECHNOL, V46, P1104, DOI 10.1021/es203036r; Mickle MH, 1998, ENVIRON HEALTH PERSP, V106, P1531, DOI 10.1289/ehp.98106s61531; Niisoe T, 2011, ENVIRON SCI TECHNOL, V45, P2856, DOI 10.1021/es103666e; Pennington DW, 2005, ENVIRON SCI TECHNOL, V39, P1119, DOI 10.1021/es034598x; Qu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046793; Roper W.L., 1991, PREVENTING LEAD POIS; US-EPA, 2010, INT EXP UPT BIOK MOD; USEPA, 2005, EPA530R05006 US EPA; World Health Organization, 1995, ENV HLTH CRIT; Xu DC, 2013, ECOTOX ENVIRON SAFE, V90, P103, DOI 10.1016/j.ecoenv.2012.12.018; Xu XG, 2004, J ENVIRON MANAGE, V70, P253, DOI 10.1016/j.jenvman.2003.12.001; Ye XB, 2006, REGUL TOXICOL PHARM, V46, P157, DOI 10.1016/j.yrtph.2006.04.003	25	10	10	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0119562	10.1371/journal.pone.0119562	http://dx.doi.org/10.1371/journal.pone.0119562			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893826	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700004
J	Yamane, T; Goenaga, J; Ronn, JL; Arnqvist, G				Yamane, Takashi; Goenaga, Julieta; Ronn, Johanna Liljestrand; Arnqvist, Goran			Male Seminal Fluid Substances Affect Sperm Competition Success and Female Reproductive Behavior in a Seed Beetle	PLOS ONE			English	Article							PROTEASE INHIBITOR; COLEOPTERA; PROTEINS; PEPTIDE; RECEPTIVITY; ALLOCATION; POLYANDRY; VIABILITY; EVOLUTION; FECUNDITY	Male seminal fluid proteins are known to affect female reproductive behavior and physiology by reducing mating receptivity and by increasing egg production rates. Such substances are also though to increase the competitive fertilization success of males, but the empirical foundation for this tenet is restricted. Here, we examined the effects of injections of size-fractioned protein extracts from male reproductive organs on both male competitive fertilization success (i.e., P2 in double mating experiments) and female reproduction in the seed beetle Callosobruchus maculatus. We found that extracts of male seminal vesicles and ejaculatory ducts increased competitive fertilization success when males mated with females 1 day after the females' initial mating, while extracts from accessory glands and testes increased competitive fertilization success when males mated with females 2 days after the females' initial mating. Moreover, different size fractions of seminal fluid proteins had distinct and partly antagonistic effects on male competitive fertilization success. Collectively, our experiments show that several different seminal fluid proteins, deriving from different parts in the male reproductive tract and of different molecular weight, affect male competitive fertilization success in C. maculatus. Our results highlight the diverse effects of seminal fluid proteins and show that the function of such proteins can be contingent upon female mating status. We also document effects of different size fractions on female mating receptivity and egg laying rates, which can serve as a basis for future efforts to identify the molecular identity of seminal fluid proteins and their function in this model species.	[Goenaga, Julieta] Aarhus Univ, Aarhus Inst Adv Studies, Aarhus, Denmark; [Ronn, Johanna Liljestrand; Arnqvist, Goran] Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden	Aarhus University; Uppsala University	Arnqvist, G (corresponding author), Uppsala Univ, Dept Ecol & Genet, Anim Ecol, Uppsala, Sweden.	Goran.Arnqvist@ebc.uu.se	Arnqvist, Göran/E-6782-2015; Goenaga, Julieta/O-4643-2016	Arnqvist, Göran/0000-0002-3501-3376; Goenaga, Julieta/0000-0002-2894-1166; Goenaga, Julieta/0000-0002-9822-5800	Japan Society for the Promotion of Science [233967]; Wenner-Gren Foundation; European Research Council [GENCON AdG-29433]; Swedish Research Council [621-2010-5266]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Wenner-Gren Foundation; European Research Council(European Research Council (ERC)European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This work was financially supported by Research Fellowships for Young Scientists (Japan Society for the Promotion of Science 233967, to TY), by the Wenner-Gren Foundation (to JG), by the European Research Council (GENCON AdG-294333, to GA) and by the Swedish Research Council (621-2010-5266, to GA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnqvist G, 2000, ANIM BEHAV, V60, P145, DOI 10.1006/anbe.2000.1446; Arnqvist Goran, 2005, pUnpaginated; Avila FW, 2011, ANNU REV ENTOMOL, V56, P21, DOI 10.1146/annurev-ento-120709-144823; BAUMANN H, 1974, J INSECT PHYSIOL, V20, P2347, DOI 10.1016/0022-1910(74)90022-5; Birkhead T, 2000, PROMISCUITY EVOLUTIO; Chapman T, 2000, P ROY SOC B-BIOL SCI, V267, P1097, DOI 10.1098/rspb.2000.1114; Chapman T, 2004, PEPTIDES, V25, P1477, DOI 10.1016/j.peptides.2003.10.023; CHEN PS, 1988, CELL, V54, P291, DOI 10.1016/0092-8674(88)90192-4; CLARK AG, 1995, GENETICS, V139, P189; DAS AK, 1980, EXPERIENTIA, V36, P918, DOI 10.1007/BF01953792; DelBarco-Trillo J, 2011, J EVOLUTION BIOL, V24, P1706, DOI 10.1111/j.1420-9101.2011.02293.x; den Boer SPA, 2008, BEHAV ECOL SOCIOBIOL, V62, P1843, DOI 10.1007/s00265-008-0613-5; EADY PE, 1991, ECOL ENTOMOL, V16, P45, DOI 10.1111/j.1365-2311.1991.tb00191.x; EADY PE, 1995, BEHAV ECOL SOCIOBIOL, V36, P25, DOI 10.1007/BF00175725; Fiumera AC, 2005, GENETICS, V169, P243, DOI 10.1534/genetics.104.032870; Fiumera AC, 2007, GENETICS, V176, P1245, DOI 10.1534/genetics.106.064915; Fricke C, 2010, J EVOLUTION BIOL, V23, P157, DOI 10.1111/j.1420-9101.2009.01882.x; Fricke C, 2009, J EVOLUTION BIOL, V22, P275, DOI 10.1111/j.1420-9101.2008.01638.x; FUCHS MS, 1970, J INSECT PHYSIOL, V16, P931, DOI 10.1016/0022-1910(70)90223-4; Garcia-Gonzalez F, 2005, CURR BIOL, V15, P271, DOI 10.1016/j.cub.2005.01.032; Gay L, 2009, J EVOLUTION BIOL, V22, P1143, DOI 10.1111/j.1420-9101.2009.01724.x; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; Hayashi N, 2014, PHYSIOL ENTOMOL, V39, P12, DOI 10.1111/phen.12042; HOLM S, 1979, SCAND J STAT, V6, P65; Holman L, 2009, FUNCT ECOL, V23, P180, DOI 10.1111/j.1365-2435.2008.01509.x; Hotzy C, 2012, CURR BIOL, V22, P2258, DOI 10.1016/j.cub.2012.10.009; Hotzy C, 2009, CURR BIOL, V19, P404, DOI 10.1016/j.cub.2009.01.045; Imamura M, 1998, INSECT BIOCHEM MOLEC, V28, P365, DOI 10.1016/S0965-1748(98)00004-6; Katvala M, 2008, J EVOLUTION BIOL, V21, P471, DOI 10.1111/j.1420-9101.2007.01494.x; KINGAN TG, 1993, J EXP BIOL, V183, P61; Kvarnemo C, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0042; LEAHY MG, 1967, J INSECT PHYSIOL, V13, P1283, DOI 10.1016/0022-1910(67)90100-X; Lung O, 2002, GENETICS, V160, P211; Maklakov AA, 2009, CURR BIOL, V19, P1903, DOI 10.1016/j.cub.2009.08.058; Mueller JL, 2008, GENETICS, V178, P1605, DOI 10.1534/genetics.107.083766; Neubaum DM, 1999, GENETICS, V153, P845; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; Perry JC, 2013, TRENDS ECOL EVOL, V28, P414, DOI 10.1016/j.tree.2013.03.005; Poiani A, 2006, BEHAV ECOL SOCIOBIOL, V60, P289, DOI 10.1007/s00265-006-0178-0; RIDLEY M, 1988, BIOL REV, V63, P509, DOI 10.1111/j.1469-185X.1988.tb00669.x; Roenn JL, 2008, J EVOLUTION BIOL, V21, P461, DOI 10.1111/j.1420-9101.2007.01493.x; Ronn J, 2007, P NATL ACAD SCI USA, V104, P10921, DOI 10.1073/pnas.0701170104; SAS Institute, 2007, JMP7; Saudan P, 2002, EUR J BIOCHEM, V269, P989, DOI 10.1046/j.0014-2956.2001.02733.x; Savalli UM, 1999, FUNCT ECOL, V13, P169, DOI 10.1046/j.1365-2435.1999.00287.x; Simmons L. W., 2001, MG BEH ECOL; Sirot LK, 2011, P NATL ACAD SCI USA, V108, P9922, DOI 10.1073/pnas.1100905108; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Thornhill R., 1983, pi; Wedell N, 2005, J EXP BIOL, V208, P3433, DOI 10.1242/jeb.01774; Wedell N, 2002, TRENDS ECOL EVOL, V17, P313, DOI 10.1016/S0169-5347(02)02533-8; Wigby S, 2005, CURR BIOL, V15, P316, DOI 10.1016/j.cub.2005.01.051; Wilson N, 1997, P ROY SOC B-BIOL SCI, V264, P1491, DOI 10.1098/rspb.1997.0206; Wolfner MF, 2002, HEREDITY, V88, P85, DOI 10.1038/sj.hdy.6800017; Yamane T, 2008, J ETHOL, V26, P225, DOI 10.1007/s10164-007-0051-2; Yamane T, 2013, ANN ENTOMOL SOC AM, V106, P258, DOI 10.1603/AN12079; Yamane T, 2013, EVOL BIOL, V40, P133, DOI 10.1007/s11692-012-9193-4; Yamane T, 2012, BEHAV ECOL, V23, P715, DOI 10.1093/beheco/ars017	58	54	56	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123770	10.1371/journal.pone.0123770	http://dx.doi.org/10.1371/journal.pone.0123770			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893888	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700056
J	Barrado, MJG; Osma, MCI; Blanco, EJ; Hernandez, MC; Robledo, VS; Iniesta, LC; Carrero, S; Carretero, J				Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Blanco, Enrique J.; Carretero Hernandez, Marta; Sanchez Robledo, Virginia; Catalano Iniesta, Leonardo; Carrero, Sixto; Carretero, Jose			Dopamine Modulates Insulin Release and Is Involved in the Survival of Rat Pancreatic Beta Cells	PLOS ONE			English	Article							IN-VITRO; PARKINSONS-DISEASE; KNOCKOUT MICE; SECRETION; INHIBITION; APOPTOSIS; GLUCOSE; TYPE-2; ACTIVATION; RECEPTORS	The local synthesis of dopamine and its effects on insulin release have been described in isolated islets. Thus, it may be accepted that dopamine exerts an auto-paracrine regulation of insulin secretion from pancreatic beta cells. The aim of the present study is to analyze whether dopamine is a regulator of the proliferation and apoptosis of rat pancreatic beta cells after glucose-stimulated insulin secretion. Glucose stimulated pancreatic islets obtained from male Wistar rats were cultured with 1 or 10 mu M dopamine from 1 to 12 h. Insulin secretion was analyzed by RIA. The cellular proliferation rate of pancreatic islets and beta cells was studied with immunocytochemical double labelling for both insulin and PCNA (proliferating cell nuclear antigen), and active caspase-3 was detected to evaluate apoptosis. The secretion of insulin from isolated islets was significantly inhibited (p<0.01), by treatment with 1 and 10 mu M dopamine, with no differences between either dose as early as 1 h after treatment. The percentage of insulin-positive cells in the islets decreased significantly (p< 0.01) after 1 h of treatment up to 12 h. The proliferation rate of insulin-positive cells in the islets decreased significantly (p< 0.01) following treatment with dopamine. Apoptosis in pancreatic islets and beta cells was increased by treatment with 1 and 10 mu M dopamine along 12 h. In conclusion, these results suggest that dopamine could modulate the proliferation and apoptosis of pancreatic beta cells and that dopamine may be involved in the maintenance of pancreatic islets.	[Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Sanchez Robledo, Virginia; Catalano Iniesta, Leonardo] Univ Salamanca, Dept Physiol & Pharmacol, Fac Med, E-37008 Salamanca, Spain; [Blanco, Enrique J.; Carretero Hernandez, Marta; Carretero, Jose] Univ Salamanca, Dept Human Anat & Histol, Fac Med, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Blanco, Enrique J.; Carrero, Sixto; Carretero, Jose] Univ Salamanca, Neuroendocrinol Lab, Inst Neurosci Castilla & Leon, E-37008 Salamanca, Spain; [Garcia Barrado, Maria Jose; Iglesias Osma, Maria Carmen; Blanco, Enrique J.; Carrero, Sixto; Carretero, Jose] Univ Salamanca, Lab Neuroendocrinol & Obes IBSAL, E-37008 Salamanca, Spain	University of Salamanca; University of Salamanca; University of Salamanca; University of Salamanca	Carretero, J (corresponding author), Univ Salamanca, Dept Human Anat & Histol, Fac Med, E-37008 Salamanca, Spain.	jcar@usal.es	Iglesias-Osma, Maria Carmen/B-1641-2013; Blanco, Enrique J/B-2243-2017; Catalano-Iniesta, Leonardo/U-7583-2019; Carretero, José J/L-6930-2014; Barrado, Maria Jose Garcia/L-4852-2014	Iglesias-Osma, Maria Carmen/0000-0002-2206-9119; Blanco, Enrique J/0000-0002-5332-4282; Catalano-Iniesta, Leonardo/0000-0003-1957-1762; Carretero, José J/0000-0003-3143-6512; Barrado, Maria Jose Garcia/0000-0003-2552-5973; Carrero Garcia, Sixto/0000-0002-1006-6615	Junta de Castilla y Leon [BIO103/SA18/11]	Junta de Castilla y Leon(Junta de Castilla y Leon)	This work was supported by Junta de Castilla y Leon grant BIO103/SA18/11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHREN B, 1985, PHARMACOLOGY, V30, P71, DOI 10.1159/000138053; ARNERIC SP, 1983, J PHARMACOL EXP THER, V224, P161; Bensellam M, 2012, MOL CELL ENDOCRINOL, V364, P1, DOI 10.1016/j.mce.2012.08.003; Radl DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018097; Bonner-Weir S, 2000, TRENDS ENDOCRIN MET, V11, P375, DOI 10.1016/S1043-2760(00)00305-2; Borelli Maria I, 2003, BMC Endocr Disord, V3, P2, DOI 10.1186/1472-6823-3-2; Borelli Maria I, 2001, BMC Endocr Disord, V1, P1, DOI 10.1186/1472-6823-1-1; Butler AE, 2003, DIABETES, V52, P2304, DOI 10.2337/diabetes.52.9.2304; Butler AE, 2003, DIABETES, V52, P102, DOI 10.2337/diabetes.52.1.102; Callier S, 2003, BIOL CELL, V95, P489, DOI 10.1016/S0248-4900(03)00089-3; Carretero J, 2006, ANAT EMBRYOL, V211, P11, DOI 10.1007/s00429-005-0058-9; CARRETERO J, 1994, NEUROPEPTIDES, V27, P1, DOI 10.1016/0143-4179(94)90009-4; Chen Y, 2014, CELL TISSUE RES, V357, P597, DOI 10.1007/s00441-014-1894-9; Choi D, 2010, AM J PHYSIOL-ENDOC M, V298, pE735, DOI 10.1152/ajpendo.00696.2009; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; DEBUYSER A, 1991, MOL CELL ENDOCRINOL, V78, P179, DOI 10.1016/0303-7207(91)90121-8; DRIVER JA, 2008, DIABETES CARE, V31, P2003, DOI [DOI 10.2337/DC08-0688, DOI 10.2337/dc08-0688]; ERICSON LE, 1977, DIABETOLOGIA, V13, P117, DOI 10.1007/BF00745138; Fleenor DE, 2001, ENDOCRINOLOGY, V142, P2805, DOI 10.1210/en.142.7.2805; Garcia-Barrado MJ, 2001, ENDOCRINOLOGY, V142, P299, DOI 10.1210/en.142.1.299; Garcia-Tornadu I, 2010, NEUROENDOCRINOLOGY, V92, P207, DOI 10.1159/000321395; Garcia-Tornadu I, 2010, ENDOCRINOLOGY, V151, P1441, DOI 10.1210/en.2009-0996; Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751; Iwatsubo K, 2007, AM J PHYSIOL-CELL PH, V293, pC1498, DOI 10.1152/ajpcell.00088.2007; Jetton TL, 2001, METABOLISM, V50, P1377, DOI 10.1053/meta.2001.26741; Jiang JL, 2007, J NEUROIMMUNOL, V192, P79, DOI 10.1016/j.jneuroim.2007.09.012; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kvist-Reimer M, 2002, CELL TISSUE RES, V307, P203, DOI 10.1007/s00441-001-0496-5; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; MILBURN JL, 1995, J BIOL CHEM, V270, P1295, DOI 10.1074/jbc.270.3.1295; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; Peterhoff M, 2003, EUR J ENDOCRINOL, V149, P343, DOI 10.1530/eje.0.1490343; Putinski C, 2013, P NATL ACAD SCI USA, V110, pE4079, DOI 10.1073/pnas.1315587110; Raffo A, 2008, J ENDOCRINOL, V198, P41, DOI 10.1677/JOE-07-0632; ROSATI G, 1976, EUR NEUROL, V14, P229, DOI 10.1159/000114744; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; RUFFOLO RR, 1991, LIFE SCI, V49, P171, DOI 10.1016/0024-3205(91)90001-R; Sakano D, 2014, NAT CHEM BIOL, V10, P141, DOI 10.1038/nchembio.1410; Shankar E, 2006, IUBMB LIFE, V58, P157, DOI 10.1080/15216540600687993; Simpson N, 2012, MOL ENDOCRINOL, V26, P1757, DOI 10.1210/me.2012-1101; Szollosi A, 2010, BRIT J PHARMACOL, V159, P669, DOI 10.1111/j.1476-5381.2009.00588.x; Ustione A, 2013, MOL ENDOCRINOL, V27, P1198, DOI 10.1210/me.2013-1083; Ustione A, 2012, MOL ENDOCRINOL, V26, P1928, DOI 10.1210/me.2012-1226; Van de Casteele M, 2003, BIOCHEM BIOPH RES CO, V312, P937, DOI 10.1016/j.bbrc.2003.11.013; van Weenen JED, 2010, BIOCHEM PHARMACOL, V79, P1827, DOI 10.1016/j.bcp.2010.01.029; Vazquez P, 2014, DIABETOLOGIA, V57, P2339, DOI 10.1007/s00125-014-3341-6; Weir GC, 2009, DIABETES OBES METAB, V11, P82, DOI 10.1111/j.1463-1326.2009.01113.x; ZERN RT, 1980, DIABETOLOGIA, V18, P341	49	20	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123197	10.1371/journal.pone.0123197	http://dx.doi.org/10.1371/journal.pone.0123197			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886074	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000050
J	Qu, C; Ling, Y; Heynderickx, I; Brinkman, WP				Qu, Chao; Ling, Yun; Heynderickx, Ingrid; Brinkman, Willem-Paul			Virtual Bystanders in a Language Lesson: Examining the Effect of Social Evaluation, Vicarious Experience, Cognitive Consistency and Praising on Students' Beliefs, Self-Efficacy and Anxiety in a Virtual Reality Environment	PLOS ONE			English	Article							PUBLIC SPEAKING; EXPOSURE THERAPY; BEHAVIOR; IMPACT; FLATTERY; GENDER; REINFORCEMENT; INGRATIATION; PERCEPTION; SIMILARITY	Bystanders in a real world's social setting have the ability to influence people's beliefs and behavior. This study examines whether this effect can be recreated in a virtual environment, by exposing people to virtual bystanders in a classroom setting. Participants (n = 26) first witnessed virtual students answering questions from an English teacher, after which they were also asked to answer questions from the teacher as part of a simulated training for spoken English. During the experiment the attitudes of the other virtual students in the classroom was manipulated; they could whisper either positive or negative remarks to each other when a virtual student was talking or when a participant was talking. The results show that the expressed attitude of virtual bystanders towards the participants affected their self-efficacy, and their avoidance behavior. Furthermore, the experience of witnessing bystanders commenting negatively on the performance of other students raised the participants' heart rate when it was their turn to speak. Two-way interaction effects were also found on self-reported anxiety and self-efficacy. After witnessing bystanders' positive attitude towards peer students, participants' self-efficacy when answering questions received a boost when bystanders were also positive towards them, and a blow when bystanders reversed their attitude by being negative towards them. Still, inconsistency, instead of consistency, between the bystanders' attitudes towards virtual peers and the participants was not found to result in a larger change in the participants' beliefs. Finally the results also reveal that virtual flattering or destructive criticizing affected the participants' beliefs not only about the virtual bystanders, but also about the neutral teacher. Together these findings show that virtual bystanders in a classroom can affect people's beliefs, anxiety and behavior.	[Qu, Chao; Brinkman, Willem-Paul] Delft Univ Technol, Interact Intelligence Grp, Delft, Netherlands; [Ling, Yun; Heynderickx, Ingrid] Eindhoven Univ Technol, Human Technol Interact Grp, NL-5600 MB Eindhoven, Netherlands	Delft University of Technology; Eindhoven University of Technology	Qu, C (corresponding author), Delft Univ Technol, Interact Intelligence Grp, Delft, Netherlands.	aquchaos@gmail.com	Brinkman, Willem-Paul/H-8159-2013	Brinkman, Willem-Paul/0000-0001-8485-7092	China Scholarship Council [F2008609199]	China Scholarship Council(China Scholarship Council)	This study is supported in part by the China Scholarship Council (F2008609199), http://en.csc.edu.cn/; The COMMIT project-Interaction for Universal Access, http://www.commit-nl.nl/projects/interaction-for-universal-access. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ajzen I, 2005, EBOOK ATTITUDES PERS; ALDEN LE, 1992, COGNITIVE THER RES, V16, P249, DOI 10.1007/BF01183280; Anderson PL, 2013, J CONSULT CLIN PSYCH, V81, P751, DOI 10.1037/a0033559; Andsager JL, 2006, COMMUN RES, V33, P3, DOI 10.1177/0093650205283099; [Anonymous], 2008, DATABASE; Arbaugh J., 2000, J MANAGEMENT ED, V24, P213, DOI DOI 10.1177/105256290002400206; Asch S.E., 1951, GROUPS LEADERSHIP ME, P177, DOI DOI 10.1037/10025-01; Bailenson JN, 2005, PRESENCE-VIRTUAL AUG, V14, P379, DOI 10.1162/105474605774785235; Bandura A, 2001, MEDIA PSYCHOL, V3, P265, DOI 10.1207/S1532785XMEP0303_03; BANDURA A, 1963, J ABNORM PSYCHOL, V67, P601, DOI 10.1037/h0045550; Bandura A., 1997, PERS PSYCHOL, V23, P604; Bandura A., 1977, COGNITIVE THERAPY RE, V1, P287, DOI [10.1007/BF01663995, DOI 10.1007/BF01663995]; Bandura Albert, 1977, SOCIAL LEARNING THEO; BARON RA, 1988, J APPL PSYCHOL, V73, P199, DOI 10.1037/0021-9010.73.2.199; Beidel DC, 1989, J ANXIETY DIORD, V3, P149, DOI DOI 10.1016/0887-6185(89)90009-1; Botella C, 2010, CYBERPSYCH BEH SOC N, V13, P407, DOI 10.1089/cyber.2009.0224; Broekens J, 2012, DYNAMIC FACIAL EXPRE; Brown M, 2007, BEHAV COGN PSYCHOTH, V35, P133, DOI 10.1017/S1352465806003481; CARLI LL, 1989, J PERS SOC PSYCHOL, V56, P565, DOI 10.1037/0022-3514.56.4.565; CHAIKEN S, 1994, J PERS SOC PSYCHOL, V66, P460, DOI 10.1037/0022-3514.66.3.460; DALY JA, 1978, COMMUN MONOGR, V45, P204, DOI 10.1080/03637757809375966; DARLEY JM, 1968, J PERS SOC PSYCHOL, V8, P377, DOI 10.1037/h0025589; Festinger L., 1957, THEORY COGNITIVE DIS, V2; Festinger L, 1954, HUM RELAT, V7, P117, DOI 10.1177/001872675400700202; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; FOA EB, 1986, PSYCHOL BULL, V99, P20, DOI 10.1037/0033-2909.99.1.20; Fox J, 2009, MEDIA PSYCHOL, V12, P1, DOI 10.1080/15213260802669474; GEEN RG, 1989, PSYCHOL GROUP INFLUE, P15; Goldstein NJ, 2008, J CONSUM RES, V35, P472, DOI 10.1086/586910; Gordon RA, 1996, J PERS SOC PSYCHOL, V71, P54, DOI 10.1037/0022-3514.71.1.54; Hartanto D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092804; Hartanto D, 2012, STUD HEALTH TECHNOL, V181, P192, DOI 10.3233/978-1-61499-121-2-192; Heider F, 1944, PSYCHOL REV, V51, P358, DOI 10.1037/h0055425; Hope DA, 1987, M ASS ADV BEH THER B; Hope DA, 1985, M ASS ADV BEH THER H; Johnson D, 2004, INT J HUM-COMPUT ST, V61, P237, DOI 10.1016/j.ijhcs.2003.12.008; Kashdan TB, 2004, COGNITIVE THER RES, V28, P119, DOI 10.1023/B:COTR.0000016934.20981.68; Kozlov MD, 2010, CYBERPSYCH BEH SOC N, V13, P711, DOI 10.1089/cyber.2009.0310; Lee EJ, 2008, INT J HUM-COMPUT ST, V66, P789, DOI 10.1016/j.ijhcs.2008.07.009; Lee Jina, 2011, Intelligent Virtual Agents. Proceedings 11th International Conference, IVA 2011, P240, DOI 10.1007/978-3-642-23974-8_26; Ling Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096144; Ling Y, 2012, PRESENCE-TELEOP VIRT, V21, P254, DOI 10.1162/PRES_a_00111; LOCKE EA, 1984, J APPL PSYCHOL, V69, P241, DOI 10.1037/0021-9010.69.2.241; MEICHENBAUM DH, 1971, J PERS SOC PSYCHOL, V17, P298, DOI 10.1037/h0030593; MILLER CT, 1984, J PERS SOC PSYCHOL, V46, P1222, DOI 10.1037/0022-3514.46.6.1222; Neerincx MA, 2014, IEEE T AFFECT COMPUT, V4, P326; Pan XN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032931; Park S, 2007, HUM FACTORS, V49, P1054, DOI 10.1518/001872007X249910; Paul G. L., 1966, INSIGHT VS DESENSITI; Pertaub DP, 2002, PRESENCE-TELEOP VIRT, V11, P68, DOI 10.1162/105474602317343668; Phillips GC, 1997, J ANXIETY DISORD, V11, P215, DOI 10.1016/S0887-6185(97)00007-8; Price M, 2011, J ANXIETY DISORD, V25, P763, DOI 10.1016/j.janxdis.2011.03.004; Qu C, 2014, COMPUT HUM BEHAV, V34, P58, DOI 10.1016/j.chb.2014.01.033; Qu C, 2013, VIRTUAL REAL-LONDON, V17, P307, DOI 10.1007/s10055-013-0231-z; Reeves B, 1996, CSLI PUBLICATIONS ST; Schubert T, 2001, PRESENCE-VIRTUAL AUG, V10, P266, DOI 10.1162/105474601300343603; Schultz PW, 2007, PSYCHOL SCI, V18, P429, DOI 10.1111/j.1467-9280.2007.01917.x; SCHUNK DH, 1984, J EDUC PSYCHOL, V76, P1159, DOI 10.1037/0022-0663.76.6.1159; Slater M, 1999, IEEE COMPUT GRAPH, V19, P6, DOI 10.1109/38.749116; Slater M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052766; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th edition.; Tabachnick B. G., 2006, USING MULTIVARIATE S; TAKATA C, 1976, JPN J PSYCHOL, V47, P74, DOI 10.4992/jjpsy.47.74; Thomasson P, 2010, SCAND J PSYCHOL, V51, P171, DOI 10.1111/j.1467-9450.2009.00731.x; Vassilopoulos SP, 2008, J ANXIETY DISORD, V22, P98, DOI 10.1016/j.janxdis.2007.01.010; Villani D, 2012, INTERACT COMPUT, V24, P265, DOI 10.1016/j.intcom.2012.04.008; Vonk R, 2002, J PERS SOC PSYCHOL, V82, P515, DOI 10.1037//0022-3514.82.4.515; WALSTER E, 1962, J ABNORM PSYCHOL, V65, P395, DOI 10.1037/h0041172; WETZEL CG, 1982, J EXP SOC PSYCHOL, V18, P253, DOI 10.1016/0022-1031(82)90053-1; Wolpe J., 1966, PRACTICE BEHAV THERA; Zitek EM, 2007, J EXP SOC PSYCHOL, V43, P867, DOI 10.1016/j.jesp.2006.10.010	72	13	13	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125279	10.1371/journal.pone.0125279	http://dx.doi.org/10.1371/journal.pone.0125279			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884211	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000156
J	Vieira, AR; Gibson, CW; Deeley, K; Xue, H; Li, Y				Vieira, Alexandre R.; Gibson, Carolyn W.; Deeley, Kathleen; Xue, Hui; Li, Yong			Weaker Dental Enamel Explains Dental Decay	PLOS ONE			English	Article							HIGH CARIES EXPERIENCE; AMELOGENIN; ASSOCIATION; RELEASE; ABSCESS; RESCUE; GENES; AMELX; MICE	Dental caries continues to be the most prevalent bacteria-mediated non-contagious disease of humankind. Dental professionals assert the disease can be explained by poor oral hygiene and a diet rich in sugars but this does not account for caries free individuals exposed to the same risk factors. In order to test the hypothesis that amount of amelogenin during enamel development can influence caries susceptibility, we generated multiple strains of mice with varying levels of available amelogenin during dental development. Mechanical tests showed that dental enamel developed with less amelogenin is "weaker" while the dental enamel of animals over-expressing amelogenin appears to be more resistant to acid dissolution.	[Vieira, Alexandre R.; Deeley, Kathleen] Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA; [Gibson, Carolyn W.; Xue, Hui; Li, Yong] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Xue, Hui] Fourth Mil Med Univ, Sch Stomatol, Dept Orthodont, Xian 710032, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Air Force Military Medical University	Vieira, AR (corresponding author), Univ Pittsburgh, Sch Dent Med, Dept Oral Biol, Pittsburgh, PA 15260 USA.	arv11@pitt.edu			NIH/National Institute of Dental and Craniofacial Research [R01-DE18914]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018914] Funding Source: NIH RePORTER	NIH/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	Support was provided by the NIH/National Institute of Dental and Craniofacial Research R01-DE18914. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahovuo-Saloranta A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001830.pub4; ALDOUS JA, 1987, J AM DENT ASSOC, V115, P861, DOI 10.1016/S0002-8177(87)56011-1; BADDOUR HM, 1979, ORAL SURG ORAL MED O, V47, P303, DOI 10.1016/0030-4220(79)90250-0; BORAAS JC, 1988, J DENT RES, V67, P1150, DOI 10.1177/00220345880670090201; Chaussain C, 2014, J DENT RES, V93, P360, DOI 10.1177/0022034514522060; CONRY JP, 1993, ARCH ORAL BIOL, V38, P937, DOI 10.1016/0003-9969(93)90106-V; Deeley K, 2008, CARIES RES, V42, P8, DOI 10.1159/000111744; FERNANDO IN, 1988, BRIT DENT J, V165, P220, DOI 10.1038/sj.bdj.4806573; Fukushima K, 2012, INTERNAL MED, V51, P3073, DOI 10.2169/internalmedicine.51.7962; Gasse B, 2013, J DENT RES, V92, P418, DOI 10.1177/0022034513482941; Gibson CW, 2007, J DENT RES, V86, P331, DOI 10.1177/154405910708600406; Gibson CW, 2011, EUR J ORAL SCI, V119, P70, DOI 10.1111/j.1600-0722.2011.00882.x; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Hunt H. R., 1944, JOUR DENTAL RES, V23, P385, DOI 10.1177/00220345440230051101; Jackson SL, 2011, AM J PUBLIC HEALTH, V101, P1900, DOI 10.2105/AJPH.2010.200915; Jeremias F, 2013, ARCH ORAL BIOL, V58, P1434, DOI 10.1016/j.archoralbio.2013.05.005; Kang SW, 2011, ORAL DIS, V17, P399, DOI 10.1111/j.1601-0825.2010.01766.x; Klein H, 1940, MILBANK MEML FUND Q, V18, P67, DOI 10.2307/3347653; Li Y, 2008, J BIOL CHEM, V283, P15056, DOI 10.1074/jbc.M707992200; Meyer-Lueckel H, 2012, CARIES RES, V46, P544, DOI 10.1159/000341807; Modesto A, 1997, AM J DENT, V10, P123; Moynihan PJ, 2014, J DENT RES, V93, P8, DOI 10.1177/0022034513508954; Nariyama M, 2004, CARIES RES, V38, P79, DOI 10.1159/000075929; Page LAF, 2013, EUR J ORAL SCI, V121, P182, DOI 10.1111/eos.12034; Patir A, 2008, CARIES RES, V42, P394, DOI 10.1159/000154785; Queiroz Celso Silva, 2008, Braz. Dent. J., V19, P21, DOI 10.1590/S0103-64402008000100004; Shanmugam KT, 2013, J CLIN DIAGN RES, V7, P1250, DOI 10.7860/JCDR/2013/5246.3053; Shimizu T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045022; Silva KG, 2010, ACTA ODONTOL SCAND, V68, P11, DOI 10.3109/00016350903260264; Slade GD, 2013, J DENT RES, V92, P376, DOI 10.1177/0022034513481190; Slayton RL, 2005, J DENT RES, V84, P711, DOI 10.1177/154405910508400805; VALLEE L, 1994, ARCH PEDIATRIE, V1, P166; Vieira AR, 1999, AM J DENT, V12, P14; Vieira AR, 1999, REV ODONTOL U S PAUL, V13, P321; WHO, 2003, WHO TECH REP SER, V916, P1; Wright JT, 2006, AM J MED GENET A, V140A, P2547, DOI 10.1002/ajmg.a.31358; Yee R, 2002, INT DENT J, V52, P1; Zachariades N, 2005, ORAL SURG ORAL MED O, V100, P70, DOI DOI 10.1016/J.TRIPLE0.2005.02.062.PMID:16182155	38	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124236	10.1371/journal.pone.0124236	http://dx.doi.org/10.1371/journal.pone.0124236			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885796	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353017000108
J	Ohno, T; Shimizu, M; Shirakami, Y; Baba, A; Kochi, T; Kubota, M; Tsurumi, H; Tanaka, T; Moriwaki, H				Ohno, Tomohiko; Shimizu, Masahito; Shirakami, Yohei; Baba, Atsushi; Kochi, Takahiro; Kubota, Masaya; Tsurumi, Hisashi; Tanaka, Takuji; Moriwaki, Hisataka			Metformin Suppresses Diethylnitrosamine-Induced Liver Tumorigenesis in Obese and Diabetic C57BL/KsJ-+Lepr(db)/+Lepr(db) Mice	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; HOMEOSTASIS MODEL ASSESSMENT; ACTIVATED PROTEIN-KINASE; SENSITIVITY CHECK INDEX; PROMOTES GLUCOSE-UPTAKE; HEPATOCELLULAR-CARCINOMA; INSULIN SENSITIVITY; GLUCOSE-TRANSPORTER-4 TRANSLOCATION; NONALCOHOLIC STEATOHEPATITIS; INDUCED HEPATOCARCINOGENESIS	Obesity and related metabolic disorders, such as diabetes mellitus, raise the risk of liver carcinogenesis. Metformin, which is widely used in the treatment of diabetes, ameliorates insulin sensitivity. Metformin is also thought to have antineoplastic activities and to reduce cancer risk. The present study examined the preventive effect ofmetformin on the development of diethylnitrosamine (DEN)-induced liver tumorigenesis in C57BL/KsJ-+Lepr(db)/+Lepr(db) (db/db) obese and diabetic mice. The mice were given a single injection of DEN at 2 weeks of age and subsequently received drinking water containing metformin for 20 weeks. Metformin administration significantly reduced the multiplicity of hepatic premalignant lesions and inhibited liver cell neoplasms. Metformin also markedly decreased serum levels of insulin and reduced insulin resistance, and inhibited phosphorylation of Akt, mammalian target of rapamycin (mTOR), and p70S6 in the liver. Furthermore, serum levels of leptin were decreased, while those of adiponectin were increased by metformin. These findings suggest that metformin prevents liver tumorigenesis by ameliorating insulin sensitivity, inhibiting the activation of Akt/mTOR/p70S6 signaling, and improving adipokine imbalance. Therefore, metformin may be a potent candidate for chemoprevention of liver tumorigenesis in patients with obesity or diabetes.	[Ohno, Tomohiko; Shimizu, Masahito; Shirakami, Yohei; Baba, Atsushi; Kochi, Takahiro; Kubota, Masaya; Tsurumi, Hisashi; Moriwaki, Hisataka] Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu, Japan; [Tanaka, Takuji] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan	Gifu University; Gifu University	Shirakami, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Gastroenterol Internal Med, Gifu, Japan.	ys2443@gifu-u.ac.jp						Akasaka Y, 2010, BBA-MOL CELL BIOL L, V1801, P1115, DOI 10.1016/j.bbalip.2010.06.009; [Anonymous], 2008, LANCET, V371, P1723, DOI [10.1056/NEJMOA0707193, 10.1016/S0140-6736(08)60733-3]; Asensio-Lopez MC, 2011, FREE RADICAL BIO MED, V51, P1861, DOI 10.1016/j.freeradbiomed.2011.08.015; Bhalla K, 2012, CANCER PREV RES, V5, P544, DOI 10.1158/1940-6207.CAPR-11-0228; Bolukbas FF, 2004, BMC GASTROENTEROL, V4, DOI 10.1186/1471-230X-4-23; Cai XB, 2013, ONCOL REP, V30, P2449, DOI 10.3892/or.2013.2718; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calvisi DF, 2011, GASTROENTEROLOGY, V140, P1071, DOI 10.1053/j.gastro.2010.12.006; Chen HP, 2013, GUT, V62, P606, DOI 10.1136/gutjnl-2011-301708; Cheng JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093256; Cheong SH, 2014, J NUTR BIOCHEM, V25, P136, DOI 10.1016/j.jnutbio.2013.09.012; Cua IHY, 2007, HEPATOLOGY, V46, P66, DOI 10.1002/hep.21703; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; El-Serag HB, 2006, CLIN GASTROENTEROL H, V4, P369, DOI 10.1016/j.cgh.2005.12.007; Emoto M, 1999, DIABETES CARE, V22, P818, DOI 10.2337/diacare.22.5.818; Eskens BJM, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-175; Evans JMM, 2005, BMJ-BRIT MED J, V330, P1304, DOI 10.1136/bmj.38415.708634.F7; Evert M, 2012, HEPATOLOGY, V55, P1473, DOI 10.1002/hep.25600; Frith C H, 1994, IARC Sci Publ, P223; Fujita H, 2005, ENDOCR J, V52, P427, DOI 10.1507/endocrj.52.427; Hagiwara A, 2012, J CELL PHYSIOL, V227, P2097, DOI 10.1002/jcp.22941; Imai K, 2010, HEPATOL RES, V40, P376, DOI 10.1111/j.1872-034X.2009.00616.x; Iwasa J, 2010, CANCER SCI, V101, P460, DOI 10.1111/j.1349-7006.2009.01402.x; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Kang S, 2003, EUR J ENDOCRINOL, V148, P147, DOI 10.1530/eje.0.1480147; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kawaguchi T, 2011, HEPATOLOGY, V54, P1063, DOI 10.1002/hep.24412; Kitade M, 2006, HEPATOLOGY, V44, P983, DOI 10.1002/hep.21338; Klein J, 2004, J ENDOCRINOL, V183, P299, DOI 10.1677/joe.1.05646; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Koketsu Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE719, DOI 10.1152/ajpendo.00253.2007; Larsson O, 2012, P NATL ACAD SCI USA, V109, P8977, DOI 10.1073/pnas.1201689109; Lee S, 2008, AM J PHYSIOL-ENDOC M, V294, pE261, DOI 10.1152/ajpendo.00676.2007; Liu ZJ, 2007, HORM METAB RES, V39, P489, DOI 10.1055/s-2007-981680; Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; Muto Y, 2006, HEPATOL RES, V35, P204, DOI 10.1016/j.hepres.2006.04.007; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Ohno T, 2012, CANCER LETT, V323, P215, DOI 10.1016/j.canlet.2012.04.015; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; POPP J A, 1989, Toxicologic Pathology, V17, P561; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Sahai A, 2004, AM J PHYSIOL-GASTR L, V287, pG1035, DOI 10.1152/ajpgi.00199.2004; Saito T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070010; Sarafidis PA, 2007, J HUM HYPERTENS, V21, P709, DOI 10.1038/sj.jhh.1002201; Sharma D, 2010, HEPATOLOGY, V52, P1713, DOI 10.1002/hep.23892; Shimizu M, 2013, SEMIN IMMUNOPATHOL, V35, P191, DOI 10.1007/s00281-012-0336-6; Shimizu M, 2012, INT J MOL SCI, V13, P579, DOI 10.3390/ijms13010579; Shimizu M, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-281; Shimizu M, 2011, CANCER PREV RES, V4, P396, DOI 10.1158/1940-6207.CAPR-10-0331; Shimizu M, 2011, CANCER PREV RES, V4, P128, DOI 10.1158/1940-6207.CAPR-10-0163; Shirakami Y, 2012, CARCINOGENESIS, V33, P268, DOI 10.1093/carcin/bgr275; Singh S, 2013, AM J GASTROENTEROL, V108, P881, DOI 10.1038/ajg.2013.5; Stumvoll M, 2007, ENDOCR RES, V32, P39, DOI 10.1080/07435800701743828; Tajima K, 2013, AM J PHYSIOL-ENDOC M, V305, pE987, DOI 10.1152/ajpendo.00133.2013; TORNKVIST A, 1994, J BIOL CHEM, V269, P13919; Toyama K, 2011, BIOCHEM BIOPH RES CO, V410, P508, DOI 10.1016/j.bbrc.2011.06.012; Villanueva EC, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.232; Yan SQ, 2001, CANCER RES, V61, P5016; Yokoyama H, 2003, DIABETES CARE, V26, P2426, DOI 10.2337/diacare.26.8.2426; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505	64	18	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124081	10.1371/journal.pone.0124081	http://dx.doi.org/10.1371/journal.pone.0124081			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879666	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500082
J	Widmann, P; Reverter, A; Weikard, R; Suhre, K; Hammon, HM; Albrecht, E; Kuehn, C				Widmann, Philipp; Reverter, Antonio; Weikard, Rosemarie; Suhre, Karsten; Hammon, Harald M.; Albrecht, Elke; Kuehn, Christa			Systems Biology Analysis Merging Phenotype, Metabolomic and Genomic Data Identifies Non-SMC Condensin I Complex, Subunit G (NCAPG) and Cellular Maintenance Processes as Major Contributors to Genetic Variability in Bovine Feed Efficiency	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; SINGLE NUCLEOTIDE POLYMORPHISMS; MILK-PRODUCTION TRAITS; BEEF-CATTLE; WIDE ASSOCIATION; GROWTH-RATE; POSITIONAL CANDIDATE; SEQUENCE VARIANTS; CHAROLAIS BULLS; REVEALS GENES	Feed efficiency is a paramount factor for livestock economy. Previous studies had indicated a substantial heritability of several feed efficiency traits. In our study, we investigated the genetic background of residual feed intake, a commonly used parameter of feed efficiency, in a cattle resource population generated from crossing dairy and beef cattle. Starting from a whole genome association analysis, we subsequently performed combined phenotype-metabolome-genome analysis taking a systems biology approach by inferring gene networks based on partial correlation and information theory approaches. Our data about biological processes enriched with genes from the feed efficiency network suggest that genetic variation in feed efficiency is driven by genetic modulation of basic processes relevant to general cellular functions. When looking at the predicted upstream regulators from the feed efficiency network, the Tumor Protein P53 (TP53) and Transforming Growth Factor beta 1 (TGFB1) genes stood out regarding significance of overlap and number of target molecules in the data set. These results further support the hypothesis that TP53 is a major upstream regulator for genetic variation of feed efficiency. Furthermore, our data revealed a significant effect of both, the Non-SMC Condensin I Complex, Subunit G (NCAPG) I442M (rs109570900) and the Growth /differentiation factor 8 (GDF8) Q204X (rs110344317) loci, on residual feed intake and feed conversion. For both loci, the growth promoting allele at the onset of puberty was associated with a negative, but favorable effect on residual feed intake. The elevated energy demand for increased growth triggered by the NCAPG 442M allele is obviously not fully compensated for by an increased efficiency in converting feed into body tissue. As a consequence, the individuals carrying the NCAPG 442M allele had an additional demand for energy uptake that is reflected by the association of the allele with increased daily energy intake as observed in our study.	[Widmann, Philipp; Weikard, Rosemarie; Kuehn, Christa] Leibniz Inst Farm Anim Biol, Inst Genome Biol, Genome Physiol Unit, Dummerstorf, Germany; [Hammon, Harald M.] Leibniz Inst Farm Anim Biol, Inst Nutr Physiol Oskar Kellner, Dummerstorf, Germany; [Albrecht, Elke] Leibniz Inst Farm Anim Biol, Inst Muscle Biol & Growth, Dummerstorf, Germany; [Reverter, Antonio] CSIRO Agr Flagship, Brisbane, Qld, Australia; [Suhre, Karsten] Weill Cornell Med Coll Qatar, Doha, Qatar; [Suhre, Karsten] German Res Ctr Environm Hlth, Inst Bioinformat & Syst Biol, Helmholtz Zentrum Munchen, Neuherberg, Germany; [Kuehn, Christa] Univ Rostock, Fac Agr & Environm Sci, D-18055 Rostock, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Forschungsinstitut fur Nutztierbiologie (FBN); Commonwealth Scientific & Industrial Research Organisation (CSIRO); Qatar Foundation (QF); Weill Cornell Medical College Qatar; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Rostock	Kuehn, C (corresponding author), Leibniz Inst Farm Anim Biol, Inst Genome Biol, Genome Physiol Unit, Dummerstorf, Germany.	kuehn@fbn-dummerstorf.de	Albrecht, Elke/ABB-6155-2021; Suhre, Karsten/AAF-1778-2020; Hammon, Harald/AAD-9990-2020; Reverter, Antonio/C-9699-2013	Albrecht, Elke/0000-0001-5974-1514; Suhre, Karsten/0000-0001-9638-3912; Reverter, Antonio/0000-0002-4681-9404; Kuehn, Christa/0000-0002-0216-424X	German Federal Ministry of Education and Research (BMBF) [FKZ 0313391C]; International Leibniz Graduate School on Functional Diversity in Farm Animals (ILGS DivA); 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar - Qatar Foundation	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); International Leibniz Graduate School on Functional Diversity in Farm Animals (ILGS DivA); 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar - Qatar Foundation	The work was supported by the German Federal Ministry of Education and Research (BMBF, http://www.bmbf.de/) within the scope of the FUGATO QUALIPID project (FKZ 0313391C). PW was supported by the International Leibniz Graduate School on Functional Diversity in Farm Animals (ILGS DivA, http://www.leibniz-gemeinschaft.de/). KS is supported by 'Biomedical Research Program' funds at Weill Cornell Medical College in Qatar, a program funded by the Qatar Foundation (http://www.qf.org.qa/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archer JA, 1997, J ANIM SCI, V75, P2024; Arthur PF, 2001, J ANIM SCI, V79, P2805; Arthur PF, 2001, LIVEST PROD SCI, V68, P131, DOI 10.1016/S0301-6226(00)00243-8; BARBER KA, 1975, J ANIM SCI, V40, P288, DOI 10.2527/jas1975.402288x; Barendse W, 2007, GENETICS, V176, P1893, DOI 10.1534/genetics.107.072637; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Bottje W, 2013, J ANIM SCI, V91, P1582, DOI 10.2527/jas.2012-5787; Brody S, 1945, BIOENERGETICS AND GR; Caraux G, 2005, BIOINFORMATICS, V21, P1280, DOI 10.1093/bioinformatics/bti141; Chen Y, 2011, ANIM GENET, V42, P475, DOI 10.1111/j.1365-2052.2011.02182.x; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Crews DH, 2005, GENET MOL RES, V4, P152; Doncheva NT, 2012, NAT PROTOC, V7, P670, DOI 10.1038/nprot.2012.004; Durunna ON, 2011, J ANIM SCI, V89, P158, DOI 10.2527/jas.2009-2514; Eberlein A, 2009, GENETICS, V183, P951, DOI 10.1534/genetics.109.106476; Fahy E, 2007, NUCLEIC ACIDS RES, V35, pW606, DOI 10.1093/nar/gkm324; Ferrell RE, 1999, GENOMICS, V62, P203, DOI 10.1006/geno.1999.5984; Fortes MRS, 2011, J ANIM SCI, V89, P1669, DOI 10.2527/jas.2010-3681; Fortes MRS, 2010, P NATL ACAD SCI USA, V107, P13642, DOI 10.1073/pnas.1002044107; Gieger C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000282; Grisart B, 2002, GENOME RES, V12, P222, DOI 10.1101/gr.224202; Grobet L, 1998, MAMM GENOME, V9, P210, DOI 10.1007/s003359900727; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Herd RM, 2009, J ANIM SCI, V87, pE64, DOI 10.2527/jas.2008-1345; Herd RM, 2000, LIVEST PROD SCI, V63, P111, DOI 10.1016/S0301-6226(99)00122-0; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Karisa BK, 2013, J ANIM SCI, V91, P3502, DOI 10.2527/jas.2012-6170; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; KOCH RM, 1963, J ANIM SCI, V22, P486, DOI 10.2527/jas1963.222486x; Kuhn C, 2002, ARCH TIERZUCHT, V45, P317; Lindholm-Perry AK, 2011, BMC GENET, V12, DOI 10.1186/1471-2156-12-103; Lkhagvadorj S, 2010, AM J PHYSIOL-REG I, V298, pR494, DOI 10.1152/ajpregu.00632.2009; Lu D, 2013, J ANIM SCI, V91, P3612, DOI 10.2527/jas.2012-5716; Moore SS, 2009, J ANIM SCI, V87, pE41, DOI 10.2527/jas.2008-1418; Nkrumah JD, 2007, J ANIM SCI, V85, P3170, DOI 10.2527/jas.2007-0234; Nkrumah JD, 2007, J ANIM SCI, V85, P2147, DOI 10.2527/jas.2006-764; Paternoster L, 2011, HUM MOL GENET, V20, P4069, DOI 10.1093/hmg/ddr309; Perez-Enciso M, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-202; Raven LA, 2014, GENET SEL EVOL, V46, DOI 10.1186/1297-9686-46-29; Reverter A, 2013, J ANIM SCI, V91, P530, DOI 10.2527/jas.2012-5780; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter Antonio, 2013, Methods Mol Biol, V1019, P437, DOI 10.1007/978-1-62703-447-0_20; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI [DOI 10.1007/s11306-011-0293-4, DOI 10.1007/S11306-011-0293-4]; Serao NVL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078530; Serao NVL, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-94; Setoguchi K, 2011, ANIM GENET, V42, P650, DOI 10.1111/j.1365-2052.2011.02196.x; Setoguchi K, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-43; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sherman EL, 2009, J ANIM SCI, V87, P37, DOI 10.2527/jas.2008-0876; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Soranzo N, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000445; Suhre K, 2012, NAT REV GENET, V13, P759, DOI 10.1038/nrg3314; Summers SA, 2010, CURR OPIN LIPIDOL, V21, P128, DOI 10.1097/MOL.0b013e3283373b66; Szabo G, 1998, MAMM GENOME, V9, P671, DOI 10.1007/s003359900843; Tetens J, 2013, ANIM GENET, V44, P467, DOI 10.1111/age.12031; Thaller G, 2003, J ANIM SCI, V81, P1911; Tozaki T, 2011, J VET MED SCI, V73, P1617, DOI 10.1292/jvms.11-0295; Turner S., QQMAN Q Q MANHATTAN; Vaysse A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002316; Weedon MN, 2008, NAT GENET, V40, P575, DOI 10.1038/ng.121; Weikard R, 2012, ANIM GENET, V43, P318, DOI 10.1111/j.1365-2052.2011.02258.x; Weikard R, 2010, PHYSIOL GENOMICS, V42A, P79, DOI 10.1152/physiolgenomics.00120.2010; Widmann P, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-798; Winter A, 2002, P NATL ACAD SCI USA, V99, P9300, DOI 10.1073/pnas.142293799	66	28	30	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124574	10.1371/journal.pone.0124574	http://dx.doi.org/10.1371/journal.pone.0124574			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875852	Green Submitted, Green Published, gold			2022-12-27	WOS:000353015800144
J	Goonesekera, SD; Fang, SC; Piccolo, RS; Florez, JC; McKinlay, JB				Goonesekera, Sunali D.; Fang, Shona C.; Piccolo, Rebecca S.; Florez, Jose C.; McKinlay, John B.			Biogeographic Ancestry Is Associated with Higher Total Body Adiposity among African-American Females: The Boston Area Community Health Survey	PLOS ONE			English	Article							GENETIC ADMIXTURE; BACH SURVEY; SOCIOECONOMIC-STATUS; DIABETES-MELLITUS; OBESITY; WOMEN; RISK; DISPARITIES; BMI	Objectives The prevalence of obesity is disproportionately higher among African-Americans and Hispanics as compared to whites. We investigated the role of biogeographic ancestry (BGA) on adiposity and changes in adiposity in the Boston Area Community Health Survey. Methods We evaluated associations between BGA, assessed via Ancestry Informative Markers, and adiposity (body mass index (BMI), percent body fat (PBF), and waist-to-hip ratio (WHR)) and changes in adiposity over 7 years for BMI and WHR and 2.5 years for PBF, per 10% greater proportion of BGA using multivariable linear regression. We also examined effect-modification by demographic and socio-behavioral variables. Results We observed positive associations between West-African ancestry and cross-sectional BMI (percent difference=0.62%; 95% CI: 0.04%, 1.20%), and PBF (beta=0.35; 95% CI: 0.11, 0.58). We also observed significant effect-modification of the association between West-African ancestry and BMI by gender (p-interaction: <0.002) with a substantially greater association in women. We observed no main associations between Native-American ancestry and adiposity but observed significant effect-modification of the association with BMI by diet (p-interaction: <0.003) with inverse associations among participants with higher Healthy Eating Scores. No associations were observed between BGA and changes in adiposity over time. Conclusion Findings support that West-African ancestry may contribute to high prevalence of total body adiposity among African-Americans, particularly African-American women.	[Goonesekera, Sunali D.; Fang, Shona C.; Piccolo, Rebecca S.; McKinlay, John B.] New England Res Inst, Dept Epidemiol & Biostat, Watertown, MA 02472 USA; [Fang, Shona C.] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA 02115 USA; [Florez, Jose C.] Massachusetts Gen Hosp, Ctr Human Genet Res, Diabet Unit, Boston, MA 02114 USA	HealthCore, Inc; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital	Goonesekera, SD (corresponding author), New England Res Inst, Dept Epidemiol & Biostat, 480 Pleasant St, Watertown, MA 02472 USA.	sgoonesekera@neriscience.com			National Institute of Diabetes and Digestive and Kidney Diseases [DK056842, DK080786]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080786, R01DK056842, U01DK056842] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by awards DK056842 and DK080786 from the National Institute of Diabetes and Digestive and Kidney Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Heart Association, AM HEART ASS DIET LI; Beydoun MA, 2009, OBESITY, V17, P169, DOI 10.1038/oby.2008.492; BUUREN S, 2011, J STAT SOFTW, V45, P1, DOI DOI 10.18637/JSS.V045.I03; Cardel M, 2011, INT J OBESITY, V35, P60, DOI 10.1038/ijo.2010.203; Centers for Disease Control and Prevention, HLTH EFF OV OB; Cheng CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032840; Cheng CY, 2010, OBESITY, V18, P563, DOI 10.1038/oby.2009.282; Deurenberg P, 2002, Obes Rev, V3, P141, DOI 10.1046/j.1467-789X.2002.00065.x; Fernandez JR, 2013, HUM HERED, V75, P98, DOI 10.1159/000353180; Fernandez JR, 2003, OBES RES, V11, P904, DOI 10.1038/oby.2003.124; Flegal KM, 2010, AM J CLIN NUTR, V91, P1020, DOI 10.3945/ajcn.2009.28589; Florez JC, 2009, DIABETOLOGIA, V52, P1528, DOI 10.1007/s00125-009-1412-x; Heeringa SG, 2017, APPL SURVEY DATA ANA, VSecond, DOI DOI 10.1201/9781315153278; Lai CQ, 2009, HUM GENET, V125, P199, DOI 10.1007/s00439-008-0612-7; Lins TC, 2012, GENET MOL BIOL, V35, P575, DOI 10.1590/S1415-47572012005000047; McDermott R, 1998, SOC SCI MED, V47, P1189, DOI 10.1016/S0277-9536(98)00191-9; McKinlay JB, 2007, EUR UROL, V52, P389, DOI 10.1016/j.eururo.2007.03.013; Nassir R, 2012, INT J OBESITY, V36, P304, DOI 10.1038/ijo.2011.84; NEEL JV, 1962, AM J HUM GENET, V14, P353; Norden-Krichmar TM, 2014, AM J HUM BIOL, V26, P347, DOI 10.1002/ajhb.22521; Oka M, 2011, PUBLIC HEALTH REP, V126, P700, DOI 10.1177/003335491112600512; Piccolo RS, 2014, ANN EPIDEMIOL, V24, P648, DOI 10.1016/j.annepidem.2014.06.098; Piccolo RS, 2014, INT J EPIDEMIOL, V43, P42, DOI 10.1093/ije/dys198; Qi L, 2012, DIABETOLOGIA, V55, P1329, DOI 10.1007/s00125-012-2486-4; ROBINS JM, 1992, EPIDEMIOLOGY, V3, P143, DOI 10.1097/00001648-199203000-00013; Speakman JR, 2008, INT J OBESITY, V32, P1611, DOI 10.1038/ijo.2008.161; Stanfield KM, 2012, INT J EPIDEMIOL, V41, P1409, DOI 10.1093/ije/dys139; Tang H, 2006, HUM GENET, V119, P624, DOI 10.1007/s00439-006-0175-4; U.S. Department of Agriculture & U.S. Department of Health and Human Services, DIET GUID AM 2010; Zhao GX, 2011, BMC PSYCHIATRY, V11, DOI 10.1186/1471-244X-11-130; Ziv E, 2006, CANCER EPIDEM BIOMAR, V15, P1878, DOI 10.1158/1055-9965.EPI-06-0092	31	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122808	10.1371/journal.pone.0122808	http://dx.doi.org/10.1371/journal.pone.0122808			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875902	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100104
J	Feng, Y; Wratten, S; Sandhu, H; Keller, M				Feng, Yi; Wratten, Steve; Sandhu, Harpinder; Keller, Michael			Host Plants Affect the Foraging Success of Two Parasitoids that Attack Light Brown Apple Moth Epiphyas postvittana (Walker) (Lepidoptera: Tortricidae)	PLOS ONE			English	Article							TRICHOGRAMMA-NUBILALE HYMENOPTERA; CORN-BORER LEPIDOPTERA; BIOLOGICAL-CONTROL; COTESIA-GLOMERATA; NATURAL ENEMIES; BEHAVIOR; VOLATILES; RESPONSES; LARVAE; RUBECULA	The light brown apple moth, Epiphyas postvittana is a key pest of wine grapes in Australia. Two parasitoids, Dolichogenidea tasmanica and Therophilus unimaculatus, attack the larval stage of this pest. D. tasmanica is dominant in vineyards, whereas T. unimaculatus is mainly active in native vegetation. We sought to understand why they differ in their use of habitats. Plants are a major component of habitats of parasitoids, and herbivore-infested plants influence parasitoid foraging efficiency by their architecture and emission of volatile chemicals. We investigated how different plant species infested by E. postvittana could affect the foraging success of the two parasitoid species in both laboratory and field experiments. Four common host-plant species were selected for this study. In paired-choice experiments to determine the innate foraging preferences for plants, both parasitoid species showed differences in innate search preferences among plant species. The plant preference of D. tasmanica was altered by oviposition experience with hosts that were feeding on other plant species. In a behavioral assay, the two parasitoid species allocated their times engaged in various types of behavior differently when foraging on different plant species. For both parasitoids, parasitism on Hardenbergia violacea was the highest of the four plant species. Significantly more larvae dropped from Myoporum insulare when attacked than from the other three host-plant species, which indicates that parasitism is also affected by interactions between plants and host insects. In vineyards, parasitism by D. tasmanica was significantly lower on M. insulare than on the other three host-plant species, but the parasitism rates were similar among the other three plant species. Our results indicate that plants play a role in the habitat preferences of these two parasitoid species by influencing their foraging behavior, and are likely to contribute to their distributions among habitats.	[Feng, Yi; Keller, Michael] Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia; [Wratten, Steve] Lincoln Univ, Bioprotect Res Ctr, Lincoln, NE, New Zealand; [Sandhu, Harpinder] Flinders Univ S Australia, Sch Environm, Adelaide, SA 5001, Australia	University of Adelaide; Lincoln University - New Zealand; Flinders University South Australia	Feng, Y (corresponding author), Univ Adelaide, Sch Agr Food & Wine, Adelaide, SA, Australia.	yi.feng@adelaide.edu.au	Sandhu, Harpinder S/E-9338-2010; Keller, Michael A/A-8371-2008; Wratten, Steve D/J-3467-2013	Sandhu, Harpinder S/0000-0001-5428-094X; Keller, Michael A/0000-0003-0721-9753; Wratten, Steve D/0000-0002-5168-8277	Chinese Scholarship Council (CSC) [2010630004]; Grape and Wine Research and Development Corporation (GWRDC) [PH1007]	Chinese Scholarship Council (CSC)(China Scholarship Council); Grape and Wine Research and Development Corporation (GWRDC)(Australian Grape and Wine Authority)	The following sources of funding have supported the work: Chinese Scholarship Council (CSC) scholarship Grant Number: 2010630004 and Grape and Wine Research and Development Corporation (GWRDC) PhD Research Scholarship, Grant Number: PH1007 to Yi Feng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABLES J R, 1980, Southwestern Entomologist, V5, P261; ANDOW DA, 1990, OECOLOGIA, V82, P162, DOI 10.1007/BF00323530; BELCHER DW, 1982, ENVIRON ENTOMOL, V11, P91, DOI 10.1093/ee/11.1.91; Bergman J.M., 1979, Bulletin of the Entomological Society of America, V25, P275; BIGLER F, 1986, J APPL ENTOMOL, V102, P303, DOI 10.1111/j.1439-0418.1986.tb00926.x; BOND AB, 1983, ANIM BEHAV, V31, P990, DOI 10.1016/S0003-3472(83)80004-9; BURBUTIS PP, 1981, J ECON ENTOMOL, V74, P246, DOI 10.1093/jee/74.2.246; CARTER MC, 1984, OECOLOGIA, V63, P394, DOI 10.1007/BF00390671; Charles JG, 1996, NEW ZEAL J CROP HORT, V24, P123, DOI 10.1080/01140671.1996.9513944; Cortesero AM, 2000, BIOL CONTROL, V17, P35, DOI 10.1006/bcon.1999.0777; De Moraes CM, 1998, NATURE, V393, P570, DOI 10.1038/31219; DUMBLETON L. J., 1935, NEW ZEALAND JOUR SCI AND TECHNOL, V17, P572; Feng Y, 2015, B ENTOMOL RES, V105, P426, DOI 10.1017/S0007485314000923; Fountain ED, 2013, ECOSYSTEM SERVICES IN NEW ZEALAND: CONDITIONS AND TRENDS, P115; Geervliet JBF, 1997, J CHEM ECOL, V23, P2935, DOI 10.1023/A:1022583515142; GEERVLIET JBF, 1994, ENTOMOL EXP APPL, V73, P289, DOI 10.1007/BF02382480; Geervliet JBF, 1996, J INSECT BEHAV, V9, P525, DOI 10.1007/BF02213877; Geervliet JBF, 1998, ENTOMOL EXP APPL, V86, P241, DOI 10.1023/A:1003186706517; Geitzenauer HL, 1996, ECOL ENTOMOL, V21, P227, DOI 10.1046/j.1365-2311.1996.t01-1-00006.x; Gingras D, 2002, ENVIRON ENTOMOL, V31, P1153, DOI 10.1603/0046-225X-31.6.1153; Gingras D, 2002, OECOLOGIA, V130, P396, DOI 10.1007/s00442-001-0819-y; Girling RD, 2011, P ROY SOC B-BIOL SCI, V278, P2646, DOI 10.1098/rspb.2010.2725; Godfray H. C. J., 1994, PARASITOIDS BEHAV EV, DOI 10.1515/9780691207025; GREVSTAD FS, 1992, OECOLOGIA, V92, P399, DOI 10.1007/BF00317466; Gurr G., 2004, ECOLOGICAL ENG PEST; HERARD F, 1988, J CHEM ECOL, V14, P1583, DOI 10.1007/BF01012524; Ishii Y, 2010, POPUL ECOL, V52, P27, DOI 10.1007/s10144-009-0185-x; KANOUR WW, 1984, J ECON ENTOMOL, V77, P103, DOI 10.1093/jee/77.1.103; KAREIVA P, 1990, NATURE, V345, P433, DOI 10.1038/345433a0; KAUFFMAN WC, 1989, ENVIRON ENTOMOL, V18, P698, DOI 10.1093/ee/18.4.698; KELLER MA, 1987, ENTOMOL EXP APPL, V43, P55, DOI 10.1007/BF00350375; KELLER MA, 1990, ENTOMOL EXP APPL, V57, P243, DOI 10.1007/BF00355023; LETOURNEAU DK, 1990, ECOL ENTOMOL, V15, P63, DOI 10.1111/j.1365-2311.1990.tb00784.x; LEWIS WJ, 1990, NATURE, V348, P635, DOI 10.1038/348635a0; Lill JT, 2002, NATURE, V417, P170, DOI 10.1038/417170a; LUCK RF, 1990, TRENDS ECOL EVOL, V5, P196, DOI 10.1016/0169-5347(90)90210-5; MACKAUER M, 1993, OECOLOGIA, V94, P339, DOI 10.1007/BF00317107; Matkin O, 1957, U C SYSTEM PRODUCING, P332; PAPAJ DR, 1990, J CHEM ECOL, V16, P3137, DOI 10.1007/BF00979616; Paull C, 2006, AUST J ENTOMOL, V45, P142, DOI 10.1111/j.1440-6055.2006.00524.x; Paull C, 2013, B ENTOMOL RES, V104, P1; Paull C., 2007, THESIS U ADELAIDE; Paull CA, 2012, BASIC APPL ECOL, V13, P542, DOI 10.1016/j.baae.2012.08.003; Poelman EH, 2009, FUNCT ECOL, V23, P951, DOI 10.1111/j.1365-2435.2009.01570.x; PRICE PW, 1980, ANNU REV ECOL SYST, V11, P41, DOI 10.1146/annurev.es.11.110180.000353; Scholefield P, 2010, 0804 GWR; Stevens NB, 2011, ZOOTAXA, P1; Suckling DM, 2010, ANNU REV ENTOMOL, V55, P285, DOI 10.1146/annurev-ento-112408-085311; Suckling DM, 1998, NEW ZEAL J CROP HORT, V26, P193, DOI 10.1080/01140671.1998.9514055; VET LEM, 1985, OIKOS, V44, P478, DOI 10.2307/3565789; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; VET LEM, 1995, CHEM ECOLOGY INSECTS; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; WACKERS FL, 1994, BIOL CONTROL, V4, P105, DOI 10.1006/bcon.1994.1018; Yazdani M, 2015, AUSTRAL ENTOMOL, V54, P325, DOI 10.1111/aen.12130; Zar JH, 1999, BIOSTATISTICAL ANAL	56	13	13	0	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124773	10.1371/journal.pone.0124773	http://dx.doi.org/10.1371/journal.pone.0124773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893966	Green Published, gold			2022-12-27	WOS:000353211700121
J	Johansson, H; Bjelkenkrantz, K; Darlin, L; Dilllner, J; Forslund, O				Johansson, Hanna; Bjelkenkrantz, Kaj; Darlin, Lotten; Dilllner, Joakim; Forslund, Ola			Presence of High-Risk HPV mRNA in Relation to Future High-Grade Lesions among High-Risk HPV DNA Positive Women with Minor Cytological Abnormalities	PLOS ONE			English	Article							ATYPICAL SQUAMOUS-CELLS; UNDETERMINED SIGNIFICANCE; FOLLOW-UP; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; SAMPLES	Objective Continuous expression of E6- and E7-oncogenes of high-risk human papillomavirus (HPV) types is necessary for the development and maintenance of the dysplastic phenotype. The aim of the study was to determine the sensitivity and specificity of the APTIMA HPV mRNA assay (Hologic) in predicting future development of high-grade cervical intraepithelial neoplasia (CIN) among high-risk HPV-DNA-positive women with atypical squamous cells of undetermined significance (ASCUS) or low-grade squamous epithelial lesion (LSIL) cytology. Methods Archived SurePath cervical samples of women >= 35 years of age with high-risk HPV DNA-positive ASCUS (n = 211) or LSIL, (n = 131) were tested for the presence of high-risk HPV E6/E7 mRNA using the APTIMA HPV assay, and the women were monitored for development of histopathologically verified CIN2+. Results Twenty-nine percent (61/211) of the women in the ASCUS group, and 34.3%(45/131) in the LSIL group developed CIN2+ within 4.5 years of follow-up. The prevalence of HPV mRNA was 90.0%(95% CI 85.9-94.0) among women with ASCUS and 95.4% (95% CI 91.8-99.0) among women with LSIL. The presence of HPV E6/E7 mRNA was associated with future development of CIN2+ among women with ASCUS and LSIL (p=0.02). The mRNA assay demonstrated high sensitivity in predicting future CIN2+ and CIN3 for index ASCUS (96.7%; 95% CI 87.6-99.4 and 100%; 95% CI 82.2-100, respectively) and LSIL (97.8%, 95% CI 86.8-99.9 and 100%, 95% CI 79.9-100, respectively). The corresponding specificity was low, 12.7% (95% CI 7.9-19.3) and 5.8%(95% CI 2.2-13.6), for future CIN2+, respectively. The negative predictive value of the HPV mRNA assay for detecting future CIN3 was 100%, since no mRNA-negative woman developed CIN3 (0/27) as compared to 13.6%(43/315) of the mRNA-positive women (p = 0.03). Conclusion The APTIMA mRNA assay demonstrated high sensitivity but low specificity in predicting future CIN2+ among women with minor cytological abnormalities. The assay had high negative predictive value for future CIN3, indicating that HPV-mRNA-negative women are at low risk of progression to high grade CIN.	[Johansson, Hanna; Forslund, Ola] Lund Univ, Dept Lab Med Med Microbiol, Malmo, Sweden; [Bjelkenkrantz, Kaj] Reg Canc Ctr South, Lund, Sweden; [Darlin, Lotten] Skane Univ Hosp, Dept Obstet & Gynecol, Lund, Sweden; [Dilllner, Joakim] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden	Lund University; Lund University; Skane University Hospital; Karolinska Institutet	Forslund, O (corresponding author), Lund Univ, Dept Lab Med Med Microbiol, Malmo, Sweden.	ola.forslund@med.lu.se			BioCARE, a strategic research program of Lund University	BioCARE, a strategic research program of Lund University	This work was supported by BioCARE, a strategic research program of Lund University. The APTIMA reagents were provided free of charge by Hologic, but had no influence on the study design or interpretation of results.	Alanen KW, 1998, CANCER CYTOPATHOL, V84, P5, DOI 10.1002/(SICI)1097-0142(19980225)84:1<5::AID-CNCR2>3.0.CO;2-Q; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Arbyn M, 2009, J CELL MOL MED, V13, P648, DOI 10.1111/j.1582-4934.2008.00631.x; Broccolo F, 2013, J MED VIROL, V85, P472, DOI 10.1002/jmv.23487; Bzhalava D, 2013, VIROLOGY, V445, P224, DOI 10.1016/j.virol.2013.07.015; Carreon JD, 2007, INT J GYNECOL PATHOL, V26, P441, DOI 10.1097/pgp.0b013e31805152ab; Cuschieri K, 2008, CANCER EPIDEM BIOMAR, V17, P2536, DOI 10.1158/1055-9965.EPI-08-0306; Cuzick J, 2008, VACCINE, V26, pK29, DOI 10.1016/j.vaccine.2008.06.019; Doorbar J, 2006, CLIN SCI, V110, P525, DOI 10.1042/CS20050369; Elfstrom KM, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g130; Gage JC, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju153; Jeantet D, 2009, J CLIN VIROL, V45, pS29, DOI 10.1016/S1386-6532(09)70006-X; Kirii Y, 1998, VIRUS GENES, V17, P117, DOI 10.1023/A:1008002905588; Lindqvist PG, 2008, EUR J OBSTET GYN R B, V137, P77, DOI 10.1016/j.ejogrb.2006.12.005; Molden T, 2007, J VIROL METHODS, V142, P204, DOI 10.1016/j.jviromet.2007.01.036; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Persson M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090023; Plummer M, 2007, J INFECT DIS, V195, P1582, DOI 10.1086/516784; Safaeian M, 2007, OBSTET GYNECOL, V109, P1325, DOI 10.1097/01.AOG.0000263461.71732.40; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Soederlund-Strand A, 2009, J CLIN MICROBIOL, V47, P541, DOI 10.1128/JCM.02007-08; Solomon D, 2004, THE BETHESDA SYSTEM; Walboomers JMM, 1999, J PATHOL, V189, P12, DOI 10.1002/(SICI)1096-9896(199909)189:1&lt;12::AID-PATH431&gt;3.0.CO;2-F; Waldstrom M, 2012, CYTOPATHOLOGY, V23, P389, DOI 10.1111/j.1365-2303.2011.00923.x; Waldstrom M, 2011, ARCH PATHOL LAB MED, V135, P1052, DOI 10.5858/2010-0411-OAR	25	23	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124460	10.1371/journal.pone.0124460	http://dx.doi.org/10.1371/journal.pone.0124460			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893988	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700096
J	Su, D; Zhou, XM; Chen, QX; Jiang, YH; Yang, X; Zheng, WH; Tao, KY; Wu, J; Yan, Z; Liu, L; Wu, SY; Mao, WM				Su, Dan; Zhou, Xinming; Chen, Qixun; Jiang, Youhua; Yang, Xun; Zheng, Weihui; Tao, Kaiyi; Wu, Jie; Yan, Zhen; Liu, Liang; Wu, Shaoyuan; Mao, Weimin			Prognostic Nomogram for Thoracic Esophageal Squamous Cell Carcinoma after Radical Esophagectomy	PLOS ONE			English	Article							LONG-TERM SURVIVAL; POSTOPERATIVE RADIATION-THERAPY; CURATIVE RESECTION; LOCAL RECURRENCE; CANCER INCIDENCE; UNITED-STATES; LYMPH-NODES; ADENOCARCINOMA; IMPACT; CHEMORADIOTHERAPY	Nomogram has demonstrated its capability in individualized estimates of survival in diverse cancers. Here we retrospectively investigated 1195 patients with esophageal squamous-cell carcinoma (ESCC) who underwent radical esophagectomy at Zhejiang Cancer Hospital in Hangzhou, China. We randomly assigned two-thirds of the patients to a training cohort (n = 797) and one-third to a validation cohort (n = 398). Cox proportional hazards regression analyses were performed using the training cohort, and a nomogram was developed for predicting 3-year and 5-year overall survival rates. Multivariate analysis identified tumor length, surgical approach, number of examined lymph node, number of positive lymph node, extent of positive lymph node, grade, and depth of invasion as independent risk factors for survival. The discriminative ability of the nomogram was externally determined using the validation cohort, showing that the nomogram exhibited a sufficient level of discrimination according to the C-index (0.715, 95% CI 0.671-0.759). The C-index of the nomogram was significantly higher than that of the sixth edition (0.664, P-value<0.0001) and the seventh edition (0.696, P-value<0.0003) of the TNM classification. This study developed the first	[Su, Dan; Zhou, Xinming; Chen, Qixun; Jiang, Youhua; Yang, Xun; Zheng, Weihui; Tao, Kaiyi; Wu, Jie; Mao, Weimin] Zhejiang Canc Hosp, Canc Res Inst, Hangzhou, Zhejiang, Peoples R China; [Su, Dan; Zhou, Xinming; Chen, Qixun; Jiang, Youhua; Yang, Xun; Zheng, Weihui; Tao, Kaiyi; Wu, Jie; Mao, Weimin] Key Lab Diag & Treatment Technol Thorac Oncol Zhe, Hangzhou, Zhejiang, Peoples R China; [Zhou, Xinming; Chen, Qixun; Jiang, Youhua; Yang, Xun; Zheng, Weihui; Tao, Kaiyi; Wu, Jie; Mao, Weimin] Zhejiang Canc Hosp, Dept Thorac Surg, Hangzhou, Zhejiang, Peoples R China; [Yan, Zhen; Liu, Liang] Univ Georgia, Dept Stat, Athens, GA 30602 USA; [Yan, Zhen; Liu, Liang] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA; [Wu, Shaoyuan] Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin, Peoples R China; [Wu, Shaoyuan] Tianjin Med Univ, Sch Basic Med Sci, Tianjin Key Lab Med Epigenet, Tianjin, Peoples R China	Zhejiang Cancer Hospital; Zhejiang Cancer Hospital; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; Tianjin Medical University; Tianjin Medical University	Wu, SY (corresponding author), Tianjin Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Tianjin, Peoples R China.	shaoyuanwu@outlook.com; weiminmao@126.com	su, dan/GYJ-1940-2022		National Nature Science Foundation of China [81172081, 31470111]; Major Science and Technology Project of Zhejiang Province of China [2011C13039-1]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Project of Zhejiang Province of China	This study was supported by grants from the National Nature Science Foundation of China (No. 81172081 and No. 31470111), and from the Major Science and Technology Project of Zhejiang Province of China (No. 2011C13039-1).	Adelstein DJ, 2009, J THORAC ONCOL, V4, P1264, DOI 10.1097/JTO.0b013e3181b26f8e; Ajani JA, 2011, J NATL COMPR CANC NE, V9, P830, DOI 10.6004/jnccn.2011.0072; Albert JM, 2012, J CLIN ONCOL, V30, P2837, DOI 10.1200/JCO.2011.41.0076; ANDREOLLO Nelson Adami, 2013, Arq. Gastroenterol., V50, P101, DOI 10.1590/S0004-28032013000200016; [Anonymous], 2001, REGRESSION MODELING; Blom RLGM, 2013, DIS ESOPHAGUS, V26, P510, DOI 10.1111/j.1442-2050.2012.01394.x; Bystricky B, 2011, DRUGS, V71, P541, DOI 10.2165/11585460-000000000-00000; Chen WQ, 2013, CHIN J CANCER, V32, P106, DOI 10.5732/cjc.013.10018; Chen WQ, 2013, CHINESE J CANCER RES, V25, P10, DOI 10.3978/j.issn.1000-9604.2012.12.04; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Eloubeidi MA, 2002, CANCER CAUSE CONTROL, V95, P1009; Feralay J, 2008, IARC CANCERBASE; Fernandes ML, 2006, AM J GASTROENTEROL, V101, P1430, DOI 10.1111/j.1572-0241.2006.00570.x; Gonzalez L, 2013, CANCER EPIDEMIOL, V37, P5, DOI 10.1016/j.canep.2012.09.002; Graesslin O, 2010, J CLIN ONCOL, V28, P2032, DOI 10.1200/JCO.2009.24.6314; Han DS, 2012, J CLIN ONCOL, V30, P3834, DOI 10.1200/JCO.2012.41.8343; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Higuchi Katsuhiko, 2009, Gastrointest Cancer Res, V3, P153; Hiripi E, 2012, ACTA ONCOL, V51, P906, DOI 10.3109/0284186X.2012.673732; Hsu CP, 2001, EUR J CARDIO-THORAC, V19, P10, DOI 10.1016/S1010-7940(00)00623-0; Hu Y, 2010, ANN SURG ONCOL, V17, P784, DOI 10.1245/s10434-009-0818-5; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lagarde SM, 2007, BRIT J SURG, V94, P1361, DOI 10.1002/bjs.5832; Lagarde SM, 2008, ANN SURG, V248, P1006, DOI 10.1097/SLA.0b013e318190a0a2; Lordick F, 2013, LANGENBECK ARCH SURG, V398, P177, DOI 10.1007/s00423-012-1001-1; Lu CL, 2010, CANCER CAUSE CONTROL, V21, P269, DOI 10.1007/s10552-009-9458-0; Luo Kong-Jia, 2009, Ai Zheng, V28, P1260; Mir MR, 2013, DIGEST SURG, V30, P331, DOI 10.1159/000354854; Peyre CG, 2008, ANN SURG, V248, P549, DOI 10.1097/SLA.0b013e318188c474; Rudloff U, 2010, J CLIN ONCOL, V28, P3762, DOI 10.1200/JCO.2009.26.8847; Schreiber D, 2010, J THORAC ONCOL, V5, P244, DOI 10.1097/JTO.0b013e3181c5e34f; Scott J S, 2001, ANN THORAC SURG, V72, P1918; Shimada H, 2006, WORLD J SURG, V30, P1441, DOI 10.1007/s00268-005-0462-6; Situ D, 2013, ANN SURG ONCOL, V20, P580, DOI 10.1245/s10434-012-2656-0; Sobin LH, 2010, TNM CLASSIFICATION M, V7; Talsma K, 2012, ANN SURG ONCOL, V19, P2142, DOI 10.1245/s10434-012-2218-5; Tapias LF, 2013, ANN THORAC SURG, V95, P1741, DOI 10.1016/j.athoracsur.2013.01.084; TENIERE P, 1991, SURG GYNECOL OBSTET, V173, P123; Trivers KF, 2008, INT J CANCER, V123, P1422, DOI 10.1002/ijc.23691; Uzunoglu FG, 2013, LANGENBECK ARCH SURG, V398, P189, DOI 10.1007/s00423-013-1052-y; Valentini V, 2011, J CLIN ONCOL, V29, P3163, DOI 10.1200/JCO.2010.33.1595; van der Gaag NA, 2012, ANN ONCOL, V23, P2642, DOI 10.1093/annonc/mds077; Wang YZ, 2013, J CLIN ONCOL, V31, P1188, DOI 10.1200/JCO.2012.41.5984; Wu N, 2012, CHINESE MED J-PEKING, V125, P4445, DOI 10.3760/cma.j.issn.0366-6999.2012.24.022; Xu YP, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-116; Yang HX, 2012, ANN THORAC SURG, V93, P1861, DOI 10.1016/j.athoracsur.2012.03.002; Yang LM, 2013, J CLIN ONCOL, V31, P468, DOI 10.1200/JCO.2012.42.4457; Yu Y, 2010, WORLD J SURG, V34, P272, DOI 10.1007/s00268-009-0341-7; Zhu Cheng-chu, 2012, Zhonghua Wei Chang Wai Ke Za Zhi, V15, P943; ZhuGe XP, 2009, THORACIC CARDIOVASCU, V16, P278; ZIEREN HU, 1995, WORLD J SURG, V19, P444, DOI 10.1007/BF00299187	51	23	23	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124437	10.1371/journal.pone.0124437	http://dx.doi.org/10.1371/journal.pone.0124437			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893524	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700093
J	Kosack, CS; de Kieviet, W; Bayrak, K; Milovic, A; Page, AL				Kosack, Cara Simone; de Kieviet, Wim; Bayrak, Kubra; Milovic, Anastacija; Page, Anne Laure			Evaluation of the Nova StatSensor (R) Xpress (TM) Creatinine Point-Of-Care Handheld Analyzer	PLOS ONE			English	Article								Creatinine is a parameter that is required to monitor renal function and is important to follow in patients under treatment with potentially toxic renal drugs, such as the anti-HIV drug Tenofovir. A point of care instrument to measure creatinine would be useful for patients monitoring in resource-limited settings, where more instruments that are sophisticated are not available. The StatSensor Xpress Creatinine (Nova Biomedical Cooperation, Waltham, MA, USA) point of care analyzer was evaluated for its diagnostic performance in indicating drug therapy change. Creatinine was measured in parallel using the Nova StatSensor Xpress Creatinine analyzer and the Vitros 5,1FS (Ortho Clinical Diagnostics, Inc, Rochester, USA), which served as reference standard. The precision (i.e., repeatability and reproducibility) and accuracy of the StatSensor Xpress Creatinine analyzer were calculated using a panel of specimens with normal, low pathological and high pathological values. Two different Nova StatSensor Xpress Creatinine analyzers were used for the assessment of accuracy using repeated measurements. The coefficient of variation of the StatSensor Xpress Creatinine analyzers ranged from 2.3 to 5.9% for repeatability and from 4.2 to 9.0% for between- run reproducibility. The concordance correlation agreement was good except for high values (> 600 mu mol/L). The Bland-Altman analysis in high pathological specimens suggests that the Nova StatSensor Xpress Creatinine test tends to underestimate high creatinine values (i. e., > 600 mu mol/L). The Nova StatSensor Xpress Creatinine analyzers showed acceptable to good results in terms of repeatability, inter-device reproducibility and between- run reproducibility over time using quality control reagents. The analyzer was found sufficiently accurate for detecting pathological values in patients (age > 10 year) and can be used with a moderate risk of misclassification.	[Kosack, Cara Simone] Med Sans Frontieres, Diagnost Network, Amsterdam, Netherlands; [de Kieviet, Wim; Bayrak, Kubra; Milovic, Anastacija] St Lucas Andreas Ziekenhuis, Dept Clin Chem, Amsterdam, Netherlands; [Page, Anne Laure] Epictr, Paris, France	Doctors Without Borders; Sint Lucas Andreas Hospital	Kosack, CS (corresponding author), Med Sans Frontieres, Diagnost Network, Amsterdam, Netherlands.	cara.kosack@amsterdam.msf.org	Sánchez-Margalet, Victor/AAB-9986-2021	Sánchez-Margalet, Victor/0000-0001-8638-8680	Sint Lucas Andreas Ziekenhuis in Amsterdam, the Netherlands	Sint Lucas Andreas Ziekenhuis in Amsterdam, the Netherlands	We thank the Sint Lucas Andreas Ziekenhuis in Amsterdam, the Netherlands for supporting this evaluation study.	AIDS Info, 2013, GUIDELINES USE ANTIR; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bygrave H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017609; Bygrave H, 2011, JAIDS-J ACQ IMM DEF, V56, pE75, DOI 10.1097/QAI.0b013e3182097505; CDC, 2013, CLIN LAB IMPR AM; Chua AC, 2012, AIDS RES THER, V9, DOI 10.1186/1742-6405-9-19; Clinical Lab Navigator, 2013, CLIA ACC TEST PERF C; Korpi-Steiner NL, 2009, AM J CLIN PATHOL, V132, P920, DOI 10.1309/AJCPTE5FEY0VCGOZ; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; QC Net, 2014, CLIA PROF LIM; Schnabl KL, 2010, CLIN BIOCHEM, V43, P1026, DOI 10.1016/j.clinbiochem.2010.04.055; Shephard M, 2010, CLIN CHEM LAB MED, V48, P1113, DOI 10.1515/CCLM.2010.238; Straseski JA, 2011, CLIN CHEM, V57, P1566, DOI 10.1373/clinchem.2011.165480; Westgard QC, 2014, DESIRABLE SPECIFICAT	14	28	28	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122433	10.1371/journal.pone.0122433	http://dx.doi.org/10.1371/journal.pone.0122433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886375	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000032
J	Masindova, I; Soltysova, A; Varga, L; Matyas, P; Ficek, A; Huckova, M; Surova, M; Safka-Brozkova, D; Anwar, S; Bene, J; Straka, S; Janicsek, I; Ahmed, ZM; Seeman, P; Melegh, B; Profant, M; Klimes, I; Riazuddin, S; Kadasi, L; Gasperikova, D				Masindova, Ivica; Soltysova, Andrea; Varga, Lukas; Matyas, Petra; Ficek, Andrej; Huckova, Miloslava; Surova, Martina; Safka-Brozkova, Dana; Anwar, Saima; Bene, Judit; Straka, Slavomir; Janicsek, Ingrid; Ahmed, Zubair M.; Seeman, Pavel; Melegh, Bela; Profant, Milan; Klimes, Iwar; Riazuddin, Saima; Kadasi, L'udevit; Gasperikova, Daniela			MARVELD2 (DFNB49) Mutations in the Hearing Impaired Central European Roma Population - Prevalence, Clinical Impact and the Common Origin	PLOS ONE			English	Article							GYPSY POPULATION; W24X MUTATION; GENE; CZECH; TRICELLULIN; SLOVAK; GJB2; DEAFNESS; FREQUENCIES; DEFICIENCY	Background In the present study we aimed: 1) To establish the prevalence and clinical impact of DFNB49 mutations in deaf Roma from 2 Central European countries (Slovakia and Hungary), and 2) to analyze a possible common origin of the c.1331+2T>C mutation among Roma and Pakistani mutation carriers identified in the present and previous studies. Methods We sequenced 6 exons of the MARVELD2 gene in a group of 143 unrelated hearing impaired Slovak Roma patients. Simultaneously, we used RFLP to detect the c.1331+2T>C mutation in 85 Hungarian deaf Roma patients, control groups of 702 normal hearing Romanies from both countries and 375 hearing impaired Slovak Caucasians. We analyzed the haplotype using 21 SNPs spanning a 5.34Mb around the mutation c.1331+2T>C. Results One pathogenic mutation (c.1331+2T>C) was identified in 12 homozygous hearing impaired Roma patients. Allele frequency of this mutation was higher in Hungarian (10%) than in Slovak (3.85%) Roma patients. The identified common haplotype in Roma patients was defined by 18 SNP markers (3.89 Mb). Fourteen common SNPs were also shared among Pakistani and Roma homozygotes. Biallelic mutation carriers suffered from prelingual bilateral moderate to profound sensorineural hearing loss. Conclusions We demonstrate different frequencies of the c.1331+2T>C mutation in hearing impaired Romanies from 3 Central European countries. In addition, our results provide support for the hypothesis of a possible common ancestor of the Slovak, Hungarian and Czech Roma as well as Pakistani deaf patients. Testing for the c.1331+2T>C mutation may be recommended in GJB2 negative Roma cases with early-onset sensorineural hearing loss.	[Masindova, Ivica; Varga, Lukas; Huckova, Miloslava; Surova, Martina; Klimes, Iwar; Gasperikova, Daniela] Slovak Acad Sci, Inst Expt Endocrinol, Lab Diabet & Metab Disorders, Bratislava, Slovakia; [Masindova, Ivica; Varga, Lukas; Huckova, Miloslava; Surova, Martina; Klimes, Iwar; Gasperikova, Daniela] Slovak Acad Sci, Inst Expt Endocrinol, DIABGENE, Bratislava, Slovakia; [Soltysova, Andrea; Ficek, Andrej; Kadasi, L'udevit] Comenius Univ, Fac Nat Sci, Dept Mol Biol, Bratislava, Slovakia; [Soltysova, Andrea; Kadasi, L'udevit] Slovak Acad Sci, Inst Mol Physiol & Genet, Bratislava 83334, Slovakia; [Varga, Lukas; Profant, Milan] Comenius Univ, Fac Med & Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Bratislava, Slovakia; [Matyas, Petra; Bene, Judit; Janicsek, Ingrid; Melegh, Bela] Univ Pecs, Ctr Clin, Dept Med Genet, Pecs, Hungary; [Huckova, Miloslava; Gasperikova, Daniela] Slovak Acad Sci, Ctr Mol Med, Bratislava 83334, Slovakia; [Safka-Brozkova, Dana; Seeman, Pavel] Charles Univ Prague, Sch Med 2, Dept Paediat Neurol, DNA Lab, Prague, Czech Republic; [Anwar, Saima; Ahmed, Zubair M.; Riazuddin, Saima] Univ Maryland, Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Baltimore, MD 21201 USA; [Bene, Judit; Melegh, Bela] Univ Pecs, Szentagothai Res Ctr, Pecs, Hungary; [Straka, Slavomir] Fac Hosp JA Reiman, Dept Otorhinolaryngol Head & Neck Surg, Presov, Slovakia	Slovak Academy of Sciences; Slovak Academy of Sciences; Comenius University Bratislava; Slovak Academy of Sciences; Comenius University Bratislava; University of Pecs; Slovak Academy of Sciences; Charles University Prague; University System of Maryland; University of Maryland Baltimore; University of Pecs	Gasperikova, D (corresponding author), Slovak Acad Sci, Inst Expt Endocrinol, Lab Diabet & Metab Disorders, Bratislava, Slovakia.	daniela.gasperikova@savba.sk	Masindova, Ivica/E-7829-2018; Anwar, Saima/C-7477-2016; Gasperikova, Daniela/E-7824-2018; Ficek, Andrej/O-5139-2018; Brozkova, Dana Safka/AAR-8453-2021; PROFANT, MILAN/ABE-2915-2020; Kadasi, Ludevit/A-4677-2013; Safka Brozkova, Dana/ABB-4837-2021; Soltysova, Andrea/E-8057-2018	Gasperikova, Daniela/0000-0002-5725-6424; Safka Brozkova, Dana/0000-0002-0572-7239; Soltysova, Andrea/0000-0002-1402-3583; Ficek, Andrej/0000-0001-7526-2361; Varga, Lukas/0000-0001-9141-3596	Slovak Research and Development Agency [APVV-0148-10]; OPRaD (Operation Program Research and Development) - ERDF (European Regional Development Fund) [ITMS 26240220071, ITMS 26240120027]; OTKA (Orszagos Tudomanyos Kutatasi Alapprogramok) [K103983]; Janos Bolyai Research Scholarship of the Hungarian academy of Sciences; National Institute on Deafness and Other Communication Disorders (NIDCD/NIH) [R01 DC011748, DC011803]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC011803, R01DC012564, R01DC011748] Funding Source: NIH RePORTER	Slovak Research and Development Agency(Slovak Research and Development Agency); OPRaD (Operation Program Research and Development) - ERDF (European Regional Development Fund); OTKA (Orszagos Tudomanyos Kutatasi Alapprogramok)(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Janos Bolyai Research Scholarship of the Hungarian academy of Sciences(Hungarian Academy of Sciences); National Institute on Deafness and Other Communication Disorders (NIDCD/NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Slovak Research and Development Agency under the contract no. APVV-0148-10 to MP and IK, project implementation (ITMS 26240220071) supported by the OPRaD (Operation Program Research and Development) funded by ERDF (European Regional Development Fund) to IK and DG, OTKA (Orszagos Tudomanyos Kutatasi Alapprogramok) K103983 grant to BM and Janos Bolyai Research Scholarship of the Hungarian academy of Sciences to JB and by National Institute on Deafness and Other Communication Disorders (NIDCD/NIH) research grants (R01 DC011748 and DC011803) to SR. This contribution is also the result of the project implementation (ITMS 26240120027) supported by the OPRaD (Operation Program Research and Development) funded by ERDF (European Regional Development Fund). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez A, 2005, AM J MED GENET A, V137A, P255, DOI 10.1002/ajmg.a.30884; Babanejad M, 2012, AM J MED GENET A, V158A, P2485, DOI 10.1002/ajmg.a.35572; Barankova L, 2008, EUR J NEUROL, V15, P548, DOI 10.1111/j.1468-1331.2008.02104.x; Bouwer S, 2007, GENET TEST, V11, P455, DOI 10.1089/gte.2007.0048; Bozikova A, 2012, J THROMB THROMBOLYS, V34, P406, DOI 10.1007/s11239-012-0736-4; Brozkova DS, 2012, CLIN GENET, V82, P579, DOI 10.1111/j.1399-0004.2011.01817.x; Chishti MS, 2008, J HUM GENET, V53, P101, DOI 10.1007/s10038-007-0209-3; Ferak V, 1987, Bratisl Lek Listy, V87, P168; Fraser A, 1995, GYPSIES PEOPLES EURO; Gabrikova D, 2012, J APPL GENET, V53, P183, DOI 10.1007/s13353-012-0088-y; Gencik A, 1989, Dev Ophthalmol, V16, P76; Hungarian Central Statistical Office, CENS 2011 CENS 2011; Hunter M, 2002, PEDIATR RES, V51, P602, DOI 10.1203/00006450-200205000-00010; Ikenouchi J, 2005, J CELL BIOL, V171, P939, DOI 10.1083/jcb.200510043; Juhasz E, 2012, PATHOL ONCOL RES, V18, P177, DOI 10.1007/s12253-011-9425-4; Kabatova Z, 2007, VIA PRACT, V4, P76; KALANIN J, 1994, AM J MED GENET, V49, P235, DOI 10.1002/ajmg.1320490215; Kalaydjieva L, 2001, BMC Med Genet, V2, P5, DOI 10.1186/1471-2350-2-5; Kling, 2014, ATLAS ROMSKYCH KOMUN; Koupilova I, 2001, SOC SCI MED, V53, P1191, DOI 10.1016/S0277-9536(00)00419-6; Lassuthova P, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/1750-1172-9-46; Mariano C, 2011, BIOCHEM BIOPH RES CO, V409, P799, DOI 10.1016/j.bbrc.2011.05.093; Melegh B, 2004, AM J MED GENET A, V131A, P121, DOI 10.1002/ajmg.a.30207; Mendizabal I, 2012, CURR BIOL, V22, P2342, DOI 10.1016/j.cub.2012.10.039; Minarik G, 2003, GEN PHYSIOL BIOPHYS, V22, P549; Moorjani P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058633; Morar B, 2004, AM J HUM GENET, V75, P596, DOI 10.1086/424759; Nayak G, 2013, J CLIN INVEST, V123, P4036, DOI 10.1172/JCI69031; Plasilova M, 1998, HUM HERED, V48, P30; Plasilova M, 1999, J MED GENET, V36, P290; Ramzan K, 2005, HUM GENET, V116, P17, DOI 10.1007/s00439-004-1205-8; Riazuddin S, 2006, AM J HUM GENET, V79, P1040, DOI 10.1086/510022; Riazuddin S, 2012, NAT GENET, V44, P1265, DOI 10.1038/ng.2426; Schrijver I, 2004, J MOL DIAGN, V6, P275, DOI 10.1016/S1525-1578(10)60522-3; Schwabova J, 2013, J NEUROGENET, V27, P163, DOI 10.3109/01677063.2013.814651; Seeman P, 2004, CLIN GENET, V66, P152, DOI 10.1111/j.1399-0004.2004.00283.x; Sharp JD, 2003, HUM MUTAT, V22, P35, DOI 10.1002/humu.10227; Van Camp G, HEREDITARY HEARING L	38	11	11	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124232	10.1371/journal.pone.0124232	http://dx.doi.org/10.1371/journal.pone.0124232			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885414	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000105
J	Siegemund, S; Shepherd, J; Xiao, CC; Sauer, K				Siegemund, Sabine; Shepherd, Jovan; Xiao, Changchun; Sauer, Karsten			hCD2-iCre and Vav-iCre Mediated Gene Recombination Patterns in Murine Hematopoietic Cells	PLOS ONE			English	Article							PLASMACYTOID DENDRITIC CELLS; STEM-CELLS; BONE-MARROW; IN-VIVO; TRANSGENIC MICE; SELF-RENEWAL; T-CELL; EXPRESSION; IDENTIFICATION; PROGENITORS	Cre-recombinase mediated conditional deletion of Lox-P site flanked ("floxed") genes is widely used for functional gene annotation in mice. Many different Cre-transgenic mouse lines have been developed for cell-type specific gene disruption. But often, the precise tissue-patterns of Cre activity remain incompletely characterized. Two widely used transgenes for conditional gene recombination in hematopoietic cells are Vav-iCre driven from the murine Vav1 promotor, and hCD2-iCre driven from the human CD2 promotor. Vav-iCre expresses active Cre in fetal and adult hematopoietic stem cells and all descendants, hCD2-iCre in immature and mature B and T lymphocytes. To better characterize which hematopoietic cells contain hCD2-iCre activity, we compared EYFP fluorescence in hCD2-iCre(+/-)R26-stop-EYFP+/- and Vav-iCre(+/-)R26-stop-EYFP+/- mice. R26-stop-EYFPubiquitously encodes EYFPpreceded by a floxed stop cassette. By removing it, Cre activity induces measurable EYFP expression. Our results confirm the known activity patterns for both Cre transgenes and unveil additional hCD2-iCre mediated reporter gene recombination in common lymphoid progenitors, in natural killer cells and their progenitors, and in plasmacytoid and conventional dendritic cells. This supports previously proposed common lymphoid origins for natural killer cells and subsets of dendritic cells, and indicates the need to consider pleiotropic effects when studying hCD2-iCre mediated conditional knockout mice. Vav-iCre(+/-)R26-stop-EYFP+/- mice did not show the non-hematopoietic recombination in vascular endothelial cells seen in other Vav-Cre mouse lines, but displayed an unexpected Vav-iCre mediated recombination in a bone cell subset lacking hematopoietic markers. This pinpoints the need to consider stromal cell contributions to phenotypes of Vav-iCre mediated conditional knockout mice. Altogether, our data provide the first detailed assessment of hCD2-iCre and Vav-iCre mediated deletion of floxed genes during lymphocyte development from hematopoietic stem cells and open up novel applications for either Cre-transgenic mouse line.	[Siegemund, Sabine; Shepherd, Jovan; Xiao, Changchun; Sauer, Karsten] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Sauer, Karsten] Scripps Res Inst, Dept Cell & Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Sauer, K (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	ksauer@scripps.edu		Shepherd, Jovan/0000-0003-2067-550X	National Institutes of Health (NIH) [AI070845, GM100785]; NIH/NCATS [UL1 TR000109]; Leukemia and Lymphoma Society Scholar Award [1440-11]; Deutsche Forschungsgemeinschaft fellowship [SI 1547/1-1]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000109] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070845] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100785] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCATS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Deutsche Forschungsgemeinschaft fellowship(German Research Foundation (DFG)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) grants AI070845 and GM100785, NIH/NCATS grant UL1 TR000109, The Leukemia and Lymphoma Society Scholar Award 1440-11 to K.S., and Deutsche Forschungsgemeinschaft fellowship SI 1547/1-1 to S.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abram CL, 2014, J IMMUNOL METHODS, V408, P89, DOI 10.1016/j.jim.2014.05.009; Arcangeli ML, 2011, BLOOD, V118, P4609, DOI 10.1182/blood-2010-12-323972; Barouch-Bentov R, 2009, MOL CELL, V33, P43, DOI 10.1016/j.molcel.2008.12.024; Bouabe H, 2013, METHODS MOL BIOL, V1064, P315, DOI 10.1007/978-1-62703-601-6_23; Carotta S, 2011, BLOOD; Carotta S, 2011, BLOOD, V117, P5449, DOI 10.1182/blood-2010-11-318956; Ceredig R, 2012, NAT IMMUNOL, V13, P309, DOI 10.1038/ni.2265; Cichocki F, 2014, SEMIN IMMUNOL, V26, P114, DOI 10.1016/j.smim.2014.02.003; Corcoran L, 2003, J IMMUNOL, V170, P4926, DOI 10.4049/jimmunol.170.10.4926; Das R, 2010, IMMUNOL REV, V238, P195, DOI 10.1111/j.1600-065X.2010.00962.x; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Fathman JW, 2011, BLOOD, V118, P5439, DOI 10.1182/blood-2011-04-348912; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Georgiades P, 2002, GENESIS, V34, P251, DOI 10.1002/gene.10161; Grzywacz B, 2011, BLOOD, V117, P3548, DOI 10.1182/blood-2010-04-281394; Hardy RR, 2007, IMMUNITY, V26, P703, DOI 10.1016/j.immuni.2007.05.013; Heffner CS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2186; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Huang YH, 2007, SCIENCE, V316, P886, DOI 10.1126/science.1138684; Jia YH, 2008, P NATL ACAD SCI USA, V105, P4739, DOI 10.1073/pnas.0800218105; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LANG G, 1988, EMBO J, V7, P1675, DOI 10.1002/j.1460-2075.1988.tb02995.x; Lattin Jane E, 2008, Immunome Res, V4, P5, DOI 10.1186/1745-7580-4-5; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Magee JA, 2012, CELL STEM CELL, V11, P415, DOI 10.1016/j.stem.2012.05.026; Michie AM, 2002, SEMIN IMMUNOL, V14, P311, DOI 10.1016/S1044-5323(02)00064-7; Miller AT, 2007, NAT IMMUNOL, V8, P514, DOI 10.1038/ni1458; Moore Amanda J, 2013, Adv Hematol, V2013, P949513, DOI 10.1155/2013/949513; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Mortensen M, 2011, J EXP MED, V208, P455, DOI 10.1084/jem.20101145; Naik SH, 2007, NAT IMMUNOL, V8, P1217, DOI 10.1038/ni1522; Ogilvy S, 1999, BLOOD, V94, P1855; Onai N, 2007, NAT IMMUNOL, V8, P1207, DOI 10.1038/ni1518; Pelayo R, 2005, BLOOD, V105, P4407, DOI 10.1182/blood-2004-07-2529; Petrie HT, 2007, ANNU REV IMMUNOL, V25, P649, DOI 10.1146/annurev.immunol.23.021704.115715; Pietras EM, 2011, J CELL BIOL, V195, P709, DOI 10.1083/jcb.201102131; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Sathe P, 2013, BLOOD, V121, P11, DOI 10.1182/blood-2012-02-413336; Satpathy AT, 2011, SEMIN IMMUNOL, V23, P388, DOI 10.1016/j.smim.2011.08.009; Sauer K, 2013, BLOOD, V121, P286, DOI 10.1182/blood-2012-05-429241; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019; Schlenner SM, 2010, IMMUNITY, V32, P426, DOI 10.1016/j.immuni.2010.03.005; Segura E, 2009, J IMMUNOL, V183, P1514, DOI 10.4049/jimmunol.0901524; Serwold T, 2009, BLOOD, V113, P807, DOI 10.1182/blood-2008-08-173682; Shi JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046590; Shortman K, 2007, NAT REV IMMUNOL, V7, P19, DOI 10.1038/nri1996; Shortman K, 2013, ADV IMMUNOL, V120, P105, DOI 10.1016/B978-0-12-417028-5.00004-1; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sullivan RP, 2012, J IMMUNOL, V188, P3019, DOI 10.4049/jimmunol.1102294; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; Vogt TK, 2009, BLOOD, V113, P3961, DOI 10.1182/blood-2008-08-176321; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson TJ, 2002, GENESIS, V33, P181, DOI 10.1002/gene.10107; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xiong JA, 2011, INT IMMUNOL, V23, P55, DOI 10.1093/intimm/dxq457	56	33	33	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124661	10.1371/journal.pone.0124661	http://dx.doi.org/10.1371/journal.pone.0124661			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884630	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000139
J	Tsuji, PA; Carlson, BA; Yoo, MH; Naranjo-Suarez, S; Xu, XM; He, YW; Asaki, E; Seifried, HE; Reinhold, WC; Davis, CD; Gladyshev, VN; Hatfield, DL				Tsuji, Petra A.; Carlson, Bradley A.; Yoo, Min-Hyuk; Naranjo-Suarez, Salvador; Xu, Xue-Ming; He, Yiwen; Asaki, Esther; Seifried, Harold E.; Reinhold, William C.; Davis, Cindy D.; Gladyshev, Vadim N.; Hatfield, Dolph L.			The 15kDa Selenoprotein and Thioredoxin Reductase 1 Promote Colon Cancer by Different Pathways	PLOS ONE			English	Article							SELENIUM SUPPLEMENTATION; NUTRITIONAL PREVENTION; 15-KDA SELENOPROTEIN; CELL-GROWTH; SEP15; EXPRESSION; CARCINOMA; TRIAL; RISK; GENE	Selenoproteins mediate much of the cancer-preventive properties of the essential nutrient selenium, but some of these proteins have been shown to also have cancer-promoting effects. We examined the contributions of the 15kDa selenoprotein (Sep15) and thioredoxin reductase 1 (TR1) to cancer development. Targeted down-regulation of either gene inhibited anchorage-dependent and anchorage-independent growth and formation of experimental metastases of mouse colon carcinoma CT26 cells. Surprisingly, combined deficiency of Sep15 and TR1 reversed the anti-cancer effects observed with down-regulation of each single gene. We found that inflammation-related genes regulated by Stat-1, especially interferon-gamma-regulated guanylate-binding proteins, were highly elevated in Sep15-deficient, but not in TR1-deficient cells. Interestingly, components of the Wnt/beta-catenin signaling pathway were up-regulated in cells lacking both TR1 and Sep15. These results suggest that Sep15 and TR1 participate in interfering regulatory pathways in colon cancer cells. Considering the variable expression levels of Sep15 and TR1 found within the human population, our results provide insights into new roles of selenoproteins in cancer.	[Tsuji, Petra A.] Towson Univ, Dept Biol Sci, Towson, MD 21252 USA; [Carlson, Bradley A.; Yoo, Min-Hyuk; Naranjo-Suarez, Salvador; Xu, Xue-Ming; Hatfield, Dolph L.] NIH, Mol Biol Selenium Sect, Mouse Canc Genet Program, Bethesda, MD 20892 USA; [He, Yiwen; Asaki, Esther] NIH, Ctr Informat Technol, Bethesda, MD 20892 USA; [Seifried, Harold E.] NIH, Nutr Sci Res Grp, Rockville, MD USA; [Reinhold, William C.] NIH, Genom & Informat Grp, Mol Pharmacol Lab, Bethesda, MD 20892 USA; [Davis, Cindy D.] NIH, Off Dietary Supplements, Rockville, MD USA; [Gladyshev, Vadim N.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	University System of Maryland; Towson University; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Tsuji, PA (corresponding author), Towson Univ, Dept Biol Sci, Towson, MD 21252 USA.	ptsuji@towson.edu	Suarez, Salvador Naranjo/K-8450-2017; Reinhold, William/J-6704-2017	Suarez, Salvador Naranjo/0000-0002-7038-0753; Reinhold, William/0000-0001-5513-9323; Gladyshev, Vadim/0000-0002-0372-7016	Towson University's Fisher College of Science and Mathematics; National Cancer Institute Intramural support; National Cancer Institute Cancer Prevention Fellowship Program; National Institutes of Health [CA080946, GM065204]; NATIONAL CANCER INSTITUTE [R01CA080946, ZIABC011620] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065204, R37GM065204] Funding Source: NIH RePORTER	Towson University's Fisher College of Science and Mathematics; National Cancer Institute Intramural support; National Cancer Institute Cancer Prevention Fellowship Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Funded by Towson University's Fisher College of Science and Mathematics (Endowed Chair, PAT), National Cancer Institute Intramural support, the National Cancer Institute Cancer Prevention Fellowship Program (PAT), and National Institutes of Health grants (CA080946, GM065204 to VNG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Cancer Society, 2013, CANC FACTS FIGURES 2; Apostolou S, 2004, ONCOGENE, V23, P5032, DOI 10.1038/sj.onc.1207683; Arner ESJ, 2006, SEMIN CANCER BIOL, V16, P420, DOI 10.1016/j.semcancer.2006.10.009; Brigelius-Flohe Regina, 2012, Int J Cell Biol, V2012, P486147, DOI 10.1155/2012/486147; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Chan JY, 2008, CANCER BIOL THER, V7, P1305, DOI 10.4161/cbt.7.8.6302; Clark LC, 1996, JAMA-J AM MED ASSOC, V276, P1957, DOI 10.1001/jama.276.24.1957; Collier J, 1998, HEPATOLOGY, V27, P273, DOI 10.1002/hep.510270140; Almondes KGD, 2010, REV ASSOC MED BRAS, V56, P484, DOI 10.1590/S0104-42302010000400025; Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630; Duffield-Lillico AJ, 2003, BJU INT, V91, P608, DOI 10.1046/j.1464-410X.2003.04167.x; Fodde R, 2002, EUR J CANCER, V38, P867, DOI 10.1016/S0959-8049(02)00040-0; GASDASKA JR, 1995, CELL GROWTH DIFFER, V6, P1643; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Hatfield DL, 2009, MOL INTERV, V9, P18, DOI 10.1124/mi.9.1.6; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Hsieh CM, 1996, J BIOL CHEM, V271, P17354, DOI 10.1074/jbc.271.29.17354; Irons R, 2006, J NUTR, V136, P1311, DOI 10.1093/jn/136.5.1311; Irons R, 2010, CANCER PREV RES, V3, P630, DOI 10.1158/1940-6207.CAPR-10-0003; Jablonska E, 2008, EUR J NUTR, V47, P47, DOI 10.1007/s00394-008-0696-9; Jao SW, 1996, DIS COLON RECTUM, V39, P628, DOI 10.1007/BF02056940; Juuti A, 2004, J CLIN PATHOL, V57, P1151, DOI 10.1136/jcp.2003.015818; Kasaikina MV, 2012, BBA-MOL CELL RES, V1823, P1633, DOI 10.1016/j.bbamcr.2012.02.018; Kasaikina MV, 2011, J BIOL CHEM, V286, P33203, DOI 10.1074/jbc.M111.259218; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Korotkov KV, 2001, J BIOL CHEM, V276, P15330, DOI 10.1074/jbc.M009861200; Kressner U, 1997, BRIT J CANCER, V76, P526, DOI 10.1038/bjc.1997.419; Kumaraswamy E, 2002, METHOD ENZYMOL, V347, P187; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lippman SM, 2009, JAMA-J AM MED ASSOC, P1; Ma XR, 2002, J BIOL CHEM, V277, P22460, DOI 10.1074/jbc.M202286200; Moos PJ, 2003, J BIOL CHEM, V278, P745, DOI 10.1074/jbc.M211134200; Patterson AD, 2013, CHEM RES TOXICOL, V26, P1088, DOI 10.1021/tx4001013; Pensa S, 2009, JAK STAT PATHWAY DIS; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Reinhold WC, 2012, CANCER RES, V72, P3499, DOI 10.1158/0008-5472.CAN-12-1370; Santin I, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.158; Suvorova ES, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006158; Tsuji PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050574; Tsuji PA, 2011, NUTRIENTS, V3, P805, DOI 10.3390/nu3090805; Villanueva A, 2012, GASTROENTEROLOGY, V143, P1660, DOI 10.1053/j.gastro.2012.09.002; Wang JW, 2006, NEUROSCI RES, V56, P80, DOI 10.1016/j.neures.2006.05.011; Wang XY, 2008, MOL CELL BIOL, V28, P3589, DOI 10.1128/MCB.00040-08; Wright ME, 2012, SELENIUM ITS MOL BIO; Xu XM, 2009, NAT PROTOC, V4, P1338, DOI 10.1038/nprot.2009.145; Yoo MH, 2006, J BIOL CHEM, V281, P13005, DOI 10.1074/jbc.C600012200; Yoo MH, 2012, SELENIUM ITS MOL BIO; Yoo MH, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001112; Yoo MH, 2010, METHOD ENZYMOL, V474, P255, DOI 10.1016/S0076-6879(10)74015-5	50	28	29	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124487	10.1371/journal.pone.0124487	http://dx.doi.org/10.1371/journal.pone.0124487			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886253	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000131
J	Tyler, CJ; Reeve, T; Cheung, SS				Tyler, Christopher James; Reeve, Tom; Cheung, Stephen S.			Cold-Induced Vasodilation during Single Digit Immersion in 0 degrees C and 8 degrees C Water in Men and Women	PLOS ONE			English	Article							HEALTHY-SUBJECTS; FINGERS; SKIN; TRAINABILITY; TEMPERATURE; RESPONSES; EXERCISE; HUMANS; HAND; AGE	The present study compared the thermal responses of the finger to 0 and 8 degrees C water immersion, two commonly used temperatures for cold-induced vasodilation (CIVD) research. On two separate and counterbalanced occasions 15 male and 15 female participants immersed their index finger in 20 degrees C water for 5 min followed by either 0 or 8 degrees C water for 30 min. Skin temperature, cardiovascular and perceptual data were recorded. Secondary analyses were performed between sexes and comparing 0.5, 1 and 4 degrees C CIVD amplitude thresholds. With a 0.5 degrees C threshold, CIVD waves were more prevalent in 8 degrees C (2 (1 -3) than in 0 degrees C (1.5 (0 3)), but the amplitude was lower (4.0 +/- 2.3 v 9.2 +/- 4.0 degrees C). Mean, minimum and maximum finger temperatures were lower in 0 degrees C during the 30 min immersion, and CIVD onset and peak time occurred later in 0 degrees C. Thermal sensation was lower and pain sensation was higher in 0 degrees C. There were no differences between males and females in any of the physiological or CIVD data with the exception of SBP, which was higher in males. Females reported feeling higher thermal sensations in 8 degrees C and lower pain sensations in 0 degrees C and 8 degrees C compared to males. Fewer CIVD responses were observed when using a 4 degrees C (1 (0 -3)) threshold to quantify a CIVD wave compared to using a 1 degrees C (2 (0 -3)) or 0.5 degrees C (2 (0 -3)) amplitude. In conclusion, both 0 and 8 degrees C can elicit CIVD but 8 degrees C may be more suitable when looking to optimise the number of CIVD waves while minimising participant discomfort. The CIVD response to water immersion does not appear to be influenced by sex. Researchers should consider the amplitude threshold that was used to determine a CIVD wave when interpreting previous data.	[Tyler, Christopher James; Reeve, Tom] Univ Roehampton, Dept Life Sci, London, England; [Cheung, Stephen S.] Brock Univ, Dept Kinesiol, St Catharines, ON L2S 3A1, Canada	Roehampton University; Brock University	Tyler, CJ (corresponding author), Univ Roehampton, Dept Life Sci, London, England.	chris.tyler@roehampton.ac.uk	Cheung, Stephen/AAE-9136-2020; Cheung, Stephen/HGU-6191-2022; Tyler, Chris/AAG-1087-2020	Cheung, Stephen/0000-0002-6149-4978; Tyler, Christopher/0000-0002-3233-0771	Canada Research Chair	Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	S.S. Cheung is supported by a Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTELINK ML, 1993, J APPL PHYSIOL, V74, P727, DOI 10.1152/jappl.1993.74.2.727; Birnie KA, 2012, J PAIN, V13, P817, DOI 10.1016/j.jpain.2012.06.005; Cheung SS, 2007, EUR J APPL PHYSIOL, V99, P701, DOI 10.1007/s00421-006-0383-6; Cheung SS, 2012, MICROCIRCULATION, V19, P65, DOI 10.1111/j.1549-8719.2011.00126.x; Cohen J., 1988, STAT POWER ANAL BEHA, P543; COOKE JP, 1990, CIRCULATION, V82, P1607, DOI 10.1161/01.CIR.82.5.1607; Costello JT, 2014, EUR J SPORT SCI, V14, P847, DOI 10.1080/17461391.2014.911354; Daanen H A, 2000, High Alt Med Biol, V1, P323, DOI 10.1089/15270290050502390; Daanen HAM, 2005, AVIAT SPACE ENVIR MD, V76, P1119; Daanen HAM, 2003, EUR J APPL PHYSIOL, V89, P411, DOI 10.1007/s00421-003-0818-2; Daanen HAM, 2012, EUR J APPL PHYSIOL, V112, P2595, DOI 10.1007/s00421-011-2233-4; Flouris AD, 2006, J APPL PHYSIOL, V101, P802, DOI 10.1152/japplphysiol.00197.2006; Flouris AD, 2008, EUR J APPL PHYSIOL, V104, P491, DOI 10.1007/s00421-008-0798-3; Geurts CLM, 2006, APPL PHYSIOL NUTR ME, V31, P717, DOI [10.1139/H06-076, 10.1139/h06-076]; KREGEL KC, 1992, J PHYSIOL-LONDON, V454, P359, DOI 10.1113/jphysiol.1992.sp019268; Lewis T, 1930, HEART-J STUD CIRC, V15, P177; Mekjavic IB, 2008, EUR J APPL PHYSIOL, V104, P193, DOI 10.1007/s00421-008-0727-5; Mekjavic IB, 2013, APPL PHYSIOL NUTR ME, V38, P14, DOI 10.1139/apnm-2012-0118; NELMS JD, 1962, J APPL PHYS, V17, P444; Nes BM, 2013, SCAND J MED SCI SPOR, V23, P697, DOI 10.1111/j.1600-0838.2012.01445.x; O'Brien C, 2005, J APPL PHYSIOL, V98, P1334, DOI 10.1152/japplphysiol.00859.2004; Sendowski I, 1997, EUR J APPL PHYSIOL O, V75, P471, DOI 10.1007/s004210050191; SPURR GB, 1955, AM HEART J, V50, P551, DOI 10.1016/0002-8703(55)90300-8; WOLFF HH, 1949, CLIN SCI, V8, P145; YOUNG AJ, 1987, J APPL PHYSIOL, V63, P1218, DOI 10.1152/jappl.1987.63.3.1218	25	10	11	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122592	10.1371/journal.pone.0122592	http://dx.doi.org/10.1371/journal.pone.0122592			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886576	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000034
J	Zapf, AC; Glindemann, LA; Vogeley, K; Falter, CM				Zapf, Alexandra C.; Glindemann, Liv A.; Vogeley, Kai; Falter, Christine M.			Sex Differences in Mental Rotation and How They Add to the Understanding of Autism	PLOS ONE			English	Article							MALE BRAIN THEORY; SPATIAL ABILITY; HANDEDNESS; TESTOSTERONE	The most consistent cognitive sex differences have been found in the visuo-spatial domain, using Mental Rotation (MR) tasks. Such sex differences have been suggested to bear implications on our understanding of autism spectrum disorders (ASD). However, it is still debated how the sex difference in MR performance relates to differences between individuals with ASD compared to typically developed control persons (TD). To provide a detailed exploration of sex differences in MR performance, we studied rotational (indicated by slopes) and non-rotational aspects (indicated by intercepts) of the MR task in TD individuals (total N = 50). Second-to-fourth digit length ratios (2D:4D) were measured to investigate the associations between prenatal testosterone and performance on MR tasks. Handedness was assessed by the use of the Edinburgh Handedness Inventory in order to examine the relation between handedness and MR performance. In addition, we investigated the relation of spatial to systemising abilities, both of which have been associated with sex differences and with ASD, employing the Intuitive Physics Test (IPT). Results showed a male advantage in rotational aspects of the MR task, which correlated with IPT results. These findings are in contrast to the MR performance of individuals with ASD who have been shown to outperform TD persons in the non-rotational aspects of the MR task. These results suggest that the differences in MR performance due to ASD are different from sex-related differences in TD persons, in other words, ASD is not a simple and continuous extension of the male cognitive profile into the psychopathological range as the extreme male brain hypothesis (EMB) of ASD would suggest.	[Zapf, Alexandra C.; Glindemann, Liv A.] Univ Groningen, Dept Clin & Dev Neuropsychol, NL-9712 TS Groningen, Netherlands; [Vogeley, Kai; Falter, Christine M.] Univ Hosp Cologne, Dept Psychiat, D-50924 Cologne, Germany; [Vogeley, Kai] Res Ctr Juelich, Inst Neurosci & Med Cognit Neurosci INM 3, D-52425 Julich, Germany	University of Groningen; University of Cologne; Helmholtz Association; Research Center Julich	Falter, CM (corresponding author), Univ Hosp Cologne, Dept Psychiat, Kerpener Str 62, D-50924 Cologne, Germany.	christine.falter@cantab.net	Vogeley, Kai/E-4860-2012	Vogeley, Kai/0000-0002-5891-5831				Aleman A, 2004, PSYCHONEUROENDOCRINO, V29, P612, DOI 10.1016/S0306-4530(03)00089-1; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Baron-Cohen S, 2002, TRENDS COGN SCI, V6, P248, DOI 10.1016/S1364-6613(02)01904-6; Baron-Cohen S., 2001, J DEV LEARNING DISOR, V5, P47, DOI DOI 10.1111/J.1467-7687.2008.00720.X; Brosnan M, 2010, EUR J COGN PSYCHOL, V22, P172, DOI 10.1080/09541440902743710; Brosnan M, 2010, J AUTISM DEV DISORD, V40, P1, DOI 10.1007/s10803-009-0815-3; Dane S, 2007, INT J DEV NEUROSCI, V25, P223, DOI 10.1016/j.ijdevneu.2007.03.005; Falter CM, 2006, BIOL PSYCHOL, V73, P132, DOI 10.1016/j.biopsycho.2006.01.011; Falter CM, 2008, J AUTISM DEV DISORD, V38, P997, DOI 10.1007/s10803-008-0552-z; Falter CM, 2008, J AUTISM DEV DISORD, V38, P507, DOI 10.1007/s10803-007-0419-8; GESCHWIND N, 1982, P NATL ACAD SCI-BIOL, V79, P5097, DOI 10.1073/pnas.79.16.5097; Hooven CK, NEUROPSYCHOLOGIA, V42, P782; Jansen P, 2010, EXP AGING RES, V36, P94, DOI 10.1080/03610730903422762; KAIL R, 1979, PERCEPT PSYCHOPHYS, V26, P182, DOI 10.3758/BF03199867; Manning JT, 1998, HUM REPROD, V13, P3000, DOI 10.1093/humrep/13.11.3000; MCGEE MG, 1978, PERCEPT MOTOR SKILL, V47, P641, DOI 10.2466/pms.1978.47.2.641; Muth A, 2014, J AUTISM DEV DISORD, V44, P3245, DOI 10.1007/s10803-014-2188-5; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pearce A. J, 2014, J AUTISM DEV DISORD, P1; Reio TG, 2004, LATERALITY, V9, P339, DOI 10.1080/13576500342000220; Schneider W., 2002, E PRIME USERS GUIDE; SHEPARD RN, 1971, SCIENCE, V171, P701, DOI 10.1126/science.171.3972.701; Tapley SM, 1977, CAN J PSYCHOL, V31, P12	23	12	12	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124628	10.1371/journal.pone.0124628	http://dx.doi.org/10.1371/journal.pone.0124628			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884501	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000138
J	Zou, MC; Dong, HM; Meng, XJ; Cai, CQ; Li, CZ; Cai, SX; Xue, YM				Zou, Mengchen; Dong, Hangming; Meng, Xiaojing; Cai, Chunqing; Li, Chenzhong; Cai, Shaoxi; Xue, Yaoming			Store-Operated Ca2+ Entry Plays a Role in HMGB1-Induced Vascular Endothelial Cell Hyperpermeability	PLOS ONE			English	Article							INCREASED SERUM HMGB1; VE-CADHERIN; CALCIUM-ENTRY; ACTIVATION; STIM1; ORAI1; PERMEABILITY; RELEASE; DISEASE; CRAC	Aims Endothelial dysfunction, including increased endothelial permeability, is considered an early marker for atherosclerosis. High-mobility group box 1 protein (HMGB1) and extracellular Ca2+ entry, primarily mediated through store-operated Ca2+ entry (SOCE), are known to be involved in increasing endothelial permeability. The aim of this study was to clarify how HMGB1 could lead to endothelia hyperpermeability. Methods and Results We have shown that human vascular endothelial cell permeability is increased, while transendothelial electrical resistance and VE-cadherin expression were reduced by HMGB1 treatment. Two SOCE inhibitors and knockdown of stromal interaction molecule 1 (STIM1), a Ca2+ sensor mediating SOCE, inhibited the HMGB1-induced influx of Ca2+ and Src activation followed by significant suppression of endothelial permeability. Moreover, knockdown of Orai1, an essential pore-subunit of SOCE channels, decreased HMGB1-induced endothelial hyperpermeability. Conclusions These data suggest that SOCE, acting via STIM1, might be the predominant mechanism of Ca2+ entry in the modulation of endothelial cell permeability. STIM1 may thus represent a possible new therapeutic target against atherosclerosis.	[Zou, Mengchen; Li, Chenzhong; Xue, Yaoming] Southern Med Univ, Dept Endocrinol & Metab, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Dong, Hangming; Cai, Shaoxi] Southern Med Univ, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China; [Meng, Xiaojing; Cai, Chunqing] Southern Med Univ, Dept Occupat Hlth & Occupat Med, Sch Publ Hlth & Trop Med, Guangzhou 510515, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China	Cai, SX (corresponding author), Southern Med Univ, Dept Resp & Crit Care Med, Chron Airways Dis Lab, Nanfang Hosp, Guangzhou 510515, Guangdong, Peoples R China.	cai_shaoxi@163.com; xue_yaoming@163.com			National Natural Science Foundation of China [81270087]; President Foundation of Nanfang Hospital, Southern Medical University [2013C008, 2012C001]; Scientific Research Initiative of Southern Medical University [PY2013N027]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); President Foundation of Nanfang Hospital, Southern Medical University; Scientific Research Initiative of Southern Medical University	This study was supported by National Natural Science Foundation of China (81270087); President Foundation of Nanfang Hospital, Southern Medical University (2013C008,2012C001); Scientific Research Initiative of Southern Medical University (PY2013N027).	Abdullaev IF, 2008, CIRC RES, V103, P1289, DOI 10.1161/01.RES.0000338496.95579.56; Alexander JS, 2000, INFLAMMATION, V24, P99, DOI 10.1023/A:1007025325451; Ambudkar IS, 2007, CELL CALCIUM, V42, P213, DOI 10.1016/j.ceca.2007.01.013; Andersson U, 2002, J LEUKOCYTE BIOL, V72, P1084; Davignon J., 2004, CIRCULATION, V109, P11127; Dejana E, 2008, J CELL SCI, V121, P2115, DOI 10.1242/jcs.017897; Dellis Olivier, 2011, BMC Pharmacology, V11, P1, DOI 10.1186/1471-2210-11-1; Ding HS, 2010, SAUDI MED J, V31, P486; Faxon DP, 2004, CIRCULATION, V109, P2595, DOI 10.1161/01.CIR.0000128517.52533.DB; Fedida-Metula S, 2012, CARCINOGENESIS, V33, P740, DOI 10.1093/carcin/bgs021; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Gilio K, 2010, J BIOL CHEM, V285, P23629, DOI 10.1074/jbc.M110.108696; Harper MT, 2006, J THROMB HAEMOST, V4, P2695, DOI 10.1111/j.1538-7836.2006.02207.x; Hirata Y, 2013, ATHEROSCLEROSIS, V231, P227, DOI 10.1016/j.atherosclerosis.2013.09.010; Hu XR, 2009, CLIN CHIM ACTA, V406, P139, DOI 10.1016/j.cca.2009.06.016; Huang WC, 2012, INFLAMMATION, V35, P350, DOI 10.1007/s10753-011-9325-5; Ichiki T, 2013, PEPTIDES, V48, P21, DOI 10.1016/j.peptides.2013.07.020; Kalinina N, 2004, ARTERIOSCL THROM VAS, V24, P2320, DOI 10.1161/01.ATV.0000145573.36113.8a; Kanellakis P, 2011, ARTERIOSCL THROM VAS, V31, P313, DOI 10.1161/ATVBAHA.110.218669; Kawahara KI, 2008, INT J MOL MED, V22, P639, DOI 10.3892/ijmm_00000066; Li W, 2006, CURR OPIN PHARMACOL, V6, P130, DOI 10.1016/j.coph.2005.10.010; Luo Y, 2013, BIOCHEM BIOPH RES CO, V438, P732, DOI 10.1016/j.bbrc.2013.07.098; McCarron JG, 2002, J CELL SCI, V115, P2207; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Miyazaki T, 2011, CIRCULATION, V124, P2522, DOI 10.1161/CIRCULATIONAHA.111.021675; Moore TM, 2000, AM J PHYSIOL-LUNG C, V279, pL691, DOI 10.1152/ajplung.2000.279.4.L691; Norwood N, 2000, AM J PHYSIOL-LUNG C, V279, pL815, DOI 10.1152/ajplung.2000.279.5.L815; Numaga-Tomita T, 2013, J CELL SCI, V126, P605, DOI 10.1242/jcs.115980; Okutani D, 2006, AM J PHYSIOL-LUNG C, V291, pL129, DOI 10.1152/ajplung.00261.2005; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Sandoval R, 2001, J PHYSIOL-LONDON, V533, P433, DOI 10.1111/j.1469-7793.2001.0433a.x; Scott J, 2002, J NEURAL TRANSM-SUPP, P1; Shinde AV, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003425; Soeki T, 2004, CIRC J, V68, P1, DOI 10.1253/circj.68.1; SoRelle R, 1999, CIRCULATION, V99, P3, DOI 10.1161/01.CIR.99.1.3; Spassova MA, 2006, P NATL ACAD SCI USA, V103, P4040, DOI 10.1073/pnas.0510050103; Tiruppathi C, 2006, MICROCIRCULATION, V13, P693, DOI 10.1080/10739680600930347; Townsley MI, 2006, MICROCIRCULATION, V13, P725, DOI 10.1080/10739680600930362; Trebak M, 2009, CIRC RES, V104, pE56, DOI 10.1161/CIRCRESAHA.109.196105; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Vandenbroucke E, 2008, ANN NY ACAD SCI, V1123, P134, DOI 10.1196/annals.1420.016; Vestweber D, 2008, ARTERIOSCL THROM VAS, V28, P223, DOI 10.1161/ATVBAHA.107.158014; West DJ, 2007, CURR PHARM DESIGN, V13, P2428; Wolfson RK, 2011, MICROVASC RES, V81, P189, DOI 10.1016/j.mvr.2010.11.010; Yan XX, 2009, ATHEROSCLEROSIS, V205, P544, DOI 10.1016/j.atherosclerosis.2008.12.016; Yuan SY, 2002, VASC PHARMACOL, V39, P213, DOI 10.1016/S1537-1891(03)00010-7; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2; Zou WY, 2012, CELL PHYSIOL BIOCHEM, V30, P221, DOI 10.1159/000339059	49	16	16	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123432	10.1371/journal.pone.0123432	http://dx.doi.org/10.1371/journal.pone.0123432			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884983	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000062
J	Altman, D; Minozzo, FC; Rassier, DE				Altman, David; Minozzo, Fabio C.; Rassier, Dilson E.			Thixotropy and Rheopexy of Muscle Fibers Probed Using Sinusoidal Oscillations	PLOS ONE			English	Article							SKELETAL-MUSCLE; CROSS-BRIDGES; BLEBBISTATIN INHIBITION; MECHANICAL-PROPERTIES; SINGLE MOLECULES; FORCE; TENSION; BEHAVIOR; STRETCH; ACTIN	Length changes of muscle fibers have previously been shown to result in a temporary reduction in fiber stiffness that is referred to as thixotropy. Understanding the mechanism of this thixotropy is important to our understanding of muscle function since there are many instances in which muscle is subjected to repeated patterns of lengthening and shortening. By applying sinusoidal length changes to one end of single permeabilized muscle fibers and measuring the force response at the opposite end, we studied the history-dependent stiffness of both relaxed and activated muscle fibers. For length change oscillations greater than 1 Hz, we observed thixotropic behavior of activated fibers. Treatment of these fibers with EDTA and blebbistatin, which inhibits myosin-actin interactions, quashed this effect, suggesting that the mechanism of muscle fiber thixotropy is cross-bridge dependent. We modeled a half-sarcomere experiencing sinusoidal length changes, and our simulations suggest that thixotropy could arise from force-dependent cross-bridge kinetics. Surprisingly, we also observed that, for length change oscillations less than 1 Hz, the muscle fiber exhibited rheopexy. In other words, the stiffness of the fiber increased in response to the length changes. Blebbistatin and EDTA did not disrupt the rheopectic behavior, suggesting that a non-cross-bridge mechanism contributes to this phenomenon.	[Altman, David] Willamette Univ, Dept Phys, Salem, OR 97301 USA; [Minozzo, Fabio C.; Rassier, Dilson E.] McGill Univ, Dept Kinesiol & Phys Educ, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Physiol, Montreal, PQ, Canada; [Rassier, Dilson E.] McGill Univ, Dept Phys, Montreal, PQ, Canada	Willamette University; McGill University; McGill University; McGill University	Altman, D (corresponding author), Willamette Univ, Dept Phys, Salem, OR 97301 USA.	daltman@gmail.com			Burroughs Wellcome Collaborative Research Travel Grant, BWF [1011279]; Natural Sciences and Engineering Research Council of Canada, NSERC [RGPIN 327310-11]	Burroughs Wellcome Collaborative Research Travel Grant, BWF; Natural Sciences and Engineering Research Council of Canada, NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	The work was supported by the following: DA, Burroughs Wellcome Collaborative Research Travel Grant, BWF ID# 1011279, http://www.bwfund.org/; and DR, Natural Sciences and Engineering Research Council of Canada, NSERC RGPIN 327310-11, http://www.nserc-crsng.gc.ca/index_eng. asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alger MSM, 1997, POLYM SCI DICT, V2nd; Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Bianco P, 2007, BIOPHYS J, V93, P2102, DOI [10.1529/biophysj.107.106153, 10.1529/biophysj.l07.106153]; Buchthal F., 1951, DAN VIDENS SELS BIOL, V21, P1; Campbell KS, 2008, BIOPHYS J, V94, P327, DOI 10.1529/biophysj.107.114322; Campbell KS, 2000, J PHYSIOL-LONDON, V525, P531, DOI 10.1111/j.1469-7793.2000.00531.x; Campbell KS, 1998, J PHYSIOL-LONDON, V510, P941, DOI 10.1111/j.1469-7793.1998.941bj.x; Campbell KS, 2002, BIOPHYS J, V82, P929, DOI 10.1016/S0006-3495(02)75454-4; Cornachione AS, 2012, AM J PHYSIOL-CELL PH, V302, pC566, DOI 10.1152/ajpcell.00355.2011; Gordon AM, 1997, J MUSCLE RES CELL M, V18, P643, DOI 10.1023/A:1018631806182; HERBST M, 1976, PFLUG ARCH EUR J PHY, V364, P71, DOI 10.1007/BF01062914; HILL DK, 1968, J PHYSIOL-LONDON, V199, P637, DOI 10.1113/jphysiol.1968.sp008672; Kawai M, 1980, J Muscle Res Cell Motil, V1, P279, DOI 10.1007/BF00711932; Kellermayer MSZ, 2008, BIOPHYS J, V94, P329, DOI 10.1529/biophysj.107.122309; Kellermayer MSZ, 2001, BIOPHYS J, V80, P852, DOI 10.1016/S0006-3495(01)76064-X; Kolega J, 2004, BIOCHEM BIOPH RES CO, V320, P1020, DOI 10.1016/j.bbrc.2004.06.045; Kovacs M, 2004, J BIOL CHEM, V279, P35557, DOI 10.1074/jbc.M405319200; LAKIE M, 1984, J PHYSIOL-LONDON, V353, P265, DOI 10.1113/jphysiol.1984.sp015335; LAKIE M, 1990, EXP PHYSIOL, V75, P123, DOI 10.1113/expphysiol.1990.sp003380; LANNERGREN J, 1971, J GEN PHYSIOL, V58, P145, DOI 10.1085/jgp.58.2.145; Minajeva A, 2001, BIOPHYS J, V80, P1442, DOI 10.1016/S0006-3495(01)76116-4; Minozzo FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068866; Minozzo FC, 2010, AM J PHYSIOL-CELL PH, V299, pC1127, DOI 10.1152/ajpcell.00073.2010; Mutungi G, 2000, J MUSCLE RES CELL M, V21, P301, DOI 10.1023/A:1005633931146; Pavlov I, 2009, AM J PHYSIOL-CELL PH, V297, pC1211, DOI 10.1152/ajpcell.00233.2009; Piazzesi G, 2007, CELL, V131, P784, DOI 10.1016/j.cell.2007.09.045; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; Rassier DE, 2014, J MUSCLE RES CELL MO; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Wang MD, 1998, SCIENCE, V282, P902, DOI 10.1126/science.282.5390.902	30	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121726	10.1371/journal.pone.0121726	http://dx.doi.org/10.1371/journal.pone.0121726			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880774	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500012
J	Aminde, LN; Takah, NF; Dzudie, A; Bonko, NM; Awungafac, G; Teno, D; Mbuagbaw, L; Sliwa, K				Aminde, Leopold Ndemnge; Takah, Noah Fongwen; Dzudie, Anastase; Bonko, Neville Mengnjo; Awungafac, George; Teno, Divine; Mbuagbaw, Lawrence; Sliwa, Karen			Occupational Post-Exposure Prophylaxis (PEP) against Human Immunodeficiency Virus (HIV) Infection in a Health District in Cameroon: Assessment of the Knowledge and Practices of Nurses	PLOS ONE			English	Article							CARE WORKERS; EXPOSURE; RISK; GUIDELINES; AWARENESS	Background Health care providers are at risk of acquiring human immunodeficiency virus (HIV) infection from occupational exposure, with nurses being the most vulnerable. There is no data on the awareness of post-exposure prophylaxis (PEP) among nurses in Cameroon. This study aimed to assess the knowledge, practices of nurses regarding PEP for HIV and their determinants in Cameroon. Methods A cross-sectional study was conducted between April and July 2013, and involved 80 nurses in a rural health district in the North West Region of Cameroon. Data was collected using a structured questionnaire and analysed using the SPSS software version 20. Results In all, 73.7% of the participants had poor knowledge about PEP for HIV. Though many (83.8%) had heard about PEP, just 10 (12.5%) had received formal training on PEP for HIV. Only 24 (30%) and 20 (25%) knew the correct drug regimen and duration of treatment respectively. The majority (85%) considered themselves to be at risk of acquiring HIV at work, with 54 (67.5%) having experienced an exposure in the past, mainly while setting up intravenous lines (57.4%), recapping needles (37.0%) and during delivery (24.1%). Of those exposed, ten (18.9%) received PEP, which was started after 24 hours in 50%. In multivariable regression analyses, awareness of hospital policy [OR: 0.043 (0.005-0.404), p-value = 0.006] was associated with Good knowledge on PEP for HIV. Conclusions The knowledge and practice of nurses on PEP for HIV in Cameroon is low. There is urgent need for training programmes and workshops to increase awareness, improve practice, and reduce the risk of HIV acquisition from work related activities among health care providers.	[Aminde, Leopold Ndemnge; Dzudie, Anastase; Bonko, Neville Mengnjo] Univ Buea, Fac Hlth Sci, Dept Med, Buea, Cameroon; [Takah, Noah Fongwen; Awungafac, George] Global Hlth Syst Solut, Limbe, Cameroon; [Dzudie, Anastase] Gen Hosp Douala, Dept Internal Med, Douala, Cameroon; [Dzudie, Anastase] Univ Cape Town, Dept Med, Fac Hlth Sci, ZA-7925 Cape Town, South Africa; [Bonko, Neville Mengnjo] Baptist Hosp, Mutengene, Cameroon; [Teno, Divine] Tubah Dist Hosp, Bambui, Cameroon; [Mbuagbaw, Lawrence] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Sliwa, Karen] Univ Cape Town, Fac Hlth Sci, Dept Med, Hatter Inst Cardiovasc Res Africa, ZA-7925 Cape Town, South Africa	University of Cape Town; McMaster University; University of Cape Town	Aminde, LN (corresponding author), Univ Buea, Fac Hlth Sci, Dept Med, Buea, Cameroon.	amindeln@gmail.com	Mbuagbaw, Lawrence/D-9381-2015; AMINDE, Leopold/K-5684-2019; Awungafac, George/Y-4075-2019; Awungafac, George/AAV-8385-2020	Mbuagbaw, Lawrence/0000-0001-5855-5461; AMINDE, Leopold/0000-0003-2787-7518; Awungafac, George/0000-0002-5859-0336; Awungafac, George/0000-0002-5859-0336; DZUDIE, Anastase/0000-0003-4038-4128				Agaba Patricia A, 2012, Niger Med J, V53, P155, DOI 10.4103/0300-1652.104386; Alenyo R., 2009, East and Central African Journal of Surgery, V14, P99; Bandolier E., 2003, OCCUPATIONAL EXPOSUR; CDC, 2007, UPD US PUBL HLTH SER; Chacko Joffi, 2007, Indian J Public Health, V51, P127; Chogle NL, 2002, NATL MED J INDIA, V15, P69; Diprose P, 2000, BRIT J ANAESTH, V84, P767, DOI 10.1093/oxfordjournals.bja.a013591; District C., 2012, INT J PHARM BIOL ARC, V3, P1394; Endalew GS, 2014, J HIV CLIN SCI RES, V1, P101; Esin IA, 2011, NIGER J CLIN PRACT, V14, P464, DOI 10.4103/1119-3077.91757; Foster TM, 2010, W INDIAN MED J, V59; Gupta A, 2008, BMC INFECT DIS, V8, DOI 10.1186/1471-2334-8-142; Krakower DS, 2015, CURR HIV AIDS REP; Mathewos B, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-508; Ministry of Health and Family Welfare: Government of India National AIDS Control Organisation, 2009, MAN OCC EXP INCL POS; Monera T, 2012, J INT AIDS SOC, V15, DOI [10.1186/1758-2652-15-4, DOI 10.1186/1758-2652-15-4]; Nwankwo TO, 2011, NIGER J CLIN PRACT, V14, P34, DOI 10.4103/1119-3077.79237; Owino SO, 2013, J PUBLIC HLTH DEV, V11, P19; Owolabi Rotimi S, 2012, J Int Assoc Physicians AIDS Care (Chic), V11, P179, DOI 10.1177/1545109711401409; Sagoe-Moses C, 2001, NEW ENGL J MED, V345, P538, DOI 10.1056/NEJM200108163450711; Sarah AO AA, 2014, OCCUP MED HLTH AFF, V02; Sharma M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105283; Taegtmeyer M, 2008, AIDS CARE, V20, P304, DOI 10.1080/09540120701583787; Takow Stephen Ekure, 2015, J Int Assoc Provid AIDS Care, V14, P77, DOI 10.1177/2325957413510607; Tebeje B, 2010, ETHIOP J HEALTH SCI, V20, P55; Tetali S., 2006, Indian Journal of Occupational and Environmental Medicine, V10, P35	26	20	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124416	10.1371/journal.pone.0124416	http://dx.doi.org/10.1371/journal.pone.0124416			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879442	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500100
J	Ande, A; McArthur, C; Ayuk, L; Awasom, C; Achu, PN; Njinda, A; Sinha, N; Rao, PSS; Agudelo, M; Nookala, AR; Simon, S; Kumar, A; Kumar, S				Ande, Anusha; McArthur, Carole; Ayuk, Leo; Awasom, Charles; Achu, Paul Ngang; Njinda, Annette; Sinha, Namita; Rao, P. S. S.; Agudelo, Marisela; Nookala, Anantha Ram; Simon, Stephen; Kumar, Anil; Kumar, Santosh			Effect of Mild-to-Moderate Smoking on Viral Load, Cytokines, Oxidative Stress, and Cytochrome P450 Enzymes in HIV-Infected Individuals	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; LC-MS/MS METHOD; CONCURRENT DETERMINATION; ALVEOLAR MACROPHAGES; NICOTINE METABOLITES; ENHANCED PRODUCTION; CIGARETTE-SMOKING; ALCOHOL; DISEASE; TOBACCO	Mild-to-moderate tobacco smoking is highly prevalent in HIV-infected individuals, and is known to exacerbate HIV pathogenesis. The objective of this study was to determine the specific effects of mild-to-moderate smoking on viral load, cytokine production, and oxidative stress and cytochrome P450 (CYP) pathways in HIV-infected individuals who have not yet received antiretroviral therapy (ART). Thirty-two human subjects were recruited and assigned to four different cohorts as follows: a) HIV negative non-smokers, b) HIV positive non-smokers, c) HIV negative mild-to-moderate smokers, and d) HIV positive mild-to-moderate smokers. Patients were recruited in Cameroon, Africa using strict selection criteria to exclude patients not yet eligible for ART and not receiving conventional or traditional medications. Those with active tuberculosis, hepatitis B or with a history of substance abuse were also excluded. Our results showed an increase in the viral load in the plasma of HIV positive patients who were mild-to-moderate smokers compared to individuals who did not smoke. Furthermore, although we did not observe significant changes in the levels of most pro-inflammatory cytokines, the cytokine IL-8 and MCP-1 showed a significant decrease in the plasma of HIV-infected patients and smokers compared with HIV negative non-smokers. Importantly, HIV-infected individuals and smokers showed a significant increase in oxidative stress compared with HIV negative non-smoker subjects in both plasma and monocytes. To examine the possible pathways involved in increased oxidative stress and viral load, we determined the mRNA levels of several antioxidant and cytochrome P450 enzymes in monocytes. The results showed that the levels of most antioxidants are unaltered, suggesting their inability to counter oxidative stress. While CYP2A6 was induced in smokers, CYP3A4 was induced in HIV and HIV positive smokers compared with HIV negative non-smokers. Overall, the findings suggest a possible association of oxidative stress and perhaps CYP pathway with smoking-mediated increased viral load in HIV positive individuals.	[Ande, Anusha; Nookala, Anantha Ram; Kumar, Anil] Univ Missouri, Sch Pharm, Div Pharmacol & Toxicol, Kansas City, MO 64110 USA; [McArthur, Carole] Univ Missouri, Sch Dent, Dept Oral & Craniofacial Sci, Kansas City, MO USA; [Ayuk, Leo; Awasom, Charles] Reg Hosp, Bamenda, North West Prov, Cameroon; [Achu, Paul Ngang; Njinda, Annette] Mezam Polyclin HIV AIDS Treatment Ctr, Bamenda, Cameroon; [Sinha, Namita; Rao, P. S. S.; Kumar, Santosh] Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Agudelo, Marisela] Florida Int Univ, Herbert Wertheim Coll Med, Dept Immunol, Miami, FL 33199 USA; [Simon, Stephen] Univ Missouri, Sch Med, Dept Med Informat, Kansas City, MO 64108 USA	University of Missouri System; University of Missouri Kansas City; University of Missouri System; University of Missouri Kansas City; University of Tennessee System; University of Tennessee Health Science Center; State University System of Florida; Florida International University; University of Missouri System; University of Missouri Kansas City	Kumar, S (corresponding author), Univ Tennessee, Ctr Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	ksantosh@uthsc.edu	KUMAR, ANIL/ACD-8340-2022; Nookala, Anantha Ram/ABV-0636-2022; Boothapati, Anil Kumar/HHS-1813-2022; Nookala, Anantha Ram/ABT-0475-2022	McArthur, Carole/0000-0002-9286-8362	National Institute of Health [DA031616, AA022063, AA020806]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020806, R01AA022063] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA031616] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by National Institute of Health (www.nih.gov) grants DA031616 (SK), AA022063 (SK), and AA020806 (AK).	ABBUD RA, 1995, J INFECT DIS, V172, P859, DOI 10.1093/infdis/172.3.859; Allam E, 2013, ORAL DIS, V19, P660, DOI 10.1111/odi.12050; Ande A, 2013, TOBACCO SMOKING EFFE; Ande A, 2012, DRUG ALCOHOL DEPEN, V125, P49, DOI 10.1016/j.drugalcdep.2012.03.015; Anzenbacher P, 2001, CELL MOL LIFE SCI, V58, P737, DOI 10.1007/PL00000897; Aquaro S, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-76; Atluri VSR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061399; Barbieri SS, 2011, CARDIOVASC RES, V90, P475, DOI 10.1093/cvr/cvr032; Benowitz NL, 2009, ANNU REV PHARMACOL, V49, P57, DOI 10.1146/annurev.pharmtox.48.113006.094742; Boelaert JR, 1996, J INFECT DIS, V173, P1045, DOI 10.1093/infdis/173.4.1045a; Buch S, 2012, CURR HIV RES, V10, P425, DOI 10.2174/157016212802138823; Burnham EL, 2013, AM J PHYSIOL-LUNG C, V304, pL873, DOI 10.1152/ajplung.00385.2012; Catalfamo M, 2012, CYTOKINE GROWTH F R, V23, P207, DOI 10.1016/j.cytogfr.2012.05.007; CHOCHOLA J, 1995, FREE RADICAL RES, V23, P197, DOI 10.3109/10715769509064034; Cioe PA, 2013, ADDICT BEHAV, V2; de-Torres JP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060260; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Dempsey D, 2002, J PHARMACOL EXP THER, V301, P594, DOI 10.1124/jpet.301.2.594; Earla R, 2014, DRUG METAB DISPOS, V42, P282, DOI 10.1124/dmd.113.055186; Elbim C, 2001, J CLIN VIROL, V20, P99, DOI 10.1016/S1386-6532(00)00133-5; Hecht SS, 2000, P NATL ACAD SCI USA, V97, P12493, DOI 10.1073/pnas.220207697; HUGHES DA, 1985, CLIN EXP IMMUNOL, V61, P459; Israel N, 1997, CELL MOL LIFE SCI, V53, P864, DOI 10.1007/s000180050106; Jin MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035505; Jin MY, 2012, J NEUROIMMUNE PHARM, V7, P289, DOI 10.1007/s11481-011-9283-6; Jin MY, 2011, ALCOHOL CLIN EXP RES, V35, P132, DOI 10.1111/j.1530-0277.2010.01330.x; Katsikis PD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002055; Kedzierska Katherine, 2001, Antiviral Chemistry and Chemotherapy, V12, P133; Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521; Kumar S, 2012, EXPERT OPIN DRUG MET, V8, P1363, DOI 10.1517/17425255.2012.714366; Levitzky YS, 2008, ATHEROSCLEROSIS, V201, P217, DOI 10.1016/j.atherosclerosis.2007.12.058; Ma Q, 2013, ANNU REV PHARMACOL, V53, P401, DOI 10.1146/annurev-pharmtox-011112-140320; MALVY DJM, 1994, CLIN CHIM ACTA, V224, P89, DOI 10.1016/0009-8981(94)90124-4; Nair MPN, 2009, J NEUROIMMUNE PHARM, V4, P129, DOI 10.1007/s11481-008-9128-0; Nelson M, 2006, INT J CLIN PRACT, V60, P976, DOI 10.1111/j.1742-1241.2006.01058.x; Pal D, 2006, J NEUROIMMUNE PHARM, V1, P323, DOI 10.1007/s11481-006-9034-2; Raza H, 2013, CELL PHYSIOL BIOCHEM, V31, P683, DOI 10.1159/000350087; Rock RB, 2008, J NEUROIMMUNE PHARM, V3, P143, DOI 10.1007/s11481-007-9098-7; Rowinski R, 2013, EXP GERONTOL, V48, P1141, DOI 10.1016/j.exger.2013.07.010; Silverstein PS, 2011, J NEUROVIROL, V17, P401, DOI 10.1007/s13365-011-0043-4; Stehbens WE, 2004, EXP MOL PATHOL, V77, P121, DOI 10.1016/j.yexmp.2004.04.007; Suzuki K, 2003, J EPIDEMIOL, V13, P29, DOI 10.2188/jea.13.29; Thea DM, 1996, ANN INTERN MED, V124, P757, DOI 10.7326/0003-4819-124-8-199604150-00009; TOLLERUD DJ, 1989, AM REV RESPIR DIS, V139, P1446, DOI 10.1164/ajrccm/139.6.1446; Torimoto N, 2003, BIOCHEMISTRY-US, V42, P15068, DOI 10.1021/bi034409n; Torre D, 2002, LANCET INFECT DIS, V2, P273, DOI 10.1016/S1473-3099(02)00262-1; Vallari A, 2010, AIDS RES HUM RETROV, V26, P109, DOI 10.1089/aid.2009.0178; Vandergeeten C, 2012, CYTOKINE GROWTH F R, V23, P143, DOI 10.1016/j.cytogfr.2012.05.001; VanderMeide PH, 1996, BIOTHERAPY, V8, P243, DOI 10.1007/BF01877210; Walubo A, 2007, EXPERT OPIN DRUG MET, V3, P583, DOI 10.1517/17425225.3.4.583; Wauthier V, 2007, CURR MED CHEM, V14, P745, DOI 10.2174/092986707780090981; Wojna V, 2007, J NEUROVIROL, V13, P561, DOI 10.1080/13550280701620747; Zangar RC, 2004, TOXICOL APPL PHARM, V199, P316, DOI 10.1016/j.taap.2004.01.018; Zhao LJ, 2010, TOXICOLOGY, V278, P242, DOI 10.1016/j.tox.2010.09.010	54	45	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122402	10.1371/journal.pone.0122402	http://dx.doi.org/10.1371/journal.pone.0122402			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879453	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500020
J	Andersen, MB; Croy, CH; Dencker, D; Werge, T; Bymaster, FP; Felder, CC; Fink-Jensen, A				Andersen, Maibritt B.; Croy, Carrie Hughes; Dencker, Ditte; Werge, Thomas; Bymaster, Frank P.; Felder, Christian C.; Fink-Jensen, Anders			Antipsychotic-Like Effect of the Muscarinic Acetylcholine Receptor Agonist BuTAC in Non-Human Primates	PLOS ONE			English	Article							XANOMELINE; INHIBITION	Cholinergic, muscarinic receptor agonists exhibit functional dopamine antagonism and muscarinic receptors have been suggested as possible future targets for the treatment of schizophrenia and drug abuse. The muscarinic ligand (5R, 6R)-6-(3-butylthio-1,2,5-thiadiazol-4-yl)- 1-azabicyclo[3.2.1]octane (BuTAC) exhibits high affinity for muscarinic receptors with no or substantially less affinity for a large number of other receptors and binding sites, including the dopamine receptors and the dopamine transporter. In the present study, we wanted to examine the possible antipsychotic-like effects of BuTAC in primates. To this end, we investigated the effects of BuTAC on d-amphetamine-induced behaviour in antipsychotic-naive Cebus paella monkeys. Possible adverse events of BuTAC, were evaluated in the same monkeys as well as in monkeys sensitized to antipsychotic-induced extrapyramidal side effects. The present data suggests that, the muscarinic receptor ligand BuTAC exhibits antipsychotic-like behaviour in primates. The behavioural data of BuTAC as well as the new biochemical data further substantiate the rationale for the use of muscarinic M-1/M-2/M-4-preferring receptor agonists as novel pharmacological tools in the treatment of schizophrenia.	[Andersen, Maibritt B.; Werge, Thomas] SCT Hans Mental Hosp, Res Inst Biol Psychiat, iPSYCH, Roskilde, Denmark; [Croy, Carrie Hughes; Felder, Christian C.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA; [Dencker, Ditte; Fink-Jensen, Anders] Univ Copenhagen, Lab Neuropsychiat, Dept Neurosci & Pharmacol, Copenhagen, Denmark; [Dencker, Ditte; Fink-Jensen, Anders] Univ Copenhagen, Psychiat Ctr Copenhagen, Copenhagen, Denmark; [Bymaster, Frank P.] Euthymics Biosci Inc, Cambridge, MA USA	Lundbeck Foundation Initiative for Integrative Psychiatric Research (iPSYCH); Eli Lilly; University of Copenhagen; University of Copenhagen	Fink-Jensen, A (corresponding author), Univ Copenhagen, Lab Neuropsychiat, Dept Neurosci & Pharmacol, Copenhagen, Denmark.	a.fink-jensen@dadlnet.dk		Fink-Jensen, Anders/0000-0001-7143-1236; Felder, Christian/0000-0003-1134-8881	Eli Lilly; Euthymics Bioscience Inc.; Lundbeck Foundation [R155-2014-1724] Funding Source: researchfish	Eli Lilly(Eli Lilly); Euthymics Bioscience Inc.; Lundbeck Foundation(Lundbeckfonden)	Eli Lilly provided funding for this study. The funder provided support in the form of salaries for authors CHC and CF, and Euthymics Bioscience Inc., provided support in the form of salaries for author FB, but neither company any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Andersen MB, 2003, NEUROPSYCHOPHARMACOL, V28, P1168, DOI 10.1038/sj.npp.1300151; Bodick NC, 1997, ARCH NEUROL-CHICAGO, V54, P465, DOI 10.1001/archneur.1997.00550160091022; Brady AE, 2008, J PHARMACOL EXP THER, V327, P941, DOI 10.1124/jpet.108.140350; Bymaster FP, 1999, LIFE SCI, V64, P527, DOI 10.1016/S0024-3205(98)00597-9; Byun NE, 2014, NEUROPSYCHOPHARMACOL, V39, P1578, DOI 10.1038/npp.2014.2; CHALMERS RK, 1964, PSYCHOPHARMACOLOGIA, V6, P31, DOI 10.1007/BF00710912; DeLapp NW, 1999, J PHARMACOL EXP THER, V289, P946; Dencker D, 2012, PSYCHOPHARMACOLOGY, V224, P277, DOI 10.1007/s00213-012-2751-8; Dencker D, 2011, J NEUROSCI, V31, P5905, DOI 10.1523/JNEUROSCI.0370-11.2011; Jones CK, 2005, J PHARMACOL EXP THER, V312, P1055, DOI 10.1124/jpet.104.075887; Peacock L, 1999, NEUROPSYCHOPHARMACOL, V20, P35, DOI 10.1016/S0893-133X(98)00049-9; Peacock L, 1999, PSYCHOPHARMACOLOGY, V144, P189, DOI 10.1007/s002130050993; PFEIFFER CC, 1957, ANN NY ACAD SCI, V66, P753, DOI 10.1111/j.1749-6632.1957.tb40764.x; Rasmussen T, 2001, SCHIZOPHR RES, V49, P193, DOI 10.1016/S0920-9964(00)00129-8; Reddymasu SC, 2007, AM J GASTROENTEROL, V102, P2036, DOI 10.1111/j.1572-0241.2007.01255.x; Shannon HE, 2000, SCHIZOPHR RES, V42, P249, DOI 10.1016/S0920-9964(99)00138-3; Shekhar A, 2008, AM J PSYCHIAT, V165, P1033, DOI 10.1176/appi.ajp.2008.06091591; Thomsen M, 2010, PSYCHOPHARMACOLOGY, V208, P401, DOI 10.1007/s00213-009-1740-z; Watt ML, 2013, NEUROPSYCHOPHARMACOL, V38, P2717, DOI 10.1038/npp.2013.186	19	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122722	10.1371/journal.pone.0122722	http://dx.doi.org/10.1371/journal.pone.0122722			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880220	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500027
J	Buckingham, S; Murphy, N; Gibb, H				Buckingham, Sebastian; Murphy, Nick; Gibb, Heloise			The Effects of Fire Severity on Macroinvertebrate Detritivores and Leaf Litter Decomposition	PLOS ONE			English	Article							DRY EUCALYPT FOREST; PINE FORESTS; BODY-SIZE; ARTHROPOD COMMUNITY; SOIL INVERTEBRATES; FLIGHT PERFORMANCE; TROPICAL SAVANNAS; GROUND BEETLES; DOMINANT ANTS; BOREAL FOREST	High severity wildfire events are a feature of forests globally and are likely to be more prevalent with climate change. As a disturbance process, fire has the potential to change important ecological functions, such as decomposition, through its impact on biodiversity. Despite the recognised importance of decomposition in terms of fuel loads and energy flow, little is known about the post-fire effects of fire severity on decomposition by litter-dwelling macroinvertebrate detritivores. We tested the hypotheses that: 1) increasing fire severity is associated with decreased rates of leaf litter decomposition by macroinvertebrate detritivores; and 2) the abundance and biomass of macroinvertebrate detritivores decreases with increasing fire severity, while body size increases. We used a litterbag experiment at long-unburnt, ground-burnt and crown-burnt sites (n = 7 for all treatments) to test the effect of fire severity on: a) macroinvertebrate-driven break-down of litter fuel loads; and b) the size and abundance of macroinvertebrate detritivores three years after fire. Microhabitat conditions differed among fire severity classes. Macroinvertebrate exclusion reduced litter decomposition by 34.7%. Macroinvertebrate detritivores were larger and less abundant following higher severity fires, possibly as a result of fire-induced changes in habitat structure. Opposing effects of fire severity on macroinvertebrate abundance and body size resulted in both similar detritivore biomass and, most interestingly, no differences in leaf litter decomposition under different fire severities. This suggests that the diversity of macroinvertebrates enhances functional resilience of litter decomposition to fire and that litter-breakdown is not inhibited within three years following a high severity fire in this forest type and where recolonisation sources are readily available. We found no support for the hypothesis that high severity fires reduce litter decomposition and therefore increase the likelihood of future fires.	[Buckingham, Sebastian; Gibb, Heloise] La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia; [Murphy, Nick] La Trobe Univ, Dept Genet, Melbourne, Vic 3086, Australia	La Trobe University; La Trobe University	Buckingham, S (corresponding author), La Trobe Univ, Dept Zool, Melbourne, Vic 3086, Australia.	jsbuckingham@students.latrobe.edu.au	Gibb, Heloise/B-8338-2013	Gibb, Heloise/0000-0001-7194-0620; Murphy, Nick/0000-0002-0907-4642	La Trobe University	La Trobe University	This study was supported by La Trobe University (PhD Scholarship; http://www.latrobe.edu.au/) and the Department of Sustainability and Environment Fieldwork expenses (www.dse.vic.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AN, 2007, DIVERS DISTRIB, V13, P438, DOI 10.1111/j.1472-4642.2007.00353.x; Andersen AN, 2012, AUSTRAL ECOL, V37, P658, DOI 10.1111/j.1442-9993.2011.02334.x; ASHTON DH, 1975, AUST J BOT, V23, P413, DOI 10.1071/BT9750413; ATTIWILL PM, 1979, AUST J BOT, V27, P439, DOI 10.1071/BT9790439; Bengtsson J, 2000, FOREST ECOL MANAG, V132, P39, DOI 10.1016/S0378-1127(00)00378-9; Berwaerts K, 2002, FUNCT ECOL, V16, P484, DOI 10.1046/j.1365-2435.2002.00650.x; Bogorodskaya AV, 2010, CONTEMP PROBL ECOL+, V3, P653, DOI 10.1134/S199542551006007X; Bond WJ, 2005, NEW PHYTOL, V165, P525, DOI 10.1111/j.1469-8137.2004.01252.x; Booth RG, 1990, COLEOPTERA CAB INT; Bradford MA, 2002, OIKOS, V99, P317, DOI 10.1034/j.1600-0706.2002.990212.x; Bradstock RA, 2010, GLOBAL ECOL BIOGEOGR, V19, P145, DOI 10.1111/j.1466-8238.2009.00512.x; Brennan KEC, 2009, GLOBAL CHANGE BIOL, V15, P2958, DOI 10.1111/j.1365-2486.2009.02011.x; Canhoto C, 1999, MICROBIAL ECOL, V37, P163, DOI 10.1007/s002489900140; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Clarke HG, 2011, INT J WILDLAND FIRE, V20, P550, DOI 10.1071/WF10070; Coleman D.C., 2004, FUNDAMENTALS SOIL EC; Coleman TW, 2006, FOREST ECOL MANAG, V233, P52, DOI 10.1016/j.foreco.2006.06.001; COUTEAUX MM, 1995, TRENDS ECOL EVOL, V10, P63, DOI 10.1016/S0169-5347(00)88978-8; Crockford RH, 2002, HYDROL PROCESS, V16, P3317, DOI 10.1002/hyp.1001; Cruz MG, 2012, FOREST ECOL MANAG, V284, P269, DOI 10.1016/j.foreco.2012.02.035; CSIRO, 1991, INS AUSTR TXB STUD R; Dahlberg A, 2001, BIOL CONSERV, V100, P151, DOI 10.1016/S0006-3207(00)00230-5; Davies KF, 2000, ECOLOGY, V81, P1450, DOI 10.2307/177221; den Boer PJ, 1990, BIOL CONSERV, V54, P175; Dias ATC, 2013, OECOLOGIA, V172, P667, DOI 10.1007/s00442-012-2541-3; Didham RK, 1998, ECOL MONOGR, V68, P295, DOI 10.1890/0012-9615(1998)068[0295:BSRTTF]2.0.CO;2; DINGLE H, 1980, EVOLUTION, V34, P371, DOI 10.1111/j.1558-5646.1980.tb04825.x; Driscoll DA, 2005, CONSERV BIOL, V19, P182, DOI 10.1111/j.1523-1739.2005.00586.x; DSE, 2005, NV2005 EVCBCS EC VEG; Farji-Brener AG, 2004, OIKOS, V104, P165, DOI 10.1111/j.0030-1299.2004.12740.x; Fattorini S, 2010, BIODIVERS CONSERV, V19, P1237, DOI 10.1007/s10531-009-9749-5; Fauria MM, 2008, PHILOS T R SOC B, V363, P2317, DOI 10.1098/rstb.2007.2202; Garcia-Palacios P, 2013, ECOL LETT, V16, P1045, DOI 10.1111/ele.12137; Gessner MO, 2010, TRENDS ECOL EVOL, V25, P372, DOI 10.1016/j.tree.2010.01.010; Gibb H, 2010, OECOLOGIA, V164, P1061, DOI 10.1007/s00442-010-1703-4; Gill A. M., 1975, Australian Forestry, V38, P4; Gould JS, 2011, FOREST ECOL MANAG, V262, P531, DOI 10.1016/j.foreco.2011.04.022; Gruner Daniel S., 2003, Pacific Science, V57, P325, DOI 10.1353/psc.2003.0021; Hodar JA, 1996, ACTA OECOL, V17, P421; Holloway JD, 1987, LEPIDOPTERA CAB INT; Kampichler C, 2009, BIOL REV, V84, P375, DOI 10.1111/j.1469-185X.2009.00078.x; Keeley JE, 2009, INT J WILDLAND FIRE, V18, P116, DOI 10.1071/WF07049; Kim Ji Won, 2008, Journal of Asia-Pacific Entomology, V11, P77, DOI 10.1016/j.aspen.2008.05.003; Kiss L, 2006, BIODIVERS CONSERV, V15, P2925, DOI 10.1007/s10531-005-3430-4; Langlands PR, 2011, J ANIM ECOL, V80, P558, DOI 10.1111/j.1365-2656.2010.01795.x; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; LAVELLE P, 1993, BIOTROPICA, V25, P130, DOI 10.2307/2389178; Makkonen M, 2012, ECOL LETT, V15, P1033, DOI 10.1111/j.1461-0248.2012.01826.x; Malmstrom A, 2010, FOREST ECOL MANAG, V260, P62, DOI 10.1016/j.foreco.2010.04.001; Mccaw WL, 2012, FOREST ECOL MANAG, V271, P170, DOI 10.1016/j.foreco.2012.02.003; Mevik BH, 2007, J STAT SOFTW, V18, P1, DOI 10.18637/jss.v018.i02; Moretti M, 2006, OECOLOGIA, V149, P312, DOI 10.1007/s00442-006-0450-z; NOBLE IR, 1980, AUST J ECOL, V5, P201, DOI 10.1111/j.1442-9993.1980.tb01243.x; Parr CL, 2007, OECOLOGIA, V151, P33, DOI 10.1007/s00442-006-0570-5; Price OF, 2012, J ENVIRON MANAGE, V113, P146, DOI 10.1016/j.jenvman.2012.08.041; Pryke JS, 2012, AUSTRAL ECOL, V37, P460, DOI 10.1111/j.1442-9993.2011.02307.x; R Development Core Team, 2007, R LANG ENV STAT COMP; Radea C, 2000, EUR J SOIL BIOL, V36, P57, DOI 10.1016/S1164-5563(00)01045-1; Raison R. J., 1983, Australian Forestry, V46, P294; RAISON RJ, 1986, AUST J SOIL RES, V24, P33, DOI 10.1071/SR9860033; Ritchie ME, 1999, NATURE, V400, P557, DOI 10.1038/23010; Robinson NM, 2013, J APPL ECOL, V50, P1321, DOI 10.1111/1365-2664.12153; Rodrigo A, 2008, ECOSCIENCE, V15, P442, DOI 10.2980/15-4-3117; ROFF DA, 1991, AM ZOOL, V31, P205; Saint-Germain M, 2005, FOREST ECOL MANAG, V212, P118, DOI 10.1016/j.foreco.2005.03.001; Saint-Germain M, 2007, J APPL ECOL, V44, P330, DOI 10.1111/j.1365-2664.2006.01269.x; Schimmel J, 1996, ECOLOGY, V77, P1436, DOI 10.2307/2265541; Schowalter TD, 2012, ANNU REV ENTOMOL, V57, P1, DOI 10.1146/annurev-ento-120710-100610; Smucker KM, 2005, ECOL APPL, V15, P1535, DOI 10.1890/04-1353; Steffan-Dewenter I, 1997, OECOLOGIA, V109, P294, DOI 10.1007/s004420050087; Swift, 1983, DECOMPOSITION TROPIC; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Teague B., 2010, 2009 VICTORIAN BUSHF; TU CM, 1980, MICROB ECOL, V5, P321, DOI 10.1007/BF02020339; Vasconcelos HL, 2008, AUSTRAL ECOL, V33, P221, DOI 10.1111/j.1442-9993.2007.01811.x; Venables WN., 2002, MODERN APPL STAT S 4; Verdasca MJ, 2012, BIOL CONSERV, V146, P14, DOI 10.1016/j.biocon.2011.10.031; Wall DH, 2008, GLOBAL CHANGE BIOL, V14, P2661, DOI 10.1111/j.1365-2486.2008.01672.x; Wardle D., 2002, COMMUNITIES ECOSYSTE; Watson PJ, 2012, INT J WILDLAND FIRE, V21, P755, DOI 10.1071/WF11034; Wikars LO, 2001, FOREST ECOL MANAG, V141, P189, DOI 10.1016/S0378-1127(00)00328-5; Woodward G, 2005, TRENDS ECOL EVOL, V20, P402, DOI 10.1016/j.tree.2005.04.005; Yanoviak SP, 2000, OIKOS, V89, P259, DOI 10.1034/j.1600-0706.2000.890206.x	83	19	19	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124556	10.1371/journal.pone.0124556	http://dx.doi.org/10.1371/journal.pone.0124556			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880062	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500106
J	Shah, S; Sanchez, J; Stewart, A; Piperakis, MM; Cosstick, R; Nichols, C; Park, CK; Ma, X; Wysocki, V; Bitinaite, J; Horton, NC				Shah, Santosh; Sanchez, Jonathan; Stewart, Andrew; Piperakis, Michael M.; Cosstick, Richard; Nichols, Claire; Park, Chad K.; Ma, Xin; Wysocki, Vicki; Bitinaite, Jurate; Horton, Nancy C.			Probing the Run-On Oligomer of Activated SgrAI Bound to DNA	PLOS ONE			English	Article							MOBILITY-MASS-SPECTROMETRY; RESTRICTION-ENDONUCLEASE; ION MOBILITY; 3'-S-PHOSPHOROTHIOLATE LINKAGE; SEQUENCE-SPECIFICITY; AUTOMATED SYNTHESIS; METABOLIC ENZYMES; PROTEIN COMPLEXES; CLEAVAGE; OLIGODEOXYNUCLEOTIDES	SgrAI is a type II restriction endonuclease with an unusual mechanism of activation involving run-on oligomerization. The run-on oligomer is formed from complexes of SgrAI bound to DNA containing its 8 bp primary recognition sequence (uncleaved or cleaved), and also binds (and thereby activates for DNA cleavage) complexes of SgrAI bound to secondary site DNA sequences which contain a single base substitution in either the 1st/8th or the 2nd/7th position of the primary recognition sequence. This modulation of enzyme activity via runon oligomerization is a newly appreciated phenomenon that has been shown for a small but increasing number of enzymes. One outstanding question regarding the mechanistic model for SgrAI is whether or not the activating primary site DNA must be cleaved by SgrAI prior to inducing activation. Herein we show that an uncleavable primary site DNA containing a 3'S-phosphorothiolate is in fact able to induce activation. In addition, we now show that cleavage of secondary site DNA can be activated to nearly the same degree as primary, provided a sufficient number of flanking base pairs are present. We also show differences in activation and cleavage of the two types of secondary site, and that effects of selected single site substitutions in SgrAI, as well as measured collisional cross-sections from previous work, are consistent with the cryo-electron microscopy model for the run-on activated oligomer of SgrAI bound to DNA.	[Shah, Santosh; Sanchez, Jonathan; Stewart, Andrew; Nichols, Claire; Park, Chad K.; Ma, Xin; Wysocki, Vicki; Horton, Nancy C.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA; [Stewart, Andrew] Univ Arizona, Grad Program Genet, Tucson, AZ 85721 USA; [Piperakis, Michael M.; Cosstick, Richard] Univ Liverpool, Dept Chem, Liverpool L69 7ZD, Merseyside, England; [Ma, Xin; Wysocki, Vicki] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Bitinaite, Jurate] New England Biolabs Inc, Ipswich, MA 01938 USA	University of Arizona; University of Arizona; University of Liverpool; University System of Ohio; Ohio State University; New England Biolabs	Horton, NC (corresponding author), Univ Arizona, Dept Chem & Biochem, Tucson, AZ 85721 USA.	nhorton@u.arizona.edu	Horton, Nancy C/E-7881-2011	Horton, Nancy C/0000-0003-2710-8284; Bitinaite, Jurate/0000-0002-9190-6355; Wysocki, Vicki/0000-0003-0495-2538; Sanchez, Jonathan/0000-0003-0097-465X; Ma, Xin/0000-0002-2917-179X; Stewart, Andrew M/0000-0002-1645-3392	NSF [MCB-1410355]; NIH [T32GM008659, S10OD013237]; New England Biolabs, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008659] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD013237] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1410355] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); New England Biolabs, Inc; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Funding for this work was provided by NSF MCB-1410355 (www.nsf.gov)(to NCH), NIH T32GM008659 (www.nih.gov) (to JS), and NIH S10OD013237 (www.nih.gov)(to CKP). New England Biolabs, Inc provided support in the form of salaries for author JB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AGGARWAL A K, 1990, Methods (Orlando), V1, P83, DOI 10.1016/S1046-2023(05)80150-1; Babic AC, 2008, J MOL BIOL, V383, P186, DOI 10.1016/j.jmb.2008.08.032; Barry RM, 2014, ELIFE, V3, DOI 10.7554/eLife.03638; Barry RM, 2011, CURR OPIN MICROBIOL, V14, P704, DOI 10.1016/j.mib.2011.09.015; Bitinaite J, 2002, P NATL ACAD SCI USA, V99, P1164, DOI 10.1073/pnas.022346799; CAREY J, 1991, METHOD ENZYMOL, V208, P103; Daniels LE, 2003, J MOL BIOL, V327, P579, DOI 10.1016/S0022-2836(03)00143-8; Dunten PW, 2008, NUCLEIC ACIDS RES, V36, P5405, DOI 10.1093/nar/gkn510; Fasman GD, HDB BIOCH MOL BIOL; Gaynor JW, 2007, NAT PROTOC, V2, P3122, DOI 10.1038/nprot.2007.451; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Hall Z, 2012, J AM CHEM SOC, V134, P3429, DOI 10.1021/ja2096859; Hingorani-Varma K, 2003, J BIOL CHEM, V278, P40392, DOI 10.1074/jbc.M304603200; Ingerson-Mahar M, 2010, NAT CELL BIOL, V12, P739, DOI 10.1038/ncb2087; Joshi HK, 2006, J BIOL CHEM, V281, P23852, DOI 10.1074/jbc.M512339200; Kim CW, 2010, P NATL ACAD SCI USA, V107, P9626, DOI 10.1073/pnas.1001292107; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Little EJ, 2011, ACTA CRYSTALLOGR D, V67, P67, DOI 10.1107/S0907444910047785; Lyumkis D, 2013, STRUCTURE, V21, P1848, DOI 10.1016/j.str.2013.08.012; Ma X, 2013, BIOCHEMISTRY-US, V52, P4373, DOI 10.1021/bi3013214; Narayanaswamy R, 2009, P NATL ACAD SCI USA, V106, P10147, DOI 10.1073/pnas.0812771106; Noree C, 2014, MOL BIOL CELL, V25, P2282, DOI 10.1091/mbc.E14-04-0912; Noree C, 2010, J CELL BIOL, V190, P541, DOI 10.1083/jcb.201003001; O'Connell JD, 2014, MOL BIOSYST, V10, P851, DOI 10.1039/c3mb70508k; O'Connell JD, 2012, ANNU REV CELL DEV BI, V28, P89, DOI 10.1146/annurev-cellbio-101011-155841; Park CK, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000554; Park CK, 2010, BIOCHEMISTRY-US, V49, P8818, DOI 10.1021/bi100557v; Petrovska I, 2014, ELIFE, V3, DOI 10.7554/eLife.02409; Piperakis MM, 2013, ORG BIOMOL CHEM, V11, P966, DOI 10.1039/c2ob26940f; Reid SL, 2001, BIOCHEMISTRY-US, V40, P2484, DOI 10.1021/bi001956p; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Sabbagh G, 2004, NUCLEIC ACIDS RES, V32, P495, DOI 10.1093/nar/gkh189	34	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124783	10.1371/journal.pone.0124783	http://dx.doi.org/10.1371/journal.pone.0124783			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880668	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500111
J	Taghizadeh, N; Boezen, HM; Schouten, JP; Schroder, CP; de Vries, EGE; Vonk, JM				Taghizadeh, Niloofar; Boezen, H. Marike; Schouten, Jan P.; Schroder, Carolien P.; de Vries, E. G. Elisabeth; Vonk, Judith M.			BMI and Lifetime Changes in BMI and Cancer Mortality Risk	PLOS ONE			English	Article							BODY-MASS INDEX; ALL-CAUSE MORTALITY; PROSTATE-CANCER; LUNG-CANCER; GENERAL-POPULATION; PHYSICAL-ACTIVITY; FOLLOW-UP; OBESITY; ASSOCIATION; OVERWEIGHT	Body Mass Index (BMI) is known to be associated with cancer mortality, but little is known about the link between lifetime changes in BMI and cancer mortality in both males and females. We studied the association of BMI measurements (at baseline, highest and lowest BMI during the study-period) and lifetime changes in BMI (calculated over different time periods (i. e. short time period: annual change in BMI between successive surveys, long time period: annual change in BMI over the entire study period) with mortality from any cancer, and lung, colorectal, prostate and breast cancer in a large cohort study (n= 8,645. Vlagt-wedde-Vlaardingen, 1965-1990) with a follow-up on mortality status on December 31st 2008. We used multivariate Cox regression models with adjustments for age, smoking, sex, and place of residence. Being overweight at baseline was associated with a higher risk of prostate cancer mortality (hazard ratio (HR) = 2.22; 95% CI 1.19-4.17). Obesity at baseline was associated with a higher risk of any cancer mortality[ all subjects (1.23 (1.01-1.50)), and females (1.40 (1.07-1.84))]. Chronically obese females (females who were obese during the entire study-period) had a higher risk of mortality from any cancer (2.16 (1.47-3.18), lung (3.22 (1.06-9.76)), colorectal (4.32 (1.53-12.20)), and breast cancer (2.52 (1.15-5.54)). We found no significant association between long-term annual change in BMI and cancer mortality risk. Both short-term annual increase and decrease in BMI were associated with a lower mortality risk from any cancer[ all subjects: (0.67 (0.47-0.94)) and (0.73 (0.55-0.97)), respectively]. In conclusion, a higher BMI is associated with a higher cancer mortality risk. This study is the first to show that short-term annual changes in BMI were associated with lower mortality from any type of cancer.	[Taghizadeh, Niloofar; Boezen, H. Marike; Schouten, Jan P.; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Boezen, H. Marike; Schouten, Jan P.; Vonk, Judith M.] Univ Groningen, Univ Med Ctr Groningen, GRIAC Res Inst, Groningen, Netherlands; [Schroder, Carolien P.; de Vries, E. G. Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Med Oncol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Boezen, HM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands.	H.M.Boezen@umcg.nl	Vonk, Judith M/ABA-3009-2020; Vonk, Judith/K-8477-2019; Taghizadeh, Niloofar/AAF-2008-2020	Vonk, Judith M/0000-0001-7531-4547; Vonk, Judith/0000-0001-7531-4547; de Vries, Elisabeth/0000-0002-8949-7425	Netherlands Asthma Found [187, 32.96.69]; Stichting Astma Bestrijding [2005/020]; Groningen University Institute for Drug Exploration	Netherlands Asthma Found; Stichting Astma Bestrijding; Groningen University Institute for Drug Exploration	This study was supported by the Netherlands Asthma Found (grant numbers 187 and 32.96.69), the Stichting Astma Bestrijding (grant number 2005/020) and Groningen University Institute for Drug Exploration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript	Aleksandrova Krasimira, 2013, Front Biosci (Elite Ed), V5, P61; Lima GAB, 2009, ARQ BRAS ENDOCRINOL, V53, P969, DOI 10.1590/S0004-27302009000800010; Bennette C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-21; Biglia N, 2013, GYNECOL ENDOCRINOL, V29, P263, DOI 10.3109/09513590.2012.736559; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Cao Y, 2011, CANCER PREV RES, P4486; De Pergola G, 2013, J OBES, V2013, DOI 10.1155/2013/291546; Derby CA, 2006, CLIN ENDOCRINOL, V65, P125, DOI 10.1111/j.1365-2265.2006.02560.x; El-Bastawissi AY, 2005, CANCER CAUSE CONTROL, V16, P407, DOI 10.1007/s10552-004-5027-8; Engeland A, 2003, BRIT J CANCER, V89, P1237, DOI 10.1038/sj.bjc.6601206; Fernandez E, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e4544; Figarska SM, 2012, EUR J EPIDEMIOL, V27, P867, DOI 10.1007/s10654-012-9736-0; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Guilera M, 2005, NUTR CANCER, V51, P140, DOI 10.1207/s15327914nc5102_3; Haggstrom C, 2012, CANCER-AM CANCER SOC, V118, P6199, DOI 10.1002/cncr.27677; Hoffman MA, 2000, J UROLOGY, V163, P824, DOI 10.1016/S0022-5347(05)67812-3; Hospers JJ, 2000, EPIDEMIOLOGY, V11, P261, DOI 10.1097/00001648-200005000-00006; Kaidar-Person O, 2011, OBES SURG, V21, P1792, DOI 10.1007/s11695-011-0490-2; Kitahara CM, 2013, J CLIN ONCOL, V31, P2450, DOI 10.1200/JCO.2012.48.4691; Kushi LH, 2012, CA-CANCER J CLIN, V62, P30, DOI 10.3322/caac.20140; Leung CC, 2011, INT J EPIDEMIOL, V40, P174, DOI 10.1093/ije/dyq134; Ma J, 2008, LANCET ONCOL, V9, P1039, DOI 10.1016/S1470-2045(08)70235-3; Michels KB, 2012, INT J CANCER, V130, P902, DOI 10.1002/ijc.26069; Nakada T, 2012, J TOXICOL SCI, V37, P555; Parr CL, 2010, LANCET ONCOL, V11, P741, DOI 10.1016/S1470-2045(10)70141-8; Petekkaya I, 2013, TUMORI J, V99, P129, DOI 10.1700/1283.14180; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Renehan AG, 2008, LANCET, V371, P569, DOI 10.1016/S0140-6736(08)60269-X; Roberts DL, 2010, ANNU REV MED, V61, P301, DOI 10.1146/annurev.med.080708.082713; Roddam AW, 2008, J NATL CANCER I, V100, P170, DOI 10.1093/jnci/djm323; Smith L, 2012, JNCI-J NATL CANCER I, V104, P778, DOI 10.1093/jnci/djs179; Tee MC, 2013, SURG ENDOSC, V27, P4449, DOI 10.1007/s00464-013-3127-9; VANDERLENDE R, 1981, CLIN RES PROC, V17, P775; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Yang Y, 2013, INT J CANCER, V132, P1162, DOI 10.1002/ijc.27719; Zajacova A, 2013, GERONTOLOGIST; Zhao J, 2012, BMC PUBLIC HEALTH, V12, P12, DOI [10.1186/1471-2458-12-12, DOI 10.1186/1471-2458-12-12]; Zheng H, 2013, AM J EPIDEMIOL, DOI 10.1093	38	63	63	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125261	10.1371/journal.pone.0125261	http://dx.doi.org/10.1371/journal.pone.0125261			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881129	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500116
J	Gaouar, SBS; Da Silva, A; Ciani, E; Kdidi, S; Aouissat, M; Dhimi, L; Lafri, M; Maftah, A; Mehtar, N				Gaouar, Samir Bachir Souheil; Da Silva, Anne; Ciani, Elena; Kdidi, Samia; Aouissat, Miloud; Dhimi, Laziz; Lafri, Mohamed; Maftah, Abderrahman; Mehtar, Nadhira			Admixture and Local Breed Marginalization Threaten Algerian Sheep Diversity	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; COMPUTER-PROGRAM; MICROSATELLITE; INFERENCE; RAREFACTION; SOFTWARE; ALLELES	Due to its geo-climatic conditions, Algeria represents a biodiversity hotspot, with sheep breeds well adapted to a patchwork of extremely heterogeneous harsh habitats. The importance of this peculiar genetic reservoir increases as climate change drives the demand for new adaptations. However, the expansion of a single breed (Ouled-Djellal) which occurred in the last decades has generated a critical situation for the other breeds; some of them are being subjected to uncontrolled cross-breeding with the favored breed and/or to marginalization (effective size contraction). This study investigated genetic diversity within and among six of the nine Algerian breeds, by use of 30 microsatellite markers. Our results showed that, in spite of the census contraction experienced by most of the considered breeds, genetic diversity is still substantial (average gene diversity ranging 0.68 to 0.76) and inbreeding was not identified as a problem. However, two breeds (Rembi and Taadmit) appeared to have lost most of their genetic originality because of intensive cross-breeding with Ouled-Djellal. Based on the above evidence, we suggest Hamra, Sidaoun, and D'man as breeds deserving the highest priority for conservation in Algeria.	[Gaouar, Samir Bachir Souheil; Mehtar, Nadhira] Aboubakr Belkaid Tlemcen Univ, Dept Biol, Tilimsen, Algeria; [Gaouar, Samir Bachir Souheil] Univ Sci & Technol, Mol & Cellular Lab USTOM, Oran, Algeria; [Da Silva, Anne; Maftah, Abderrahman] INRA, Genet Mol Anim UMR1061, Limoges, France; [Da Silva, Anne; Maftah, Abderrahman] Univ Limoges, Genet Mol Anim UMR1061, Limoges, France; [Ciani, Elena] Univ Bari, Dept Biosci Biotechnol & Biopharmaceut, Bari, Italy; [Kdidi, Samia] Arid Lands Inst Medenine, Livestock & Wildlife Lab, Medenine, Tunisia; [Kdidi, Samia] Tunis El Manar Univ, Fac Sci, Lab Genet Immunol & Human Pathol, Tunis, Tunisia; [Aouissat, Miloud] Tech Inst Breeding ITElv Ain El Hadjar, Saida, Algeria; [Dhimi, Laziz] Tech Inst Breeding ITElv Ain Mlila, Constantine, Algeria; [Lafri, Mohamed] Univ Blida, Lab Biotechnol Liees Reprod Anim LBRA, Blida, Algeria	INRAE; Universite de Limoges; Universita degli Studi di Bari Aldo Moro; Institut des Regions Arides; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Universite Saad Dahlab de Blida	Da Silva, A (corresponding author), INRA, Genet Mol Anim UMR1061, Limoges, France.	anne.blondeau@unilim.fr	Gaouar, Semir Bechir Suheil/J-1055-2019	ciani, elena/0000-0001-5673-0975; Gaouar, Semir Bechir Suheil/0000-0001-8691-7116	Italian Ministry of Agricultural, Food and Forestry Policies/University of Limoges (France)/University of Mohamed Boudiaf (Algeria)	Italian Ministry of Agricultural, Food and Forestry Policies/University of Limoges (France)/University of Mohamed Boudiaf (Algeria)	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The partners of the project are "TROVIGEN", financed by the Italian Ministry of Agricultural, Food and Forestry Policies/University of Limoges (France)/University of Mohamed Boudiaf (Algeria).	BELKHIR K, 2000, 9060 CNRS UPR U MONT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Calvo JH, 2006, SMALL RUMINANT RES, V64, P116, DOI 10.1016/j.smallrumres.2005.04.010; Chellig R, 1992, RACES OVINES ALGERIE, P1; Chybicki IJ, 2009, J HERED, V100, P106, DOI 10.1093/jhered/esn088; Ciani E, 2013, SMALL RUMINANT RES, V112, P21, DOI 10.1016/j.smallrumres.2012.12.013; Devendra C., 1982, GOAT SHEEP PRODUCTIO; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Ferrah A, 2013, ALGERIA ANAL FOOD AG; Food and Agricultural Organization of the United Nations, 1999, GLOB STRAT MAN FARM; Food and Agricultural Organization of the United Nations, 2011, MOL GEN CHAR AN GEN, V9, P65; Food and Agricultural Organization of the United Nations, 2014, CHAR VAL ADD LOC BRE; Gaouar S, 2005, Applications of Gene-Based Technologies for Improving Animal Production and Health in Developing Countries, P641, DOI 10.1007/1-4020-3312-5_48; Gaouar S, 2011, EAAP PUBLICATION, V129, P52; Gaouar S. B. S., 2014, Livestock Research for Rural Development, V26, P118; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hedrick PW, 2013, J HERED, V104, P298, DOI 10.1093/jhered/ess139; Herold P, 2012, LIVEST PROD SCI, V129, P63; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kalinowski ST, 2004, CONSERV GENET, V5, P539, DOI 10.1023/B:COGE.0000041021.91777.1a; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lafri M, 2011, 4 JOURN VET; LAHLOU-KASSI A, 1989, Small Ruminant Research, V2, P225, DOI 10.1016/0921-4488(89)90003-5; Lewis P, 1999, GENETIC DATA ANAL CO; MADR, 2006, STAT AGR SYST INF; Miller SA, 1998, NUCLEIC ACIDS RES, V16, P12; National Report of the delinquency, 2009, CRIM FRANC; Peter C, 2007, ANIM GENET, V38, P37, DOI 10.1111/j.1365-2052.2007.01561.x; Petit RJ, 1998, CONSERV BIOL, V12, P844, DOI 10.1046/j.1523-1739.1998.96489.x; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rege JEO, 2003, ECOL ECON, V45, P319, DOI 10.1016/S0921-8009(03)00087-9; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Santucci F, 2007, HEREDITY, V99, P340, DOI 10.1038/sj.hdy.6801006; Tapio I, 2005, HEREDITY, V94, P448, DOI 10.1038/sj.hdy.6800640; Tapio M, 2003, MOL ECOL, V12, P2045, DOI 10.1046/j.1365-294X.2003.01893.x; Trouette G., 1933, SELECTION OVINE TROU, P1; Upton M, 2004, 10 PPLPI FAO; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	47	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122667	10.1371/journal.pone.0122667	http://dx.doi.org/10.1371/journal.pone.0122667			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875832	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100092
J	Ge, B; Tian, Y; Hu, XT; Chen, HB; Zhu, DJ; Zhang, T; Han, JW; Guo, L; Liu, TM				Ge, Bao; Tian, Yin; Hu, Xintao; Chen, Hanbo; Zhu, Dajiang; Zhang, Tuo; Han, Junwei; Guo, Lei; Liu, Tianming			Construction of Multi-Scale Consistent Brain Networks: Methods and Applications	PLOS ONE			English	Article							STATE FUNCTIONAL CONNECTIVITY; WHITE-MATTER; SMALL-WORLD; ANATOMICAL NETWORKS; ARCHITECTURE; REGIONS; MRI; SEGMENTATION; ORGANIZATION; ATTENTION	Mapping human brain networks provides a basis for studying brain function and dysfunction, and thus has gained significant interest in recent years. However, modeling human brain networks still faces several challenges including constructing networks at multiple spatial scales and finding common corresponding networks across individuals. As a consequence, many previous methods were designed for a single resolution or scale of brain network, though the brain networks are multi-scale in nature. To address this problem, this paper presents a novel approach to constructing multi-scale common structural brain networks from DTI data via an improved multi-scale spectral clustering applied on our recently developed and validated DICCCOLs (Dense Individualized and Common Connectivity-based Cortical Landmarks). Since the DICCCOL landmarks possess intrinsic structural correspondences across individuals and populations, we employed the multi-scale spectral clustering algorithm to group the DICCCOL landmarks and their connections into sub-networks, meanwhile preserving the intrinsically-established correspondences across multiple scales. Experimental results demonstrated that the proposed method can generate multi-scale consistent and common structural brain networks across subjects, and its reproducibility has been verified by multiple independent datasets. As an application, these multi-scale networks were used to guide the clustering of multi-scale fiber bundles and to compare the fiber integrity in schizophrenia and healthy controls. In general, our methods offer a novel and effective framework for brain network modeling and tract-based analysis of DTI data.	[Ge, Bao] Minist Educ, Key Lab Modern Teaching Technol, Xian, Peoples R China; [Ge, Bao] Shaanxi Normal Univ, Sch Phys & Informat Technol, Xian, Peoples R China; [Tian, Yin] Xian Commun Inst, Dept Commun, Xian, Peoples R China; [Hu, Xintao; Zhang, Tuo; Han, Junwei; Guo, Lei] Northwestern Polytech Univ, Sch Automat, Xian 710072, Peoples R China; [Chen, Hanbo; Zhu, Dajiang; Liu, Tianming] Univ Georgia, Dept Comp Sci, Cort Architecture Imaging & Discovery Lab, Athens, GA 30602 USA; [Chen, Hanbo; Zhu, Dajiang; Liu, Tianming] Univ Georgia, Bioimaging Res Ctr, Athens, GA 30602 USA	Shaanxi Normal University; Northwestern Polytechnical University; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Liu, TM (corresponding author), Univ Georgia, Dept Comp Sci, Cort Architecture Imaging & Discovery Lab, Athens, GA 30602 USA.	tliu@cs.uga.edu	Liu, Tianming/AAA-4602-2022		NIH [R01 DA-033393, R01 AG-042599]; NSF [CBET-1302089, IIS-1149260]; NATIONAL INSTITUTE ON AGING [R01AG042599] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033393] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This study was supported by NIH R01 DA-033393, NIH R01 AG-042599, NSF CAREER Award IIS-1149260, and NSF CBET-1302089. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard S, 2007, PLOS COMPUT BIOL, V3, P174, DOI 10.1371/journal.pcbi.0030017; Anderson ML, 2013, NEUROIMAGE, V73, P50, DOI 10.1016/j.neuroimage.2013.01.071; Azran A, 2006, SPECTRAL METHODS FOR, V1, P190; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Camara E, 2007, FRONTIERS IN HUMAN N, V2, P19; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Ellison-Wright I, 2009, SCHIZOPHR RES, V108, P3, DOI 10.1016/j.schres.2008.11.021; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fedorenko E, 2013, P NATL ACAD SCI USA, V110, P16616, DOI 10.1073/pnas.1315235110; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Foong J, 2002, NEUROREPORT, V13, P333, DOI 10.1097/00001756-200203040-00017; Fornito A, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00022; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; Ge Bao, 2013, Inf Process Med Imaging, V23, P692, DOI 10.1007/978-3-642-38868-2_58; Ge B, 2013, NEUROINFORMATICS, V11, P119, DOI 10.1007/s12021-012-9169-7; Ge B, 2011, LECT NOTES COMPUT SC, V6892, P149, DOI 10.1007/978-3-642-23629-7_19; Gerig G, 2004, P ANN INT IEEE EMBS, V26, P4421; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hagmann P, 2010, J NEUROSCI METH, V194, P34, DOI 10.1016/j.jneumeth.2010.01.014; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; Honey CJ, 2009, P NATL ACAD SCI USA, V106, P2035, DOI 10.1073/pnas.0811168106; Iturria-Medina Y, 2008, NEUROIMAGE, V40, P1064, DOI 10.1016/j.neuroimage.2007.10.060; Jbabdi S, 2009, NEUROIMAGE, V44, P373, DOI 10.1016/j.neuroimage.2008.08.044; Kanaan RAA, 2005, BIOL PSYCHIAT, V58, P921, DOI 10.1016/j.biopsych.2005.05.015; Kanwisher N, 2010, P NATL ACAD SCI USA, V107, P11163, DOI 10.1073/pnas.1005062107; Kennedy DN, 2010, NEUROINFORMATICS, V8, P61, DOI 10.1007/s12021-010-9070-1; Kubicki M, 2007, J PSYCHIATR RES, V41, P15, DOI 10.1016/j.jpsychires.2005.05.005; Kyriakopoulos M, 2008, EUR PSYCHIAT, V23, P255, DOI 10.1016/j.eurpsy.2007.12.004; Laird Angela R, 2009, Front Neuroinform, V3, P23, DOI 10.3389/neuro.11.023.2009; Liu TM, 2008, NEUROIMAGE, V40, P991, DOI 10.1016/j.neuroimage.2007.12.027; Liu TM, 2007, NEUROIMAGE, V38, P114, DOI 10.1016/j.neuroimage.2007.07.002; Lv J, 2014, IEEE TRANS BIOMED EN; Maddah M, 2006, I S BIOMED IMAGING, P53; Meskaldji DE, 2013, NEUROIMAGE, V80, P416, DOI 10.1016/j.neuroimage.2013.04.084; Meunier D, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00200; Muller-Linow M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000190; Nakic M, 2006, NEUROIMAGE, V31, P1752, DOI 10.1016/j.neuroimage.2006.02.022; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Peters J, 2009, J NEUROSCI, V29, P15727, DOI 10.1523/JNEUROSCI.3489-09.2009; Petersen SE, 2012, ANNU REV NEUROSCI, V35, P73, DOI 10.1146/annurev-neuro-062111-150525; Rotarska-Jagiela A, 2008, NEUROIMAGE, V39, P1522, DOI 10.1016/j.neuroimage.2007.10.063; Salvador R, 2005, CEREB CORTEX, V15, P1332, DOI 10.1093/cercor/bhi016; Seghier ML, 2011, CEREB CORTEX, V21, P1519, DOI 10.1093/cercor/bhq203; Shaywitz BA, 2001, NEUROIMAGE, V13, P601, DOI 10.1006/nimg.2000.0726; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Sporns O., 2010, NETWORKS OF THE BRAI; Surazhsky V, 2005, ACM T GRAPHIC, V24, P553, DOI 10.1145/1073204.1073228; van den Heuvel MP, 2008, NEUROIMAGE, V43, P528, DOI 10.1016/j.neuroimage.2008.08.010; van den Heuvel M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002001; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; von Luxburg U, 2007, STAT COMPUT, V17, P395, DOI 10.1007/s11222-007-9033-z; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Yan CG, 2011, CEREB CORTEX, V21, P449, DOI 10.1093/cercor/bhq111; Yuan YX, 2013, NEUROINFORMATICS, V11, P47, DOI 10.1007/s12021-012-9165-y; Zalesky A, 2010, NEUROIMAGE, V50, P970, DOI 10.1016/j.neuroimage.2009.12.027; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhou CS, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.238103; Zhu DJ, 2013, CEREB CORTEX, V23, P786, DOI 10.1093/cercor/bhs072	60	6	6	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118175	10.1371/journal.pone.0118175	http://dx.doi.org/10.1371/journal.pone.0118175			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876038	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100003
J	Jones, HD; Yoo, J; Crother, TR; Kyme, P; Ben-Shlomo, A; Khalafi, R; Tseng, CW; Parks, WC; Arditi, M; Liu, GY; Shimada, K				Jones, Heather D.; Yoo, Jeena; Crother, Timothy R.; Kyme, Pierre; Ben-Shlomo, Anat; Khalafi, Ramtin; Tseng, Ching W.; Parks, William C.; Arditi, Moshe; Liu, George Y.; Shimada, Kenichi			Nicotinamide Exacerbates Hypoxemia in Ventilator-Induced Lung Injury Independent of Neutrophil Infiltration	PLOS ONE			English	Article							COLONY-ENHANCING FACTOR; HYPOXIC PULMONARY VASOCONSTRICTION; BINDING-PROTEIN-EPSILON; NITRIC-OXIDE SYNTHASE; ALVEOLAR MACROPHAGES; MECHANICAL VENTILATION; INFLAMMATION; RESVERATROL; LIPOPOLYSACCHARIDE; ACTIVATION	Background Ventilator-induced lung injury is a form of acute lung injury that develops in critically ill patients on mechanical ventilation and has a high degree of mortality. Nicotinamide phosphoribosyltransferase is an enzyme that is highly upregulated in ventilator-induced lung injury and exacerbates the injury when given exogenously. Nicotinamide (vitamin B3) directly inhibits downstream pathways activated by Nicotinamide phosphoribosyltransferase and is protective in other models of acute lung injury. Methods We administered nicotinamide i.p. to mice undergoing mechanical ventilation with high tidal volumes to study the effects of nicotinamide on ventilator-induced lung injury. Measures of injury included oxygen saturations and bronchoalveolar lavage neutrophil counts, protein, and cytokine levels. We also measured expression of nicotinamide phosophoribosyltransferase, and its downstream effectors Sirt1 and Cebpa, Cebpb, Cebpe. We assessed the effect of nicotinamide on the production of nitric oxide during ventilator-induced lung injury. We also studied the effects of ventilator-induced lung injury in mice deficient in C/EBP epsilon. Results Nicotinamide treatment significantly inhibited neutrophil infiltration into the lungs during ventilator-induced lung injury, but did not affect protein leakage or cytokine production. Surprisingly, mice treated with nicotinamide developed significantly worse hypoxemia during mechanical ventilation. This effect was not linked to increases in nitric oxide production or alterations in expression of Nicotinamide phosphoribosyl transferase, Sirt1, or Cebpa and Cebpb. Cebpe mRNA levels were decreased with either nicotinamide treatment or mechanical ventilation, but mice lacking C/EBP epsilon developed the same degree of hypoxemia and ventilator-induced lung injury as wild-type mice. Conclusions Nicotinamide treatment during VILI inhibits neutrophil infiltration of the lungs consistent with a strong anti-inflammatory effect, but paradoxically also leads to the development of significant hypoxemia. These findings suggest that pulmonary neutrophilia is not linked to hypoxemia in ventilator-induced lung injury, and that nicotinamide exacerbates hypoxemia during VILI.	[Jones, Heather D.; Yoo, Jeena; Parks, William C.] Cedars Sinai Med Ctr, Div Pulm & Crit Care Med, Los Angeles, CA 90048 USA; [Crother, Timothy R.; Kyme, Pierre; Tseng, Ching W.; Arditi, Moshe; Liu, George Y.; Shimada, Kenichi] Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA; [Jones, Heather D.; Crother, Timothy R.; Kyme, Pierre; Tseng, Ching W.; Arditi, Moshe; Liu, George Y.; Shimada, Kenichi] Cedars Sinai Med Ctr, Infect & Immunol Dis Res Ctr, Los Angeles, CA 90048 USA; [Ben-Shlomo, Anat; Khalafi, Ramtin] Cedars Sinai Med Ctr, Dept Med, Pituitary Ctr, Los Angeles, CA 90048 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center	Shimada, K (corresponding author), Cedars Sinai Med Ctr, Div Pediat Infect Dis & Immunol, Los Angeles, CA 90048 USA.	kenichi.shimada@cshs.org	Crother, Timothy R/E-2879-2010; Ben-Shlomo, Anat/AAH-6009-2021; Parks, William C./AAH-6786-2021	Crother, Timothy R/0000-0001-8465-6127; 	National Institutes of Health grant [UL1TR000124, AI067995]; Cedars-Sinai Research Institute Eigler-Mann-Whiting Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER	National Institutes of Health grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cedars-Sinai Research Institute Eigler-Mann-Whiting Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	National Institutes of Health grant UL1TR000124 (HJ), Cedars-Sinai Research Institute Eigler-Mann-Whiting Grant (HJ), National Institutes of Health grant AI067995 (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham E, 2000, AM J PHYSIOL-LUNG C, V279, pL1137, DOI 10.1152/ajplung.2000.279.6.L1137; Adyshev DM, 2013, AM J RESP CELL MOL B; Ahmad SF, 2014, MOL IMMUNOL; Altemeier WA, 2004, AM J PHYSIOL-LUNG C, V287, pL533, DOI 10.1152/ajplung.00004.2004; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bhatia M, 1998, INT J PANCREATOL, V24, P77; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Caudrillier A, 2012, J CLIN INVEST, V122, P2661, DOI 10.1172/JCI61303; Cheng OZ, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00001; Dhanireddy S, 2006, LAB INVEST, V86, P790, DOI 10.1038/labinvest.3700440; Eyal FG, 2007, INTENS CARE MED, V33, P1212, DOI 10.1007/s00134-007-0651-x; Fernandes CA, 2011, AM J PHYSIOL-LUNG C, V300, pL354, DOI 10.1152/ajplung.00198.2010; Frank JA, 2006, AM J PHYSIOL-LUNG C, V291, pL1191, DOI 10.1152/ajplung.00055.2006; Galli M, 2010, CANCER RES, V70, P8, DOI 10.1158/0008-5472.CAN-09-2465; Gill SE, 2010, AM J PATHOL, V176, P64, DOI 10.2353/ajpath.2010.090158; Grommes J, 2011, MOL MED, V17, P293, DOI 10.2119/molmed.2010.00138; Gurujeyalakshmi G, 2000, J PHARMACOL EXP THER, V293, P82; Hong SB, 2008, AM J RESP CRIT CARE, V178, P605, DOI 10.1164/rccm.200712-1822OC; Jia SH, 2004, J CLIN INVEST, V113, P1318, DOI [10.1172/JCI19930, 10.1172/JCI200419930]; Jones HD, 2014, AM J RESP CELL MOL, V50, P270, DOI 10.1165/rcmb.2013-0087OC; Kapoor K, 2014, MOL CELL BIOCH; Kobayashi A, 1998, CHEST, V113, P1632, DOI 10.1378/chest.113.6.1632; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kuipers MT, 2012, ANESTHESIOLOGY, V116, P1104, DOI 10.1097/ALN.0b013e3182518bc0; Kwon WY, 2011, CRIT CARE MED, V39, P328, DOI 10.1097/CCM.0b013e3181feeae4; Kyme P, 2012, J CLIN INVEST, V122, P3316, DOI 10.1172/JCI62070; Lee W L, 2001, Curr Opin Crit Care, V7, P1, DOI 10.1097/00075198-200102000-00001; Legutko A, 2009, OPEN IMMUNOL J, V2, P42; Lekstrom-Himes J, 1999, BLOOD, V93, P3096; Li TX, 2013, MOL MED REP, V7, P1889, DOI 10.3892/mmr.2013.1444; Liaudet L, 2002, AM J RESP CRIT CARE, V165, P372, DOI 10.1164/ajrccm.165.3.2106050; Liu P, 2009, CELL BIOL INT, V33, P19, DOI 10.1016/j.cellbi.2008.10.015; Matsuda A, 2013, ANN SURG; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matute-Bello G, 2008, AM J PHYSIOL-LUNG C, V295, pL379, DOI 10.1152/ajplung.00010.2008; Matute-Bello G, 2011, AM J RESP CELL MOL, V44, P725, DOI 10.1165/rcmb.2009-0210ST; Moreno-Vinasco L., 2014, AM J RESP CELL MOL B; NAGAI A, 1994, EUR RESPIR J, V7, P1125; PELLATDECEUNYNCK C, 1994, BIOCHEM J, V297, P53, DOI 10.1042/bj2970053; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Revollo JR, 2007, CELL METAB, V6, P363, DOI 10.1016/j.cmet.2007.09.003; Sittipunt C, 2001, AM J RESP CRIT CARE, V163, P503, DOI 10.1164/ajrccm.163.2.2004187; Skokowa J, 2009, NAT MED, V15, P151, DOI 10.1038/nm.1913; Soehnlein O, 2008, EUR RESPIR J, V32, P405, DOI 10.1183/09031936.00173207; Spohr F, 2005, AM J PHYSIOL-HEART C, V289, pH823, DOI 10.1152/ajpheart.00605.2004; Spragg RG, 2010, AM J RESP CRIT CARE, V181, P1121, DOI 10.1164/rccm.201001-0024WS; Su CF, 2007, EUR RESPIR J, V30, P199, DOI 10.1183/09031936.00025107; Suzuki E, 2010, LIFE SCI, V86, P676, DOI 10.1016/j.lfs.2010.02.019; Ullrich R, 1999, J CLIN INVEST, V104, P1421, DOI 10.1172/JCI6590; Ungerstedt JS, 2003, J THROMB HAEMOST, V1, P2554, DOI 10.1046/j.1538-7836.2003.00463.x; Ungerstedt JS, 2003, CLIN EXP IMMUNOL, V131, P48, DOI 10.1046/j.1365-2249.2003.02031.x; Van Gool F, 2009, NAT MED, V15, P206, DOI 10.1038/nm.1906; Villar J, 2011, MINERVA ANESTESIOL, V77, P647; WANG QJ, 1991, BIOCHEM PHARMACOL, V42, P1115, DOI 10.1016/0006-2952(91)90296-H; WANG QJ, 1990, J BIOCHEM TOXICOL, V5, P13, DOI 10.1002/jbt.2570050104; Wosten-van Asperen RM, 2010, AM J PATHOL, V176, P2219, DOI 10.2353/ajpath.2010.090565; Wu CT, 2008, CHINESE J PHYSIOL, V51, P363; Wurfel Mark M, 2007, Proc Am Thorac Soc, V4, P77, DOI 10.1513/pats.200608-149JG; Yamanaka R, 1997, P NATL ACAD SCI USA, V94, P13187, DOI 10.1073/pnas.94.24.13187; Ye SQ, 2005, MICROVASC RES, V70, P142, DOI 10.1016/j.mvr.2005.08.003; Ye SQ, 2005, AM J RESP CRIT CARE, V171, P361, DOI 10.1164/rccm.200404-563OC; Yeh DYW, 2014, TRANSPL P, V46, P1131, DOI 10.1016/j.transproceed.2013.11.094; Yeh DYW, 2006, CHINESE J PHYSIOL, V49, P305; Zemans RL, 2009, AM J RESP CELL MOL, V40, P519, DOI 10.1165/rcmb.2008-0348TR; Zhang HX, 2014, PULM PHARMACOL THER, V27, P150, DOI 10.1016/j.pupt.2013.07.007; Zhang LQ, 2008, FEBS LETT, V582, P1802, DOI 10.1016/j.febslet.2008.04.061; Zhang Z, 2014, MOL MED REP, V10, P101, DOI 10.3892/mmr.2014.2226	67	25	26	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123460	10.1371/journal.pone.0123460	http://dx.doi.org/10.1371/journal.pone.0123460			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875775	Green Published, gold			2022-12-27	WOS:000352845100178
J	Ospina, MB; Voaklander, D; Senthilselvan, A; Stickland, MK; King, M; Harris, AW; Rowe, BH				Ospina, Maria B.; Voaklander, Don; Senthilselvan, Ambikaipakan; Stickland, Michael K.; King, Malcolm; Harris, Andrew W.; Rowe, Brian H.			Incidence and Prevalence of Chronic Obstructive Pulmonary Disease among Aboriginal Peoples in Alberta, Canada	PLOS ONE			English	Article							GLOBAL BURDEN; SOCIOECONOMIC-STATUS; COPD; HEALTH; ASTHMA; METAANALYSIS; POPULATION	Background Chronic obstructive pulmonary disease (COPD) is a major respiratory disorder, largely caused by smoking that has been linked with large health inequalities worldwide. There are important gaps in our knowledge about how COPD affects Aboriginal peoples. This retrospective cohort study assessed the epidemiology of COPD in a cohort of Aboriginal peoples relative to a non-Aboriginal cohort. Methods We used linkage of administrative health databases in Alberta (Canada) from April 1, 2002 to March 31, 2010 to compare the annual prevalence, and the incidence rates of COPD between Aboriginal and non-Aboriginal cohorts aged 35 years and older. Poisson regression models adjusted the analysis for important sociodemographic factors. Results Compared to a non-Aboriginal cohort, prevalence estimates of COPD from 2002 to 2010 were 2.3 to 2.4 times greater among Registered First Nations peoples, followed by the Inuit (1.86 to 2.10 times higher) and the Metis (1.59 to 1.67 times higher). All Aboriginal peoples had significantly higher COPD incidence rates than the non-Aboriginal group (incidence rate ratio [IRR]: 2.1; 95% confidence interval [CI]: 1.97, 2.27). COPD incidence rates were higher in First Nation peoples (IRR: 2.37; 95% CI: 2.19, 2.56) followed by Inuit (IRR: 1.92; 95% CI: 1.64, 2.25) and Metis (IRR: 1.49; 95% CI: 1.32, 1.69) groups. Conclusions We found a high burden of COPD among Aboriginal peoples living in Alberta; a province with the third largest Aboriginal population in Canada. Altogether, the three Aboriginal peoples groups have higher prevalence and incidence of COPD compared to a non-Aboriginal cohort. The condition affects the three Aboriginal groups differently; Registered First Nations and Inuit have the highest burden of COPD. Reasons for these differences should be further explored within a framework of social determinants of health to help designing interventions that effectively influence modifiable COPD risk factors in each of the Aboriginal groups.	[Ospina, Maria B.; Voaklander, Don; Senthilselvan, Ambikaipakan; Rowe, Brian H.] Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada; [Stickland, Michael K.; Rowe, Brian H.] Univ Alberta, Fac Med & Dent, Div Pulm Med, Edmonton, AB, Canada; [King, Malcolm] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Harris, Andrew W.] Alberta Hlth, Edmonton, AB, Canada; [Rowe, Brian H.] Univ Alberta, Dept Emergency Med, Fac Med & Dent, Edmonton, AB, Canada	University of Alberta; University of Alberta; Simon Fraser University; Alberta Health Services (AHS); University of Alberta	Rowe, BH (corresponding author), Univ Alberta, Sch Publ Hlth, Edmonton, AB, Canada.	brian.rowe@ualberta.ca		King, Malcolm/0000-0002-1712-0303; Ospina, Maria/0000-0001-9305-7521	Canadian Thoracic Society; Canadian Lung Association; Ottawa (Canada), (CLA/CTS Studentship)	Canadian Thoracic Society; Canadian Lung Association; Ottawa (Canada), (CLA/CTS Studentship)	This work was supported by the Canadian Thoracic Society and the Canadian Lung Association; Ottawa (Canada), (CLA/CTS Studentship to Maria B. Ospina). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson M, 2006, 1 NATIONS INUIT METI; Aschan-Leygonie C, 2013, INT J HEALTH GEOGR, V12, DOI 10.1186/1476-072X-12-19; Canadian Institute for Health Information, 2001, CAN ENH ICD 10; Eisner MD, 2011, J EPIDEMIOL COMMUN H, V65, P26, DOI 10.1136/jech.2009.089722; Evans J, 2010, RECOMMENDATIONS CANA; Gershon AS, 2009, COPD, V6, P388, DOI 10.1080/15412550903140865; Gershon AS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095899; Griffiths RI, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-32; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Johnson JA, 2009, CAN J PUBLIC HEALTH, V100, P231, DOI 10.1007/BF03405547; Klein-Geltink J, 2012, RESP DIS METIS NATIO; Laupand KB, 2006, J CRIT CARE, V21, P243, DOI 10.1016/j.jcrc.2006.03.012; MacMillan HL, 1996, CAN MED ASSOC J, V155, P1569; Mannino DM, 2007, LANCET, V370, P765, DOI 10.1016/S0140-6736(07)61380-4; Mannino DM, 2006, EUR RESPIR J, V27, P627, DOI 10.1183/09031936.06.00024605; Martens P., 2010, PROFILE METIS HLTH S; Menezes AMB, 2005, LANCET, V366, P1875, DOI 10.1016/S0140-6736(05)67632-5; Ospina MB, 2012, CAN RESPIR J, V19, P355, DOI 10.1155/2012/825107; Physicians for a Smoke-Free Canada, 2013, FACTSH SMOK AB CAN; Prescott E, 1999, EUR RESPIR J, V13, P1109, DOI 10.1034/j.1399-3003.1999.13e28.x; Rothman K., 1998, MODERN EPIDEMIOLOGY; Rycroft CE, 2012, INT J CHRONIC OBSTR, V7, P457, DOI 10.2147/COPD.S32330; SENTHILSELVAN A, 1995, J CLIN EPIDEMIOL, V48, P1277, DOI 10.1016/0895-4356(95)00019-Z; Sin DD, 2002, CHEST, V121, P1841, DOI 10.1378/chest.121.6.1841; Statistics Canada, 2009, CAN COMM HLTH SURV 2; Statistics Canada, 2013, AB PEOPL CAN 1 NAT P; Statistics Canada, 1994, 1991 CENS HIGHL; Wang F, 2002, IEA 16 WORLD C EP MO; World Health Organization, 1979, INT STAT CLASS DIS I	29	23	23	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123204	10.1371/journal.pone.0123204	http://dx.doi.org/10.1371/journal.pone.0123204			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875817	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100151
J	Teng, MS; Hsu, LA; Wu, SM; Sun, YC; Juan, SH; Ko, YL				Teng, Ming-Sheng; Hsu, Lung-An; Wu, Semon; Sun, Yu-Chen; Juan, Shu-Hui; Ko, Yu-Lin			Association of CDH13 Genotypes/Haplotypes with Circulating Adiponectin Levels, Metabolic Syndrome, and Related Metabolic Phenotypes: The Role of the Suppression Effect	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; INSULIN-RESISTANCE; T-CADHERIN; CARDIOVASCULAR-DISEASE; DEPENDENT PATHWAY; SENSITIVITY; PROTEIN; OBESITY; GENE; METAANALYSIS	Objective Previous genome-wide association studies have indicated an association between CDH13 genotypes and adiponectin levels. In this study, we used mediation analysis to assess the statistical association between CDH13 locus variants and adiponectin levels, metabolic syndrome, and related metabolic phenotypes. Methods and results A sample population of 530 Taiwanese participants was enrolled. Four CDH13 gene variants in the promoter and intron 1 regions were genotyped. After adjustment for clinical covariates, the CDH13 genotypes/haplotypes exhibited an association with the adiponectin levels (lowest P = 1.95 x 10(-11) for rs4783244 and lowest P = 3.78 x 10(-13) for haplotype ATTT). Significant correlations were observed between the adiponectin levels and the various metabolic syndrome- related phenotypes (all P <= 0.005). After further adjustment for the adiponectin levels, participants with a minor allele of rs12051272 revealed a considerable association with a more favorable metabolic profile, including higher insulin sensitivity, highdensity lipoprotein cholesterol levels, lower diastolic blood pressure, circulating levels of fasting plasma glucose, and triglycerides, and as a lower risk of metabolic syndrome (all P < 0.05). The mediation analysis further revealed a suppression effect of the adiponectin levels on the association between CDH13 genotypes and metabolic syndrome and its related phenotypes (Sobel test; all P < 0.001). Conclusion The genetic polymorphisms at the CDH13 locus independently affect the adiponectin levels, whereas the adiponectin levels exhibit a suppressive effect on the association between CDH13 locus variants and various metabolic phenotypes and metabolic syndrome. In addition, these results provide further evidence of the association between the CDH13 gene variants and the risks of metabolic syndrome and atherosclerotic cardiovascular disease.	[Teng, Ming-Sheng; Juan, Shu-Hui] Taipei Med Univ, Coll Med, Dept Physiol, Grad Inst Med Sci, Taipei, Taiwan; [Teng, Ming-Sheng; Wu, Semon] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Res, Taipei, Taiwan; [Hsu, Lung-An] Chang Gung Mem Hosp, Dept Internal Med, Cardiovasc Div 1, Taoyuan, Taiwan; [Hsu, Lung-An] Chang Gung Univ, Coll Med, Taoyuan, Taiwan; [Wu, Semon] Chinese Culture Univ, Dept Life Sci, Taipei, Taiwan; [Sun, Yu-Chen] Chang Gung Mem Hosp, Dept Lab Med, Taoyuan, Taiwan; [Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Ko, Yu-Lin] Buddhist Tzu Chi Med Fdn, Taipei Tzu Chi Hosp, Cardiovasc Med Ctr, Taipei, Taiwan; [Ko, Yu-Lin] Tzu Chi Univ, Sch Med, Hualien, Taiwan	Taipei Medical University; Chang Gung Memorial Hospital; Chang Gung University; Chinese Culture University; Chang Gung Memorial Hospital; Tzu Chi University	Juan, SH (corresponding author), Taipei Med Univ, Coll Med, Dept Physiol, Grad Inst Med Sci, Taipei, Taiwan.	juansh@tmu.edu.tw; yulinkotw@yahoo.com.tw	Stefanadis, Christodoulos/ABH-2232-2020	Stefanadis, Christodoulos/0000-0001-5974-6454; Hsu, Lung-An/0000-0002-0012-2804	National Science Council, Taiwan [NSC101-2314-B-303-023-MY3]; Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation [TCRD-TPE-NSC-102-01, TCRD-TPE-102-3, TCRD-TPE-103-22]; Tzu Chi University [TCIRP102001-02Y1]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation; Tzu Chi University	This study was supported by a grant from the National Science Council, Taiwan (No. NSC101-2314-B-303-023-MY3), grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (No. TCRD-TPE-NSC-102-01), grants from the Tzu Chi University (No. TCIRP102001-02Y1) to YLK, and grants from the Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (TCRD-TPE-102-3, TCRD-TPE-103-22) to MST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiello AE, 2008, J INFECT DIS, V197, P34, DOI 10.1086/524144; Antoniades C, 2009, OBES REV, V10, P269, DOI 10.1111/j.1467-789X.2009.00571.x; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Bauche IB, 2006, BIOCHEM BIOPH RES CO, V345, P1414, DOI 10.1016/j.bbrc.2006.05.033; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Cesari M, 2007, J CLIN ENDOCR METAB, V92, P3082, DOI 10.1210/jc.2007-0403; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Henneman P, 2010, DIABETES CARE, V33, P908, DOI 10.2337/dc09-1385; Hsu LA, 2009, METABOLISM, V58, P983, DOI 10.1016/j.metabol.2009.02.021; Jee SH, 2010, AM J HUM GENET, V87, P545, DOI 10.1016/j.ajhg.2010.09.004; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kondo H, 2002, DIABETES, V51, P2325, DOI 10.2337/diabetes.51.7.2325; Lee MH, 2008, BIOCHEMISTRY-US, V47, P11682, DOI 10.1021/bi801451f; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Liu PH, 2008, TWIN RES HUM GENET, V11, P495, DOI 10.1375/twin.11.5.495; MacKinnon D P, 1994, NIDA Res Monogr, V139, P127; MacKinnon D P, 2000, Prev Sci, V1, P173, DOI 10.1023/A:1026595011371; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Menzaghi C, 2007, DIABETES, V56, P1198, DOI 10.2337/db06-0506; Morisaki H, 2012, HUM MUTAT, V33, P402, DOI 10.1002/humu.21652; Ouchi N, 2000, CIRCULATION, V102, P1296, DOI 10.1161/01.CIR.102.11.1296; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Sobel M.E., 1982, SOCIOL METHODOL, V13, P290, DOI [10.2307/270723, DOI 10.2307/270723]; Sobel ME, 1987, SOCIOL METHOD RES, V15, P151; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Tan CE, 2004, DIABETES CARE, V27, P1182, DOI 10.2337/diacare.27.5.1182; Teng MS, 2013, ATHEROSCLEROSIS, V228, P406, DOI 10.1016/j.atherosclerosis.2013.03.032; Weyer C, 2001, J CLIN ENDOCR METAB, V86, P1930, DOI 10.1210/jc.86.5.1930; Wu Y, 2014, HUM MOL GENET, V23, P1108, DOI 10.1093/hmg/ddt488; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yamauchi T, 2007, NAT MED, V13, P332, DOI 10.1038/nm1557; Yang WS, 2006, J MOL MED, V84, P112, DOI 10.1007/s00109-005-0011-7	38	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122664	10.1371/journal.pone.0122664	http://dx.doi.org/10.1371/journal.pone.0122664			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875811	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100091
J	Zhang, Y; Wang, RX; Miao, LM; Zhu, LB; Jiang, HB; Yuan, H				Zhang, Yu; Wang, Ruixia; Miao, Limin; Zhu, Longbiao; Jiang, Hongbing; Yuan, Hua			Different Levels in Alcohol and Tobacco Consumption in Head and Neck Cancer Patients from 1957 to 2013	PLOS ONE			English	Article							SQUAMOUS-CELL CARCINOMA; AERODIGESTIVE TRACT CANCERS; ORAL-CAVITY; HUMAN-PAPILLOMAVIRUS; RISK-FACTORS; SOCIOECONOMIC INEQUALITIES; SMOKING; DRINKING; PHARYNGEAL; ETIOLOGY	Objective To provide a precise quantification of the association between alcohol and tobacco consumption trends in head and neck cancer patients over the past 45 years. Methods We combined findings from all studies published until March 2014 and evaluated the association between different levels in alcohol and tobacco consumption and head and neck cancers through a meta-analytic approach. Results We included 28 studies involving 13830 patients with head and neck cancer. In patients with alcohol consumption, the pooled odds ratio (OR) and 95% confidence interval (CI) were 1.29(1.06-1.57), 2.67(2.05-3.48) and 6.63(5.02-8.74) for light drinkers, moderate drinkers and heavy drinkers, respectively. In patients with tobacco consumption, the pooled OR and 95% CI were 2.33(1.84-2.95), 4.97(3.67-6.71) and 6.77(4.81-9.53) for light smokers, moderate smokers and heavy smokers, respectively. Conclusion The increased alcohol and tobacco consumption trends increased the risk of head and neck cancer over the past 45 years. Tobacco consumption was found to be a stronger risk factor for head and neck cancer than alcohol consumption. Thus, the control should be considered to limit the intake of alcohol and tobacco.	[Zhang, Yu; Wang, Ruixia; Miao, Limin; Zhu, Longbiao; Jiang, Hongbing; Yuan, Hua] Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China; [Zhang, Yu; Jiang, Hongbing; Yuan, Hua] Stomatol Hosp Jiangsu Prov, Dept Oral & Maxillofacial Surg, Nanjing, Jiangsu, Peoples R China; [Miao, Limin] Nanjing Med Univ, Ctr Canc, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Clin Epidemiol Sect, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Yuan, H (corresponding author), Nanjing Med Univ, Jiangsu Key Lab Oral Dis, Nanjing, Jiangsu, Peoples R China.	rolener@gmail.com		Jiang, Hongbing/0000-0002-3748-0381	National Natural Science Foundation of China [81302361]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20133234120013]; China Postdoctoral Science Foundation [2013M540457]; Jiangsu Planned Projects for Postdoctoral Research Funds [1301018A]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [2014-37]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Jiangsu Planned Projects for Postdoctoral Research Funds; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	Funding was provided by National Natural Science Foundation of China (81302361), Specialized Research Fund for the Doctoral Program of Higher Education of China (20133234120013), China Postdoctoral Science Foundation (2013M540457), Jiangsu Planned Projects for Postdoctoral Research Funds (1301018A), A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, 2014-37). The funders had no role in studydesign, data collection and analysis, decision to publish, or preparation of the manuscript.	Anantharaman D, 2011, ORAL ONCOL, V47, P725, DOI 10.1016/j.oraloncology.2011.05.004; Applebaum KM, 2007, JNCI-J NATL CANCER I, V99, P1801, DOI 10.1093/jnci/djm233; Bagnardi V, 2001, BRIT J CANCER, V85, P1700, DOI 10.1054/bjoc.2001.2140; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; BLOT WJ, 1988, CANCER RES, V48, P3282; Boing AF, 2011, J EPIDEMIOL COMMUN H, V65, P709, DOI 10.1136/jech.2009.097691; Bouchardy C, 2000, INT J CANCER, V87, P734, DOI 10.1002/1097-0215(20000901)87:5<734::AID-IJC17>3.0.CO;2-E; Bradshaw PT, 2012, AM J EPIDEMIOL, V175, P1225, DOI 10.1093/aje/kwr468; Bravi F, 2013, BRIT J CANCER, V109, P2904, DOI 10.1038/bjc.2013.667; BRUGERE J, 1986, CANCER, V57, P391, DOI 10.1002/1097-0142(19860115)57:2<391::AID-CNCR2820570235>3.0.CO;2-Q; Castellsague X, 2004, INT J CANCER, V108, P741, DOI 10.1002/ijc.11627; CHOI SY, 1991, INT J EPIDEMIOL, V20, P878, DOI 10.1093/ije/20.4.878; Coronado GD, 2011, SALUD PUBLICA MEXICO, V53, P440; De Stefani E, 2007, CANCER LETT, V246, P282, DOI 10.1016/j.canlet.2006.03.008; Faggiano F, 1997, IARC Sci Publ, P65; Fedirko V, 2011, ANN ONCOL, V22, P1958, DOI 10.1093/annonc/mdq653; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; FRANCESCHI S, 1990, CANCER RES, V50, P6502; Freedman ND, 2008, INT J CANCER, V122, P2330, DOI 10.1002/ijc.23319; Garrote LF, 2001, BRIT J CANCER, V85, P46, DOI 10.1054/bjoc.2000.1825; Gillison ML, 2008, JNCI-J NATL CANCER I, V100, P407, DOI 10.1093/jnci/djn025; GOEDDE HW, 1992, HUM GENET, V88, P344; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Hamling J, 2008, STAT MED, V27, P954, DOI 10.1002/sim.3013; Hansson BG, 2005, ACTA OTO-LARYNGOL, V125, P1337, DOI 10.1080/00016480510043945; Harris SL, 2010, HEAD NECK-J SCI SPEC, V32, P499, DOI 10.1002/hed.21220; Hayes RB, 1999, CANCER CAUSE CONTROL, V10, P27, DOI 10.1023/A:1008876115797; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hobbs CGL, 2006, CLIN OTOLARYNGOL, V31, P259, DOI 10.1111/j.1749-4486.2006.01246.x; KELLER AZ, 1965, AM J PUBLIC HEALTH N, V55, P1578, DOI 10.2105/AJPH.55.10.1578; Macfarlane TV, 2010, CANCER CAUSE CONTROL, V21, P2213, DOI 10.1007/s10552-010-9641-3; MAIER H, 1992, CLIN INVESTIGATOR, V70, P320; MAIER H, 1994, OTOLARYNG HEAD NECK, V110, P168, DOI 10.1177/019459989411000205; Matsuo K, 2012, CANCER EPIDEM BIOMAR, V21, P1986, DOI 10.1158/1055-9965.EPI-12-0662; Menvielle G, 2004, EUR J CANCER PREV, V13, P165, DOI 10.1097/01.cej.0000130017.93310.76; Menvielle G, 2007, INT J CANCER, V121, P649, DOI 10.1002/ijc.22721; MERLETTI F, 1989, CANCER RES, V49, P4919; Montero PH, 2012, ARCH OTOLARYNGOL, V138, P817, DOI 10.1001/archoto.2012.1792; OREGGIA F, 1991, CANCER, V67, P180, DOI 10.1002/1097-0142(19910101)67:1<180::AID-CNCR2820670130>3.0.CO;2-R; Oze I, 2010, CANCER SCI, V101, P1875, DOI 10.1111/j.1349-7006.2010.01599.x; PAULY JL, 1995, CANCER RES, V55, P253; Peters ES, 2006, CANCER EPIDEM BIOMAR, V15, P2196, DOI 10.1158/1055-9965.EPI-06-0503; Radoi L, 2013, EUR J CANCER PREV, V22, P268, DOI 10.1097/CEJ.0b013e3283592cce; Rethman Michael P, 2012, Tex Dent J, V129, P491; Rosenquist K, 2005, ACTA OTO-LARYNGOL, V125, P991, DOI 10.1080/00016480510043440; Schlecht NF, 2001, CANCER CAUSE CONTROL, V12, P579, DOI 10.1023/A:1011226520220; Schwartz SM, 2001, CANCER EPIDEM BIOMAR, V10, P1137; Smith EM, 2012, J ONCOL, V2012, DOI 10.1155/2012/571862; Sobus SL, 2014, CANCER-AM CANCER SOC, V120, P3617, DOI 10.1002/cncr.28904; Subapriya R, 2007, EUR J CANCER PREV, V16, P251, DOI 10.1097/01.cej.0000228402.53106.9e; TUYNS AJ, 1988, INT J CANCER, V41, P483, DOI 10.1002/ijc.2910410403; Vlajinac HD, 2006, CANCER DETECT PREV, V30, P152, DOI 10.1016/j.cdp.2006.02.001; WYNDER EL, 1957, BRIT MED J, V1, P1137, DOI 10.1136/bmj.1.5028.1137; WYNDER EL, 1956, CANCER-AM CANCER SOC, V9, P86, DOI 10.1002/1097-0142(195601/02)9:1<86::AID-CNCR2820090108>3.0.CO;2-6; Yokoyama A, 2001, CARCINOGENESIS, V22, P433, DOI 10.1093/carcin/22.3.433; Zavras AI, 2001, ORAL ONCOL, V37, P28, DOI 10.1016/S1368-8375(00)00060-9; ZHENG TZ, 1990, CANCER CAUSE CONTROL, V1, P173, DOI 10.1007/BF00053170; Znaor A, 2003, INT J CANCER, V105, P681, DOI 10.1002/ijc.11114	58	16	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124045	10.1371/journal.pone.0124045	http://dx.doi.org/10.1371/journal.pone.0124045			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875934	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100234
J	Abbasi, A; Woo, CS; Ibrahim, RW; Islam, S				Abbasi, Almas; Woo, Chaw Seng; Ibrahim, Rabha Waell; Islam, Saeed			Invariant Domain Watermarking Using Heaviside Function of Order Alpha and Fractional Gaussian Field	PLOS ONE			English	Article								Digital image watermarking is an important technique for the authentication of multimedia content and copyright protection. Conventional digital image watermarking techniques are often vulnerable to geometric distortions such as Rotation, Scaling, and Translation (RST). These distortions desynchronize the watermark information embedded in an image and thus disable watermark detection. To solve this problem, we propose an RST invariant domain watermarking technique based on fractional calculus. We have constructed a domain using Heaviside function of order alpha (HFOA). The HFOA models the signal as a polynomial for watermark embedding. The watermark is embedded in all the coefficients of the image. We have also constructed a fractional variance formula using fractional Gaussian field. A cross correlation method based on the fractional Gaussian field is used for watermark detection. Furthermore the proposed method enables blind watermark detection where the original image is not required during the watermark detection thereby making it more practical than non-blind watermarking techniques. Experimental results confirmed that the proposed technique has a high level of robustness.	[Abbasi, Almas; Woo, Chaw Seng] Univ Malaya, Dept Artificial Intelligence, Fac Comp Sci & Informat Technol, Kuala Lumpur, Malaysia; [Ibrahim, Rabha Waell] Univ Malaya, Inst Math Sci, Kuala Lumpur, Malaysia; [Islam, Saeed] Abdul Wali Khan Univ, Dept Math, Shankar, Pakistan	Universiti Malaya; Universiti Malaya	Islam, S (corresponding author), Abdul Wali Khan Univ, Dept Math, Shankar, Pakistan.	saeedislam@awkum.edu.pk	Ibrahim, Rabha W./D-3312-2017; Saeed, Islam/AAD-6067-2020	Ibrahim, Rabha W./0000-0001-9341-025X; Saeed, Islam/0000-0001-5263-4871	IPPP [PS036-2012A, UM.C/BSU/606/BSP 133(3)-11]; Bright Spark University of Malaya [PS036-2012A, UM.C/BSU/606/BSP 133(3)-11]	IPPP; Bright Spark University of Malaya	The authors would like to acknowledge the IPPP and Bright Spark University of Malaya for the financial support through Grant number PS036-2012A and UM.C/BSU/606/BSP 133(3)-11.	Darmstaedter V, 1998, LECT NOTES COMPUT SC, V1425, P190; Dobric V., 2006, IMS LECT NOTES MONOG, V51, P77; Hernandez JR, 2000, IEEE T IMAGE PROCESS, V9, P55, DOI 10.1109/83.817598; Ibrahim RW, 2013, DISCRETE DYN NAT SOC; Ibrahim RW, 2013, DISCRETE DYN NAT SOC; Jalab HA, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/149289; Jalab HA, 2012, DISCRETE DYN NAT SOC, V2012, DOI 10.1155/2012/529849; Kim HS, 2003, IEEE T CIRC SYST VID, V13, P766, DOI 10.1109/TCSVT.2003.815955; Krishnamoorthi R., 2009, INT J SIGNAL PROCESS, V5, P146; Kundur D, 1998, INT CONF ACOUST SPEE, P2969, DOI 10.1109/ICASSP.1998.678149; Le L, 2006, 2006 IEEE INTERNATIONAL CONFERENCE ON MULTIMEDIA AND EXPO - ICME 2006, VOLS 1-5, PROCEEDINGS, P1569, DOI 10.1109/ICME.2006.262844; Nikolaidis N, 1998, SIGNAL PROCESS, V66, P385, DOI 10.1016/S0165-1684(98)00017-6; Pereira S, 2001, INF HID WORKSH PITTS; Podlubny I., 1999, FRACTIONAL DIFFERENT; Tsougenis ED, 2012, J SYST SOFTWARE, V85, P1864, DOI 10.1016/j.jss.2012.02.045; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wolfgang RB, 1996, INTERNATIONAL CONFERENCE ON IMAGE PROCESSING, PROCEEDINGS - VOL III, P219, DOI 10.1109/ICIP.1996.560423	17	2	2	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123427	10.1371/journal.pone.0123427	http://dx.doi.org/10.1371/journal.pone.0123427			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884854	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000061
J	Chang, X; Li, J; Guo, YR; Wei, Z; Mentch, FD; Hou, CP; Zhao, Y; Qiu, HJ; Kim, C; Sleiman, PMA; Hakonarson, H				Chang, Xiao; Li, Jin; Guo, Yiran; Wei, Zhi; Mentch, Frank D.; Hou, Cuiping; Zhao, Yan; Qiu, Haijun; Kim, Cecilia; Sleiman, Patrick M. A.; Hakonarson, Hakon			Genome-Wide Association Study of Serum Minerals Levels in Children of Different Ethnic Background	PLOS ONE			English	Article							GENE; DATABASE; PLASMA	Calcium, magnesium, potassium, sodium, chloride and phosphorus are the major dietary minerals involved in various biological functions and are commonly measured in the blood serum. Sufficient mineral intake is especially important for children due to their rapid growth. Currently, the genetic mechanisms influencing serum mineral levels are poorly understood, especially for children. We carried out a genome-wide association (GWA) study on 5,602 European-American children and 4,706 African-American children who had mineral measures available in their electronic medical records (EMR). While no locus met the criteria for genome-wide significant association, our results demonstrated a nominal association of total serum calcium levels with a missense variant in the calcium -sensing receptor (CASR) gene on 3q13 (rs1801725, P = 1.96 x 10(-3)) in the African-American pediatric cohort, a locus previously reported in Caucasians. We also confirmed the association result in our pediatric European-American cohort (P = 1.38 x 10(-4)). We further replicated two other loci associated with serum calcium levels in the European-American cohort (rs780094, GCKR, P = 4.26 x 10(-3); rs10491003, GATA3, P = 0.02). In addition, we replicated a previously reported locus on 1q21, demonstrating association of serum magnesium levels with MUC1 (rs4072037, P = 2.04 x 10(-6)). Moreover, in an extended gene-based association analysis we uncovered evidence for association of calcium levels with the previously reported gene locus DGKD in both European-American children and African-American children. Taken together, our results support a role for CASR and DGKD mediated calcium regulation in both African-American and European-American children, and corroborate the association of calcium levels with GCKR and GATA3, and the association of magnesium levels with MUC1 in the European-American children.	[Chang, Xiao; Li, Jin; Guo, Yiran; Mentch, Frank D.; Hou, Cuiping; Zhao, Yan; Qiu, Haijun; Kim, Cecilia; Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Wei, Zhi] New Jersey Inst Technol, Dept Comp Sci, Newark, NJ 07102 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Sleiman, Patrick M. A.; Hakonarson, Hakon] Childrens Hosp Philadelphia, Div Human Genet, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; New Jersey Institute of Technology; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Sleiman, PMA (corresponding author), Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA.	patricksleiman@me.com; hakonarson@email.chop.edu	Xiao, Chang/AAO-9713-2020; Guo, Yiran/H-4120-2011; , AndyWei/H-4415-2012	Wei, Zhi/0000-0001-6059-4267	Institutional Development Fund from The Children's Hospital of Philadelphia; Kubert Estate Family; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	Institutional Development Fund from The Children's Hospital of Philadelphia; Kubert Estate Family; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The study was funded by an Institutional Development Fund from The Children's Hospital of Philadelphia and by a donation from the Kubert Estate Family. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baranzini SE, 2013, AM J HUM GENET, V92, P854, DOI 10.1016/j.ajhg.2013.04.019; Chang X, 2013, SCI REP-UK, V3, DOI 10.1038/srep01691; Cole DEC, 2000, J AM SOC NEPHROL, V11, P1937, DOI 10.1681/ASN.V11101937; D'Souza-Li Lília, 2006, Arq Bras Endocrinol Metab, V50, P628, DOI 10.1590/S0004-27302006000400008; Huang DW, 2007, NUCLEIC ACIDS RES, V35, pW169, DOI 10.1093/nar/gkm415; Hunter DJ, 2002, CLIN SCI, V103, P259, DOI 10.1042/cs1030259; Kapur K, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001035; Li J, 2013, HUM MOL GENET, V22, P1457, DOI 10.1093/hmg/dds534; Liu JZ, 2010, AM J HUM GENET, V87, P139, DOI 10.1016/j.ajhg.2010.06.009; Meyer TE, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001045; O'Seaghdha CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003796; O'Seaghdha CM, 2010, HUM MOL GENET, V19, P4296, DOI 10.1093/hmg/ddq342; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Razick S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-405; WHITFIELD JB, 1984, ANN CLIN BIOCHEM, V21, P176, DOI 10.1177/000456328402100303; WILLIAMS PD, 1992, CLIN SCI, V82, P493, DOI 10.1042/cs0820493	17	17	17	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123499	10.1371/journal.pone.0123499	http://dx.doi.org/10.1371/journal.pone.0123499			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886283	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000071
J	Guan, F; Wang, X; He, F				Guan, Feng; Wang, Xin; He, Fa			Promotion of Cell Migration by Neural Cell Adhesion Molecule (NCAM) Is Enhanced by PSA in a Polysialyltransferase-Specific Manner	PLOS ONE			English	Article							POLYSIALIC ACID; BREAST-CANCER; TUMOR INVASION; LUNG-CANCER; EXPRESSION; POLYSIALYLATION; GLYCOSYLATION; GLYCOPROTEINS; CARCINOMA; MOTILITY	Neural cell adhesion molecule 140 (NCAM-140) is a glycoprotein and always highly polysialylated in cancer. Functions of polysialic acid (PSA) that binds to N-glycan termini on NCAM remain unclear. ldlD-14 cells, a CHO cell mutant deficient in UDP-Gal 4-epimerase, are useful for structural and functional studies of Gal-containing glycoproteins because their abnormal glycosylation can be converted to normal status by exogenous addition of galactose (Gal). We cloned the genes for NCAM-140 and for polysialyltransferases STX and PST (responsible for PSA synthesis) from normal murine mammary gland epithelial (NMuMG) cells and transfected them into ldlD-14 and human breast cancer cells MCF-7. The effect of PSA on NCAM-mediated cell proliferation, motility, migration and adhesion was studied. We found that NCAM-140 significantly promoted cell proliferation, motility and migration, while polysialylation of NCAM-140 catalyzed by STX, but not by PST, enhanced NCAM-mediated cell migration, but not cell proliferation or motility. In addition, PSA catalyzed by different polysialyltransferases affected the adhesion of NCAM to different extracellular matrix (ECM) components.	[Guan, Feng; Wang, Xin; He, Fa] Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China	Jiangnan University	Guan, F (corresponding author), Jiangnan Univ, Key Lab Carbohydrate Chem & Biotechnol, Minist Educ, Sch Biotechnol, Wuxi, Peoples R China.	fengguan@jiangnan.edu.cn			National Science Foundation for Young Scientists of China [81201572]; Natural Science Foundation of Jiangsu Province, China [BK2012113]; Jiangsu Province Recruiting Plan for High-level, Innovative and Entrepreneurial Talents; Fundamental Research Funds for the Central Universities [JUSRP51319B]; Jiangsu Province "Six Summit Talent" Foundation [2013-SWYY-019]; 111 Project [111-2-06]	National Science Foundation for Young Scientists of China; Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Jiangsu Province Recruiting Plan for High-level, Innovative and Entrepreneurial Talents; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Jiangsu Province "Six Summit Talent" Foundation; 111 Project(Ministry of Education, China - 111 Project)	This study was supported by the National Science Foundation for Young Scientists of China (No. 81201572), the Natural Science Foundation of Jiangsu Province, China (No. BK2012113), Jiangsu Province Recruiting Plan for High-level, Innovative and Entrepreneurial Talents, the Fundamental Research Funds for the Central Universities (No. JUSRP51319B), Jiangsu Province "Six Summit Talent" Foundation (2013-SWYY-019) and the 111 Project (No. 111-2-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; ALBRECHTBUEHLER G, 1977, CELL, V11, P395, DOI 10.1016/0092-8674(77)90057-5; ALETSEEUFRECHT MC, 1990, FEBS LETT, V267, P295, DOI 10.1016/0014-5793(90)80948-I; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; Angata K, 2002, J BIOL CHEM, V277, P36808, DOI 10.1074/jbc.M204632200; Barranco WT, 2006, BRIT J CANCER, V94, P884, DOI 10.1038/sj.bjc.6603009; Beggs HE, 1997, J BIOL CHEM, V272, P8310, DOI 10.1074/jbc.272.13.8310; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Cavallaro U, 2001, BBA-REV CANCER, V1552, P39, DOI 10.1016/S0304-419X(01)00038-5; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Daniel L, 2001, ONCOGENE, V20, P997, DOI 10.1038/sj.onc.1204176; Daniel L, 2003, HUM PATHOL, V34, P528, DOI 10.1016/S0046-8177(03)00178-3; Davis NM, 2014, ONCOTARGET, V5, P4603, DOI 10.18632/oncotarget.2209; Falconer RA, 2012, CURR CANCER DRUG TAR, V12, P925; FAN SJ, 1995, CANCER RES, V55, P1649; Goridis C, 1992, Semin Cell Biol, V3, P189; Grosheva I, 2001, J CELL SCI, V114, P695; Guan F, 2011, NEUROCHEM RES, V36, P1645, DOI 10.1007/s11064-010-0379-9; Hintermann E, 2001, J CELL BIOL, V153, P465, DOI 10.1083/jcb.153.3.465; Hirohashi S, 1998, AM J PATHOL, V153, P333, DOI 10.1016/S0002-9440(10)65575-7; Kelishadi R, 2005, J QAZVIN U MED SCI, V9, P88; KIBBELAAR RE, 1989, J PATHOL, V159, P23, DOI 10.1002/path.1711590108; KINGSLEY DM, 1986, CELL, V44, P749, DOI 10.1016/0092-8674(86)90841-X; Lehembre F, 2008, EMBO J, V27, P2603, DOI 10.1038/emboj.2008.178; Lei JH, 2012, VET PARASITOL, V187, P196, DOI 10.1016/j.vetpar.2011.12.017; Li J, 2011, GLYCOBIOLOGY, V21, P1010, DOI 10.1093/glycob/cwr020; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Martersteck CM, 1996, GLYCOBIOLOGY, V6, P289, DOI 10.1093/glycob/6.3.289; Muhlenhoff M, 1998, CURR OPIN STRUC BIOL, V8, P558, DOI 10.1016/S0959-440X(98)80144-9; Muller D, 1996, NEURON, V17, P413, DOI 10.1016/S0896-6273(00)80174-9; Nagaraja GM, 2006, ONCOGENE, V25, P2328, DOI 10.1038/sj.onc.1209265; Nakamura-Tsuruta S, 2006, J BIOCHEM, V140, P285, DOI 10.1093/jb/mvj148; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; Rutishauser U, 1996, TRENDS NEUROSCI, V19, P422; RUTISHAUSER U, 1988, SCIENCE, V240, P53, DOI 10.1126/science.3281256; Stone EL, 2009, MOL CELL BIOL, V29, P3770, DOI 10.1128/MCB.00204-09; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tan ZQ, 2014, J PROTEOME RES, V13, P2783, DOI 10.1021/pr401185z; Tanaka F, 2000, CANCER RES, V60, P3072; Walmod PS, 2004, NEUROCHEM RES, V29, P2015, DOI 10.1007/s11064-004-6875-z; Yang GL, 2015, J PROTEOME RES, V14, P639, DOI 10.1021/pr5006026; Yang GL, 2013, PROTEOMICS, V13, P1481, DOI 10.1002/pmic.201200259	44	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124237	10.1371/journal.pone.0124237	http://dx.doi.org/10.1371/journal.pone.0124237			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885924	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000109
J	Su, YY; Sun, W; Wang, CQ; Wu, XF; Miao, Y; Xiong, H; Bai, L; Dong, LL				Su, Yuying; Sun, Wei; Wang, Chenqiong; Wu, Xuefen; Miao, Ye; Xiong, Hui; Bai, Lin; Dong, Lingli			Detection of Serum IgG4 Levels in Patients with IgG4-Related Disease and Other Disorders	PLOS ONE			English	Article							COMPREHENSIVE DIAGNOSTIC-CRITERIA	Objective Elevated serum IgG4 levels are an important hallmark for diagnosing IgG4-related disease (IgG4-RD), but can also be observed in other diseases. This study aimed to compare two different testing methods for IgG4: ELISA and nephelometric assay. Both assays were used to measure serum IgG4 concentrations, and to assess the prevalence of high serum IgG4 levels in both IgG4-RD and non-IgG4-RD diseases. Methods A total of 80 serum samples were tested using the nephelometric assay and ELISA method that we established. Serum IgG4 concentrations were determined by ELISA for 957 patients with distinct diseases, including 12 cases of IgG4-RD and 945 cases of non-IgG4-RD. Results IgG4 levels from 80 selected serum samples examined by ELISA were in agreement with those detected using the nephelometry assay. Meanwhile, the serum IgG4 concentrations measured by ELISA were also consistent with the clinical diagnoses of patients with IgG4-RD during the course of disease. The Elevated levels of serum IgG4 (>1.35 g/L) were detected in all IgG4-RD (12/12) patients, and the prevalence of high IgG4 serum levels was 3.39% in non-IgG4-RD cases. Among them, the positive rates of serum IgG4 were 2.06% in patients with carcinoma and 6.3% in patients with other non-IgG4 autoimmune diseases. Conclusion Our established ELISA method is a reliable and convenient technique, which could be extensively used in the clinic to measure serum IgG4 levels. High levels of IgG4 were observed in IgG4-RD. However, this phenomenon could also be observed in other diseases, such as carcinomas and other autoimmune diseases. Thus, a diagnosis of IgG4 disease cannot only be dependent on the detection of elevated serum IgG4 levels.	[Su, Yuying; Wang, Chenqiong; Wu, Xuefen; Miao, Ye; Xiong, Hui; Bai, Lin; Dong, Lingli] Huazhong Univ Sci & Technol, Dept Rheumatol & Immunol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Sun, Wei] Huazhong Univ Sci & Technol, Dept Stomatol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Dong, LL (corresponding author), Huazhong Univ Sci & Technol, Dept Rheumatol & Immunol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China.	dongll@tjh.tjmu.edu.cn			National Natural Science Foundation of China [31270965]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This paper was supported by Grants from National Natural Science Foundation of China (no. 31270965 to Lingli Dong). It contributed to data collection and analysis.	Carruthers MN, 2015, ANN RHEUM DIS, V74, P14, DOI 10.1136/annrheumdis-2013-204907; Dorn L, 2012, HPB, V14, P122, DOI 10.1111/j.1477-2574.2011.00413.x; Ghazale A, 2007, AM J GASTROENTEROL, V102, P1646, DOI 10.1111/j.1572-0241.2007.01264.x; Hamano H, 2001, NEW ENGL J MED, V344, P732, DOI 10.1056/NEJM200103083441005; Kamisawa T, 2006, WORLD J GASTROENTERO, V12, P6225, DOI 10.3748/wjg.v12.i38.6225; Kamisawa T, 2011, J GASTROENTEROL, V46, P108, DOI 10.1007/s00535-010-0317-2; Khosroshahi A, 2014, ARTHRITIS RHEUMATOL, V66, P213, DOI 10.1002/art.38193; Khosroshahi A, 2011, CURR OPIN RHEUMATOL, V23, P57, DOI 10.1097/BOR.0b013e3283418057; Lin GG, 2010, RHEUMATOL INT, V30, P837, DOI 10.1007/s00296-009-1330-8; Masaki Y, 2009, ANN RHEUM DIS, V68, P1310, DOI 10.1136/ard.2008.089169; Masaki Y, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/580814; Ngwa TN, 2014, PANCREAS, V43, P704, DOI 10.1097/MPA.0000000000000118; Okazaki K, 2012, INT J RHEUMATOL, V2012, DOI 10.1155/2012/357071; Sah RP, 2011, CURR OPIN RHEUMATOL, V23, P108, DOI 10.1097/BOR.0b013e3283413469; Sato Y, 2010, J CLIN PATHOL, V63, P1084, DOI 10.1136/jcp.2010.082958; Smyrk TC, 2011, CURR OPIN RHEUMATOL, V23, P74, DOI 10.1097/BOR.0b013e328341347b; Sun W, 2013, J HUAZHONG U SCI-MED, V33, P611, DOI 10.1007/s11596-013-1167-y; Tabata T, 2011, INTERNAL MED, V50, P69, DOI 10.2169/internalmedicine.50.4321; Umehara H, 2012, MOD RHEUMATOL, V22, P21, DOI 10.1007/s10165-011-0571-z; Yamamoto M, 2012, MOD RHEUMATOL, V22, P414, DOI 10.1007/s10165-011-0520-x; Yamamoto M, 2010, INTERNAL MED, V49, P1365, DOI 10.2169/internalmedicine.49.3532	21	20	26	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124233	10.1371/journal.pone.0124233	http://dx.doi.org/10.1371/journal.pone.0124233			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885536	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000106
J	Ingrasciotta, Y; Sultana, J; Giorgianni, F; Fontana, A; Santangelo, A; Tari, DU; Santoro, D; Arcoraci, V; Perrotta, M; Ibanez, L; Trifiro, G				Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Fontana, Andrea; Santangelo, Antonio; Tari, Daniele Ugo; Santoro, Domenico; Arcoraci, Vincenzo; Perrotta, Margherita; Ibanez, Luisa; Trifiro, Gianluca			Association of Individual Non-Steroidal Anti-Inflammatory Drugs and Chronic Kidney Disease: A Population-Based Case Control Study	PLOS ONE			English	Article							CHRONIC RENAL-DISEASE; ANALGESIC USE; PRESCRIBING PATTERN; GENERAL-PRACTICE; INTERACTION RISK; FAILURE; ACETAMINOPHEN; ASPIRIN; BURDEN; MEN	Background Non-steroidal anti-inflammatory agents (NSAIDs) are known to be associated with renal damage. No clear evidence exists regarding differential risk of chronic kidney disease (CKD), specifically, across various NSAIDs. Aim The aim of this population-based case-control study was to evaluate the association between use of individual NSAIDs and risk of CKD in a general population of Southern Italy. Methods A nested case-control study was carried out using the general practice Arianna database, identifying incident CKD patients as cases and matched controls from 2006 to 2011. The date of first CKD diagnosis was defined as the index date (ID). Conditional logistic regressions were performed to estimate the risk of CKD associated with NSAIDs by class and individual drugs as compared to non-use during different time windows (within one year, six or three months prior to ID), with the latter being defined as current users. Among current users, the effect of cumulative exposure to these drugs was evaluated. Results Overall, 1,989 CKD cases and 7,906 matched controls were identified. A statistically significant increase in the risk of CKD was found for current users of oxicams (adjusted OR: 1.68; 95% CI: 1.15-2.44) and concerning individual compounds, for ketorolac (adj. OR: 2.54; 95% CI: 1.45-4.44), meloxicam (adj. OR: 1.98; 95% CI: 1.01-3.87) and piroxicam (adj. OR: 1.95; 95% CI: 1.19-3.21). Conclusions The risk of CKD varies across individual NSAIDs. Increased risk has been found for ketorolac, which may precipitate subclinical CKD through acute renal damage, and long-term exposure to oxicams, especially meloxicam and piroxicam.	[Ingrasciotta, Ylenia; Sultana, Janet; Giorgianni, Francesco; Santangelo, Antonio; Santoro, Domenico; Arcoraci, Vincenzo; Trifiro, Gianluca] Univ Messina, Dept Clin & Expt Med, Messina, Italy; [Fontana, Andrea] IRCCS Casa Sollievo Sofferenza, Biostat Unit, San Giovanni Rotondo, FG, Italy; [Tari, Daniele Ugo; Perrotta, Margherita] Caserta Local Hlth Serv, Caserta, Italy; [Ibanez, Luisa] Univ Autonoma Barcelona, WHO Collaborating Ctr Res & Training Pharmacoepid, Dept Pharmacol Toxicol & Therapeut, Fdn Inst Catala Farmacol,Inst Catala Salut, E-08193 Barcelona, Spain	University of Messina; IRCCS Casa Sollievo Della Sofferenza; Autonomous University of Barcelona	Trifiro, G (corresponding author), Univ Messina, Dept Clin & Expt Med, Messina, Italy.	trifirog@unime.it	Tari, Daniele Ugo/AAY-8658-2021; Sultana, Janet/Z-4817-2019; santoro, domenico/P-7902-2014; Arcoraci, Vincenzo/HGA-3713-2022; Ibanez, Luisa/M-2986-2013; Fontana, Andrea/J-8584-2016	Tari, Daniele Ugo/0000-0002-7312-419X; santoro, domenico/0000-0002-4279-6559; Arcoraci, Vincenzo/0000-0003-0061-0477; Sultana, Janet/0000-0001-9622-169X; Ibanez, Luisa/0000-0002-1175-0574; Fontana, Andrea/0000-0002-6660-5315				ADAMS DH, 1986, LANCET, V1, P57; Adams RJ, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-70; Agenzia Italiana del Farmaco, AG IT FARM KET MON; Alacqua M, 2008, ARTHRIT RHEUM-ARTHR, V59, P568, DOI 10.1002/art.23526; Alacqua M, 2009, EPILEPSY RES, V85, P107, DOI 10.1016/j.eplepsyres.2009.03.002; Curhan GC, 2004, ARCH INTERN MED, V164, P1519, DOI 10.1001/archinte.164.14.1519; Davies NM, 2000, CLIN PHARMACOKINET, V38, P377, DOI 10.2165/00003088-200038050-00001; DELMAS PD, 1995, BRIT J RHEUMATOL, V34, P25; Delzell E, 1998, MEDICINE, V77, P102, DOI 10.1097/00005792-199803000-00003; Eckardt KU, 2013, LANCET, V382, P158, DOI 10.1016/S0140-6736(13)60439-0; Ejaz P, 2004, J Assoc Physicians India, V52, P632; El Nahas AM, 2005, LANCET, V365, P331, DOI 10.1016/S0140-6736(05)17789-7; European Medicines Agency (EMA), 2011, CMDHPHVWP0452012 EMA; Evans PD., 2011, MEDICINE, V39, P402, DOI DOI 10.1016/J.MPMED.2011.04.007; Fored CM, 2001, NEW ENGL J MED, V345, P1801, DOI 10.1056/NEJMoa010323; GARELLA S, 1984, MEDICINE, V63, P165, DOI 10.1097/00005792-198405000-00003; Gooch K, 2007, AM J MED, V120, DOI 10.1016/j.amjmed.2006.02.015; Harirforoosh S, 2009, EXPERT OPIN DRUG SAF, V8, P669, DOI 10.1517/14740330903311023; Huerta C, 2005, AM J KIDNEY DIS, V45, P531, DOI 10.1053/j.ajkd.2004.12.005; Ibanez L, 2005, KIDNEY INT, V67, P2393, DOI 10.1111/j.1523-1755.2005.00346.x; Ingrasciotta Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089072; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; KLEINKNECHT D, 1995, SEMIN NEPHROL, V15, P228; Kurth T, 2003, AM J KIDNEY DIS, V42, P234, DOI 10.1016/S0272-6386(03)00647-4; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Gonzalez ELM, 2010, ARTHRITIS RHEUM-US, V62, P1592, DOI 10.1002/art.27412; McLaughlin JK, 1998, KIDNEY INT, V54, P679, DOI 10.1046/j.1523-1755.1998.00043.x; Ministero della Salute, 2007, LIN GUID CLASS COND; Mylan Pharmaceuticals, MYL PHARM PIR MON; NANRA RS, 1993, KIDNEY INT, V44, pS86; National Collaborating Centre for Chronic Conditions, 2008, CHRON KIDN DIS NAT C; Naughton CA, 2008, AM FAM PHYSICIAN, V78, P743; Oteri A, 2010, BRIT J CLIN PHARMACO, V70, P514, DOI 10.1111/j.1365-2125.2010.03619.x; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; PERNEGER TV, 1994, NEW ENGL J MED, V331, P1675, DOI 10.1056/NEJM199412223312502; Piacentini N, 2005, EUR J CLIN PHARMACOL, V61, P615, DOI 10.1007/s00228-005-0972-z; REPCHINSKY C, 2003, COMPENDIUM PHARM SPE; Rexrode KM, 2001, JAMA-J AM MED ASSOC, V286, P315, DOI 10.1001/jama.286.3.315; SANDLER DP, 1991, ANN INTERN MED, V115, P165, DOI 10.7326/0003-4819-115-3-165; Schneider V, 2006, AM J EPIDEMIOL, V164, P881, DOI 10.1093/aje/kwj331; SCHRIER RW, 1984, JAMA-J AM MED ASSOC, V251, P1301, DOI 10.1001/jama.251.10.1301; Trifiro G, 2008, EUR J CLIN PHARMACOL, V64, P619, DOI 10.1007/s00228-007-0459-1; Trifiro G, 2008, PARKINSONISM RELAT D, V14, P420, DOI 10.1016/j.parkreldis.2007.10.010; Trifiro G, 2006, BRIT J CLIN PHARMACO, V62, P582, DOI 10.1111/j.1365-2125.2006.02687.x; *US REN DAT SYST, 2003, AM J KIDNEY DIS S, V42, pS37; Winkelmayer WC, 2008, AM J MED, V121, P1092, DOI 10.1016/j.amjmed.2008.06.035; Zoccali C, 2010, NEPHROL DIAL TRANSPL, V25, P1731, DOI 10.1093/ndt/gfq250	47	45	48	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122899	10.1371/journal.pone.0122899	http://dx.doi.org/10.1371/journal.pone.0122899			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880729	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500031
J	Moustakas, D; Mezzio, M; Rodriguez, BR; Constable, MA; Mulligan, ME; Voura, EB				Moustakas, Dimitrios; Mezzio, Michael; Rodriguez, Branden R.; Constable, Mic Andre; Mulligan, Margaret E.; Voura, Evelyn B.			Guarana Provides Additional Stimulation over Caffeine Alone in the Planarian Model	PLOS ONE			English	Article							IMPROVED COGNITIVE PERFORMANCE; PAULLINIA-CUPANA; ENERGY DRINKS; NERVOUS-SYSTEM; WITHDRAWAL; BEHAVIOR; COCAINE; FATIGUE; EXTRACT; ANTAGONIST	The stimulant effect of energy drinks is primarily attributed to the caffeine they contain. Many energy drinks also contain other ingredients that might enhance the tonic effects of these caffeinated beverages. One of these additives is guarana. Guarana is a climbing plant native to the Amazon whose seeds contain approximately four times the amount of caffeine found in coffee beans. The mix of other natural chemicals contained in guarana seeds is thought to heighten the stimulant effects of guarana over caffeine alone. Yet, despite the growing use of guarana as an additive in energy drinks, and a burgeoning market for it as a nutritional supplement, the science examining guarana and how it affects other dietary ingredients is lacking. To appreciate the stimulant effects of guarana and other natural products, a straightforward model to investigate their physiological properties is needed. The planarian provides such a system. The locomotor activity and convulsive response of planarians with substance exposure has been shown to provide an excellent system to measure the effects of drug stimulation, addiction and withdrawal. To gauge the stimulant effects of guarana we studied how it altered the locomotor activity of the planarian species Dugesia tigrina. We report evidence that guarana seeds provide additional stimulation over caffeine alone, and document the changes to this stimulation in the context of both caffeine and glucose.	[Voura, Evelyn B.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA; [Moustakas, Dimitrios; Mezzio, Michael; Rodriguez, Branden R.; Constable, Mic Andre; Mulligan, Margaret E.; Voura, Evelyn B.] Dominican Coll, Dept Math & Sci, Orangeburg, NY 10962 USA; [Moustakas, Dimitrios] New York Coll Podiatr Med, New York, NY USA	Colgate University	Moustakas, D (corresponding author), Dominican Coll, Dept Math & Sci, Orangeburg, NY 10962 USA.	evelyn.voura@gmail.com			Dominican College; Colgate University	Dominican College; Colgate University	We would like to thank John G. Golfinos (Department of Neurosurgery, New York University Langone Medical Center) and Madeline Micceri Mignone (Department of Math and Science, Dominican College), for helpful discussions, support and encouragement. We also thank Adam F. Green and Mala Misra (Department of Biology, Colgate University), and Colleen A. Evans (Department of Math and Science, Dominican College) for comments on the manuscript. We greatly appreciate Siobhan O'Sullivan for her assistance. We are also grateful to Dominican College for their support of undergraduate research in the Department of Math and Science, and Colgate University for providing a publication grant to support this work.	Alford C, 2001, AMINO ACIDS, V21, P139, DOI 10.1007/s007260170021; Avci S, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2013.06.031; Babu KM, 2008, CLIN PEDIATR EMERG M, V9, P35, DOI 10.1016/j.cpem.2007.12.002; BEST JB, 1962, J COMP PHYSIOL PSYCH, V55, P560, DOI 10.1037/h0044394; Bittencourt LS, 2013, FOOD CHEM TOXICOL, V53, P119, DOI 10.1016/j.fct.2012.11.041; Breda JJ, 2014, FRONT PUBLIC HEALTH, V2, DOI 10.3389/fpubh.2014.00134; Buttarelli FR, 2008, COMP BIOCHEM PHYS C, V147, P399, DOI 10.1016/j.cbpc.2008.01.009; Campos AR, 2005, PHYTOTHER RES, V19, P441, DOI 10.1002/ptr.1471; Childs E, 2006, PSYCHOPHARMACOLOGY, V185, P514, DOI 10.1007/s00213-006-0341-3; Campos MPD, 2011, J ALTERN COMPLEM MED, V17, P505, DOI 10.1089/acm.2010.0571; del Giglio Adriana Braz, 2013, Journal of Dietary Supplements, V10, P325, DOI 10.3109/19390211.2013.830676; DelCoso J, 2012, PLOS ONE, V7, P1; ERIKSSON KS, 1994, J COMP NEUROL, V345, P528, DOI 10.1002/cne.903450405; Espinola EB, 1997, J ETHNOPHARMACOL, V55, P223, DOI 10.1016/S0378-8741(96)01506-1; FREDHOLM BB, 1995, PHARMACOL TOXICOL, V76, P93, DOI 10.1111/j.1600-0773.1995.tb00111.x; Gurley BJ, 2015, CLIN THER, V37, P275, DOI 10.1016/j.clinthera.2014.08.012; Haskell CF, 2007, J PSYCHOPHARMACOL, V21, P65, DOI 10.1177/0269881106063815; Haskell CF, 2013, NUTR RES REV, V26, P49, DOI 10.1017/S0954422413000036; Haskell CF, 2005, PSYCHOPHARMACOLOGY, V179, P813, DOI 10.1007/s00213-004-2104-3; Higgins JP, 2010, MAYO CLIN PROC, V85, P1033, DOI 10.4065/mcp.2010.0381; Kennedy DO, 2008, APPETITE, V50, P506, DOI 10.1016/j.appet.2007.10.007; Kennedy DO, 2004, PHARMACOL BIOCHEM BE, V79, P401, DOI 10.1016/j.pbb.2004.07.014; Miranda VD, 2009, J ALTERN COMPLEM MED, V15, P431, DOI 10.1089/acm.2008.0324; NEHLIG A, 1992, BRAIN RES REV, V17, P139, DOI 10.1016/0165-0173(92)90012-B; Nishimura K, 2010, NEUROSCIENCE, V168, P18, DOI 10.1016/j.neuroscience.2010.03.038; Pagan OR, 2013, NEUROSCIENCE, V246, P265, DOI 10.1016/j.neuroscience.2013.05.010; Pagan OR, 2008, PHARMACOL BIOCHEM BE, V89, P160, DOI 10.1016/j.pbb.2007.12.008; Pagan OR, 2009, EUR J PHARMACOL, V615, P118, DOI 10.1016/j.ejphar.2009.05.022; Passarelli F, 1999, COMP BIOCHEM PHYS C, V124, P51, DOI 10.1016/S0742-8413(99)00048-1; Pesta DH, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-71; Prokai D, 2013, INT J MOL SCI, V14, P23289, DOI 10.3390/ijms141223289; Raffa R.B., 2008, MODEL DRUG ACTION AB; Raffa RB, 2001, J PHARMACOL TOXICOL, V45, P223, DOI 10.1016/S1056-8719(01)00152-6; Raffa RB, 2001, EUR J PHARMACOL, V430, P143, DOI 10.1016/S0014-2999(01)01358-9; Raffa RB, 2007, EUR J PHARMACOL, V564, P88, DOI 10.1016/j.ejphar.2007.02.006; Raffa RB, 2006, BRAIN RES, V1114, P31, DOI 10.1016/j.brainres.2006.07.037; Raffa RB, 2006, EUR J PHARMACOL, V540, P200, DOI 10.1016/j.ejphar.2006.04.027; Rawls SM, 2010, BEHAV PHARMACOL, V21, P301, DOI 10.1097/FBP.0b013e32833b0098; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Rodrigues M, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/428560; Sacavage S, 2008, NEUROSCI LETT, V439, P84, DOI 10.1016/j.neulet.2008.04.086; Schimpl FC, 2014, PHYTOCHEMISTRY, V105, P25, DOI 10.1016/j.phytochem.2014.04.018; Schimpl FC, 2013, J ETHNOPHARMACOL, V150, P14, DOI 10.1016/j.jep.2013.08.023; Scholey AB, 2004, PSYCHOPHARMACOLOGY, V176, P320, DOI 10.1007/s00213-004-1935-2; Seifert SM, 2013, CLIN TOXICOL, V51, P566, DOI 10.3109/15563650.2013.820310; Seifert SM, 2011, PEDIATRICS, V127, P511, DOI 10.1542/peds.2009-3592; Smith N, 2010, EVID-BASED COMPL ALT, V7, P279, DOI 10.1093/ecam/nem162; Tallarida CS, 2014, NEUROPHARMACOLOGY, V79, P590, DOI 10.1016/j.neuropharm.2014.01.002; Tran Jason, 2014, J Public Health Epidemiol, V8, P202; Trunzo JJ, 2014, J PSYCHOACTIVE DRUGS, V46, P396, DOI 10.1080/02791072.2014.965291; Umeda S, 2004, BRAIN RES, V1018, P181, DOI 10.1016/j.brainres.2004.05.057; VENTURINI G, 1983, COMP BIOCHEM PHYS C, V74, P23, DOI 10.1016/0742-8413(83)90141-X; Vyas CA, 2011, J PHARMACOL TOX MET, V63, P119, DOI 10.1016/j.vascn.2010.08.002; Weckerle CS, 2003, PHYTOCHEMISTRY, V64, P735, DOI 10.1016/S0031-9422(03)00372-8; White D.J., 2014, NUTR NEUROSCI; Zeidan-Chulia F, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/791795; Zhang C, 2013, PHYSIOL BEHAV, V112, P8, DOI 10.1016/j.physbeh.2013.02.002	57	21	21	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123310	10.1371/journal.pone.0123310	http://dx.doi.org/10.1371/journal.pone.0123310			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880065	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500046
J	Park, HYL; Jeong, HJ; Kim, YH; Park, CK				Park, Hae Young Lopilly; Jeong, Hyun Jin; Kim, Yoon Hee; Park, Chan Kee			Optic Disc Hemorrhage Is Related to Various Hemodynamic Findings by Disc Angiography	PLOS ONE			English	Article							NORMAL-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; FLUORESCEIN FILLING DEFECTS; OCULAR PERFUSION-PRESSURE; NERVE HEAD; AUTONOMIC DYSFUNCTION; BLOOD-FLOW; PROGRESSION; RISK; FLUCTUATION	Background To investigate the hemodynamic characteristics of glaucoma eyes with disc hemorrhage (DH) by disc fluorescein angiography, and its relationship with glaucomatous changes of the optic disc and surrounding retinal nerve fiber layer (RNFL). Methods This study included 35 glaucoma eyes with DH who were followed up at least 5 years and had DH at presentation. Eyes were classified as eyes with DH at the border of localized RNFL defects and eyes with DH not related to localized RNFL defects. Prevalence of DH and location of the proximal border were recorded from disc photographs. Fluorescein angiography was performed 3 months after detecting the DH. Arm-retina time, arteriovenous transit time, disc filling time, choroidal filling time, and venous filling time were measured as retinal circulation parameters. The presence of disc filling defects and disc leaks were evaluated. Results There were 19 (54.3%) eyes with DH accompanying localized RNFL defects. The arm-retina time was prolonged in eyes with DH not related to RNFL defects (P = 0.044) and the arteriovenous transit time was prolonged in eyes with DH accompanying RNFL defects (P = 0.029). Among eyes with DH accompanying RNFL defects, 11 (57.9%) had vessel filling defects or delayed filling indicating blood flow stasis at the cup margin proximal to where DH occurred. Eyes with DH not related to RNFL defects did not show vessel filling defects or delayed filling. Conclusions and Relevance Eyes with DH related to RNFL defects showed prolonged arteriovenous transit time and had frequent vessel filling defects or delayed filling indicating blood flow stasis and thrombus formation at the site DH occurred. These findings suggest that vascular and hemodynamic changes due to glaucomatous structural changes cause DH in relation to localized RNFL defects.	[Park, Hae Young Lopilly; Jeong, Hyun Jin; Kim, Yoon Hee; Park, Chan Kee] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital	Park, CK (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Seoul, South Korea.	ckpark@catholic.ac.kr			Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea	This study was supported by Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2002, AM J OPHTHALMOL, V134, P920, DOI 10.1016/S0002-9394(02)01791-9; Arend O, 2005, GRAEF ARCH CLIN EXP, V243, P659, DOI 10.1007/s00417-004-1092-7; Arend O, 2004, BRAIN RES BULL, V62, P517, DOI 10.1016/j.brainresbull.2003.07.008; ASHTON N, 1963, Br J Ophthalmol, V47, P521, DOI 10.1136/bjo.47.9.521; Bengtsson B, 2008, OPHTHALMOLOGY, V115, P2044, DOI 10.1016/j.ophtha.2008.05.031; Bennett PC, 2009, THROMB HAEMOSTASIS, V101, P1032, DOI 10.1160/TH08-08-0518; Budenz DL, 2006, OPHTHALMOLOGY, V113, P2137, DOI 10.1016/j.ophtha.2006.06.022; Choi J, 2007, INVEST OPHTH VIS SCI, V48, P104, DOI 10.1167/iovs.06-0615; de Beaufort HC, 2010, GRAEF ARCH CLIN EXP, V248, P839, DOI 10.1007/s00417-010-1306-0; Delaney Y, 2006, OPTOMETRY VISION SCI, V83, P406, DOI 10.1097/01.opx.0000225877.13217.01; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; DRANCE SM, 1989, SURV OPHTHALMOL, V33, P331, DOI 10.1016/0039-6257(89)90010-6; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; Graham SL, 1999, SURV OPHTHALMOL, V43, pS10, DOI 10.1016/S0039-6257(99)00016-8; Grieshaber MC, 2006, ACTA OPHTHALMOL SCAN, V84, P62, DOI 10.1111/j.1600-0420.2005.00590.x; Healey P, 2011, CLIN EXP OPHTHALMOL, V39, P485, DOI 10.1111/j.1442-9071.2011.02648.x; Ishida K, 2000, AM J OPHTHALMOL, V129, P707, DOI 10.1016/S0002-9394(00)00441-4; Jonas JB, 2002, INVEST OPHTH VIS SCI, V43, P2956; Kim SH, 2006, OPHTHALMOLOGY, V113, P598, DOI 10.1016/j.ophtha.2005.12.018; KITAZAWA Y, 1986, OPHTHALMOLOGY, V93, P853; Michelson G, 1998, GRAEF ARCH CLIN EXP, V236, P80, DOI 10.1007/s004170050046; Na KS, 2010, J GLAUCOMA, V19, P377, DOI 10.1097/IJG.0b013e3181c4ae58; Nitta K, 2011, J GLAUCOMA, V20, P189, DOI 10.1097/IJG.0b013e3181e0799c; Park HYL, 2012, AM J OPHTHALMOL, V154, P466, DOI 10.1016/j.ajo.2012.03.028; Park HYL, 2012, OPHTHALMOLOGY, V119, P10, DOI 10.1016/j.ophtha.2011.07.033; Park HYL, 2011, ARCH OPHTHALMOL-CHIC, V129, P1299, DOI 10.1001/archophthalmol.2011.249; Plange N, 2004, ARCH OPHTHALMOL-CHIC, V122, P195, DOI 10.1001/archopht.122.2.195; Plange N, 2003, BRIT J OPHTHALMOL, V87, P731, DOI 10.1136/bjo.87.6.731; Plange N, 2010, OPHTHAL PHYSL OPT, V30, P315, DOI 10.1111/j.1475-1313.2010.00717.x; QUIGLEY HA, 1981, ARCH OPHTHALMOL-CHIC, V99, P635, DOI 10.1001/archopht.1981.03930010635009; Schwartz B, 1994, Surv Ophthalmol, V38 Suppl, pS23, DOI 10.1016/0039-6257(94)90044-2; SCHWARTZ B, 1977, ARCH OPHTHALMOL-CHIC, V95, P1961; Sihota R, 2006, OPTOMETRY VISION SCI, V83, P520, DOI 10.1097/01.opx.0000225910.51370.02; Sonnsjo B, 2002, PROG RETIN EYE RES, V21, P35, DOI 10.1016/S1350-9462(01)00019-2; SONNSJO B, 1991, ACTA OPHTHALMOL, V69, P217; Spaeth G L, 1975, Trans Am Ophthalmol Soc, V73, P491; Sugiyama K, 1997, OPHTHALMOLOGY, V104, P1926, DOI 10.1016/S0161-6420(97)30005-0; Sugiyama T, 2006, AM J OPHTHALMOL, V141, P394, DOI 10.1016/j.ajo.2005.08.037; Sugiyama T, 2000, OPHTHALMIC RES, V32, P79, DOI 10.1159/000055594; Sung KR, 2009, INVEST OPHTH VIS SCI, V50, P5266, DOI 10.1167/iovs.09-3716; TALUSAN E, 1977, ARCH OPHTHALMOL-CHIC, V95, P2166; USUI T, 1991, BRIT J OPHTHALMOL, V75, P224, DOI 10.1136/bjo.75.4.224	42	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120000	10.1371/journal.pone.0120000	http://dx.doi.org/10.1371/journal.pone.0120000			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879852	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500004
J	Rangel, J; Strauss, K; Seedorf, K; Hjelmen, CE; Johnston, JS				Rangel, Juliana; Strauss, Kim; Seedorf, Kaileah; Hjelmen, Carl E.; Johnston, J. Spencer			Endopolyploidy Changes with Age-Related Polyethism in the Honey Bee, Apis mellifera	PLOS ONE			English	Article							CELL-CYCLE; GENE-EXPRESSION; NUCLEAR-DNA; MUSCLE; ENDOREDUPLICATION; POLYPLOIDY; SIZE; PATTERNS; SKELETAL; GENOMES	Honey bees (Apis mellifera) exhibit age polyethism, whereby female workers assume increasingly complex colony tasks as they age. While changes in DNA methylation accompany age polyethism, other DNA modifications accompanying age polyethism are less known. Changes in endopolyploidy (DNA amplification in the absence of cell division) with increased larval age are typical in many insect cells and are essential in adults for creating larger cells, more copies of essential loci, or greater storage capacity in secretory cells. However, changes in endopolyploidy with increased adult worker age and polyethism are unstudied. In this study, we examined endopolyploidy in honey bee workers ranging in age from newly emerged up to 55 days old. We found a nonsignificant increase in ploidy levels with age (P < 0.1) in the most highly endopolyploid secretory cells, the Malpighian tubules. All other cell types decreased ploidy levels with age. Endopolyploidy decreased the least amount (nonsignificant) in neural (brain) cells and the stinger (P < 0.1). There was a significant reduction of endopolyploidy with age in leg (P < 0.05) and thoracic (P < 0.001) muscles. Ploidy in thoracic muscle dropped from an average of 0.5 rounds of replication in newly emerged workers to essentially no rounds of replication (0.125) in the oldest workers. Ploidy reduction in flight muscle cells is likely due to the production of G1 (2C) nuclei by amitotic division in the multinucleate striated flight muscles that are essential to foragers, the oldest workers. We suggest that ploidy is constrained by the shape, size and makeup of the multinucleate striated muscle cells. Furthermore, the presence of multiple 2C nuclei might be optimal for cell function, while higher ploidy levels might be a dead-end strategy of some aging adult tissues, likely used to increase cell size and storage capacity in secretory cells.	[Rangel, Juliana; Strauss, Kim; Seedorf, Kaileah; Hjelmen, Carl E.; Johnston, J. Spencer] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Rangel, J (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	jrangel@tamu.edu	Hjelmen, Carl/AAO-8084-2020	Hjelmen, Carl/0000-0003-3061-6458	Texas AgriLife Research Hatch Project [TEX09557]; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund	Texas AgriLife Research Hatch Project; Office of the Vice President for Research; Texas A&M University Online Access to Knowledge (OAK) Fund	This work was funded in part by Texas AgriLife Research Hatch Project TEX09557 awarded to JR. The open access publishing fees for this article have been covered by the Texas A&M University Online Access to Knowledge (OAK) Fund, supported by the University Libraries and the Office of the Vice President for Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anatskaya OV, 2010, FUNCT INTEGR GENOMIC, V10, P433, DOI 10.1007/s10142-010-0180-5; Aron S, 2005, CURR BIOL, V15, P824, DOI 10.1016/j.cub.2005.03.017; Augustin H, 2009, BBA-GEN SUBJECTS, V1790, P1084, DOI 10.1016/j.bbagen.2009.06.011; BARLOW PW, 1978, ACTA BIOTHEOR, V27, P1, DOI 10.1007/BF00048400; Barow M, 2003, PLANT CELL ENVIRON, V26, P571, DOI 10.1046/j.1365-3040.2003.00988.x; BENNETT MD, 1972, PROC R SOC SER B-BIO, V181, P109, DOI 10.1098/rspb.1972.0042; Bennett MD, 1982, GENOME EVOLUTION; CIFUENTESDIAZ C, 1991, TISSUE CELL, V23, P801, DOI 10.1016/0040-8166(91)90032-O; Cortes F, 2003, MUTAGENESIS, V18, P105, DOI 10.1093/mutage/18.2.105; Crossley A.C., 1978, P499; D'Amato F., 1984, EMBRYOLOGY ANGIOSPER, P519, DOI DOI 10.1007/978-3-642-69302-1_11; Dade H.A., 1994, ANATOMY DISSECTION H; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Elango N, 2009, P NATL ACAD SCI USA, V106, P11206, DOI 10.1073/pnas.0900301106; Flemming AJ, 2000, P NATL ACAD SCI USA, V97, P5285, DOI 10.1073/pnas.97.10.5285; Follette PJ, 1998, CURR BIOL, V8, P235, DOI 10.1016/S0960-9822(98)70089-2; FRANCKE OF, 1979, J ARACHNOL, V7, P223; GALBRAITH DW, 1983, SCIENCE, V220, P1049, DOI 10.1126/science.220.4601.1049; Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251; GATTI M, 1989, GENE DEV, V3, P438, DOI 10.1101/gad.3.4.438; Hagen JL, 2004, J GERONTOL A-BIOL, V59, P1099, DOI 10.1093/gerona/59.11.1099; Hepple RT, 2006, REJUV RES, V9, P219, DOI 10.1089/rej.2006.9.219; Johnston JS, 2004, INSECT MOL BIOL, V13, P581, DOI 10.1111/j.0962-1075.2004.00514.x; Jones JC, 2005, J COMP PHYSIOL A, V191, P1121, DOI 10.1007/s00359-005-0035-z; KATO Y, 1987, DEVELOPMENT, V99, P137; Larkins BA, 2001, J EXP BOT, V52, P183, DOI 10.1093/jexbot/52.355.183; Lee HO, 2009, GENE DEV, V23, P2461, DOI 10.1101/gad.1829209; Lilly MA, 2005, ONCOGENE, V24, P2765, DOI 10.1038/sj.onc.1208610; MASZEWSKI J, 1991, PLANT SYST EVOL, V177, P39, DOI 10.1007/BF00937825; MERRIAM RW, 1954, CHROMOSOMA, V6, P522; MITTWOCH U, 1966, NATURE, V210, P264, DOI 10.1038/210264a0; Mosieniak G, 2010, CURR PHARM DESIGN, V16, P734, DOI 10.2174/138161210790883714; NAGL W, 1976, NATURE, V261, P614, DOI 10.1038/261614a0; NAGL W, 1978, ENDOPOLYPLOIDY POLYT; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Peres LMC, 2014, APIDOLOGIE, V45, P601, DOI 10.1007/s13592-014-0277-2; PESSACQ TA, 1969, EXPERIENTIA, V25, P977, DOI 10.1007/BF01898100; RASCH EM, 1975, J HISTOCHEM CYTOCHEM, V23, P317; Riley BB, 2010, DEV DYNAM, V239, P828, DOI 10.1002/dvdy.22227; Schmidt-Ott U, 2009, DEV GENES EVOL, V219, P207, DOI 10.1007/s00427-009-0281-0; Scholes DR, 2014, J HYMENOPT RES, V37, P113, DOI 10.3897/JHR.37.6824; Scholes DR, 2013, ECOL EVOL, V3, P2128, DOI 10.1002/ece3.623; Seeley T.D., 2010, HONEYBEE DEMOCRACY; SHEN EYF, 1967, J CELL BIOL, V35, P377, DOI 10.1083/jcb.35.2.377; SOHAL RS, 1976, GERONTOLOGY, V22, P317, DOI 10.1159/000212146; TOSELLI PA, 1968, J CELL BIOL, V37, P462, DOI 10.1083/jcb.37.2.462; White M. J. D, 1973, ANIMAL CYTOLOGY EVOL; Winston M.L., 1991, BIOL HONEY BEE; Wu CY, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000523	49	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122208	10.1371/journal.pone.0122208	http://dx.doi.org/10.1371/journal.pone.0122208			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881205	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500017
J	De Buck, E; Dieltjens, T; Compernolle, V; Vandekerckhove, P				De Buck, Emmy; Dieltjens, Tessa; Compernolle, Veerle; Vandekerckhove, Philippe			Is Having Sex with Other Men a Risk Factor for Transfusion-Transmissible Infections in Male Blood Donors in Western Countries? A Systematic Review	PLOS ONE			English	Review							C VIRUS-INFECTION; HAD SEX; NO EVIDENCE; ANTIBODIES; DONATION; CRITERIA; IMPACT; POLICY; MSM	Background Although increased prevalence of transfusion transmissible infections (TTI) among "men who have sex with men" (MSM) has been well documented, the exclusion of MSM as blood donors is contested. The aim of this systematic review is to find studies that describe the risk of TTI in MSM blood donors. Methods We searched MEDLINE, Embase, The Cochrane Central Register of Controlled Trials, Cinahl, and Web of Science, and used GRADE for determining evidence quality. We included studies comparing MSM and non-MSM blood donors (or people eligible to give blood), living in areas most relevant for our Blood Service. Results Out of 18 987 articles, 14 observational studies were included. Two studies directly compared MSM with non-MSM donors showing that MSM donors have a statistically significant higher risk of HIV-1 infections. In one of these studies it was shown that this was related to recent (<12 months) MSM contact. In two additional studies no evidence was shown in favour of a certain deferral period for MSM. Ten studies, applying permanent deferral for MSM, compared infected versus non-infected donors. One study found that MSM is a statistically significant risk factor for HIV-1 infection in blood donors. For other TTI such as HBV or HCV, an increased risk of infection could not be demonstrated, because the precision of the results was affected by the low numbers of donors with MSM as risk factor, or because of risk of bias in the included studies. All studies included low level evidence, because of risk of bias and imprecision of the results. Conclusions High-quality studies investigating the risk of TTI in MSM who donate blood are scarce. The available evidence suggests a link between MSM blood donors and HIV-1 infection, but is too limited to be able to unambiguously/clearly recommend a certain deferral policy.	[De Buck, Emmy; Dieltjens, Tessa] Belgian Red Cross Flanders, Ctr Evidence Based Practice, Mechelen, Belgium; [Compernolle, Veerle] Belgian Red Cross Flanders, Blood Serv, Mechelen, Belgium; [Compernolle, Veerle] Univ Ghent, Fac Med & Hlth Sci, B-9000 Ghent, Belgium; [Vandekerckhove, Philippe] Belgian Red Cross Flanders, Mechelen, Belgium; [Vandekerckhove, Philippe] Katholieke Univ Leuven, Dept Publ Hlth & Primary Care, Fac Med, Leuven, Belgium; [Vandekerckhove, Philippe] Univ Ghent, Fac Med, B-9000 Ghent, Belgium	Ghent University; KU Leuven; Ghent University	Vandekerckhove, P (corresponding author), Belgian Red Cross Flanders, Mechelen, Belgium.	philippe.vandekerckhove@rodekruis.be			Foundation for Scientific Research of the Belgian Red Cross-Flanders	Foundation for Scientific Research of the Belgian Red Cross-Flanders(Fonds de la Recherche Scientifique - FNRS)	This work was made possible through funding from the Foundation for Scientific Research of the Belgian Red Cross-Flanders. All authors are employees at the Belgian Red Cross-Flanders and were involved in the development of this systematic review. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison RD, 2012, J INFECT DIS, V206, P654, DOI 10.1093/infdis/jis410; Alpaugh K, 1985, LAB MED, V16, P485; Benjamin RJ, 2011, VOX SANG, V101, P339, DOI 10.1111/j.1423-0410.2011.01489.x; Brooks JP, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b318; BUSCH MP, 1994, TRANSFUSION, V34, P858, DOI 10.1046/j.1537-2995.1994.341095026970.x; Christensen PB, 2001, VOX SANG, V81, P222, DOI 10.1046/j.0042-9007.2001.00113.x; Cohen IG, 2014, JAMA-J AM MED ASSOC, V312, P337, DOI 10.1001/jama.2014.8037; Delamothe T, 2004, BMJ-BRIT MED J, V328, P1, DOI 10.1136/bmj.328.7430.1; Epstein J, 2014, VOX SANG, V107, P416, DOI 10.1111/vox.12166; Friedman MR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087139; KALDOR JM, 1992, MED J AUSTRALIA, V157, P227, DOI 10.5694/j.1326-5377.1992.tb137123.x; Leiss W, 2008, TRANSFUS MED REV, V22, P35, DOI 10.1016/j.tmrv.2007.09.002; Macdonald G, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001930.pub3; Martucci J, 2010, SOC STUD SCI, V40, P215, DOI 10.1177/0306312709346579; Mayer KH, 2008, SEXUALLY TRANSMITTED, P203; Menitove JE, 2014, TRANSFUSION, V54, P753, DOI 10.1111/trf.12569; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moore MC, 1997, VOX SANG, V72, P79, DOI 10.1046/j.1423-0410.1997.7220079.x; Murphy EL, 2000, HEPATOLOGY, V31, P756, DOI 10.1002/hep.510310329; NEAL KR, 1994, EPIDEMIOL INFECT, V112, P595, DOI 10.1017/S0950268800051293; Offergeld R, 2014, VOX SANG, V107, P420, DOI 10.1111/vox.12179; Roehr B, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b311; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Sanchez AM, 2005, TRANSFUSION, V45, P404, DOI 10.1111/j.1537-2995.2005.03421.x; Schmidt M, 2006, VOX SANG, V91, P237, DOI 10.1111/j.1423-0410.2006.00818.x; Seed CR, 2014, VOX SANG, V106, P14, DOI 10.1111/vox.12093; Seed CR, 2010, TRANSFUSION, V50, P2722, DOI 10.1111/j.1537-2995.2010.02793.x; SERFATY L, 1993, HEPATOLOGY, V17, P183, DOI 10.1002/hep.1840170204; Slowther A, 2013, TRANSFUS MED HEMOTH, V40, P155, DOI 10.1159/000351770; Suligoil B, 2013, BLOOD TRANSFUS-ITALY, V11, P441, DOI 10.2450/2013.0162-12; TULLEN E, 1993, SCHWEIZ MED WSCHR, V123, P57; Vamvakas EC, 2011, DECISION MAKING TRAN, P201; Vamvakas EC, 2009, TRANSFUSION, V49, P1037, DOI 10.1111/j.1537-2995.2009.02175.x; VANDERPOEL C, 1991, TRANSFUSION, V31, P777	34	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122523	10.1371/journal.pone.0122523	http://dx.doi.org/10.1371/journal.pone.0122523			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875812	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800062
J	Wang, CC; Su, KY; Chen, HY; Chang, SY; Shen, CF; Hsieh, CH; Hong, QS; Chiang, CC; Chang, GC; Yu, SL; Chen, JJW				Wang, Chi-Chung; Su, Kang-Yi; Chen, Hsuan-Yu; Chang, So-Yi; Shen, Chi-Fan; Hsieh, Chia-Hung; Hong, Qi-Sheng; Chiang, Ching-Cheng; Chang, Gee-Chen; Yu, Sung-Liang; Chen, Jeremy J. W.			HOXA5 Inhibits Metastasis via Regulating Cytoskeletal Remodelling and Associates with Prolonged Survival in Non-Small-Cell Lung Carcinoma	PLOS ONE			English	Article							BREAST-CANCER CELLS; HOMEOBOX GENES; ARP2/3 COMPLEX; TUMOR-CELLS; EXPRESSION; MOTILITY; PAXILLIN; INVASION; PROTEIN; IDENTIFICATION	Homeobox genes comprise a family of regulatory genes that contain a common homeobox domain and act as transcription factors. Recent studies indicate that homeobox A5 (HOXA5) may serve as a tumour suppressor gene in breast cancers. However, the precise role and the underlying mechanism of HOXA5 in lung cancer remain unclear. Oligonucleotide microarrays and an invasion/metastasis lung adenocarcinoma cell line model were used to determine the correlation between HOXA5 expression and cancer cell invasion ability. We found that ectopic expression of HOXA5 in highly invasive cancer cells suppressed cell migration, invasion, and filopodia formation in vitro and inhibited metastatic potential in vivo. Knockdown of HOXA5 promoted the invasiveness of lung cancer cells. In addition, HOXA5 expression was associated with better clinical outcome in non-small cell lung cancer patients with wild-type EGFR. Furthermore, genome-wide transcriptomic and pathway analyses were performed to identify the potential molecular mechanisms. Our data showed that HOXA5 may bind to the promoters of the cytoskeleton-related genes and downregulate their mRNA and protein expression levels. Our studies provide new insights into how HOXA5 may contribute to the suppression of metastasis in lung cancer via cytoskeleton remodelling regulation. Therefore, targeted induction of HOXA5 may represent a promising approach for non-small-cell lung cancer therapy.	[Wang, Chi-Chung; Shen, Chi-Fan] Fu Jen Catholic Univ, Grad Inst Basic Med, New Taipei, Taiwan; [Su, Kang-Yi; Hong, Qi-Sheng; Chiang, Ching-Cheng; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Clin & Lab Sci & Med Biotechnol, Taipei 10764, Taiwan; [Su, Kang-Yi; Chen, Hsuan-Yu; Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, NTU Ctr Genom Med, Taipei 10764, Taiwan; [Chen, Hsuan-Yu] Acad Sinica, Inst Stat Sci, Taipei 11529, Taiwan; [Chang, So-Yi] Natl Taiwan Univ, Coll Med, Inst Biochem & Mol Biol, Taipei 10764, Taiwan; [Hsieh, Chia-Hung] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan; [Chang, Gee-Chen] Taichung Vet Gen Hosp, Dept Internal Med, Div Chest Med, Taichung, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Dept Pathol, Taipei, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Grad Inst Pathol, Taipei 10764, Taiwan; [Yu, Sung-Liang] Natl Taiwan Univ, Coll Med, Ctr Optoelect Biomed, Taipei 10764, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan; [Chen, Jeremy J. W.] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 40227, Taiwan	Fu Jen Catholic University; National Taiwan University; National Taiwan University; Academia Sinica - Taiwan; National Taiwan University; China Medical University Taiwan; Taichung Veterans General Hospital; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University; National Taiwan University; National Chung Hsing University; National Chung Hsing University	Chen, JJW (corresponding author), Natl Chung Hsing Univ, Inst Biomed Sci, Taichung 40227, Taiwan.	jwchen@dragon.nchu.edu.tw	SU, KANG-YI/GNM-5753-2022; Chen, Hsuan-Yu/AAE-8428-2019	SU, KANG-YI/0000-0002-6538-9526; Chen, Jeremy J.W./0000-0003-1049-3825; YU, SUNG-LIANG/0000-0003-4535-9036	National Science Council (NSC), Taiwan [NSC97-2314-B-030-007-MY2, NSC99-2628-B-030-002-MY3]; Fu Jen Catholic University, Taiwan [9991A01-409931034019]; Ministry of Education, Taiwan	National Science Council (NSC), Taiwan(Ministry of Science and Technology, Taiwan); Fu Jen Catholic University, Taiwan; Ministry of Education, Taiwan(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council (NSC), Taiwan, R.O.C. (NSC97-2314-B-030-007-MY2 and NSC99-2628-B-030-002-MY3 to CCW), as well as by grants from the Fu Jen Catholic University, Taiwan, R.O.C. (9991A01-409931034019 to CCW) and by the Ministry of Education, Taiwan, R.O.C. under the ATU plan (to JJWC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 2006, ONCOL REP, V15, P797; Apiou F, 1996, CYTOGENET CELL GENET, V73, P114, DOI 10.1159/000134320; Bailly M, 2002, NAT CELL BIOL, V4, pE292, DOI 10.1038/ncb1202-e292; Baljinnyam E, 2010, CANCER RES, V70, P5607, DOI 10.1158/0008-5472.CAN-10-0056; Chen CH, 2012, MOL CANCER RES, V10, P1319, DOI 10.1158/1541-7786.MCR-12-0189; Chen HX, 2005, J BIOL CHEM, V280, P19373, DOI 10.1074/jbc.M413528200; Chen HX, 2004, MOL CELL BIOL, V24, P924, DOI 10.1128/MCB.24.2.924-935.2004; Chen JJW, 2001, CANCER RES, V61, P5223; Chen Y, 2008, BLOOD, V111, P1217, DOI 10.1182/blood-2007-07-104133; Cillo C, 2001, J CELL PHYSIOL, V188, P161, DOI 10.1002/jcp.1115; DEVITA G, 1993, EUR J CANCER, V29A, P887, DOI 10.1016/S0959-8049(05)80432-0; Ford HL, 1998, CELL BIOL INT, V22, P397, DOI 10.1006/cbir.1998.0329; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; Golpon HA, 2001, AM J PATHOL, V158, P955, DOI 10.1016/S0002-9440(10)64042-4; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hsiao KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069354; Jagadeeswaran R, 2008, CANCER RES, V68, P132, DOI 10.1158/0008-5472.CAN-07-1998; Kerber ML, 2011, J CELL SCI, V124, P3733, DOI 10.1242/jcs.023549; Kim DS, 2009, MOL CARCINOGEN, V48, P1109, DOI 10.1002/mc.20561; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; LEVINE M, 1988, CELL, V55, P537, DOI 10.1016/0092-8674(88)90209-7; Liu XH, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-348; Mark M, 1997, PEDIATR RES, V42, P421, DOI 10.1203/00006450-199710000-00001; MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N; Mountain CF, 1997, CHEST, V111, P1710, DOI 10.1378/chest.111.6.1710; Nunes Fabio Daumas, 2003, Pesqui Odontol Bras, V17, P94; Ong CC, 2011, P NATL ACAD SCI USA, V108, P7177, DOI 10.1073/pnas.1103350108; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Rettig M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042012; Sakakura C, 2003, ANTICANCER RES, V23, P3691; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Semba S, 2006, CLIN CANCER RES, V12, P2449, DOI 10.1158/1078-0432.CCR-05-2566; Shen K, 1998, NEURON, V21, P593, DOI 10.1016/S0896-6273(00)80569-3; Shibao K, 2010, CELL CALCIUM, V48, P315, DOI 10.1016/j.ceca.2010.09.005; Shiraishi M, 2002, ONCOGENE, V21, P3804, DOI 10.1038/sj.onc.1205454; Stasinopoulos IA, 2005, J BIOL CHEM, V280, P2294, DOI 10.1074/jbc.M411018200; Subauste MC, 2004, J CELL BIOL, V165, P371, DOI 10.1083/jcb.200308011; Taylor HS, 2000, SEMIN REPROD MED, V18, P81, DOI 10.1055/s-2000-13478; TIBERIO C, 1994, INT J CANCER, V58, P608, DOI 10.1002/ijc.2910580426; Tsai MF, 2006, JNCI-J NATL CANCER I, V98, P825, DOI 10.1093/jnci/djj229; Uyeno LA, 2001, J SURG RES, V100, P46, DOI 10.1006/jsre.2001.6174; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Vider BZ, 1997, BIOCHEM BIOPH RES CO, V232, P742, DOI 10.1006/bbrc.1997.6364; Wang L, 2003, J BIOL CHEM, V278, P44617, DOI 10.1074/jbc.M308929200; Yoo YD, 2007, J BIOL CHEM, V282, P7616, DOI 10.1074/jbc.M607596200; Zhang ML, 2014, TUMOR BIOL; Zheng HC, 2008, ANTICANCER RES, V28, P2225; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221	49	31	32	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124191	10.1371/journal.pone.0124191	http://dx.doi.org/10.1371/journal.pone.0124191			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875824	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700059
J	Dillon, RT; Jacquemin, SJ				Dillon, Robert T., Jr.; Jacquemin, Stephen J.			The Heritability of Shell Morphometrics in the Freshwater Pulmonate Gastropod Physa	PLOS ONE			English	Article							CRYPTIC PHENOTYPIC PLASTICITY; PREDATOR-INDUCED DEFENSES; GENETIC-VARIATION; SHAPE VARIATION; LIFE-HISTORY; WILD-CAUGHT; SNAIL; HETEROSTROPHA; POPULATIONS; MORPHOLOGY	The cosmopolitan freshwater pulmonate snail Physa acuta hybridizes readily with Physa carolinae in the laboratory, although their F1 progeny are sterile. The two species differ qualitatively in shell shape, the former bearing a more globose shell and the latter more fusiform. We performed a hybridization experiment, measuring a set of 14 traditional (linear) and landmark-based shell morphological variables on even-aged parents and their offspring from both hybrids and purebred control lines. Parent-offspring regression yielded a strikingly high heritability estimate for score on the first relative warp axis, h(2) = 0.819 +/- 0.073, a result that would seem to confirm the value of geometric morphometrics as a tool for retrieving evolutionary relationships from gastropod shell form. Score on the second relative warp axis was also significantly heritable (h(2) = 0.312 +/- 0.123), although more moderate, as were scores on second principal components extracted from traditional measurements (correlation h(2) = 0.308 +/- 0.069, covariance h(2) = 0.314 +/- 0.050). Although score on the first relative warp axis was significantly correlated with centroid size (p < 0.001), scores on none of the three second axes were so correlated. This result suggests that second axis score might prove especially useful for estimating genetic divergence among mixed-age populations of gastropods sampled from the field.	[Dillon, Robert T., Jr.] Coll Charleston, Dept Biol, Charleston, SC 29424 USA; [Jacquemin, Stephen J.] Wright State Univ, Dept Biol, Celina, OH USA	College of Charleston; University System of Ohio; Wright State University Dayton	Dillon, RT (corresponding author), Coll Charleston, Dept Biol, Charleston, SC 29424 USA.	DillonR@cofc.edu						[Anonymous], 2015, PC ORD MULTIVARIATE; Auld JR, 2011, EVOL ECOL, V25, P189, DOI 10.1007/s10682-010-9394-1; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blackith RE., 1971, MULTIVARIATE MORPHOM; BOULDING EG, 1993, EVOLUTION, V47, P576, DOI 10.1111/j.1558-5646.1993.tb02114.x; Britton DK, 2004, AM MALACOL BULL, V19, P93; Bronmark C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030467; Bronmark C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021773; Bryant EH, 1998, EVOLUTION, V52, P626, DOI [10.2307/2411098, 10.1111/j.1558-5646.1998.tb01662.x]; Carballo M, 2001, J SHELLFISH RES, V20, P415; Chaves-Campos J, 2012, EVOL ECOL RES, V14, P743; Conde-Padin P, 2007, EVOL ECOL, V21, P635, DOI 10.1007/s10682-006-9142-8; DeWitt TJ, 1998, J EVOLUTION BIOL, V11, P465, DOI 10.1007/s000360050100; Dillon RT, 2013, HYDROBIOLOGIA, V709, P117, DOI 10.1007/s10750-012-1441-1; Dillon RT, 2014, ZOOL STUD, V53, DOI 10.1186/s40555-014-0031-5; Dillon RT, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-144; Dillon RT, 2009, NAUTILUS, V123, P276; Dillon RT, 2009, J FRESHWATER ECOL, V24, P261, DOI 10.1080/02705060.2009.9664291; DILLON RT, 1994, BIOCHEM GENET, V32, P75, DOI 10.1007/BF00554416; DILLON RT, 1995, SYST BIOL, V44, P400, DOI 10.2307/2413600; DILLON RT, 1984, MALACOLOGIA, V25, P503; DILLON RT, 1992, J HERED, V83, P208, DOI 10.1093/oxfordjournals.jhered.a111194; DILLON RT, 1984, SYST ZOOL, V33, P69, DOI 10.2307/2413133; Dillon RT, 2002, INVERTEBR BIOL, V121, P226, DOI 10.1111/j.1744-7410.2002.tb00062.x; Dunithan A, 2012, AM MALACOL BULL, V30, P127; DupontNivet M, 1997, J ZOOL, V241, P757, DOI 10.1111/j.1469-7998.1997.tb05746.x; Falconer D. S., 1996, INTRO QUANTITATIVE G; GOULD SJ, 1974, SYST ZOOL, V23, P518, DOI 10.2307/2412470; Guerra-Varela J, 2009, EVOL ECOL, V23, P261, DOI 10.1007/s10682-007-9221-5; Gustafson KD, 2014, EVOL ECOL RES, V16, P77; Hoverman J, OIKOS, V121, P1219; Hoverman JT, 2009, FUNCT ECOL, V23, P1179, DOI 10.1111/j.1365-2435.2009.01586.x; HUMPHRIES JM, 1981, SYST ZOOL, V30, P291, DOI 10.2307/2413251; JACKSON DA, 1993, ECOLOGY, V74, P2204, DOI 10.2307/1939574; Jason K, 1983, MAR BIOL, V74, P49; JOHNSTON MR, 1991, PALEOBIOLOGY, V17, P19, DOI 10.1017/S0094837300010320; Krist AC, 2002, INVERTEBR BIOL, V121, P235; LAM PKS, 1988, J MOLLUS STUD, V54, P197, DOI 10.1093/mollus/54.2.197; Langerhans RB, 2002, EVOL ECOL RES, V4, P857; Lucas T, 2006, AQUACULTURE, V259, P146, DOI 10.1016/j.aquaculture.2006.05.039; Lynch M., 1998, GENETICS ANAL QUANTI; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; RAUP DAVID M., 1966, J PALEONTOL, V40, P1178; Reyment RA, 1984, MULTIVARIATE MORPHOM; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; ROHLF FJ, 1993, TRENDS ECOL EVOL, V8, P129, DOI 10.1016/0169-5347(93)90024-J; Rohlf FJ, 2007, TPSRELW VERSION 1 38; Rohlf FJ, 2008, TPSDIG VERSION 2 11; Rundle SD, 2004, P ROY SOC B-BIOL SCI, V271, pS67, DOI 10.1098/rsbl.2003.0106; Salice CJ, 2011, EVOL ECOL RES, V13, P373; Smith UE, 2013, SYST BIOL, V62, P366, DOI 10.1093/sysbio/syt002; Solas MR, 2013, AQUAT BIOL, V18, P253, DOI 10.3354/ab00508; Stone JR, 1998, SYST BIOL, V47, P254, DOI 10.1080/106351598260905; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Urabe M, 1998, J MOLLUS STUD, V64, P329, DOI 10.1093/mollus/64.3.329; van der Linde K, 2009, EVOL BIOL, V36, P311, DOI 10.1007/s11692-009-9061-z; Van Vleck L.D., 1987, GENETICS ANIMAL SCI; Wagner PJ, 1996, EVOLUTION, V50, P990, DOI 10.1111/j.1558-5646.1996.tb02341.x; WAGNER PJ, 1995, PALEOBIOLOGY, V21, P248, DOI 10.1017/S0094837300013294; Webster M, 2010, PALEONTOLOGICAL SOC, V,, P163, DOI DOI 10.1017/S1089332600001868; Weigensberg I, 1996, EVOLUTION, V50, P2149, DOI 10.1111/j.1558-5646.1996.tb03605.x; Wethington AR, 2009, NAUTILUS, V123, P282; Wethington AR, 1997, INVERTEBR BIOL, V116, P192, DOI 10.2307/3226896; WETHINGTON AR, 1993, P ROY SOC B-BIOL SCI, V252, P109, DOI 10.1098/rspb.1993.0053; Wethington AR, 1996, ANIM BEHAV, V51, P1107, DOI 10.1006/anbe.1996.0112; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	66	14	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121962	10.1371/journal.pone.0121962	http://dx.doi.org/10.1371/journal.pone.0121962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876155	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100053
J	Nataraj, V; Pang, PC; Haslam, SM; Veerapen, N; Minnikin, DE; Dell, A; Besra, GS; Bhatt, A				Nataraj, Vijayashankar; Pang, Poh-choo; Haslam, Stuart M.; Veerapen, Natacha; Minnikin, David E.; Dell, Anne; Besra, Gurdyal S.; Bhatt, Apoorva			MKAN27435 Is Required for the Biosynthesis of Higher Subclasses of Lipooligosaccharides in Mycobacterium kansasii	PLOS ONE			English	Article							TREHALOSE-CONTAINING LIPOOLIGOSACCHARIDES; MARINUM; TUBERCULOSIS; INFECTION; PULMONARY; ANTIGENS; ENVELOPE; BCG	Lipooligosaccharides are glycolipids found in the cell wall of many mycobacterial species including the opportunistic pathogen Mycobacterium kansasii. The genome of M. kansasii ATCC12478 contains a cluster with genes orthologous to Mycobacterium marinum LOS biosynthesis genes. To initiate a genetic dissection of this cluster and demonstrate its role in LOS biosynthesis in M. kansasii, we chose MKAN27435, a gene encoding a putative glycosyltransferase. Using Specialized Transduction, a phage-based gene knockout tool previously used to generate null mutants in other mycobacteria, we generated a MKAN27435 null mutant. The mutant strain was found to be defective in the biosynthesis of higher LOS subspecies, viz LOS-IV, LOS-V, LOS-VI and LOS-VII. Additionally, a range of low abundance species were detected in the mutant strain and mass spectroscopic analysis indicated that these were shunt products generated from LOS-III by the addition of up to six molecules of a pentose.	[Nataraj, Vijayashankar; Veerapen, Natacha; Minnikin, David E.; Besra, Gurdyal S.; Bhatt, Apoorva] Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England; [Nataraj, Vijayashankar; Veerapen, Natacha; Minnikin, David E.; Besra, Gurdyal S.; Bhatt, Apoorva] Univ Birmingham, Inst Microbiol & Infect, Birmingham B15 2TT, W Midlands, England; [Pang, Poh-choo; Haslam, Stuart M.; Dell, Anne] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London SW7 2AZ, England	University of Birmingham; University of Birmingham; Imperial College London	Bhatt, A (corresponding author), Univ Birmingham, Sch Biosci, Birmingham B15 2TT, W Midlands, England.	a.bhatt@bham.ac.uk		Dell, Anne/0000-0003-1380-2347; Besra, Gurdyal/0000-0002-5605-0395	Medical Research Council (UK); Biotechnology and Biological Sciences Research Council [BB/K016164/1] Funding Source: researchfish; Medical Research Council [MR/K012118/1, G0600105] Funding Source: researchfish; BBSRC [BB/K016164/1] Funding Source: UKRI; MRC [MR/K012118/1, G0600105] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by grants from the Medical Research Council (UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alibaud L, 2014, J BIOL CHEM, V289, P215, DOI 10.1074/jbc.M113.525550; Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007; Bardarov S, 1997, P NATL ACAD SCI USA, V94, P10961, DOI 10.1073/pnas.94.20.10961; BELISLE JT, 1989, J BACTERIOL, V171, P3465, DOI 10.1128/jb.171.6.3465-3470.1989; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burguiere A, 2005, J BIOL CHEM, V280, P42124, DOI 10.1074/jbc.M507500200; COLLINS FM, 1981, INFECT IMMUN, V32, P614, DOI 10.1128/IAI.32.2.614-624.1981; DAFFE M, 1991, BIOCHEMISTRY-US, V30, P378, DOI 10.1021/bi00216a011; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; Dobson G., 1985, CHEM METHODS BACTERI, P237; Evans SA, 1996, THORAX, V51, P1248, DOI 10.1136/thx.51.12.1248; HUNTER SW, 1984, J BIOL CHEM, V259, P9729; HUNTER SW, 1985, BIOCHEMISTRY-US, V24, P2798, DOI 10.1021/bi00332a030; HUNTER SW, 1983, J BIOL CHEM, V258, P481; Larsen Michelle H, 2007, Curr Protoc Microbiol, VChapter 10, DOI 10.1002/9780471729259.mc10a02s6; LILLO M, 1990, REV INFECT DIS, V12, P760; Minnikin D E, 1989, Acta Leprol, V7 Suppl 1, P51; Picardeau M, 1997, J CLIN MICROBIOL, V35, P25, DOI 10.1128/JCM.35.1.25-32.1997; Ren HP, 2007, MOL MICROBIOL, V63, P1345, DOI 10.1111/j.1365-2958.2007.05603.x; Rombouts Y, 2010, J AM CHEM SOC, V132, P16073, DOI 10.1021/ja105807s; Rombouts Y, 2009, J BIOL CHEM, V284, P20975, DOI 10.1074/jbc.M109.011429; Sarkar D, 2011, J BACTERIOL, V193, P2336, DOI 10.1128/JB.00065-11; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Tompkins JC, 2007, INT J TUBERC LUNG D, V11, P331; van der Woude AD, 2012, J BIOL CHEM, V287, P20417, DOI 10.1074/jbc.M111.336461	26	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0122804	10.1371/journal.pone.0122804	http://dx.doi.org/10.1371/journal.pone.0122804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893968	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700017
J	Periasamy, M; Schafleitner, R; Muthukalingan, K; Ramasamy, S				Periasamy, Malini; Schafleitner, Roland; Muthukalingan, Krishnan; Ramasamy, Srinivasan			Phylogeographical Structure in Mitochondrial DNA of Legume Pod Borer (Maruca vitrata) Population in Tropical Asia and Sub-Saharan Africa	PLOS ONE			English	Article							COII GENE-SEQUENCES; CORN-BORER; TESTULALIS LEPIDOPTERA; OSTRINIA-FURNACALIS; SEX-PHEROMONE; IDENTIFICATION; DIFFERENTIATION; HAPLOTYPES; NUBILALIS; PYRALIDAE	This study was undertaken to assess the genetic diversity and host plant races of M. vitrata population in South and Southeast Asia and sub-Saharan Africa. The cytochrome c oxidase subunit 1 (cox1) gene was used to understand the phylogenetic relationship of geographically different M. vitrata population, but previous studies did not include population from Southeast Asia, the probable center of origin for Maruca, and from east Africa. Extensive sampling was done from different host plant species in target countries. Reference populations from Oceania and Latin America were used. An amplicon of 658 bp was produced by polymerase chain reaction, and 64 haplotypes were identified in 686 M. vitrata individuals. Phylogenetic analysis showed no difference among the M. vitrata population from different host plants. However, the results suggested that M. vitrata has formed two putative subspecies (which cannot be differentiated based on morphological characters) in Asia and sub-Saharan Africa, as indicated by the high pairwise F-ST values (0.44-0.85). The extremely high F-ST values (>= 0.93) of Maruca population in Latin America and Oceania compared to Asian and African population seem to indicate a different species. On the continental or larger geographical region basis, the genetic differentiation is significantly correlated with the geographical distance. In addition, two putative species of Maruca, including M. vitrata occur in Australia, Indonesia and Papua New Guinea. The negative Tajima's D and Fu's F-S values showed the recent demographic expansion of Maruca population. The haplotype network and Automatic Barcode Gap Discovery analyses confirmed the results of phylogenetic analysis. Thus, this study confirmed the presence of three putative Maruca species, including one in Latin America, one in Oceania (including Indonesia) and M. vitrata in Asia, Africa and Oceania. Hence, the genetic differences in Maruca population should be carefully considered while designing the pest management strategies in different regions.	[Periasamy, Malini; Schafleitner, Roland; Ramasamy, Srinivasan] World Vegetable Ctr, Asian Vegetable Res & Dev Ctr, Tainan 74199, Taiwan; [Periasamy, Malini; Muthukalingan, Krishnan] Bharathidasan Univ, Dept Environm Biotechnol, Tiruchirappalli 620024, Tamil Nadu, India	Bharathidasan University	Ramasamy, S (corresponding author), World Vegetable Ctr, Asian Vegetable Res & Dev Ctr, POB 42, Tainan 74199, Taiwan.	srini.ramasamy@worldveg.org	Ramasamy, Srinivasan/N-1686-2019; Periasamy, Malini/AAX-6478-2021	Ramasamy, Srinivasan/0000-0002-8454-7331; Schafleitner, Roland/0000-0003-3637-7603	Federal Ministry for Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH. GIZ Project [09.7860.1-001.00. SR]	Federal Ministry for Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH. GIZ Project	Funded by Federal Ministry for Economic Cooperation and Development (BMZ) through Deutsche Gesellschaft fur Internationale Zusammenarbeit (GIZ) GmbH. GIZ Project No: 09.7860.1-001.00. SR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adati T, 1999, J CHEM ECOL, V25, P105, DOI 10.1023/A:1020841217376; AFUN JVK, 1991, CROP PROT, V10, P363, DOI 10.1016/S0261-2194(06)80025-6; Agunbiade TA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092072; [Anonymous], 2014, BARCODE INDEX NUMBER; Arodokoun D. Y., 2003, Insect Science and its Application, V23, P103; BayScience Foundation, 2012, MAR GEN; CAB International, 2005, CROP PROT COMP; Chang JC, 2013, ANN ENTOMOL SOC AM, V106, P359, DOI 10.1603/AN12136; Chang JC, 2016, MITOCHONDRIAL DNA A, V27, P198, DOI [10.3109/19401736.2014.880890, 10.1155/2014/454156]; Coates BS, 2005, INT J BIOL SCI, V1, P13; Coates BS, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.35; De Barro PJ, 2011, ANNU REV ENTOMOL, V56, P1, DOI 10.1146/annurev-ento-112408-085504; Downham MCA, 2004, ENTOMOL EXP APPL, V110, P151, DOI 10.1111/j.0013-8703.2004.00128.x; Downham MCA, 2003, J CHEM ECOL, V29, P989, DOI 10.1023/A:1022996103147; DREYER H, 1994, INT J PEST MANAGE, V40, P252, DOI 10.1080/09670879409371893; EXCOFFIER L, 1992, GENETICS, V131, P479; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1995, THEOR POPUL BIOL, V48, P172, DOI 10.1006/tpbi.1995.1025; Fu YX, 1997, GENETICS, V147, P915; Grant WS, 1998, J HERED, V89, P415, DOI 10.1093/jhered/89.5.415; Graves JL., 2010, REV BLACK POLIT ECON, V37, P43; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hassan MN, 2007, THESIS U GREENWICH, P244; Herbison-Evans D, 1787, MARUCA VITRATA; Hoshizaki S, 2008, B ENTOMOL RES, V98, P519, DOI 10.1017/S0007485308005841; Huang C. C., 2004, Plant Protection Bulletin (Taichung), V46, P81; JACKAI LEN, 1981, ANN ENTOMOL SOC AM, V74, P402, DOI 10.1093/aesa/74.4.402; Jaramillo C, 2001, MEM I OSWALDO CRUZ, V96, P1043, DOI 10.1590/S0074-02762001000800003; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; KAREL AK, 1985, J ECON ENTOMOL, V78, P1323, DOI 10.1093/jee/78.6.1323; Kim CG, 1999, APPL ENTOMOL ZOOL, V34, P405, DOI 10.1303/aez.34.405; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kirti Jagbir Singh, 2005, Zoos Print Journal, V20, P1930; Liao PC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-124; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Long Khuat Dang, 2012, Tap Chi Sinh Hoc, V34, P48; Malini P, 2014, FORM ENTOMOL, V33, P356; Margam VM, 2011, MOL BIOL REP, V38, P893, DOI 10.1007/s11033-010-0182-3; NEI M, 1981, GENETICS, V97, P145; NEI M, 1979, P NATL ACAD SCI USA, V76, P5269, DOI 10.1073/pnas.76.10.5269; Ohno S, 2006, B ENTOMOL RES, V96, P243, DOI 10.1079/BER2006418; Polzin T, 2003, OPER RES LETT, V31, P12, DOI 10.1016/S0167-6377(02)00185-2; Puillandre N, 2012, MOL ECOL, V21, P1864, DOI 10.1111/j.1365-294X.2011.05239.x; Rathore Y. S., 1998, Indian Journal of Pulses Research, V11, P152; ROSE HS, 1989, J ADV ZOOL, V10, P99; Schlager S, 2012, GESUNDE PFLANZ, V64, P183, DOI 10.1007/s10343-012-0287-9; SCHNEIDER S, 1997, ARLEQUIN VERSION 1 1; Sharma HC, 1998, CROP PROT, V17, P373, DOI 10.1016/S0261-2194(98)00045-3; Singh SR, 1990, INSECT PESTS TROPICA, P43; Smith Hobart M., 1997, Herpetological Review, V28, P13; Srinivasan R., 2013, Proceedings SEAVEG 2012, Chiang Mai, Thailand, 24-26 January 2012. High value vegetables in Southeast Asia: production, supply and demand, P76; Srinivasan R, 2013, CURR SCI INDIA, V105, P6; TAJIMA F, 1989, GENETICS, V123, P585; Tamo M., 1997, Advances in cowpea research, P259; Tamo M, 2002, CHALLENGES OPPORTUNI, P81; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor T. A., 1967, Journal of the West African Science Association, V12, P111; Templeton AR, 1998, AM ANTHROPOL, V100, P632, DOI 10.1525/aa.1998.100.3.632; Ulrichs C, 2004, J APPL ENTOMOL, V128, P426, DOI 10.1111/j.1439-0418.2004.00867.x; van Achterberg C, 2010, ZOOKEYS, P1, DOI 10.3897/zookeys.54.475	61	24	28	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124057	10.1371/journal.pone.0124057	http://dx.doi.org/10.1371/journal.pone.0124057			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893977	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700070
J	Raggi, L; Bitocchi, E; Russi, L; Marconi, G; Sharbel, TF; Veronesi, F; Albertini, E				Raggi, Lorenzo; Bitocchi, Elena; Russi, Luigi; Marconi, Gianpiero; Sharbel, Timothy F.; Veronesi, Fabio; Albertini, Emidio			Understanding Genetic Diversity and Population Structure of a Poa pratensis Worldwide Collection through Morphological, Nuclear and Chloroplast Diversity Analysis	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; KENTUCKY BLUEGRASS; DNA-CONTENT; CULTIVARS; MARKERS; L.; INFERENCE; APOMIXIS; TRAITS; NUMBER	Poa pratensis L. is a forage and turf grass species well adapted to a wide range of mesic to moist habitats. Due to its genome complexity little is known regarding evolution, genome composition and intraspecific phylogenetic relationships of this species. In the present study we investigated the morphological and genetic diversity of 33 P. pratensis accessions from 23 different countries using both nuclear and chloroplast molecular markers as well as flow cytometry of somatic tissues. This with the aim of shedding light on the genetic diversity and phylogenetic relationships of the collection that includes both cultivated and wild materials. Morphological characterization showed that the most relevant traits able to distinguish cultivated from wild forms were spring growth habit and leaf colour. The genome size analysis revealed high variability both within and between accessions in both wild and cultivated materials. The sequence analysis of the trnL-F chloroplast region revealed a low polymorphism level that could be the result of the complex mode of reproduction of this species. In addition, a strong reduction of chloroplast SSR variability was detected in cultivated materials, where only two alleles were conserved out of the four present in wild accessions. Contrarily, at nuclear level, high variability exist in the collection where the analysis of 11 SSR loci allowed the detection of a total of 91 different alleles. A Bayesian analysis performed on nuclear SSR data revealed that studied materials belong to two main clusters. While wild materials are equally represented in both clusters, the domesticated forms are mostly belonging to cluster P2 which is characterized by lower genetic diversity compared to the cluster P1. In the Neighbour Joining tree no clear distinction was found between accessions with the exception of those from China and Mongolia that were clearly separated from all the others.	[Raggi, Lorenzo; Russi, Luigi; Marconi, Gianpiero; Veronesi, Fabio; Albertini, Emidio] Univ Perugia, Dipartimento Sci Agr Alimentari & Ambiental, I-06100 Perugia, Italy; [Bitocchi, Elena] Univ Politecn Marche, Dipartimento Sci Agrarie Alimentari & Ambientali, Ancona, Italy; [Sharbel, Timothy F.] Leibniz Inst Plant Genet & Crop Plant Res IPK, Dept Cytogenet & Genome Anal, Apomixis Res Grp, Gatersleben, Germany	University of Perugia; Marche Polytechnic University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Albertini, E (corresponding author), Univ Perugia, Dipartimento Sci Agr Alimentari & Ambiental, I-06100 Perugia, Italy.	emidio.albertini@unipg.it	Raggi, Lorenzo/G-5645-2013; Russi, Luigi/AAE-8230-2020; Bitocchi, Elena/J-7996-2019; Albertini, Emidio/F-7393-2014; Sharbel, Timothy/AAV-9578-2020	Raggi, Lorenzo/0000-0003-0484-8669; Russi, Luigi/0000-0002-7521-2126; Bitocchi, Elena/0000-0002-2152-4634; Sharbel, Timothy/0000-0002-3450-2733; Veronesi, Fabio/0000-0001-7884-6987; Albertini, Emidio/0000-0003-2585-5649; MARCONI, GIANPIERO/0000-0003-2669-0399	Italian Ministry of Education and Scientific Research (MIUR); Dipartimento di Scienze Agrarie Alimentari e Ambientali of Universita degli Studi di Perugia	Italian Ministry of Education and Scientific Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); Dipartimento di Scienze Agrarie Alimentari e Ambientali of Universita degli Studi di Perugia	The research was funded by the Italian Ministry of Education and Scientific Research (MIUR) "Genetic aspects of seed production: genomic and functional characterization of candidate genes for apomictic reproduction" and by the Dipartimento di Scienze Agrarie Alimentari e Ambientali of Universita degli Studi di Perugia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerberg E, 1939, HEREDITAS, V25, P359; Arumuganathan K, 1999, CROP SCI, V39, P1518; Bashaw E., 1987, PRINCIPLES CULTIVAR, P40; BENNETT MD, 1995, ANN BOT-LONDON, V76, P113, DOI 10.1006/anbo.1995.1085; Caceres ME, 1998, THEOR APPL GENET, V96, P559, DOI 10.1007/s001220050774; Carrier L., 1916, AGRON J, V8, P256, DOI [10.2134/agronj1916.00021962000800040007x, DOI 10.2134/AGRONJ1916.00021962000800040007X]; Casler MD, 2006, J AGR SCI-CAMBRIDGE, V144, P189, DOI 10.1017/S0021859606006137; Cidade FW, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-50; CLAUSEN J, 1961, EUPHYTICA, V10, P87, DOI 10.1007/BF00037208; CRONQUIST A, 1977, INTERMOUNTAIN FLORA, V6; Curley J, 2004, CROP SCI, V44, P1299, DOI 10.2135/cropsci2004.1299; DON RH, 1991, NUCLEIC ACIDS RES, V19, P4008, DOI 10.1093/nar/19.14.4008; Duell R. W., 1985, Forages: the science of grassland agriculture, P188; Eaton TD, 2004, CROP SCI, V44, P2168, DOI 10.2135/cropsci2004.2168; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fard JR, 2012, HORTIC ENVIRON BIOTE, V53, P298, DOI 10.1007/s13580-012-0120-5; FELSENSTEIN J, 1993, PHYLOGENY INFERENCE; Goldman JJ, 2008, PLANT BREEDING, V127, P644, DOI 10.1111/j.1439-0523.2008.01526.x; Harlan JR, 1992, CROPS MAN, V2nd; HARTLEY W., 1961, AUSTRALIAN JOUR BOT, V9, P152, DOI 10.1071/BT9610152; Heslop-Harrison J. S., 1995, Probe. Newsletter of the USDA Plant Genome Research Program, V5, P14; Holt SDS, 2005, PLANT SOIL ENVIRON, V51, P94, DOI 10.17221/3561-PSE; Honig JA, 2012, HORTSCIENCE, V47, P1356, DOI 10.21273/HORTSCI.47.9.1356; Honig JA, 2010, HORTSCIENCE, V45, P1759, DOI 10.21273/HORTSCI.45.11.1759; Huff D.R., 2003, TURFGRASS BIOL GENET, P27; HUFF DR, 1993, THEOR APPL GENET, V87, P201, DOI 10.1007/BF00223765; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Johnson RC, 2002, GENET RESOUR CROP EV, V49, P349, DOI 10.1023/A:1020662108929; Jungmann L, 2010, GENOME, V53, P698, DOI [10.1139/G10-055, 10.1139/g10-055]; Kellog E., 1990, SYST BOT, V15, P112; Krauss SL, 2000, MOL ECOL, V9, P1241, DOI 10.1046/j.1365-294x.2000.01001.x; Lo EYY, 2009, MOL ECOL, V18, P1145, DOI 10.1111/j.1365-294X.2009.04091.x; LOVE A, 1952, HEREDITAS, V38, P11; LYNCH M, 1994, MOL ECOL, V3, P91, DOI 10.1111/j.1365-294X.1994.tb00109.x; Majesky L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041868; Matzk F, 2000, PLANT J, V21, P97, DOI 10.1046/j.1365-313x.2000.00647.x; MOWFORTH MA, 1989, FUNCT ECOL, V3, P289, DOI 10.2307/2389368; Muntzing A, 1940, HEREDITAS, V26, P115; Murovec J, 2009, ACTA BIOL CRACOV BOT, V51, P45; NEI M, 1974, GENETICS, V76, P379; Patterson JT, 2005, GENOME, V48, P76, DOI 10.1139/G04-102; Porceddu A, 2002, THEOR APPL GENET, V104, P273, DOI 10.1007/s001220100659; Pritchard JK, 2000, GENETICS, V155, P945; RAYBURN AL, 1989, J EXP BOT, V40, P1179, DOI 10.1093/jxb/40.11.1179; Rozen S, 2000, Methods Mol Biol, V132, P365; Sokal RR, 2012, BIOMETRY THE PRINCIP; SORENG RJ, 1985, GREAT BASIN NAT, V45, P395; SORENG RJ, 1990, AM J BOT, V77, P1383, DOI 10.2307/2444749; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; UPOV (Union Internationale Pour La Protection Des Obtentions Vegetales), 1990, GUIDELINES FOR THE C; Vekemans X., 2002, LABORATOIRE DE GENET; Vigna B. B. Z., 2011, Tropical Plant Biology, V4, P157, DOI 10.1007/s12042-011-9078-1; Wedin W, 1996, COOL SEASON FORAGE G; Welsh S, 1987, GREAT BASIN NATURALI; Wieners RR, 2006, GENET RESOUR CROP EV, V53, P1531, DOI 10.1007/s10722-005-7766-0; Zhivotovsky LA, 1999, MOL ECOL, V8, P907, DOI 10.1046/j.1365-294x.1999.00620.x	59	16	17	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124709	10.1371/journal.pone.0124709	http://dx.doi.org/10.1371/journal.pone.0124709			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893249	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700117
J	Brown, RE; Ghannoum, MA; Mukherjee, PK; Gillevet, PM; Sikaroodi, M				Brown, Robert E.; Ghannoum, Mahmoud A.; Mukherjee, Pranab K.; Gillevet, Patrick M.; Sikaroodi, Masoumeh			Quorum-Sensing Dysbiotic Shifts in the HIV-Infected Oral Metabiome	PLOS ONE			English	Article							NETWORKS; BIOFILMS	We implemented a Systems Biology approach using Correlation Difference Probability Network (CDPN) analysis to provide insights into the statistically significant functional differences between HIV-infected patients and uninfected individuals. The analysis correlates bacterial microbiome ("bacteriome"), fungal microbiome ("mycobiome"), and metabolome data to model the underlying biological processes comprising the Human Oral Metabiome. CDPN highlights the taxa-metabolite-taxa differences between the cohorts that frequently capture quorum-sensing modifications that reflect communication disruptions in the dysbiotic HIV cohort. The results also highlight the significant role of cyclic mono and dipeptides as quorum-sensing (QS) mediators between oral bacteria and fungal genus. The developed CDPN approach allowed us to model the interactions of taxa and key metabolites, and hypothesize their possible contribution to the etiology of Oral Candidiasis (OC).	[Brown, Robert E.] George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA; [Ghannoum, Mahmoud A.; Mukherjee, Pranab K.] Case Western Reserve Univ, Ctr Med Mycol, Cleveland, OH 44106 USA; [Ghannoum, Mahmoud A.; Mukherjee, Pranab K.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Gillevet, Patrick M.; Sikaroodi, Masoumeh] George Mason Univ, Dept Environm Sci & Policy, Microbiome Anal Ctr, Fairfax, VA 22030 USA	George Mason University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; George Mason University	Brown, RE (corresponding author), George Mason Univ, Sch Syst Biol, Fairfax, VA 22030 USA.	RBrownF@gmu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036219] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Atkinson S, 2009, J R SOC INTERFACE, V6, P959, DOI 10.1098/rsif.2009.0203; Campbell J, 2009, ACS CHEM BIOL, V4, P1051, DOI 10.1021/cb900165y; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Filoche SK, 2007, ORAL MICROBIOL IMMUN, V22, P73, DOI 10.1111/j.1399-302X.2007.00323.x; Ghannoum M. A., 2011, PLOS PATHOLOGY; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Han TL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071364; Henrik Christensen MFB, 2011, CLASSIFICATION PASTE; Jang WS, 2010, MOL MICROBIOL, V77, P354, DOI 10.1111/j.1365-2958.2010.07210.x; Kapfhammer D, 2005, APPL ENVIRON MICROB, V71, P3840, DOI 10.1128/AEM.71.7.3840-3847.2005; Meyer HW, 2005, INDOOR AIR, V15, P73, DOI 10.1111/j.1600-0668.2005.00351.x; Morgenthal K, 2006, BIOSYSTEMS, V83, P108, DOI 10.1016/j.biosystems.2005.05.017; Mukherjee PK, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003996; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shiboski CH, 2002, ORAL DIS, V8, P44, DOI 10.1034/j.1601-0825.2002.00011.x; Shiboski CH, 2001, J ADOLESCENT HEALTH, V29, P109, DOI 10.1016/S1054-139X(01)00280-4; Somers E, 2005, APPL ENVIRON MICROB, V71, P1803, DOI 10.1128/AEM.71.4.1803-1810.2005; Thompson GR, 2010, ORAL SURG ORAL MED O, V109, P488, DOI 10.1016/j.tripleo.2009.11.026; Toivari M, 2012, METAB ENG, V14, P427, DOI 10.1016/j.ymben.2012.03.002; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004	20	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123880	10.1371/journal.pone.0123880	http://dx.doi.org/10.1371/journal.pone.0123880			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886290	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000091
J	Datta, S; Mukhopadhyay, S				Datta, Sutapa; Mukhopadhyay, Subhasis			A Grammar Inference Approach for Predicting Kinase Specific Phosphorylation Sites	PLOS ONE			English	Article							CONTEXT-FREE GRAMMARS; PROTEIN SEQUENCES; RNA; LANGUAGE; MODEL; TOOL; GPS; DESIGN; SERVER	Kinase mediated phosphorylation site detection is the key mechanism of post translational mechanism that plays an important role in regulating various cellular processes and phenotypes. Many diseases, like cancer are related with the signaling defects which are associated with protein phosphorylation. Characterizing the protein kinases and their substrates enhances our ability to understand the mechanism of protein phosphorylation and extends our knowledge of signaling network; thereby helping us to treat such diseases. Experimental methods for predicting phosphorylation sites are labour intensive and expensive. Also, manifold increase of protein sequences in the databanks over the years necessitates the improvement of high speed and accurate computational methods for predicting phosphorylation sites in protein sequences. Till date, a number of computational methods have been proposed by various researchers in predicting phosphorylation sites, but there remains much scope of improvement. In this communication, we present a simple and novel method based on Grammatical Inference (GI) approach to automate the prediction of kinase specific phosphorylation sites. In this regard, we have used a popular GI algorithm Alergia to infer Deterministic Stochastic Finite State Automata (DSFA) which equally represents the regular grammar corresponding to the phosphorylation sites. Extensive experiments on several datasets generated by us reveal that, our inferred grammar successfully predicts phosphorylation sites in a kinase specific manner. It performs significantly better when compared with the other existing phosphorylation site prediction methods. We have also compared our inferred DSFA with two other GI inference algorithms. The DSFA generated by our method performs superior which indicates that our method is robust and has a potential for predicting the phosphorylation sites in a kinase specific manner.	[Datta, Sutapa] Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India; Univ Calcutta, Distributed Informat Ctr Bioinformat, Kolkata, W Bengal, India	University of Calcutta; University of Calcutta	Datta, S (corresponding author), Univ Calcutta, Dept Biophys Mol Biol & Bioinformat, Kolkata, W Bengal, India.	sutapadatta2005@gmail.com			Department of Biotechnology, India [BT/BI/04/026/93, BT/BI/010/019/99]	Department of Biotechnology, India(Department of Biotechnology (DBT) India)	This work was supported by BT/BI/04/026/93 and BT/BI/010/019/99, Department of Biotechnology, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blom N, 2004, PROTEOMICS, V4, P1633, DOI 10.1002/pmic.200300771; Cai Y, 2007, BIOINFORMATICS, V23, P2760, DOI 10.1093/bioinformatics/btm446; Carrasco R. C., 1994, GRAMMATICAL INFERENC, V862, P139; Chen YC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020025; COLLADOVIDES J, 1992, P NATL ACAD SCI USA, V89, P9405, DOI 10.1073/pnas.89.20.9405; Datta S, 2014, INT J NANOMED, V9, P2225, DOI 10.2147/IJN.S57526; Datta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054843; Dinkel H, 2011, NUCLEIC ACIDS RES, V39, pD261, DOI 10.1093/nar/gkq1104; Dupont P., 1994, Grammatical Inference and Applications. Second International Colloquium, ICGI-94 Proceedings, P25; Dupont P., 1996, Grammatical Inference: Learning Syntax from Sentences. Third International Colloquium, ICGI-96 Proceedings, P222, DOI 10.1007/BFb0033357; Dyrka W, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-323; Gao JJ, 2010, MOL CELL PROTEOMICS, V9, P2586, DOI 10.1074/mcp.M110.001388; Horn H, 2014, NAT METHODS, V11, P603, DOI 10.1038/nmeth.2968; Huang HD, 2005, NUCLEIC ACIDS RES, V33, pW226, DOI 10.1093/nar/gki471; Jung I, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S1-S10; Knudsen B, 2003, NUCLEIC ACIDS RES, V31, P3423, DOI 10.1093/nar/gkg614; Knudsen B, 1999, BIOINFORMATICS, V15, P446, DOI 10.1093/bioinformatics/15.6.446; Kobayashi K, 2003, J NEUROL SCI, V208, P17, DOI 10.1016/S0022-510X(02)00410-0; Lee TY, 2011, NUCLEIC ACIDS RES, V39, pD777, DOI 10.1093/nar/gkq970; Leung SW, 2001, BIOINFORMATICS, V17, P226, DOI 10.1093/bioinformatics/17.3.226; LI L, 2003, P NATL ACAD SCI USA, V100, P4463, DOI DOI 10.1073/PNAS.0737647100; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Loose C, 2006, NATURE, V443, P867, DOI 10.1038/nature05233; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; MATTHEWS HR, 1995, PHARMACOL THERAPEUT, V67, P323, DOI 10.1016/0163-7258(95)00020-8; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; ONCINA J, 1992, S MACH PERC, V1, P49; Peris P, 2006, LECT NOTES ARTIF INT, V4201, P175; Peris P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-367; Pinna LA, 1996, BBA-MOL CELL RES, V1314, P191, DOI 10.1016/S0167-4889(96)00083-3; Plewczynski D, 2008, J MOL MODEL, V14, P69, DOI 10.1007/s00894-007-0250-3; Plewczynski D, 2012, AMINO ACIDS, V43, P573, DOI 10.1007/s00726-012-1290-2; Rivas E, 2000, BIOINFORMATICS, V16, P334, DOI 10.1093/bioinformatics/16.4.334; Sakakibara Y, 2005, IEEE T PATTERN ANAL, V27, P1051, DOI 10.1109/TPAMI.2005.140; SAKAKIBARA Y, 1994, NUCLEIC ACIDS RES, V22, P5112, DOI 10.1093/nar/22.23.5112; Salway J.G., 2017, METABOLISM GLANCE; Searls DB, 1997, COMPUT APPL BIOSCI, V13, P333; Searls DB, 2002, NATURE, V420, P211, DOI 10.1038/nature01255; Su MG, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S16-S2; Suo SB, 2014, SCI REP-UK, V4, DOI 10.1038/srep04524; Trost B, 2011, BIOINFORMATICS, V27, P2927, DOI 10.1093/bioinformatics/btr525; Tsafnat G, 2011, BIOINFORMATICS, V27, P791, DOI 10.1093/bioinformatics/btr036; Wan J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm848; Xue Y, 2005, NUCLEIC ACIDS RES, V33, pW184, DOI 10.1093/nar/gki393; Xue Y, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-163; Xue YK, 2010, CLIM DYNAM, V35, P1, DOI 10.1007/s00382-010-0831-1; Xue Y, 2008, MOL CELL PROTEOMICS, V7, P1598, DOI 10.1074/mcp.M700574-MCP200; Yu ZW, 2010, IEEE T NANOBIOSCI, V9, P132, DOI 10.1109/TNB.2010.2043682; Zhou FF, 2004, BIOCHEM BIOPH RES CO, V325, P1443, DOI 10.1016/j.bbrc.2004.11.001	49	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122294	10.1371/journal.pone.0122294	http://dx.doi.org/10.1371/journal.pone.0122294			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886273	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000031
J	Kim, DH; Rogers, JR; Fulchino, LA; Kim, CA; Solomon, DH; Kim, SC				Kim, Dae Hyun; Rogers, James R.; Fulchino, Lisa A.; Kim, Caroline A.; Solomon, Daniel H.; Kim, Seoyoung C.			Bisphosphonates and Risk of Cardiovascular Events: A Meta-Analysis	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; BONE-MINERAL DENSITY; ATRIAL-FIBRILLATION; CLINICAL-TRIALS; SUBCLINICAL ATHEROSCLEROSIS; POSTMENOPAUSAL OSTEOPOROSIS; CORONARY ATHEROSCLEROSIS; AORTIC CALCIFICATION; ZOLEDRONIC ACID; IN-VITRO	Background and Objectives Some evidence suggests that bisphosphonates may reduce atherosclerosis, while concerns have been raised about atrial fibrillation. We conducted a meta-analysis to determine the effects of bisphosphonates on total adverse cardiovascular (CV) events, atrial fibrillation, myocardial infarction (MI), stroke, and CV death in adults with or at risk for low bone mass. Methods A systematic search of MEDLINE and EMBASE through July 2014 identified 58 randomized controlled trials with longer than 6 months in duration that reported CV events. Absolute risks and the Mantel-Haenszel fixed-effects odds ratios (ORs) and 95% confidence intervals (CIs) of total CV events, atrial fibrillation, MI, stroke, and CV death were estimated. Subgroup analyses by follow-up duration, population characteristics, bisphosphonate types, and route were performed. Results Absolute risks over 25-36 months in bisphosphonate-treated versus control patients were 6.5% versus 6.2% for total CV events; 1.4% versus 1.5% for atrial fibrillation; 1.0% versus 1.2% for MI; 1.6% versus 1.9% for stroke; and 1.5% versus 1.4% for CV death. Bisphosphonate treatment up to 36 months did not have any significant effects on total CV events (14 trials; ORs [95% CI]: 0.98 [0.84-1.14]; I-2 = 0.0%), atrial fibrillation (41 trials; 1.08 [0.92-1.25]; I-2 = 0.0%), MI (10 trials; 0.96 [0.69-1.34]; I-2 = 0.0%), stroke (10 trials; 0.99 [0.82-1.19]; I-2 = 5.8%), and CV death (14 trials; 0.88 [0.72-1.07]; I-2 = 0.0%) with little between-study heterogeneity. The risk of atrial fibrillation appears to be modestly elevated for zoledronic acid (6 trials; 1.24 [0.96-1.61]; I-2 = 0.0%), not for oral bisphosphonates (26 trials; 1.02 [0.83-1.24]; I-2 = 0.0%). The CV effects did not vary by subgroups or study quality. Conclusions Bisphosphonates do not have beneficial or harmful effects on atherosclerotic CV events, but zoledronic acid may modestly increase the risk of atrial fibrillation. Given the large reduction in fractures with bisphosphonates, changes in osteoporosis treatment decision due to CV risk are not justified.	[Kim, Dae Hyun; Rogers, James R.; Fulchino, Lisa A.; Solomon, Daniel H.; Kim, Seoyoung C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02115 USA; [Solomon, Daniel H.; Kim, Seoyoung C.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy,Dept Med, Boston, MA USA; [Kim, Dae Hyun; Kim, Caroline A.] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Div Gerontol,Dept Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kim, DH (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02115 USA.	dkim12@partners.org	Kim, Seoyoung/L-6561-2019	Kim, Seoyoung/0000-0002-2517-3579	KL2 Medical Research Investigator Training award from Harvard Catalyst / The Harvard Clinical and Translational Science Center (National Center for Research Resources, NIH) [1KL2 TR001100-01]; KL2 Medical Research Investigator Training award from Harvard Catalyst / The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH) [1KL2 TR001100-01]; Alosa Foundation; National Heart, Lung, and Blood Institute (NIH) [T32 HL007374-35]; NIH [K24-AR055989, P60-AR047782, R01-AR056215, K23 AR059677]; Amgen; Lilly; Pfizer; Novartis; Bristol Myers Squibb; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001100] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007374] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K23AR059677, P60AR047782, K24AR055989, R01AR056215] Funding Source: NIH RePORTER	KL2 Medical Research Investigator Training award from Harvard Catalyst / The Harvard Clinical and Translational Science Center (National Center for Research Resources, NIH); KL2 Medical Research Investigator Training award from Harvard Catalyst / The Harvard Clinical and Translational Science Center (National Center for Advancing Translational Sciences, NIH); Alosa Foundation; National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Amgen(Amgen); Lilly(Eli Lilly); Pfizer(Pfizer); Novartis(Novartis); Bristol Myers Squibb(Bristol-Myers Squibb); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors have read the journal's policy and have the following competing interests: * DHK is supported by a KL2 Medical Research Investigator Training award from Harvard Catalyst / The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, NIH Award 1KL2 TR001100-01). DHK provides paid consultative services on geriatrics care to the Alosa Foundation, a nonprofit educational organization with no relationship to any drug or device manufacturers. * CAK is supported by a T32 Cardiovascular Research Training award from National Heart, Lung, and Blood Institute (NIH Award, T32 HL007374-35). * DHS is supported by the NIH grants K24-AR055989, P60-AR047782, and R01-AR056215. Solomon receives research grants from Amgen, Lilly and Pfizer. He serves in unpaid roles on studies sponsored by Pfizer, Novartis, Lilly, and Bristol Myers Squibb. He also receives royalties from UpToDate.com. * SCK is supported by the NIH grant K23 AR059677. She received research support from Pfizer and Lilly". This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Anagnostis P, 2009, OSTEOPOROSIS INT, V20, P197, DOI 10.1007/s00198-008-0648-5; Barengolts EI, 1998, CALCIFIED TISSUE INT, V62, P209, DOI 10.1007/s002239900419; Barrett-Connor E, 2012, OSTEOPOROSIS INT, V23, P233, DOI 10.1007/s00198-011-1546-9; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bhuriya R, 2010, INT J CARDIOL, V142, P213, DOI 10.1016/j.ijcard.2009.11.041; Black DM, 2007, NEW ENGL J MED, V356, P1809, DOI 10.1056/NEJMoa067312; Blumenthal RS, 2006, JAMA-J AM MED ASSOC, V295, P1583, DOI 10.1001/jama.295.13.jed60019; Bradburn MJ, 2007, STAT MED, V26, P53, DOI 10.1002/sim.2528; BROWNER WS, 1991, LANCET, V338, P355, DOI 10.1016/0140-6736(91)90489-C; Celiloglu M, 2009, MENOPAUSE, V16, P689, DOI 10.1097/gme.0b013e318194cafd; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; Cummings SR, 2007, NEW ENGL J MED, V356, P1895, DOI 10.1056/NEJMc076132; D'Ascenzo F, 2013, ATHEROSCLEROSIS, V226, P178, DOI 10.1016/j.atherosclerosis.2012.10.065; Demer LL, 2003, ARTERIOSCL THROM VAS, V23, P1739, DOI 10.1161/01.ATV.0000093547.63630.0F; Derry S, 2001, BMC Med Res Methodol, V1, P7, DOI 10.1186/1471-2288-1-7; Doherty MJ, 1998, J BONE MINER RES, V13, P828, DOI 10.1359/jbmr.1998.13.5.828; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fiore C E, 2009, J Endocrinol Invest, V32, P38; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; HOLLANDER W, 1979, ATHEROSCLEROSIS, V33, P111, DOI 10.1016/0021-9150(79)90202-8; Howard PA, 2010, AM J CARDIOVASC DRUG, V10, P359, DOI 10.2165/11584720-000000000-00000; Ikeda K, 2013, EUR J PREV CARDIOL, V20, P1069, DOI 10.1177/2047487312451539; Jackson B, 2000, ARZNEIMITTEL-FORSCH, V50, pE380; Jeziorska M, 1998, VIRCHOWS ARCH, V433, P559, DOI 10.1007/s004280050289; Kado DM, 2000, J BONE MINER RES, V15, P1974, DOI 10.1359/jbmr.2000.15.10.1974; Kanazawa I, 2010, AM J MED SCI, V339, P519, DOI 10.1097/MAJ.0b013e3181db6dfe; Kang JH, 2013, OSTEOPOROSIS INT, V24, P271, DOI 10.1007/s00198-012-2213-5; Kang JH, 2012, OSTEOPOROSIS INT, V23, P2551, DOI 10.1007/s00198-012-1894-0; Karam R, 2007, NEW ENGL J MED, V357, P712; Kawahara T, 2013, CIRCULATION, V127, P2327, DOI 10.1161/CIRCULATIONAHA.113.001534; Kiel DP, 2001, CALCIFIED TISSUE INT, V68, P271, DOI 10.1007/BF02390833; Kim SY, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2938; Koshiyama H, 2000, J CLIN ENDOCR METAB, V85, P2793, DOI 10.1210/jc.85.8.2793; Lewiecki EM, 2010, INT J CLIN PRACT, V64, P821, DOI 10.1111/j.1742-1241.2010.02335.x; Loke YK, 2009, DRUG SAFETY, V32, P219, DOI 10.2165/00002018-200932030-00004; Looker AC, 1997, J BONE MINER RES, V12, P1761, DOI 10.1359/jbmr.1997.12.11.1761; Lyles KW, 2007, NEW ENGL J MED, V357, P1799, DOI 10.1056/NEJMoa074941; Mak A, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-113; McFarlane SI, 2004, ENDOCRINE, V23, P1, DOI 10.1385/ENDO:23:1:01; Nitta K, 2004, AM J KIDNEY DIS, V44, P680, DOI 10.1053/j.ajkd.2004.06.009; Pazianas M, 2010, J BONE MINER RES, V25, P2, DOI 10.1359/jbmr.091201; Santos LL, 2012, CLIN MED INSIGHTS-EN, V5, P47, DOI 10.4137/CMED.S10007; SCHOR AM, 1990, J CELL SCI, V97, P449; Shaffer JR, 2007, CALCIFIED TISSUE INT, V81, P430, DOI 10.1007/s00223-007-9079-0; Sharma A, 2014, AM J CARDIOL, V113, P1815, DOI 10.1016/j.amjcard.2014.03.008; Sharma A, 2013, CHEST, V144, P1311, DOI 10.1378/chest.13-0675; Tanko LB, 2005, OSTEOPOROSIS INT, V16, P184, DOI 10.1007/s00198-004-1662-x; The US Food and Drug Administration, UPD SAF REV FOLL UP; Toussaint ND, 2010, AM J KIDNEY DIS, V56, P57, DOI 10.1053/j.ajkd.2009.12.039; van der Klift M, 2002, CALCIFIED TISSUE INT, V70, P443, DOI 10.1007/s00223-001-2076-9; von der Recke P, 1999, AM J MED, V106, P273, DOI 10.1016/S0002-9343(99)00028-5; Wolfe F, 2013, J BONE MINER RES, V28, P984, DOI 10.1002/jbmr.1792; YLITALO R, 1994, J LAB CLIN MED, V123, P769	53	68	74	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122646	10.1371/journal.pone.0122646	http://dx.doi.org/10.1371/journal.pone.0122646			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884398	gold, Green Published			2022-12-27	WOS:000353017000037
J	Wang, TD; Yang, S; Wang, L; Feng, HL				Wang, Tianda; Yang, Sheng; Wang, Lei; Feng, Hailan			Use of Poly (Amidoamine) Dendrimer for Dentinal Tubule Occlusion: A Preliminary Study	PLOS ONE			English	Article							CALCIUM-PHOSPHATE PRECIPITATION; PAMAM DENDRIMERS; AMMONIUM HEXAFLUOROSILICATE; CARBONATED APATITE; IN-VITRO; HYDROXYAPATITE; SURFACE; FLUORIDE; OXALATE; SEM	The occlusion of dentinal tubules is an effective method to alleviate the symptoms caused by dentin hypersensitivity, a significant health problem in dentistry and daily life. The in situ mineralization within dentinal tubules is a promising treatment for dentin hypersensitivity as it induces the formation of mineral on the sensitive regions and occludes the dentinal tubules. This study was carried out to evaluate the in vitro effect of a whole generation poly (amidoamine) (PAMAM) dendrimer (G3.0) on dentinal tubule occlusion by inducing mineralization within dentinal tubules. Dentin discs were treated with PAMAM dendrimers using two methods, followed by the in vitro characterization using Attenuated total reflection Fourier-transform infrared spectroscopy (ATR-FTIR), X-ray diffraction (XRD), Field emission scanning electron microscopy (FE-SEM) and Energy-Dispersive X-ray Spectroscopy (EDS). These results showed that G3.0 PAMAM dendrimers coated on dentin surface and infiltrated in dentinal tubules could induce hydroxyapatite formation and resulted in effective dentinal tubule occlusion. Moreover, crosslinked PAMAM dendrimers could induce the remineralization of demineralized dentin and thus had the potential in dentinal tubule occlusion. In this in vitro study, dentinal tubules occlusion could be achieved by using PAMAM dendrimers. This could lead to the development of a new therapeutic technique for the treatment of dentin hypersensitivity.	[Wang, Tianda; Yang, Sheng; Wang, Lei; Feng, Hailan] Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Yang, Sheng] Chongqing Med Univ, Coll Stomatol, Chongqing Key Lab Oral Dis & Biomed Sci, Chongqing, Peoples R China	Peking University; Chongqing Medical University	Feng, HL (corresponding author), Peking Univ, Dept Prosthodont, Sch & Hosp Stomatol, Beijing 100871, Peoples R China.	Kqfenghl@bjmu.edu.cn	Wang, Tianda/AAV-9811-2020		Specialized Research Fund for the Doctoral Program of Higher Education of China [20100001110092]	Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was supported by the Specialized Research Fund for the Doctoral Program of Higher Education of China (No. 20100001110092). [http://www.cutech.edu.cn/cn/kyjj/gdxxbsdkyjj/A010301index_1.htm]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bedran-Russo AKB, 2007, J BIOMED MATER RES B, V80B, P268, DOI 10.1002/jbm.b.30593; BRANNSTR.M, 1968, J DENT RES, V47, P679, DOI 10.1177/00220345680470050201; BRANNSTROM M, 1966, ORAL SURG ORAL MED O, V21, P517, DOI 10.1016/0030-4220(66)90411-7; Canadian Advisory Board on Dentin Hypersensitivity, 2002, J CAN DENT ASSOC, V69, P221; Chang MC, 2002, BIOMATERIALS, V23, P4811, DOI 10.1016/S0142-9612(02)00232-6; Chiang YC, 2010, J DENT RES, V89, P236, DOI 10.1177/0022034509357148; Damen JJM, 1998, CARIES RES, V32, P435, DOI 10.1159/000016484; Davies M, 2011, EUR J ORAL SCI, V119, P497, DOI 10.1111/j.1600-0722.2011.00872.x; Duncan R, 2005, ADV DRUG DELIVER REV, V57, P2215, DOI 10.1016/j.addr.2005.09.019; Esfand R, 2001, DRUG DISCOV TODAY, V6, P427, DOI 10.1016/S1359-6446(01)01757-3; Gillam DG, 2004, J ORAL REHABIL, V31, P245, DOI 10.1046/j.0305-182X.2003.01230.x; Gillam DG, 2001, J ORAL REHABIL, V28, P1037, DOI 10.1046/j.1365-2842.2001.00775.x; GOLDBERG M, 1993, HISTOCHEM J, V25, P781; Grossman LI, 1935, J AM DENT ASSOC, V22, P592, DOI [DOI 10.14219/JADA.ARCHIVE.1935.0110, 10.14219/jada.archive.1935.0110]; Habelitz S, 2002, J STRUCT BIOL, V138, P227, DOI 10.1016/S1047-8477(02)00029-1; He G, 2005, J BIOL CHEM, V280, P33109, DOI 10.1074/jbc.M500159200; ISHIKAWA K, 1994, J DENT RES, V73, P1197, DOI 10.1177/00220345940730061101; Kim YK, 2010, J DENT RES, V89, P230, DOI 10.1177/0022034509357172; Kolker Justine L, 2002, J Adhes Dent, V4, P211; Liu Y, 2011, J DENT RES, V90, P953, DOI 10.1177/0022034510391799; Liu Y, 2011, ACTA BIOMATER, V7, P1742, DOI 10.1016/j.actbio.2010.11.028; Lynch E, 2012, DENT MATER, V28, P168, DOI 10.1016/j.dental.2011.11.021; Markowitz K, 2007, J DENT RES, V86, P292, DOI 10.1177/154405910708600401; Mitra T, 2014, J CHEM SCI, V126, P127, DOI 10.1007/s12039-013-0543-2; Morris MF, 1999, AM J DENT, V12, P72; Nancollas GH, 2000, J CRYST GROWTH, V211, P137, DOI 10.1016/S0022-0248(99)00816-7; Niederberger M, 2006, PHYS CHEM CHEM PHYS, V8, P3271, DOI 10.1039/b604589h; Orchardson R, 2006, J AM DENT ASSOC, V137, P990, DOI 10.14219/jada.archive.2006.0321; Pereira JC, 2005, DENT MATER, V21, P129, DOI 10.1016/j.dental.2004.02.007; Pillon FL, 2004, J PERIODONTOL, V75, P1461, DOI 10.1902/jop.2004.75.11.1461; Qia YP, 2012, ACTA BIOMATER, V8, P836, DOI 10.1016/j.actbio.2011.10.033; Rehman I, 1997, J MATER SCI-MATER M, V8, P1, DOI 10.1023/A:1018570213546; Sevenson S, 2012, ADV DRUG DELIVER REV, V64, P102, DOI 10.1016/j.addr.2012.09.030; Shetty S, 2010, J PERIODONTOL, V81, P1781, DOI 10.1902/jop.2010.100172; Suge T, 1995, J DENT RES, V74, P1709, DOI 10.1177/00220345950740101301; SUGE T, 1995, J DENT RES, V74, P1079, DOI 10.1177/00220345950740040801; Suge T, 2008, DENT MATER, V24, P192, DOI 10.1016/j.dental.2007.03.009; Suge T, 2006, AM J DENT, V19, P248; Tanahashi M, 1997, J BIOMED MATER RES, V34, P305; Tay FR, 2008, BIOMATERIALS, V29, P1127, DOI 10.1016/j.biomaterials.2007.11.001; Tian LL, 2014, DENT MATER J, V33, P125, DOI 10.4012/dmj.2013-215; Tirapelli Camila, 2010, Braz. oral res., V24, P381, DOI 10.1590/S1806-83242010000400002; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; Toworfe GK, 2006, BIOMATERIALS, V27, P631, DOI 10.1016/j.biomaterials.2005.06.017; Wang RZ, 1998, CONNECT TISSUE RES, V39, P269, DOI 10.3109/03008209809021502; Wang TD, 2015, RSC ADV, V5, P11136, DOI 10.1039/c4ra14744h; Wang ZJ, 2010, J DENT, V38, P400, DOI 10.1016/j.jdent.2010.01.007; Wenk HR, 1999, BONE, V24, P361, DOI 10.1016/S8756-3282(98)00192-6; Wong Tak-Sing, 2009, Molecular & Cellular Biomechanics, V6, P1; Xie LB, 2011, POLYM BULL, V66, P119, DOI 10.1007/s00289-010-0350-6; Xu Z, 2011, J BIOMED MATER RES B, V98B, P150, DOI 10.1002/jbm.b.31844; Yan SJ, MAT CHEM, V2; Yang S, 2011, CHEM COMMUN, V47, P10100, DOI 10.1039/c1cc13661e; Zhang Q, 2013, ACS APPL MATER INTER, V5, P1907, DOI 10.1021/am400155b; Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874; Zhang X, 2012, J MATER SCI-MATER M, V23, P733, DOI 10.1007/s10856-012-4550-5; Zhou ZH, 2007, MATER RES BULL, V42, P1611, DOI 10.1016/j.materresbull.2006.11.041	57	6	8	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124735	10.1371/journal.pone.0124735	http://dx.doi.org/10.1371/journal.pone.0124735			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885090	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000143
J	Wegier, P; Spaniol, J				Wegier, Pete; Spaniol, Julia			The Effect of Time Pressure on Risky Financial Decisions from Description and Decisions from Experience	PLOS ONE			English	Article							UNCERTAINTY; SAMPLE; REWARD; CHOICE; SCALE	Time pressure has been found to impact decision making in various ways, but studies on the effects time pressure in risky financial gambles have been largely limited to description-based decision tasks and to the gain domain. We present two experiments that investigated the effect of time pressure on decisions from description and decisions from experience, across both gain and loss domains. In description-based choice, time pressure decreased risk seeking for losses, whereas for gains there was a trend in the opposite direction. In experience-based choice, no impact of time pressure was observed on risk-taking, suggesting that time constraints may not alter attitudes towards risk when outcomes are learned through experience.	[Wegier, Pete; Spaniol, Julia] Ryerson Univ, Dept Psychol, Toronto, ON, Canada	Toronto Metropolitan University	Wegier, P (corresponding author), Ryerson Univ, Dept Psychol, Toronto, ON, Canada.	pwegier@psych.ryerson.ca	Wegier, Pete/C-7834-2016; Wegier, Pete/P-4605-2017	Wegier, Pete/0000-0003-0191-136X; Wegier, Pete/0000-0003-0191-136X	Natural Sciences and Engineering Research Council of Canada [358797-2013]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by Discovery Grant from the Natural Sciences and Engineering Research Council of Canada (# 358797-2013) to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao T, 2012, J ECON DYN CONTROL, V36, P1101, DOI 10.1016/j.jedc.2012.03.006; Beilock SL, 2005, PSYCHOL SCI, V16, P101, DOI 10.1111/j.0956-7976.2005.00789.x; BENZUR H, 1981, ACTA PSYCHOL, V47, P89, DOI 10.1016/0001-6918(81)90001-9; Brainard DH, 1997, SPATIAL VISION, V10, P433, DOI 10.1163/156856897X00357; BUSEMEYER JR, 1985, J EXP PSYCHOL LEARN, V11, P538, DOI 10.1037/0278-7393.11.3.538; Busemeyer JR, 1993, TIME PRESSURE STRESS, P181; Byrnes JP, 1999, PSYCHOL BULL, V125, P367, DOI 10.1037/0033-2909.125.3.367; CACIOPPO JT, 1984, J PERS ASSESS, V48, P306, DOI 10.1207/s15327752jpa4803_13; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada and Social Sciences and Humanities Research Council of Can-ada, 2010, TRI COUNC POL STAT E; CARVER CS, 1994, J PERS SOC PSYCHOL, V67, P319, DOI 10.1037/0022-3514.67.2.319; Deakin J, 2004, J INT NEUROPSYCH SOC, V10, P590, DOI 10.1017/S1355617704104104; DeDonno MA, 2008, JUDGM DECIS MAK, V3, P636; Hau R, 2010, J BEHAV DECIS MAKING, V23, P48, DOI 10.1002/bdm.665; Hau R, 2008, J BEHAV DECIS MAKING, V21, P493, DOI 10.1002/bdm.598; Hertwig R, 2004, PSYCHOL SCI, V15, P534, DOI 10.1111/j.0956-7976.2004.00715.x; Hertwig R, 2009, TRENDS COGN SCI, V13, P517, DOI 10.1016/j.tics.2009.09.004; Hommes C, 2008, J ECON BEHAV ORGAN, V67, P116, DOI 10.1016/j.jebo.2007.06.006; JOHNSON EJ, 1985, MANAGE SCI, V31, P395, DOI 10.1287/mnsc.31.4.395; Klapproth F, 2008, COGN AFFECT BEHAV NE, V8, P509, DOI 10.3758/CABN.8.4.509; Lipkus IM, 2001, MED DECIS MAKING, V21, P37, DOI 10.1177/0272989X0102100105; Mather M, 2012, CURR DIR PSYCHOL SCI, V21, P36, DOI 10.1177/0963721411429452; Maule A.J., 1997, DECISION MAKING COGN, P189; Maule AJ, 2000, ACTA PSYCHOL, V104, P283, DOI 10.1016/S0001-6918(00)00033-0; Meertens RM, 2008, J APPL SOC PSYCHOL, V38, P1506, DOI 10.1111/j.1559-1816.2008.00357.x; Mohr PNC, 2010, NEUROSCI BIOBEHAV R, V34, P678, DOI 10.1016/j.neubiorev.2009.05.010; Ordonez L, 1997, ORGAN BEHAV HUM DEC, V71, P121, DOI 10.1006/obhd.1997.2717; Ozel F, 2001, SAFETY SCI, V38, P95, DOI 10.1016/S0925-7535(00)00061-8; PAYNE JW, 1988, J EXP PSYCHOL LEARN, V14, P534, DOI 10.1037/0278-7393.14.3.534; Spaniol J, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00036; Svenson O., 1993, TIME PRESSURE STRESS; Tangney JP, 2004, J PERS, V72, P271, DOI 10.1111/j.0022-3506.2004.00263.x; Weber EU, 2002, J BEHAV DECIS MAKING, V15, P263, DOI 10.1002/bdm.414; WRIGHT P, 1974, J APPL PSYCHOL, V59, P555, DOI 10.1037/h0037186	33	8	8	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123740	10.1371/journal.pone.0123740	http://dx.doi.org/10.1371/journal.pone.0123740			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25885034	Green Published, gold			2022-12-27	WOS:000353017000082
J	Xu, Q; Chen, JY; Li, J; Zhao, CF; Yuan, CY				Xu, Qiang; Chen, Jianyun; Li, Jng; Zhao, Chunfeng; Yuan, Chenyang			Study on the Constitutive Model for Jointed Rock Mass	PLOS ONE			English	Article							SURFACE; ROUGHNESS; BEHAVIOR; SLOPE	A new elasto-plastic constitutive model for jointed rock mass, which can consider the persistence ratio in different visual angle and anisotropic increase of plastic strain, is proposed. The proposed the yield strength criterion, which is anisotropic, is not only related to friction angle and cohesion of jointed rock masses at the visual angle but also related to the intersection angle between the visual angle and the directions of the principal stresses. Some numerical examples are given to analyze and verify the proposed constitutive model. The results show the proposed constitutive model has high precision to calculate displacement, stress and plastic strain and can be applied in engineering analysis.	[Chen, Jianyun] Dalian Univ Technol, State Key Lab Coastal & Offshore Engn, Dalian, Peoples R China; [Xu, Qiang; Chen, Jianyun; Li, Jng; Zhao, Chunfeng; Yuan, Chenyang] Dalian Univ Technol, Sch Civil & Hydraul Engn, Dalian, Peoples R China	Dalian University of Technology; Dalian University of Technology	Xu, Q (corresponding author), Dalian Univ Technol, Sch Civil & Hydraul Engn, Dalian, Peoples R China.	xuqiang528826@163.com	yuan, chen/N-7118-2019	Li, Jing/0000-0002-2256-9818; chunfeng, zhao/0000-0002-2512-8399	State Key Development Program for Basic Research of China [2013CB035905]; National Natural Science Foundation of China [51138001, 51178081]; Fundamental Research Funds for the Central Universities [DUT14QY10]	State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This study was supported by the State Key Development Program for Basic Research of China (No. 2013CB035905), the National Natural Science Foundation of China (Grant No. 51138001, 51178081) and Fundamental Research Funds for the Central Universities(DUT14QY10).	Cai M, 2004, INT J ROCK MECH MIN, V41, P3, DOI 10.1016/S1365-1609(03)00025-X; EINSTEIN HH, 1983, ROCK MECH ROCK ENG, V16, P39, DOI 10.1007/BF01030217; EINSTEIN HH, 1983, INT J ROCK MECH MIN, V20, P227, DOI 10.1016/0148-9062(83)90003-7; Fardin N, 2001, INT J ROCK MECH MIN, V38, P659, DOI 10.1016/S1365-1609(01)00028-4; Grasselli G, 2003, INT J ROCK MECH MIN, V40, P25, DOI 10.1016/S1365-1609(02)00101-6; Grasselli G, 2002, INT J ROCK MECH MIN, V39, P789, DOI 10.1016/S1365-1609(02)00070-9; Jing L, 2004, INT J ROCK MECH MIN, V41, P383, DOI 10.1016/j.ijrmms.2003.12.044; Jing L, 2003, INT J ROCK MECH MIN, V40, P283, DOI 10.1016/S1365-1609(03)00013-3; Lanaro F, 2000, INT J ROCK MECH MIN, V37, P1195, DOI 10.1016/S1365-1609(00)00052-6; [刘远明 Liu Yuanming], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P1467; Maghous S, 2002, MECH RES COMMUN, V29, P45, DOI 10.1016/S0093-6413(02)00225-2; Qin SQ, 2001, INT J SOLIDS STRUCT, V38, P8093, DOI 10.1016/S0020-7683(01)00060-9; Rice JR, 2001, J MECH PHYS SOLIDS, V49, P1865, DOI 10.1016/S0022-5096(01)00042-4; Shilin Y., 2001, J HUAZHONG U SCI TEC, V29, P64; Sitharam TG, 2001, INT J ROCK MECH MIN, V38, P437, DOI 10.1016/S1365-1609(01)00010-7; Yan SL, 2001, J HUAZHONG U SCI TEC, V29, P60; [朱道建 ZHU Dao-jian], 2010, [岩土工程学报, Chinese Journal of Geotechnical Engineering], V32, P185; Zienkiewicz O. C., 1977, International Journal for Numerical and Analytical Methods in Geomechanics, V1, P219, DOI 10.1002/nag.1610010302; 汪小刚, 1992, 岩石力学与工程学报, V11, P345	19	5	5	3	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121850	10.1371/journal.pone.0121850	http://dx.doi.org/10.1371/journal.pone.0121850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885695	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000027
J	Harris, RMB; Carter, O; Gilfedder, L; Porfirio, LL; Lee, G; Bindoff, NL				Harris, Rebecca Mary Bernadette; Carter, Oberon; Gilfedder, Louise; Porfirio, Luciana Laura; Lee, Greg; Bindoff, Nathaniel Lee			Noah's Ark Conservation Will Not Preserve Threatened Ecological Communities under Climate Change	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; DISTRIBUTIONS; BIODIVERSITY; WOODLANDS; FUTURE; SHIFTS; PREDICTIONS; PROJECTIONS; MANAGEMENT; RESPONSES	Background Effective conservation of threatened ecological communities requires knowledge of where climatically suitable habitat is likely to persist into the future. We use the critically endangered Lowland Grassland community of Tasmania, Australia as a case study to identify options for management in cases where future climatic conditions become unsuitable for the current threatened community. Methods We model current and future climatic suitability for the Lowland Themeda and the Lowland Poa Grassland communities, which make up the listed ecological community. We also model climatic suitability for the structurally dominant grass species of these communities, and for closely related grassland and woodland communities. We use a dynamically down-scaled regional climate model derived from six CMIP3 global climate models, under the A2 SRES emissions scenario. Results All model projections showed a large reduction in climatically suitable area by mid-century. Outcomes are slightly better if closely related grassy communities are considered, but the extent of suitable area is still substantially reduced. Only small areas within the current distribution are projected to remain climatically suitable by the end of the century, and very little of that area is currently in good condition. Conclusions As the climate becomes less suitable, a gradual change in the species composition, structure and habitat quality of the grassland communities is likely. Conservation management will need to focus on maintaining diversity, structure and function, rather than attempting to preserve current species composition. Options for achieving this include managing related grassland types to maintain grassland species at the landscape-scale, and maximising the resilience of grasslands by reducing further fragmentation, weed invasion and stress from other land uses, while accepting that change is inevitable. Attempting to maintain the status quo by conserving the current structure and composition of Lowland Grassland communities is unlikely to be a viable management option in the long term.	[Harris, Rebecca Mary Bernadette; Lee, Greg; Bindoff, Nathaniel Lee] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr ACE, Hobart, Tas, Australia; [Carter, Oberon; Gilfedder, Louise] Dept Primary Ind Pk Water & Environm, Resource Management & Conservat Div, Hobart, Tas, Australia; [Porfirio, Luciana Laura] Australian Natl Univ, Fenner Sch Environm & Soc, Canberra, ACT, Australia; [Bindoff, Nathaniel Lee] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Bindoff, Nathaniel Lee] Univ New S Wales, ARC Ctr Excellence Climate Syst Sci, Sydney, NSW, Australia	Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; Australian National University; University of Tasmania; ARC Centre of Excellence for Climate System Science; University of New South Wales Sydney	Harris, RMB (corresponding author), Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr ACE, Hobart, Tas, Australia.	rmharris@utas.edu.au	Bindoff, Nathaniel L/C-8050-2011; Harris, Rebecca/N-2790-2013	Bindoff, Nathaniel L/0000-0001-5662-9519; Harris, Rebecca/0000-0002-6426-2179	Australian Government's National Environmental Research Program [L0018856]	Australian Government's National Environmental Research Program(Australian Government)	This research is an output from the Landscapes and Policy Research Hub, which is supported through funding from the Australian Government's National Environmental Research Program (Grant number L0018856) (http://www.environment.gov.au/science/nerp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson RP, 2011, ECOL MODEL, V222, P2796, DOI 10.1016/j.ecolmodel.2011.04.011; [Anonymous], 2010, CLIMATE FUTURES TASM; Araujo MB, 2007, TRENDS ECOL EVOL, V22, P42, DOI 10.1016/j.tree.2006.09.010; Austin MP, 2011, J BIOGEOGR, V38, P1, DOI 10.1111/j.1365-2699.2010.02416.x; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Bond WJ, 2012, PHILOS T R SOC B, V367, P601, DOI 10.1098/rstb.2011.0182; Bucklin DN, 2015, DIVERS DISTRIB, V21, P23, DOI 10.1111/ddi.12247; Chen IC, 2011, SCIENCE, V333, P1024, DOI 10.1126/science.1206432; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Corney S., 2010, CLIMATE FUTURES TASM; Corney S, 2013, J GEOPHYS RES-ATMOS, V118, P11936, DOI 10.1002/2013JD020087; Diniz JAF, 2010, INSECT CONSERV DIVER, V3, P213, DOI 10.1111/j.1752-4598.2010.00090.x; DPIPWE, 2008, REV CONS STAT LOWL T; Dunlop M., 2012, IMPLICATIONS CLIMATE; Dunlop M, 2013, CLIMATE READY CONSER; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Field C.B., 2014, CLIMATE CHANGE 2014, DOI [10.1016/j.renene.2009.11.012, DOI 10.1016/J.RENENE.2009.11.012]; Garcia RA, 2014, SCIENCE, V344, P486, DOI 10.1126/science.1247579; Grose MR, 2013, CLIM DYNAM, V40, P2035, DOI 10.1007/s00382-012-1405-1; Guisan A, 2013, ECOL LETT, V16, P1424, DOI 10.1111/ele.12189; Gvozdik L, 2012, BIOL LETTERS, V8, P262, DOI 10.1098/rsbl.2011.0960; Harris Rebecca M. B., 2013, Ecological Management & Restoration, V14, P230, DOI 10.1111/emr.12055; Harris RMB, 2014, WIRES CLIM CHANGE, V5, P621, DOI 10.1002/wcc.291; Heller NE, 2014, CONSERV BIOL, V28, P696, DOI 10.1111/cobi.12269; Heller NE, 2009, BIOL CONSERV, V142, P14, DOI 10.1016/j.biocon.2008.10.006; Heltberg R, 2009, GLOBAL ENVIRON CHANG, V19, P89, DOI 10.1016/j.gloenvcha.2008.11.003; Henwood William D., 2010, Great Plains Research, V20, P121; HilleRisLambers J, 2013, ANN NY ACAD SCI, V1297, P112, DOI 10.1111/nyas.12182; Hovenden MJ, 2010, AUSTRAL ECOL, V35, P665, DOI 10.1111/j.1442-9993.2009.02074.x; Iftekhar MS, 2014, BIOL CONSERV, V169, P176, DOI 10.1016/j.biocon.2013.10.013; IPCC, 2007, CLIM CHANG 2007 PHYS; Irving DB, 2012, AUST METEOROL OCEAN, V62, P211; Kearney M, 2009, P NATL ACAD SCI USA, V106, P3835, DOI 10.1073/pnas.0808913106; Kirkpatrick J. B., 2005, Ecological Management & Restoration, V6, P51, DOI 10.1111/j.1442-8903.2005.00219.x; Kirkpatrick J. B., 1995, AUSTR MOST THREATENE; Lee T, 2013, J CLIMATE, V26, P5810, DOI 10.1175/JCLI-D-12-00591.1; Lunt ID, 2013, BIOL CONSERV, V157, P172, DOI 10.1016/j.biocon.2012.08.034; LUNT ID, 1990, AUST J ECOL, V15, P155, DOI 10.1111/j.1442-9993.1990.tb01524.x; Macinnis-Ng C, 2011, ECOHYDROLOGY, V4, P379, DOI 10.1002/eco.138; Markovic M, 2013, CLIMATIC CHANGE, V120, P197, DOI 10.1007/s10584-013-0782-8; Martin TG, 2012, INVASIVE SPECIES AND; Matthews HD, 2013, SCIENCE, V340, P438, DOI 10.1126/science.1236372; McIntyre S., 2002, MANAGING CONSERVING; McShea WJ, 2014, ENVIRON CONSERV, V41, P93, DOI 10.1017/S0376892913000581; Murphy BP, 2014, J BIOGEOGR, V41, P133, DOI 10.1111/jbi.12204; Old K, 1990, EUCALYPT DIEBACK FOR; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pau S, 2013, GLOBAL CHANGE BIOL, V19, P184, DOI 10.1111/gcb.12037; Pearson RG, 2003, GLOBAL ECOL BIOGEOGR, V12, P361, DOI 10.1046/j.1466-822X.2003.00042.x; Peters GP, 2013, NAT CLIM CHANGE, V3, P4, DOI 10.1038/nclimate1783; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2008, ECOGRAPHY, V31, P161, DOI 10.1111/j.0906-7590.2008.5203.x; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Prober SM, 2012, BIODIVERS CONSERV, V21, P1627, DOI 10.1007/s10531-012-0268-4; Radosavljevic A, 2014, J BIOGEOGR, V41, P629, DOI 10.1111/jbi.12227; Rahmstorf S, 2007, SCIENCE, V316, P709, DOI 10.1126/science.1136843; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Ross RE, 2013, DIVERS DISTRIB, V19, P433, DOI 10.1111/ddi.12010; Sage RF, 2003, PHOTOSYNTH RES, V77, P209, DOI 10.1023/A:1025882003661; Schwartz MW, 2012, BIOL CONSERV, V155, P149, DOI 10.1016/j.biocon.2012.06.011; Sinclair SJ, 2010, ECOL SOC, V15, DOI 10.5751/ES-03089-150108; Smith I, 2010, CLIMATIC CHANGE, V102, P377, DOI 10.1007/s10584-009-9757-1; Synes NW, 2011, GLOBAL ECOL BIOGEOGR, V20, P904, DOI 10.1111/j.1466-8238.2010.00635.x; TasVeg3, 2016, TASVEG VERS 3; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; Vogel A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036992; Volder A, 2013, GLOBAL CHANGE BIOL, V19, P843, DOI 10.1111/gcb.12068; Wand SJE, 1999, GLOB CHANGE BIOL, V5, P723, DOI 10.1046/j.1365-2486.1999.00265.x; Williams SE, 2008, PLOS BIOL, V6, P2621, DOI 10.1371/journal.pbio.0060325; Witt GB, 2009, AUST J BOT, V57, P572, DOI 10.1071/BT08217; Xu T., 2011, ANUCLIM VERSION 6 1	73	11	11	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124014	10.1371/journal.pone.0124014	http://dx.doi.org/10.1371/journal.pone.0124014			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881302	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500078
J	Lauron-Moreau, A; Pitre, FE; Argus, GW; Labrecque, M; Brouillet, L				Lauron-Moreau, Aurelien; Pitre, Frederic E.; Argus, George W.; Labrecque, Michel; Brouillet, Luc			Phylogenetic Relationships of American Willows (Salix L., Salicaceae)	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; SEQUENCE ALIGNMENT; CHLOROPLAST DNA; NORTH-AMERICA; RIBOSOMAL-RNA; DISPERSAL; INFERENCE; TERTIARY; BARCODE; GENES	Salix L. is the largest genus in the family Salicaceae (450 species). Several classifications have been published, but taxonomic subdivision has been under continuous revision. Our goal is to establish the phylogenetic structure of the genus using molecular data on all American willows, using three DNA markers. This complete phylogeny of American willows allows us to propose a biogeographic framework for the evolution of the genus. Material was obtained for the 122 native and introduced willow species of America. Sequences were obtained from the ITS (ribosomal nuclear DNA) and two plastid regions, matK and rbcL. Phylogenetic analyses (parsimony, maximum likelihood, Bayesian inference) were performed on the data. Geographic distribution was mapped onto the tree. The species tree provides strong support for a division of the genus into two subgenera, Salix and Vetrix. Subgenus Salix comprises temperate species from the Americas and Asia, and their disjunction may result from Tertiary events. Subgenus Vetrix is composed of boreo-arctic species of the Northern Hemisphere and their radiation may coincide with the Quaternary glaciations. Sixteen species have ambiguous positions; genetic diversity is lower in subg. Vetrix. A molecular phylogeny of all species of American willows has been inferred. It needs to be tested and further resolved using other molecular data. Nonetheless, the genus clearly has two clades that have distinct biogeographic patterns.	[Lauron-Moreau, Aurelien; Pitre, Frederic E.; Labrecque, Michel; Brouillet, Luc] Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada; [Argus, George W.] Canadian Museum Nat, Ottawa, ON K1P 6P4, Canada	Universite de Montreal	Labrecque, M (corresponding author), Univ Montreal, Inst Rech Biol Vegetale, Montreal, PQ H1X 2B2, Canada.	michel.labrecque@umontreal.ca			Centre de recherche sur les grains (CEROM); Conseil pour le developpement de l'agriculture au Quebec (CDAQ)	Centre de recherche sur les grains (CEROM); Conseil pour le developpement de l'agriculture au Quebec (CDAQ)	This study was supported by the Centre de recherche sur les grains (CEROM) and the Conseil pour le developpement de l'agriculture au Quebec (CDAQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahzadeh A., 2011, Iranian Journal of Botany, V17, P244; Alford MH, 2009, WHAT ARE CLOSEST REL; Alvarez I, 2003, MOL PHYLOGENET EVOL, V29, P417, DOI 10.1016/S1055-7903(03)00208-2; Argus, 1986, SYST BOT MONOGR, V9, P1, DOI [10.2307/25027618, DOI 10.2307/25027618]; Argus G.W., 2010, FLORA N AM N MEXICO, V7, P23; Argus G. W., 1997, SYST BOT MONOGR, V52, P1, DOI DOI 10.2307/25096638; Argus George W., 2007, Harvard Papers in Botany, V12, P335, DOI 10.3100/1043-4534(2007)12[335:SSDMAA]2.0.CO;2; Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; Azuma T, 2000, AM J BOT, V87, P67, DOI 10.2307/2656686; Bailey CD, 2003, MOL PHYLOGENET EVOL, V29, P435, DOI 10.1016/j.ympev.2003.08.021; Ball CR, 1961, FLORA TEXAS, V3, P369; Birky CW, 2001, ANNU REV GENET, V35, P125, DOI 10.1146/annurev.genet.35.102401.090231; Brunsfeld SJ, 2007, SYST BOT, V32, P129, DOI 10.1600/036364407780360094; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase Mark W., 2002, Kew Bulletin, V57, P141, DOI 10.2307/4110825; Chen JH, 2010, TAXON, V59, P29, DOI 10.1002/tax.591004; Chmelar J, 1978, FOLIA DENDROLOGICA, V4, P5; Condamine FL, 2013, J BIOGEOGR, V40, P9, DOI 10.1111/j.1365-2699.2012.02787.x; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Davis CC, 2010, AM J BOT, V97, P2031, DOI 10.3732/ajb.1000146; DORN RD, 1976, CAN J BOT, V54, P2769, DOI 10.1139/b76-297; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ehlers J, 2007, QUATERN INT, V164-65, P6, DOI 10.1016/j.quaint.2006.10.008; Fang C.F., 1999, FLORA CHINA, P139; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guidi W., 2013, BIOMASS NOW SUSTAINA, DOI [10.5772/51111, DOI 10.5772/51111]; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guo XY, 2008, FUNCT INTEGR GENOMIC, V8, P101, DOI 10.1007/s10142-007-0067-2; Hardig T. M., 2010, Journal of Botany, V2010, P197696, DOI 10.1155/2010/197696; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Holderegger R, 2002, MOL ECOL, V11, P1409, DOI 10.1046/j.1365-294X.2002.01548.x; Hollingsworth PM, 2011, P NATL ACAD SCI USA, V108, P19451, DOI 10.1073/pnas.1116812108; Karp A, 2011, J INTEGR PLANT BIOL, V53, P151, DOI 10.1111/j.1744-7909.2010.01015.x; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kimura A, 1928, BOT MAG TOKYO, V42, P287; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuzmina ML, 2012, BMC ECOL, V12, DOI 10.1186/1472-6785-12-25; Kuzovkina YA, 2008, HORTICUL RE, V34, P447; Lauron-Moreau Aurelien, 2013, Plants-Basel, V2, P203, DOI 10.3390/plants2020203; Leskinen E, 1999, PLANT SYST EVOL, V215, P209, DOI 10.1007/BF00984656; Levin RA, 2003, AM J BOT, V90, P107, DOI 10.3732/ajb.90.1.107; Lindegaard K. N., 1997, Aspects of Applied Biology, P155; Manchester SR, 1999, ANN MO BOT GARD, V86, P472, DOI 10.2307/2666183; Manchester SR, 2001, INT J PLANT SCI, V162, pS19, DOI 10.1086/323657; McCauley DE, 1996, AM J BOT, V83, P727, DOI 10.2307/2445849; Milne RI, 2006, ANN BOT-LONDON, V98, P465, DOI 10.1093/aob/mcl148; Nakai T., 1920, BOT MAG TOKYO, V34, P66; Newsholme C, 1992, WILLOWS GENUS SALIX; Nylander JAA, 2008, SYSTEMATIC BIOL, V57, P257, DOI 10.1080/10635150802044003; Oliver MJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-143; Percy DM, 2014, MOL ECOL, V23, P4737, DOI 10.1111/mec.12837; Rambaut A., 2007, TRACER V1 4; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; REHDER A., 1949, BIBLIO CULTIVATED TR; RENZAGLIA KS, 1994, CAN J BOT, V72, P1436, DOI 10.1139/b94-177; ROGERS SO, 1987, PLANT MOL BIOL, V9, P509, DOI 10.1007/BF00015882; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Roy M, 2004, GEOL SOC AM BULL, V116, P30, DOI 10.1130/B25325.1; Schneider C, 1919, BOT GAZ, V67, P309, DOI 10.1086/332476; Skvortsov A.K., 1999, FACULTY MATH NATURAL; Skvortsov AK, 1968, WILLOWS OF THE URSS; Sneader W, 2000, BRIT MED J, V321, P1591, DOI 10.1136/bmj.321.7276.1591; Stegemann S, 2012, P NATL ACAD SCI USA, V109, P2434, DOI 10.1073/pnas.1114076109; Stott KG, 1984, ECOLOGY MANAGEMENT F, P233; SWOFFORD DL, 1993, J GEN PHYSIOL, V102, pA9; Takhtajan AL., 1986, FLORISTIC REGIONS WO; TIFFNEY BH, 1985, J ARNOLD ARBORETUM, V66, P243, DOI 10.5962/bhl.part.13183; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Tsai YHE, 2013, J BIOGEOGR, V40, P131, DOI 10.1111/j.1365-2699.2012.02775.x; Turgeon J, 2005, AM NAT, V165, pE78, DOI 10.1086/428682; Vijaykumar A, 2010, J HERED, V101, P177, DOI 10.1093/jhered/esp084; Volk TA, 2006, BIOMASS BIOENERG, V30, P715, DOI 10.1016/j.biombioe.2006.03.001; Wen J, 2001, INT J PLANT SCI, V162, pS117, DOI 10.1086/322940; Xiang QY, 2000, MOL PHYLOGENET EVOL, V15, P462, DOI 10.1006/mpev.2000.0766; Xiang QYJ, 2001, INT J PLANT SCI, V162, pS29, DOI 10.1086/323332	80	40	43	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121965	10.1371/journal.pone.0121965	http://dx.doi.org/10.1371/journal.pone.0121965			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880993	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500014
J	Morita, M; Mii, A; Shimizu, A; Yasuda, F; Shoji, J; Masuda, Y; Ohashi, R; Nagahama, K; Kaneko, T; Tsuruoka, S				Morita, Megumi; Mii, Akiko; Shimizu, Akira; Yasuda, Fumihiko; Shoji, Jun; Masuda, Yukinari; Ohashi, Ryuji; Nagahama, Kiyotaka; Kaneko, Tomohiro; Tsuruoka, Shuichi			Glomerular Endothelial Cell Injury and Focal Segmental Glomerulosclerosis Lesion in Idiopathic Membranous Nephropathy	PLOS ONE			English	Article							GROWTH-FACTOR; NEPHROTIC SYNDROME; PROGNOSTIC-FACTORS; VEGF INHIBITION; EXPRESSION; GLOMERULONEPHRITIS; HYPERTROPHY; PODOCYTES; URINE	Background Focal segmental glomerulosclerosis (FSGS) lesions have often been discussed as a negative predictor in idopathic membranous nephropathy (MN). The mechanism of the development of FSGS lesion in MN is still uncertain. Methods From 250 cases of MN, 26 cases contained FSGS lesion. We compared the clinicopathological characteristics between MN cases with FSGS lesion [MN-FSGS(+)] and MN without FSGS lesion [MN-FSGS(-)], matched for gender, age, stage of MN. Results The glomerular filtration rate (eGFR) was significantly lower in MN-FSGS(+) cases compared to MN-FSGS(-), although nephrotic syndrome, hematuria, and systolic blood pressure levels were not significantly different between the two groups. Pathologically, glomeruli in MN-FSGS(+) cases showed narrowing and loss of glomerular capillaries with separating from GBM or disappearance of CD34+ endothelial cells, and accumulation of extracellular matrix (ECM) in capillary walls, indicating the development of glomerular capillary injury. These findings of endothelial injury were seen even in MN-FSGS(-) cases, but they were more prominent in MN-FSGS(+) than MN-FSGS(-) by computer assessed morphometric analysis. In MN-FSGS(+) cases, 44 out of 534 glomeruli (8.2%) contained FSGS lesions (n = 31, NOS lesion; n = 13, perihilar lesion). Significant thickness of GBM with ECM accumulation was evident in MN-FSGS(+) cases. Podocyte injury with effacement of foot processes was also noted, but the expression of VEGF on podocytes was not different between the two groups, which suggests that the significant thickness of capillary walls may influence the function of VEGF from podocyte resulting in the glomerular capillary injury that contribute to the development of FSGS lesion in MN. Conclusion Glomerular capillary injury was seen in all MN cases. Furthermore, the prominent injuries of glomerular capillaries may be associated with the deterioration of eGFR and the formation of FSGS lesions in MN.	[Morita, Megumi; Mii, Akiko; Yasuda, Fumihiko; Kaneko, Tomohiro; Tsuruoka, Shuichi] Nippon Med Sch, Dept Nephrol, Tokyo 113, Japan; [Shimizu, Akira; Masuda, Yukinari; Nagahama, Kiyotaka] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan; [Shoji, Jun] George Washington Univ, Dept Neurol, Washington, DC 20037 USA; [Ohashi, Ryuji] Nippon Med Sch, Div Diagnost Pathol, Tokyo 113, Japan	Nippon Medical School; Nippon Medical School; George Washington University; Nippon Medical School	Mii, A (corresponding author), Nippon Med Sch, Dept Nephrol, 1-1-5 Sendagi, Tokyo 113, Japan.	s3072@nms.ac.jp	Tsuruoka, Shuichi/ABF-8453-2020; Tsuruoka, Shuichi/W-3322-2019	Mii, Akiko/0000-0003-0326-8267	Japanese Society for the Promotion of Science [B23790963, C24591217]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Study funding was provided by Grants-in-Aid for Scientific Research (B23790963 to AM and C24591217 to AS) from the Japanese Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avihingsanon Y, 2009, KIDNEY INT, V75, P1340, DOI 10.1038/ki.2009.75; Barisoni L, 2007, CLIN J AM SOC NEPHRO, V2, P529, DOI 10.2215/CJN.04121206; Cattran DC, 2001, KIDNEY INT, V59, P1983, DOI 10.1046/j.1523-1755.2001.0590051983.x; CATTRAN DC, 1992, NEPHROL DIAL TRANSPL, V7, P48; Cattran DC, 1997, KIDNEY INT, V51, P901, DOI 10.1038/ki.1997.127; D'Agati VD, 2004, AM J KIDNEY DIS, V43, P368, DOI 10.1053/j.ajkd.2003.10.024; Dumoulin A, 2003, AM J KIDNEY DIS, V41, P38, DOI 10.1053/ajkd.2003.50015; Ehrenreich T, 1968, PATHOL ANNU, P145; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Fervenza FC, 2008, CLIN J AM SOC NEPHRO, V3, P905, DOI 10.2215/CJN.04321007; Gupta R, 2010, NEPHROL DIAL TRANSPL, V25, P444, DOI 10.1093/ndt/gfp521; Haas M, 1997, AM J KIDNEY DIS, V30, P621, DOI 10.1016/S0272-6386(97)90485-6; Hara M, 2005, J AM SOC NEPHROL, V16, P408, DOI 10.1681/ASN.2004070564; Hara M, 2001, NEPHRON, V89, P342, DOI 10.1159/000046097; Hara M, 2010, HUM PATHOL, V41, P1265, DOI 10.1016/j.humpath.2010.02.004; Heeringa SF, 2007, NEPHROL DIAL TRANSPL, V22, P2201, DOI 10.1093/ndt/gfm188; Honkanen E, 2003, AM J KIDNEY DIS, V42, P1139, DOI 10.1053/j.ajkd.2003.08.014; Honkanen EO, 2000, KIDNEY INT, V57, P2343, DOI 10.1046/j.1523-1755.2000.00094.x; Hughson MD, 2002, AM J KIDNEY DIS, V39, P679, DOI 10.1053/ajkd.2002.31980; Katavetin P, 2008, NEW ENGL J MED, V359, P205, DOI 10.1056/NEJMc080770; LEE HS, 1993, CLIN NEPHROL, V39, P7; Machado JR, 2012, INT J NEPHROL, V2012, DOI 10.1155/2012/937623; Nishimoto K, 1999, CLIN NEPHROL, V51, P209; NOCHY D, 1994, CLIN NEPHROL, V42, P9; Polanco N, 2010, J AM SOC NEPHROL, V21, P697, DOI 10.1681/ASN.2009080861; Reichert LJM, 1998, AM J KIDNEY DIS, V31, P1, DOI 10.1053/ajkd.1998.v31.pm9428445; SCHIEPPATI A, 1993, NEW ENGL J MED, V329, P85, DOI 10.1056/NEJM199307083290203; Schrijvers BF, 2004, KIDNEY INT, V65, P2003, DOI 10.1111/j.1523-1755.2004.00621.x; Shiiki H, 2004, KIDNEY INT, V65, P1400, DOI 10.1111/j.1523-1755.2004.00518.x; Shulman K, 1996, J AM SOC NEPHROL, V7, P661; Sison K, 2010, J AM SOC NEPHROL, V21, P1691, DOI 10.1681/ASN.2010030295; Troyanov S, 2006, KIDNEY INT, V69, P1641, DOI 10.1038/sj.ki.5000289; VANDAMME B, 1990, J PATHOL, V161, P47, DOI 10.1002/path.1711610109; WAKAI S, 1992, KIDNEY INT, V41, P428, DOI 10.1038/ki.1992.59; Yoshimoto K, 2004, KIDNEY INT, V65, P148, DOI 10.1111/j.1523-1755.2004.00403.x	35	22	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0116700	10.1371/journal.pone.0116700	http://dx.doi.org/10.1371/journal.pone.0116700			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875837	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800001
J	Gokhale, PJ; Au-Young, JK; Dadi, S; Keys, DN; Harrison, NJ; Jones, M; Soneji, S; Enver, T; Sherlock, JK; Andrews, PW				Gokhale, Paul J.; Au-Young, Janice K.; Dadi, SriVidya; Keys, David N.; Harrison, Neil J.; Jones, Mark; Soneji, Shamit; Enver, Tariq; Sherlock, Jon K.; Andrews, Peter W.			Culture Adaptation Alters Transcriptional Hierarchies among Single Human Embryonic Stem Cells Reflecting Altered Patterns of Differentiation	PLOS ONE			English	Article							HUMAN TERATOCARCINOMA CELLS; MONOCLONAL-ANTIBODY; GLOBO-SERIES; PLURIPOTENT; STATES; LINES; NAIVE; HETEROGENEITY; EQUILIBRIUM; COMMITMENT	We have used single cell transcriptome analysis to re-examine the substates of early passage, karyotypically Normal, and late passage, karyotypically Abnormal ('Culture Adapted') human embryonic stem cells characterized by differential expression of the cell surface marker antigen, SSEA3. The results confirmed that culture adaptation is associated with alterations to the dynamics of the SSEA3(+) and SSEA3(-) substates of these cells, with SSEA3(-) Adapted cells remaining within the stem cell compartment whereas the SSEA3(-) Normal cells appear to have differentiated. However, the single cell data reveal that these substates are characterized by further heterogeneity that changes on culture adaptation. Notably the Adapted population includes cells with a transcriptome substate suggestive of a shift to a more naive-like phenotype in contrast to the cells of the Normal population. Further, a subset of the Normal SSEA3(+) cells expresses genes typical of endoderm differentiation, despite also expressing the undifferentiated stem cell genes, POU5F1 (OCT4) and NANOG, whereas such apparently lineage-primed cells are absent from the Adapted population. These results suggest that the selective growth advantage gained by genetically variant, culture adapted human embryonic stem cells may derive in part from a changed substate structure that influences their propensity for differentiation.	[Gokhale, Paul J.; Harrison, Neil J.; Jones, Mark; Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Au-Young, Janice K.; Dadi, SriVidya; Keys, David N.; Sherlock, Jon K.] ThermoFisher, Foster City, CA USA; [Soneji, Shamit; Enver, Tariq] Univ Oxford, Weatherall Inst Mol Med, Oxford, England	University of Sheffield; University of Oxford	Andrews, PW (corresponding author), Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	p.w.andrews@sheffield.ac.uk		Andrews, Peter/0000-0001-7215-4410; Gokhale, Paul/0000-0001-7225-4403; Sherlock, Jon/0000-0001-5475-2361	Medical Research Council, UK [G0300268]; Human Frontiers Science Program [RGP0001/2012]; European Union's Seventh Framework Programme for research, technological development and demonstration [602423]; MRC [G0300268, G0700785] Funding Source: UKRI; Cancer Research UK [12796] Funding Source: researchfish; Medical Research Council [G0700785, G0300268] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Human Frontiers Science Program(Human Frontier Science Program); European Union's Seventh Framework Programme for research, technological development and demonstration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work described was funded by: Medical Research Council, UK (http://www.mrc.ac. uk), G0300268, PJG, NJH, MJ, PWA; Human Frontiers Science Program, RGP0001/2012, PJG, PWA; and European Union's Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602423, TE, PWA. The above funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Work was a collaboration with Thermo Fisher (JKA-Y SVD DNK, JS) who provided reagents, helped design the study, performed experiments, collected and analysed data and helped prepare the manuscript.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Allegrucci C, 2007, HUM MOL GENET, V16, P1253, DOI 10.1093/hmg/ddm074; Amps K, 2011, NAT BIOTECHNOL, V29, P1132, DOI 10.1038/nbt.2051; Avery S, 2013, STEM CELL REP, V1, P379, DOI 10.1016/j.stemcr.2013.10.005; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Blauwkamp TA, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2064; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Canham MA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000379; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cheng T, 1996, P NATL ACAD SCI USA, V93, P13158, DOI 10.1073/pnas.93.23.13158; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Fazeli A, 2011, INT J DEV BIOL, V55, P175, DOI 10.1387/ijdb.103177af; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Gafni O, 2013, NATURE, V504, P282, DOI 10.1038/nature12745; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hong SH, 2011, CELL STEM CELL, V9, P24, DOI 10.1016/j.stem.2011.06.002; Hough SR, 2014, STEM CELL REP, V2, P881, DOI 10.1016/j.stemcr.2014.04.014; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; KANNAGI R, 1983, J BIOL CHEM, V258, P8934; KANNAGI R, 1983, EMBO J, V2, P2355, DOI 10.1002/j.1460-2075.1983.tb01746.x; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Marks H, 2012, CELL, V149, P590, DOI 10.1016/j.cell.2012.03.026; Mekhoubad S, 2012, CELL STEM CELL, V10, P595, DOI 10.1016/j.stem.2012.02.014; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Pera MF, 2010, NATURE, V465, P713, DOI 10.1038/nature09228; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; SHEVINSKY LH, 1982, CELL, V30, P697, DOI 10.1016/0092-8674(82)90274-4; Singh AM, 2013, STEM CELL REP, V1, P532, DOI 10.1016/j.stemcr.2013.10.009; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tonge PD, 2011, STEM CELL RES, V7, P145, DOI 10.1016/j.scr.2011.04.006; Tonge PD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010901; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Ware CB, 2014, P NATL ACAD SCI USA, V111, P4484, DOI 10.1073/pnas.1319738111; Welling M, 2013, TRENDS CELL BIOL, V23, P442, DOI 10.1016/j.tcb.2013.04.004; Xu Y., 2010, P NATL ACAD SCI US	46	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123467	10.1371/journal.pone.0123467	http://dx.doi.org/10.1371/journal.pone.0123467			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875838	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353014700032
J	Chen, MZ; Hudson, CA; Vincent, EE; de Berker, DAR; May, MT; Hers, I; Dayan, CM; Andrews, RC; Tavare, JM				Chen, Mimi Z.; Hudson, Claire A.; Vincent, Emma E.; de Berker, David A. R.; May, Margaret T.; Hers, Ingeborg; Dayan, Colin M.; Andrews, Robert C.; Tavare, Jeremy M.			Bariatric Surgery in Morbidly Obese Insulin Resistant Humans Normalises Insulin Signalling but Not Insulin-Stimulated Glucose Disposal	PLOS ONE			English	Article							Y GASTRIC BYPASS; HUMAN SKELETAL-MUSCLE; PROTEIN-KINASE B; WEIGHT-LOSS; FATTY-ACID; DIABETES-MELLITUS; DOSE-RESPONSE; AKT PHOSPHORYLATION; GLYCOGEN-SYNTHASE; IN-VIVO	Aims Weight-loss after bariatric surgery improves insulin sensitivity, but the underlying molecular mechanism is not clear. To ascertain the effect of bariatric surgery on insulin signalling, we examined glucose disposal and Akt activation in morbidly obese volunteers before and after Roux-en-Y gastric bypass surgery (RYGB), and compared this to lean volunteers. Materials and Methods The hyperinsulinaemic euglycaemic clamp, at five infusion rates, was used to determine glucose disposal rates (GDR) in eight morbidly obese (body mass index, BMI=47.3 +/- 2.2 kg/m(2)) patients, before and after RYGB, and in eight lean volunteers (BMI=20.7 +/- 0.7 kg/m(2)). Biopsies of brachioradialis muscle, taken at fasting and insulin concentrations that induced half-maximal (GDR(50)) and maximal (GDR(100)) GDR in each subject, were used to examine the phosphorylation of Akt-Thr308, Akt-473, and pras40, in vivo biomarkers for Akt activity. Results Pre-operatively, insulin-stimulated GDR was lower in the obese compared to the lean individuals (P<0.001). Weight-loss of 29.9 +/- 4 kg after surgery significantly improved GDR(50) (P=0.004) but not GDR(100) (P=0.3). These subjects still remained significantly more insulin resistant than the lean individuals (p<0.001). Weight loss increased insulin-stimulated skeletal muscle Akt-Thr308 and Akt-Ser473 phosphorylation, P=0.02 and P=0.03 respectively (MANCOVA), and Akt activity towards the substrate PRAS40 (P=0.003, MANCOVA), and in contrast to GDR, were fully normalised after the surgery (obese vs lean, P=0.6, P=0.35, P=0.46, respectively). Conclusions Our data show that although Akt activity substantially improved after surgery, it did not lead to a full restoration of insulin-stimulated glucose disposal. This suggests that a major defect downstream of, or parallel to, Akt signalling remains after significant weight-loss.	[Chen, Mimi Z.; Hudson, Claire A.; Andrews, Robert C.] Univ Bristol, Sch Clin Sci, Bristol, Avon, England; [Vincent, Emma E.; Tavare, Jeremy M.] Univ Bristol, Sch Biochem, Bristol, Avon, England; [de Berker, David A. R.] Bristol Royal Infirm & Gen Hosp, Bristol Dermatol Ctr, Bristol, Avon, England; [May, Margaret T.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Hers, Ingeborg] Univ Bristol, Sch Physiol & Pharmacol, Bristol, Avon, England; [Dayan, Colin M.] Cardiff Univ, Sch Med, Inst Mol & Expt Med, Cardiff CF10 3AX, S Glam, Wales	University of Bristol; University of Bristol; Bristol Royal Infirmary; University of Bristol; University of Bristol; Cardiff University	Andrews, RC (corresponding author), Univ Bristol, Sch Clin Sci, Bristol, Avon, England.	Rob.Andrews@bristol.ac.uk	Dayan, Colin/AAH-6242-2019; Hers, Ingeborg/ABG-3357-2020	Dayan, Colin/0000-0002-6557-3462; Hudson, Claire/0000-0002-5588-8196; Hers, Ingeborg/0000-0002-6467-5715; andrews, robert/0000-0003-4939-1738; Vincent, Emma/0000-0002-8917-7384	Diabetes Research and Wellness Foundation; Medical Research Council; AstraZeneca	Diabetes Research and Wellness Foundation; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca)	This study was funded by a grant from Diabetes Research and Wellness Foundation, Medical Research Council and AstraZeneca. These funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1996, EMBO J, V15, P6541, DOI 10.1002/j.1460-2075.1996.tb01045.x; Bakker LEH, 2014, DIABETES, V63, P248, DOI 10.2337/db13-0696; Ballantyne GH, 2006, OBES SURG, V16, P1189, DOI 10.1381/096089206778392158; Belfort R, 2005, DIABETES, V54, P1640, DOI 10.2337/diabetes.54.6.1640; Benedetti G, 2000, J AM COLL NUTR, V19, P270, DOI 10.1080/07315724.2000.10718926; BONADONNA RC, 1990, METABOLISM, V39, P452, DOI 10.1016/0026-0495(90)90002-T; Brozinick JT, 2003, DIABETES, V52, P935, DOI 10.2337/diabetes.52.4.935; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Chang L, 2004, MOL MED, V10, P65, DOI 10.2119/2005-00029.Saltiel; Chen MZ, 2014, DIABETIC MED, V31, P42; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; COLDITZ GA, 1995, ANN INTERN MED, V122, P481, DOI 10.7326/0003-4819-122-7-199504010-00001; Cong LN, 1997, MOL ENDOCRINOL, V11, P1881, DOI 10.1210/me.11.13.1881; Dar MS, 2012, OBES SURG, V22, P1077, DOI 10.1007/s11695-012-0624-1; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; DiGiorgi M, 2010, SURG OBES RELAT DIS, V6, P249, DOI 10.1016/j.soard.2009.09.019; Dugani CB, 2005, EMBO REP, V6, P1137, DOI 10.1038/sj.embor.7400584; Garvey WT, 1998, J CLIN INVEST, V101, P2377, DOI 10.1172/JCI1557; GARVEY WT, 1992, DIABETES, V41, P465, DOI 10.2337/diabetes.41.4.465; Gonzalez E, 2006, MOL BIOL CELL, V17, P4484, DOI 10.1091/mbc.E06-07-0585; Gonzalez N, 2005, REGUL PEPTIDES, V126, P203, DOI 10.1016/j.regpep.2004.10.002; Grimmsmann T, 2002, J ENDOCRINOL, V172, P645, DOI 10.1677/joe.0.1720645; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Kim YB, 1999, J CLIN INVEST, V104, P733, DOI 10.1172/JCI6928; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kohn AD, 1996, J BIOL CHEM, V271, P31372, DOI 10.1074/jbc.271.49.31372; Korner J, 2007, SURG OBES RELAT DIS, V3, P597, DOI 10.1016/j.soard.2007.08.004; Krook A, 1998, DIABETES, V47, P1281, DOI 10.2337/diabetes.47.8.1281; Kruszynska YT, 2002, J CLIN ENDOCR METAB, V87, P226, DOI 10.1210/jc.87.1.226; Leng Y, 2004, REV ENDOCR METAB DIS, V5, P111, DOI 10.1023/B:REMD.0000021432.84588.f6; Mari A, 2006, DIABETOLOGIA, V49, P2136, DOI 10.1007/s00125-006-0337-x; Meyer MM, 2002, DIABETOLOGIA, V45, P813, DOI 10.1007/s00125-002-0830-9; Middelbeek RJW, 2013, NUTR DIABETES, V3, DOI 10.1038/nutd.2013.13; Miras AD, 2014, DIABETES OBES METAB, V16, P86, DOI 10.1111/dom.12177; Moore SF, 2011, J BIOL CHEM, V286, P24553, DOI 10.1074/jbc.M110.202341; Muniyappa R, 2008, AM J PHYSIOL-ENDOC M, V294, pE15, DOI 10.1152/ajpendo.00645.2007; Oh E, 2006, J BIOL CHEM, V281, P17624, DOI 10.1074/jbc.M601581200; Pournaras DJ, 2011, BR J SURG; RANDLE PJ, 1963, LANCET, V1, P785; RIZZA RA, 1981, AM J PHYSIOL, V240, pE630, DOI 10.1152/ajpendo.1981.240.6.E630; Rosa G, 2007, INT J OBESITY, V31, P1429, DOI 10.1038/sj.ijo.0803630; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shulman GI, 2000, J CLIN INVEST, V106, P171, DOI 10.1172/JCI10583; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Storgaard H, 2004, J CLIN ENDOCR METAB, V89, P1301, DOI 10.1210/jc.2003-031243; Vincent EE, 2011, BRIT J CANCER, V104, P1755, DOI 10.1038/bjc.2011.132; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; Wickremesekera K, 2005, OBES SURG, V15, P474, DOI 10.1381/0960892053723402	50	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0120084	10.1371/journal.pone.0120084	http://dx.doi.org/10.1371/journal.pone.0120084			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876175	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100019
J	Ostergren, C; Shim, J; Larsen, JV; Nielsen, LB; Bentzon, JF				Ostergren, Caroline; Shim, Jeong; Larsen, Jens Vinther; Nielsen, Lars Bo; Bentzon, Jacob F.			Genetic Analysis of Ligation-Induced Neointima Formation in an F2 Intercross of C57BL/6 and FVB/N Inbred Mouse Strains	PLOS ONE			English	Article							ATHEROSCLEROSIS SUSCEPTIBILITY; CAROTID-ARTERY; LOCI; HYPERPLASIA; MICE; MECHANISMS; EXPRESSION; CESSATION; FLOW; WALL	Objective Proliferation and migration of vascular smooth muscle cells (SMCs) are central for arterial diseases including atherosclerosis and restenosis. We hypothesized that the underlying mechanisms may be modeled by carotid ligation in mice. In FVB/N inbred mice, ligation leads to abundant neointima formation with proliferating media-derived SMCs, whereas in C57BL/6 mice hardly any neointima is formed. In the present study, we aimed to identify the chromosomal location of the causative gene variants in an F2 intercross between these two mouse strains. Methods and Results The neointimal cross-sectional area was significantly different between FVB/N, C57BL/6 and F1 female mice 4 weeks after ligation. Carotid artery ligation and a genome scan using 800 informative SNP markers were then performed in 157 female F2 mice. Using quantitative trait loci (QTL) analysis, we identified suggestive, but no genome-wide significant, QTLs on chromosomes 7 and 12 for neointimal cross-sectional area and on chromosome 14 for media area. Further analysis of the cross revealed 4 QTLs for plasma cholesterol, which combined explained 69% of the variation among F2 mice. Conclusions We identified suggestive QTLs for neointima and media area after carotid ligation in an intercross of FVB/N and C57BL/6 mice, but none that reached genome-wide significance indicating a complex genetic architecture of the traits. Genome-wide significant QTLs for total cholesterol levels were identified on chromosomes 1, 3, 9, and 12.	[Ostergren, Caroline; Shim, Jeong; Larsen, Jens Vinther; Bentzon, Jacob F.] Aarhus Univ, Dept Clin Med, Aarhus, Denmark; [Ostergren, Caroline; Shim, Jeong; Larsen, Jens Vinther; Bentzon, Jacob F.] Aarhus Univ Hosp, Dept Cardiol, DK-8000 Aarhus, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Rigshosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Biomed Sci, Copenhagen, Denmark; [Nielsen, Lars Bo] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark	Aarhus University; Aarhus University; Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen	Bentzon, JF (corresponding author), Aarhus Univ, Dept Clin Med, Aarhus, Denmark.	jben@clin.au.dk	Bentzon, Jacob/B-5302-2016; Bentzon, Jacob Fog/ABC-4460-2021	Bentzon, Jacob/0000-0002-3020-5002; Bentzon, Jacob Fog/0000-0002-3020-5002	Danish Heart Foundation; Novo Nordic Foundation; Danish Medical Research Council	Danish Heart Foundation; Novo Nordic Foundation(Novo Nordisk Foundation); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Support was provided by the Danish Heart Foundation [www.hjerteforeningen.dk], Novo Nordic Foundation [http://www.novonordiskfonden.dk/], and the Danish Medical Research Council [www.http://ufm.dk/en/research-and-innovation/]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentzon JF, 2014, CIRC RES, V114, P1852, DOI 10.1161/CIRCRESAHA.114.302721; Bonta PI, 2010, CIRCULATION, V121, P2023, DOI 10.1161/CIRCULATIONAHA.109.885673; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Choi ET, 2004, CIRCULATION, V109, P1564, DOI 10.1161/01.CIR.0000121733.68724.FF; Cox A, 2009, GENETICS, V182, P1335, DOI 10.1534/genetics.109.105486; da Cunha V, 2006, J LIPID RES, V47, P476, DOI 10.1194/jlr.M500341-JLR200; Dallinga-Thie GM, 2007, J LIPID RES, V48, P2788, DOI 10.1194/jlr.D700021-JLR200; Dansky HM, 1999, ARTERIOSCL THROM VAS, V19, P1960, DOI 10.1161/01.ATV.19.8.1960; Dansky HM, 2002, GENETICS, V160, P1599; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Godin D, 2000, CIRCULATION, V102, P2861; Harmon KJ, 2000, AM J PATHOL, V156, P1741, DOI 10.1016/S0002-9440(10)65045-6; Hillebrandt S, 2005, NAT GENET, V37, P835, DOI 10.1038/ng1599; Holdt LM, 2008, ARTERIOSCL THROM VAS, V28, P1097, DOI 10.1161/ATVBAHA.108.165654; Inoue S, 2007, J VASC SURG, V46, P756, DOI 10.1016/j.jvs.2007.05.055; Jukema JW, 2012, NAT REV CARDIOL, V9, P53, DOI 10.1038/nrcardio.2011.132; Korshunov VA, 2009, ARTERIOSCL THROM VAS, V29, P47, DOI 10.1161/ATVBAHA.108.178111; Kuhel DG, 2002, ARTERIOSCL THROM VAS, V22, P955, DOI 10.1161/01.ATV.0000017994.77066.75; Kumar A, 1997, ARTERIOSCL THROM VAS, V17, P2238, DOI 10.1161/01.ATV.17.10.2238; Kuzuya M, 2003, CIRCULATION, V108, P1375, DOI 10.1161/01.CIR.0000086463.15540.3C; Levine GN, 2011, J AM COLL CARDIOL, V58, pE44, DOI 10.1016/j.jacc.2011.08.007; Libby P, 2013, NEW ENGL J MED, V368, P2004, DOI 10.1056/NEJMra1216063; Moore KJ, 2000, ANNU REV GENET, V34, P653, DOI 10.1146/annurev.genet.34.1.653; Moura R, 2007, ARTERIOSCL THROM VAS, V27, P2163, DOI 10.1161/ATVBAHA.107.151282; Nestor AL, 2006, PHYSIOL GENOMICS, V25, P286, DOI 10.1152/physiolgenomics.00135.2005; REUE K, 1991, J BIOL CHEM, V266, P12715; Shim J, 2011, ARTERIOSCL THROM VAS, V31, P1814, DOI 10.1161/ATVBAHA.111.229674; Silvestre-Roig C, 2014, CIRC-CARDIOVASC GENE, V7, P59, DOI 10.1161/CIRCGENETICS.113.000305; Smith JD, 2003, ARTERIOSCL THROM VAS, V23, P117, DOI 10.1161/01.ATV.0000047461.18902.80; Teupser D, 2006, P NATL ACAD SCI USA, V103, P123, DOI 10.1073/pnas.0509570102; Teupser D, 2009, ARTERIOSCL THROM VAS, V29, P678, DOI 10.1161/ATVBAHA.108.179408; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Wang XS, 2005, NAT GENET, V37, P365, DOI 10.1038/ng1524; Wang XS, 2004, GENOME RES, V14, P1767, DOI 10.1101/gr.2668204; Wang XS, 2002, ARTERIOSCL THROM VAS, V22, P884, DOI 10.1161/01.ATV.0000022201.18709.A1; Welch CL, 2001, P NATL ACAD SCI USA, V98, P7946, DOI 10.1073/pnas.141239098; Willer CJ, 2013, NAT GENET, V45, P1274, DOI 10.1038/ng.2797	37	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0121899	10.1371/journal.pone.0121899	http://dx.doi.org/10.1371/journal.pone.0121899			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875831	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100051
J	Dare, S; Mackay, DF; Pell, JP				Dare, Shadrach; Mackay, Daniel F.; Pell, Jill P.			Relationship between Smoking and Obesity: A Cross-Sectional Study of 499,504 Middle-Aged Adults in the UK General Population	PLOS ONE			English	Article							BODY-MASS INDEX; SOCIOECONOMIC-STATUS; LONGITUDINAL CHANGES; WEIGHT-GAIN; CESSATION; SMOKERS; CONSEQUENCES	Background There is a general perception that smoking protects against weight gain and this may influence commencement and continuation of smoking, especially among young women. Methods A cross-sectional study was conducted using baseline data from UK Biobank. Logistic regression analyses were used to explore the association between smoking and obesity; defined as body mass index (BMI) > 30kg/m(2). Smoking was examined in terms of smoking status, amount smoked, duration of smoking and time since quitting and we adjusted for the potential confounding effects of age, sex, socioeconomic deprivation, physical activity, alcohol consumption, hypertension and diabetes. Results The study comprised 499,504 adults aged 31 to 69 years. Overall, current smokers were less likely to be obese than never smokers (adjusted OR 0.83 95% CI 0.81-0.86). However, there was no significant association in the youngest sub-group (<= 40 years). Former smokers were more likely to be obese than both current smokers (adjusted OR 1.33 95% CI 1.30-1.37) and never smokers (adjusted OR 1.14 95% CI 1.12-1.15). Among smokers, the risk of obesity increased with the amount smoked and former heavy smokers were more likely to be obese than former light smokers (adjusted OR 1.60, 95% 1.56-1.64, p< 0.001). Risk of obesity fell with time from quitting. After 30 years, former smokers still had higher risk of obesity than current smokers but the same risk as never smokers. Conclusion Beliefs that smoking protects against obesity may be over-simplistic; especially among younger and heavier smokers. Quitting smoking may be associated with temporary weight gain. Therefore, smoking cessation interventions should include weight management support.	[Dare, Shadrach; Mackay, Daniel F.; Pell, Jill P.] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Dare, Shadrach] Univ Cape Coast, Sch Nursing, Coll Hlth & Allied Sci, Cape Coast, Ghana	University of Glasgow; University of Cape Coast	Pell, JP (corresponding author), Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland.	jill.pell@glasgow.ac.uk	Matsuo, Keitaro/H-6758-2019	Matsuo, Keitaro/0000-0003-1761-6314; Pell, Jill/0000-0002-8898-7035; Dare, Shadrach/0000-0002-2528-5263	Commonwealth Scholarship Commission in the United Kingdom; Medical Research Council [MC_qA137853] Funding Source: researchfish	Commonwealth Scholarship Commission in the United Kingdom; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Shadrach Dare (SD) is funded by Commonwealth Scholarship Commission in the United Kingdom http://cscuk.dfid.gov.uk/.	Allen N, 2012, HEALTH POLICY TECHN, V1, P123, DOI 10.1016/j.hlpt.2012.07.003; Aubin HJ, 2009, INT J ENV RES PUB HE, V6, P943, DOI 10.3390/ijerph6030943; Bakhshi E, 2008, J PUBLIC HEALTH-UK, V30, P429, DOI 10.1093/pubmed/fdn024; Berlin I, 2009, CURR MED RES OPIN, V25, P527, DOI 10.1185/03007990802707626; Cabanac M, 2002, PHYSIOL BEHAV, V76, P539, DOI 10.1016/S0031-9384(02)00783-7; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Doll R, 2004, BMJ-BRIT MED J, V328, P1519, DOI 10.1136/bmj.38142.554479.AE; Dvorak RD, 2009, J HEALTH PSYCHOL, V14, P919, DOI 10.1177/1359105309341005; Eisenberg D, 2006, HEALTH SERV RES, V41, P2255, DOI 10.1111/j.1475-6773.2006.00594.x; Farley CA, 2012, BMJ, V345; HELLIWELL PS, 1994, ANN RHEUM DIS, V53, P726, DOI 10.1136/ard.53.11.726; Hughes JR, 2003, J GEN INTERN MED, V18, P1053, DOI 10.1111/j.1525-1497.2003.20640.x; Basterra-Gortari FJ, 2010, REV ESP CARDIOL, V63, P20, DOI 10.1016/S0300-8932(10)70005-1; Jitnarin Nattinee, 2008, Journal of the Medical Association of Thailand, V91, P1109; Kadonaga Y, 2009, PREV MED, V48, P567, DOI 10.1016/j.ypmed.2009.03.018; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kim J., 2012, PLOS ONE, V7; KLESGES RC, 1989, PSYCHOL BULL, V106, P204, DOI 10.1037/0033-2909.106.2.204; Laaksonen M, 2005, EUR J PUBLIC HEALTH, V15, P262, DOI 10.1093/eurpub/cki115; Macera CA, 2011, NICOTINE TOB RES, V13, P965, DOI 10.1093/ntr/ntr104; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Meyers AW, 1997, J CONSULT CLIN PSYCH, V65, P448, DOI 10.1037/0022-006X.65.3.448; Morgenstern Matthis, 2010, Przegl Lek, V67, P826; Munafo MR, 2009, NICOTINE TOB RES, V11, P765, DOI 10.1093/ntr/ntp062; Niedhammer I, 2000, INT J OBESITY, V24, P1111, DOI 10.1038/sj.ijo.0801375; Paccaud F, 2001, REV EPIDEMIOL SANTE, V49, P33; Peeters A, 2003, ANN INTERN MED, V138, P24, DOI 10.7326/0003-4819-138-1-200301070-00008; Potter BK, 2004, NICOTINE TOB RES, V6, P397, DOI 10.1080/14622200410001696529; Reas DL, 2009, SCAND J PUBLIC HEALT, V37, P774, DOI 10.1177/1403494809344654; Rigotti NA, 2002, NEW ENGLAND J MED; Shah NR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033308; Sneve M, 2008, SCAND J PUBLIC HEALT, V36, P397, DOI 10.1177/1403494807088453; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stavropoulos-Kalinoglou A, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2429; Townsend PP., 1988, HLTH DEPRIVATION INE; Travier N, 2012, PREV MED, V54, P183, DOI 10.1016/j.ypmed.2011.09.003; UKBiobank, 2007, UK BIOB PROT LARG SC; USDHHS, 1990, HLTH BEN SMOK CESS R; WACK JT, 1982, AM J CLIN NUTR, V35, P366, DOI 10.1093/ajcn/35.2.366; World Health Organisation, 2013, OB FACT SHEET; YOUNGHWAN J, 2012, J NEUROBIOL, V53, P618; Zbikowski SM, 2011, NICOTINE TOB RES, V13, P319, DOI 10.1093/ntr/ntq257; Zhang LH, 2001, SURGERY, V130, P133, DOI 10.1067/msy.2001.115513	43	150	156	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123579	10.1371/journal.pone.0123579	http://dx.doi.org/10.1371/journal.pone.0123579			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886648	Green Accepted, Green Published, gold			2022-12-27	WOS:000353017000075
J	Kundu, A; Patel, A; Paul, S; Pal, A				Kundu, Anirban; Patel, Anju; Paul, Sujay; Pal, Amita			Transcript Dynamics at Early Stages of Molecular Interactions of MYMIV with Resistant and Susceptible Genotypes of the Leguminous Host, Vigna mungo	PLOS ONE			English	Article							YELLOW MOSAIC-VIRUS; DISEASE RESISTANCE; OXIDATIVE BURST; DOWN-REGULATION; PHOTOSYSTEM-II; PLANT; PROTEIN; RESPONSES; GENES; PHOSPHORYLATION	Initial phases of the MYMIV- Vigna mungo interaction is crucial in determining the infection phenotype upon challenging with the virus. During incompatible interaction, the plant deploys multiple stratagems that include extensive transcriptional alterations defying the virulence factors of the pathogen. Such molecular events are not frequently addressed by genomic tools. In order to obtain a critical insight to unravel how Vigna mungo respond to Mungbean yellow mosaic India virus (MYMIV), we have employed the PCR based suppression subtractive hybridization technique to identify genes that exhibit altered expressions. Dynamics of 345 candidate genes are illustrated that differentially expressed either in compatible or incompatible reactions and their possible biological and cellular functions are predicted. The MYMIV-induced physiological aspects of the resistant host include reactive oxygen species generation, induction of Ca2+ mediated signaling, enhanced expression of transcripts involved in phenylpropanoid and ubiquitin-proteasomal pathways; all these together confer resistance against the invader. Elicitation of genes implicated in salicylic acid (SA) pathway suggests that immune response is under the regulation of SA signaling. A significant fraction of modulated transcripts are of unknown function indicating participation of novel candidate genes in restricting this viral pathogen. Susceptibility on the other hand, as exhibited by Vigna mungo Cv. T9 is perhaps due to the poor execution of these transcript modulation exhibiting remarkable repression of photosynthesis related genes resulting in chlorosis of leaves followed by penalty in crop yield. Thus, the present findings revealed an insight on the molecular warfare during host-virus interaction suggesting plausible signaling mechanisms and key biochemical pathways overriding MYMIV invasion in resistant genotype of Vigna mungo. In addition to inflate the existing knowledge base, the genomic resources identified in this orphan crop would be useful for integrating MYMIV-tolerance trait in susceptible cultivars of Vigna mungo.	[Kundu, Anirban; Patel, Anju; Paul, Sujay; Pal, Amita] Bose Inst, Div Plant Biol, Kolkata 700054, W Bengal, India; [Paul, Sujay] Univ Nacl Agr, Lab Micol & Biotecnol, Lima, Peru	Department of Science & Technology (India); Bose Institute; University Nacional Agraria La Molina	Pal, A (corresponding author), Bose Inst, Div Plant Biol, Kolkata 700054, W Bengal, India.	amita_pal@yahoo.com	Pal, Amita/H-7660-2019; Paul, Sujay/R-7572-2019	Paul, Sujay/0000-0001-5024-7261; Kundu, Anirban/0000-0002-0351-7131	Department of Biotechnology, India [BT/01/COE/06/03]; Council of Scientific and Industrial Research, New-Delhi, India [21(0884)/12/EMR-II]	Department of Biotechnology, India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, New-Delhi, India(Council of Scientific & Industrial Research (CSIR) - India)	Department of Biotechnology, India (Sanction no. BT/01/COE/06/03) AP and also by the Council of Scientific and Industrial Research, New-Delhi, India for the Emeritus Scientists Scheme to AP (Sanction No. 21(0884)/12/EMR-II) AP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076619; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Azevedo C, 2006, EMBO J, V25, P2007, DOI 10.1038/sj.emboj.7601084; Basak J, 2004, MOL BREEDING, V14, P375, DOI 10.1007/s11032-004-0238-y; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Boyle B, 2005, APPL ENVIRON MICROB, V71, P1546, DOI 10.1128/AEM.71.3.1546-1552.2005; Brini F, 2012, ISRN MOL BIOL, DOI [10.5402/2012/927436, DOI 10.5402/2012/927436]; Herranz MC, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-164; Chen MH, 2005, PLANT PHYSIOL, V138, P1866, DOI 10.1104/pp.105.064386; Clarke JD, 2000, PLANT CELL, V12, P2175, DOI 10.1105/tpc.12.11.2175; COLON LT, 1995, EUR J PLANT PATHOL, V101, P387, DOI 10.1007/BF01874852; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; DWIVEDI S, 1985, Z PFLANZENZUCHT, V95, P281; Garcia-Brugger A, 2006, MOL PLANT MICROBE IN, V19, P711, DOI 10.1094/MPMI-19-0711; Garcia-Neria MA, 2011, MOL PLANT MICROBE IN, V24, P172, DOI 10.1094/MPMI-06-10-0126; Gomez-Gomez L, 2004, MOL IMMUNOL, V41, P1055, DOI 10.1016/j.molimm.2004.06.008; Havelda Z, 2008, PLANT J, V55, P278, DOI 10.1111/j.1365-313X.2008.03501.x; Hubert DA, 2003, EMBO J, V22, P5679, DOI 10.1093/emboj/cdg547; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Jantasuriyarat C, 2005, PLANT PHYSIOL, V138, P105, DOI 10.1104/pp.104.055624; Jin HL, 2003, PLANT J, V33, P719, DOI 10.1046/j.1365-313X.2003.01664.x; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Klink VP, 2007, PLANTA, V226, P1389, DOI 10.1007/s00425-007-0581-4; Klusener B, 2002, PLANT PHYSIOL, V130, P2152, DOI 10.1104/pp.012187; Kotchoni SO, 2006, J BIOSCIENCES, V31, P389, DOI 10.1007/BF02704112; Kundu A, 2013, PLANT CELL REP, V32, P1647, DOI 10.1007/s00299-013-1478-2; Kundu A, 2012, FIELD CROP RES, V135, P116, DOI 10.1016/j.fcr.2012.07.006; Kundu S, 2013, PROTEOME SCI, V11, DOI 10.1186/1477-5956-11-15; Kundu S, 2011, J PROTEOMICS, V74, P337, DOI 10.1016/j.jprot.2010.11.012; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Liu PP, 2010, MOL PLANT PATHOL, V11, P155, DOI [10.1111/j.1364-3703.2009.00564.x, 10.1111/j.1364-3703.2009.00564.X]; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maiti S, 2012, MOL BIOTECHNOL, V52, P217, DOI 10.1007/s12033-011-9488-1; Mandadi KK, 2013, PLANT CELL, V25, P1489, DOI 10.1105/tpc.113.111658; Manickavelu A, 2010, DNA RES, V17, P211, DOI 10.1093/dnares/dsq009; Mao GH, 2011, PLANT CELL, V23, P1639, DOI 10.1105/tpc.111.084996; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; Menke FLH, 2004, PLANT CELL, V16, P897, DOI 10.1105/tpc.015552; Orlowska E, 2012, PLANT CELL REP, V31, P187, DOI 10.1007/s00299-011-1155-2; Pallas V, 2011, J GEN VIROL, V92, P2691, DOI 10.1099/vir.0.034603-0; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pitzschke A, 2009, CURR OPIN PLANT BIOL, V12, P421, DOI 10.1016/j.pbi.2009.06.008; Polesani M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-117; Romeis T, 2001, CURR OPIN PLANT BIOL, V4, P407, DOI 10.1016/S1369-5266(00)00193-X; Schraudner M, 1998, PLANT J, V16, P235, DOI 10.1046/j.1365-313x.1998.00294.x; SINGH DP, 1980, THEOR APPL GENET, V57, P233, DOI 10.1007/BF00264676; Spetea C, 1999, P NATL ACAD SCI USA, V96, P6547, DOI 10.1073/pnas.96.11.6547; STRASSER RJ, 1995, PHOTOCHEM PHOTOBIOL, V61, P32, DOI 10.1111/j.1751-1097.1995.tb09240.x; Taj G, 2010, PLANT SIGNAL BEHAV, V5, P1370, DOI 10.4161/psb.5.11.13020; Takahashi A, 2003, P NATL ACAD SCI USA, V100, P11777, DOI 10.1073/pnas.2033934100; Vadassery J, 2009, PLANT SIGNAL BEHAV, V4, P1024, DOI 10.4161/psb.4.11.9800; Venisse JS, 2002, MOL PLANT MICROBE IN, V15, P1204, DOI 10.1094/MPMI.2002.15.12.1204; Vogt T, 2010, MOL PLANT, V3, P2, DOI 10.1093/mp/ssp106; Wan Jinrong, 2002, Funct Integr Genomics, V2, P259, DOI 10.1007/s10142-002-0080-4; Whitham SA, 2006, MOL PLANT MICROBE IN, V19, P1207, DOI 10.1094/MPMI-19-1207; Yoshioka M, 2006, J BIOL CHEM, V281, P21660, DOI 10.1074/jbc.M602896200; Zou JJ, 2005, MOL PLANT MICROBE IN, V18, P1161, DOI 10.1094/MPMI-18-1161	57	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124687	10.1371/journal.pone.0124687	http://dx.doi.org/10.1371/journal.pone.0124687			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884711	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000140
J	Liang, Z; Shi, XM; Liu, LF; Chen, XP; Shanl, ZL; Lin, K; Li, J; Chen, FK; Li, YG; Guo, HY; Wang, YT				Liang, Zhuo; Shi, Xiang-min; Liu, Li-feng; Chen, Xin-pei; Shan, Zhao-liang; Lin, Kun; Li, Jian; Chen, Fu-kun; Li, Yan-guang; Guo, Hong-yang; Wang, Yu-tang			Renal Denervation Suppresses Atrial Fibrillation in a Model of Renal Impairment	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; SYMPATHETIC DENERVATION; ACTIVATION; SYSTEM	Background A close association exists between renal impairment (RI) and atrial fibrillation (AF) occurrence. Increased activity of the sympathetic nervous system (SNS) may contribute to the development of AF associated with RI. Renal denervation (RDN) decreases central sympathetic activity. Objective The main objective of the study was to explore the effects of RDN on AF occurrence and its possible mechanisms in beagles with RI. Methods Unilateral RI was induced in beagles by embolization of small branches of the renal artery in the right kidney using gelatin sponge granules in Model (n = 6) and RDN group (n = 6). The Sham group (n = 6) underwent the same procedure, except for embolization. Then animals in RDN group underwent radiofrequency ablation of the renal sympathetic nerve. Cardiac electrophysiological parameters, blood pressure, left ventricular end-diastolic pressure, and AF inducibility were investigated. The activity of the SNS, renin-angiotensin-aldosterone system (RAAS), inflammation and atrial interstitial fibrosis were measured. Results Embolization of small branches of the renal artery in the right kidney led to ischemic RI. Heart rate, P wave duration and BP were increased by RI, which were prevented or attenuated by RDN. Atrial effective refractory period was shortened and AF inducibility was increased by RI, which were prevented by RDN. Antegrade Wenckebach point was shortened, atrial and ventricular rates during AF were increased by RI, which were attenuated or prevented by RDN. Levels of norepinephrine, renin and aldosterone in plasma, norepinephrine, angiotensin II, aldosterone, interleukin-6 and high sensitivity C-reactive protein in atrial tissue were elevated, and atrial interstitial fibrosis was enhanced by RI, which were attenuated by RDN. Conclusions RDN significantly reduced AF inducibility, prevented the atrial electrophysiological changes in a model of RI by combined reduction of sympathetic drive and RAAS activity, and inhibition of inflammation activity and fibrotic pathway in atrial tissue.	[Liang, Zhuo; Shi, Xiang-min; Liu, Li-feng; Shan, Zhao-liang; Lin, Kun; Chen, Fu-kun; Li, Yan-guang; Guo, Hong-yang] Chinese Peoples Liberat Army Gen Hosp, Dept Cardiol, Beijing 100853, Peoples R China; [Chen, Xin-pei] Tsinghua Univ, Beijing Tsinghua Changgeng Hosp Med Ctr, Dept Emergency, Beijing 100084, Peoples R China; [Li, Jian; Wang, Yu-tang] Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China	Chinese People's Liberation Army General Hospital; Tsinghua University; Chinese People's Liberation Army General Hospital	Wang, YT (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Dept Geriatr Cardiol, Beijing 100853, Peoples R China.	wyt301@sina.com	, Fred/B-8158-2013; Chen, Xinpei/AAO-1879-2021	, Fred/0000-0003-2809-9930; 	Military Key Project of Health [11BJZ10]	Military Key Project of Health	The present study is supported by the Military Key Project of Health Grant number: 11BJZ10.	Alonso A, 2011, CIRCULATION, V123, P2946, DOI 10.1161/CIRCULATIONAHA.111.020982; Bianchi S, 2009, HEART RHYTHM, V6, P1282, DOI 10.1016/j.hrthm.2009.05.011; Chen LY, 2007, HEART RHYTHM, V4, pS1, DOI 10.1016/j.hrthm.2006.12.018; Everett TH, 2007, HEART RHYTHM, V4, pS24, DOI 10.1016/j.hrthm.2006.12.040; Ewen S, 2013, CURR HYPERTENS REP, V15, P370, DOI 10.1007/s11906-013-0365-0; Fukunaga N, 2012, HEART RHYTHM, V9, P2023, DOI 10.1016/j.hrthm.2012.08.019; Hou YM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078218; Liang Z, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105974; Linz D, 2013, HYPERTENSION, V62, P767, DOI 10.1161/HYPERTENSIONAHA.113.01728; Linz D, 2013, HYPERTENSION, V61, P225, DOI 10.1161/HYPERTENSIONAHA.111.00182; Linz D, 2012, HYPERTENSION, V60, P172, DOI 10.1161/HYPERTENSIONAHA.112.191965; Mayyas F, 2013, INT J CARDIOL, V168, P5135, DOI 10.1016/j.ijcard.2013.08.022; Ogawa M, 2009, HEART RHYTHM, V6, P1772, DOI 10.1016/j.hrthm.2009.08.011; Park HW, 2012, CURR OPIN CARDIOL, V27, P24, DOI 10.1097/HCO.0b013e32834dc4e8; Redpath CJ, 2006, J MOL CELL CARDIOL, V40, P717, DOI 10.1016/j.yjmcc.2006.01.012; Savelieva I, 2011, EUROPACE, V13, P610, DOI 10.1093/europace/eur023; Schlaich MP, 2009, J AM SOC NEPHROL, V20, P933, DOI 10.1681/ASN.2008040402; Siragy HM, 2010, AM J NEPHROL, V31, P541, DOI 10.1159/000313363; Soliman EZ, 2010, AM HEART J, V159, P1102, DOI 10.1016/j.ahj.2010.03.027; Watanabe T, 2007, J VET MED SCI, V69, P1015, DOI 10.1292/jvms.69.1015; Wienemann H, 2014, MINERVA CARDIOANGIOL, V62, P235; Ye SH, 2002, AM J HYPERTENS, V15, P717, DOI 10.1016/S0895-7061(02)02959-X; Zhao QY, 2013, INT J CARDIOL, V168, P1672, DOI 10.1016/j.ijcard.2013.03.091; Zhao QY, 2012, J INTERV CARD ELECTR, V35, P119, DOI 10.1007/s10840-012-9717-y; Zimmerman D, 2012, NEPHROL DIAL TRANSPL, V27, P3816, DOI 10.1093/ndt/gfs416	25	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124123	10.1371/journal.pone.0124123	http://dx.doi.org/10.1371/journal.pone.0124123			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884946	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000102
J	Pantano, F; Santoni, M; Procopio, G; Rizzo, M; Lacovelli, R; Porta, C; Conti, A; Lugini, A; Milella, M; Galli, L; Ortega, C; Guida, FM; Silletta, M; Schinzari, G; Verzoni, E; Modica, D; Crucitti, P; Rauco, A; Felici, A; Ballatore, V; Cascinu, S; Tonini, G; Carteni, G; Russo, A; Santini, D				Pantano, Francesco; Santoni, Matteo; Procopio, Giuseppe; Rizzo, Mimma; Lacovelli, Roberto; Porta, Camillo; Conti, Alessandro; Lugini, Antonio; Milella, Michele; Galli, Luca; Ortega, Cinzia; Guida, Francesco Maria; Silletta, Marianna; Schinzari, Giovanni; Verzoni, Elena; Modica, Daniela; Crucitti, Pierfilippo; Rauco, Annamaria; Felici, Alessandra; Ballatore, Valentina; Cascinu, Stefano; Tonini, Giuseppe; Carteni, Giacomo; Russo, Antonio; Santini, Daniele			The Changes of Lipid Metabolism in Advanced Renal Cell Carcinoma Patients Treated with Everolimus: A New Pharmacodynamic Marker?	PLOS ONE			English	Article							MAMMALIAN TARGET; THERAPEUTIC STRATEGIES; MTOR; CHOLESTEROL; RAPAMYCIN; EXPRESSION; CANCER; TRIAL	Background Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved for the treatment of metastatic renal cell carcinoma (mRCC). We aimed to assess the association between the baseline values and treatmentrelated modifications of total serum cholesterol (C), triglycerides (T), body mass index (BMI), fasting blood glucose level (FBG) and blood pressure (BP) levels and the outcome of patients treated with everolimus for mRCC. Methods 177 patients were included in this retrospective analysis. Time to progression (TTP), clinical benefit (CB) and overall survival (OS) were evaluated. Results Basal BMI was significantly higher in patients who experienced a CB (p=0,0145). C, T and C+T raises were significantly associated with baseline BMI (p=0.0412, 0.0283 and 0.0001). Median TTP was significantly longer in patients with T raise compared to patients without T (10 vs 6, p=0.030), C (8 vs 5, p=0.042) and C+T raise (10.9 vs 5.0, p=0.003). At the mu analysis, only C+T increase was associated with improved TTP (p=0.005). T raise (21.0 vs 14.0, p=0.002) and C+T increase (21.0 vs 14.0, p=0.006) were correlated with improved OS but were not significant at multivariate analysis. Conclusion C+T raise is an early predictor for everolimus efficacy for patients with mRCC.	[Pantano, Francesco; Guida, Francesco Maria; Silletta, Marianna; Tonini, Giuseppe; Santini, Daniele] Campus Biomed Univ Rome, Dept Med Oncol, I-00128 Rome, Italy; [Santoni, Matteo; Cascinu, Stefano] Univ Politecn Marche, AOU Osped Riuniti, Dept Med Oncol, I-60121 Ancona, Italy; [Procopio, Giuseppe; Verzoni, Elena] Fdn IRCCS Ist Nazl Tumori, Dept Med Oncol, I-20133 Milan, Italy; [Rizzo, Mimma; Carteni, Giacomo] Cardarelli Hosp, Dept Med Oncol, I-80131 Naples, Italy; [Lacovelli, Roberto; Modica, Daniela] Univ Roma La Sapienza, Dept Oncol, Oncol Unit B, I-00185 Rome, Italy; [Porta, Camillo] IRCCS San Matteo Univ Hosp Fdn, Dept Med Oncol, I-27100 Pavia, Italy; [Conti, Alessandro] Univ Politecn Marche, Dept Clin & Specialist Sci, Urol, I-60121 Ancona, Italy; [Lugini, Antonio; Rauco, Annamaria] San Camillo De Lellis Hosp, Dept Med Oncol, I-02100 Rieti, Italy; [Milella, Michele; Felici, Alessandra] Regina Elena Inst Canc Res, Dept Med Oncol, Med Oncol A, I-00128 Rome, Italy; [Galli, Luca] Azienda Osped Univ Pisana, Dept Med Oncol, I-56126 Pisa, Italy; [Ortega, Cinzia; Ballatore, Valentina] Inst Canc Res & Treatment IRCC, Dept Med Oncol, I-10060 Turin, Italy; [Schinzari, Giovanni] Univ Cattolica Sacro Cuore, Dept Med Oncol, I-00168 Rome, Italy; [Crucitti, Pierfilippo] Campus Biomed Univ Rome, Dept Surg, I-00128 Rome, Italy; [Russo, Antonio] Univ Palermo, Dept Surg Oncol & Oral Sci, Palermo, Italy	University Campus Bio-Medico - Rome Italy; Marche Polytechnic University; Fondazione IRCCS Istituto Nazionale Tumori Milan; Antonio Cardarelli Hospital; Sapienza University Rome; IRCCS Fondazione San Matteo; Marche Polytechnic University; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Pisa; Azienda Ospedaliero Universitaria Pisana; IRCCS Fondazione del Piemonte per l'Oncologia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; University Campus Bio-Medico - Rome Italy; University of Palermo	Santini, D (corresponding author), Campus Biomed Univ Rome, Dept Med Oncol, Via Alvaro del Fortino 200, I-00128 Rome, Italy.	d.santini@unicampus.it	Iacovelli, Roberto/AAB-9850-2019; Cascinu, Stefano/AAN-1923-2020; Verzoni, Elena/K-6025-2016; Porta, Camillo/AAB-9482-2020; Schinzari, Giovanni/AAC-1547-2019; Pantano, Francesco/D-8459-2012; Cascinu, Stefano/G-2399-2017; Procopio, Giuseppe/K-2072-2016; GIACOMO, CARTENI/K-5810-2016; Rizzo, Mimma/AAB-6677-2022; rizzo, mimma/AAB-9892-2020	Iacovelli, Roberto/0000-0002-1750-2117; Verzoni, Elena/0000-0001-9756-6112; Pantano, Francesco/0000-0002-2894-9686; Cascinu, Stefano/0000-0003-2215-0731; Procopio, Giuseppe/0000-0002-2498-402X; GIACOMO, CARTENI/0000-0003-1441-6376; rizzo, mimma/0000-0001-7743-741X; Galli, Luca/0000-0001-6008-0266; Tonini, Giuseppe/0000-0003-4442-8677; Porta, Camillo/0000-0003-2412-1563; Santini, Daniele/0000-0002-9118-3337; Conti, Alessandro/0000-0002-7322-9880; Crucitti, Pierfilippo/0000-0003-1509-6714; Santoni, Matteo/0000-0001-7340-6173				Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Bronte F, 2014, CURR MED CHEM, V21, P966, DOI 10.2174/09298673113209990234; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Cho DC, 2012, CLIN CANCER RES, V18, P2999, DOI 10.1158/1078-0432.CCR-12-0953; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484, DOI 10.2174/156800910791517172; Drabkin HA, 2010, ADV CANCER RES, V107, P39, DOI 10.1016/S0065-230X(10)07002-8; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; Figlin RA, 2011, J CLIN ONCOL S7, V29; Fujita S, 2007, J PHYSIOL-LONDON, V582, P813, DOI 10.1113/jphysiol.2007.134593; GEBHARD RL, 1987, J LIPID RES, V28, P1177; Gueguen Y, 2007, BASIC CLIN PHARMACOL, V100, P392, DOI 10.1111/j.1742-7843.2007.00066.x; Hartford CM, 2009, CLIN CANCER RES, V15, P1428, DOI 10.1158/1078-0432.CCR-08-2076; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Jellinger Paul S, 2012, Endocr Pract, V18 Suppl 1, P1; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kaelin WG, 2004, CLIN CANCER RES, V10, p6290S, DOI 10.1158/1078-0432.CCR-sup-040025; Kasiske BL, 2008, AM J TRANSPLANT, V8, P1384, DOI 10.1111/j.1600-6143.2008.02272.x; Kim WY, 2004, J CLIN ONCOL, V22, P4991, DOI 10.1200/JCO.2004.05.061; Lee CK, 2012, CLIN CANCER RES, V18, P3188, DOI 10.1158/1078-0432.CCR-11-3137; Linehan WM, 2010, NAT REV UROL, V7, P277, DOI 10.1038/nrurol.2010.47; Luyimbazi D, 2010, MOL CANCER THER, V9, P2770, DOI 10.1158/1535-7163.MCT-09-0980; Ma KL, 2010, AM J PHYSIOL-HEART C, V298, pH1646, DOI 10.1152/ajpheart.00492.2009; Michaelson MD, 2013, SEMIN ONCOL, V40, P459, DOI 10.1053/j.seminoncol.2013.05.001; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Mueller MA, 2008, ATHEROSCLEROSIS, V198, P39, DOI 10.1016/j.atherosclerosis.2007.09.019; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Rolfo C, 2014, EXPERT REV GASTROENT, V8, P875, DOI 10.1586/17474124.2014.922870; Rolfo C, 2014, CANCER TREAT REV, V40, P990, DOI 10.1016/j.ctrv.2014.05.009; Sharpe LJ, 2008, BIOCHEM BIOPH RES CO, V373, P670, DOI 10.1016/j.bbrc.2008.06.108; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Singer EA, 2012, CURR OPIN ONCOL, V24, P284, DOI 10.1097/CCO.0b013e328351c646; Soliman GA, 2011, CELL CYCLE, V10, P861, DOI 10.4161/cc.10.6.14930; Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005; Tokunaga C, 2004, BIOCHEM BIOPH RES CO, V313, P443, DOI 10.1016/j.bbrc.2003.07.019; Wang BT, 2011, P NATL ACAD SCI USA, V108, P15201, DOI 10.1073/pnas.1103746108; WHO CRITERIA, 2000, THE INTERNATIONAL CL; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Zhang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054465, 10.1371/journal.pone.0059840, 10.1371/journal.pone.0059796, 10.1371/journal.pone.0066382]	40	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120427	10.1371/journal.pone.0120427	http://dx.doi.org/10.1371/journal.pone.0120427			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885920	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000009
J	Rivera-Pagan, AF; Rivera-Aponte, DE; Melnik-Martinez, KV; Zayas-Santiago, A; Kucheryavykh, LY; Martins, AH; Cubano, LA; Skatchkov, SN; Eaton, MJ				Rivera-Pagan, Aixa F.; Rivera-Aponte, David E.; Melnik-Martinez, Katya V.; Zayas-Santiago, Astrid; Kucheryavykh, Lilia Y.; Martins, Antonio H.; Cubano, Luis A.; Skatchkov, Serguei N.; Eaton, Misty J.			Up-Regulation of TREK-2 Potassium Channels in Cultured Astrocytes Requires De Novo Protein Synthesis: Relevance to Localization of TREK-2 Channels in Astrocytes after Transient Cerebral Ischemia	PLOS ONE			English	Article							MESSENGER-RNA TRANSLATION; K+ CHANNEL; P-BODIES; CORTICAL ASTROCYTES; GLUTAMATE UPTAKE; BRAIN ISCHEMIA; GLIAL-CELLS; EXPRESSION; DEGRADATION; KIR4.1	Excitotoxicity due to glutamate receptor over-activation is one of the key mediators of neuronal death after an ischemic insult. Therefore, a major function of astrocytes is to maintain low extracellular levels of glutamate. The ability of astrocytic glutamate transporters to regulate the extracellular glutamate concentration depends upon the hyperpolarized membrane potential of astrocytes conferred by the presence of K+ channels in their membranes. We have previously shown that TREK-2 potassium channels in cultured astrocytes are up-regulated by ischemia and may support glutamate clearance by astrocytes during ischemia. Thus, herein we determine the mechanism leading to this up-regulation and assess the localization of TREK-2 channels in astrocytes after transient middle cerebral artery occlusion. By using a cell surface biotinylation assay we confirmed that functional TREK-2 protein is up-regulated in the astrocytic membrane after ischemic conditions. Using real time RTPCR, we determined that the levels of TREK-2 mRNA were not increased in response to ischemic conditions. By using Western blot and a variety of protein synthesis inhibitors, we demonstrated that the increase of TREK-2 protein expression requires De novo protein synthesis, while protein degradation pathways do not contribute to TREK-2 up-regulation after ischemic conditions. Immunohistochemical studies revealed TREK-2 localization in astrocytes together with increased expression of the selective glial marker, glial fibrillary acidic protein, in brain 24 hours after transient middle cerebral occlusion. Our data indicate that functional TREK-2 channels are up-regulated in the astrocytic membrane during ischemia through a mechanism requiring De novo protein synthesis. This study provides important information about the mechanisms underlying TREK-2 regulation, which has profound implications in neurological diseases such as ischemia where astrocytes play an important role.	[Rivera-Pagan, Aixa F.; Rivera-Aponte, David E.; Melnik-Martinez, Katya V.; Kucheryavykh, Lilia Y.; Martins, Antonio H.; Skatchkov, Serguei N.; Eaton, Misty J.] Univ Cent Caribe, Dept Biochem, Bayamon, PR 00960 USA; [Cubano, Luis A.] Univ Cent Caribe, Dept Anat, Bayamon, PR USA; [Cubano, Luis A.] Univ Cent Caribe, Dept Cell Biol, Bayamon, PR USA; [Zayas-Santiago, Astrid; Skatchkov, Serguei N.] Univ Cent Caribe, Dept Physiol, Bayamon, PR USA		Rivera-Pagan, AF (corresponding author), Univ Cent Caribe, Dept Biochem, Bayamon, PR 00960 USA.	aixafernanda@gmail.com; serguei.skatchkov@uccaribe.edu		Zayas-Santiago, Astrid/0000-0003-4028-0564	National Institute of General Medical Sciences [SC1-GM088019]; National Institute of Neurological Disorders and Stroke [R01-NS065201]; National Institute of Minority Health and Health Disparities [G12-MD007583]; Office of the Associate Dean for Research and Graduate Studies (OADRGS) Predoctoral Scholarship; US Department of Education [P031M105050]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM110513, SC1GM088019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065201] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007583] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); Office of the Associate Dean for Research and Graduate Studies (OADRGS) Predoctoral Scholarship; US Department of Education(US Department of Education); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	Support was provided by: National Institute of General Medical Sciences: SC1-GM088019 (to MJE); National Institute of Neurological Disorders and Stroke: R01-NS065201 (to SNS); National Institute of Minority Health and Health Disparities: G12-MD007583 (for core facilities); Office of the Associate Dean for Research and Graduate Studies (OADRGS) Predoctoral Scholarship (to AFRP); Title V Promoting Postbaccalaureate Opportunities for Hispanic Americans (PPOHA) grant number P031M105050 from the US Department of Education (to LAC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bang H, 2000, J BIOL CHEM, V275, P17412, DOI 10.1074/jbc.M000445200; BURTRUM D, 1994, EXP NEUROL, V126, P112, DOI 10.1006/exnr.1994.1047; CHUA B, 1979, J BIOL CHEM, V254, P6617; Doerr A, 2011, NAT METHODS, V8, P711, DOI 10.1038/nmeth.1686; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Ferroni S, 2003, J NEUROSCI RES, V72, P363, DOI 10.1002/jnr.10580; Ford G, 2006, BRAIN RES, V1071, P226, DOI 10.1016/j.brainres.2005.11.090; Gnatenco C, 2002, BRAIN RES, V931, P56, DOI 10.1016/S0006-8993(02)02261-8; Huang DY, 2008, MED HYPOTHESES, V70, P618, DOI 10.1016/j.mehy.2007.06.016; KEMPSKI O, 1991, ANN NY ACAD SCI, V633, P306; Kim D, 2003, TRENDS PHARMACOL SCI, V24, P648, DOI 10.1016/j.tips.2003.10.008; Kucheryavykh Lilia Y, 2009, Open Neurosci J, V3, P40; Kucheryavykh YV, 2007, GLIA, V55, P274, DOI 10.1002/glia.20455; Lecker SH, 2006, J AM SOC NEPHROL, V17, P1807, DOI 10.1681/ASN.2006010083; Lent R, 2012, EUR J NEUROSCI, V35, P1, DOI 10.1111/j.1460-9568.2011.07923.x; Li LZ, 2008, J CEREBR BLOOD F MET, V28, P468, DOI 10.1038/sj.jcbfm.9600546; Li ZB, 2005, BIOCHEM BIOPH RES CO, V327, P1163, DOI 10.1016/j.bbrc.2004.12.124; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Marx J, 2005, SCIENCE, V310, P764, DOI 10.1126/science.310.5749.764; Matsuyama N, 2000, CIRCULATION S3, V102; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Neusch C, 2006, J NEUROPHYSIOL, V95, P1843, DOI 10.1152/jn.00996.2005; Olsen ML, 2007, J NEUROPHYSIOL, V98, P786, DOI 10.1152/jn.00340.2007; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Pivonkova H, 2010, NEUROCHEM INT, V57, P783, DOI 10.1016/j.neuint.2010.08.016; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; REHNCRONA S, 1982, J NEUROCHEM, V38, P84, DOI 10.1111/j.1471-4159.1982.tb10857.x; Seifert G, 2009, J NEUROSCI, V29, P7474, DOI 10.1523/JNEUROSCI.3790-08.2009; Skatchkov SN, 2006, GLIA, V53, P266, DOI 10.1002/glia.20280; Stanimirovic DB, 1997, GLIA, V19, P123, DOI 10.1002/(SICI)1098-1136(199702)19:2<123::AID-GLIA4>3.0.CO;2-1; Taylor MH, 2002, FEBS LETT, V514, P199, DOI 10.1016/S0014-5793(02)02364-5; Thomzig A, 2001, MOL CELL NEUROSCI, V18, P671, DOI 10.1006/mcne.2001.1048; Valenzuela SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056948; Whitfield J., 2003, NATURE REV MOL CELL, V3, P112; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wu X, 2013, J MOL NEUROSCI, V49, P499, DOI 10.1007/s12031-012-9875-5; Xu XH, 2004, MOL BRAIN RES, V120, P205, DOI 10.1016/j.molbrainres.2003.09.020; YOSHIKAWA M, 1978, PLANT PHYSIOL, V61, P314, DOI 10.1104/pp.61.3.314; Zayas-Santiago A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097155	39	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125195	10.1371/journal.pone.0125195	http://dx.doi.org/10.1371/journal.pone.0125195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886567	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000154
J	Berg, M; Nordgaard, O; Korner, H; Oltedal, S; Smaaland, R; Soreide, JA; Soreide, K				Berg, Marianne; Nordgaard, Oddmund; Korner, Hartwig; Oltedal, Satu; Smaaland, Rune; Soreide, Jon Arne; Soreide, Kjetil			Molecular Subtypes in Stage II-III Colon Cancer Defined by Genomic Instability: Early Recurrence-Risk Associated with a High Copy-Number Variation and Loss of RUNX3 and CDKN2A	PLOS ONE			English	Article							ISLAND METHYLATOR PHENOTYPE; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; CPG ISLAND; CHROMOSOMAL INSTABILITY; BRAF MUTATION; CLASSIFICATION; GENE; CARCINOMAS; EXPRESSION	Objective We sought to investigate various molecular subtypes defined by genomic instability that may be related to early death and recurrence in colon cancer. Methods We sought to investigate various molecular subtypes defined by instability at microsatellites (MSI), changes in methylation patterns (CpG island methylator phenotype, CIMP) or copy number variation (CNV) in 8 genes. Stage II-III colon cancers (n = 64) were investigated by methylation-specific multiplex ligated probe amplification (MS-MLPA). Correlation of CNV, CIMP and MSI, with mutations in KRAS and BRAFV600E were assessed for overlap in molecular subtypes and early recurrence risk by uni-and multivariate regression. Results The CIMP phenotype occurred in 34% (22/64) and MSI in 27% (16/60) of the tumors, with noted CIMP/MSI overlap. Among the molecular subtypes, a high CNV phenotype had an associated odds ratio (OR) for recurrence of 3.2 (95% CI 1.1-9.3; P = 0.026). Losses of CACNA1G (OR of 2.9, 95% CI 1.4-6.0; P = 0.001), IGF2 (OR of 4.3, 95% CI 1.1-15.8; P = 0.007), CDKN2A (p16) (OR of 2.0, 95% CI 1.1-3.6; P = 0.024), and RUNX3 (OR of 3.4, 95% CI 1.3-8.7; P = 0.002) were associated with early recurrence, while MSI, CIMP, KRAS or BRAF V600E mutations were not. The CNV was significantly higher in deceased patients (CNV in 6 of 8) compared to survivors (CNV in 3 of 8). Only stage and loss of RUNX3 and CDKN2A were significant in the multivariable risk-model for early recurrence. Conclusions A high copy number variation phenotype is a strong predictor of early recurrence and death, and may indicate a dose-dependent relationship between genetic instability and outcome. Loss of tumor suppressors RUNX3 and CDKN2A were related to recurrence-risk and warrants further investigation.	[Berg, Marianne] Univ Stavanger, Ctr Organelle Res CORE, Stavanger, Norway; [Berg, Marianne; Korner, Hartwig; Soreide, Jon Arne; Soreide, Kjetil] Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway; [Nordgaard, Oddmund; Oltedal, Satu; Smaaland, Rune] Stavanger Univ Hosp, Dept Hematol & Oncol, Stavanger, Norway; [Korner, Hartwig; Soreide, Jon Arne; Soreide, Kjetil] Univ Bergen, Dept Clin Med, Bergen, Norway	Universitetet i Stavanger; Stavanger University Hospital; Stavanger University Hospital; University of Bergen	Soreide, K (corresponding author), Stavanger Univ Hosp, Dept Gastrointestinal Surg, Stavanger, Norway.	kjetil.soreide@k1.uib.no	Søreide, Kjetil/A-9797-2010; Smaaland, Rune/AAH-2149-2021; Søreide, Jon Arne/H-7518-2019; Kørner, Hartwig/T-9372-2019	Søreide, Kjetil/0000-0001-7594-4354; Søreide, Jon Arne/0000-0001-7572-1089; 	Folke Hermansens Cancer Foundation [424508]; Mjaaland Cancer Research Fund [424506]	Folke Hermansens Cancer Foundation; Mjaaland Cancer Research Fund	This study was funded in part by grants from the Folke Hermansens Cancer Foundation (grant #424508 to KS for MB as a post-doctoral fellow, http://www.folke-fondet.org/Folke_Hermansen.html) and the Mjaaland Cancer Research Fund (grant #424506 to KS).	Ahlquist T, 2008, NEOPLASIA, V10, P680, DOI 10.1593/neo.08312; Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; Bacolod MD, 2011, ANN SURG ONCOL, V18, P3694, DOI 10.1245/s10434-011-1615-5; Berg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086657; Berg M, 2013, MOL MED, V19, P286, DOI 10.2119/molmed.2013.00049; Berg M, 2011, INT J MOL SCI, V12, P9426, DOI 10.3390/ijms12129426; Berg M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-100; Brenner H, 2014, LANCET, V383, P1490, DOI 10.1016/S0140-6736(13)61649-9; Brim H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082185; Camps J, 2008, CANCER RES, V68, P1284, DOI 10.1158/0008-5472.CAN-07-2864; Camps J, 2009, GENE CHROMOSOME CANC, V48, P1002, DOI 10.1002/gcc.20699; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Domingo E, 2013, J PATHOL, V229, P441, DOI 10.1002/path.4139; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gilje B, 2008, J MOL DIAGN, V10, P325, DOI 10.2353/jmoldx.2008.070183; Guastadisegni C, 2010, EUR J CANCER, V46, P2788, DOI 10.1016/j.ejca.2010.05.009; Hosmer DW, 1997, STAT MED, V16, P965; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Kaneda A, 2005, CANCER RES, V65, P11236, DOI 10.1158/0008-5472.CAN-05-2959; Kang GH, 2011, ARCH PATHOL LAB MED, V135, P698, DOI 10.1043/2010-0523-RA.1; Kloor M, 2014, LANGENBECK ARCH SURG, V399, P23, DOI 10.1007/s00423-013-1112-3; Kozlowski P, 2008, ELECTROPHORESIS, V29, P4627, DOI 10.1002/elps.200800126; Lea D, 2014, SCAND J GASTROENTERO, V49, P1153, DOI 10.3109/00365521.2014.950692; Lee CWL, 2010, CANCER RES, V70, P4243, DOI 10.1158/0008-5472.CAN-09-3805; Li XH, 2013, J NANOPART RES, V15, DOI 10.1007/s11051-013-1472-1; Livide G, 2012, PATHOL ONCOL RES, V18, P703, DOI 10.1007/s12253-012-9498-8; Lochhead P, 2013, JNCI-J NATL CANCER I, V105, P1151, DOI 10.1093/jnci/djt173; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nazemalhosseini Mojarad Ehsan, 2013, Gastroenterol Hepatol Bed Bench, V6, P120; Nordgard O, 2012, ANN SURG ONCOL, V19, P3719, DOI 10.1245/s10434-012-2454-8; Nordgard O, 2009, ANN SURG, V249, P602, DOI 10.1097/SLA.0b013e31819ec923; Ogino S, 2008, J MOL DIAGN, V10, P13, DOI 10.2353/jmoldx.2008.070082; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; Peltomaki P, 2012, EXP CELL RES, V318, P299, DOI 10.1016/j.yexcr.2011.12.001; Shima K, 2011, INT J CANCER, V128, P1080, DOI 10.1002/ijc.25432; Sideris M, 2014, ANTICANCER RES, V34, P2061; Simons CCJM, 2013, ANN ONCOL, V24, P2048, DOI 10.1093/annonc/mdt076; Simpkins SB, 1999, HUM MOL GENET, V8, P661, DOI 10.1093/hmg/8.4.661; Soong R, 2009, BRIT J CANCER, V100, P676, DOI 10.1038/sj.bjc.6604899; Soreide K, 2010, SCAND J GASTROENTERO, V45, P1255, DOI 10.3109/00365521.2010.496492; Soreide K, 2009, WORLD J SURG, V33, P2695, DOI 10.1007/s00268-009-0255-4; Soreide K, 2009, CANCER-AM CANCER SOC, V115, P271, DOI 10.1002/cncr.24024; Stuppia L, 2012, INT J MOL SCI, V13, P3245, DOI 10.3390/ijms13033245; Toyota M, 2000, P NATL ACAD SCI USA, V97, P710, DOI 10.1073/pnas.97.2.710; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Toyota M, 1999, CANCER RES, V59, P4535; Trautmann K, 2006, CLIN CANCER RES, V12, P6379, DOI 10.1158/1078-0432.CCR-06-1248; Veen T, 2013, DIGEST SURG, V30, P1, DOI 10.1159/000349923; Walther A, 2008, GUT, V57, P941, DOI 10.1136/gut.2007.135004; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xing X, 2013, BRIT J CANCER, V108, P2542, DOI 10.1038/bjc.2013.251; Yamauchi M, 2012, GUT, V61, P847, DOI 10.1136/gutjnl-2011-300865; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9	56	20	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122391	10.1371/journal.pone.0122391	http://dx.doi.org/10.1371/journal.pone.0122391			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879218	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353016500019
J	Muniz, LC; Menezes, AMB; Assuncao, MCF; Wehrmeister, FC; Martinez-Mesa, J; Goncalves, H; Domingues, MR; Gigante, DP; Horta, BL; Barros, FC				Muniz, Ludmila Correa; Baptista Menezes, Ana Maria; Formoso Assuncao, Maria Cecilia; Wehrmeister, Fernando Cesar; Martinez-Mesa, Jeovany; Goncalves, Helen; Domingues, Marlos Rodrigues; Gigante, Denise Petrucci; Horta, Bernardo Lessa; Barros, Fernando C.			Breastfeeding and Bone Mass at the Ages of 18 and 30: Prospective Analysis of Live Births from the Pelotas (Brazil) 1982 and 1993 Cohorts	PLOS ONE			English	Article							BODY-COMPOSITION; OSTEOPOROTIC FRACTURES; CHILDHOOD GROWTH; MATERNAL SMOKING; CALCIUM INTAKE; DENSITY; ADOLESCENCE; CHILDREN; WEIGHT; SIZE	Objective To evaluate the effect of total breastfeeding, breastfeeding duration and type of breastfeeding at 3 months of age on bone mass at 18 and 30 years. Study Design A prospective, longitudinal study was conducted with two birth cohorts (1982 and 1993) in Pelotas, Southern Brazil. Measurements of bone mineral content (BMC) and bone mineral density (BMD) at 18 and 30 years of age were obtained by dual-energy X-ray absorptiometry (DXA). Information on breastfeeding was collected during the first 4 years of life. Analyses were performed by linear regression and stratified by sex. Results A total of 1109 and 3226 participants provided complete information on breastfeeding in early life and bone mass at 18 and 30 years, respectively. No association between breastfeeding and bone mass was observed in women at both ages nor among men at age 30. Among men at the age of 18, BMC and BMD were higher among those breastfed regardless of duration (p= 0.032 and p= 0.043, respectively). Conclusions Despite a very weak positive effect of breastfeeding (yes/no) on BMC and BMD at age 18 in men, most findings pointed to a lack of association between breastfeeding and bone mass until young adulthood.	[Muniz, Ludmila Correa; Baptista Menezes, Ana Maria; Formoso Assuncao, Maria Cecilia; Wehrmeister, Fernando Cesar; Martinez-Mesa, Jeovany; Goncalves, Helen; Gigante, Denise Petrucci; Horta, Bernardo Lessa; Barros, Fernando C.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil; [Domingues, Marlos Rodrigues] Univ Fed Pelotas, Postgrad Program Phys Educ, Pelotas, Brazil	Universidade Federal de Pelotas; Universidade Federal de Pelotas	Muniz, LC (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, Brazil.	ludmuniz@yahoo.com.br	Gigante, Denise/G-9285-2015; Gonçalves, Helen/P-2381-2018; MESA, JEOVANY MARTINEZ/AAE-9703-2020; Domingues, Marlos R/A-4758-2009; Wehrmeister, Fernando/A-3006-2014; Menezes, Ana MB/G-7266-2012; Gonçalves, Helen/M-1603-2017; Horta, Bernardo/A-7604-2008	Gigante, Denise/0000-0001-7309-5838; Domingues, Marlos R/0000-0002-2503-2944; Wehrmeister, Fernando/0000-0001-7137-1747; Menezes, Ana MB/0000-0002-2996-9427; Gonçalves, Helen/0000-0001-6470-3352; Horta, Bernardo/0000-0001-9843-412X	Wellcome Trust; International Development Research Center; World Health Organization; Overseas Development Administration; European Union; National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq); Brazilian Public Health Association (ABRASCO); Brazilian Ministry of Health	Wellcome Trust(Wellcome TrustEuropean Commission); International Development Research Center; World Health Organization(World Health Organization); Overseas Development Administration; European Union(European Commission); National Support Program for Centers of Excellence (PRONEX); Brazilian National Research Council (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Brazilian Public Health Association (ABRASCO); Brazilian Ministry of Health	This article is based on data from the studies "Pelotas Birth Cohort, 1982 and 1993" conducted by the Postgraduate Program in Epidemiology at the Universidade Federal de Pelotas. The 1982 and 1993 birth cohort studies are currently supported by Wellcome Trust. The International Development Research Center, the World Health Organization, Overseas Development Administration, European Union, National Support Program for Centers of Excellence (PRONEX), the Brazilian National Research Council (CNPq), the Brazilian Public Health Association (ABRASCO) and the Brazilian Ministry of Health supported previous phases of the studies. The aforementioned funders had no role in the design, analysis or writing of this article.	[Anonymous], 2004, LIFE COURSE APPROACH; Araujo CL, 2010, CAD SAUDE PUBLICA, V26, P1875, DOI 10.1590/S0102-311X2010001000003; BATES CJ, 1994, PHARMACOL THERAPEUT, V62, P193, DOI 10.1016/0163-7258(94)90011-6; Butte NF, 2000, PEDIATRICS, V106, P1355, DOI 10.1542/peds.106.6.1355; Cooper C, 2006, OSTEOPOROSIS INT, V17, P337, DOI 10.1007/s00198-005-2039-5; Cooper C, 1997, ANN RHEUM DIS, V56, P17, DOI 10.1136/ard.56.1.17; COOPER C, 1995, J BONE MINER RES, V10, P940; de Onis M, 2007, B WORLD HEALTH ORGAN, V85, P660, DOI 10.2471/BLT.07.043497; Fewtrell M, 2011, CURR OPIN CLIN NUTR, V14, P297, DOI 10.1097/MCO.0b013e328345361b; Fewtrell MS, 2013, BR J NUTR, V110, P1; Foley S, 2009, BONE, V44, P752, DOI 10.1016/j.bone.2008.11.009; Goncalves H, 2014, INT J EPIDEMIOL, V43, P1082, DOI 10.1093/ije/dyu077; Gonzalez-Chica DA, 2012, INT J EPIDEMIOL, V41, P743, DOI 10.1093/ije/dys002; HANSEN MA, 1991, BMJ-BRIT MED J, V303, P961, DOI 10.1136/bmj.303.6808.961; Harvey NC, 2009, BRIT J NUTR, V102, P915, DOI 10.1017/S0007114509317420; Hasselstrom H, 2006, CALCIFIED TISSUE INT, V79, P7, DOI 10.1007/s00223-006-0012-8; Heaney RP, 2000, OSTEOPOROSIS INT, V11, P985, DOI 10.1007/s001980070020; Jones G, 2013, OSTEOPOROSIS INT, V24, P1605, DOI 10.1007/s00198-012-2207-3; Jones G, 2000, OSTEOPOROSIS INT, V11, P146, DOI 10.1007/PL00004176; Kelly TL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007038; Lewiecki EM, 2004, J CLIN ENDOCR METAB, V89, P3651, DOI 10.1210/jc.2004-0124; Marshall D, 1996, BRIT MED J, V312, P1254, DOI 10.1136/bmj.312.7041.1254; Molgaard C, 2011, AM J CLIN NUTR, V94, p1865S, DOI 10.3945/ajcn.110.001214; MORLEY R, 1994, ACTA PAEDIATR, V83, P123, DOI 10.1111/j.1651-2227.1994.tb13410.x; NGUYEN T, 1993, BRIT MED J, V307, P1111, DOI 10.1136/bmj.307.6912.1111; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/00006450-200212000-00009; Pirila S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019068; Prentice A, 2003, J NUTR, V133, p1693S, DOI 10.1093/jn/133.5.1693S; Rea Marina Ferreira, 2003, Cad. Saúde Pública, V19, pS37, DOI 10.1590/S0102-311X2003000700005; Torgerson DJ, 2011, EFFECTIVE MANAGEMENT, P111, DOI [DOI 10.1093/BMB/LDU016, 10.1093/bmb/ldu016]; VALIMAKI MJ, 1994, BMJ-BRIT MED J, V309, P230, DOI 10.1136/bmj.309.6949.230; Victora CG, 2008, CAD SAUDE PUBLICA, V24, pS409, DOI 10.1590/S0102-311X2008001500006; Victora CG, 2006, REV SAUDE PUBL, V40, P39, DOI 10.1590/S0034-89102006000100008; Victora CG, 1993, INT J EPIDEMIOL, V2008, P704, DOI DOI 10.1093/IJEIDYRN277; Wells JCK, 2007, BEST PRACT RES CL EN, V21, P415, DOI 10.1016/j.beem.2007.04.007; WELTEN DC, 1994, J BONE MINER RES, V9, P1089, DOI 10.1002/jbmr.5650090717; Young RJ, 2005, J PEDIATR GASTR NUTR, V41, P88, DOI 10.1097/01.MPG.0000162481.81900.E6	37	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122759	10.1371/journal.pone.0122759	http://dx.doi.org/10.1371/journal.pone.0122759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880483	gold, Green Published			2022-12-27	WOS:000353016500029
J	Lu, HY; Huang, CY; Shih, CM; Chang, WH; Tsai, CS; Lin, FY; Shih, CC				Lu, Hsin Ying; Huang, Chun Yao; Shih, Chun Ming; Chang, Wei Hung; Tsai, Chein Sung; Lin, Feng Yen; Shih, Chun Che			Dipeptidyl Peptidase-4 Inhibitor Decreases Abdominal Aortic Aneurysm Formation through GLP-1-Dependent Monocytic Activity in Mice	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ENDOTHELIAL PROGENITOR CELLS; E-DEFICIENT MICE; ATHEROSCLEROTIC LESIONS; MATRIX METALLOPROTEINASES; MECHANICAL-PROPERTIES; MACROPHAGE-MIGRATION; RECEPTOR AGONIST; KAPPA-B; EXPRESSION	Abdominal aortic aneurysm (AAA) is a life-threatening situation affecting almost 10% of elders. There has been no effective medication for AAA other than surgical intervention. Dipeptidyl peptidase-4 (DPP-4) inhibitors have been shown to have a protective effect on cardiovascular disease. Whether DPP-4 inhibitors may be beneficial in the treatment of AAA is unclear. We investigated the effects of DPP-4 inhibitor sitagliptin on the angiotensin II (Ang II)-infused AAA formation in apoE-deficient (apoE(-/-)) mice. Mice with induced AAA were treated with placebo or 2.5, 5 or 10 mg/kg/day sitagliptin. Ang II-infused apoE(-/-) mice exhibited a 55.6% incidence of AAA formation, but treatment with sitagliptin decreased AAA formation. Specifically, administered sitagliptin in Ang II-infused mice exhibited decreased expansion of the suprarenal aorta, reduced elastin lamina degradation of the aorta, and diminished vascular inflammation by macrophage infiltration. Treatment with sitagliptin decreased gelatinolytic activity and apoptotic cells in aorta tissues. Sitaglipitn, additionally, was associated with increased levels of plasma active glucagon-like peptide-1 (GLP-1). In vitro studies, GLP-1 decreased reactive oxygen species (ROS) production, cell migration, and MMP-2 as well as MMP-9 activity in Ang II-stimulated monocytic cells. The results conclude that oral administration of sitagliptin can prevent abdominal aortic aneurysm formation in Ang II-infused apoE(-/-) mice, at least in part, by increasing of GLP-1 activity, decreasing MMP-2 and MMP-9 production from macrophage infiltration. The results indicate that sitagliptin may have therapeutic potential in preventing the development of AAA.	[Lu, Hsin Ying; Chang, Wei Hung; Shih, Chun Che] Natl Yang Ming Univ, Inst Clin Med, Taipei 112, Taiwan; [Huang, Chun Yao; Shih, Chun Ming; Lin, Feng Yen] Taipei Med Univ Hosp, Dept Internal Med, Div Cardiol, Taipei, Taiwan; [Tsai, Chein Sung] Triserv Gen Hosp, Div Cardiovasc Surg, Taipei, Taiwan; [Shih, Chun Che] Taipei Vet Gen Hosp, Div Cardiovasc Surg, Taipei, Taiwan	National Yang Ming Chiao Tung University; Taipei Medical University; Taipei Medical University Hospital; Tri-Service General Hospital; Taipei Veterans General Hospital	Lin, FY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Dept Internal Med, Taipei, Taiwan.	g870905@tmu.edu.tw; ccshih@vghtpe.gov.tw			National Science Council, Taiwan [NSC98-2314-B-010-035-MY3, 99-2314-B-075-011-MV3]; Taipei Veterans General Hospital, Taiwan [V98C1-003, V98F-007, V98A-044, V100C-018, VGHUST100-G7-4-2]; Tri-Service General Hospital, Taiwan [DV103-04]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital); Tri-Service General Hospital, Taiwan	This work was supported by grants from the National Science Council, Taiwan (NSC98-2314-B-010-035-MY3 and 99-2314-B-075-011-MV3), Taipei Veterans General Hospital, Taiwan (V98C1-003,V98F-007, V98A-044, V100C-018, and VGHUST100-G7-4-2) and Tri-Service General Hospital, Taiwan (DV103-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arakawa M, 2010, DIABETES, V59, P1030, DOI 10.2337/db09-1694; Bao W, 2014, J VASC SURG, V59, P1098, DOI 10.1016/j.jvs.2013.04.048; BAXTER BT, 1992, J VASC SURG, V16, P192, DOI 10.1016/0741-5214(92)90107-J; Bose AK, 2005, DIABETES, V54, P146, DOI 10.2337/diabetes.54.1.146; Burgmaier M, 2013, ATHEROSCLEROSIS, V231, P427, DOI 10.1016/j.atherosclerosis.2013.08.033; Byrd JB, 2007, J ALLERGY CLIN IMMUN, V120, P403, DOI 10.1016/j.jaci.2007.04.012; Carmeliet P, 1997, NAT GENET, V17, P439, DOI 10.1038/ng1297-439; Cassis LA, 2009, AM J PHYSIOL-HEART C, V296, pH1660, DOI 10.1152/ajpheart.00028.2009; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; DOBRIN PB, 1984, ARCH SURG-CHICAGO, V119, P405; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Fadini GP, 2010, DIABETES CARE, V33, P1607, DOI 10.2337/dc10-0187; Ferreira L, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/592760; Forte A, 2010, CARDIOVASC RES, V88, P395, DOI 10.1093/cvr/cvq224; Gaspari T, 2013, DIABETES VASC DIS RE, V10, P353, DOI 10.1177/1479164113481817; Goetzl EJ, 1996, J IMMUNOL, V156, P1; Gorrell MD, 2001, SCAND J IMMUNOL, V54, P249, DOI 10.1046/j.1365-3083.2001.00984.x; HE CM, 1994, J VASC SURG, V20, P6, DOI 10.1016/0741-5214(94)90169-4; Huang CY, 2012, BRIT J PHARMACOL, V167, P1506, DOI 10.1111/j.1476-5381.2012.02102.x; Irvine CD, 2000, EUR J VASC ENDOVASC, V20, P374, DOI 10.1053/ejvs.2000.1187; JOHNSTON KW, 1991, J VASC SURG, V13, P452, DOI 10.1067/mva.1991.26737; Kang JH, 2009, J ENDOCRINOL, V202, P65, DOI 10.1677/JOE-08-0507; Knipp BS, 2004, J SURG RES, V116, P70, DOI 10.1016/S0022-4804(03)00306-8; Kodera R, 2014, BIOCHEM BIOPH RES CO, V443, P828, DOI 10.1016/j.bbrc.2013.12.049; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Ma GF, 2014, ACTA PHARMACOL SIN, V35, P195, DOI 10.1038/aps.2013.128; Maeda I, 2007, J PEPT SCI, V13, P263, DOI 10.1002/psc.845; Manning MW, 2003, ARTERIOSCL THROM VAS, V23, P483, DOI 10.1161/01.ATV.0000058404.92759.32; Manning MW, 2002, VASC MED, V7, P45, DOI 10.1191/1358863x02vm413ra; Mannucci E, 2008, NUTR METAB CARDIOVAS, V18, P639, DOI 10.1016/j.numecd.2008.08.002; Matsubara J, 2012, J AM COLL CARDIOL, V59, P265, DOI 10.1016/j.jacc.2011.07.053; Mentlein R, 1999, REGUL PEPTIDES, V85, P9, DOI 10.1016/S0167-0115(99)00089-0; Monami M, 2012, ADV THER, V29, P14, DOI 10.1007/s12325-011-0088-z; Ocana E, 2008, ATHEROSCLEROSIS, V200, P264, DOI 10.1016/j.atherosclerosis.2007.12.043; Okamoto K, 2012, INT J ONCOL, V41, P573, DOI 10.3892/ijo.2012.1499; Shah Z, 2011, CIRCULATION, V124, P2339, DOI 10.1161/CIRCULATIONAHA.111.041418; Shirakawa J, 2011, DIABETES, V60, P1246, DOI 10.2337/db10-1338; Tashiro Y, 2014, PEPTIDES, V54, P19, DOI 10.1016/j.peptides.2013.12.015; Terasaki M, 2012, METABOLISM, V61, P974, DOI 10.1016/j.metabol.2011.11.011; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Verspohl EJ, 2009, PHARMACOL THERAPEUT, V124, P113, DOI 10.1016/j.pharmthera.2009.06.002; Vittone F, 2012, DIABETOLOGIA, V55, P2267, DOI 10.1007/s00125-012-2582-5	43	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0121077	10.1371/journal.pone.0121077	http://dx.doi.org/10.1371/journal.pone.0121077			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25876091	Green Submitted, gold, Green Published			2022-12-27	WOS:000353014700008
J	Togo, S; Kagawa, T; Uno, Y				Togo, Shunta; Kagawa, Takahiro; Uno, Yoji			Control Model for Dampening Hand Vibrations Using Information of Internal and External Coordinates	PLOS ONE			English	Article							HUMAN ARM STIFFNESS; IMPEDANCE CONTROL; MOVEMENTS; SKYHOOK; MAINTENANCE; DIRECTION; GRAVITY; POSTURE; TORQUE; FORCE	In the present study, we investigate a control mechanism that dampens hand vibrations. Here, we propose a control method with two components to suppress hand vibrations. The first is a passive suppression method that lowers the joint stiffness to passively dampen the hand vibrations. The second is an active suppression method that adjusts an equilibrium point based on skyhook control to actively dampen the hand vibrations. In a simulation experiment, we applied these two methods to dampen hand vibrations during the shoulder's horizontal oscillation. We also conducted a measurement experiment wherein a subject's shoulder was sinusoidally oscillated by a platform that generated horizontal oscillations. The results of the measurement experiments showed that the jerk of each part of the arm in a task using a cup filled with water was smaller than the shoulder jerk and that in a task with a cup filled with stones was larger than the shoulder jerk. Moreover, the amplitude of the hand trajectory in both horizontal and vertical directions was smaller in a task using a cup filled with water than in a task using a cup filled with stones. The results of the measurement experiments were accurately reproduced by the active suppression method based on skyhook control. These results suggest that humans dampen hand vibrations by controlling the equilibrium point through the information of the external workspace and the internal body state rather than by lowering joint stiffness only by using internal information.	[Togo, Shunta] Adv Telecommun Res Inst Int, Cognit Mech Labs, Kyoto, Japan; [Togo, Shunta] Japan Soc Promot Sci, Tokyo, Japan; [Kagawa, Takahiro; Uno, Yoji] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648601, Japan	Advanced Telecommunications Research Institute International; Japan Society for the Promotion of Science; Nagoya University	Togo, S (corresponding author), Adv Telecommun Res Inst Int, Cognit Mech Labs, Kyoto, Japan.	togo@atr.jp	Kagawa, Takahiro/AAW-6244-2020	Kagawa, Takahiro/0000-0002-4539-1813	Japan Society for the Promotion of Science (JSPS) [267576, 26289129]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for JSPS Fellows 267576, and Grand-in-Aid for Scientific Research (B) 26289129. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BIZZI E, 1984, J NEUROSCI, V4, P2738; Choi SB, 2001, MECHATRONICS, V11, P345, DOI 10.1016/S0957-4158(00)00022-2; Crevecoeur F, 2009, J NEUROPHYSIOL, V102, P786, DOI 10.1152/jn.00113.2009; DOLAN JM, 1993, IEEE T SYST MAN CYB, V23, P698, DOI 10.1109/21.256543; FLASH T, 1985, J NEUROSCI, V5, P1688, DOI 10.1523/jneurosci.05-07-01688.1985; FLASH T, 1990, EXP BRAIN RES, V82, P315; Foo E, 2000, CONTROL ENG PRACT, V8, P507, DOI 10.1016/S0967-0661(99)00188-4; Gaveau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022045; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Gomi H, 1996, SCIENCE, V272, P117, DOI 10.1126/science.272.5258.117; Gribble PL, 2003, J NEUROPHYSIOL, V89, P2396, DOI 10.1152/jn.01020.2002; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hoshijima K, 2007, INT J CONTROL AUTOM, V5, P614; KARNOPP D, 1974, J ENG IND-T ASME, V96, P619, DOI 10.1115/1.3438373; Kavanagh JJ, 2005, HUM MOVEMENT SCI, V24, P574, DOI 10.1016/j.humov.2005.07.003; Koike Y, 2006, JPN PSYCHOL RES, V48, P174, DOI 10.1111/j.1468-5884.2006.00316.x; Li H, 1999, CONTROL ENG PRACT, V7, P843, DOI 10.1016/S0967-0661(99)00048-9; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; Menz HB, 2003, GAIT POSTURE, V18, P35, DOI 10.1016/S0966-6362(02)00159-5; MILNER TE, 1993, EXP BRAIN RES, V94, P522; MUSSAIVALDI FA, 1985, J NEUROSCI, V5, P2732; Osu R, 2004, J NEUROPHYSIOL, V92, P1199, DOI 10.1152/jn.00519.2003; Osu R, 2009, NEUROSCI RES, V65, P6, DOI 10.1016/j.neures.2009.05.012; Papaxanthis C, 2003, NEUROSCIENCE, V117, P779, DOI 10.1016/S0306-4522(02)00964-8; Papaxanthis C, 1998, NEUROSCI LETT, V253, P103, DOI 10.1016/S0304-3940(98)00604-1; Papaxanthis C, 1998, EXP BRAIN RES, V120, P233, DOI 10.1007/s002210050397; Sammier D, 2003, VEHICLE SYST DYN, V39, P279, DOI 10.1076/vesd.39.4.279.14149; Shin D, 2009, J NEUROPHYSIOL, V101, P387, DOI 10.1152/jn.00584.2007; TAKEGAKI M, 1981, J DYN SYST-T ASME, V103, P119, DOI 10.1115/1.3139651; Togo S, 2014, EXP BRAIN RES, V232, P3101, DOI 10.1007/s00221-014-3994-x; Togo S, 2012, EXP BRAIN RES, V216, P81, DOI 10.1007/s00221-011-2909-3; TSUJI T, 1995, BIOL CYBERN, V72, P475, DOI 10.1007/BF00199890; UNO Y, 1989, BIOL CYBERN, V61, P89, DOI 10.1007/BF00204593; Winter D.A., 2004, BIOMECHANICS MOTOR C, V3rd, P63; Yoshida K, 2000, INT J COMPUT APPL T, V13, P52, DOI 10.1504/IJCAT.2000.000223	36	0	0	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0125464	10.1371/journal.pone.0125464	http://dx.doi.org/10.1371/journal.pone.0125464			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876037	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100295
J	Almquist, J; Bendrioua, L; Adiels, CB; Goksor, M; Hohmann, S; Jirstrand, M				Almquist, Joachim; Bendrioua, Loubna; Adiels, Caroline Beck; Goksor, Mattias; Hohmann, Stefan; Jirstrand, Mats			A Nonlinear Mixed Effects Approach for Modeling the Cell-To-Cell Variability of Mig1 Dynamics in Yeast	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; IDENTIFIABILITY ANALYSIS; SNF1 KINASE; KINETICS; HETEROGENEITY; DISTRIBUTIONS; ADAPTATION; REPRESSION; INFERENCE	The last decade has seen a rapid development of experimental techniques that allow data collection from individual cells. These techniques have enabled the discovery and characterization of variability within a population of genetically identical cells. Nonlinear mixed effects (NLME) modeling is an established framework for studying variability between individuals in a population, frequently used in pharmacokinetics and pharmacodynamics, but its potential for studies of cell-to-cell variability in molecular cell biology is yet to be exploited. Here we take advantage of this novel application of NLME modeling to study cell-to-cell variability in the dynamic behavior of the yeast transcription repressor Mig1. In particular, we investigate a recently discovered phenomenon where Mig1 during a short and transient period exits the nucleus when cells experience a shift from high to intermediate levels of extracellular glucose. A phenomenological model based on ordinary differential equations describing the transient dynamics of nuclear Mig1 is introduced, and according to the NLME methodology the parameters of this model are in turn modeled by a multivariate probability distribution. Using time-lapse microscopy data from nearly 200 cells, we estimate this parameter distribution according to the approach of maximizing the population likelihood. Based on the estimated distribution, parameter values for individual cells are furthermore characterized and the resulting Mig1 dynamics are compared to the single cell times-series data. The proposed NLME framework is also compared to the intuitive but limited standard two-stage (STS) approach. We demonstrate that the latter may overestimate variabilities by up to almost five fold. Finally, Monte Carlo simulations of the inferred population model are used to predict the distribution of key characteristics of the Mig1 transient response. We find that with decreasing levels of post-shift glucose, the transient response of Mig1 tend to be faster, more extended, and displays an increased cell-to-cell variability.	[Almquist, Joachim; Jirstrand, Mats] Fraunhofer Chalmers Ctr, Gothenburg, Sweden; [Almquist, Joachim] Chalmers Univ Technol, Syst & Synthet Biol, Dept Chem & Biol Engn, S-41296 Gothenburg, Sweden; [Bendrioua, Loubna; Hohmann, Stefan] Univ Gothenburg, Dept Chem & Mol Biol, Gothenburg, Sweden; [Bendrioua, Loubna; Adiels, Caroline Beck; Goksor, Mattias] Univ Gothenburg, Dept Phys, Gothenburg, Sweden	Chalmers University of Technology; Fraunhofer-Chalmers Research Centre for Industrial Mathematics; Chalmers University of Technology; University of Gothenburg; University of Gothenburg	Almquist, J (corresponding author), Fraunhofer Chalmers Ctr, Chalmers Sci Pk, Gothenburg, Sweden.	joachim.almquist@fcc.chalmers.se	Hohmann, Stefan/K-9895-2013; Almquist, Joachim/U-8894-2019	Hohmann, Stefan/0000-0002-0809-1985; Almquist, Joachim/0000-0002-4745-9332; Jirstrand, Mats/0000-0002-6612-8037; Beck Adiels, Caroline/0000-0002-2403-2213	Swedish Foundation for Strategic Research; Swedish Research Council (VR); European Commission FP7 through the UNICELLSYS project [201142]; European Commission FP7 through ISOLATE project [289995]	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Research Council (VR)(Swedish Research Council); European Commission FP7 through the UNICELLSYS project; European Commission FP7 through ISOLATE project	This work has been supported by funds from the Swedish Foundation for Strategic Research (SSF, to MJ), the Swedish Research Council (VR, to SH) as well as the European Commission FP7 through the UNICELLSYS project (grant 201142, to SH, MG and MJ) and the ISOLATE project (grant 289995, to SH and MG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almquist J., 2008, 9 INT C SYST BIOL; Almquist J, 2015, J PHARMACOKINET PHAR, V42, P191, DOI 10.1007/s10928-015-9409-1; Almquist J, 2014, METAB ENG, V24, P38, DOI 10.1016/j.ymben.2014.03.007; Babazadeh R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080901; Bendrioua L, 2014, J BIOL CHEM, V289, P12863, DOI 10.1074/jbc.M114.547976; Berglund M, 2012, MATH MED BIOL, V29, P361, DOI 10.1093/imammb/dqr021; Bodvard K, 2011, BBA-MOL CELL RES, V1813, P358, DOI 10.1016/j.bbamcr.2010.12.004; Cai L, 2008, NATURE, V455, P485, DOI 10.1038/nature07292; CARLSON M, 1981, GENETICS, V98, P25; Chen WW, 2010, GENE DEV, V24, P1861, DOI 10.1101/gad.1945410; Cheong R, 2010, WIRES SYST BIOL MED, V2, P34, DOI 10.1002/wsbm.49; Cohen-Saidon C, 2009, MOL CELL, V36, P885, DOI 10.1016/j.molcel.2009.11.025; Davidian M, 2003, J AGR BIOL ENVIR ST, V8, P387, DOI 10.1198/1085711032697; DeVit MJ, 1999, CURR BIOL, V9, P1231, DOI 10.1016/S0960-9822(99)80503-X; DeVit MJ, 1997, MOL BIOL CELL, V8, P1603, DOI 10.1091/mbc.8.8.1603; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Feinerman O, 2008, SCIENCE, V321, P1081, DOI 10.1126/science.1158013; Frey S, 2011, MOL BIOSYST, V7, P215, DOI 10.1039/c005305h; Gancedo JM, 1998, MICROBIOL MOL BIOL R, V62, P334, DOI 10.1128/MMBR.62.2.334-361.1998; Garcia-Salcedo R, 2014, FEBS J, V281, P1901, DOI 10.1111/febs.12753; Gaudet S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002482; Gonzalez AM, 2013, EUR CONTR C 2013; Hasenauer J, 2010, PROCEDIA COMPUT SCI, V1, P1649, DOI 10.1016/j.procs.2010.04.185; Hasenauer J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-125; Hong SP, 2003, P NATL ACAD SCI USA, V100, P8839, DOI 10.1073/pnas.1533136100; Janzen D., 2012, STANDARD 2 STAGE NON; Jeschke M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003357; Kalita MK, 2011, J BIOL CHEM, V286, P37741, DOI 10.1074/jbc.M111.280925; Kallenberger SM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004738; Kaltenbach HM, 2009, FEBS LETT, V583, P3923, DOI 10.1016/j.febslet.2009.10.074; Karlsson J., 2012, IFAC PROC VOL, V45, P941, DOI 10.3182/20120711-3-BE-2027.00381; Klim S, 2009, COMPUT METH PROG BIO, V94, P279, DOI 10.1016/j.cmpb.2009.02.001; Koeppl H, 2012, INT J ROBUST NONLIN, V22, P1103, DOI 10.1002/rnc.2804; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; Kristensen NR, 2005, J PHARMACOKINET PHAR, V32, P109, DOI 10.1007/s10928-005-2105-9; Leander J, 2015, AAPS J, V17, P586, DOI 10.1208/s12248-015-9718-8; Limpert E, 2001, BIOSCIENCE, V51, P341, DOI 10.1641/0006-3568(2001)051[0341:LNDATS]2.0.CO;2; Limpert E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021403; Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717; Love KR, 2010, BIOTECHNOL BIOENG, V106, P319, DOI 10.1002/bit.22688; McCartney RR, 2001, J BIOL CHEM, V276, P36460, DOI 10.1074/jbc.M104418200; Mettetal JT, 2008, SCIENCE, V319, P482, DOI 10.1126/science.1151582; Meyer R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00451; Muzzey D, 2009, CELL, V138, P160, DOI 10.1016/j.cell.2009.04.047; Nath N, 2003, MOL CELL BIOL, V23, P3909, DOI 10.1128/MCB.23.11.3909-3917.2003; Niepel M, 2009, CURR OPIN CHEM BIOL, V13, P556, DOI 10.1016/j.cbpa.2009.09.015; Papamichos-Chronakis M, 2004, EMBO REP, V5, P368, DOI 10.1038/sj.embor.7400120; Ramsey SA, 2006, NAT GENET, V38, P1082, DOI 10.1038/ng1869; Raue A, 2009, BIOINFORMATICS, V25, P1923, DOI 10.1093/bioinformatics/btp358; Raue A, 2014, BIOINFORMATICS, V30, P1440, DOI 10.1093/bioinformatics/btu006; Sanz P, 2000, MOL CELL BIOL, V20, P1321, DOI 10.1128/MCB.20.4.1321-1328.2000; Savic RM, 2009, AAPS J, V11, P558, DOI 10.1208/s12248-009-9133-0; Schaber J, 2009, IET SYST BIOL, V3, P1, DOI 10.1049/iet-syb:20070042; Schaber J, 2011, CURR OPIN BIOTECH, V22, P109, DOI 10.1016/j.copbio.2010.09.014; Schliemann M, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-204; SHEINER LB, 1983, J PHARMACOKINET BIOP, V11, P303, DOI 10.1007/BF01061870; Sutherland CM, 2003, CURR BIOL, V13, P1299, DOI 10.1016/S0960-9822(03)00459-7; Swain PS, 2002, P NATL ACAD SCI USA, V99, P12795, DOI 10.1073/pnas.162041399; Tyson JJ, 2003, CURR OPIN CELL BIOL, V15, P221, DOI 10.1016/S0955-0674(03)00017-6; VanKampen NG, 2007, NORTH-HOLL PERS LIBR, P1; Wang YN, 2007, J PHARMACOKINET PHAR, V34, P575, DOI 10.1007/s10928-007-9060-6; Wilkinson DJ, 2009, NAT REV GENET, V10, P122, DOI 10.1038/nrg2509; Woodcock DJ, 2013, BIOINFORMATICS, V29, P1519, DOI 10.1093/bioinformatics/btt201; Wright S, 1999, NUMERICAL OPTIMIZATI, V35, P7; Zechner C, 2014, NAT METHODS, V11, P197, DOI [10.1038/NMETH.2794, 10.1038/nmeth.2794]; Zechner C, 2012, P NATL ACAD SCI USA, V109, P8340, DOI 10.1073/pnas.1200161109	66	12	14	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124050	10.1371/journal.pone.0124050	http://dx.doi.org/10.1371/journal.pone.0124050			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893847	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700069
J	Cabiddu, R; Trimer, R; Borghi-Silva, A; Migliorini, M; Mendes, RG; Oliveira, AD; Costa, FSM; Bianchi, AM				Cabiddu, Ramona; Trimer, Renata; Borghi-Silva, Audrey; Migliorini, Matteo; Mendes, Renata G.; Oliveira, Antonio D., Jr.; Costa, Fernando S. M.; Bianchi, Anna M.			Are Complexity Metrics Reliable in Assessing HRV Control in Obese Patients During Sleep?	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; AIRWAY PRESSURE TREATMENTS; NERVOUS-SYSTEM ACTIVITY; DYNAMICS; ENTROPY; APNEA	Obesity is associated with cardiovascular mortality. Linear methods, including time domain and frequency domain analysis, are normally applied on the heart rate variability (HRV) signal to investigate autonomic cardiovascular control, whose imbalance might promote cardiovascular disease in these patients. However, given the cardiac activity non-linearities, non-linear methods might provide better insight. HRV complexity was hereby analyzed during wakefulness and different sleep stages in healthy and obese subjects. Given the short duration of each sleep stage, complexity measures, normally extracted from long-period signals, needed be calculated on short-term signals. Sample entropy, Lempel-Ziv complexity and detrended fluctuation analysis were evaluated and results showed no significant differences among the values calculated over ten-minute signals and longer durations, confirming the reliability of such analysis when performed on short-term signals. Complexity parameters were extracted from ten-minute signal portions selected during wakefulness and different sleep stages on HRV signals obtained from eighteen obese patients and twenty controls. The obese group presented significantly reduced complexity during light and deep sleep, suggesting a deficiency in the control mechanisms integration during these sleep stages. To our knowledge, this study reports for the first time on how the HRV complexity changes in obesity during wakefulness and sleep. Further investigation is needed to quantify altered HRV impact on cardiovascular mortality in obesity.	[Cabiddu, Ramona; Migliorini, Matteo; Bianchi, Anna M.] Politecn Milan, DEIB, I-20133 Milan, Italy; [Trimer, Renata; Borghi-Silva, Audrey; Mendes, Renata G.] Univ Fed Sao Carlos, Cardiopulmonary Physiotherapy Lab, BR-13560 Sao Carlos, SP, Brazil; [Oliveira, Antonio D., Jr.; Costa, Fernando S. M.] Sleep Inst Sao Carlos, Sao Paulo, Brazil	Polytechnic University of Milan; Universidade Federal de Sao Carlos	Cabiddu, R (corresponding author), Politecn Milan, DEIB, I-20133 Milan, Italy.	ramona.cabiddu@gmail.com	Mendes, Renata Gonçalves/E-9284-2013; Cabiddu, Ramona/A-7723-2015; Borghi-Silva, Audrey/F-5702-2012; Bianchi, Anna M./AAA-4258-2020	Mendes, Renata Gonçalves/0000-0003-4683-2657; Borghi-Silva, Audrey/0000-0002-3891-6941; Bianchi, Anna M./0000-0002-8290-7460				Austin MA, 1998, AM J CARDIOL, V81, p7B, DOI 10.1016/S0002-9149(98)00031-9; Bianchi AM, 2010, METHOD INFORM MED, V49, P479, DOI 10.3414/ME09-02-0037; Bunde A, 2000, PHYS REV LETT, V85, P3736, DOI 10.1103/PhysRevLett.85.3736; Cabiddu R, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00045; Camm AJ, 1996, CIRCULATION, V93, P1043; Caples SM, 2007, SLEEP, V30, P291, DOI 10.1093/sleep/30.3.291; Chhabra L, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/856793; Costa M, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.068102; Curtis BM, 2002, MAYO CLIN PROC, V77, P45, DOI 10.4065/77.1.45; Davy KP, 1997, CLIN PHYSIOL, V17, P31, DOI 10.1046/j.1365-2281.1997.01010.x; de Gonzalez AB, 2010, NEW ENGL J MED, V363, P2211, DOI 10.1056/NEJMoa1000367; Gans F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.098701; Gastaldelli A, 1999, ANN NY ACAD SCI, V879, P249, DOI 10.1111/j.1749-6632.1999.tb10427.x; Gomes RM, 2013, CELL PHYSIOL BIOCHEM, V32, P310, DOI 10.1159/000354439; Guzzetti S, 2000, AUTON NEUROSCI-BASIC, V86, P114, DOI 10.1016/S1566-0702(00)00239-3; Hu J, 2006, IEEE T BIO-MED ENG, V53, P2606, DOI 10.1109/TBME.2006.883825; Iber C, 2007, AASM MANUAL SCORING; Jiang Jieying, 2013, Prev Med, V57, P60, DOI 10.1016/j.ypmed.2013.04.014; KAPLAN DT, 1991, BIOPHYS J, V59, P945, DOI 10.1016/S0006-3495(91)82309-8; KAY SM, 1981, P IEEE, V69, P1380, DOI 10.1109/PROC.1981.12184; Kufoy E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033769; Lips MA, 2013, EUR J ENDOCRINOL, V169, P383, DOI 10.1530/EJE-13-0506; Malliani A, 1998, CIRCULATION, V98, P2640; Nemati S, 2013, RESP PHYSIOL NEUROBI, V189, P27, DOI 10.1016/j.resp.2013.06.016; Nielsen JDJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065764; PAN J, 1985, IEEE T BIO-MED ENG, V32, P230, DOI 10.1109/TBME.1985.325532; Patruno V, 2007, CHEST, V131, P1393, DOI 10.1378/chest.06-2192; Patruno V, 2014, EUR J INTERN MED, V25, P164, DOI 10.1016/j.ejim.2013.11.009; PENG CK, 1995, CHAOS, V5, P82, DOI 10.1063/1.166141; Perakakis P, 2009, BIOL PSYCHOL, V82, P82, DOI 10.1016/j.biopsycho.2009.06.004; Porta A, 2007, CHAOS, V17, DOI 10.1063/1.2404630; Porta A, 2007, J APPL PHYSIOL, V103, P1143, DOI 10.1152/japplphysiol.00293.2007; Ravesloot MJL, 2012, EUR ARCH OTO-RHINO-L, V269, P1865, DOI 10.1007/s00405-012-1948-0; Richman JS, 2000, AM J PHYSIOL-HEART C, V278, pH2039; Ruehland WR, 2009, SLEEP, V32, P150, DOI 10.1093/sleep/32.2.150; Saul JP., 1987, COMPUT CARDIOL, P419; Schumann AY, 2010, SLEEP, V33, P943, DOI 10.1093/sleep/33.7.943; Silber MH, 2007, J CLIN SLEEP MED, V3, P121; Silva LEV, 2012, CHAOS, V22, DOI 10.1063/1.4758815; Trunkvalterova Z, 2008, PHYSIOL MEAS, V29, P817, DOI 10.1088/0967-3334/29/7/010; Vigo DE, 2010, AUTON NEUROSCI-BASIC, V154, P84, DOI 10.1016/j.autneu.2009.10.007; Viola AU, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019002; Virtanen I, 2007, AUTON NEUROSCI-BASIC, V134, P74, DOI 10.1016/j.autneu.2007.01.010	43	6	6	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124458	10.1371/journal.pone.0124458	http://dx.doi.org/10.1371/journal.pone.0124458			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893856	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700095
J	Egnatios, J; Kaushal, K; Kalmaz, D; Zarrinpar, A				Egnatios, Jeremy; Kaushal, Khushboo; Kalmaz, Denise; Zarrinpar, Amir			Video Capsule Endoscopy in Patients with Chronic Abdominal Pain with or without Associated Symptoms: A Retrospective Study	PLOS ONE			English	Article							BOWEL CROHNS-DISEASE; DIAGNOSTIC YIELD; CLINICAL-PRACTICE; CT ENTEROGRAPHY; UNITED-STATES; MULTICENTER; DIARRHEA; APPROPRIATENESS; METAANALYSIS; PREVALENCE	Background Chronic abdominal pain (CAP) is a common indication for gastroenterology referrals. More insidious causes of CAP isolated to the small bowel, such as malignancies and Crohn's disease, are rising in incidence and causing more gastroenterologists to evaluate their patients with video capsule endoscopy (VCE). However, the role of VCE in patients with CAP is still unclear. Aims We assessed the efficacy of VCE in patients with CAP and whether it led to findings that contributed to disease management and meaningful interventions. Methods This retrospective study evaluated 607 capsule endoscopy studies at an open referral endoscopy unit. Ninety of the studies were for CAP. These studies were compared to those performed for other indications to compare diagnostic yield. In addition, we investigated whether VCE led to an intervention that improved clinical outcomes. Results Overall, the number of abnormal findings in CAP patients was significantly lower than VCE performed for other indications (24.4% vs 39.0%, respectively p = 0.009). When patients with CAP presented with other pertinent clinical findings (e.g. nausea, weight loss, anemia, history of in inflammatory bowel disease, etc.), the likelihood of an abnormal finding increased to a level that was not different from those who received VCE for other indications (27.1%, p = 0.10). The findings from VCE lead to changed management and improved outcomes in 16.2% of CAP patients with associated symptoms. However, the subgroup that benefited the most were those who had a prior history of Crohn's disease. Patients with CAP who did not have any associated symptoms continued to have a significantly lower abnormal finding rate compared to those who received VCE for other indications (19.4%, p = 0.03) and VCE rarely led to a change in management that would improve outcomes (5.6%). Conclusions VCE for CAP has a lower rate of abnormal findings than other indications. However, VCE is a useful diagnostic tool that can help provide a possible etiology of CAP in patients with associated symptoms. However, a change in management from VCE is likely to be limited to those with a history of Crohn's disease.	[Egnatios, Jeremy; Kaushal, Khushboo; Kalmaz, Denise; Zarrinpar, Amir] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Kaushal, Khushboo; Kalmaz, Denise; Zarrinpar, Amir] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Kalmaz, Denise; Zarrinpar, Amir] Univ Calif San Diego, Div Gastroenterol, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Zarrinpar, A (corresponding author), Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA.	azarrinpar@ucsd.edu	Zarrinpar, Amir/L-4077-2019; , Amir/AAJ-6732-2020	Zarrinpar, Amir/0000-0001-6423-5982; Egnatios, Jeremy/0000-0003-4292-7392	National Institute of Health T32 Training Grant [DK07202]; American Association for the Study of Liver Diseases Liver Scholar Award; National Institute of Health R25 Training Grant [MH71544]; University of California, San Diego Sam and Rose Stein Institute for Research on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH071544] Funding Source: NIH RePORTER	National Institute of Health T32 Training Grant; American Association for the Study of Liver Diseases Liver Scholar Award; National Institute of Health R25 Training Grant; University of California, San Diego Sam and Rose Stein Institute for Research on Aging; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	AZ was supported by National Institute of Health T32 Training Grant (DK07202) and American Association for the Study of Liver Diseases Liver Scholar Award. JE was supported by National Institute of Health R25 Training Grant (MH71544) and University of California, San Diego Sam and Rose Stein Institute for Research on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burri E, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-57; Cheifetz AS, 2006, J CLIN GASTROENTEROL, V40, P688, DOI 10.1097/00004836-200609000-00005; Dionisio PM, 2010, AM J GASTROENTEROL, V105, P1240, DOI 10.1038/ajg.2009.713; Esaki M, 2010, DIGEST DIS SCI, V55, P2294, DOI 10.1007/s10620-009-1036-5; Fry LC, 2006, ENDOSCOPY, V38, P498, DOI 10.1055/s-2006-925340; Goldfarb Neil I, 2004, Dis Manag, V7, P292, DOI 10.1089/dis.2004.7.292; Hamilton Matthew J, 2012, Diagn Ther Endosc, V2012, P467979, DOI 10.1155/2012/467979; Hara AK, 2006, RADIOLOGY, V238, P128, DOI 10.1148/radiol.2381050296; Heo HM, 2012, EUR RADIOL, V22, P1159, DOI 10.1007/s00330-011-2374-1; Hulisz Darrell, 2004, J Manag Care Pharm, V10, P299; Jensen MD, 2011, CLIN GASTROENTEROL H, V9, P124, DOI 10.1016/j.cgh.2010.10.019; Jewell DM, 2006, CHALLENGES INFLAMATO; Katsinelos P, 2011, MED PRIN PRACT, V20, P362, DOI 10.1159/000324548; Katsinelos P, 2011, EUR J INTERN MED, V22, pE63, DOI 10.1016/j.ejim.2011.06.012; Kopylov U, 2014, WORLD J GASTROENTERO, V20, P1155, DOI 10.3748/wjg.v20.i5.1155; Lai LH, 2006, AM J GASTROENTEROL, V101, P1224, DOI 10.1111/j.1572-0241.2006.00565.x; Leighton Jonathan A, 2006, Gastrointest Endosc Clin N Am, V16, P229, DOI 10.1016/j.giec.2006.03.004; Long MD, 2011, INFLAMM BOWEL DIS, V17, P1855, DOI 10.1002/ibd.21571; Makins R, 2006, ALIMENT PHARM THERAP, V24, P293, DOI 10.1111/j.1365-2036.2006.02991.x; May A, 2007, ENDOSCOPY, V39, P606, DOI 10.1055/s-2007-966640; Middleton Kimberly R, 2006, Adv Data, P1; Morini S, 2001, GASTROINTEST ENDOSC, V54, P175, DOI 10.1067/mge.2001.116565; Myer PA, 2013, AM J GASTROENTEROL, V108, P1496, DOI 10.1038/ajg.2013.199; Ng Siew C, 2013, Gastroenterol Hepatol (N Y), V9, P28; Quigley EMM, 2006, ALIMENT PHARM THER, V24, P411, DOI 10.1111/j.1365-2036.2006.02989.x; Qvigstad G, 2006, SCAND J GASTROENTERO, V41, P614, DOI 10.1080/00365520500335159; Raju Gottumukkala S, 2007, Gastroenterology, V133, P1697, DOI 10.1053/j.gastro.2007.06.007; Rondonotti E, 2010, EUR J GASTROEN HEPAT, V22, P1380, DOI 10.1097/MEG.0b013e3283352ced; Sandler RS, 2000, DIGEST DIS SCI, V45, P1166, DOI 10.1023/A:1005554103531; Santhakumar Cositha, 2014, World J Gastrointest Pathophysiol, V5, P479, DOI 10.4291/wjgp.v5.i4.479; Santillan CS, 2014, MAGN RESON IMAGING C, V22, P1, DOI 10.1016/j.mric.2013.07.004; Shim KN, 2006, SCAND J GASTROENTERO, V41, P983, DOI 10.1080/00365520600548974; Solem CA, 2008, GASTROINTEST ENDOSC, V68, P255, DOI 10.1016/j.gie.2008.02.017; Spada C, 2006, DIGEST LIVER DIS, V38, P696, DOI 10.1016/j.dld.2006.05.011; Swain P, 2005, GUT, V54, P323, DOI 10.1136/gut.2004.047282; Townsend CO, 2005, J PAIN, V6, P75, DOI 10.1016/j.jpain.2004.10.009; Triester SL, 2006, AM J GASTROENTEROL, V101, P954, DOI 10.1111/j.1572-0241.2006.00506.x; Xue M, 2015, GASTROINTEST ENDOSC, V81, P186, DOI 10.1016/j.gie.2014.04.062; Yamagami H, 2013, CLIN ENDOSC, V46, P321, DOI 10.5946/ce.2013.46.4.321; Yang LP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087396; Zamboni Giulia A, 2010, Gastrointest Endosc Clin N Am, V20, P347, DOI 10.1016/j.giec.2010.02.017	41	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0126509	10.1371/journal.pone.0126509	http://dx.doi.org/10.1371/journal.pone.0126509			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893440	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700144
J	Kaur, K; Helgesen, KO; Bakke, MJ; Horsberg, TE				Kaur, Kiranpreet; Helgesen, Kari Olli; Bakke, Marit Jorgensen; Horsberg, Tor Einar			Mechanism behind Resistance against the Organophosphate Azamethiphos in Salmon Lice (Lepeophtheirus salmonis)	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; HUMAN ACETYLCHOLINESTERASE; INSECTICIDE-INSENSITIVITY; CULEX-TRITAENIORHYNCHUS; TETRANYCHUS-URTICAE; ACTIVE-CENTER; SEA LICE; CHOLINESTERASES; MUTATIONS; RESIDUES	Acetylcholinesterase (AChE) is the primary target for organophosphates (OP). Several mutations have been reported in AChE to be associated with the reduced sensitivity against OP in various arthropods. However, to the best of our knowledge, no such reports are available for Lepeophtheirus salmonis. Hence, in the present study, we aimed to determine the association of AChE(s) gene(s) with resistance against OP. We screened the AChE genes (L. salmonis ace1a and ace1b) in two salmon lice populations: one sensitive (n=5) and the other resistant (n=5) for azamethiphos, a commonly used OP in salmon farming. The screening led to the identification of a missense mutation Phe362Tyr in L. salmonis ace1a, (corresponding to Phe331 in Torpedo californica AChE) in all the samples of the resistant population. We confirmed the potential role of the mutation, with reduced sensitivity against azamethiphos in L. salmonis, by screening for Phe362Tyr in 2 sensitive and 5 resistant strains. The significantly higher frequency of the mutant allele (362Tyr) in the resistant strains clearly indicated the possible association of Phe362Tyrmutation in L. salmonis ace1a with resistance towards azamethiphos. The 3D modelling, short term survival experiments and enzymatic assays further supported the imperative role of Phe362Tyrin reduced sensitivity of L. salmonis for azamethiphos. Based on all these observations, the present study, for the first time, presents the mechanism of resistance in L. salmonisagainst azamethiphos. In addition, we developed a rapid diagnostic tool for the high throughput screening of Phe362Tyr mutation using High Resolution Melt analysis.	[Kaur, Kiranpreet; Helgesen, Kari Olli; Bakke, Marit Jorgensen; Horsberg, Tor Einar] NMBU, Sch Vet Sci, Sea Lice Res Ctr, NO-0033 Oslo, Norway	Norwegian University of Life Sciences	Kaur, K (corresponding author), NMBU, Sch Vet Sci, Sea Lice Res Ctr, POB 8146 Dept, NO-0033 Oslo, Norway.	kiran.kaur@nmbu.no	Kaur, Kiran/R-3535-2018	Kaur, Kiran/0000-0002-7285-5513	Norwegian Research Council [NFR 203513/O30, NFR 199778/S40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The study was financially supported by the Norwegian Research Council through the Centre for Innovation Sea Lice Research Centre, grant number NFR 203513/O30 and the project PrevenT, grant number NFR 199778/S40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDRIDGE WN, 1950, BIOCHEM J, V46, P451, DOI 10.1042/bj0460451; Alon M, 2008, INSECT BIOCHEM MOLEC, V38, P940, DOI 10.1016/j.ibmb.2008.07.007; Anazawa Y, 2003, INSECT BIOCHEM MOLEC, V33, P509, DOI 10.1016/S0965-1748(03)00025-0; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Bar-On P, 2002, BIOCHEMISTRY-US, V41, P3555, DOI 10.1021/bi020016x; Benting J, 2004, PEST MANAG SCI, V60, P1051, DOI 10.1002/ps.971; Boublik Y, 2002, PROTEIN ENG, V15, P43, DOI 10.1093/protein/15.1.43; Denholm I, 2002, PEST MANAG SCI, V58, P528, DOI 10.1002/ps.482; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; FOURNIER D, 1994, COMP BIOCHEM PHYS C, V108, P19, DOI 10.1016/1367-8280(94)90084-1; Grave K, 2004, DIS AQUAT ORGAN, V60, P123, DOI 10.3354/dao060123; Grontvedt R. N., 2014, SURVEILLANCE PROGRAM; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; Helgesen KO, 2014, J FISH DIS, V37, P877, DOI 10.1111/jfd.12223; Helgesen KO, 2013, J FISH DIS, V36, P261, DOI 10.1111/jfd.12053; HOSEA NA, 1995, BIOCHEMISTRY-US, V34, P11528, DOI 10.1021/bi00036a028; Hotelier T, 2010, J PESTIC SCI, V35, P315, DOI 10.1584/jpestics.R10-10; Kaur K., 2015, PLOS ONE IN PRESS; Kwon DH, 2012, INSECT BIOCHEM MOLEC, V42, P212, DOI 10.1016/j.ibmb.2011.12.003; Low VL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079928; Muhammet MA, 2014, TURKIYE PARAZITOL DE, V38, P111, DOI [10.5152/tpd.2014.3388, DOI 10.5152/TPD.2014.3388]; Nabeshima T, 2004, BIOCHEM BIOPH RES CO, V313, P794, DOI 10.1016/j.bbrc.2003.11.141; Nabeshima T, 2003, BIOCHEM BIOPH RES CO, V307, P15, DOI 10.1016/S0006-291X(03)01101-X; Oh SH, 2006, PESTIC BIOCHEM PHYS, V85, P46, DOI 10.1016/j.pestbp.2005.10.003; Ordentlich A, 1999, BIOCHEMISTRY-US, V38, P3055, DOI 10.1021/bi982261f; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Riaz MA, 2013, AQUAT TOXICOL, V126, P326, DOI 10.1016/j.aquatox.2012.09.010; Shafferman A, 1996, BIOCHEM J, V318, P833, DOI 10.1042/bj3180833; SHAFFERMAN A, 1992, EMBO J, V11, P3561, DOI 10.1002/j.1460-2075.1992.tb05439.x; Shi MA, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-5; Surendran SN, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-34; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Torrissen O, J FISH DIS, V213, P171; World Health Organization, 1998, WHOCDSCPCMAL98	35	34	34	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124220	10.1371/journal.pone.0124220	http://dx.doi.org/10.1371/journal.pone.0124220			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893248	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000353211700078
J	Crank, MC; Gordon, IJ; Yamshchikov, GV; Sitar, S; Hu, ZH; Enama, ME; Holman, LA; Bailer, RT; Pearce, MB; Koup, RA; Mascola, JR; Nebel, GJ; Tumpey, TM; Schwartz, RM; Graham, BS; Ledgerwood, JE				Crank, Michelle C.; Gordon, Ingelise J.; Yamshchikov, Galina V.; Sitar, Sandra; Hu, Zonghui; Enama, Mary E.; Holman, LaSonji A.; Bailer, Robert T.; Pearce, Melissa B.; Koup, Richard A.; Mascola, John R.; Nebel, Gary J.; Tumpey, Terrence M.; Schwartz, Richard M.; Graham, Barney S.; Ledgerwood, Julie E.		VRC 308 Study Team	Phase 1 Study of Pandemic H1 DNA Vaccine in Healthy Adults	PLOS ONE			English	Article							I CLINICAL-TRIAL; SEASONAL INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; PROTECTIVE IMMUNITY; CANDIDATE VACCINE; HEPATITIS-B; VIRUS; IMMUNOGENICITY; RESPONSES; HUMANS	Background A novel, swine-origin influenza A (H1N1) virus was detected worldwide in April 2009, and the World Health Organization (WHO) declared a global pandemic that June. DNA vaccine priming improves responses to inactivated influenza vaccines. We describe the rapid production and clinical evaluation of a DNA vaccine encoding the hemagglutinin protein of the 2009 pandemic A/California/04/2009(H1N1) influenza virus, accomplished nearly two months faster than production of A/California/07/2009(H1N1) licensed monovalent inactivated vaccine (MIV). Methods 20 subjects received three H1 DNA vaccinations (4 mg intramuscularly with Biojector) at 4-week intervals. Eighteen subjects received an optional boost when the licensed H1N1 MIV became available. The interval between the third H1 DNA injection and MIV boost was 3-17 weeks. Vaccine safety was assessed by clinical observation, laboratory parameters, and 7-day solicited reactogenicity. Antibody responses were assessed by ELISA, HAI and neutralization assays, and T cell responses by ELISpot and flow cytometry. Results Vaccinations were safe and well-tolerated. As evaluated by HAI, 6/20 developed positive responses at 4 weeks after third DNA injection and 13/18 at 4 weeks after MIV boost. Similar results were detected in neutralization assays. T cell responses were detected after DNA and MIV. The antibody responses were significantly amplified by the MIV boost, however, the boost did not increased T cell responses induced by DNA vaccine. Conclusions H1 DNA vaccine was produced quickly, was well-tolerated, and had modest immunogenicity as a single agent. Other HA DNA prime-MIV boost regimens utilizing one DNA prime vaccination and longer boost intervals have shown significant immunogenicity. Rapid and large-scale production of HA DNA vaccines has the potential to contribute to an efficient response against future influenza pandemics.	[Crank, Michelle C.; Gordon, Ingelise J.; Yamshchikov, Galina V.; Sitar, Sandra; Enama, Mary E.; Holman, LaSonji A.; Bailer, Robert T.; Koup, Richard A.; Mascola, John R.; Nebel, Gary J.; Schwartz, Richard M.; Graham, Barney S.; Ledgerwood, Julie E.] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA; [Hu, Zonghui] NIAID, Biostat Res Branch, Div Clin Res, NIH, Bethesda, MD 20892 USA; [Pearce, Melissa B.; Tumpey, Terrence M.] US Ctr Dis Control & Prevent, Influenza Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA	Ledgerwood, JE (corresponding author), NIAID, Vaccine Res Ctr, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	Ledgerwood@mail.nih.gov	Graham, Barney S./AAC-5898-2019; Mascola, John/AAI-7193-2021	Graham, Barney S./0000-0001-8112-0853; 	National Institutes of Health Intramural Research Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI005073, ZICAI005124, ZICAI005123, ZIBAI005109, ZIAAI005047] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This research was supported by the National Institutes of Health Intramural Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Catanzaro AT, 2007, VACCINE, V25, P4085, DOI 10.1016/j.vaccine.2007.02.050; Catanzaro AT, 2006, J INFECT DIS, V194, P1638, DOI 10.1086/509258; CDC, 2019, 2009 H1N1 PAND H1N1P; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Drape RJ, 2006, VACCINE, V24, P4475, DOI 10.1016/j.vaccine.2005.08.012; FDA, 2009, FDA APPR VACC 2009 H; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Graham BS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059340; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jackson L, 2013, MMWR-MORBID MORTAL W, V62, P32; JILG W, 1989, J INFECT DIS, V160, P766, DOI 10.1093/infdis/160.5.766; Jones S, 2009, VACCINE, V27, P2506, DOI 10.1016/j.vaccine.2009.02.061; Khurana S, 2013, J INFECT DIS, V208, P413, DOI 10.1093/infdis/jit178; Kong WP, 2006, P NATL ACAD SCI USA, V103, P15987, DOI 10.1073/pnas.0607564103; Ledgerwood JE, 2013, J INFECT DIS, V208, P418, DOI 10.1093/infdis/jit180; Ledgerwood JE, 2011, LANCET INFECT DIS, V11, P916, DOI 10.1016/S1473-3099(11)70240-7; Ledgerwood JE, 2011, J INFECT DIS, V203, P1396, DOI 10.1093/infdis/jir054; Ledgerwood JE, 2009, HUM VACCINES, V5, P623, DOI 10.4161/hv.8627; Martin JE, 2007, J INFECT DIS, V196, P1732, DOI 10.1086/523650; Martin JE, 2006, CLIN VACCINE IMMUNOL, V13, P1267, DOI 10.1128/CVI.00162-06; Martin JE, 2008, VACCINE, V26, P6338, DOI 10.1016/j.vaccine.2008.09.026; OLIVEIRA PMC, 1995, VACCINE, V13, P791; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Pearce MB, 2012, J VIROL, V86, P7118, DOI 10.1128/JVI.00674-12; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Smith LR, 2010, VACCINE, V28, P2565, DOI 10.1016/j.vaccine.2010.01.029; Stephenson I, 2004, VIRUS RES, V103, P91, DOI 10.1016/j.virusres.2004.02.019; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; Vasan S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019252; WHO, 2009, INFL SEAS; World Health Organization, 2009, STAT PRESS WHO DIR G; Yang ZY, 2004, NATURE, V428, P561, DOI 10.1038/nature02463; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	36	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123969	10.1371/journal.pone.0123969	http://dx.doi.org/10.1371/journal.pone.0123969			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884189	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000096
J	Graichen, U; Eichardt, R; Fiedler, P; Strohmeier, D; Zanow, F; Haueisen, J				Graichen, Uwe; Eichardt, Roland; Fiedler, Patrique; Strohmeier, Daniel; Zanow, Frank; Haueisen, Jens			SPHARA - A Generalized Spatial Fourier Analysis for Multi-Sensor Systems with Non-Uniformly Arranged Sensors: Application to EEG	PLOS ONE			English	Article							COMPONENT ANALYSIS; MATCHING PURSUIT; REPRESENTATIONS; DECOMPOSITION; LOCALIZATION; LAPLACIANS; ALGORITHMS	Important requirements for the analysis of multichannel EEG data are efficient techniques for signal enhancement, signal decomposition, feature extraction, and dimensionality reduction. We propose a new approach for spatial harmonic analysis (SPHARA) that extends the classical spatial Fourier analysis to EEG sensors positioned non-uniformly on the surface of the head. The proposed method is based on the eigenanalysis of the discrete Laplace-Beltrami operator defined on a triangular mesh. We present several ways to discretize the continuous Laplace-Beltrami operator and compare the properties of the resulting basis functions computed using these discretization methods. We apply SPHARA to somatosensory evoked potential data from eleven volunteers and demonstrate the ability of the method for spatial data decomposition, dimensionality reduction and noise suppression. When employing SPHARA for dimensionality reduction, a significantly more compact representation can be achieved using the FEM approach, compared to the other discretization methods. Using FEM, to recover 95% and 99% of the total energy of the EEG data, on average only 35% and 58% of the coefficients are necessary. The capability of SPHARA for noise suppression is shown using artificial data. We conclude that SPHARA can be used for spatial harmonic analysis of multi-sensor data at arbitrary positions and can be utilized in a variety of other applications.	[Graichen, Uwe; Eichardt, Roland; Fiedler, Patrique; Strohmeier, Daniel; Haueisen, Jens] Tech Univ Ilmenau, Fac Comp Sci & Automat, Inst Biomed Engn & Informat, Ilmenau, Germany; [Zanow, Frank] Eemagine GmbH, Berlin, Germany; [Haueisen, Jens] Univ Clin Jena, Biomagnet Ctr, Dept Neurol, Jena, Germany	Technische Universitat Ilmenau; Friedrich Schiller University of Jena	Graichen, U (corresponding author), Tech Univ Ilmenau, Fac Comp Sci & Automat, Inst Biomed Engn & Informat, Ilmenau, Germany.	uwe.graichen@tu-ilmenau.de	Fiedler, Patrique/J-6173-2012; Graichen, Uwe/B-8275-2015; Graichen, Uwe/GPX-1634-2022; Haueisen, Jens/B-7183-2011	Fiedler, Patrique/0000-0001-9196-0717; Graichen, Uwe/0000-0003-2144-4682; Haueisen, Jens/0000-0003-3871-2890	German Federal Ministry for Economic Affairs and Energy [KF2250111ED2]; German Federal Ministry of Education and Research [03IP605A]; German Research Foundation [Ha2899/14-1]; European Union [FP7-PEOPLE Marie Curie IAPP project 610950]; eemagine GmbH	German Federal Ministry for Economic Affairs and Energy; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); German Research Foundation(German Research Foundation (DFG)); European Union(European Commission); eemagine GmbH	This work was supported by the following: German Federal Ministry for Economic Affairs and Energy, Grant-No: KF2250111ED2, http://www.bmwi.de/EN/root.html, funding a research position; German Federal Ministry of Education and Research, Grant-No: 03IP605A, http://www.bmbf.de/en/, funding a research position; German Research Foundation, Grant-No: Ha2899/14-1, http://www.dfg.de/en/, funding a research position; and European Union, Grant-No: FP7-PEOPLE Marie Curie IAPP project 610950, http://ec.europa.eu/research/mariecurieactions/, funding two research positions. The eemagine GmbH provided support in the form of salaries for author FZ, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the "author contributions" section.	Anderson E., 1999, LAPACK USERS GUIDE, V3rd; Bashashati A, 2007, J NEURAL ENG, V4, pR32, DOI 10.1088/1741-2560/4/2/R03; Bayliss JD, 2000, IEEE T REHABIL ENG, V8, P188, DOI 10.1109/86.847811; BELL AJ, 1995, NEURAL COMPUT, V7, P1129, DOI 10.1162/neco.1995.7.6.1129; Bradshaw LA, 2001, ANN BIOMED ENG, V29, P202, DOI 10.1114/1.1352642; Brunner C, 2007, PATTERN RECOGN LETT, V28, P957, DOI 10.1016/j.patrec.2007.01.002; Chavel I, 1984, EIGENVALUES RIEMANNI, V115; Chung F. R. K., 1997, CBMS REGIONAL C SERI, V92; Cichocki A, 2008, COMPUTER, V41, P34, DOI 10.1109/MC.2008.431; Cruccu G, 2008, CLIN NEUROPHYSIOL, V119, P1705, DOI 10.1016/j.clinph.2008.03.016; De Lucia M, 2010, BRAIN TOPOGR, V23, P119, DOI 10.1007/s10548-010-0145-y; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DESANTIS A, 1991, GEOPHYS J INT, V106, P253, DOI 10.1111/j.1365-246X.1991.tb04615.x; Dhillon IS, 2004, LINEAR ALGEBRA APPL, V387, P1, DOI 10.1016/j.laa.2003.12.028; Durka PJ, 2005, J NEUROSCI METH, V148, P49, DOI 10.1016/j.jneumeth.2005.04.001; DURKA PJ, 1995, ANN BIOMED ENG, V23, P608, DOI 10.1007/BF02584459; Dyer R., 2007, INVESTIGATION SPECTR; FUJIWARA K, 1995, P AM MATH SOC, V123, P2585, DOI 10.2307/2161293; Golub GH., 2013, MATRIX COMPUTATIONS; Graichen U., 2011, Proceedings of the 2011 8th International Symposium on Noninvasive Functional Source Imaging of the Brain and Heart and the 2011 8th International Conference on Bioelectromagnetism (NFSI and ICBEM), P18, DOI 10.1109/NFSI.2011.5936811; Gramfort Alexandre, 2007, 2007 Joint Meeting of the 6th International Symposium on Noninvasive Functional Source Imaging of the Brain and Heart and the International Conference on Functional Biomedical Imaging, P169, DOI 10.1109/NFSI-ICFBI.2007.4387717; Gratkowski M, 2008, METHOD INFORM MED, V47, P26, DOI 10.3414/ME0355; Gratkowski M, 2007, PRZ ELEKTROTECHNICZN, V83, P138; HAINES GV, 1988, COMPUT GEOSCI, V14, P413, DOI 10.1016/0098-3004(88)90027-1; Hyvarinen A, 2001, INDEPENDENT COMPONENT ANALYSIS: PRINCIPLES AND PRACTICE, P71; Hyvarinen A, 2000, NEURAL NETWORKS, V13, P411, DOI 10.1016/S0893-6080(00)00026-5; Jung TP, 2001, HUM BRAIN MAPP, V14, P166, DOI 10.1002/hbm.1050; KOLES ZJ, 1995, ELECTROEN CLIN NEURO, V95, P219, DOI 10.1016/0013-4694(95)00083-B; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Mauguiere F, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P79; Max Wardetzky, 2007, S GEOMETRY PROCESSIN, P33, DOI [DOI 10.2312/SGP/SGP07/033-037, 10.2312/SGP/SGP07/033-037]; Meyer M., 2002, VISUALIZATION MATH, V3, P52, DOI DOI 10.1007/978-3-662-05105-4_2; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Morup M, 2006, NEUROIMAGE, V29, P938, DOI 10.1016/j.neuroimage.2005.08.005; Neymeyr K., 2003, NUMERICAL METHODS SC, P74; Nunez Paul L., 1994, Brain Topography, V6, P221, DOI 10.1007/BF01187712; NUNEZ PL, 1994, ELECTROEN CLIN NEURO, V90, P40, DOI 10.1016/0013-4694(94)90112-0; Pinkall U., 1993, EXP MATH, V2, P15, DOI DOI 10.1080/10586458.1993.10504266; Polthier K., 2002, P CLAY SUMM SCH GLOB; Pourtois G, 2008, BRAIN TOPOGR, V20, P265, DOI 10.1007/s10548-008-0053-6; Ramirez-Velez M, 2006, I S BIOMED IMAGING, P956; Rao KR, 2010, SIGNALS COMMUN TECHN, P1, DOI 10.1007/978-1-4020-6629-0; Reuter M, 2006, COMPUT AIDED DESIGN, V38, P342, DOI 10.1016/j.cad.2005.10.011; Rosenberg S, 1997, LONDON MATH SOC STUD, V31; Serby H, 2005, IEEE T NEUR SYS REH, V13, P89, DOI 10.1109/TNSRE.2004.841878; SOONG ACK, 1995, IEEE T BIO-MED ENG, V42, P59, DOI 10.1109/10.362918; Sorkine O, 2006, COMPUT GRAPH FORUM, V25, P789, DOI 10.1111/j.1467-8659.2006.00999.x; Taubin G, 1995, P 22 ANN C COMPUTER, P351, DOI [DOI 10.1145/218380.218473, 10.1145/218380.218473]; Taubin G, 2000, STAR P EUR 2000 EUR; Vallet B, 2007, INRIA00186931 U NANC; Wingeier BM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051916; Zhang H, 2010, COMPUT GRAPH FORUM, V29, P1865, DOI 10.1111/j.1467-8659.2010.01655.x; Zhang H, 2007, P EUR STAT OF THE AR, P1, DOI DOI 10.1109/IPDPS.2007.370248	54	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121741	10.1371/journal.pone.0121741	http://dx.doi.org/10.1371/journal.pone.0121741			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885290	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000024
J	Li, X; Zhou, YL; Yang, YQ; Yang, SH; Sun, XD; Yang, YP				Li, Xiong; Zhou, Yanli; Yang, Yunqiang; Yang, Shihai; Sun, Xudong; Yang, Yongping			Physiological and Proteomics Analyses Reveal the Mechanism of Eichhornia crassipes Tolerance to High-Concentration Cadmium Stress Compared with Pistia stratiotes	PLOS ONE			English	Article							2-DIMENSIONAL ELECTROPHORESIS; HYDROGEN-PEROXIDE; PROTEIN PROFILES; HIGH-TEMPERATURE; ROOT PROTEOME; FREE PROLINE; RESPONSES; LEAVES; TOXICITY; EXPOSURE	Cadmium (Cd) pollution is an environmental problem worldwide. Phytoremediation is a convenient method of removing Cd from both soil and water, but its efficiency is still low, especially in aquatic environments. Scientists have been trying to improve the ability of plants to absorb and accumulate Cd based on interactions between plants and Cd, especially the mechanism by which plants resist Cd. Eichhornia crassipes and Pistia stratiotes are aquatic plants commonly used in the phytoremediation of heavy metals. In the present study, we conducted physiological and biochemical analyses to compare the resistance of these two species to Cd stress at 100 mg/L. E. crassipes showed stronger resistance and was therefore used for subsequent comparative proteomics to explore the potential mechanism of E. crassipes tolerance to Cd stress at the protein level. The expression patterns of proteins in different functional categories revealed that the physiological activities and metabolic processes of E. crassipes were affected by exposure to Cd stress. However, when some proteins related to these processes were negatively inhibited, some analogous proteins were induced to compensate for the corresponding functions. As a result, E. crassipes could maintain more stable physiological parameters than P. stratiotes. Many stress-resistance substances and proteins, such as proline and heat shock proteins (HSPs) and post translational modifications, were found to be involved in the protection and repair of functional proteins. In addition, antioxidant enzymes played important roles in ROS detoxification. These findings will facilitate further understanding of the potential mechanism of plant response to Cd stress at the protein level.	[Li, Xiong; Zhou, Yanli; Yang, Yunqiang; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Peoples R China; [Li, Xiong; Zhou, Yanli; Yang, Yunqiang; Sun, Xudong; Yang, Yongping] Chinese Acad Sci, Kunming Inst Bot, China Germplasm Bank Wild Species, Kunming 650204, Peoples R China; [Li, Xiong; Zhou, Yanli; Yang, Shihai] Univ Chinese Acad Sci, Beijing 100049, Peoples R China; [Yang, Shihai] Chinese Acad Sci, Inst Tibetan Plateau Res, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Tibetan Plateau Research, CAS	Yang, YP (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Key Lab Plant Divers & Biogeog East Asia, Kunming 650201, Peoples R China.	yangyp@mail.kib.ac.cn	Yang, Shihai/J-1593-2012; Sun, Xudong/HHN-3905-2022	Yang, Shihai/0000-0002-6497-968X; 				Able AJ, 2003, PROTOPLASMA, V221, P137, DOI 10.1007/s00709-002-0064-1; Ahsan N, 2007, CR BIOL, V330, P735, DOI 10.1016/j.crvi.2007.08.001; Alvarez S, 2009, PROTEOMICS, V9, P3220, DOI [10.1002/pmic.200800478, 10.1002/pmic.200990042]; Ashraf M, 2007, ENVIRON EXP BOT, V59, P206, DOI 10.1016/j.envexpbot.2005.12.006; Barros E, 2010, PLANT BIOTECHNOL J, V8, P436, DOI 10.1111/j.1467-7652.2009.00487.x; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Chaney RL, 1997, CURR OPIN BIOTECH, V8, P279, DOI 10.1016/S0958-1669(97)80004-3; Chardonnens AN, 1998, PHYSIOL PLANTARUM, V104, P75, DOI 10.1034/j.1399-3054.1998.1040110.x; Cho K, 2008, J PROTEOME RES, V7, P2980, DOI 10.1021/pr800128q; Colmsee C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-245; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Curie C, 2009, ANN BOT-LONDON, V103, P1, DOI 10.1093/aob/mcn207; D'Alessandro A, 2013, J PROTEOME RES, V12, P4979, DOI 10.1021/pr400793e; Dixit V, 2001, J EXP BOT, V52, P1101, DOI 10.1093/jexbot/52.358.1101; Durand TC, 2010, PROTEOMICS, V10, P349, DOI 10.1002/pmic.200900484; Gardea-Torresdey JL, 2005, ARCH ENVIRON CON TOX, V48, P225, DOI 10.1007/s00244-003-0162-x; GRILL E, 1989, P NATL ACAD SCI USA, V86, P6838, DOI 10.1073/pnas.86.18.6838; Guo WJ, 2008, PLANT PHYSIOL, V146, P1697, DOI 10.1104/pp.108.115782; Hajduch M, 2001, ELECTROPHORESIS, V22, P2824, DOI 10.1002/1522-2683(200108)22:13&lt;2824::AID-ELPS2824&gt;3.0.CO;2-C; Hossain Z, 2012, AMINO ACIDS, V43, P2393, DOI 10.1007/s00726-012-1319-6; Hothem SD, 2003, J PLANT NUTR, V26, P845, DOI 10.1081/PLN-120018569; Hradilova J, 2010, ELECTROPHORESIS, V31, P421, DOI 10.1002/elps.200900477; [胡绵好 Hu Mianhao], 2009, [环境工程学报, Chinese Journal of Environmental Engineering], V3, P2163; Iannelli MA, 2002, PLANT PHYSIOL BIOCH, V40, P977, DOI 10.1016/S0981-9428(02)01455-9; Jia, 2011, J HYDROECOLOGY, V32, P69, DOI 10.15928/j.1674-3075.2011.02.012; Jiang MY, 2001, PLANT CELL PHYSIOL, V42, P1265, DOI 10.1093/pcp/pce162; Jozefczak M, 2012, INT J MOL SCI, V13, P3145, DOI 10.3390/ijms13033145; KATO S, 1993, PLANT CELL PHYSIOL, V34, P367; KESSELER A, 1995, PLANT PHYSIOL BIOCH, V33, P519; Kieffer P, 2008, PROTEOMICS, V8, P2514, DOI 10.1002/pmic.200701110; Kieffer P, 2009, J PROTEOME RES, V8, P400, DOI 10.1021/pr800561r; Kulik A, 2012, PLANT PHYSIOL, V160, P868, DOI 10.1104/pp.112.194472; KUMAR PBAN, 1995, ENVIRON SCI TECHNOL, V29, P1232, DOI 10.1021/es00005a014; Kuznetsov VV, 1997, PHYSIOL PLANTARUM, V100, P320, DOI 10.1034/j.1399-3054.1997.1000214.x; Lee K, 2010, J PLANT PHYSIOL, V167, P161, DOI 10.1016/j.jplph.2009.09.006; Li X, 2015, ENVIRON SCI POLLUT R, V22, P8643, DOI 10.1007/s11356-014-4020-3; Li X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107605; Li X, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0099857, 10.1371/journal.pone.0098410]; Lombi E, 2002, PLANT PHYSIOL, V128, P1359, DOI 10.1104/pp.010731; Marmiroli M, 2013, CHEMOSPHERE, V93, P1333, DOI 10.1016/j.chemosphere.2013.07.065; Martins LL, 2011, ACTA PHYSIOL PLANT, V33, P1375, DOI 10.1007/s11738-010-0671-y; Mayfield JD, 2012, J EXP BOT, V63, P3061, DOI 10.1093/jxb/ers022; Mihailova G, 2011, PHOTOSYNTH RES, V108, P5, DOI 10.1007/s11120-011-9644-2; Mills RF, 2003, PLANT J, V35, P164, DOI 10.1046/j.1365-313X.2003.01790.x; Mishra S, 2006, PLANT PHYSIOL BIOCH, V44, P25, DOI 10.1016/j.plaphy.2006.01.007; Mishra S, 2009, BIORESOURCE TECHNOL, V100, P2155, DOI 10.1016/j.biortech.2008.10.041; Muneer S, 2014, INT J MOL SCI, V15, P6343, DOI 10.3390/ijms15046343; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Papoyan A, 2004, PLANT PHYSIOL, V136, P3814, DOI 10.1104/pp.104.044503; Perfus-Barbeoch L, 2002, PLANT J, V32, P539, DOI 10.1046/j.1365-313X.2002.01442.x; Plekhanov SE, 2003, BIOL BULL+, V30, P506, DOI 10.1023/A:1025806921291; Raskin I, 1997, CURR OPIN BIOTECH, V8, P221, DOI 10.1016/S0958-1669(97)80106-1; Rodriguez-Celma J, 2010, J PROTEOMICS, V73, P1694, DOI 10.1016/j.jprot.2010.05.001; Sandalio LM, 2001, J EXP BOT, V52, P2115, DOI 10.1093/jexbot/52.364.2115; Sarry JE, 2006, PROTEOMICS, V6, P2180, DOI 10.1002/pmic.200500543; Schat H, 1997, PHYSIOL PLANTARUM, V101, P477, DOI 10.1111/j.1399-3054.1997.tb01026.x; Schneider T, 2009, PROTEOMICS, V9, P2668, DOI 10.1002/pmic.200800806; Semane B, 2010, J PLANT PHYSIOL, V167, P247, DOI 10.1016/j.jplph.2009.09.015; Shah K, 2001, PLANT SCI, V161, P1135, DOI 10.1016/S0168-9452(01)00517-9; STOHS SJ, 1995, FREE RADICAL BIO MED, V18, P321, DOI 10.1016/0891-5849(94)00159-H; Suzuki N, 2001, PLANT CELL ENVIRON, V24, P1177, DOI 10.1046/j.1365-3040.2001.00773.x; Tian GT, 2014, J YANGZE U NAT SCI E, V11, P54, DOI DOI 10.16772/J.CNKI.1673-1409.2014.11.004; Tschuschke S, 2002, J BIOL CHEM, V277, P5120, DOI 10.1074/jbc.M108426200; Tuomainen MH, 2006, PROTEOMICS, V6, P3696, DOI 10.1002/pmic.200501357; Ueno D, 2010, P NATL ACAD SCI USA, V107, P16500, DOI 10.1073/pnas.1005396107; Villiers F, 2011, PROTEOMICS, V11, P1650, DOI 10.1002/pmic.201000645; Waalkes MP, 2000, J INORG BIOCHEM, V79, P241, DOI 10.1016/S0162-0134(00)00009-X; Wagner A, 2009, PLANT PHYSIOL, V149, P370, DOI 10.1104/pp.108.125765; Wan XY, 2008, MOL CELL PROTEOMICS, V7, P1469, DOI 10.1074/mcp.M700488-MCP200; Wang Z, 2012, CHEMOSPHERE, V89, P1255, DOI 10.1016/j.chemosphere.2012.08.001; Xu WF, 2013, PLANT PHYSIOL, V163, P1817, DOI 10.1104/pp.113.224758; [严政 Yan Zheng], 2012, [安全与环境学报, Journal of Safety and Environment], V12, P1; Yang YQ, 2012, J PROTEOME RES, V11, P3605, DOI 10.1021/pr300027a; Young C, 2012, ANAL BIOCHEM, V421, P330, DOI 10.1016/j.ab.2011.10.045; Zeng XW, 2011, CHEMOSPHERE, V82, P321, DOI 10.1016/j.chemosphere.2010.10.030; Zhao L, 2011, CHEMOSPHERE, V85, P56, DOI 10.1016/j.chemosphere.2011.06.029; 胡笳, 2005, [科学通报, Chinese science bulletin], V50, P1061	78	32	32	3	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124304	10.1371/journal.pone.0124304	http://dx.doi.org/10.1371/journal.pone.0124304			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886466	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000113
J	Maxfield-Taylor, SA; Mujic, AB; Rao, S				Maxfield-Taylor, Sarah A.; Mujic, Alija B.; Rao, Sujaya			First Detection of the Larval Chalkbrood Disease Pathogen Ascosphaera apis (Ascomycota: Eurotiomycetes: Ascosphaerales) in Adult Bumble Bees	PLOS ONE			English	Article							AGRI-ENVIRONMENT SCHEMES; MEGACHILE-ROTUNDATA; WILD POLLINATORS; DNA-SEQUENCES; MIXED MODELS; SOLITARY BEE; DECLINE; FUNGUS; CONSERVATION; HYMENOPTERA	Fungi in the genus Ascosphaera (Ascomycota: Eurotiomycetes: Ascosphaerales) cause chalkbrood disease in larvae of bees. Here, we report the first-ever detection of the fungus in adult bumble bees that were raised in captivity for studies on colony development. Wild queens of Bombus griseocollis, B. nevadensis and B. vosnesenskii were collected and maintained for establishment of nests. Queens that died during rearing or that did not lay eggs within one month of capture were dissected, and tissues were examined microscopically for the presence of pathogens. Filamentous fungi that were detected were plated on artificial media containing broad spectrum antibiotics for isolation and identification. Based on morphological characters, the fungus was identified as Ascosphaera apis (Maasen ex Claussen) Olive and Spiltoir, a species that has been reported earlier only from larvae of the European honey bee, Apis mellifera, the Asian honey bee, Apis cerana, and the carpenter bee Xylocopa californica arizonensis. The identity of the fungus was confirmed using molecular markers and phylogenetic analysis. Ascosphaera apis was detected in queens of all three bumble bee species examined. Of 150 queens dissected, 12 (8%) contained vegetative and reproductive stages of the fungus. Both fungal stages were also detected in two workers collected from colonies with Ascosphaera-infected B. nevadensis queens. In this study, wild bees could have been infected prior to capture for rearing, or, the A. apis infection could have originated via contaminated European honey bee pollen fed to the bumble bees in captivity. Thus, the discovery of A. apis in adult bumble bees in the current study has important implications for commercial production of bumble bee colonies and highlights potential risks to native bees via pathogen spillover from infected bees and infected pollen.	[Maxfield-Taylor, Sarah A.; Rao, Sujaya] Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA; [Mujic, Alija B.] Oregon State Univ, Dept Bot & Plant Pathol, Corvallis, OR 97331 USA	Oregon State University; Oregon State University	Rao, S (corresponding author), Oregon State Univ, Dept Crop & Soil Sci, Corvallis, OR 97331 USA.	sujaya@oregonstate.edu			Agricultural Research Foundation; Oregon State University [3958]	Agricultural Research Foundation; Oregon State University	This work was supported by the Agricultural Research Foundation (http://agresearchfoundation.oregonstate.edu/), Oregon State University, Grant # 3958 received by SR. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DL, 1998, MYCOL RES, V102, P541, DOI 10.1017/S0953756297005261; [Anonymous], EC CHALL POS DECL PO; Aronstein KA, 2010, J INVERTEBR PATHOL, V103, pS20, DOI 10.1016/j.jip.2009.06.018; Beekman M, 1998, P ROY SOC B-BIOL SCI, V265, P1535, DOI 10.1098/rspb.1998.0469; Biesmeijer JC, 2006, SCIENCE, V313, P351, DOI 10.1126/science.1127863; BISSETT J, 1988, CAN J BOT, V66, P2541, DOI [10.1139/b88-346, 10.1139/b88-057]; Carvell C, 2007, J APPL ECOL, V44, P29, DOI 10.1111/j.1365-2664.2006.01249.x; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Evison SEF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030641; Flores JM, 2005, MYCOLOGIA, V97, P1171, DOI 10.3852/mycologia.97.6.1171; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; GILLIAM M, 1994, J INVERTEBR PATHOL, V63, P307, DOI 10.1006/jipa.1994.1057; Gilliam M, 1997, HONEY BEE PESTS PRED, P81; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2003, BUMBLEBEES THEIR BEH; Graystock P, 2013, J APPL ECOL, V50, P1207, DOI 10.1111/1365-2664.12134; Grixti JC, 2009, BIOL CONSERV, V142, P75, DOI 10.1016/j.biocon.2008.09.027; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HEATH LAF, 1987, J APICULT RES, V26, P243, DOI 10.1080/00218839.1987.11100768; Jensen AB, 2012, FEMS MICROBIOL LETT, V330, P17, DOI 10.1111/j.1574-6968.2012.02515.x; KISH LP, 1988, MYCOLOGIA, V80, P312, DOI 10.2307/3807627; Kleijn D, 2006, ECOL LETT, V9, P243, DOI 10.1111/j.1461-0248.2005.00869.x; Koch J, 2012, USDA PUBLICATION; Murray TE, 2013, BIOL CONSERV, V159, P269, DOI 10.1016/j.biocon.2012.10.021; Oregon Department of Agriculture, OR APPR INS LIST; Otterstatter MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002771; Pitts-Singer TL, 2011, ANNU REV ENTOMOL, V56, P221, DOI 10.1146/annurev-ento-120709-144836; PLOWRIGHT R C, 1966, Journal of Apicultural Research, V5, P155; POMEROY N, 1980, CAN ENTOMOL, V112, P321, DOI 10.4039/Ent112321-3; Pridal A, 1997, ACTA U AGR SILVIC ME, V3-4, P59; Pridal A, 2001, ACTA U AGR SILVIC ME, V5, P41; Qin X, 2006, INSECT MOL BIOL, V15, P715, DOI 10.1111/j.1365-2583.2006.00694.x; Rao S., 2010, PSYCHE, DOI [10.1155/2010/354072, DOI 10.1155/2010/354072]; Rao S, 2007, PAN-PAC ENTOMOL, V83, P360, DOI 10.3956/2007-10.1; Rehner SA, 2009, MOL ECOL RESOUR, V9, P855, DOI 10.1111/j.1755-0998.2008.02455.x; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Singh R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014357; Skou JP., 1986, APIMONDIA, V30, P260; Smith KM, 2013, ECOHEALTH, V10, P434, DOI 10.1007/s10393-013-0870-2; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stephen WP, 1957, ORE STATE U AGR EXP, V40; Stephen WP, 1981, ORE STATE U AGR EXP, V653; Thorp Robbin W., 2003, P21; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; Velthuis HHW, 2006, APIDOLOGIE, V37, P421, DOI 10.1051/apido:2006019; White T. J, 1990, PCR PROTOCOLS GUIDE, V18, P315, DOI DOI 10.1016/B978-0-12-372180-8.50042-1; Williams PH, 2009, APIDOLOGIE, V40, P367, DOI 10.1051/apido/2009025; Wubie AJ, 2013, J FOOD AGRIC ENVIRON, V11, P2190; Wynns AA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073419; Wynns AA, 2012, MYCOLOGIA, V104, P108, DOI 10.3852/10-047	51	29	39	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124868	10.1371/journal.pone.0124868	http://dx.doi.org/10.1371/journal.pone.0124868			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885679	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000147
J	Steinbacher, P; Feichtinger, RG; Kedenko, L; Kedenko, I; Reinhardt, S; Schonauer, AL; Leitner, I; Sanger, AM; Stoiber, W; Kofler, B; Forster, H; Paulweber, B; Ring-Dimitriou, S				Steinbacher, Peter; Feichtinger, Rene G.; Kedenko, Lyudmyla; Kedenko, Igor; Reinhardt, Sandra; Schoenauer, Anna-Lena; Leitner, Isabella; Saenger, Alexandra M.; Stoiber, Walter; Kofler, Barbara; Foerster, Holger; Paulweber, Bernhard; Ring-Dimitriou, Susanne			The Single Nucleotide Polymorphism Gly482Ser in the PGC-1 alpha Gene Impairs Exercise-Induced Slow-Twitch Muscle Fibre Transformation in Humans	PLOS ONE			English	Article							HUMAN SKELETAL-MUSCLE; TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; RECEPTOR-GAMMA COACTIVATOR-1-ALPHA; INDUCED MITOCHONDRIAL BIOGENESIS; LIFE-STYLE INTERVENTION; INSULIN-RESISTANCE; GLUCOSE-TOLERANCE; 1-ALPHA PGC-1-ALPHA; METABOLIC SYNDROME; DIABETES-MELLITUS	PGC-1 alpha (peroxisome proliferator-activated receptor. co-activator 1 alpha) is an important regulator of mitochondrial biogenesis and a master regulator of enzymes involved in oxidative phosphorylation. Recent evidence demonstrated that the Gly482Ser single nucleotide polymorphism (SNP) in the PGC-1 alpha gene affects insulin sensitivity, blood lipid metabolism and binding to myocyte enhancer factor 2 (MEF2). Individuals carrying this SNP were shown to have a reduced cardiorespiratory fitness and a higher risk to develop type 2 diabetes. Here, we investigated the responses of untrained men with the Gly482Ser SNP to a 10 week programme of endurance training (cycling, 3 x 60 min/week, heart rate at 70-90% VO2peak). Quantitative data from analysis of biopsies from vastus lateralis muscle revealed that the SNP group, in contrast to the control group, lacked a training-induced increase in content of slow contracting oxidative fibres. Capillary supply, mitochondrial density, mitochondrial enzyme activities and intramyocellular lipid content increased similarly in both groups. These results indicate that the impaired binding of MEF2 to PGC-1 alpha in humans with this SNP impedes exercise-induced fast-to-slow muscle fibre transformation.	[Steinbacher, Peter; Reinhardt, Sandra; Schoenauer, Anna-Lena; Leitner, Isabella; Saenger, Alexandra M.; Stoiber, Walter] Paris Lodron Univ Salzburg, Dept Cell Biol, Salzburg, Austria; [Feichtinger, Rene G.; Kofler, Barbara] Paracelsus Med Univ Salzburg, Dept Pedicatr, Res Program Receptor Biochem & Tumor Metab, Salzburg, Austria; [Kedenko, Lyudmyla; Kedenko, Igor; Paulweber, Bernhard] Paracelsus Med Univ Salzburg, Dept Internal Med 1, Salzburg, Austria; [Foerster, Holger] Med Off Pediat & Sports Med, Salzburg, Austria; [Ring-Dimitriou, Susanne] Paris Lodron Univ Salzburg, Dept Sport Sci & Kinesiol, Paris, Austria	Salzburg University; Paracelsus Private Medical University; Paracelsus Private Medical University	Steinbacher, P (corresponding author), Paris Lodron Univ Salzburg, Dept Cell Biol, Salzburg, Austria.	peter.steinbacher@sbg.ac.at	Ring-Dimitriou, Susanne/AAG-4323-2020	Ring-Dimitriou, Susanne/0000-0002-5317-3891; Kofler, Barbara/0000-0002-1198-4776; Steinbacher, Peter/0000-0001-8033-5190	Austrian National Bank [J14156]	Austrian National Bank	This work was sponsored by the Austrian National Bank (www.oenb.at) (Grant: J14156). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmetov II, 2009, HUM GENET, V126, P751, DOI 10.1007/s00439-009-0728-4; Amati F, 2011, DIABETES, V60, P2588, DOI 10.2337/db10-1221; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Andrulionyte L, 2006, DIABETES, V55, P2148, DOI 10.2337/db05-1629; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Berger A, 2003, ACTA NEUROPATHOL, V105, P245, DOI 10.1007/s00401-002-0638-1; BERGSTROM J, 1975, SCAND J CLIN LAB INV, V35, P606, DOI 10.3109/00365517509095787; BUCHFUHRER MJ, 1983, J APPL PHYSIOL, V55, P1558, DOI 10.1152/jappl.1983.55.5.1558; Chen CJ, 1999, FLORA CHINA, V4, P1; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Chinsomboon J, 2009, P NATL ACAD SCI USA, V106, P21401, DOI 10.1073/pnas.0909131106; Choi YS, 2006, BIOCHEM BIOPH RES CO, V344, P708, DOI 10.1016/j.bbrc.2006.03.193; Cobley JN, 2012, BIOGERONTOLOGY, V13, P621, DOI 10.1007/s10522-012-9408-1; COGGAN AR, 1992, J APPL PHYSIOL, V72, P1780, DOI 10.1152/jappl.1992.72.5.1780; Dube JJ, 2008, AM J PHYSIOL-ENDOC M, V294, pE882, DOI 10.1152/ajpendo.00769.2007; Dumke CL, 2009, EUR J APPL PHYSIOL, V107, P419, DOI 10.1007/s00421-009-1143-1; Ek J, 2001, DIABETOLOGIA, V44, P2220, DOI 10.1007/s001250100032; Feichtinger Rene G, 2011, Front Biosci (Elite Ed), V3, P194, DOI 10.2741/e233; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Fitts RH, 2001, J EXP BIOL, V204, P3201; Geng TY, 2010, AM J PHYSIOL-CELL PH, V298, pC572, DOI 10.1152/ajpcell.00481.2009; Gibala MJ, 2006, J PHYSIOL-LONDON, V575, P901, DOI 10.1113/jphysiol.2006.112094; Goodpaster BH, 2002, OBES RES, V10, P575, DOI 10.1038/oby.2002.78; Goodpaster BH, 2001, J CLIN ENDOCR METAB, V86, P5755, DOI 10.1210/jc.86.12.5755; Hakim AA, 1999, CIRCULATION, V100, P9, DOI 10.1161/01.CIR.100.1.9; Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Hara K, 2002, DIABETOLOGIA, V45, P740, DOI 10.1007/s00125-002-0803-z; Holloszy JO, 2008, J PHYSIOL PHARMACOL, V59, P5; HOLLOSZY JO, 1967, J BIOL CHEM, V242, P2278; Holloszy JO, 2003, AM J PHYSIOL-ENDOC M, V284, pE453, DOI 10.1152/ajpendo.00463.2002; HOWALD H, 1985, PFLUG ARCH EUR J PHY, V403, P369, DOI 10.1007/BF00589248; INGJER F, 1979, J PHYSIOL-LONDON, V294, P419, DOI 10.1113/jphysiol.1979.sp012938; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; JANSSON E, 1978, ACTA PHYSIOL SCAND, V104, P235, DOI 10.1111/j.1748-1716.1978.tb06272.x; Kang CH, 2013, J SPORT HEALTH SCI, V2, P81, DOI 10.1016/j.jshs.2013.03.005; Kelley DE, 2000, DIABETES, V49, P677, DOI 10.2337/diabetes.49.5.677; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Koves TR, 2013, J LIPID RES, V54, P522, DOI 10.1194/jlr.P028910; Koves TR, 2005, J BIOL CHEM, V280, P33588, DOI 10.1074/jbc.M507621200; Kramer DK, 2006, ACTA PHYSIOL, V188, P207, DOI 10.1111/j.1748-1716.2006.01620.x; Laaksonen DE, 2005, DIABETES, V54, P158, DOI 10.2337/diabetes.54.1.158; LEAN MEJ, 1995, BRIT MED J, V311, P158, DOI 10.1136/bmj.311.6998.158; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Little JP, 2011, AM J PHYSIOL-REG I, V300, pR1303, DOI 10.1152/ajpregu.00538.2010; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Lucia A, 2005, J APPL PHYSIOL, V99, P344, DOI 10.1152/japplphysiol.00037.2005; Mathai AS, 2008, J APPL PHYSIOL, V105, P1098, DOI 10.1152/japplphysiol.00847.2007; McGee SL, 2006, FASEB J, V20, P348, DOI 10.1096/fj.05-4671fje; Meierhofer D, 2004, CARCINOGENESIS, V25, P1005, DOI 10.1093/carcin/bgh104; Mora S, 2000, J BIOL CHEM, V275, P16323, DOI 10.1074/jbc.M910259199; Oberkofler H, 2003, BIOCHEM J, V371, P89, DOI 10.1042/BJ20021665; Olesen J, 2010, PFLUG ARCH EUR J PHY, V460, P153, DOI 10.1007/s00424-010-0834-0; Pan XR, 1997, DIABETES CARE, V20, P537, DOI 10.2337/diacare.20.4.537; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Pilegaard H, 2005, METABOLISM, V54, P1048, DOI 10.1016/j.metabol.2005.03.008; Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Putman CT, 2004, EUR J APPL PHYSIOL, V92, P376, DOI 10.1007/s00421-004-1104-7; Rasbach KA, 2010, P NATL ACAD SCI USA, V107, P21866, DOI 10.1073/pnas.1016089107; Ring-Dimitriou S., 2014, J EXERC PHYSL ONLINE, V17, P1, DOI 10.1519/JSC.0b013e3181874564; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Sandhofer A, 2007, EUR J CLIN INVEST, V37, P109, DOI 10.1111/j.1365-2362.2007.01751.x; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Scheuermann BW, 1998, RESP PHYSIOL, V114, P227, DOI 10.1016/S0034-5687(98)00097-8; Schiaffino S, 2010, ACTA PHYSIOL, V199, P451, DOI 10.1111/j.1748-1716.2010.02130.x; Shaw CS, 2008, HISTOCHEM CELL BIOL, V129, P65, DOI 10.1007/s00418-007-0349-8; Shono N, 2002, J ATHEROSCLER THROMB, V9, P1; Stefan N, 2007, J CLIN ENDOCR METAB, V92, P1827, DOI 10.1210/jc.2006-1785; Steinbacher P, 2010, TISSUE CELL, V42, P37, DOI 10.1016/j.tice.2009.07.001; Summermatter S, 2010, J BIOL CHEM, V285, P32793, DOI 10.1074/jbc.M110.145995; Tarnopolsky MA, 2007, AM J PHYSIOL-REG I, V292, pR1271, DOI 10.1152/ajpregu.00472.2006; Thayer R, 2000, J SPORT MED PHYS FIT, V40, P284; Timmons JA, 2006, GENOMICS, V87, P165, DOI 10.1016/j.ygeno.2005.09.007; Tuomilehto Jaakko, 2001, New England Journal of Medicine, V344, P1343, DOI 10.1056/NEJM200105033441801; van Loon LJC, 2006, PFLUG ARCH EUR J PHY, V451, P606, DOI 10.1007/s00424-005-1509-0; Vohl MC, 2005, MOL GENET METAB, V86, P300, DOI 10.1016/j.ymgme.2005.07.002; WASSERMAN K, 1964, AM J CARDIOL, V14, P844, DOI 10.1016/0002-9149(64)90012-8; Wasserman K, 2005, PRINCIPLES EXERCISE; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200; Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963; Yan Z, 2011, J APPL PHYSIOL, V110, P264, DOI 10.1152/japplphysiol.00993.2010; Zechner C, 2010, CELL METAB, V12, P633, DOI 10.1016/j.cmet.2010.11.008; Zhang SL, 2007, CHINESE MED J-PEKING, V120, P1878, DOI 10.1097/00029330-200711010-00005	87	18	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123881	10.1371/journal.pone.0123881	http://dx.doi.org/10.1371/journal.pone.0123881			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886402	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000092
J	Zhu, JF; Jin, YY; Wang, K; Zhou, YM; Feng, Y; Yu, MH; Jin, XQ				Zhu, Jianfang; Jin, Yuanyuan; Wang, Kai; Zhou, Yumiao; Feng, Yue; Yu, Maihong; Jin, Xiaoqing			Frequency-Dependent Changes in the Regional Amplitude and Synchronization of Resting-State Functional MRI in Stroke	PLOS ONE			English	Article							BRAIN ACTIVITY; FMRI; CONNECTIVITY; MOVEMENT; VARIABILITY; CHILDREN; RECOVERY	Resting-state functional magnetic resonance imaging (R-fMRI) has been intensively used to assess alterations of inter-regional functional connectivity in patients with stroke, but the regional properties of brain activity in stroke have not yet been fully investigated. Additionally, no study has examined a frequency effect on such regional properties in stroke patients, although this effect has been shown to play important roles in both normal brain functioning and functional abnormalities. Here we utilized R-fMRI to measure the amplitude of low-frequency fluctuations (ALFF) and regional homogeneity (ReHo), two major methods for characterizing the regional properties of R-fMRI, in three different frequency bands (slow-5: 0.01-0.027 Hz; slow-4: 0.027-0.73 Hz; and typical band: 0.01-0.1 Hz) in 19 stroke patients and 15 healthy controls. Both the ALFF and ReHo analyses revealed changes in brain activity in a number of brain regions, particularly the parietal cortex, in stroke patients compared with healthy controls. Remarkably, the regions with changed activity as detected by the slow-5 band data were more extensive, and this finding was true for both the ALFF and ReHo analyses. These results not only confirm previous studies showing abnormality in the parietal cortex in patients with stroke, but also suggest that R-fMRI studies of stroke should take frequency effects into account when measuring intrinsic brain activity.	[Zhu, Jianfang; Jin, Yuanyuan; Wang, Kai; Yu, Maihong; Jin, Xiaoqing] Zhejiang Hosp, Dept Acupuncture & Moxibust, Hangzhou, Zhejiang, Peoples R China; [Zhou, Yumiao] Zhejiang Hosp, Dept Neurol, Hangzhou, Zhejiang, Peoples R China; [Feng, Yue] Zhejiang Hosp, Dept Radiol, Hangzhou, Zhejiang, Peoples R China		Jin, XQ (corresponding author), Zhejiang Hosp, Dept Acupuncture & Moxibust, 12 Lingyin Rd, Hangzhou, Zhejiang, Peoples R China.	zjyyjxq@163.com			Zhejiang Provincial Natural Science Foundation [LY12H27001]; Zhejiang Provincial administration of Traditional Chinese Medicine [2011ZA009]	Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial administration of Traditional Chinese Medicine	This work was supported by Zhejiang Provincial Natural Science Foundation (LY12H27001) and Zhejiang Provincial administration of Traditional Chinese Medicine (2011ZA009). XQJ received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altamura C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-151; Anderson JS, 2011, AM J NEURORADIOL, V32, P548, DOI 10.3174/ajnr.A2330; Baria AT, 2011, J NEUROSCI, V31, P7910, DOI 10.1523/JNEUROSCI.1296-11.2011; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cho SY, 2013, CHIN J INTEGR MED, V19, P269, DOI 10.1007/s11655-013-1436-4; Daly JJ, 2008, J NEUROSCI METH, V175, P133, DOI 10.1016/j.jneumeth.2008.07.025; Dechaumont-Palacin S, 2008, NEUROREHAB NEURAL RE, V22, P154, DOI 10.1177/1545968307307118; Di Martino A, 2008, BIOL PSYCHIAT, V64, P607, DOI 10.1016/j.biopsych.2008.03.008; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Garrett DD, 2010, J NEUROSCI, V30, P4914, DOI 10.1523/JNEUROSCI.5166-09.2010; Golestani AM, 2013, NEUROREHAB NEURAL RE, V27, P153, DOI 10.1177/1545968312457827; Han Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028664; Han Y, 2011, NEUROIMAGE, V55, P287, DOI 10.1016/j.neuroimage.2010.11.059; He Y, 2007, NEUROIMAGE, V35, P488, DOI 10.1016/j.neuroimage.2006.11.042; Hoptman MJ, 2010, SCHIZOPHR RES, V117, P13, DOI 10.1016/j.schres.2009.09.030; Inman CS, 2012, NEUROIMAGE, V59, P227, DOI 10.1016/j.neuroimage.2011.07.083; Jung TD, 2013, J REHABIL MED, V45, P546, DOI 10.2340/16501977-1165; Ledberg A, 1998, NEUROIMAGE, V8, P113, DOI 10.1006/nimg.1998.0336; Li ZJ, 2012, J MAGN RESON IMAGING, V36, P344, DOI 10.1002/jmri.23670; Nunn CL, 1998, AM NAT, V152, P82, DOI 10.1086/286151; Raichle ME, 2006, SCIENCE, V314, P1249, DOI 10.1126/science.1134405; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rongjun Y, 2012, HUMAN BRAIN MAPPING, V0000, P00; Shehzad Z, 2009, CEREB CORTEX, V19, P2209, DOI 10.1093/cercor/bhn256; Smits M, 2012, ARCH PHYS MED REHAB, V93, pS4, DOI 10.1016/j.apmr.2011.02.023; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009; van Oers CAMM, 2010, NEUROIMAGE, V49, P885, DOI 10.1016/j.neuroimage.2009.08.057; Varkuti B, 2013, NEUROREHAB NEURAL RE, V27, P53, DOI 10.1177/1545968312445910; Wang ZQ, 2011, HUM BRAIN MAPP, V32, P1720, DOI 10.1002/hbm.21140; Wang ZT, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0097907, 10.1371/journal.pone.0114792, 10.1371/journal.pone.0103645, 10.1371/journal.pone.0089948, 10.1371/journal.pone.0087381, 10.1371/journal.pone.0091755, 10.1371/journal.pone.0109571, 10.1371/journal.pone.0104657]; Yan CG, 2013, NEUROIMAGE, V76, P183, DOI 10.1016/j.neuroimage.2013.03.004; Yin D, 2013, NEURORADIOLOGY, V17, P19, DOI [10.1186/1687-9856-2013-17, DOI 10.1186/1687-9856-2013-17]; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zuo XN, 2010, NEUROIMAGE, V49, P1432, DOI 10.1016/j.neuroimage.2009.09.037	36	22	24	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123850	10.1371/journal.pone.0123850	http://dx.doi.org/10.1371/journal.pone.0123850			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885897	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000088
J	Fu, LW; Rab, A; Tang, LP; Bebok, Z; Rowe, SM; Bartoszewski, R; Collawn, JF				Fu, Lianwu; Rab, Andras; Tang, Li Ping; Bebok, Zsuzsa; Rowe, Steven M.; Bartoszewski, Rafal; Collawn, James F.			Delta F508 CFTR Surface Stability Is Regulated by DAB2 and CHIP-Mediated Ubiquitination in Post-Endocytic Compartments	PLOS ONE			English	Article							TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; QUALITY-CONTROL; ENDOPLASMIC-RETICULUM; EARLY ENDOSOMES; KEY REGULATOR; MYOSIN-VI; CLATHRIN; DEGRADATION; DISABLED-2	The Delta F508 mutant form of the cystic fibrosis transmembrane conductance regulator (Delta F508 CFTR) that is normally degraded by the ER-associated degradative pathway can be rescued to the cell surface through low-temperature (27 degrees C) culture or small molecular corrector treatment. However, it is unstable on the cell surface, and rapidly internalized and targeted to the lysosomal compartment for degradation. To understand the mechanism of this rapid turnover, we examined the role of two adaptor complexes (AP-2 and Dab2) and three E3 ubiquitin ligases (c-Cbl, CHIP, and Nedd4-2) on low-temperature rescued Delta F508 CFTR endocytosis and degradation in human airway epithelial cells. Our results demonstrate that siRNA depletion of either AP-2 or Dab2 inhibits Delta F508 CFTR endocytosis by 69% and 83%, respectively. AP-2 or Dab2 depletion also increases the rescued protein half-life of Delta F508 CFTR by similar to 18% and similar to 91%, respectively. In contrast, the depletion of each of the E3 ligases had no effect on Delta F508 CFTR endocytosis, whereas CHIP depletion significantly increased the surface half-life of Delta F508 CFTR. To determine where and when the ubiquitination occurs during Delta F508 CFTR turnover, we monitored the ubiquitination of rescued Delta F508 CFTR during the time course of CFTR endocytosis. Our results indicate that ubiquitination of the surface pool of Delta F508 CFTR begins to increase 15 min after internalization, suggesting that CFTR is ubiquitinated in a postendocytic compartment. This post-endocytic ubiquination of Delta F508 CFTR could be blocked by either inhibiting endocytosis, by siRNA knockdown of CHIP, or by treating cells with the CFTR corrector, VX-809. Our results indicate that the post-endocytic ubiquitination of CFTR by CHIP is a critical step in the peripheral quality control of cell surface Delta F508 CFTR.	[Fu, Lianwu; Rab, Andras; Bebok, Zsuzsa; Collawn, James F.] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA; [Tang, Li Ping; Rowe, Steven M.] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Fu, Lianwu; Rab, Andras; Tang, Li Ping; Bebok, Zsuzsa; Rowe, Steven M.; Collawn, James F.] Univ Alabama Birmingham, Gregory Fleming James Cyst Fibrosis Res Ctr, Birmingham, AL 35294 USA; [Bartoszewski, Rafal] Med Univ Gdansk, Dept Biol & Pharmaceut Bot, Gdansk, Poland	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Fahrenheit Universities; Medical University Gdansk	Fu, LW (corresponding author), Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL 35233 USA.	lianwufu@uab.edu; jcollawn@uab.edu	Rab, András/AAR-7804-2021; Rab, Andras/AAI-9402-2021; Bartoszewski, Rafal A/D-6311-2011	Rab, András/0000-0003-2154-0017; Bartoszewski, Rafal A/0000-0002-2864-6757; Collawn, James/0000-0002-2528-2759; Fu, Karl/0000-0001-5386-9429	CF Foundation [R464-CR07]; NIH [P30 DK072482, R01 DK60065, R01 HK076587]; Ministry of Science and Higher Education of the Republic of Poland, KNOW Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072482, R01DK060065] Funding Source: NIH RePORTER	CF Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Science and Higher Education of the Republic of Poland, KNOW Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by CF Foundation Grant R464-CR07 (www.cff.org) and NIH P30 DK072482 (www.nih.gov) through Dr. Eric Sorscher, R01 DK60065 to JFC and R01 HK076587 to ZB. RB was supported by the Ministry of Science and Higher Education of the Republic of Poland, KNOW Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acconcia F, 2009, EXP CELL RES, V315, P1610, DOI 10.1016/j.yexcr.2008.10.014; Alberti S, 2004, MOL BIOL CELL, V15, P4003, DOI 10.1091/mbc.E04-04-0293; Arora K, 2014, BIOCHEMISTRY-US, V53, P4169, DOI 10.1021/bi401263h; Bebok Z, 2005, J PHYSIOL-LONDON, V569, P601, DOI 10.1113/jphysiol.2005.096669; Bebok Z, 1998, J BIOL CHEM, V273, P29873, DOI 10.1074/jbc.273.45.29873; Bond LM, 2012, J BIOL CHEM; Boucher RC, 2007, J INTERN MED, V261, P5, DOI 10.1111/j.1365-2796.2006.01744.x; Caohuy H, 2009, J BIOL CHEM, V284, P25241, DOI 10.1074/jbc.M109.035345; Chibalina MV, 2007, J CELL SCI, V120, P4278, DOI 10.1242/jcs.014217; Cholon DM, 2010, AM J PHYSIOL-LUNG C, V298, pL304, DOI 10.1152/ajplung.00016.2009; Cihil KM, 2012, J BIOL CHEM, V287, P15087, DOI 10.1074/jbc.M112.341875; Collaco A, 2010, J BIOL CHEM, V285, P17177, DOI 10.1074/jbc.M110.127613; Collawn JF, 2010, EXPERT REV PROTEOMIC, V7, P495, DOI [10.1586/epr.10.45, 10.1586/EPR.10.45]; Collawn JF, 2009, AM J RESP CELL MOL, V40, P385, DOI 10.1165/rcmb.2008-0006ED; Deborde S, 2008, NATURE, V452, P719, DOI 10.1038/nature06828; DENNING GM, 1992, NATURE, V358, P761, DOI 10.1038/358761a0; Eckford PDW, 2014, CHEM BIOL, V21, P666, DOI 10.1016/j.chembiol.2014.02.021; Fu LW, 2012, BIOCHEM J, V441, P633, DOI 10.1042/BJ20111566; Grove DE, 2009, MOL BIOL CELL, V20, P4059, DOI 10.1091/mbc.E08-09-0929; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Jurkuvenaite A, 2006, J BIOL CHEM, V281, P3329, DOI 10.1074/jbc.M508131200; Koeppen K, 2012, AM J PHYSIOL-LUNG C, V303, pL720, DOI 10.1152/ajplung.00409.2011; Loo TW, 2013, BIOCHEM PHARMACOL, V86, P612, DOI 10.1016/j.bcp.2013.06.028; Loo TW, 2011, BIOCHEMISTRY-US, V50, P4393, DOI 10.1021/bi2004813; Madden Dean R, 2012, Commun Integr Biol, V5, P473, DOI 10.4161/cib.21375; Meacham GC, 2001, NAT CELL BIOL, V3, P100, DOI 10.1038/35050509; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Naren AP, 2003, P NATL ACAD SCI USA, V100, P342, DOI 10.1073/pnas.0135434100; Okiyoneda T, 2010, SCIENCE, V329, P805, DOI 10.1126/science.1191542; Polo S, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-25; Prince LS, 1999, J BIOL CHEM, V274, P3602, DOI 10.1074/jbc.274.6.3602; Riordan JR, 2008, ANNU REV BIOCHEM, V77, P701, DOI 10.1146/annurev.biochem.75.103004.142532; Rowe SM, 2006, CURR OPIN PEDIATR, V18, P604, DOI 10.1097/MOP.0b013e3280109b90; Sharma M, 2004, J CELL BIOL, V164, P923, DOI 10.1083/jcb.200312018; Sharma M, 2001, J BIOL CHEM, V276, P8942, DOI 10.1074/jbc.M009172200; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; Tjelle TE, 1996, J CELL SCI, V109, P2905; Van Goor F, 2011, P NATL ACAD SCI USA, V108, P18843, DOI 10.1073/pnas.1105787108; Varga K, 2008, BIOCHEM J, V410, P555, DOI 10.1042/BJ20071420; Weixel KM, 2001, PFLUG ARCH EUR J PHY, V443, pS70; Weixel KM, 2001, J BIOL CHEM, V276, P46251, DOI 10.1074/jbc.M104545200; Weixel KM, 2000, J BIOL CHEM, V275, P3655, DOI 10.1074/jbc.275.5.3655; White S, 1998, J BIOL CHEM, V273, P14355, DOI 10.1074/jbc.273.23.14355; Ye SY, 2010, J BIOL CHEM, V285, P27008, DOI 10.1074/jbc.M110.139881; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041; Younger JM, 2004, J CELL BIOL, V167, P1075, DOI 10.1083/jcb.200410065	47	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123131	10.1371/journal.pone.0123131	http://dx.doi.org/10.1371/journal.pone.0123131			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879443	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500040
J	Gotink, RA; Chu, P; Busschbach, JJV; Benson, H; Fricchione, GL; Hunink, MGM				Gotink, Rinske A.; Chu, Paula; Busschbach, Jan J. V.; Benson, Herbert; Fricchione, Gregory L.; Hunink, M. G. Myriam			Standardised Mindfulness-Based Interventions in Healthcare: An Overview of Systematic Reviews and Meta-Analyses of RCTs	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; STRESS REDUCTION; COGNITIVE THERAPY; CANCER CARE; DEPRESSION; MEDITATION; PREVENTION; DISORDERS; SYMPTOMS; BENEFITS	Background Mindfulness-based therapies are being used in a wide range of common chronic conditions in both treatment and prevention despite lack of consensus about their effectiveness in different patient categories. Objective To systematically review the evidence of effectiveness MBSR and MBCT in different patient categories. Methods A systematic review and meta-analysis of systematic reviews of RCTs, using the standardized MBSR or MBCT programs. We used PRISMA guidelines to assess the quality of the included reviews and performed a random effects meta-analysis with main outcome measure Cohen's d. All types of participants were considered. Results The search produced 187 reviews: 23 were included, covering 115 unique RCTs and 8,683 unique individuals with various conditions. Compared to wait list control and compared to treatment as usual, MBSR and MBCT significantly improved depressive symptoms (d= 0.37; 95% CI 0.28 to 0.45, based on 5 reviews, N = 2814), anxiety (d = 0.49; 95% CI 0.37 to 0.61, based on 4 reviews, N = 2525), stress (d = 0.51; 95% CI 0.36 to 0.67, based on 2 reviews, N = 1570), quality of life (d = 0.39; 95% CI 0.08 to 0.70, based on 2 reviews, N = 511) and physical functioning (d = 0.27; 95% CI 0.12 to 0.42, based on 3 reviews, N = 1015). Limitations include heterogeneity within patient categories, risk of publication bias and limited long-term follow-up in several studies. Conclusion The evidence supports the use of MBSR and MBCT to alleviate symptoms, both mental and physical, in the adjunct treatment of cancer, cardiovascular disease, chronic pain, depression, anxiety disorders and in prevention in healthy adults and children.	[Gotink, Rinske A.; Hunink, M. G. Myriam] Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands; [Gotink, Rinske A.; Busschbach, Jan J. V.] Erasmus MC, Dept Psychiat, Sect Med Psychol & Psychotherapy, Rotterdam, Netherlands; [Gotink, Rinske A.; Hunink, M. G. Myriam] Erasmus MC, Dept Radiol, Rotterdam, Netherlands; [Chu, Paula] Harvard Univ, Dept Hlth Policy, Cambridge, MA 02138 USA; [Benson, Herbert] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Benson Henry Inst Mind Body Med, Boston, MA USA; [Fricchione, Gregory L.] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Benson, Herbert; Fricchione, Gregory L.] Harvard Univ, Sch Med, Dept Med, Massachusetts Gen Hosp, Boston, MA USA; [Hunink, M. G. Myriam] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Hunink, MGM (corresponding author), Erasmus MC, Dept Epidemiol, Rotterdam, Netherlands.	m.hunink@erasmusmc.nl	Busschbach, Jan/P-1584-2019	Busschbach, Jan/0000-0002-8602-0381; Gotink, Rinske/0000-0002-4760-3226	Erasmus MC grant	Erasmus MC grant	There was no sponsor involvement in the design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript. Funding for this study was provided by an internal Erasmus MC grant.	Abbott RA, 2014, J PSYCHOSOM RES, V76, P341, DOI 10.1016/j.jpsychores.2014.02.012; Amuthan A, 2014, PHARMABIZ, P1, DOI DOI 10.1080/13548506.2014; Baer RA, 2004, ASSESSMENT, V11, P191, DOI 10.1177/1073191104268029; Bishop SR, 2004, CLIN PSYCHOL-SCI PR, V11, P230, DOI 10.1093/clipsy/bph077; Bohlmeijer E, 2010, J PSYCHOSOM RES, V68, P539, DOI 10.1016/j.jpsychores.2009.10.005; Brown KW, 2003, J PERS SOC PSYCHOL, V84, P822, DOI 10.1037/0022-3514.84.4.822; Burke CA, 2009, J CHILD FAM STUD; Cash E, 2014, ANN BEHAV MED; Chang BH, 2011, PSYCHOSOMATICS, V52, P550, DOI 10.1016/j.psym.2011.05.001; Chen KW, 2012, DEPRESS ANXIETY, V29, P545, DOI 10.1002/da.21964; Chiesa A, 2010, PSYCHOL MED, V40, P1239, DOI 10.1017/S0033291709991747; Chiesa A, 2011, PSYCHIAT RES, V187, P441, DOI 10.1016/j.psychres.2010.08.011; Coelho HF, 2007, J CONSULT CLIN PSYCH, V75, P1000, DOI 10.1037/0022-006X.75.6.1000; Collaboration TC, 2014, REV MAN REVMAN; Collip D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066747; Cramer H, 2012, BMC COMPLEMENT ALTER, V12; Cramer H, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-162; Davis L, 2012, AM J PSYCHIATR REHAB, V15, P202, DOI 10.1080/15487768.2012.679578; de Vibe M., 2012, CAMPBELL SYSTEMATIC, V3, P1, DOI [DOI 10.4073/CSR.2012.3, 10.4073/csr.2012.3]; Dusek JA, 2006, MED SCI MONITOR, V12, pCR1; Flook L, 2013, MIND BRAIN EDUC, V7, P182, DOI 10.1111/mbe.12026; Geschwind N, 2012, BRIT J PSYCHIAT, V201, P320, DOI 10.1192/bjp.bp.111.104851; Gonzalez-Garcia M, 2013, AIDS BEHAV; Goyal M, 2014, JAMA INTERN MED; Grossman P, 2004, J PSYCHOSOM RES, V57, P35, DOI 10.1016/S0022-3999(03)00573-7; Gunaratana H., 1993, MINDFULNESS PLAIN EN; Hofmann SG, 2010, PSYCHIAT CLIN N AM, V33, P701, DOI 10.1016/j.psc.2010.04.006; Jedel S, 2014, DIGESTION, V89, P142, DOI 10.1159/000356316; Johns SA, 2014, PSYCHOONCOLOGY; Julieta Galante SJIaPFP, 2012, J RES NURSING, V0, P1; KABATZINN J, 1985, J BEHAV MED, V8, P163, DOI 10.1007/BF00845519; Kapleau P, 2000, 3 PILLARS ZEN TEACHI; Klainin-Yobas P, 2012, INT J NURS STUD, V49, P109, DOI 10.1016/j.ijnurstu.2011.08.014; Kozasa EH, 2012, CURR PAIN HEADACHE R, V16, P383, DOI 10.1007/s11916-012-0285-8; la Cour P, 2014, PAIN MED; Lakhan SE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071834; Ledesma D, 2009, PSYCHO-ONCOLOGY, V18, P571, DOI 10.1002/pon.1400; Lengacher CA, 2014, PSYCHOONCOLOGY; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Moss AS, 2014, J APPL GERONTOL; Mularski RA, 2009, J ALTERN COMPLEM MED, V15, P1083, DOI 10.1089/acm.2009.0037; Napoli M, 2005, J APPL SCH PSYCHOL, V21, P99, DOI 10.1300/J370v21n01_05; Ott MJ, 2006, INTEGR CANCER THER, V5, P98, DOI 10.1177/1534735406288083; Parswani Manish J, 2013, Int J Yoga, V6, P111, DOI 10.4103/0973-6131.113405; Pickut BA, 2013, CLIN NEUROL NEUROSUR, V115, P2419, DOI 10.1016/j.clineuro.2013.10.002; Piet J, 2012, J CONSULT CLIN PSYCH, V80, P1007, DOI 10.1037/a0028329; Piet J, 2011, CLIN PSYCHOL REV, V31, P1032, DOI 10.1016/j.cpr.2011.05.002; Power M, 2011, J ROY SOC MED, V104, P155, DOI 10.1258/jrsm.2011.100271; Proulx Kathryn, 2003, Holist Nurs Pract, V17, P201; Regehr C, 2012, J AFFECTIVE DISORD; Samuelson M, 2007, PRISON J, V87, P254, DOI 10.1177/0032885507303753; Shennan C, 2011, PSYCHO-ONCOLOGY, V20, P681, DOI 10.1002/pon.1819; Smith JE, 2005, J ADV NURS, V52, P315, DOI 10.1111/j.1365-2648.2005.03592.x; Strauss C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096110; Sundquist J, 2014, BR J PSYCHIAT; Teasdale JD, 2000, J CONSULT CLIN PSYCH, V68, P615, DOI 10.1037//0022-006X.68.4.615; van Ravesteijn H, 2013, MINDING THE BODY, V82, P65; Veehof MM, 2011, PAIN, V152, P533, DOI 10.1016/j.pain.2010.11.002; WHO, 2013, CHRON DIS; Wong SYS, 2011, CLIN J PAIN, V27, P724, DOI 10.1097/AJP.0b013e3182183c6e	61	303	310	11	201	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124344	10.1371/journal.pone.0124344	http://dx.doi.org/10.1371/journal.pone.0124344			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25881019	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500094
J	Lam, BCC; Koh, GCH; Chen, C; Wong, MTK; Fallows, SJ				Lam, Benjamin Chih Chiang; Koh, Gerald Choon Huat; Chen, Cynthia; Wong, Michael Tack Keong; Fallows, Stephen J.			Comparison of Body Mass Index (BMI), Body Adiposity Index (BAI), Waist Circumference (WC), Waist-To-Hip Ratio (WHR) and Waist-To-Height Ratio (WHtR) as Predictors of Cardiovascular Disease Risk Factors in an Adult Population in Singapore	PLOS ONE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; ANTHROPOMETRIC INDEXES; SCREENING TOOL; OBESITY; INDICATORS; HEALTH; HYPERTENSION; SERUM; FAT	Background Excess adiposity is associated with cardiovascular disease (CVD) risk factors such as hypertension, diabetes mellitus and dyslipidemia. Amongst the various measures of adiposity, the best one to help predict these risk factors remains contentious. A novel index of adiposity, the Body Adiposity Index (BAI) was proposed in 2011, and has not been extensively studied in all populations. Therefore, the purpose of this study is to compare the relationship between Body Mass Index (BMI), Waist Circumference (WC), Waist-to-Hip Ratio (WHR), Waist-to-Height Ratio (WHtR), Body Adiposity Index (BAI) and CVD risk factors in the local adult population. Methods and Findings This is a cross sectional study involving 1,891 subjects (Chinese 59.1% Malay 22.2%, Indian 18.7%), aged 21-74 years, based on an employee health screening (2012) undertaken at a hospital in Singapore. Anthropometric indices and CVD risk factor variables were measured, and Spearman correlation, Receiver Operating Characteristic (ROC) curves and multiple logistic regressions were used. BAI consistently had the lower correlation, area under ROC and odd ratio values when compared with BMI, WC and WHtR, although differences were often small with overlapping 95% confidence intervals. After adjusting for BMI, BAI did not further increase the odds of CVD risk factors, unlike WC and WHtR (for all except hypertension and low high density lipoprotein cholesterol). When subjects with the various CVD risk factors were grouped according to established cut-offs, a BMI of >= 23.0 kg/m(2)and/or WHtR >= 0.5 identified the highest proportion for all the CVD risk factors in both genders, even higher than a combination of BMI and WC. Conclusions BAI may function as a measure of overall adiposity but it is unlikely to be better than BMI. A combination of BMI and WHtR could have the best clinical utility in identifying patients with CVD risk factors in an adult population in Singapore.	[Lam, Benjamin Chih Chiang; Wong, Michael Tack Keong] Khoo Teck Puat Hosp, Dept Family & Community Med, Singapore, Singapore; [Koh, Gerald Choon Huat; Chen, Cynthia] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore; [Fallows, Stephen J.] Univ Chester, Dept Clin Sci & Nutr, Chester, Cheshire, England	National University of Singapore; University of Chester	Lam, BCC (corresponding author), Khoo Teck Puat Hosp, Dept Family & Community Med, Singapore, Singapore.	lam.benjamin.cc@alexandrahealth.com.sg	Lam, Benjamin/U-1015-2019; CHEN, CYNTHIA/O-6203-2016	Koh, Choon Huat Gerald/0000-0002-6453-6897	Clinical Research Unit, Khoo Teck Puat Hospital, Singapore	Clinical Research Unit, Khoo Teck Puat Hospital, Singapore	We acknowledge the support of the Clinical Research Unit, Khoo Teck Puat Hospital, Singapore. We also want to thank the Outreach team from the Department of Family and Community Medicine, Khoo Teck Puat Hospital, Singapore, for the assistance rendered in acquiring the data and providing the necessary support where required in the conducting of this study.	Albarwani S, 2014, WORLD J CARDIOL, V6, P728, DOI 10.4330/wjc.v6.i8.728; Alberti KGMM, 2007, DIABETIC MED, V24, P451, DOI 10.1111/j.1464-5491.2007.02157.x; ALLAIN CC, 1974, CLIN CHEM, V20, P470; Ashwell M, 2012, OBES REV, V13, P275, DOI 10.1111/j.1467-789X.2011.00952.x; Ashwell M, 1996, BRIT MED J, V313, P559; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Brenner DR, 2010, DIABETOL METAB SYNDR, V2, DOI 10.1186/1758-5996-2-28; Browning LM, 2010, NUTR RES REV, V23, P247, DOI 10.1017/S0954422410000144; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Cornier MA, 2011, CIRCULATION, V124, P1996, DOI 10.1161/CIR.0b013e318233bc6a; Dong XL, 2011, POSTGRAD MED J, V87, P251, DOI 10.1136/pgmj.2010.100453; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guh DP, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-88; He YH, 2012, EUR J NUTR, V51, P81, DOI 10.1007/s00394-011-0195-2; Hou XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057319; Hughes K, 1998, ATHEROSCLEROSIS, V137, P253, DOI 10.1016/S0021-9150(97)00268-2; Huxley R, 2008, OBES REV, V9, P53, DOI 10.1111/j.1467-789X.2007.00439.x; Jackson AS, 2002, INT J OBESITY, V26, P789, DOI 10.1038/sj.ijo.0802006; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Lam BCC, 2013, OBESITY, V21, pE634, DOI 10.1002/oby.20504; Langenberg C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001230; Lee CMY, 2008, J CLIN EPIDEMIOL, V61, P646, DOI 10.1016/j.jclinepi.2007.08.012; Huerta JM, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-7; Menke A, 2007, OBESITY, V15, P785, DOI 10.1038/oby.2007.593; Nyamdorj R, 2008, OBESITY, V16, P1622, DOI 10.1038/oby.2008.73; Nyamdorj R, 2008, J HYPERTENS, V26, P866, DOI 10.1097/HJH.0b013e3282f624b7; Paniagua L, 2008, OBES RES CLIN PRACT, V2, P215, DOI 10.1016/j.orcp.2008.05.003; Park SH, 2009, CIRC J, V73, P1643, DOI 10.1253/circj.CJ-09-0161; Pua YH, 2005, ASIA PAC J CLIN NUTR, V14, P74; Savva SC, 2013, DIABET METAB SYND OB, V6, P403, DOI 10.2147/DMSO.S34220; Schneider HJ, 2007, J CLIN ENDOCR METAB, V92, P589, DOI 10.1210/jc.2006-0254; SUGIUCHI H, 1995, CLIN CHEM, V41, P717; Tietz NW, 1995, CLIN GUIDE LAB TESTS, V3rd; van Dijk SB, 2012, NETH HEART J, V20, P208, DOI 10.1007/s12471-011-0237-7; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Zhu SK, 2002, AM J CLIN NUTR, V76, P743, DOI 10.1093/ajcn/76.4.743	38	156	165	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122985	10.1371/journal.pone.0122985	http://dx.doi.org/10.1371/journal.pone.0122985			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880905	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500033
J	Benenson, JF; Markovits, H; Whitmore, B; Van, C; Margolius, S; Wrangham, RW				Benenson, Joyce F.; Markovits, Henry; Whitmore, Bjorn; Van, Christophe; Margolius, Sara; Wrangham, Richard W.			Do Young Children Understand Relative Value Comparisons?	PLOS ONE			English	Article							BEHAVIOR	Many forms of judgments, such as those used in economic games or measures of social comparison, require understanding relative value, as well as the more complex ability to make comparisons between relative values. To examine whether young children can accurately compare relative values, we presented children 4 to 7 years with simple judgments of relative value in two scenarios. Children then were asked to compare the relative values in the two scenarios. Results show that even the youngest children downgraded evaluations of a reward when another has a larger amount, indicating the ability to make relative value judgments. When asked to compare relative values however, only the oldest children were able to make these comparisons consistently. We then extended this analysis to economic game performance. Specifically, previous results using economic games suggest that younger children are more generous than older ones. We replicate this result, and then show that a simple change in procedure, based on the initial study, is sufficient to change young children's choices. Our results strongly suggest that conclusions regarding young children's pro-social motives based on relative value comparisons should be viewed cautiously.	[Benenson, Joyce F.; Whitmore, Bjorn; Van, Christophe; Wrangham, Richard W.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Benenson, Joyce F.; Margolius, Sara] Univ Cambridge Emmanuel Coll, Dept Psychol, Boston, MA USA; [Markovits, Henry] Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada	Harvard University; University of Quebec; University of Quebec Montreal	Markovits, H (corresponding author), Univ Quebec, Dept Psychol, Montreal, PQ H3C 3P8, Canada.	henrymarkovits@gmail.com			Social Sciences and Humanities Research Council of Canada [435-2012-1713]	Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by the Social Sciences and Humanities Research Council of Canada, 435-2012-1713; http://www.sshrc-crsh.gc.ca/home-accueil-eng.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Bjorklund D.F., 2007, WHY YOUTH IS NOT WAS; Blake PR, 2011, COGNITION, V120, P215, DOI 10.1016/j.cognition.2011.04.006; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Boseovski JJ, 2010, CHILD DEV PERSPECT, V4, P212, DOI 10.1111/j.1750-8606.2010.00149.x; Brosnan SF, 2003, NATURE, V425, P297, DOI 10.1038/nature01963; Butler R, 1998, CHILD DEV, V69, P1054, DOI 10.1111/j.1467-8624.1998.tb06160.x; Camerer C.F., 2003, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; DAMON W, 1975, CHILD DEV, V46, P301, DOI 10.2307/1128122; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2010, BEHAV BRAIN SCI, V33, P111, DOI 10.1017/S0140525X10000725; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; HOOK JG, 1979, PSYCHOL BULL, V86, P429, DOI 10.1037/0033-2909.86.3.429; House BR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103422; House BR, 2013, P NATL ACAD SCI USA, V110, P14586, DOI 10.1073/pnas.1221217110; MASTERS JC, 1985, J EXP SOC PSYCHOL, V21, P407, DOI 10.1016/0022-1031(85)90027-7; MOESSINGER P, 1977, HUM DEV, V20, P178, DOI 10.1159/000271556; RUBLE DN, 1980, DEV PSYCHOL, V16, P105, DOI 10.1037/0012-1649.16.2.105	20	2	2	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122215	10.1371/journal.pone.0122215	http://dx.doi.org/10.1371/journal.pone.0122215			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875949	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800045
J	Sanderson, WC; Scherbov, S				Sanderson, Warren C.; Scherbov, Sergei			Faster Increases in Human Life Expectancy Could Lead to Slower Population Aging	PLOS ONE			English	Article								Counterintuitively, faster increases in human life expectancy could lead to slower population aging. The conventional view that faster increases in human life expectancy would lead to faster population aging is based on the assumption that people become old at a fixed chronological age. A preferable alternative is to base measures of aging on people's time left to death, because this is more closely related to the characteristics that are associated with old age. Using this alternative interpretation, we show that faster increases in life expectancy would lead to slower population aging. Among other things, this finding affects the assessment of the speed at which countries will age.	[Sanderson, Warren C.] SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA; [Sanderson, Warren C.; Scherbov, Sergei] Int Inst Appl Syst Anal, World Populat Program, A-2361 Laxenburg, Austria; [Sanderson, Warren C.; Scherbov, Sergei] IIASA, Wittgenstein Ctr Demog & Global Human Capital, VID OAW, WU, Laxenburg, Austria	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; International Institute for Applied Systems Analysis (IIASA); International Institute for Applied Systems Analysis (IIASA)	Sanderson, WC (corresponding author), SUNY Stony Brook, Dept Econ, Stony Brook, NY 11794 USA.	warren.sanderson@stonybrook.edu	Scherbov, Sergey/F-3158-2019; Sanderson, Warren/R-3398-2019	Scherbov, Sergey/0000-0001-5902-3790; Scherbov, Sergei/0000-0002-0881-1073; Sanderson, Warren/0000-0002-2205-948X	European Research Council under the European Union [ERC2013-AdG 323947-ReAgeing]	European Research Council under the European Union(European Research Council (ERC))	The research leading to these results has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement no ERC2013-AdG 323947-ReAgeing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], COUNTRIES WITH AGING; Bloomberg, BLOOMBERG; Brass W., 1971, BIOL ASPECTS DEMOGRA; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; European Commission, 2012, 22010 EUR COMM; FUCHS VR, 1984, MILBANK FUND Q, V62, P143; Lutz W., 2014, WORLD POPULATION HUM; Lutz W, 2008, NATURE, V451, P716, DOI 10.1038/nature06516; Miller T, 2001, DEMOGRAPHY, V38, P215, DOI 10.1353/dem.2001.0018; Preston S, 2000, DEMOGRAPHY MEASURING; Robine J.-M., 2013, ANN REV GERONTOLOGY, V33; RYDER NB, 1975, POPUL INDEX, V41, P3, DOI 10.2307/2734140; Sanderson W, 2008, RETHINKING AGE AGING; Sanderson WC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096289; Sanderson WC, 2013, POPUL DEV REV, V39, P673, DOI 10.1111/j.1728-4457.2013.00633.x; Sanderson WC, 2010, SCIENCE, V329, P1287, DOI 10.1126/science.1193647; Sanderson WC, 2005, NATURE, V435, P811, DOI 10.1038/nature03593; Siegel J, 2008, DEMOGRAPHY EPIDEMIOL; Siegel Jacob S., 1984, SERIES US BUREAU CEN, V43; Siegel JS, 1993, GENERATION CHANGE PR, DOI [10.1371/journal.pone.0058669, DOI 10.1371/JOURNAL.PONE.0058669]; Skirbekk V, 2013, INTELLIGENCE, V41, P169, DOI 10.1016/j.intell.2013.02.001; UN, 2013, STESASERA348 UN; United Nations, 2013, WORLD POP AG 2013; University of California Berkley Max Planck Institute for Demographic Research, 2014, HUM MORT DAT; Vaupel JW, 2010, NATURE, V464, P536, DOI 10.1038/nature08984; VID, 2014, EUR DEM DAT SHEET 20	26	32	35	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121922	10.1371/journal.pone.0121922	http://dx.doi.org/10.1371/journal.pone.0121922			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25876033	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353015800035
J	Liao, J; Wen, SC; Cao, LP; Zhou, YF; Feng, ZS				Liao, Juan; Wen, Shichao; Cao, Lipeng; Zhou, Yunfeng; Feng, Zhisong			Effect of Eradication of Helicobacter pylori on Expression Levels of FHIT, IL-8 and P73 in Gastric Mucosa of First-Degree Relatives of Gastric Cancer Patients	PLOS ONE			English	Article							PROTEIN EXPRESSION; CLINICOPATHOLOGICAL SIGNIFICANCE; ESOPHAGEAL CANCER; GENE ALTERATIONS; INFECTION; RISK; POLYMORPHISMS; CARCINOMA; ASSOCIATION; PROGRESSION	Objectives Helicobacter pylori (H. pylori) infection plays an important role in the carcinogenesis and development of gastric cancer. Eradication of H. pylori can effectively reduce the risk of gastric cancer, but the underlying mechanisms are not fully understood. This study aimed to investigate the effect of eradication of H. pylori on the expression levels of FHIT, IL-8 and P73 in the gastric mucosa of first-degree relatives of gastric cancer patients. Methods One hundred and thirty-two patients with functional dyspepsia having first-degree relatives with gastric cancer were prospectively recruited in this study. Nine patients presented with H. pylori infection and family histories of gastric cancer, 61 with H. pylori infection and without family histories of gastric cancer, 6 without H. pylori infection and with family histories of gastric cancer, and 56 without H. pylori infection and family histories of gastric cancer. The protein and mRNA expression levels of FHIT, IL-8 and P73 in gastric mucosa of the subjects were detected by immunohistochemical staining and polymerase chain reaction, respectively. Results Compared with the patients without H. pylori infection and family histories of gastric cancer, both the protein and mRNA levels of FIHT significantly decreased in patients with H. pylori infection and/or family histories of gastric cancer, and both the protein and mRNA levels of IL-8 significantly increased. After eradication of H. pylori, both the protein and mRNA levels of FHIT were significantly higher, and both the protein and mRNA levels of IL-8 were significantly lower. However, H. pylori infection and family histories of gastric cancer had no major effect on P73 expression. Conclusions Down-regulation of FHIT and up-regulation of IL-8 may be involved in the pathogenesis of H. pylori infection in the first-degree relatives of gastric cancer patients.	[Liao, Juan; Wen, Shichao; Cao, Lipeng; Zhou, Yunfeng; Feng, Zhisong] North Sichuan Med Coll, Affiliated Hosp, Dept Gastroenterol, Nanchong 637000, Sichuan Provinc, Peoples R China	North Sichuan Medical University	Feng, ZS (corresponding author), North Sichuan Med Coll, Affiliated Hosp, Dept Gastroenterol, 63 Wenhua Rd, Nanchong 637000, Sichuan Provinc, Peoples R China.	fengzhisong2013@sohu.com		, Juan Liao/0000-0002-2446-9861				Baffa R, 1998, CANCER RES, V58, P4708; Bria E, 2013, ANN ONCOL, V24, P693, DOI 10.1093/annonc/mds506; Campiglio M, 1999, CANCER RES, V59, P3866; Carrasco G, 2010, CLIN CANCER RES, V16, P3253, DOI 10.1158/1078-0432.CCR-09-2491; de Martel C, 2013, GASTROENTEROL CLIN N, V42, P219, DOI 10.1016/j.gtc.2013.01.003; Demirel BB, 2013, ASIAN PAC J CANCER P, V14, P1797, DOI 10.7314/APJCP.2013.14.3.1797; Ernst PB, 2006, GASTROENTEROLOGY, V130, P188, DOI 10.1053/j.gastro.2005.06.032; Ge H, 2007, DIS ESOPHAGUS, V20, P290, DOI 10.1111/j.1442-2050.2007.00672.x; Hadaczek P, 1998, CANCER RES, V58, P2946; Hao XP, 2000, CANCER RES, V60, P18; Hao XP, 1997, VIRCHOWS ARCH, V431, P167, DOI 10.1007/s004280050084; Ishii H, 2004, CURR GENE THER, V4, P53, DOI 10.2174/1566523044578031; Ishii H, 2001, CANCER RES, V61, P1578; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Kang JM, 2009, J CLIN GASTROENTEROL, V43, P420, DOI 10.1097/MCG.0b013e318178d1d3; Kang MJ, 2000, CLIN CANCER RES, V6, P1767; Kim K, 2011, CRIT REV EUKAR GENE, V21, P237, DOI 10.1615/CritRevEukarGeneExpr.v21.i3.20; Kitadai Y, 2003, BIOCHEM BIOPH RES CO, V311, P809, DOI 10.1016/j.bbrc.2003.10.077; Kitadai Y, 1998, AM J PATHOL, V152, P93; Kitamura K, 2008, ONCOL REP, V19, P847; Kondo T, 2009, INT J ONCOL, V35, P547, DOI 10.3892/ijo_00000366; Kusters JG, 2006, CLIN MICROBIOL REV, V19, P449, DOI 10.1128/CMR.00054-05; Moll UM, 2004, MOL CANCER RES, V2, P371; Nakachi N, 2000, FEMS IMMUNOL MED MIC, V29, P23, DOI 10.1111/j.1574-695X.2000.tb01500.x; Nishizaki M, 2004, CANCER RES, V64, P5745, DOI 10.1158/0008-5472.CAN-04-0195; Osborn JF, 2013, CANCER PREV RES, V6, P695, DOI 10.1158/1940-6207.CAPR-12-0428; Ouakaa-Kchaou Asma, 2010, Tunis Med, V88, P459; Petursdottir TE, 2002, ANTICANCER RES, V22, P3205; Rocco A, 2003, J CANCER RES CLIN, V129, P84, DOI 10.1007/s00432-002-0409-3; Safaee A, 2011, ASIAN PAC J CANCER P, V12, P3117; Sard L, 1999, P NATL ACAD SCI USA, V96, P8489, DOI 10.1073/pnas.96.15.8489; Sepulveda Antonia R, 2013, Curr Pathobiol Rep, V1, P9; Shin Cheol Min, 2010, J Clin Gastroenterol, V44, pe34, DOI 10.1097/MCG.0b013e3181a159c4; Skopelitou AS, 2003, EUR J GASTROEN HEPAT, V15, P515, DOI 10.1097/01.meg.0000059113.41030.67; Stec-Michalska K, 2005, WORLD J GASTROENTERO, V11, P17, DOI 10.3748/wjg.v11.i1.17; Stec-Michalska K, 2009, HELICOBACTER, V14, P126, DOI 10.1111/j.1523-5378.2009.00715.x; Sugimoto M, 2010, WORLD J GASTROENTERO, V16, P1188, DOI 10.3748/wjg.v16.i10.1188; TAHARA E, 1994, EUR J GASTROEN HEPAT, V6, pS97; Talley NJ, 2008, AM J GASTROENTEROL, V103, P510, DOI 10.1111/j.1572-0241.2008.01819.x; Tannapfel A, 2001, J PATHOL, V195, P163, DOI 10.1002/path.947; Thomopoulou GE, 2003, EUR J ENDOCRINOL, V148, P81, DOI 10.1530/eje.0.1480081; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Wei A, 2008, GASTROENTEROLOGY, V134, P1412, DOI 10.1053/j.gastro.2008.01.072; Yamada H, 2001, BIOCHEM PHARMACOL, V61, P1595, DOI 10.1016/S0006-2952(01)00628-1; Yamaoka Y, 2001, HELICOBACTER, V6, P116, DOI 10.1046/j.1523-5378.2001.00017.x; Zhang LW, 2010, MOL BIOL REP, V37, P3983, DOI 10.1007/s11033-010-0057-7; Zhao P, 2005, WORLD J GASTROENTERO, V11, P5735, DOI 10.3748/wjg.v11.i36.5735; Zhu JH, 1998, CANCER RES, V58, P5061; Zou TT, 1997, ONCOGENE, V15, P101, DOI 10.1038/sj.onc.1201169	49	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0124576	10.1371/journal.pone.0124576	http://dx.doi.org/10.1371/journal.pone.0124576			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875960	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700070
J	Mizuuchi, H; Suda, K; Sato, K; Tomida, S; Fujita, Y; Kobayashi, Y; Maehara, Y; Sekido, Y; Nishio, K; Mitsudomi, T				Mizuuchi, Hiroshi; Suda, Kenichi; Sato, Katsuaki; Tomida, Shuta; Fujita, Yoshihiko; Kobayashi, Yoshihisa; Maehara, Yoshihiko; Sekido, Yoshitaka; Nishio, Kazuto; Mitsudomi, Tetsuya			Collateral Chemoresistance to Anti-Microtubule Agents in a Lung Cancer Cell Line with Acquired Resistance to Erlotinib	PLOS ONE			English	Article							GROWTH-FACTOR-RECEPTOR; MET AMPLIFICATION; MESENCHYMAL TRANSITION; GEFITINIB RESISTANCE; MULTIDRUG-RESISTANCE; 1ST-LINE TREATMENT; DRUG-RESISTANCE; OPEN-LABEL; EGFR; EXPRESSION	Various alterations underlying acquired resistance to epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) have been described. Although treatment strategies specific for these mechanisms are under development, cytotoxic agents are currently employed to treat many patients following failure of EGFR-TKIs. However, the effect of TKI resistance on sensitivity to these cytotoxic agents is mostly unclear. This study investigated the sensitivity of erlotinib-resistant tumor cells to five cytotoxic agents using an in vitro EGFR-TKI-resistant model. Four erlotinib-sensitive lung adenocarcinoma cell lines and their resistant derivatives were tested. Of the resistant cell lines, all but one showed a similar sensitivity to the tested drugs as their parental cells. HCC4006ER cells with epithelial mesenchymal transition features acquired resistance to the three microtubule-targeting agents, docetaxel, paclitaxel and vinorelbine, but not to cisplatin and gemcitabine. Gene expression array and immunoblotting demonstrated that ATP-binding cassette subfamily B, member 1 (ABCB1) was up-regulated in HCC4006ER cells. ABCB1 knockdown by siRNA partially restored sensitivity to the anti-microtubule agents but not to erlotinib. Moreover, the histone deacetylase inhibitor entinostat sensitized HCC4006ER cells to anti-microtubule agents through ABCB1 suppression. Our study indicates that sensitivity of tumor cells to cytotoxic agents in general does not change before and after failure of EGFR-TKIs. However, we describe that two different molecular alterations confer acquired resistance to EGFR-TKIs and cytotoxic agents, respectively. This phenomenon should be kept in mind in selection of subsequent therapy after failure of EGFR-TKIs.	[Mizuuchi, Hiroshi; Suda, Kenichi; Sato, Katsuaki; Kobayashi, Yoshihisa; Mitsudomi, Tetsuya] Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan; [Mizuuchi, Hiroshi; Suda, Kenichi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Tomida, Shuta; Fujita, Yoshihiko; Nishio, Kazuto] Kinki Univ, Fac Med, Dept Genome Biol, Osaka, Japan; [Sekido, Yoshitaka] Aichi Canc Ctr, Res Inst, Div Mol Oncol, Nagoya, Aichi 464, Japan	Kindai University (Kinki University); Kyushu University; Kindai University (Kinki University); Aichi Cancer Center	Mitsudomi, T (corresponding author), Kinki Univ, Fac Med, Dept Surg, Div Thorac Surg, Osaka, Japan.	mitsudom@surg.med.kindai.ac.jp	Sekido, Yoshitaka/P-9756-2015	Sekido, Yoshitaka/0000-0002-2428-3848; Kobayashi, Yoshihisa/0000-0003-2057-408X; Mitsudomi, Tetsuya/0000-0001-9860-8505; Suda, Kenichi/0000-0002-0842-8832	Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology, Japan [25830119]; Kaibara Morikazu Medical Science Promotion Foundation	Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kaibara Morikazu Medical Science Promotion Foundation(Kaibara Morikazu Medical Science Promotion Foundation)	This work was partly supported by Takeda Science Foundation to T.M., Grants-in-Aid for Scientific Research (25830119 to K.S.) from the Ministry of Education, Culture, Sports, Science and Technology, Japan and Kaibara Morikazu Medical Science Promotion Foundation to K.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS DJ, 1995, INVEST NEW DRUG, V13, P13, DOI 10.1007/BF02614215; Breen L, 2008, TOXICOL IN VITRO, V22, P1234, DOI 10.1016/j.tiv.2008.04.005; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Chen LM, 2009, ANTICANCER RES, V29, P4597; Chin TM, 2008, CLIN CANCER RES, V14, P6867, DOI 10.1158/1078-0432.CCR-08-0093; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Furugaki K, 2014, LUNG CANCER, V83, P44, DOI 10.1016/j.lungcan.2013.10.003; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hurbin A, 2011, J PATHOL, V225, P83, DOI 10.1002/path.2897; Koizumi F, 2005, INT J CANCER, V116, P36, DOI 10.1002/ijc.20985; Kurahashi I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063249; Kurokawa M, 2013, CANCER SCI, V104, P904, DOI 10.1111/cas.12171; Li WJ, 2013, MOL BIOL REP, V40, P6143, DOI 10.1007/s11033-013-2725-x; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; McDonald SL, 2005, EUR J CANCER, V41, P1086, DOI 10.1016/j.ejca.2005.01.018; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Noguchi K, 2009, CANCER SCI, V100, P1701, DOI 10.1111/j.1349-7006.2009.01213.x; Puri Neelu, 2008, J Carcinog, V7, P9; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Shien K, 2013, CANCER RES, V73, P3051, DOI 10.1158/0008-5472.CAN-12-4136; Suda K, 2014, INT J CANCER, V135, P1002, DOI 10.1002/ijc.28737; Suda K, 2012, CANCER METAST REV, V31, P807, DOI 10.1007/s10555-012-9391-7; Suda K, 2011, J THORAC ONCOL, V6, P1152, DOI 10.1097/JTO.0b013e318216ee52; Suda K, 2010, CLIN CANCER RES, V16, P5489, DOI 10.1158/1078-0432.CCR-10-1371; Suda K, 2010, CANCER METAST REV, V29, P49, DOI 10.1007/s10555-010-9209-4; Ware KE, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.4; Yabuki N, 2007, CANCER GENET CYTOGEN, V173, P1, DOI 10.1016/j.cancergencyto.2006.07.020; Yamamoto C, 2010, CANCER RES, V70, P8715, DOI 10.1158/0008-5472.CAN-10-0043; Yang YL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093997; Yoshida T, 2010, CANCER SCI, V101, P167, DOI 10.1111/j.1349-7006.2009.01368.x; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zhu YZ, 2013, MOL CANCER THER, V12, P1829, DOI 10.1158/1535-7163.MCT-13-0208	33	9	9	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123901	10.1371/journal.pone.0123901	http://dx.doi.org/10.1371/journal.pone.0123901			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875914	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700051
J	Narang, S; Best, A; Curtis, S; Manocha, D				Narang, Sahil; Best, Andrew; Curtis, Sean; Manocha, Dinesh			Generating Pedestrian Trajectories Consistent with the Fundamental Diagram Based on Physiological and Psychological Factors	PLOS ONE			English	Article								Pedestrian crowds often have been modeled as many-particle system including microscopic multi-agent simulators. One of the key challenges is to unearth governing principles that can model pedestrian movement, and use them to reproduce paths and behaviors that are frequently observed in human crowds. To that effect, we present a novel crowd simulation algorithm that generates pedestrian trajectories that exhibit the speed-density relationships expressed by the Fundamental Diagram. Our approach is based on biomechanical principles and psychological factors. The overall formulation results in better utilization of free space by the pedestrians and can be easily combined with well-known multi-agent simulation techniques with little computational overhead. We are able to generate human-like dense crowd behaviors in large indoor and outdoor environments and validate the results with captured real-world crowd trajectories.	[Narang, Sahil; Best, Andrew; Curtis, Sean; Manocha, Dinesh] Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Manocha, D (corresponding author), Univ N Carolina, Dept Comp Sci, Chapel Hill, NC 27599 USA.	dm@cs.unc.edu			NSF [1000579, 1117127, 1305286]; Intel; Boeing Company	NSF(National Science Foundation (NSF)); Intel(Intel Corporation); Boeing Company	This work was supported by NSF awards 1000579, 1117127, 1305286, Intel, and a grant from the Boeing Company. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Also, this does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Best A., 2014, P ACM SIGGRAPH EUR S, P97; Blue V.J., 1999, TRANSPORT RES REC, V1678, P135, DOI [10.3141/1678-17, DOI 10.3141/1678-17]; Burghardt S, 2012, PEDESTRIAN EVACUATIO; Burstedde C, 2001, PHYSICA A, V295, P507, DOI 10.1016/S0378-4371(01)00141-8; Chattaraj U, 2009, ADV COMPLEX SYST, V12, P393, DOI 10.1142/S0219525909002209; Chraibi M, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046111; Curtis S., 2014, PEDESTRIAN EVACUATIO, P875, DOI 10.1007/978-3-319-02447-9_73; DEAN GA, 1965, ERGONOMICS, V8, P31, DOI 10.1080/00140136508930772; Degond P, 2013, J STAT PHYS, V152, P1033, DOI 10.1007/s10955-013-0805-x; Gerin-Lajoie M, 2005, MOTOR CONTROL, V9, P242, DOI 10.1123/mcj.9.3.242; Golas Abhinav, 2013, P ACM SIGGRAPH S INT, P29, DOI DOI 10.1145/2448196.2448200; Guy SJ, 2010, PROCEEDINGS OF THE TWENTY-SIXTH ANNUAL SYMPOSIUM ON COMPUTATIONAL GEOMETRY (SCG'10), P115, DOI 10.1145/1810959.1810981; Hartmann D, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/4/043032; He L, 2013, IEEE INT CONF ROBOT, P2839, DOI 10.1109/ICRA.2013.6630970; Helbing D, 2000, NATURE, V407, P487, DOI 10.1038/35035023; Helbing D, 2014, J STAT PHYS, P1; Hughes RL, 2002, TRANSPORT RES B-METH, V36, P507, DOI 10.1016/S0191-2615(01)00015-7; Inman V., 1981, HUMAN WALKING; Jaillet L, 2004, INT C INT ROB SYST, V2, P1606, DOI DOI 10.1109/IROS.2004.1389625; Kim S., 2013, P 12 ACM SIGGRAPHEUR, P125; Klupfel H, 2001, THEORETICAL AND PRACTICAL ISSUES ON CELLULAR AUTOMATA, P63; Kretz T., 2011, 2011 IEEE International Conference on Computer Vision Workshops (ICCV Workshops), P166, DOI 10.1109/ICCVW.2011.6130239; Kretz T, 2006, LECT NOTES COMPUT SC, V4173, P712; Kretz T, 2009, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2009/03/P03012; LaValle S.M., 2006, PLANNING ALGORITHMS, P1007; Lemercier S, 2012, COMPUT GRAPH FORUM, V31, P489, DOI 10.1111/j.1467-8659.2012.03028.x; Moussaid M, 2011, P NATL ACAD SCI USA, V108, P6884, DOI 10.1073/pnas.1016507108; Narain R, 2009, ACM T GRAPHIC, V28, DOI 10.1145/1618452.1618468; Ondrej J, 2010, P 2010 ACM SIGGRAPH, V123, P9; Pelechano N, 2007, SYMPOSIUM ON COMPUTER ANIMATION 2007: ACM SIGGRAPH/ EUROGRAPHICS SYMPOSIUM PROCEEDINGS, P99; Pettre J., 2009, SCA 09 P 2009 ACM SI, P189, DOI [10.1145/1599470.1599495, DOI 10.1145/1599470.1599495]; Reynolds C.W., 1987, P 14 ANN C COMPUTER, V21, P25, DOI DOI 10.1145/37402.37406; Reynolds CW, 1999, GAME DEV C; Schadschneider A, 2002, PEDESTRIAN AND EVACUATION DYNAMICS, P75; Schadschneider A., 2011, PEDESTRIAN EVACUATIO, P557; Seyfried A, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/10/P10002; Snook G., 2000, GAME PROGRAMMING GEM, P288; Sud A, 2007, VRST 2007: ACM SYMPOSIUM ON VIRTUAL REALITY SOFTWARE AND TECHNOLOGY, PROCEEDINGS, P99; Treuille A, 2006, ACM T GRAPHIC, V25, P1160, DOI 10.1145/1141911.1142008; van den Berg J., 2009, INT S ROB RES; van den Berg J, 2008, I3D 2008: SYMPOSIUM ON INTERACTIVE 3D GRAPHICS AND GAMES, PROCEEDINGS, P139; van Toll WG, 2012, COMPUT ANIMAT VIRT W, V23, P535, DOI 10.1002/cav.1468; van Toll WG, 2012, COMPUT ANIMAT VIRT W, V23, P59, DOI 10.1002/cav.1424; Weidmann U., 1993, TRANSPORTTECHNIK FUS; Zhang J, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/02/P02002; Zhang J, 2011, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2011/06/P06004	46	13	14	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0117856	10.1371/journal.pone.0117856	http://dx.doi.org/10.1371/journal.pone.0117856			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875932	Green Submitted, gold, Green Published			2022-12-27	WOS:000352845100002
J	Saito, M; Takano, T; Nishimura, T; Kohara, M; Tsukiyama-Kohara, K				Saito, Makoto; Takano, Takashi; Nishimura, Tomohiro; Kohara, Michinori; Tsukiyama-Kohara, Kyoko			3 beta-Hydroxysterol Delta 24-Reductase on the Surface of Hepatitis C Virus-Related Hepatocellular Carcinoma Cells Can Be a Target for Molecular Targeting Therapy	PLOS ONE			English	Article							INTRACELLULAR CHOLESTEROL TRANSPORT; GRANULIN-EPITHELIN PRECURSOR; LIVER-TRANSPLANTATION; INDUCED APOPTOSIS; CYCLOSPORINE-A; EXPRESSION; ANTIBODY; GENE; CANCER; SORAFENIB	In our previous study, we demonstrated that 3 beta-hydroxysterol Delta 24-reductase (DHCR24) was overexpressed in hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC), and that its expression was induced by HCV. Using a monoclonal antibody against DHCR24 (2-152a MAb), we found that DHCR24 was specifically expressed on the surface of HCC cell lines. Based on these findings, we aimed to establish a novel targeting strategy using 2-152a MAb to treat HCV-related HCC. In the present study, we examined the antitumor activity of 2-152a MAb. In the presence of complement, HCC-derived HuH-7 cells were killed by treatment with 2-152a MAb, which was mediated by complement-dependent cytotoxicity (CDC). In addition, the antigen recognition domain of 2-152a MAb was responsible for the unique anti-HCV activity. These findings demonstrate the feasibility of using 2-152a MAb for antibody therapy against HCV-related HCC. In addition, surface DHCR24 on HCC cells exhibited a functional property, agonist-induced internalization. We showed that 2-152a MAb-mediated binding of a cytotoxic agent (a saponin-conjugated secondary antibody) to surface DHCR24 led to significant cytotoxicity. This suggests that surface DHCR24 on HCC cells can function as a carrier for internalization. Therefore, surface DHCR24 could be a valuable target for HCV-related HCC therapy, and 2-152a MAb appears to be useful for this targeted therapy.	[Saito, Makoto; Takano, Takashi; Nishimura, Tomohiro; Tsukiyama-Kohara, Kyoko] Kumamoto Univ, Dept Expt Phylaxiol, Fac Life Sci, Kumamoto, Kumamoto, Japan; [Saito, Makoto; Kohara, Michinori] Tokyo Metropolitan Inst Med Sci, Dept Microbiol & Cell Biol, Setagaya Ku, Tokyo 113, Japan; [Takano, Takashi] Nippon Vet & Life Sci Univ, Div Vet Publ Hlth, Musashino, Tokyo, Japan; [Nishimura, Tomohiro] Kikuchi Res Ctr, Chemo Sero Therapeut Res Inst, Kumamoto, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Transboundary Anim Dis Ctr, Kagoshima, Kagoshima 890, Japan; [Tsukiyama-Kohara, Kyoko] Kagoshima Univ, Joint Fac Vet Med, Lab Anim Hyg, Kagoshima, Kagoshima 890, Japan	Kumamoto University; Tokyo Metropolitan Institute of Medical Science; Nippon Veterinary & Life Science University; Kagoshima University; Kagoshima University	Tsukiyama-Kohara, K (corresponding author), Kumamoto Univ, Dept Expt Phylaxiol, Fac Life Sci, 1-1-1 Honjo, Kumamoto, Kumamoto, Japan.	kkohara@vet.kagoshima-u.ac.jp			Japan Science and Technology Agency [AS221Z04401G]; Ministry of Health and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation; Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases; Grants-in-Aid for Scientific Research [15H04739] Funding Source: KAKEN	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation(National Institute of Biomedical Innovation); Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by grants from the Japan Science and Technology Agency (Grant Number AS221Z04401G), the Ministry of Health and Welfare of Japan, the Ministry of Education, Culture, Sports, Science and Technology of Japan, the Program for the Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation, and the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Re-emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Alfa GK, 2014, J HEPATOL, V60, P319, DOI 10.1016/j.jhep.2013.09.008; Alberti A, 1999, J HEPATOL, V31, P17, DOI 10.1016/S0168-8278(99)80369-9; Asghar U, 2012, J HEPATOL, V56, P686, DOI 10.1016/j.jhep.2011.07.031; Bonaccorsi L, 2008, LAB INVEST, V88, P1049, DOI 10.1038/labinvest.2008.80; Cabrera R, 2013, ALIMENT PHARM THER, V37, P91, DOI 10.1111/apt.12098; Corton JC, 1998, CANCER LETT, V134, P61, DOI 10.1016/S0304-3835(98)00241-9; Crameri A, 2006, EMBO J, V25, P432, DOI 10.1038/sj.emboj.7600938; Di Stasi D, 2005, INT J CANCER, V115, P224, DOI 10.1002/ijc.20885; Fang P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049717; Feng MQ, 2013, P NATL ACAD SCI USA, V110, pE1083, DOI 10.1073/pnas.1217868110; Gauthier A, 2013, HEPATOL RES, V43, P147, DOI 10.1111/j.1872-034X.2012.01113.x; Ho JC, 2008, HEPATOLOGY, V47, P1524, DOI 10.1002/hep.22191; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ishiguro T, 2008, CANCER RES, V68, P9832, DOI 10.1158/0008-5472.CAN-08-1973; Jiang H, 2014, CANCER LETT, V342, P113, DOI 10.1016/j.canlet.2013.08.038; Jiang H, 2011, J BIOL CHEM, V286, P5913, DOI 10.1074/jbc.M110.192252; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Koike K, 2008, J GASTROEN HEPATOL, V23, pS87, DOI 10.1111/j.1440-1746.2007.05292.x; Lim SO, 2002, BIOCHEM BIOPH RES CO, V291, P1031, DOI 10.1006/bbrc.2002.6547; Luciani P, 2005, J CLIN ENDOCR METAB, V90, P6156, DOI 10.1210/jc.2005-0633; Luciani P, 2004, J CLIN ENDOCR METAB, V89, P1332, DOI 10.1210/jc.2003-031065; Maluf DG, 2010, EXPERT REV GASTROENT, V4, P445, DOI 10.1586/EGH.10.39; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Maxfield FR, 2002, J CLIN INVEST, V110, P891, DOI 10.1172/JCI200216500; Mohr L, 2004, GASTROENTEROLOGY, V127, pS225, DOI 10.1053/j.gastro.2004.09.037; Mohr L, 1999, HEPATOLOGY, V29, P82, DOI 10.1002/hep.510290148; Nakano K, 2009, BIOCHEM BIOPH RES CO, V378, P279, DOI 10.1016/j.bbrc.2008.11.033; Nishimura T, 2009, J BIOL CHEM, V284, P36442, DOI 10.1074/jbc.M109.043232; Nuti F, 2009, J PATHOL, V219, P491, DOI 10.1002/path.2622; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Ranieri G, 2012, CURR MED CHEM, V19, P938, DOI 10.2174/092986712799320736; Rubin A, 2011, CLIN RES HEPATOL GAS, V35, P805, DOI 10.1016/j.clinre.2011.04.009; Saito M, 2012, J MED VIROL, V84, P733, DOI 10.1002/jmv.23250; Salem NE, 2013, MICROBIOL IMMUNOL, V57, P179, DOI 10.1111/1348-0421.12025; Sangro B, 2013, J HEPATOL, V59, P81, DOI 10.1016/j.jhep.2013.02.022; Satoh M, 2011, J INFECT DIS, V204, P1172, DOI 10.1093/infdis/jir501; Shiraishi S, 2000, NEUROSCI LETT, V293, P211, DOI 10.1016/S0304-3940(00)01513-5; Soccio RE, 2004, ARTERIOSCL THROM VAS, V24, P1150, DOI 10.1161/01.ATV.0000131264.66417.d5; Takano T, 2011, J HEPATOL, V55, P512, DOI 10.1016/j.jhep.2010.12.011; Tran TT, 2000, J BIOL CHEM, V275, P35708, DOI 10.1074/jbc.M005636200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Vainio S, 2003, ANN MED, V35, P146, DOI 10.1080/07853890310008198; Watanabe T, 2006, GENE THER, V13, P883, DOI 10.1038/sj.gt.3302734; Waterham HR, 2001, AM J HUM GENET, V69, P685, DOI 10.1086/323473; Wong NCL, 2014, MOL CANCER THER, V13, P3001, DOI 10.1158/1535-7163.MCT-14-0012; Zhu AX, 2007, CANCER-AM CANCER SOC, V110, P581, DOI 10.1002/cncr.22829	46	5	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124197	10.1371/journal.pone.0124197	http://dx.doi.org/10.1371/journal.pone.0124197			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875901	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100244
J	Raczkowska, A; Trzos, J; Lewandowska, O; Nieckarz, M; Brzostek, K				Raczkowska, Adrianna; Trzos, Joanna; Lewandowska, Olga; Nieckarz, Marta; Brzostek, Katarzyna			Expression of the AcrAB Components of the AcrAB-TolC Multidrug Efflux Pump of Yersinia enterocolitica Is Subject to Dual Regulation by OmpR	PLOS ONE			English	Article							MULTIPLE ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; SALMONELLA-ENTERICA; SIGNAL-TRANSDUCTION; SYSTEM; PROTEIN; GENES; TYPHIMURIUM; RAMA; IDENTIFICATION	OmpR is a transcriptional regulator implicated in the control of various cellular processes and functions in Enterobacteriaceae. This study was undertaken to identify genes comprising the OmpR regulon in the human gastrointestinal pathogen Yersinia enterocolitica. Derivatives of an ompR-negative strain with random transposon insertions creating transcriptional fusions with the reporter gene lacZ were isolated. These were supplied with the wild-type ompR allele in trans and then screened for OmpR-dependent changes in beta-galactosidase activity. Using this strategy, five insertions in genes/operons positively regulated by OmpR and two insertions in genes negatively regulated by this protein were identified. Genetic analysis of one of these fusion strains revealed that the gene acrR, encoding transcriptional repressor AcrR is negatively regulated by OmpR. Differential analysis of membrane proteins by SDS-PAGE followed by mass spectrometry identified the protein AcrB, a component of the AcrAB-TolC multidrug efflux pump, as being positively regulated by OmpR. Analysis of the activity of the acrR and acrAB promoters using gfp fusions confirmed their OmpR-dependent repression and activation, respectively. The identification of putative OmpR-binding sites and electrophoretic mobility shift assays confirmed that this regulator binds specifically to both promoter regions with different affinity. Examination of the activity of the acrR and acrAB promoters after the exposure of cells to different chemicals showed that bile salts can act as an OmpR-independent inducer. Taken together, our findings suggest that OmpR positively controls the expression of the AcrAB-TolC efflux pump involved in the adaptive response of Y. enterocolitica O:9 to different chemical stressors, thus conferring an advantage in particular ecological niches.	[Raczkowska, Adrianna; Trzos, Joanna; Lewandowska, Olga; Nieckarz, Marta; Brzostek, Katarzyna] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland	University of Warsaw	Raczkowska, A (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland.	araczko@biol.uw.edu.pl	Raczkowska, Adrianna/AAJ-2244-2020; Raczkowska, Adrianna/ABD-8025-2020	Raczkowska, Adrianna/0000-0002-4311-1689; Brzostek, Katarzyna/0000-0002-7464-1228; Nieckarz, Marta/0000-0002-3813-4923	National Science Center, Poland [2011/01/B/NZ6/01845]	National Science Center, Poland(National Science Centre, Poland)	This research was supported by a grant from the National Science Center, Poland (grant 2011/01/B/NZ6/01845). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT LM, 1989, ANNU REV GENET, V23, P311, DOI 10.1146/annurev.ge.23.120189.001523; Bailey AM, 2008, ANTIMICROB AGENTS CH, V52, P3604, DOI 10.1128/AAC.00661-08; Bang IS, 2002, MOL MICROBIOL, V44, P1235, DOI 10.1046/j.1365-2958.2002.02937.x; BERNARDINI ML, 1990, J BACTERIOL, V172, P6274, DOI 10.1128/jb.172.11.6274-6281.1990; Blair JMA, 2009, CURR OPIN MICROBIOL, V12, P512, DOI 10.1016/j.mib.2009.07.003; Bottone EJ, 1997, CLIN MICROBIOL REV, V10, P257, DOI 10.1128/CMR.10.2.257; Brzostek K, 2007, FOLIA MICROBIOL, V52, P73, DOI 10.1007/BF02932142; Brzostek K, 2003, FEMS MICROBIOL LETT, V228, P265, DOI 10.1016/S0378-1097(03)00779-1; Brzostkowska M, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00153; Cameron ADS, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002615; Clarke EJ, 2011, BIOTECHNOL BIOENG, V108, P666, DOI 10.1002/bit.22966; DORMAN CJ, 1989, INFECT IMMUN, V57, P2136, DOI 10.1128/IAI.57.7.2136-2140.1989; Dupont M, 2007, ANTIMICROB AGENTS CH, V51, P3190, DOI 10.1128/AAC.01481-06; Egger LA, 1997, GENES CELLS, V2, P167, DOI 10.1046/j.1365-2443.1997.d01-311.x; Fabrega A, 2010, INT J MED MICROBIOL, V300, P457, DOI 10.1016/j.ijmm.2010.02.003; Flamez C, 2008, INT J MED MICROBIOL, V298, P193, DOI 10.1016/j.ijmm.2007.05.005; FORST SA, 1994, RES MICROBIOL, V145, P363, DOI 10.1016/0923-2508(94)90083-3; GALAN JE, 1990, INFECT IMMUN, V58, P1879; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gueguen E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066615; Huang KJ, 1996, J MOL BIOL, V262, P615, DOI 10.1006/jmbi.1996.0540; Jair KW, 1996, J BACTERIOL, V178, P2507, DOI 10.1128/jb.178.9.2507-2513.1996; Kenney LJ, 2002, CURR OPIN MICROBIOL, V5, P135, DOI 10.1016/S1369-5274(02)00310-7; Lee AK, 2000, J BACTERIOL, V182, P771, DOI 10.1128/JB.182.3.771-781.2000; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Ma D, 1996, MOL MICROBIOL, V19, P101, DOI 10.1046/j.1365-2958.1996.357881.x; Miller JH., 1972, EXPT MOL GENETICS; MILLER PF, 1994, ANTIMICROB AGENTS CH, V38, P1773, DOI 10.1128/AAC.38.8.1773; Miller WG, 2000, MOL PLANT MICROBE IN, V13, P1243, DOI 10.1094/MPMI.2000.13.11.1243; Murakami S, 2002, NATURE, V419, P587, DOI 10.1038/nature01050; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Nikaido E, 2008, J BIOL CHEM, V283, P24245, DOI 10.1074/jbc.M804544200; Nikaido E, 2011, MICROBIOL-SGM, V157, P648, DOI 10.1099/mic.0.045757-0; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; O Croinin T, 2006, MOL MICROBIOL, V62, P869, DOI 10.1111/j.1365-2958.2006.05416.x; PAN WB, 1994, MOL MICROBIOL, V11, P769, DOI 10.1111/j.1365-2958.1994.tb00354.x; Pott AS, 1998, MICROBIOL-SGM, V144, P1881, DOI 10.1099/00221287-144-7-1881; PRATT LA, 1995, MOL MICROBIOL, V17, P565, DOI 10.1111/j.1365-2958.1995.mmi_17030565.x; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Raczkowska A, 2011, FOLIA MICROBIOL, V56, P313, DOI 10.1007/s12223-011-0054-9; Raczkowska Adrianna, 2004, Polish Journal of Microbiology, V53, P11; Raczkowska A, 2011, FEMS MICROBIOL LETT, V321, P43, DOI 10.1111/j.1574-6968.2011.02308.x; Raczkowska A, 2011, ANTON LEEUW INT J G, V99, P381, DOI 10.1007/s10482-010-9503-8; Randall LP, 2002, RES VET SCI, V72, P87, DOI 10.1053/rvsc.2001.0537; Rentschler AE, 2013, MICROBIOL-SGM, V159, P316, DOI 10.1099/mic.0.059386-0; Robleto EA, 2003, J BACTERIOL, V185, P453, DOI 10.1128/JB.185.2.453-460.2003; Rosenberg EY, 2003, MOL MICROBIOL, V48, P1609, DOI 10.1046/j.1365-2958.2003.03531.x; Rosner BM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-337; RUSSO FD, 1991, J MOL BIOL, V222, P567, DOI 10.1016/0022-2836(91)90497-T; Sambrook J., 2001, MOL CLONING LAB MANU; Schneiders T, 2003, ANTIMICROB AGENTS CH, V47, P2831, DOI 10.1128/AAC.47.9.2831-2837.2003; Schuldiner S, 2006, NATURE, V443, P156, DOI 10.1038/443156b; SIMON R, 1989, GENE, V80, P161, DOI 10.1016/0378-1119(89)90262-X; Skorek K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079525; Stincone A, 2011, NUCLEIC ACIDS RES, V39, P7512, DOI 10.1093/nar/gkr338; STOCK JB, 1989, MICROBIOL REV, V53, P450, DOI 10.1128/MMBR.53.4.450-490.1989; STRALEY SC, 1995, TRENDS MICROBIOL, V3, P310, DOI 10.1016/S0966-842X(00)88960-X; Udani RA, 2006, ANTIMICROB AGENTS CH, V50, P2971, DOI 10.1128/AAC.00015-06; Zhang WP, 2013, ENVIRON MICROBIOL, V15, P557, DOI 10.1111/1462-2920.12005	59	18	20	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124248	10.1371/journal.pone.0124248	http://dx.doi.org/10.1371/journal.pone.0124248			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893523	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700080
J	Rogovskyy, AS; Casselli, T; Tourand, Y; Jones, CR; Owen, JP; Mason, KL; Scoles, GA; Bankhead, T				Rogovskyy, Artem S.; Casselli, Timothy; Tourand, Yvonne; Jones, Cami R.; Owen, Jeb P.; Mason, Kathleen L.; Scoles, Glen A.; Bankhead, Troy			Evaluation of the Importance of VlsE Antigenic Variation for the Enzootic Cycle of Borrelia burgdorferi	PLOS ONE			English	Article							WHITE-FOOTED MICE; LYME-DISEASE SPIROCHETE; OUTER-SURFACE PROTEIN; IXODES-SCAPULARIS TICKS; GENETIC-VARIATION; RESERVOIR COMPETENCE; PROTECTIVE IMMUNITY; LINEAR PLASMID-25; ANTIBODY-RESPONSE; ANIMAL-MODELS	Efficient acquisition and transmission of Borrelia burgdorferi by the tick vector, and the ability to persistently infect both vector and host, are important elements for the life cycle of the Lyme disease pathogen. Previous work has provided strong evidence implicating the significance of the vls locus for B. burgdorferi persistence. However, studies involving vls mutant clones have thus far only utilized in vitro-grown or host-adapted spirochetes and laboratory strains of mice. Additionally, the effects of vls mutation on tick acquisition and transmission has not yet been tested. Thus, the importance of VlsE antigenic variation for persistent infection of the natural reservoir host, and for the B. burgdorferi enzootic life cycle in general, has not been examined to date. In the current work, Ixodes scapularis and Peromyscus maniculatus were infected with different vls mutant clones to study the importance of the vls locus for the enzootic cycle of the Lyme disease pathogen. The findings highlight the significance of the vls system for long-term infection of the natural reservoir host, and show that VlsE antigenic variability is advantageous for efficient tick acquisition of B. burgdorferi from the mammalian reservoir. The data also indicate that the adaptation state of infecting spirochetes influences B. burgdorferi avoidance from host antibodies, which may be in part due to its respective VlsE expression levels. Overall, the current findings provide the most direct evidence on the importance of VlsE for the enzootic cycle of Lyme disease spirochetes, and underscore the significance of VlsE antigenic variation for maintaining B. burgdorferi in nature.	[Rogovskyy, Artem S.; Casselli, Timothy; Tourand, Yvonne; Bankhead, Troy] Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA; [Jones, Cami R.; Owen, Jeb P.] Washington State Univ, Dept Entomol, Pullman, WA 99164 USA; [Mason, Kathleen L.; Scoles, Glen A.] Washington State Univ, USDA ARS, Anim Dis Res Unit, Pullman, WA 99164 USA; [Bankhead, Troy] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA	Washington State University; Washington State University; United States Department of Agriculture (USDA); Washington State University; Washington State University	Bankhead, T (corresponding author), Washington State Univ, Dept Vet Microbiol & Pathol, Pullman, WA 99164 USA.	tbankhead@vetmed.wsu.edu	Bankhead, Troy/V-9033-2019	Bankhead, Troy/0000-0002-4336-0298; Casselli, Timothy/0000-0003-1954-2443; Owen, Jeb/0000-0002-2042-0526	National Institute of Allergy and Infectious Diseases, National Institutes of Health [1R01AI108704]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108704] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was funded by the National Institute of Allergy and Infectious Diseases, National Institutes of Health, grant number 1R01AI108704 to TB (http://www.niaid.nih.gov/Pages/default.aspx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Alghaferi MY, 2005, J CLIN MICROBIOL, V43, P1879, DOI 10.1128/JCM.43.4.1879-1884.2005; Anderson J F, 1989, Conn Med, V53, P343; ANDERSON JF, 1987, J CLIN MICROBIOL, V25, P1564, DOI 10.1128/JCM.25.8.1564-1566.1987; ANDERSON JF, 1986, ZBL BAKT-INT J MED M, V263, P34; Bankhead T, 2007, MOL MICROBIOL, V65, P1547, DOI 10.1111/j.1365-2958.2007.05895.x; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4955, DOI 10.1128/IAI.61.12.4955-4961.1993; BARTHOLD SW, 1993, INFECT IMMUN, V61, P4696, DOI 10.1128/IAI.61.11.4696-4702.1993; BARTHOLD SW, 1995, LAB INVEST, V72, P127; Baum E, 2012, MBIO, V3, DOI 10.1128/mBio.00434-12; Brisson D, 2004, GENETICS, V168, P713, DOI 10.1534/genetics.104.028738; Brisson D, 2012, ANNU REV GENET, V46, P515, DOI 10.1146/annurev-genet-011112-112140; Bunikis J, 1999, INFECT IMMUN, V67, P2874, DOI 10.1128/IAI.67.6.2874-2883.1999; Coutte L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000293; Crother TR, 2003, INFECT IMMUN, V71, P3419, DOI 10.1128/IAI.71.6.3419-3428.2003; de Silva AM, 1998, J INFECT DIS, V177, P395, DOI 10.1086/514200; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Elias AF, 2002, INFECT IMMUN, V70, P2139, DOI 10.1128/IAI.70.4.2139-2150.2002; Embers ME, 2012, PATHOGENIC SPIROCHET, P113; FIKRIG E, 1993, PARASITOL TODAY, V9, P129, DOI 10.1016/0169-4758(93)90176-G; Frohlich M, 1986, Arch Geschwulstforsch, V56, P125; Golde WT, 1998, J CLIN MICROBIOL, V36, P1015, DOI 10.1128/JCM.36.4.1015-1019.1998; Grimm D, 2005, J MED ENTOMOL, V42, P676, DOI 10.1603/0022-2585(2005)042[0676:DPRBBB]2.0.CO;2; Grimm D, 2004, INFECT IMMUN, V72, P5938, DOI 10.1128/IAI.72.10.5938-5946.2004; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Guttman DS, 1996, J CLIN MICROBIOL, V34, P652, DOI 10.1128/JCM.34.3.652-656.1996; Herrmann Jean Louis, 1995, Clin Microbiol Infect, V1, P72, DOI 10.1111/j.1469-0691.1995.tb00448.x; Hofmeister EK, 1999, INFECT IMMUN, V67, P5709, DOI 10.1128/IAI.67.11.5709-5716.1999; Hove PR, 2014, INFECT IMMUN, V82, P43, DOI 10.1128/IAI.01061-13; Hovius JW, 2008, J INFECT DIS, V198, P1189, DOI 10.1086/591917; HUGHES CAN, 1992, J CLIN MICROBIOL, V30, P698, DOI 10.1128/JCM.30.3.698-703.1992; Indest KJ, 2001, INFECT IMMUN, V69, P7083, DOI 10.1128/IAI.69.11.7083-7090.2001; JONSSON M, 1995, MICROB PATHOGENESIS, V18, P109, DOI 10.1016/S0882-4010(95)90101-9; Krause PJ, 2006, AM J TROP MED HYG, V75, P1090, DOI 10.4269/ajtmh.2006.75.1090; Kung F, 2013, FUTURE MICROBIOL, V8, P41, DOI [10.2217/FMB.12.121, 10.2217/fmb.12.121]; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, 2003, INFECT IMMUN, V71, P4608, DOI 10.1128/IAI.71.8.4608-4613.2003; LANE RS, 1991, J MED ENTOMOL, V28, P719, DOI 10.1093/jmedent/28.5.719; Lawrenz MB, 2004, INFECT IMMUN, V72, P6577, DOI 10.1128/IAI.72.11.6577-6585.2004; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Liang FT, 2002, J EXP MED, V195, P415, DOI 10.1084/jem.20011870; Liveris D, 1999, J CLIN MICROBIOL, V37, P565, DOI 10.1128/JCM.37.3.565-569.1999; Margos G, 2008, P NATL ACAD SCI USA, V105, P8730, DOI 10.1073/pnas.0800323105; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; McDowell JV, 2002, INFECT IMMUN, V70, P4196, DOI 10.1128/IAI.70.8.4196-4203.2002; McKisic MD, 2000, INFECT IMMUN, V68, P5190, DOI 10.1128/IAI.68.9.5190-5197.2000; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Norris SJ, 2006, MOL MICROBIOL, V60, P1319, DOI 10.1111/j.1365-2958.2006.05204.x; Nowakowski J, 1997, ANN INTERN MED, V127, P130, DOI 10.7326/0003-4819-127-2-199707150-00006; Nowakowski J, 2003, AM J MED, V115, P91, DOI 10.1016/S0002-9343(03)00308-5; Ohnishi J, 2003, J BACTERIOL, V185, P4432, DOI 10.1128/JB.185.15.4432-4441.2003; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; PEAVEY CA, 1995, J PARASITOL, V81, P175, DOI 10.2307/3283916; Philipp Mario T., 1994, Trends in Microbiology, V2, P431, DOI 10.1016/0966-842X(94)90800-1; Philipp MT, 2001, J INFECT DIS, V184, P870, DOI 10.1086/323392; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Purser JE, 2000, P NATL ACAD SCI USA, V97, P13865, DOI 10.1073/pnas.97.25.13865; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; RAND PW, 1993, J MED ENTOMOL, V30, P614, DOI 10.1093/jmedent/30.3.614; Rogovskyy AS, 2014, INFECT IMMUN, V82, P4542, DOI 10.1128/IAI.01817-14; Rogovskyy AS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061226; SALAZAR JC, 1993, J PEDIATR-US, V122, P591, DOI 10.1016/S0022-3476(05)83541-3; SCHWAN TG, 1989, INFECT IMMUN, V57, P3445, DOI 10.1128/IAI.57.11.3445-3451.1989; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Steere AC, 2001, NEW ENGL J MED, V345, P115, DOI 10.1056/NEJM200107123450207; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Strother KO, 2005, VECTOR-BORNE ZOONOT, V5, P237, DOI 10.1089/vbz.2005.5.237; Strother KO, 2005, J BACTERIOL, V187, P5776, DOI 10.1128/JB.187.16.5776-5781.2005; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019; Tsao K, 2013, APPL ENVIRON MICROB, V79, P958, DOI 10.1128/AEM.03106-12; Wang GQ, 2003, APPL ENVIRON MICROB, V69, P4561, DOI 10.1128/AEM.69.8.4561-4565.2003; Wang IN, 1999, GENETICS, V151, P15; WEBER K, 1986, INFECTION, V14, P32, DOI 10.1007/BF01644807; WILSKE B, 1993, INFECT IMMUN, V61, P2182, DOI 10.1128/IAI.61.5.2182-2191.1993; Wormser GP, 2003, ANN INTERN MED, V138, P697, DOI 10.7326/0003-4819-138-9-200305060-00005; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Zhang JR, 1997, CELL, V89, P275, DOI 10.1016/S0092-8674(00)80206-8; Zhang JR, 1998, INFECT IMMUN, V66, P3689, DOI 10.1128/IAI.66.8.3689-3697.1998; Zhang JR, 1998, INFECT IMMUN, V66, P3698, DOI 10.1128/IAI.66.8.3698-3704.1998	80	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124268	10.1371/journal.pone.0124268	http://dx.doi.org/10.1371/journal.pone.0124268			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893989	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700083
J	Xu, BS; Xu, HW; Wu, YH; Li, XL; Zhang, Y; Ma, XL; Yang, Q				Xu, Baoshan; Xu, Haiwei; Wu, Yaohong; Li, Xiulan; Zhang, Yang; Ma, Xinlong; Yang, Qiang			Intervertebral Disc Tissue Engineering with Natural Extracellular Matrix-Derived Biphasic Composite Scaffolds	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; ANNULUS FIBROSUS CELLS; HUMAN NUCLEUS PULPOSUS; REGENERATION; HYDROGEL; REPLACEMENT; MODEL; TRANSPLANTATION; DEGENERATION	Tissue engineering has provided an alternative therapeutic possibility for degenerative disc diseases. However, we lack an ideal scaffold for IVD tissue engineering. The goal of this study is to fabricate a novel biomimetic biphasic scaffold for IVD tissue engineering and evaluate the feasibility of developing tissue-engineered IVD in vitro and in vivo. In present study we developed a novel integrated biphasic IVD scaffold using a simple freeze-drying and cross-linking technique of pig bone matrix gelatin (BMG) for the outer annulus fibrosus (AF) phase and pig acellular cartilage ECM (ACECM) for the inner nucleus pulposus (NP) phase. Histology and SEM results indicated no residual cells remaining in the scaffold that featured an interconnected porous microstructure (pore size of AF and NP phase 401.4 +/- 13.1 mu m and 231.6 +/- 57.2 mu m, respectively). PKH26-labeled AF and NP cells were seeded into the scaffold and cultured in vitro. SEM confirmed that seeded cells could anchor onto the scaffold. Live/dead staining showed that live cells (green fluorescence) were distributed in the scaffold, with no dead cells (red fluorescence) being found. The cell-scaffold constructs were implanted subcutaneously into nude mice and cultured for 6 weeks in vivo. IVD-like tissue formed in nude mice as confirmed by histology. Cells in hybrid constructs originated from PKH26-labeled cells, as confirmed by in vivo fluorescence imaging system. In conclusion, the study demonstrates the feasibility of developing a tissue-engineered IVD in vivo with a BMG- and ACECM-derived integrated AF-NP biphasic scaffold. As well, PKH26 fluorescent labeling with in vivo fluorescent imaging can be used to track cells and analyse cell-scaffold constructs in vivo.	[Xu, Baoshan; Xu, Haiwei; Wu, Yaohong; Ma, Xinlong; Yang, Qiang] Tianjin Hosp, Dept Minimally Invas Spine Surg, Tianjin 300211, Peoples R China; [Xu, Haiwei; Wu, Yaohong; Yang, Qiang] Tianjin Med Univ, Tianjin 300070, Peoples R China; [Li, Xiulan; Zhang, Yang] Tianjin Hosp, Cell Engn Lab Orthopaed Inst, Tianjin 300211, Peoples R China	Tianjin Medical University	Ma, XL (corresponding author), Tianjin Hosp, Dept Minimally Invas Spine Surg, 406 Jie Fang Nan Rd, Tianjin 300211, Peoples R China.	maxinlong8686@sina.com; yangqiang1980@126.com	yang, qiang/GYJ-0971-2022		National Natural Science Foundation of China [31300798, 31000432, 81272046]; China Postdoctoral Science Foundation [2011M500530, 2012T50235]; Research Foundation of the Tianjin Health Bureau [2013KR16, 2012KY24]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Foundation of the Tianjin Health Bureau	This study was supported by the National Natural Science Foundation of China (Nos. 31300798, 31000432 and 81272046), China Postdoctoral Science Foundation funded project (Nos. 2011M500530 and 2012T50235), and the Research Foundation of the Tianjin Health Bureau (Nos. 2013KR16 and 2012KY24). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alini M, 2003, SPINE, V28, P446, DOI 10.1097/00007632-200303010-00007; Blanquer SBG, 2012, J APPL BIOMATER FUNC, V10, P177, DOI 10.5301/JABFM.2012.10354; CASSIDY JJ, 1989, CONNECT TISSUE RES, V23, P75, DOI 10.3109/03008208909103905; Chan LKY, 2013, ACTA BIOMATER, V9, P5262, DOI 10.1016/j.actbio.2012.09.005; Chang G, 2007, EUR SPINE J, V16, P1848, DOI 10.1007/s00586-007-0364-4; Dang JM, 2006, BIOMATERIALS, V27, P406, DOI 10.1016/j.biomaterials.2005.07.033; Devereaux M, 2009, MED CLIN N AM, V93, P477, DOI 10.1016/j.mcna.2008.09.013; Foss BL, 2014, J MECH BEHAV BIOMED, V29, P56, DOI 10.1016/j.jmbbm.2013.08.020; Francisco AT, 2014, ACTA BIOMATER, V10, P1102, DOI 10.1016/j.actbio.2013.11.013; Frith JE, 2013, BIOMATERIALS, V34, P9430, DOI 10.1016/j.biomaterials.2013.08.072; Gorapalli D, 2012, LIFE SCI, V91, P1328, DOI 10.1016/j.lfs.2012.10.014; Gruber Helen E, 2004, Spine J, V4, P44, DOI 10.1016/S1529-9430(03)00425-X; Kim SH, 2011, J BIOMATER SCI POLYM, V29, P31; Lazebnik M, 2011, J TISSUE ENG REGEN M, V5, pE179, DOI 10.1002/term.412; Le Visage C, 2006, SPINE, V31, P2423, DOI 10.1097/01.brs.0000238684.04792.eb; Leone G, 2008, J BIOMED MATER RES A, V84A, P391, DOI 10.1002/jbm.a.31334; Li XD, 2006, BIOMATERIALS, V27, P2426, DOI 10.1016/j.biomaterials.2005.11.040; Mercuri JJ, 2011, J BIOMED MATER RES A, V96A, P422, DOI 10.1002/jbm.a.33001; Mizuno H, 2004, SPINE, V29, P1290, DOI 10.1097/01.BRS.0000128264.46510.27; OEGEMA TR, 1993, CLIN SPORT MED, V12, P419; Park SH, 2012, TISSUE ENG PT A, V18, P447, DOI [10.1089/ten.tea.2011.0195, 10.1089/ten.TEA.2011.0195]; Richardson SM, 2006, BIOMATERIALS, V27, P4069, DOI 10.1016/j.biomaterials.2006.03.017; Saad L, 2004, J BIOMED MATER RES A, V71A, P233, DOI 10.1002/jbm.a.30150; Sakai D, 2003, BIOMATERIALS, V24, P3531, DOI 10.1016/S0142-9612(03)00222-9; Seguin CA, 2004, SPINE, V29, P1299, DOI 10.1097/01.BRS.0000127183.43765.AF; Serigano K, 2010, J ORTHOP RES, V28, P1267, DOI 10.1002/jor.21147; Shao XX, 2007, J BIOMED MATER RES A, V82A, P701, DOI 10.1002/jbm.a.31030; Smith LJ, 2011, DIS MODEL MECH, V4, P31, DOI 10.1242/dmm.006403; Wan YQ, 2008, BIOMATERIALS, V29, P643, DOI 10.1016/j.biomaterials.2007.10.031; Wilke HJ, 2006, EUR SPINE J, V15, pS433, DOI 10.1007/s00586-006-0177-x; Wiltsey C, 2013, J MATER SCI-MATER M, V24, P837, DOI 10.1007/s10856-013-4857-x; Yang Q, 2008, BIOMATERIALS, V29, P2378, DOI 10.1016/j.biomaterials.2008.01.037; Zeng C, 2014, MAT SCI ENG C-MATER, V37, P232, DOI 10.1016/j.msec.2014.01.012; Zhang RY, 2004, MACROMOL BIOSCI, V4, P100, DOI 10.1002/mabi.200300017; Zhuang Y, 2011, BIOCHEM BIOPH RES CO, V407, P327, DOI 10.1016/j.bbrc.2011.03.015	35	25	30	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124774	10.1371/journal.pone.0124774	http://dx.doi.org/10.1371/journal.pone.0124774			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894203	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700122
J	Zhang, P; Zhong, ZH; Yu, HT; Liu, B				Zhang, Ping; Zhong, Zhi-Hong; Yu, Hao-Tao; Liu, Bin			Significance of Increased Leptin Expression in Osteoarthritis Patients	PLOS ONE			English	Article							RADIOGRAPHIC KNEE OSTEOARTHRITIS; ADIPOKINE LEVELS; SYNOVIAL-FLUID; ASSOCIATION; ADIPONECTIN; PLASMA; HIP; HETEROGENEITY; CARTILAGE; RECEPTOR	Objective Alterations in leptin expression contributes to the progression of various diseases, including cancers. This meta-analysis investigated the clinical significance of leptin levels in osteoarthritis (OA) patients, with the goal of building a leptin-based diagnostic criterion for OA. Method Multiple scientific databases in English and Chinese languages, such as the Cochrane Library Database, CINAHL, Chinese Biomedical (CBM), EMBASE, PubMed, and Web of Science, were exhaustively searched, without any language restrictions, to identify high-quality studies relevant to leptin and OA. Version 12.0 STATA software was used for data analysis. We used odds ratios (OR) and 95% confidence intervals (CI) to test the correlation between serum leptin levels and OA progression. Results A total of 11 clinical studies were finally selected for their high quality and relevance to the topic in this meta-analysis. The 11 case-control studies contained a combined total of 3,625 subjects. The meta-analysis results showed that leptin expression was significantly increased in OA patients, compared with the controls (SMD = 0.87, 95% CI: 0.72-1.02, P < 0.001), and there was also a strong association between leptin expression levels and gender (SMD = 8.55, 95% CI: 4.74-12.35, P < 0.001). In ethnicity-stratified subgroup analysis, all the study populations, irrespective of ethnicity, showed remarkably high leptin expression levels in females and in OA patients (all P < 0.05), compared to their respective counterparts. Conclusion The present study revealed that increased leptin expression levels are associated with disease severity in OA patients, especially among the female OA patients. Based on our results, we propose that leptin level may be a useful biomarker for the assessment of the clinical status in OA patients.	[Zhang, Ping; Zhong, Zhi-Hong; Yu, Hao-Tao] Guangzhou Med Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510000, Guangdong, Peoples R China; [Liu, Bin] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510000, Guangdong, Peoples R China	Guangzhou Medical University; Sun Yat Sen University	Liu, B (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Orthoped, Guangzhou 510000, Guangdong, Peoples R China.	liubin_1216@126.com						ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Attur M, 2013, CURR OPIN RHEUMATOL, V25, P136, DOI 10.1097/BOR.0b013e32835a9381; Bao JP, 2010, MOL BIOL REP, V37, P3265, DOI 10.1007/s11033-009-9911-x; Bartell SM, 2011, J BONE MINER RES, V26, P1710, DOI 10.1002/jbmr.406; Beekhuizen M, 2013, OSTEOARTHR CARTILAGE, V21, P918, DOI 10.1016/j.joca.2013.04.002; Bohler H, 2010, FERTIL STERIL, V94, P795, DOI 10.1016/j.fertnstert.2009.03.079; Chaganti RK, 2011, CURR REV MUSCULOSKE, V4, P99, DOI 10.1007/s12178-011-9088-5; de Boer TN, 2012, OSTEOARTHR CARTILAGE, V20, P846, DOI 10.1016/j.joca.2012.05.002; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Gandhi R, 2010, J ORTHOP RES, V28, P329, DOI 10.1002/jor.21000; Gegout PP, 2008, JOINT BONE SPINE, V75, P669, DOI 10.1016/j.jbspin.2008.07.008; Honsawek S, 2010, ARCH MED RES, V41, P593, DOI 10.1016/j.arcmed.2010.11.007; Issa RI, 2012, PATHOBIOL AGING AGE, V9, DOI DOI 10.3402/PBA.V2I0.17470; Jackson D, 2012, STAT MED, V31, P3805, DOI 10.1002/sim.5453; Jarde T, 2011, EUR J CANCER, V47, P33, DOI 10.1016/j.ejca.2010.09.005; Kajikawa Y, 2011, INT HEART J, V52, P17, DOI 10.1536/ihj.52.17; Karvonen-Gutierrez CA, 2012, OSTEOARTHR CARTILAGE, V20, P614, DOI 10.1016/j.joca.2012.02.644; Karvonen-Gutierrez CA, 2013, ARTHRIT CARE RES, V65, P936, DOI 10.1002/acr.21922; Ku JH, 2009, CLIN RHEUMATOL, V28, P1431, DOI 10.1007/s10067-009-1242-8; Massengale M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047860; Massengale M, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3864; Mutabaruka MS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar2925; Perruccio AV, 2014, J RHEUMATOL, V41, P334, DOI 10.3899/jrheum.130709; Peters JL, 2006, JAMA-J AM MED ASSOC, V295, P676, DOI 10.1001/jama.295.6.676; Qin JH, 2010, J HUM GENET, V55, P704, DOI 10.1038/jhg.2010.86; Roemmich JN, 1998, AM J PHYSIOL-ENDOC M, V275, pE543, DOI 10.1152/ajpendo.1998.275.3.E543; Simopoulou T, 2007, OSTEOARTHR CARTILAGE, V15, P872, DOI 10.1016/j.joca.2007.01.018; Sowers MR, 2010, CURR OPIN RHEUMATOL, V22, P533, DOI 10.1097/BOR.0b013e32833b4682; Staikos C, 2013, RHEUMATOLOGY, V52, P1077, DOI 10.1093/rheumatology/kes422; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stannus OP, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3022; Tong KM, 2008, CELL SIGNAL, V20, P1478, DOI 10.1016/j.cellsig.2008.04.003; Vuolteenaho K, 2009, MEDIAT INFLAMM, V2009, DOI 10.1155/2009/345838; Wang ZH, 2007, MED INFORM, V20, P1222; Zintzaras E, 2005, BIOINFORMATICS, V21, P3672, DOI 10.1093/bioinformatics/bti536	35	21	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123224	10.1371/journal.pone.0123224	http://dx.doi.org/10.1371/journal.pone.0123224			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893833	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700030
J	Bai, Y; Zhu, XJ; Chao, J; Zhang, Y; Qian, C; Li, PC; Liu, DF; Han, B; Zhao, L; Zhang, JQ; Buch, S; Teng, GJ; Hu, G; Yao, HH				Bai, Ying; Zhu, Xinjian; Chao, Jie; Zhang, Yuan; Qian, Cheng; Li, Peicheng; Liu, Dongfang; Han, Bing; Zhao, Lei; Zhang, Jianqiong; Buch, Shilpa; Teng, Gaojun; Hu, Gang; Yao, Honghong			Pericytes Contribute to the Disruption of the Cerebral Endothelial Barrier via Increasing VEGF Expression: Implications for Stroke	PLOS ONE			English	Article							BLOOD-BRAIN-BARRIER; GROWTH-FACTOR; MICROVASCULAR PERICYTES; LEUCINE-ENKEPHALIN; UP-REGULATION; CELLS; INDUCTION; ANGIOGENESIS; RECEPTOR; LEAKAGE	Disruption of the blood-brain barrier (BBB) integrity occurring during the early onset of stroke is not only a consequence of, but also contributes to the further progression of stroke. Although it has been well documented that brain microvascular endothelial cells and astrocytes play a critical role in the maintenance of BBB integrity, pericytes, sandwiched between endothelial cells and astrocytes, remain poorly studied in the pathogenesis of stroke. Our findings demonstrated that treatment of human brain microvascular pericytes with sodium cyanide (NaCN) and glucose deprivation resulted in increased expression of vascular endothelial growth factor (VEGF) via the activation of tyrosine kinase Src, with downstream activation of mitogen activated protein kinase and PI3K/Akt pathways and subsequent translocation of NF-kappa B into the nucleus. Conditioned medium from NaCN-treated pericytes led to increased permeability of endothelial cells, and this effect was significantly inhibited by VEGF-neutralizing antibody. The in vivo relevance of these findings was further corroborated in the stroke model of mice wherein the mice, demonstrated disruption of the BBB integrity and concomitant increase in the expression of VEGF in the brain tissue as well as in the isolated microvessel. These findings thus suggest the role of pericyte-derived VEGF in modulating increased permeability of BBB during stroke. Understanding the regulation of VEGF expression could open new avenues for the development of potential therapeutic targets for stroke and other neurological disease.	[Bai, Ying; Zhu, Xinjian; Zhang, Yuan; Han, Bing; Zhao, Lei] Southeast Univ, Sch Med, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China; [Chao, Jie] Southeast Univ, Dept Physiol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Qian, Cheng; Li, Peicheng; Liu, Dongfang; Teng, Gaojun] Southeast Univ, Dept Radiol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Zhang, Jianqiong] Southeast Univ, Dept Immunol, Sch Med, Nanjing, Jiangsu, Peoples R China; [Buch, Shilpa] Univ Nebraska Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA; [Hu, Gang] Nanjing Med Univ, Dept Pharmacol, Nanjing, Jiangsu, Peoples R China	Southeast University - China; Southeast University - China; Southeast University - China; Southeast University - China; University of Nebraska System; University of Nebraska Medical Center; Nanjing Medical University		yaohh@seu.edu.cn	Jie, Chao/J-1004-2019	Jie, Chao/0000-0002-7800-3557; Buch, Shilpa/0000-0002-3103-6685	National Natural Science Foundation of China [81322048]; Award for Jiangsu Specially-Appointed Professor; Major State Basic Research Development Program of China (973 Program) [2013CB733800, 2013CB733803]; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Award for Jiangsu Specially-Appointed Professor; Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by grants from the National Natural Science Foundation of China (no. 81322048), Award for Jiangsu Specially-Appointed Professor and the Major State Basic Research Development Program of China (973 Program) (2013CB733800, 2013CB733803). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abumiya T, 1999, J CEREBR BLOOD F MET, V19, P1038, DOI 10.1097/00004647-199909000-00012; Argaw AT, 2012, J CLIN INVEST, V122, P2454, DOI 10.1172/JCI60842; Argaw AT, 2009, P NATL ACAD SCI USA, V106, P1977, DOI 10.1073/pnas.0808698106; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Arumugam TV, 2006, NAT MED, V12, P621, DOI 10.1038/nm1403; Bauer AT, 2010, J CEREBR BLOOD F MET, V30, P837, DOI 10.1038/jcbfm.2009.248; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Chen F, 2007, EUR J RADIOL, V63, P68, DOI 10.1016/j.ejrad.2007.01.005; Cheung WM, 2000, CHINESE J PHYSIOL, V43, P119; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Dore-Duffy P, 2006, J CEREBR BLOOD F MET, V26, P613, DOI 10.1038/sj.jcbfm.9600272; Duan PF, 2014, PHARMAZIE, V69, P70, DOI 10.1691/ph.2014.3655; Engelhardt S, 2014, BRIT J PHARMACOL, V171, P1210, DOI 10.1111/bph.12489; Fernandez-Klett F, 2013, J CEREBR BLOOD F MET, V33, P428, DOI 10.1038/jcbfm.2012.187; Gauberti M, 2013, STROKE, V44, P1988, DOI 10.1161/STROKEAHA.111.000544; Huang YH, 2014, ANGIOGENESIS, V17, P407, DOI 10.1007/s10456-013-9386-1; Kovac A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-139; Li YN, 2014, J NEUROCHEM, V129, P120, DOI 10.1111/jnc.12611; Liu DF, 2014, NANOSCALE, V6, P15161, DOI 10.1039/c4nr03942d; McColl BW, 2010, J CEREBR BLOOD F MET, V30, P267, DOI 10.1038/jcbfm.2009.217; Melgar MA, 2005, NEUROSURGERY, V56, P571, DOI 10.1227/01.NEU.0000154702.23664.3D; MEYER J, 1991, J NEUROCHEM, V57, P1971, DOI 10.1111/j.1471-4159.1991.tb06411.x; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Neuhaus W, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00352; Omar HA, 2013, TOXICOL APPL PHARM, V272, P616, DOI 10.1016/j.taap.2013.07.014; Persidsky Y, 2006, J NEUROIMMUNE PHARM, V1, P223, DOI 10.1007/s11481-006-9025-3; Plate KH, 1999, J NEUROPATH EXP NEUR, V58, P654, DOI 10.1097/00005072-199906000-00010; Rose K, 2005, J CELL PHYSIOL, V204, P131, DOI 10.1002/jcp.20283; Shibuya M, 2009, FEBS J, V276, P4636, DOI 10.1111/j.1742-4658.2009.07175.x; Takata F, 2007, CELL MOL NEUROBIOL, V27, P317, DOI 10.1007/s10571-006-9125-x; Takata F, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-106; Tang YB, 2014, BRIT J PHARMACOL, V171, P2440, DOI 10.1111/bph.12611; Hernandez-Hernandez OT, 2012, J STEROID BIOCHEM, V132, P127, DOI 10.1016/j.jsbmb.2012.04.005; Thanabalasundaram G, 2011, INT J BIOCHEM CELL B, V43, P1284, DOI 10.1016/j.biocel.2011.05.002; Thanabalasundaram G, 2010, BRAIN RES, V1347, P1, DOI 10.1016/j.brainres.2010.05.096; UMEMURA K, 1993, STROKE, V24, P1077, DOI 10.1161/01.STR.24.7.1077; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Wardlaw JM, 2009, ANN NEUROL, V65, P194, DOI 10.1002/ana.21549; Witmer AN, 2004, J HISTOCHEM CYTOCHEM, V52, P39, DOI 10.1177/002215540405200105; Yao H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5386; Yao HH, 2011, J NEUROSCI, V31, P12449, DOI 10.1523/JNEUROSCI.2330-11.2011; Yao HH, 2011, J NEUROSCI, V31, P5942, DOI 10.1523/JNEUROSCI.5618-10.2011; Yao HH, 2010, BLOOD, V115, P4951, DOI 10.1182/blood-2010-01-266221; Yao Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4413; Yi HW, 2014, J NEUROIMMUNE PHARM, V9, P629, DOI 10.1007/s11481-014-9553-1; Zan L, 2014, NEUROSCIENCE, V262, P118, DOI 10.1016/j.neuroscience.2013.12.060; Zhang YQ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031849, 10.1371/journal.pone.0030262]; Zhang ZG, 2000, J CLIN INVEST, V106, P829, DOI 10.1172/JCI9369; Zipser BD, 2007, NEUROBIOL AGING, V28, P977, DOI 10.1016/j.neurobiolaging.2006.05.016; ZLOKOVIC BV, 1989, J NEUROCHEM, V53, P1333, DOI 10.1111/j.1471-4159.1989.tb08522.x; ZLOKOVIC BV, 1987, J NEUROCHEM, V49, P310, DOI 10.1111/j.1471-4159.1987.tb03431.x; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8; ZLOKOVIC BV, 1995, PHARM RES-DORDR, V12, P1395, DOI 10.1023/A:1016254514167; Zlokovic BV, 1997, NEUROSURGERY, V40, P789, DOI 10.1097/00006123-199704000-00027; ZLOKOVIC BV, 1985, BRAIN RES, V336, P125, DOI 10.1016/0006-8993(85)90423-8	57	57	59	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124362	10.1371/journal.pone.0124362	http://dx.doi.org/10.1371/journal.pone.0124362			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884837	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000121
J	Etokebe, GE; Zienolddiny, S; Kupanovac, Z; Enersenl, M; Balen, S; Flego, V; Bulat-Kardum, L; Radojcic-Badovinac, A; Skaug, V; Bakke, P; Haugen, A; Dembic, Z				Etokebe, Godfrey Essien; Zienolddiny, Shanbeh; Kupanovac, Zeljko; Enersen, Morten; Balen, Sanja; Flego, Veljko; Bulat-Kardum, Ljiljana; Radojcic-Badovinac, Andelka; Skaug, Vidar; Bakke, Per; Haugen, Aage; Dembic, Zlatko			Association of the FAM46A Gene VNTRs and BAG6 rs3117582 SNP with Non Small Cell Lung Cancer (NSCLC) in Croatian and Norwegian Populations	PLOS ONE			English	Article							MICROSATELLITE INSTABILITY; KNEE OSTEOARTHRITIS; ANTAGONIST GENE; RISK; SUSCEPTIBILITY; POLYMORPHISMS; IDENTIFICATION; VARIANTS; FAMILIES; C6ORF37	We analyzed for associations between a variable number of tandem repeat (VNTR) polymorphism in the Family with sequence similarity 46, member A (FAM46A) gene and a single nucleotide polymorphism (rs3117582) in the BCL2-Associated Athanogene 6 (BAG6) with non small cell lung cancer in Croatian and Norwegian subjects. A total of 503 (262 Croatian and 241 Norwegian) non small cell lung cancer patients and 897 controls (568 Croatian and 329 Norwegian) were analyzed. We found that the frequency of allele b (three VNTR repeats) of FAM46A gene was significantly increased in the patients compared to the healthy controls in the Croatian and the combined Croatian and Norwegian subjects. Genotype frequencies of cd (four and five VNTR repeats) and cc (four VNTR repeats homozygote) of the FAM46A gene were significantly decreased in the patients compared to the healthy controls in the Croatian and Norwegian subjects, respectively. Logistic regression analyses revealed FAM46A genotype cc to be an independent predictive factor for non small cell lung cancer risk in the Norwegian subjects after adjustment for age, gender and smoking status. This is the first study to suggest an association between the FAM46A gene VNTR polymorphisms and non small cell lung cancer. We found also that BAG6 rs3117582 SNP was associated with non small cell lung cancer in the Norwegian subjects and the combined Croatian-Norwegian subjects corroborating the earlier finding that BAG6 rs3117582 SNP was associated with lung cancer in Europeans. Logistic regression analyses revealed that genotypes and alleles of BAG6 were independent predictive factor for non small cell lung cancer risk in the Norwegian and combined Croatian-Norwegian subjects, after adjustment for age and gender.	[Etokebe, Godfrey Essien; Kupanovac, Zeljko; Enersen, Morten; Dembic, Zlatko] Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway; [Kupanovac, Zeljko; Flego, Veljko; Bulat-Kardum, Ljiljana] Univ Rijeka, Clin Hosp Ctr, Dept Internal Med, Sect Pulmol, Rijeka, Croatia; [Zienolddiny, Shanbeh; Skaug, Vidar; Haugen, Aage] Natl Inst Occupat Hlth, Dept Chem & Biol Working Environm, Oslo, Norway; [Balen, Sanja] Univ Rijeka, Clin Hosp Ctr, Inst Transfus Med, Rijeka, Croatia; [Bakke, Per] Univ Bergen, Dept Clin Sci, Bergen, Norway; [Radojcic-Badovinac, Andelka] Univ Rijeka, Fac Med, Dept Biol & Med Genet, Rijeka, Croatia	University of Oslo; University of Rijeka; University of Rijeka; University of Bergen; University of Rijeka	Etokebe, GE (corresponding author), Univ Oslo, Fac Dent, Inst Oral Biol, Oslo, Norway.	godfreye@odontuio.no	Zienolddiny, Shanbeh/O-7392-2015; Badovinac, Andelka Radojcic/R-3366-2018; Balen, Sanja/S-5253-2018; Dembic, Zlatko/A-1833-2008	Badovinac, Andelka Radojcic/0000-0001-5949-5245; Balen, Sanja/0000-0003-2408-6868; Dembic, Zlatko/0000-0002-9970-6497; Zienolddiny, Shan/0000-0001-9747-9625				Aguillon JC, 2006, IMMUNOBIOLOGY, V211, P75, DOI 10.1016/j.imbio.2005.09.005; Albright F, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-138; Azzoli CG, 2008, J THORAC ONCOL, V3, P84, DOI 10.1097/JTO.0b013e31815efe24; Barragan I, 2008, ANN HUM GENET, V72, P26, DOI 10.1111/j.1469-1809.2007.00393.x; Brennan P, 2011, LANCET ONCOL, V12, P399, DOI 10.1016/S1470-2045(10)70126-1; Campbell L, 2010, EXPERT OPIN PHARMACO, V11, P1343, DOI 10.1517/14656566.2010.481283; Colland F, 2004, GENOME RES, V14, P1324, DOI 10.1101/gr.2334104; Cote ML, 2012, EUR J CANCER, V48, P1957, DOI 10.1016/j.ejca.2012.01.038; Cui J, 2006, CLIN CHIM ACTA, V368, P155, DOI 10.1016/j.cca.2005.12.043; Dong J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003190; Etokebe GE, 2014, J ORTHOP RES; Etokebe GE, 2009, ARCH ORAL BIOL, V54, P1002, DOI 10.1016/j.archoralbio.2009.08.005; Etokebe GE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091385; Fan WC, 2014, LUNG CANCER, V85, P472, DOI 10.1016/j.lungcan.2014.07.001; Farhat FS, 2012, CRIT REV ONCOL HEMAT, V84, P149, DOI 10.1016/j.critrevonc.2012.02.012; Gridelli C, 2010, ANTICANCER RES, V30, P1301; Hannan AJ, 2010, DISCOV MED, V10, P314; Hannan AJ, 2010, TRENDS GENET, V26, P59, DOI 10.1016/j.tig.2009.11.008; Hart K, 2011, LUNG CANCER, V71, P123, DOI 10.1016/j.lungcan.2010.04.016; Hu ZB, 2006, CANCER LETT, V236, P269, DOI 10.1016/j.canlet.2005.05.015; Jacobsen B, 2014, WORLD J CLIN ONCOL, V5, P621, DOI 10.5306/wjco.v5.i4.621; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jotanovic Z, 2012, RHEUMATOL INT, V32, P2135, DOI 10.1007/s00296-011-1946-3; Jotanovic Z, 2011, J ORTHOP RES, V29, P1137, DOI 10.1002/jor.21378; Kaarvatn MH, 2013, SCAND J IMMUNOL, V77, P151, DOI 10.1111/sji.12016; Kamper N, 2012, FASEB J, V26, P104, DOI 10.1096/fj.11-189670; Kawabata M, 1999, ANN NY ACAD SCI, V886, P73, DOI 10.1111/j.1749-6632.1999.tb09402.x; Kuchta K, 2009, NUCLEIC ACIDS RES, V37, P7701, DOI 10.1093/nar/gkp854; Lagali PS, 2002, BIOCHEM BIOPH RES CO, V293, P356, DOI 10.1016/S0006-291X(02)00228-0; Lim J, 2006, CELL, V125, P801, DOI 10.1016/j.cell.2006.03.032; Lind H, 2005, LUNG CANCER, V50, P285, DOI 10.1016/j.lungcan.2005.07.003; Lindstedt BA, 1999, ANTICANCER RES, V19, P5523; Liu B, 2012, AM J HUM GENET, V91, P384, DOI 10.1016/j.ajhg.2012.07.003; Nguyen P, 2008, MOL CELL BIOL, V28, P6720, DOI 10.1128/MCB.00568-08; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Rudd MF, 2006, GENOME RES, V16, P693, DOI 10.1101/gr.5120106; RYBERG D, 1995, CANCER RES, V55, P3996; Sasaki T, 2007, GENE DEV, V21, P848, DOI 10.1101/gad.1534107; Shih MCM, 2011, MOL CELL ENDOCRINOL, V336, P80, DOI 10.1016/j.mce.2010.12.017; Spitz MR, 2007, JNCI-J NATL CANCER I, V99, P715, DOI 10.1093/jnci/djk153; Timofeeva MN, 2012, HUM MOL GENET, V21, P4980, DOI 10.1093/hmg/dds334; Truong T, 2010, CARCINOGENESIS, V31, P625, DOI 10.1093/carcin/bgq001; Tsukazaki T, 1998, CELL, V95, P779, DOI 10.1016/S0092-8674(00)81701-8; Walsh KM, 2013, CANCER EPIDEM BIOMAR, V22, P251, DOI 10.1158/1055-9965.EPI-12-1007-T; Wang YF, 2008, NAT GENET, V40, P1407, DOI 10.1038/ng.273; Wu YH, 2004, J BIOL CHEM, V279, P19264, DOI 10.1074/jbc.M307049200	46	21	21	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122651	10.1371/journal.pone.0122651	http://dx.doi.org/10.1371/journal.pone.0122651			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884493	Green Published, gold			2022-12-27	WOS:000353017000038
J	Grode, KD; Rogers, SL				Grode, Kyle D.; Rogers, Stephen L.			The Non-Catalytic Domains of Drosophila Katanin Regulate Its Abundance and Microtubule-Disassembly Activity	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; SPASTIC PARAPLEGIA; SEVERING PROTEIN; SPINDLE; DYNAMICS; ENZYMES; MOTORS; LIGASE; ATPASE; MEL-26	Microtubule severing is a biochemical reaction that generates an internal break in a microtubule and regulation of microtubule severing is critical for cellular processes such as ciliogenesis, morphogenesis, and meiosis and mitosis. Katanin is a conserved heterodimeric ATPase that severs and disassembles microtubules, but the molecular determinants for regulation of microtubule severing by katanin remain poorly defined. Here we show that the non-catalytic domains of Drosophila katanin regulate its abundance and activity in living cells. Our data indicate that the microtubule-interacting and trafficking (MIT) domain and adjacent linker region of the Drosophila katanin catalytic subunit Kat60 cooperate to regulate microtubule severing in two distinct ways. First, the MIT domain and linker region of Kat60 decrease its abundance by enhancing its proteasome-dependent degradation. The Drosophila katanin regulatory subunit Kat80, which is required to stabilize Kat60 in cells, conversely reduces the proteasome-dependent degradation of Kat60. Second, the MIT domain and linker region of Kat60 augment its microtubule-disassembly activity by enhancing its association with microtubules. On the basis of our data, we propose that the non-catalytic domains of Drosophila katanin serve as the principal sites of integration of regulatory inputs, thereby controlling its ability to sever and disassemble microtubules.	[Grode, Kyle D.; Rogers, Stephen L.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA; [Rogers, Stephen L.] Univ N Carolina, Carolina Ctr Genome Sci, Chapel Hill, NC USA; [Rogers, Stephen L.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Rogers, SL (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA.	srogers@bio.unc.edu			National Institutes of Health (NIH) training grant [T32-HD04639-05]; American Heart Association predoctoral fellowship [11PRE6240000]; NIH [R01-GM081645]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081645] Funding Source: NIH RePORTER	National Institutes of Health (NIH) training grant; American Heart Association predoctoral fellowship(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a National Institutes of Health (NIH) training grant (T32-HD04639-05) to KDG, by an American Heart Association predoctoral fellowship (11PRE6240000) to KDG, and by a NIH grant (R01-GM081645) to SLR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Buster D, 2002, J CELL SCI, V115, P1083; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Cox GA, 2000, NAT GENET, V26, P198, DOI 10.1038/79923; Cummings CM, 2009, J BIOL CHEM, V284, P11663, DOI 10.1074/jbc.M809374200; Currie JD, 2011, MOL BIOL CELL, V22, P4343, DOI 10.1091/mbc.E11-06-0520; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Diaz-Valencia JD, 2011, BIOPHYS J, V100, P2440, DOI 10.1016/j.bpj.2011.03.062; Eckert T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050161; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Hartman JJ, 1998, CELL, V93, P277, DOI 10.1016/S0092-8674(00)81578-0; Hartman JJ, 1999, SCIENCE, V286, P782, DOI 10.1126/science.286.5440.782; Hazan J, 1999, NAT GENET, V23, P296, DOI 10.1038/15472; Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624; Iwaya N, 2010, J BIOL CHEM, V285, P16822, DOI 10.1074/jbc.M110.108365; Loughlin R, 2011, CELL, V147, P1397, DOI 10.1016/j.cell.2011.11.014; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; Mao CX, 2014, DEVELOPMENT, V141, P1064, DOI 10.1242/dev.097774; MCNALLY FJ, 1993, CELL, V75, P419, DOI 10.1016/0092-8674(93)90377-3; McNally K, 2014, MOL BIOL CELL, V25, P1037, DOI 10.1091/mbc.E13-12-0764; McNally KP, 2011, MOL BIOL CELL, V22, P1550, DOI 10.1091/mbc.E10-12-0951; McNally KP, 2000, J CELL SCI, V113, P1623; Muller-Reichert T, 2010, CELL MOL LIFE SCI, V67, P2195, DOI 10.1007/s00018-010-0324-8; O'Donnell L, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002698; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Rogers SL, 2002, J CELL BIOL, V158, P873, DOI 10.1083/jcb.200202032; Roll-Mecak A, 2008, NATURE, V451, P363, DOI 10.1038/nature06482; Roll-Mecak A, 2010, CURR OPIN CELL BIOL, V22, P96, DOI 10.1016/j.ceb.2009.11.001; Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236; Sharp DJ, 2012, J CELL SCI, V125, P2561, DOI 10.1242/jcs.101139; Siegrist SE, 2007, GENE DEV, V21, P483, DOI 10.1101/gad.1511207; Smith LB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002697; Srayko M, 2000, GENE DEV, V14, P1072; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Stoppin-Mellet V, 2007, PLANT PHYSIOL BIOCH, V45, P867, DOI 10.1016/j.plaphy.2007.09.005; TAYLOR J, 2012, ANTIOCH REV, V70, P179, DOI DOI 10.1016/J.JSB.2012.03.002; Whitehead E, 2013, J MOL BIOL, V425, P214, DOI 10.1016/j.jmb.2012.11.022; Wilson KJ, 2012, MOL BIOL CELL, V23, P2623, DOI 10.1091/mbc.E12-01-0055; Wittmann T, 2001, NAT CELL BIOL, V3, pE28, DOI 10.1038/35050669; Yang SW, 2013, J NEUROSCI, V33, P12728, DOI 10.1523/JNEUROSCI.0698-13.2013; Yu WQ, 2005, J NEUROSCI, V25, P5573, DOI 10.1523/JNEUROSCI.0834-05.2005; Zhang D, 2007, J CELL BIOL, V177, P231, DOI 10.1083/jcb.200612011; Zhang D, 2011, NAT CELL BIOL, V13, P361, DOI 10.1038/ncb2206	42	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123912	10.1371/journal.pone.0123912	http://dx.doi.org/10.1371/journal.pone.0123912			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886649	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000095
J	Wolcott, DM; Reitz, RL; Weckerly, FW				Wolcott, Daniel M.; Reitz, Ryan L.; Weckerly, Floyd W.			Biological and Environmental Influences on Parturition Date and Birth Mass of a Seasonal Breeder	PLOS ONE			English	Article							SENSITIVE REPRODUCTIVE ALLOCATION; WHITE-TAILED DEER; BODY-MASS; FITNESS COMPONENTS; CLIMATE-CHANGE; SYNCHRONY; GESTATION; SURVIVAL; SENESCENCE; DYNAMICS	Natal features (e.g. Julian birth date and birth mass) often have fitness consequences and can be influenced by endogenous responses by the mother to seasonal fluctuations in nutritional quality and photoperiodic cues. We sought to further understand the biological and environmental factors that influence the natal features of a polytocous species in an environment with constant nutritional resources and limited seasonal variation. During a 36-year study we assessed the influence of biological factors (maternal age and litter type [ i.e., litter size and sexual composition]) and environmental factors (total precipitation and mean maximum temperature during months encompassing conception, the last trimester of gestation, and the entire length of gestation) on Julian birth date and birth mass using linear-mixed effects models. Linear and quadratic functions of maternal age influenced both natal features with earliest Julian birth dates and heaviest birth masses occurring at prime-age and older individuals, which ranged from 5-9 years of age. Litter type influenced Julian birth date and birth mass. Interestingly, environmental factors affected Julian birth date and birth mass even though mothers were continuously allowed access to a high-quality diet. Random effects revealed considerable variation among mothers and years. This study demonstrates that, in long-lived polytocous species, environmental factors may have a greater influence on natal features than previously supposed and the influence from biological factors is also complex. The documented responses to environmental influences provide unique insights into how mammalian seasonal reproductive dynamics may respond to current changes in climate.	[Wolcott, Daniel M.; Weckerly, Floyd W.] Texas State Univ, Dept Biol, San Marcos, TX 78666 USA; [Reitz, Ryan L.] Texas Parks & Wildlife Dept, Kerr Wildlife Management Area, Hunt, TX USA	Texas State University System; Texas State University San Marcos	Wolcott, DM (corresponding author), Texas State Univ, Dept Biol, San Marcos, TX 78666 USA.	dmw5@txstate.edu			Texas Parks and Wildlife Department; Kerr Wildlife Management Area	Texas Parks and Wildlife Department; Kerr Wildlife Management Area	We thank the Texas Parks and Wildlife Department and Kerr Wildlife Management Area for establishing the Donnie E. Harmel White-tailed Deer Research Facility and for continued funding and support of research at the Kerr Wildlife Management Area. Specifically, we thank Donnie Harmel and Donnie Frels for providing the dataset for these analyses. We also thank the many Texas Parks and Wildlife Department employees, technicians, and volunteers who aided in the collection of this data. We appreciate R. T. Bowyer's and Paul L. Leberg's review of an earlier draft of the manuscript.	Ahrestani FS, 2012, OIKOS, V121, P1300, DOI 10.1111/j.1600-0706.2011.20244.x; Aiken MRE, 2014, CAN J ZOOL, V92, P637, DOI 10.1139/cjz-2013-0232; Bardsen BJ, 2008, ECOLOGY, V89, P829, DOI 10.1890/07-0414.1; Bardsen BJ, 2010, OECOLOGIA, V162, P627, DOI 10.1007/s00442-009-1537-0; Bartoskewitz ML, 2003, WILDLIFE SOC B, V31, P1218; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Beier P., 1990, Wildlife Monographs; BERGER J, 1992, ECOLOGY, V73, P323, DOI 10.2307/1938743; Bowyer RT, 1998, J MAMMAL, V79, P1332, DOI 10.2307/1383025; Bronson FH, 2009, PHILOS T R SOC B, V364, P3331, DOI 10.1098/rstb.2009.0140; Bunnell FL, 1982, CAN J ZOOL, V58, P1027; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Churkina G, 1998, ECOSYSTEMS, V1, P206, DOI 10.1007/s100219900016; Clements MN, 2011, FUNCT ECOL, V25, P691, DOI 10.1111/j.1365-2435.2010.01812.x; Clutton-Brock TH., 1982, RED DEER BEHAV ECOLO; CLUTTONBROCK TH, 1984, AM NAT, V123, P212, DOI 10.1086/284198; CLUTTONBROCK TH, 1983, J ANIM ECOL, V52, P367, DOI 10.2307/4560; Cook JG, 2004, WILDLIFE MONOGR, P1; Cote SD, 2001, OECOLOGIA, V127, P230, DOI 10.1007/s004420000584; Ditchkoff SS, 2011, BIOLOGY AND MANAGEMENT OF WHITE-TAILED DEER, P43; Dye MP, 2012, WILDLIFE SOC B, V36, P107, DOI 10.1002/wsb.98; Festa-Bianchet M, 1996, CAN J ZOOL, V75, P1372; FESTABIANCHET M, 1988, J ZOOL, V214, P653, DOI 10.1111/j.1469-7998.1988.tb03764.x; FestaBianchet M, 1996, CAN J ZOOL, V74, P330, DOI 10.1139/z96-041; Gaillard JM, 2000, ANNU REV ECOL SYST, V31, P367, DOI 10.1146/annurev.ecolsys.31.1.367; GAILLARD JM, 1993, J ANIM ECOL, V62, P778; Gilbert BA, 2004, J WILDLIFE MANAGE, V68, P120, DOI 10.2193/0022-541X(2004)068[0120:RDOBDI]2.0.CO;2; GUINNESS FE, 1978, J ANIM ECOL, V47, P817, DOI 10.2307/3673; GUINNESS FE, 1978, J REPROD FERTIL, V54, P325, DOI 10.1530/jrf.0.0540325; Hamel S, 2009, J ANIM ECOL, V78, P143, DOI 10.1111/j.1365-2656.2008.01459.x; Haskell SP, 2008, J MAMMAL, V89, P448, DOI 10.1644/07-MAMM-A-127R.1; Hewison AJM, 2001, J ANIM ECOL, V70, P600, DOI 10.1046/j.1365-2656.2001.00528.x; Holand O, 2004, BEHAV ECOL SOCIOBIOL, V57, P69, DOI 10.1007/s00265-004-0827-0; Korsten P, 2009, BIOL LETTERS, V5, P663, DOI 10.1098/rsbl.2009.0366; Kuhl A, 2007, P ROY SOC B-BIOL SCI, V274, P1293, DOI 10.1098/rspb.2007.0038; Langvatn R, 2004, AM NAT, V163, P763, DOI 10.1086/383594; LILLIEFORS HW, 1967, J AM STAT ASSOC, V62, P399, DOI 10.2307/2283970; Lockwood MA, 2007, J WILDLIFE MANAGE, V71, P2732, DOI 10.2193/2005-517; Loison A, 2005, BEHAV ECOL, V16, P624, DOI 10.1093/beheco/ari037; Mazerolle MJ, 2014, R PACKAGE VERSION 2; Monteith KL, 2014, WILDLIFE MONOGR, V186, P1, DOI 10.1002/wmon.1011; Monteith KL, 2013, J ANIM ECOL, V82, P377, DOI 10.1111/1365-2656.12016; Mysterud A, 2009, J ANIM ECOL, V78, P1002, DOI 10.1111/j.1365-2656.2009.01553.x; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Nilsen EB, 2004, J ANIM ECOL, V73, P44, DOI 10.1111/j.1365-2656.2004.00790.x; Nussey DH, 2006, ECOL LETT, V9, P1342, DOI 10.1111/j.1461-0248.2006.00989.x; Nussey DH, 2011, ECOLOGY, V92, P1936, DOI 10.1890/11-0308.1; Parra CA, 2014, CAN J ZOOL, V92, P273, DOI 10.1139/cjz-2013-0201; Pekins PJ, 1998, CAN J ZOOL, V76, P1091, DOI 10.1139/cjz-76-6-1091; Pinheiro J, 2000, MIXED EFFECTS MODELS; Post E, 2003, CAN J ZOOL, V81, P1709, DOI 10.1139/Z03-172; Post E, 2008, PHILOS T R SOC B, V363, P2369, DOI 10.1098/rstb.2007.2207; R Core Team, 2021, R LANGUAGE ENV STAT; RACHLOW JL, 1991, J MAMMAL, V72, P487, DOI 10.2307/1382131; ROBBINS CT, 1975, J WILDLIFE MANAGE, V39, P355, DOI 10.2307/3799914; ROBBINS CT, 1979, AM NAT, V114, P101, DOI 10.1086/283456; ROBINETTE WL, 1973, J WILDLIFE MANAGE, V37, P312, DOI 10.2307/3800121; RUTBERG AT, 1984, J MAMMAL, V65, P418, DOI 10.2307/1381088; Ryan BC, 2002, NEUROSCI BIOBEHAV R, V26, P665, DOI 10.1016/S0149-7634(02)00038-6; Stewart KM, 2005, OECOLOGIA, V143, P85, DOI 10.1007/s00442-004-1785-y; VERME LJ, 1989, J MAMMAL, V70, P438, DOI 10.2307/1381538; VERME LOUIS J., 1965, J WILDLIFE MANAGE, V29, P74, DOI 10.2307/3798633; Weladji RB, 2006, P ROY SOC B-BIOL SCI, V273, P1239, DOI 10.1098/rspb.2005.3393; Weladji RB, 2010, OECOLOGIA, V162, P261, DOI 10.1007/s00442-009-1443-5; Wolcott DM, 2014, J WILDLIFE MANAGE, V78, P1335, DOI 10.1002/jwmg.777; Zerbe P, 2012, BIOL REV, V87, P965, DOI 10.1111/j.1469-185X.2012.00238.x	66	17	17	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124431	10.1371/journal.pone.0124431	http://dx.doi.org/10.1371/journal.pone.0124431			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885545	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000126
J	Zhang, XX; Liu, L; Zhao, X; Zheng, J; Yang, M; Zhang, JQ				Zhang, Xiao-xiao; Liu, Li; Zhao, Xian; Zheng, Jian; Yang, Meng; Zhang, Ji-qi			Towards a Three-Component Model of Fan Loyalty: A Case Study of Chinese Youth	PLOS ONE			English	Article							CUSTOMER LOYALTY; ONLINE; SATISFACTION; CONSUMPTION; COMMUNITY; IMAGE	The term "fan loyalty" refers to the loyalty felt and expressed by a fan towards the object of his/her fanaticism in both everyday and academic discourses. However, much of the literature on fan loyalty has paid little attention to the topic from the perspective of youth pop culture. The present study explored the meaning of fan loyalty in the context of China. Data were collected by the method of in-depth interviews with 16 young Chinese people aged between 19 and 25 years who currently or once were pop fans. The results indicated that fan loyalty entails three components: involvement, satisfaction, and affiliation. These three components regulate the process of fan loyalty development, which can be divided into four stages: inception, upgrade, zenith, and decline. This model provides a conceptual explanation of why and how young Chinese fans are loyal to their favorite stars. The implications of the findings are discussed.	[Zhang, Xiao-xiao; Liu, Li; Zhao, Xian; Zheng, Jian; Yang, Meng; Zhang, Ji-qi] Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China; [Zhao, Xian] Univ Kansas, Dept Psychol, Lawrence, KS 66045 USA	Beijing Normal University; University of Kansas	Liu, L (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing Key Lab Appl Expt Psychol, Beijing 100875, Peoples R China.	l.liu@bnu.edu.cn	Liu, Li/T-6645-2017	Liu, Li/0000-0002-4898-3013	National Natural Science Foundation of China [71071021]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This research was supported by the National Natural Science Foundation of China (71071021), and the Fundamental Research Funds for the Central Universities awarded to Li Liu. The funders had no role in study design, data collection, the decision to publish, or the preparation of the manuscript.	Algesheimer R, 2005, J MARKETING, V69, P19, DOI 10.1509/jmkg.69.3.19.66363; [Anonymous], 2007, SHANGHAI DAILY; [Anonymous], 1972, SOCIOLOGICAL THEORIE; Bauer HH, 2008, J SPORT MANAGE, V22, P205, DOI 10.1123/jsm.22.2.205; Bierstedt R., 1964, EXCHANGE POWER SOCIA; BLOCH PH, 1983, J MARKETING, V47, P69, DOI 10.2307/1251198; Bolton RN, 1998, MARKET SCI, V17, P45, DOI 10.1287/mksc.17.1.45; Casalo LV, 2010, INT J INFORM MANAGE, V30, P357, DOI 10.1016/j.ijinfomgt.2010.01.004; Chen P, 2004, SPORT CLUB UNDERSTAN, P1; Chen P. J., 2006, Journal of Sport Tourism, V11, P201, DOI 10.1080/14775080701400620; Chung E., 2007, 2007 AUSTR NZ MARK A; Chung E, 2005, P ANZMAC 2005 PERTH; CIALDINI RB, 1976, J PERS SOC PSYCHOL, V34, P366, DOI 10.1037//0022-3514.34.3.366; Clarke K., 1979, ADV CONSUMER RES, V6, P313; Corbin Juliet M., 2007, BASICS QUALITATIVE R; CROSBY LA, 1987, J MARKETING RES, V24, P404, DOI 10.1177/002224378702400408; Crouch M, 2006, SOC SCI INFORM, V45, P483, DOI 10.1177/0539018406069584; De Wever B, 2006, COMPUT EDUC, V46, P6, DOI 10.1016/j.compedu.2005.04.005; Depken C. A., 2000, Journal of Sports Economics, V1, P124; Duck S.W., 1982, PERS RELATIONSHIP, V4, P1; Duff PA, 2002, J ADOLESC ADULT LIT, V45, P482; Ehrenreich Barbara, 1992, ADORING AUDIENCE FAN, P84; Flick U., 2000, QUALITATIVE RES TEXT, DOI [10.4135/9781849209731.n5, DOI 10.4135/9781849209731.N5]; Fung AYH, 2009, EUR J CULT STUD, V12, P285, DOI 10.1177/1367549409105365; Gee Louise, 2003, Health Qual Life Outcomes, V1, P31, DOI 10.1186/1477-7525-1-31; Giles DC, 2004, PERS INDIV DIFFER, V36, P813, DOI 10.1016/S0191-8869(03)00154-5; Giles DC, 2002, MEDIA PSYCHOL, V4, P279, DOI 10.1207/S1532785XMEP0403_04; Giulianotti R., 2002, Journal of Sport & Social Issues, V26, P25, DOI 10.1177/0193723502261003; Glaser B.G, 1978, THEORETICAL SENSITIV; Gounaris S., 2004, J BRAND MANAG, V11, P283, DOI DOI 10.1057/PALGRAVE.BM.2540174; GREENE AL, 1990, SEX ROLES, V23, P335, DOI 10.1007/BF00289224; Gwinner K., 2003, J SERV MARK, V17, P275, DOI [DOI 10.1108/08876040310474828, https://doi.org/10.1108/08876040310474828]; Harrington CL, 2010, INT J CULTURAL STUD, V13, P429, DOI 10.1177/1367877910372702; Hills M, 2005, AM BEHAV SCI, V48, P801, DOI 10.1177/0002764204273169; HOMANS GC, 1961, SOCIAL BEHAV ITS ELE; Hong J. B., 2005, International Journal of Sport Management and Marketing, V1, P141, DOI 10.1504/IJSMM.2005.007126; Houston M. J., 1978, RES FRONTIERS MARKET, V184, P262; Jacoby J., 1978, BRAND LOYALTY MEASUR; KBS, 2009, TVXQ GUINN WORLD REC; Kim WG, 2004, TOURISM MANAGE, V25, P343, DOI 10.1016/S0261-5177(03)00142-0; Kozinets RV, 2001, J CONSUM RES, V28, P67, DOI 10.1086/321948; Kumar V, 2004, J RETAILING, V80, P317, DOI 10.1016/j.jretai.2004.10.007; Lastovicka J.L., 1978, ADV CONSUM RES, V5, P87; Lin YT, 2007, THESIS LYNN U; Mahony D. F., 2000, SPORT MARKET Q, V9, P15; Maltby J, 2006, PERS INDIV DIFFER, V40, P273, DOI 10.1016/j.paid.2005.07.004; Maltby J, 2003, J NERV MENT DIS, V191, P25, DOI 10.1097/00005053-200301000-00005; Maltby J., 2001, N AM J PSYCHOL, V3, P441; Meyer MDE, 2012, COMMUN STUD, V63, P263, DOI 10.1080/10510974.2012.684291; Neale L, 2010, CONTINUUM-J MEDIA CU, V24, P905, DOI 10.1080/10304312.2010.510596; Oliver RL, 1999, J MARKETING, V63, P33, DOI 10.2307/1252099; PARK CW, 1986, J MARKETING, V50, P135, DOI 10.2307/1251291; Pimentel R., 2004, ACAD MARK REV, V5; Pratt MK, 2010, M JACKSON KING POP; Red Cross Society of China, 2006, CHIN RED CROSS FDN D; Riley A, 2005, J YOUTH STUD, V8, P297, DOI DOI 10.1080/13676260500261892; Roberts S. D., 2003, J MARKETING THEORY P, V11, P1, DOI DOI 10.1080/10696679.2003.11658504; RUBIN RB, 1987, J BROADCAST ELECTRON, V31, P279; Sandvoss C, 2005, AM BEHAV SCI, V48, P822, DOI 10.1177/0002764204273170; Sansone RA, 2014, INNOVATIONS CLIN NEU, V11, P39; Shankar V, 2003, INT J RES MARK, V20, P153, DOI 10.1016/S0167-8116(03)00016-8; Sherrell D. L., 2010, J MANAGEMENT MARKETI, V3, P1; Showbiz B, 2009, ONE MILLION FANS EXP; Stever G., 2009, J MEDIA PSYCHOL-GER, V14, P1; STEVER GS, 1991, PSYCHOL REP, V68, P859, DOI 10.2466/PR0.68.3.859-866; Strauss AL., 1987, QUALITATIVE ANAL SOC, Vxv, P319; Tao DF, 2009, FAN CULTURES READER; Tulloch John, 1995, SCI FICTION AUDIENCE; Turner J. C., 1975, EUROPEAN J SOCIAL PS, V5, P1, DOI [10.1002/ejsp.2420050102, DOI 10.1002/EJSP.2420050102]; WRIGHT PL, 1973, J MARKETING RES, V10, P53, DOI 10.2307/3149409; Zeisler Andi., 2008, FEMINISM POP CULTURE, P121	71	13	15	7	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124312	10.1371/journal.pone.0124312	http://dx.doi.org/10.1371/journal.pone.0124312			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886557	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000114
J	Wang, JX; He, LY; Jia, LP; Tian, J; Benson, V				Wang, Jingxin; He, Liyuan; Jia, Liping; Tian, Jing; Benson, Valerie			The 'Positive Effect' Is Present in Older Chinese Adults: Evidence from an Eye Tracking Study	PLOS ONE			English	Article							CULTURAL VARIATION; NEGATIVE IMAGES; MEMORY; AGE; MOVEMENTS; COGNITION; EMOTION	The 'Positive Effect'is defined as the phenomenon of preferential cognitive processing of positive affective information, and avoidance or dismissal of negative affective information in the social environment. The 'Positive Effect'is found for older people compared with younger people in western societies and is believed to reflect a preference for positive emotional regulation in older adults. It is not known whether such an effect is Universal, and in East Asian cultures, there is a highly controversial debate concerning this question. In the current experiment we explored whether Chinese older participants showed a 'Positive Effect' when they inspected picture pairs that were either a positive or a negative picture presented with a neutral picture, or a positive and negative picture paired together. The results indicated that both groups of participants showed an attentional bias to both pleasant (more processing of) and unpleasant pictures (initial orienting to) when these were paired with neutral pictures. When pleasant and unpleasant pictures were paired together both groups showed an initial orientation bias for the pleasant picture, but the older participants showed this bias for initial orienting and increased processing measures, providing evidence of a 'Positive Effect'in older Chinese adults.	[Wang, Jingxin; He, Liyuan; Jia, Liping; Tian, Jing] Tianjin Normal Univ, Acad Psychol & Behav, Tianjin, Peoples R China; [Benson, Valerie] Univ Southampton, Sch Psychol, Ctr Visual Cognit, Southampton, Hants, England	Tianjin Normal University; University of Southampton	Benson, V (corresponding author), Univ Southampton, Sch Psychol, Ctr Visual Cognit, Southampton, Hants, England.	Vb1@soton.ac.uk	Jia, li/GPW-8015-2022; li, jia/GVT-7587-2022	Benson, Valerie/0000-0002-0351-4563	Chinese Department of Education Social Science Key Research Grant [13JJD190005]	Chinese Department of Education Social Science Key Research Grant	The study was funded by an award to Dr Jingxin Wang from the Chinese Department of Education Social Science Key Research Grant - 13JJD190005. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Carstensen L.L., 2006, HDB PSYCHOL AGING, P343, DOI DOI 10.1016/B978-012101264-9/50018-5; Carstensen LL, 2005, CURR DIR PSYCHOL SCI, V14, P117, DOI 10.1111/j.0963-7214.2005.00348.x; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles S. T., 2003, J EXP PSYCHOL, V85, P163; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Chua HF, 2005, P NATL ACAD SCI USA, V102, P12629, DOI 10.1073/pnas.0506162102; Chung C, 2012, INT J AGING HUM DEV, V75, P31, DOI 10.2190/AG.75.1.d; Diener E, 2003, ANNU REV PSYCHOL, V54, P403, DOI 10.1146/annurev.psych.54.101601.145056; Fung HH, 2008, PSYCHOL AGING, V23, P440, DOI 10.1037/0882-7974.23.2.440; Gruhn D, 2007, PSYCHOL AGING, V22, P644, DOI 10.1037/0882-7974.22.3.644; Gruhn D, 2005, PSYCHOL AGING, V20, P579, DOI 10.1037/0882-7974.20.4.579; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Kennedy Q, 2004, PSYCHOL SCI, V15, P208, DOI 10.1111/j.0956-7976.2004.01503011.x; Ko SG, 2011, PSYCHOL AGING, V26, P48, DOI 10.1037/a0020222; Kwon Y, 2009, PSYCHOL AGING, V24, P748, DOI 10.1037/a0016054; Leigland LA, 2004, NEUROBIOL AGING, V25, P1117, DOI 10.1016/j.neurobiolaging.2003.10.015; Liversedge SP, 2000, TRENDS COGN SCI, V4, P6, DOI 10.1016/S1364-6613(99)01418-7; Masuda T, 2001, J PERS SOC PSYCHOL, V81, P922, DOI 10.1037//0022-3514.81.5.922; Mather M, 2000, PSYCHOL AGING, V15, P596, DOI 10.1037/0882-7974.15.4.596; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Nummenmaa L, 2006, EMOTION, V6, P257, DOI 10.1037/1528-3542.6.2.257; Qiu L., 2008, APPL PSYCHOL, P249, DOI 10.1093/molbev/msx285/4596561; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Scheibe S, 2009, PSYCHOL AGING, V24, P217, DOI 10.1037/a0013807; Tsai JL, 2006, J PERS SOC PSYCHOL, V90, P288, DOI 10.1037/0022-3514.90.2.288; Wang JX, 2010, CONSTRUCTION MANAGEM, V8, P61; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Yarbus A.L., 1967, EYE MOVEMENTS VISION, DOI 10.1007/978-1-4899-5379-7	32	5	6	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121372	10.1371/journal.pone.0121372	http://dx.doi.org/10.1371/journal.pone.0121372			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25880585	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500010
J	Alba, A; Dorea, FC; Arinero, L; Sanchez, J; Cordon, R; Puig, P; Revie, CW				Alba, Anna; Dorea, Fernanda C.; Arinero, Lucas; Sanchez, Javier; Cordon, Ruben; Puig, Pere; Revie, Crawford W.			Exploring the Surveillance Potential of Mortality Data: Nine Years of Bovine Fallen Stock Data Collected in Catalonia (Spain)	PLOS ONE			English	Article							OUTBREAK	The potential of fallen stock data to monitor the health status of animal populations has been noted in previous studies. However, further research is required to implement these systems for surveillance. This work presents a novel approach to determining the baselines associated with bovine fallen stock, comparing patterns between subpopulations and identifying subpopulations in which an abnormal event may occur. This study was based on data from 193,873 disposal visits carried out between 2004 and 2012 across a total of 2,991 bovine farms. Proxy measurements such as the number of collections carried out and the weight of carcasses collected were used. Both outcomes were aggregated weekly at different geographical scales for three production types (beef cattle, dairy cattle and heifer fattening). The analysis of these data combined autoregressive integrated moving average modelling and hierarchical time series methods. The three production types exhibited historical baselines that differed notably from one another. Based on the 757 beef cattle farms monitored, the mean number of collections registered per week at the regional level was 37 (range: 10-83). This series was relatively constant over time and showed a marked yearly seasonality. In contrast, for the 426 dairy cattle farms the mean number of disposal visits registered weekly was 121 (range: 71-180), showing half-yearly and yearly seasonality and a marked increase over the period monitored. From the 1,808 heifer fattening farms the mean number of disposal visits was 248 (range: 166-357) and the pattern presented a marked alternating trend over time. These patterns were assessed and compared at regional, provincial, county and municipal levels. The use of hierarchical time series approaches appeared to be a useful tool for comparing the patterns within different subpopulations over time as well as for assessing the spatial extent to which various abnormal events could be detected.	[Alba, Anna; Cordon, Ruben] IRTA, CReSA, Barcelona 08193, Spain; [Dorea, Fernanda C.] Natl Vet Inst SVA, Dept Dis Control & Epidemiol, Uppsala, Sweden; [Arinero, Lucas] Govt Catalonia, Minist Agr Livestock Fisheries Food & Nat Environ, Barcelona, Spain; [Sanchez, Javier] UPEI, AVC, Ctr Vet Epidemiol Res, Charlottetown, PE, Canada; [Puig, Pere] Univ Autonoma Barcelona, Dept Matemat, E-08193 Barcelona, Spain	IRTA; National Veterinary Institute SVA; University of Prince Edward Island; Autonomous University of Barcelona	Alba, A (corresponding author), IRTA, CReSA, Campus UAB, Barcelona 08193, Spain.	ana.alba@cresa.uab.es	Puig, Pedro/K-4414-2014; sanchez, javier/AAA-4179-2022; Revie, Crawford/B-5002-2011	Puig, Pedro/0000-0002-6607-9642; Revie, Crawford/0000-0002-5018-0340; Dorea, Fernanda/0000-0001-8638-8525				Backer JA, 2011, PREV VET MED, V99, P38, DOI 10.1016/j.prevetmed.2010.10.008; Benschop J, 2008, EPIDEMIOL INFECT, V136, P1511, DOI 10.1017/S0950268807000234; Biswas PK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098471; Chatfield Ch, 2004, THE ANALYSIS OF TIME, P33; Cowpertwait PSP, 2009, USE R, P1, DOI 10.1007/978-0-387-88698-5_1; Dorea FC, 2014, PREV VET MED, V116, P313, DOI 10.1016/j.prevetmed.2014.04.001; Dorea FC, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0114; Dorea FC, 2011, PREV VET MED, V101, P1, DOI 10.1016/j.prevetmed.2011.05.004; Dupuy C, 2013, PREV VET MED, V111, P220, DOI 10.1016/j.prevetmed.2013.06.005; HILLERS JK, 1984, J DAIRY SCI, V67, P861, DOI 10.3168/jds.S0022-0302(84)81378-8; Hyndman RJ, 2013, HTS AN R PACKAGE FOR; Hyndman RJ, 2011, COMPUT STAT DATA AN, V55, P2579, DOI 10.1016/j.csda.2011.03.006; Lee HS, 2013, PREV VET MED, V110, P190, DOI 10.1016/j.prevetmed.2012.12.003; Morignat E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093176; Morina D, 2011, STAT MED, V30, P3125, DOI 10.1002/sim.4336; Neumann EJ, 2014, NEW ZEAL VET J, V62, P110, DOI 10.1080/00480169.2013.853278; Perrin JB, 2012, PREV VET MED, V105, P244, DOI 10.1016/j.prevetmed.2011.12.015; Perrin JB, 2010, EPIDEMICS-NETH, V2, P207, DOI 10.1016/j.epidem.2010.10.002; R Core Team, 2021, R LANGUAGE ENV STAT; Roy JHB, 1980, STUDIES IN THE AGRIC, P67; Seegers H, 1998, J NATL GTV, P57; Skvortsov A, 2012, MATH BIOSCI, V240, P12, DOI 10.1016/j.mbs.2012.05.010; UAB-Produccio Animal. Fac.Veterinaria, 2013, MANUAL DE PRODUCCIO; Van der Loo MPJ, 2012, LEARNING R STUDIO FO; Van Horn HH, 1992, LARGE DAIRY HERD MAN, P597; Vial F, 2014, BMC VET RES, V10, DOI 10.1186/1746-6148-10-33	27	16	17	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122547	10.1371/journal.pone.0122547	http://dx.doi.org/10.1371/journal.pone.0122547			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876036	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000353015800063
J	Krasnow, MM; Delton, AW; Cosmides, L; Tooby, J				Krasnow, Max M.; Delton, Andrew W.; Cosmides, Leda; Tooby, John			Group Cooperation without Group Selection: Modest Punishment Can Recruit Much Cooperation	PLOS ONE			English	Article							STRONG RECIPROCITY; PUBLIC-GOODS; CONFORMIST TRANSMISSION; SIZABLE GROUPS; EVOLUTION; FAIRNESS; GAMES; ENFORCEMENT; EMERGENCE; ALTRUISM	Humans everywhere cooperate in groups to achieve benefits not attainable by individuals. Individual effort is often not automatically tied to a proportionate share of group benefits. This decoupling allows for free-riding, a strategy that (absent countermeasures) outcompetes cooperation. Empirically and formally, punishment potentially solves the evolutionary puzzle of group cooperation. Nevertheless, standard analyses appear to show that punishment alone is insufficient, because second-order free riders (those who cooperate but do not punish) can be shown to outcompete punishers. Consequently, many have concluded that other processes, such as cultural or genetic group selection, are required. Here, we present a series of agent-based simulations that show that group cooperation sustained by punishment easily evolves by individual selection when you introduce into standard models more biologically plausible assumptions about the social ecology and psychology of ancestral humans. We relax three unrealistic assumptions of past models. First, past models assume all punishers must punish every act of free riding in their group. We instead allow punishment to be probabilistic, meaning punishers can evolve to only punish some free riders some of the time. This drastically lowers the cost of punishment as group size increases. Second, most models unrealistically do not allow punishment to recruit labor; punishment merely reduces the punished agent's fitness. We instead realistically allow punished free riders to cooperate in the future to avoid punishment. Third, past models usually restrict agents to interact in a single group their entire lives. We instead introduce realistic social ecologies in which agents participate in multiple, partially overlapping groups. Because of this, punitive tendencies are more expressed and therefore more exposed to natural selection. These three moves toward greater model realism reveal that punishment and cooperation easily evolve by direct selection-even in sizeable groups.	[Krasnow, Max M.] Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA; [Delton, Andrew W.] SUNY Stony Brook, Coll Business, Ctr Behav Polit Econ, Dept Polit Sci, Stony Brook, NY 11794 USA; [Cosmides, Leda; Tooby, John] Univ Calif Santa Barbara, Ctr Evolutionary Psychol, Santa Barbara, CA 93106 USA; [Cosmides, Leda] Univ Calif Santa Barbara, Dept Psychol & Brain Sci, Santa Barbara, CA 93106 USA; [Tooby, John] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA	Harvard University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Krasnow, MM (corresponding author), Harvard Univ, Dept Psychol, Cambridge, MA 02138 USA.	krasnow@fas.harvard.edu			National Institutes of Health; National Science Foundation [0951597]; John Templeton Foundation [29468]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); John Templeton Foundation	This research was made possible by a National Institutes of Health Director's Pioneer Award to LC (http://www.nih.gov/), National Science Foundation grant #0951597 to LC and JT (http://www.nsf.gov/), and John Templeton Foundation grant #29468 (http://www.templeton.org/). The opinions expressed in this publication are those of the authors and do not necessarily reflect the views of the John Templeton Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1965, LOGIC COLLECTIVE ACT; Barclay P, 2004, EVOL HUM BEHAV, V25, P209, DOI 10.1016/j.evolhumbehav.2004.04.002; Baumard N, 2013, BEHAV BRAIN SCI, V36, P59, DOI 10.1017/S0140525X11002202; Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; BOYD R, 1992, ETHOL SOCIOBIOL, V13, P171, DOI 10.1016/0162-3095(92)90032-Y; Brandt H, 2003, P ROY SOC B-BIOL SCI, V270, P1099, DOI 10.1098/rspb.2003.2336; Cimino A, 2011, J COGN CULT, V11, P241, DOI 10.1163/156853711X591242; Cimino A, 2010, HUM NATURE-INT BIOS, V21, P186, DOI 10.1007/s12110-010-9088-y; CLUTTONBROCK TH, 1995, NATURE, V373, P209, DOI 10.1038/373209a0; Cosmides L, 2010, P NATL ACAD SCI USA, V107, P9007, DOI 10.1073/pnas.0914623107; Delton AW, 2015, MORAL BRAIN: A MULTIDISCIPLINARY PERSPECTIVE, P19; Delton AW, 2014, CURR DIR PSYCHOL SCI, V23, P115, DOI 10.1177/0963721414521631; Delton AW, 2013, J PERS SOC PSYCHOL, V105, P621, DOI 10.1037/a0033495; Delton AW, 2012, J PERS SOC PSYCHOL, V102, P1252, DOI 10.1037/a0027026; Delton AW, 2010, EVOL PSYCHOL-US, V8, P317; Delton AW, 2010, SCIENCE, V329, P389, DOI 10.1126/science.329.5990.389-a; Delton AW, 2011, P NATL ACAD SCI US; Dos Santos M, 2014, EVOL HUM BEHAV, DOI [10.1016/j.evolhumbehav.2014.09.001, DOI 10.1016/J.EV0LHUMBEHAV.2014.09.001]; Fehr E, 2002, HUM NATURE-INT BIOS, V13, P1, DOI 10.1007/s12110-002-1012-7; Fehr E, 2003, DAHL WS ENV, P55; Fehr E, 2000, AM ECON REV, V90, P980, DOI 10.1257/aer.90.4.980; Gallistel C. R., 1990, ORG LEARNING; Gintis H, 2000, J THEOR BIOL, V206, P169, DOI 10.1006/jtbi.2000.2111; Gurven M, 2004, BEHAV BRAIN SCI, V27, P543, DOI 10.1017/S0140525X04000123; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Hagen EH, 2003, HUM NATURE-INT BIOS, V14, P21, DOI 10.1007/s12110-003-1015-z; Hauert C, 2004, DISCRETE CONT DYN-B, V4, P575; Hauert C, 2007, SCIENCE, V316, P1905, DOI 10.1126/science.1141588; Henrich J, 1998, EVOL HUM BEHAV, V19, P215, DOI 10.1016/S1090-5138(98)00018-X; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Henrich J, 2001, J THEOR BIOL, V208, P79, DOI 10.1006/jtbi.2000.2202; Henrich J, 2010, SCIENCE, V327, P1480, DOI 10.1126/science.1182238; Kiyonari T, 2008, J PERS SOC PSYCHOL, V95, P826, DOI 10.1037/a0011381; Krasnow M. M., BEHAV BRAIN IN PRESS; Krasnow MM, 2013, SCI REP-UK, V3, DOI 10.1038/srep01747; Krasnow MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045662; Krasnow MM, 2011, EVOL HUM BEHAV, V32, P1, DOI 10.1016/j.evolhumbehav.2010.07.003; Lamba S, 2011, P NATL ACAD SCI USA, V108, P14426, DOI 10.1073/pnas.1105186108; Mathew S, 2009, P R SOC B, V276, P1167, DOI 10.1098/rspb.2008.1623; McKelvey RD, 2000, J ECON BEHAV ORGAN, V42, P523, DOI 10.1016/S0167-2681(00)00102-5; Ostrom E., 1990, GOVERNING COMMONS EV; Rand DG, 2010, J THEOR BIOL, V265, P624, DOI 10.1016/j.jtbi.2010.06.010; Sasaki T, 2014, BIOL LETTERS, V10, DOI 10.1098/rsbl.2013.0903; Sell A, 2009, P NATL ACAD SCI USA, V106, P15073, DOI 10.1073/pnas.0904312106; Sigmund K, 2001, P NATL ACAD SCI USA, V98, P10757, DOI 10.1073/pnas.161155698; Sigmund K, 2010, NATURE, V466, P861, DOI 10.1038/nature09203; Silva AS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1435; Stephens D., 2007, FORAGING BEHAV ECOLO; Takezawa M, 2010, J THEOR BIOL, V264, P188, DOI 10.1016/j.jtbi.2010.01.028; Tooby J, 2006, MANAG DECIS ECON, V27, P103, DOI 10.1002/mde.1287; YAMAGISHI T, 1986, J PERS SOC PSYCHOL, V51, P110, DOI 10.1037/0022-3514.51.1.110; YAMAGISHI T, 1988, J EXP SOC PSYCHOL, V24, P530, DOI 10.1016/0022-1031(88)90051-0; Yamagishi T, 2000, SOC PSYCHOL QUART, V63, P116, DOI 10.2307/2695887	53	20	20	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124561	10.1371/journal.pone.0124561	http://dx.doi.org/10.1371/journal.pone.0124561			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893241	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700104
J	Lin, CY; Huang, Z; Wen, W; Wu, A; Wang, CZ; Niu, L				Lin, Chi-Yen; Huang, Zhen; Wen, Wei; Wu, Andrew; Wang, Congzhou; Niu, Li			Enhancing Protein Expression in HEK-293 Cells by Lowering Culture Temperature	PLOS ONE			English	Article							MONOCLONAL-ANTIBODY PRODUCTION; INTERFERON-GAMMA PRODUCTION; HIGH-LEVEL EXPRESSION; HYPOTHERMIC GROWTH; MAMMALIAN-CELLS; AMPA RECEPTOR; CHO-CELLS; PRODUCTIVITY; KINETICS; MOUSE	Animal cells and cell lines, such as HEK-293 cells, are commonly cultured at 37 degrees C. These cells are often used to express recombinant proteins. Having a higher expression level or a higher protein yield is generally desirable. As we demonstrate in this study, dropping culture temperature to 33 degrees C, but not lower, 24 hours after transient transfection in HEK-293S cells will give rise to similar to 1.5-fold higher expression of green fluorescent protein (GFP) and a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors. By following the time course of the GFP-expressing cells growing at 37 degrees C and 33 degrees C from 24 hours after transfection (including 19 hours recovery at 37 degrees C in the normal growth medium), we found that a mild hypothermia (i.e., 33 degrees C) reduces the growth rate of HEK-293S cells, while increasing cellular productivity of recombinant proteins. As a result, green cells remain undivided in a longer period of time. Not surprisingly, the property of a recombinant protein expressed in the cells grown at 33 degrees C is unaffected, as shown by the use of AMPA receptors. We further demonstrate with the use of PC12 cells that this method may be especially useful when a recombinant protein is difficult to express using a chemical-based, transient transfection method.	[Niu, Li] SUNY Albany, Dept Chem, Albany, NY 12222 USA; SUNY Albany, Ctr Neurosci Res, Albany, NY 12222 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Niu, L (corresponding author), SUNY Albany, Dept Chem, Albany, NY 12222 USA.	lniu@albany.edu		Wen, Wei/0000-0003-1422-856X	National Institutes of Health/National Institute of Neurological Disorders and Stroke [RO1 NS060812]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060812] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	National Institutes of Health/National Institute of Neurological Disorders and Stroke RO1 NS060812 to Li Niu.	Ali SH, 2001, SEMIN CANCER BIOL, V11, P15, DOI 10.1006/scbi.2000.0342; ALRUBEAI M, 1990, J BIOTECHNOL, V16, P67, DOI 10.1016/0168-1656(90)90066-K; BARNABE N, 1994, BIOTECHNOL BIOENG, V44, P1235, DOI 10.1002/bit.260441011; BERG DT, 1993, BIOTECHNIQUES, V14, P972; BLOEMKOLK JW, 1992, BIOTECHNOL BIOENG, V40, P427, DOI 10.1002/bit.260400312; BORTH N, 1992, J BIOTECHNOL, V25, P319, DOI 10.1016/0168-1656(92)90164-5; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Dingledine R, 1999, PHARMACOL REV, V51, P7; Ducommun P, 2002, BIOTECHNOL BIOENG, V77, P838, DOI 10.1002/bit.10185; Fox SR, 2005, BIOTECHNOL APPL BIOC, V41, P265, DOI 10.1042/BA20040067; Fox SR, 2004, BIOTECHNOL BIOENG, V85, P177, DOI 10.1002/bit.10861; Furukawa K, 1998, CYTOTECHNOLOGY, V26, P153, DOI 10.1023/A:1007934216507; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Grau Cristina Malagelada, 2012, Methods Mol Biol, V846, P201, DOI 10.1007/978-1-61779-536-7_18; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Huang Z, 2005, J NEUROSCI METH, V142, P159, DOI 10.1016/j.jneumeth.2004.09.009; Kaufmann H, 1999, BIOTECHNOL BIOENG, V63, P573, DOI 10.1002/(SICI)1097-0290(19990605)63:5<573::AID-BIT7>3.0.CO;2-Y; Kim JY, 2012, APPL MICROBIOL BIOT, V93, P917, DOI 10.1007/s00253-011-3758-5; Lee JH, 2008, J TISSUE ENG REGEN M, V2, P288, DOI 10.1002/term.94; Li G, 2003, BIOCHEMISTRY-US, V42, P12358, DOI 10.1021/bi0347961; Pei WM, 2007, BIOCHEMISTRY-US, V46, P2027, DOI 10.1021/bi062213s; Penmatsa A, 2013, NATURE, V503, P85, DOI 10.1038/nature12533; RAO PN, 1965, SCIENCE, V148, P1092, DOI 10.1126/science.148.3673.1092; Reeves PJ, 2002, P NATL ACAD SCI USA, V99, P13413, DOI 10.1073/pnas.212519199; REUVENY S, 1986, J IMMUNOL METHODS, V86, P53, DOI 10.1016/0022-1759(86)90264-4; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; SEEBURG PH, 1993, TRENDS NEUROSCI, V16, P359, DOI 10.1016/0166-2236(93)90093-2; Standfuss J, 2007, J MOL BIOL, V372, P1179, DOI 10.1016/j.jmb.2007.03.007; Standfuss J, 2011, NATURE, V471, P656, DOI 10.1038/nature09795; STEINMAN RM, 1983, J CELL BIOL, V96, P1, DOI 10.1083/jcb.96.1.1; STILLMAN BW, 1985, MOL CELL BIOL, V5, P2051, DOI 10.1128/MCB.5.8.2051; Sunley K, 2008, BIOTECHNOL PROGR, V24, P898, DOI 10.1021/bp.9; Sunley K, 2010, BIOTECHNOL ADV, V28, P385, DOI 10.1016/j.biotechadv.2010.02.003; SURESHKUMAR GK, 1991, BIOTECHNOL BIOENG, V37, P292, DOI 10.1002/bit.260370313; Thomas Philip, 2005, Journal of Pharmacological and Toxicological Methods, V51, P187, DOI 10.1016/j.vascn.2004.08.014; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Trummer E, 2006, BIOTECHNOL BIOENG, V94, P1045, DOI 10.1002/bit.20958; UDGAONKAR JB, 1987, P NATL ACAD SCI USA, V84, P8758, DOI 10.1073/pnas.84.24.8758; Wang CZ, 2011, BIOCHEMISTRY-US, V50, P7284, DOI 10.1021/bi2007977; WATANABE I, 1967, J CELL BIOL, V32, P309, DOI 10.1083/jcb.32.2.309; WEIDEMANN R, 1994, CYTOTECHNOLOGY, V15, P111, DOI 10.1007/BF00762385; Yoon SK, 2003, BIOTECHNOL BIOENG, V82, P289, DOI 10.1002/bit.10566	47	37	38	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123562	10.1371/journal.pone.0123562	http://dx.doi.org/10.1371/journal.pone.0123562			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893827	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700043
J	Hoofs, H; Jansen, NWH; Mohren, DCL; Jansen, MWJ; Kant, IJ				Hoofs, H.; Jansen, N. W. H.; Mohren, D. C. L.; Jansen, M. W. J.; Kant, I. J.			The Context Dependency of the Self-Report Version of the Strength and Difficulties Questionnaire (SDQ): A Cross-Sectional Study between Two Administration Settings	PLOS ONE			English	Article							CONFIRMATORY FACTOR-ANALYSIS; OF-FIT INDEXES; MEASUREMENT INVARIANCE; MENTAL-HEALTH; PSYCHOMETRIC PROPERTIES; UNITED-STATES; CHILDREN; VALIDITY; ADOLESCENTS; COMMUNITY	Background The Strength and Difficulties Questionnaire (SDQ) is a screening instrument for psychosocial problems in children and adolescents, which is applied in "individual" and "collective" settings. Assessment in the individual setting is confidential for clinical applications, such as preventive child healthcare, while assessment in the collective setting is anonymous and applied in (epidemiological) research. Due to administration differences between the settings it remains unclear whether results and conclusions actually can be used interchangeably. This study therefore aims to investigate whether the SDQ is invariant across settings. Methods Two independent samples were retrieved (mean age = 14.07 years), one from an individual setting (N = 6,594) and one from a collective setting (N = 4,613). The SDQ was administered in the second year of secondary school in both settings. Samples come from the same socio-geographic population in the Netherlands. Results Confirmatory factor analysis showed that the SDQ was measurement invariant/equivalent across settings and gender. On average, children in the individual setting scored lower on total difficulties (mean difference = 2.05) and the psychosocial problems subscales compared to those in the collective setting. This was also reflected in the cut-off points for caseness, defined by the 90th percentiles, which were lower in the individual setting. Using cutoff points from the collective in the individual setting therefore resulted in a small number of cases, 2 to 3%, while similar to 10% is expected. Conclusion The SDQ has the same connotation across the individual and collective setting. The observed structural differences regarding the mean scores, however, undermine the validity of the cross-use of absolute SDQ-scores between these settings. Applying cut-off scores from the collective setting in the individual setting could, therefore, result in invalid conclusions and potential misuse of the instrument. To correctly apply cut-off scores these should be retrieved from the applied setting.	[Hoofs, H.; Jansen, N. W. H.; Kant, I. J.] Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands; [Hoofs, H.; Mohren, D. C. L.; Jansen, M. W. J.] Publ Hlth Serv Southern Limburg, Acad Collaborat Ctr Publ Hlth Limburg, Geleen, Netherlands; [Jansen, M. W. J.] Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI Sch Publ Hlth & Primary Care, Dept Hlth Serv Res, NL-6200 MD Maastricht, Netherlands	Maastricht University; Maastricht University	Hoofs, H (corresponding author), Maastricht Univ, Fac Hlth Med & Life Sci, CAPHRI Sch Publ Hlth & Primary Care, Dept Epidemiol, NL-6200 MD Maastricht, Netherlands.	Huub.Hoofs@maastrichtuniversity.nl			Maastricht University; Public Health Service Southern Limburg; Province of Limburg [CWZW2011/57962]	Maastricht University; Public Health Service Southern Limburg; Province of Limburg	This project was financially supported by Maastricht University, Public Health Service Southern Limburg and the Province of Limburg (Grant nr CWZW2011/57962).	Beauducel A, 2006, STRUCT EQU MODELING, V13, P186, DOI 10.1207/s15328007sem1302_2; Becker A, 2006, EUR CHILD ADOLES PSY, V15, P56, DOI 10.1007/s00787-006-1008-7; Bourdon KH, 2005, J AM ACAD CHILD PSY, V44, P557, DOI 10.1097/01.chi.0000159157.57075.c8; Bowling A, 2005, J PUBLIC HEALTH-UK, V27, P281, DOI 10.1093/pubmed/fdi031; Brown JL, 2009, J APPL SOC PSYCHOL, V39, P2756, DOI 10.1111/j.1559-1816.2009.00547.x; Calam R, 2005, PSYCHOSOM MED, V67, P105, DOI 10.1097/01.psy.0000151490.77622.37; CBS, 2014, FOR BACKGBR; CBS, 2009, KEY FIG POSTC AR; CCMO, 2014, FIL RES; Chen FF, 2007, STRUCT EQU MODELING, V14, P464, DOI 10.1080/10705510701301834; Cheung GW, 2000, J CROSS CULT PSYCHOL, V31, P187, DOI 10.1177/0022022100031002003; Cheung GW, 2002, STRUCT EQU MODELING, V9, P233, DOI 10.1207/S15328007SEM0902_5; Crone MR, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-106; Dickey WC, 2004, J AM ACAD CHILD PSY, V43, P1159, DOI 10.1097/01.chi.0000132808.36708.a9; Durant LE, 2002, J BEHAV MED, V25, P439, DOI 10.1023/A:1020419023766; Durlak JA, 1998, AM J COMMUN PSYCHOL, V26, P775, DOI 10.1023/A:1022162015815; Flora DB, 2004, PSYCHOL METHODS, V9, P466, DOI 10.1037/1082-989X.9.4.466; Giannakopoulos George, 2009, Ann Gen Psychiatry, V8, P20, DOI 10.1186/1744-859X-8-20; Goodman A, 2010, J ABNORM CHILD PSYCH, V38, P1179, DOI 10.1007/s10802-010-9434-x; Goodman A, 2009, J AM ACAD CHILD PSY, V48, P400, DOI 10.1097/CHI.0b013e3181985068; Goodman R, 1999, J CHILD PSYCHOL PSYC, V40, P791, DOI 10.1017/S0021963099004096; Goodman R, 2002, BRIT MED J, V324, P1496, DOI 10.1136/bmj.324.7352.1496; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Goodman R, 2001, J AM ACAD CHILD PSY, V40, P1337, DOI 10.1097/00004583-200111000-00015; Goodman R, 2000, BRIT J PSYCHIAT, V177, P534, DOI 10.1192/bjp.177.6.534; Hill CR, 2007, SCHOOL PSYCHOL QUART, V22, P380, DOI 10.1037/1045-3830.22.3.380; Hofstra MB, 2001, BRIT J PSYCHIAT, V179, P203, DOI 10.1192/bjp.179.3.203; HORN JL, 1992, EXP AGING RES, V18, P117, DOI 10.1080/03610739208253916; Hox JJ., 2017, MULTILEVEL ANAL TECH, DOI DOI 10.4324/9781315650982; Kline R.B., 2011, PRINCIPLES PRACTICE; Knol F., 2012, NEIGHBOURHOOD STATUS; Koskelainen M, 2000, EUR CHILD ADOLES PSY, V9, P277, DOI 10.1007/s007870070031; Krumpal I, 2013, QUAL QUANT, V47, P2025, DOI 10.1007/s11135-011-9640-9; Kuo AA, 2006, PEDIATRICS, V118, P1692, DOI 10.1542/peds.2006-0620; Lamberts PHG, 2011, HLTH VIEW S LIMBURG; Lelkes Y, 2012, J EXP SOC PSYCHOL, V48, P1291, DOI 10.1016/j.jesp.2012.07.002; Licence K, 2004, CHILD CARE HLTH DEV, V30, P623, DOI 10.1111/j.1365-2214.2004.00473.x; Marsh HW, 2010, PSYCHOL ASSESSMENT, V22, P471, DOI 10.1037/a0019227; Marsh HW, 2004, STRUCT EQU MODELING, V11, P320, DOI 10.1207/s15328007sem1103_2; Meade AW, 2008, J APPL PSYCHOL, V93, P568, DOI 10.1037/0021-9010.93.3.568; MEREDITH W, 1993, PSYCHOMETRIKA, V58, P525, DOI 10.1007/BF02294825; Mieloo C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036805; Millsap RE, 2004, MULTIVAR BEHAV RES, V39, P479, DOI 10.1207/S15327906MBR3903_4; Millsap RE, 2011, STAT APPROACHES MEAS; Ministry of Health Welfare and Sport CBS, 2014, YOUTH MON; Moffitt TE, 2001, DEV PSYCHOPATHOL, V13, P355, DOI 10.1017/S0954579401002097; Muris P, 2003, EUR CHILD ADOLES PSY, V12, P1, DOI 10.1007/s00787-003-0298-2; Murthy RS, 2001, WORLD HLTH REP 2001; Muthen LK, 2012, MPLUS LANGUAGE ADDED; Nation J.R., 1997, RES METHODS; Niclasen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032025; O'Malley PM, 2000, J DRUG ISSUES, V30, P35, DOI 10.1177/002204260003000103; Ong AD, 2000, J APPL SOC PSYCHOL, V30, P1691, DOI 10.1111/j.1559-1816.2000.tb02462.x; Palmieri PA, 2007, PSYCHOL ASSESSMENT, V19, P189, DOI 10.1037/1040-3590.19.2.189; Ravens-Sieberer U, 2008, CLIN PSYCHOL PSYCHOT, V15, P154, DOI 10.1002/cpp.574; Reijneveld SA, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-197; Rhemtulla M, 2012, PSYCHOL METHODS, V17, P354, DOI 10.1037/a0029315; Sanne B, 2009, PSYCHOL ASSESSMENT, V21, P352, DOI 10.1037/a0016317; Sass DA, 2014, STRUCT EQU MODELING, V21, P167, DOI 10.1080/10705511.2014.882658; Schmitt N, 2008, HUM RESOUR MANAGE R, V18, P210, DOI 10.1016/j.hrmr.2008.03.003; Schreiber JB, 2006, J EDUC RES, V99, P323, DOI 10.3200/JOER.99.6.323-338; Sijtsma K, 2009, PSYCHOMETRIKA, V74, P107, DOI 10.1007/s11336-008-9101-0; Smedje H, 1999, EUR CHILD ADOLES PSY, V8, P63, DOI 10.1007/s007870050086; Stark S, 2006, J APPL PSYCHOL, V91, P1292, DOI 10.1037/0021-9010.91.6.1292; Stone LL, 2010, CLIN CHILD FAM PSYCH, V13, P254, DOI 10.1007/s10567-010-0071-2; van de Looij-Jansen PM, 2006, J YOUTH ADOLESCENCE, V35, P659, DOI 10.1007/s10964-005-9027-0; van de Schoot R, 2012, EUR J DEV PSYCHOL, V9, P486, DOI 10.1080/17405629.2012.686740; Van Roy B, 2006, EUR CHILD ADOLES PSY, V15, P189, DOI 10.1007/s00787-005-0521-4; Van Roy B, 2008, J CHILD PSYCHOL PSYC, V49, P1304, DOI 10.1111/j.1469-7610.2008.01942.x; van Widenfelt BM, 2003, EUR CHILD ADOLES PSY, V12, P281, DOI 10.1007/s00787-003-0341-3; Vandenberg RJ, 2000, ORGAN RES METHODS, V3, P4, DOI 10.1177/109442810031002; Vogels AGC, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-489; Vostanis P, 2006, CURR OPIN PSYCHIATR, V19, P367, DOI 10.1097/01.yco.0000228755.72366.05	73	8	8	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e01209301	10.1371/journal.pone.0120930	http://dx.doi.org/10.1371/journal.pone.0120930			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886464	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000013
J	Mohamed, MA; Gadeau, AP; Fliegel, L; Lopaschuk, G; Mlih, M; Abdulrahman, N; Fillmore, N; Mraiche, F				Mohamed, Man A.; Gadeau, Alain-Pierre; Fliegel, Larry; Lopaschuk, Gary; Mlih, Mohamed; Abdulrahman, Nabeel; Fillmore, Natasha; Mraiche, Fatima			Na+/H+ Exchanger Isoform 1-Induced Osteopontin Expression Facilitates Cardiomyocyte Hypertrophy	PLOS ONE			English	Article							CARDIAC-HYPERTROPHY; THERAPEUTIC-TARGET; GENE-EXPRESSION; CALCINEURIN ACTIVATION; HEART-FAILURE; SMOOTH-MUSCLE; CELL-LINE; IN-VITRO; T-CELLS; DIFFERENTIATION	Enhanced expression and activity of the Na+/H+ exchanger isoform 1 (NHE1) has been implicated in cardiomyocyte hypertrophy in various experimental models. The upregulation of NHE1 was correlated with an increase in osteopontin (OPN) expression in models of cardiac hypertrophy (CH), and the mechanism for this remains to be delineated. To determine whether the expression of active NHE1-induces OPN and contributes to the hypertrophic response in vitro, cardiomyocytes were infected with the active form of the NHE1 adenovirus or transfected with OPN silencing RNA (siRNA-OPN) and characterized for cardiomyocyte hypertrophy. Expression of NHE1 in cardiomyocytes resulted in a significant increase in cardiomyocyte hypertrophy markers: cell surface area, protein content, ANP mRNA and expression of phosphorylated-GATA4. NHE1 activity was also significantly increased in cardiomyocytes expressing active NHE1. Interestingly, transfection of cardiomyocytes with siRNA-OPN significantly abolished the NHE1-induced cardiomyocyte hypertrophy. siRNA-OPN also significantly reduced the activity of NHE1 in cardiomyocytes expressing NHE1 (68.5 +/- 0.24%; P< 0.05), confirming the role of OPN in the NHE1-induced hypertrophic response. The hypertrophic response facilitated by NHE1-induced OPN occurred independent of the extracellular-signal-regulated kinases and Akt, but required p90-ribosomal S6 kinase (RSK). The ability of OPN to facilitate the NHE1-induced hypertrophic response identifies OPN as a potential therapeutic target to reverse the hypertrophic effect induced by the expression of active NHE1.	[Mohamed, Man A.; Mlih, Mohamed; Abdulrahman, Nabeel; Mraiche, Fatima] Qatar Univ, Coll Pharm, Doha, Qatar; [Gadeau, Alain-Pierre] Univ Bordeaux, Adaptat Cardiovasc Ischemie, UMR1034, Pessac, France; [Fliegel, Larry] Univ Alberta, Dept Biochem, Fac Med & Dent, Edmonton, AB, Canada; [Lopaschuk, Gary; Fillmore, Natasha] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada	Qatar University; UDICE-French Research Universities; Universite de Bordeaux; University of Alberta; University of Alberta	Mraiche, F (corresponding author), Qatar Univ, Coll Pharm, Doha, Qatar.	fatima.mraiche@qu.edu.qa	Gadeau, Alain-Pierre/H-7889-2016; Mlih, Mohamed/O-4834-2019	Gadeau, Alain-Pierre/0000-0003-1312-6481; Mlih, Mohamed/0000-0003-3491-9616	National Priorities Research Program grant by the Qatar National Research Fund, Doha, Qatar [NPRP 5 - 330 - 3 - 090]	National Priorities Research Program grant by the Qatar National Research Fund, Doha, Qatar	This work was supported by the National Priorities Research Program grant (NPRP 5 - 330 - 3 - 090) provided by the Qatar National Research Fund, Doha, Qatar (http://www.qnrf.org). Lead principal investigator (PI): FM, PI: LF, AG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Avkiran M, 2008, CURR OPIN PHARMACOL, V8, P133, DOI 10.1016/j.coph.2007.12.007; Chen MZ, 2012, MOL CELL BIOCHEM, V371, P77, DOI 10.1007/s11010-012-1424-6; Coccaro E, 2007, MOL CELL BIOCHEM, V302, P145, DOI 10.1007/s11010-007-9436-3; Coccaro E, 2009, AM J PHYSIOL-HEART C, V297, pH846, DOI 10.1152/ajpheart.01231.2008; Dai J, 2014, CIRC-HEART FAIL, V7, P184, DOI 10.1161/CIRCHEARTFAILURE.113.000649; Diao HY, 2008, P NATL ACAD SCI USA, V105, P15884, DOI 10.1073/pnas.0806089105; Doehn U, 2009, MOL CELL, V35, P511, DOI 10.1016/j.molcel.2009.08.002; Ennis IL, 2003, HYPERTENSION, V41, P1324, DOI 10.1161/01.HYP.0000071180.12012.6E; Fliegel L, 2009, EXPERT OPIN THER TAR, V13, P55, DOI [10.1517/14728220802600707, 10.1517/14728220802600707 ]; Frangogiannis NG, 2012, PHYSIOL REV, V92, P635, DOI 10.1152/physrev.00008.2011; Fu GX, 2012, ENDOCRINE, V42, P676, DOI 10.1007/s12020-012-9675-2; Gao YA, 2004, MATRIX BIOL, V23, P457, DOI 10.1016/j.matbio.2004.09.003; Graf K, 1997, CIRCULATION, V96, P3063, DOI 10.1161/01.CIR.96.9.3063; Guo JA, 2011, CIRC-HEART FAIL, V4, P79, DOI 10.1161/CIRCHEARTFAILURE.110.957969; Heineke J, 2006, NAT REV MOL CELL BIO, V7, P589, DOI 10.1038/nrm1983; Hisamitsu T, 2012, MOL CELL BIOL, V32, P3265, DOI 10.1128/MCB.00145-12; Huber JD, 2012, J MED CHEM; Inoue M, 2011, IMMUNOL RES, V49, P160, DOI 10.1007/s12026-010-8179-5; Jalvy S, 2007, CARDIOVASC RES, V75, P738, DOI 10.1016/j.cardiores.2007.05.019; Kageyama K, 2002, J BIOL CHEM, V277, P19255, DOI 10.1074/jbc.M112377200; Karki P, 2010, BBA-BIOMEMBRANES, V1798, P1565, DOI 10.1016/j.bbamem.2010.05.005; Karmazyn M, 2013, J MOL CELL CARDIOL, V61, P77, DOI 10.1016/j.yjmcc.2013.02.006; Kazanecki CC, 2007, J CELL BIOCHEM, V102, P912, DOI 10.1002/jcb.21558; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kilic A, 2005, CIRCULATION, V112, P2307, DOI 10.1161/CIRCULATIONAHA.105.542209; Kilic A, 2010, CARDIOVASC RES, V88, P434, DOI 10.1093/cvr/cvq254; KIMES BW, 1976, EXP CELL RES, V98, P367, DOI 10.1016/0014-4827(76)90447-X; Ku PM, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-57; Lenga Y, 2008, CIRC RES, V102, P319, DOI 10.1161/CIRCRESAHA.107.160408; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Lyle AN, 2013, J BIOL CHEM; Malo ME, 2006, CAN J PHYSIOL PHARM, V84, P1081, DOI 10.1139/Y06-065; Marian AJ, 2007, CARDIAC HYPERTROPHY, P1177; Menard C, 1999, J BIOL CHEM, V274, P29063, DOI 10.1074/jbc.274.41.29063; Merten KE, 2006, J PHARMACOL EXP THER, V319, P934, DOI 10.1124/jpet.106.108845; Mraiche F, 2011, MOL CELL BIOCHEM, V358, P179, DOI 10.1007/s11010-011-0933-z; Mraiche F, 2011, BASIC RES CARDIOL, V106, P603, DOI 10.1007/s00395-011-0161-4; Nakamura TY, 2008, CIRC RES, V103, P891, DOI 10.1161/CIRCRESAHA.108.175141; Nilsson-Berglund LM, 2010, ARTERIOSCL THROM VAS, V30, P218, DOI 10.1161/ATVBAHA.109.199299; Paradise RK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015746; Pereira SL, 2011, CARDIOVASC TOXICOL, V11, P180, DOI 10.1007/s12012-011-9112-4; Prasad V, 2013, J MOL CELL CARDIOL; Renault MA, 2010, CIRC-HEART FAIL, V3, P431, DOI 10.1161/CIRCHEARTFAILURE.109.898114; Rittling SR, 1998, BIOCHEM BIOPH RES CO, V250, P287, DOI 10.1006/bbrc.1998.9306; Sardao VA, 2009, CELL BIOL TOXICOL, V25, P227, DOI 10.1007/s10565-008-9070-1; Schunke KJ, 2013, J CELL PHYSIOL, V228, P2006, DOI 10.1002/jcp.24367; Shibata M, 2011, AM J PHYSIOL-HEART C, V301, pH2154, DOI 10.1152/ajpheart.00483.2011; Sodhi CP, 2001, DIABETES, V50, P1482, DOI 10.2337/diabetes.50.6.1482; Summerton JE, 2007, CURR TOP MED CHEM, V7, P651, DOI 10.2174/156802607780487740; Voelkl J, 2013, CELL PHYSIOL BIOCHEM, V32, P25, DOI 10.1159/000350120; Voelkl J, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0236-2; Wakabayashi S, 1997, BIOCHEMISTRY-US, V36, P12854, DOI 10.1021/bi9715472; Waller AH, 2010, CARDIOL REV, V18, P125, DOI 10.1097/CRD.0b013e3181cfb646; Wang YG, 2009, HEART VESSELS, V24, P116, DOI 10.1007/s00380-008-1094-1; Watkins SJ, 2011, IN VITRO CELL DEV-AN, V47, P125, DOI 10.1007/s11626-010-9368-1; World Health Organization, 2017, CARD DIS CVDS; Xia Y, 2007, J PHARMACOL EXP THER, V320, P14, DOI 10.1124/jpet.106.110494; Xie ZL, 2004, HYPERTENSION, V44, P826, DOI 10.1161/01.HYP.0000148458.03202.48; Xie ZL, 2004, J CELL PHYSIOL, V198, P399, DOI 10.1002/jcp.10419; Xue J, 2010, PHYSIOL GENOMICS, V42, P374, DOI 10.1152/physiolgenomics.00064.2010; Young M, 2003, ENDOCRINOLOGY, V144, P3848, DOI 10.1210/en.2003-0039; Zhao YS, 2007, CANCER RES, V67, P5821, DOI 10.1158/0008-5472.CAN-06-4499	63	4	4	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123318	10.1371/journal.pone.0123318	http://dx.doi.org/10.1371/journal.pone.0123318			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884410	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000057
J	AlFaleh, HF; Al Shamiri, MQ; Ullah, A; AlHabib, KF; Hersi, AS; AlSaif, S; AlNemer, K; Taraben, A; Malik, A; Abuosa, AM; Mimish, LA; Kashour, T				AlFaleh, Hussam F.; Al Shamiri, Mostafa Q.; Ullah, Anhar; AlHabib, Khalid F.; Hersi, Ahmad Salah; AlSaif, Shukri; AlNemer, Khalid; Taraben, Amir; Malik, Asif; Abuosa, Ahmed M.; Mimish, L. A.; Kashour, Tarek			Disparities in Health Care Delivery and Hospital Outcomes between Non-Saudis and Saudi Nationals Presenting with Acute Coronary Syndromes in Saudi Arabia	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; CARDIAC PROCEDURES; TASK-FORCE; MANAGEMENT; COUNTRIES; ACCESS; TIME	Background Saudi Arabia has a non-Saudi workers population. We investigated the differences and similarities of expatriate non-Saudi patients (NS) and Saudi nationals (SN) presenting with acute coronary syndromes (ACS) with respect to therapies and clinical outcomes. Methods The study evaluated 2031 of the 5055 ACS patients enrolled in the Saudi Project for Assessment of Acute Coronary Syndrome (SPACE) from 2005 to 2007. Propensity score matching and logistic regression analysis were performed to account for major imbalances in age and sex in the two groups. Results The mean patient age was 56.2 +/- 9.8, and 83.5% of the study cohort were male. SN were more likely to have risk factors of atherosclerosis. ST-elevation MI (STEMI) was the most common ACS presentation in NS, while non-ST ACS was more common in SN. The median symptom-to-door time was significantly greater in NS patients (Median 175 min (197) vs. 130 min (167), p=0.027). The only difference in pharmacological therapies between the two groups was that NS were more likely to receive fibrinolytic therapy. NS were less likely than SN to undergo percutaneous coronary interventions (PCI; 32.6% vs. 42.8%, p=0.0001) or primary PCI (7.8% vs. 22.8%, p<0.001). Hospital mortality, cardiogenic shock, and heart failure were significantly higher in NS compared to SN. After adjusting for baseline variables and therapies, the odds ratios for hospital mortality and cardiogenic shock in NS were 2.9 (95% CI 1.5-6.2, p=0.004) and 2.8 (95% CI 1.5-4.9, p<0.001), respectively. Conclusion Our findings indicate disparities in hospital care between NS and SN ACS patients. NS patients had worse hospital outcomes, which may reflect unequal health coverage and access-to-care issues.	[AlFaleh, Hussam F.; Al Shamiri, Mostafa Q.; Ullah, Anhar; AlHabib, Khalid F.; Hersi, Ahmad Salah; Kashour, Tarek] King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh 11461, Saudi Arabia; [AlSaif, Shukri] Saud AlBabtain Cardiac Ctr, Dammam, Saudi Arabia; [AlNemer, Khalid] Secur Forces Hosp, Dept Med, Riyadh, Saudi Arabia; [Taraben, Amir] King Faisal Specialist Hosp & Res Ctr, Jeddah, Saudi Arabia; [Malik, Asif] King Fahad Gen Hosp, Jeddah, Saudi Arabia; [Abuosa, Ahmed M.] King Khalid Natl Guard Hosp, Jeddah, Saudi Arabia; [Mimish, L. A.] King Abdulaziz Univ, King Abdul Aziz Univ Hosp, Jeddah 21413, Saudi Arabia	King Saud University; Security Forces Hospital - Saudi Arabia; King Faisal Specialist Hospital & Research Center; King Fahd Hospital Jeddah; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Jeddah; King Abdulaziz University	AlFaleh, HF (corresponding author), King Saud Univ, Coll Med, Cardiac Sci Dept, Riyadh 11461, Saudi Arabia.	halfaleh@ksu.edu.sa	Ullah, Anhar/CAJ-2116-2022; AlSaif, Shukri/GZM-0822-2022; Hersi, Ahmad/ABC-9266-2020	Ullah, Anhar/0000-0001-6768-2112; Alhabib, Khalid/0000-0002-6692-3874	Sanofi-Aventis; Saudi Heart Association	Sanofi-Aventis(Sanofi-Aventis); Saudi Heart Association	The SPACE registry is managed under the auspices of the Saudi Heart Association and financially sponsored by Sanofi-Aventis, which had no role in data extraction or analyses, the writing of the manuscript, or the decision to submit the manuscript for publication.	Afilalo J, 2008, CAN J CARDIOL, V24, P213, DOI 10.1016/S0828-282X(08)70587-7; AlHabib KF, 2011, J SAUDI HEART ASSOC, V23, P233, DOI 10.1016/j.jsha.2011.05.004; AlHabib KF, 2009, CAN J CARDIOL, V25, pE255, DOI 10.1016/S0828-282X(09)70513-6; Alter DA, 1999, NEW ENGL J MED, V341, P1359, DOI 10.1056/NEJM199910283411806; Boersma E, 1996, LANCET, V348, P771, DOI 10.1016/S0140-6736(96)02514-7; Cannon CP, 2001, J AM COLL CARDIOL, V38, P2114, DOI 10.1016/S0735-1097(01)01702-8; Funk M, 2002, NURS RES, V51, P148, DOI 10.1097/00006199-200205000-00003; Hussey P, 2003, HEALTH POLICY, V66, P215, DOI 10.1016/S0168-8510(03)00050-2; Krumholz HM, 2011, CIRCULATION, V124, P1038, DOI 10.1161/CIRCULATIONAHA.111.044107; O'Gara PT, 2013, CIRCULATION, V127, pE362, DOI 10.1161/CIR.0b013e3182742cf6; Pilote L, 2003, AM HEART J, V146, P1030, DOI 10.1016/S0002-8703(03)00448-4; Rathore SS, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1807; Reddy KS, 2004, NEW ENGL J MED, V350, P2438, DOI 10.1056/NEJMp048024; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9	14	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124012	10.1371/journal.pone.0124012	http://dx.doi.org/10.1371/journal.pone.0124012			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881231	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500077
J	Chen, LX; Ning, GZ; Zhou, ZR; Li, YL; Zhang, D; Wu, QL; Zhang, TS; Cheng, L; Feng, SQ				Chen, Ling-Xiao; Ning, Guang-Zhi; Zhou, Zhi-Rui; Li, Yu-Lin; Zhang, Di; Wu, Qiu-Li; Zhang, Tian-Song; Cheng, Lei; Feng, Shi-Qing			The Carcinogenicity of Alendronate in Patients with Osteoporosis: Evidence from Cohort Studies	PLOS ONE			English	Article							ORAL BISPHOSPHONATE USE; ESOPHAGEAL CANCER; POSTMENOPAUSAL WOMEN; COLORECTAL-CANCER; NATIONWIDE POPULATION; BREAST-CANCER; REDUCED RISK; METAANALYSIS; MANAGEMENT; EXPOSURE	Context Alendronate may relate to the incidence of cancers, especially esophageal and colon cancer. But the results are inconsistent in different studies. Objective To quantify the association between the use of alendronate and the occurrence of different types of cancer. Data Sources We searched Embase, Pubmed, CENTRAL, SIGLE and clinicaltrials.gov, up to 2014 June. Study Selection Cohort studies reporting association between alendronate or bisphosphonate therapy including alendronate in patients with osteoporosis and risk of cancer were selected by two authors. Data Extraction Two authors independently extracted the data. The Chi-square test and the I-square test were used for testing heterogeneity between studies. Data Synthesis Eight cohort studies were included in the meta-analysis. Meta-analysis result manifested that alendronate significantly increased the incidence of lung cancer (HR 1.23, 95% CI 1.03 to 1.47, P value = 0.03), nevertheless, there was no significant difference after we excluded either Lee's 2012 study (HR 1.17, 95% CI 0.95 to 1.44, P value = 0.13) or Chiang's 2012 study (HR 1.47, 95% CI 1 to 2.17, P value = 0.05). For the incidence of colorectal cancer, no significant difference occurred (HR 0.91, 95% CI 0.74 to 1.13, P value = 0.39), but there was a positive relationship when we used fixed model (HR 0.85, 95% CI 0.78 to 0.93, P value = 0.004). For the incidence of liver cancer, there was no significant difference (HR 1.36, 95% CI 0.9 to 2.04, P value = 0.14), however, the result changed after we excluded Chiang's 2012 study (HR 1.69, 95% CI 1.03 to 2.77, P value = 0.04). There was no significant difference in other types of cancer. Conclusion Based on current evidences, alendronate therapy may be associated with a high risk of lung cancer, may with an excess risk of liver cancer, a low risk of colorectal and no related risk of other cancers.	[Chen, Ling-Xiao; Ning, Guang-Zhi; Li, Yu-Lin; Zhang, Di; Wu, Qiu-Li; Feng, Shi-Qing] Tianjin Med Univ, Gen Hosp, Dept Orthopaed, Tianjin 300052, Peoples R China; [Zhou, Zhi-Rui] Fudan Univ, Shanghai Canc Ctr, Dept Radiat Oncol, Shanghai 200032, Peoples R China; [Zhou, Zhi-Rui] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200032, Peoples R China; [Zhang, Tian-Song] Jingan Dist Cent Hosp Shanghai, Internal Med Tradit Chinese Med Dept, Shanghai 200040, Peoples R China; [Cheng, Lei] Nanjing Univ, Sch Med, Clin Canc Inst, Comprehens Canc Ctr,Drum Tower Hosp, Nanjing 210008, Jiangsu, Peoples R China	Tianjin Medical University; Fudan University; Fudan University; Nanjing University	Chen, LX (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Orthopaed, 154 Anshan Rd, Tianjin 300052, Peoples R China.	fengsq321@gmail.com	Chen, Lingxiao/M-7806-2019	Chen, Lingxiao/0000-0001-7721-0493				Abrahamsen B, 2012, J BONE MINER RES, V27, P679, DOI 10.1002/jbmr.1481; Andrici J, 2012, ALIMENT PHARM THER, V36, P708, DOI 10.1111/apt.12041; Cardwell CR, 2010, JAMA-J AM MED ASSOC, V304, P657, DOI 10.1001/jama.2010.1098; Chen YM, 2011, J AM GERIATR SOC, V59, P2379, DOI 10.1111/j.1532-5415.2011.03693.x; Chiang CH, 2012, J BONE MINER RES, V27, P1951, DOI 10.1002/jbmr.1645; Chlebowski RT, 2010, J CLIN ONCOL, V28, P3582, DOI 10.1200/JCO.2010.28.2095; Compston J, 2013, MATURITAS, V75, P392, DOI 10.1016/j.maturitas.2013.05.013; Green J, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4444; Ho YF, 2012, CANCER EPIDEM BIOMAR, V21, P993, DOI 10.1158/1055-9965.EPI-12-0259; Hue TF, 2014, JAMA INTERNAL MED; Khan SN, 2013, CLIN OBSTET GYNECOL, V56, P694, DOI 10.1097/01.grf.0000437016.19989.61; Lee WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053032; Lin Xiufeng, 2005, Zhongguo Fei Ai Za Zhi, V8, P510, DOI 10.3779/j.issn.1009-3419.2005.06.05; Liu YP, 2012, CLIN BREAST CANCER, V12, P276, DOI 10.1016/j.clbc.2012.04.003; Mazzantini M, 2014, REUMATISMO, V66, P144, DOI 10.4081/reumatismo.2014.787; Nguyen DM, 2010, DIGEST DIS SCI, V55, P3404, DOI 10.1007/s10620-010-1198-1; Passarelli MN, 2013, J BONE MINER RES, V28, P2043, DOI 10.1002/jbmr.1930; Pazianas M, 2012, OSTEOPOROSIS INT, V23, P2693, DOI 10.1007/s00198-012-1902-4; Singh S, 2013, CLIN GASTROENTEROL H, V11, P232, DOI 10.1016/j.cgh.2012.11.026; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Sun K, 2013, OSTEOPOROSIS INT, V24, P279, DOI 10.1007/s00198-012-2158-8; The Cochrane Collaboration, 2011, COCHRANE HDB SYSTEMA; Thosani N, 2013, J CLIN ONCOL, V31, P623, DOI 10.1200/JCO.2012.42.9530; Vestergaard P, 2011, CALCIFIED TISSUE INT, V89, P434, DOI 10.1007/s00223-011-9539-4; Vestergaard P, 2011, CALCIFIED TISSUE INT, V88, P255, DOI 10.1007/s00223-011-9463-7; Vinogradova Y, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f114; Wells GA, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001155.pub2; Wright E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047616	28	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123080	10.1371/journal.pone.0123080	http://dx.doi.org/10.1371/journal.pone.0123080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881304	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500038
J	El Daker, S; Sacchi, A; Tempestilli, M; Carducci, C; Goletti, D; Vanini, V; Colizzi, V; Lauria, FN; Martini, F; Martino, A				El Daker, Sary; Sacchi, Alessandra; Tempestilli, Massimo; Carducci, Claudia; Goletti, Delia; Vanini, Valentina; Colizzi, Vittorio; Lauria, Francesco Nicola; Martini, Federico; Martino, Angelo			Granulocytic Myeloid Derived Suppressor Cells Expansion during Active Pulmonary Tuberculosis Is Associated with High Nitric Oxide Plasma Level	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; T-CELLS; AUTOPHAGIC FLUX; INFECTION; MACROPHAGES	Tuberculosis (TB) is still the principal cause of death caused by a single infectious agent, and the balance between the bacillus and host defense mechanisms reflects the different manifestations of the pathology. The aim of this work was to study the role of myeloid-derived suppressor cells (MDSCs) during active pulmonary tuberculosis at the site of infection. We observed an expansion of MDSCs in the lung and blood of patients with active TB, which are correlated with an enhanced amount of nitric oxide in the plasma. We also found that these cells have the remarkable ability to suppress T-cell response, suggesting an important role in the modulation of the immune response against TB. Interestingly, a trend in the diminution of MDSCs was found after an efficacious anti-TB therapy, suggesting that these cells may be used as a potential biomarker for monitoring anti-TB therapy efficacy.	[El Daker, Sary; Sacchi, Alessandra; Martini, Federico; Martino, Angelo] Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy; [El Daker, Sary] Inst Pasteur, Dept Immunol, Unite Biol Populat Lymphocytaires, F-75724 Paris, France; [El Daker, Sary; Colizzi, Vittorio] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Tempestilli, Massimo] Lazzaro Spallanzani Natl Inst Infect Dis, Clin Biochem & Pharmacol Lab, Rome, Italy; [Carducci, Claudia] Univ Roma La Sapienza, Dept Expt Med, I-00185 Rome, Italy; [Goletti, Delia; Vanini, Valentina] Lazzaro Spallanzani Natl Inst Infect Dis, Translat Res Unit, Rome, Italy; [Lauria, Francesco Nicola] Lazzaro Spallanzani Natl Inst Infect Dis, Resp Infect Dis Unit, Rome, Italy	IRCCS Lazzaro Spallanzani; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Rome Tor Vergata; IRCCS Lazzaro Spallanzani; Sapienza University Rome; IRCCS Lazzaro Spallanzani; IRCCS Lazzaro Spallanzani	El Daker, S (corresponding author), Lazzaro Spallanzani Natl Inst Infect Dis, Cellular Immunol Lab, Rome, Italy.	saryeldaker@yahoo.it	carducci, claudia/K-5412-2018; Vanini, Valentina/K-4475-2016; goletti, delia/AAM-6577-2020; Sacchi, Alessandra/K-7782-2016; tempestilli, massimo/K-5952-2016	Vanini, Valentina/0000-0001-8476-964X; Sacchi, Alessandra/0000-0003-4964-386X; tempestilli, massimo/0000-0003-3107-7441; Goletti, Delia/0000-0001-8360-4376; CARDUCCI, Claudia/0000-0003-0515-9208	INMI Lazzaro Spallanzani Ricerca Corrente grants from Italian Ministry of Health	INMI Lazzaro Spallanzani Ricerca Corrente grants from Italian Ministry of Health	This work was supported by INMI Lazzaro Spallanzani Ricerca Corrente grants from Italian Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chiacchio T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027539; du Plessis N, 2013, AM J RESP CRIT CARE, V188, P724, DOI 10.1164/rccm.201302-0249OC; El Daker S, 2013, CELL IMMUNOL, V282, P106, DOI 10.1016/j.cellimm.2013.05.001; Goletti D, 2013, CYTOKINE GROWTH F R, V24, P335, DOI 10.1016/j.cytogfr.2013.01.002; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Gupta A, 2012, IMMUNOBIOLOGY, V217, P363, DOI 10.1016/j.imbio.2011.07.008; Herzmann C, 2012, EUR RESPIR J, V40, P1450, DOI 10.1183/09031936.00214611; Obregon-Henao A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080669; Ochoa AC, 2007, CLIN CANCER RES, V13, p721S, DOI 10.1158/1078-0432.CCR-06-2197; Petruccioli E, 2012, J INFECT DIS, V205, P1425, DOI 10.1093/infdis/jis226; Rich EA, 1997, TUBERCLE LUNG DIS, V78, P247, DOI 10.1016/S0962-8479(97)90005-8; Romagnoli A, 2012, AUTOPHAGY, V8, P1357, DOI 10.4161/auto.20881; Schuster R, 1998, J CHROMATOGR, V43, P271; Sendide K, 2004, INFECT IMMUN, V72, P4200, DOI 10.1128/IAI.72.7.4200-4209.2004; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; WADEE AA, 1995, CLIN EXP IMMUNOL, V100, P434; Yang BF, 2014, IMMUNOL LETT, V158, P66, DOI 10.1016/j.imlet.2013.12.003; YOUNG MR, 1987, CANCER RES, V47, P100; Zuniga J, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/193923	21	54	55	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123772	10.1371/journal.pone.0123772	http://dx.doi.org/10.1371/journal.pone.0123772			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879532	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500061
J	How, C; Pintilie, M; Bruce, JP; Hui, ABY; Clarke, BA; Wong, P; Yin, SM; Yan, R; Waggott, D; Boutros, PC; Fyles, A; Hedley, DW; Hill, RP; Milosevic, M; Liu, FF				How, Christine; Pintilie, Melania; Bruce, Jeff P.; Hui, Angela B. Y.; Clarke, Blaise A.; Wong, Philip; Yin, Shaoming; Yan, Rui; Waggott, Daryl; Boutros, Paul C.; Fyles, Anthony; Hedley, David W.; Hill, Richard P.; Milosevic, Michael; Liu, Fei-Fei			Developing a Prognostic Micro-RNA Signature for Human Cervical Carcinoma	PLOS ONE			English	Article							INTRATUMORAL HETEROGENEITY; EXPRESSION PROFILES; MESSENGER-RNA; CANCER; TUMOR; IDENTIFICATION; SURVIVAL; GENE; PREDICTION; FROZEN	Cervical cancer remains the third most frequently diagnosed and fourth leading cause of cancer death in women worldwide. We sought to develop a micro-RNA signature that was prognostic for disease-free survival, which could potentially allow tailoring of treatment for cervical cancer patients. A candidate prognostic 9-micro-RNA signature set was identified in the training set of 79 frozen specimens. However, three different approaches to validate this signature in an independent cohort of 87 patients with formalin-fixed paraffin-embedded (FFPE) specimens, were unsuccessful. There are several challenges and considerations associated with developing a prognostic micro-RNA signature for cervical cancer, namely: tumour heterogeneity, lack of concordance between frozen and FFPE specimens, and platform selection for global micro-RNA expression profiling in this disease. Our observations provide an important cautionary tale for future miRNA signature studies for cervical cancer, which can also be potentially applicable to miRNA profiling studies involving other types of human malignancies.	[How, Christine; Bruce, Jeff P.; Hui, Angela B. Y.; Wong, Philip; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Ontario Canc Inst, Ontario Canc Inst, Toronto, ON M4X 1K9, Canada; [How, Christine; Bruce, Jeff P.; Boutros, Paul C.; Hedley, David W.; Hill, Richard P.; Liu, Fei-Fei] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Pintilie, Melania] Princess Margaret Canc Ctr, Univ Hlth Network, Div Biostat, Toronto, ON, Canada; [Clarke, Blaise A.] Univ Hlth Network, Dept Pathol, Toronto, ON, Canada; [Wong, Philip; Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Princess Margaret Canc Ctr, Univ Hlth Network, Dept Radiat Oncol, Toronto, ON, Canada; [Wong, Philip; Fyles, Anthony; Milosevic, Michael; Liu, Fei-Fei] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada; [Yin, Shaoming; Yan, Rui; Waggott, Daryl; Boutros, Paul C.] Ontario Inst Canc Res, Informat & Biocomp Platform, Toronto, ON, Canada; [Boutros, Paul C.] Univ Toronto, Dept Pharmacol & Toxicol, Toronto, ON, Canada; [Hedley, David W.] Princess Margaret Canc Ctr, Univ Hlth Network, Div Med Oncol, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; Ontario Institute for Cancer Research; University of Toronto; University Toronto Affiliates; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	How, C (corresponding author), Ontario Canc Inst, Ontario Canc Inst, 500 Sherbourne St, Toronto, ON M4X 1K9, Canada.	Fei-Fei.Liu@rmp.uhn.on.ca	Bruce, Jeff/AAF-1350-2019	Bruce, Jeff/0000-0001-5509-9990; Boutros, Paul/0000-0003-0553-7520; Hedley, David/0000-0003-1323-2655; Spence, Tara/0000-0001-7098-4103; Clarke, Blaise/0000-0002-2585-8391; Liu, Fei-Fei/0000-0003-4344-6486; Fyles, Anthony/0000-0002-3633-2483; Hill, Richard Peter/0000-0001-5331-8045; Milosevic, Michael/0000-0002-9620-6876	Ontario Institute for Cancer Research [10NOV-399]; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	Ontario Institute for Cancer Research; Lawrence, Ila and William Gifford Scholarship Fund; Campbell Family Institute for Cancer Research; Ministry of Health and Long-term Planning	This work was supported by funds from the Ontario Institute for Cancer Research (Grant Number: 10NOV-399). Christine How is a CIHR Strategic Training Fellow in the Excellence in Radiation Research for the 21st Century (EIRR21) Program, and is supported by the Lawrence, Ila and William Gifford Scholarship Fund. Support is also provided from the Campbell Family Institute for Cancer Research and the Ministry of Health and Long-term Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alajez NM, 2011, CANCER RES, V71, P2381, DOI 10.1158/0008-5472.CAN-10-2754; American Cancer Society, 2012, CANC FACTS FIG 2012; Bachtiary B, 2006, CLIN CANCER RES, V12, P5632, DOI 10.1158/1078-0432.CCR-06-0357; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Budhu A, 2008, HEPATOLOGY, V47, P897, DOI 10.1002/hep.22160; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; CHANG AR, 1994, INT J GYNECOL PATHOL, V13, P330, DOI 10.1097/00004347-199410000-00006; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; de Biase D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035596; Doleshal M, 2008, J MOL DIAGN, V10, P203, DOI 10.2353/jmoldx.2008.070153; Fyles A, 2002, J CLIN ONCOL, V20, P680, DOI 10.1200/JCO.2002.20.3.680; Gilad S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003148; Glazov EA, 2008, GENOME RES, V18, P957, DOI 10.1101/gr.074740.107; Glud M, 2009, J INVEST DERMATOL, V129, P1219, DOI 10.1038/jid.2008.347; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Guo ZM, 2001, MODERN PATHOL, V14, P54, DOI 10.1038/modpathol.3880256; Hanke Merle, 2010, Urol Oncol, V28, P655, DOI 10.1016/j.urolonc.2009.01.027; Harfe BD, 2005, CURR OPIN GENET DEV, V15, P410, DOI 10.1016/j.gde.2005.06.012; Hu XX, 2010, CANCER RES, V70, P1441, DOI 10.1158/0008-5472.CAN-09-3289; Hui ABY, 2009, LAB INVEST, V89, P597, DOI 10.1038/labinvest.2009.12; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kelly AD, 2013, GENOMICS, V102, P8, DOI 10.1016/j.ygeno.2013.03.008; Kolbert CP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052517; Koopman LA, 2000, J EXP MED, V191, P961, DOI 10.1084/jem.191.6.961; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P533, DOI 10.1016/j.urolonc.2009.05.008; Li XH, 2010, GUT, V59, P579, DOI 10.1136/gut.2008.175497; Li Y, 2011, J PATHOL, V224, P484, DOI 10.1002/path.2873; Liu AH, 2009, INT J CLIN EXP PATHO, V2, P519; Liu N, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70102-X; Lovendorf MB, 2012, EXP DERMATOL, V21, P299, DOI 10.1111/j.1600-0625.2012.01445.x; Lyng H, 2004, INT J CANCER, V111, P358, DOI 10.1002/ijc.20258; Lyng H, 2001, INT J CANCER, V96, P182; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nair VS, 2012, JNCI-J NATL CANCER I, V104, P528, DOI 10.1093/jnci/djs027; NGUYEN HN, 1993, CANCER, V71, P2543, DOI 10.1002/1097-0142(19930415)71:8<2543::AID-CNCR2820710818>3.0.CO;2-U; Nonn L, 2010, EXP MOL PATHOL, V88, P45, DOI 10.1016/j.yexmp.2009.10.005; Park NJ, 2009, CLIN CANCER RES, V15, P5473, DOI 10.1158/1078-0432.CCR-09-0736; Pereira PM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011780; Raponi M, 2009, CANCER RES, V69, P5776, DOI 10.1158/0008-5472.CAN-09-0587; Raychaudhuri M, 2012, J MOL DIAGN, V14, P376, DOI 10.1016/j.jmoldx.2012.01.016; Ries LAG EM, 2003, SEER CANC STAT REV 1, DOI [10.1016/j.healun.2014.01.862, DOI 10.1016/J.HEALUN.2014.01.862]; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Tibshirani R, 1997, STAT MED, V16, P385, DOI 10.1002/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; Waggott D, 2012, BIOINFORMATICS, V28, P1546, DOI 10.1093/bioinformatics/bts188; Wang XH, 2014, P NATL ACAD SCI USA, V111, P4262, DOI 10.1073/pnas.1401430111; Wang X, 2008, PLOS ONE, V3, DOI [10.1371/journal.pone.0003839, 10.1371/journal.pone.0002557]; Weng LH, 2010, J PATHOL, V222, P41, DOI 10.1002/path.2736; Wong RKW, 1997, INT J RADIAT ONCOL, V39, P405, DOI 10.1016/S0360-3016(97)00328-3; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yu SL, 2008, CANCER CELL, V13, P48, DOI 10.1016/j.ccr.2007.12.008; Zhang X, 2008, J MOL DIAGN, V10, P513, DOI 10.2353/jmoldx.2008.080077	54	28	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123946	10.1371/journal.pone.0123946	http://dx.doi.org/10.1371/journal.pone.0123946			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880806	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500072
J	Kudo, T; Kanetaka, H; Mochizuki, K; Tominami, K; Nunome, S; Abe, G; Kosukegawa, H; Abe, T; Mori, H; Mori, K; Takagi, T; Izumi, S				Kudo, Tada-aki; Kanetaka, Hiroyasu; Mochizuki, Kentaro; Tominami, Kanako; Nunome, Shoko; Abe, Genji; Kosukegawa, Hiroyuki; Abe, Toshihiko; Mori, Hitoshi; Mori, Kazumi; Takagi, Toshiyuki; Izumi, Shin-ichi			Induction of Neurite Outgrowth in PC12 Cells Treated with Temperature-Controlled Repeated Thermal Stimulation	PLOS ONE			English	Article							NERVE GROWTH-FACTOR; ACTIVATED PROTEIN-KINASE; BONE MORPHOGENETIC PROTEIN-2; NEURONAL DIFFERENTIATION; HEAT-SHOCK; IN-VITRO; NEUROTROPHIC FACTOR; SIGNALING PATHWAYS; GENE-EXPRESSION; AXONAL GROWTH	To promote the functional restoration of the nervous system following injury, it is necessary to provide optimal extracellular signals that can induce neuronal regenerative activities, particularly neurite formation. This study aimed to examine the regulation of neuritogenesis by temperature-controlled repeated thermal stimulation (TRTS) in rat PC12 pheochromocytoma cells, which can be induced by neurotrophic factors to differentiate into neuron-like cells with elongated neurites. A heating plate was used to apply thermal stimulation, and the correlation of culture medium temperature with varying surface temperature of the heating plate was monitored. Plated PC12 cells were exposed to TRTS at two different temperatures via heating plate (preset surface temperature of the heating plate, 39.5 degrees C or 42 degrees C) in growth or differentiating medium for up to 18 h per day. We then measured the extent of growth, neuritogenesis, or acetylcholine esterase (AChE) activity (a neuronal marker). To analyze the mechanisms underlying the effects of TRTS on these cells, we examined changes in intracellular signaling using the following: tropomyosin-related kinase A inhibitor GW441756; p38 mitogen-activated protein kinase (MAPK) inhibitor SB203580; and MAPK/extracellular signal-regulated kinase (ERK) kinase (MEK) inhibitor U0126 with its inactive analog, U0124, as a control. While a TRTS of 39.5 degrees C did not decrease the growth rate of cells in the cell growth assay, it did increase the number of neurite-bearing PC12 cells and AChE activity without the addition of other neuritogenesis inducers. Furthermore, U0126, and SB203580, but not U0124 and GW441756, considerably inhibited TRTS-induced neuritogenesis. These results suggest that TRTS can induce neuritogenesis and that participation of both the ERK1/2 and p38 MAPK signaling pathways is required for TRTS-dependent neuritogenesis in PC12 cells. Thus, TRTS may be an effective technique for regenerative neuromedicine.	[Kudo, Tada-aki] Tohoku Univ, Grad Sch Dent, Div Oral Physiol, Sendai, Miyagi 980, Japan; [Kanetaka, Hiroyasu] Tohoku Univ, Grad Sch Dent, Liaison Ctr Innovat Dent, Sendai, Miyagi 980, Japan; [Kanetaka, Hiroyasu; Tominami, Kanako; Izumi, Shin-ichi] Tohoku Univ, Grad Sch Biomed Engn, Sendai, Miyagi 980, Japan; [Mochizuki, Kentaro] Tohoku Univ, Inst Dev Aging & Canc, Cell Resource Ctr Biomed Res, Sendai, Miyagi 980, Japan; [Nunome, Shoko] Tohoku Univ, Grad Sch Dent, Div Oral Dysfunct Sci, Sendai, Miyagi 980, Japan; [Abe, Genji; Izumi, Shin-ichi] Tohoku Univ, Grad Sch Med, Dept Phys Med & Rehabil, Sendai, Miyagi 980, Japan; [Kosukegawa, Hiroyuki; Takagi, Toshiyuki] Tohoku Univ, Inst Fluid Sci, Sendai, Miyagi 980, Japan; [Abe, Toshihiko; Mori, Hitoshi; Mori, Kazumi] IFG Co Ltd, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University; Tohoku University	Kudo, T (corresponding author), Tohoku Univ, Grad Sch Dent, Div Oral Physiol, Sendai, Miyagi 980, Japan.	tkudo@m.tohoku.ac.jp	Kosukegawa, Hiroyuki/AAC-3014-2019; TAKAGI, Toshiyuki/S-9785-2019	TAKAGI, Toshiyuki/0000-0003-1283-4320; Tominami, Kanako/0000-0003-4342-6979; Kudo, Tada-aki/0000-0003-1666-9588; Kanetaka, Hiroyasu/0000-0001-7744-3879	Japan Society for the Promotion of Science KAKENHI grant [25861880]; Cooperative Research Project of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University	Japan Society for the Promotion of Science KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Cooperative Research Project of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University	This work was supported in part by the Japan Society for the Promotion of Science (www.jsps.go.jp) KAKENHI grant number 25861880, and by the Cooperative Research Project of Joint Usage/Research Center at the Institute of Development, Aging, and Cancer, Tohoku University (www.idac.tohoku.ac.jp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn N.G., 1999, PROMEGA NOTES, V71, P4; Ahn TB, 2006, BRAIN RES, V1087, P159, DOI 10.1016/j.brainres.2006.02.097; Cheng BC, 2008, NEUROSCI LETT, V443, P140, DOI 10.1016/j.neulet.2008.07.083; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; El Omri A, 2010, J ETHNOPHARMACOL, V131, P451, DOI 10.1016/j.jep.2010.07.006; Fantetti KN, 2012, DEV NEUROBIOL, V72, P1213, DOI 10.1002/dneu.20988; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GREENE LA, 1981, J BIOL CHEM, V256, P6363; Hansen TV, 2003, NEUROSCI LETT, V347, P57, DOI 10.1016/S0304-3940(03)00581-0; Hardiansyah A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-497; Heldin CH, 1997, NATURE, V390, P465, DOI 10.1038/37284; Heo DK, 2012, CELL SIGNAL, V24, P899, DOI 10.1016/j.cellsig.2011.12.011; Higgins S, 2013, BIORESEARCH OPEN ACC, V2, P212, DOI 10.1089/biores.2013.0008; Hogan BLM, 1996, CURR OPIN GENET DEV, V6, P432, DOI 10.1016/S0959-437X(96)80064-5; Iwasaki S, 1996, J BIOL CHEM, V271, P17360, DOI 10.1074/jbc.271.29.17360; Iwasaki S, 1999, J BIOL CHEM, V274, P26503, DOI 10.1074/jbc.274.37.26503; Jang Y, 2012, J BIOL CHEM, V287, P6014, DOI 10.1074/jbc.M111.316315; Jung EJ, 2008, EXP MOL MED, V40, P276, DOI 10.3858/emm.2008.40.3.276; Kao SC, 2001, J BIOL CHEM, V276, P18169, DOI 10.1074/jbc.M008870200; Kim HS, 2006, EXP MOL MED, V38, P85, DOI 10.1038/emm.2006.10; Kimura N, 2000, J BIOL CHEM, V275, P17647, DOI 10.1074/jbc.M908622199; Koike T, 2006, NEUROSCI LETT, V410, P212, DOI 10.1016/j.neulet.2006.10.008; Kudo T, 2013, CELL STRUCT FUNCT, V38, P15, DOI 10.1247/csf.12030; Kudo T, 2011, GENES CELLS, V16, P1121, DOI 10.1111/j.1365-2443.2011.01556.x; Kudo T, 2010, TOHOKU J EXP MED, V222, P121, DOI 10.1620/tjem.222.121; Li ZX, 2012, J MATER SCI-MATER M, V23, P2461, DOI 10.1007/s10856-012-4735-y; Li ZX, 2012, J BIOMED MATER RES A, V100A, P2537, DOI 10.1002/jbm.a.34185; Liang P, 1997, J CELL SCI, V110, P1431; Liu JH, 2003, INT J DEV NEUROSCI, V21, P277, DOI 10.1016/S0736-5748(03)00040-6; Morooka T, 1998, J BIOL CHEM, V273, P24285, DOI 10.1074/jbc.273.38.24285; Muramatsu R, 2009, BIOSCI TRENDS, V3, P179; Omori H, 2014, NEUROSCI RES, V79, P13, DOI 10.1016/j.neures.2013.11.005; PANG L, 1995, J BIOL CHEM, V270, P13585, DOI 10.1074/jbc.270.23.13585; Peregrin S, 2006, CURR BIOL, V16, P2042, DOI 10.1016/j.cub.2006.08.083; Radio NM, 2008, NEUROTOXICOLOGY, V29, P361, DOI 10.1016/j.neuro.2008.02.011; Rakhit S, 2001, MOL PHARMACOL, V60, P63, DOI 10.1124/mol.60.1.63; Read DE, 2008, BRAIN RES, V1221, P14, DOI 10.1016/j.brainres.2008.05.028; Ruggeri P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094568; RYDEL RE, 1987, J NEUROSCI, V7, P3639; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Williams KL, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-24; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Xiao BL, 2011, NAT CHEM BIOL, V7, P351, DOI [10.1038/NCHEMBIO.558, 10.1038/nchembio.558]; Yan SY, 2014, BRAZ J MED BIOL RES, V47, P947, DOI 10.1590/1414-431X20143808; Yanagisawa M, 2001, GENES CELLS, V6, P1091, DOI 10.1046/j.1365-2443.2001.00483.x; Yao H, 1998, J BIOL CHEM, V273, P8240, DOI 10.1074/jbc.273.14.8240; Yung LY, 2008, CELL SIGNAL, V20, P1538, DOI 10.1016/j.cellsig.2008.04.007	47	15	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124024	10.1371/journal.pone.0124024	http://dx.doi.org/10.1371/journal.pone.0124024			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879210	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500079
J	Wan, K; Zhao, JX; Huang, H; Zhang, Q; Chen, X; Zeng, Z; Zhang, L; Chen, YC				Wan, Ke; Zhao, Jianxun; Huang, Hao; Zhang, Qing; Chen, Xi; Zeng, Zhi; Zhang, Li; Chen, Yucheng			The Association between Triglyceride/High-Density Lipoprotein Cholesterol Ratio and All-Cause Mortality in Acute Coronary Syndrome after Coronary Revascularization	PLOS ONE			English	Article							HDL-CHOLESTEROL; INSULIN-RESISTANCE; HEART-DISEASE; ARTERIAL STIFFNESS; PHENOTYPE-B; RISK; CHILDREN; ADOLESCENTS; ACCURACY; EVENTS	Aims High triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C) are cardiovascular risk factors. A positive correlation between elevated TG/HDL-C ratio and all-cause mortality and cardiovascular events exists in women. However, utility of TG to HDL-C ratio for prediction is unknown among acute coronary syndrome (ACS). Methods Fasting lipid profiles, detailed demographic data, and clinical data were obtained at baseline from 416 patients with ACS after coronary revascularization. Subjects were stratified into three levels of TG/HDL-C. We constructed multivariate Cox-proportional hazard models for all-cause mortality over a median follow-up of 3 years using log TG to HDL-C ratio as a predictor variable and analyzing traditional cardiovascular risk factors. We constructed a logistic regression model for major adverse cardiovascular events (MACEs) to prove that the TG/HDL-C ratio is a risk factor. Results The subject's mean age was 64 +/- 11 years; 54.5% were hypertensive, 21.8% diabetic, and 61.0% current or prior smokers. TG/HDL-C ratio ranged from 0.27 to 14.33. During the follow-up period, there were 43 deaths. In multivariate Cox models after adjusting for age, smoking, hypertension, diabetes, and severity of angiographic coronary disease, patients in the highest tertile of ACS had a 5.32-fold increased risk of mortality compared with the lowest tertile. After adjusting for conventional coronary heart disease risk factors by the logistic regression model, the TG/HDL-C ratio was associated with MACEs. Conclusion The TG to HDL-C ratio is a powerful independent predictor of all-cause mortality and is a risk factor of cardiovascular events.	[Wan, Ke; Zhao, Jianxun; Zhang, Qing; Chen, Xi; Zeng, Zhi; Zhang, Li; Chen, Yucheng] Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Sichuan Provinc, Peoples R China; [Huang, Hao] Peoples Hosp Sichuan Prov, Div Cardiol, Chengdu, Sichuan, Peoples R China	Sichuan University	Wan, K (corresponding author), Sichuan Univ, West China Hosp, Dept Cardiol, Chengdu 610064, Sichuan Provinc, Peoples R China.	LiZhangdoc@yahoo.com; chenyucheng2003@126.com	Chen, Yu/Y-3292-2019; Chen, Yucheng/AAF-6181-2020; Chen, Yi/HIR-2608-2022	Huang, Hao/0000-0003-1748-1245				Ballantyne CM, 2001, CIRCULATION, V104, P3046, DOI 10.1161/hc5001.100624; Barter P, 2007, NEW ENGL J MED, V357, P1301, DOI 10.1056/NEJMoa064278; Bhalodkar NC, 2006, AM J CARDIOL, V97, P1007, DOI 10.1016/j.amjcard.2005.10.036; Bittner V, 2009, AM HEART J, V157, P548, DOI 10.1016/j.ahj.2008.11.014; Brehm A, 2004, CLIN CHEM, V50, P2316, DOI 10.1373/clinchem.2004.037556; Cordero A, 2008, AM J CARDIOL, V102, P424, DOI 10.1016/j.amjcard.2008.03.079; da Luz PL, 2008, CLINICS, V63, P427, DOI 10.1590/S1807-59322008000400003; de Giorgis T, 2014, EUR J ENDOCRINOL, V170, P173, DOI 10.1530/EJE-13-0452; deGoma EM, 2008, J AM COLL CARDIOL, V51, P49, DOI 10.1016/j.jacc.2007.07.086; Dobiasova M, 2001, CLIN BIOCHEM, V34, P583, DOI 10.1016/S0009-9120(01)00263-6; Fuster V, 2011, J AM COLL CARDIOL, V58, P1208, DOI 10.1016/j.jacc.2011.05.038; Gaziano JM, 1997, CIRCULATION, V96, P2520, DOI 10.1161/01.CIR.96.8.2520; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; Giannini C, 2011, DIABETES CARE, V34, P1869, DOI 10.2337/dc10-2234; Hanak V, 2004, AM J CARDIOL, V94, P219, DOI 10.1016/j.amjcard.2004.03.069; Hermans MP, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-132; Hermans MP, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-88; Maki KC, 2011, J CLIN LIPIDOL, V5, P141, DOI 10.1016/j.jacl.2011.02.003; Maruyama Chizuko, 2003, J Atheroscler Thromb, V10, P186; Neil HAW, 2010, ATHEROSCLEROSIS, V211, P618, DOI 10.1016/j.atherosclerosis.2010.03.006; Pacifico L, 2014, NUTR METAB CARDIOVAS, V24, P737, DOI 10.1016/j.numecd.2014.01.010; Shimizu Y, 2013, ATHEROSCLEROSIS, V228, P491, DOI 10.1016/j.atherosclerosis.2013.03.021; St-Pierre AC, 2004, METAB SYNDR RELAT D, V2, P57, DOI 10.1089/met.2004.2.57; Sumner AE, 2010, METAB SYNDR RELAT D, V8, P511, DOI 10.1089/met.2010.0028; Thomas GS, 2013, J AM COLL CARDIOL, V62, P2178, DOI 10.1016/j.jacc.2013.07.081; Urbina EM, 2013, PEDIATRICS, V131, pE1082, DOI 10.1542/peds.2012-1726; Wakabayashi I, 2013, AM J HYPERTENS, V26, P888, DOI 10.1093/ajh/hpt033; Winkler L, 1989, Przegl Lek, V46, P595	28	46	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123521	10.1371/journal.pone.0123521	http://dx.doi.org/10.1371/journal.pone.0123521			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880982	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500054
J	Wei, ZZ; Vatcher, G; Tin, AHY; Teng, JL; Wang, J; Cui, QH; Chen, JG; Yu, ACH				Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Teng, Jun Lin; Wang, Juan; Cui, Qing Hua; Chen, Jian Guo; Yu, Albert Cheung Hoi			Positively-Charged Semi-Tunnel Is a Structural and Surface Characteristic of Polyphosphate-Binding Proteins: An In-Silico Study	PLOS ONE			English	Article							INORGANIC POLYPHOSPHATE; CRYSTAL-STRUCTURE; EXOPOLYPHOSPHATASE; KINASE; IDENTIFICATION; PHOSPHATASE; METABOLISM; EUKARYOTE; ALIGNMENT; COMPLEX	Phosphate is essential for all major life processes, especially energy metabolism and signal transduction. A linear phosphate polymer, polyphosphate (polyP), linked by high-energy phosphoanhydride bonds, can interact with various proteins, playing important roles as an energy source and regulatory factor. However, polyP-binding structures are largely unknown. Here we proposed a putative polyP binding site, a positively-charged semi-tunnel (PCST), identified by surface electrostatics analyses in polyP kinases (PPKs) and many other polyP-related proteins. We found that the PCSTs in varied proteins were folded in different secondary structure compositions. Molecular docking calculations revealed a significant value for binding affinity to polyP in PCST-containing proteins. Utilizing the PCST identified in the beta subunit of PPK3, we predicted the potential polyP-binding domain of PPK3. The discovery of this feature facilitates future searches for polyP-binding proteins and discovery of the mechanisms for polyP-binding activities. This should greatly enhance the understanding of the many physiological functions of protein-bound polyP and the involvement of polyP and polyP-binding proteins in various human diseases.	[Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Neurosci Res Inst, Beijing 100191, Peoples R China; [Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Dept Neurobiol, Sch Basic Med Sci, Beijing 100191, Peoples R China; [Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Key Lab Neurosci, Minist Educ, Beijing 100191, Peoples R China; [Wei, Zheng Zachory; Vatcher, Greg; Tin, Alvin Hok Yan; Yu, Albert Cheung Hoi] Peking Univ, Key Lab Neurosci, Natl Hlth & Family Planning Commiss, Beijing 100191, Peoples R China; [Teng, Jun Lin; Chen, Jian Guo] Peking Univ, Key Lab Cell Proliferat & Differentiat, State Key Lab Biomembrane & Membrane Bioengn, Minist Educ,Coll Life Sci, Beijing 100871, Peoples R China; [Wang, Juan; Cui, Qing Hua] Peking Univ, Sch Basic Med Sci, Dept Med Informat, Beijing 100191, Peoples R China; [Yu, Albert Cheung Hoi] Peking Univ, Ctr Infect Dis, Beijing 100191, Peoples R China; [Yu, Albert Cheung Hoi] Peking Univ, Inst Syst Biomed, Lab Translat Med, Beijing 100191, Peoples R China	Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University; Peking University	Wei, ZZ (corresponding author), Peking Univ, Neurosci Res Inst, Beijing 100191, Peoples R China.	achy@hsc.pku.edu.cn	Wei, Zheng Zachory/I-2109-2019	Wei, Zheng Zachory/0000-0001-7682-9286	National Basic Research Program of China (973 program) [2011CB504400]; National Natural Science Foundation of China [31070974, 31171009, 81221002]; Foundation for Innovative Research Groups of the National Natural Science Foundation of China [81221002]	National Basic Research Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Foundation for Innovative Research Groups of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding for this study was provided by the National Basic Research Program of China (973 program, 2011CB504400), the National Natural Science Foundation of China (31070974, 31171009, 81221002) and the Foundation for Innovative Research Groups of the National Natural Science Foundation of China (81221002).	Abbracchio MP, 2009, TRENDS NEUROSCI, V32, P19, DOI 10.1016/j.tins.2008.10.001; Abramov AY, 2007, P NATL ACAD SCI USA, V104, P18091, DOI 10.1073/pnas.0708959104; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarado J, 2006, STRUCTURE, V14, P1263, DOI 10.1016/j.str.2006.06.009; Ariganello MB, 2014, J CELL BIOCHEM, V115, P2089, DOI 10.1002/jcb.24886; Aschar-Sobbi R, 2008, J FLUORESC, V18, P859, DOI 10.1007/s10895-008-0315-4; Bates PA, 2001, PROTEINS, P39; Campos E, 2007, INSECT BIOCHEM MOLEC, V37, P1103, DOI 10.1016/j.ibmb.2007.06.003; Dedkova EN, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00260; Tommaso P, 2011, NUCLEIC ACIDS RES, V39, pW13, DOI 10.1093/nar/gkr245; Diaz JM, 2010, ENVIRON SCI TECHNOL, V44, P4665, DOI 10.1021/es100191h; Garavaglia S, 2004, J BIOL CHEM, V279, P40980, DOI 10.1074/jbc.M406586200; GASTEIGER J, 1980, TETRAHEDRON, V36, P3219, DOI 10.1016/0040-4020(80)80168-2; Gomez-Garcia MR, 2004, P NATL ACAD SCI USA, V101, P15876, DOI 10.1073/pnas.0406923101; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI [10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P, 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X]; Han KY, 2007, BIOCHEM J, V406, P49, DOI 10.1042/BJ20061542; Harada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078612; Harada K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074650; Hernandez-Ruiz L, 2006, HAEMATOLOGICA, V91, P1180; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Holmstrom KM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2364; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Illergard K, 2009, PROTEINS, V77, P499, DOI 10.1002/prot.22458; Jain S, 2012, P NATL ACAD SCI USA, V109, P12938, DOI 10.1073/pnas.1204928109; Kawai S, 2005, J BIOSCI BIOENG, V99, P320, DOI 10.1263/jbb.99.320; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kristensen O, 2004, BIOCHEMISTRY-US, V43, P8894, DOI 10.1021/bi049083c; Kristensen O, 2008, J MOL BIOL, V375, P1469, DOI 10.1016/j.jmb.2007.11.073; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lee A, 2010, ANAL CHEM, V82, P6838, DOI 10.1021/ac1008018; Lieberman L, 1888, BER CHEM GES, V21, P598, DOI DOI 10.1002/CBER.188802101109; Liu XQ, 2009, NUCLEIC ACIDS RES, V37, pW33, DOI 10.1093/nar/gkp428; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Lorenz B, 2001, BBA-PROTEIN STRUCT M, V1547, P254, DOI 10.1016/S0167-4838(01)00193-5; Mukai T, 2004, J BIOL CHEM, V279, P50591, DOI 10.1074/jbc.M408126200; Mutch NJ, 2010, J THROMB HAEMOST, V8, P548, DOI 10.1111/j.1538-7836.2009.03723.x; Nocek B, 2008, P NATL ACAD SCI USA, V105, P17730, DOI 10.1073/pnas.0807563105; Ohashi K, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2262; Omelon S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005634; Pavlov E, 2010, J BIOL CHEM, V285, P9420, DOI 10.1074/jbc.M109.013011; Rangarajan ES, 2006, J MOL BIOL, V359, P1249, DOI 10.1016/j.jmb.2006.04.031; Segawa S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023278; Seidlmayer LK, 2012, J GEN PHYSIOL, V139, P321, DOI 10.1085/jgp.201210788; Seufferheld MJ, 2010, PLANT MOL BIOL REP, V28, P549, DOI 10.1007/s11105-010-0187-z; Shiba T, 2003, J BIOL CHEM, V278, P26788, DOI 10.1074/jbc.M303468200; Shindyalov IN, 1998, PROTEIN ENG, V11, P739, DOI 10.1093/protein/11.9.739; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; Stewart JJP, 2007, J MOL MODEL, V13, P1173, DOI 10.1007/s00894-007-0233-4; Stotz SC, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-42; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tsutsumi K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086834; Ugochukwu E, 2007, J MOL BIOL, V371, P1007, DOI 10.1016/j.jmb.2007.05.066; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wrench AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076428; Yang ZX, 2010, MOL MICROBIOL, V77, P618, DOI 10.1111/j.1365-2958.2010.07233.x; Yu SP, 2013, TRANSL STROKE RES, V4, P76, DOI 10.1007/s12975-012-0251-0; Zakharian E, 2007, BIOPHYS J, V92, P588, DOI 10.1529/biophysj.106.095273; Zhang HY, 2007, P NATL ACAD SCI USA, V104, P16486, DOI 10.1073/pnas.0706847104; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150; Zhu Y, 2005, EMBO REP, V6, P681, DOI 10.1038/sj.embor.7400448	65	5	7	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123713	10.1371/journal.pone.0123713	http://dx.doi.org/10.1371/journal.pone.0123713			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879219	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500059
J	Wolf, S; Grunewald, S				Wolf, Steffen; Gruenewald, Stefan			Sequence, Structure and Ligand Binding Evolution of Rhodopsin-Like G Protein-Coupled Receptors: A Crystal Structure-Based Phylogenetic Analysis	PLOS ONE			English	Article							OPIOID RECEPTOR; MOLECULAR RECOGNITION; OLFACTORY RECEPTOR; GPCR; COMPLEX; ACTIVATION; PREDICTION; ALIGNMENT; REVEALS; SODIUM	G protein-coupled receptors (GPCRs) form the largest family of membrane receptors in the human genome. Advances in membrane protein crystallization so far resulted in the determination of 24 receptors available as high-resolution atomic structures. We performed the first phylogenetic analysis of GPCRs based on the available set of GPCR structures. We present a new phylogenetic tree of known human rhodopsin-like GPCR sequences based on this structure set. We can distinguish the three separate classes of small-ligand binding GPCRs, peptide binding GPCRs, and olfactory receptors. Analyzing different structural sub-domains, we found that small molecule binding receptors most likely have evolved from peptide receptor precursors, with a rhodopsin/S1PR1 ancestor, most likely an ancestral opsin, forming the link between both classes. A light-activated receptor therefore seems to be the origin of the small molecule hormone receptors of the central nervous system. We find hints for a common evolutionary path of both ligand binding site and central sodium/water binding site. Surprisingly, opioid receptors exhibit both a binding cavity and a central sodium/water binding site similar to the one of biogenic amine receptors instead of peptide receptors, making them seemingly prone to bind small molecule ligands, e.g. opiates. Our results give new insights into the relationship and the pharmacological properties of rhodopsin-like GPCRs.	[Wolf, Steffen] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Dept Biophys,CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China; [Wolf, Steffen] Ruhr Univ Bochum, Dept Biophys, Bochum, Germany; [Gruenewald, Stefan] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Ruhr University Bochum; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society	Wolf, S (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Computat Biol, Dept Biophys,CAS MPG Partner Inst Computat Biol, Shanghai, Peoples R China.	swolf@picb.ac.cn	Wolf, Steffen/A-1721-2010	Wolf, Steffen/0000-0003-1752-6175	Chinese Academy of Sciences Fellowship for Young International Scientists; National Natural Science Foundation of China (NSFC) Research Fund for International Young Scientists [31250110070]	Chinese Academy of Sciences Fellowship for Young International Scientists; National Natural Science Foundation of China (NSFC) Research Fund for International Young Scientists	SW is funded by a Chinese Academy of Sciences Fellowship for Young International Scientists. This work was supported by a grant from the National Natural Science Foundation of China (NSFC) Research Fund for International Young Scientists (grant No. 31250110070). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Allaby RG, 2007, EVOL BIOINFORM, V3, P357; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angel TE, 2009, P NATL ACAD SCI USA, V106, P8555, DOI 10.1073/pnas.0903545106; Apweiler R, 2014, NUCLEIC ACIDS RES, V42, pD191, DOI 10.1093/nar/gkt1140; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Blanchet MA, 1996, NAT STRUCT BIOL, V3, P934, DOI 10.1038/nsb1196-934; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; Choe HW, 2011, NATURE, V471, P651, DOI 10.1038/nature09789; Chung S, 2008, BRIT J PHARMACOL, V153, pS339, DOI 10.1038/sj.bjp.0707606; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Feigin ME, 2014, P NATL ACAD SCI USA, V111, P4191, DOI 10.1073/pnas.1320239111; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Feuda R, 2012, P NATL ACAD SCI USA, V109, P18868, DOI 10.1073/pnas.1204609109; Firestein S, 2001, NATURE, V413, P211, DOI 10.1038/35093026; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gehring WJ, 2014, WIRES DEV BIOL, V3, P1, DOI 10.1002/wdev.96; Gelis L, 2012, ANGEW CHEM INT EDIT, V51, P1274, DOI 10.1002/anie.201103980; Gerwert K, 2014, BBA-BIOENERGETICS, V1837, P606, DOI 10.1016/j.bbabio.2013.09.006; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Granier S, 2012, NATURE, V485, P400, DOI 10.1038/nature11111; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Gutierrez-de-Teran H, 2013, STRUCTURE, V21, P2175, DOI 10.1016/j.str.2013.09.020; Haga K, 2012, NATURE, V482, P547, DOI 10.1038/nature10753; Hankins MW, 2008, TRENDS NEUROSCI, V31, P27, DOI 10.1016/j.tins.2007.11.002; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hollenstein K, 2013, NATURE, V499, P438, DOI 10.1038/nature12357; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; Jafurulla M, 2012, CMC, V20, P47, DOI DOI 10.2174/0929867311302010006; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Kane BE, 2006, AAPS J, V8, pE126, DOI 10.1208/aapsj080115; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; KOLAKOWSKI LF, 1994, RECEPTOR CHANNEL, V2, P1; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Kruse AC, 2012, NATURE, V482, P552, DOI 10.1038/nature10867; KUHNER MK, 1994, MOL BIOL EVOL, V11, P459; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Lebon G, 2011, NATURE, V474, P521, DOI 10.1038/nature10136; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Liu W, 2012, SCIENCE, V337, P232, DOI 10.1126/science.1219218; Lundstrom K, 2006, CURR PROTEIN PEPT SC, V7, P465, DOI 10.2174/138920306778559403; Madabushi S, 2004, J BIOL CHEM, V279, P8126, DOI 10.1074/jbc.M312671200; Manglik A, 2012, NATURE, V485, P321, DOI 10.1038/nature10954; Mihalek I, 2004, J MOL BIOL, V336, P1265, DOI 10.1016/j.jmb.2003.12.078; Miller-Gallacher JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092727; Molinari P, 2010, J BIOL CHEM, V285, P12522, DOI 10.1074/jbc.M109.059410; Mombaerts P, 2001, ANNU REV GENOM HUM G, V2, P493, DOI 10.1146/annurev.genom.2.1.493; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Niimura Y, 2009, GENOME BIOL EVOL, V1, P34, DOI 10.1093/gbe/evp003; Okada T, 2004, J MOL BIOL, V342, P571, DOI 10.1016/j.jmb.2004.07.044; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Park JH, 2013, ANGEW CHEM INT EDIT, V52, P11021, DOI 10.1002/anie.201302374; Pele J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019094; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rodriguez GJ, 2010, P NATL ACAD SCI USA, V107, P7787, DOI 10.1073/pnas.0914877107; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schrodinger L, 2010, THE PYMOL MOLECULAR; Schuenke M, 2010, THIEME ATLAS OF ANAT; Shimamura T, 2011, NATURE, V475, P65, DOI 10.1038/nature10236; Siu FY, 2013, NATURE, V499, P444, DOI 10.1038/nature12393; Stewart A, 2011, REV NEUROSCIENCE, V22, P95, DOI 10.1515/RNS.2011.011; Surgand JS, 2006, PROTEINS, V62, P509, DOI 10.1002/prot.20768; Tan QX, 2013, SCIENCE, V341, P1387, DOI 10.1126/science.1241475; Thompson AA, 2012, NATURE, V485, P395, DOI 10.1038/nature11085; Vogel R, 2001, J BIOL CHEM, V276, P38487, DOI 10.1074/jbc.M105423200; Wacker D, 2013, SCIENCE, V340, P615, DOI 10.1126/science.1232808; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Wang C, 2013, SCIENCE, V340, P610, DOI 10.1126/science.1232807; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; White JF, 2012, NATURE, V490, P508, DOI 10.1038/nature11558; Wu BL, 2010, SCIENCE, V330, P1066, DOI 10.1126/science.1194396; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Wu HX, 2012, NATURE, V485, P327, DOI 10.1038/nature10939; Yuan S, 2015, ANGEW CHEM INT EDIT, V127, P566; Yuan SG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5733; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhang KH, 2014, NATURE, V509, P115, DOI 10.1038/nature13083	96	41	42	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123533	10.1371/journal.pone.0123533	http://dx.doi.org/10.1371/journal.pone.0123533			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881057	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500055
J	Yoon, YE; Lee, KS; Choi, KH; Kim, KH; Yang, SC; Han, WK				Yoon, Young Eun; Lee, Kwang Suk; Choi, Kyung Hwa; Kim, Kwang Hyun; Yang, Seung Choul; Han, Woong Kyu			Preconditioning Strategies for Kidney Ischemia Reperfusion Injury: Implications of the "Time-Window" in Remote Ischemic Preconditioning	PLOS ONE			English	Article							GENE-EXPRESSION; RENAL ISCHEMIA; NITRIC-OXIDE; PROTECTION; RAT; CELLS; MECHANISMS; BIOMARKERS; ADENOSINE; HEART	Remote ischemic preconditioning (IP) is a potential renoprotective strategy. However, there has been no demonstrated result in large animals and the role of time window in remote IP remains to be defined. Using a single-kidney porcine model, we evaluated organ protective function of remote IP in renal ischemia reperfusion injury. Fifteen Yorkshire pigs, 20 weeks old and weighing 35-38 kg were used. One week after left nephrectomy, we performed remote IP (clamping right external iliac artery, 2 cycles of 10 minutes) and right renal artery clamping (warm ischemia; 90 minutes). The animals were randomly divided into three groups: control group, warm ischemia without IP; group 1 (remote IP with early window [IP-E]), IP followed by warm ischemia with a 10-minute time window; and group 2 (remote IP with late window [IP-L]), IP followed by warm ischemia after a 24-hour time window. There were no differences in serum creatinine changes between groups. The IP-L group had lower urinary neutrophil gelatinase-associated lipocalin than control and IP-E at 72 hours post-ischemia. At 72 hours post-ischemia, the urinary kidney injury molecule-1 (KIM-1) was lower in the IP-L group than in the control and IP-E groups, and the IP-L group KIM-1 was near pre-ischemic levels, whereas the control and IP-E group KIM-1 levels were rising. Microalbumin also tended to be lower in the IP-L group. Taken together, remote IP showed a significant reduction in renal injury biomarkers from ischemia reperfusion injury. To effectively provide kidney protection, remote IP might require a considerable, rather than short, time window of ischemia.	[Yoon, Young Eun; Lee, Kwang Suk; Yang, Seung Choul; Han, Woong Kyu] Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea; [Choi, Kyung Hwa] CHA Univ, CHA Bundang Med Ctr, Dept Urol, Songnam, South Korea; [Kim, Kwang Hyun] Ewha Womans Univ, Mokdong Hosp, Dept Urol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Pochon Cha University; Ewha Womans University	Han, WK (corresponding author), Yonsei Univ, Coll Med, Urol Sci Inst, Dept Urol, Seoul, South Korea.	hanwk@yuhs.ac		Yoon, Young Eun/0000-0001-8059-6649; Han, Woong Kyu/0000-0002-2527-4046; Lee, Kwang Suk/0000-0002-7961-8393	National Research Foundation of Korea (NRF) grant - Korea government (MEST) [NRF-2012R1A1A1042968]	National Research Foundation of Korea (NRF) grant - Korea government (MEST)	This work (No. NRF-2012R1A1A1042968) was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST).	Ayupova DA, 2009, AM J PHYSIOL-RENAL, V297, pF95, DOI 10.1152/ajprenal.90632.2008; Bellomo R, 2004, INTENS CARE MED, V30, P33, DOI 10.1007/s00134-003-2078-3; Burne-Taney MJ, 2006, J IMMUNOL, V176, P7015, DOI 10.4049/jimmunol.176.11.7015; Cernaro V, 2011, CURR PHARM DESIGN, V17, P844, DOI 10.2174/138161211795428939; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Devarajan P, 2003, MOL GENET METAB, V80, P365, DOI 10.1016/j.ymgme.2003.09.012; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Fu WJ, 2012, DIABETES RES CLIN PR, V95, P105, DOI 10.1016/j.diabres.2011.09.031; Gardner DS, 2014, AM J PHYSIOL-RENAL, V306, pF873, DOI 10.1152/ajprenal.00576.2013; Haase M, 2009, AM J KIDNEY DIS, V54, P1012, DOI 10.1053/j.ajkd.2009.07.020; Halestrap AP, 2007, BBA-BIOENERGETICS, V1767, P1007, DOI 10.1016/j.bbabio.2007.05.008; Hausenloy DJ, 2009, ATHEROSCLEROSIS, V204, P334, DOI 10.1016/j.atherosclerosis.2008.10.029; Hernandez DJ, 2008, J ENDOUROL, V22, P2531, DOI 10.1089/end.2008.0145; Hotter G, 1996, BIOCHEM BIOPH RES CO, V222, P27, DOI 10.1006/bbrc.1996.0692; Huang JW, 2013, BJU INT, V112, P74, DOI 10.1111/bju.12004; Ichimura T, 1998, J BIOL CHEM, V273, P4135, DOI 10.1074/jbc.273.7.4135; Ishida T, 1997, SHOCK, V8, P86, DOI 10.1097/00024382-199708000-00003; JEROME SN, 1995, AM J PHYSIOL-HEART C, V268, pH2063, DOI 10.1152/ajpheart.1995.268.5.H2063; Joo JD, 2006, J AM SOC NEPHROL, V17, P3115, DOI 10.1681/ASN.2006050424; Konstantinov IE, 2004, PHYSIOL GENOMICS, V19, P143, DOI 10.1152/physiolgenomics.00046.2004; Kosieradzki M, 2003, SURGERY, V133, P81, DOI 10.1067/msy.2003.93; Li FZ, 2005, ACTA PHARMACOL SIN, V26, P851, DOI 10.1111/j.1745-7254.2005.00109.x; Li L, 2006, NAT CLIN PRACT NEPHR, V2, P432, DOI 10.1038/ncpneph0238; Maulik N, 1996, FEBS LETT, V396, P233, DOI 10.1016/0014-5793(96)01109-X; Moon SJ, 2013, J KOREAN MED SCI, V28, P1181, DOI 10.3346/jkms.2013.28.8.1181; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Orvieto MA, 2007, UROLOGY, V69, P984, DOI 10.1016/j.urology.2007.01.100; Park KM, 2003, J BIOL CHEM, V278, P27256, DOI 10.1074/jbc.M301778200; PerezPinzon MA, 1997, J CEREBR BLOOD F MET, V17, P175, DOI 10.1097/00004647-199702000-00007; Salehipour M, 2007, UROL INT, V79, P328, DOI 10.1159/000109718; Soni SS, 2009, BLOOD PURIFICAT, V28, P165, DOI 10.1159/000227785; SPEECHLYDICK ME, 1994, CIRC RES, V75, P586, DOI 10.1161/01.RES.75.3.586; Treska Vladislav, 2006, Exp Clin Transplant, V4, P439; Wever KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032296; Yamashita N, 1998, J MOL CELL CARDIOL, V30, P1181, DOI 10.1006/jmcc.1998.0682; Yin DP, 1998, TRANSPLANTATION, V66, P152, DOI 10.1097/00007890-199807270-00002	36	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124130	10.1371/journal.pone.0124130	http://dx.doi.org/10.1371/journal.pone.0124130			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879855	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500084
J	de Kerckhove, DT; Minns, CK; Chu, C				de Kerckhove, Derrick Tupper; Minns, Charles Kenneth; Chu, Cindy			Estimating Fish Exploitation and Aquatic Habitat Loss across Diffuse Inland Recreational Fisheries	PLOS ONE			English	Article							TROUT SALVELINUS-NAMAYCUSH; NO NET LOSS; PRODUCTIVE CAPACITY; UNITED-STATES; LAKE TROUT; CANADA; MANAGEMENT; CONSERVATION; BIODIVERSITY; COMPENSATION	The current state of many freshwater fish stocks worldwide is largely unknown but suspected to be vulnerable to exploitation from recreational fisheries and habitat degradation. Both these factors, combined with complex ecological dynamics and the diffuse nature of inland fisheries could lead to an invisible collapse: the drastic decline in fish stocks without great public or management awareness. In this study we provide a method to address the pervasive knowledge gaps in regional rates of exploitation and habitat degradation, and demonstrate its use in one of North America's largest and most diffuse recreational freshwater fisheries (Ontario, Canada). We estimated that 1) fish stocks were highly exploited and in apparent danger of collapse in management zones close to large population centres, and 2) fish habitat was under a low but constant threat of degradation at rates comparable to deforestation in Ontario and throughout Canada. These findings confirm some commonly held, but difficult to quantify, beliefs in inland fisheries management but also provide some further insights including 1) large anthropogenic projects greater than one hectare could contribute much more to fish habitat loss on an area basis than the cumulative effect of smaller projects within one year, 2) hooking mortality from catch-and-release fisheries is likely a greater source of mortality than the harvest itself, and 3) in most northern management zones over 50% of the fisheries resources are not yet accessible to anglers. While this model primarily provides a framework to prioritize management decisions and further targeted stock assessments, we note that our regional estimates of fisheries productivity and exploitation were similar to broadscale monitoring efforts by the Province of Ontario. We discuss the policy implications from our results and extending the model to other jurisdictions and countries.	[de Kerckhove, Derrick Tupper; Minns, Charles Kenneth; Chu, Cindy] Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada	University of Toronto	de Kerckhove, DT (corresponding author), Univ Toronto, Dept Ecol & Evolutionary Biol, Toronto, ON, Canada.	fish.research@gmail.com	Minns, Charles/GYU-2209-2022	Chu, Cindy/0000-0002-1914-3218	Natural Science and Engineering Research Council of Canada	Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	Funding provided by Natural Science and Engineering Research Council of Canada Post Graduate Scholarship to DDK and Natural Science and Engineering Research Council of Canada Postdoctoral Fellowship to CC, http://www.nserc-crsng.gc.ca/index_eng.asp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS GF, 1977, J FISH RES BOARD CAN, V34, P1613, DOI 10.1139/f77-226; Arlinghaus R, 2005, SCIENCE, V307, P1561, DOI 10.1126/science.307.5715.1561; Arlinghaus R, 2006, ENVIRON CONSERV, V33, P46, DOI 10.1017/S0376892906002700; Bigford TE, 2013, FISHERIES, V38, P196, DOI 10.1080/03632415.2013.792608; Cardoso AC, 2007, HYDROBIOLOGIA, V584, P3, DOI 10.1007/s10750-007-0584-y; CARLANDER KD, 1977, J FISH RES BOARD CAN, V34, P1602, DOI 10.1139/f77-225; Chu C, 2003, CAN J FISH AQUAT SCI, V60, P624, DOI 10.1139/F03-048; Coleman FC, 2004, SCIENCE, V305, P1958, DOI 10.1126/science.1100397; Cooke SJ, 2006, BIOL CONSERV, V128, P93, DOI 10.1016/j.biocon.2005.09.019; Cote D, 2007, J FISH BIOL, V70, P1134, DOI 10.1111/j.1095-8649.2007.01384.x; Cowx IG, 2010, J FISH BIOL, V76, P2194, DOI 10.1111/j.1095-8649.2010.02686.x; de Kerckhove DT, 2013, CAN J FISH AQUAT SCI, V70, P517, DOI 10.1139/cjfas-2012-0411; Downing JA, 2014, INLAND WATERS, V4, P215, DOI 10.5268/IW-4.2.753; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Dudgeon D, 2006, BIOL REV, V81, P163, DOI 10.1017/S1464793105006950; Edwards SF, EC GUIDE ALLOCATION; Esselman Peter C., 2011, Ecological Restoration, V29, P133, DOI 10.3368/er.29.1-2.133; EVANS DO, 1991, CAN J FISH AQUAT SCI, V48, P134, DOI 10.1139/f91-312; Favaro B, 2012, SCIENCE, V337, P154, DOI 10.1126/science.1225523; Fisheries and Oceans Canada, 2014, FISH PROT PROGR; Fisheries and Oceans Canada, 2012, SURV RECR FISH CAN 2; Foley NS, 2012, INT J ECOL, V2012, DOI DOI 10.1155/2012/861635; Gale MK, 2013, FISH FISH, V14, P1, DOI 10.1111/j.1467-2979.2011.00441.x; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Government of Ontario, 2012, GEON S ONT; Griffiths D, 2006, ECOL FRESHW FISH, V15, P86, DOI 10.1111/j.1600-0633.2006.00125.x; Gunn JM, 2000, CAN J FISH AQUAT SCI, V57, P97, DOI 10.1139/cjfas-57-S2-97; Halverson MA, 2008, FISHERIES, V33, P69, DOI 10.1577/1548-8446-33.2.69; Hanson PC, 2007, FRESHWATER BIOL, V52, P814, DOI 10.1111/j.1365-2427.2007.01730.x; Harper DJ, 2005, ENVIRON MANAGE, V36, P343, DOI 10.1007/s00267-004-0114-x; Hogg SE, 2010, 2005 SURVEY RECREATI; Hogg SE, 2010, EFFECTIVENESS 2005 R; Hunt LM, 2011, ECOL APPL, V21, P2555, DOI 10.1890/10-1237.1; Hutchings JA, 2013, FISHERIES, V38, P497, DOI 10.1080/03632415.2013.848345; Kaufman SD, 2009, CAN J FISH AQUAT SCI, V66, P212, DOI 10.1139/F08-205; Killen SS, 2003, N AM J FISH MANAGE, V23, P1238, DOI 10.1577/M02-164; Knowler DJ, 2003, J ENVIRON MANAGE, V69, P261, DOI 10.1016/j.jenvman.2003.09.001; Lange M, 2001, CAN MS REP FISH AQUA, V2576, P1; Lester NP, 2003, N AM J FISH MANAGE, V23, P1312, DOI 10.1577/M01-230AM; Lewin WC, 2006, REV FISH SCI, V14, P305, DOI 10.1080/10641260600886455; Linke J, 2012, REMOTE SENS ENVIRON, V125, P112, DOI 10.1016/j.rse.2012.07.011; MacNeil J. E., 2008, Canadian Manuscript Report of Fisheries and Aquatic Sciences, V2840, P1; MAHON R, 1985, CAN J FISH AQUAT SCI, V42, P1211, DOI 10.1139/f85-148; McGarvey DJ, 2010, J N AM BENTHOL SOC, V29, P1212, DOI 10.1899/09-094.1; McKenna JE, 2005, N AM J FISH MANAGE, V25, P391, DOI 10.1577/M04-022.1; McKenney DW, 2010, CLIMATE CHANGE RES R, V16, P1; McMurtry M. J., 1997, Lake and Reservoir Management, V13, P199; Minns CK, 2010, AQUAT ECOSYST HEALTH, V13, P107, DOI 10.1080/14634981003788821; Minns CK, 2008, CAN J FISH AQUAT SCI, V65, P1763, DOI 10.1139/F08-110; Minns CK, 2006, CAN J FISH AQUAT SCI, V63, P1172, DOI 10.1139/F06-025; Minns CK, 2011, CAN J FISH AQUAT SCI, V68, P2204, DOI 10.1139/F2011-130; Minns CK, 2009, AQUAT ECOSYST HEALTH, V12, P152, DOI 10.1080/14634980902905775; Minns CK, 2003, CAN J FISH AQUAT SCI, V60, P100, DOI 10.1139/F02-168; Moilanen A, 2009, RESTOR ECOL, V17, P470, DOI 10.1111/j.1526-100X.2008.00382.x; Noges T, 2009, HYDROBIOLOGIA, V633, P33, DOI 10.1007/s10750-009-9874-x; Office of the Auditor General of Canada, 2009, SPRING REP COMM ENV; Post JR, 2008, ECOL APPL, V18, P1038, DOI 10.1890/07-0465.1; Post JR, 2013, FISHERIES MANAG ECOL, V20, P99, DOI 10.1111/fme.12008; Post JR, 2002, FISHERIES, V27, P6, DOI 10.1577/1548-8446(2002)027&lt;0006:CRF&gt;2.0.CO;2; Quigley JT, 2006, ENVIRON MANAGE, V37, P351, DOI 10.1007/s00267-004-0263-y; Radford A, EC EVALUATION INLAND, P1; Radomski P, 2010, FISHERIES, V35, P489, DOI 10.1577/1548-8446-35.10.489; RANDALL RG, 1995, CAN J FISH AQUAT SCI, V52, P631, DOI 10.1139/f95-063; Rosenfeld JS, 2008, N AM J FISH MANAGE, V28, P1108, DOI 10.1577/M07-027.1; Ryall KL, 2006, ECOLOGY, V87, P1086, DOI 10.1890/0012-9658(2006)87[1086:ROPTLA]2.0.CO;2; Scarborough G.C., 1993, LAKE RESERV MANAGE, V10, P155; SCHLESINGER DA, 1982, T AM FISH SOC, V111, P141, DOI 10.1577/1548-8659(1982)111<141:CAMIOF>2.0.CO;2; Schlesinger DA, 1983, ONTARIO FISHERIES TE, V10; Soranno PA, 2010, BIOSCIENCE, V60, P440, DOI 10.1525/bio.2010.60.6.8; Stammler KL, 2008, CAN J FISH AQUAT SCI, V65, P509, DOI 10.1139/F07-183; Stanfield L, 2010, ONTARIO RIVER ASSESS; Stanfield LW, 2006, AM FISH S S, V48, P577; Swales S, 2006, LAKE RESERV MANAGE, V22, P167, DOI 10.1080/07438140609353894; Sweeney BW, 2004, P NATL ACAD SCI USA, V101, P14132, DOI 10.1073/pnas.0405895101; U.S. Fish and Wildlife, 2012, NAT SURV FISH HUNT W; Velez-Espino LA, 2009, AQUAT CONSERV, V19, P676, DOI 10.1002/aqc.1023; Water Service of Canada, 1977, REF IND HYDSR MAP SU	77	7	7	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0121895	10.1371/journal.pone.0121895	http://dx.doi.org/10.1371/journal.pone.0121895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875790	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800034
J	Georges, JF; Liu, XW; Eschbacher, J; Nichols, J; Mooney, MA; Joy, A; Spetzler, RF; Feuerstein, BG; Preul, MC; Anderson, T; Yan, H; Nakaji, P				Georges, Joseph F.; Liu, Xiaowei; Eschbacher, Jennifer; Nichols, Joshua; Mooney, Michael A.; Joy, Anna; Spetzler, Robert F.; Feuerstein, Burt G.; Preul, Mark C.; Anderson, Trent; Yan, Hao; Nakaji, Peter			Use of a Conformational Switching Aptamer for Rapid and Specific Ex Vivo Identification of Central Nervous System Lymphoma in a Xenograft Model	PLOS ONE			English	Article							IN-VIVO; CELLS; GLIOBLASTOMA; SELECTION; EVOLUTION; LIGANDS; PROBE	Improved tools for providing specific intraoperative diagnoses could improve patient care. In neurosurgery, intraoperatively differentiating non-operative lesions such as CNS B-cell lymphoma from operative lesions can be challenging, often necessitating immunohistochemical (IHC) procedures which require up to 24-48 hours. Here, we evaluate the feasibility of generating rapid ex vivo specific labeling using a novel lymphoma-specific fluorescent switchable aptamer. Our B-cell lymphoma-specific switchable aptamer produced only low-level fluorescence in its unbound conformation and generated an 8-fold increase in fluorescence once bound to its target on CD20-positive lymphoma cells. The aptamer demonstrated strong binding to B-cell lymphoma cells within 15 minutes of incubation as observed by flow cytometry. We applied the switchable aptamer to ex vivo xenograft tissue harboring B-cell lymphoma and astrocytoma, and within one hour specific visual identification of lymphoma was routinely possible. In this proof-of-concept study in human cell culture and orthotopic xenografts, we conclude that a fluorescent switchable aptamer can provide rapid and specific labeling of B-cell lymphoma, and that developing aptamer-based labeling approaches could simplify tissue staining and drastically reduce time to histopathological diagnoses compared with IHC-based methods. We propose that switchable aptamers could enhance expeditious, accurate intraoperative decision-making.	[Georges, Joseph F.; Joy, Anna] St Josephs Hosp, Barrow Neurol Inst, Div Neurosci, Phoenix, AZ USA; [Georges, Joseph F.; Mooney, Michael A.; Spetzler, Robert F.; Preul, Mark C.; Nakaji, Peter] St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA; [Eschbacher, Jennifer] St Josephs Hosp, Barrow Neurol Inst, Div Neuropathol, Phoenix, AZ USA; [Liu, Xiaowei; Yan, Hao] Arizona State Univ, Biodesign Inst, Tempe, AZ USA; [Nichols, Joshua; Feuerstein, Burt G.; Anderson, Trent] Univ Arizona, Coll Med, Phoenix, AZ USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Arizona State University; Arizona State University-Tempe; University of Arizona	Nakaji, P (corresponding author), St Josephs Hosp, Barrow Neurol Inst, Div Neurol Surg, Phoenix, AZ 85013 USA.	Neuropub@dignityhealth.org	Feuerstein, Burt G/A-5186-2015; Liu, Xiaowei/L-2383-2016	Feuerstein, Burt G/0000-0001-7276-8842; 				Blank M, 2001, J BIOL CHEM, V276, P16464, DOI 10.1074/jbc.M100347200; Chu PGG, 2006, AM J CLIN PATHOL, V126, P534, DOI 10.1309/3WG32YRAMQ7RB9D4; ELLINGTON AD, 1990, NATURE, V346, P818, DOI 10.1038/346818a0; Foersch S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041760; Georges JF, 2014, J CLIN NEUROSCI, V21, P846, DOI 10.1016/j.jocn.2014.02.007; Haybaeck J, 2012, PATHOLOGE, V33, P379, DOI 10.1007/s00292-012-1604-x; Hicke BJ, 2006, J NUCL MED, V47, P668; Hofman F.M., 2013, CURR PROTOC IMMUNOL, V103, P4; Hokfelt T, 1999, BRAIN RES BULL, V50, P371, DOI 10.1016/S0361-9230(99)00109-4; Keefe AD, 2010, NAT REV DRUG DISCOV, V9, P537, DOI 10.1038/nrd3141; Liu XW, 2011, SMALL, V7, P1673, DOI 10.1002/smll.201002292; Mallikaratchy PR, 2011, NUCLEIC ACIDS RES, V39, P2458, DOI 10.1093/nar/gkq996; Nimmerjahn A, 2004, NAT METHODS, V1, P31, DOI 10.1038/nmeth706; Plesec TP, 2007, ARCH PATHOL LAB MED, V131, P1532; Safi MAA, 2010, SAUDI MED J, V31, P359; Sankar T, 2010, NEUROSURGERY, V66, P410, DOI 10.1227/01.NEU.0000365772.66324.6F; SCHIFFER D, 1986, BASIC APPL HISTOCHEM, V30, P253; Sefah K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014269; Shi H, 2011, P NATL ACAD SCI USA, V108, P3900, DOI 10.1073/pnas.1016197108; Tang ZW, 2008, J AM CHEM SOC, V130, P11268, DOI 10.1021/ja804119s; Tang ZW, 2007, ANAL CHEM, V79, P4900, DOI 10.1021/ac070189y; TUERK C, 1990, SCIENCE, V249, P505, DOI 10.1126/science.2200121; Wu CC, 2013, ACS NANO, V7, P5724, DOI 10.1021/nn402517v	23	13	13	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123607	10.1371/journal.pone.0123607	http://dx.doi.org/10.1371/journal.pone.0123607			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876071	Green Published, gold			2022-12-27	WOS:000353015800107
J	Veres, G; Hegedus, P; Barnucz, E; Zoller, R; Klein, S; Schmidt, H; Radovits, T; Korkmaz, S; Karck, M; Szabo, G				Veres, Gabor; Hegedus, Peter; Barnucz, Eniko; Zoeller, Raphael; Klein, Stephanie; Schmidt, Harald; Radovits, Tamas; Korkmaz, Sevil; Karck, Matthias; Szabo, Gabor			Endothelial Dysfunction of Bypass Graft: Direct Comparison of In Vitro and In Vivo Models of Ischemia-Reperfusion Injury	PLOS ONE			English	Article							HYDROGEN-PEROXIDE; COLD-STORAGE; SELECTIVE PHOSPHODIESTERASE-5-INHIBITOR; CARDIOVASCULAR-SURGERY; HYPOXIA-REOXYGENATION; ORGAN PRESERVATION; PULMONARY-ARTERY; CELL INJURY; HYPOCHLORITE; VARDENAFIL	Background Although, ischemia/reperfusion induced vascular dysfunction has been widely described, no comparative study of in vivo- and in vitro-models exist. In this study, we provide a direct comparison between models (A) ischemic storage and in-vitro reoxygenation (B) ischemic storage and in vitro reperfusion (C) ischemic storage and in-vivo reperfusion. Methods and Results Aortic arches from rats were stored for 2 hours in saline. Arches were then (A) in vitro reoxygenated (B) in vitro incubated in hypochlorite for 30 minutes (C) in vivo reperfused after heterotransplantation (2, 24 hours and 7 days reperfusion). Endothelium-dependent and independent vasorelaxations were assessed in organ bath. DNA strand breaks were assessed by TUNEL-method, mRNA expressions (caspase-3, bax, bcl-2, eNOS) by quantitative real-time PCR, proteins by Western blot analysis and the expression of CD-31 by immunochemistry. Endothelium-dependent maximal relaxation was drastically reduced in the in-vivo models compared to ischemic storage and in-vitro reperfusion group, and no difference showed between ischemic storage and control group. CD31-staining showed significantly lower endothelium surface ratio in-vivo, which correlated with TUNEL-positive ratio. Increased mRNA and protein levels of pro-and anti-apoptotic gens indicated a significantly higher damage in the in-vivo models. Conclusion Even short-period of ischemia induces severe endothelial damage (in-vivo reperfusion model). In-vitro models of ischemia-reperfusion injury can be limitedly suited for reliable investigations. Time course of endothelial stunning is also described.	[Veres, Gabor; Hegedus, Peter; Barnucz, Eniko; Zoeller, Raphael; Klein, Stephanie; Schmidt, Harald; Korkmaz, Sevil; Karck, Matthias; Szabo, Gabor] Heidelberg Univ, Dept Cardiac Surg, Heidelberg, Germany; [Hegedus, Peter; Radovits, Tamas] Semmelweis Univ, Ctr Heart, H-1085 Budapest, Hungary	Ruprecht Karls University Heidelberg; Semmelweis University	Veres, G (corresponding author), Heidelberg Univ, Dept Cardiac Surg, Heidelberg, Germany.	gaborveres@yahoo.com		Szabo, Gabor/0000-0001-6038-9968				Barnucz E, 2013, J PHARMACOL EXP THER, V345, P25, DOI 10.1124/jpet.112.200790; Besse S, 2002, MECH AGEING DEV, V123, P275, DOI 10.1016/S0047-6374(01)00327-X; Boyle EM, 1996, ANN THORAC SURG, V62, P1868, DOI 10.1016/S0003-4975(96)00950-2; Carrasco-Martin C, 2005, EXP PHYSIOL, V90, P557, DOI 10.1113/expphysiol.2005.030163; Chu Y, 2004, J HEART LUNG TRANSPL, V23, P592, DOI 10.1016/S1053-2498(03)00304-8; Ebner A, 2012, J VASC SURG, V56, P189, DOI 10.1016/j.jvs.2011.12.012; Fournet-Bourguignon MP, 2000, CIRC RES, V86, P854, DOI 10.1161/01.RES.86.8.854; Garbe S, 2011, J VASC SURG, V53, P1063, DOI 10.1016/j.jvs.2010.10.093; Hummitzsch L, 2014, EXP CELL RES, V322, P62, DOI 10.1016/j.yexcr.2013.12.022; Inauen W, 1990, AM J PHYSIOL, V259, P134; Inauen W, 1990, AM J PHYSIOL, V259, P925; Kang YH, 2001, MOL CELL BIOCHEM, V216, P37, DOI 10.1023/A:1011040026620; Koch A, 2001, EUR J CARDIO-THORAC, V20, P996, DOI 10.1016/S1010-7940(01)00905-8; Korkmaz S, 2009, EUR J PHARMACOL, V615, P155, DOI 10.1016/j.ejphar.2009.05.020; LOCKERMAN ZS, 1986, CHEST, V89, P647, DOI 10.1378/chest.89.5.647; LUSCHER TF, 1991, CURR OPIN CARDIOL, V6, P868; Maathuis MHJ, 2007, TRANSPLANTATION, V83, P1289, DOI 10.1097/01.tp.0000265586.66475.cc; PEARSON PJ, 1990, CIRC RES, V67, P385, DOI 10.1161/01.RES.67.2.385; PEARSON PJ, 1992, ANN THORAC SURG, V54, P1078, DOI 10.1016/0003-4975(92)90073-D; Radovits T, 2009, BRIT J PHARMACOL, V156, P909, DOI 10.1111/j.1476-5381.2008.00098.x; Radovits T, 2008, J HEART LUNG TRANSPL, V27, P208, DOI 10.1016/j.healun.2007.11.002; Radovits T, 2007, EXP BIOL MED, V232, P1204, DOI 10.3181/0701-RM-16; Radovits T, 2007, EUR J PHARMACOL, V564, P158, DOI 10.1016/j.ejphar.2007.02.060; Radovits T, 2013, EUR J PHARMACOL, V710, P110, DOI 10.1016/j.ejphar.2013.04.012; Radovits T, 2009, VASC PHARMACOL, V51, P37, DOI 10.1016/j.vph.2009.01.009; Sand C, 2003, CLIN EXP PHARMACOL P, V30, P249, DOI 10.1046/j.1440-1681.2003.03822.x; Sellke FW, 1996, ANN THORAC SURG, V62, P1222, DOI 10.1016/0003-4975(96)00538-3; TADA T, 1990, ANN NY ACAD SCI, V598, P507, DOI 10.1111/j.1749-6632.1990.tb42326.x; Thomas SR, 2006, FREE RADICAL BIO MED, V41, P681, DOI 10.1016/j.freeradbiomed.2006.05.012; Veres G, 2013, EUR J VASC ENDOVASC, V46, P242, DOI 10.1016/j.ejvs.2013.05.006; Wilbring M, 2011, EUR J CARDIO-THORAC, V40, P811, DOI 10.1016/j.ejcts.2011.01.024; YANG BC, 1992, LIFE SCI, V50, P1805, DOI 10.1016/0024-3205(92)90065-W; Yokoyama S, 1996, AM J PHYSIOL-REG I, V270, pR1126, DOI 10.1152/ajpregu.1996.270.5.R1126	33	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124025	10.1371/journal.pone.0124025	http://dx.doi.org/10.1371/journal.pone.0124025			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875813	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000353015800128
J	Kollewe, K; Wurster, U; Sinzenich, T; Korner, S; Dengler, R; Mohammadi, B; Petri, S				Kollewe, Katja; Wurster, Ulrich; Sinzenich, Thomas; Koerner, Sonja; Dengler, Reinhard; Mohammadi, Bahram; Petri, Susanne			Anti-Ganglioside Antibodies in Amyotrophic Lateral Sclerosis Revisited	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; ANTI-GM1 GANGLIOSIDE ANTIBODIES; MILLER-FISHER; IGM ANTIBODIES; PERIPHERAL NEUROPATHIES; MULTIPLE-SCLEROSIS; GM1 GANGLIOSIDE; HUMAN MOTOR; ALSFRS-R; SERUM	Background Amyotrophic Lateral Sclerosis (ALS) is a devastating neurodegenerative disorder with typical onset in the 5th-6th decade of life. The hypothesis of an autoimmune origin of ALS receives less attention today, but immunological phenomena still seem to be involved and mechanisms such as protective autoimmunity may be important. Detection of antibodies against a variety of gangliosides has been repeatedly described in ALS-patients by several authors, but widely differing frequencies and titres have been reported. Therefore, we investigated the presence of six common antibodies with a commercially available test panel for GA1, GM1, GM2, GD1a, GD1b and GQ1b in a large group of clinically well-characterized ALS patients and compared them to a collective of 200 healthy blood donors. Methods IgG and IgM antibodies to the six gangliosides asialoGM1 (GA1), GM1, GM2, GD1a, GD1b, GQ1b were determined by GanglioCombi ELISA in sera of 84 ALS patients. Results were expressed as a %-ratio of a highly positive control and categorized as negative (<30%), borderline (30-50%), moderately (50-100%) and strongly positive (>100%). The values obtained from 200 Swiss blood donors served as a reference group. Results In twenty-two (26.2%) ALS-patients elevated anti-ganglioside antibodies could be detected: Taking all subspecific antibodies together, IgG antibodies were found in 9/84 (10.7%) and IgM in 15/84 (17.9%) patients. There was no correlation between age, gender, site of onset or survival and anti-ganglioside-positive/-negative titres in ALS-patients. No statistically significant difference in the frequency of anti-ganglioside antibodies compared to the group of healthy blood donors was found. Conclusion Even with this more comprehensive approach, anti-ganglioside antibody frequencies and patterns in our ALS cohort closely resembled the values measured in healthy controls. In accordance with other studies, we did not observe any association of a distinct ALS phenotype with elevated anti-ganglioside antibodies or an impact on survival.	[Kollewe, Katja; Wurster, Ulrich; Sinzenich, Thomas; Koerner, Sonja; Dengler, Reinhard; Petri, Susanne] Hannover Med Sch, Dept Neurol, Hannover, Germany; [Mohammadi, Bahram] Univ Lubeck, Dept Neurol, Lubeck, Germany; [Mohammadi, Bahram] Int Neurosci Inst, CNS LAB, Hannover, Germany	Hannover Medical School; University of Lubeck	Kollewe, K (corresponding author), Hannover Med Sch, Dept Neurol, Hannover, Germany.	kollewe.katja@mh-hannover.de	Petri, Susanne/AID-7665-2022					ADAMS D, 1991, J NEUROIMMUNOL, V32, P223, DOI 10.1016/0165-5728(91)90192-A; Ariga T, 2014, J NEUROSCI RES, V92, P1227, DOI 10.1002/jnr.23411; Benkler M, 2009, INT J NEUROSCI, V119, P2133, DOI 10.3109/00207450903178786; BENYOUNESCHENNOUFI A, 1992, NEUROCHEM INT, V20, P353; Biessels GJ, 1997, J NEUROL, V244, P143, DOI 10.1007/s004150050065; Brooks BR, 2000, AMYOTROPH LATERAL SC, V1, P293, DOI 10.1080/146608200300079536; Carpo M, 1996, ANN NEUROL, V39, P539, DOI 10.1002/ana.410390417; Cats EA, 2010, NEUROLOGY, V75, P1961, DOI 10.1212/WNL.0b013e3181ff94c2; Caudie C, 2013, CLIN LAB, V59, P1277, DOI 10.7754/Clin.Lab.2013.121116; Cedarbaum JM, 1999, J NEUROL SCI, V169, P13, DOI 10.1016/S0022-510X(99)00210-5; CHAPMAN J, 1988, NEUROSCI LETT, V86, P235, DOI 10.1016/0304-3940(88)90577-0; Chiba A, 1997, BRAIN RES, V745, P32, DOI 10.1016/S0006-8993(96)01123-7; CHIBA A, 1993, NEUROLOGY, V43, P1911, DOI 10.1212/WNL.43.10.1911; CORBO M, 1992, ANN NEUROL, V32, P487, DOI 10.1002/ana.410320402; CORBO M, 1993, NEUROLOGY, V43, P809, DOI 10.1212/WNL.43.4.809; Czaplinski A, 2006, J NEUROL, V253, P1428, DOI 10.1007/s00415-006-0226-8; Czaplinski A, 2006, MUSCLE NERVE, V34, P702, DOI 10.1002/mus.20658; Eisele L, 2012, ANN HEMATOL, V91, P243, DOI 10.1007/s00277-011-1293-1; ENDO T, 1984, J IMMUNOL, V132, P1793; Farbu E, 2003, J NEUROIMMUNOL, V139, P141, DOI 10.1016/S0165-5728(03)00123-1; Furukawa K, 2011, NEUROCHEM RES, V36, P1578, DOI 10.1007/s11064-011-0494-2; GURNEY ME, 1984, NEW ENGL J MED, V311, P933, DOI 10.1056/NEJM198410113111501; HAMBERGER A, 1971, J NEUROCHEM, V18, P1821, DOI 10.1111/j.1471-4159.1971.tb09587.x; ILYAS AA, 1992, J NEUROL SCI, V107, P111, DOI 10.1016/0022-510X(92)90217-9; ILYAS AA, 1992, J NEUROIMMUNOL, V36, P69, DOI 10.1016/0165-5728(92)90031-F; Khandelwal D, 2006, NEUROL INDIA, V54, P399; Kollewe K, 2008, J NEUROL SCI, V275, P69, DOI 10.1016/j.jns.2008.07.016; KORNBERG AJ, 1994, MUSCLE NERVE, V17, P100, DOI 10.1002/mus.880170115; Kornberg AJ, 2000, J CLIN NEUROSCI, V7, P191, DOI 10.1054/jocn.1999.0194; Kornberg AJ, 1996, NEUROLOGY, V47, P1317, DOI 10.1212/WNL.47.5.1317; Kusunoki S, 2011, J NEUROCHEM, V116, P828, DOI 10.1111/j.1471-4159.2010.07029.x; LAMB NL, 1991, MUSCLE NERVE, V14, P1021, DOI 10.1002/mus.880141014; LATOV N, 1988, NEUROLOGY, V38, P763, DOI 10.1212/WNL.38.5.763; Ledeen RW, 2006, CAN J PHYSIOL PHARM, V84, P393, DOI 10.1139/Y05-133; Liu JX, 2009, INVEST OPHTH VIS SCI, V50, P3226, DOI 10.1167/iovs.08-3333; Lloyd KO, 1998, GLYCOCONJUGATE J, V15, P627, DOI 10.1023/A:1006924128550; Marconi S, 2006, MULT SCLER J, V12, P302, DOI 10.1191/135248506ms1279oa; Meuth SG, 2010, EUR NEUROL, V63, P193, DOI 10.1159/000282734; Niebroj-Dobosz I, 1999, ACTA NEUROL SCAND, V100, P238; Niebroj-Dobosz I, 2004, EUR J NEUROL, V11, P13, DOI 10.1046/j.1351-5101.2003.00697.x; NOBILEORAZIO E, 1990, NEUROLOGY, V40, P1747, DOI 10.1212/WNL.40.11.1747; NOBILEORAZIO E, 1992, J NEUROL SCI, V109, P200, DOI 10.1016/0022-510X(92)90169-L; OGAWAGOTO K, 1990, J NEUROCHEM, V55, P1486, DOI 10.1111/j.1471-4159.1990.tb04930.x; OGAWAGOTO K, 1992, J NEUROCHEM, V59, P1844, DOI 10.1111/j.1471-4159.1992.tb11018.x; PESTRONK A, 1989, ANN NEUROL, V25, P98, DOI 10.1002/ana.410250118; PESTRONK A, 1988, NEUROLOGY, V38, P1457, DOI 10.1212/WNL.38.9.1457; Plomp JJ, 2009, J PHYSIOL-LONDON, V587, P3979, DOI 10.1113/jphysiol.2009.171702; SADIQ SA, 1990, NEUROLOGY, V40, P1067, DOI 10.1212/WNL.40.7.1067; SIMONE IL, 1993, J NEUROL SCI, V114, P49, DOI 10.1016/0022-510X(93)90048-4; Susuki K, 2007, GLIA, V55, P746, DOI 10.1002/glia.20503; Taylor BV, 1996, NEUROLOGY, V47, P951, DOI 10.1212/WNL.47.4.951; van Doorn PA, 2008, LANCET NEUROL, V7, P939, DOI 10.1016/S1474-4422(08)70215-1; VANSCHAIK IN, 1995, NEUROLOGY, V45, P1570, DOI 10.1212/WNL.45.8.1570; Vlam L, 2012, NAT REV NEUROL, V8, P48, DOI 10.1038/nrneurol.2011.175; Willison HJ, 1999, J NEUROIMMUNOL, V100, P3, DOI 10.1016/S0165-5728(99)00213-1; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; WOLFGRAM F, 1973, SCIENCE, V179, P579, DOI 10.1126/science.179.4073.579; YOUNESCHENNOUFI AB, 1992, ANN NEUROL, V32, P18, DOI 10.1002/ana.410320105; YU RK, 1994, PROG BRAIN RES, V101, P31; Yu RK, 2009, J LIPID RES, V50, pS440, DOI 10.1194/jlr.R800028-JLR200; Yuki N, 2014, J NEUROIMMUNOL, V272, P62, DOI 10.1016/j.jneuroim.2014.04.014; Zappia M, 2002, ACTA NEUROL SCAND, V106, P54, DOI 10.1034/j.1600-0404.2002.01240.x	62	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0125339	10.1371/journal.pone.0125339	http://dx.doi.org/10.1371/journal.pone.0125339			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875836	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700075
J	Zhong, LL; Yeh, TYJ; Hao, J; Pourtabatabaei, N; Mahata, SK; Shao, JH; Chessler, SD; Chi, NW				Zhong, Linlin; Yeh, Tsung-Yin J.; Hao, Jun; Pourtabatabaei, Nasim; Mahata, Sushil K.; Shao, Jianhua; Chessler, Steven D.; Chi, Nai-Wen			Nutritional Energy Stimulates NAD(+) Production to Promote Tankyrase-Mediated PARsylation in Insulinoma Cells	PLOS ONE			English	Article							POLY(ADP-RIBOSE) POLYMERASE; METABOLISM; SECRETION; GLUCOSE; GLUT4; NAMPT; SIRT1; IRAP; GLYCOHYDROLASE; BIOSYNTHESIS	The poly-ADP-ribosylation (PARsylation) activity of tankyrase (TNKS) regulates diverse physiological processes including energy metabolism and wnt/beta-catenin signaling. This TNKS activity uses NAD(+) as a co-substrate to post-translationally modify various acceptor proteins including TNKS itself. PARsylation by TNKS often tags the acceptors for ubiquitination and proteasomal degradation. Whether this TNKS activity is regulated by physiological changes in NAD(+) levels or, more broadly, in cellular energy charge has not been investigated. Because the NAD(+) biosynthetic enzyme nicotinamide phosphoribosyltransferase (NAMPT) in vitro is robustly potentiated by ATP, we hypothesized that nutritional energy might stimulate cellular NAMPT to produce NAD(+) and thereby augment TNKS catalysis. Using insulin-secreting cells as a model, we showed that glucose indeed stimulates the autoPARsylation of TNKS and consequently its turnover by the ubiquitin-proteasomal system. This glucose effect on TNKS is mediated primarily by NAD(+) since it is mirrored by the NAD(+) precursor nicotinamide mononucleotide (NMN), and is blunted by the NAMPT inhibitor FK866. The TNKS-destabilizing effect of glucose is shared by other metabolic fuels including pyruvate and amino acids. NAD(+) flux analysis showed that glucose and nutrients, by increasing ATP, stimulate NAMPT-mediated NAD(+) production to expand NAD(+) stores. Collectively our data uncover a metabolic pathway whereby nutritional energy augments NAD(+) production to drive the PARsylating activity of TNKS, leading to autoPARsylation-dependent degradation of the TNKS protein. The modulation of TNKS catalytic activity and protein abundance by cellular energy charge could potentially impose a nutritional control on the many processes that TNKS regulates through PARsylation. More broadly, the stimulation of NAD(+) production by ATP suggests that nutritional energy may enhance the functions of other NAD(+)-driven enzymes including sirtuins.	[Zhong, Linlin; Mahata, Sushil K.; Chi, Nai-Wen] VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA; [Zhong, Linlin; Yeh, Tsung-Yin J.; Hao, Jun; Pourtabatabaei, Nasim; Mahata, Sushil K.; Chi, Nai-Wen] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Hao, Jun] Hebei Med Univ, Dept Pathol, Shijiazhuang, Peoples R China; [Shao, Jianhua] Univ Calif San Diego, La Jolla, CA 92093 USA; [Chessler, Steven D.] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Hebei Medical University; University of California System; University of California San Diego; University of California System; University of California Irvine	Chi, NW (corresponding author), VA San Diego Healthcare Syst, Res Serv, San Diego, CA 92161 USA.	nwchi@ucsd.edu	Mahata, Sushil/AAF-8781-2021		Department of Veterans Affairs Merit Award [5-I01-BX000702]; American Diabetes Association Career Development Award [7-05-CD-05]	Department of Veterans Affairs Merit Award(US Department of Veterans Affairs); American Diabetes Association Career Development Award(American Diabetes Association)	Funding provided by Department of Veterans Affairs (http://www.research.va.gov) Merit Award 5-I01-BX000702; American Diabetes Association (http://www.diabetes.org) Career Development Award 7-05-CD-05. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bordone L, 2006, PLOS BIOL, V4, P210, DOI 10.1371/journal.pbio.0040031; Burgos ES, 2011, CURR MED CHEM, V18, P1947; Burgos ES, 2009, P NATL ACAD SCI USA, V106, P13748, DOI 10.1073/pnas.0903898106; Canto C, 2012, PHARMACOL REV, V64, P166, DOI 10.1124/pr.110.003905; Caton PW, 2013, DIABETOLOGIA, V56, P1068, DOI 10.1007/s00125-013-2851-y; Chang P, 2005, NAT CELL BIOL, V7, P1133, DOI 10.1038/ncb1322; Chen D, 2008, GENE DEV, V22, P1753, DOI 10.1101/gad.1650608; Chi NW, 2000, J BIOL CHEM, V275, P38437, DOI 10.1074/jbc.M007635200; Dezaki K, 2011, DIABETES, V60, P2315, DOI 10.2337/db11-0368; Feng XX, 2013, INT REV CEL MOL BIO, V304, P227, DOI 10.1016/B978-0-12-407696-9.00005-1; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; FURST P, 1989, METABOLISM, V38, P67, DOI 10.1016/0026-0495(89)90145-5; Germain M, 1999, J BIOL CHEM, V274, P28379, DOI 10.1074/jbc.274.40.28379; Goehring I, 2012, J BIOL CHEM, V287, P15706, DOI 10.1074/jbc.M111.314567; Grimsby J, 2003, SCIENCE, V301, P370, DOI 10.1126/science.1084073; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Hara N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022781; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Idevall-Hagren O, 2010, J BIOL CHEM, V285, P23005, DOI 10.1074/jbc.M109.095992; Johnson D, 2007, DIABETES, V56, P1694, DOI 10.2337/db07-0026; Kamitani T, 2001, J BIOL CHEM, V276, P46655, DOI 10.1074/jbc.M108636200; Kover K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058767; KRONFELD DS, 1964, BIOCHEM J, V93, P517, DOI 10.1042/bj0930517; Lau C, 2010, J BIOL CHEM, V285, P18868, DOI 10.1074/jbc.M110.107631; Lee SJ, 2009, MOL CELLS, V28, P167, DOI 10.1007/s10059-009-0119-7; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Lehtio L, 2013, FEBS J, V280, P3576, DOI 10.1111/febs.12320; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Mouchiroud L, 2013, CRIT REV BIOCHEM MOL, V48, P397, DOI 10.3109/10409238.2013.789479; Nathan DM, 2007, DIABETES CARE, V30, P753, DOI 10.2337/dc07-9920; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Ramsey KM, 2009, SCIENCE, V324, P651, DOI 10.1126/science.1171641; Rippmann JF, 2002, J MOL BIOL, V323, P217, DOI 10.1016/S0022-2836(02)00946-4; Sbodio JI, 2002, J BIOL CHEM, V277, P31887, DOI 10.1074/jbc.M203916200; Seimiya H, 2004, MOL CELL BIOL, V24, P1944, DOI 10.1128/MCB.24.5.1944-1955.2004; SERVICE FJ, 1995, NEW ENGL J MED, V332, P1144, DOI 10.1056/NEJM199504273321707; SHIMOYAMA M, 1970, BIOCHIM BIOPHYS ACTA, V215, P207, DOI 10.1016/0304-4165(70)90410-1; Suckow AT, 2010, AM J PHYSIOL-ENDOC M, V299, pE23, DOI 10.1152/ajpendo.00664.2009; Tan B, 2013, J BIOL CHEM, V288, P3500, DOI 10.1074/jbc.M112.394510; Virag L, 2002, PHARMACOL REV, V54, P375, DOI 10.1124/pr.54.3.375; Wang T, 2006, NAT STRUCT MOL BIOL, V13, P661, DOI 10.1038/nsmb1114; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Yeh TYJ, 2007, BIOCHEM J, V402, P279, DOI 10.1042/BJ20060793; Yeh TYJ, 2006, BIOCHEM J, V399, P415, DOI 10.1042/BJ20060713; Yeh TYJ, 2009, DIABETES, V58, P2476, DOI 10.2337/db08-1781; Yeh TYJ, 2005, MOL CELL BIOCHEM, V276, P183, DOI 10.1007/s11010-005-4059-z; Zhang Y, 2011, NAT CELL BIOL, V13, P623, DOI 10.1038/ncb2222; Zhao Y, 2014, CNS NEUROSCI THER, V20, P539, DOI 10.1111/cns.12273	50	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122948	10.1371/journal.pone.0122948	http://dx.doi.org/10.1371/journal.pone.0122948			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876076	Green Published, gold			2022-12-27	WOS:000352845100120
J	Kitts-Morgan, SE; Caires, KC; Bohannon, LA; Parsons, EI; Hilburn, KA				Kitts-Morgan, Susanna E.; Caires, Kyle C.; Bohannon, Lisa A.; Parsons, Elizabeth I.; Hilburn, Katharine A.			Free-Ranging Farm Cats: Home Range Size and Predation on a Livestock Unit In Northwest Georgia	PLOS ONE			English	Article							FELIS-CATUS; FERAL CATS; ACTIVITY PATTERNS; DOMESTIC CATS; HOUSE CATS; PREY; AUSTRALIA; MOVEMENTS; BEHAVIOR; ECOLOGY	This study's objective was to determine seasonal and diurnal vs. nocturnal home range size, as well as predation for free-ranging farm cats at a livestock unit in Northwest Georgia. Seven adult cats were tracked with attached GPS units for up to two weeks for one spring and two summer seasons from May 2010 through August 2011. Three and five cats were tracked for up to two weeks during the fall and winter seasons, respectively. Feline scat was collected during this entire period. Cats were fed a commercial cat food daily. There was no seasonal effect (P > 0.05) on overall (95% KDE and 90% KDE) or core home range size (50% KDE). Male cats tended (P = 0.08) to have larger diurnal and nocturnal core home ranges (1.09 ha) compared to female cats (0.64 ha). Reproductively intact cats (n = 2) had larger (P < 0.0001) diurnal and nocturnal home ranges as compared to altered cats. Feline scat processing separated scat into prey parts, and of the 210 feline scats collected during the study, 75.24% contained hair. Of these 158 scat samples, 86 contained non-cat hair and 72 contained only cat hair. Other prey components included fragments of bone in 21.43% of scat and teeth in 12.86% of scat. Teeth were used to identify mammalian prey hunted by these cats, of which the Hispid cotton rat (Sigmodon hispidus) was the primary rodent. Other targeted mammals were Peromyscus sp., Sylvilagus sp. and Microtus sp. Invertebrates and birds were less important as prey, but all mammalian prey identified in this study consisted of native animals. While the free-ranging farm cats in this study did not adjust their home range seasonally, sex and reproductive status did increase diurnal and nocturnal home range size. Ultimately, larger home ranges of free-ranging cats could negatively impact native wildlife.	[Kitts-Morgan, Susanna E.; Caires, Kyle C.; Bohannon, Lisa A.; Hilburn, Katharine A.] Berry Coll, Dept Anim Sci, Mt Berry, GA 30149 USA; [Parsons, Elizabeth I.] Berry Coll, Dept Biol, Mt Berry, GA USA		Kitts-Morgan, SE (corresponding author), Berry Coll, Dept Anim Sci, Mt Berry, GA 30149 USA.	skittsmorgan@berry.edu		Kitts-Morgan, Susanna/0000-0001-5032-4693; Calvo-Amodio, Javier/0000-0002-0332-8752				ADAMEC RE, 1976, BEHAV BIOL, V18, P263, DOI 10.1016/S0091-6773(76)92166-0; [Anonymous], 2010, ARCGIS GIS SOFTWARE; Banko P.C., 1992, Wildfowl, V43, P99; Barratt DG, 1997, ECOGRAPHY, V20, P271, DOI 10.1111/j.1600-0587.1997.tb00371.x; Barratt DG, 1997, WILDLIFE RES, V24, P263, DOI 10.1071/WR96020; Beck R.A., 1992, Virginia Journal of Science, V43, P197; Blottner S, 2007, REPROD DOMEST ANIM, V42, P536, DOI 10.1111/j.1439-0531.2006.00817.x; Brown JL, 2006, THERIOGENOLOGY, V66, P25, DOI 10.1016/j.theriogenology.2006.03.011; DAY MG, 1966, J ZOOL, V148, P201, DOI 10.1111/j.1469-7998.1966.tb02948.x; Dowding JE, 2001, BIOL CONSERV, V99, P47, DOI 10.1016/S0006-3207(00)00187-7; Elton C. S., 1953, British Journal of Animal Behaviour, V1, P151, DOI 10.1016/S0950-5601(53)80015-8; Gehrt SD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075718; Geospatial Modelling Environment, 2012, GEOSP MOD ENV VERS 0; Gibbons J., 1984, Oryx, V18, P82; Gillies C, 2003, J ZOOL, V259, P309, DOI 10.1017/S095283690200328X; Golley F. B., 1962, MAMMALS GEORGIA STUD; Guttilla DA, 2010, J MAMMAL, V91, P482, DOI 10.1644/09-MAMM-A-111.1; Hawkins CC, 1998, THESIS TEXAS A M U; Hess Steven C., 2004, Proceedings of the Vertebrate Pest Conference, V21, P21; Horn JA, 2011, J WILDLIFE MANAGE, V75, P1177, DOI 10.1002/jwmg.145; KIRKPATRICK RD, 1986, BIOTROPICA, V18, P72, DOI 10.2307/2388365; KONECNY MJ, 1987, OIKOS, V50, P17, DOI 10.2307/3565397; Langton SD, 2001, J APPL ECOL, V38, P699, DOI 10.1046/j.1365-2664.2001.00631.x; Lepczyk CA, 2008, 126 STAT M AM ORN UN; Loss SR, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2380; Loyd KAT, 2013, BIOL CONSERV, V160, P183, DOI 10.1016/j.biocon.2013.01.008; Molsher R, 1999, WILDLIFE RES, V26, P593, DOI 10.1071/WR98058; PANAMAN R, 1981, Z TIERPSYCHOL, V56, P59; PRESNALL CLIFFORD C., 1958, JOUR WILDLIFE MANAGEMENT, V22, P45, DOI 10.2307/3797296; R Core Team, 2021, R LANGUAGE ENV STAT; REYNOLDS JC, 1991, MAMMAL REV, V21, P97, DOI 10.1111/j.1365-2907.1991.tb00113.x; ROBINSON R, 1970, Laboratory Animals (London), V4, P99, DOI 10.1258/002367770781036616; SAMUEL MD, 1985, J ANIM ECOL, V54, P711, DOI 10.2307/4373; SCOTT P P, 1955, Proc Soc Study Fertil, V7, P123; Singleton GR, 2005, BIOL J LINN SOC, V84, P617, DOI 10.1111/j.1095-8312.2005.00458.x; Smith David G., 2002, Pacific Science, V56, P451, DOI 10.1353/psc.2002.0044; Tennent J, 2008, AFR ZOOL, V43, P218, DOI 10.3377/1562-7020-43.2.218; TURNER DC, 1986, BEHAVIOUR, V99, P22, DOI 10.1163/156853986X00397; TURNER DC, 1988, DOMESTIC CAT BIOL IT; WARNER RE, 1985, J WILDLIFE MANAGE, V49, P340, DOI 10.2307/3801527; Weber JM, 1998, J ZOOL, V245, P234, DOI 10.1111/j.1469-7998.1998.tb00096.x	41	21	22	1	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0120513	10.1371/journal.pone.0120513	http://dx.doi.org/10.1371/journal.pone.0120513			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894078	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700006
J	Bernatz, JT; Tueting, JL; Anderson, PA				Bernatz, James T.; Tueting, Jonathan L.; Anderson, Paul A.			Thirty-Day Readmission Rates in Orthopedics: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							HOSPITAL READMISSION; RISK-FACTORS; TOTAL HIP; UNPLANNED READMISSION; KNEE ARTHROPLASTY; PREDICTORS; SURGERY	Background Hospital readmission rates are being used to evaluate performance. A survey of the present rates is needed before policies can be developed to decrease incidence of readmission. We address three questions: What is the present rate of 30-day readmission in orthopedics? How do factors such as orthopedic specialty, data source, patient insurance, and time of data collection affect the 30-day readmission rate? What are the causes and risk factors for 30-day readmissions? Methods/Findings A review was first registered with Prospero (CRD42014010293, 6/17/2014) and a meta-analysis was performed to assess the current 30-day readmission rate in orthopedics. Studies published after 2006 were retrieved, and 24 studies met the inclusion criteria. The 30-day readmission rate was extrapolated from each study along with the orthopedic subspecialty, data source, patient insurance, time of collection, patient demographics, and cause of readmission. A sensitivity analysis was completed on the stratified groups. The overall 30-day readmission rate across all orthopedics was 5.4 percent (95% confidence interval: 4.8,6.0). There was no significant difference between subspecialties. Studies that retrieved data from a multicenter registry had a lower 30-day readmission rate than those reporting data from a single hospital or a large national database. Patient populations that only included Medicare patients had a higher 30-day readmission rate than populations of all insurance. The 30-day readmission rate has decreased in the past ten years. Age, length of stay, discharge to skilled nursing facility, increased BMI, ASA score greater than 3, and Medicare/Medicaid insurance showed statistically positive correlation with increased 30-day readmissions in greater than 75 percent of studies. Surgical site complications accounted for 46 percent of 30-day readmissions. Conclusions This meta-analysis shows the present rate of 30-day readmissions in orthopedics. Demonstrable heterogeneity between studies underlines the importance of uniform collection and reporting of readmission rates for hospital evaluation and reimbursement.	[Bernatz, James T.; Tueting, Jonathan L.; Anderson, Paul A.] Univ Wisconsin, Dept Orthoped & Rehabil Med, Sch Med & Publ Hlth, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Bernatz, JT (corresponding author), Univ Wisconsin, Dept Orthoped & Rehabil Med, Sch Med & Publ Hlth, Madison, WI 53706 USA.	jbernatz@wisc.edu			Shapiro Summer Research Program at the University of Wisconsin School of Medicine and Public Health	Shapiro Summer Research Program at the University of Wisconsin School of Medicine and Public Health	James Bernatz received support from the Shapiro Summer Research Program at the University of Wisconsin School of Medicine and Public Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No other outside funding was involved.	Amin BY, 2012, J NEUROSURG-SPINE, V16, P105, DOI 10.3171/2011.9.SPINE11644; Au AG, 2014, ACAD MED, V89, P517, DOI 10.1097/ACM.0000000000000154; Basques BA, 2014, SPINE, V39, P833, DOI 10.1097/BRS.0000000000000276; Bosco JA, 2014, J ARTHROPLASTY, V29, P903, DOI 10.1016/j.arth.2013.11.006; Centers for Medicare & Medicaid Services, 2014, READM RED PROGR; Chen AF, 2013, J ARTHROPLASTY, V28, P18, DOI 10.1016/j.arth.2013.03.036; Clement RC, 2013, J ARTHROPLASTY, V28, P7, DOI 10.1016/j.arth.2013.04.055; Cram P, 2012, MAYO CLIN PROC, V87, P341, DOI 10.1016/j.mayocp.2011.11.017; Cullen C, 2006, ANN ROY COLL SURG, V88, P475, DOI 10.1308/003588406X116909; Dailey EA, 2013, J BONE JOINT SURG AM, V95A, P1012, DOI 10.2106/JBJS.K.01569; Hageman MG, 2014, J ORTHOP TRAUMA, P5; Hayden JA, 2013, ANN INTERN MED, V158, P280, DOI 10.7326/0003-4819-158-4-201302190-00009; Hoyer EH, 2014, J HOSP MED, V9, P277, DOI 10.1002/jhm.2152; Huguet A, 2013, SYST REV-LONDON, V2, DOI 10.1186/2046-4053-2-71; Issa K, 2014, J KNEE SURG, P5; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Joynt KE, 2011, JAMA-J AM MED ASSOC, V305, P675, DOI 10.1001/jama.2011.123; Kassin MT, 2012, J AM COLL SURGEONS, V215, P322, DOI 10.1016/j.jamcollsurg.2012.05.024; Kim BD, 2014, J NEUROSURG-SPINE, V20, P606, DOI 10.3171/2014.3.SPINE13699; Kocher RP, 2011, JAMA-J AM MED ASSOC, V306, P1794, DOI 10.1001/jama.2011.1561; Kurtz S, 2007, J BONE JOINT SURG AM, V89A, P780, DOI 10.2106/JBJS.F.00222; Leaper DJ, 2014, INT WOUND J, P2; Lovecchio F, 2014, SPINE, V39, P127, DOI 10.1097/BRS.0000000000000051; McCormack R, 2013, J HEALTHC MANAG, V58, P64, DOI 10.1097/00115514-201301000-00011; McCormack RA, 2012, SPINE, V37, P1260, DOI 10.1097/BRS.0b013e318245f561; Medicare Payment Advisory Commission, 2008, REP C REF DEL SYST; Mednick RE, 2014, J BONE JOINT SURG AM, V96A, P1201, DOI 10.2106/JBJS.M.00556; Mesko NW, 2014, J ARTHROPLASTY, P5, DOI [10.1093/jscr/rju043, DOI 10.1093/JSCR/RJU043]; Morris MS, 2014, JAMA SURG, V149, P348, DOI 10.1001/jamasurg.2013.4064; Pugely AJ, 2014, SPINE, P4; Pugely AJ, 2014, SPINE, V39, P761, DOI 10.1097/BRS.0000000000000270; Richmond JC, 2013, CLIN ORTHOP RELAT R, V471, P2372, DOI 10.1007/s11999-013-2909-7; Sacks GD, 2014, JAMA SURG, P6; Schairer WW, 2014, CLIN ORTHOP RELAT R, V472, P464, DOI 10.1007/s11999-013-3121-5; Schairer WW, 2013, SPINE, V38, P1681, DOI 10.1097/BRS.0b013e31829c08c9; Schairer WW, 2014, CLIN ORTHOP RELAT R, V472, P181, DOI 10.1007/s11999-013-3030-7; Spagnolo A M, 2013, J Prev Med Hyg, V54, P131; Vorhies JS, 2012, CLIN ORTHOP RELAT R, V470, P166, DOI 10.1007/s11999-011-1957-0; Vorhies JS, 2011, J ARTHROPLASTY, V26, P119, DOI 10.1016/j.arth.2011.04.036; Wang MC, 2012, SPINE J, V12, P902, DOI 10.1016/j.spinee.2012.09.051; Wright JG, 2003, J BONE JOINT SURG AM, V85A, P1, DOI 10.2106/00004623-200301000-00001; Zmistowski B, 2013, J BONE JOINT SURG AM, V95A, P1869, DOI 10.2106/JBJS.L.00679	42	80	80	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123593	10.1371/journal.pone.0123593	http://dx.doi.org/10.1371/journal.pone.0123593			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884444	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000077
J	Chen, WB; Liu, CX; Xiao, YT; Zhang, DD; Zhang, YD; Li, XC; Tabashnik, BE; Wu, KM				Chen, Wenbo; Liu, Chenxi; Xiao, Yutao; Zhang, Dandan; Zhang, Yongdong; Li, Xianchun; Tabashnik, Bruce E.; Wu, Kongming			A Toxin-Binding Alkaline Phosphatase Fragment Synergizes Bt Toxin Cry1Ac against Susceptible and Resistant Helicoverpa armigera	PLOS ONE			English	Article							BACILLUS-THURINGIENSIS TOXINS; MOSQUITO ANOPHELES-GAMBIAE; FIELD-EVOLVED RESISTANCE; INSECT RESISTANCE; MANDUCA-SEXTA; LEPIDOPTERA-NOCTUIDAE; SPODOPTERA-EXIGUA; AMINOPEPTIDASE-N; PINK-BOLLWORM; HELIOTHIS-VIRESCENS	Evolution of resistance by insects threatens the continued success of pest control using insecticidal crystal (Cry) proteins from the bacterium Bacillus thuringiensis (Bt) in sprays and transgenic plants. In this study, laboratory selection with Cry1Ac yielded five strains of cotton bollworm, Helicoverpa armigera, with resistance ratios at the median lethal concentration (LC50) of activated Cry1Ac ranging from 22 to 1700. Reduced activity and reduced transcription of an alkaline phosphatase protein that binds Cry1Ac was associated with resistance to Cry1Ac in the four most resistant strains. A Cry1Ac-binding fragment of alkaline phosphatase from H. armigera (HaALP1f) was not toxic by itself, but it increased mortality caused by Cry1Ac in a susceptible strain and in all five resistant strains. Although synergism of Bt toxins against susceptible insects by toxin-binding fragments of cadherin and aminopeptidase N has been reported previously, the results here provide the first evidence of synergism of a Bt toxin by a toxin-binding fragment of alkaline phosphatase. The results here also provide the first evidence of synergism of a Bt toxin by any toxin-binding peptide against resistant insects.	[Chen, Wenbo; Liu, Chenxi; Xiao, Yutao; Zhang, Dandan; Zhang, Yongdong; Wu, Kongming] Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, Beijing 100193, Peoples R China; [Li, Xianchun; Tabashnik, Bruce E.] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA	Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; University of Arizona	Wu, KM (corresponding author), Chinese Acad Agr Sci, State Key Lab Biol Plant Dis & Insect Pests, Inst Plant Protect, West Yuanmingyuan Rd, Beijing 100193, Peoples R China.	kmwu@ippcaas.cn			Key Project for Breeding Genetic Modified Organisms [2011ZX08012-004]; National Natural Science Foundation of China [31210103921, 31201525, 31321004]	Key Project for Breeding Genetic Modified Organisms; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Key Project for Breeding Genetic Modified Organisms (2011ZX08012-004) and the National Natural Science Foundation of China (Grant No. 31210103921, No. 31201525 and No. 31321004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdullah MAF, 2009, PEST MANAG SCI, V65, P1097, DOI 10.1002/ps.1798; ADANG MJ, 1985, GENE, V36, P289, DOI 10.1016/0378-1119(85)90184-2; Alcantara E, 2011, CROP PROT, V30, P554, DOI 10.1016/j.cropro.2010.12.019; Alvi AHK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047309; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Caccia S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009975; Cao GC, 2014, SCI REP-UK, V4, DOI 10.1038/srep05629; Cao GC, 2013, J ECON ENTOMOL, V106, P2514, DOI 10.1603/EC13301; Chen J, 2007, P NATL ACAD SCI USA, V104, P13901, DOI 10.1073/pnas.0706011104; Dhurua S, 2011, PEST MANAG SCI, V67, P898, DOI 10.1002/ps.2127; Dorsch JA, 2002, INSECT BIOCHEM MOLEC, V32, P1025, DOI 10.1016/S0965-1748(02)00040-1; Downes S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012567; Ferre J, 2002, ANNU REV ENTOMOL, V47, P501, DOI 10.1146/annurev.ento.47.091201.145234; Flores-Escobar B, 2013, APPL ENVIRON MICROB, V79, P4543, DOI 10.1128/AEM.01062-13; Gahan LJ, 2001, SCIENCE, V293, P857, DOI 10.1126/science.1060949; Gao YL, 2011, PEST MANAG SCI, V67, P1076, DOI 10.1002/ps.2149; Gassmann AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022629; Gilroy T. E., 1992, US Patent, Patent No. [5,128,130, 5128130]; Gunning RV, 2005, APPL ENVIRON MICROB, V71, P2558, DOI 10.1128/AEM.71.5.2558-2563.2005; Heckel DG, 2007, J INVERTEBR PATHOL, V95, P192, DOI 10.1016/j.jip.2007.03.008; Herrero S, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-96; Hua G, 2008, BIOCHEMISTRY-US, V47, P5101, DOI 10.1021/bi7023578; Hua G, 2014, INSECT BIOCHEM MOLEC, V45, P11, DOI 10.1016/j.ibmb.2013.10.007; Hua G, 2013, INSECT BIOCHEM MOLEC, V43, P153, DOI 10.1016/j.ibmb.2012.11.007; Hua G, 2009, BIOCHEMISTRY-US, V48, P9785, DOI 10.1021/bi9014538; Huang Fangneng, 2012, GM Crops Food, V3, P245, DOI 10.4161/gmcr.20539; Janmaat AF, 2003, P ROY SOC B-BIOL SCI, V270, P2263, DOI 10.1098/rspb.2003.2497; Jin L, 2015, NAT BIOTECHNOL, V33, P169, DOI 10.1038/nbt.3100; Jurat-Fuentes JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017606; Li Y, 2012, SYST RES BEHAV SCI, V29, P101, DOI 10.1002/sres.2099; Liang GM, 2008, J INVERTEBR PATHOL, V97, P142, DOI 10.1016/j.jip.2007.09.007; Liang GeMei, 2000, Scientia Agricultura Sinica, V33, P46; Liang GeMei, 1999, Plant Protection, V25, P15; Liu CX, 2014, SCI REP-UK, V4, DOI 10.1038/srep07219; Liu CX, 2009, J INSECT PHYSIOL, V55, P686, DOI 10.1016/j.jinsphys.2009.05.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu Q, 2012, J INTEGR AGR, V11, P628, DOI 10.1016/S2095-3119(12)60050-1; Lu YH, 2012, NATURE, V487, P362, DOI 10.1038/nature11153; Luttrell R., 2004, P 2004 BELTW COTT C, V2004, P1373; Ma G, 2005, INSECT BIOCHEM MOLEC, V35, P729, DOI 10.1016/j.ibmb.2005.02.011; Mendelsohn M, 2003, NAT BIOTECHNOL, V21, P1003, DOI 10.1038/nbt0903-1003; Morin S, 2003, P NATL ACAD SCI USA, V100, P5004, DOI 10.1073/pnas.0831036100; Ning CM, 2010, J INSECT PHYSIOL, V56, P666, DOI 10.1016/j.jinsphys.2010.02.003; Pacheco S, 2009, PEPTIDES, V30, P583, DOI 10.1016/j.peptides.2008.08.006; Pardo-Lopez L, 2013, FEMS MICROBIOL REV, V37, P3, DOI 10.1111/j.1574-6976.2012.00341.x; Park Y, 2009, APPL ENVIRON MICROB, V75, P7280, DOI 10.1128/AEM.01870-09; Park Y, 2009, APPL ENVIRON MICROB, V75, P3086, DOI 10.1128/AEM.00268-09; Peng DH, 2010, RES MICROBIOL, V161, P383, DOI 10.1016/j.resmic.2010.04.004; Peng DH, 2010, APPL MICROBIOL BIOT, V85, P1033, DOI 10.1007/s00253-009-2142-1; Rahman K, 2012, APPL ENVIRON MICROB, V78, P354, DOI 10.1128/AEM.06212-11; Rajagopal R, 2009, BIOCHEM J, V419, P309, DOI 10.1042/BJ20081152; Rodriguez-Almazan C, 2012, BIOCHEM J, V443, P711, DOI 10.1042/BJ20111579; RUSSELL R M, 1977, Bulletin of the Entomological Society of America, V23, P209; Sanahuja G, 2011, PLANT BIOTECHNOL J, V9, P283, DOI 10.1111/j.1467-7652.2011.00595.x; Sarjan M, 2009, J ILMU DASAR, V10, P77; *SAS I, 1998, SAS STAT US GUID REL; Storer NP, 2010, J ECON ENTOMOL, V103, P1031, DOI 10.1603/EC10040; TABASHNIK BE, 1994, ANNU REV ENTOMOL, V39, P47, DOI 10.1146/annurev.en.39.010194.000403; TABASHNIK BE, 1990, J ECON ENTOMOL, V83, P1671, DOI 10.1093/jee/83.5.1671; Tabashnik BE, 2002, J ECON ENTOMOL, V95, P1018, DOI 10.1603/0022-0493-95.5.1018; TABASHNIK BE, 1992, APPL ENVIRON MICROB, V58, P3343, DOI 10.1128/AEM.58.10.3343-3346.1992; Tabashnik BE, 2008, NAT BIOTECHNOL, V26, P199, DOI 10.1038/nbt1382; Tabashnik BE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080496; Tabashnik BE, 2013, NAT BIOTECHNOL, V31, P510, DOI 10.1038/nbt.2597; Tabashnik BE, 2009, J ECON ENTOMOL, V102, P2011, DOI 10.1603/029.102.0601; Fernandez-Luna MT, 2010, J INVERTEBR PATHOL, V104, P231, DOI 10.1016/j.jip.2010.03.007; Thammasittirong A, 2011, APPL ENVIRON MICROB, V77, P6836, DOI 10.1128/AEM.05775-11; van Rensburg J. B. J., 2007, South African Journal of Plant and Soil, V24, P147; Wan P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029975; WOLFERSBERGER M, 1987, COMP BIOCHEM PHYS A, V86, P301, DOI 10.1016/0300-9629(87)90334-3; Wu KM, 2005, ANNU REV ENTOMOL, V50, P31, DOI 10.1146/annurev.ento.50.071803.130349; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Wu YD, 2014, ADV INSECT PHYSIOL, V47, P297, DOI 10.1016/B978-0-12-800197-4.00006-3; Xiao YT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06184; Xie RY, 2005, J BIOL CHEM, V280, P8416, DOI 10.1074/jbc.M408403200; Xu XJ, 2005, APPL ENVIRON MICROB, V71, P948, DOI 10.1128/AEM.71.2.948-954.2005; Zhang HN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053418; Zhang HN, 2012, P NATL ACAD SCI USA, V109, P10275, DOI 10.1073/pnas.1200156109; Zhang HN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022874; Zhang R, 2008, BIOCHEMISTRY-US, V47, P11263, DOI 10.1021/bi801181g; Zhang R, 2010, BIOCHEMISTRY-US, V49, P8512, DOI 10.1021/bi1009908; Zhang SP, 2009, INSECT BIOCHEM MOLEC, V39, P421, DOI 10.1016/j.ibmb.2009.04.003	82	15	19	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0126288	10.1371/journal.pone.0126288	http://dx.doi.org/10.1371/journal.pone.0126288			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885820	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000168
J	Dulermo, R; Onodera, T; Coste, G; Passot, F; Dutertre, M; Porteron, M; Confalonieri, F; Sommer, S; Pasternak, C				Dulermo, Remi; Onodera, Takefumi; Coste, Genevieve; Passot, Fanny; Dutertre, Murielle; Porteron, Martine; Confalonieri, Fabrice; Sommer, Suzanne; Pasternak, Cecile			Identification of New Genes Contributing to the Extreme Radioresistance of Deinococcus radiodurans Using a Tn5-Based Transposon Mutant Library	PLOS ONE			English	Article							C-DI-AMP; RADIATION-RESISTANT BACTERIUM; STRAND BREAK REPAIR; FE-S CLUSTER; ESCHERICHIA-COLI; TN5 TRANSPOSASE; IONIZING-RADIATION; PROTEIN-KINASE; CATALASE KATA; DNA-REPAIR	Here, we have developed an extremely efficient in vivo Tn5-based mutagenesis procedure to construct a Deinococcus radiodurans insertion mutant library subsequently screened for sensitivity to genotoxic agents such as. and UV radiations or mitomycin C. The genes inactivated in radiosensitive mutants belong to various functional categories, including DNA repair functions, stress responses, signal transduction, membrane transport, several metabolic pathways, and genes of unknown function. Interestingly, preliminary characterization of previously undescribed radiosensitive mutants suggests the contribution of cyclic di-AMP signaling in the recovery of D. radiodurans cells from genotoxic stresses, probably by modulating several pathways involved in the overall cell response. Our analyses also point out a new transcriptional regulator belonging to the GntR family, encoded by DR0265, and a predicted RNase belonging to the newly described Y family, both contributing to the extreme radioresistance of D. radiodurans. Altogether, this work has revealed new cell responses involved either directly or indirectly in repair of various cell damage and confirmed that D. radiodurans extreme radiation resistance is determined by a multiplicity of pathways acting as a complex network.	[Dulermo, Remi; Onodera, Takefumi; Coste, Genevieve; Passot, Fanny; Dutertre, Murielle; Porteron, Martine; Confalonieri, Fabrice; Sommer, Suzanne; Pasternak, Cecile] Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, Orsay, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Pasternak, C (corresponding author), Univ Paris Saclay, Univ Paris Sud, Inst Integrat Biol Cell I2BC, CEA,CNRS, Orsay, France.	cecile.pasternak@igmors.u-psud.fr		Passot, Fanny/0000-0002-0257-816X; Pasternak, Cecile/0000-0002-7884-2422	Agence Nationale de la Recherche, ANR [Radioresistance-11-BSV3-01701]	Agence Nationale de la Recherche, ANR(French National Research Agency (ANR))	This work was supported by Agence Nationale de la Recherche, ANR Radioresistance-11-BSV3-01701 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Basu B, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.011734; Bejerano-Sagie M, 2006, CELL, V125, P679, DOI 10.1016/j.cell.2006.03.039; Bender RA, 2012, MICROBIOL MOL BIOL R, V76, P565, DOI 10.1128/MMBR.00014-12; Bentchikou E, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000774; Buchan BW, 2008, APPL ENVIRON MICROB, V74, P2637, DOI 10.1128/AEM.02882-07; Byrne RT, 2014, J BACTERIOL, V196, P3534, DOI 10.1128/JB.01589-14; Commichau FM, 2009, MOL CELL PROTEOMICS, V8, P1350, DOI 10.1074/mcp.M800546-MCP200; Confalonieri F, 2011, J PHYS CONF SER, V261, DOI 10.1088/1742-6596/261/1/012005; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Daly MJ, 2012, DNA REPAIR, V11, P12, DOI 10.1016/j.dnarep.2011.10.024; Daly MJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012570; Daly MJ, 2009, NAT REV MICROBIOL, V7, P237, DOI 10.1038/nrmicro2073; DALY MJ, 1995, J BACTERIOL, V177, P5495, DOI 10.1128/jb.177.19.5495-5505.1995; Daly MJ, 1996, J BACTERIOL, V178, P4461, DOI 10.1128/jb.178.15.4461-4471.1996; Das AD, 2012, BBA-GEN SUBJECTS, V1820, P1052, DOI 10.1016/j.bbagen.2012.03.014; Das S, 2005, J MICROBIOL METH, V63, P89, DOI 10.1016/j.mimet.2005.02.011; de Almeida CB, 2002, MOL GENET GENOMICS, V268, P28, DOI 10.1007/s00438-002-0718-x; de la Tour CB, 2011, DNA REPAIR, V10, P1223, DOI 10.1016/j.dnarep.2011.09.010; DEAN CJ, 1970, BIOCHEM BIOPH RES CO, V39, P126, DOI 10.1016/0006-291X(70)90767-9; Devigne A, 2015, MOL MICROBI IN PRESS; Devigne A, 2013, DNA REPAIR, V12, P265, DOI 10.1016/j.dnarep.2013.01.004; Durand S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002520; Figaro S, 2013, J BACTERIOL, V195, P2340, DOI 10.1128/JB.00164-13; FLINT DH, 1993, J BIOL CHEM, V268, P22369; Ghosal D, 2005, FEMS MICROBIOL REV, V29, P361, DOI 10.1016/j.fmrre.2004.12.007; Goryshin IY, 1998, J BIOL CHEM, V273, P7367, DOI 10.1074/jbc.273.13.7367; Goryshin IY, 2000, NAT BIOTECHNOL, V18, P97, DOI 10.1038/72017; HANSEN MT, 1978, J BACTERIOL, V134, P71, DOI 10.1128/JB.134.1.71-75.1978; Harris DR, 2009, J BACTERIOL, V191, P5240, DOI 10.1128/JB.00502-09; Harris DR, 2004, PLOS BIOL, V2, P1629, DOI 10.1371/journal.pbio.0020304; Hua YJ, 2003, BIOCHEM BIOPH RES CO, V306, P354, DOI 10.1016/S0006-291X(03)00965-3; Hunt A, 2006, MICROBIOL-SGM, V152, P2895, DOI 10.1099/mic.0.29152-0; Jolivet E, 2006, MOL MICROBIOL, V59, P338, DOI 10.1111/j.1365-2958.2005.04946.x; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Knobloch JKM, 2003, APPL ENVIRON MICROB, V69, P5812, DOI 10.1128/AEM.69.10.5812-5818.2003; Kobayashi I, 2006, J BIOSCI BIOENG, V101, P315, DOI 10.1263/jbb.101.315; Kostner M, 2006, APPL ENVIRON MICROB, V72, P4717, DOI 10.1128/AEM.00492-06; Kota S, 2014, J GENET, V93, P349, DOI 10.1007/s12041-014-0382-z; Kota S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085288; Krysan PJ, 1999, PLANT CELL, V11, P2283, DOI 10.1105/tpc.11.12.2283; Laalami S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054062; Larsen RA, 2002, ARCH MICROBIOL, V178, P193, DOI 10.1007/s00203-002-0442-2; Lecointe F, 2004, GENE, V336, P25, DOI 10.1016/j.gene.2004.04.006; Levin-Zaidman S, 2003, SCIENCE, V299, P254, DOI 10.1126/science.1077865; Liedert C, 2012, J BACTERIOL, V194, P1552, DOI 10.1128/JB.06429-11; Liu YQ, 2003, P NATL ACAD SCI USA, V100, P4191, DOI 10.1073/pnas.0630387100; Lu HM, 2009, MOL CELL PROTEOMICS, V8, P481, DOI 10.1074/mcp.M800123-MCP200; Luan HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085649; Ludanyi M, 2014, MOL MICROBIOL, V94, P434, DOI 10.1111/mmi.12774; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mailloux RJ, 2011, ANTON LEEUW INT J G, V99, P433, DOI 10.1007/s10482-010-9538-x; Makarova KS, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000955; Makarova KS, 2001, MICROBIOL MOL BIOL R, V65, P44, DOI 10.1128/MMBR.65.1.44-79.2001; Markillie LM, 1999, J BACTERIOL, V181, P666, DOI 10.1128/JB.181.2.666-669.1999; MATTIMORE V, 1995, J BACTERIOL, V177, P5232, DOI 10.1128/jb.177.18.5232-5237.1995; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Meima R, 2001, J BACTERIOL, V183, P3169, DOI 10.1128/JB.183.10.3169-3175.2001; Mennecier S, 2004, MOL GENET GENOMICS, V272, P460, DOI 10.1007/s00438-004-1077-6; Nachin L, 2003, EMBO J, V22, P427, DOI 10.1093/emboj/cdg061; Nelson JW, 2013, NAT CHEM BIOL, V9, P834, DOI [10.1038/NCHEMBIO.1363, 10.1038/nchembio.1363]; Nguyen HH, 2009, MOL MICROBIOL, V73, P240, DOI 10.1111/j.1365-2958.2009.06766.x; Norais C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056558; Ogura Y, 2001, J BACTERIOL, V183, P3833, DOI 10.1128/JB.183.13.3833-3841.2001; Oppenheimer-Shaanan Y, 2011, EMBO REP, V12, P594, DOI 10.1038/embor.2011.77; Polard P, 2002, NUCLEIC ACIDS RES, V30, P1593, DOI 10.1093/nar/30.7.1593; Rajpurohit YS, 2013, INT J BIOCHEM CELL B, V45, P2541, DOI 10.1016/j.biocel.2013.08.011; Rajpurohit YS, 2010, MOL MICROBIOL, V77, P1470, DOI 10.1111/j.1365-2958.2010.07301.x; Rigali S, 2002, J BIOL CHEM, V277, P12507, DOI 10.1074/jbc.M110968200; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; Sandler SJ, 2000, J BACTERIOL, V182, P9, DOI 10.1128/JB.182.1.9-13.2000; Schroder J, 2012, FEMS MICROBIOL LETT, V331, P136, DOI 10.1111/j.1574-6968.2012.02564.x; Shahbabian K, 2009, EMBO J, V28, P3523, DOI 10.1038/emboj.2009.283; Slade D, 2011, MICROBIOL MOL BIOL R, V75, P133, DOI 10.1128/MMBR.00015-10; Slade D, 2009, CELL, V136, P1044, DOI 10.1016/j.cell.2009.01.018; Solovjev V, 2011, METAGENOMICITAPP, P61; Tanaka M, 2004, GENETICS, V168, P21, DOI 10.1534/genetics.104.029249; UDUPA KS, 1994, J BACTERIOL, V176, P7439, DOI 10.1128/JB.176.24.7439-7446.1994; Vujicic-Zagar A, 2009, J MOL BIOL, V386, P704, DOI 10.1016/j.jmb.2008.12.062; Wang LY, 2008, MOL MICROBIOL, V67, P1211, DOI 10.1111/j.1365-2958.2008.06113.x; WEINREICH MD, 1994, GENE DEV, V8, P2363, DOI 10.1101/gad.8.19.2363; WEINREICH MD, 1994, J BACTERIOL, V176, P5494, DOI 10.1128/JB.176.17.5494-5504.1994; WIEGAND TW, 1992, J BACTERIOL, V174, P1229, DOI 10.1128/jb.174.4.1229-1239.1992; Yao SY, 2010, J BACTERIOL, V192, P3279, DOI 10.1128/JB.00230-10; Yigit H, 1997, J BACTERIOL, V179, P1704, DOI 10.1128/jb.179.5.1704-1713.1997; Zahradka K, 2006, NATURE, V443, P569, DOI 10.1038/nature05160; Zeevi MK, 2013, J BACTERIOL, V195, P5250, DOI 10.1128/JB.00794-13; Zhang CC, 2005, PROTEOMICS, V5, P138, DOI 10.1002/pmic.200300875; Zhang L, 2013, J BIOL CHEM, V288, P3085, DOI 10.1074/jbc.M112.428110; Zhou M, 1998, J MOL BIOL, V276, P913, DOI 10.1006/jmbi.1997.1579; Zhou M, 1997, J MOL BIOL, V271, P362, DOI 10.1006/jmbi.1997.1188; Zimmerman JM, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-17	94	24	24	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124358	10.1371/journal.pone.0124358	http://dx.doi.org/10.1371/journal.pone.0124358			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884619	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000119
J	Jensen, MK; Vogt, JK; Bressendorff, S; Seguin-Orlando, A; Petersen, M; Sicheritz-Ponten, T; Mundy, J				Jensen, Michael Krogh; Vogt, Josef Korbinian; Bressendorff, Simon; Seguin-Orlando, Andaine; Petersen, Morten; Sicheritz-Ponten, Thomas; Mundy, John			Transcriptome and Genome Size Analysis of the Venus Flytrap	PLOS ONE			English	Article							CARNIVOROUS PLANT; BLADDERWORT UTRICULARIA; RNA-SEQ; EVOLUTION; DNA; LENTIBULARIACEAE; ARABIDOPSIS; PHYLOGENY; SEQUENCES; SARRACENIA	The insectivorous Venus flytrap (Dionaea muscipula) is renowned from Darwin's studies of plant carnivory and the origins of species. To provide tools to analyze the evolution and functional genomics of D. muscipula, we sequenced a normalized cDNA library synthesized from mRNA isolated from D. muscipula flowers and traps. Using the Oases transcriptome assembler 79,165,657 quality trimmed reads were assembled into 80,806 cDNA contigs, with an average length of 679 bp and an N50 length of 1,051 bp. A total of 17,047 unique proteins were identified, and assigned to Gene Ontology (GO) and classified into functional categories. A total of 15,547 full-length cDNA sequences were identified, from which open reading frames were detected in 10,941. Comparative GO analyses revealed that D. muscipula is highly represented in molecular functions related to catalytic, antioxidant, and electron carrier activities. Also, using a single copy sequence PCR-based method, we estimated that the genome size of D. muscipula is approx. 3 Gb. Our genome size estimate and transcriptome analyses will contribute to future research on this fascinating, monotypic species and its heterotrophic adaptations.	[Jensen, Michael Krogh; Bressendorff, Simon; Petersen, Morten; Mundy, John] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Vogt, Josef Korbinian; Sicheritz-Ponten, Thomas] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Seguin-Orlando, Andaine] Natl High Throughput DNA Sequencing Ctr, Copenhagen, Denmark	University of Copenhagen; Technical University of Denmark	Sicheritz-Ponten, T (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	thomas@cbs.dtu.dk; mundy@bio.ku.dk	mundy, john/A-2361-2013; Petersen, Morten/J-5023-2014; Sicheritz-Ponten, Thomas/A-4325-2017	mundy, john/0000-0001-7490-4588; Petersen, Morten/0000-0002-3035-5991; Bressendorff, Simon/0000-0002-1093-2114; Sicheritz-Ponten, Thomas/0000-0001-6615-1141; Jensen, Michael Krogh/0000-0001-7574-4707; Vogt, Josef Korbinian/0000-0002-6472-381X	Danish Research Council [DFF-1323-00267]	Danish Research Council(Det Frie Forskningsrad (DFF))	This work was supported by a grant to JM from the Danish Research Council (#DFF-1323-00267; http://ufm.dk/forskning-og-innovation/rad-og-udvalg/det-frie-forskningsrad/radet/dff-natur-og-univers). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMEC L, 1995, FOLIA GEOBOT PHYTOTX, V30, P53, DOI 10.1007/BF02813219; ALBERT VA, 1992, SCIENCE, V257, P1491, DOI 10.1126/science.1523408; Albert VA, 2010, J EXP BOT, V61, P5, DOI 10.1093/jxb/erp349; Bekesiova I, 1999, PLANT MOL BIOL REP, V17, P269, DOI 10.1023/A:1007627509824; Bennett MD, 2003, ANN BOT-LONDON, V91, P547, DOI 10.1093/aob/mcg057; Britt AB, 1996, ANNU REV PLANT PHYS, V47, P75, DOI 10.1146/annurev.arplant.47.1.75; Cameron KM, 2002, AM J BOT, V89, P1503, DOI 10.3732/ajb.89.9.1503; Darwin C., 1875, INSECTIVOROUS PLANTS; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Ellison AM, 2009, J EXP BOT, V60, P19, DOI 10.1093/jxb/ern179; Friedman WE, 2009, AM J BOT, V96, P5, DOI 10.3732/ajb.0800150; Gibson TC, 2009, NEW PHYTOL, V183, P575, DOI 10.1111/j.1469-8137.2009.02935.x; Greilhuber J, 2006, PLANT BIOLOGY, V8, P770, DOI 10.1055/s-2006-924101; Hoshi Yoshikazu, 1998, Cytologia (Tokyo), V63, P329; Ibarra-Laclette E, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-101; Jobson RW, 2004, P NATL ACAD SCI USA, V101, P18064, DOI 10.1073/pnas.0408092101; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Meimberg H, 2000, PLANT BIOLOGY, V2, P218, DOI 10.1055/s-2000-9460; Min XJ, 2005, NUCLEIC ACIDS RES, V33, pW669, DOI 10.1093/nar/gki436; Muller KF, 2006, PLANT BIOLOGY, V8, P748, DOI 10.1055/s-2006-924706; Pellicer J, 2010, BOT J LINN SOC, V164, P10, DOI 10.1111/j.1095-8339.2010.01072.x; Poppinga S, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.24685; Renner T, 2012, MOL BIOL EVOL, V29, P2971, DOI 10.1093/molbev/mss106; Rivadavia F, 2003, AM J BOT, V90, P123, DOI 10.3732/ajb.90.1.123; Rogers WL, 2010, CONSERV GENET RESOUR, V2, P75, DOI 10.1007/s12686-009-9165-x; Rozen S, 2000, Methods Mol Biol, V132, P365; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schulze WX, 2012, MOL CELL PROTEOMICS, V11, P1306, DOI 10.1074/mcp.M112.021006; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Sirova D, 2010, J EXP BOT, V61, P99, DOI 10.1093/jxb/erp286; Srivastava A, 2011, DNA RES, V18, P253, DOI 10.1093/dnares/dsr014; Swarbreck D, 2008, NUCLEIC ACIDS RES, V36, pD1009, DOI 10.1093/nar/gkm965; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wilhelm J, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gkg056; Zhulidov PA, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh031; Zwickl DJ, 2002, SYST BIOL, V51, P588, DOI 10.1080/10635150290102339	37	11	11	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123887	10.1371/journal.pone.0123887	http://dx.doi.org/10.1371/journal.pone.0123887			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886597	Green Published, gold			2022-12-27	WOS:000353017000094
J	Mahendran, P; Soni, S; Goubet, S; Saunsbury, E; Roberts, J; Fisher, M				Mahendran, Prini; Soni, Suneeta; Goubet, Stephanie; Saunsbury, Emma; Roberts, Jonathan; Fisher, Martin			Testing Initiatives Increase Rates of HIV Diagnosis in Primary Care and Community Settings: An Observational Single-Centre Cohort Study	PLOS ONE			English	Article							SEXUAL TRANSMISSION; INFECTION	Objectives The primary objective was to examine trends in new HIV diagnoses in a UK area of high HIV prevalence between 2000 and 2012 with respect to site of diagnosis and stage of HIV infection. Design Single-centre observational cohort study. Setting An outpatient HIV department in a secondary care UK hospital. Participants 1359 HIV-infected adults. Main Outcome Measures Demographic information (age, gender, ethnicity, and sexual orientation), site of initial HIV diagnosis (Routine settings such as HIV/GUM clinics versus Non-Routine settings such as primary care and community venues), stage of HIV infection, CD4 count and seroconversion symptoms were collated for each participant. Results There was a significant increase in the proportion of new HIV diagnoses made in Non-Routine settings (from 27.0% in 2000 to 58.8% in 2012; p<0.001). Overall there was a decrease in the rate of late diagnosis from 50.7% to 32.9%(p=0.001). Diagnosis of recent infection increased from 23.0% to 47.1%(p=0.001). Of those with recent infection, significantly more patients were likely to report symptoms consistent with a seroconversion illness over the 13 years (17.6% to 65.0%; p<0.001). Conclusions This is the first study, we believe, to demonstrate significant improvements in HIV diagnosis and a shift in diagnosis of HIV from HIV/GUM settings to primary practice and community settings due to multiple initiatives.	[Mahendran, Prini; Soni, Suneeta; Roberts, Jonathan; Fisher, Martin] Brighton & Sussex Univ Hosp NHS Trust, Dept GU Med, Brighton, E Sussex, England; [Goubet, Stephanie] Brighton & Sussex Univ Hosp NHS Trust, Clin Invest & Res Unit, Brighton, E Sussex, England; [Saunsbury, Emma; Fisher, Martin] Brighton & Sussex Med Sch, Brighton, E Sussex, England	Brighton and Sussex University Hospitals NHS Trust; University of Brighton; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Brighton; University of Sussex	Soni, S (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Dept GU Med, Brighton, E Sussex, England.	suneetasoni@gmail.com			Department of Health; BD Probetec; Bristol Myers Squibb; AbbVie; Gilead; Merck; Janssen; Viiv	Department of Health; BD Probetec; Bristol Myers Squibb(Bristol-Myers Squibb); AbbVie(AbbVie); Gilead(Gilead Sciences); Merck(Merck & Company); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Viiv	The authors have read the journal's policy and the authors of this manuscript have the following competing interests: All authors declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work. This is with the following exceptions: SS and MF acknowledge the Department of Health for funding which was awarded for a testing pilot described as part of this study but was not directly related to the submitted work. SS has received honoraria, speakers fees or funding to attend conferences from the following companies: BD Probetec and Bristol Myers Squibb, outside the submitted work. MF has received honoraria, speakers fees or funding to attend conferences from the following pharmaceutical companies: AbbVie, Bristol Myers Squibb, Gilead, Merck, Janssen and Viiv. He has also received a research grant from Gilead, outside the submitted work. This does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	[Anonymous], 2021, HIV TESTING NEW HIV; [Anonymous], 2014, OBS STUD HIV POS PEO; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Creswell F, 2013, MEDICINE, V41, P456; Ellis S, 2012, CLIN MED, V12, P430, DOI 10.7861/clinmedicine.12-5-430; Fisher M, 2010, AIDS, V24, P1739, DOI 10.1097/QAD.0b013e32833ac9e6; Gray RH, 2007, BRIT MED J, V335, P188, DOI 10.1136/bmj.39210.582801.BE; Health Protection Agency, 2011, TIM TES HIV EXP HIV; Health Protection Agency, 2012, HIV UK 2012 REP; Iwuji CC, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-397; Krentz HB, 2012, AIDS RES TREAT, V2012, DOI 10.1155/2012/757135; Marks G, 2006, AIDS, V20, P1447, DOI 10.1097/01.aids.0000233579.79714.8d; Moreno S, 2010, ANTIVIR THER, V15, P9, DOI 10.3851/IMP1523; NHS Health Research Authority Medical Research Council, 2013, MED RES COUNC DEC TO; Pilcher CD, 2004, J INFECT DIS, V189, P1785, DOI 10.1086/386333; Raben D, 2012, HIV INDICATOR CONDIT; Schacker T, 1996, ANN INTERN MED, V125, P257, DOI 10.7326/0003-4819-125-4-199608150-00001; Sudarshi D, 2007, SEX TRANSM INFECT, V84, P14, DOI 10.1136/sti.2007.026963	18	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124394	10.1371/journal.pone.0124394	http://dx.doi.org/10.1371/journal.pone.0124394			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885092	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000123
J	Tan, YW; Ye, Y; Zhou, XB; Chen, L; Wen, DF				Tan, Youwen; Ye, Yun; Zhou, Xinbei; Chen, Li; Wen, Danfeng			Age as a Predictor of Significant Fibrosis Features in HBeAg-Negative Chronic Hepatitis B Virus Infection with Persistently Normal Alanine Aminotransferase	PLOS ONE			English	Article							HBV-DNA LEVELS; NORMAL ALT; PEGINTERFERON ALPHA-2A; LAMIVUDINE TREATMENT; LIVER-DISEASE; C PATIENTS; FOLLOW-UP; CARRIERS; COMBINATION; HISTOLOGY	Background Although alanine aminotransferase (ALT) levels reflect the degree of liver damage, not all patients with chronic hepatitis B virus (HBV) infection exhibit persistently elevated ALT levels. In the present study, we aimed to comprehensively evaluate the characteristics of histological abnormalities in a large population of Chinese patients with chronic HBV and persistently normal ALT levels. Methods In total, 2303 consecutive patients who underwent liver biopsy were screened. Of these patients, 273 were categorized as having persistently normal ALT levels (PNALT), whereas 618 were categorized as having persistently or intermittently elevated ALT levels (PIALT). All these patients had at least three ALT values recorded in the year prior to the baseline liver biopsy. Results Significant necroinflammation was observed in 9.7% (11/113) patients with PNALT, 23.3% (42/180) patients with PIALT (ALT 1-2x upper limit of normal [ULN]), and 27.8%(42/151) patients with PIALT (ALT > 2x ULN), whereas significant fibrosis was observed in 8.8% (10/113) patients with PNALT, 27.8% (42/151) patients with PIALT (ALT 1-2x ULN), and 21.2% (32/151) patients with PIALT (ALT > 2x ULN). Multiple logistic regression analysis indicated that age parameters were associated with significant histological abnormalities in patients with PNALT. The area under the curve showed that age was associated with significant fibrosis characteristics in patients with hepatitis B extracellular antigen (HBeAg)-negative PNALT. Conclusion Significant histological abnormalities are not often observed in Chinese patients with PNALT. Interestingly, age appears to be a predictor of significant fibrosis in patients with HBeAg-negative PNALT.	[Tan, Youwen] Soochow Univ, Dept Infect Dis, Affiliated Hosp 1, Suzhou, Peoples R China; [Tan, Youwen; Ye, Yun; Zhou, Xinbei; Chen, Li; Wen, Danfeng] Jiangsu Univ, Dept Hepatosis, Hosp Zhenjiang Affiliated 3, Zhenjiang, Peoples R China	Soochow University - China; Jiangsu University	Tan, YW (corresponding author), Soochow Univ, Dept Infect Dis, Affiliated Hosp 1, Suzhou, Peoples R China.	tyw915@sina.com	Zhou, Xinbei/HGC-1253-2022		Natural Science Foundation of Jiangsu Province, China [BK2011515]; Medical Project of Health Department, Jiangsu Province [H201248]; Preventive medicine research projects, Jiangsu Province [Y2012016]; Social Development Project of Zhenjiang City [SH2013056]	Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Medical Project of Health Department, Jiangsu Province; Preventive medicine research projects, Jiangsu Province; Social Development Project of Zhenjiang City	This work was supported by the Natural Science Foundation of Jiangsu Province, China (BK2011515) (http://www.jstd.gov.cn/), Medical Project of Health Department, Jiangsu Province (H201248) (http://www.jswst.gov.cn/), Preventive medicine research projects, Jiangsu Province (Y2012016) (http://www.jswst.gov.cn/), and the Social Development Project of Zhenjiang City (SH2013056) (http://kjj.zhenjiang.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreani T, 2007, CLIN GASTROENTEROL H, V5, P636, DOI 10.1016/j.cgh.2007.01.005; Arora S, 2006, J GASTROEN HEPATOL, V21, P406, DOI 10.1111/j.1440-1746.2005.04059.x; Bonora E, 2000, DIABETES CARE, V23, P57, DOI 10.2337/diacare.23.1.57; Chan WK, 2014, J GASTROEN HEPATOL, V29, P1470, DOI 10.1111/jgh.12557; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Dai CY, 2009, HEPATOLOGY, V49, P704, DOI 10.1002/hep.22723; Hui CK, 2007, ALIMENT PHARM THER, V25, P1283, DOI 10.1111/j.1365-2036.2007.03318.x; Kim WR, 2008, HEPATOLOGY, V47, P1363, DOI 10.1002/hep.22109; Kirschberg O, 2004, J CLIN VIROL, V29, P39, DOI 10.1016/S1386-6532(03)00084-2; KNODELL RG, 1981, HEPATOLOGY, V1, P431, DOI 10.1002/hep.1840010511; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lesmana CRA, 2011, J DIGEST DIS, V12, P476, DOI 10.1111/j.1751-2980.2011.00540.x; Liao BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078672; Lin CL, 2007, HEPATOLOGY, V45, P1193, DOI 10.1002/hep.21585; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Manesis EK, 2002, GASTROENTEROLOGY, V122, P2092, DOI 10.1053/gast.2002.34021; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martinot-Peignoux M, 2002, J HEPATOL, V36, P543, DOI 10.1016/S0168-8278(02)00004-1; McMahon BJ, 2004, SEMIN LIVER DIS, V24, P17, DOI 10.1055/s-2004-828674; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Papatheodoridis GV, 2008, HEPATOLOGY, V48, P1451, DOI 10.1002/hep.22518; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Park JY, 2008, J VIRAL HEPATITIS, V15, P615, DOI 10.1111/j.1365-2893.2008.00989.x; Perrillo RP, 2002, HEPATOLOGY, V36, P186, DOI 10.1053/jhep.2002.34294; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; ter Borg F, 2000, J CLIN PATHOL, V53, P541, DOI 10.1136/jcp.53.7.541; Tseng KC, 2014, ANTIVIR THER, V19, P755, DOI 10.3851/IMP2754; Wang H, 2013, J VIRAL HEPATITIS, V20, pe3, DOI 10.1111/jvh.12010; Wang H, 2013, PROTEIN CELL, V4, P643, DOI 10.1007/s13238-013-3048-3; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049; Yuen MF, 2007, HEPATOLOGY, V46, P1695, DOI 10.1002/hep.21939; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136; Zacharakis G, 2008, J HEPATOL, V49, P884, DOI 10.1016/j.jhep.2008.06.009; Zoulim F, 2012, GUT, V61, P333, DOI 10.1136/gutjnl-2011-300937	37	20	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123452	10.1371/journal.pone.0123452	http://dx.doi.org/10.1371/journal.pone.0123452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885705	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000067
J	Castino, MR; Cornish, JL; Clemens, KJ				Castino, Matthew R.; Cornish, Jennifer L.; Clemens, Kelly J.			Inhibition of Histone Deacetylases Facilitates Extinction and Attenuates Reinstatement of Nicotine Self-Administration in Rats	PLOS ONE			English	Article							LONG-TERM-MEMORY; CUE-INDUCED REINSTATEMENT; COCAINE-SEEKING BEHAVIOR; SODIUM-BUTYRATE; PREFRONTAL CORTEX; ACQUISITION; RECONSOLIDATION; ACETYLATION; EXPRESSION; PREFERENCE	Chromatin remodelling is integral to the formation of long-term memories. Recent evidence suggests that histone modification may play a role in the persistence of memories associated with drug use. The present series of experiments aimed to examine the effect of histone deacetylase (HDAC) inhibition on the extinction and reinstatement of nicotine self-administration. Rats were trained to intravenously self-administer nicotine for 12 days on a fixed-ratio 1 schedule. In Experiment 1, responding was then extinguished through removal of nicotine and response-contingent cues. After each extinction session, the HDAC inhibitor, sodium butyrate (NaB), was administered immediately, or six hours after each session. In Experiment 2, response-contingent cues remained available across extinction to increase rates of responding during this phase, and NaB was administered immediately after the session. Finally, in Experiment 3, the effect of NaB treatment on extinction of responding for sucrose pellets was assessed. Across all experiments reinstatement to the cue and/or the reward itself was then tested. In the first experiment, treatment with NaB significantly attenuated nicotine and nicotine + cue reinstatement when administered immediately, but not six hours after each extinction session. When administered after cue-extinction (Expt. 2), NaB treatment specifically facilitated the rate of extinction across sessions, indicating that HDAC inhibition enhanced consolidation of the extinction memory. In contrast, there was no effect of NaB on the extinction and reinstatement of sucrose-seeking (Expt. 3), indicating that the observed effects are specific to a drug context. These results provide the first demonstration that HDAC inhibition facilitates the extinction of responding for an intravenously self-administered drug of abuse and further highlight the potential of HDAC inhibitors in the treatment of drug addiction.	[Castino, Matthew R.; Cornish, Jennifer L.; Clemens, Kelly J.] Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia; [Castino, Matthew R.; Clemens, Kelly J.] Univ New S Wales, Sch Psychol, Sydney, NSW, Australia	Macquarie University; University of New South Wales Sydney	Clemens, KJ (corresponding author), Macquarie Univ, Dept Psychol, Sydney, NSW 2109, Australia.	k.clemens@unsw.edu.au		Cornish, Jennifer/0000-0002-9754-8069; Clemens, Kelly/0000-0003-2709-218X; Castino, Matthew/0000-0002-2100-5914	Australian Research Council (ARC) [DE120100235]	Australian Research Council (ARC)(Australian Research Council)	This funding was supported by an Australian Research Council (ARC) Discovery Early Career Researcher Award (DECRA) to KJC (Grant No. DE120100235; http://www.arc.gov.au/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel T, 1998, BRAIN RES REV, V26, P360, DOI 10.1016/S0165-0173(97)00050-7; Alberini CM, 2009, PHYSIOL REV, V89, P121, DOI 10.1152/physrev.00017.2008; Bahari-Javan S, 2012, J NEUROSCI, V32, P5062, DOI 10.1523/JNEUROSCI.0079-12.2012; Bird KD, 2004, ANALYSIS OF VARIANCE; Bouton ME, 2012, BEHAV PROCESS, V90, P130, DOI 10.1016/j.beproc.2012.03.004; Bredy TW, 2008, LEARN MEMORY, V15, P39, DOI 10.1101/lm.801108; Bredy TW, 2007, LEARN MEMORY, V14, P268, DOI 10.1101/lm.500907; Caggiula AR, 2001, PHARMACOL BIOCHEM BE, V70, P515, DOI 10.1016/S0091-3057(01)00676-1; Clemens KJ, 2010, PSYCHOPHARMACOLOGY, V211, P43, DOI 10.1007/s00213-010-1866-z; Cooper J, 2011, AUST NZ J PUBL HEAL, V35, P368, DOI 10.1111/j.1753-6405.2011.00733.x; Donny EC, 1998, PSYCHOPHARMACOLOGY, V136, P83, DOI 10.1007/s002130050542; Gipson CD, 2013, P NATL ACAD SCI USA, V110, P9124, DOI 10.1073/pnas.1220591110; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Itzhak Y, 2013, NEUROBIOL LEARN MEM, V102, P34, DOI 10.1016/j.nlm.2013.03.007; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lattal KM, 2007, BEHAV NEUROSCI, V121, P1125, DOI 10.1037/0735-7044.121.5.1125; Levine A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003062; Liu X, 2006, PSYCHOPHARMACOLOGY, V184, P417, DOI 10.1007/s00213-005-0134-0; Liu X, 2008, PSYCHOPHARMACOLOGY, V196, P365, DOI 10.1007/s00213-007-0967-9; Malvaez M, 2013, P NATL ACAD SCI USA, V110, P2647, DOI 10.1073/pnas.1213364110; Malvaez M, 2011, J NEUROSCI, V31, P16941, DOI 10.1523/JNEUROSCI.2747-11.2011; Malvaez M, 2010, BIOL PSYCHIAT, V67, P36, DOI 10.1016/j.biopsych.2009.07.032; McQuown SC, 2011, NEUROBIOL LEARN MEM, V96, P27, DOI [10.1016/j.nlm.2011.04.005, 10.1016/j.nlm.2011.04.002]; McQuown SC, 2011, J NEUROSCI, V31, P764, DOI 10.1523/JNEUROSCI.5052-10.2011; Motbey CP, 2013, J PSYCHOPHARMACOL, V27, P823, DOI 10.1177/0269881113490325; Pastor V, 2011, J NEUROCHEM, V116, P636, DOI 10.1111/j.1471-4159.2010.07149.x; Paterson NE, 2005, NEUROPSYCHOPHARMACOL, V30, P119, DOI 10.1038/sj.npp.1300524; Peterson AB, 2014, PSYCHOPHARMACOLOGY, V231, P1305, DOI 10.1007/s00213-013-3321-4; Ploense KL, 2013, BEHAV PHARMACOL, V24, P164, DOI 10.1097/FBP.0b013e32836104ea; Portero-Tresserra M, 2013, NEUROBIOL LEARN MEM, V100, P1, DOI 10.1016/j.nlm.2012.11.003; Raybuck JD, 2013, PHARMACOL BIOCHEM BE, V106, P109, DOI 10.1016/j.pbb.2013.02.009; Romieu P, 2008, J NEUROSCI, V28, P9342, DOI 10.1523/JNEUROSCI.0379-08.2008; Romieu P, 2011, CURR NEUROPHARMACOL, V9, P21, DOI 10.2174/157015911795017317; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P3, DOI 10.1007/s00213-002-1224-x; Simon-O'Brien E, 2015, ADDICT BIOL, V20, P676, DOI 10.1111/adb.12161; Sun J, 2008, NEUROSCI LETT, V441, P72, DOI 10.1016/j.neulet.2008.05.010; Wang R, 2010, NEUROSCI LETT, V483, P137, DOI 10.1016/j.neulet.2010.07.080; Wang YP, 2015, J MOL NEUROSCI, V55, P269, DOI 10.1007/s12031-014-0317-4	39	21	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124796	10.1371/journal.pone.0124796	http://dx.doi.org/10.1371/journal.pone.0124796			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880762	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500112
J	Li, CY; Lin, CP; Lin, YS; Wu, LS; Chang, CJ; Chu, PH				Li, Chen-Yu; Lin, Chia-Pin; Lin, Yu-Sheng; Wu, Lung-Sheng; Chang, Chee-Jen; Chu, Pao-Hsien			Newly Diagnosed Atrial Fibrillation Is an Independent Factor for Future Major Adverse Cardiovascular Events	PLOS ONE			English	Article							RISK-FACTORS; HEART-FAILURE; FOLLOW-UP; HOSPITAL DIAGNOSIS; MORTALITY; TAIWAN; STROKE; DISEASE; TRENDS; CARE	Objectives This study aims to investigate the impact of newly diagnosed atrial fibrillation (AF) on future major adverse cardiac events (MACE). AF is the most common form of cardiac arrhythmia and is associated with several other cardiovascular (CV) events. Little is known about whether newly diagnosed AF is an independent factor for future MACE, especially in patients without such a history. Methods and Results We evaluated data from the National Health Insurance Research Database, which represented a retrospective cohort of 713,288 adults in Taiwan from 2006 to 2010. Individuals with previous MACE were excluded. Newly diagnosed AF patients were identified by assigning International Classification of Diseases codes. Propensity score matching adjusted for gender, age, hypertension, diabetes mellitus and dyslipidemia. Cox proportional hazard models estimated future MACE ratios. We compared a total of 3,737 patients with newly diagnosed AF and 704,225 patients without. After matching, there was no difference in baseline demographic characteristics in patients across newly diagnosed AF and non-AF groups. The result showed that newly diagnosed AF in multivariate analysis were associated with increased incidents of MACE (hazard ratio: 3.11-3.51 in different models) and mortality. Newly diagnosed AF without other CV risk factors had 8.45 times the risk of developing future MACE than healthy adults. The more associated CV risk factors in addition to AF, the increased rate of future CV events. Conclusions Newly diagnosed AF is an independent factor that leads to future CV events after gender, age, hypertension, diabetes mellitus and dyslipidemia matching. AF is associated with a higher mortality rate.	[Lin, Chia-Pin; Lin, Yu-Sheng; Wu, Lung-Sheng; Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Dept Cardiol, Taipei, Taiwan; [Lin, Chia-Pin; Lin, Yu-Sheng; Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Healthcare Ctr, Taipei, Taiwan; [Li, Chen-Yu; Chang, Chee-Jen] Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taipei, Taiwan; [Chu, Pao-Hsien] Chang Gung Univ, Coll Med, Chang Gung Mem Hosp, Heart Failure Ctr, Taipei, Taiwan	Chang Gung Memorial Hospital; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital; Chang Gung University	Chang, CJ (corresponding author), Chang Gung Univ, Coll Med, Clin Informat & Med Stat Res Ctr, Taipei, Taiwan.	cjchang@mail.cgu.edu.tw; pchu@adm.cgmh.org.tw	Chu, Pao-Hsien/P-5249-2019; Chu, Pao-Hsien/G-3685-2010	Chu, Pao-Hsien/0000-0003-0361-6348; Li, Chen-Yu/0000-0003-1097-838X	Ministry of Science and Technology [99-2314-B-182A-106-MY3, 102-2314-B-182A-060-MY2]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	Dr. Chu P-H is supported by the Ministry of Science and Technology (99-2314-B-182A-106-MY3 and 102-2314-B-182A-060-MY2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamin EJ, 1998, CIRCULATION, V98, P946, DOI 10.1161/01.CIR.98.10.946; Chiang TL, 1997, HEALTH POLICY, V39, P225, DOI 10.1016/S0168-8510(96)00877-9; Curb JD, 1996, JAMA-J AM MED ASSOC, V276, P1886, DOI 10.1001/jama.276.23.1886; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; Frost L, 1999, EUR HEART J, V20, P1592, DOI 10.1053/euhj.1999.1713; Frost L, 2005, INT J CARDIOL, V103, P78, DOI 10.1016/j.ijcard.2004.08.024; Kempler P, 2005, DIABETES RES CLIN PR, V68, pS43, DOI 10.1016/j.diabres.2005.03.005; Kober L, 2006, EUR J HEART FAIL, V8, P591, DOI 10.1016/j.ejheart.2005.11.007; KRAHN AD, 1995, AM J MED, V98, P476, DOI 10.1016/S0002-9343(99)80348-9; Lin LY, 2011, ATHEROSCLEROSIS, V217, P292, DOI 10.1016/j.atherosclerosis.2011.03.033; Lin YS, 2011, AM J CARDIOL, V107, P325, DOI 10.1016/j.amjcard.2010.08.073; Lu JFR, 2003, HEALTH AFFAIR, V22, P77, DOI 10.1377/hlthaff.22.3.77; Majeed A, 2001, HEART, V86, P284, DOI 10.1136/heart.86.3.284; Marijon E, 2013, CIRCULATION, V128, P2192, DOI 10.1161/CIRCULATIONAHA.112.000491; McManus DD, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.005694; Miyasaka Y, 2007, J AM COLL CARDIOL, V49, P986, DOI 10.1016/j.jacc.2006.10.062; Nieuwlaat R, 2008, EUR HEART J, V29, P1181, DOI 10.1093/eurheartj/ehn139; Olsson LG, 2006, J AM COLL CARDIOL, V47, P1997, DOI 10.1016/j.jacc.2006.01.060; Patel PJ, 2004, AM J CARDIOL, V94, P1379, DOI 10.1016/j.amjcard.2004.08.011; Sedlak TL, 2013, AM HEART J, V166, P38, DOI 10.1016/j.ahj.2013.03.015; STAMLER J, 1993, DIABETES CARE, V16, P434, DOI 10.2337/diacare.16.2.434; Stevenson WG, 1996, J AM COLL CARDIOL, V28, P1458, DOI 10.1016/S0735-1097(96)00358-0; Stewart S, 2002, AM J MED, V113, P359, DOI 10.1016/S0002-9343(02)01236-6; Tang CH, 2009, STROKE, V40, P1162, DOI 10.1161/STROKEAHA.108.540880; Vidaillet H, 2002, AM J MED, V113, P365, DOI 10.1016/S0002-9343(02)01253-6; WOLF PA, 1987, ARCH INTERN MED, V147, P1561, DOI 10.1001/archinte.147.9.1561; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wu LS, 2012, AM J MED SCI	28	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123211	10.1371/journal.pone.0123211	http://dx.doi.org/10.1371/journal.pone.0123211			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25875922	Green Published, gold, Green Submitted			2022-12-27	WOS:000353015800088
J	Bartneck, C; Duenser, A; Moltchanova, E; Zawieska, K				Bartneck, Christoph; Duenser, Andreas; Moltchanova, Elena; Zawieska, Karolina			Comparing the Similarity of Responses Received from Studies in Amazon's Mechanical Turk to Studies Conducted Online and with Direct Recruitment	PLOS ONE			English	Article							QUALITY; PAPER	Computer and internet based questionnaires have become a standard tool in Human-Computer Interaction research and other related fields, such as psychology and sociology. Amazon's Mechanical Turk (AMT) service is a new method of recruiting participants and conducting certain types of experiments. This study compares whether participants recruited through AMT give different responses than participants recruited through an online forum or recruited directly on a university campus. Moreover, we compare whether a study conducted within AMT results in different responses compared to a study for which participants are recruited through AMT but which is conducted using an external online questionnaire service. The results of this study show that there is a statistical difference between results obtained from participants recruited through AMT compared to the results from the participant recruited on campus or through online forums. We do, however, argue that this difference is so small that it has no practical consequence. There was no significant difference between running the study within AMT compared to running it with an online questionnaire service. There was no significant difference between results obtained directly from within AMT compared to results obtained in the campus and online forum condition. This may suggest that AMT is a viable and economical option for recruiting participants and for conducting studies as setting up and running a study with AMT generally requires less effort and time compared to other frequently used methods. We discuss our findings as well as limitations of using AMT for empirical studies.	[Bartneck, Christoph; Moltchanova, Elena] Univ Canterbury, Christchurch 8140, New Zealand; [Duenser, Andreas] CSIRO Computat Informat Castray Esplanade, Hobart, Tas 7000, Australia; [Zawieska, Karolina] Ind Res Inst Automat & Measurements PIAP, PL-02486 Warsaw, Poland	University of Canterbury; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Industrial Research Institute for Automation & Measurements	Bartneck, C (corresponding author), Univ Canterbury, Private Bag 4800, Christchurch 8140, New Zealand.	christoph.bartneck@canterbury.ac.nz	Bartneck, Christoph/B-5699-2008; , AndreasDuenser/I-9279-2014	Bartneck, Christoph/0000-0003-4566-4815; , AndreasDuenser/0000-0002-7423-0736; Zawieska, Karolina/0000-0003-0504-5227				Agresti A., 2005, STAT METHODS APPL, V14, P297, DOI DOI 10.1007/S10260-005-0121-Y; Barkhuus L, 2007, FROM MICE TO MEN 24; Bartneck C, 2013, 1ST INTERNATIONAL CO; Berinsky AJ, 2012, POLIT ANAL, V20, P351, DOI 10.1093/pan/mpr057; Birnbaum MH, 2005, HANDBOOK OF HUMAN FACTORS IN WEB DESIGN, P471; Buhrmester M, 2011, PERSPECT PSYCHOL SCI, V6, P3, DOI 10.1177/1745691610393980; Bulmer M., 2004, QUESTIONNAIRES; Campbell D. T., 1966, EXPERIMENTAL AND QUA; Couper MP, 2005, SOC SCI COMPUT REV, V23, P486, DOI 10.1177/0894439305278972; Croteau AM, 2010, IEEE T PROF COMMUN, V53, P249, DOI 10.1109/TPC.2010.2052852; de Leeuw E., 2003, FIELD METHOD, V15, P223, DOI DOI 10.1177/1525822X03254714; EKMAN P, 1971, J PERS SOC PSYCHOL, V17, P124, DOI 10.1037/h0030377; Gelman A, 2009, BAYESIAN DATA ANALYS; Goodman JK, 2012, DATA COLLECTION IN A; Hanscom B, 2002, SPINE, V27, P1797, DOI 10.1097/00007632-200208150-00020; Hedeker D, 2003, STAT MED, V22, P1433, DOI 10.1002/sim.1522; Heer J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P203; Horton J. J., 2010, P 11 ACM C EL COMM, P209, DOI DOI 10.1145/1807342.1807376; Horton JJ, 2011, EXP ECON, V14, P399, DOI 10.1007/s10683-011-9273-9; Hultsch DF, 2002, INT J BEHAV DEV, V26, P345, DOI 10.1080/01650250143000247; Kelly Diane, 2009, Foundations and Trends in Information Retrieval, V3, P1, DOI 10.1561/1500000012; Kelly D, 2008, INFORM PROCESS MANAG, V44, P122, DOI 10.1016/j.ipm.2007.02.007; Kittur A, 2008, CHI 2008: 26TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS VOLS 1 AND 2, CONFERENCE PROCEEDINGS, P453; Komarov Steven, 2013, P SIGCHI C HUMAN FAC, P207, DOI [10.1145/2470654.2470684, DOI 10.1145/2470654.2470684]; Kosara R., 2010, P BEYOND TIM ERR NOV, P373; Lonsdale C, 2006, J SPORT EXERCISE PSY, V28, P100, DOI 10.1123/jsep.28.1.100; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Mason W., 2010, SIGKDD EXPLORATIONS, V11, P100, DOI [DOI 10.1145/1809400.1809422, 10.1145/1600150.1600175]; Mason W, 2012, BEHAV RES METHODS, V44, P1, DOI 10.3758/s13428-011-0124-6; McCoy S, 2004, ELECTRONIC VERSUS PA; Obaid M, 2009, P ACM INT C ADV COMP, P285, DOI [10.1145/1690388.1690437, DOI 10.1145/1690388.1690437]; Paolacci G, 2010, JUDGM DECIS MAK, V5, P411; Pontin J, 2007, THE NEW YORK TIMES; Potter T, 2008, PSYCHON B REV, V15, P615, DOI 10.3758/PBR.15.3.615; Rand DG, 2012, J THEOR BIOL, V299, P172, DOI 10.1016/j.jtbi.2011.03.004; Reips UD, 2000, THE WEB EXPERIMENT M, P89; Ritter L. A., 2007, CONDUCTING ONLINE SU; Ross J., 2010, HUMAN FACTORS COMPUT, DOI [10.1145/1753846.1753873, DOI 10.1145/1753846.1753873]; Roztocki N, 2001, ENGINEERING MANAGEMENT: IT'S ABOUT PEOPLE, PROCEEDINGS, P290; Schulze T, 2011, PROCEEDINGS OF THE E; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; SPROULL LS, 1986, ACAD MANAGE J, V29, P159, DOI 10.2307/255867; Tourangeau R, 1984, COGNITIVE ASPECTS SU, P73; Tuten TL, 1997, ELECTRONIC DATA COLL	44	196	196	3	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0121595	10.1371/journal.pone.0121595	http://dx.doi.org/10.1371/journal.pone.0121595			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EB	25876027	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700010
J	Bassiouni, A; Cleland, EJ; Psaltis, AJ; Vreugde, S; Wormald, PJ				Bassiouni, Ahmed; Cleland, Edward John; Psaltis, Alkis James; Vreugde, Sarah; Wormald, Peter-John			Sinonasal Microbiome Sampling: A Comparison of Techniques	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS; CHRONIC RHINOSINUSITIS; BIOFILMS; DIVERSITY; INFLAMMATION; BACTERIAL; SEARCH	Background The role of the sino-nasal microbiome in CRS remains unclear. We hypothesized that the bacteria within mucosal-associated biofilms may be different from the more superficiallying, free-floating bacteria in the sinuses and that this may impact on the microbiome results obtained. This study investigates whether there is a significant difference in the microbiota of a sinonasal mucosal tissue sample versus a swab sample. Methods Cross-sectional study with paired design. Mucosal biopsy and swab samples were obtained intra-operatively from the ethmoid sinuses of 6 patients with CRS. Extracted DNA was sequenced on a Roche-454 sequencer using 16S-rRNA gene targeted primers. Data were analyzed using QIIME 1.8 software package. Results At a maximum subsampling depth of 1,100 reads, the mean observed species richness was 33.3 species (30.6 for swab, versus 36 for mucosa; p > 0.05). There was no significant difference in phylogenetic and non-phylogenetic alpha diversity metrics (Faith's PD_Whole_Tree and Shannon's index) between the two sampling methods (p > 0.05). The type of sample also had no significant effect on phylogenetic and non-phylogenetic beta diversity metrics (Unifrac and Bray-Curtis; p > 0.05). Conclusion We observed no significant difference between the microbiota of mucosal tissue and swab samples. This suggests that less invasive swab samples are representative of the sinonasal mucosa microbiome and can be used for future sinonasal microbiome studies.	[Bassiouni, Ahmed; Cleland, Edward John; Psaltis, Alkis James; Vreugde, Sarah; Wormald, Peter-John] Univ Adelaide, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia	University of Adelaide	Wormald, PJ (corresponding author), Univ Adelaide, Dept Surg Otorhinolaryngol Head & Neck Surg, Adelaide, SA, Australia.	peterj.wormald@adelaide.edu.au		Vreugde, Sarah/0000-0003-4719-9785; Psaltis, Alkis/0000-0003-2967-1855; Bassiouni, Ahmed/0000-0002-5545-0194	Garnett Passe and Rodney Williams Memorial Foundation: Conjoint Grant; Garnett Passe and Rodney Williams Memorial Foundation: Academic Surgeon-Scientist Research Scholarship grant	Garnett Passe and Rodney Williams Memorial Foundation: Conjoint Grant; Garnett Passe and Rodney Williams Memorial Foundation: Academic Surgeon-Scientist Research Scholarship grant	This work was supported by grants from the Garnett Passe and Rodney Williams Memorial Foundation: (1) The Conjoint Grant; and (2) The Academic Surgeon-Scientist Research Scholarship grant to EC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu NA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003783; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Aurora R, 2013, JAMA OTOLARYNGOL, V139, P1328, DOI 10.1001/jamaoto.2013.5465; Bendouah Z, 2006, OTOLARYNG HEAD NECK, V134, P991, DOI 10.1016/j.otohns.2006.03.001; Boase S, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-210; Cantero D, 2013, INT FORUM ALLERGY RH, V3, P556, DOI 10.1002/alr.21146; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Choi EB, 2014, ALLERGY, V69, P517, DOI 10.1111/all.12374; Cleland EJ, 2013, INT FORUM ALLERGY RH, V3, P642, DOI 10.1002/alr.21159; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feazel LM, 2012, LARYNGOSCOPE, V122, P467, DOI 10.1002/lary.22398; Foreman A, 2011, ALLERGY, V66, P1449, DOI 10.1111/j.1398-9995.2011.02678.x; Foreman A, 2010, LARYNGOSCOPE, V120, P1701, DOI 10.1002/lary.21024; Handl S, 2011, FEMS MICROBIOL ECOL, V76, P301, DOI 10.1111/j.1574-6941.2011.01058.x; Hekiert AM, 2009, OTOLARYNG HEAD NECK, V141, P448, DOI 10.1016/j.otohns.2009.06.090; Hochstim CJ, 2010, OTOLARYNG HEAD NECK, V143, P697, DOI 10.1016/j.otohns.2010.07.017; Honda K, 2011, CELL HOST MICROBE, V10, P423, DOI 10.1016/j.chom.2011.10.008; Kim R, 2013, INT FORUM ALLERGY RH, V3, P349, DOI [10.1002/alr.21117, 10.2500/ajra.2013.27.3974]; Kuczynski J, 2012, NAT REV GENET, V13, P47, DOI 10.1038/nrg3129; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Liu CM, 2013, INT FORUM ALLERGY RH, V3, DOI 10.1002/alr.21195; Oksanen J., **DATA OBJECT**; Perez F, 2007, COMPUT SCI ENG, V9, P21, DOI 10.1109/MCSE.2007.53; Psaltis AJ, 2008, ROLE BACTERIAL BIOFI; Psaltis AJ, 2008, AM J RHINOL, V22, P1, DOI 10.2500/ajr.2008.22.3119; R Core Team, 2018, R LANG ENV STAT COMP; Ramakrishnan VR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085507; Reeder J, 2010, NAT METHODS, V7, P668, DOI 10.1038/nmeth0910-668b; Singhal D, 2011, LARYNGOSCOPE, V121, P1578, DOI 10.1002/lary.21805; Singhal D, 2010, AM J RHINOL ALLERGY, V24, P169, DOI 10.2500/ajra.2010.24.3462; Tan NCW, 2013, INT FORUM ALLERGY RH, V3, P261, DOI 10.1002/alr.21154; Vazquez-Baeza Y, 2013, GIGASCIENCE, V2, DOI 10.1186/2047-217X-2-16	38	45	47	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123216	10.1371/journal.pone.0123216	http://dx.doi.org/10.1371/journal.pone.0123216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25876035	gold, Green Published, Green Submitted			2022-12-27	WOS:000353014700028
J	Sangket, U; Vijasika, S; Noh, H; Chantratita, W; Klungthong, C; Yoon, IK; Fernandez, S; Rutvisuttinunt, W				Sangket, Unitsa; Vijasika, Sukanya; Noh, Hasnee; Chantratita, Wasun; Klungthong, Chonticha; Yoon, In Kyu; Fernandez, Stefan; Rutvisuttinunt, Wiriya			SNPer: An R Library for Quantitative Variant Analysis on Single Nucleotide Polymorphisms among Influenza Virus Populations	PLOS ONE			English	Article							DNA-SEQUENCING DATA; FRAMEWORK	Influenza virus (IFV) can evolve rapidly leading to genetic drifts and shifts resulting in human and animal influenza epidemics and pandemics. The genetic shift that gave rise to the 2009 influenza A/H1N1 pandemic originated from a triple gene reassortment of avian, swine and human IFVs. More minor genetic alterations in genetic drift can lead to influenza drug resistance such as the H274Y mutation associated with oseltamivir resistance. Hence, a rapid tool to detect IFV mutations and the potential emergence of new virulent strains can better prepare us for seasonal influenza outbreaks as well as potential pandemics. Furthermore, identification of specific mutations by closely examining single nucleotide polymorphisms (SNPs) in IFV sequences is essential to classify potential genetic markers associated with potentially dangerous IFV phenotypes. In this study, we developed a novel R library called "SNPer" to analyze quantitative variants in SNPs among IFV subpopulations. The computational SNPer program was applied to three different subpopulations of published IFV genomic information. SNPer queried SNPs data and grouped the SNPs into (1) universal SNPs, (2) likely common SNPs, and (3) unique SNPs. SNPer outperformed manual visualization in terms of time and labor. SNPer took only three seconds with no errors in SNP comparison events compared with 40 hours with errors using manual visualization. The SNPer tool can accelerate the capacity to capture new and potentially dangerous IFV strains to mitigate future influenza outbreaks.	[Sangket, Unitsa; Vijasika, Sukanya; Noh, Hasnee] Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Thailand; [Chantratita, Wasun] Mahidol Univ, Ramathibodhi Hosp, Fac Med, Dept Pathol, Bangkok 10700, Thailand; [Klungthong, Chonticha; Yoon, In Kyu; Fernandez, Stefan; Rutvisuttinunt, Wiriya] Armed Forces Res Inst Med Sci, Dept Virol, Bangkok 10400, Thailand	Prince of Songkla University; Mahidol University; United States Department of Defense; United States Army; Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	Sangket, U (corresponding author), Prince Songkla Univ, Fac Sci, Dept Mol Biotechnol & Bioinformat, Hat Yai, Thailand.	unitsa.s@psu.ac.th			Thailand Center of Excellence for Life Sciences (TCELS)	Thailand Center of Excellence for Life Sciences (TCELS)	This work was funded by Thailand Center of Excellence for Life Sciences (TCELS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barzon L, 2011, INT J MOL SCI, V12, P7861, DOI 10.3390/ijms12117861; Danecek P, 2011, BIOINFORMATICS, V27, P2156, DOI 10.1093/bioinformatics/btr330; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Ebbert MTW, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-S7-S12; GENTLEMAN R, 1996, J COMPUTATIONAL GRAP, V5, P299; Grada A, 2013, J INVEST DERMATOL, V133, pE1, DOI 10.1038/jid.2013.248; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Reimers M, 2006, METHOD ENZYMOL, V411, P119, DOI 10.1016/S0076-6879(06)11008-3; Rutvisuttinunt W, 2014, J CLIN VIRO IN PRESS; Rutvisuttinunt W, 2013, J VIROL METHODS, V193, P394, DOI 10.1016/j.jviromet.2013.07.001; Sangket U, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-217; Schaefer C, 2012, BIOINFORMATICS, V28, P601, DOI 10.1093/bioinformatics/btr705; Schwarz DF, 2008, BIOINFORMATICS, V24, P146, DOI 10.1093/bioinformatics/btm551; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; Zhirnov OP, 2009, J CLIN VIROL, V45, P322, DOI 10.1016/j.jcv.2009.05.030	17	3	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122812	10.1371/journal.pone.0122812	http://dx.doi.org/10.1371/journal.pone.0122812			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876137	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100105
J	Barbosa, C; Garcia-Martinez, J; Perez-Ortin, JE; Mendes-Ferreiral, A				Barbosa, Catarina; Garcia-Martinez, Jose; Perez-Ortin, Jose E.; Mendes-Ferreiral, Ana			Comparative Transcriptomic Analysis Reveals Similarities and Dissimilarities in Saccharomyces cerevisiae Wine Strains Response to Nitrogen Availability	PLOS ONE			English	Article							GLOBAL GENE-EXPRESSION; ALCOHOLIC FERMENTATION; STRESS-RESPONSE; YEAST STRAINS; SLUGGISH FERMENTATIONS; CHEMOSTAT CULTURES; AROMA COMPOUNDS; MOLECULAR-BASIS; GROWTH; WINEMAKING	Nitrogen levels in grape-juices are of major importance in winemaking ensuring adequate yeast growth and fermentation performance. Here we used a comparative transcriptome analysis to uncover wine yeasts responses to nitrogen availability during fermentation. Gene expression was assessed in three genetically and phenotypically divergent commercial wine strains (CEG, VL1 and QA23), under low (67 mg/L) and high nitrogen (670 mg/L) regimes, at three time points during fermentation (12h, 24h and 96h). Two-way ANOVA analysis of each fermentation condition led to the identification of genes whose expression was dependent on strain, fermentation stage and on the interaction of both factors. The high fermenter yeast strain QA23 was more clearly distinct from the other two strains, by differential expression of genes involved in flocculation, mitochondrial functions, energy generation and protein folding and stabilization. For all strains, higher transcriptional variability due to fermentation stage was seen in the high nitrogen fermentations. A positive correlation between maximum fermentation rate and the expression of genes involved in stress response was observed. The finding of common genes correlated with both fermentation activity and nitrogen up-take underlies the role of nitrogen on yeast fermentative fitness. The comparative analysis of genes differentially expressed between both fermentation conditions at 12h, where the main difference was the level of nitrogen available, showed the highest variability amongst strains revealing strain-specific responses. Nevertheless, we were able to identify a small set of genes whose expression profiles can quantitatively assess the common response of the yeast strains to varying nitrogen conditions. The use of three contrasting yeast strains in gene expression analysis prompts the identification of more reliable, accurate and reproducible biomarkers that will facilitate the diagnosis of deficiency of this nutrient in the grape-musts and the development of strategies to optimize yeast performance in industrial fermentations.	[Barbosa, Catarina; Mendes-Ferreiral, Ana] Univ Tras Os Montes & Alto Douro, Ctr Agr Genom & Biotechnol CGBA, Vila Real, Portugal; [Garcia-Martinez, Jose] Univ Valencia, Dept Genet, Valencia, Spain; [Garcia-Martinez, Jose] ERI Biotecmed, Valencia, Spain; [Barbosa, Catarina; Perez-Ortin, Jose E.] Univ Valencia, Dept Bioquim & Biol Mol, Valencia, Spain; [Barbosa, Catarina; Perez-Ortin, Jose E.] ERI Biotecmed, Valencia, Spain	University of Tras-os-Montes & Alto Douro; University of Valencia; University of Valencia	Mendes-Ferreiral, A (corresponding author), Univ Tras Os Montes & Alto Douro, Ctr Agr Genom & Biotechnol CGBA, Vila Real, Portugal.	anamf@utad.pt	Pérez-Ortín, José E./K-8582-2014; Garcia-Martinez, Jose/X-4995-2019; Barbosa, Catarina/B-6066-2018; Ferreira, Ana Mendes/I-6211-2012; Garcia-Martinez, Jose/F-6790-2016	Pérez-Ortín, José E./0000-0002-1992-513X; Garcia-Martinez, Jose/0000-0001-5866-5994; Barbosa, Catarina/0000-0003-2383-2101; Ferreira, Ana Mendes/0000-0002-2624-0761; Garcia-Martinez, Jose/0000-0001-5866-5994	FEDER [COMPETE-FCOMP-01-0124-FEDER-014043 (PTDC/AGR-ALI/111224/2009)]; North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN) through the European Regional Development Fund (FEDER) [NORTE-07-0124-FEDER-000032]; National Funds (PIDDAC) through the Portuguese Foundation for Science and Technology (FCT/MEC); FCT [SFRH/BD/61881/2009]	FEDER(European Commission); North Portugal Regional Operational Programme (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN) through the European Regional Development Fund (FEDER); National Funds (PIDDAC) through the Portuguese Foundation for Science and Technology (FCT/MEC); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	The research presented in this paper was financially supported by FEDER through COMPETE-FCOMP-01-0124-FEDER-014043 (PTDC/AGR-ALI/111224/2009) and Project ENOEXEL - FROM VINEYARD TO WINE: TARGETING GRAPE AND WINE EXCELLENCY - NORTE-07-0124-FEDER-000032, financed by the North Portugal Regional Operational Programme (ON.2 - O Novo Norte), under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER), as well as by National Funds (PIDDAC) through the Portuguese Foundation for Science and Technology (FCT/MEC). C.B. is a recipient of a Ph.D. granted by FCT (SFRH/BD/61881/2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberola TM, 2004, INT MICROBIOL, V7, P199; Albers E, 2007, APPL ENVIRON MICROB, V73, P4839, DOI 10.1128/AEM.00425-07; Ambroset C, 2011, G3-GENES GENOM GENET, V1, P263, DOI 10.1534/g3.111.000422; Backhus LE, 2001, FEMS YEAST RES, V1, P111, DOI 10.1016/S1567-1356(01)00019-8; Barbosa C, 2014, AMB EXPRESS, V4, DOI 10.1186/s13568-014-0039-6; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BEZENGER MC, 1988, BIOTECHNOL BIOENG, V31, P747, DOI 10.1002/bit.260310719; Bisson LF, 2000, AM J ENOL VITICULT, V51, P168; Bisson LF, 1999, AM J ENOL VITICULT, V50, P107; Boer VM, 2003, J BIOL CHEM, V278, P3265, DOI 10.1074/jbc.M209759200; Brauer MJ, 2008, MOL BIOL CELL, V19, P352, DOI 10.1091/mbc.E07-08-0779; Breitling R, 2004, FEBS LETT, V573, P83, DOI 10.1016/j.febslet.2004.07.055; Brice C, 2014, APPL ENVIRON MICROB, V80, P1330, DOI 10.1128/AEM.03856-13; Brion C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-681; Broach JR, 2012, GENETICS, V192, P73, DOI 10.1534/genetics.111.135731; Cardenas ME, 1999, GENE DEV, V13, P3271, DOI 10.1101/gad.13.24.3271; Carrasco P, 2003, SYST APPL MICROBIOL, V26, P471, DOI 10.1078/072320203322497518; Carreto L, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-201; Cavalieri D, 2000, P NATL ACAD SCI USA, V97, P12369, DOI 10.1073/pnas.210395297; Crepin L, 2012, APPL ENVIRON MICROB, V78, P8102, DOI 10.1128/AEM.02294-12; Davey HM, 2012, ENVIRON MICROBIOL, V14, P1249, DOI 10.1111/j.1462-2920.2012.02705.x; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Erasmus DJ, 2003, FEMS YEAST RES, V3, P375, DOI 10.1016/S1567-1356(02)00203-9; Fay JC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-r26; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godard P, 2007, MOL CELL BIOL, V27, P3065, DOI 10.1128/MCB.01084-06; Govender P, 2008, APPL ENVIRON MICROB, V74, P6041, DOI 10.1128/AEM.00394-08; Griffioen G, 1996, MICROBIOL-UK, V142, P2279, DOI 10.1099/13500872-142-8-2279; Gutierrez A, 2013, FOOD MICROBIOL, V34, P227, DOI 10.1016/j.fm.2012.12.004; Gutierrez A, 2012, FOOD MICROBIOL, V31, P25, DOI 10.1016/j.fm.2012.02.012; Henschke P. A., 1993, WINE MICROBIOLOGY BI, P77, DOI DOI 10.1089/END.2014.0018; HUEY B, 1989, J BACTERIOL, V171, P2528, DOI 10.1128/jb.171.5.2528-2532.1989; Jimenez-Marti E, 2007, ANTON LEEUW INT J G, V92, P61, DOI 10.1007/s10482-006-9135-1; JIRANEK V, 1995, AM J ENOL VITICULT, V46, P75; Klosinska MM, 2011, GENE DEV, V25, P336, DOI 10.1101/gad.2011311; Kvitek DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000223; Landry CR, 2006, GENE, V366, P343, DOI 10.1016/j.gene.2005.10.042; Legras JL, 2003, FEMS MICROBIOL LETT, V221, P249, DOI 10.1016/S0378-1097(03)00205-2; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; MARINI AM, 1994, EMBO J, V13, P3456, DOI 10.1002/j.1460-2075.1994.tb06651.x; Marks VD, 2003, FEMS YEAST RES, V3, P269, DOI 10.1016/S1567-1356(02)00201-5; Marks VD, 2008, FEMS YEAST RES, V8, P35, DOI 10.1111/j.1567-1364.2007.00338.x; Martinez C, 2014, ELECTRON J BIOTECHN, V17, P150, DOI 10.1016/j.ejbt.2014.04.006; Mendes-Ferreira A, 2007, APPL ENVIRON MICROB, V73, P5363, DOI 10.1128/AEM.01029-07; Mendes-Ferreira A, 2007, APPL ENVIRON MICROB, V73, P3049, DOI 10.1128/AEM.02754-06; Mendes-Ferreira A, 2004, J APPL MICROBIOL, V97, P540, DOI 10.1111/j.1365-2672.2004.02331.x; Mendes-Ferreira A, 2010, APPL ENVIRON MICROB, V76, P7918, DOI 10.1128/AEM.01535-10; Mendes-Ferreira A, 2009, J IND MICROBIOL BIOT, V36, P571, DOI 10.1007/s10295-009-0527-x; Orozco H, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-1; Parrou JL, 1999, YEAST, V15, P191, DOI 10.1002/(SICI)1097-0061(199902)15:3<191::AID-YEA358>3.0.CO;2-O; Penacho V, 2012, INT J FOOD MICROBIOL, V153, P176, DOI 10.1016/j.ijfoodmicro.2011.11.005; Petti AA, 2011, P NATL ACAD SCI USA, V108, pE1089, DOI 10.1073/pnas.1101494108; Piggott N, 2011, G3-GENES GENOM GENET, V1, P353, DOI 10.1534/g3.111.000836; Pizarro FJ, 2008, APPL ENVIRON MICROB, V74, P6358, DOI 10.1128/AEM.00602-08; Powers T, 1999, MOL BIOL CELL, V10, P987, DOI 10.1091/mbc.10.4.987; Pretorius IS, 2000, YEAST, V16, P675, DOI 10.1002/1097-0061(20000615)16:8<675::AID-YEA585>3.0.CO;2-B; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rossignol T, 2003, YEAST, V20, P1369, DOI 10.1002/yea.1046; Rossouw D, 2012, GENETICS, V190, P251, DOI 10.1534/genetics.111.132720; Rossouw D, 2009, APPL ENVIRON MICROB, V75, P6600, DOI 10.1128/AEM.01251-09; Rossouw D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-530; Soares EV, 2011, J APPL MICROBIOL, V110, P1, DOI 10.1111/j.1365-2672.2010.04897.x; Tai SL, 2007, MICROBIOL-SGM, V153, P877, DOI 10.1099/mic.0.2006/002873-0; Tesniere C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061645; Treu L, 2014, APPL MICROBIOL BIOT, V98, P4119, DOI 10.1007/s00253-014-5679-6; Varela C, 2005, YEAST, V22, P369, DOI 10.1002/yea.1217; Walker ME, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-552; Wu H, 2006, APPL ENVIRON MICROB, V72, P7353, DOI 10.1128/AEM.01097-06; Wu J, 2004, P NATL ACAD SCI USA, V101, P3148, DOI 10.1073/pnas.0308321100; Zuzuarregui A, 2006, APPL ENVIRON MICROB, V72, P836, DOI 10.1128/AEM.72.1.836-847.2006	70	20	21	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122709	10.1371/journal.pone.0122709	http://dx.doi.org/10.1371/journal.pone.0122709			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884705	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000040
J	Cesano, A; Willman, CL; Kopecky, KJ; Gayko, U; Putta, S; Louie, B; Wesdall, M; Purvis, N; Spellmeyer, DC; Marimpietri, C; Cohen, AC; Hackett, J; Shi, J; Walker, MG; Sun, ZX; Paietta, E; Tallman, MS; Cripe, LD; Atwater, S; Appelbaum, FR; Radich, JP				Cesano, Alessandra; Willman, Cheryl L.; Kopecky, Kenneth J.; Gayko, Urte; Putta, Santosh; Louie, Brent; Wesdall, Matt; Purvis, Norman; Spellmeyer, David C.; Marimpietri, Carol; Cohen, Aileen C.; Hackett, James; Shi, Jing; Walker, Michael G.; Sun, Zhuoxin; Paietta, Elisabeth; Tallman, Martin S.; Cripe, Larry D.; Atwater, Susan; Appelbaum, Frederick R.; Radich, Jerald P.			Cell Signaling-Based Classifier Predicts Response to Induction Therapy in Elderly Patients with Acute Myeloid Leukemia	PLOS ONE			English	Article							OLDER PATIENTS; EARLY DEATH; DAUNORUBICIN; TRIAL; CHEMOTHERAPY; MITOXANTRONE; CYTARABINE; ADULTS; AML	Single-cell network profiling (SCNP) data generated from multi-parametric flow cytometry analysis of bone marrow (BM) and peripheral blood (PB) samples collected from patients >55 years old with non-M3 AML were used to train and validate a diagnostic classifier (DXSCNP) for predicting response to standard induction chemotherapy (complete response [CR] or CR with incomplete hematologic recovery [CRi] versus resistant disease [RD]). SCNP-evaluable patients from four SWOG AML trials were randomized between Training (N = 74 patients with CR, CRi or RD; BM set = 43; PB set = 57) and Validation Analysis Sets (N = 71; BM set = 42, PB set = 53). Cell survival, differentiation, and apoptosis pathway signaling were used as potential inputs for DXSCNP. Five DXSCNP classifiers were developed on the SWOG Training set and tested for prediction accuracy in an independent BM verification sample set (N = 24) from ECOG AML trials to select the final classifier, which was a significant predictor of CR/CRi (area under the receiver operating characteristic curve AUROC = 0.76, p = 0.01). The selected classifier was then validated in the SWOG BM Validation Set (AUROC = 0.72, p = 0.02). Importantly, a classifier developed using only clinical and molecular inputs from the same sample set (DXCLINICAL2) lacked prediction accuracy: AUROC = 0.61 (p = 0.18) in the BM Verification Set and 0.53 (p = 0.38) in the BM Validation Set. Notably, the DXSCNP classifier was still significant in predicting response in the BM Validation Analysis Set after controlling for DXCLINICAL2 (p = 0.03), showing that DXSCNP provides information that is independent from that provided by currently used prognostic markers. Taken together, these data show that the proteomic classifier may provide prognostic information relevant to treatment planning beyond genetic mutations and traditional prognostic factors in elderly AML.	[Cesano, Alessandra; Gayko, Urte; Putta, Santosh; Louie, Brent; Wesdall, Matt; Purvis, Norman; Spellmeyer, David C.; Marimpietri, Carol; Cohen, Aileen C.; Hackett, James; Shi, Jing; Walker, Michael G.] Nodality Inc, San Francisco, CA 94080 USA; [Willman, Cheryl L.] Univ New Mexico, Ctr Canc, Albuquerque, NM 87131 USA; [Kopecky, Kenneth J.] Fred Hutchinson Canc Res Ctr, SWOG Stat Ctr, Seattle, WA 98104 USA; [Sun, Zhuoxin] Frontier Sci, ECOG Coordinating Ctr, Boston, MA USA; [Paietta, Elisabeth] Montefiore Med Ctr, North Div, Bronx, NY 10467 USA; [Tallman, Martin S.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Cripe, Larry D.] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46204 USA; [Atwater, Susan] Stanford Univ, Palo Alto, CA 94304 USA; [Appelbaum, Frederick R.; Radich, Jerald P.] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA	University of New Mexico; Fred Hutchinson Cancer Center; Southwest Oncology Group; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Memorial Sloan Kettering Cancer Center; Indiana University System; Indiana University-Purdue University Indianapolis; Stanford University; Fred Hutchinson Cancer Center	Putta, S (corresponding author), Nodality Inc, San Francisco, CA 94080 USA.	sputta@nodality.com			Nodality; NIH grants: National Cancer Institute, DHHS [CA32102, CA38926, CA12213, CA20319, CA14958, CA49883, CA17145, CA21115]; NATIONAL CANCER INSTITUTE [U10CA180820, U10CA180828, U10CA021115, U10CA012213, U10CA032102, U10CA038926, U10CA049883, U10CA180888, U10CA017145, P01CA018029, U10CA020319, U10CA014958, U24CA114737, U24CA196172, U10CA180791, U10CA180794] Funding Source: NIH RePORTER	Nodality; NIH grants: National Cancer Institute, DHHS; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by Nodality. and employees of Nodality played a role in design, data collection and analysis, decision to publish, or preparation of the manuscript. Authors SP, DS, BL are employees and shareholders of Nodality Inc. AC, UG, CW were employees of Nodality at the time of conduct of the this study. The specific roles of these authors are articulated in the 'author contributions' section. The authors acknowledge the following NIH grants: PHS Cooperative Agreement grant numbers awarded by the National Cancer Institute, DHHS: CA32102, CA38926, CA12213, CA20319, CA14958, CA49883, CA17145 and CA21115.	Anderson JE, 2002, BLOOD, V100, P3869, DOI 10.1182/blood-2001-12-0354; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Buchner T, 1999, BLOOD, V93, P4116; Buchner T, 2009, J CLIN ONCOL, V27, P61, DOI 10.1200/JCO.2007.15.4245; Cesano A, 2011, BLOOD, V118; Cesano A, 2010, ASH ANN M, V116, P4843; Cesano A, 2013, HAEMATOLOGICA, V98, P626, DOI 10.3324/haematol.2012.071910; Cesano A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056714; Cesano A, 2012, CYTOM PART B-CLIN CY, V82B, P158, DOI 10.1002/cyto.b.21007; Chauncey TR, 2010, BRIT J HAEMATOL, V148, P48, DOI 10.1111/j.1365-2141.2009.07919.x; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Cripe LD, 2010, BLOOD, V116, P4077, DOI 10.1182/blood-2010-04-277269; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; FIRTH D, 1993, BIOMETRIKA, V80, P27, DOI 10.2307/2336755; Godwin JE, 1998, BLOOD, V91, P3607, DOI 10.1182/blood.V91.10.3607.3607_3607_3615; Goeman JJ, 2010, BIOMETRICAL J, V52, P70, DOI 10.1002/bimj.200900028; Grimwade D, 2001, BLOOD, V98, P1312, DOI 10.1182/blood.V98.5.1312; Harrell FE, 2001, REGRESSION MODELING; Hollander MaW, 1999, NONPARAMETRIC STAT M; Kornblau SM, 2010, CLIN CANCER RES, V16, P3721, DOI 10.1158/1078-0432.CCR-10-0093; Krug U, 2010, LANCET, V376, P2000, DOI 10.1016/S0140-6736(10)62105-8; Lacayo NJ, 2013, BRIT J HAEMATOL, V162, P250, DOI 10.1111/bjh.12370; Lacayo NJ, 2011, BLOOD, V118, P1512, DOI 10.1182/blood.V118.21.3544.3544; Law A, 2002, R NEWS; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Lowenberg B, 2009, NEW ENGL J MED, V361, P1235, DOI 10.1056/NEJMoa0901409; MASON SJ, 2002, Q J ROY METEOR SOC, V128, P21; Obuchowski NA, 1998, ACAD RADIOL, V5, P561, DOI 10.1016/S1076-6332(98)80208-0; Pepe M. S., 2003, STAT EVALUATION MED; POCOCK SJ, 1975, BIOMETRICS, V31, P103, DOI 10.2307/2529712; Rosen DB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013543; Rowe JM, 2004, BLOOD, V103, P479, DOI 10.1182/blood-2003-05-1686; Vo TT, 2012, CELL, V151, P344, DOI 10.1016/j.cell.2012.08.038; Walter RB, 2011, J CLIN ONCOL, V29, P4417, DOI 10.1200/JCO.2011.35.7525; Walter RB, 2010, BLOOD, V116, P2420, DOI 10.1182/blood-2010-05-285387	35	5	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0118485	10.1371/journal.pone.0118485	http://dx.doi.org/10.1371/journal.pone.0118485			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884949	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000002
J	de la Mora-de la Mora, I; Torres-Larios, A; Enriquez-Flores, S; Mendez, ST; Castillo-Villanueva, A; Gomez-Manzo, S; Lopez-Velazquez, G; Marcial-Quino, J; Torres-Arroyo, A; Garcia-Torres, I; Reyes-Vivas, H; Oria-Hernandez, J				de la Mora-de la Mora, Ignacio; Torres-Larios, Alfredo; Enriquez-Flores, Sergio; Mendez, Sara-Teresa; Castillo-Villanueva, Adriana; Gomez-Manzo, Saul; Lopez-Velazquez, Gabriel; Marcial-Quino, Jaime; Torres-Arroyo, Angelica; Garcia-Torres, Itzhel; Reyes-Vivas, Horacio; Oria-Hernandez, Jesus			Structural Effects of Protein Aging: Terminal Marking by Deamidation in Human Triosephosphate Isomerase	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; GIARDIA-LAMBLIA; ENZYME; EVOLUTION; ELECTROPHORESIS; SUSCEPTIBILITY; ASPARAGINE; PREDICTION; CATALYSIS; PEPTIDES	Deamidation, the loss of the ammonium group of asparagine and glutamine to form aspartic and glutamic acid, is one of the most commonly occurring post-translational modifications in proteins. Since deamidation rates are encoded in the protein structure, it has been proposed that they can serve as molecular clocks for the timing of biological processes such as protein turnover, development and aging. Despite the importance of this process, there is a lack of detailed structural information explaining the effects of deamidation on the structure of proteins. Here, we studied the effects of deamidation on human triosephosphate isomerase (HsTIM), an enzyme for which deamidation of N15 and N71 has been long recognized as the signal for terminal marking of the protein. Deamidation was mimicked by site directed mutagenesis; thus, three mutants of HsTIM (N15D, N71D and N15D/N71D) were characterized. The results show that the N71D mutant resembles, structurally and functionally, the wild type enzyme. In contrast, the N15D mutant displays all the detrimental effects related to deamidation. The N15D/N71D mutant shows only minor additional effects when compared with the N15D mutation, supporting that deamidation of N71 induces negligible effects. The crystal structures show that, in contrast to the N71D mutant, where minimal alterations are observed, the N15D mutation forms new interactions that perturb the structure of loop 1 and loop 3, both critical components of the catalytic site and the interface of HsTIM. Based on a phylogenetic analysis of TIM sequences, we propose the conservation of this mechanism for mammalian TIMs.	[de la Mora-de la Mora, Ignacio; Enriquez-Flores, Sergio; Mendez, Sara-Teresa; Castillo-Villanueva, Adriana; Gomez-Manzo, Saul; Lopez-Velazquez, Gabriel; Marcial-Quino, Jaime; Torres-Arroyo, Angelica; Garcia-Torres, Itzhel; Reyes-Vivas, Horacio; Oria-Hernandez, Jesus] Inst Nacl Pediat, Lab Bioquim Genet, Secretaria Salud, Mexico City, DF, Mexico; [Torres-Larios, Alfredo] Univ Nacl Autonoma Mexico, Dept Bioquim & Biol Estruct, Inst Fisiol Celular, Mexico City 04510, DF, Mexico	Universidad Nacional Autonoma de Mexico	Oria-Hernandez, J (corresponding author), Inst Nacl Pediat, Lab Bioquim Genet, Secretaria Salud, Mexico City, DF, Mexico.	hreyesvivas@yahoo.com.mx; jesus.oria.inp@gmail.com	Lopez-Velazquez, Gabriel/F-2411-2013; Oria-Hernández, Jesús/AAG-1243-2019; De la Mora, José Ignacio De la Mora/AAB-5370-2020	Lopez-Velazquez, Gabriel/0000-0003-0470-1069; Oria-Hernández, Jesús/0000-0001-7147-1879; De la Mora, José Ignacio De la Mora/0000-0002-5654-8089; enriquez flores, sergio/0000-0003-2058-5707; Torres-Arroyo, Angelica/0000-0003-3236-5779; Torres-Larios, Alfredo/0000-0002-0702-350X; Reyes-Vivas, Horacio/0000-0002-3604-9629; Garcia, Itzhel/0000-0002-3018-060X; Castillo-Villanueva, Adriana/0000-0001-5582-6940; Marcial Quino, Jaime/0000-0002-4591-7379; Mendez-Cruz, Sara Teresa/0000-0001-8619-1220; Gomez-Manzo, Saul/0000-0003-2095-9182	Consejo Nacional de Ciencia y Tecnologia [106126, 104841, CB2011-164838]; Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA) [IN201213]; U.S. DOE [DE-AC02-06CH11357]; Michigan Technology Tri-Corridor [085P1000817]	Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA); U.S. DOE(United States Department of Energy (DOE)); Michigan Technology Tri-Corridor	JOH was supported by Consejo Nacional de Ciencia y Tecnologia grant 106126. HRV was supported by Consejo Nacional de Ciencia y Tecnologia grant 104841. ATL was supported by Consejo Nacional de Ciencia y Tecnologia grant CB2011-164838 and Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, Universidad Nacional Autonoma de Mexico (PAPIIT-DGAPA) grant IN201213. Use of the Advanced Photon Source, an Office of Science User Facility operated for the U.S. Department of Energy ( DOE) Office of Science by Argonne National Laboratory, was supported by the U.S. DOE under Contract No. DE-AC02-06CH11357. Use of the LS-CAT Sector 21 was supported by the Michigan Economic Development Corporation and the Michigan Technology Tri-Corridor, Grant 085P1000817. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguirre B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021035; ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; Aritomi M, 1997, J BIOL CHEM, V272, P27886, DOI 10.1074/jbc.272.44.27886; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BENNER SA, 1994, PROTEIN ENG, V7, P1323, DOI 10.1093/protein/7.11.1323; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; De La Mora ID, 2013, BBA-PROTEINS PROTEOM, V1834, P2702, DOI 10.1016/j.bbapap.2013.08.012; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Enriquez-Flores S, 2008, MOL BIOCHEM PARASIT, V157, P179, DOI 10.1016/j.molbiopara.2007.10.013; Enriquez-Flores S, 2011, PROTEINS, V79, P2711, DOI 10.1002/prot.23100; Eschenburg S, 2000, PROTEINS, V40, P290, DOI 10.1002/(SICI)1097-0134(20000801)40:2<290::AID-PROT90>3.0.CO;2-0; Esposito L, 2000, J MOL BIOL, V297, P713, DOI 10.1006/jmbi.2000.3597; Go MK, 2010, BIOCHEMISTRY-US, V49, P5377, DOI 10.1021/bi100538b; Gracy RW, 1998, J EXP ZOOL, V282, P18; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kinoshita T, 2005, ACTA CRYSTALLOGR F, V61, P346, DOI 10.1107/S1744309105008341; KNOWLES JR, 1991, NATURE, V350, P121, DOI 10.1038/350121a0; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; Michelitsch MD, 2000, P NATL ACAD SCI USA, V97, P11910, DOI 10.1073/pnas.97.22.11910; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Noguchi S, 1998, J MOL BIOL, V278, P231, DOI 10.1006/jmbi.1998.1674; Noguchi S, 2010, BIOPOLYMERS, V93, P1003, DOI 10.1002/bip.21514; Oesper P, 1950, THE DETERMINATION OF; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Rester U, 2000, ACTA CRYSTALLOGR D, V56, P581, DOI 10.1107/S0907444900003048; Reyes-Vivas H, 2002, PROTEINS, V48, P580, DOI 10.1002/prot.10179; Richard JP, 2012, BIOCHEMISTRY-US, V51, P2652, DOI 10.1021/bi300195b; Robinson A B, 1974, Curr Top Cell Regul, V8, P247; ROBINSON AB, 1970, P NATL ACAD SCI USA, V66, P753, DOI 10.1073/pnas.66.3.753; ROBINSON AB, 1979, MECH AGEING DEV, V9, P225, DOI 10.1016/0047-6374(79)90101-5; ROBINSON AB, 1974, P NATL ACAD SCI USA, V71, P885, DOI 10.1073/pnas.71.3.885; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P4367, DOI 10.1073/pnas.071066498; Robinson NE, 2001, P NATL ACAD SCI USA, V98, P944, DOI 10.1073/pnas.98.3.944; Robinson NE, 2004, MOLECULAR CLOCKS DEA; Robinson NE, 2008, BIOPOLYMERS, V90, P297, DOI 10.1002/bip.20852; Rodriguez-Almazan C, 2008, J BIOL CHEM, V283, P23254, DOI 10.1074/jbc.M802145200; SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2; Shi YH, 2013, J AM CHEM SOC, V135, P15897, DOI 10.1021/ja407801x; SUN AQ, 1995, ARCH BIOCHEM BIOPHYS, V322, P361, DOI 10.1006/abbi.1995.1476; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Ugur I, 2012, J PHYS CHEM B, V116, P6288, DOI 10.1021/jp3013305; Verma A, 2013, INFECT IMMUN, V81, P278, DOI 10.1128/IAI.00863-12; Wierenga RK, 2010, CELL MOL LIFE SCI, V67, P3961, DOI 10.1007/s00018-010-0473-9; YUAN PM, 1981, MECH AGEING DEV, V17, P151, DOI 10.1016/0047-6374(81)90081-6; YUKSEL KU, 1986, ARCH BIOCHEM BIOPHYS, V248, P452, DOI 10.1016/0003-9861(86)90498-4; Zarate-Perez F, 2008, PROG MOL BIOL TRANSL, V84, P251, DOI 10.1016/S0079-6603(08)00407-8	50	10	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123379	10.1371/journal.pone.0123379	http://dx.doi.org/10.1371/journal.pone.0123379			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884638	gold, Green Submitted, Green Published			2022-12-27	WOS:000353017000059
J	Hou, J; Wang, F; Kong, PZ; Yu, PKN; Wang, HZ; Han, W				Hou, Jue; Wang, Fan; Kong, Peizhong; Yu, Peter K. N.; Wang, Hongzhi; Han, Wei			Gene Profiling Characteristics of Radioadaptive Response in AG01522 Normal Human Fibroblasts	PLOS ONE			English	Article							INDUCED ADAPTIVE RESPONSE; LOW-DOSE-RATE; IONIZING-RADIATION; GERM-CELLS; MICROARRAY ANALYSIS; TRAIL RESISTANCE; CYTOSCAPE PLUGIN; STRESS GENES; NITRIC-OXIDE; IN-VITRO	Radioadaptive response (RAR) in mammalian cells refers to the phenomenon where a low-dose ionizing irradiation alters the gene expression profiles, and protects the cells from the detrimental effects of a subsequent high dose exposure. Despite the completion of numerous experimental studies on RAR, the underlying mechanism has remained unclear. In this study, we aimed to have a comprehensive investigation on the RAR induced in the AG01522 human fibroblasts first exposed to 5 cGy (priming dose) and then followed by 2 Gy (challenge dose) of X-ray through comparisons to those cells that had only received a single 2 Gy dose. We studied how the priming dose affected the expression of gene transcripts, and to identify transcripts or pathways that were associated with the reduced chromosomal damages (in terms of the number of micronuclei) after application of the challenging dose. Through the mRNA and microRNA microarray analyses, the transcriptome alteration in AG01522 cells was examined, and the significantly altered genes were identified for different irradiation procedures using bioinformatics approaches. We observed that a low-dose X-ray exposure produced an alert, triggering and altering cellular responses to defend against subsequent high dose-induced damages, and accelerating the cell repair process. Moreover, the p53 signaling pathway was found to play critial roles in regulating DNA damage responses at the early stage after application of the challenging dose, particularly in the RAR group. Furthermore, microRNA analyses also revealed that cell communication and intercellular signaling transduction played important roles after low-dose irradiation. We conclude that RAR benefits from the alarm mechanisms triggered by a low-dose priming radation dose.	[Hou, Jue; Kong, Peizhong; Wang, Hongzhi; Han, Wei] Chinese Acad Sci, Ctr Med Phys & Technol, Hefei Inst Phys Sci, Hefei, Peoples R China; [Yu, Peter K. N.] City Univ Hong Kong, Dept Phys & Mat Sci, Kowloon Tong, Hong Kong, Peoples R China; [Wang, Fan] Anhui Med Univ, Dept Radiat Oncol, Affiliated Hosp 1, Hefei, Peoples R China; [Wang, Hongzhi; Han, Wei] Chinese Acad Sci, Canc Hosp, Hefei Inst Phys Sci, Hefei, Peoples R China	Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; City University of Hong Kong; Anhui Medical University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS	Han, W (corresponding author), Chinese Acad Sci, Ctr Med Phys & Technol, Hefei Inst Phys Sci, Hefei, Peoples R China.	hanw@hfcas.ac.cn	Hou, Jue/S-8184-2017; Yu, Peter K.N./C-7051-2013	Hou, Jue/0000-0001-9913-8365; Yu, Peter K.N./0000-0003-1669-5348	National Natural Science Foundation of China [81172602]; "Hundred Talents Program" of the Chinese Academy of Sciences	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Hundred Talents Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was funded by the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) under Grant No. 81172602, and "Hundred Talents Program" of the Chinese Academy of Sciences (http://www.cas.cn/ggzy/rcpy/brjh/). Wei Han as grants funder played roles in the study design, decision to publish, and preparation of the manuscript.	Amundson SA, 1999, RADIAT RES, V152, P225, DOI 10.2307/3580321; Amundson SA, 2003, MOL CANCER RES, V1, P445; AZZAM EI, 1994, RADIAT RES, V138, pS28, DOI 10.2307/3578755; Bindea G, 2013, BIOINFORMATICS, V29, P661, DOI 10.1093/bioinformatics/btt019; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boothman DA, 1996, MUTAT RES-FUND MOL M, V358, P143, DOI 10.1016/S0027-5107(96)00115-7; CAI L, 1995, MUTAGENESIS, V10, P95, DOI 10.1093/mutage/10.2.95; CAI L, 1993, MUTAT RES, V303, P157, DOI 10.1016/0165-7992(93)90017-P; CAI L, 1990, INT J RADIAT BIOL, V58, P187, DOI 10.1080/09553009014551541; Chen SL, 1999, TOXICOL LETT, V105, P141, DOI 10.1016/S0378-4274(98)00393-2; Choi VWY, 2013, J RADIOL PROT, V33, P91, DOI 10.1088/0952-4746/33/1/91; Choi VWY, 2011, RADIAT MEAS, V46, P1795, DOI 10.1016/j.radmeas.2011.06.052; Choi VWY, 2010, ENVIRON SCI TECHNOL, V44, P8829, DOI 10.1021/es101535f; Choi VWY, 2010, NUCL INSTRUM METH B, V268, P651, DOI 10.1016/j.nimb.2009.12.002; Choi V. W. Y., 2014, J RADIAT RES, V55, pi114, DOI [10. 1093/ jrr/ rru004, DOI 10.1093/JRR/RRU004]; Choi V.W.Y., 2014, J RADIAT RES, V55, pI115, DOI [10.1093/jrr/rrt165, DOI 10.1093/JRR/RRT165]; Choi VWY, 2010, J RADIAT RES, V51, P657, DOI 10.1269/jrr.10054; Coleman MA, 2005, RADIAT RES, V164, P369, DOI 10.1667/RR3356.1; COOPER GP, 1968, AM J PHYSIOL, V215, P803, DOI 10.1152/ajplegacy.1968.215.4.803; Corpas FJ, 2004, PLANT PHYSIOL, V136, P2722, DOI 10.1104/pp.104.042812; Corpas FJ, 2001, TRENDS PLANT SCI, V6, P145, DOI 10.1016/S1360-1385(01)01898-2; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; de Toledo SM, 1998, CELL GROWTH DIFFER, V9, P887; Ding LH, 2005, RADIAT RES, V164, P17, DOI 10.1667/RR3354; Emmert-Streib F, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002053; FAROOQI Z, 1993, MUTAT RES, V302, P83, DOI 10.1016/0165-7992(93)90008-J; Feinendegen LE, 1999, HUM EXP TOXICOL, V18, P426, DOI 10.1191/096032799678840309; FUKS Z, 1993, RADIAT ONCOL INVEST, V1, P81; Garofalo M, 2008, ONCOGENE, V27, P3845, DOI 10.1038/onc.2008.6; Garofalo M, 2009, CANCER CELL, V16, P498, DOI 10.1016/j.ccr.2009.10.014; Ghandhi SA, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-63; Ghosh S, 1996, J BIOL CHEM, V271, P8472, DOI 10.1074/jbc.271.14.8472; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Guo HT, 2006, BIOCHEM J, V394, P379, DOI 10.1042/BJ20051730; IKUSHIMA T, 1989, MUTAT RES, V227, P241, DOI 10.1016/0165-7992(89)90104-8; Jen KY, 2005, CANCER RES, V65, P7666, DOI 10.1158/0008-5472.CAN-05-1039; Johnson CD, 2007, CANCER RES, V67, P7713, DOI 10.1158/0008-5472.CAN-07-1083; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kalanxhi E, 2012, RADIAT RES, V177, P35, DOI 10.1667/RR2694.1; Kandasamy K, 2002, CANCER RES, V62, P4929; Kis E, 2006, INT J RADIAT ONCOL, V66, P1506, DOI 10.1016/j.ijrobp.2006.08.004; Lee JK, 2008, NEUROBIOL DIS, V30, P174, DOI 10.1016/j.nbd.2008.01.004; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liu ZG, 1996, NATURE, V384, P273, DOI 10.1038/384273a0; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mehrara BJ, 2010, FASEB J, V24, P4877, DOI 10.1096/fj.10-155762; Mezentsev A, 2011, RADIAT RES, V175, P677, DOI 10.1667/RR2483.1; Mosse I, 2000, RADIAT ENVIRON BIOPH, V39, P47, DOI 10.1007/PL00007685; Nagata K, 1998, EMBO J, V17, P149, DOI 10.1093/emboj/17.1.149; OLIVIERI G, 1984, SCIENCE, V223, P594, DOI 10.1126/science.6695170; Park WY, 2002, ONCOGENE, V21, P8521, DOI 10.1038/sj.onc.1205977; SAGAR SM, 1991, INT J RADIAT ONCOL, V20, P771, DOI 10.1016/0360-3016(91)90021-U; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; Seong Jinsil, 1994, Yonsei Medical Journal, V35, P77; Smith ML, 1996, MUTAT RES-REV GENET, V340, P109, DOI 10.1016/S0165-1110(96)90043-3; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sorensen KJ, 2002, MUTAT RES-GEN TOX EN, V519, P15, DOI 10.1016/S1383-5718(02)00110-9; Stecca C, 1998, BIOCHEM PHARMACOL, V55, P941, DOI 10.1016/S0006-2952(97)00448-6; Streffer C, 2004, MUTAT RES-FUND MOL M, V568, P79, DOI 10.1016/j.mrfmmm.2004.07.014; Tapio S, 2007, RADIAT ENVIRON BIOPH, V46, P1, DOI 10.1007/s00411-006-0078-8; Turtoi A, 2010, RADIAT RES, V174, P125, DOI 10.1667/RR1659.1; Venkat S, 2001, J Environ Pathol Toxicol Oncol, V20, P165; Wang B, 2004, RADIAT RES, V161, P264, DOI 10.1667/RR3141; Wolff S, 1996, MUTAT RES-FUND MOL M, V358, P135, DOI 10.1016/S0027-5107(96)00114-5; Yin E, 2003, INT J RADIAT BIOL, V79, P759, DOI 10.1080/09553000310001610961; YOSHIDA N, 1993, J RADIAT RES, V34, P269, DOI 10.1269/jrr.34.269; Yu Wenru, 1995, Chinese Medical Sciences Journal, V10, P50; Yunis R, 2012, J RADIAT RES, V53, P860, DOI 10.1093/jrr/rrs063; Zaichkina S I, 1999, Radiats Biol Radioecol, V39, P404; Zasukhina G D, 1999, Radiats Biol Radioecol, V39, P58	71	20	21	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123316	10.1371/journal.pone.0123316	http://dx.doi.org/10.1371/journal.pone.0123316			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886619	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000055
J	Jelsone-Swain, L; Persad, C; Burkard, D; Welsh, RC				Jelsone-Swain, Laura; Persad, Carol; Burkard, David; Welsh, Robert C.			Action Processing and Mirror Neuron Function in Patients with Amyotrophic Lateral Sclerosis: An fMRI Study	PLOS ONE			English	Article							COGNITIVE IMPAIRMENT; ALE METAANALYSIS; SCREENING TOOL; MOTOR; BRAIN; RECOGNITION; SIMULATION; PLASTICITY; DEFICITS; SYSTEM	Amyotrophic lateral sclerosis (ALS) is a highly debilitating and rapidly fatal neurodegenerative disease. It has been suggested that social cognition may be affected, such as impairment in theory of mind (ToM) ability. Despite these findings, research in this area is scarce and the investigation of neural mechanisms behind such impairment is absent. Nineteen patients with ALS and eighteen healthy controls participated in this study. Because the mirror neuron system (MNS) is thought to be involved in theory of mind, we first implemented a straightforward action-execution and observation task to assess basic MNS function. Second, we examined the social-cognitive ability to understand actions of others, which is a component of ToM. We used fMRI to assess BOLD activity differences between groups during both experiments. Theory of mind was also measured behaviorally using the Reading the Mind in the Eyes test (RME). ALS patients displayed greater BOLD activity during the action-execution and observation task, especially throughout right anterior cortical regions. These areas included the right inferior operculum, premotor and primary motor regions, and left inferior parietal lobe. A conjunction analysis showed significantly more co-activated voxels during both the observation and action-execution conditions in the patient group throughout MNS regions. These results support a compensatory response in the MNS during action processing. In the action understanding experiment, healthy controls performed better behaviorally and subsequently recruited greater regions of activity throughout the prefrontal cortex and middle temporal gyrus. Lastly, action understanding performance was able to cluster patients with ALS into high and lower performing groups, which then differentiated RME performance. Collectively, these data suggest that social cognition, particularly theory of mind, may be affected in a subset of patients with ALS. This impairment may be related to functioning of the MNS and other regions related to action processing and understanding. Implications for future research are discussed.	[Jelsone-Swain, Laura] Univ South Carolina Aiken, Dept Psychol, Aiken, SC 29801 USA; [Jelsone-Swain, Laura; Burkard, David; Welsh, Robert C.] Univ Michigan, Dept Radiol, Ann Arbor, MI 48109 USA; [Persad, Carol; Welsh, Robert C.] Univ Michigan, Dept Psychiat, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Jelsone-Swain, L (corresponding author), Univ South Carolina Aiken, Dept Psychol, Aiken, SC 29801 USA.	laurasw@usca.edu	Welsh, Robert/ABH-3526-2021	Jelsone-Swain, Laura/0000-0002-9179-8884	National Center for Advancing Translational Sciences (NCATS) through the National Institutes of Health (NIH) [2UL1TR000433]; NIH/NINDS [R01 NS052514-01A1]; University of Michigan Functional Magnetic Resonance Laboratory [2UL1TR000433]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052514] Funding Source: NIH RePORTER	National Center for Advancing Translational Sciences (NCATS) through the National Institutes of Health (NIH); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Michigan Functional Magnetic Resonance Laboratory; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grant numbers 2UL1TR000433 from the National Center for Advancing Translational Sciences (NCATS) through the National Institutes of Health (NIH) and the grant NIH/NINDS R01 NS052514-01A1 (RCW). University of Michigan Functional Magnetic Resonance Laboratory (LJS) also helped fund this work, and the translational grant number is 2UL1TR000433. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1997, PERFORMANCE AMYOTROP, V152, pS1; [Anonymous], 2014, VERBAL FLUENCY INDEX, V15, P388; [Anonymous], 2000, VERBAL FLUENCY EXECU, V38, P734; [Anonymous], 2010, DETECTING FRONTOTEMP, V11, P303; [Anonymous], 2012, ARCH REV, V10, P3, DOI [DOI 10.5121/IJAIA.2012.3412161,(19), DOI 10.2151/JMSJ.2012-A02]; Babiloni C, 2009, NEUROIMAGE, V45, P512, DOI 10.1016/j.neuroimage.2008.11.035; Bak TH, 2012, CORTEX, V48, P936, DOI 10.1016/j.cortex.2011.07.008; Baron-Cohen S, 2001, J CHILD PSYCHOL PSYC, V42, P241, DOI 10.1017/S0021963001006643; Buccino G, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0185; Caspers S, 2010, NEUROIMAGE, V50, P1148, DOI 10.1016/j.neuroimage.2009.12.112; Cattaneo L, 2009, J NEUROSCI, V29, P11134, DOI 10.1523/JNEUROSCI.2605-09.2009; Cattaneo L, 2009, ARCH NEUROL-CHICAGO, V66, P557, DOI 10.1001/archneurol.2009.41; Cavallo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025948; DIPELLEGRINO G, 1992, EXP BRAIN RES, V91, P176, DOI 10.1007/BF00230027; Eisen A, 2014, MUSCLE NERVE, V49, P469, DOI 10.1002/mus.24132; Fabbri-Destro M, 2008, PHYSIOLOGY, V23, P171, DOI 10.1152/physiol.00004.2008; FADIGA L, 1995, J NEUROPHYSIOL, V73, P2608, DOI 10.1152/jn.1995.73.6.2608; Filimon F, 2007, NEUROIMAGE, V37, P1315, DOI 10.1016/j.neuroimage.2007.06.008; Fiori F, 2013, EXP BRAIN RES, V226, P537, DOI 10.1007/s00221-013-3465-9; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Gibbons ZC, 2007, NEUROPSYCHOLOGIA, V45, P1196, DOI 10.1016/j.neuropsychologia.2006.10.008; Giordana MT, 2011, NEUROL SCI, V32, P9, DOI 10.1007/s10072-010-0439-6; Girardi A, 2011, NEUROPSYCHOLOGY, V25, P53, DOI 10.1037/a0020357; Gobbini MI, 2007, J COGNITIVE NEUROSCI, V19, P1803, DOI 10.1162/jocn.2007.19.11.1803; Grace GM, 2011, CAN J NEUROL SCI, V38, P88; Grossman M, 2008, NEUROLOGY, V71, P1396, DOI 10.1212/01.wnl.0000319701.50168.8c; Hanagasi HA, 2002, COGNITIVE BRAIN RES, V14, P234, DOI 10.1016/S0926-6410(02)00110-6; Hesslow G, 2002, TRENDS COGN SCI, V6, P242, DOI 10.1016/S1364-6613(02)01913-7; Higuchi S, 2012, NEUROIMAGE, V59, P1668, DOI 10.1016/j.neuroimage.2011.09.021; Hillis AE, 2004, ANN NEUROL, V55, P268, DOI 10.1002/ana.10812; Iacoboni M, 1999, SCIENCE, V286, P2526, DOI 10.1126/science.286.5449.2526; Iacoboni M, 2005, PLOS BIOL, V3, P529, DOI 10.1371/journal.pbio.0030079; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; Jelsone-Swain L, 2012, MIRROR NEURON FUNCTI; Kelly AMC, 2005, CEREB CORTEX, V15, P1089, DOI 10.1093/cercor/bhi005; KEW JJM, 1993, BRAIN, V116, P655, DOI 10.1093/brain/116.3.655; Keysers C, 2010, CURR BIOL, V20, pR353, DOI 10.1016/j.cub.2010.03.013; Kilner JM, 2011, TRENDS COGN SCI, V15, P352, DOI 10.1016/j.tics.2011.06.005; Kollewe K, 2011, J NEUROL, V258, P804, DOI 10.1007/s00415-010-5842-7; Konrad C, 2002, EXP BRAIN RES, V143, P51, DOI 10.1007/s00221-001-0981-9; Lule D, 2007, NEUROREHAB NEURAL RE, V21, P518, DOI 10.1177/1545968307300698; Lule D, 2007, J NEUROL, V254, P519, DOI 10.1007/s00415-006-0409-3; Lule D, 2010, J NEUROL NEUROSUR PS, V81, P899, DOI 10.1136/jnnp.2009.192260; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Meiri H, 2012, NEUROSCI LETT, V510, P43, DOI 10.1016/j.neulet.2011.12.066; Merrilees J, 2010, AMYOTROPH LATERAL SC, V11, P298, DOI 10.3109/17482961003605788; Mohammadi B, 2011, HUM BRAIN MAPP, V32, P750, DOI 10.1002/hbm.21064; Molenberghs P, 2012, NEUROIMAGE, V59, P608, DOI 10.1016/j.neuroimage.2011.07.080; Montgomery KJ, 2007, SOC COGN AFFECT NEUR, V2, P114, DOI 10.1093/scan/nsm004; Montuschi A, 2014, J NEUROLOGY NEUROSUR; Murphy JM, 2007, ARCH NEUROL-CHICAGO, V64, P530, DOI 10.1001/archneur.64.4.530; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Newsom-Davis IC, 1999, J NEUROL SCI, V169, P22, DOI 10.1016/S0022-510X(99)00211-7; Palmieri A, 2014, J NEUROLOGY NEUROSUR; Phukan J, 2012, J NEUROL NEUROSUR PS, V83, P102, DOI 10.1136/jnnp-2011-300188; Pineda JA, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-47; Poujois A, 2013, HUM BRAIN MAPP, V34, P2391, DOI 10.1002/hbm.22070; Raaphorst J, 2012, NEUROLOGY, V79, P1377, DOI 10.1212/WNL.0b013e31826c1aa1; Rizzolatti G, 2005, ANAT EMBRYOL, V210, P419, DOI 10.1007/s00429-005-0039-z; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Rizzolatti G, 2010, NAT REV NEUROSCI, V11, P264, DOI 10.1038/nrn2805; Rizzolatti G, 2009, NAT CLIN PRACT NEURO, V5, P24, DOI 10.1038/ncpneuro0990; Rusina R, 2010, EUR J NEUROL, V17, P23, DOI 10.1111/j.1468-1331.2009.02717.x; Schmolck H, 2007, NEUROLOGY, V69, P2232, DOI 10.1212/01.wnl.0000296001.16603.b3; Schoenfeld MA, 2005, J NEUROL, V252, P944, DOI 10.1007/s00415-005-0787-y; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Stoppel CM, 2014, NEUROIMAGE-CLIN, V5, P277, DOI 10.1016/j.nicl.2014.07.007; Strong MJ, 2009, AMYOTROPH LATERAL SC, V10, P131, DOI 10.1080/17482960802654364; Terada T, 2011, J NEUROL SCI, V309, P136, DOI 10.1016/j.jns.2011.06.049; Tessitore A, 2006, BRAIN RES BULL, V69, P489, DOI 10.1016/j.brainresbull.2006.01.013; van Veluw SJ, 2014, BRAIN IMAGING BEHAV, V8, P24, DOI 10.1007/s11682-013-9266-8; Vogt S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00807; Weschler IS, 1932, ARCH NEUROLOGY PSYCH, P858; Witgert M, 2010, EUR J NEUROL, V17, P103, DOI 10.1111/j.1468-1331.2009.02801.x; Woolley SC, 2010, AMYOTROPH LATERAL SC, V11, P303, DOI 10.3109/17482961003727954; YESAVAGE JA, 1988, PSYCHOPHARMACOL BULL, V24, P709; York C, 2014, J NEUROL, V261, P1073, DOI 10.1007/s00415-014-7314-y; Zimmerman EK, 2007, COGN BEHAV NEUROL, V20, P79, DOI 10.1097/WNN.0b013e31804c700b	80	23	24	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0119862	10.1371/journal.pone.0119862	http://dx.doi.org/10.1371/journal.pone.0119862			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885533	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000006
J	Kessel, L; Larsen, M				Kessel, Line; Larsen, Michael			Action Spectrum for Photobleaching of Human Lenses by Short Wavelength Visible Irradiation	PLOS ONE			English	Article							CATARACT-SURGERY; OCULAR MEDIA; PROTEINS; AGE; GLYCATION; UV; PHOTOOXIDATION; ARGPYRIMIDINE; TRANSMISSION; CHROMOPHORES	Purpose Cataract is the world-leading cause of blindness. In search for a new treatment of cataract we have found that the yellow discolouration of aged human lenses can be photobleached using a non-invasive, infra-red, femtosecond laser treatment. These results were presented in an earlier PlosOne publication. The objective of the study was to characterize the single-photon photobleaching action spectrum of the aged human lens in vitro. Methods Ninety-one human donor lenses were irradiated with continuous wave laser light at 375, 405, 420, 445, 457 or 473 nm. Photobleaching was monitored by photography and transmission measurements. Results The action spectrum peaked at 420 nm followed by, in order of decreasing effect, 445, 457, 473, 405 and 375 nm. Younger and less absorbent lenses showed smaller changes than older and more absorbent lenses. There was a dose-dependent increase in lens transmission with increasing laser irradiation. Conclusions For a 75 year old lens an effect corresponding to elimination of 15 years or more of optical ageing was obtained. This study of the spectral characteristics and intensity needed to bleach the human lens with single-photon laser effects found an action-spectrum peak at 420 nm tailing gradually off toward longer wavelengths and more steeply toward shorter wavelengths. The results may be used to guide experiments with two-photon bleaching.	[Kessel, Line; Larsen, Michael] Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark; [Larsen, Michael] Univ Copenhagen, Dept Clin Med, Fac Hlth Sci, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen	Kessel, L (corresponding author), Glostrup Cty Hosp, Dept Ophthalmol, Glostrup, Denmark.	line.kessel@dadlnet.dk	Larsen, Michael/E-9620-2010	Larsen, Michael/0000-0002-5172-5891; Kessel, Line/0000-0002-9375-1510	Danish Medical Research Council (Det Frie Forskningsrad); National Danish Advanced Science Foundation; CIP (Competitiveness and Innovation framework programme) [621088]; Foundation of June 15 (15. Juni Fonden)	Danish Medical Research Council (Det Frie Forskningsrad); National Danish Advanced Science Foundation; CIP (Competitiveness and Innovation framework programme); Foundation of June 15 (15. Juni Fonden)	The study received financial support from the Danish Medical Research Council (Det Frie Forskningsrad), the National Danish Advanced Science Foundation, CIP (Competitiveness and Innovation framework programme 2007-2013) grant number 621088 and the Foundation of June 15 (15. Juni Fonden). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Algvere PV, 2006, ACTA OPHTHALMOL SCAN, V84, P4, DOI 10.1111/j.1600-0420.2005.00627.x; ANDLEY UP, 1994, INVEST OPHTH VIS SCI, V35, P367; Balasubramanian D, 2005, PHOTOCHEM PHOTOBIOL, V81, P498, DOI 10.1562/2004-11-01-RA-354.1; Barbazetto IA, 2004, EXP EYE RES, V78, P917, DOI 10.1016/j.exer.2004.01.003; Bloemendal H, 2004, PROG BIOPHYS MOL BIO, V86, P407, DOI 10.1016/j.pbiomolbio.2003.11.012; Bockelbrink A, 2008, SURV OPHTHALMOL, V53, P359, DOI 10.1016/j.survophthal.2008.04.001; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Davies MJ, 2001, J PHOTOCH PHOTOBIO B, V63, P114, DOI 10.1016/S1011-1344(01)00208-1; FOSTER A, 1991, LANCET, V337, P1267, DOI 10.1016/0140-6736(91)92929-V; GORGELS TGMF, 1995, INVEST OPHTH VIS SCI, V36, P851; He L, 2010, CURR OPIN OPHTHALMOL; Holm Thomas, 2015, BMC Res Notes, V8, P5, DOI 10.1186/s13104-015-0977-3; JACQUES SL, 1992, SURG CLIN N AM, V72, P531; Kessel L, 2005, ACTA OPHTHALMOL SCAN, V83, P221, DOI 10.1111/j.1600-0420.2005.00388.x; Kessel L, 2011, ACTA OPHTHALMOL, V89, pe289, DOI 10.1111/j.1755-3768.2009.01839.x; Kessel L, 2010, J CATARACT REFR SURG, V36, P308, DOI 10.1016/j.jcrs.2009.08.035; Kessel L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009711; McNulty R, 2004, J PHYSIOL-LONDON, V559, P883, DOI 10.1113/jphysiol.2004.068619; MONNIER VM, 1981, SCIENCE, V211, P491, DOI 10.1126/science.6779377; Oriowo OM, 2001, INVEST OPHTH VIS SCI, V42, P2596; Ortwerth BJ, 1997, PHOTOCHEM PHOTOBIOL, V65, P666, DOI 10.1111/j.1751-1097.1997.tb01909.x; Ortwerth BJ, 2002, EXP EYE RES, V74, P217, DOI 10.1006/exer.2001.1114; Padayatti PS, 2001, INVEST OPHTH VIS SCI, V42, P1299; PIRIE A, 1971, BIOCHEM J, V125, P203, DOI 10.1042/bj1250203; Ponce A, 2006, MOL VIS, V12, P879; Regini JW, 2004, J MOL BIOL, V336, P1185, DOI 10.1016/S0022-2836(03)00814-3; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; Roberts JE, 2001, PHOTOCHEM PHOTOBIOL, V74, P740, DOI 10.1562/0031-8655(2001)074<0740:POLPWX>2.0.CO;2; Tuulonen A, 2009, ACTA OPHTHALMOL; Ulrich P, 2001, RECENT PROG HORM RES, V56, P1, DOI 10.1210/rp.56.1.1; van de Kraats J, 2007, J OPT SOC AM A, V24, P1842, DOI 10.1364/JOSAA.24.001842; Vogel A, 2005, APPL PHYS B-LASERS O, V81, P1015, DOI 10.1007/s00340-005-2036-6; WEALE RA, 1988, J PHYSIOL-LONDON, V395, P577, DOI 10.1113/jphysiol.1988.sp016935	33	0	0	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123732	10.1371/journal.pone.0123732	http://dx.doi.org/10.1371/journal.pone.0123732			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884924	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000081
J	Li, ZQ; Zhao, BZ; Wang, QY; Cao, XY; Zhang, JB				Li, Zengqiang; Zhao, Bingzi; Wang, Qingyun; Cao, Xiaoyan; Zhang, Jiabao			Differences in Chemical Composition of Soil Organic Carbon Resulting From Long-Term Fertilization Strategies	PLOS ONE			English	Article							C-13 NMR-SPECTROSCOPY; SOLID-STATE NMR; MANURE APPLICATION; MICROBIAL BIOMASS; PADDY SOIL; LAND-USE; MATTER; NITROGEN; FRACTIONS; DENSITY	Chemical composition of soil organic carbon (SOC) is central to soil fertility. We hypothesize that change in SOC content resulting from various long-term fertilization strategies accompanies the shift in SOC chemical structure. This study examined the effect of fertilization strategies along with the time of fertilizer application on the SOC composition by C-13 nuclear magnetic resonance (NMR) spectroscopy. The soils (Aquic Inceptisol) subjected to seven fertilizer treatments were collected in 1989, 1999 and 2009, representing 0, 10 and 20 years of fertilization, respectively. The seven fertilizer treatments were (1-3) balanced fertilization with application of nitrogen (N), phosphorus (P) and potassium (K) including organic compost (OM), half organic compost plus half chemical fertilizer (1/2OM), and pure chemical NPK fertilizer (NPK); (4-6) unbalanced chemical fertilization without application of one of the major elements including NP fertilizer (NP), PK fertilizer (PK), and NK fertilizer (NK); and (7) an unamended control (CK). The SOC content in the balanced fertilization treatments were 2.3-52.6% and 9.4-64.6% higher than in the unbalanced fertilization/CK treatments in 1999 and 2009, respectively, indicating significant differences in SOC content with time of fertilizer application between the two treatment groups. There was a significantly greater proportion of O-alkyl C and a lower proportion of aromatic C in the balanced fertilization than in unbalanced fertilization/CK treatments in 1999, but not in 2009, because their proportions in the former treatments approached the latter in 2009. Principal component analysis further showed that the C functional groups from various fertilization strategies tended to become compositionally similar with time. The results suggest that a shift in SOC chemical composition may be firstly dominated by fertilization strategies, followed by fertilization duration.	[Li, Zengqiang; Zhao, Bingzi; Wang, Qingyun; Zhang, Jiabao] Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China; [Li, Zengqiang] Chinese Acad Sci, Grad Sch, Beijing, Peoples R China; [Cao, Xiaoyan] Brandeis Univ, Dept Chem, Waltham, MA 02254 USA	Chinese Academy of Sciences; Institute of Soil Science, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Brandeis University	Zhao, BZ (corresponding author), Chinese Acad Sci, Inst Soil Sci, State Key Lab Soil & Sustainable Agr, Nanjing, Jiangsu, Peoples R China.	bzhao@issas.ac.cn	Cao, Xiaoyan/E-3492-2012	Cao, Xiaoyan/0000-0001-7571-6482	National Basic Research Program of China [2011CB100506]; National Natural Science Foundation of China [41271311]; National Key Technology Support Program [2012BAD05B0203]; Chinese Academy of Sciences [CXJQ120111, ISSASIP1118]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Technology Support Program(National Key Technology R&D Program); Chinese Academy of Sciences(Chinese Academy of Sciences)	This project was supported by the National Basic Research Program of China (2011CB100506), the National Natural Science Foundation of China (41271311), National Key Technology Support Program (2012BAD05B0203), and the Knowledge Innovation Program of the Chinese Academy of Sciences (CXJQ120111, ISSASIP1118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaria A, 2009, SOIL SCI SOC AM J, V73, P812, DOI 10.2136/sssaj2008.0075; Brown S, 2011, ENVIRON SCI TECHNOL, V45, P7451, DOI 10.1021/es2010418; Cai ZC, 2006, GEODERMA, V136, P708, DOI 10.1016/j.geoderma.2006.05.008; Cao XY, 2011, SOIL SCI SOC AM J, V75, P1374, DOI 10.2136/sssaj2010.0382; Carter MR, 2003, CAN J SOIL SCI, V83, P11, DOI 10.4141/S01-087; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Dieckow J, 2005, EUR J SOIL SCI, V56, P705, DOI 10.1111/j.1365-2389.2005.00705.x; Ding WX, 2007, SOIL BIOL BIOCHEM, V39, P669, DOI 10.1016/j.soilbio.2006.09.024; Dungait JAJ, 2012, GLOBAL CHANGE BIOL, V18, P1781, DOI 10.1111/j.1365-2486.2012.02665.x; Fan JL, 2014, GEODERMA, V230, P22, DOI 10.1016/j.geoderma.2014.03.027; Fortuna A, 2003, SOIL SCI, V168, P434, DOI [10.1097/00010694-200306000-00005, 10.1097/01.ss.0000075288.53382.91]; Gallo ME, 2005, GLOBAL CHANGE BIOL, V11, P1514, DOI 10.1111/j.1365-2486.2005.01001.x; Guinto DF, 1999, AUST J SOIL RES, V37, P123, DOI 10.1071/S97034; HAGEMEYER A, 1991, J MAGN RESON, V92, P628, DOI 10.1016/0022-2364(91)90360-6; Helfrich M, 2006, GEODERMA, V136, P331, DOI 10.1016/j.geoderma.2006.03.048; Hsu JH, 1999, ENVIRON POLLUT, V104, P189, DOI 10.1016/S0269-7491(98)00193-6; Kogel-Knabner I, 1997, GEODERMA, V80, P243, DOI 10.1016/S0016-7061(97)00055-4; Mahieu N, 1999, SOIL SCI SOC AM J, V63, P307, DOI 10.2136/sssaj1999.03615995006300020008x; Mao JD, 2000, SOIL SCI SOC AM J, V64, P873, DOI 10.2136/sssaj2000.643873x; Mao JD, 2008, GEODERMA, V146, P353, DOI 10.1016/j.geoderma.2008.06.003; Mathers NJ, 2007, SOIL BIOL BIOCHEM, V39, P993, DOI 10.1016/j.soilbio.2006.11.009; Mathers NJ, 2003, GEODERMA, V114, P19, DOI 10.1016/S0016-7061(02)00339-7; Nelson D.W., 1996, METHODS SOIL ANAL, P961, DOI DOI 10.2136/SSSAB00KSER5.3.C34; Ng EL, 2014, SOIL BIOL BIOCHEM, V70, P54, DOI 10.1016/j.soilbio.2013.12.004; Nierop KGJ, 1999, GEODERMA, V90, P111, DOI 10.1016/S0016-7061(98)00095-0; Olk DC, 2006, SOIL BIOL BIOCHEM, V38, P3303, DOI 10.1016/j.soilbio.2006.04.009; Qin ShengWu, 1998, Acta Pedologica Sinica, V35, P367; REID ID, 1991, CAN J BOT, V69, P156, DOI 10.1139/b91-022; Schmidt MWI, 1997, EUR J SOIL SCI, V48, P319, DOI 10.1111/j.1365-2389.1997.tb00552.x; SKJEMSTAD JO, 1994, AUST J SOIL RES, V32, P1215, DOI 10.1071/SR9941215; Spaccini R, 2009, SOIL BIOL BIOCHEM, V41, P1164, DOI 10.1016/j.soilbio.2009.02.026; Wang QJ, 2012, J PLANT NUTR SOIL SC, V175, P920, DOI 10.1002/jpln.201100350; Wang QJ, 2012, SOIL USE MANAGE, V28, P337, DOI 10.1111/j.1475-2743.2012.00414.x; Wang XY, 2012, ENVIRON SCI TECHNOL, V46, P7159, DOI 10.1021/es300522x; Yan X, 2013, SOIL TILL RES, V130, P42, DOI 10.1016/j.still.2013.01.013; Yu HY, 2012, SOIL TILL RES, V124, P170, DOI 10.1016/j.still.2012.06.011; Zhang JC, 2013, EUR J SOIL SCI, V64, P797, DOI 10.1111/ejss.12104; Zhang JJ, 2009, EUR J SOIL SCI, V60, P966, DOI 10.1111/j.1365-2389.2009.01191.x; Zhao BZ, 2013, J PLANT NUTR SOIL SC, V176, P99, DOI 10.1002/jpln.201200076; Zhao BZ, 2010, GEODERMA, V160, P218, DOI 10.1016/j.geoderma.2010.09.024; Zheng SX, 2009, SOIL BIOL BIOCHEM, V41, P2094, DOI 10.1016/j.soilbio.2009.07.019; Zhou P, 2010, EUR J SOIL SCI, V61, P231, DOI 10.1111/j.1365-2389.2009.01223.x	43	17	22	7	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124359	10.1371/journal.pone.0124359	http://dx.doi.org/10.1371/journal.pone.0124359			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884713	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000120
J	Martinez-Ramirez, D; Giugni, JC; Little, CS; Chapman, JP; Ahmed, B; Monari, E; Shukla, AW; Hess, CW; Okun, MS				Martinez-Ramirez, Daniel; Giugni, Juan C.; Little, Christopher S.; Chapman, John P.; Ahmed, Bilal; Monari, Erin; Shukla, Aparna Wagle; Hess, Christopher W.; Okun, Michael S.			Missing Dosages and Neuroleptic Usage May Prolong Length of Stay in Hospitalized Parkinson's Disease Patients	PLOS ONE			English	Article							MEDICATION; ADMISSIONS; OUTCOMES; MULTICENTER; ADHERENCE; PEOPLE; RISK	Background Parkinson's disease patients are more likely to be hospitalized, have higher rates of hospital complications, and have an increased risk of deterioration during hospitalization. Length of stay is an important underlying factor for these increased risks. We aimed to investigate potential medication errors that may occur during hospitalization and its impact on length of hospital stay. Methods A cross-sectional chart review of 339 consecutive hospital encounters from 212 PD subjects was performed. Medication errors were defined as wrong timing or omission of administration for dopaminergic drugs and administration of contraindicated dopamine blockers. An analysis of covariance was applied to examine whether these medication errors were related to increased length of hospital stays. Results A significant effect for dopaminergic administration (p<0.01) on length of hospital stay was observed. Subjects who had delayed administration or missed at least one dose stayed longer (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4). Contraindicated dopamine blocking agents were administered in 23% (71/339) of cases, and this was also significantly related to an increased length of stay (M=8.2 days, SD=8.9 vs. M=3.6 days SD=3.4), p<0.05. Participants who received a contraindicated dopamine blocker stayed in the hospital longer (M=7.5 days, SD=9.1) compared to those who did not (M=5.9 days, SD=6.8). Neurologists were consulted in 24.5% of encounters. Specialty consultation had no effect on the medication related errors. Conclusions Missing dopaminergic dosages and administration of dopamine blockers occur frequently in hospitalized Parkinson's disease patients and this may impact length of stay. These potentially modifiable factors may reduce the risk of a longer stay related to hospitalization.	[Martinez-Ramirez, Daniel; Giugni, Juan C.; Little, Christopher S.; Chapman, John P.; Ahmed, Bilal; Monari, Erin; Shukla, Aparna Wagle; Hess, Christopher W.; Okun, Michael S.] Univ Florida, Coll Med, Dept Neurol, Ctr Movement Disorders & Neurorestorat, Gainesville, FL USA; [Okun, Michael S.] Univ Florida, Coll Med, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Okun, MS (corresponding author), Univ Florida, Coll Med, Dept Neurosurg, Ctr Movement Disorders & Neurorestorat, Gainesville, FL 32611 USA.	okun@neurology.ufl.edu	Ramirez, Daniel Martinez/O-6719-2018; Martinez-Ramirez, Daniel/H-2546-2016; Ahmed, Bilal/A-6926-2016; Shukla, Aparna Wagle/AAN-1344-2020	Ramirez, Daniel Martinez/0000-0001-8003-0610; Martinez-Ramirez, Daniel/0000-0001-8003-0610; Ahmed, Bilal/0000-0001-9110-4136; Hess, Christopher/0000-0002-7317-8999; Hastings Monari, Erin/0000-0002-4075-3360; Okun, Michael/0000-0002-6247-9358; WAGLE SHUKLA, APARNA/0000-0002-9757-9973	National Parkinson Foundation; Tyler's Hope; Bachmann-Strauss Foundation	National Parkinson Foundation; Tyler's Hope; Bachmann-Strauss Foundation	We would like to acknowledge the support of the National Parkinson Foundation, Tyler's Hope and the Bachmann-Strauss Foundation to the Center. Also we would like to acknowledge the UF Foundation and the UF INFORM database, as well as Dr. Masa-aki Higuchi and Caroline Mignacca for helping obtaining data.	Aminoff MJ, 2011, PARKINSONISM RELAT D, V17, P139, DOI 10.1016/j.parkreldis.2010.11.009; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Braga M, 2014, PARKINSONISM RELAT D, V20, P488, DOI 10.1016/j.parkreldis.2014.01.022; Buetow S, 2010, PARKINSONS DIS-US, V2010, DOI 10.4061/2010/432983; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chou KL, 2011, PARKINSONISM RELAT D, V17, P440, DOI 10.1016/j.parkreldis.2011.03.002; Cilia R, 2014, J NEUROL NEUROSURG P; Dent E, 2014, AGE AGEING, V43, P477, DOI 10.1093/ageing/aft181; Derry CP, 2010, POSTGRAD MED J, V86, P334, DOI 10.1136/pgmj.2009.080432; Driver JA, 2008, NEUROLOGY, V70, P1423, DOI 10.1212/01.wnl.0000310414.85144.ee; Gerlach OHH, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-13; Gerlach OHH, 2011, PARKINSONISM RELAT D, V17, P498, DOI 10.1016/j.parkreldis.2011.04.004; Gerlach OHH, 2011, MOVEMENT DISORD, V26, P197, DOI 10.1002/mds.23449; Gilboy N, 2012, EMERGENCY SEVERITY I; Goldman JG, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-013-0281-2; Grosset D, 2009, MOVEMENT DISORD, V24, P826, DOI 10.1002/mds.22112; Hassan A, 2013, PARKINSONISM RELAT D, V19, P949, DOI 10.1016/j.parkreldis.2013.06.006; Hassan Anhar, 2012, Parkinsonism Relat Disord, V18 Suppl 3, pS10, DOI 10.1016/j.parkreldis.2012.06.014; Hely MA, 2005, MOVEMENT DISORD, V20, P190, DOI 10.1002/mds.20324; Hou JG, 2012, PARKINSONISM RELAT D, V18, P377, DOI 10.1016/j.parkreldis.2011.12.007; Kulkarni AS, 2008, MOVEMENT DISORD, V23, P359, DOI 10.1002/mds.21831; Lubomski M, 2014, J NEUROL NEUROSURG P; Magdalinou KN, 2007, PARKINSONISM RELAT D, V13, P539, DOI 10.1016/j.parkreldis.2006.11.006; Martignoni E, 2004, NEUROL SCI, V25, P66, DOI 10.1007/s10072-004-0232-5; Skelly R, 2014, PARKINSONISM RELAT D, V20, P1242, DOI 10.1016/j.parkreldis.2014.09.015; Vossius C, 2010, ACTA NEUROL SCAND, V121, P38, DOI 10.1111/j.1600-0404.2009.01239.x; Woodford H, 2005, MOVEMENT DISORD, V20, P1104, DOI 10.1002/mds.20485; Zhan CL, 2003, JAMA-J AM MED ASSOC, V290, P1868, DOI 10.1001/jama.290.14.1868	28	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124356	10.1371/journal.pone.0124356	http://dx.doi.org/10.1371/journal.pone.0124356			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884484	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000118
J	Pallares, S; Arribas, P; Bilton, DT; Millan, A; Velasco, J				Pallares, Susana; Arribas, Paula; Bilton, David T.; Millan, Andres; Velasco, Josefa			The Comparative Osmoregulatory Ability of Two Water Beetle Genera Whose Species Span the Fresh-Hypersaline Gradient in Inland Waters (Coleoptera: Dytiscidae, Hydrophilidae)	PLOS ONE			English	Article							PREDACEOUS DIVING BEETLE; SALINITY TOLERANCE; TENEBRIONID BEETLE; OSMOTIC REGULATION; HEMOLYMPH OSMOREGULATION; PHYSIOLOGICAL-MECHANISMS; HYPEROSMOTIC FLUID; AQUATIC HABITATS; AEDES-AEGYPTI; AMINO-ACID	A better knowledge of the physiological basis of salinity tolerance is essential to understanding the ecology and evolutionary history of organisms that have colonized inland saline waters. Coleoptera are amongst the most diverse macroinvertebrates in inland waters, including saline habitats; however, the osmoregulatory strategies they employ to deal with osmotic stress remain unexplored. Survival and haemolymph osmotic concentration at different salinities were examined in adults of eight aquatic beetle species which inhabit different parts of the fresh-hypersaline gradient. Studied species belong to two unrelated genera which have invaded saline waters independently from freshwater ancestors; Nebrioporus (Dytiscidae) and Enochrus (Hydrophilidae). Their osmoregulatory strategy (osmoconformity or osmoregulation) was identified and osmotic capacity (the osmotic gradient between the animal's haemolymph and the external medium) was compared between species pairs co-habiting similar salinities in nature. We show that osmoregulatory capacity, rather than osmoconformity, has evolved independently in these different lineages. All species hyperegulated their haemolymph osmotic concentration in diluted waters; those living in fresh or low-salinity waters were unable to hyporegulate and survive in hyperosmotic media (>340 mosmol kg(-1)). In contrast, the species which inhabit the hypo-hypersaline habitats were effective hyporegulators, maintaining their haemolymph osmolality within narrow limits (ca. 300 mosmol kg(-1)) across a wide range of external concentrations. The hypersaline species N. ceresyi and E. jesusarribasi tolerated conductivities up to 140 and 180 mS cm(-1), respectively, and maintained osmotic gradients over 3500 mosmol kg(-1), comparable to those of the most effective insect osmoregulators known to date. Syntopic species of both genera showed similar osmotic capacities and in general, osmotic responses correlated well with upper salinity levels occupied by individual species in nature. Therefore, osmoregulatory capacity may mediate habitat segregation amongst congeners across the salinity gradient.	[Pallares, Susana; Millan, Andres; Velasco, Josefa] Univ Murcia, Dept Ecol & Hydrol, Murcia, Spain; [Arribas, Paula] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Arribas, Paula] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, London, England; [Bilton, David T.] Univ Plymouth, Marine Biol & Ecol Res Ctr, Sch Marine Sci & Engn, Plymouth PL4 8AA, Devon, England	University of Murcia; Natural History Museum London; Imperial College London; University of Plymouth	Pallares, S (corresponding author), Univ Murcia, Dept Ecol & Hydrol, Murcia, Spain.	susana.pallares@um.es	Pallarés, Susana/AAI-2417-2019; Millan, Andres/D-3655-2009; Arribas, Paula/ABG-9998-2020	Millan, Andres/0000-0003-0036-363X; Arribas, Paula/0000-0002-0358-8271; Pallares, Susana/0000-0001-8677-7475; Bilton, David/0000-0003-1136-0848	University of Murcia, Spain; Royal Society UK; Ministerio de Economia y Competitividad, Spain [CGL2010-15378]; FEDER	University of Murcia, Spain; Royal Society UK(Royal Society of London); Ministerio de Economia y Competitividad, Spain; FEDER(European Commission)	This study was supported by funding from a pre-doctoral grant from the University of Murcia, Spain (http://www.um.es/) to SP, from a postdoctoral grant from the Royal Society UK (Newton International Program) (https://royalsociety.org/) to PA, by project CGL2010-15378 from Ministerio de Economia y Competitividad, Spain to JV and co-financed by FEDER funds (http://europa.eu/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aikins MJ, 2008, INSECT BIOCHEM MOLEC, V38, P740, DOI 10.1016/j.ibmb.2008.04.006; Alarie Y, 1998, CAN ENTOMOL, V130, P615, DOI 10.4039/Ent130615-5; Albers MA, 2011, PHYSIOL BIOCHEM ZOOL, V84, P258, DOI 10.1086/659769; ARMOLD MT, 1969, COMP BIOCHEM PHYSIOL, V31, P685, DOI 10.1016/0010-406X(69)92068-4; Arribas P, 2009, ECOSISTEMAS, V18, P1; Arribas P, 2014, MOL ECOL, V23, P360, DOI 10.1111/mec.12605; BARTONBROWNE L, 1964, ANNU REV ENTOMOL, V9, P63, DOI 10.1146/annurev.en.09.010164.000431; Bayly I.A.E., 1972, Annual Rev Ecol Syst, V3, P233, DOI 10.1146/annurev.es.03.110172.001313; Beadle LC, 1943, BIOL REV CAMB PHILOS, V18, P172, DOI 10.1111/j.1469-185X.1943.tb00297.x; BEAMENT JW, 1961, J EXP BIOL, V38, P277; Bernhard D, 2006, ZOOL SCR, V35, P597, DOI 10.1111/j.1463-6409.2006.00251.x; Bradley T. J., 2008, Aquatic insects: challenges to populations, P20, DOI 10.1079/9781845933968.0020; Bradley Timothy J., 1994, P303; Bradley TJ, 2009, INTEGR COMP BIOL, V49, P590, DOI 10.1093/icb/icp043; Bradley TJ, 2009, OXF ANIMAL BIOL SER, P1; BRADLEY TJ, 1977, J EXP BIOL, V66, P111; BRADLEY TJ, 1975, J EXP BIOL, V63, P331; BRADLEY TJ, 1977, J EXP BIOL, V66, P97; BRADLEY TJ, 1987, ANNU REV ENTOMOL, V32, P439, DOI 10.1146/annurev.en.32.010187.002255; BRADLEY TJ, 2002, ENCY INSECTS, P380; BROZA M, 1976, ISRAEL J MED SCI, V12, P868; Calosi P, 2005, COMP BIOCHEM PHYS A, V142, P267, DOI 10.1016/j.cbpb.2005.06.012; Canedo-Arguelles M, 2013, ENVIRON POLLUT, V173, P157, DOI 10.1016/j.envpol.2012.10.011; Carbonell JA, 2012, FRESHWATER BIOL, V57, P2580, DOI 10.1111/fwb.12029; Cespedes V, 2013, J INSECT PHYSIOL, V59, P1076, DOI 10.1016/j.jinsphys.2013.08.006; CHARMANTIER G, 1984, CR ACAD SCI III-VIE, V299, P863; Chown S.L., 2004, INSECT PHYSL ECOLOGY, DOI DOI 10.1002/joc.5086; CLOUDSLEYTHOMPS.JL, 1975, ANNU REV ENTOMOL, V20, P261, DOI 10.1146/annurev.en.20.010175.001401; COHEN AC, 1986, COMP BIOCHEM PHYS A, V85, P743, DOI 10.1016/0300-9629(86)90288-4; COUTCHIE PA, 1979, PHYSIOL ZOOL, V52, P88, DOI 10.1086/physzool.52.1.30159934; DEATON LE, 1981, PHYSIOL ZOOL, V54, P109, DOI 10.1086/physzool.54.1.30155809; Donini A, 2005, J EXP BIOL, V208, P603, DOI 10.1242/jeb.01422; EDWARDS HA, 1982, J EXP BIOL, V101, P135; Evans D. H., 2008, OSMOTIC IONIC REGULA; Evans DH, 1981, ENV PHYSL FISHES, P93; FRISBIE MP, 1988, J COMP PHYSIOL B, V158, P91, DOI 10.1007/BF00692732; FRISBIE MP, 1988, COMP BIOCHEM PHYS A, V89, P409, DOI 10.1016/0300-9629(88)91049-3; FRISBIE MP, 1988, CAN J ZOOL, V66, P1553, DOI 10.1139/z88-227; GAINEY LF, 1984, PHYSIOL ZOOL, V57, P663, DOI 10.1086/physzool.57.6.30155992; GARRETT M, 1984, J EXP BIOL, V113, P133; GARRETT MA, 1987, J EXP BIOL, V129, P231; Gibbs AG, 1997, J EXP BIOL, V200, P1821; Gomez-Mestre I, 2005, J EVOLUTION BIOL, V18, P847, DOI 10.1111/j.1420-9101.2004.00878.x; Gruber CW, 2014, EXP PHYSIOL, V99, P55, DOI 10.1113/expphysiol.2013.072561; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; Havird JC, 2014, J EXP BIOL, V217, P2309, DOI 10.1242/jeb.103051; HERBST DB, 1988, J INSECT PHYSIOL, V34, P369, DOI 10.1016/0022-1910(88)90105-9; HERBST DB, 1988, J INSECT PHYSIOL, V34, P903, DOI 10.1016/0022-1910(88)90125-4; Herbst DB, 1999, GREAT BASIN NAT, V59, P127; Herbst DB, 2001, HYDROBIOLOGIA, V466, P209, DOI 10.1023/A:1014508026349; Hofmann GE, 2010, ANNU REV PHYSIOL, V72, P127, DOI 10.1146/annurev-physiol-021909-135900; HOLDGATE MW, 1956, J EXP BIOL, V33, P107; Hunt T, 2007, SCIENCE, V318, P1913, DOI 10.1126/science.1146954; JACOB J, 1986, BIOCHEM SYST ECOL, V14, P207, DOI 10.1016/0305-1978(86)90064-5; Jach MA, 2008, HYDROBIOLOGIA, V595, P419, DOI 10.1007/s10750-007-9117-y; Kefford B. J., 2002, Australasian Journal of Ecotoxicology, V8, P63; Kefford BJ, 2004, ENVIRON POLLUT, V129, P355, DOI 10.1016/j.envpol.2003.12.005; KOKKINN MJ, 1986, AUST J MAR FRESH RES, V37, P243; Larsen EH, 2014, COMPR PHYSIOL, V4, P405, DOI 10.1002/cphy.c130004; Lignot JH, 2000, AQUACULTURE, V191, P209, DOI 10.1016/S0044-8486(00)00429-4; Millan A, 2011, J ARID ENVIRON, V75, P1352, DOI 10.1016/j.jaridenv.2010.12.010; Millan Andres, 2006, Memorie della Societa Entomologica Italiana, V85, P137; Montes C, 1987, REAL ACAD CIENCIAS E, P95; Munoz J, 2008, MOL ECOL, V17, P3160, DOI 10.1111/j.1365-294X.2008.03818.x; Naidu SG, 2006, EUR J ENTOMOL, V103, P305, DOI 10.14411/eje.2006.039; Naidu SG, 2001, J INSECT PHYSIOL, V47, P1429, DOI 10.1016/S0022-1910(01)00133-0; NAYAR JK, 1974, ENTOMOL EXP APPL, V17, P367, DOI 10.1007/BF00334981; NEMENZ H, 1969, VIE MILIEU C BIOL TE, V20, P171; NEUMANN D, 1976, ANNU REV ENTOMOL, V21, P387, DOI 10.1146/annurev.en.21.010176.002131; NICHOLLS SP, 1983, J INSECT PHYSIOL, V29, P541, DOI 10.1016/0022-1910(83)90086-0; NICOLSON SW, 1980, J INSECT PHYSIOL, V26, P315, DOI 10.1016/0022-1910(80)90140-7; O'Donnell MJ, 1997, COMP PHYSL, P1207; PANNABECKER T, 1995, ANNU REV ENTOMOL, V40, P493, DOI 10.1146/annurev.en.40.010195.002425; Patrick ML, 2006, J EXP BIOL, V209, P4638, DOI 10.1242/jeb.02551; Patrick ML, 2000, J EXP BIOL, V203, P821; Pinceel T, 2013, FRESHWATER BIOL, V58, P1556, DOI 10.1111/fwb.12137; Quinn GP, 2003, EXPT DESIGN DATA ANA; RIDDLE WA, 1986, COMP BIOCHEM PHYS A, V83, P619, DOI 10.1016/0300-9629(86)90700-0; RIDDLE WA, 1976, J COMP PHYSIOL, V112, P295, DOI 10.1007/BF00692300; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sang HM, 2004, AQUACULTURE, V234, P601, DOI 10.1016/j.aquaculture.2004.01.008; Scudder GE, 1976, MARINE INSECTS, P265; SCUDDER GGE, 1983, HYDROBIOLOGIA, V105, P143, DOI 10.1007/BF00025184; Serrano X, 2011, MAR FRESHW BEHAV PHY, V44, P185, DOI 10.1080/10236244.2011.585745; Short AEZ, 2013, SYST ENTOMOL, V38, P723, DOI 10.1111/syen.12024; Shull VL, 2001, SYST BIOL, V50, P945, DOI 10.1080/106351501753462894; Somero GN, 2011, AM J PHYSIOL-REG I, V301, pR1, DOI 10.1152/ajpregu.00719.2010; Stafflinger E, 2008, P NATL ACAD SCI USA, V105, P3262, DOI 10.1073/pnas.0710897105; TONES PI, 1978, COMP BIOCHEM PHYS A, V60, P247, DOI 10.1016/0300-9629(78)90242-6; TONES PI, 1975, CAN J ZOOL, V53, P1207, DOI 10.1139/z75-144; Torres G, 2011, AQUAT BIOL, V12, P249, DOI 10.3354/ab00341; TREHERNE J. E., 1954, TRANS ROY ENT SOC LONDON, V105, P117; Velasco Josefa, 2006, Saline Syst, V2, P12, DOI 10.1186/1746-1448-2-12; WICHARD W, 1974, J INSECT PHYSIOL, V20, P1611, DOI 10.1016/0022-1910(74)90090-0; Wigglesworth VB, 1938, J EXP BIOL, V15, P235; Willmer P, 2005, ENV PHYSL ANIMALS; WILSON SD, 1986, ECOLOGY, V67, P1236, DOI 10.2307/1938679	97	28	29	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124299	10.1371/journal.pone.0124299	http://dx.doi.org/10.1371/journal.pone.0124299			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886355	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000112
J	Rayamajhi, A; Nightingale, S; Bhatta, NK; Singh, R; Ledger, E; Bista, KP; Lewthwaite, P; Mahaseth, C; Turtle, L; Robinson, JS; Galbraith, SE; Wnek, M; Johnson, BW; Faragher, B; Griffiths, MJ; Solomon, T				Rayamajhi, Ajit; Nightingale, Sam; Bhatta, Nisha Keshary; Singh, Rupa; Ledger, Elizabeth; Bista, Krishna Prasad; Lewthwaite, Penny; Mahaseth, Chandeshwar; Turtle, Lance; Robinson, Jaimie Sue; Galbraith, Sareen Elizabeth; Wnek, Malgorzata; Johnson, Barbara Wilmot; Faragher, Brian; Griffiths, Michael John; Solomon, Tom			A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; TUMOR-NECROSIS-FACTOR; NILE-VIRUS-INFECTION; MONOCLONAL-ANTIBODY; CYTOKINE PRODUCTION; NEUTRALIZING ANTIBODY; WEST; MICE; INTERLEUKIN-6; MODULATION	Background Japanese encephalitis (JE) virus (JEV) is a mosquito-borne flavivirus found across Asia that is closely related to West Nile virus. There is no known antiviral treatment for any flavivirus. Results from in vitro studies and animal models suggest intravenous immunoglobulin (IVIG) containing virus-specific neutralizing antibody may be effective in improving outcome in viral encephalitis. IVIG's anti-inflammatory properties may also be beneficial. Methodology/Principal Findings We performed a pilot feasibility randomized double-blind placebo-controlled trial of IVIG containing anti-JEV neutralizing antibody (ImmunoRel, 400mg/kg/day for 5 days) in children with suspected JE at two sites in Nepal; we also examined the effect on serum neutralizing antibody titre and cytokine profiles. 22 children were recruited, 13 of whom had confirmed JE; 11 received IVIG and 11 placebo, with no protocol violations. One child (IVIG group) died during treatment and two (placebo) subsequently following hospital discharge. Overall, there was no difference in outcome between treatment groups at discharge or follow up. Passive transfer of anti-JEV antibody was seen in JEV negative children. JEV positive children treated with IVIG had JEV-specific neutralizing antibody titres approximately 16 times higher than those treated with placebo (p=0.2), which was more than could be explained by passive transfer alone. IL-4 and IL-6 were higher in the IVIG group. Conclusions/Significance A trial of IVIG for JE in Nepal is feasible. IVIG may augment the development of neutralizing antibodies in JEV positive patients. IVIG appears an appealing option for JE treatment that warrants further study.	[Rayamajhi, Ajit; Nightingale, Sam; Ledger, Elizabeth; Lewthwaite, Penny; Turtle, Lance; Wnek, Malgorzata; Griffiths, Michael John; Solomon, Tom] Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England; [Rayamajhi, Ajit; Mahaseth, Chandeshwar] Natl Acad Med Sci, Kathmandu, Nepal; [Rayamajhi, Ajit; Bista, Krishna Prasad; Mahaseth, Chandeshwar] Kanti Childrens Hosp, Kathmandu, Nepal; [Bhatta, Nisha Keshary; Singh, Rupa] BP Koirala Inst Hlth Sci, Dharan, Nepal; [Robinson, Jaimie Sue; Johnson, Barbara Wilmot] Ctr Dis Control & Prevent, Arbovirus Dis Branch, Diagnost & Reference Lab, Div Vector Borne Dis, Ft Collins, CO USA; [Galbraith, Sareen Elizabeth] Leeds Metropolitan Univ, Inst Hlth & Wellbeing, Leeds LS1 3HE, W Yorkshire, England; [Faragher, Brian] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Griffiths, Michael John] Alder Hey Childrens Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England; [Solomon, Tom] Walton Ctr Natl Hlth Serv Fdn Trust, Liverpool, Merseyside, England; [Solomon, Tom] Natl Consortium Zoonosis Res, Liverpool, Merseyside, England; [Solomon, Tom] Natl Inst Hlth Res, Hlth Protect Res Unit Emerging & Zoonot Infect, Liverpool, Merseyside, England	University of Liverpool; B.P. Koirala Institute of Health Sciences; Centers for Disease Control & Prevention - USA; Leeds Beckett University; Liverpool School of Tropical Medicine; University of Liverpool; Alder Hey Children's NHS Foundation Trust; Walton Centre; University of Liverpool	Rayamajhi, A (corresponding author), Univ Liverpool, Inst Infect & Global Hlth, Liverpool L69 3BX, Merseyside, England.	ajitrnp@yahoo.com	Nightingale, Sam/CAF-3554-2022; Bista, Krishna/F-1079-2011	Nightingale, Sam/0000-0001-7870-5287; Bista, Krishna/0000-0001-7893-8275; Turtle, Lance/0000-0002-0778-1693; Galbraith, Sareen/0000-0002-1009-6179; Solomon, Tom/0000-0001-7266-6547	Liverpool Brain Infections Group; Program for Appropriate Technology in Health (PATH); MRC [G116/194] Funding Source: UKRI; Medical Research Council [G116/194] Funding Source: researchfish; National Institute for Health Research [NF-SI-0514-10177, CL-2013-07-005, IS-HPU-1112-10117] Funding Source: researchfish	Liverpool Brain Infections Group; Program for Appropriate Technology in Health (PATH); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the Liverpool Brain Infections Group. Sam Nightingale is a UK Medical Research Council (MRC) clinical fellow. Lance Turtle is a Wellcome Trust MB PhD postdoctoral research training fellow. Professor Tom Solomon is an MRC senior clinical fellow. Penny Lewthwaite was supported by a grant from the Program for Appropriate Technology in Health (PATH). The funders of this study had no role in study design, data collection, data analysis, data interpretation, decision to publish or preparation of the manuscript.	Abraham CS, 1996, NEUROSCI LETT, V208, P85; Agrawal AG, 2003, J INFECT DIS, V188, P1, DOI 10.1086/376871; Atrasheuskaya A, 2003, FEMS IMMUNOL MED MIC, V35, P33, DOI 10.1111/j.1574-695X.2003.tb00646.x; AUKRUST P, 1994, BLOOD, V84, P2136; Ben-Nathan D, 2003, J INFECT DIS, V188, P5, DOI 10.1086/376870; Ben-Nathan D, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-18; Bista M B, 2005, JNMA J Nepal Med Assoc, V44, P51; Bista MB, 2001, LANCET, V358, P791, DOI 10.1016/S0140-6736(01)05967-0; BLASCZYK R, 1993, LANCET, V341, P789, DOI 10.1016/0140-6736(93)90563-V; BRETT FM, 1995, J NEUROPATH EXP NEUR, V54, P766, DOI 10.1097/00005072-199511000-00003; BURKES EJ, 1992, J PROSTHET DENT, V67, P847, DOI 10.1016/0022-3913(92)90599-6; Campbell GL, 2011, B WORLD HEALTH ORGAN, V89, P766, DOI 10.2471/BLT.10.085233; Caramello P, 2006, CLIN INFECT DIS, V43, P1620, DOI 10.1086/509644; Chen CJ, 2004, J VIROL, V78, P12107, DOI 10.1128/JVI.78.22.12107-12119.2004; Dejnirattisai W, 2010, SCIENCE, V328, P745, DOI 10.1126/science.1185181; Diamond MS, 2003, J VIROL, V77, P2578, DOI 10.1128/JVI.77.4.2578-2586.2003; Engle MJ, 2003, J VIROL, V77, P12941, DOI 10.1128/JVI.77.24.12941-12949.2003; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; GAJANANA A, 1995, B WORLD HEALTH ORGAN, V73, P237; German AC, 2006, T ROY SOC TROP MED H, V100, P1135, DOI 10.1016/j.trstmh.2006.02.008; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Granerod J, 2010, LANCET INFECT DIS, V10, P835, DOI 10.1016/S1473-3099(10)70222-X; Griffin DE, 2003, NAT REV IMMUNOL, V3, P493, DOI 10.1038/nri1105; Gupta AK, 2003, ACTA VIROL, V47, P141; Ibanez C, 2005, BIODRUGS, V19, P59; Irani DN, 2001, CURR OPIN NEUROL, V14, P347, DOI 10.1097/00019052-200106000-00013; Johnson AJ, 2000, J CLIN MICROBIOL, V38, P1827, DOI 10.1128/JCM.38.5.1827-1831.2000; Johnson BW, 2009, CLIN VACCINE IMMUNOL, V16, P1052, DOI 10.1128/CVI.00095-09; JOHNSON RT, 1985, ANN NEUROL, V18, P567, DOI 10.1002/ana.410180510; Jolles S, 1999, J AM ACAD DERMATOL, V40, P121, DOI 10.1016/S0190-9622(99)70544-X; Kimura T, 2003, VIROLOGY, V311, P28, DOI 10.1016/S0042-6822(03)00110-7; KIMURAKURODA J, 1988, J IMMUNOL, V141, P3606; KLUGER G, 1995, LANCET, V346, P1502, DOI 10.1016/S0140-6736(95)92527-9; Kneen R, 2012, J INFECTION, V64, P449, DOI 10.1016/j.jinf.2011.11.013; Kneen R, 2002, ARCH DIS CHILD, V87, P181, DOI 10.1136/adc.87.3.181; Konishi E, 2003, VACCINE, V21, P3675, DOI 10.1016/S0264-410X(03)00382-7; Kumar R, 2009, CLIN INFECT DIS, V48, P400, DOI 10.1086/596309; Lang TA, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000619; Le VT, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000854; Lewthwaite P, 2010, B WORLD HEALTH ORGAN, V88, P584, DOI 10.2471/BLT.09.071357; LI ZS, 1988, CHINESE MED J-PEKING, V101, P768; LING ZD, 1990, CELL IMMUNOL, V129, P95, DOI 10.1016/0008-8749(90)90189-X; Liu T, 2001, J VIROL, V75, P2107, DOI 10.1128/JVI.75.5.2107-2118.2001; Llaurado G, 2012, DIABETES CARE, V35, P1083, DOI 10.2337/dc11-1475; Martin DA, 2000, J CLIN MICROBIOL, V38, P1823, DOI 10.1128/JCM.38.5.1823-1826.2000; Martin DA, 2002, CLIN DIAGN LAB IMMUN, V9, P544, DOI 10.1128/CDLI.9.3.544-549.2002; MIYAKE MASASHL, 1964, BULL WORLD HLTH ORGAN, V30, P153; Morrey JD, 2007, ANTIMICROB AGENTS CH, V51, P2396, DOI 10.1128/AAC.00147-07; Morrey JD, 2006, J INFECT DIS, V194, P1300, DOI 10.1086/508293; Morris MM, 1997, J NEUROIMMUNOL, V74, P185, DOI 10.1016/S0165-5728(96)00786-2; Mouzaki A, 2002, BLOOD, V100, P1774, DOI 10.1182/blood.V100.5.1774.h81702001774_1774_1779; Munoz-Fernandez MA, 1998, PROG NEUROBIOL, V56, P307; Ng CT, 2010, NAT MED, V16, P1117, DOI 10.1038/nm.2233; Pant GR, 2006, ANN NY ACAD SCI, V1081, P124, DOI 10.1196/annals.1373.013; Parida M, 2006, EMERG INFECT DIS, V12, P1427, DOI 10.3201/eid1209.060200; Paul R, 2003, BRAIN, V126, P1873, DOI 10.1093/brain/awg171; PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.iy.05.040187.002241; Pigard N, 2009, J NEUROIMMUNOL, V209, P114, DOI 10.1016/j.jneuroim.2009.01.014; Ramakrishna C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002071; Rayamajhi A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-294; Rayamajhi A, 2006, ANN TROP PAEDIATR, V26, P293, DOI 10.1179/146532806X152818; Reske D, 2009, NEUROIMMUNOMODULAT, V16, P385, DOI 10.1159/000228913; Solomon T, 2004, NEW ENGL J MED, V351, P370, DOI 10.1056/NEJMra030476; Solomon T, 2000, BRIT MED J, V321, P1484, DOI 10.1136/bmj.321.7275.1484; Solomon T, 2002, BRAIN, V125, P1084, DOI 10.1093/brain/awf116; Solomon T, 2000, J NEUROL NEUROSUR PS, V68, P405, DOI 10.1136/jnnp.68.4.405; Solomon T, 1998, LANCET, V351, P1094, DOI 10.1016/S0140-6736(97)07509-0; Solomon T, 2003, LANCET, V361, P821, DOI 10.1016/S0140-6736(03)12709-2; Solomon T, 2006, NEW ENGL J MED, V355, P869, DOI 10.1056/NEJMp058263; SVENSON M, 1993, J CLIN INVEST, V92, P2533, DOI 10.1172/JCI116862; Tandan JB, 2007, VACCINE; Tawfik DS, 2012, PEDIAT ALLERG IMM-UK, V23, P88, DOI 10.1111/j.1399-3038.2010.01129.x; Van Wagoner NJ, 1999, J NEUROIMMUNOL, V100, P124, DOI 10.1016/S0165-5728(99)00187-3; VANSNICK J, 1990, ANNU REV IMMUNOL, V8, P253, DOI 10.1146/annurev.immunol.8.1.253; Wang SM, 2006, J CLIN VIROL, V37, P47, DOI 10.1016/j.jcv.2006.05.009; Wang Y, 2003, J VIROL, V77, P13323, DOI [10.1128/JVI.77.24.13323-13334.2003, 10.1128/JVi.77.24.13323-13334.2003]; Winter PM, 2004, J INFECT DIS, V190, P1618, DOI 10.1086/423328; Wu KH, 2006, PEDIAT ALLERG IMM-UK, V17, P60, DOI 10.1111/j.1399-3038.2005.00344.x; ZHANG MJ, 1989, J MED VIROL, V29, P133, DOI 10.1002/jmv.1890290211	79	31	33	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122608	10.1371/journal.pone.0122608	http://dx.doi.org/10.1371/journal.pone.0122608			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886645	Green Accepted, gold, Green Published			2022-12-27	WOS:000353017000035
J	Vulliez-Le Normand, B; Faber, BW; Saul, FA; van der Eijk, M; Thomas, AW; Singh, B; Kocken, CHM; Bentley, GA				Vulliez-Le Normand, Brigitte; Faber, Bart W.; Saul, Frederick A.; van der Eijk, Marjolein; Thomas, Alan W.; Singh, Balbir; Kocken, Clemens H. M.; Bentley, Graham A.			Crystal Structure of Plasmodium knowlesi Apical Membrane Antigen 1 and Its Complex with an Invasion-Inhibitory Monoclonal Antibody	PLOS ONE			English	Article							MALARIA VACCINE CANDIDATE; BLOOD-STAGE VACCINE; HOST-CELL INVASION; POPULATION-STRUCTURE; NATURAL-SELECTION; MOVING JUNCTION; PROTEIN; AMA1; VIVAX; IMMUNIZATION	The malaria parasite Plasmodium knowlesi, previously associated only with infection of macaques, is now known to infect humans as well and has become a significant public health problemin Southeast Asia. This species should therefore be targeted in vaccine and therapeutic strategies against human malaria. Apical Membrane Antigen 1 (AMA1), which plays a role in Plasmodium merozoite invasion of the erythrocyte, is currently being pursued in human vaccine trials against P. falciparum. Recent vaccine trials in macaques using the P. knowlesi orthologue PkAMA1 have shown that it protects against infection by this parasite species and thus should be developed for human vaccination as well. Here, we present the crystal structure of Domains 1 and 2 of the PkAMA1 ectodomain, and of its complex with the invasion-inhibitory monoclonal antibody R31C2. The Domain 2 (D2) loop, which is displaced upon binding the Rhoptry Neck Protein 2 (RON2) receptor, makes significant contacts with the antibody. R31C2 inhibits binding of the Rhoptry Neck Protein 2 (RON2) receptor by steric blocking of the hydrophobic groove and by preventing the displacement of the D2 loop which is essential for exposing the complete binding site on AMA1. R31C2 recognizes a non-polymorphic epitope and should thus be cross-strain reactive. PkAMA1 is much less polymorphic than the P. falciparum and P. vivax orthologues. Unlike these two latter species, there are no polymorphic sites close to the RON2-binding site of PkAMA1, suggesting that P. knowlesi has not developed a mechanism of immune escape from the host's humoral response to AMA1.	[Vulliez-Le Normand, Brigitte; Saul, Frederick A.; Bentley, Graham A.] Inst Pasteur, Unite Immunol Struct, Dept Biol Struct & Chim, Paris, France; [Vulliez-Le Normand, Brigitte; Saul, Frederick A.; Bentley, Graham A.] CNRS, URA 2185, Paris, France; [Faber, Bart W.; van der Eijk, Marjolein; Thomas, Alan W.; Kocken, Clemens H. M.] Biomed Primate Res Ctr, Dept Parasitol, Rijswijk, Netherlands; [Singh, Balbir] Univ Malaysia Sarawak, Malaria Res Ctr, Fac Med & Hlth Sci, Kuching, Sarawak, Malaysia	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); University of Malaysia Sarawak	Vulliez-Le Normand, B (corresponding author), Univ Paris Diderot, Unite Microbiol Struct, Dept Biol Struct & Chim, Inst Pasteur,CNRS,UMR 3528,Sorbonne Paris Cite,Mi, Paris, France.	bvulliez@pasteur.fr; faber@bprc.nl	Singh, Balbir/A-3610-2009	Singh, Balbir/0000-0002-9143-3965; Faber, Bart/0000-0001-6808-1204; Kocken, Clemens/0000-0002-4784-1734	European Commission (EUROMALVAV2) [QLK2- CT-2002-01197]; European Commission (EviMalaR); European Commission (E(M)VI); European Commission (EMVDA) [LSHP-CT-2007-037506]; Pasteur Institute; Centre National de la Recherche Scientifique; Biomedical Primate Research Centre; Universiti Malaysia Sarawak [01 (TD03)/1003/2013(01), E14054/F05/54/PKI/09/2012(01)]	European Commission (EUROMALVAV2); European Commission (EviMalaR)(European CommissionEuropean Commission Joint Research Centre); European Commission (E(M)VI); European Commission (EMVDA); Pasteur Institute; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Biomedical Primate Research Centre; Universiti Malaysia Sarawak	This work was funded by the European Commission (EUROMALVAV2 contract QLK2- CT-2002-01197, EviMalaR, E(M)VI and EMVDA grant LSHP-CT-2007-037506), the Pasteur Institute, the Centre National de la Recherche Scientifique, the Biomedical Primate Research Centre and the Universiti Malaysia Sarawak (grant numbers 01 (TD03)/1003/2013(01) and E14054/F05/54/PKI/09/2012(01)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Anders RF, 1998, VACCINE, V16, P240, DOI 10.1016/S0264-410X(97)88331-4; Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506; Bai T, 2005, P NATL ACAD SCI USA, V102, P12736, DOI 10.1073/pnas.0501808102; Bannister LH, 2003, J CELL SCI, V116, P3825, DOI 10.1242/jcs.00665; Bargieri D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004273; Besteiro S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000309; Bricogne G, 2011, BUSTER VERSIONS 2 9; Cao J, 2009, PARASITOL INT, V58, P29, DOI 10.1016/j.parint.2008.09.005; Chesne-Seck ML, 2005, MOL BIOCHEM PARASIT, V144, P55, DOI 10.1016/j.molbiopara.2005.07.007; Coley AM, 2007, PLOS PATHOG, V3, P1308, DOI 10.1371/journal.ppat.0030138; Collins CR, 2007, J BIOL CHEM, V282, P7431, DOI 10.1074/jbc.M610562200; Cox-Singh J, 2008, CLIN INFECT DIS, V46, P165, DOI 10.1086/524888; Crawford J, 2010, J BIOL CHEM, V285, P15644, DOI 10.1074/jbc.M109.092619; Daneshvar C, 2009, CLIN INFECT DIS, V49, P852, DOI 10.1086/605439; De Lano W, 2015, PYMOL MOL GRAPHICS S; DEANS JA, 1982, CLIN EXP IMMUNOL, V49, P297; DEANS JA, 1988, PARASITE IMMUNOL, V10, P535, DOI 10.1111/j.1365-3024.1988.tb00241.x; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Faber BW, 2015, GENE; Figtree M, 2000, MOL BIOCHEM PARASIT, V108, P53, DOI 10.1016/S0166-6851(00)00204-8; Gaffar FR, 2004, INFECT IMMUN, V72, P2947, DOI 10.1128/IAI.72.5.2947-2955.2004; Giovannini D, 2011, CELL HOST MICROBE, V10, P591, DOI 10.1016/j.chom.2011.10.012; Hamid MMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020547; Harvey KL, 2014, INT J PARASITOL, V44, P853, DOI 10.1016/j.ijpara.2014.08.001; Hehl AB, 2000, INFECT IMMUN, V68, P7078, DOI 10.1128/IAI.68.12.7078-7086.2000; Henderson KA, 2007, STRUCTURE, V15, P1452, DOI 10.1016/j.str.2007.09.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lamarque M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001276; Lamarque MH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5098; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Lebrun M, 2005, CELL MICROBIOL, V7, P1823, DOI 10.1111/j.1462-5822.2005.00646.x; Lefranc MP, 2015, NUCLEIC ACIDS RES, V43, pD413, DOI 10.1093/nar/gku1056; Malkin EM, 2005, INFECT IMMUN, V73, P3677, DOI 10.1128/IAI.73.6.3677-3685.2005; Marshall VM, 1996, MOL BIOCHEM PARASIT, V77, P109, DOI 10.1016/0166-6851(96)02583-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mitchell GH, 2004, INFECT IMMUN, V72, P154, DOI 10.1128/IAI.72.1.154-158.2004; Moon SU, 2010, ACTA TROP, V114, P71, DOI 10.1016/j.actatropica.2010.01.006; Narum DL, 2000, INFECT IMMUN, V68, P2899, DOI 10.1128/IAI.68.5.2899-2906.2000; Oliveira DA, 1996, MOL BIOCHEM PARASIT, V76, P333, DOI 10.1016/0166-6851(95)02548-0; Pizarro JC, 2005, SCIENCE, V308, P408, DOI 10.1126/science.1107449; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Singh B, 2013, CLIN MICROBIOL REV, V26, P165, DOI 10.1128/CMR.00079-12; Srinivasan P, 2001, P NATL ACAD SCI USA, V108, P13275; Stowers AW, 2002, INFECT IMMUN, V70, P6961, DOI 10.1128/IAI.70.12.6961-6967.2002; Thakur A, 2008, GENE, V419, P35, DOI 10.1016/j.gene.2008.04.012; Thera MA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001465; THOMAS AW, 1984, MOL BIOCHEM PARASIT, V13, P187, DOI 10.1016/0166-6851(84)90112-9; Tonkin ML, 2013, PROTEIN SCI, V22, P114, DOI 10.1002/pro.2193; Tonkin ML, 2011, SCIENCE, V333, P463, DOI 10.1126/science.1204988; Vulliez-Le Normand B, 2004, ACTA CRYSTALLOGR D, V60, P2040, DOI 10.1107/S090744490402116X; Vulliez-Le Normand B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002755; WATERS AP, 1990, J BIOL CHEM, V265, P17974; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	58	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123567	10.1371/journal.pone.0123567	http://dx.doi.org/10.1371/journal.pone.0123567			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886591	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000074
J	Grizard, S; Versteegh, MA; Ndithia, HK; Salles, JF; Tieleman, BI				Grizard, Stephanie; Versteegh, Maaike A.; Ndithia, Henry K.; Salles, Joana F.; Tieleman, B. Irene			Shifts in Bacterial Communities of Eggshells and Antimicrobial Activities in Eggs during Incubation in a Ground-Nesting Passerine	PLOS ONE			English	Article							MICROBIAL DIVERSITY; PIED FLYCATCHERS; BARN SWALLOW; LIFE-HISTORY; SHELF-LIFE; AVIAN EGG; TEMPERATURE; BIRDS; PROTEINS; EMBRYO	Microbial invasion of egg contents is a cause of embryonic death. To counter infection risks, the embryo is protected physically by the eggshell and chemically by antimicrobial proteins. If microbial pressure drives embryo mortality, then females may have evolved, through natural selection, to adapt their immune investment into eggs. Although frequently hypothesized, this match between immune allocation and microorganisms has not been explored yet. To examine if correlations between microbes on eggs and immunity in eggs exist, we collected eggs from red-capped larks (Calandrella cinerea) and simultaneously examined their bacterial communities and antimicrobial components-pH, lysozyme and ovotransferrin-during natural incubation. Using molecular techniques, we find that bacterial communities are highly dynamic: bacterial abundance increases from the onset to late incubation, Shannon's a-diversity index increases during early incubation stages, and beta-diversity analysis shows that communities from 1 day-old clutches are phylogenetically more similar to each other than the older ones. Regarding the antimicrobials, we notice a decrease of pH and lysozyme concentration, while ovotransferrin concentration increases during incubation. Interestingly, we show that two eggs of the same clutch share equivalent immune protection, independent of clutch age. Lastly, our results provide limited evidence of significant correlation between antimicrobial compounds and bacterial communities. Our study examined simultaneously, for the first time in a wild bird, the dynamics of bacterial communities present on eggshells and of albumen-associated antimicrobial components during incubation and investigated their relationship. However, the link between microorganisms and immunity of eggs remains to be elucidated further. Identifying invading microbes and their roles in embryo mortality, as well as understanding the role of the eggshell microbiome, might be key to better understand avian strategies of immune maternal investment.	[Grizard, Stephanie; Versteegh, Maaike A.; Ndithia, Henry K.; Tieleman, B. Irene] Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands; [Grizard, Stephanie; Salles, Joana F.] Univ Groningen, Ctr Ecol & Evolutionary Studies, Dept Microbial Ecol, Groningen, Netherlands; [Ndithia, Henry K.] Natl Museums Kenya, Ornithol Sect, Dept Zool, Nairobi, Kenya	University of Groningen; University of Groningen	Grizard, S (corresponding author), Univ Groningen, Ctr Ecol & Evolutionary Studies, Anim Ecol Grp, Groningen, Netherlands.	s.grizard@rug.nl	Falcao Salles, Joana/A-7313-2008; Salles, Joana Falcao/AAG-7070-2020	Falcao Salles, Joana/0000-0003-4317-7263; Salles, Joana Falcao/0000-0003-4317-7263	Netherlands Organisation for Scientific Research	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	Financial support was provided by a VIDI grant from the Netherlands Organisation for Scientific Research (to BIT).	AR A, 1980, AM ZOOL, V20, P373; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bedrani L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-128; Beissinger SR, 2005, ECOLOGY, V86, P2164, DOI 10.1890/04-1624; Berg G, 2005, ENVIRON MICROBIOL, V7, P1673, DOI 10.1111/j.1462-2920.2005.00891.x; Bisson IA, 2007, MICROB ECOL, V54, P65, DOI 10.1007/s00248-006-9173-2; Board R.G., 1995, EGG SCI TECHNOLOGY, V4th, P81; BOARD RG, 1974, BIOL REV, V49, P15, DOI 10.1111/j.1469-185X.1974.tb01297.x; BOARD RG, 1982, BIOL REV, V57, P1, DOI 10.1111/j.1469-185X.1982.tb00362.x; Bonisoli-Alquati A, 2010, BEHAV ECOL SOCIOBIOL, V64, P845, DOI 10.1007/s00265-010-0901-8; BROOKS J, 1959, BIOCHIM BIOPHYS ACTA, V32, P237, DOI 10.1016/0006-3002(59)90574-8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Clarke A, 2008, FUNCT ECOL, V22, P58, DOI 10.1111/j.1365-2435.2007.01341.x; Cook MI, 2005, ECOL LETT, V8, P532, DOI 10.1111/j.1461-0248.2005.00748.x; Cook MI, 2005, BEHAV ECOL, V16, P30, DOI 10.1093/beheco/arh131; Cook MI, 2003, P ROY SOC B-BIOL SCI, V270, P2233, DOI 10.1098/rspb.2003.2508; Cucco M, 2011, ETHOL ECOL EVOL, V23, P343, DOI 10.1080/03949370.2011.584565; Cucco M, 2007, COMP BIOCHEM PHYS A, V147, P1038, DOI 10.1016/j.cbpa.2007.03.014; CUNNINGHAM FE, 1974, POULTRY SCI, V53, P1561, DOI 10.3382/ps.0531561; D'Alba L, 2010, NATURWISSENSCHAFTEN, V97, P1089, DOI 10.1007/s00114-010-0735-2; Del Hoyo J, 2004, HDB BIRDS WORLD CONT, V9; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Fang J, 2012, ITAL J ANIM SCI, V11, DOI 10.4081/ijas.2012.e17; Fang J, 2012, J FOOD AGRIC ENVIRON, V10, P423; Garbeva P, 2006, ENVIRON MICROBIOL, V8, P233, DOI 10.1111/j.1462-2920.2005.00888.x; Giraudeau M, 2014, J ORNITHOL, V155, P671, DOI 10.1007/s10336-014-1050-z; Godard RD, 2007, J AVIAN BIOL, V38, P709, DOI 10.1111/j.0908-8857.2007.04052.x; Goodenough AE, 2012, MICROB ECOL, V63, P986, DOI 10.1007/s00248-011-9992-7; Goodenough AE, 2010, MICROB ECOL, V59, P221, DOI 10.1007/s00248-009-9591-z; Grizard S, 2014, ECOL EVOL, V4, P1140, DOI 10.1002/ece3.1011; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; He XS, 2014, ISME J, V8, P564, DOI 10.1038/ismej.2013.172; Horrocks NPC, 2014, FRONT ZOOL, V11, DOI 10.1186/1742-9994-11-49; Horrocks NPC, 2012, PHYSIOL BIOCHEM ZOOL, V85, P504, DOI 10.1086/666988; Horrocks NPC, 2011, METHODS ECOL EVOL, V2, P518, DOI 10.1111/j.2041-210X.2011.00096.x; Javurkova V, 2014, IBIS, V156, P374, DOI 10.1111/ibi.12126; KATO A, 1975, AGR BIOL CHEM TOKYO, V39, P541, DOI 10.1080/00021369.1975.10861614; Ko KY, 2009, POULTRY SCI, V88, P406, DOI 10.3382/ps.2008-00218; Lee WY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103959; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Lozupone C, 2011, ISME J, V5, P169, DOI 10.1038/ismej.2010.133; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Peralta-Sanchez JM, 2014, MICROB ECOL, V67, P480, DOI 10.1007/s00248-013-0338-5; Peralta-Sanchez JM, 2012, IBIS, V154, P725, DOI 10.1111/j.1474-919X.2012.01256.x; Mine Y, 2003, J AGR FOOD CHEM, V51, P249, DOI 10.1021/jf020597x; Monteiro RA, 2012, PLANT SOIL, V356, P175, DOI 10.1007/s11104-012-1125-7; Pinheiro J., 2011, R PACKAGE VERSION, V3, P1; Potter Beth A., 2013, Open Ornithology Journal, V6, P32; PRINZINGER R, 1991, COMP BIOCHEM PHYS A, V99, P499, DOI 10.1016/0300-9629(91)90122-S; R Development Core Team, 2013, R LANG ENV STAT COMP, DOI [10.3758/s13428-013-0330-5, DOI 10.3758/S13428-013-0330-5]; Reijrink IAM, 2008, WORLD POULTRY SCI J, V64, P581, DOI 10.1017/S0043933908000214; Ricklefs Robert E., 1998, Oxford Ornithology Series, V8, P31; Romanoff AL, 1929, BIOL BULL-US, V57, P300, DOI 10.2307/1537038; Rosconi F, 2013, ENVIRON MICROBIOL, V15, P916, DOI 10.1111/1462-2920.12075; Ruiz-De-Castaneda R, 2011, BEHAV PROCESS, V88, P142, DOI 10.1016/j.beproc.2011.08.012; Ruiz-de-Castaneda R, 2011, J ZOO WILDLIFE MED, V42, P313, DOI 10.1638/2010-0056.1; Ruiz-de-Castaneda R, 2011, J FIELD ORNITHOL, V82, P215, DOI 10.1111/j.1557-9263.2011.00324.x; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; Saino N, 2004, FUNCT ECOL, V18, P50, DOI 10.1046/j.0269-8463.2004.00808.x; Saino N, 2002, J EVOLUTION BIOL, V15, P735, DOI 10.1046/j.1420-9101.2002.00448.x; Shawkey MD, 2008, BEHAV ECOL, V19, P920, DOI 10.1093/beheco/arn019; Shawkey MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004522; Shawkey MD, 2005, MICROB ECOL, V50, P40, DOI 10.1007/s00248-004-0089-4; Soler Juan Jose, 2010, Open Ornithology Journal, V3, P93, DOI 10.2174/1874453201003010093; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tieleman BI, 2004, FUNCT ECOL, V18, P571, DOI 10.1111/j.0269-8463.2004.00882.x; TRANTER HS, 1984, J APPL BACTERIOL, V56, P53, DOI 10.1111/j.1365-2672.1984.tb04696.x; Versteegh MA, 2008, COMP BIOCHEM PHYS A, V150, P452, DOI 10.1016/j.cbpa.2008.05.006; Wang JM, 2009, WILSON J ORNITHOL, V121, P512, DOI 10.1676/08-116.1; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wellman-Labadie O, 2007, WORLD POULTRY SCI J, V63, P421, DOI 10.1017/S0043933907001559; Wellman-Labadie O, 2008, COMP BIOCHEM PHYS B, V149, P640, DOI 10.1016/j.cbpb.2008.01.001; Wellman-Labadie O, 2008, PHYSIOL BIOCHEM ZOOL, V81, P235, DOI 10.1086/524149; Xin YH, 2009, INT J SYST EVOL MICR, V59, P139, DOI 10.1099/ijs.0.000547-0	76	20	21	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0121716	10.1371/journal.pone.0121716	http://dx.doi.org/10.1371/journal.pone.0121716			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880684	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500011
J	Lee, ZM; Steger, L; Corman, JR; Neveu, M; Poret-Peterson, AT; Souza, V; Elser, JJ				Lee, Zarraz M.; Steger, Laura; Corman, Jessica R.; Neveu, Marc; Poret-Peterson, Amisha T.; Souza, Valeria; Elser, James J.			Response of a Stoichiometrically Imbalanced Ecosystem to Manipulation of Nutrient Supplies and Ratios	PLOS ONE			English	Article							SHALLOW LAKES; FRESH-WATER; PHOSPHORUS LIMITATION; CUATRO CIENEGAS; NITROGEN; EUTROPHICATION; PHYTOPLANKTON; TERRESTRIAL; COMMUNITIES; WETLANDS	Cuatro Cienegas Basin (CCB) is a desert ecosystem that hosts a large diversity of water bodies. Many surface waters in this basin have imbalanced nitrogen (N) to phosphorus (P) stoichiometry (total N:P > 100 by atoms), where P is likely to be a limiting nutrient. To investigate the effects of nutrient stoichiometry on planktonic and sediment ecosystem components and processes, we conducted a replicated in situ mesocosm experiment in Lagunita, a shallow pond located in the southwest region of the basin. Inorganic N and P were periodically added to mesocosms under three different N:P regimes (P only, N:P = 16 and N:P = 75) while the control mesocosms were left unamended. After three weeks of fertilization, more than two thirds of the applied P was immobilized into seston or sediment. The rapid uptake of P significantly decreased biomass C:P and N:P ratios, supporting the hypothesis that Lagunita is P-limited. Meanwhile, simultaneous N and P enrichment significantly enhanced planktonic growth, increasing total planktonic biomass by more than 2-fold compared to the unenriched control. With up to 76% of added N sequestered into the seston, it is suspected that the Lagunita microbial community also experienced strong N-limitation. However, when N and P were applied at N:P = 75, the microbes remained in a P-limitation state as in the untreated control. Two weeks after the last fertilizer application, seston C:P and N:P ratios returned to initial levels but chlorophyll a and seston C concentrations remained elevated. Additionally, no P release from the sediment was observed in the fertilized mesocosms. Overall, this study provides evidence that Lagunita is highly sensitive to nutrient perturbation because the biota is primarily P-limited and experiences a secondary N-limitation despite its high TN:TP ratio. This study serves as a strong basis to justify the need for protection of CCB ecosystems and other low-nutrient microbe-dominated systems from anthropogenic inputs of both N and P.	[Lee, Zarraz M.; Steger, Laura; Corman, Jessica R.; Elser, James J.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Neveu, Marc; Poret-Peterson, Amisha T.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ USA; [Souza, Valeria] Univ Nacl Autonoma Mexico, Inst Ecol, Dept Ecol Evolut, Mexico City 04510, DF, Mexico	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Universidad Nacional Autonoma de Mexico	Lee, ZM (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	leezarraz@gmail.com	Elser, James J/AAL-6199-2020; LEE, ZARRAZ/AAK-7459-2020; Elser, James/A-7082-2008; Neveu, Marc/H-4766-2019	Elser, James J/0000-0002-1460-2155; Elser, James/0000-0002-1460-2155; Neveu, Marc/0000-0002-6220-2869; souza, valeria/0000-0002-2992-4229; Poret-Peterson, Amisha/0000-0002-7329-5175; Corman, Jessica/0000-0002-2633-8080	U.S. National Science Foundation (NSF) grant [DEB-0950175]; National Aeronautics and Space Administration Astrobiology (NASA) grant [NAI5-0018]; Direct For Biological Sciences [0950179] Funding Source: National Science Foundation	U.S. National Science Foundation (NSF) grant(National Science Foundation (NSF)); National Aeronautics and Space Administration Astrobiology (NASA) grant; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study was funded by the U.S. National Science Foundation (NSF) grant DEB-0950175 and the National Aeronautics and Space Administration Astrobiology (NASA) grant NAI5-0018 awarded to JJE.	American Public Health Association (APHA), 2005, STANDARD METHODS EXA; Arar E.J., 1997, 4450 US ENV PROT AG; Bergstrom AK, 2010, AQUAT SCI, V72, P277, DOI 10.1007/s00027-010-0132-0; Breitbart M, 2009, ENVIRON MICROBIOL, V11, P16, DOI 10.1111/j.1462-2920.2008.01725.x; Bronk DA, 2007, BIOGEOSCIENCES, V4, P283, DOI 10.5194/bg-4-283-2007; Bushaw KL, 1996, NATURE, V381, P404, DOI 10.1038/381404a0; COLE JJ, 1990, LIMNOL OCEANOGR, V35, P1230, DOI 10.4319/lo.1990.35.6.1230; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Dittrich M, 2002, HYDROBIOLOGIA, V469, P49, DOI 10.1023/A:1015571410442; DOWNING JA, 1992, LIMNOL OCEANOGR, V37, P936, DOI 10.4319/lo.1992.37.5.0936; Edwards GP, 1965, J AM WATER WORKS ASS, V57, P917, DOI DOI 10.1002/J.1551-8833.1965.TB01479.X; Elser JJ, 2007, ECOL LETT, V10, P1135, DOI 10.1111/j.1461-0248.2007.01113.x; Elser JJ, 2009, SCIENCE, V326, P835, DOI 10.1126/science.1176199; Elser JJ, 2005, FRESHWATER BIOL, V50, P1808, DOI 10.1111/j.1365-2427.2005.01451.x; Elser JJ, 2000, ECOSYSTEMS, V3, P293, DOI 10.1007/s100210000027; ELSER JJ, 1990, CAN J FISH AQUAT SCI, V47, P1468, DOI 10.1139/f90-165; Evans S.B., 2005, USING CHEM DATA DEFI; Havens KE, 1999, FRESHWATER BIOL, V42, P329, DOI 10.1046/j.1365-2427.1999.444479.x; HOLLIS GE, 1990, HYDROLOG SCI J, V35, P411, DOI 10.1080/02626669009492443; JANSSON M, 1994, AMBIO, V23, P320; Jeppesen E, 2007, HYDROBIOLOGIA, V581, P269, DOI 10.1007/s10750-006-0507-3; Lewis WM, 2008, INT REV HYDROBIOL, V93, P446, DOI 10.1002/iroh.200811065; Lopez-Lozano NE, 2012, ASTROBIOLOGY, V12, P699, DOI 10.1089/ast.2012.0840; Moss B, 1997, HYDROBIOLOGIA, V342, P257, DOI 10.1023/A:1017059928028; Moss B, 2013, HYDROBIOLOGIA, V710, P3, DOI 10.1007/s10750-012-1033-0; Neveu M, 2014, LIMNOL OCEANOGR-METH, V12, P519, DOI 10.4319/lom.2014.12.519; R-Core-Team, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Ramos J, 2012, EC SOC AM 97 ANN M P; Schindler DW, 2006, LIMNOL OCEANOGR, V51, P356, DOI 10.4319/lo.2006.51.1_part_2.0356; Schindler DW, 2008, P NATL ACAD SCI USA, V105, P11254, DOI 10.1073/pnas.0805108105; Schindler DW, 2012, P ROY SOC B-BIOL SCI, V279, P4322, DOI 10.1098/rspb.2012.1032; Scott JT, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00042; Sondergaard M, 2003, HYDROBIOLOGIA, V506, P135, DOI 10.1023/B:HYDR.0000008611.12704.dd; Souza V, 2006, P NATL ACAD SCI USA, V103, P6565, DOI 10.1073/pnas.0601434103; Souza V., 2007, PROTECTING WINDOW AN; Souza V, 2008, NAT REV MICROBIOL, V6, P559, DOI 10.1038/nrmicro1917; Sterner RW, 1997, AM NAT, V150, P663, DOI 10.1086/286088; Stevens L. E., 2008, ARIDLAND SPRINGS N A; Taylor BW, 2007, J N AM BENTHOL SOC, V26, P167, DOI 10.1899/0887-3593(2007)26[167:ITFAMM]2.0.CO;2; Urabe J, 2002, ECOLOGY, V83, P619, DOI 10.2307/3071868; Williamson CE, 2008, FRONT ECOL ENVIRON, V6, P247, DOI 10.1890/070140	41	18	18	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123949	10.1371/journal.pone.0123949	http://dx.doi.org/10.1371/journal.pone.0123949			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881015	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500074
J	Alves, CRR; Borelli, MTC; Paineli, VD; Azevedo, RD; Borelli, CCG; Lancha, AH; Gualano, B; Artioli, GG				Rodrigues Alves, Christiano Robles; Caetano Borelli, Marcello Tadeu; Paineli, Vitor de Salles; Azevedo, Rafael de Almeida; Gomes Borelli, Claudia Cristine; Lancha Junior, Antonio Herbert; Gualano, Bruno; Artioli, Guilherme Giannini			Development of a Specific Anaerobic Field Test for Aerobic Gymnastics	PLOS ONE			English	Article							RHYTHMIC GYMNASTICS; RELIABILITY	The current investigation aimed to develop a valid specific field test to evaluate anaerobic physical performance in Aerobic Gymnastics athletes. We first designed the Specific Aerobic Gymnast Anaerobic Test (SAGAT), which included gymnastics-specific elements performed in maximal repeated sprint fashion, with a total duration of 80-90 s. In order to validate the SAGAT, three independent sub-studies were performed to evaluate the concurrent validity (Study I, n=8), the reliability (Study II, n=10) and the sensitivity (Study III, n=30) of the test in elite female athletes. In Study I, a positive correlation was shown between lower-body Wingate test and SAGAT performance (Mean power: p = 0.03, r = -0.69, CI: -0.94 to 0.03 and Peak power: p = 0.02, r = -0.72, CI: -0.95 to -0.04) and between upper-body Wingate test and SAGAT performance (Mean power: p = 0.03, r = -0.67, CI: -0.94 to 0.02 and Peak power: p = 0.03, r = -0.69, CI: -0.94 to 0.03). Additionally, plasma lactate was similarly increased in response to SAGAT (p = 0.002), lower-body Wingate Test (p = 0.021) and a simulated competition (p = 0.007). In Study II, no differences were found between the time to complete the SAGAT in repeated trials (p = 0.84; Cohen's d effect size = 0.09; ICC = 0.97, CI: 0.89 to 0.99; MDC95 = 0.12 s). Finally, in Study III the time to complete the SAGAT was significantly lower during the competition cycle when compared to the period before the preparatory cycle (p < 0.001), showing an improvement in SAGAT performance after a specific Aerobic Gymnastics training period. Taken together, these data have demonstrated that SAGAT is a specific, reliable and sensitive measurement of specific anaerobic performance in elite female Aerobic Gymnastics, presenting great potential to be largely applied in training settings.	[Rodrigues Alves, Christiano Robles; Paineli, Vitor de Salles; Azevedo, Rafael de Almeida; Lancha Junior, Antonio Herbert; Gualano, Bruno; Artioli, Guilherme Giannini] Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil; [Caetano Borelli, Marcello Tadeu; Gomes Borelli, Claudia Cristine] Sociedade Esportiva Palmeiras, Aerobic Gymnast Dept, Sao Paulo, SP, Brazil	Universidade de Sao Paulo	Alves, CRR (corresponding author), Univ Sao Paulo, Sch Phys Educ & Sport, Sao Paulo, SP, Brazil.	christiano.alves@usp.br	Artioli, Guilherme Giannini/K-5925-2013; Alves, Christiano RR/C-5912-2013; Gualano, Bruno/ABA-9571-2020; Gualano, Bruno/C-7190-2012; Lancha, Antonio Herbert/C-9130-2012	Artioli, Guilherme Giannini/0000-0001-8463-2213; Alves, Christiano RR/0000-0002-2646-9689; Gualano, Bruno/0000-0001-7100-8681; Gualano, Bruno/0000-0001-7100-8681; Lancha, Antonio Herbert/0000-0003-2128-1182				[Anonymous], 2009, ARCH SEX BEHAV, DOI DOI 10.1007/s10508-008-9314-4; Barker AR, 2011, MED SPORT SCI, V56, P106, DOI 10.1159/000320642; Brooks TJ, 2003, STRENGTH COND J, V25, P23, DOI 10.1519/1533-4295(2003)025<0023:WCGAMA>2.0.CO;2; Currell K, 2008, SPORTS MED, V38, P297, DOI 10.2165/00007256-200838040-00003; Deutz RC, 2000, MED SCI SPORT EXER, V32, P659, DOI 10.1097/00005768-200003000-00017; Douda HT, 2008, INTJ SPORT PHYSIOL, V3, P41, DOI 10.1123/ijspp.3.1.41; French DN, 2004, J STRENGTH COND RES, V18, P101; Guidetti L, 2000, INT J SPORTS MED, V21, P205, DOI 10.1055/s-2000-8879; INBAR O, 1986, MED SCI SPORT EXER, V18, P264, DOI 10.1249/00005768-198606000-00002; Jemni M, 2003, CAN J APPL PHYSIOL, V28, P240, DOI 10.1139/h03-019; Jemni M, 2006, J STRENGTH COND RES, V20, P899; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Prassas S, 2006, SPORT BIOMECH, V5, P261, DOI 10.1080/14763140608522878; Vicente-Rodriguez G, 2007, INT J SPORTS MED, V28, P386, DOI 10.1055/s-2006-924397; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Wonisch M, 2003, BRIT J SPORT MED, V37, P115, DOI 10.1136/bjsm.37.2.115	16	6	7	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123115	10.1371/journal.pone.0123115	http://dx.doi.org/10.1371/journal.pone.0123115			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876039	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100136
J	Cerqueira, B; Arenas-Lago, D; Andrade, ML; Vega, FA				Cerqueira, Beatriz; Arenas-Lago, Daniel; Luisa Andrade, Maria; Vega, Flora A.			Validation of TOF-SIMS and FE-SEM/EDS Techniques Combined with Sorption and Desorption Experiments to Check Competitive and Individual Pb2+ and Cd2+ Association with Components of B Soil Horizons	PLOS ONE			English	Article							HEAVY-METALS; SEQUENTIAL EXTRACTION; LEAD; CADMIUM; ADSORPTION; RETENTION; MOBILITY; COPPER; AREA; FRACTIONATION	Sorption and desorption experiments were performed by the batch method on the B horizons of five natural soils: Umbric Cambisol, Endoleptic Luvisol, Mollic Umbrisol, Dystric Umbrisol, and Dystric Fluvisol. Individual and competitive sorption and desorption capacity and hysteresis were determined. The results showed that Pb2+ was sorbed and retained in a greater quantity than Cd2+ and that the hysteresis of the first was greater than that of the second. The most influential characteristics of the sorption and retention of Pb2+ were pH, ECEC, Fe and Mn oxides and clay contents. For Cd2+ they were mainly pH and, to a lesser extent, Mn oxides and clay content. The combined use of TOF-SIMS, FE-SEM/EDS and sorption and desorption analyses was suitable for achieving a better understanding of the interaction between soil components and the two heavy metals. They show the preferential association of Pb2+ with vermiculite, chlorite, Fe and Mn oxides, and of Cd2+ with the same components, although to a much lesser extent and intensity. This was due to the latter's higher mobility as it competed unfavourably with the Pb2+ sorption sites. TOF-SIMS and FE-SEM/EDS techniques confirmed the results of the sorption experiments, and also provided valuable information on whether the soil components (individually or in association) retain Cd2+ and / or Pb2+; this could help to propose effective measures for the remediation of contaminated soils.	[Cerqueira, Beatriz; Arenas-Lago, Daniel; Luisa Andrade, Maria; Vega, Flora A.] Univ Vigo, Fac Biol, Dept Plant Biol & Soil Sci, Vigo 36310, Pontevedra, Spain	Universidade de Vigo	Arenas-Lago, D (corresponding author), Univ Vigo, Fac Biol, Dept Plant Biol & Soil Sci, Vigo 36310, Pontevedra, Spain.	darenas@uvigo.es	Alonso Vega, Flora/F-3429-2012; Arenas-Lago, Daniel/K-3308-2015	Arenas-Lago, Daniel/0000-0002-9036-2181; Cerqueira, Beatriz/0000-0002-2293-3982; A. Vega, Flora/0000-0001-9454-5519	Xunta de Galicia [EM2013/18]	Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This research was supported by Project EM2013/18 (Xunta de Galicia). F.A. Vega is hired under a Ramon y Cajal contract at the University of Vigo. D. Arenas-Lago is grateful to the Spanish Ministry of Science and Innovation and the University of Vigo for the FPI-MICINN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriano D.C., 2001, TRACE ELEMENTS TERRE, V2nd Edn, P264, DOI DOI 10.1007/978-0-387-21510-5_8; Ahmadipour F, 2014, CHEM SPEC BIOAVAILAB, V26, P31, DOI 10.3184/095422914X13884321932037; Alloway BJ., 1995, HEAVY METALS SOILS B, P368, DOI [10.1007/978-94-011-1344-1, DOI 10.1007/978-94-011-1344-1]; [Anonymous], 1998, 1484 UNEEN; Arenas-Lago D, 2014, GEODERMA, V230, P108, DOI 10.1016/j.geoderma.2014.04.011; Businelli D, 2009, SOIL SCI, V174, P380, DOI 10.1097/SS.0b013e3181ac6786; Cerqueira B, 2011, PEDOSPHERE, V21, P603, DOI 10.1016/S1002-0160(11)60162-8; Cerqueira B, 2011, J HAZARD MATER, V195, P422, DOI 10.1016/j.jhazmat.2011.08.059; CHUNG FH, 1974, J APPL CRYSTALLOGR, V7, P519, DOI 10.1107/S0021889874010375; Cipakova A, 2011, J RADIOANAL NUCL CH, V287, P157, DOI 10.1007/s10967-010-0667-5; Covelo EF, 2008, J HAZARD MATER, V159, P342, DOI 10.1016/j.jhazmat.2008.02.025; Covelo EF, 2004, J COLLOID INTERF SCI, V280, P1, DOI 10.1016/j.jcis.2004.07.024; Covelo EF, 2004, J HAZARD MATER, V143, P419; D'Emilio M, 2013, ENVIRON MONIT ASSESS, V185, P5951, DOI 10.1007/s10661-012-2997-y; Day P.R., 1965, METHODS SOIL ANAL PA, V9, P545, DOI [10.2134/agronmonogr9.1.c43, DOI 10.2134/AGRONMONOGR9.1.C43]; Fontes MPF, 2003, APPL GEOCHEM, V18, P795, DOI 10.1016/S0883-2927(02)00188-9; Galunin E, 2014, J HAZARD MATER, V265, P280, DOI 10.1016/j.jhazmat.2013.11.010; Gamino-Gutierrez SP, 2013, ENVIRON GEOCHEM HLTH, V35, P37, DOI 10.1007/s10653-012-9469-8; GILES CH, 1974, J COLLOID INTERF SCI, V47, P755, DOI 10.1016/0021-9797(74)90252-5; Gomes PC, 2001, SOIL SCI SOC AM J, V65, P1115, DOI 10.2136/sssaj2001.6541115x; Gurel A, 2006, ENVIRON GEOL, V51, P333, DOI 10.1007/s00254-006-0329-7; HENDERSHOT WH, 1986, SOIL SCI SOC AM J, V50, P605, DOI 10.2136/sssaj1986.03615995005000030013x; Huang ZY, 2012, ENVIRON GEOCHEM HLTH, V34, P55, DOI 10.1007/s10653-011-9390-6; IUSS, 2014, WORLD SOIL RES REP, V106; Kabata-Pendias Alina, 2010, P1; Lair GJ, 2007, ENVIRON CHEM LETT, V5, P23, DOI 10.1007/s10311-006-0059-9; Li TQ, 2013, ENVIRON EARTH SCI, V68, P1599, DOI 10.1007/s12665-012-1853-2; MCKEAGUE JA, 1966, CAN J SOIL SCI, V46, P13, DOI 10.4141/cjss66-003; Pathak P, 2014, J HAZARD TOXIC RADIO, V18, P64, DOI 10.1061/(ASCE)HZ.2153-5515.0000199; Putz H., KREUZHERRENSTR, V102; Shaheen SM, 2013, ADV COLLOID INTERFAC, V201, P43, DOI 10.1016/j.cis.2013.10.005; Shaheen SM, 2009, GEODERMA, V153, P61, DOI 10.1016/j.geoderma.2009.07.017; Sherdrick ~ BH, 1975, CAN J SOIL SCI, V55, P77, DOI DOI 10.4141/CJSS75-012; Sipos P, 2009, J HAZARD MATER, V168, P1512, DOI 10.1016/j.jhazmat.2009.03.033; SLATTERY WJ, 1999, SOIL ANAL INTERPRETA, P103; US Soil Conservation Service, 1972, 1 US SOIL CONS SERV; Vega FA, 2008, J COLLOID INTERF SCI, V327, P275, DOI 10.1016/j.jcis.2008.08.027; Vega FA, 2010, J HAZARD MATER, V174, P522, DOI 10.1016/j.jhazmat.2009.09.083; Vega FA, 2009, J COLLOID INTERF SCI, V331, P312, DOI 10.1016/j.jcis.2008.11.047; Zheng SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049664	40	6	6	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123977	10.1371/journal.pone.0123977	http://dx.doi.org/10.1371/journal.pone.0123977			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893518	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700067
J	Dickey, AM; Kumar, V; Hoddle, MS; Funderburk, JE; Morgan, JK; Jara-Cavieres, A; Shatters, RGJ; Osborne, LS; McKenzie, CL				Dickey, Aaron M.; Kumar, Vivek; Hoddle, Mark S.; Funderburk, Joe E.; Morgan, J. Kent; Jara-Cavieres, Antonella; Shatters, Robert G. Jr.; Osborne, Lance S.; McKenzie, Cindy L.			The Scirtothrips dorsalis Species Complex: Endemism and Invasion in a Global Pest	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MITOCHONDRIAL-DNA; THYSANOPTERA THRIPIDAE; POPULATION-GROWTH; MOLECULAR CHARACTERIZATION; STATISTICAL TESTS; SPOT VIRUS; HOOD; IDENTIFICATION; NEUTRALITY	Invasive arthropods pose unique management challenges in various environments, the first of which is correct identification. This apparently mundane task is particularly difficult if multiple species are morphologically indistinguishable but accurate identification can be determined with DNA barcoding provided an adequate reference set is available. Scirtothrips dorsalis is a highly polyphagous plant pest with a rapidly expanding global distribution and this species, as currently recognized, may be comprised of cryptic species. Here we report the development of a comprehensive DNA barcode library for S. dorsalis and seven nuclear markers via next-generation sequencing for identification use within the complex. We also report the delimitation of nine cryptic species and two morphologically distinguishable species comprising the S. dorsalis species complex using histogram analysis of DNA barcodes, Bayesian phylogenetics, and the multi-species coalescent. One member of the complex, here designated the South Asia 1 cryptic species, is highly invasive, polyphagous, and likely the species implicated in tospovirus transmission. Two other species, South Asia 2, and East Asia 1 are also highly polyphagous and appear to be at an earlier stage of global invasion. The remaining members of the complex are regionally endemic, varying in their pest status and degree of polyphagy. In addition to patterns of invasion and endemism, our results provide a framework both for identifying members of the complex based on their DNA barcode, and for future species delimiting efforts.	[Dickey, Aaron M.; Kumar, Vivek; Osborne, Lance S.] Univ Florida, Mid Florida Res & Educ Ctr, Apopka, FL USA; [Dickey, Aaron M.; Kumar, Vivek; Morgan, J. Kent; Jara-Cavieres, Antonella; Shatters, Robert G. Jr.; McKenzie, Cindy L.] US Hort Res Lab, Ft Pierce, FL 34945 USA; [Hoddle, Mark S.] Univ Calif Riverside, Dept Entomol, Riverside, CA 92521 USA; [Hoddle, Mark S.] Univ Calif Riverside, Ctr Invas Species Res, Riverside, CA 92521 USA; [Funderburk, Joe E.] Univ Florida, North Florida Res & Educ Ctr, Quincy, FL USA; [Morgan, J. Kent; Shatters, Robert G. Jr.; McKenzie, Cindy L.] USDA ARS, Ft Pierce, FL USA; [Jara-Cavieres, Antonella] Univ Florida, Indian River Res & Educ Ctr, Ft Pierce, FL USA	State University System of Florida; University of Florida; University of California System; University of California Riverside; University of California System; University of California Riverside; State University System of Florida; University of Florida; United States Department of Agriculture (USDA); State University System of Florida; University of Florida	McKenzie, CL (corresponding author), US Hort Res Lab, Ft Pierce, FL 34945 USA.	Cindy.McKenzie@ars.usda.gov	Kumar, Vivek/B-8500-2011	Kumar, Vivek/0000-0003-1988-2536; Dickey, Aaron/0000-0003-1250-1390; Shatters, Robert/0000-0002-3903-772X	Floriculture and Nursery Research Initiative [402626]; USDA	Floriculture and Nursery Research Initiative; USDA(United States Department of Agriculture (USDA))	This research was partially funded by the Floriculture and Nursery Research Initiative, http:// www.ars.usda.gov/research/projects/projects.htm?ACCN_NO=402626. Additional funding was provided internally by the USDA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMIN PW, 1981, PLANT DIS, V65, P663, DOI 10.1094/PD-65-663; [Anonymous], 2012, EVOL BIOINFORM, V8, P1, DOI 10.4137/EBO.S8532; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CABI, 2013, INV SPEC COMP; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Campbell B., 2000, P59; Carolan JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029251; Chiemsombat P, 2008, ARCH VIROL, V153, P571, DOI 10.1007/s00705-007-0024-3; Chu FH, 2001, PHYTOPATHOLOGY, V91, P856, DOI 10.1094/PHYTO.2001.91.9.856; Cognato AI, 2005, AGR FOREST ENTOMOL, V7, P87, DOI 10.1111/j.1461-9555.2005.00243.x; Condamine FL, 2013, CLADISTICS, V29, P88, DOI 10.1111/j.1096-0031.2012.00412.x; Dickey AM, 2014, FLA ENTOMOL, V97, P362, DOI 10.1653/024.097.0204; Dickey AM, 2012, FLA ENTOMOL, V95, P790, DOI 10.1653/024.095.0336; Dinsdale A, 2010, ANN ENTOMOL SOC AM, V103, P196, DOI 10.1603/AN09061; Dowton M, 2014, SYST BIOL, V63, P639, DOI 10.1093/sysbio/syu028; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Farris RE, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.2601; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; GILBERT MJ, 1986, J ENTOMOL SOC S AFR, V49, P159; Gopal K., 2010, Archives of Phytopathology and Plant Protection, V43, P421, DOI 10.1080/03235400701850920; Hajibabaei M, 2006, MOL ECOL NOTES, V6, P959, DOI 10.1111/j.1471-8286.2006.01470.x; HARPENDING HC, 1994, HUM BIOL, V66, P591; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hoddle MS, 2008, ANN ENTOMOL SOC AM, V101, P491, DOI 10.1603/0013-8746(2008)101[491:RASOST]2.0.CO;2; Hoddle MS, 2008, FLA ENTOMOL, V91, P16, DOI 10.1653/0015-4040(2008)091[0016:SOFSST]2.0.CO;2; Hoddle MS, 2003, ZOOTAXA, V268, P1, DOI DOI 10.11646/ZOOTAXA.268.1.1; Ivanova NV, 2006, MOL ECOL NOTES, V6, P998, DOI 10.1111/j.1471-8286.2006.01428.x; Jinbo U, 2011, ENTOMOL SCI, V14, P107, DOI 10.1111/j.1479-8298.2011.00449.x; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kittler R, 2003, CURR BIOL, V13, P1414, DOI 10.1016/S0960-9822(03)00507-4; Kumar V, 2013, WEED PEST CONTROL CO, DOI [10.5772/55045, DOI 10.5772/55045]; Lanfear R, 2012, MOL BIOL EVOL, V29, P1695, DOI 10.1093/molbev/mss020; Leache AD, 2010, P ROY SOC B-BIOL SCI, V277, P3071, DOI 10.1098/rspb.2010.0662; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Lombaert E, 2011, MOL ECOL, V20, P4654, DOI 10.1111/j.1365-294X.2011.05322.x; MADDISON W.P., 2001, MESQUITE MODULAR SYS; Magnacca KN, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-174; Meissner H, 2005, EVALUATION POSSIBLE; Minamikawa J, 1960, TEA RES J, V16, P23; Morse JG, 2006, ANNU REV ENTOMOL, V51, P67, DOI 10.1146/annurev.ento.51.110104.151044; Mound LA, 2010, ZOOTAXA, P59; MOUND LA, 1981, B ENTOMOL RES, V71, P467, DOI 10.1017/S0007485300008488; Mound Laurence A., 2011, Zootaxa, V2786, P51; Nietschke BS, 2008, FLA ENTOMOL, V91, P79, DOI 10.1653/0015-4040(2008)091[0079:CPFSDT]2.0.CO;2; O Foighil D, 1998, MAR BIOL, V131, P497, DOI 10.1007/s002270050341; Papadopoulou A, 2010, MOL BIOL EVOL, V27, P1659, DOI 10.1093/molbev/msq051; Peccoud J, 2009, P NATL ACAD SCI USA, V106, P7495, DOI 10.1073/pnas.0811117106; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER VERSION 1 6; Rambaut A., 2007, FIGTREE GRAPHICAL VI; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Rannala B, 2013, GENETICS, V194, P245, DOI 10.1534/genetics.112.149039; Rebijith KB, 2012, ENTOMOL NEWS, V122, P201, DOI 10.3157/021.122.0301; Riley DG, 2011, J INTEGR PEST MANAG, V2, DOI 10.1603/IPM10020; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rozen S, 2000, Methods Mol Biol, V132, P365; Rubinoff D, 2006, CONSERV BIOL, V20, P1548, DOI 10.1111/j.1523-1739.2006.00542.x; Rugman-Jones PF, 2006, J ECON ENTOMOL, V99, P1813, DOI 10.1603/0022-0493-99.5.1813; Rugman-Jones PF, J EC ENTOMOL, V103, P877; Schenekar T, 2011, HEREDITY, V107, P511, DOI 10.1038/hdy.2011.48; Seal DR, 2006, CROP PROT, V25, P949, DOI 10.1016/j.cropro.2005.12.008; Seal DR, 2010, ENVIRON ENTOMOL, V39, P1389, DOI 10.1603/EN09236; Shao RF, 2003, MOL BIOL EVOL, V20, P1612, DOI 10.1093/molbev/msg176; Shao RF, 2003, MOL BIOL EVOL, V20, P362, DOI 10.1093/molbev/msg045; Simon C, 2006, ANNU REV ECOL EVOL S, V37, P545, DOI 10.1146/annurev.ecolsys.37.091305.110018; Smith MA, 2007, P NATL ACAD SCI USA, V104, P4967, DOI 10.1073/pnas.0700050104; Song H, 2008, P NATL ACAD SCI USA, V105, P13486, DOI 10.1073/pnas.0803076105; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Swofford DL., 2003, PAUP PHYLOGENETIC AN; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Toda S, 2002, B ENTOMOL RES, V92, P359, DOI 10.1079/BER2002177; Toda S, 2014, APPL ENTOMOL ZOOL, V49, P231, DOI 10.1007/s13355-013-0241-z; Venette RC, 2004, MINIRISK ASSESSMENT; Worner SP, 2006, J APPL ECOL, V43, P858, DOI 10.1111/j.1365-2664.2006.01202.x; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xia XH, 2009, PHYLOGENETIC HANDBOOK: A PRACTICAL APPROACH TO PHYLOGENETIC ANALYSIS AND HYPOTHESIS TESTING, 2ND EDITION, P615; Xie WG, 2011, SYST BIOL, V60, P150, DOI 10.1093/sysbio/syq085; Yang ZH, 2010, P NATL ACAD SCI USA, V107, P9264, DOI 10.1073/pnas.0913022107	86	38	43	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123747	10.1371/journal.pone.0123747	http://dx.doi.org/10.1371/journal.pone.0123747			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893251	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700052
J	Boivin, N; Baillargeon, J; Doss, PMIA; Roy, AP; Rangachari, M				Boivin, Nicolas; Baillargeon, Joanie; Doss, Prenitha Mercy Ignatius Arokia; Roy, Andree-Pascale; Rangachari, Manu			Interferon-beta Suppresses Murine Th1 Cell Function in the Absence of Antigen-Presenting Cells	PLOS ONE			English	Article							CHRONIC VIRAL-INFECTION; T-HELPER TYPE-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; RELAPSING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; IFN-BETA; TRANSCRIPTION FACTOR; GLATIRAMER ACETATE; TIM-3 EXPRESSION; I INTERFERON	Interferon (IFN)-beta is a front-line therapy for the treatment of the relapsing-remitting form of multiple sclerosis. However, its immunosuppressive mechanism of function remains incompletely understood. While it has been proposed that IFN-beta suppresses the function of inflammatory myelin antigen-reactive T cells by promoting the release of immunomodulatory cytokines such as IL-27 from antigen-presenting cells (APCs), its direct effects on inflammatory CD4(+) Th1 cells are less clear. Here, we establish that IFN-beta inhibits mouse IFN-gamma(+) Th1 cell function in the absence of APCs. CD4(+) T cells express the type I interferon receptor, and IFN-beta can suppress Th1 cell proliferation under APC-free stimulation conditions. IFN-beta-treated myelin antigen-specific Th1 cells are impaired in their ability to induce severe experimental autoimmune encephalomyelitis (EAE) upon transfer to lymphocyte-deficient Rag1(-/-) mice. Polarized Th1 cells downregulate IFN-gamma and IL-2, and upregulate the negative regulatory receptor Tim-3, when treated with IFN-beta in the absence of APCs. Further, IFN-beta treatment of Th1 cells upregulates phosphorylation of Stat1, and downregulates phosphorylation of Stat4. Our data indicate that IFN-gamma-producing Th1 cells are directly responsive to IFN-beta and point to a novel mechanism of IFN-beta-mediated T cell suppression that is independent of APC-derived signals.	[Boivin, Nicolas; Baillargeon, Joanie; Doss, Prenitha Mercy Ignatius Arokia; Roy, Andree-Pascale; Rangachari, Manu] Univ Laval, CHU Quebec, Ctr Rech, Dept Neurosci, Quebec City, PQ G1V 4G2, Canada; [Doss, Prenitha Mercy Ignatius Arokia; Roy, Andree-Pascale] Univ Laval, Fac Med, Grad Programme Microbiol & Immunol, Quebec City, PQ G1V 0A6, Canada; [Rangachari, Manu] Univ Laval, Fac Med, Dept Mol Med, Quebec City, PQ G1V 0A6, Canada	Laval University; Laval University; Laval University	Rangachari, M (corresponding author), Univ Laval, CHU Quebec, Ctr Rech, Dept Neurosci, Quebec City, PQ G1V 4G2, Canada.	manu.rangachari@crchudequebec.ulaval.ca			Universite Laval; EMD Serono, Canada; MS Research and Training Network Transitional Career Development Award from MS Society of Canada; Multiple Sclerosis Scientific Research Foundation; Junior-1 Research Scholar Career Award from the Fonds de Recherche Sante-Quebec (FRQS); John R. Evans Leaders Fund Award from the Canada Foundation for Innovation (CFI); CHU de Quebec-Universite Laval	Universite Laval; EMD Serono, Canada; MS Research and Training Network Transitional Career Development Award from MS Society of Canada; Multiple Sclerosis Scientific Research Foundation; Junior-1 Research Scholar Career Award from the Fonds de Recherche Sante-Quebec (FRQS); John R. Evans Leaders Fund Award from the Canada Foundation for Innovation (CFI); CHU de Quebec-Universite Laval	P.M.I.A.D. and A.P.R. are supported by funds from Universite Laval. M.R. is supported by the EMD Serono, Canada and MS Research and Training Network Transitional Career Development Award from the MS Society of Canada and the Multiple Sclerosis Scientific Research Foundation; by a Junior-1 Research Scholar Career Award from the Fonds de Recherche Sante-Quebec (FRQS); by a John R. Evans Leaders Fund Award from the Canada Foundation for Innovation (CFI); and by funds from the CHU de Quebec-Universite Laval. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2003, J CLIN IMMUNOL, V23, P147, DOI 10.1023/A:1023381027062; Anderson AC, 2010, EUR J IMMUNOL, V40, P859, DOI 10.1002/eji.200939842; Arnason BGW, 1999, ANNU REV MED, V50, P291; Ascherio A, 2013, EXPERT REV NEUROTHER, V13, P3, DOI 10.1586/14737175.2013.865866; Avolio C, 2003, BRAIN RES BULL, V61, P357, DOI 10.1016/S0361-9230(03)00098-4; Axtell RC, 2013, CLIN REV ALLERG IMMU, V44, P114, DOI 10.1007/s12016-011-8296-5; Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Beck CA, 2005, MULT SCLER J, V11, P516, DOI 10.1191/1352458505ms1192oa; Bettelli E, 2004, J EXP MED, V200, P79, DOI 10.1084/jem.20031819; Bettelli E, 2003, J EXP MED, V197, P1073, DOI 10.1084/jem.20021603; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brod SA, 1997, INT J NEUROSCI, V90, P135, DOI 10.3109/00207459709000633; Burks Jack, 2005, Expert Rev Neurother, V5, P153, DOI 10.1586/14737175.5.2.153; Chitnis T, 2001, J CLIN INVEST, V108, P739, DOI 10.1172/JCI200112563; Clerico M, 2007, EXPERT OPIN BIOL TH, V7, P535, DOI 10.1517/14712598.7.4.535; Deonarain R, 2003, P NATL ACAD SCI USA, V100, P13453, DOI 10.1073/pnas.2230460100; El-behi M, 2010, J NEUROIMMUNE PHARM, V5, P189, DOI 10.1007/s11481-009-9188-9; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Guo BC, 2008, J CLIN INVEST, V118, P1680, DOI 10.1172/JCI33342; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Hwang ES, 2005, SCIENCE, V307, P430, DOI 10.1126/science.1103336; Inoges S, 1999, CLIN EXP IMMUNOL, V115, P521; JACOBS L, 1994, ARCH NEUROL-CHICAGO, V51, P1245, DOI 10.1001/archneur.1994.00540240089022; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Jin HT, 2010, P NATL ACAD SCI USA, V107, P14733, DOI 10.1073/pnas.1009731107; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kamiya S, 2004, J IMMUNOL, V173, P3871, DOI 10.4049/jimmunol.173.6.3871; Karp CL, 2001, CURR OPIN NEUROL, V14, P361, DOI 10.1097/00019052-200106000-00016; Kieseier BC, 2011, CNS DRUGS, V25, P491, DOI 10.2165/11591110-000000000-00000; Kimura A, 2007, P NATL ACAD SCI USA, V104, P12099, DOI 10.1073/pnas.0705268104; Koguchi K, 2006, J EXP MED, V203, P1413, DOI 10.1084/jem.20060210; Kraus J, 2006, DRUG DISCOV TODAY, V11, P755, DOI 10.1016/j.drudis.2006.06.008; Liu YW, 2014, NAT MED, V20, P272, DOI 10.1038/nm.3485; Liu ZG, 2001, J NEUROIMMUNOL, V112, P153, DOI 10.1016/S0165-5728(00)00403-3; Lombardi G, 2000, J IMMUNOL, V165, P3782, DOI 10.4049/jimmunol.165.7.3782; Luca ME, 1999, J NEUROIMMUNOL, V100, P190, DOI 10.1016/S0165-5728(99)00198-8; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; McRae BL, 1997, EUR J IMMUNOL, V27, P2650, DOI 10.1002/eji.1830271026; McRae BL, 1998, J IMMUNOL, V160, P4298; Melo A, 2008, ARQ NEURO-PSIQUIAT, V66, P8, DOI 10.1590/S0004-282X2008000100003; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; NORONHA A, 1993, J NEUROIMMUNOL, V46, P145, DOI 10.1016/0165-5728(93)90244-S; NYLAND H, 1982, NEUROPATH APPL NEURO, V8, P403, DOI 10.1111/j.1365-2990.1982.tb00308.x; Pennell LM, 2014, J INTERF CYTOK RES, V34, P330, DOI 10.1089/jir.2013.0088; Petermann F, 2011, FEBS LETT, V585, P3747, DOI 10.1016/j.febslet.2011.03.064; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Polman CH, 2003, LANCET NEUROL, V2, P563, DOI 10.1016/S1474-4422(03)00505-2; Pozzilli C, 2006, NEUROL SCI, V27, pS369, DOI 10.1007/s10072-006-0697-5; Prinz M, 2008, IMMUNITY, V28, P675, DOI 10.1016/j.immuni.2008.03.011; Ramgolam VS, 2009, J IMMUNOL, V183, P5418, DOI 10.4049/jimmunol.0803227; Rangachari M, 2013, J AUTOIMMUN, V45, P31, DOI 10.1016/j.jaut.2013.06.008; Rangachari M, 2012, NAT MED, V18, P1394, DOI 10.1038/nm.2871; Rep MHG, 1996, J NEUROIMMUNOL, V67, P111; Rio J, 2006, ANN NEUROL, V59, P344, DOI 10.1002/ana.20740; Rudick RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019262; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; SHATA MT, 1995, J INTERF CYTOK RES, V15, P291, DOI 10.1089/jir.1995.15.291; Shinohara ML, 2008, IMMUNITY, V29, P68, DOI 10.1016/j.immuni.2008.05.008; Sprent J, 2000, PHILOS T R SOC B, V355, P317, DOI 10.1098/rstb.2000.0568; Starossom SC, 2012, IMMUNITY, V37, P249, DOI 10.1016/j.immuni.2012.05.023; Sweeney CM, 2011, BRAIN BEHAV IMMUN, V25, P1170, DOI 10.1016/j.bbi.2011.03.007; Szabo SJ, 2000, CELL, V100, P655, DOI 10.1016/S0092-8674(00)80702-3; Tigno-Aranjuez JT, 2009, J IMMUNOL, V183, P5654, DOI 10.4049/jimmunol.0900645; Usui T, 2006, J EXP MED, V203, P755, DOI 10.1084/jem.20052165; Veldhoen M, 2006, NAT IMMUNOL, V7, P1151, DOI 10.1038/ni1391; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Weber MS, 2007, NEUROTHERAPEUTICS, V4, P647, DOI 10.1016/j.nurt.2007.08.002; Yang L, 2008, J IMMUNOL, V180, P4409, DOI 10.4049/jimmunol.180.7.4409; Zhang JW, 2002, CLIN THER, V24, P1998, DOI 10.1016/S0149-2918(02)80094-7; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271; Zhu C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7072	77	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124802	10.1371/journal.pone.0124802	http://dx.doi.org/10.1371/journal.pone.0124802			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885435	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000145
J	Kashojiya, S; Okajima, K; Shimada, T; Tokutomi, S				Kashojiya, Sachiko; Okajima, Koji; Shimada, Takashi; Tokutomi, Satoru			Essential Role of the A 'alpha/A beta Gap in the N-Terminal Upstream of LOV2 for the Blue Light Signaling from LOV2 to Kinase in Arabidopsis Photototropin1, a Plant Blue Light Receptor	PLOS ONE			English	Article							STRUCTURAL BASIS; PHOTOTROPIN 1; CONFORMATIONAL-CHANGES; PHOTORECEPTOR DOMAIN; MUTATIONAL ANALYSIS; BINDING DOMAINS; PRIMARY STEP; INSIGHTS; OXYGEN; NPL1	Phototropin (phot) is a blue light (BL) receptor in plants and is involved in phototropism, chloroplast movement, stomata opening, etc. A phot molecule has two photo-receptive domains named LOV (Light-Oxygen-Voltage) 1 and 2 in its N-terminal region and a serine/threonine kinase (STK) in its C-terminal region. STK activity is regulated mainly by LOV2, which has a cyclic photoreaction, including the transient formation of a flavin mononucleotide (FMN)-cysteinyl adduct (S390). One of the key events for the propagation of the BL signal from LOV2 to STK is conformational changes in a J alpha-helix residing downstream of the LOV2 C-terminus. In contrast, we focused on the role of the A'alpha-helix, which is located upstream of the LOV2 N-terminus and interacts with the Ja-helix. Using LOV2-STK polypeptides from Arabidopsis thaliana phot1, we found that truncation of the A'alpha-helix and amino acid substitutions at Glu474 and Lys475 in the gap between the A'alpha and the A beta strand of LOV2 (A'alpha/A beta gap) to Ala impaired the BL-induced activation of the STK, although they did not affect S390 formation. Trypsin digested the LOV2-STK at Lys603 and Lys475 in a light-dependent manner indicating BL-induced structural changes in both the Ja-helix and the gap. The digestion at Lys603 is faster than at Lys475. These BL-induced structural changes were observed with the Glu474Ala and the Lys475Ala substitutes, indicating that the BL signal reached the Ja-helix as well as the A'alpha/A beta gap but could not activate STK. The amino acid residues, Glu474 and Lys475, in the gap are conserved among the phots of higher plants and may act as a joint to connect the structural changes in the Ja-helix with the activation of STK.	[Kashojiya, Sachiko; Okajima, Koji; Tokutomi, Satoru] Osaka Prefecture Univ, Dept Biol Sci, Sakai, Osaka 591, Japan; [Shimada, Takashi] Shimadzu Co Ltd, Life Sci Res Ctr, Tokyo, Japan	Osaka Metropolitan University; Shimadzu Corporation	Okajima, K (corresponding author), Osaka Prefecture Univ, Dept Biol Sci, Sakai, Osaka 591, Japan.	okajima@b.s.osakafu-u.ac.jp			MEXT Japan [17084008]; JSPS Japan [22120005, 23657105]	MEXT Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-Aid from the MEXT Japan to S.T. (No. 17084008) and from the JSPS Japan to S.T. (No. 22120005 and No. 23657105).	Aihara Y, 2012, J BIOL CHEM, V287, P9901, DOI 10.1074/jbc.M111.324723; Bogre L, 2003, TRENDS PLANT SCI, V8, P424, DOI 10.1016/S1360-1385(03)00188-2; Briggs WR, 2002, TRENDS PLANT SCI, V7, P204, DOI 10.1016/S1360-1385(02)02245-8; Christie JM, 2002, PLANT J, V32, P205, DOI 10.1046/j.1365-313X.2002.01415.x; Christie JM, 1998, SCIENCE, V282, P1698, DOI 10.1126/science.282.5394.1698; Christie JM, 2007, ANNU REV PLANT BIOL, V58, P21, DOI 10.1146/annurev.arplant.58.032806.103951; Christie JM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001076; Circolone F, 2012, J MOL BIOL, V417, P362, DOI 10.1016/j.jmb.2012.01.056; Crosson S, 2001, P NATL ACAD SCI USA, V98, P2995, DOI 10.1073/pnas.051520298; Crosson S, 2002, PLANT CELL, V14, P1067, DOI 10.1105/tpc.010475; Demarsy E, 2012, EMBO J, V31, P3457, DOI 10.1038/emboj.2012.186; Eitoku T, 2007, J MOL BIOL, V371, P1290, DOI 10.1016/j.jmb.2007.06.035; Freddolino PL, 2013, PHOTOCH PHOTOBIO SCI, V12, P1158, DOI 10.1039/c3pp25400c; Halavaty AS, 2007, BIOCHEMISTRY-US, V46, P14001, DOI 10.1021/bi701543e; Halavaty AS, 2013, ACTA CRYSTALLOGR F, V69, P1316, DOI 10.1107/S1744309113029199; Harper SM, 2004, BIOCHEMISTRY-US, V43, P16184, DOI 10.1021/bi048092i; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Harper SM, 2004, J AM CHEM SOC, V126, P3390, DOI 10.1021/ja038224f; Inoue S, 2008, P NATL ACAD SCI USA, V105, P5626, DOI 10.1073/pnas.0709189105; Jarillo JA, 2001, NATURE, V410, P952, DOI 10.1038/35073622; Jones MA, 2007, J BIOL CHEM, V282, P6405, DOI 10.1074/jbc.M605969200; Kagawa T, 2001, SCIENCE, V291, P2138, DOI 10.1126/science.291.5511.2138; Kasahara M, 2002, PLANT PHYSIOL, V129, P762, DOI 10.1104/pp.002410; Katsura H, 2009, FEBS LETT, V583, P526, DOI 10.1016/j.febslet.2009.01.019; Kinoshita T, 2001, NATURE, V414, P656, DOI 10.1038/414656a; Mitre D, 2012, STRUCTURE, V20, P698, DOI 10.1016/j.str.2012.02.016; Moglich A, 2007, J MOL BIOL, V373, P112, DOI 10.1016/j.jmb.2007.07.039; Moglich A, 2010, ANNU REV PLANT BIOL, V61, P21, DOI 10.1146/annurev-arplant-042809-112259; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Nakasako M, 2004, BIOCHEMISTRY-US, V43, P14881, DOI 10.1021/bi0485530; Nakasako M, 2008, J MOL BIOL, V381, P718, DOI 10.1016/j.jmb.2008.06.033; Nash AI, 2011, P NATL ACAD SCI USA, V108, P9449, DOI 10.1073/pnas.1100262108; Nash AI, 2008, BIOCHEMISTRY-US, V47, P13842, DOI 10.1021/bi801430e; Nozaki D, 2004, BIOCHEMISTRY-US, V43, P8373, DOI 10.1021/bi0494727; Okajima K, 2012, J BIOL CHEM, V287, P40972, DOI 10.1074/jbc.M112.406512; Okajima K, 2011, FEBS LETT, V585, P3391, DOI 10.1016/j.febslet.2011.10.003; Quail PH, 2002, CURR OPIN CELL BIOL, V14, P180, DOI 10.1016/S0955-0674(02)00309-5; Rinaldi J, 2012, J MOL BIOL, V420, P112, DOI 10.1016/j.jmb.2012.04.006; Sakai T, 2001, P NATL ACAD SCI USA, V98, P6969, DOI 10.1073/pnas.101137598; Salomon M, 2000, BIOCHEMISTRY-US, V39, P9401, DOI 10.1021/bi000585+; Sharma S, 2014, PLANT PHYSIOL, V164, P2030, DOI 10.1104/pp.113.232306; Song SH, 2011, BIOCHEMISTRY-US, V50, P2411, DOI 10.1021/bi200198x; Sullivan S, 2008, MOL PLANT, V1, P178, DOI 10.1093/mp/ssm017; Swartz TE, 2001, J BIOL CHEM, V276, P36493, DOI 10.1074/jbc.M103114200; Takayama Y, 2011, BIOCHEMISTRY-US, V50, P1174, DOI 10.1021/bi101689b; Takeda K, 2013, J PHYS CHEM B, V117, P15606, DOI 10.1021/jp406109j; Takemiya A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3094; Zayner JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087074; Zayner JP, 2012, J MOL BIOL, V419, P61, DOI 10.1016/j.jmb.2012.02.037	49	13	13	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124284	10.1371/journal.pone.0124284	http://dx.doi.org/10.1371/journal.pone.0124284			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886203	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000111
J	Liu, JH; Zhang, J; Hu, W; Miao, HX; Zhang, JB; Jia, CH; Wang, Z; Xu, BY; Jin, ZQ				Liu, Juhua; Zhang, Jing; Hu, Wei; Miao, Hongxia; Zhang, Jianbin; Jia, Caihong; Wang, Zhuo; Xu, Biyu; Jin, Zhiqiang			Banana Ovate Family Protein MaOFP1 and MADS-Box Protein MuMADS1 Antagonistically Regulated Banana Fruit Ripening	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; ETHYLENE BIOSYNTHESIS; GENE FAMILY; SUBCELLULAR-LOCALIZATION; ARABIDOPSIS-THALIANA; TOMATO FRUIT; LAND PLANTS; IN-VITRO; EVOLUTION; COMPLEXES	The ovate family protein named MaOFP1 was identified in banana (Musa acuminata L. AAA) fruit by a yeast two-hybrid (Y2H) method using the banana MADS-box gene MuMADS1 as bait and a 2 day postharvest (DPH) banana fruit cDNA library as prey. The interaction between MuMADS1 and MaOFP1 was further confirmed by Y2H and Bimolecular Fluorescence Complementation (BiFC) methods, which showed that the MuMADS1 K domain interacted with MaOFP1. Real-time quantitative PCR evaluation of MuMADS1 and MaOFP1 expression patterns in banana showed that they are highly expressed in 0 DPH fruit, but present in low levels in the stem, which suggests that simultaneous but different expression patterns exist for both MuMADS1 and MaOFP1 in different tissues and developing fruits. Meanwhile, MuMADS1 and MaOFP1 expression was highly stimulated and greatly suppressed, respectively, by exogenous ethylene. In contrast, MaOFP1 expression was highly stimulated while MuMADS1 was greatly suppressed by the ethylene competitor 1-methylcyclopropene (1-MCP). These results indicate that MuMADS1 and MaOFP1 are antagonistically regulated by ethylene and might play important roles in postharvest banana fruit ripening.	[Liu, Juhua; Zhang, Jing; Hu, Wei; Miao, Hongxia; Zhang, Jianbin; Jia, Caihong; Wang, Zhuo; Xu, Biyu; Jin, Zhiqiang] Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China; [Jin, Zhiqiang] Chinese Acad Trop Agr Sci, Haikou Expt Stn, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Tropical Agricultural Sciences	Xu, BY (corresponding author), Chinese Acad Trop Agr Sci, Inst Trop Biosci & Biotechnol, Minist Agr, Key Lab Trop Crop Biotechnol, Haikou, Hainan, Peoples R China.	xubiyu@itbb.org.cn; jinzhiqiang@itbb.org.cn			National Natural Science Foundation of China (NNSFC) [31471924]; 973 program earlier research project [2014CB160314]; Ministry of Science and Technology of the People's Republic of China [2011AA10020605]; earmarked fund for Modern Agro-industry Technology Research System [CARS-32]	National Natural Science Foundation of China (NNSFC)(National Natural Science Foundation of China (NSFC)); 973 program earlier research project(National Basic Research Program of China); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China); earmarked fund for Modern Agro-industry Technology Research System	The work is financially supported by the National Natural Science Foundation of China (NNSFC) (Grant No. 31471924), the 973 program earlier research project (2014CB160314), the Ministry of Science and Technology of the People's Republic of China (No. 2011AA10020605), and by the earmarked fund for Modern Agro-industry Technology Research System (CARS-32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benlloch R, 2009, PLANT J, V60, P102, DOI 10.1111/j.1365-313X.2009.03939.x; Brambilla V, 2007, PLANT CELL, V19, P2544, DOI 10.1105/tpc.107.051797; Citovsky V, 2006, J MOL BIOL, V362, P1120, DOI 10.1016/j.jmb.2006.08.017; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davies B, 1996, EMBO J, V15, P4330, DOI 10.1002/j.1460-2075.1996.tb00807.x; de Folter S, 2005, PLANT CELL, V17, P1424, DOI 10.1105/tpc.105.031831; Dreni L, 2014, NEW PHYTOL, V201, P717, DOI 10.1111/nph.12555; Elitzur T, 2010, J EXP BOT, V61, P1523, DOI 10.1093/jxb/erq017; Fan HY, 1997, PLANT J, V12, P999, DOI 10.1046/j.1365-313X.1997.12050999.x; Ferrario S, 2006, PLANT PHYSIOL, V140, P890, DOI 10.1104/pp.105.072660; Ferrario S, 2003, PLANT CELL, V15, P914, DOI 10.1105/tpc.010280; Hackbusch J, 2005, P NATL ACAD SCI USA, V102, P4908, DOI 10.1073/pnas.0501181102; Hake S, 2004, ANNU REV CELL DEV BI, V20, P125, DOI 10.1146/annurev.cellbio.20.031803.093824; Hamant O, 2010, CR BIOL, V333, P371, DOI 10.1016/j.crvi.2010.01.015; Inaba A, 2007, J EXP BOT, V58, P1047, DOI 10.1093/jxb/erl265; Ito Y, 2008, PLANT J, V55, P212, DOI 10.1111/j.1365-313X.2008.03491.x; Kaufmann K, 2005, GENE, V347, P183, DOI 10.1016/j.gene.2004.12.014; Kaufmann K, 2009, PLOS BIOL, V7, P854, DOI 10.1371/journal.pbio.1000090; Li EY, 2011, PLANT J, V67, P328, DOI 10.1111/j.1365-313X.2011.04595.x; Liu DM, 2014, PLANT J, V77, P284, DOI 10.1111/tpj.12387; Liu D, 2014, ANN BOT-LONDON, V113, P1219, DOI 10.1093/aob/mcu061; Liu JP, 2002, P NATL ACAD SCI USA, V99, P13302, DOI 10.1073/pnas.162485999; Liu JH, 2013, POSTHARVEST BIOL TEC, V84, P43, DOI 10.1016/j.postharvbio.2013.04.005; Liu JH, 2013, PLANT CELL REP, V32, P129, DOI 10.1007/s00299-012-1347-4; Liu JH, 2009, PLANT CELL REP, V28, P103, DOI 10.1007/s00299-008-0613-y; Liu XJ, 1999, PLANT PHYSIOL, V121, P1257, DOI 10.1104/pp.121.4.1257; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Mara CD, 2008, PLANT PHYSIOL, V147, P707, DOI 10.1104/pp.107.115634; Masiero S, 2002, J BIOL CHEM, V277, P26429, DOI 10.1074/jbc.M202546200; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P144, DOI 10.1093/nar/gkn900; Melzer R, 2009, NUCLEIC ACIDS RES, V37, P2723, DOI 10.1093/nar/gkp129; Pagnussat GC, 2007, PLANT CELL, V19, P3578, DOI 10.1105/tpc.107.054890; PNUELI L, 1991, PLANT J, V1, P255, DOI 10.1111/j.1365-313X.1991.00255.x; Seymour GB, 2011, J EXP BOT, V62, P1179, DOI 10.1093/jxb/erq360; Shima Y, 2014, BIOSCI BIOTECH BIOCH, V78, P231, DOI 10.1080/09168451.2014.878221; Smaczniak C, 2012, DEVELOPMENT, V139, P3081, DOI 10.1242/dev.074674; Smaczniak C, 2012, P NATL ACAD SCI USA, V109, P1560, DOI 10.1073/pnas.1112871109; Sridhar VV, 2006, DEVELOPMENT, V133, P3159, DOI 10.1242/dev.02498; Tadiello A, 2009, J EXP BOT, V60, P651, DOI 10.1093/jxb/ern313; Theissen G, 1996, J MOL EVOL, V43, P484, DOI 10.1007/PL00006110; Tonaco IAN, 2006, J EXP BOT, V57, P33, DOI 10.1093/jxb/erj011; Tsaballa A, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-46; Vandenbussche M, 2003, PLANT CELL, V15, P2680, DOI 10.1105/tpc.017376; Vrebalov J, 2002, SCIENCE, V296, P343, DOI 10.1126/science.1068181; WAN CY, 1994, ANAL BIOCHEM, V223, P7, DOI 10.1006/abio.1994.1538; Wang S, 2011, PLOS ONE, V6; Wang S, 2007, PLANT J, V50, P858, DOI 10.1111/j.1365-313X.2007.03096.x; Wang SF, 2014, J EXP BOT, V65, P3005, DOI 10.1093/jxb/eru137; Wang YA, 2010, J PLANT PHYSIOL, V167, P989, DOI 10.1016/j.jplph.2009.11.019; Yang ZR, 2014, MOL GENET GENOMICS, V289, P873, DOI 10.1007/s00438-014-0856-y; Yap YK, 2005, PLANT PHYSIOL, V139, P127, DOI 10.1104/pp.105.065656	51	11	22	6	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123870	10.1371/journal.pone.0123870	http://dx.doi.org/10.1371/journal.pone.0123870			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886169	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000090
J	Song, YX; An, XP; Zhang, L; Fu, MZ; Peng, JY; Han, P; Hou, JX; Zhou, ZQ; Cao, BY				Song, Yuxuan; An, Xiaopeng; Zhang, Lei; Fu, Mingzhe; Peng, Jiayin; Han, Peng; Hou, Jingxing; Zhou, Zhanqin; Cao, Bingyun			Identification and Profiling of microRNAs in Goat Endometrium during Embryo Implantation	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CAPRA-HIRCUS; EXPRESSION; MIR-449A; TARGET; PROGESTERONE; UTERUS; TRANSCRIPTION; BIOGENESIS; MIR-216A	Background MicroRNAs (miRNAs) are short, highly conserved small noncoding RNAs that had fundamental roles in post-transcriptional gene expression, and they are crucial for proper control of biological processes and known to participate in embryo implantation. However, miRNA expression profiles in the pre-receptive and receptive phases of the goat endometrium during embryo implantation are unknown. Results A total of 1,069 and 847 miRNAs were expressed in receptive (R) and pre-receptive (P) goat endometrium, and 632 miRNAs were co-expressed in both phases. We identified 545 (50.98%) known miRNAs in the R library and 522 (61.63%) in the P library. There were 110 up-expressed miRNAs and 33 down-expressed miRNAs in receptive endometrium compared with the pre-receptive endometrium meeting the criteria of P-values<0.05. Moreover, GO and KEGG analysis of the target genes of the differentially expressed miRNAs revealed some candidate miRNAs, genes and pathways that may involve in the formation of the receptive endometrium. Based on stem-loop RT-qPCR, 15 miRNAs were detected and the results suggested that the majority of the miRNA expression data measured by Solexa deep sequencing could represent actual miRNA expression levels. Conclusions Our data revealed the first miRNA profile related to the biology of the goat receptive endometrium during embryo implantation, and the results suggested that a subset of miRNAs might play important roles in the formation of endometrial receptivity. Thus, elucidating the physiological roles of endometrial miRNAs will help us better understand the genetic control of embryo implantation in goats.	[Song, Yuxuan; An, Xiaopeng; Zhang, Lei; Fu, Mingzhe; Peng, Jiayin; Han, Peng; Hou, Jingxing; Zhou, Zhanqin; Cao, Bingyun] Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China	Northwest A&F University - China	Cao, BY (corresponding author), Northwest A&F Univ, Coll Anim Sci & Technol, Yangling 712100, Shaanxi, Peoples R China.	binyun_cao@163.com			National Support Program of China [2011BAD28B05-3]; Science and Technology Innovation Project of Shaanxi Province [2011KTCL02-09]	National Support Program of China; Science and Technology Innovation Project of Shaanxi Province	This study was supported by the National Support Program of China (2011BAD28B05-3) and Science and Technology Innovation Project of Shaanxi Province (2011KTCL02-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Berezikov E, 2005, CELL, V120, P21, DOI 10.1016/j.cell.2004.12.031; Caiment F, 2010, GENOME RES, V20, P1651, DOI 10.1101/gr.108787.110; Carletti MZ, 2009, J ANIM SCI, V87, pE29, DOI 10.2527/jas.2008-1331; Chakrabarty A, 2007, P NATL ACAD SCI USA, V104, P15144, DOI 10.1073/pnas.0705917104; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chen C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031426; Chen H, 2012, CANCER LETT, V320, P40, DOI 10.1016/j.canlet.2012.01.027; Chen PJ, 2012, HEPATOLOGY, V56, P632, DOI 10.1002/hep.25695; Chen SH, 2014, ONCOL LETT, V7, P568, DOI 10.3892/ol.2013.1737; Chen X, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r78; Chitwood DH, 2007, NAT GENET, V39, P935, DOI 10.1038/ng0807-935; Dey SK, 2004, ENDOCR REV, V25, P341, DOI 10.1210/er.2003-0020; Dey SK, 1996, REPROD ENDOCRINOLOGY, V1, P421; Egashira Mahiro, 2013, Reproductive Medicine and Biology, V12, P127, DOI 10.1007/s12522-013-0153-1; Estella C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041080; Flores-Jasso CF, 2009, ACTA PHARMACOL SIN, V30, P1177, DOI 10.1038/aps.2009.108; Guo Y, 2013, CELL PHYSIOL BIOCHEM, V32, P581, DOI 10.1159/000354462; Gupta A, 2012, BIOCHEM SOC T, V40, P752, DOI 10.1042/BST20110763; Hackl M, 2011, J BIOTECHNOL, V153, P62, DOI 10.1016/j.jbiotec.2011.02.011; Hao DC, 2012, PHYSIOL PLANTARUM, V146, P388, DOI 10.1111/j.1399-3054.2012.01668.x; Hu JH, 2014, DIGEST DIS SCI, V59, P336, DOI 10.1007/s10620-013-2923-3; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Igwebuike UM, 2009, ANIM REPROD SCI, V112, P1, DOI 10.1016/j.anireprosci.2008.12.010; Ji ZB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049463; Jiao Y, 2014, MAR BIOTECHNOL, V16, P54, DOI 10.1007/s10126-013-9528-x; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Khanum SA, 2007, ANIM REPROD SCI, V102, P267, DOI 10.1016/j.anireprosci.2006.11.010; Koler M, 2009, HUM REPROD, V24, P2541, DOI 10.1093/humrep/dep193; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kuokkanen S, 2010, BIOL REPROD, V82, P791, DOI 10.1095/biolreprod.109.081059; Lee H, 2012, MODERN PATHOL, V25, P1508, DOI 10.1038/modpathol.2012.111; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Li MZ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0015168, 10.1371/journal.pone.0011541]; Li ZM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041658, 10.1371/journal.pone.0053176]; Lian L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051003; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Ling YH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-339; Lize M, 2010, CELL DEATH DIFFER, V17, P452, DOI 10.1038/cdd.2009.188; Matsumoto H, 2002, DEV BIOL, V245, P280, DOI 10.1006/dbio.2002.0645; Menghini R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.556; Mi X, 2014, COMP BIOCHEM PHYS D, V10, P1, DOI 10.1016/j.cbd.2014.01.001; Munro SK, 2010, MOL HUM REPROD, V16, P297, DOI 10.1093/molehr/gaq010; Noonan EJ, 2009, ONCOGENE, V28, P1714, DOI 10.1038/onc.2009.19; Paik S, 2012, STEM CELLS DEV, V21, P3298, DOI 10.1089/scd.2011.0732; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Perrier D'hauterive S, 2002, J Gynecol Obstet Biol Reprod (Paris), V31, P440; Ratner ES, 2010, GYNECOL ONCOL, V118, P251, DOI 10.1016/j.ygyno.2010.05.010; Revel A, 2011, HUM REPROD, V26, P2830, DOI 10.1093/humrep/der255; Su LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087867; Su RW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015513; Sun JJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-42; Tranguch S, 2014, INT J DEV BIOL, V58, P79, DOI 10.1387/ijdb.130332st; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Wang CQF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0025832, 10.1371/journal.pone.0018907]; Wessels JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072264; Wheeler G, 2006, FEBS LETT, V580, P2195, DOI 10.1016/j.febslet.2006.03.019; Wu D, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00035; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Xia HF, 2014, FEBS J, V281, P1872, DOI 10.1111/febs.12751; Xia HF, 2010, INT J MOL SCI, V11, P719, DOI 10.3390/ijms11020719; Xie SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016235; Yang CX, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096669; Yang H, 2014, GENE, V536, P308, DOI 10.1016/j.gene.2013.12.006; Yang XJ, 2009, GENE DEV, V23, P2388, DOI 10.1101/gad.1819009; Yuan C, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-511; Yun KW, 2014, PEDIATR CARDIOL, V35, P745, DOI 10.1007/s00246-013-0846-6; Zhang BH, 2009, GENE, V443, P100, DOI 10.1016/j.gene.2009.04.027; Zhang CY, 2009, LIVEST SCI, V125, P60, DOI 10.1016/j.livsci.2009.03.002; Zhang XD, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-157; Zhang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081076; Zhao YD, 2008, CANCER INFORM, V6, P9	75	35	36	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122202	10.1371/journal.pone.0122202	http://dx.doi.org/10.1371/journal.pone.0122202			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886011	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000029
J	Yang, XL; Zhao, JY; Wang, C; Duan, YG; Zhao, ZP; Chen, R; Zhang, LY; Xing, L; Lai, CC; Zhang, SG; Wang, XL; Yang, PH				Yang, Xiaolan; Zhao, Jianyu; Wang, Cheng; Duan, Yuegiang; Zhao, Zhongpeng; Chen, Rui; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Zhang, Shaogeng; Wang, Xiliang; Yang, Penghui			Immunization with a Live Attenuated H7N9 Influenza Vaccine Protects Mice against Lethal Challenge	PLOS ONE			English	Article							VIRUS-VACCINE; A VIRUS; PROVIDES PROTECTION; REVERSE GENETICS; IMMUNE-RESPONSES; HUMAN INFECTION; FERRETS; CANDIDATE; LAIV	The emergence of severe cases of human influenza A (H7N9) viral infection in China in the spring of 2003 resulted in a global effort to rapidly develop an effective candidate vaccine. In this study, a cold-adapted (ca), live attenuated monovalent reassortant influenza H7N9 virus (Ah01/AA ca) was generated using reverse genetics that contained hemagglutinin (HA) and neuraminidase (NA) genes from a 2013 pandemic A H7N9 isolate, A/Anhui/01/2013 virus (Ah01/H7N9); the remaining six backbone genes derived from the cold-adapted influenza H2N2 A/Ann Arbor/6/60 virus (AA virus). Ah01/AA ca virus exhibited temperature sensitivity (ts), ca, and attenuation (att) phenotypes. Intranasal immunization of female BALB/c mice with Ah01/AA ca twice at a 2-week interval induced robust humoral, mucosal, and cell-mediated immune responses in a dose-dependent manner. Furthermore, the candidate Ah01/AA ca virus was immunogenic and offered partial or complete protection of mice against a lethal challenge by the live 2013 influenza A H7N9 (A/Anhui/01/2013). Protection was demonstrated by the inhibition of viral replication and the attenuation of histopathological changes in the challenged mouse lung. Taken together, these data support the further evaluation of this Ah01/AA ca candidate vaccine in primates.	[Yang, Xiaolan; Duan, Yuegiang; Zhao, Zhongpeng; Chen, Rui; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Wang, Xiliang; Yang, Penghui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Zhao, Jianyu] China Astronaut Res & Training Ctr, Beijing, Peoples R China; [Wang, Cheng] Acad Med Sci, Beijing Hosp 307, Beijing, Peoples R China; [Zhang, Shaogeng; Yang, Penghui] Beijing 302 Hosp, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Beijing Hospital; Fifth Medical Center of Chinese PLA General Hospital	Wang, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiliangw@126.com; ypenghuiamms@hotmail.com		zhongpeng, zhao/0000-0002-9147-6252	National Natural Scientific Foundation [81370518]; National Programs for High Technology Research and Development of China [SS2015AA020924]; Ministry of Science and Technology of China [2012CB518905, 2013ZX10004003, SS2012AA020905]; Beijing Nova Program [Z141107001814054]	National Natural Scientific Foundation(National Natural Science Foundation of China (NSFC)); National Programs for High Technology Research and Development of China(National High Technology Research and Development Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Nova Program(Beijing Municipal Science & Technology Commission)	This work was supported by funding from the National Natural Scientific Foundation (81370518), National Programs for High Technology Research and Development of China (SS2015AA020924), and the Ministry of Science and Technology of China (2012CB518905, 2013ZX10004003, and SS2012AA020905). PY was supported by Beijing Nova Program (No. Z141107001814054). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors declare no financial or commercial conflicts of interest.	Belser JA, 2013, NATURE, V501, P556, DOI 10.1038/nature12391; Chang FY, 2013, NEW ENGL J MED, V369, P879, DOI 10.1056/NEJMc1308255; Chen HL, 2003, VACCINE, V21, P1974, DOI 10.1016/S0264-410X(02)00809-5; Chen ZY, 2014, J VIROL, V88, P7016, DOI 10.1128/JVI.00100-14; Chen ZY, 2009, J VIROL, V83, P65, DOI 10.1128/JVI.01775-08; Dormitzer PR, 2012, HUM VACC IMMUNOTHER, V8, P45, DOI 10.4161/hv.8.1.18859; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; HERLOCHER ML, 1993, P NATL ACAD SCI USA, V90, P6032, DOI 10.1073/pnas.90.13.6032; Jang YH, 2013, VACCINE, V31, P1320, DOI 10.1016/j.vaccine.2012.12.072; Joseph T, 2008, VIROLOGY, V378, P123, DOI 10.1016/j.virol.2008.05.021; Krammer F, 2014, CLIN VACCINE IMMUNOL, V21, P1153, DOI 10.1128/CVI.00272-14; Krammer F, 2014, J VIROL, V88, P3976, DOI 10.1128/JVI.03095-13; Lanthier PA, 2011, VACCINE, V29, P7849, DOI 10.1016/j.vaccine.2011.07.093; Lee Chang-Won, 2008, V436, P99, DOI 10.1007/978-1-59745-279-3_12; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Suguitan AL, 2006, PLOS MED, V3, P1541, DOI 10.1371/journal.pmed.0030360; Talaat KR, 2009, VACCINE, V27, P3744, DOI 10.1016/j.vaccine.2009.03.082; Voeten JTM, 2010, ARCH VIROL, V155, P1391, DOI 10.1007/s00705-010-0719-8; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Yang PH, 2010, CELL MOL IMMUNOL, V7, P116, DOI 10.1038/cmi.2009.116	21	7	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123659	10.1371/journal.pone.0123659	http://dx.doi.org/10.1371/journal.pone.0123659			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884801	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000080
J	Reyes-Rivera, J; Canche-Escamilla, G; Soto-Hernandez, M; Terrazas, T				Reyes-Rivera, Jorge; Canche-Escamilla, Gonzalo; Soto-Hernandez, Marcos; Terrazas, Teresa			Wood Chemical Composition in Species of Cactaceae: The Relationship between Lignification and Stem Morphology	PLOS ONE			English	Article							LIGNIN BIOSYNTHESIS; S/G RATIO; GROWTH FORM; SYRINGYL; EVOLUTION; GUAIACYL; BIOMECHANICS; EUCALYPTUS; HARDWOODS	In Cactaceae, wood anatomy is related to stem morphology in terms of the conferred support. In species of cacti with dimorphic wood, a unique process occurs in which the cambium stops producing wide-band tracheids (WBTs) and produces fibers; this is associated with the aging of individuals and increases in size. Stem support and lignification have only been studied in fibrous tree-like species, and studies in species with WBTs or dimorphic wood are lacking. In this study, we approach this process with a chemical focus, emphasizing the role of wood lignification. We hypothesized that the degree of wood lignification in Cactaceae increases with height of the species and that its chemical composition varies with wood anatomy. To test this, we studied the chemical composition (cellulose, hemicellulose, and lignin content) in 13 species (2 WBTs wood, 3 dimorphic, and 8 fibrous) with contrasting growth forms. We also analyzed lignification in dimorphic and fibrous species to determine the chemical features of WBTs and fibers and their relationship with stem support. The lignin contents were characterized by Fourier transform infrared spectroscopy and high performance liquid chromatography. We found that 11 species have a higher percentage (> 35%) of lignin in their wood than other angiosperms or gymnosperms. The lignin chemical composition in fibrous species is similar to that of other dicots, but it is markedly heterogeneous in non-fibrous species where WBTs are abundant. The lignification in WBTs is associated with the resistance to high water pressure within cells rather than the contribution to mechanical support. Dimorphic wood species are usually richer in syringyl lignin, and tree-like species with lignified rays have more guaiacyl lignin. The results suggest that wood anatomy and lignin distribution play an important role in the chemical composition of wood, and further research is needed at the cellular level.	[Reyes-Rivera, Jorge; Terrazas, Teresa] Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico; [Canche-Escamilla, Gonzalo] Ctr Invest Cient Yucatan, Unidad Mat, Merida, Yucatan, Mexico; [Soto-Hernandez, Marcos] Colegio Postgrad Ciencias Agr, Programa Bot, Montecillo, Estado De Mexic, Mexico	Universidad Nacional Autonoma de Mexico; Centro de Investigacion Cientifica de Yucatan; Colegio de Postgraduados - Mexico	Reyes-Rivera, J (corresponding author), Univ Nacl Autonoma Mexico, Inst Biol, Dept Bot, Mexico City 04510, DF, Mexico.	tterrazas@ib.unam.mx			Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, DGAPA, Universidad Nacional Autonoma de Mexico [IN209012]; CONACYT [220343]	Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, DGAPA, Universidad Nacional Autonoma de Mexico; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	The authors received funding from Project IN209012 Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica, DGAPA, Universidad Nacional Autonoma de Mexico TT and CONACYT (220343) to JRR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias Montes S., 2001, ANALES I BIOL U NA B, V72, P157; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Bernal-Salazar S, 2005, J ARID ENVIRON, V63, P671, DOI 10.1016/j.jaridenv.2005.04.006; BLANCHETTE RA, 1988, CAN J BOT, V66, P1841, DOI 10.1139/b88-251; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bonawitz ND, 2010, ANNU REV GENET, V44, P337, DOI 10.1146/annurev-genet-102209-163508; Brebu M, 2011, CELL CHEM TECHNOL, V45, P43; Carballo AL, 2004, REV CHAPINGO S CIENC, V10, P57; Chen F, 2013, PLANT J, V73, P201, DOI 10.1111/tpj.12012; Cornejo DO, 1997, AM J BOT, V84, P1482, DOI 10.2307/2446610; Davison BH, 2006, APPL BIOCHEM BIOTECH, V130, P427, DOI 10.1385/ABAB:130:1:427; Derkacheva O, 2008, MACROMOL SYMP, V265, P61, DOI 10.1002/masy.200850507; DONNELLY BJ, 1973, CEREAL CHEM, V50, P548; Eckardt NA, 2002, PLANT CELL, V14, P1185, DOI 10.1105/tpc.140610; FAIX O, 1991, HOLZFORSCHUNG, V45, P21, DOI 10.1515/hfsg.1991.45.s1.21; Fengel D., 1984, Wood: chemistry, ultrastructure, reactions.; FERGUS BJ, 1970, HOLZFORSCHUNG, V24, P113, DOI 10.1515/hfsg.1970.24.4.113; Fonseca-Prieto FV, 2014, BIOMASS CONVERS BIOR, V4, P95, DOI 10.1007/s13399-013-0099-x; Garrett TY, 2010, AM J BOT, V97, P1951, DOI 10.3732/ajb.1000286; GIBSON A C, 1973, Biotropica, V5, P29, DOI 10.2307/2989678; Gibson AC, 1986, CACTUS PRIMER, P286, DOI DOI 10.4159/HARVARD.9780674281714; Hernandez-Hernandez T, 2011, AM J BOT, V98, P44, DOI 10.3732/ajb.1000129; HIGUCHI T, 1990, WOOD SCI TECHNOL, V24, P23, DOI 10.1007/BF00225306; HOFFMANN GC, 1972, TAPPI, V55, P733; KIRK TK, 1975, WOOD SCI TECHNOL, V9, P81, DOI 10.1007/BF00353387; Kishimoto T, 2010, J AGR FOOD CHEM, V58, P895, DOI 10.1021/jf9035172; Loza-Cornejo S, 2003, INTERCIENCIA, V28, P83; Loza-Cornejo S., 1996, BOT SCI, V59, P13, DOI [10.17129/botsci.1502, DOI 10.17129/BOTSCI.1502]; Ludwig CH, 1971, LIGNINS OCCURRENCE F; Mauseth JD, 2006, ANN BOT-LONDON, V98, P901, DOI 10.1093/aob/mcl133; Mauseth JD, 2000, AM J BOT, V87, P1107, DOI 10.2307/2656647; Mauseth JD, 2004, J PLANT RES, V117, P69, DOI 10.1007/s10265-003-0131-5; Mauseth JD, 2001, INT J PLANT SCI, V162, P767, DOI 10.1086/320769; MAUSETH JD, 1995, AM J BOT, V82, P1199, DOI 10.2307/2446241; Mellerowicz EJ, 2001, PLANT MOL BIOL, V47, P239, DOI 10.1023/A:1010699919325; Mellerowicz EJ, 2008, CURR OPIN PLANT BIOL, V11, P293, DOI 10.1016/j.pbi.2008.03.003; MUSHA Y, 1975, WOOD SCI TECHNOL, V9, P45, DOI 10.1007/BF00351914; Niklas KJ, 1999, AM J BOT, V86, P767, DOI 10.2307/2656697; Niklas KJ, 2000, AM J BOT, V87, P469, DOI 10.2307/2656590; Nunes CA, 2010, BIORESOURCE TECHNOL, V101, P4056, DOI 10.1016/j.biortech.2010.01.012; Nuopponen MH, 2006, J APPL POLYM SCI, V102, P810, DOI 10.1002/app.24143; Ohra-aho T, 2013, J ANAL APPL PYROL, V101, P166, DOI 10.1016/j.jaap.2013.01.015; Olson ME, 2007, SYST BIODIVERS, V5, P145, DOI 10.1017/S1477200006002180; Orea IU, 2004, REV CHAPINGO S CIENC, V10, P51; Panshin AJ, 1980, TXB WOOD TECHNOLOGY, P652; Rana R, 2010, WOOD SCI TECHNOL, V44, P225, DOI 10.1007/s00226-009-0281-2; Reyes-Rivera J, 2010, THESIS U NACL AUTONO; SAKA S, 1988, HOLZFORSCHUNG, V42, P149, DOI 10.1515/hfsg.1988.42.3.149; Saka S, 2001, WOOD AND CELLULOSIC CHEMISTRY, SECOND EDITION, P51; Saka S., 1985, BIOSYNTHESIS BIODEGR, P51; Sarkanen K.V., 1971, LIGNINS OCCURRENCE F, P916; TAPPI (US Technical Association of Pulp and Paper Industry), 2002, T 222 OM 02 AC INS L; Terrazas Salgado T, 2002, CACTI BIOL USES, P23; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vazquez-Sanchez M, 2013, SYST BIODIVERS, V11, P103, DOI 10.1080/14772000.2013.775191; Vazquez-Sanchez M, 2012, BOT SCI, V90, P97, DOI 10.17129/botsci.477; Vazquez-Sanchez M, 2011, TREES-STRUCT FUNCT, V25, P755, DOI 10.1007/s00468-011-0553-y; Weng JK, 2010, PLANT CELL, V22, P1033, DOI 10.1105/tpc.109.073528; Xu F, 2006, IND CROP PROD, V23, P180, DOI 10.1016/j.indcrop.2005.05.008	59	20	20	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123919	10.1371/journal.pone.0123919	http://dx.doi.org/10.1371/journal.pone.0123919			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880223	Green Published, gold			2022-12-27	WOS:000353016500067
J	Yu, GY; Jiang, P; Xiang, Y; Zhang, Y; Zhu, Z; Zhang, CR; Lee, S; Lee, W; Zhang, Y				Yu, Guoyu; Jiang, Ping; Xiang, Yang; Zhang, Yong; Zhu, Zhu; Zhang, Chuanrao; Lee, Siman; Lee, Wenhui; Zhang, Yun			Increased Expression of Protease-Activated Receptor 4 and Trefoil Factor 2 in Human Colorectal Cancer	PLOS ONE			English	Article							DECREASED EXPRESSION; ABERRANT EXPRESSION; CELL-PROLIFERATION; MIGRATION; MOTILITY; TFF2; SKIN	Protease-activated receptor 4 (PAR4), a member of G-protein coupled receptors family, was recently reported to exhibit decreased expression in gastric cancer and esophageal squamous cancer, yet increased expression during the progression of prostate cancer. Trefoil factor 2 (TFF2), a small peptide constitutively expressed in the gastric mucosa, plays a protective role in restitution of gastric mucosa. Altered TFF2 expression was also related to the development of gastrointestinal cancer. TFF2 has been verified to promote cell migration via PAR4, but the roles of PAR4 and TFF2 in the progress of colorectal cancer are still unknown. In this study, the expression level of PAR4 and TFF2 in colorectal cancer tissues was measured using real-time PCR (n = 38), western blotting (n = 38) and tissue microarrays (n = 66). The mRNA and protein expression levels of PAR4 and TFF2 were remarkably increased in colorectal cancer compared with matched noncancerous tissues, especially in positive lymph node and poorly differentiated cancers. The colorectal carcinoma cell LoVo showed an increased response to TFF2 as assessed by cell invasion upon PAR4 expression. However, after intervention of PAR4 expression, PAR4 positive colorectal carcinoma cell HT-29 was less responsive to TFF2 in cell invasion. Genomic bisulfite sequencing showed the hypomethylation of PAR4 promoter in colorectal cancer tissues and the hypermethylation in the normal mucosa that suggested the low methylation of promoter was correlated to the increased PAR4 expression. Taken together, the results demonstrated that the up-regulated expression of PAR4 and TFF2 frequently occurs in colorectal cancer tissues, and that overexpression of PAR4 may be resulted from promoter hypomethylation. While TFF2 promotes invasion activity of LoVo cells overexpressing PAR4, and this effect was significantly decreased when PAR4 was knockdowned in HT-29 cells. Our findings will be helpful in further investigations into the functions and molecular mechanisms of Proteinase-activated receptors (PARs) and Trefoil factor factors (TFFs) during the progression of colorectal cancer.	[Yu, Guoyu; Jiang, Ping; Xiang, Yang; Zhang, Yong; Lee, Wenhui; Zhang, Yun] Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China; [Yu, Guoyu; Lee, Siman] Kunming Med Univ, Dept Biochem, Kunming 650500, Yunnan, Peoples R China; [Jiang, Ping] Kunming Med Univ, Dept Pathol & Pathophysiol, Kunming 650500, Yunnan, Peoples R China; [Zhu, Zhu] Kunming Med Univ, Affiliated Hosp 1, Dept Gastroenterol, Kunming 650032, Peoples R China; [Zhang, Chuanrao] Kunming Med Univ, Dept Funct Expt Ctr, Kunming 650500, Yunnan, Peoples R China	Chinese Academy of Sciences; Kunming Institute of Zoology; Kunming Medical University; Kunming Medical University; Kunming Medical University; Kunming Medical University	Xiang, Y (corresponding author), Chinese Acad Sci, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, Kunming 650223, Yunnan, Peoples R China.	yang_xiang000@hotmail.com; zhangy@mail.kiz.ac.cn			Chinese National Natural Science Foundation [81160302, 31270835]; Chinese Academy of Sciences [KJZD-EW-L03]; Yunnan Province Science and Technology Department Basic Research Foundation [2011FZ109]; State Key Laboratory of Genetic Resource and Evolution [GREKF11-13]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Yunnan Province Science and Technology Department Basic Research Foundation; State Key Laboratory of Genetic Resource and Evolution	This work was supported by grants from the Chinese National Natural Science Foundation (81160302, 31270835), the Chinese Academy of Sciences (KJZD-EW-L03), Yunnan Province Science and Technology Department Basic Research Foundation (2011FZ109) and State Key Laboratory of Genetic Resource and Evolution (GREKF11-13).	Black PC, 2007, PROSTATE, V67, P743, DOI 10.1002/pros.20503; Boire A, 2005, CELL, V120, P303, DOI 10.1016/j.cell.2004.12.018; Camerer E, 2007, THROMB RES, V120, pS75, DOI 10.1016/S0049-3848(07)70134-2; Chuang YY, 2004, CANCER RES, V64, P8271, DOI 10.1158/0008-5472.CAN-04-2097; Chung DC, 2000, GASTROENTEROLOGY, V119, P854, DOI 10.1053/gast.2000.16507; Darmoul D, 2003, AM J PATHOL, V162, P1503, DOI 10.1016/S0002-9440(10)64283-6; Dhar DK, 2003, LAB INVEST, V83, P1343, DOI 10.1097/01.LAB.0000085190.99749.15; Elste AP, 2010, J MOL HISTOL, V41, P89, DOI 10.1007/s10735-010-9274-6; Goerge T, 2006, CANCER RES, V66, P7766, DOI 10.1158/0008-5472.CAN-05-3897; Gratio V, 2009, INT J CANCER, V124, P1517, DOI 10.1002/ijc.24070; Hu GY, 2003, WORLD J GASTROENTERO, V9, P910; Jiang P, 2014, ONCOL LETT, V7, P1525, DOI 10.3892/ol.2014.1904; Jiang P, 2013, ASIAN PAC J CANCER P, V14, P3793, DOI 10.7314/APJCP.2013.14.6.3793; Jones PA, 1999, NAT GENET, V21, P163, DOI 10.1038/5947; Kaufmann R, 2002, INT J ONCOL, V20, P177; Kaufmann R, 2007, J CELL PHYSIOL, V211, P699, DOI 10.1002/jcp.21027; Kjellev S, 2009, CELL MOL LIFE SCI, V66, P1350, DOI 10.1007/s00018-008-8646-5; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Lee S, 2014, NEOPLASMA, V61, P546, DOI 10.4149/neo_2014_067; Liu SB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001770; Macfarlane SR, 2001, PHARMACOL REV, V53, P245; Madsen J, 2007, J HISTOCHEM CYTOCHEM, V55, P505, DOI 10.1369/jhc.6A7100.2007; Moss SF, 2008, CLIN CANCER RES, V14, P4161, DOI 10.1158/1078-0432.CCR-07-4381; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Rattenholl A, 2007, J INVEST DERMATOL, V127, P2245, DOI 10.1038/sj.jid.5700847; Taupin D, 2003, NAT REV MOL CELL BIO, V4, P721, DOI 10.1038/nrm1203; Thim L, 1997, CELL MOL LIFE SCI, V53, P888, DOI 10.1007/s000180050108; Venkatachalam R, 2010, CANCER GENET CYTOGEN, V203, P1, DOI 10.1016/j.cancergencyto.2010.08.013; Wong WM, 1999, GUT, V44, P890, DOI 10.1136/gut.44.6.890; Xu WF, 1998, P NATL ACAD SCI USA, V95, P6642, DOI 10.1073/pnas.95.12.6642; Zhang Y, 2011, CELL MOL LIFE SCI, V68, P3771, DOI 10.1007/s00018-011-0678-6; Zhang Y, 2011, INT J BIOCHEM CELL B, V43, P1277, DOI 10.1016/j.biocel.2011.05.008	33	20	22	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122678	10.1371/journal.pone.0122678	http://dx.doi.org/10.1371/journal.pone.0122678			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876034	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100093
J	Giollo, M; Minervini, G; Scalzotto, M; Leonardi, E; Ferrari, C; Tosatto, SCE				Giollo, Manuel; Minervini, Giovanni; Scalzotto, Marta; Leonardi, Emanuela; Ferrari, Carlo; Tosatto, Silvio C. E.			BOOGIE: Predicting Blood Groups from High Throughput Sequencing Data	PLOS ONE			English	Article							GENOTYPING REPLACE SEROLOGY; FUTURE; IDENTIFICATION; TRANSFUSION; ASSOCIATION; VARIANTS; MEDICINE; ALLELES; PROJECT; COMMON	Over the last decade, we have witnessed an incredible growth in the amount of available genotype data due to high throughput sequencing (HTS) techniques. This information may be used to predict phenotypes of medical relevance, and pave the way towards personalized medicine. Blood phenotypes (e.g. ABO and Rh) are a purely genetic trait that has been extensively studied for decades, with currently over thirty known blood groups. Given the public availability of blood group data, it is of interest to predict these phenotypes from HTS data which may translate into more accurate blood typing in clinical practice. Here we propose BOOGIE, a fast predictor for the inference of blood groups from single nucleotide variant (SNV) databases. We focus on the prediction of thirty blood groups ranging from the well known ABO and Rh, to the less studied Junior or Diego. BOOGIE correctly predicted the blood group with 94% accuracy for the Personal Genome Project whole genome profiles where good quality SNV annotation was available. Additionally, our tool produces a high quality haplotype phase, which is of interest in the context of ethnicity-specific polymorphisms or traits. The versatility and simplicity of the analysis make it easily interpretable and allow easy extension of the protocol towards other phenotypes. BOOGIE can be down-loaded from URL http://protein.bio.unipd.it/download/.	[Giollo, Manuel; Minervini, Giovanni; Scalzotto, Marta; Tosatto, Silvio C. E.] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy; [Giollo, Manuel; Ferrari, Carlo] Univ Padua, Dept Informat Engn, I-35121 Padua, Italy; [Leonardi, Emanuela] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy	University of Padua; University of Padua; University of Padua	Tosatto, SCE (corresponding author), Univ Padua, Dept Biomed Sci, Viale G Colombo 3, I-35131 Padua, Italy.	silvio.tosatto@unipd.it	Minervini, Giovanni/D-1200-2013; Tosatto, Silvio/B-2840-2009; leonardi, emanuela/AAN-2392-2020; Ferrari, Carlo/AAU-8107-2021	Minervini, Giovanni/0000-0001-7013-5785; Tosatto, Silvio/0000-0003-4525-7793; leonardi, emanuela/0000-0001-8486-8461; FERRARI, CARLO/0000-0003-3665-0446	Italian Ministry of Health [GR-2011-02346845]; FIRB Futuro in Ricerca [RBFR08ZSXY]; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Italian Ministry of Health(Ministry of Health, Italy); FIRB Futuro in Ricerca(Ministry of Education, Universities and Research (MIUR)Fund for Investment in Basic Research (FIRB)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	GM is an AIRC research fellow. This work was also supported by Italian Ministry of Health grant GR-2011-02346845 and FIRB Futuro in Ricerca grant RBFR08ZSXY to ST. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; Amado M, 2000, VOX SANG, V79, P219, DOI 10.1046/j.1423-0410.2000.7940219.x; Anstee DJ, 2009, BLOOD, V114, P248, DOI 10.1182/blood-2008-11-146860; Avent ND, 2009, TRANSFUS MED HEMOTH, V36, P162, DOI 10.1159/000218192; Ball MP, 2012, P NATL ACAD SCI USA, V109, P11920, DOI 10.1073/pnas.1201904109; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Bugert P, 2009, TRANSFUSION, V49, P1793, DOI 10.1111/j.1537-2995.2009.02220.x; Burke W, 2007, JAMA-J AM MED ASSOC, V298, P1682, DOI 10.1001/jama.298.14.1682; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Church GM, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100040; COLIN Y, 1986, J BIOL CHEM, V261, P229; Cooper GM, 2011, NAT REV GENET, V12, P628, DOI 10.1038/nrg3046; Denomme GA, 2011, TRANSFUS APHER SCI, V44, P53, DOI 10.1016/j.transci.2010.12.010; Doscher A, 2009, TRANSFUSION, V49, P1803, DOI 10.1111/j.1537-2995.2009.02221.x; Flegel WA, 2011, TRANSFUS APHER SCI, V44, P81, DOI 10.1016/j.transci.2010.12.013; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Giardine B, 2007, HUM MUTAT, V28, P554, DOI 10.1002/humu.20484; Goodnough LT, 2013, LANCET, V381, P1845, DOI 10.1016/S0140-6736(13)60650-9; Goodnough LT, 1999, NEW ENGL J MED, V340, P438, DOI 10.1056/NEJM199902113400606; Gubin AN, 2000, BLOOD, V96, P2621; Helias V, 2012, NAT GENET, V44, P170, DOI 10.1038/ng.1069; Horaitis O, 2007, NAT GENET, V39, P425, DOI 10.1038/ng0407-425; Huang CH, 1999, TRANSFUSION, V39, P1259, DOI 10.1046/j.1537-2995.1999.39111259.x; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Kasprzyk A, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar049; Kauppi L, 2004, NAT REV GENET, V5, P413, DOI 10.1038/nrg1346; Legler TJ, 1999, TRANSFUSION, V39, P852, DOI 10.1046/j.1537-2995.1999.39080852.x; Lublin DM, 2000, TRANSFUSION, V40, P208, DOI 10.1046/j.1537-2995.2000.40020208.x; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Patnaik SK, 2012, NUCLEIC ACIDS RES, V40, pD1023, DOI 10.1093/nar/gkr958; Rentas FJ, 1999, MIL MED, V164, P785, DOI 10.1093/milmed/164.11.785; Saison C, 2012, NAT GENET, V44, P174, DOI 10.1038/ng.1070; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Storry JR, 2009, TRANSFUS MED HEMOTH, V36, P232, DOI 10.1159/000214939; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Telen MJ, 1996, J BIOL CHEM, V271, P7147, DOI 10.1074/jbc.271.12.7147; Thorisson GA, 2005, GENOME RES, V15, P1592, DOI 10.1101/gr.4413105; van de Pas NCA, 2012, J LIPID RES, V53, P2734, DOI 10.1194/jlr.M031930; van der Schoot CE, 2009, TRANSFUS MED HEMOTH, V36, P234, DOI 10.1159/000214840; von Bubnoff A, 2008, CELL, V132, P721, DOI 10.1016/j.cell.2008.02.028; Yip SP, 2002, ANN HUM GENET, V66, P1, DOI 10.1017/S0003480001008995	42	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124579	10.1371/journal.pone.0124579	http://dx.doi.org/10.1371/journal.pone.0124579			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893845	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700107
J	Otto, GP; Hurtado-Oliveros, J; Chung, HY; Knoll, K; Neumann, T; Mueller, HJ; Herbsleb, M; Kohl, M; Busch, M; Sossdorf, M; Claus, RA				Otto, Gordon P.; Hurtado-Oliveros, Jorge; Chung, Ha-Yeun; Knoll, Kristin; Neumann, Thomas; Mueller, Hans J.; Herbsleb, Marco; Kohl, Matthias; Busch, Martin; Sossdorf, Maik; Claus, Ralf A.			Plasma Neutrophil Gelatinase-Associated Lipocalin Is Primarily Related to Inflammation during Sepsis: A Translational Approach	PLOS ONE			English	Article							ACUTE KIDNEY INJURY; INTRACELLULAR IRON; IDENTIFICATION; BIOMARKER; NGAL; ADMISSION; INFECTION; PROTEINS; PREDICTS; IL-10	Acute kidney injury (AKI) during sepsis is common and underestimated. Plasma neutrophil gelatinase-associated lipocalin (plasma-NGAL) is discussed as new biomarker for AKI diagnosis, but during inflammation its function and diagnostic impact remain unclear. The association between plasma-NGAL and inflammatory markers in septic patients, but also in healthy controls and patients with chronic inflammation before and after either maximum exercise test or treatment with an anti-TNF therapy were investigated. In-vitro blood stimulations with IL-6, lipopolysaccharide, NGAL or its combinations were performed to investigate cause-effect-relationship. Plasma-NGAL levels were stronger associated with inflammation markers including IL-6 (Sepsis: r=0.785 P<0.001; chronic inflammation after anti-TNF: r=0.558 P<0.001), IL-8 (Sepsis: r=0.714 P<0.004; healthy controls after exercise r=0.786 P<0.028; chronic inflammation before anti-TNF: r=0.429 P<0.041) and IL-10 (healthy controls before exercise: r=0.791 P<0.028) than with kidney injury or function. Correlation to kidney injury or function was found only in septic patients (for creatinine: r=0.906 P<0.001; for eGFR: r=-0.686 P=0.005) and in patients with rheumatic disease after anti-TNF therapy (for creatinine: r=0.466 P<0.025). In stimulation assays with IL-6 and lipopolysaccharide plasma-NGAL was increased. Co-stimulation of lipopolysaccharide with plasma-NGAL decreased cellular injury (P<0.05) and in trend IL-10 levels (P=0.057). Septic mice demonstrated a significantly improved survival rate after NGAL treatment (P<0.01). Plasma-NGAL seams to be strongly involved in inflammation. For clinical relevance, it might not only be useful for AKI detection during severe inflammation - indeed it has to be interpreted carefully within this setting - but additionally might offer therapeutic potential.	[Otto, Gordon P.; Hurtado-Oliveros, Jorge; Chung, Ha-Yeun; Sossdorf, Maik; Claus, Ralf A.] Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany; [Otto, Gordon P.; Sossdorf, Maik; Claus, Ralf A.] Jena Univ Hosp, Clin Anesthesiol & Intens Care, Jena, Germany; [Knoll, Kristin; Neumann, Thomas] Jena Univ Hosp, Clin Internal Med Rheumatol KIM 3, Jena, Germany; [Mueller, Hans J.; Herbsleb, Marco] Univ Jena, Dept Sports Med & Hlth Promot, Jena, Germany; [Kohl, Matthias] Furtwangen Univ, Dept Med & Life Sci, Villingen Schwenningen, Germany; [Busch, Martin] Jena Univ Hosp, Clin Internal Med Nephrol KIM 3, Jena, Germany	Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Otto, GP (corresponding author), Jena Univ Hosp, Ctr Sepsis Control & Care, Jena, Germany.	gordonpotto@googlemail.com	Kohl, Matthias/R-6096-2019; Neumann, Thomas/F-2116-2016; Claus, Ralf A./Q-4035-2016	Kohl, Matthias/0000-0001-9514-8910; Neumann, Thomas/0000-0001-6810-6889; Claus, Ralf A./0000-0001-7232-4088	Federal Ministry of Education and Research (BMBF) [FKZ 01EO1002, D1.21]	Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This publication was funded by research funding from the Federal Ministry of Education and Research (BMBF, FKZ 01EO1002) to the Center of Sepsis Control and Care (to GPO, project number D1.21). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arena A, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/613937; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; Bao GH, 2010, NAT CHEM BIOL, V6, P602, DOI [10.1038/nchembio.402, 10.1038/NCHEMBIO.402]; BAUD L, 1989, KIDNEY INT, V35, P1111, DOI 10.1038/ki.1989.98; Bellmann-Weiler R, 2013, IMMUNOBIOLOGY, V218, P969, DOI 10.1016/j.imbio.2012.11.004; Berger T, 2006, P NATL ACAD SCI USA, V103, P1834, DOI 10.1073/pnas.0510847103; Bihorac A, 2013, J TRAUMA ACUTE CARE, V74, P1005, DOI 10.1097/TA.0b013e31828586ec; Chertow GM, 2005, J AM SOC NEPHROL, V16, P3365, DOI 10.1681/ASN.2004090740; Clerico A, 2012, CLIN CHEM LAB MED, V50, P1505, DOI 10.1515/cclm-2011-0814; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Cowland JB, 1997, GENOMICS, V45, P17, DOI 10.1006/geno.1997.4896; Cowland JB, 2003, J IMMUNOL, V171, P6630, DOI 10.4049/jimmunol.171.12.6630; Cunningham PN, 2002, J IMMUNOL, V168, P5817, DOI 10.4049/jimmunol.168.11.5817; Darmon M, 2011, AM J RESP CRIT CARE, V184, P142, DOI 10.1164/ajrccm.184.1.142a; de Geus HRH, 2013, BIOMARK MED, V7, P415, DOI [10.2217/BMM.13.5, 10.2217/bmm.13.5]; de Geus HRH, 2011, AM J RESP CRIT CARE, V183, P907, DOI 10.1164/rccm.200908-1214OC; Eichacker PQ, 2002, AM J RESP CRIT CARE, V166, P1197, DOI 10.1164/rccm.200204-302OC; Eller K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067693; Esposito BP, 2003, BLOOD, V102, P2670, DOI 10.1182/blood-2003-03-0807; Flo TH, 2004, NATURE, V432, P917, DOI 10.1038/nature03104; Haase M, 2012, AM J RESP CRIT CARE, V185, P343, DOI 10.1164/ajrccm.185.3.343a; Han M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-25; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Huang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082250; Katagiri D, 2013, J CRIT CARE, V28, P564, DOI 10.1016/j.jcrc.2013.01.009; Kjeldsen L, 2000, BBA-PROTEIN STRUCT M, V1482, P272, DOI 10.1016/S0167-4838(00)00152-7; KJELDSEN L, 1994, BLOOD, V83, P799; Landro L, 2008, CLIN EXP IMMUNOL, V152, P57, DOI 10.1111/j.1365-2249.2008.03592.x; Langenberg C, 2007, INTENS CARE MED, V33, P1614, DOI 10.1007/s00134-007-0734-8; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Li JY, 2004, AM J PHYSIOL-CELL PH, V287, pC1547, DOI 10.1152/ajpcell.00260.2004; LIU QS, 1995, J BIOL CHEM, V270, P22565, DOI 10.1074/jbc.270.38.22565; MEHEUS LA, 1993, J IMMUNOL, V151, P1535; Mellor A, 2013, DIS MARKERS, V2013, P537, DOI 10.1155/2013/601214; Mishra J, 2004, J AM SOC NEPHROL, V15, P3073, DOI 10.1097/01.ASN.0000145013.44578.45; Mishra J, 2003, J AM SOC NEPHROL, V14, P2534, DOI 10.1097/01.ASN.0000088027.54400.C6; Mori K, 2005, J CLIN INVEST, V115, P610, DOI 10.1172/JCI200523056; Nairz M, 2009, BLOOD, V114, P3642, DOI 10.1182/blood-2009-05-223354; Oikonomou KA, 2012, J GASTROENTEROL, V47, P519, DOI 10.1007/s00535-011-0516-5; Otto GP, 2013, CRIT CARE, V17, DOI 10.1186/cc12540; Otto GP, 2012, CRIT CARE, V16, DOI 10.1186/cc11205; Otto GP, 2015, NEPHRON; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Roudkenar MH, 2011, FREE RADICAL RES, V45, P810, DOI 10.3109/10715762.2011.581279; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schmidt-Ott KM, 2007, J AM SOC NEPHROL, V18, P407, DOI 10.1681/ASN.2006080882; Tilg H, 2002, J IMMUNOL, V169, P2204, DOI 10.4049/jimmunol.169.4.2204; Wan Li, 2003, Curr Opin Crit Care, V9, P496, DOI 10.1097/00075198-200312000-00006	49	29	29	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124429	10.1371/journal.pone.0124429	http://dx.doi.org/10.1371/journal.pone.0124429			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893429	Green Submitted, gold, Green Published			2022-12-27	WOS:000353211700092
J	Gao, J; Roan, E; Williams, JL				Gao, Jie; Roan, Esra; Williams, John L.			Regional Variations in Growth Plate Chondrocyte Deformation as Predicted By Three-Dimensional Multi-Scale Simulations	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; ARTICULAR-CARTILAGE; TISSUE STRAIN; ION CHANNELS; CELL; BEHAVIOR; INDENTATION; CARTERS; STRESS	The physis, or growth plate, is a complex disc-shaped cartilage structure that is responsible for longitudinal bone growth. In this study, a multi-scale computational approach was undertaken to better understand how physiological loads are experienced by chondrocytes embedded inside chondrons when subjected to moderate strain under instantaneous compressive loading of the growth plate. Models of representative samples of compressed bone/growth-plate/bone from a 0.67mm thick 4-month old bovine proximal tibial physis were subjected to a prescribed displacement equal to 20% of the growth plate thickness. At the macroscale level, the applied compressive deformation resulted in an overall compressive strain across the proliferative-hypertrophic zone of 17%. The microscale model predicted that chondrocytes sustained compressive height strains of 12% and 6% in the proliferative and hypertrophic zones, respectively, in the interior regions of the plate. This pattern was reversed within the outer 300 mu m region at the free surface where cells were compressed by 10% in the proliferative and 26% in the hypertrophic zones, in agreement with experimental observations. This work provides a new approach to study growth plate behavior under compression and illustrates the need for combining computational and experimental methods to better understand the chondrocyte mechanics in the growth plate cartilage. While the current model is relevant to fast dynamic events, such as heel strike in walking, we believe this approach provides new insight into the mechanical factors that regulate bone growth at the cell level and provides a basis for developing models to help interpret experimental results at varying time scales.	[Gao, Jie] Univ Memphis, Dept Mech Engn, Memphis, TN 38152 USA; [Roan, Esra; Williams, John L.] Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA	University of Memphis; University of Memphis	Roan, E (corresponding author), Univ Memphis, Dept Biomed Engn, Memphis, TN 38152 USA.	erean@memphis.edu	Williams, John Leicester/B-9452-2008	Williams, John Leicester/0000-0001-8251-4176				ABAQUS, ABAQUS 6 12 DOC; Allen DM, 2004, J STRUCTURAL BIOL, V145; Amini S, 2010, J BIOMECHANICS, V43; Amini S, 2011, STRESS RELAXATION GR; Amini S, 2013, BIOMECH MODEL MECHAN, V12, P67, DOI 10.1007/s10237-012-0382-y; Appelman TP, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4003314; BURRIDGE K, 1988, ANNU REV CELL BIOL, V4, P487, DOI 10.1146/annurev.cb.04.110188.002415; CARTER DR, 1988, J ORTHOPAED RES, V6, P804, DOI 10.1002/jor.1100060604; Carter DR, 2003, PHILOS T ROYAL SOC B, V358; Chahine NO, 2007, EUR CELLS MATER, V13, P100, DOI 10.22203/eCM.v013a11; Choi JB, 2007, J BIOMECHANICS, V40; COHEN B, 1994, J ORTHOP RES, V12, P804, DOI 10.1002/jor.1100120608; Cohen B, 1998, J BIOMECHANICAL ENG, V120; Destrade M, 2012, INT J NUMER METH ENG, V90, P403, DOI 10.1002/nme.3326; EGGLI PS, 1985, ANAT REC, V211, P246, DOI 10.1002/ar.1092110304; FROST HM, 1990, ANAT RECORD, V226, P423, DOI 10.1002/ar.1092260404; Frost HM, 1997, BONE, V20, P385, DOI 10.1016/S8756-3282(97)00019-7; Gao J., 2014, OPEN J BIOPHYS, V4, P13, DOI [DOI 10.4236/OJBIPHY.2014.41003, 10.4236/ojbiphy.2014.41003]; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Guilak F, 2000, J BIOMECH, V33, P1663, DOI 10.1016/S0021-9290(00)00105-6; HORI RY, 1976, J BIOMECH, V9, P259, DOI 10.1016/0021-9290(76)90012-9; Hueter C, 1862, VIRKOWS ARCH PATH AN, V25, P28; Hui TH, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.118101; Jiang HY, 2013, BIOPHYS J, V105, P609, DOI 10.1016/j.bpj.2013.06.021; Jin H, 2004, J BIOMECH ENG-T ASME, V126, P138, DOI 10.1115/1.1688772; Koay EJ, 2003, J BIOMECH ENG-T ASME, V125, P334, DOI 10.1115/1.1572517; Lai VK, 2013, J BIOMECHANICAL ENG, V135; Leipzig ND, 2005, J BIOMECH, V38, P77, DOI 10.1016/j.jbiomech.2004.03.013; Lerner AL, 1997, J ORTHOP RES, V15, P353, DOI 10.1002/jor.1100150307; Lerner AL, 1998, J BIOMECH, V31, P327, DOI 10.1016/S0021-9290(98)00015-3; LIPPIELLO L, 1989, J ORTHOPAED RES, V7, P868, DOI 10.1002/jor.1100070613; Madden R, 2013, J BIOMECH, V46, P554, DOI 10.1016/j.jbiomech.2012.09.021; Mao JJ, 2004, AM J ORTHOD DENTOFAC, V125, P676, DOI 10.1016/j.ajodo.2003.08.024; Mobasheri A, 2002, CELL BIOL INT, V26, P1, DOI 10.1006/cbir.2001.0826; Moeendarbary E, 2013, NAT MATER, V12, P253, DOI [10.1038/NMAT3517, 10.1038/nmat3517]; Moo EK, 2014, J BIOMECH, V47, P1004, DOI 10.1016/j.jbiomech.2014.01.003; Nguyen BV, 2010, J ROYAL SOC INTERFAC, V7; Ofek G, 2009, BIOPHYS J, V97, P1873, DOI 10.1016/j.bpj.2009.07.050; PAUWELS F, 1960, Z Anat Entwicklungsgesch, V121, P478, DOI 10.1007/BF00523401; Piszczatowski S, 2012, ACTA BIOENG BIOMECH, V14, P93; Piszczatowski S, 2011, ACTA BIOENG BIOMECH, V13, P3; Radhakrishnan P, 2004, ANNALS OF BIOMEDICAL, V32; Rieppo J, 2001, 47 ANN M ORTH RES SO, P0440; SACHS F, 1991, MOL CELL BIOCHEM, V104, P57; Sergerie K, 2009, J BIOMECHANICS, V42; Shieh AC, 2006, J BIOMECH, V39, P1595, DOI 10.1016/j.jbiomech.2005.05.002; Stokes I. A. F., 2002, Journal of Musculoskeletal & Neuronal Interactions, V2, P277; Trickey WR, 2000, J ORTHOPAED RES, V18, P891, DOI 10.1002/jor.1100180607; Tutorino JC, 2001, 47 ANN M ORTH RES SO; Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286; Villemure I, 2007, J BIOMECHANICS, V40; Villemure I, 2009, J BIOMECHANICS, V42; Volkmann R., 1882, HDB ALLGEMEINEN SPEC; WATSON PA, 1991, FASEB J, V5, P2013, DOI 10.1096/fasebj.5.7.1707019; Wosu R, 2012, BIOMECH MODEL MECHAN, V11, P303, DOI 10.1007/s10237-011-0310-6; Zhou EH, 2009, P NATL ACAD SCI USA, V106, P10632, DOI 10.1073/pnas.0901462106	56	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124862	10.1371/journal.pone.0124862	http://dx.doi.org/10.1371/journal.pone.0124862			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885547	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000146
J	Li, ZY; Wang, N; Dong, L; Bai, H; Quan, JZ; Liu, L; Dong, ZP				Li, Zhi Yong; Wang, Nan; Dong, Li; Bai, Hui; Quan, Jian Zhang; Liu, Lei; Dong, Zhi-Ping			Differential Gene Expression in Foxtail Millet during Incompatible Interaction with Uromyces setariae-italicae	PLOS ONE			English	Article							CONFERS RESISTANCE; PROTEIN-KINASE; PLANT; IDENTIFICATION; PATHOGEN; DEFENSE; STRESS; RUST; SGT1; RNA	Foxtail millet (Setaria italica) is an important food and fodder grain crop that is grown for human consumption. Production of this species is affected by several plant diseases, such as rust. The cultivar Shilixiang has been identified as resistant to the foxtail millet rust pathogen, Uromyces setariae-italicae. In order to identify signaling pathways and genes related to the plant's defense mechanisms against rust, the Shilixiang cultivar was used to construct a digital gene expression (DGE) library during the interaction of foxtail millet with U. setariae-italicae. In this study, we determined the most abundant differentially expressed signaling pathways of up-regulated genes in foxtail millet and identified significantly up-regulated genes. Finally, quantitative real-time polymerase chain reaction (qRT-PCR) analysis was used to analyze the expression of nine selected genes, and the patterns observed agreed well with DGE analysis. Expression levels of the genes were also compared between a resistant cultivar Shilixiang and a susceptible cultivar Yugu-1, and the result indicated that expression level of Shilixiang is higher than that of Yugu-1. This study reveals the relatively comprehensive mechanisms of rust-responsive transcription in foxtail millet.	[Li, Zhi Yong; Wang, Nan; Dong, Li; Bai, Hui; Quan, Jian Zhang; Liu, Lei; Dong, Zhi-Ping] Hebei Acad Agr & Forestry Sci, Dept Plant Protect, Minor Cereal Crops Lab Hebei Prov, Natl Foxtail Millet Improvement Ctr,Millet Inst, Shijiazhuang, Peoples R China; [Wang, Nan] Hebei Normal Univ, Coll Life Sci, Shijiazhuang, Peoples R China	Hebei Academy of Agricultural & Forestry Sciences; Hebei Normal University	Dong, ZP (corresponding author), Hebei Acad Agr & Forestry Sci, Dept Plant Protect, Minor Cereal Crops Lab Hebei Prov, Natl Foxtail Millet Improvement Ctr,Millet Inst, Shijiazhuang, Peoples R China.	dzping001@163.corn		li, zhiyong/0000-0001-6668-3009	National Natural Science Foundation of China [31271787, 31101163]; Natural Science Foundation of China of Hebei [C2013301037, C2014301028]; Special Project for Key Basic Research of 973 Program [2014CB160305]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China of Hebei; Special Project for Key Basic Research of 973 Program	This work was supported by the National Natural Science Foundation of China (31271787, 31101163), the Natural Science Foundation of China of Hebei (C2013301037, C2014301028), and Special Project for Key Basic Research of 973 Program (2014CB160305). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin MJ, 2002, SCIENCE, V295, P2077, DOI 10.1126/science.1067747; Azevedo C, 2002, SCIENCE, V295, P2073, DOI 10.1126/science.1067554; Bennetzen JL, 2012, NAT BIOTECHNOL, V30, P555, DOI 10.1038/nbt.2196; Bravo JM, 2003, PLANT MOL BIOL, V52, P745, DOI 10.1023/A:1025016416951; Cai GH, 2014, PLANT SCI, V214, P57, DOI 10.1016/j.plantsci.2013.09.014; Chi YJ, 2013, MOL PLANT, V6, P287, DOI 10.1093/mp/sst026; Crampton BG, 2009, MOL PLANT PATHOL, V10, P291, DOI 10.1111/j.1364-3703.2008.00532.x; Dangl JL, 2001, NATURE, V411, P826, DOI 10.1038/35081161; de Wit PJGM, 2007, CELL MOL LIFE SCI, V64, P2726, DOI 10.1007/s00018-007-7284-7; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; FOFANA B, 2007, INT J PLANT GENOMICS, P1, DOI DOI 10.1155/2007/17542; Gomez-Vasquez R, 2004, ANN BOT-LONDON, V94, P87, DOI 10.1093/aob/mch107; Goodman R. N., 1994, HYPERSENSITIVE REACT; Jia GQ, 2013, NAT GENET, V45, P957, DOI 10.1038/ng.2673; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kobayashi M, 2012, NEW PHYTOL, V196, P223, DOI 10.1111/j.1469-8137.2012.04226.x; Kumar KRR, 2011, PLANT MOL BIOL, V75, P497, DOI 10.1007/s11103-011-9747-3; Lata C, 2013, CRIT REV BIOTECHNOL, V33, P328, DOI 10.3109/07388551.2012.716809; Li YG, 2011, AGR SCI CHINA, V10, P902, DOI 10.1016/S1671-2927(11)60075-8; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig AA, 2005, P NATL ACAD SCI USA, V102, P10736, DOI 10.1073/pnas.0502954102; Macho AP, 2014, MOL CELL, V54, P263, DOI 10.1016/j.molcel.2014.03.028; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Menke FLH, 2005, MOL PLANT MICROBE IN, V18, P1027, DOI 10.1094/MPMI-18-1027; Muthamilarasan M, 2015, THEOR APPL GENET, V128, P1, DOI 10.1007/s00122-014-2399-3; Muthamilarasan M, 2013, J BIOSCIENCES, V38, P433, DOI 10.1007/s12038-013-9302-2; NARASIMHAN MJ, 1964, MYCOLOGIA, V56, P555, DOI 10.2307/3756360; Qi XH, 2012, GENOMICS, V99, P160, DOI 10.1016/j.ygeno.2011.12.008; Rep M, 2002, PLANT PHYSIOL, V130, P904, DOI 10.1104/pp.007427; Sekhon RS, 2006, PHYSIOL MOL PLANT P, V69, P109, DOI 10.1016/j.pmpp.2007.02.004; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Tian DQ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-827; Xiao SQ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-544; Yang YO, 1997, GENE DEV, V11, P1621, DOI 10.1101/gad.11.13.1621; Zhao LiQiang, 2010, Scientia Agricultura Sinica, V43, P4349; Zhou J, 2014, MOL PLANT PATHOL, V15, P637, DOI 10.1111/mpp.12118	37	8	8	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123825	10.1371/journal.pone.0123825	http://dx.doi.org/10.1371/journal.pone.0123825			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885767	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000087
J	Liu, Y; Li, M; Yang, D; Zhang, XN; Wu, AS; Yao, SL; Xue, ZG; Yue, Y				Liu, Yu; Li, Min; Yang, Dong; Zhang, Xuena; Wu, Anshi; Yao, Shanglong; Xue, Zhanggang; Yue, Yun			Closed-Loop Control Better than Open-Loop Control of Profofol TCI Guided by BIS: A Randomized, Controlled, Multicenter Clinical Trial to Evaluate the CONCERT-CL Closed-Loop System	PLOS ONE			English	Article							BISPECTRAL INDEX; DELIVERY-SYSTEM; PROPOFOL; REMIFENTANIL; ANESTHESIA; TITRATION; CONSCIOUSNESS; PERFORMANCE; INFUSION; SURGERY	Background The CONCERT-CL closed-loop infusion system designed by VERYARK Technology Co., Ltd. (Guangxi, China) is an innovation using TCI combined with closed-loop controlled intravenous anesthesia under the guide of BIS. In this study we performed a randomized, controlled, multicenter study to compare closed-loop control and open-loop control of propofol by using the CONCERT-CL closed-loop infusion system. Methods 180 surgical patients from three medical centers undergone TCI intravenous anesthesia with propofol and remifentanil were randomly assigned to propofol closed-loop group and propofol opened-loop groups. Primary outcome was global score (GS, GS = (MDAPE + Wobble)/% of time of bispectral index (BIS) 40-60). Secondary outcomes were doses of the anesthetics and emergence time from anesthesia, such as, time to tracheal extubation. Results There were 89 and 86 patients in the closed-loop and opened-loop groups, respectively. GS in the closed-loop groups (22.21 +/- 8.50) were lower than that in the opened-loop group (27.19 +/- 15.26) (p= 0.009). The higher proportion of time of BIS between 40 and 60 was also observed in the closed-loop group (84.11 +/- 9.50%), while that was 79.92 +/- 13.17% in the opened-loop group, (p= 0.016). No significant differences in propofol dose and time of tracheal extubation were observed. The frequency of propofol regulation in the closed-loop group (31.55 +/- 9.46 times/hr) was obverse higher than that in the opened-loop group (6.84 +/- 6.21 times/hr) (p= 0.000). Conclusion The CONCERT-CL closed-loop infusion system can automatically regulate the TCI of propofol, maintain the BIS value in an adequate range and reduce the workload of anesthesiologists better than open-loop system.	[Liu, Yu; Zhang, Xuena; Wu, Anshi; Yue, Yun] Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Li, Min; Xue, Zhanggang] Fudan Univ, Zhongshan Hosp, Dept Anesthesiol, Shanghai 200433, Peoples R China; [Yang, Dong; Yao, Shanglong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Anesthesiol, Wuhan 430074, Peoples R China	Capital Medical University; Fudan University; Huazhong University of Science & Technology	Yue, Y (corresponding author), Capital Med Univ, Beijing Chaoyang Hosp, Dept Anesthesiol, Beijing, Peoples R China.	yueyun@hotmail.com	Yang, Dong/GSD-6859-2022	Wu, Anshi/0000-0003-2353-2184				Agarwal J, 2009, ACTA ANAESTH SCAND, V53, P390, DOI 10.1111/j.1399-6576.2008.01884.x; Biswas I, 2013, PEDIATR ANESTH, V23, P1145, DOI 10.1111/pan.12265; Dussaussoy C, 2014, J CLIN MONIT COMPUT, V28, P35, DOI 10.1007/s10877-013-9453-6; Guignard B, 2000, ANESTH ANALG, V90, P161, DOI 10.1097/00000539-200001000-00034; Hemmerling TM, 2013, BRIT J ANAESTH, V110, P1031, DOI 10.1093/bja/aet001; Hemmerling TM, 2010, CAN J ANESTH, V57, P725, DOI 10.1007/s12630-010-9335-z; Iselin-Chaves IA, 1998, ANESTH ANALG, V87, P949; Kenny GN, 1999, BR J ANAESTH; Liu N, 2006, ANESTHESIOLOGY, V104, P686, DOI 10.1097/00000542-200604000-00012; Liu N, 2008, J CARDIOTHOR VASC AN, V22, P611, DOI 10.1053/j.jvca.2008.04.022; Liu N, 2012, ANESTHESIOLOGY, V116, P286, DOI 10.1097/ALN.0b013e318242ad4f; Liu N, 2011, ANESTH ANALG, V112, P546, DOI 10.1213/ANE.0b013e318205680b; MARSH B, 1991, BRIT J ANAESTH, V67, P41, DOI 10.1093/bja/67.1.41; Minto CF, 1997, ANESTHESIOLOGY, V86, P10, DOI 10.1097/00000542-199701000-00004; Puri GD, 2007, ANAESTH INTENS CARE, V35, P357, DOI 10.1177/0310057X0703500306; SCHWILDEN H, 1989, BRIT J ANAESTH, V62, P290, DOI 10.1093/bja/62.3.290; VARVEL JR, 1992, J PHARMACOKINET BIOP, V20, P63, DOI 10.1007/BF01143186; Westenskow DR, 1987, J CLIN MONIT COMPUT, V2, P69	18	9	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123862	10.1371/journal.pone.0123862	http://dx.doi.org/10.1371/journal.pone.0123862			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886041	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000089
J	Smeulers, M; Verweij, L; Maaskant, JM; de Boer, M; Krediet, CTP; van Dijkum, EJMN; Vermeulen, H				Smeulers, Marian; Verweij, Lotte; Maaskant, Jolanda M.; de Boer, Monica; Krediet, C. T. Paul; van Dijkum, Els J. M. Nieveen; Vermeulen, Hester			Quality Indicators for Safe Medication Preparation and Administration: A Systematic Review	PLOS ONE			English	Review							EVIDENCE-BASED MEDICINE; HEALTH-CARE; IMPROVEMENT	Background One-third of all medication errors causing harm to hospitalized patients occur in the medication preparation and administration phase, which is predominantly a nursing activity. To monitor, evaluate and improve the quality and safety of this process, evidence-based quality indicators can be used. Objectives The aim of study was to identify evidence-based quality indicators (structure, process and outcome) for safe in-hospital medication preparation and administration. Methods MEDLINE, EMBASE and CINAHL were searched for relevant studies published up to January 2015. Additionally, nine databases were searched to identify relevant grey literature. Two reviewers independently selected studies if (1) the method for quality indicator development combined a literature search with expert panel opinion, (2) the study contained quality indicators on medication safety, and (3) any of the quality indicators were applicable to hospital medication preparation and administration. A multidisciplinary team appraised the studies independently using the AIRE instrument, which contains four domains and 20 items. Quality indicators applicable to in-hospital medication preparation and administration were extracted using a structured form. Results The search identified 1683 studies, of which 64 were reviewed in detail and five met the inclusion criteria. Overall, according to the AIRE domains, all studies were clear on purpose; most of them applied stakeholder involvement and used evidence reasonably; usage of the indicator in practice was scarcely described. A total of 21 quality indicators were identified: 5 structure indicators (e.g. safety management and high alert medication), 11 process indicators (e.g. verification and protocols) and 5 outcome indicators (e.g. harm and death). These quality indicators partially cover the 7 rights. Conclusion Despite the relatively small number of included studies, the identified quality indicators can serve as an excellent starting point for further development of nursing specific quality indicators for medication safety. Especially on the right patient, right route, right time and right documentation there is room future development of quality indicators.	[Smeulers, Marian; Verweij, Lotte; Vermeulen, Hester] Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, NL-1105 AZ Amsterdam, Netherlands; [Maaskant, Jolanda M.] Univ Amsterdam, Acad Med Ctr, Emma Childrens Hosp, NL-1105 AZ Amsterdam, Netherlands; [Maaskant, Jolanda M.] Univ Amsterdam, Acad Med Ctr, Fac Med, Dept Clin Epidemiol Biostat & Bioinformat, NL-1105 AZ Amsterdam, Netherlands; [de Boer, Monica] Univ Amsterdam, Acad Med Ctr, Dept Hosp Pharm, NL-1105 AZ Amsterdam, Netherlands; [Krediet, C. T. Paul] Univ Amsterdam, Acad Med Ctr, Dept Internal Med, NL-1105 AZ Amsterdam, Netherlands; [van Dijkum, Els J. M. Nieveen; Vermeulen, Hester] Univ Amsterdam, Acad Med Ctr, Dept Surg, NL-1105 AZ Amsterdam, Netherlands; [Vermeulen, Hester] Amsterdam Sch Hlth Profess, Dept Nursing, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Smeulers, M (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Qual Assurance & Proc Innovat, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	m.smeuters@amc.uva.nl	van dijkum, elisabeth nieveen/M-2243-2019; Vermeulen, Hester/P-5739-2016	Vermeulen, Hester/0000-0002-0743-2979; Krediet, C T Paul/0000-0002-3433-6907; Verweij, Lotte/0000-0002-4727-0126	internal hospital fund for quality improvement	internal hospital fund for quality improvement	This work was supported by internal hospital fund for quality improvement: "What if your mother was in the hospital". There are no other sources of support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1995, QRC ADVISOR, V11, P1; Aspden P, 2007, PREVENTING MEDICATIO; Barker KN, 2002, ARCH INTERN MED, V162, P1897, DOI 10.1001/archinte.162.16.1897; Brook RH, 2000, INT J QUAL HEALTH C, V12, P281, DOI 10.1093/intqhc/12.4.281; Campbell SM, 2003, BRIT MED J, V326, P816, DOI 10.1136/bmj.326.7393.816; Cheng R, 2010, HEALTHCARE Q, V13; Classen DC, 1997, JAMA-J AM MED ASSOC, V277, P301, DOI 10.1001/jama.277.4.301; de Koning J, 2006, APPRAISAL INDICATORS, DOI [10.1111/acem.12591, DOI 10.1111/ACEM.12591]; Donabedian A., 1980, EXPLORATION QUALITY; Fitch K., 2001, RAND UCLA APPROPRIAT; Glasziou P, 2011, BMJ QUAL SAF, V20, pI13, DOI 10.1136/bmjqs.2010.046524; Hughes RG, 2008, PATIENT SAFETY QUALI, P397; Institute for Safe Medication Practices ISMP, 2011, AC CAR GUID TIM ADM; ISMP, 2007, 5 RIGHTS DEST MAP; Krahenbuhl-Melcher A, 2007, DRUG SAFETY, V30, P379; LEAPE LL, 1995, JAMA-J AM MED ASSOC, V274, P35, DOI 10.1001/jama.1995.03530010049034; Levin RF, 2010, J NURS CARE QUAL, V25, P117, DOI 10.1097/NCQ.0b013e3181b5f19f; Lisby M, 2010, INT J QUAL HEALTH C, V22, P507, DOI 10.1093/intqhc/mzq059; Mainz J, 2003, INT J QUAL HEALTH C, V15, P523, DOI 10.1093/intqhc/mzg081; McLoughlin V, 2006, INT J QUAL HEALTH C, V18, P14, DOI 10.1093/intqhc/mzl030; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; National Institution for Health and Care Excellence NICE, 2014, NICE GUID SAF STAFF; Nigam Rita, 2008, Healthc Q, V11, P47; NSW Therapeutic Advisory Group, 2007, IND QUAL US MED AUST; Pape Theresa M, 2003, Medsurg Nurs, V12, P77; Sackett DL, 2007, CLIN ORTHOP RELAT R, P3, DOI 10.1097/BLO.06013e31802fba1e; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; The National Coordinating Council for Medication Error Reporting and Prevention (NCCMERP), WHAT IS MED ERR; Wakefield DS, 1999, AM J MED QUAL, V14, P73, DOI 10.1177/106286069901400202	29	34	39	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122695	10.1371/journal.pone.0122695	http://dx.doi.org/10.1371/journal.pone.0122695			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884623	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000039
J	Xu, XB; Tan, Y; Chen, S; Yang, GS; Su, WZ				Xu, Xibao; Tan, Yan; Chen, Shuang; Yang, Guishan; Su, Weizhong			Urban Household Carbon Emission and Contributing Factors in the Yangtze River Delta, China	PLOS ONE			English	Article							GREENHOUSE-GAS EMISSIONS; DIOXIDE EMISSIONS; CO2 EMISSIONS; LIFE-STYLE; ENERGY USE; IMPACT; CONSUMPTION; TRANSPORT; BEHAVIOR; FRANCE	Carbon reduction at the household level is an integral part of carbon mitigation. This study analyses the characteristics, effects, contributing factors and policies for urban household carbon emissions in the Yangtze River Delta of China. Primary data was collected through structured questionnaire surveys in three cities in the region - Nanjing, Ningbo, and Changzhou in 2011. The survey data was first used to estimate the magnitude of household carbon emissions in different urban contexts. It then examined how, and to what extent, each set of demographic, economic, behavioral/cognitive and spatial factors influence carbon emissions at the household level. The average of urban household carbon emissions in the region was estimated to be 5.96 tonnes CO2 in 2010. Energy consumption, daily commuting, garbage disposal and long-distance travel accounted for 51.2%, 21.3%, 16.0% and 11.5% of the total emission, respectively. Regulating rapidly growing car-holdings of urban households, stabilizing population growth, and transiting residents' low-carbon awareness to household behavior in energy saving and other spheres of consumption in the context of rapid population aging and the growing middle income class are suggested as critical measures for carbon mitigation among urban households in the Yangtze River Delta.	[Xu, Xibao; Chen, Shuang; Yang, Guishan; Su, Weizhong] Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China; [Tan, Yan] Univ Adelaide, Dept Geog Environm & Populat, Adelaide, SA, Australia	Chinese Academy of Sciences; Nanjing Institute of Geography & Limnology, CAS; University of Adelaide	Xu, XB (corresponding author), Chinese Acad Sci, Nanjing Inst Geog & Limnol, Key Lab Watershed Geog Sci, Nanjing, Jiangsu, Peoples R China.	xbxu@niglas.ac.cn		Tan, Yan/0000-0002-4013-1713	Knowledge Innovation Project of the Chinese Academy of Sciences [KZCX2-EW-315]; National Natural Science Foundation of China [41030745, 41101565, 41371532]; Interdisciplinary Frontier Project of NIGLAS [NIGLAS2012135019]; Australian Research Council Discovery project [DP110105522]	Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Interdisciplinary Frontier Project of NIGLAS; Australian Research Council Discovery project(Australian Research Council)	This work was supported by the Knowledge Innovation Project of the Chinese Academy of Sciences (KZCX2-EW-315) (http://www.cas.cn/), supporting study design, data collection and analysis; National Natural Science Foundation of China (41030745; 41101565; 41371532) (http://www.nsfc.gov.cn/), supporting data collection and analysis, preparation of the manuscript; Interdisciplinary Frontier Project of NIGLAS (NIGLAS2012135019) (http://www.niglas.ac.cn/), supporting data collection and analysis, and preparation of the manuscript; and Australian Research Council Discovery project (DP110105522) (http://www.arc.gov.au/ncgp/dp/dp_default.htm), supporting preparation of the manuscript.	Baiocchi G, 2010, J IND ECOL, V14, P50, DOI 10.1111/j.1530-9290.2009.00216.x; Bin S, 2005, ENERG POLICY, V33, P197, DOI 10.1016/S0301-4215(03)00210-6; Boussauw K, 2009, TRANSPORT RES A-POL, V43, P580, DOI 10.1016/j.tra.2009.02.005; Buchs M, 2013, ECOL ECON, V90, P114, DOI 10.1016/j.ecolecon.2013.03.007; Chancel L, 2014, ECOL ECON, V100, P195, DOI 10.1016/j.ecolecon.2014.02.009; Dalton M, 2008, ENERG ECON, V30, P642, DOI 10.1016/j.eneco.2006.07.002; Davis J, 2010, FOOD RES INT, V43, P1874, DOI 10.1016/j.foodres.2009.08.017; Dietz T, 2009, P NATL ACAD SCI USA, V106, P18452, DOI 10.1073/pnas.0908738106; Druckman A, 2012, ECOL ECON, V84, P153, DOI 10.1016/j.ecolecon.2012.09.008; Duffy A, 2013, TRANSPORT RES D-TR E, V19, P13, DOI 10.1016/j.trd.2012.09.005; Editorial Committee of Annual Report on Development of Small and Medium-Sized Cities in China, 2010, ANN REP DEV SMALL ME; EHRLICH PR, 1971, SCIENCE, V171, P1212, DOI 10.1126/science.171.3977.1212; Fan JL, 2013, APPL ENERG, V101, P323, DOI 10.1016/j.apenergy.2012.01.020; Feng KS, 2009, ECOL ECON, V69, P145, DOI 10.1016/j.ecolecon.2009.08.007; Feng ZH, 2011, ENERGY, V36, P656, DOI 10.1016/j.energy.2010.09.049; Golley J, 2012, ENERG ECON, V34, P1864, DOI 10.1016/j.eneco.2012.07.025; Gu ZH, 2013, SUSTAIN CITIES SOC, V7, P52, DOI 10.1016/j.scs.2012.11.004; Guan D, 2008, GLOBAL ENVIRON CHANG, V18, P626, DOI 10.1016/j.gloenvcha.2008.08.001; International Energy Agency, 2013, CO2 EM FUEL COMB 201; IPCC, 2006, 2006 IPCC GUIDELINES; IPCC, 2014, CLIM CHANG 2014 SYNT; Jin RL, 2010, INT J NONLINEAR SCI, V10, P259; Kim T, 2013, HABITAT INT, V38, P192, DOI 10.1016/j.habitatint.2012.06.006; Kok R, 2006, ENERG POLICY, V34, P2744, DOI 10.1016/j.enpol.2005.04.006; Lin T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055642; Lu L, 2010, SCI TECHNOLOGY INFOR, V27, P253; Meier T, 2012, INT J LIFE CYCLE ASS, V17, P550, DOI 10.1007/s11367-012-0387-x; National Development and Reform Commission, 2010, REG PLAN YANGTZ RIV; National People's Congress, 2013, REP URB DEV; Olivier JGJ, 2013, TRENDS GLOBAL CO2 EM; Qi Y., 2012, ANN REV LOW CARBON D; Social Development Squad of the Ministry of Science and Technology, 2007, HDB EN SAV EM RED; Tian GJ, 2011, ECOL MODEL, V222, P865, DOI 10.1016/j.ecolmodel.2010.09.036; Vieux F, 2012, ECOL ECON, V75, P91, DOI 10.1016/j.ecolecon.2012.01.003; Wang Hai-kun, 2011, China Environmental Science, V31, P1029; Wang Z, 2012, THESIS U SCI TECHNOL; Weber CL, 2008, ECOL ECON, V66, P379, DOI 10.1016/j.ecolecon.2007.09.021; Wei YM, 2007, ENERG POLICY, V35, P247, DOI 10.1016/j.enpol.2005.11.020; White House, 2014, US CHIN JOINT ANN CL; Wright LA, 2011, CARBON MANAG, V2, P61, DOI 10.4155/CMT.10.39; [谢鸿宇 XIE Hongyu], 2011, [生态学报, Acta Ecologica Sinica], V31, P3551; Xinhuanet, 2014, CHIN URB PLAN 2014 2; Xinhuanet, 2013, CHIN EAS ON CHILD PO; [杨选梅 Yang Xuanmei], 2010, [中国人口·资源与环境, China Population·Resources and Environment], V20, P35; [翟石艳 Zhai Shiyan], 2013, [长江流域资源与环境, Resources and Environment in the Yangtze Basin], V22, P94; Zhang Q., 2012, CHINA POPULATION ENV, V22, P35; 张涛, 2012, [环境污染与防治, Environmental Pollution & Control], V34, P102	47	35	36	11	105	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121604	10.1371/journal.pone.0121604	http://dx.doi.org/10.1371/journal.pone.0121604			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25884853	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000021
J	Yildirim, C; Vogel, DYS; Hollander, MR; Baggen, JM; Fontijn, RD; Nieuwenhuis, S; Haverkamp, A; de Vries, MR; Quax, PHA; Garcia-Vallejo, JJ; van der Laan, AM; Dijkstra, CD; Kraan, TCTMV; van Royen, N; Horrevoets, AJG				Yildirim, Cansu; Vogel, Daphne Y. S.; Hollander, Maurits R.; Baggen, Josefien M.; Fontijn, Ruud D.; Nieuwenhuis, Sylvia; Haverkamp, Anouk; de Vries, Margreet R.; Quax, Paul H. A.; Garcia-Vallejo, Juan J.; van der Laan, Anja M.; Dijkstra, Christine D.; Kraan, Tineke C. T. M. van der Pouw; van Royen, Niels; Horrevoets, Anton J. G.			Galectin-2 Induces a Proinflammatory, Anti-Arteriogenic Phenotype in Monocytes and Macrophages	PLOS ONE			English	Article							GROWTH FACTOR-A; FACTOR-B; POLARIZATION; MECHANISMS; ROLES; ANGIOGENESIS; STIMULATION; ACTIVATION; EXPRESSION; MOLECULES	Galectin-2 is a monocyte-expressed carbohydrate-binding lectin, for which increased expression is genetically determined and associated with decreased collateral arteriogenesis in obstructive coronary artery disease patients. The inhibiting effect of galectin-2 on arteriogenesis was confirmed in vivo, but the mechanism is largely unknown. In this study we aimed to explore the effects of galectin-2 on monocyte/macrophage phenotype in vitro and vivo, and to identify the receptor by which galectin-2 exerts these effects. We now show that the binding of galectin-2 to different circulating human monocyte subsets is dependent on monocyte surface expression levels of CD14. The high affinity binding is blocked by an anti-CD14 antibody but not by carbohydrates, indicating a specific protein-protein interaction. Galectin-2 binding to human monocytes modulated their transcriptome by inducing proinflammatory cytokines and inhibiting pro-arteriogenic factors, while attenuating monocyte migration. Using specific knock-out mice, we show that galectin-2 acts through the CD14/toll-like receptor (TLR)-4 pathway. Furthermore, galectin-2 skews human macrophages to a M1-like proinflammatory phenotype, characterized by a reduced motility and expression of an anti-arteriogenic cytokine/growth factor repertoire. This is accompanied by a switch in surface protein expression to CD40-high and CD206-low (M1). In a murine model we show that galectin-2 administration, known to attenuate arteriogenesis, leads to increased numbers of CD40-positive (M1) and reduced numbers of CD206-positive (M2) macrophages surrounding actively remodeling collateral arteries. In conclusion galectin-2 is the first endogenous CD14/TLR4 ligand that induces a proinflammatory, non-arteriogenic phenotype in monocytes/macrophages. Interference with CD14-Galectin-2 interaction may provide a new intervention strategy to stimulate growth of collateral arteries in genetically compromised cardiovascular patients.	[Yildirim, Cansu; Vogel, Daphne Y. S.; Baggen, Josefien M.; Fontijn, Ruud D.; Nieuwenhuis, Sylvia; Haverkamp, Anouk; Garcia-Vallejo, Juan J.; Dijkstra, Christine D.; Kraan, Tineke C. T. M. van der Pouw; Horrevoets, Anton J. G.] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Hollander, Maurits R.; van Royen, Niels] Vrije Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands; [de Vries, Margreet R.; Quax, Paul H. A.] Leiden Univ, Med Ctr, Einthoven Labs, Dept Vasc Surg, Leiden, Netherlands; [van der Laan, Anja M.] Univ Amsterdam, Acad Med Ctr, Dept Cardiol, NL-1105 AZ Amsterdam, Netherlands	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam	Horrevoets, AJG (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands.	aj.horrevoets@vumc.nl	Quax, Paul/W-8520-2019; Vallejo, Juan Garcia/AAA-3765-2020; Quax, Paul/ABD-5294-2020; de Vries, Margreet/Z-5653-2019; Garcia-Vallejo, Juan/H-4162-2012; van Royen, Niels/Q-1097-2017; YILDIRIM, CANSU/ABB-8045-2021	Quax, Paul/0000-0002-6853-5760; Garcia-Vallejo, Juan/0000-0001-6238-7069; YILDIRIM, CANSU/0000-0002-9015-6636	ICaR-VU (Institute for Cardiovascular Research) of the VU Medical Center in the Netherlands	ICaR-VU (Institute for Cardiovascular Research) of the VU Medical Center in the Netherlands	This work was supported by an interinstitutional grant from ICaR-VU (Institute for Cardiovascular Research, http://www.vumc.nl/afdelingen/ICar-VU/) of the VU Medical Center in the Netherlands to AJGH and TvdPK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAGAWA KS, 1985, J EXP MED, V162, P1444, DOI 10.1084/jem.162.5.1444; Al-Ansari S, 2009, TRENDS CARDIOVAS MED, V19, P164, DOI 10.1016/j.tcm.2009.10.001; Aron-Wisnewsky J, 2009, J CLIN ENDOCR METAB, V94, P4619, DOI 10.1210/jc.2009-0925; Beyer M, 2012, PLOS ONE, V7, P1; Buschmann I, 2003, MICROCIRCULATION, V10, P371, DOI 10.1038/sj.mn.7800199; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; Clayton JA, 2008, CIRC RES, V103, P1027, DOI 10.1161/CIRCRESAHA.108.181115; Cole JE, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/393946; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Fung E, 2012, FRONT PHYSIOL, V3, P1, DOI [10.3389/fphys.2012.00001, DOI 10.3389/FPHYS.2012.00001]; Gal P, 2011, ACTA HISTOCHEM CYTOC, V44, P191, DOI 10.1267/ahc.11014; Gao YF, 2011, CHINESE MED J-PEKING, V124, P127, DOI 10.3760/cma.j.issn.0366-6999.2011.01.023; Grundmann S, 2007, EUR J CLIN INVEST, V37, P755, DOI 10.1111/j.1365-2362.2007.01861.x; Hamm A, 2013, EMBO MOL MED, V5, P843, DOI 10.1002/emmm.201302695; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Hokama A, 2008, WORLD J GASTROENTERO, V14, P5133, DOI 10.3748/wjg.14.5133; Jetten N, 2014, ANGIOGENESIS, V17, P109, DOI 10.1007/s10456-013-9381-6; Kupatt C, 2010, J AM COLL CARDIOL, V56, P414, DOI 10.1016/j.jacc.2010.03.050; la Sala A, 2012, TRENDS MOL MED, V18, P494, DOI 10.1016/j.molmed.2012.06.007; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Liu FT, 2012, ANN NY ACAD SCI, V1253, P80, DOI 10.1111/j.1749-6632.2011.06386.x; Liu FT, 2010, ANN NY ACAD SCI, V1183, P158, DOI 10.1111/j.1749-6632.2009.05131.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Paclik D, 2008, INFLAMM BOWEL DIS, V14, P1366, DOI 10.1002/ibd.20499; Paclik D, 2011, CELL IMMUNOL, V271, P97, DOI 10.1016/j.cellimm.2011.06.003; Paz A, 2001, ONCOGENE, V20, P7486, DOI 10.1038/sj.onc.1204950; Powell RJ, 2008, CIRCULATION, V118, P58, DOI 10.1161/CIRCULATIONAHA.107.727347; Rabinovich GA, 2009, NAT REV IMMUNOL, V9, P338, DOI 10.1038/nri2536; Schirmer SH, 2009, HEART, V95, P191, DOI 10.1136/hrt.2007.136119; Seiler C, 2010, EUR J CLIN INVEST, V40, P465, DOI 10.1111/j.1365-2362.2010.02282.x; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Troidl C, 2013, CURR VASC PHARMACOL, V11, P5, DOI 10.2174/157016113804547629; ULEVITCH RJ, 1995, ANNU REV IMMUNOL, V13, P437, DOI 10.1146/annurev.iy.13.040195.002253; Van den Akker NMS, 2008, DEV DYNAM, V237, P494, DOI 10.1002/dvdy.21436; van der Laan AM, 2012, EUR HEART J, V33, P1076, DOI 10.1093/eurheartj/ehr220; van Oostrom MC, 2008, J LEUKOCYTE BIOL, V84, P1379, DOI 10.1189/jlb.0508281; van Royen N, 2002, FASEB J, V16, P432, DOI 10.1096/fj.01-0563fje; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; Wafai R, 2009, J VASC RES, V46, P45, DOI 10.1159/000139132; Wu S, 2010, MOL CELL BIOCHEM, V343, P223, DOI 10.1007/s11010-010-0517-3; Yang Ri-Yao, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000719; Zajac E, 2013, BLOOD, V122, P4054, DOI 10.1182/blood-2013-05-501494; Zhang JH, 2009, FASEB J, V23, P153, DOI 10.1096/fj.08-113860; Zivkovic A, 2011, J IMMUNOL, V186, P1608, DOI 10.4049/jimmunol.1001665	49	38	40	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124347	10.1371/journal.pone.0124347	http://dx.doi.org/10.1371/journal.pone.0124347			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884209	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000116
J	Majeed, A; Piah, AM; Gobithaasan, RU; Yahya, ZR				Majeed, Abdul; Piah, Abd Rahni Mt; Gobithaasan, R. U.; Yahya, Zainor Ridzuan			Craniofacial Reconstruction Using Rational Cubic Ball Curves	PLOS ONE			English	Article							ALGORITHM	This paper proposes the reconstruction of craniofacial fracture using rational cubic Ball curve. The idea of choosing Ball curve is based on its robustness of computing efficiency over Bezier curve. The main steps are conversion of Digital Imaging and Communications in Medicine (Dicom) images to binary images, boundary extraction and corner point detection, Ball curve fitting with genetic algorithm and final solution conversion to Dicom format. The last section illustrates a real case of craniofacial reconstruction using the proposed method which clearly indicates the applicability of this method. A Graphical User Interface (GUI) has also been developed for practical application.	[Majeed, Abdul] Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan; [Piah, Abd Rahni Mt] Univ Sains Malaysia, Sch Math Sci, George Town 11800, Malaysia; [Gobithaasan, R. U.] Univ Malaysia Terengganu, Sch Informat & Appl Math, Kuala Terengganu 21030, Malaysia; [Yahya, Zainor Ridzuan] Univ Malaysia Perlis, Inst Engn Math, Pauh 02600, Perlis, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Terengganu; Universiti Malaysia Perlis	Majeed, A (corresponding author), Univ Educ, Div Sci & Technol, Town Ship Lahore, Pakistan.	abdulmajeed@ue.edu.pk	Rudrusamy, Gobithaasan/H-8891-2018; Yahya, Zainor/GNH-4483-2022	Rudrusamy, Gobithaasan/0000-0003-3077-8772; 	Ministry of Education of Malaysia; Universiti Sains Malaysia [203/PMATHS/6711365]	Ministry of Education of Malaysia; Universiti Sains Malaysia(Universiti Sains Malaysia)	The authors would like to extend their gratitude to the Ministry of Education of Malaysia and Universiti Sains Malaysia for supporting this work under its Fundamental Research Grant Scheme (FRGS), Account No. 203/PMATHS/6711365. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ball A. A., 1974, Computer Aided Design, V6, P243, DOI 10.1016/0010-4485(74)90009-8; Bhatt A.D., 2008, COMPUT AIDED DES APP, V5, P194; Eck M., 1996, P SIGGRAPH, V96, P325; FANG Z., 2005, THESIS DREXEL U; Farin G., 2002, CURVES SURFACES CAGD; GOODMAN TNT, 1991, COMPUT AIDED DESIGN, V23, P554, DOI 10.1016/0010-4485(91)90056-3; Kou XY, 2007, COMPUT AIDED DESIGN, V39, P284, DOI 10.1016/j.cad.2006.12.007; Li WS, 2005, COMPUT AIDED DESIGN, V37, P791, DOI 10.1016/j.cad.2004.09.008; Lian Q, 2006, COMPUT AIDED DESIGN, V38, P507, DOI 10.1016/j.cad.2005.12.001; Magnenat-Thalmann N, 2000, IEEE T INF TECHNOL B, V4, P137, DOI 10.1109/4233.845206; Majeed A., 2014, APPL MATH SCI, V8, P3683, DOI DOI 10.12988/AMS.2014.43201; Park H, 2007, COMPUT AIDED DESIGN, V39, P439, DOI 10.1016/j.cad.2006.12.006; Piah ARM, 2011, SAINS MALAYS, V40, P1173; SAID HB, 1989, ACM T GRAPHIC, V8, P360, DOI 10.1145/77269.77275; Sarfraz M, 2006, COMPUT IMAGING VIS, V32, P528; Vandermeulen D, 2006, FORENSIC SCI INT, V159, pS164, DOI 10.1016/j.forsciint.2006.02.036; Yahya ZR, 2012, COMM COM INF SC, V295, P379; Yoshimoto F, 2003, COMPUT AIDED DESIGN, V35, P751, DOI 10.1016/S0010-4485(03)00006-X	18	10	10	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122854	10.1371/journal.pone.0122854	http://dx.doi.org/10.1371/journal.pone.0122854			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880632	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500030
J	Wei, XJ; Zhang, JY; Niu, JR; Zhou, XZ; Li, JY; Li, B				Wei, Xiaojuan; Zhang, Jiyu; Niu, Jianrong; Zhou, Xuzheng; Li, Jianyong; Li, Bing			Evaluation of Arecoline Hydrobromide Toxicity after a 14-Day Repeated Oral Administration in Wistar Rats	PLOS ONE			English	Article								A subchronic toxicity test was conducted in rats on the basis of a previous acute toxicity test to evaluate the safety of arecoline hydrobromide (Ah), to systematically study its pharmacological effects and to provide experimental support for a safe clinical dose. Eighty rats were randomly divided into four groups: a high-dose group (1000 mg/kg), medium-dose group (200 mg/kg), low-dose group (100mg/kg) and blank control group. The doses were administered daily via gastric lavage for 14 consecutive days. There were no significant differences in the low-dose Ah group compared to the control group (P> 0.05) with regard to body weight, organ coefficients, hematological parameters and histopathological changes. The high-dose of Ah influenced some of these parameters, which requires further study. The results of this study indicated that a long-term, continuous high dose of Ah was toxic. However, it is safe to use Ah according to the clinically recommended dosing parameters. The level of Ah at which no adverse effects were observed was 100 mg/kg/day under the present study conditions.	[Wei, Xiaojuan; Zhang, Jiyu; Niu, Jianrong; Zhou, Xuzheng; Li, Jianyong; Li, Bing] Lanzhou Inst Husb & Pharmaceut Sci CAAS, Lanzhou 730050, Gansu, Peoples R China	Chinese Academy of Agricultural Sciences; Lanzhou Institute of Husbandry & Pharmaceutical Sciences, CAAS	Wei, XJ (corresponding author), Lanzhou Inst Husb & Pharmaceut Sci CAAS, Lanzhou 730050, Gansu, Peoples R China.	wxjsqss@163.com			China Agriculture Research System [cars-38]	China Agriculture Research System	The project was supported by the earmarked fund for China Agriculture Research System (cars-38). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARJUNGI KN, 1976, ARZNEIMITTEL-FORSCH, V26, P951; Azeez S., 2007, KUWAIT MED J, V39, P48; BEVERIDGE I, 1976, AUST VET J, V52, P369, DOI 10.1111/j.1751-0813.1976.tb09491.x; Burkhill IH, 1935, DICT ECONOMICPRODUCT, V1, P222; Chempakam B., 1993, Indian Journal of Experimental Biology, V31, P474; CHRISTIE JE, 1981, BRIT J PSYCHIAT, V138, P46, DOI 10.1192/bjp.138.1.46; El Hilaly J, 2004, J ETHNOPHARMACOL, V91, P43, DOI 10.1016/j.jep.2003.11.009; Feng Q, 1999, Zhong Yao Cai, V22, P572; Jaiswal P, 2008, PESTIC BIOCHEM PHYS, V92, P164, DOI 10.1016/j.pestbp.2008.07.011; Kaplan A, 1995, CLIN CHEM INTERPRETA; Kuo FC, 2005, J PERINAT MED, V33, P399, DOI 10.1515/JPM.2005.072; Li B, 2014, J CHROMATOGR B, V969, P12, DOI 10.1016/j.jchromb.2014.07.043; Rahman MF, 2001, HUM EXP TOXICOL, V20, P243, DOI 10.1191/096032701678227730; Tofovic SP, 1999, J CARDIOVASC PHARM, V33, P360, DOI 10.1097/00005344-199903000-00003; van der Ven LTM, 2006, TOXICOL SCI, V94, P281, DOI 10.1093/toxsci/kfl113; Zha Chuanlong, 1990, J NANJING U TRADITIO, V6, P266; Zhao WA, 2003, MODERN J INTEGRATED, V12, P237	17	11	11	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0120165	10.1371/journal.pone.0120165	http://dx.doi.org/10.1371/journal.pone.0120165			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880067	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500006
J	Xu, H; Sun, YJ; Wang, XJ; Wang, J; Fu, Y				Xu Hao; Sun Yujun; Wang Xinjie; Wang Jin; Fu Yao			Linear Mixed-Effects Models to Describe Individual Tree Crown Width for China-Fir in Fujian Province, Southeast China	PLOS ONE			English	Article								A multiple linear model was developed for individual tree crown width of Cunninghamia lanceolata (Lamb.) Hook in Fujian province, southeast China. Data were obtained from 55 sample plots of pure China-fir plantation stands. An Ordinary Linear Least Squares (OLS) regression was used to establish the crown width model. To adjust for correlations between observations from the same sample plots, we developed one level linear mixed-effects (LME) models based on the multiple linear model, which take into account the random effects of plots. The best random effects combinations for the LME models were determined by the Akaike's information criterion, the Bayesian information criterion and the -2logarithm likelihood. Heteroscedasticity was reduced by three residual variance functions: the power function, the exponential function and the constant plus power function. The spatial correlation was modeled by three correlation structures: the first-order autoregressive structure [AR(1)], a combination of first-order autoregressive and moving average structures [ARMA (1,1)], and the compound symmetry structure (CS). Then, the LME model was compared to the multiple linear model using the absolute mean residual (AMR), the root mean square error (RMSE), and the adjusted coefficient of determination (adj-R-2). For individual tree crown width models, the one level LME model showed the best performance. An independent dataset was used to test the performance of the models and to demonstrate the advantage of calibrating LME models.	[Xu Hao; Sun Yujun; Wang Xinjie; Wang Jin; Fu Yao] Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China	Beijing Forestry University	Sun, YJ (corresponding author), Beijing Forestry Univ, Coll Forestry, Minist Educ, Key Lab Silviculture & Conservat, Beijing, Peoples R China.	sunyj@bjfu.edu			Special Public Interest Research and Industry Fund of Forestry [200904003-1]; project of forestry science and technology research [2012-07]	Special Public Interest Research and Industry Fund of Forestry; project of forestry science and technology research	This work was supported by the Special Public Interest Research and Industry Fund of Forestry (No. 200904003-1) and the project of forestry science and technology research (No. 2012-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adame P, 2008, FOREST ECOL MANAG, V256, P88, DOI 10.1016/j.foreco.2008.04.006; Adame P, 2006, ANN FOREST SCI, V63, P929, DOI 10.1051/forest:2006076; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P667, DOI 10.1109/TAC.1974.1100707; Alexander ME, 2011, SYNTHESIS KNOWLEDGE, VI; BIGING GS, 1985, FOREST SCI, V31, P248; Bragg DC, 2001, NORTH J APPL FOR, V18, P1; Calama R, 2005, SILVA FENN, V39, P37, DOI 10.14214/sf.394; Calama R, 2004, CAN J FOREST RES, V34, P150, DOI [10.1139/x03-199, 10.1139/X03-199]; Canavan SJ, 2000, NORTH J APPL FOR, V17, P2; Crecente-Campo F, 2013, FORESTRY, V86, P481, DOI 10.1093/forestry/cpt019; Crecente-Campo F, 2010, FOREST ECOL MANAG, V259, P943, DOI 10.1016/j.foreco.2009.11.036; Davidian M., 1995, NONLINEAR MODELS REP; Dutilleul P, 1998, CAN J FOREST RES, V28, P56, DOI 10.1139/cjfr-28-1-56; Fang Z, 2001, FOREST SCI, V47, P3; Fox JC, 2001, FOREST ECOL MANAG, V154, P261, DOI 10.1016/S0378-1127(00)00632-0; Fu L, 2013, FOREST ECOL MANAG, V302; Gomez-Vazquez I, 2013, ANN FOREST SCI; Gonzalez-Benecke CA, 2014, J FORESTRY RES, V25, P43, DOI 10.1007/s11676-014-0427-4; Gregoire TG, 1995, CAN J FOREST RES, V1, P25, DOI DOI 10.1139/X95-017; Gregorie TG, 1987, FOREST SCI, V33, P2; IHAKA R, 2004, R LANG ENV STAT COMP; Keselman HJ, 1999, BRIT J MATH STAT PSY, V52, P63, DOI 10.1348/000711099158964; KJELGREN RK, 1992, INT J BIOMETEOROL, V36, P165, DOI 10.1007/BF01224821; LAPPI J, 1994, FOREST SCI, V40, P715; Leak W, 1996, FOREST SCI, V1, P12; Leites LP, 2009, CAN J FOREST RES, V39, P655, DOI 10.1139/X08-205; Lhotka JM, 2011, FOREST ECOL MANAG, V261, P3; LINDSTROM MJ, 1990, BIOMETRICS, V46, P673, DOI 10.2307/2532087; Matos LA, 2012, COMPUT STAT DATA AN, V57, P1; Meng SX, 2009, FOREST SCI, V55, P238; Nigh G, 2012, FOREST CHRON, V88, P340, DOI 10.5558/tfc2012-061; OMULE SAY, 1991, CAN J FOREST RES, V21, P1418, DOI 10.1139/x91-199; PALMER MJ, 1991, BIOMETRICS, V47, P623, DOI 10.2307/2532151; Peper PJ, 2001, J ARBORICULT, V27, P6; Peugh JL, 2005, EDUC PSYCHOL MEAS, V65, P5; Pinheiro JC, 2000, MIXED EFFECTS MODELS, P291; Schabenberger Oliver, 1995, Silva Fennica, V29, P49; Sonmez T, 2009, AFRICAN J AGR RES, V4, P3; Tahvanainen T, 2008, FOREST ECOL MANAG, V255, P455, DOI 10.1016/j.foreco.2007.09.035; Timilsina N, 2013, FOREST SCI, V59, P27, DOI 10.5849/forsci.10-028; Uzoh FCC, 2008, FOREST ECOL MANAG, V256, P438, DOI 10.1016/j.foreco.2008.04.046; Vonesh E.F., 1997, LINEAR NONLINEAR MOD; Warbington R, 1993, STAND INVENTORY TECH, P319; WARING RH, 1982, CAN J FOREST RES, V12, P556, DOI 10.1139/x82-086; Weiss RE., 2005, MODELING LONGITUDINA, DOI 10.1007/0-387-28314-5; WYKOFF WR, 1990, FOREST SCI, V36, P1077; Zhao L, 2012, J FOREST RES, V18, P4	47	31	43	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122257	10.1371/journal.pone.0122257	http://dx.doi.org/10.1371/journal.pone.0122257			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876178	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800047
J	Takahashi, K; Endo, M; Miyoshi, T; Tsuritani, M; Shimazu, Y; Hosoda, H; Saga, K; Tamai, K; Flake, AW; Yoshimatsu, J; Kimura, T				Takahashi, Kei; Endo, Masayuki; Miyoshi, Takekazu; Tsuritani, Mitsuhiro; Shimazu, Yukiko; Hosoda, Hiroshi; Saga, Kotaro; Tamai, Katsuto; Flake, Alan W.; Yoshimatsu, Jun; Kimura, Tadashi			Immune Tolerance Induction Using Fetal Directed Placental Injection in Rodent Models: A Murine Model	PLOS ONE			English	Article							HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; ENGRAFTMENT; MICE	Objectives Induction of the immune response is a major problem in replacement therapies for inherited protein deficiencies. Tolerance created in utero can facilitate postnatal treatment. In this study, we aimed to induce immune tolerance towards a foreign protein with early gestational cell transplantation into the chorionic villi under ultrasound guidance in the murine model. Methods Pregnant C57BL/6 (B6) mice on day 10 of gestation were anesthetized and imaged by high resolution ultrasound. Murine embryos and their placenta were positioned to get a clear view in B-mode with power mode of the labyrinth, which is the equivalent of chorionic villi in the human. Bone marrow cells (BMCs) from B6-Green Fluorescence Protein (B6GFP) transgenic mice were injected into the fetal side of the placenta which includes the labyrinth with glass microcapillary pipettes. Each fetal mouse received 2 x 10(5) viable GFP-BMCs. After birth, we evaluated the humoral and cell-mediated immune response against GFP. Results Bone marrow transfer into fetal side of placenta efficiently distributed donor cells to the fetal mice. The survival rate of this procedure was 13.5%(5 out of 37). Successful engraftment of the B6-GFP donor skin grafts was observed in all recipient (5 out of 5) mice 6 weeks after birth. Induction of anti-GFP antibodies was completely inhibited. Cytotoxic immune reactivity of thymic cells against cells harboring GFP was suppressed by ELISPOT assay. Conclusions In this study, we utilized early gestational placental injection targeting the murine fetus, to transfer donor cells carrying a foreign protein into the fetal circulation. This approach is sufficient to induce both humoral and cell-mediated immune tolerance against the foreign protein.	[Takahashi, Kei; Endo, Masayuki; Shimazu, Yukiko; Kimura, Tadashi] Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan; [Miyoshi, Takekazu; Tsuritani, Mitsuhiro; Yoshimatsu, Jun] Natl Cerebral & Cardiovasc Ctr, Dept Perinatol & Gynecol, Suita, Osaka, Japan; [Hosoda, Hiroshi] Natl Cerebral & Cardiovasc Ctr, Dept Biochem, Suita, Osaka, Japan; [Saga, Kotaro] Osaka Univ, Grad Sch Med, Dept Gene Therapy Sci, Suita, Osaka, Japan; [Tamai, Katsuto] Osaka Univ, Grad Sch Med, Dept Stem Cell Therapy Sci, Suita, Osaka, Japan; [Flake, Alan W.] Childrens Hosp Philadelphia, Ctr Fetal Diag & Treatment, Philadelphia, PA 19104 USA	Osaka University; National Cerebral & Cardiovascular Center - Japan; National Cerebral & Cardiovascular Center - Japan; Osaka University; Osaka University; University of Pennsylvania; Childrens Hospital of Philadelphia	Endo, M (corresponding author), Osaka Univ, Grad Sch Med, Dept Obstet & Gynecol, Suita, Osaka, Japan.	endoh@gyne.med.osaka-u.ac.jp	Yoshimatsu, Jun/AFD-9150-2022; Yoshimatsu, Jun/AAE-9474-2022					Aboussaouira T, 1998, FETAL DIAGN THER, V13, P216, DOI 10.1159/000020841; Billingham RE, 1953, NATURE; Bruscia EM, 2006, STEM CELLS, V24, P2299, DOI 10.1634/stemcells.2006-0166; Chino T, 2008, AM J PATHOL, V173, P803, DOI 10.2353/ajpath.2008.070977; Christensen G, 2000, CIRCULATION; Endoh M, 2002, MOL THER, V5, P501, DOI 10.1006/mthe.2002.0577; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; Mattar CN, 2012, BEST PRACT RES CL OB, V26, P683, DOI 10.1016/j.bpobgyn.2012.06.005; Nijagal A, 2012, CLIN PERINATOL, V39, P301, DOI 10.1016/j.clp.2012.04.004; Palmer AC, 2011, ADV NUTR, V2, P377, DOI 10.3945/an.111.000570; Peranteau WH, 2006, BLOOD, V108, P4268, DOI 10.1182/blood-2006-04-018986; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Shaaban AF, 2006, EXP HEMATOL, V34, P1278, DOI 10.1016/j.exphem.2006.05.007; Soper BW, 2003, J IMMUNOL, V171, P3270, DOI 10.4049/jimmunol.171.6.3270; Vanleene M, 2011, BLOOD, V117, P1053, DOI 10.1182/blood-2010-05-287565; Watson ED, 2005, PHYSIOLOGY, V20, P180, DOI 10.1152/physiol.00001.2005; WHITELAW A, 1988, BRIT MED BULL, V44, P1037, DOI 10.1093/oxfordjournals.bmb.a072288	17	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123712	10.1371/journal.pone.0123712	http://dx.doi.org/10.1371/journal.pone.0123712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876079	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100201
J	Zakynthinaki, MS				Zakynthinaki, Maria S.			Modelling Heart Rate Kinetics	PLOS ONE			English	Article							OXYGEN-UPTAKE KINETICS; TIME-DELAYED PHASES; STOCHASTIC OPTIMIZATION; MUSCULAR EXERCISE; RECOVERY	The objective of the present study was to formulate a simple and at the same time effective mathematical model of heart rate kinetics in response to movement (exercise). Based on an existing model, a system of two coupled differential equations which give the rate of change of heart rate and the rate of change of exercise intensity is used. The modifications introduced to the existing model are justified and discussed in detail, while models of blood lactate accumulation in respect to time and exercise intensity are also presented. The main modification is that the proposed model has now only one parameter which reflects the overall cardiovascular condition of the individual. The time elapsed after the beginning of the exercise, the intensity of the exercise, as well as blood lactate are also taken into account. Application of the model provides information regarding the individual's cardiovascular condition and is able to detect possible changes in it, across the data recording periods. To demonstrate examples of successful numerical fit of the model, constant intensity experimental heart rate data sets of two individuals have been selected and numerical optimization was implemented. In addition, numerical simulations provided predictions for various exercise intensities and various cardiovascular condition levels. The proposed model can serve as a powerful tool for a complete means of heart rate analysis, not only in exercise physiology (for efficiently designing training sessions for healthy subjects) but also in the areas of cardiovascular health and rehabilitation (including application in population groups for which direct heart rate recordings at intense exercises are not possible or not allowed, such as elderly or pregnant women).	[Zakynthinaki, Maria S.] Tech Univ Crete, Technol Educ Inst Crete, Dept Elect, Khania, Greece; [Zakynthinaki, Maria S.] Tech Univ Crete, Appl Math & Comp Lab, Khania, Greece	Hellenic Mediterranean University; Technical University of Crete; Technical University of Crete	Zakynthinaki, MS (corresponding author), Tech Univ Crete, Technol Educ Inst Crete, Dept Elect, Khania, Greece.	marzak@science.tuc.gr						Arrowsmith D.K., 1990, INTRO DYNAMICAL SYST; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Bangsbo J, 2000, AM J PHYSIOL-REG I, V279, pR899, DOI 10.1152/ajpregu.2000.279.3.R899; BARSTOW TJ, 1991, J APPL PHYSIOL, V71, P2099, DOI 10.1152/jappl.1991.71.6.2099; Bowers RW, 1992, SPORTS PHYSL; Brooks G. A., 2004, EXERCISE PHYSL HUMAN; Burke E., 1998, PRECISION HEART RATE; Carter H, 2000, J APPL PHYSIOL, V89, P1744, DOI 10.1152/jappl.2000.89.5.1744; DAVIES CTM, 1972, J APPL PHYSIOL, V32, P618, DOI 10.1152/jappl.1972.32.5.618; Goodwin Matthew L, 2007, J Diabetes Sci Technol, V1, P558; Guckenheimer J., 2002, NONLINEAR OSCILLATIO; Hairer E., 1993, SOLVING ORDINARY DIF; Hill AV, 1923, Q J MED, V16, P135, DOI 10.1093/qjmed/os-16.62.135; Jones AM, 2000, SPORTS MED, V29, P373, DOI 10.2165/00007256-200029060-00001; Jones AM, 2011, MED SCI SPORT EXER, V43, P2046, DOI 10.1249/MSS.0b013e31821fcfc1; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; LINNARSSON D, 1974, ACTA PHYSIOL SCAND, P1; Maffetone P, 1996, HIGH PERFORMANCE HEA; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; Maughan RJ, 2004, BIOCH BASIS SPORTS P; McArdle W, 2010, EXERCISE PHYSL ENERG; Miller T, 2012, NSCAS GUIDE TESTS AS; Noakes T., 2003, LORE RUNNING; Powers S.K., 2007, EXERCISE PHYSL THEOR; Stirling JR, 2009, J APPL PHYSIOL, V107, P1665, DOI 10.1152/japplphysiol.00158.2009a; Stirling J, 2008, J NONLINEAR MATH PHY, V15, P426, DOI 10.2991/jnmp.2008.15.s3.41; Sherwood L, 2010, HUMAN PHYSL CELLS SY; Stirling JR, 2008, B MATH BIOL, V70, P1348, DOI 10.1007/s11538-008-9302-9; Stirling JR, 2005, B MATH BIOL, V67, P989, DOI 10.1016/j.bulm.2004.12.005; Wasserman K., 1999, PRINCIPLES EXERCISE; Weltman A, 1995, HUMAN KINETICS; WHIPP BJ, 1972, J APPL PHYSIOL, V33, P351, DOI 10.1152/jappl.1972.33.3.351; Whipp BJ, 2009, J APPL PHYSIOL, V107, P1663, DOI 10.1152/japplphysiol.00158.2009; Wilmore JK, 2007, PHYSL SPORT EXERCISE; Zakynthinaki MS, 2007, COMPUT PHYS COMMUN, V176, P98, DOI 10.1016/j.cpc.2006.08.005; Zakynthinaki MS, 2011, COMPUT PHYS COMMUN, V182, P683, DOI 10.1016/j.cpc.2010.11.027; Zakynthinaki MS, 2008, COMPUT PHYS COMMUN, V179, P888, DOI 10.1016/j.cpc.2008.07.012; Zakynthinaki M.S., 2010, CHAOS, V20, DOI DOI 10.1063/1.3337690; Zakynthinaki MS, 2013, APPL MATH COMPUT, V219, P8910, DOI 10.1016/j.amc.2013.03.030	39	17	17	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0118263	10.1371/journal.pone.0118263	http://dx.doi.org/10.1371/journal.pone.0118263			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876164	Green Published, Green Submitted, gold			2022-12-27	WOS:000352845100004
J	Kilpatrick, LA; Mayer, EA; Labus, JS; Gupta, A; Hamaguchi, T; Mizuno, T; Komuro, H; Kano, M; Kanazawa, M; Aoki, M; Fukudo, S				Kilpatrick, Lisa A.; Mayer, Emeran A.; Labus, Jennifer S.; Gupta, Arpana; Hamaguchi, Toyohiro; Mizuno, Tomoko; Komuro, Hazuki; Kano, Michiko; Kanazawa, Motoyori; Aoki, Masashi; Fukudo, Shin			Serotonin Transporter Gene Polymorphism Modulates Activity and Connectivity within an Emotional Arousal Network of Healthy Men during an Aversive Visceral Stimulus	PLOS ONE			English	Article							BRAIN ACTIVATION; AMYGDALA; METAANALYSIS; GLUTAMATE; STRESS; INDIVIDUALISM; COLLECTIVISM; STIMULATION; ASSOCIATION; PREVALENCE	Background and Aims The 5-hydroxytryptamine transporter gene-linked polymorphic region (5-HTTLPR) has been linked to increased stress responsiveness and negative emotional states. During fearful face recognition individuals with the s allele of 5-HTTLPR show greater amygdala activation. We aimed to test the hypothesis that the 5-HTTLPR polymorphism differentially affects connectivity within brain networks during an aversive visceral stimulus. Methods Twenty-three healthy male subjects were enrolled. DNA was extracted from the peripheral blood. The genotype of 5-HTTLPR was determined using polymerase chain reaction. Subjects with the s/s genotype (n = 13) were compared to those with the l allele (genotypes l/s, l/l, n = 10). Controlled rectal distension from 0 to 40 mmHg was delivered in random order using a barostat. Radioactive H2[O15-] saline was injected at time of distension followed by positron emission tomography (PET). Changes in regional cerebral blood flow (rCBF) were analyzed using partial least squares (PLS) and structural equation modeling (SEM). Results During baseline, subjects with s/s genotype demonstrated a significantly increased negative influence of pregenual ACC (pACC) on amygdala activity compared to l-carriers. During inflation, subjects with s/s genotype demonstrated a significantly greater positive influence of hippocampus on amygdala activity compared to l-carriers. Conclusion In male Japanese subjects, individuals with s/s genotype show alterations in the connectivity of brain regions involved in stress responsiveness and emotion regulation during aversive visceral stimuli compared to those with l carriers.	[Kilpatrick, Lisa A.; Mayer, Emeran A.; Labus, Jennifer S.; Gupta, Arpana] Univ Calif Los Angeles, David Geffen Sch Med, Oppenheimer Family Ctr Neurobiol Stress, Div Digest Dis, Los Angeles, CA 90095 USA; [Hamaguchi, Toyohiro; Mizuno, Tomoko; Komuro, Hazuki; Kano, Michiko; Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan; [Kanazawa, Motoyori; Fukudo, Shin] Tohoku Univ, Grad Sch Med, Dept Psychosomat Med, Sendai, Miyagi 980, Japan; [Aoki, Masashi] Tohoku Univ, Grad Sch Med, Dept Neurol, Sendai, Miyagi 980, Japan	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Tohoku University; Tohoku University; Tohoku University	Fukudo, S (corresponding author), Tohoku Univ, Grad Sch Med, Dept Behav Med, Sendai, Miyagi 980, Japan.	sfukudo@med.tohoku.ac.jp	Labus, Jennifer S/M-4567-2017; Hamaguchi, Toyohiro/AAG-7808-2020; Hamaguchi, Toyohiro/J-4911-2019; Fukudo, Shin/J-4813-2014	Labus, Jennifer S/0000-0002-6634-2551; Hamaguchi, Toyohiro/0000-0001-5645-0439	Ministry of Education, Science, and Culture of Japan [7201-22249024-5001]; Ministry of Health, Welfare, and Labor of Japan; NIDDK [DK 048351]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK085133, P50DK064539, R01DK048351] Funding Source: NIH RePORTER	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare, and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture of Japan No. 7201-22249024-5001 (http://www.mext.go.jp/english/) and a Grant-in-Aid for Scientific Research from the Ministry of Health, Welfare, and Labor of Japan and partially supported by NIDDK grant DK 048351. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andolina D, 2013, NEUROPSYCHOPHARMACOL, V38, P2057, DOI 10.1038/npp.2013.107; Ansorge MS, 2004, SCIENCE, V306, P879, DOI 10.1126/science.1101678; Banks SJ, 2007, SOC COGN AFFECT NEUR, V2, P303, DOI 10.1093/scan/nsm029; Barnes NM, 2009, NEUROPHARMACOLOGY, V56, P273, DOI 10.1016/j.neuropharm.2008.08.003; Berry WD, 1984, NONRECURSIVE CAUSAL, P7; Camilleri M, 2008, AM J PHYSIOL-GASTR L, V295, pG219, DOI 10.1152/ajpgi.90202.2008; Caspi A, 2003, SCIENCE, V301, P386, DOI 10.1126/science.1083968; Chiao JY, 2010, P ROY SOC B-BIOL SCI, V277, P529, DOI 10.1098/rspb.2009.1650; Christian BT, 2013, J NEUROSCI, V33, P2512, DOI 10.1523/JNEUROSCI.4182-12.2013; Colucci R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054831; Du LS, 1999, BIOL PSYCHIAT, V46, P196, DOI 10.1016/S0006-3223(98)00376-X; El-Hage W, 2013, NEUROIMAGE, V76, P90, DOI 10.1016/j.neuroimage.2013.03.003; Fabre V, 2000, EUR J NEUROSCI, V12, P2299, DOI 10.1046/j.1460-9568.2000.00126.x; First MB, 2002, STRUCTURED CLIN INTE; Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Fukudo S, 2009, NEUROIMAGE, V47, P946, DOI 10.1016/j.neuroimage.2009.04.083; Fukudo S, 2011, J GASTROEN HEPATOL, V26, P110, DOI 10.1111/j.1440-1746.2011.06631.x; Hamaguchi T, 2013, PSYCHOSOM MED, V75, P453, DOI 10.1097/PSY.0b013e3182926682; Hanna GL, 1998, NEUROPSYCHOPHARMACOL, V18, P102, DOI 10.1016/S0893-133X(97)00097-3; Hariri AR, 2002, SCIENCE, V297, P400, DOI 10.1126/science.1071829; Hyman S. E., 2013, PRINCIPLES NEURAL SC, P1402; JORESKOG KG, 1971, PSYCHOMETRIKA, V36, P409, DOI 10.1007/BF02291366; Kano M, 2007, PAIN, V132, P252, DOI 10.1016/j.pain.2007.01.032; Karg K, 2011, ARCH GEN PSYCHIAT, V68, P444, DOI 10.1001/archgenpsychiatry.2010.189; Kawakami N, 2004, PSYCHIAT RES, V121, P293, DOI 10.1016/S0165-1781(03)00239-7; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Labus JS, 2011, GUT, V60, P1196, DOI 10.1136/gut.2010.213447; Lesch KP, 1996, SCIENCE, V274, P1527, DOI 10.1126/science.274.5292.1527; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Mayer EA, 2011, NAT REV NEUROSCI, V12, P453, DOI 10.1038/nrn3071; McIntosh AR, 1996, NEUROIMAGE, V3, P143, DOI 10.1006/nimg.1996.0016; MCINTOSH AR, 1994, J NEUROPHYSIOL, V72, P1717, DOI 10.1152/jn.1994.72.4.1717; McIntosh AR, 2004, NEUROIMAGE, V23, pS250, DOI 10.1016/j.neuroimage.2004.07.020; Mizuno T, 2006, J PSYCHOSOM RES, V60, P91, DOI 10.1016/j.jpsychores.2005.06.068; Niddam DM, 2011, AM J GASTROENTEROL, V106, P1503, DOI 10.1038/ajg.2011.120; Palazzo E, 2011, J NEUROSCI, V31, P4687, DOI 10.1523/JNEUROSCI.2938-10.2011; Park SM, 2012, REV NEUROSCIENCE, V23, P555, DOI 10.1515/revneuro-2012-0052; Pezawas L, 2005, NAT NEUROSCI, V8, P828, DOI 10.1038/nn1463; Schaub N, 2013, GASTROENTEROLOGY, V144, pS560; Schmahmann JD, 2006, FIBER PATHWAYS BRAIN, P1; Suzuki H, 2009, PSYCHOSOM MED, V71, P619, DOI 10.1097/PSY.0b013e31819b69ca; Talairach J., 1988, COPLANAR STEREOTAXIC; Tellez R, 2012, NEUROBIOL LEARN MEM, V98, P66, DOI 10.1016/j.nlm.2012.05.001; Tillisch K, 2011, GASTROENTEROLOGY, V140, P91, DOI 10.1053/j.gastro.2010.07.053; Van Kerkhoven LAS, 2007, ALIMENT PHARM THER, V26, P979, DOI 10.1111/j.1365-2036.2007.03453.x; Way BM, 2010, SOC COGN AFFECT NEUR, V5, P203, DOI 10.1093/scan/nsq059; Williams RB, 2001, PSYCHOSOM MED, V63, P300, DOI 10.1097/00006842-200103000-00016; Yoshida K, 2002, PROG NEURO-PSYCHOPH, V26, P383, DOI 10.1016/S0278-5846(01)00287-1	50	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123183	10.1371/journal.pone.0123183	http://dx.doi.org/10.1371/journal.pone.0123183			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893242	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700026
J	Liu, S; Sun, W; Chu, J; Huang, XF; Wu, ZX; Yan, MX; Zhang, Q; Zhao, P; Igietseme, JU; Black, CM; He, C; Li, YQ				Liu, Shanshan; Sun, Wei; Chu, Jun; Huang, Xiufen; Wu, Zongxue; Yan, Minxin; Zhang, Qiang; Zhao, Peng; Igietseme, Joseph U.; Black, Carolyn M.; He, Cheng; Li, Yongqing			Construction of Recombinant HVT Expressing PmpD, and Immunological Evaluation against Chlamydia psittaci and Marek's Disease Virus	PLOS ONE			English	Article							CHLAMYDOPHILA-PSITTACI; DNA VACCINATION; INFECTIONS; TURKEYS; PROTECTION; HERPESVIRUS; CHALLENGE; CHICKENS; ADJUVANT	Chlamydia psittaci (C. psittaci) is an obligate intracellular zoonotic pathogen that can be transmitted to humans from birds. No efficacious commercial vaccine is available for clearing chlamydial infection due to lack of potential vaccine candidates and effective delivery vehicles. Herpesvirus of turkeys (HVT) is an efficacious commercially available vaccine against Marek's Disease virus (MDV). In this study, a recombinant HVT-delivered vaccine against C. psittaci and Marek's disease was developed and examined. The 5'-terminus of pmpD gene (pmpD-N) encoding the N-terminal fragment of polymorphic membrane protein D of C. psittaci was inserted into a nonessential region of HVT genome using reverse genetics based on an infectious bacterial artificial chromosome (BAC) clone of HVT. The recombinant virus (rHVT-pmpD-N) was recovered from primary chicken embryo fibroblast (CEF) cells by transfection of modified HVT BAC DNA containing the pmpD-N gene. The rHVT-pmpD-N construct was confirmed to express PmpD-N by immunoblot and immunofluorescence. The rHVT-pmpD-N was stable during 20 passages in vitro. The growth kinetics of rHVT-pmpD-N was comparable to that of parental HVT in vitro and in vivo. One-day-old SPF chickens inoculated subcutaneously with rHVT-pmpD-N displayed increased PmpD-specific antibody levels and a vigorous PmpD-specific lymphocyte proliferation response using HVT vector or CEF cells as control. Furthermore, the percentage of CD4+ cells was significantly elevated in rHVT-pmpD-N-immunized birds as compared to the parental HVT. All chickens vaccinated with rHVT-pmpD-N or parental HVT were protected completely against challenge with a very virulent strain of Marek's Disease virus (MDV) RB-1B. Post challenge with C. psittaci CB7 strain, a significant decrease in respiratory distress, lesions and Chlamydia load was found in the rHVT-pmpD-N-vaccinated group compared to the parental HVT. In conclusion, our study suggests that the rHVT-pmpD-N live vaccine may be viable as a candidate dual vaccine that provides protection against both very virulent MDV and C. psittaci.	[Liu, Shanshan; Chu, Jun; Wu, Zongxue; Zhang, Qiang; Zhao, Peng; He, Cheng] China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China; [Liu, Shanshan; Sun, Wei; Huang, Xiufen; Yan, Minxin; Li, Yongqing] Beijing Acad Agr & Forestry Sci, Inst Anim Husb & Vet Med, Beijing 100097, Peoples R China; [Igietseme, Joseph U.; Black, Carolyn M.] CDC, Natl Ctr Emerging & Zoonot Infect Dis, Atlanta, GA 30333 USA	China Agricultural University; Ministry of Agriculture & Rural Affairs; Beijing Academy of Agriculture & Forestry; Centers for Disease Control & Prevention - USA	He, C (corresponding author), China Agr Univ, Coll Vet Med, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100193, Peoples R China.	hecheng@cau.edu.cn; liyngqng@yahoo.com	Zhao, Peng/HDO-7507-2022		Beijing Municipal Science and Technology Project [Z121100001212001]; National Natural Science Foundation of China [31172305, 31372420]; Ministry of Science and Technology (MoST) [2012BAD31B05]; Beijing Natural Science Foundation [6122018]	Beijing Municipal Science and Technology Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology (MoST)(Ministry of Science and Technology, China); Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by Beijing Municipal Science and Technology Project (Grant No. Z121100001212001), the National Natural Science Foundation of China (Grant No. 31172305 and 31372420) Ministry of Science and Technology (MoST) (Grant No. 2012BAD31B05) and Beijing Natural Science Foundation (Grant No. 6122018). All of the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AA, 1997, J VET DIAGN INVEST, V9, P159, DOI 10.1177/104063879700900209; Baigent SJ, 2006, J GEN VIROL, V87, P769, DOI 10.1099/vir.0.81498-0; BARRON AL, 1970, ARCH GES VIRUSFORSCH, V32, P389, DOI 10.1007/BF01250067; Chu J, 2014, GENOMEA, V2; Crane DD, 2006, P NATL ACAD SCI USA, V103, P1894, DOI 10.1073/pnas.0508983103; Dickx V, 2010, J CLIN MICROBIOL, V48, P3244, DOI 10.1128/JCM.00698-10; Farris CM, 2011, INFECT IMMUN, V79, P986, DOI 10.1128/IAI.00881-10; Gaede W, 2008, ZOONOSES PUBLIC HLTH, V55, P184, DOI 10.1111/j.1863-2378.2008.01108.x; Gerdts V, 2006, VET RES, V37, P487, DOI 10.1051/vetres:2006012; Harkinezhad T, 2009, VET RES, V40, DOI 10.1051/vetres/2009044; Iqbal M, 2012, BIOENGINEERED, V3, P222, DOI 10.4161/bioe.20476; Islam A, 2004, J VIROL METHODS, V119, P103, DOI 10.1016/j.jviromet.2004.03.006; Lagae S, 2014, J MED MICROBIOL, V63, P399, DOI 10.1099/jmm.0.064675-0; Laroucau K, 2009, INFECT GENET EVOL, V9, P1240, DOI 10.1016/j.meegid.2009.08.005; Le Gros FX, 2009, VACCINE, V27, P592, DOI 10.1016/j.vaccine.2008.10.094; Li YQ, 2011, VACCINE, V29, P8257, DOI 10.1016/j.vaccine.2011.08.115; Longbottom D, 2006, VET J, V171, P263, DOI 10.1016/j.tvjl.2004.09.006; Loots K, 2006, VACCINE, V24, P4598, DOI 10.1016/j.vaccine.2005.08.042; Ou CB, 2013, INT IMMUNOPHARMACOL, V16, P505, DOI 10.1016/j.intimp.2013.04.027; Petherbridge L, 2004, J VIROL, V78, P13376, DOI 10.1128/JVI.78.23.13376-13380.2004; Robertson T, 2010, VET MICROBIOL, V145, P373, DOI 10.1016/j.vetmic.2010.04.007; Rodolakis A, 2010, VET MICROBIOL, V140, P382, DOI 10.1016/j.vetmic.2009.03.014; SCHAT KA, 1978, JNCI-J NATL CANCER I, V60, P1075, DOI 10.1093/jnci/60.5.1075; Vanrompay D, 1999, CLIN EXP IMMUNOL, V118, P49; VANROMPAY D, 1995, VET MICROBIOL, V45, P93, DOI 10.1016/0378-1135(95)00033-7; Vanrompay D, 1999, VACCINE, V17, P2628, DOI 10.1016/S0264-410X(99)00053-5; Verminnen K, 2005, VACCINE, V23, P4509, DOI 10.1016/j.vaccine.2005.04.014; Verminnen K, 2010, VACCINE, V28, P3095, DOI 10.1016/j.vaccine.2010.02.064; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wheelhouse NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049190; Wu ZX, 2013, NOVEL MODEL AVIAN CH; Yang JJ, 2011, AVIAN DIS, V55, P76, DOI 10.1637/9419-060710-Reg.1; Yin LZ, 2013, VET MICROBIOL, V162, P740, DOI 10.1016/j.vetmic.2012.09.026; Yuan JL, 2013, EVALUATION IMMUNE RE; Zhang FM, 2008, AVIAN DIS, V52, P74, DOI 10.1637/8019-051207-Reg; Zhao XJ, 2011, VACCINE, V29, P9611, DOI 10.1016/j.vaccine.2011.10.053; Zhou JZ, 2007, VACCINE, V25, P6367, DOI 10.1016/j.vaccine.2007.06.031	39	12	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124992	10.1371/journal.pone.0124992	http://dx.doi.org/10.1371/journal.pone.0124992			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893439	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700131
J	Lynch, CJ; Xu, YP; Hajnal, A; Salzberg, AC; Kawasawa, YI				Lynch, Christopher J.; Xu, Yuping; Hajnal, Andras; Salzberg, Anna C.; Kawasawa, Yuka Imamura			RNA Sequencing Reveals a Slow to Fast Muscle Fiber Type Transition after Olanzapine Infusion in Rats	PLOS ONE			English	Article							OXIDATIVE ENZYME-ACTIVITY; HUMAN SKELETAL-MUSCLE; SARCOMERIC M-BAND; INSULIN-RESISTANCE; SARCOPLASMIC-RETICULUM; MESSENGER-RNA; FAST-TWITCH; 2ND-GENERATION ANTIPSYCHOTICS; GENE-EXPRESSION; ALPHA	Second generation antipsychotics (SGAs), like olanzapine, exhibit acute metabolic side effects leading to metabolic inflexibility, hyperglycemia, adiposity and diabetes. Understanding how SGAs affect the skeletal muscle transcriptome could elucidate approaches for mitigating these side effects. Male Sprague-Dawley rats were infused intravenously with vehicle or olanzapine for 24h using a dose leading to a mild hyperglycemia. RNA-Seq was performed on gastrocnemius muscle, followed by alignment of the data with the Rat Genome Assembly 5.0. Olanzapine altered expression of 1347 out of 26407 genes. Genes encoding skeletal muscle fiber-type specific sarcomeric, ion channel, glycolytic, O-2- and Ca2+-handling, TCA cycle, vascularization and lipid oxidation proteins and pathways, along with NADH shuttles and LDH isoforms were affected. Bioinformatics analyses indicate that olanzapine decreased the expression of slower and more oxidative fiber type genes (e.g., type 1), while up regulating those for the most glycolytic and least metabolically flexible, fast twitch fiber type, IIb. Protein turnover genes, necessary to bring about transition, were also up regulated. Potential upstream regulators were also identified. Olanzapine appears to be rapidly affecting the muscle transcriptome to bring about a change to a fast-glycolytic fiber type. Such fiber types are more susceptible than slow muscle to atrophy, and such transitions are observed in chronic metabolic diseases. Thus these effects could contribute to the altered body composition and metabolic disease olanzapine causes. A potential interventional strategy is implicated because aerobic exercise, in contrast to resistance exercise, can oppose such slow to fast fiber transitions.	[Lynch, Christopher J.; Xu, Yuping] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA; [Hajnal, Andras] Penn State Univ, Dept Neural & Behav Sci, Coll Med, Hershey, PA 17033 USA; [Salzberg, Anna C.] Penn State Univ, Dept Publ Hlth Sci, Coll Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Dept Pharmacol, Coll Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Dept Biochem & Mol Biol, Coll Med, Hershey, PA 17033 USA; [Kawasawa, Yuka Imamura] Penn State Univ, Inst Personalized Med, Coll Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Lynch, CJ (corresponding author), Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	clynch@hmc.psu.edu			National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK084428]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084428] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The study was funded by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK: http://www.niddk.nih.gov/Pages/default.aspx) grant DK084428. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann MA, 2009, MOL BIOL CELL, V20, P2963, DOI 10.1091/mbc.E08-12-1251; Ader M, 2005, DIABETES, V54, P862, DOI 10.2337/diabetes.54.3.862; Agarkova I, 2004, EUR J CELL BIOL, V83, P193, DOI 10.1078/0171-9335-00383; Albaugh VL, 2011, MOL PSYCHIATR, V16, P569, DOI 10.1038/mp.2010.33; Albaugh VL, 2006, OBESITY, V14, P36, DOI 10.1038/oby.2006.6; Albaugh VL, 2012, SCHIZOPHRENIA BULL, V38, P153, DOI 10.1093/schbul/sbq053; Albaugh VL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022662; Almon RR, 2007, PHYSIOL GENOMICS, V30, P282, DOI 10.1152/physiolgenomics.00242.2006; Arikawa E, 2007, DIABETES, V56, P1410, DOI 10.2337/db06-0655; Assie MB, 2008, EUR J PHARMACOL, V592, P160, DOI 10.1016/j.ejphar.2008.06.105; Bamford JA, 2003, CAN J PHYSIOL PHARM, V81, P1072, DOI 10.1139/Y03-110; Beha A, 2006, AM J PHYSIOL-ENDOC M, V290, pE989, DOI 10.1152/ajpendo.00459.2005; Burniston JG, 2013, PHYSIOL GENOMICS, V45, P228, DOI 10.1152/physiolgenomics.00149.2012; Carroll SL, 1997, J PHYSIOL-LONDON, V501, P573, DOI 10.1111/j.1469-7793.1997.573bm.x; Chauvigne F, 2005, DEV DYNAM, V233, P659, DOI 10.1002/dvdy.20371; Chemello F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016807; Chen LN, 2013, INT J MOL MED, V32, P892, DOI 10.3892/ijmm.2013.1453; Chintoh AF, 2008, J CLIN PSYCHOPHARM, V28, P494, DOI 10.1097/JCP.0b013e318184b4c5; Cottle DL, 2007, J CELL SCI, V120, P1423, DOI 10.1242/jcs.004739; de Leon J, 2007, SCHIZOPHR RES, V92, P95, DOI 10.1016/j.schres.2007.01.015; Deng C, 2013, ENDOCRIN METAB CLIN, V42, P545, DOI 10.1016/j.ecl.2013.05.006; eder-Ischia Ursula, 2005, Essent Psychopharmacol, V6, P112; Fertuzinhos S, 2014, CELL REP, V6, P938, DOI 10.1016/j.celrep.2014.01.036; Frey N, 2008, J CLIN INVEST, V118, P3598, DOI 10.1172/JCI36277; Friedman RA, 2012, NY TIMES, pD6; Fujita Naoto, 2012, ScientificWorldJournal, V2012, P637978, DOI 10.1100/2012/637978; Hahn MK, 2013, J CLIN PSYCHOPHARM, V33, P740, DOI 10.1097/JCP.0b013e31829e8333; Hasnain M, 2012, POSTGRAD MED, V124, P154, DOI 10.3810/pgm.2012.07.2577; He J, 2001, DIABETES, V50, P817, DOI 10.2337/diabetes.50.4.817; HEIZMANN CW, 1982, P NATL ACAD SCI-BIOL, V79, P7243, DOI 10.1073/pnas.79.23.7243; Kaddurah-Daouk R, 2007, MOL PSYCHIATR, V12, P934, DOI 10.1038/sj.mp.4002000; Kelleher AR, 2014, PHYSIOL REP, V2, DOI 10.1002/phy2.246; Kim JW, 2007, DIFFERENTIATION, V75, P147, DOI 10.1111/j.1432-0436.2006.00118.x; Klingerman CM, 2014, SCHIZOPHRENIA BULL, V40, P327, DOI 10.1093/schbul/sbs196; Kyriazis IA, 2006, J CLIN PSYCHOPHARM, V26, P92, DOI 10.1097/01.jcp.0000196116.78129.86; Laimer M, 2005, J CLIN PSYCHOPHARM, V25, P183, DOI 10.1097/01.jcp.0000155827.05327.88; Laing NG, 2008, LANDES BIOSCIENCE, pxxii; Lynch CJ, 2014, NAT REV ENDOCRINOL, V10, P723, DOI 10.1038/nrendo.2014.171; MacArthur DG, 2004, BIOESSAYS, V26, P786, DOI 10.1002/bies.20061; MacIntosh BR, 2006, SKELETAL MUSCLE FORM, pviii; Maher Alicia R, 2012, J Manag Care Pharm, V18, pS1; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; Mogensen M, 2007, DIABETES, V56, P1592, DOI 10.2337/db06-0981; Mullen AJ, 2000, GENE, V242, P313, DOI 10.1016/S0378-1119(99)00519-3; Nagatomo F, 2011, ACTA HISTOCHEM CYTOC, V44, P73, DOI 10.1267/ahc.10041; Newcomer JW, 2007, J CLIN PSYCHIAT, V68, P20; Norman B, 2009, J APPL PHYSIOL, V106, P959, DOI 10.1152/japplphysiol.91435.2008; Oberbach A, 2006, DIABETES CARE, V29, P895, DOI 10.2337/diacare.29.04.06.dc05-1854; Olfson M, 2006, AM J PSYCHIAT, V163, P1821, DOI 10.1176/appi.ajp.163.10.1821; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; SCHANTZ PG, 1986, ACTA PHYSIOL SCAND, V128, P397, DOI 10.1111/j.1748-1716.1986.tb07993.x; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Simoneau JA, 1997, J APPL PHYSIOL, V83, P166, DOI 10.1152/jappl.1997.83.1.166; SMERDU V, 1994, AM J PHYSIOL-CELL PH, V267, pC1723, DOI 10.1152/ajpcell.1994.267.6.C1723; Stevens L, 2000, AM J PHYSIOL-CELL PH, V279, pC1558, DOI 10.1152/ajpcell.2000.279.5.C1558; Summermatter S, 2013, P NATL ACAD SCI USA, V110, P8738, DOI 10.1073/pnas.1212976110; Tajsharghi H, 2004, J NEUROL, V251, P179, DOI 10.1007/s00415-004-0295-5; Talmadge RJ, 2007, BBA-GEN SUBJECTS, V1770, P1187, DOI 10.1016/j.bbagen.2007.03.013; Thompson CB, 1996, J BIOL CHEM, V271, P32653, DOI 10.1074/jbc.271.51.32653; Tiffin N, 2006, NUCLEIC ACIDS RES, V34, P3067, DOI 10.1093/nar/gkl381; Tiso N, 1997, BIOCHEM BIOPH RES CO, V230, P347, DOI 10.1006/bbrc.1996.5958; Towbin KE, 2006, AM J PSYCHIAT, V163, P2034, DOI 10.1176/appi.ajp.163.12.2034; Vary TC, 2008, AM J PHYSIOL-REG I, V294, pR1777, DOI 10.1152/ajpregu.00056.2008; Vidarsdottir S, 2010, J CLIN ENDOCR METAB, V95, P118, DOI 10.1210/jc.2008-1815; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wang ZC, 2003, BIOCHEM BIOPH RES CO, V305, P244, DOI 10.1016/S0006-291X(03)00730-7; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WU KD, 1993, AM J PHYSIOL, V264, pC333, DOI 10.1152/ajpcell.1993.264.2.C333; Yang N, 2009, MED SPORT SCI, V54, P88, DOI 10.1159/000235698; YANO K, 1994, MOL CELL BIOCHEM, V135, P61, DOI 10.1007/BF00925961; Zhang YL, 1995, GENOMICS, V30, P415, DOI 10.1006/geno.1995.1259	71	15	15	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123966	10.1371/journal.pone.0123966	http://dx.doi.org/10.1371/journal.pone.0123966			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893406	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700066
J	Zhao, CM; Peng, LY; Li, L; Liu, XY; Wang, J; Zhang, XL; Yuan, F; Li, RG; Qiu, XB; Yang, YQ				Zhao, Cui-Mei; Peng, Lu-Ying; Li, Li; Liu, Xing-Yuan; Wang, Juan; Zhang, Xian-Ling; Yuan, Fang; Li, Ruo-Gu; Qiu, Xing-Biao; Yang, Yi-Qing			PITX2 Loss-of-Function Mutation Contributes to Congenital Endocardial Cushion Defect and Axenfeld-Rieger Syndrome	PLOS ONE			English	Article							LEFT-RIGHT ASYMMETRY; HEART-DISEASE; SPORADIC TETRALOGY; CHINESE PATIENTS; GENE-EXPRESSION; GATA5 MUTATIONS; ADULT PATIENTS; NKX2-5 GENE; SPECTRUM; PREVALENCE	Congenital heart disease (CHD), the most common type of birth defect, is still the leading non-infectious cause of infant morbidity and mortality in humans. Aggregating evidence demonstrates that genetic defects are involved in the pathogenesis of CHD. However, CHD is genetically heterogeneous and the genetic components underpinning CHD in an overwhelming majority of patients remain unclear. In the present study, the coding exons and flanking introns of the PITX2 gene, which encodes a paired-like homeodomain transcription factor 2essential for cardiovascular morphogenesis as well as maxillary facial development, was sequenced in 196 unrelated patients with CHD and subsequently in the mutation carrier's family members available. As a result, a novel heterozygous PITX2 mutation, p.Q102X for PITX2a, or p.Q148X for PITX2b, or p.Q155X for PITX2c, was identified in a family with endocardial cushion defect (ECD) and Axenfeld-Rieger syndrome (ARS). Genetic analysis of the pedigree showed that the nonsense mutation co-segregated with ECD and ARS transmitted in an autosomal dominant pattern with complete penetrance. The mutation was absent in 800 control chromosomes from an ethnically matched population. Functional analysis by using a dual-luciferase reporter assay system revealed that the mutant PITX2 had no transcriptional activity and that the mutation eliminated synergistic transcriptional activation between PITX2 and NKX2.5, another transcription factor pivotal for cardiogenesis. To our knowledge, this is the first report on the association of PITX2 loss-of-function mutation with increased susceptibility to ECD and ARS. The findings provide novel insight into the molecular mechanisms underpinning ECD and ARS, suggesting the potential implications for the antenatal prophylaxis and personalized treatment of CHD and ARS.	[Zhao, Cui-Mei; Wang, Juan] Tongji Univ, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China; [Zhao, Cui-Mei; Peng, Lu-Ying; Li, Li] Tongji Univ, Sch Med, Div Med Genet, Shanghai 200092, Peoples R China; [Liu, Xing-Yuan] Tongji Univ, Tongji Hosp, Sch Med, Dept Pediat, Shanghai 200092, Peoples R China; [Zhang, Xian-Ling] Tongji Univ, Sch Med, Shanghai Tenth Peoples Hosp, Dept Cardiol, Shanghai 200092, Peoples R China; [Yuan, Fang; Li, Ruo-Gu; Qiu, Xing-Biao; Yang, Yi-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiol, Shanghai 200030, Peoples R China; [Yang, Yi-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cardiovasc Res Lab, Shanghai 200030, Peoples R China; [Yang, Yi-Qing] Shanghai Jiao Tong Univ, Shanghai Chest Hosp, Dept Cent Lab, Shanghai 200030, Peoples R China	Tongji University; Tongji University; Tongji University; Tongji University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Zhao, CM (corresponding author), Tongji Univ, Sch Med, Dept Cardiol, Shanghai 200092, Peoples R China.	cuimeizhao@sina.com; luying_peng@163.com; dryyq@tongji.edu.cn			National Natural Science Fund of China [81270161, 81270231, 81370298]; National Basic Research Program of China [2012CB9668003]; key basic research program of Shanghai, China [14JC1405500]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); key basic research program of Shanghai, China(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported by grants from the National Natural Science Fund of China (81270161, 81270231, and 81370298), the National Basic Research Program of China (2012CB9668003), and the key basic research program of Shanghai, China (14JC1405500).	Ai D, 2006, DEV BIOL, V296, P437, DOI 10.1016/j.ydbio.2006.06.009; Al Turki S, 2014, AM J HUM GENET, V94, P574, DOI 10.1016/j.ajhg.2014.03.007; Alonso-Gonzalez R, 2013, CIRCULATION, V127, P882, DOI 10.1161/CIRCULATIONAHA.112.126755; Banerjee-Basu S, 1999, HUM MUTAT, V14, P312, DOI 10.1002/(SICI)1098-1004(199910)14:4<312::AID-HUMU6>3.0.CO;2-S; Bansal V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085375; Cai BX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089609; Campbell AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035822; Carter DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095253; Chang SW, 2013, HUM MUTAT, V34, P1226, DOI 10.1002/humu.22366; Chen DF, 2013, GENE, V512, P185, DOI 10.1016/j.gene.2012.10.066; Costa MW, 2013, CIRC-CARDIOVASC GENE, V6, P238, DOI 10.1161/CIRCGENETICS.113.000057; Cowan J, 2014, HUM MUTAT, V35, P66, DOI 10.1002/humu.22457; Cox CJ, 2002, J BIOL CHEM, V277, P25001, DOI 10.1074/jbc.M201737200; Dagle JM, 2003, DEV BIOL, V262, P268, DOI 10.1016/S0012-1606(03)00389-0; de Lange FJ, 2004, CIRC RES, V95, P645, DOI 10.1161/01.RES.0000141429.13560.cb; Dimopoulos K, 2014, EUR HEART J, V35, P691, DOI 10.1093/eurheartj/eht437; Doward W, 1999, J MED GENET, V36, P152; Fahed AC, 2014, HEART FAIL CLIN, V10, P219, DOI 10.1016/j.hfc.2013.09.017; Furtado MB, 2011, DEV DYNAM, V240, P195, DOI 10.1002/dvdy.22492; Galli D, 2008, DEVELOPMENT, V135, P1157, DOI 10.1242/dev.014563; Ganga M, 2003, J BIOL CHEM, V278, P22437, DOI 10.1074/jbc.M210163200; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Gong XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076314; Hjalt TA, 2001, J CELL BIOL, V152, P545, DOI 10.1083/jcb.152.3.545; Hjalt Tord A., 2005, Expert Reviews in Molecular Medicine, V7, P1, DOI 10.1017/S1462399405010082; Hoffmann A, 2010, HEART, V96, P1223, DOI 10.1136/hrt.2010.196147; Hsu J, 2012, CIRC-CARDIOVASC GENE, V5, P327, DOI 10.1161/CIRCGENETICS.111.961631; Huang RT, 2014, INT J MOL MED, V33, P1227, DOI 10.3892/ijmm.2014.1674; Huang RT, 2013, INT J MOL MED, V31, P1119, DOI 10.3892/ijmm.2013.1316; Huang RT, 2013, INT J MOL MED, V31, P51, DOI 10.3892/ijmm.2012.1188; Huang WH, 2013, GENE, V524, P152, DOI 10.1016/j.gene.2013.04.043; Hunter RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059734; Jiang JQ, 2013, INT J CARDIOL, V165, P570, DOI 10.1016/j.ijcard.2012.09.039; Kahr PC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026389; Kirchhof P, 2011, CIRC-CARDIOVASC GENE, V4, P123, DOI 10.1161/CIRCGENETICS.110.958058; Kitamura K, 1999, DEVELOPMENT, V126, P5749; Kobayashi J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102796; Kroonstrom LA, 2014, INT J CARDIOL, V170, P358, DOI 10.1016/j.ijcard.2013.11.014; Lahm H, 2013, EUR J MED GENET, V56, P591, DOI 10.1016/j.ejmg.2013.09.001; Lalani SR, 2014, EUR J MED GENET, V57, P402, DOI 10.1016/j.ejmg.2014.04.010; Li J, 2014, GENE, V548, P174, DOI 10.1016/j.gene.2014.07.022; Li RG, 2013, BIOCHEM BIOPH RES CO, V439, P591, DOI 10.1016/j.bbrc.2013.09.023; Liang DD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103097; Lin B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090215; Liu APY, 2014, EUR J MED GENET, V57, P306, DOI 10.1016/j.ejmg.2014.03.014; Liu CY, 2002, DEVELOPMENT, V129, P5081; Liu CY, 2001, DEVELOPMENT, V128, P2039; Liu Y, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0106787, 10.1371/journal.pone.0098157, 10.1371/journal.pone.0085323]; Long F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072515; Lozano-Velasco E, 2011, CELLS TISSUES ORGANS, V194, P349, DOI 10.1159/000323533; Lozic Bernarda, 2014, Med Sci Monit, V20, P1531, DOI 10.12659/MSM.890916; Lukasz A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066861; Martinez-Quintana E, 2013, PEDIATR CARDIOL, V34, P912, DOI 10.1007/s00246-012-0571-6; McCulley DJ, 2012, CURR TOP DEV BIOL, V100, P253, DOI 10.1016/B978-0-12-387786-4.00008-7; Moutafi AC, 2014, INT J CARDIOL, V173, P566, DOI 10.1016/j.ijcard.2014.03.120; Muller J, 2012, INT J CARDIOL, V154, P265, DOI 10.1016/j.ijcard.2010.09.029; Mulkey SB, 2013, PEDIATR CARDIOL, V34, P1772, DOI 10.1007/s00246-013-0712-6; Ohuchi H, 2009, AM HEART J, V158, P30, DOI 10.1016/j.ahj.2009.04.021; Perry JC, 2012, PEDIATR CARDIOL, V33, P484, DOI 10.1007/s00246-012-0171-5; Qiu XB, 2014, CLINICS, V69, P15, DOI 10.6061/clinics/2014(01)03; Rajagopal SK, 2007, J MOL CELL CARDIOL, V43, P677, DOI 10.1016/j.yjmcc.2007.06.004; Reamon-Buettner SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083295; Reamon-Buettner SM, 2010, HUM MUTAT, V31, P1185, DOI 10.1002/humu.21345; Rushani D, 2013, CIRCULATION, V128, P1412, DOI 10.1161/CIRCULATIONAHA.113.001827; Sanchez-Castro M, 2013, HUM MUTAT, V34, P1628, DOI 10.1002/humu.22449; Schott JJ, 1998, SCIENCE, V281, P108, DOI 10.1126/science.281.5373.108; Schweickert A, 2000, MECH DEVELOP, V90, P41, DOI 10.1016/S0925-4773(99)00227-0; Semina EV, 1996, NAT GENET, V14, P392, DOI 10.1038/ng1296-392; Shi LM, 2014, INT J MOL MED, V33, P1219, DOI 10.3892/ijmm.2014.1700; Simard A, 2009, DEV DYNAM, V238, P2459, DOI 10.1002/dvdy.22062; Topf A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095453; Torrado M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090561; Tumer Z, 2009, EUR J HUM GENET, V17, P1527, DOI 10.1038/ejhg.2009.93; Tutarel O, 2014, EUR HEART J, V35, P725, DOI 10.1093/eurheartj/eht257; Wang C, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0065120, 10.1371/journal.pone.0068807]; Wang EL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072423; Wang E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062138; Wang J, 2013, DNA CELL BIOL, V32, P708, DOI 10.1089/dna.2013.2185; Wang J, 2014, INT J MOL MED, V34, P1581, DOI 10.3892/ijmm.2014.1971; Wang J, 2014, EUR J MED GENET, V57, P25, DOI 10.1016/j.ejmg.2013.11.004; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058041; Wang ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070979; Wei D, 2014, INT J MOL MED, V33, P1201, DOI 10.3892/ijmm.2014.1689; Wu M, 2013, INT J MOL MED, V31, P899, DOI 10.3892/ijmm.2013.1275; Xia K, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.022434; Xiang R, 2014, GENE, V534, P320, DOI 10.1016/j.gene.2013.10.028; Xu J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089636; Xu L, 2014, INT J MOL MED, V34, P1315, DOI 10.3892/ijmm.2014.1896; Yang YQ, 2013, ARCH MED SCI, V9, P976, DOI 10.5114/aoms.2013.39788; Yang YQ, 2013, HUM MUTAT, V34, P1662, DOI 10.1002/humu.22434; Yang YQ, 2013, INT J CARDIOL, V168, P2873, DOI 10.1016/j.ijcard.2013.03.141; Yu H, 2014, INT J MED SCI, V11, P554, DOI 10.7150/ijms.8407; Yuan F, 2013, INT J MED SCI, V10, P1422, DOI 10.7150/ijms.6809; Zaidi S, 2013, NATURE, V498, P220, DOI 10.1038/nature12141; Zhao L, 2014, EUR J MED GENET, V57, P579, DOI 10.1016/j.ejmg.2014.08.005; Zhou YM, 2013, INT J MOL MED, V32, P827, DOI 10.3892/ijmm.2013.1463; Zhu XM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087437	98	19	20	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124409	10.1371/journal.pone.0124409	http://dx.doi.org/10.1371/journal.pone.0124409			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893250	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700091
J	Kong, FC; Zhang, Y; Chen, H				Kong, Fanchang; Zhang, Yan; Chen, Hong			Inhibition Ability of Food Cues between Successful and Unsuccessful Restrained Eaters: A Two-Choice Oddball Task	PLOS ONE			English	Article							EATING BEHAVIOR; SELF-CONTROL; RESPONSE-INHIBITION; MODEL; DEPLETION; P300	Background Previous studies have presented mixed findings on the inhibition ability in restrained eaters (REs) due to the limited amount of neural evidence and limitations of behavioral measures. The current study explores the neural correlations of the specific inhibition ability among successful restrained eaters (S-REs), unsuccessful restrained eaters (US-REs), and unrestrained eaters (UREs). Methodology and Principal Findings Three groups of females (with 13 participants in each group) completed a two-choice Odd-ball task, while the event-related potentials (ERPs) are recorded synchronously. Results indicate that S-REs showed inhibition deficit in processing high-energy food cues whereas US-REs show inhibition deficit in processing both low-and high-energy food cues. Conclusion Results indicate that S-REs and US-REs differ in terms of specific inhibition ability and that enhanced inhibition is essential to a successful diet.	[Kong, Fanchang] Cent China Normal Univ, Minist Educ, Key Lab Adolescent CyberPsychol & Behav, Wuhan, Peoples R China; [Kong, Fanchang] Cent China Normal Univ, Sch Psychol, Wuhan, Peoples R China; [Kong, Fanchang; Chen, Hong] Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China; [Kong, Fanchang; Chen, Hong] Southwest Univ, Fac Psychol, Chongqing, Peoples R China; [Zhang, Yan] Huazhong Univ Sci & Technol, Acad Educ Sci, Wuhan 430074, Peoples R China	Central China Normal University; Central China Normal University; Southwest University - China; Southwest University - China; Huazhong University of Science & Technology	Chen, H (corresponding author), Southwest Univ, Minist Educ, Key Lab Cognit & Personal, Chongqing, Peoples R China.	kfcpsy@sina.com	Kong, Fanchang/AIE-1078-2022	Kong, Fanchang/0000-0002-0340-8445	Chinese National Natural Science Foundation [31170981, 31200787]; Postgraduate Innovation Foundation of Science and Technology in Southwest University [kb2010014]; China Postdoctoral Science Foundation funded project [2013M531712]; Ministry of Education-China Mobile Foundation [MCM20130601]; Fundamental Research Funds for the Central Universities, China [CCNU13A03011]	Chinese National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Postgraduate Innovation Foundation of Science and Technology in Southwest University(Southwest University - China); China Postdoctoral Science Foundation funded project(China Postdoctoral Science Foundation); Ministry of Education-China Mobile Foundation; Fundamental Research Funds for the Central Universities, China(Fundamental Research Funds for the Central Universities)	This research was supported and granted by Chinese National Natural Science Foundation (31170981 & 31200787), Postgraduate Innovation Foundation of Science and Technology in Southwest University (kb2010014), China Postdoctoral Science Foundation funded project (2013M531712), The Ministry of Education-China Mobile Foundation (MCM20130601), and Fundamental Research Funds for the Central Universities, China (CCNU13A03011). The funders had no role in study design, data	ALEXANDER JE, 1995, COGNITIVE BRAIN RES, V2, P277, DOI 10.1016/0926-6410(95)90019-5; Babiloni C, 2011, CLIN NEUROPHYSIOL, V122, P1348, DOI 10.1016/j.clinph.2010.12.001; BAKER RC, 1993, BEHAV THER, V24, P377, DOI 10.1016/S0005-7894(05)80212-6; Beaver JD, 2006, J NEUROSCI, V26, P5160, DOI 10.1523/JNEUROSCI.0350-06.2006; Blechert J, 2010, APPETITE, V54, P262, DOI 10.1016/j.appet.2009.11.007; Choo V, 2002, LANCET, V360, P235, DOI 10.1016/S0140-6736(02)09512-0; Danhauer SC, 2004, PREV MED, V39, P783, DOI 10.1016/j.ypmed.2004.03.003; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Falkenstein M, 1999, ACTA PSYCHOL, V101, P267, DOI 10.1016/S0001-6918(99)00008-6; Graziano PA, 2009, INT J OBE, V4, P633; Guerrieri R, 2012, APPETITE, V59, P96, DOI 10.1016/j.appet.2012.04.006; Hachl P, 2003, INT J PSYCHOPHYSIOL, V49, P111, DOI 10.1016/S0167-8760(03)00099-0; Hagger MS, 2010, PSYCHOL BULL, V136, P495, DOI 10.1037/a0019486; HERMAN CP, 1987, J ABNORM PSYCHOL, V96, P264, DOI 10.1037/0021-843X.96.3.264; Jansen A, 2009, BEHAV RES THER, V47, P105, DOI 10.1016/j.brat.2008.10.016; Kong F. C., 2012, THESIS SW U CHINA; Kuijer R, 2008, APPETITE, V51, P506, DOI 10.1016/j.appet.2008.03.014; Leitch MA, 2013, APPETITE, V69, P54, DOI 10.1016/j.appet.2013.05.007; LOWE MR, 1993, PSYCHOL BULL, V114, P100, DOI 10.1037/0033-2909.114.1.100; Meule A, 2014, APPETITE, V79, P174, DOI 10.1016/j.appet.2014.04.014; Meule A, 2012, APPETITE, V58, P638, DOI 10.1016/j.appet.2011.11.023; Meule A, 2011, APPETITE, V57, P582, DOI 10.1016/j.appet.2011.07.013; Meule A, 2011, EAT BEHAV, V12, P152, DOI 10.1016/j.eatbeh.2011.01.006; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Musso F, 2011, NEUROIMAGE, V9, P269; Nederkoorn C, 2004, PERS INDIV DIFFER, V37, P1651, DOI 10.1016/j.paid.2004.02.020; Nederkoorn C, 2010, HEALTH PSYCHOL, V29, P389, DOI 10.1037/a0019921; Nordgren LF, 2009, PSYCHOL SCI, V20, P1523, DOI 10.1111/j.1467-9280.2009.02468.x; Ouwehand C, 2010, APPETITE, V55, P56, DOI 10.1016/j.appet.2010.04.009; Papies EK, 2008, J EXP SOC PSYCHOL, V44, P1283, DOI 10.1016/j.jesp.2008.04.008; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Stroebe W, 2008, J EXP SOC PSYCHOL, V44, P26, DOI 10.1016/j.jesp.2007.01.005; Thorpe S, 1996, NATURE, V381, P520, DOI 10.1038/381520a0; van Koningsbruggen GM, 2013, APPETITE, V60, P81, DOI 10.1016/j.appet.2012.09.016; Van Strien T, 2000, INT J EAT DISORDER, V28, P333, DOI 10.1002/1098-108X(200011)28:3&lt;333::AID-EAT11&gt;3.0.CO;2-#; Watson TD, 2013, APPETITE, V71, P40, DOI 10.1016/j.appet.2013.07.007; Yuan JJ, 2008, PSYCHOPHYSIOLOGY, V45, P986, DOI 10.1111/j.1469-8986.2008.00693.x	37	23	25	4	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0120522	10.1371/journal.pone.0120522	http://dx.doi.org/10.1371/journal.pone.0120522			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25886063	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000010
J	Pandey, JL; Wang, B; Diehl, BG; Richard, TL; Chen, G; Anderson, CT				Pandey, Jyotsna L.; Wang, Bo; Diehl, Brett G.; Richard, Tom L.; Chen, Gong; Anderson, Charles T.			A Versatile Click-Compatible Monolignol Probe to Study Lignin Deposition in Plant Cell Walls	PLOS ONE			English	Article							FLUORESCENCE-TAGGED MONOLIGNOLS; CONFOCAL RAMAN MICROSCOPY; RADIATA D DON; STATE 2D NMR; BIOFUEL PRODUCTION; QUANTITATIVE C-13; LIVE CELLS; LIGNIFICATION; VISUALIZATION; BIOSYNTHESIS	Lignin plays important structural and functional roles in plants by forming a hydrophobic matrix in secondary cell walls that enhances mechanical strength and resists microbial decay. While the importance of the lignin matrix is well documented and the biosynthetic pathways for monolignols are known, the process by which lignin precursors or monolignols are transported and polymerized to form this matrix remains a subject of considerable debate. In this study, we have synthesized and tested an analog of coniferyl alcohol that has been modified to contain an ethynyl group at the C-3 position. This modification enables fluorescent tagging and imaging of this molecule after its incorporation into plant tissue by click chemistry- assisted covalent labeling with a fluorescent azide dye, and confers a distinct Raman signature that could be used for Raman imaging. We found that this monolignol analog is incorporated into in vitro-polymerized dehydrogenation polymer (DHP) lignin and into root epidermal cell walls of 4-day-old Arabidopsis seedlings. Incorporation of the analog in stem sections of 6-week-old Arabidopsis thaliana plants and labeling with an Alexa-594 azide dye revealed the precise locations of new lignin polymerization. Results from this study indicate that this molecule can provide high-resolution localization of lignification during plant cell wall maturation and lignin matrix assembly.	[Pandey, Jyotsna L.; Diehl, Brett G.; Richard, Tom L.] Penn State Univ, Dept Agr & Biol Engn, University Pk, PA 16802 USA; [Wang, Bo; Chen, Gong] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Anderson, Charles T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Pandey, Jyotsna L.; Wang, Bo; Diehl, Brett G.; Richard, Tom L.; Chen, Gong; Anderson, Charles T.] Penn State Univ, Ctr Lignocellulose Struct & Format, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Anderson, CT (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	cta3@psu.edu	Chen, Gong/A-8063-2013	Chen, Gong/0000-0002-5067-9889; Pandey, Jyotsna L./0000-0001-8173-0424; Richard, Tom/0000-0002-0833-4844	Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center - U. S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0001090]	Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center - U. S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported as part of The Center for LignoCellulose Structure and Formation, an Energy Frontier Research Center funded by the U. S. Department of Energy, Office of Science, Basic Energy Sciences under Award # DE-SC0001090. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal UP, 2006, PLANTA, V224, P1141, DOI 10.1007/s00425-006-0295-z; Alejandro S, 2012, CURR BIOL, V22, P1207, DOI 10.1016/j.cub.2012.04.064; Anderson CT, 2012, P NATL ACAD SCI USA, V109, P1329, DOI 10.1073/pnas.1120429109; Azoulay M, 2006, BIOORG MED CHEM LETT, V16, P3147, DOI 10.1016/j.bmcl.2006.03.073; Baucher M, 1998, CRIT REV PLANT SCI, V17, P125, DOI 10.1016/S0735-2689(98)00360-8; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Bukowski N, 2014, BIOCONJUGATE CHEM, V25, P2189, DOI 10.1021/bc500411u; Burton RA, 2010, NAT CHEM BIOL, V6, P724, DOI [10.1038/NCHEMBIO.439, 10.1038/nchembio.439]; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Capanema EA, 2004, J AGR FOOD CHEM, V52, P1850, DOI 10.1021/jf035282b; Chabannes M, 2001, PLANT J, V28, P271, DOI 10.1046/j.1365-313X.2001.01159.x; Chen F, 2007, NAT BIOTECHNOL, V25, P759, DOI 10.1038/nbt1316; Coletta VC, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-43; Donaldson LA, 2001, PHYTOCHEMISTRY, V57, P859, DOI 10.1016/S0031-9422(01)00049-8; DONALDSON LA, 1991, WOOD SCI TECHNOL, V25, P15, DOI 10.1007/BF00195553; DONALDSON LA, 1992, IAWA BULL, V13, P381, DOI 10.1163/22941932-90001291; Flors C, 2013, J MICROSC-OXFORD, V251, P1, DOI 10.1111/jmi.12054; Gierlinger N, 2006, PLANT PHYSIOL, V140, P1246, DOI 10.1104/pp.105.066993; Gierlinger N, 2007, SPECTROSC-INT J, V21, P69, DOI 10.1155/2007/498206; Gierlinger N, 2012, NAT PROTOC, V7, P1694, DOI 10.1038/nprot.2012.092; Grabber JH, 2008, BIOMACROMOLECULES, V9, P2510, DOI 10.1021/bm800528f; Grabber JH, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-114; Holtman KM, 2006, J WOOD CHEM TECHNOL, V26, P21, DOI 10.1080/02773810600582152; Hsu TL, 2007, P NATL ACAD SCI USA, V104, P2614, DOI 10.1073/pnas.0611307104; IIYAMA K, 1994, PLANT PHYSIOL, V104, P315, DOI 10.1104/pp.104.2.315; Jones L, 2001, PLANT J, V26, P205, DOI 10.1046/j.1365-313x.2001.01021.x; Kaneda M, 2011, J EXP BOT, V62, P2063, DOI 10.1093/jxb/erq416; Kaneda M, 2010, J INTEGR PLANT BIOL, V52, P234, DOI 10.1111/j.1744-7909.2010.00925.x; Kim H, 2008, BIOENERG RES, V1, P56, DOI 10.1007/s12155-008-9004-z; Kim H, 2010, ORG BIOMOL CHEM, V8, P576, DOI 10.1039/b916070a; Laughlin ST, 2009, P NATL ACAD SCI USA, V106, P12, DOI 10.1073/pnas.0811481106; Lawoko M, 2006, HOLZFORSCHUNG, V60, P156, DOI 10.1515/HF.2006.025; Link AJ, 2004, J AM CHEM SOC, V126, P10598, DOI 10.1021/ja047629c; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; Lu FC, 2008, ORG BIOMOL CHEM, V6, P3681, DOI 10.1039/b809464k; Mansfield SD, 2012, NAT PROTOC, V7, P1579, DOI 10.1038/nprot.2012.064; Miao YC, 2010, P NATL ACAD SCI USA, V107, P22728, DOI 10.1073/pnas.1007747108; Palonpon AF, 2013, NAT PROTOC, V8, P677, DOI 10.1038/nprot.2013.030; Prescher JA, 2005, NAT CHEM BIOL, V1, P13, DOI 10.1038/nchembio0605-13; Ralph John, 2004, Phytochemistry Reviews, V3, P29, DOI 10.1023/B:PHYT.0000047809.65444.a4; Rohrig UF, 2012, J MED CHEM, V55, P5270, DOI 10.1021/jm300260v; SAKA S, 1982, WOOD SCI TECHNOL, V16, P167, DOI 10.1007/BF00353866; Schmidt M, 2009, PLANTA, V230, P589, DOI 10.1007/s00425-009-0963-x; Schuetz M, 2014, PLANT PHYSIOL, V166, P798, DOI 10.1104/pp.114.245597; Seo TS, 2004, P NATL ACAD SCI USA, V101, P5488, DOI 10.1073/pnas.0401138101; Shadle G, 2007, PHYTOCHEMISTRY, V68, P1521, DOI 10.1016/j.phytochem.2007.03.022; Shieh P, 2014, P NATL ACAD SCI USA, V111, P5456, DOI 10.1073/pnas.1322727111; Simmons BA, 2010, CURR OPIN PLANT BIOL, V13, P313, DOI 10.1016/j.pbi.2010.03.001; Singh S, 2009, BIOTECHNOL BIOENG, V104, P68, DOI 10.1002/bit.22386; TERASHIMA N, 1995, HOLZFORSCHUNG, V49, P521, DOI 10.1515/hfsg.1995.49.6.521; Tobimatsu Y, 2014, CHEM COMMUN, V50, P12262, DOI 10.1039/c4cc04692g; Tobimatsu Y, 2013, PLANT J, V76, P357, DOI 10.1111/tpj.12299; Tobimatsu Y, 2011, BIOMACROMOLECULES, V12, P1752, DOI 10.1021/bm200136x; Tronchet M, 2010, MOL PLANT PATHOL, V11, P83, DOI [10.1111/j.1364-3703.2009.00578.x, 10.1111/j.1364-3703.2009.00578.X]; Vallet C, 1996, ANN BOT-LONDON, V78, P625, DOI 10.1006/anbo.1996.0170; Vanholme R, 2012, NEW PHYTOL, V196, P978, DOI 10.1111/j.1469-8137.2012.04337.x; Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; Vishnoi S, 2009, J AGR FOOD CHEM, V57, P3261, DOI 10.1021/jf8034385; Wang Y, 2013, FRONT PLANT SCI, V4, DOI [10.3389/fpls.2013.00220, 10.3389/fpls.2013.00314]; Wardrop A. B., 1957, TAPPI, V40, P225; Weng JK, 2010, NEW PHYTOL, V187, P273, DOI 10.1111/j.1469-8137.2010.03327.x; Wilkerson CG, 2014, SCIENCE, V344, P90, DOI 10.1126/science.1250161; Yamakoshi H, 2012, J AM CHEM SOC, V134, P20681, DOI 10.1021/ja308529n; Yuan TQ, 2011, J AGR FOOD CHEM, V59, P10604, DOI 10.1021/jf2031549; Zessin PJM, 2012, J STRUCT BIOL, V177, P344, DOI 10.1016/j.jsb.2011.12.015	65	17	17	4	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121334	10.1371/journal.pone.0121334	http://dx.doi.org/10.1371/journal.pone.0121334			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884205	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000016
J	Yu, H; Chen, K; Wu, JG; Yang, ZY; Shi, LF; Barlow, LL; Aronoff, DM; Garey, KW; Savidge, TC; von Rosenvinge, EC; Kelly, CP; Feng, HP				Yu, Hua; Chen, Kevin; Wu, Jianguo; Yang, Zhiyong; Shi, Lianfa; Barlow, Lydia L.; Aronoff, David M.; Garey, Kevin W.; Savidge, Tor C.; von Rosenvinge, Erik C.; Kelly, Ciaran P.; Feng, Hanping			Identification of Toxemia in Patients with Clostridium difficile Infection	PLOS ONE			English	Article							PSEUDOMEMBRANOUS COLITIS; TOXIN-A; MONOCLONAL-ANTIBODIES; DISEASE; ENTEROCOLITIS; PROTECTION; HAMSTERS; RECEPTOR; SOCIETY; MODELS	Toxemia can develop in Clostridium difficile-infected animals, and correlates with severe and fulminant disease outcomes. Circumstantial evidence suggests that toxemia may occur in patients with C. difficile infection (CDI), but positive diagnosis is extremely rare. We analyzed the potential for C. difficile toxemia in patients, determined its characteristics, and assessed challenges. C. difficile toxins in serum from patients were tested using an ultrasensitive cell-based assay and further confirmed by Rac1 glucosylation assay. The factors that hinder a diagnosis of toxemia were assessed, including investigation of toxin stability, the level of toxins-specific neutralizing antibodies in sera and its effect on diagnosis limits. CDI patients develop detectable toxemia in some cases (2.3%). Toxins were relatively stable in stored sera. Neutralizing anti-toxin antibodies were present during infection and positively correlated with the diagnosis limits. Thus, the masking effect of toxin-specific neutralizing antibodies is the major obstacle in diagnosing C. difficile toxemia using cell-based bioassays.	[Yu, Hua; Chen, Kevin; Wu, Jianguo; Yang, Zhiyong; Shi, Lianfa; Feng, Hanping] Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA; [Barlow, Lydia L.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Aronoff, David M.] Vanderbilt Univ, Med Ctr, Dept Med, Div Infect Dis, Nashville, TN USA; [Aronoff, David M.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; [Garey, Kevin W.] Univ Houston, Coll Pharm, Houston, TX 77030 USA; [Garey, Kevin W.] Baylor St Lukes Med Ctr, Houston, TX USA; [Garey, Kevin W.] Univ Texas Houston, Sch Publ Hlth, Houston, TX USA; [Savidge, Tor C.] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Savidge, Tor C.] Texas Childrens Hosp, Texas Childrens Microbiome Ctr, Houston, TX 77030 USA; [von Rosenvinge, Erik C.] Univ Maryland, Dept Med, Div Gastroenterol & Hepatol, Baltimore, MD 21201 USA; [von Rosenvinge, Erik C.] VA Maryland Hlth Care Syst, Baltimore, MD USA; [Kelly, Ciaran P.] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Kelly, Ciaran P.] Beth Israel Deaconess Med Ctr, Celiac Ctr, Boston, MA 02215 USA; [Kelly, Ciaran P.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Boston, MA 02215 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Vanderbilt University; Vanderbilt University; University of Houston System; University of Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas School Public Health; Baylor College of Medicine; Baylor College of Medicine; University System of Maryland; University of Maryland Baltimore; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Feng, HP (corresponding author), Univ Maryland, Sch Dent, Dept Microbial Pathogenesis, Baltimore, MD 21201 USA.	hfeng@umaryland.edu	Garey, Kevin/AAH-5540-2019; Wu, Jian/AAU-5221-2020; Wu, Jian/AAU-5221-2020	Garey, Kevin/0000-0003-2063-7503; Wu, Jian/0000-0001-9933-7364; Wu, Jian/0000-0002-3394-1507; Aronoff, David/0000-0003-4587-6121; von Rosenvinge, Erik C./0000-0002-1862-7288	National Institutes of Health [R56AI99458, R01AI088748, R01DK084509, R01AI0094001, DK56338, U19-A209087]; Merck [LKR-87405, 50729]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088748, U19AI109776, R56AI099458, R01AI100914] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK084509, P30DK056338] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Merck(Merck & Company); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health [R56AI99458, R01AI088748, R01DK084509, R01AI0094001, DK56338 and U19-A209087] and partially by Merck [LKR-87405 and 50729]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARTLETT JG, 1978, AM J VET RES, V39, P1525; Bartlett JG, 2008, CLIN INFECT DIS, V46, pS12, DOI 10.1086/521863; Brandes V, 2012, BIOL CHEM, V393, P77, DOI 10.1515/BC-2011-198; Brito GAC, 2002, J INFECT DIS, V185, P1297, DOI 10.1086/340236; Clerk A, 2001, MOL CELL BIOL, V21, P1173, DOI 10.1128/MCB.21.4.1173-1184.2001; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Cunney RJ, 1998, NEPHROL DIAL TRANSPL, V13, P2842, DOI 10.1093/ndt/13.11.2842; Dallal RM, 2002, ANN SURG, V235, P363, DOI 10.1097/00000658-200203000-00008; Davies NL, 2013, CLIN VACCINE IMMUNOL, V20, P377, DOI 10.1128/CVI.00625-12; Dobson G, 2003, INTENS CARE MED, V29, P1030, DOI 10.1007/s00134-003-1754-7; FLORIN I, 1991, MICROB PATHOGENESIS, V11, P337, DOI 10.1016/0882-4010(91)90019-7; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Grossmann EM, 2000, J SURG RES, V88, P165, DOI 10.1006/jsre.1999.5736; Hamm EE, 2006, P NATL ACAD SCI USA, V103, P14176, DOI 10.1073/pnas.0604725103; He XY, 2009, INFECT IMMUN, V77, P2294, DOI 10.1128/IAI.01577-08; He XY, 2009, J MICROBIOL METH, V78, P97, DOI 10.1016/j.mimet.2009.04.007; Issa M, 2008, INFLAMM BOWEL DIS, V14, P1432, DOI 10.1002/ibd.20500; Jacob SS, 2004, HEART LUNG, V33, P265, DOI 10.1016/j.hrtlng.2004.04.003; Jacobs A, 2001, MEDICINE, V80, P88, DOI 10.1097/00005792-200103000-00002; Jafari NV, 2010, METHODS MOL BIOL, V646, P135, DOI 10.1007/978-1-60327-365-7_9; Jafri SF, 1996, SOUTHERN MED J, V89, P1014, DOI 10.1097/00007611-199610000-00019; Johnson S, 2001, ANN INTERN MED, V135, P434, DOI 10.7326/0003-4819-135-6-200109180-00012; Kelly Ciaran P, 2008, N Engl J Med, V359, P1932, DOI 10.1056/NEJMra0707500; Kotloff KL, 2001, INFECT IMMUN, V69, P988, DOI 10.1128/IAI.69.2.988-995.2001; Libby DB, 2009, INT J INFECT DIS, V13, pE305, DOI 10.1016/j.ijid.2009.01.014; Lowy I, 2010, NEW ENGL J MED, V362, P197, DOI 10.1056/NEJMoa0907635; Mazuski JE, 2000, ARCH SURG-CHICAGO, V135, P1206, DOI 10.1001/archsurg.135.10.1206; Mullan N, 2011, INFECT IMMUN, V79, P1623, DOI 10.1128/IAI.00686-10; Owens RC, 2006, PHARMACOTHERAPY, V26, P299, DOI 10.1592/phco.26.3.299; QUALMAN SJ, 1990, AM J CLIN PATHOL, V94, P410, DOI 10.1093/ajcp/94.4.410; Sakurai T, 2001, SCAND J INFECT DIS, V33, P69, DOI 10.1080/003655401750064112; Salcedo J, 1997, GUT, V41, P366, DOI 10.1136/gut.41.3.366; Shaikh N, 2008, INTENS CARE MED, V34, P963, DOI 10.1007/s00134-007-0922-6; Solomon K, 2005, INFECT IMMUN, V73, P1625, DOI 10.1128/IAI.73.3.1625-1634.2005; Steele J, 2012, J INFECT DIS, V205, P384, DOI 10.1093/infdis/jir748; Steele J, 2010, J INFECT DIS, V201, P428, DOI 10.1086/649799; Sun XM, 2010, TOXINS, V2, P1848, DOI 10.3390/toxins2071848; TORRES JF, 1995, INFECT IMMUN, V63, P4619, DOI 10.1128/IAI.63.12.4619-4627.1995; Voth DE, 2005, CLIN MICROBIOL REV, V18, P247, DOI 10.1128/CMR.18.2.247-263.2005; Wang HY, 2012, INFECT IMMUN, V80, P2678, DOI 10.1128/IAI.00215-12; Yang GL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-192; ZWIENER RJ, 1989, PEDIATR INFECT DIS J, V8, P876, DOI 10.1097/00006454-198912000-00010	42	27	27	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124235	10.1371/journal.pone.0124235	http://dx.doi.org/10.1371/journal.pone.0124235			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885671	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000107
J	Friedman, EJ; Young, K; Tremper, G; Liang, JS; Landsberg, AS; Schuff, N				Friedman, Eric J.; Young, Karl; Tremper, Graham; Liang, Jason; Landsberg, Adam S.; Schuff, Norbert		Alzheimer's Dis Neuroimaging Initi	Directed Network Motifs in Alzheimer's Disease and Mild Cognitive Impairment	PLOS ONE			English	Article							BRAIN NETWORKS; PATTERNS; PROGRESSION	Directed network motifs are the building blocks of complex networks, such as human brain networks, and capture deep connectivity information that is not contained in standard network measures. In this paper we present the first application of directed network motifs in vivo to human brain networks, utilizing recently developed directed progression networks which are built upon rates of cortical thickness changes between brain regions. This is in contrast to previous studies which have relied on simulations and in vitro analysis of nonhuman brains. We show that frequencies of specific directed network motifs can be used to distinguish between patients with Alzheimer's disease (AD) and normal control (NC) subjects. Especially interesting from a clinical standpoint, these motif frequencies can also distinguish between subjects with mild cognitive impairment who remained stable over three years (MCI) and those who converted to AD (CONV). Furthermore, we find that the entropy of the distribution of directed network motifs increased from MCI to CONV to AD, implying that the distribution of pathology is more structured in MCI but becomes less so as it progresses to CONV and further to AD. Thus, directed network motifs frequencies and distributional properties provide new insights into the progression of Alzheimer's disease as well as new imaging markers for distinguishing between normal controls, stable mild cognitive impairment, MCI converters and Alzheimer's disease.	[Friedman, Eric J.] Int Comp Sci Inst, Berkeley, CA 94704 USA; [Friedman, Eric J.; Tremper, Graham; Liang, Jason] Univ Calif Berkeley, Dept Comp Sci, Berkeley, CA 94720 USA; [Young, Karl; Schuff, Norbert] Univ Calif San Francisco, Dept Radiol & Biomed Imaging, San Francisco, CA 94143 USA; [Young, Karl; Schuff, Norbert] VA Med Ctr, San Francisco, CA USA; [Landsberg, Adam S.] Pitzer Coll, Claremont McKenna Coll, WM Keck Sci Dept, Claremont, CA 91711 USA; [Landsberg, Adam S.] Scripps Coll, Claremont, CA 91711 USA	University of California System; University of California Berkeley; University of California System; University of California San Francisco; Claremont Colleges; Claremont Graduate School; Claremont McKenna College; Pitzer College; Claremont Colleges; Scripps College	Friedman, EJ (corresponding author), Int Comp Sci Inst, Berkeley, CA 94704 USA.	ejf@icsi.berkeley.edu			National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32 EB001631-05]; National Institute of Neurological Disorders and Stroke [K25 NS-703689-01]; National Center for Research Resources; National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) [P41 RR 023953]; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; NIH [P30 AG010129, K01 AG030514]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR023953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB001631] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG010129, U01AG024904] Funding Source: NIH RePORTER	National Institute of Biomedical Imaging and Bioengineering (NIBIB)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH); Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded in part by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) [T32 EB001631-05] to NS and the National Institute of Neurological Disorders and Stroke [K25 NS-703689-01] to EJF, by the National Center for Research Resources and the National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health (NIH) through Grant Number P41 RR 023953 to NS and KY, and with resources of the Veterans Affairs Medical Center, San Francisco, California. Data collection and sharing for this project was funded by the Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904) to NS and KY. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The funders had no role in study design, data collection and analysis or preparation of the manuscript. ADNI approved the decision to publish the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berger A, 2010, LECT NOTES COMPUT SC, V6410, P220; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Braak H, 2012, CURR OPIN NEUROL, V25, P708, DOI 10.1097/WCO.0b013e32835a3432; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; DeCarli C, 2003, LANCET NEUROL, V2, P15, DOI 10.1016/S1474-4422(03)00262-X; Dickson D, 2011, NEURODEGENERATION TH; Drachman DA, 2006, NEUROLOGY, V67, P1340, DOI 10.1212/01.wnl.0000240127.89601.83; Du AT, 2007, BRAIN, V130, P1159, DOI 10.1093/brain/awm016; DUNN OJ, 1961, J AM STAT ASSOC, V56, P52, DOI 10.2307/2282330; Erdos P, 1961, B I INTERNAT STAT; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Friedman E, 2014, NEUROIMAGE; Friedman EJ, 2014, BRAIN CONNECT, V4, P384, DOI 10.1089/brain.2014.0235; Guo DQ, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.051921; Hartikainen P, 2012, J ALZHEIMERS DIS, V29, P1, DOI [10.3233/JAD-2012-111424, DOI 10.3233/JAD-2012-111424]; He Y, 2008, J NEUROSCI, V28, P4756, DOI 10.1523/JNEUROSCI.0141-08.2008; He Y, 2007, CEREB CORTEX, V17, P2407, DOI 10.1093/cercor/bhl149; He Y, 2009, NEUROSCIENTIST, V15, P333, DOI 10.1177/1073858409334423; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Jack CR, 2005, NEUROLOGY, V65, P1227, DOI 10.1212/01.wnl.0000180958.22678.91; Kashani ZRM, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-318; Li CG, 2008, PHYS REV E, V78, DOI 10.1103/PhysRevE.78.037101; Li Y, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.11.008; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Newman MEJ, 2001, PHYS REV E, V64, DOI [10.1103/PhysRevE.64.016131, 10.1103/PhysRevE.64.016132]; Owen JP, 2013, BRAIN CONNECT, V3, P160, DOI 10.1089/brain.2012.0121; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Raj A, 2012, NEURON, V73, P1204, DOI 10.1016/j.neuron.2011.12.040; Renyi A, 1961, P 4 BERK S MATH STAT, V1; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; Richards BA, 2009, NEUROBIOL AGING, V30, P1626, DOI 10.1016/j.neurobiolaging.2007.12.019; Schofield EC, 2011, MOVEMENT DISORD, V26, P256, DOI 10.1002/mds.23295; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Sporns O, 2004, PLOS BIOL, V2, P1910, DOI 10.1371/journal.pbio.0020369; Sporns O., 2010, NETWORKS BRAIN; Sporns O, 2006, P NATL ACAD SCI USA, V103, P19219, DOI 10.1073/pnas.0609523103; Sporns O, 2006, BIOSYSTEMS, V85, P55, DOI 10.1016/j.biosystems.2006.02.008; Xie Teng, 2011, Front Psychiatry, V2, P77, DOI 10.3389/fpsyt.2011.00077	39	9	10	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124453	10.1371/journal.pone.0124453	http://dx.doi.org/10.1371/journal.pone.0124453			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879535	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500101
J	Santos, NC; Costa, PS; Amorim, L; Moreira, PS; Cunha, P; Cotter, J; Sousa, N				Santos, Nadine Correia; Costa, Patricio Soares; Amorim, Liliana; Moreira, Pedro Silva; Cunha, Pedro; Cotter, Jorge; Sousa, Nuno			Exploring the Factor Structure of Neurocognitive Measures in Older Individuals	PLOS ONE			English	Article							REPORTING PRACTICES; PARALLEL ANALYSIS; NUMBER; INTERFERENCE; PERFORMANCE; COMPONENTS; RESPONSES; MODELS; TASK	Here we focus on factor analysis from a best practices point of view, by investigating the factor structure of neuropsychological tests and using the results obtained to illustrate on choosing a reasonable solution. The sample (n= 1051 individuals) was randomly divided into two groups: one for exploratory factor analysis (EFA) and principal component analysis (PCA), to investigate the number of factors underlying the neurocognitive variables; the second to test the "best fit" model via confirmatory factor analysis (CFA). For the exploratory step, three extraction (maximum likelihood, principal axis factoring and principal components) and two rotation (orthogonal and oblique) methods were used. The analysis methodology allowed exploring how different cognitive/psychological tests correlated/discriminated between dimensions, indicating that to capture latent structures in similar sample sizes and measures, with approximately normal data distribution, reflective models with oblimin rotation might prove the most adequate.	[Santos, Nadine Correia; Costa, Patricio Soares; Amorim, Liliana; Moreira, Pedro Silva; Cunha, Pedro; Cotter, Jorge; Sousa, Nuno] Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal; [Santos, Nadine Correia; Costa, Patricio Soares; Amorim, Liliana; Moreira, Pedro Silva; Cunha, Pedro; Cotter, Jorge; Sousa, Nuno] PT Govt Associate Lab, ICVS 3Bs, Braga, Portugal; [Cunha, Pedro; Cotter, Jorge] Ctr Hosp Alto Ave EPE, Guimaraes, Portugal	Universidade do Minho	Santos, NC (corresponding author), Univ Minho, Sch Hlth Sci, Life & Hlth Sci Res Inst ICVS, Braga, Portugal.	nsantos@ecsaude.uminho.pt	Cunha, Pedro G/K-6743-2014; Costa, Patrício/A-3072-2013; Santos, Nadine/K-7431-2015; Amorim, Liliana/Q-7807-2019; Amorim, Liliana/T-5481-2018; Santos, Nadine Correia/AAC-2873-2019; Cunha, Pedro/AAE-6732-2019; Moreira, Pedro Silva/E-4471-2018; Sousa, Nuno JC/N-9137-2017	Cunha, Pedro G/0000-0002-8518-4130; Costa, Patrício/0000-0002-1201-9177; Santos, Nadine/0000-0001-8110-7173; Amorim, Liliana/0000-0002-5105-7045; Amorim, Liliana/0000-0002-5105-7045; Cunha, Pedro/0000-0002-8518-4130; Moreira, Pedro Silva/0000-0002-2800-3903; Sousa, Nuno JC/0000-0002-8755-5126; Cotter, Jorge/0000-0002-0151-4826	European Commission FP7 initiative [HEALTH-F2-2010-259772]; Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER); SwitchBox post-doctoral fellowship; "MyHealth" project [DoIT-13853]	European Commission FP7 initiative; Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER); SwitchBox post-doctoral fellowship; "MyHealth" project	The study is integrated in the "Maintaining health in old age through homeostasis (SWITCHBOX)" (http://www.switchbox-online.eu/) collaborative project funded by the European Commission FP7 initiative (grant HEALTH-F2-2010-259772) and co-financed by the Portuguese North Regional Operational Program (ON.2 - O Novo Norte) under the National Strategic Reference Framework (QREN), through the European Regional Development Fund (FEDER). NCS is supported by a SwitchBox post-doctoral fellowship, LA and PSM are supported by "MyHealth" project (Contract DoIT-13853)" doctoral fellowships. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H., 2003, ENCY RES METHODS SOC, P792; Adams R L, 1996, NEUROPSYCHOLOGY CLIN; Arbuckle JL, 2009, AMOS 18 USERS GUIDE; Bartlett MS, 1950, B J PSYCHOL-STAT SEC, V3, P77, DOI 10.1111/j.2044-8317.1950.tb00285.x; Belanger S, 2010, NEUROPSYCHOLOGIA, V48, P581, DOI 10.1016/j.neuropsychologia.2009.10.021; Belleville S, 2006, BRAIN COGNITION, V62, P113, DOI 10.1016/j.bandc.2006.04.006; Brown T.A., 2015, CONFIRMATORY FACTOR, V2nd ed., DOI DOI 10.5860/CHOICE.44-2769; Bryant F.B., 1995, READING UNDERSTANDIN, P99, DOI DOI 10.3109/07420528.2010.540363; Burt C., 1940, FACTORS MING; Buschke H, 1995, J Int Neuropsychol Soc, V1, P483; Byrne BM, 2005, J PERS ASSESS, V85, P17, DOI 10.1207/s15327752jpa8501_02; Cattell R.B., 1978, SCI USE FACTOR ANAL, DOI [DOI 10.1007/978-1-4684-2262-7_5, 10.1007/978-1-4684-2262-7_5]; CATTELL RB, 1966, MULTIVAR BEHAV RES, V1, P245, DOI 10.1207/s15327906mbr0102_10; Child D., 1990, ESSENTIALS FACTOR AN; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Daniels K., 2006, LIFESPAN COGNITION M, P96; de Winter JCF, 2012, J APPL STAT, V39, P695, DOI 10.1080/02664763.2011.610445; Fabrigar LR, 1999, PSYCHOL METHODS, V4, P272, DOI 10.1037/1082-989X.4.3.272; Flora DB, 2012, FRONT PSYCHOL, P3; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FORNELL C, 1981, J MARKETING RES, V18, P39, DOI 10.2307/3151312; FRANKLIN SB, 1995, J VEG SCI, V6, P99, DOI 10.2307/3236261; Gorsuch R., 1983, FACTOR ANAL; Graffar M., 1956, COURRIER, V6, P455; Grandjean J, 2011, BRAIN COGNITION, V77, P237, DOI 10.1016/j.bandc.2011.08.004; Greenwood PM, 2000, J INT NEUROPSYCH SOC, V6, P705, DOI 10.1017/S1355617700666092; Hair J., 2005, MULTIVAR DATA ANAL; Hedden T, 2004, NAT REV NEUROSCI, V5, P87, DOI 10.1038/nrn1323; Hilborn JV, 2009, J CLIN EXP NEUROPSYC, V31, P412, DOI 10.1080/13803390802232659; Hogge M, 2008, PSYCHOL BELG, V48, P1; HORN JL, 1965, PSYCHOMETRIKA, V30, P179, DOI 10.1007/BF02289447; Hutchison KA, 2010, PSYCHOL AGING, V25, P545, DOI 10.1037/a0018498; Jackson DL, 2009, PSYCHOL METHODS, V14, P6, DOI 10.1037/a0014694; Jennrich RI, 2011, PSYCHOMETRIKA, V76, P537, DOI 10.1007/s11336-011-9218-4; KAISER HF, 1960, EDUC PSYCHOL MEAS, V20, P141, DOI 10.1177/001316446002000116; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; King JA, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00358; Kline P, 2002, EASY GUIDE FACTOR AN; Kline R, 2005, PRINCIPLES PRACTICE; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Lawley DM, 1940, P ROY SOC EDINB, V60, P46; Ledesma RD, 2007, PRACT ASSESS RES EVA, V12, P1, DOI [https://doi.org/10.7275/wjnc-nm63, DOI 10.7275/WJNC-NM63]; Lezak MD., 2004, NEUROPSYCHOLOGICAL A, V(4th ed.), P429; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; McDonald RP., 1985, FACTOR ANAL RELATED; Nunnally JC, 1994, PSYCHOMETRIC THEORY, V3rd, DOI DOI 10.1037/018882; Nyberg L, 2012, TRENDS COGN SCI, V16, P292, DOI 10.1016/j.tics.2012.04.005; O'Connor BP, 2000, BEHAV RES METH INS C, V32, P396, DOI 10.3758/BF03200807; Osborne J., 2005, PRACTICAL ASSESSMENT, V10, P1, DOI [10.7275/jyj1-4868, DOI 10.7275/JYJ1-4868, 10.4135/9781412995627.d8, DOI 10.4135/9781412995627.D8]; Osborne J.W., 2012, PRACTICAL ASSESSMENT, V17, P11, DOI [10.7275/39h8-n858, DOI 10.7275/39H8-N858]; Paulo AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024553; Preacher K. J., 2003, UNDERSTANDING STAT, V2, P13, DOI DOI 10.1207/S15328031US0201_02; Sala SD, 1995, ANN NY ACAD SCI, V769, P161, DOI 10.1111/j.1749-6632.1995.tb38137.x; Salthouse TA, 2010, J INT NEUROPSYCH SOC, V16, P754, DOI 10.1017/S1355617710000706; Salthouse TA, 2009, NEUROBIOL AGING, V30, P507, DOI 10.1016/j.neurobiolaging.2008.09.023; Santos NC, 2013, AGE, V35, P1983, DOI 10.1007/s11357-012-9482-y; Schreiber JB, 2008, RES SOC ADM PHARM, V4, P83, DOI 10.1016/j.sapharm.2007.04.003; Singh-Manoux A, 2012, BRIT MED J, V344, DOI 10.1136/bmj.d7622; Stevens J.P., 2009, APPL MULTIVARIATE ST, V5th ed.; Strauss E, 2006, COMPENDIUM NEUROPSYC, DOI DOI 10.1212/WNL.41.11.1856-A; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; STUSS DT, 1984, PSYCHOL BULL, V95, P3, DOI 10.1037/0033-2909.95.1.3; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; VELICER WF, 1976, PSYCHOMETRIKA, V41, P321, DOI 10.1007/BF02293557; Watkins MW, 2006, J MOD APPL STAT METH, V5, P344; Wechsler D., 2010, WAIS 4 WECHSLER ADUL; Weiten W, 2010, PSYCHOL THEMES VARIA; Yaremko R. M., 1986, HDB RES QUANTITATIVE	69	18	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124229	10.1371/journal.pone.0124229	http://dx.doi.org/10.1371/journal.pone.0124229			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25880732	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500091
J	Lin, MH; Shu, JC; Lin, LP; Chong, KY; Cheng, YW; Du, JF; Liu, ST				Lin, Mei Hui; Shu, Jwu Ching; Lin, Li Ping; Chong, Kowit Yu; Cheng, Ya Wen; Du, Jia Fu; Liu, Shih-Tung			Elucidating the Crucial Role of Poly N-Acetylglucosamine from Staphylococcus aureus in Cellular Adhesion and Pathogenesis	PLOS ONE			English	Article							POLYSACCHARIDE INTERCELLULAR ADHESIN; BIOFILM FORMATION; EPIDERMIDIS; BINDING; RESTRICTION; SYSTEMS; PROTEIN; ACID; GENE; PIA	Staphylococcus aureus is an important pathogen that forms biofilms on the surfaces of medical implants. Biofilm formation by S. aureus is associated with the production of poly N-acetylglucosamine (PNAG), also referred to as polysaccharide intercellular adhesin (PIA), which mediates bacterial adhesion, leading to the accumulation of bacteria on solid surfaces. This study shows that the ability of S. aureus SA113 to adhere to nasal epithelial cells is reduced after the deletion of the ica operon, which contains genes encoding PIA/PNAG synthesis. However, this ability is restored after a plasmid carrying the entire ica operon is transformed into the mutant strain, S. aureus SA113 Delta ica, showing that the synthesis of PIA/PNAG is important for adhesion to epithelial cells. Additionally, S. carnosus TM300, which does not produce PIA/PNAG, forms a biofilm and adheres to epithelial cells after the bacteria are transformed with a PIA/PNAG-expressing plasmid, pTXicaADBC. The adhesion of S. carnosus TM300 to epithelial cells is also demonstrated by adding purified exopolysaccharide (EPS), which contains PIA/PNAG, to the bacteria. In addition, using a mouse model, we find that the abscess lesions and bacterial burden in lung tissues is higher in mice infected with S. aureus SA113 than in those infected with the mutant strain, S. aureus-SA113 Delta ica. The results indicate that PIA/PNAG promotes the adhesion of S. aureus to human nasal epithelial cells and lung infections in a mouse model. This study elucidates a mechanism that is important to the pathogenesis of S. aureus infections.	[Lin, Mei Hui; Shu, Jwu Ching; Lin, Li Ping; Chong, Kowit Yu; Cheng, Ya Wen; Du, Jia Fu] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Coll Med, Taoyuan, Taiwan; [Liu, Shih-Tung] Chang Gung Univ, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan; [Liu, Shih-Tung] Chang Gung Mem Hosp, Chiayi Branch, Dept Med Res & Dev, Chiayi, Taiwan	Chang Gung University; Chang Gung University; Chang Gung Memorial Hospital	Liu, ST (corresponding author), Chang Gung Univ, Dept Microbiol & Immunol, Coll Med, Taoyuan, Taiwan.	cgliu@mail.cgu.edu.tw	lin, liping/HGE-0871-2022	Chong, Kowit Yu/0000-0003-0974-0673; Lin, Mei-Hui/0000-0002-3498-9377	Chang Gung Memorial Hospital [CMRPD1B0071-3, CMRPD190281-3]; National Science Council of the Republic of China, Taiwan [NSC 102-2320-B-182-027-MY3]	Chang Gung Memorial Hospital(Chang Gung Memorial Hospital); National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan)	This work was supported by grants from the Chang Gung Memorial Hospital (grant number CMRPD1B0071-3 and CMRPD190281-3) and from the National Science Council of the Republic of China, Taiwan (grant number NSC 102-2320-B-182-027-MY3). (The funders' websites are: http://web1.nsc.gov.tw/mp.aspx?mp=7, http://www.cgmh.org.tw/eng2002/index.asp.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chavakis T, 2005, THROMB HAEMOSTASIS, V94, P278, DOI 10.1160/TH05-05-0306; Clarke SR, 2006, ADV MICROB PHYSIOL, V51, P187, DOI 10.1016/S0065-2911(06)51004-5; Costa AR, 2009, EUR J CLIN MICROBIOL, V28, P623, DOI 10.1007/s10096-008-0684-2; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cramton SE, 2001, INFECT IMMUN, V69, P4079, DOI 10.1128/IAI.69.6.4079-4085.2001; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Gerke C, 1998, J BIOL CHEM, V273, P18586, DOI 10.1074/jbc.273.29.18586; Gotz F, 2004, CURR OPIN MICROBIOL, V7, P477, DOI 10.1016/j.mib.2004.08.014; Gotz F, 1990, Soc Appl Bacteriol Symp Ser, V19, p49S; Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x; HANAHAN D, 1991, METHOD ENZYMOL, V204, P63, DOI DOI 10.1016/0076-6879(91)04006-A; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 2011, ADV EXP MED BIOL, V715, P105, DOI 10.1007/978-94-007-0940-9_7; Hussain M, 2002, INFECT IMMUN, V70, P2933, DOI 10.1128/IAI.70.6.2933-2940.2002; Hussain M, 2001, J BACTERIOL, V183, P6778, DOI 10.1128/JB.183.23.6778-6786.2001; IORDANESCU S, 1976, J GEN MICROBIOL, V96, P277, DOI 10.1099/00221287-96-2-277; Jang JH, 2005, BIOTECHNOL LETT, V27, P13, DOI 10.1007/s10529-004-6305-y; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Krevvata MI, 2011, CONNECT TISSUE RES, V52, P183, DOI 10.3109/03008207.2010.505309; Krishna S, 2012, CURR OPIN MICROBIOL, V15, P28, DOI 10.1016/j.mib.2011.11.003; Lin MH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034388; Lin MH, 2011, ANTIMICROB AGENTS CH, V55, P1021, DOI 10.1128/AAC.00843-10; Lin TP, 1999, J BACTERIOL, V181, P5060, DOI 10.1128/JB.181.16.5060-5067.1999; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; PATTI JM, 1995, J BIOL CHEM, V270, P12005, DOI 10.1074/jbc.270.20.12005; Rosenstein R, 2009, APPL ENVIRON MICROB, V75, P811, DOI 10.1128/AEM.01982-08; Sinha B, 1999, CELL MICROBIOL, V1, P101, DOI 10.1046/j.1462-5822.1999.00011.x; Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200; Vuong C, 2004, CELL MICROBIOL, V6, P269, DOI 10.1046/j.1462-5822.2004.00367.x; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wertheim HFL, 2008, PLOS MED, V5, P104, DOI 10.1371/journal.pmed.0050017; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Xia GQ, 2010, INT J MED MICROBIOL, V300, P148, DOI 10.1016/j.ijmm.2009.10.001	36	37	38	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0124216	10.1371/journal.pone.0124216	http://dx.doi.org/10.1371/journal.pone.0124216			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876106	gold, Green Submitted, Green Published			2022-12-27	WOS:000353015800134
J	Yamana, S; Tokiyama, A; Mizutani, K; Hirata, K; Takai, Y; Rikitake, Y				Yamana, Shota; Tokiyama, Amina; Mizutani, Kiyohito; Hirata, Ken-ichi; Takai, Yoshimi; Rikitake, Yoshiyuki			The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation	PLOS ONE			English	Article							VASCULAR ENDOTHELIAL CADHERIN; ACTIN STRESS FIBERS; SMALL G-PROTEINS; GROWTH-FACTOR; TUMOR-SUPPRESSOR; IN-VITRO; ADHERENS JUNCTIONS; SIGNALING-PATHWAY; FOCAL ADHESIONS; BETA-CATENIN	Contact inhibition of cell movement and proliferation is critical for proper organogenesis and tissue remodeling. We show here a novel regulatory mechanism for this contact inhibition using cultured vascular endothelial cells. When the cells were confluently cultured, Necl-4 was up-regulated and localized at cell-cell contact sites where it cis-interacted with the vascular endothelial growth factor (VEGF) receptor. This interaction inhibited the tyrosine-phosphorylation of the VEGF receptor through protein-tyrosine phosphatase, non-receptor type 13 (PTPN13), eventually reducing cell movement and proliferation. When the cells were sparsely cultured, Necl-4 was down-regulated but accumulated at leading edges where it inhibited the activation of Rho-associated protein kinase through PTPN13, eventually facilitating the VEGF-induced activation of Rac1 and enhancing cell movement. Necl-4 further facilitated the activation of extracellular signal-regulated kinase 1/2, eventually enhancing cell proliferation. Thus, Necl-4 serves as a novel regulator for contact inhibition of cell movement and proliferation cooperatively with the VEGF receptor and PTPN13.	[Yamana, Shota; Hirata, Ken-ichi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan; [Tokiyama, Amina; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Signal Transduct, Kobe, Hyogo 657, Japan; [Mizutani, Kiyohito; Takai, Yoshimi; Rikitake, Yoshiyuki] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Mol & Cellular Biol, Kobe, Hyogo 657, Japan; [Takai, Yoshimi] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Div Pathogenet Signaling, Kobe, Hyogo 657, Japan	Kobe University; Kobe University; Kobe University; Kobe University	Rikitake, Y (corresponding author), Kobe Univ, Grad Sch Med, Dept Internal Med, Div Cardiovasc Med, Kobe, Hyogo 657, Japan.	rikitake@med.kobe-u.ac.jp	Mizutani, Kiyohito/L-8474-2019		Japan Society for the Promotion of Science [21227005, 25461128]; Global Center of Excellence; Takeda Science Foundation; Naito Foundation; SENSHIN Medical Research Foundation; Grants-in-Aid for Scientific Research [24790284, 26860190] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global Center of Excellence(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Naito Foundation(Naito Memorial Foundation); SENSHIN Medical Research Foundation(SENSHIN Medical Research Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (https://www.jsps.go.jp/english/e-grants) (to YT (21227005) and YR (25461128)) and by grants from the Global Center of Excellence (http://www.jsps.go.jp/english/e-globalcoe) (to SY, KH, YR), the Takeda Science Foundation (http://www.takeda-sci.or.jp), the Naito Foundation (https://www.naito-f.or.jp), and the SENSHIN Medical Research Foundation (http://www.mt-pharma.co.jp/zaidan) (to YR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Astin JW, 2010, NAT CELL BIOL, V12, P1194, DOI 10.1038/ncb2122; Biederer T, 2006, GENOMICS, V87, P139, DOI 10.1016/j.ygeno.2005.08.017; Cascone I, 2003, J BIOL CHEM, V278, P50702, DOI 10.1074/jbc.M307234200; Coleman SK, 2003, J NEUROSCI, V23, P798; Cooper J, 2014, FEBS LETT, V588, P2743, DOI 10.1016/j.febslet.2014.04.001; Copits BA, 2013, J BIOL CHEM, V288, P8952, DOI 10.1074/jbc.M112.440719; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0; Fujita H, 2005, J BIOL CHEM, V280, P5022, DOI 10.1074/jbc.M409701200; Fujito T, 2005, J CELL BIOL, V171, P165, DOI 10.1083/jcb.200501090; Fukuhara H, 2001, ONCOGENE, V20, P5401, DOI 10.1038/sj.onc.1204696; Gourlaouen M, 2013, J BIOL CHEM, V288, P7467, DOI 10.1074/jbc.M112.446401; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Halbleib JM, 2007, MOL BIOL CELL, V18, P4261, DOI 10.1091/mbc.E07-04-0308; Holmes K, 2007, CELL SIGNAL, V19, P2003, DOI 10.1016/j.cellsig.2007.05.013; Ikeda W, 2003, J BIOL CHEM, V278, P28167, DOI 10.1074/jbc.M303586200; Kajita M, 2007, GENES CELLS, V12, P345, DOI 10.1111/j.1365-2443.2007.01062.x; Kakunaga S, 2005, J CELL SCI, V118, P1267, DOI 10.1242/jcs.01656; Kawano S, 2009, J BIOL CHEM, V284, P23793, DOI 10.1074/jbc.M109.025155; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Kinugasa M, 2012, CIRC RES, V110, P716, DOI 10.1161/CIRCRESAHA.111.256834; Kitt KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017841; Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624; Lai YJ, 2007, J BIOL CHEM, V282, P24381, DOI 10.1074/jbc.M701499200; Lampugnani MG, 2006, J CELL BIOL, V174, P593, DOI 10.1083/jcb.200602080; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; LAMPUGNANI MG, 1995, J CELL BIOL, V129, P203, DOI 10.1083/jcb.129.1.203; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Li W, 2012, EMBO REP, V13, P204, DOI 10.1038/embor.2012.11; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Mayor R, 2010, TRENDS CELL BIOL, V20, P319, DOI 10.1016/j.tcb.2010.03.005; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; Miyata M, 2009, J BIOL CHEM, V284, P24595, DOI 10.1074/jbc.M109.016436; Moleirinho S, 2014, FEBS LETT, V588, P2693, DOI 10.1016/j.febslet.2014.02.006; Murphy JG, 2014, CELL REP, V7, P1577, DOI 10.1016/j.celrep.2014.04.027; Nagata M, 2012, INT J CANCER, V130, P1329, DOI 10.1002/ijc.26160; Nakashima A, 2013, CELL, V154, P1314, DOI 10.1016/j.cell.2013.08.033; Perrais M, 2007, MOL BIOL CELL, V18, P2013, DOI 10.1091/mbc.E06-04-0348; Reymond N, 2004, J EXP MED, V199, P1331, DOI 10.1084/jem.20032206; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Rikitake Y, 2005, CIRCULATION, V111, P3261, DOI 10.1161/CIRCULATIONAHA.105.534024; Rikitake Y, 2011, INT REV CEL MOL BIO, V287, P97, DOI 10.1016/B978-0-12-386043-9.00003-7; Sato T, 2006, J BIOL CHEM, V281, P5288, DOI 10.1074/jbc.M510070200; Shingai T, 2003, J BIOL CHEM, V278, P35421, DOI 10.1074/jbc.M305387200; Soga N, 2001, EXP CELL RES, V269, P73, DOI 10.1006/excr.2001.5295; Sugiyama H, 2013, GENES CELLS, V18, P519, DOI 10.1111/gtc.12056; Takahashi T, 1999, ONCOGENE, V18, P2221, DOI 10.1038/sj.onc.1202527; Takai Y, 2008, ANNU REV CELL DEV BI, V24, P309, DOI 10.1146/annurev.cellbio.24.110707.175339; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Taliana L, 2005, INVEST OPHTH VIS SCI, V46, P96, DOI 10.1167/iovs.04-0145; Tan WF, 2008, FASEB J, V22, P1829, DOI 10.1096/fj.07-096438; Tawa H, 2010, CIRC RES, V106, P1731, DOI 10.1161/CIRCRESAHA.110.216747; Vinals F, 1999, MOL CELL BIOL, V19, P2763; Williams YN, 2006, ONCOGENE, V25, P1446, DOI 10.1038/sj.onc.1209192; Yamada A, 2013, MOL CELL NEUROSCI, V56, P234, DOI 10.1016/j.mcn.2013.06.003	58	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124259	10.1371/journal.pone.0124259	http://dx.doi.org/10.1371/journal.pone.0124259			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893857	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700082
J	Adu-Gyasi, D; Asante, KP; Newton, S; Dosoo, D; Amoako, S; Adjei, G; Amoako, N; Ankrah, L; Tchum, SK; Mahama, E; Agyemang, V; Kayan, K; Owusu-Agyei, S				Adu-Gyasi, Dennis; Asante, Kwaku Poku; Newton, Sam; Dosoo, David; Amoako, Sabastina; Adjei, George; Amoako, Nicholas; Ankrah, Love; Tchum, Samuel Kofi; Mahama, Emmanuel; Agyemang, Veronica; Kayan, Kingsley; Owusu-Agyei, Seth			Evaluation of the Diagnostic Accuracy of CareStart G6PD Deficiency Rapid Diagnostic Test (RDT) in a Malaria Endemic Area in Ghana, Africa	PLOS ONE			English	Article							GLUCOSE-6-PHOSPHATE DEHYDROGENASE; CHILDREN; INFANTS; VIVAX	Background Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most widespread enzyme defect that can result in red cell breakdown under oxidative stress when exposed to certain medicines including antimalarials. We evaluated the diagnostic accuracy of CareStart G6PD deficiency Rapid Diagnostic Test (RDT) as a point-of-care tool for screening G6PD deficiency. Methods A cross-sectional study was conducted among 206 randomly selected and consented participants from a group with known G6PD deficiency status between February 2013 and June 2013. A maximum of 1.6ml of capillary blood samples were used for G6PD deficiency screening using CareStart G6PD RDT and Trinity qualitative with Trinity quantitative methods as the "gold standard". Samples were also screened for the presence of malaria parasites. Data entry and analysis were done using Microsoft Access 2010 and Stata Software version 12. Kintampo Health Research Centre Institutional Ethics Committee granted ethical approval. Results The sensitivity (SE) and specificity (SP) of CareStart G6PD deficiency RDT was 100% and 72.1% compared to Trinity quantitative method respectively and was 98.9% and 96.2% compared to Trinity qualitative method. Malaria infection status had no significant (P= 0.199) change on the performance of the G6PD RDT test kit compared to the "gold standard". Conclusions The outcome of this study suggests that the diagnostic performance of the CareStart G6PD deficiency RDT kit was high and it is acceptable at determining the G6PD deficiency status in a high malaria endemic area in Ghana. The RDT kit presents as an attractive tool for point-of-care G6PD deficiency for rapid testing in areas with high temperatures and less expertise. The CareStart G6PD deficiency RDT kit could be used to screen malaria patients before administration of the fixed dose primaquine with artemisinin-based combination therapy.	[Adu-Gyasi, Dennis; Asante, Kwaku Poku; Newton, Sam; Dosoo, David; Amoako, Sabastina; Adjei, George; Amoako, Nicholas; Ankrah, Love; Tchum, Samuel Kofi; Mahama, Emmanuel; Agyemang, Veronica; Kayan, Kingsley; Owusu-Agyei, Seth] Kintampo Hlth Res Ctr, Kintampo, Brong Ahafo, Ghana	Kintampo Health Research Centre	Adu-Gyasi, D (corresponding author), Kintampo Hlth Res Ctr, POB 200, Kintampo, Brong Ahafo, Ghana.	adugyasidennis@yahoo.co.uk		Adu-Gyasi, Dennis/0000-0002-9449-2565; Owusu-Agyei, Seth/0000-0002-0807-1781	KHRC	KHRC	The study team wish to thank the participants involved in this study. Our appreciation also goes to the staff of Kintampo Health Research Centre (KHRC), especially those who assisted in this work. We are also grateful to the scientific team in KHRC who helped shape the scientific content as well as the institutional ethics committee. We also appreciate KHRC who also funded this study.	Adu-Gyasi D, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-238; Amoako N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112868; Asante KP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-211; Asante KP, 2013, J INFECT DIS, V208, P1504, DOI 10.1093/infdis/jit366; Baird JK, 2002, AM J TROP MED HYG, V66, P280, DOI 10.4269/ajtmh.2002.66.280; Baird JK, 2014, TRANSLATIONAL RES; Bancone G, 2015, AM J TROP MED HYG, P14; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; Carter N, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-241; Culleton RL, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-174; Domingo GJ, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-391; Dosoo DK, 2014, AM J TROP MED HYG, V90, P767, DOI 10.4269/ajtmh.13-0098; Dosoo DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036308; Goo YK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097390; Kim S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028357; KORNBERG A, 1955, METHOD ENZYMOL, V1, P323, DOI 10.1016/0076-6879(55)01046-X; Kotea R, 1999, BRIT J HAEMATOL, V104, P849, DOI 10.1046/j.1365-2141.1999.01230.x; LOHR GW, 1974, METHOD ENZYMAT AN, P636; Meissner PE, 2005, BRIT J HAEMATOL, V131, P395, DOI 10.1111/j.1365-2141.2005.05778.x; Ministry of Health/Ghana Health Service G, 2010, STAND TREATM GUID IN, P376; Osorio L, 2015, AM J TROP MED HYG, V92, P22, DOI 10.4269/ajtmh.14-0298; Owusu-Agyei S, 2012, GLOBAL HLTH ACTION, V5; Owusu-Agyei S, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-220; Pamba A, 2012, BLOOD, V120, P4123, DOI 10.1182/blood-2012-03-416032; Roca-Feltrer A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116143; Tinley KE, 2010, AM J TROP MED HYG, V82, P210, DOI 10.4269/ajtmh.2010.09-0416; von Fricken ME, 2014, AM J TROP MED HYG, P14; VULLIAMY TJ, 1991, P NATL ACAD SCI USA, V88, P8568, DOI 10.1073/pnas.88.19.8568; W.H.O, 2012, WHO SINGL DOS PRIM G; White NJ, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-418; WHO, 2013, WORLD MALARIA REPORT 2013, P1; Winstanley P, 2001, Lancet Infect Dis, V1, P242, DOI 10.1016/S1473-3099(01)00119-0	32	27	28	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125796	10.1371/journal.pone.0125796	http://dx.doi.org/10.1371/journal.pone.0125796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885097	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000163
J	Lee, RF				Lee, Ray F.			Dual Logic and Cerebral Coordinates for Reciprocal Interaction in Eye Contact	PLOS ONE			English	Article							SOCIAL COGNITIVE NEUROSCIENCE; NEURAL MECHANISMS; CINGULATE CORTEX; EXCLUSIVE-OR; BRAIN; CORE; INFORMATION; JUDGMENT; NETWORK; HUMANS	In order to scientifically study the human brain's response to face-to-face social interaction, the scientific method itself needs to be reconsidered so that both quantitative observation and symbolic reasoning can be adapted to the situation where the observer is also observed. In light of the recent development of dyadic fMRI which can directly observe dyadic brain interacting in one MRI scanner, this paper aims to establish a new form of logic, dual logic, which provides a theoretical platform for deductive reasoning in a complementary dual system with emergence mechanism. Applying the dual logic in the dfMRI experimental design and data analysis, the exogenous and endogenous dual systems in the BOLD responses can be identified; the non-reciprocal responses in the dual system can be suppressed; a cerebral coordinate for reciprocal interaction can be generated. Elucidated by dual logic deductions, the cerebral coordinate for reciprocal interaction suggests: the exogenous and endogenous systems consist of the empathy network and the mentalization network respectively; the default-mode network emerges from the resting state to activation in the endogenous system during reciprocal interaction; the cingulate plays an essential role in the emergence from the exogenous system to the endogenous system. Overall, the dual logic deductions are supported by the dfMRI experimental results and are consistent with current literature. Both the theoretical framework and experimental method set the stage to formally apply the scientific method in studying complex social interaction.	Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA	Princeton University	Lee, RF (corresponding author), Princeton Univ, Princeton Neurosci Inst, Princeton, NJ 08544 USA.	raylee@princeton.edu			Princeton University	Princeton University(Princeton University)	This work is fully funded by the author's startup fund and author's director discretionary account, both are from the Princeton University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2009, ANNU REV PSYCHOL, V60, P693, DOI 10.1146/annurev.psych.60.110707.163514; Anders S, 2011, NEUROIMAGE, V54, P439, DOI 10.1016/j.neuroimage.2010.07.004; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Aziz-Zadeh L, 2006, J NEUROSCI, V26, P2964, DOI 10.1523/JNEUROSCI.2921-05.2006; Baess P, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00083; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Chen S, 1999, DUAL-PROCESS THEORIES IN SOCIAL PSYCHOLOGY, P73; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dumas G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012166; Evans JSBT, 2008, ANNU REV PSYCHOL, V59, P255, DOI 10.1146/annurev.psych.59.103006.093629; Gindikin SG, 1985, ALGEBRAIC LOGIC, Vxviii; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Hasson U, 2012, TRENDS COGN SCI, V16, P114, DOI 10.1016/j.tics.2011.12.007; Hooker CI, 2003, COGNITIVE BRAIN RES, V17, P406, DOI 10.1016/S0926-6410(03)00143-5; Iacoboni M, 2005, CURR OPIN NEUROBIOL, V15, P632, DOI 10.1016/j.conb.2005.10.010; Itier RJ, 2009, NEUROSCI BIOBEHAV R, V33, P843, DOI 10.1016/j.neubiorev.2009.02.004; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Keysers C, 2007, TRENDS COGN SCI, V11, P194, DOI 10.1016/j.tics.2007.02.002; Klemm K, 2000, PHYS REV LETT, V84, P3013, DOI 10.1103/PhysRevLett.84.3013; Lee RF, 2012, MAGN RESON MED, V68, P1087, DOI 10.1002/mrm.23313; Lee RF, 2013, DYADIC INTERACTION I, P667; Leech R, 2012, J NEUROSCI, V32, P215, DOI 10.1523/JNEUROSCI.3689-11.2012; Lieberman MD, 2007, ANNU REV PSYCHOL, V58, P259, DOI 10.1146/annurev.psych.58.110405.085654; Lieberman MD, 2002, ADV EXP SOC PSYCHOL, V34, P199, DOI 10.1016/S0065-2601(02)80006-5; MAZZIOTTA JC, 1995, NEUROIMAGE, V2, P89, DOI 10.1006/nimg.1995.1012; Montague PR, 2002, NEUROIMAGE, V16, P1159, DOI 10.1006/nimg.2002.1150; Ochsner KN, 2008, BIOL PSYCHIAT, V64, P48, DOI 10.1016/j.biopsych.2008.04.024; Redcay E, 2010, NEUROIMAGE, V50, P1639, DOI 10.1016/j.neuroimage.2010.01.052; Schilbach L, 2006, NEUROPSYCHOLOGIA, V44, P718, DOI 10.1016/j.neuropsychologia.2005.07.017; Schippers MB, 2010, P NATL ACAD SCI USA, V107, P9388, DOI 10.1073/pnas.1001791107; Smith JD, 2011, J EXP PSYCHOL-ANIM B, V37, P20, DOI 10.1037/a0019497; Stanovich KE, 2000, BEHAV BRAIN SCI, V23, P645, DOI 10.1017/S0140525X00003435; Tognoli E, 2007, P NATL ACAD SCI USA, V104, P8190, DOI 10.1073/pnas.0611453104; Tomlin D, 2006, SCIENCE, V312, P1047, DOI 10.1126/science.1125596; Woolrich MW, 2004, NEUROIMAGE, V21, P1748, DOI 10.1016/j.neuroimage.2003.12.024; Worsley K., 2001, FUNCTIONAL MRI INTRO, V61	38	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0121791	10.1371/journal.pone.0121791	http://dx.doi.org/10.1371/journal.pone.0121791			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885446	Green Published, gold			2022-12-27	WOS:000353017000025
J	Singh, A; Jha, SK; Bagri, J; Pandey, GK				Singh, Amarjeet; Jha, Saroj K.; Bagri, Jayram; Pandey, Girdhar K.			ABA Inducible Rice Protein Phosphatase 2C Confers ABA Insensitivity and Abiotic Stress Tolerance in Arabidopsis	PLOS ONE			English	Article							REGULATES ABSCISIC-ACID; SIGNAL-TRANSDUCTION PATHWAY; COLD-ACCLIMATION; CALCIUM SENSOR; GENOME-WIDE; FRUIT-DEVELOPMENT; DROUGHT STRESS; GENE FAMILIES; CROSS-TALK; KINASE	Arabidopsis PP2C belonging to group A have been extensively worked out and known to negatively regulate ABA signaling. However, rice (Oryza sativa) orthologs of Arabidopsis group A PP2C are scarcely characterized functionally. We have identified a group A PP2C from rice (OsPP108), which is highly inducible under ABA, salt and drought stresses and localized predominantly in the nucleus. Genetic analysis revealed that Arabidopsis plants overexpressing OsPP108 are highly insensitive to ABA and tolerant to high salt and mannitol stresses during seed germination, root growth and overall seedling growth. At adult stage, OsPP108 overexpression leads to high tolerance to salt, mannitol and drought stresses with far better physiological parameters such as water loss, fresh weight, chlorophyll content and photosynthetic potential (Fv/Fm) in transgenic Arabidopsis plants. Expression profile of various stress marker genes in OsPP108 overexpressing plants revealed interplay of ABA dependent and independent pathway for abiotic stress tolerance. Overall, this study has identified a potential rice group A PP2C, which regulates ABA signaling negatively and abiotic stress signaling positively. Transgenic rice plants overexpressing this gene might provide an answer to the problem of low crop yield and productivity during adverse environmental conditions.	[Singh, Amarjeet; Jha, Saroj K.; Bagri, Jayram; Pandey, Girdhar K.] Univ Delhi, Dept Plant Mol Biol, New Delhi, India	University of Delhi	Pandey, GK (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus,Benito Juarez Rd, New Delhi, India.	gkpandey@south.du.ac.in		PANDEY, GIRDHAR KUMAR/0000-0001-9180-0924	Council of Scientific and Industrial Research (CSIR), India	Council of Scientific and Industrial Research (CSIR), India(Council of Scientific & Industrial Research (CSIR) - India)	Support was provided by the Council of Scientific and Industrial Research (CSIR), India. The funder had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Antoni R, 2012, PLANT PHYSIOL, V158, P970, DOI 10.1104/pp.111.188623; Bhaskara GB, 2012, PLANT PHYSIOL, V160, P379, DOI 10.1104/pp.112.202408; Chae L, 2010, ABIOTIC STRESS ADAPTATION IN PLANTS: PHYSIOLOGICAL, MOLECULAR AND GENOMIC FOUNDATION, P123, DOI 10.1007/978-90-481-3112-9_7; Chaerle L, 2007, J EXP BOT, V58, P773, DOI 10.1093/jxb/erl257; Chakrabarty R, 2007, MOL PLANT MICROBE IN, V20, P740, DOI 10.1094/MPMI-20-7-0740; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Cheong YH, 2007, PLANT J, V52, P223, DOI 10.1111/j.1365-313X.2007.03236.x; Chinnusamy V, 2004, J EXP BOT, V55, P225, DOI 10.1093/jxb/erh005; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cutler SR, 2010, ANNU REV PLANT BIOL, V61, P651, DOI 10.1146/annurev-arplant-042809-112122; D'Angelo C, 2006, PLANT J, V48, P857, DOI 10.1111/j.1365-313X.2006.02921.x; Ding ZJ, 2014, PLANT J, V79, P13, DOI 10.1111/tpj.12538; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Fujii H, 2009, NATURE, V462, P660, DOI 10.1038/nature08599; Fujii H, 2009, P NATL ACAD SCI USA, V106, P8380, DOI 10.1073/pnas.0903144106; Fujita Y, 2011, J PLANT RES, V124, P509, DOI 10.1007/s10265-011-0412-3; Fujita Y, 2009, PLANT CELL PHYSIOL, V50, P2123, DOI 10.1093/pcp/pcp147; Guo Y, 2002, DEV CELL, V3, P233, DOI 10.1016/S1534-5807(02)00229-0; Himmelbach A, 2002, EMBO J, V21, P3029, DOI 10.1093/emboj/cdf316; Jain M, 2004, BBA-GENE STRUCT EXPR, V1676, P182, DOI 10.1016/j.bbaexp.2003.11.012; Jakab G, 2005, PLANT PHYSIOL, V139, P267, DOI 10.1104/pp.105.065698; Kim H, 2012, J EXP BOT, V63, P1013, DOI 10.1093/jxb/err338; Kim KN, 2003, PLANT CELL, V15, P411, DOI 10.1105/tpc.006858; Kim W, 2013, PLANT CELL PHYSIOL, V54, P555, DOI 10.1093/pcp/pct017; Komatsu K, 2009, PLANT MOL BIOL, V70, P327, DOI 10.1007/s11103-009-9476-z; KOORNNEEF M, 1982, THEOR APPL GENET, V61, P385, DOI 10.1007/BF00272861; Kuhn JM, 2006, PLANT PHYSIOL, V140, P127, DOI 10.1104/pp.105.070318; LANG V, 1992, PLANT MOL BIOL, V20, P951, DOI 10.1007/BF00027165; Leung J, 1997, PLANT CELL, V9, P759, DOI 10.1105/tpc.9.5.759; Leung J, 1998, ANNU REV PLANT PHYS, V49, P199, DOI 10.1146/annurev.arplant.49.1.199; Liu LX, 2009, J PLANT PHYSIOL, V166, P531, DOI 10.1016/j.jplph.2008.07.008; Ma Y, 2009, SCIENCE, V324, P1064, DOI 10.1126/science.1172408; Mao XG, 2010, J EXP BOT, V61, P683, DOI 10.1093/jxb/erp331; Merlot S, 2001, PLANT J, V25, P295, DOI 10.1046/j.1365-313x.2001.00965.x; Mishra M, 2013, OMICS, V17, P439, DOI 10.1089/omi.2012.0074; Mizoguchi M, 2010, PLANT CELL PHYSIOL, V51, P842, DOI 10.1093/pcp/pcq041; Mustilli AC, 2002, PLANT CELL, V14, P3089, DOI 10.1105/tpc.007906; Narusaka Y, 2003, PLANT J, V34, P137, DOI 10.1046/j.1365-313X.2003.01708.x; OKADA K, 1990, SCIENCE, V250, P274, DOI 10.1126/science.250.4978.274; Pandey GK, 2008, MOL PLANT, V1, P238, DOI 10.1093/mp/ssn003; Pandey GK, 2005, PLANT PHYSIOL, V139, P1185, DOI 10.1104/pp.105.066324; Pandey GK, 2004, PLANT CELL, V16, P1912, DOI 10.1105/tpc.021311; Park SY, 2009, SCIENCE, V324, P1068, DOI 10.1126/science.1173041; Rubio S, 2009, PLANT PHYSIOL, V150, P1345, DOI 10.1104/pp.109.137174; Saez A, 2004, PLANT J, V37, P354, DOI 10.1046/j.1365-313X.2003.01966.x; Santiago J, 2009, NATURE, V462, P665, DOI 10.1038/nature08591; Sato A, 2009, BIOCHEM J, V424, P439, DOI 10.1042/BJ20091221; Seo M, 2002, TRENDS PLANT SCI, V7, P41, DOI 10.1016/S1360-1385(01)02187-2; Shinozaki K, 2000, CURR OPIN PLANT BIOL, V3, P217, DOI 10.1016/S1369-5266(00)00067-4; Singh A, 2012, J PLANT BIOCHEM BIOT, V21, pS100, DOI 10.1007/s13562-012-0150-1; Singh A, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030947, 10.1371/journal.pone.0044728, 10.1371/journal.pone.0039812, 10.1371/journal.pone.0044931]; Singh A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-435; Sun L, 2011, J EXP BOT, V62, P5659, DOI 10.1093/jxb/err252; Tahtiharju S, 2001, PLANT J, V26, P461, DOI 10.1046/j.1365-313X.2001.01048.x; Thomashow MF, 1999, ANNU REV PLANT PHYS, V50, P571, DOI 10.1146/annurev.arplant.50.1.571; Umezawa T, 2010, PLANT CELL PHYSIOL, V51, P1821, DOI 10.1093/pcp/pcq156; Umezawa T, 2009, P NATL ACAD SCI USA, V106, P17588, DOI 10.1073/pnas.0907095106; Uno Y, 2000, P NATL ACAD SCI USA, V97, P11632, DOI 10.1073/pnas.190309197; Wang YP, 2012, J PLANT PHYSIOL, V169, P1874, DOI 10.1016/j.jplph.2012.07.017; Xue TT, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-550; Yoshida R, 2002, PLANT CELL PHYSIOL, V43, P1473, DOI 10.1093/pcp/pcf188; Yoshida T, 2006, PLANT PHYSIOL, V140, P115, DOI 10.1104/pp.105.070128; You J, 2014, PLANT PHYSIOL, V166, P2100, DOI 10.1104/pp.114.251116; Zhang WH, 2004, P NATL ACAD SCI USA, V101, P9508, DOI 10.1073/pnas.0402112101	64	108	115	3	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125168	10.1371/journal.pone.0125168	http://dx.doi.org/10.1371/journal.pone.0125168			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886365	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000152
J	Uhl, MK; Oberdorfer, G; Steinkellner, G; Riegler-Berket, L; Mink, D; van Assema, F; Schurmann, M; Gruber, K				Uhl, Michael K.; Oberdorfer, Gustav; Steinkellner, Georg; Riegler-Berket, Lina; Mink, Daniel; van Assema, Friso; Schurmann, Martin; Gruber, Karl			The Crystal Structure of D-Threonine Aldolase from Alcaligenes xylosoxidans Provides Insight into a Metal Ion Assisted PLP-Dependent Mechanism	PLOS ONE			English	Article							GENE CLONING; SPECIFICITY; ENZYME; PARAMETERIZATION; DEHYDRATASE; RACEMASE; MODEL; ACIDS	Threonine aldolases catalyze the pyridoxal phosphate (PLP) dependent cleavage of threonine into glycine and acetaldehyde and play a major role in the degradation of this amino acid. In nature, L- as well as D-specific enzymes have been identified, but the exact physiological function of D-threonine aldolases (DTAs) is still largely unknown. Both types of enantio-complementary enzymes have a considerable potential in biocatalysis for the stereospecific synthesis of various beta-hydroxy amino acids, which are valuable building blocks for the production of pharmaceuticals. While several structures of L-threonine aldolases (LTAs) have already been determined, no structure of a DTA is available to date. Here, we report on the determination of the crystal structure of the DTA from Alcaligenes xylosoxidans (AxDTA) at 1.5 angstrom resolution. Our results underline the close relationship of DTAs and alanine racemases and allow the identification of a metal binding site close to the PLP-cofactor in the active site of the enzyme which is consistent with the previous observation that divalent cations are essential for DTA activity. Modeling of AxDTA substrate complexes provides a rationale for this metal dependence and indicates that binding of the beta-hydroxy group of the substrate to the metal ion very likely activates this group and facilitates its deprotonation by His193. An equivalent involvement of a metal ion has been implicated in the mechanism of a serine dehydratase, which harbors a metal ion binding site in the vicinity of the PLP cofactor at the same position as in DTA. The structure of AxDTA is completely different to available structures of LTAs. The enantio-complementarity of DTAs and LTAs can be explained by an approximate mirror symmetry of crucial active site residues relative to the PLP-cofactor.	[Uhl, Michael K.; Oberdorfer, Gustav; Steinkellner, Georg; Gruber, Karl] Austrian Ctr Ind Biotechnol, A-8010 Graz, Austria; [Oberdorfer, Gustav; Riegler-Berket, Lina; Gruber, Karl] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria; [Mink, Daniel; van Assema, Friso; Schurmann, Martin] DSM Chem Technol R&D BV Innovat Synth, NL-6167 Geleen, Netherlands	Austrian Centre of Industrial Biotechnology; University of Graz; DSM NV	Gruber, K (corresponding author), Austrian Ctr Ind Biotechnol, Petersgasse 14, A-8010 Graz, Austria.	karl.gruber@uni-graz.at	Gruber, Karl/GPP-6706-2022	Gruber, Karl/0000-0002-3485-9740; Steinkellner, Georg/0000-0001-7565-8868; Schurmann, Martin/0000-0003-3286-122X; Riegler-Berket, Lina/0000-0002-1127-0861; Oberdorfer, Gustav/0000-0002-6144-9114	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program; DSM Chemical Technology R D BV	Federal Ministry of Science, Research and Economy (BMWFW); Federal Ministry of Traffic, Innovation and Technology (bmvit); Styrian Business Promotion Agency SFG; Standortagentur Tirol; ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program; DSM Chemical Technology R D BV	This work has been supported by the Federal Ministry of Science, Research and Economy (BMWFW), the Federal Ministry of Traffic, Innovation and Technology (bmvit), the Styrian Business Promotion Agency SFG, the Standortagentur Tirol and ZIT-Technology Agency of the City of Vienna through the COMET-Funding Program managed by the Austrian Research Promotion Agency FFG. DSM Chemical Technology R & D BV provided support in the form of salaries for authors D. M., F. v. A. and M. S., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; DiMaio F, 2011, NATURE, V473, P540, DOI 10.1038/nature09964; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fesko K, 2008, BIOORG MED CHEM LETT, V18, P5987, DOI 10.1016/j.bmcl.2008.08.031; Fesko K, 2010, ANGEW CHEM INT EDIT, V49, P121, DOI 10.1002/anie.200904395; Franz SE, 2014, ADV APPL MICROBIOL, V88, P57, DOI 10.1016/B978-0-12-800260-5.00003-6; Hendlich M, 2003, J MOL BIOL, V326, P607, DOI 10.1016/S0022-2836(02)01408-0; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Kataoka M, 1997, EUR J BIOCHEM, V248, P385, DOI 10.1111/j.1432-1033.1997.00385.x; Kielkopf CL, 2002, BIOCHEMISTRY-US, V41, P11711, DOI 10.1021/bi020393+; Kim JH, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.88; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; Krieger E, 2004, PROTEINS, V57, P678, DOI 10.1002/prot.20251; Krieger E, 2006, J MOL GRAPH MODEL, V25, P481, DOI 10.1016/j.jmgm.2006.02.009; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu JQ, 1998, J BIOL CHEM, V273, P16678, DOI 10.1074/jbc.273.27.16678; Liu JQ, 1998, EUR J BIOCHEM, V255, P220, DOI 10.1046/j.1432-1327.1998.2550220.x; Liu JQ, 2000, APPL MICROBIOL BIOT, V54, P44, DOI 10.1007/s002539900301; Maeda T, 2010, J BIOCHEM, V148, P705, DOI 10.1093/jb/mvq106; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mugford PF, 2008, ANGEW CHEM INT EDIT, V47, P8782, DOI 10.1002/anie.200705159; Paiardini A, 2003, BBA-PROTEINS PROTEOM, V1647, P214, DOI 10.1016/S1570-9639(03)00050-5; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Seebeck FP, 2003, J AM CHEM SOC, V125, P10158, DOI 10.1021/ja036707d; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sillitoe I, 2013, NUCLEIC ACIDS RES, V41, pD490, DOI 10.1093/nar/gks1211; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Steinkellner G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5150; Steinreiber J, 2007, TETRAHEDRON, V63, P918, DOI 10.1016/j.tet.2006.11.035; Sun SX, 1999, BIOCHEMISTRY-US, V38, P4058, DOI 10.1021/bi982924t; Tanaka H, 2011, J BIOL CHEM, V286, P27548, DOI 10.1074/jbc.M110.201160; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WOEHL EU, 1995, COORDIN CHEM REV, V144, P147, DOI 10.1016/0010-8545(94)08001-8	41	15	16	3	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124056	10.1371/journal.pone.0124056	http://dx.doi.org/10.1371/journal.pone.0124056			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884707	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000100
J	Zhang, CC; Yu, HN; Ni, XF; Shen, SR; Das, UN				Zhang, Chengcheng; Yu, Haining; Ni, Xiaofeng; Shen, Shengrong; Das, Undurti N.			Growth Inhibitory Effect of Polyunsaturated Fatty Acids (PUFAs) on Colon Cancer Cells via Their Growth Inhibitory Metabolites and Fatty Acid Composition Changes	PLOS ONE			English	Article							LINOLEIC-ACID; LIPOXIN A(4); APOPTOSIS; CYCLOOXYGENASE-2; EXPRESSION; RESOLVINS; CARCINOMA; RADIATION; INVASION; SYNTHASE	Background Colorectal cancer is common. Polyunsaturated fatty acids (PUFAs) exert growth-inhibitory and pro-apoptotic effects on colon cancer cells. Metabolites of PUFAs such as prostaglandins (PGs), leukotrienes (LTs) and lipoxins (LXs) play a significant role in colon cancer. Methods Human colon cancer LoVo and RKO cells were cultured with different concentration of PUFAs and 5-fluorouracil (5-FU) in vitro. Cell morphological changes, fatty acid composition, formation of PGE2, LTB4 and LXA4 and expression of COX-2, ALOX5, PGD synthase (PGDS), microsomal prostaglandin E synthase (mPGES) were assessed in LoVo and RKO cells when supplemented with PUFAs and 5-FU. Results PUFAs and 5-FU inhibited growth of LoVo and RKO cells to the same extent at the doses used and produced significant alterations in their shape. As expected, higher concentrations of supplemented PUFAs were noted in the cells compared to control. LA, GLA, AA, ALA and EPA supplementation to LoVo cells suppressed production of PGE(2), LTB4, and ALOX5, mPGES expression, but enhanced that of LXA(4); whereas DHA enhanced PGE(2) and LXA(4) synthesis but decreased LTB4 formation and COX-2, ALOX5, mPGES expression. In contrast, 5-FU enhanced formation of PGE(2), LTB4 and mPGES expression, but suppressed LXA(4) synthesis and COX-2 expression. PGE(2), LTB4 synthesis and ALOX5 expression was suppressed by LA, GLA, ALA and DHA; whereas AA, EPA and 5-FU enhanced PGE(2) but paradoxically AA decreased and EPA and 5-FU enhanced LTB4 synthesis in RKO cells. All the PUFAs tested enhanced, while 5-FU decreased LXA(4) formation in RKO cells; whereas GLA, AA, and 5-FU augmented while LA, ALA, EPA and DHA enhanced COX-2 expression in RKO cells. Conclusions Tumoricidal action of PUFAs on colorectal LoVo and RKO cancer cells in vitro was associated with increased formation of LXA(4), decreased synthesis of PGE(2) and LTB4 and suppressed expression of COX-2, ALOX5, mPGES, whereas 5-FU produced contrasting actions on these indices.	[Zhang, Chengcheng; Ni, Xiaofeng; Shen, Shengrong] Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Yu, Haining] Zhejiang Univ Technol, Coll Pharmaceut Sci, Hangzhou 310032, Zhejiang, Peoples R China; [Das, Undurti N.] UND Life Sci, Federal Way, WA 98003 USA; [Das, Undurti N.] GVP Hosp, Dept Med, Visakhapatnam 530048, Andhra Pradesh, India; [Das, Undurti N.] GVP Hosp, BioSci Res Ctr, Visakhapatnam 530048, Andhra Pradesh, India	Zhejiang University; Zhejiang University of Technology	Shen, SR (corresponding author), Zhejiang Univ, Coll Biosyst Engn & Food Sci, Hangzhou 310058, Zhejiang, Peoples R China.	shrshen@zju.edu.cn; Undurti@hotmail.com	Yu, Haining/HHC-0235-2022	Zhang, Chengcheng/0000-0002-0152-3001	Department of Biotechnology (DBT) [BT/PR11627/MED/30/157/2010]; Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA) [IR/SO/LU/03/2008/1]; Department of Biotechnology, New Delhi	Department of Biotechnology (DBT)(Department of Biotechnology (DBT) India); Department of Science and Technology under Intensification of Research in High Priority Areas (IRPHA); Department of Biotechnology, New Delhi(Department of Biotechnology (DBT) India)	UND is in receipt of Ramalingaswami fellowship of the Department of Biotechnology, New Delhi during the tenure of this study. This work was supported, in part, by grants from the Department of Biotechnology (DBT No. BT/PR11627/MED/30/157/2010), Department of Science and Technology (No. IR/SO/LU/03/2008/1) under Intensification of Research in High Priority Areas (IRPHA) to UND. Author UND is the President and CEO of UND Life Sciences without any financial compensation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cai F, 2014, CLIN NUTR, V33, P164, DOI 10.1016/j.clnu.2013.04.005; Chae BS, 2008, ARCH PHARM RES, V31, P503, DOI 10.1007/s12272-001-1185-6; Chen EP, 2011, PROSTAG OTH LIPID M, V96, P14, DOI 10.1016/j.prostaglandins.2011.08.005; Chen ZY, 2000, PROSTAG LEUKOTR ESS, V63, P301, DOI 10.1054/plef.2000.0218; Cheng J, 2014, TOXICOL APPL PHARM, V274, P96, DOI 10.1016/j.taap.2013.10.021; Dai JF, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-71; Das UN, 2006, PROSTAG LEUKOTR ESS, V74, P165, DOI 10.1016/j.plefa.2006.01.002; Das UN, 2004, PROSTAGLANDINS LEUKO, V70, P419; Das UN, 2006, CURR PHARM BIOTECHNO, V7, P467, DOI 10.2174/138920106779116856; Das Undurti N., 2006, Biotechnology Journal, V1, P420, DOI 10.1002/biot.200600012; Das UN, 2012, PROSTAG LEUKOTR ESS, V86, P3, DOI 10.1016/j.plefa.2011.09.008; Das UN, 2011, CANCER METAST REV, V30, P311, DOI 10.1007/s10555-011-9316-x; Das UN, 2011, CLIN LIPIDOL, V6, P463, DOI 10.2217/CLP.11.34; Das UN, 2013, CLIN LIPIDOL, V8, P437, DOI 10.2217/CLP.13.31; Divangahi M, 2013, ADV EXP MED BIOL, V783, P103, DOI 10.1007/978-1-4614-6111-1_6; DUNBAR LM, 1975, J BIOL CHEM, V250, P1152; Fasano E, 2012, BBA-MOL BASIS DIS, V1822, P1762, DOI 10.1016/j.bbadis.2012.08.003; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Hao H, 2011, CANCER LETT, V309, P85, DOI 10.1016/j.canlet.2011.05.020; Hartwich J, 2001, Med Sci Monit, V7, P1171; Jachak SM, 2007, CURR OPIN INVEST DR, V8, P411; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Koeberle A, 2009, MOL CANCER THER, V8, P2348, DOI 10.1158/1535-7163.MCT-09-0290; Kojima F, 2005, FUND CLIN PHARMACOL, V19, P255, DOI 10.1111/j.1472-8206.2005.00316.x; Kolar S, 2011, CANCER-AM CANCER SOC, V117, P5294, DOI 10.1002/cncr.26205; KORATKAR R, 1993, PROSTAG LEUKOTR ESS, V48, P175, DOI 10.1016/0952-3278(93)90107-8; Kummer NT, 2012, J CELL BIOCHEM, V113, P1998, DOI 10.1002/jcb.24069; Lu XF, 2010, J ZHEJIANG UNIV-SC B, V11, P923, DOI 10.1631/jzus.B1000125; Lu XF, 2010, LIPIDS HEALTH DIS, V9, DOI 10.1186/1476-511X-9-106; Meng HZ, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-160; MORTON RE, 1979, BIOCHIM BIOPHYS ACTA, V573, P321, DOI 10.1016/0005-2760(79)90065-1; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Polavarapu S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114766; Qualtrough D, 2007, INT J CANCER, V121, P734, DOI 10.1002/ijc.22755; Ramesh G, 1996, CANCER LETT, V100, P199, DOI 10.1016/0304-3835(95)04095-1; RAMESH G, 1995, CANCER LETT, V95, P237, DOI 10.1016/0304-3835(95)03896-5; Ramesh G, 1998, CANCER LETT, V123, P207, DOI 10.1016/S0304-3835(97)00426-6; Roelofs HMJ, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/1471-230X-14-1; Samuelsson B, 2007, PHARMACOL REV, V59, P207, DOI 10.1124/pr.59.3.1; Seppanen-Laakso T, 2002, ANAL CHIM ACTA, V465, P39, DOI 10.1016/S0003-2670(02)00397-5; Serhan CN, 2004, LIPIDS, V39, P1125, DOI 10.1007/s11745-004-1339-7; Sinicrope FA, 2004, CANCER METAST REV, V23, P63, DOI 10.1023/A:1025863029529; SURYAPRABHA P, 1991, PROSTAG LEUKOTR ESS, V43, P251, DOI 10.1016/0952-3278(91)90038-7; Tateishi N, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-30; Urade Y, 2002, PROSTAG OTH LIPID M, V68-9, P375, DOI 10.1016/S0090-6980(02)00042-4; van Meeteren ME, 2005, EUR J CLIN NUTR, V59, P1347, DOI 10.1038/sj.ejcn.1602255; Yoshida T, 1998, SURG TODAY, V28, P740, DOI 10.1007/BF02484622	48	27	28	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123256	10.1371/journal.pone.0123256	http://dx.doi.org/10.1371/journal.pone.0123256			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886460	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000053
J	Gumus, A; Lee, S; Ahsan, SS; Karlsson, K; Gabrielson, R; Guglielmo, CG; Winkler, DW; Erickson, D				Gumus, Abdurrahman; Lee, Seoho; Ahsan, Syed S.; Karlsson, Kolbeinn; Gabrielson, Richard; Guglielmo, Christopher G.; Winkler, David W.; Erickson, David			Lab-on-a-Bird: Biophysical Monitoring of Flying Birds	PLOS ONE			English	Article							METABOLIC-RESPONSES; MIGRATORY FLIGHT; GLUCOSE SENSOR; DESIGN	The metabolism of birds is finely tuned to their activities and environments, and thus research on avian systems can play an important role in understanding organismal responses to environmental changes. At present, however, the physiological monitoring of bird metabolism is limited by the inability to take real-time measurements of key metabolites during flight. In this study, we present an implantable biosensor system that can be used for continuous monitoring of uric acid levels of birds during various activities including flight. The system consists of a needle-type enzymatic biosensor for the amperometric detection of uric acid in interstitial fluids. A lightweight two-electrode potentiostat system drives the biosensor, reads the corresponding output current and wirelessly transfers the data or records to flash memory. We show how the device can be used to monitor, in real time, the effects of short-term flight and rest cycles on the uric acid levels of pigeons. In addition, we demonstrate that our device has the ability to measure uric acid level increase in homing pigeons while they fly freely. Successful application of the sensor in migratory birds could open up a new way of studying birds in flight which would lead to a better understanding of the ecology and biology of avian movements.	[Gumus, Abdurrahman; Karlsson, Kolbeinn] Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14850 USA; [Lee, Seoho; Erickson, David] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA; [Ahsan, Syed S.] Cornell Univ, Appl & Engn Phys, Ithaca, NY USA; [Gabrielson, Richard; Winkler, David W.] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY USA; [Guglielmo, Christopher G.] Univ Western Ontario, Dept Biol, Adv Facil Avian Res, London, ON, Canada	Cornell University; Cornell University; Cornell University; Cornell University; Western University (University of Western Ontario)	Gumus, A (corresponding author), Cornell Univ, Sch Elect & Comp Engn, Ithaca, NY 14850 USA.	de54@cornell.edu	Erickson, David/A-3319-2009	Erickson, David/0000-0002-1624-9711	United States National Science Foundation (NSF), Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) [1014891]	United States National Science Foundation (NSF), Division of Civil, Mechanical, and Manufacturing Innovation (CMMI)(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by the United States National Science Foundation (NSF), Division of Civil, Mechanical, and Manufacturing Innovation (CMMI) with an award number 1014891 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1014891&HistoricalAwards=false). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BINDRA DS, 1991, ANAL CHEM, V63, P1692, DOI 10.1021/ac00017a008; Bowlin MS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002154; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Choleau C, 2002, BIOSENS BIOELECTRON, V17, P641, DOI 10.1016/S0956-5663(01)00306-2; Endo H, 2009, BIOSENS BIOELECTRON, V24, P1417, DOI 10.1016/j.bios.2008.08.038; Guiseppi-Elie A, 2011, ANAL BIOANAL CHEM, V399, P403, DOI 10.1007/s00216-010-4271-x; Gumus A, 2014, ANALYST, V139, P742, DOI [10.1039/c3an01787g, 10.1039/C3AN01787G]; Hau M, 2008, GEN COMP ENDOCR, V157, P241, DOI 10.1016/j.ygcen.2008.05.008; Helton Kristen L, 2011, J Diabetes Sci Technol, V5, P632; Hu YB, 1997, J NEUROCHEM, V68, P1745; HU YB, 1993, ANAL CHIM ACTA, V281, P503, DOI 10.1016/0003-2670(93)85008-8; Jenni L, 1998, J AVIAN BIOL, V29, P521, DOI 10.2307/3677171; Jenni-Eiermann S, 2002, ZOOLOGY, V105, P239, DOI 10.1078/0944-2006-00066; Jenni-Eiermann S, 2002, J EXP BIOL, V205, P2453; JENNIEIERMANN S, 1991, J COMP PHYSIOL B, V161, P465; Johnson RJ, 2009, J COMP PHYSIOL B, P179; Kern M, 2005, CONDOR, V107, P665, DOI 10.1650/0010-5422(2005)107[0665:BMACLI]2.0.CO;2; Kern MD, 2007, COMP BIOCHEM PHYS A, V147, P70, DOI 10.1016/j.cbpa.2006.11.006; Landys MM, 2005, P ROY SOC B-BIOL SCI, V272, P295, DOI 10.1098/rspb.2004.2952; Lee WH, 2011, MEAS SCI TECHNOL, V22, DOI 10.1088/0957-0233/22/4/042001; MacCurdy Robert, 2009, Journal of Communications, V4, P487, DOI 10.4304/jcm.4.7.487-495; RAPPOLE JH, 1991, J FIELD ORNITHOL, V62, P335; Robinson WD, 2010, FRONT ECOL ENVIRON, V8, P354, DOI 10.1890/080179; Schwilch R, 1996, J COMP PHYSIOL B, V166, P77, DOI 10.1007/BF00301171; Suman S, 2005, SENSOR ACTUAT B-CHEM, V107, P768, DOI 10.1016/j.snb.2004.12.016; Wada H, 2006, PHYSIOL BIOCHEM ZOOL, V79, P784, DOI 10.1086/505509; Wilson LJ, 2009, BIOL CONSERV, V142, P1808, DOI 10.1016/j.biocon.2009.03.019; Wright LJ, 2009, J ANIM ECOL, V78, P1191, DOI 10.1111/j.1365-2656.2009.01582.x; Yoneyama Y, 2009, TALANTA, V80, P909, DOI 10.1016/j.talanta.2009.08.014	29	12	12	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123947	10.1371/journal.pone.0123947	http://dx.doi.org/10.1371/journal.pone.0123947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880904	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500073
J	Li, ZH; Li, P; Shi, ZC				Li, Zhi-Hua; Li, Ping; Shi, Ze-Chao			Chronic Exposure to Tributyltin Induces Brain Functional Damage in Juvenile Common Carp (Cyprinus carpio)	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; INDUCED OXIDATIVE STRESS; NA+-K+-ATPASE; RAT-LIVER; MONOAMINE-OXIDASE; SEBASTISCUS-MARMORATUS; INTEGRATED ASSESSMENT; LIPID-PEROXIDATION; DIFFERENT TISSUES; RESPONSES	The aim of the present study was to investigate the effect of Tributyltin (TBT) on brain function and neurotoxicity of freshwater teleost. The effects of long-term exposure to TBT on antioxidant related indices (MDA, malondialdehyde; SOD, superoxide dismutase; CAT, catalase; GR, glutathione reductase; GPx, glutathione peroxidase), Na+-K+-ATPase and neurological parameters (AChE, acetylcholinesterase; MAO, monoamine oxidase; NO, nitric oxide) in the brain of common carp were evaluated. Fish were exposed to sublethal concentrations of TBT (75 ng/L, 0.75 mu g/L and 7.5 mu g/L) for 15, 30, and 60 days. Based on the results, a low level and short-term TBT-induced stress could not induce the notable responses of the fish brain, but long-term exposure (more than 15 days) to TBT could lead to obvious physiological-biochemical responses (based on the measured parameters). The results also strongly indicated that neurotoxicity of TBT to fish. Thus, the measured physiological responses in fish brain could provide useful information to better understand the mechanisms of TBT-induced bio-toxicity.	[Li, Zhi-Hua; Li, Ping; Shi, Ze-Chao] Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Key Field Stn Fishery Resource & Environm Upper M, Key Lab Freshwater Biodivers Conservat,Minist Agr, Wuhan 430223, Peoples R China; [Li, Zhi-Hua; Li, Ping] Univ South Bohemia Ceske Budejovice, Fac Fisheries & Protect Waters, South Bohemian Res Ctr Aquaculture & Biodivers Hy, Res Inst Fish Culture & Hydrobiol, Vodnany 38925, Czech Republic	Chinese Academy of Fishery Sciences; Yangtze River Fisheries Research Institute, CAFS; Ministry of Agriculture & Rural Affairs; University of South Bohemia Ceske Budejovice	Li, ZH (corresponding author), Chinese Acad Fishery Sci, Yangtze River Fisheries Res Inst, Key Field Stn Fishery Resource & Environm Upper M, Key Lab Freshwater Biodivers Conservat,Minist Agr, Wuhan 430223, Peoples R China.	zhihuali06@yahoo.com	LI, ZHIHUA/G-2896-2015; LI, PING/G-2915-2015; Li, ZhiHua/GYU-9914-2022	LI, ZHIHUA/0000-0002-6484-657X; LI, PING/0000-0002-8663-8552; 	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences [2014A02YQ01]; Technology Foundation for Selected Overseas Chinese Scholar of MOHRSS; CENAKVA [CZ.1.05/2.1.00/01.0024]; MEYS of the CR under the NPU I program [LO1205]; Grant agency of Czech Republic [P503/11/1130]	Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences; Technology Foundation for Selected Overseas Chinese Scholar of MOHRSS; CENAKVA; MEYS of the CR under the NPU I program; Grant agency of Czech Republic(Grant Agency of the Czech Republic)	This study was supported by Special Scientific Research Funds for Central Non-profit Institutes, Chinese Academy of Fishery Sciences (2014A02YQ01), Technology Foundation for Selected Overseas Chinese Scholar of MOHRSS, and the CENAKVA CZ.1.05/2.1.00/01.0024, the project LO1205 with financial support from the MEYS of the CR under the NPU I program, the project P503/11/1130 of the Grant agency of Czech Republic.	Agrahari S, 2008, PESTIC BIOCHEM PHYS, V92, P57, DOI 10.1016/j.pestbp.2008.06.003; ALDRIDGE WN, 1970, BIOCHEM J, V118, P171, DOI 10.1042/bj1180171; Andersen JK, 2004, NAT MED, V10, pS18, DOI 10.1038/nrn1434; Antizar-Ladislao B, 2008, ENVIRON INT, V34, P292, DOI 10.1016/j.envint.2007.09.005; ARNAIZ GRD, 1967, J NEUROCHEM, V14, P215; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Basha DC, 2012, INT J DEV NEUROSCI, V30, P343, DOI 10.1016/j.ijdevneu.2012.01.004; Beliaeff B, 2002, ENVIRON TOXICOL CHEM, V21, P1316, DOI 10.1002/etc.5620210629; Broeg K, 2006, MAR POLLUT BULL, V53, P508, DOI 10.1016/j.marpolbul.2006.02.004; CARLBERG I, 1975, J BIOL CHEM, V250, P5475; Casalino E, 2002, TOXICOLOGY, V179, P37, DOI 10.1016/S0300-483X(02)00245-7; Devi CB, 2005, INT J DEV NEUROSCI, V23, P375, DOI 10.1016/j.ijdevneu.2004.11.003; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Elsabbagh HS, 2002, PHARMACOL RES, V45, P201, DOI 10.1006/phrs.2001.0909; Feng MB, 2014, ENVIRON TOXICOL, V29, P1460, DOI 10.1002/tox.21876; Gennari A, 2000, TOXICOL APPL PHARM, V169, P185, DOI 10.1006/taap.2000.9076; GOTH L, 1991, CLIN CHIM ACTA, V196, P143, DOI 10.1016/0009-8981(91)90067-M; Hartl MGJ, 2001, AQUAT TOXICOL, V55, P125, DOI 10.1016/S0166-445X(01)00184-9; Holmqvist B, 1997, BRAIN RES, V745, P67, DOI 10.1016/S0006-8993(96)01128-6; Horiguchi Toshihiro, 2006, Environmental Sciences, V13, P77; JAIN SK, 1989, DIABETES, V38, P1539, DOI 10.2337/diabetes.38.12.1539; John S, 2001, J NUTR BIOCHEM, V12, P500, DOI 10.1016/S0955-2863(01)00160-7; Kavitha P, 2009, ECOTOX ENVIRON SAFE, V72, P1727, DOI 10.1016/j.ecoenv.2009.05.010; Kim S, 2011, BIOL TRACE ELEM RES, V142, P683, DOI 10.1007/s12011-010-8791-1; Kim WK, 2010, J HAZARD MATER, V180, P395, DOI 10.1016/j.jhazmat.2010.04.044; LAWRENCE RA, 1976, BIOCHEM BIOPH RES CO, V71, P952, DOI 10.1016/0006-291X(76)90747-6; Li ZH, 2011, J HAZARD MATER, V185, P870, DOI 10.1016/j.jhazmat.2010.09.102; Li ZH, 2010, COMP BIOCHEM PHYS C, V152, P392, DOI 10.1016/j.cbpc.2010.06.006; Li ZH, 2010, AQUAT TOXICOL, V98, P297, DOI 10.1016/j.aquatox.2010.02.017; Li ZH, 2010, COMP BIOCHEM PHYS C, V151, P137, DOI 10.1016/j.cbpc.2009.09.006; Liu CM, 2013, ENVIRON TOXICOL PHAR, V35, P502, DOI 10.1016/j.etap.2013.02.009; Livingstone DR, 2001, MAR POLLUT BULL, V42, P656, DOI 10.1016/S0025-326X(01)00060-1; Lushchak VI, 2011, AQUAT TOXICOL, V101, P13, DOI 10.1016/j.aquatox.2010.10.006; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Mitra S, 2015, ENVIRON TOXICOL, V30, P1393, DOI 10.1002/tox.22009; Mitra S, 2014, ENVIRON TOXICOL PHAR, V37, P1048, DOI 10.1016/j.etap.2014.03.020; Morcillo Y, 2000, ENVIRON POLLUT, V107, P47, DOI 10.1016/S0269-7491(99)00133-5; Mortensen AS, 2007, COMP BIOCHEM PHYS C, V145, P431, DOI 10.1016/j.cbpc.2007.01.013; Nakayama K, 2004, CHEMOSPHERE, V55, P1331, DOI 10.1016/j.chemosphere.2003.11.050; Nava-Ruiz C, 2010, EXP TOXICOL PATHOL, V62, P311, DOI 10.1016/j.etp.2009.04.006; Nesci S, 2011, TOXICOL IN VITRO, V25, P951, DOI 10.1016/j.tiv.2011.03.004; Oruc EO, 2002, B ENVIRON CONTAM TOX, V69, P271, DOI 10.1007/s00128-002-0057-y; Pandey S, 2003, SCI TOTAL ENVIRON, V309, P105, DOI 10.1016/S0048-9697(03)00006-8; Park K, 2012, FISH SHELLFISH IMMUN, V32, P426, DOI 10.1016/j.fsi.2011.11.031; Porte C, 2006, COMP BIOCHEM PHYS C, V143, P303, DOI 10.1016/j.cbpc.2006.03.004; Rajeshkumar S, 2013, ECOTOX ENVIRON SAFE, V98, P8, DOI 10.1016/j.ecoenv.2013.07.029; Reddy GR, 2007, NEUROTOXICOLOGY, V28, P402, DOI 10.1016/j.neuro.2006.03.018; Sahin E, 2004, BEHAV BRAIN RES, V155, P241, DOI 10.1016/j.bbr.2004.04.022; Samuel PM, 1998, J APPL TOXICOL, V18, P383, DOI 10.1002/(SICI)1099-1263(1998090)18:5<383::AID-JAT523>3.3.CO;2-S; St-Jean SD, 2002, MAR ECOL PROG SER, V236, P155, DOI 10.3354/meps236155; STUEHR DJ, 1989, BIOCHEM BIOPH RES CO, V161, P420, DOI 10.1016/0006-291X(89)92615-6; TABAKOFF B, 1972, ANAL CHEM, V44, P427, DOI 10.1021/ac60310a040; Tiano L, 2003, BBA-MOL CELL RES, V1640, P105, DOI 10.1016/S0167-4889(03)00025-9; Tiano L, 2001, APPL ORGANOMET CHEM, V15, P575, DOI 10.1002/aoc.207; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; YADWAD VB, 1990, B ENVIRON CONTAM TOX, V44, P585, DOI 10.1007/BF01700880; Zhang JL, 2008, CHEMOSPHERE, V73, P337, DOI 10.1016/j.chemosphere.2008.05.072; Zhang JL, 2007, AQUAT TOXICOL, V83, P174, DOI 10.1016/j.aquatox.2007.03.018; Zhang X, 2008, AQUAT TOXICOL, V86, P4, DOI 10.1016/j.aquatox.2007.07.002; Zhou J, 2010, J HAZARD MATER, V183, P428, DOI 10.1016/j.jhazmat.2010.07.042	60	39	40	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123091	10.1371/journal.pone.0123091	http://dx.doi.org/10.1371/journal.pone.0123091			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879203	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500039
J	Maas, F; Spoorenberg, A; Brouwer, E; Bos, R; Efde, M; Chaudhry, RN; Veeger, NJGM; van Ooijen, PMA; Wolf, R; Bootsma, H; van der Veer, E; Arends, S				Maas, Fiona; Spoorenberg, Anneke; Brouwer, Elisabeth; Bos, Reinhard; Efde, Monique; Chaudhry, Rizwana N.; Veeger, Nic J. G. M.; van Ooijen, Peter M. A.; Wolf, Rinze; Bootsma, Hendrika; van der Veer, Eveline; Arends, Suzanne			Spinal Radiographic Progression in Patients with Ankylosing Spondylitis Treated with TNF-alpha Blocking Therapy: A Prospective Longitudinal Observational Cohort Study	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ACTIVITY SCORE ASDAS; DAMAGE; DISCONTINUATION; PREDICTORS; LEAD	Objectives To evaluate spinal radiographic damage over time and to explore the associations of radiographic progression with patient characteristics and clinical assessments including disease activity in ankylosing spondylitis (AS) patients treated with tumor necrosis factor-alpha (TNF-alpha) blocking therapy in daily clinical practice. Methods Consecutive outpatients from the Groningen Leeuwarden AS (GLAS) cohort were included based on the availability of cervical and lumbar radiographs before start of TNF-alpha blocking therapy and after 2, 4, and/or 6 years of follow-up. Clinical data were assessed at the same time points. Radiographs were scored by two independent readers using the modified Stoke AS Spine Score (mSASSS). Spinal radiographic progression in relation to clinical assessments was analyzed using generalized estimating equations. Results 176 AS patients were included, 58% had syndesmophytes at baseline. Median mSASSS increased significantly from 10.7 (IQR: 4.6-24.0) at baseline to 14.8 (IQR: 7.9-32.8) at 6 years. At the group level, spinal radiographic progression was linear with a mean progression rate of 1.3 mSASSS units per 2 years. Both spinal radiographic damage at baseline and radiographic progression were highly variable between AS patients. Male gender, older age, longer disease duration, higher BMI, longer smoking duration, high CRP, and high ASDAS were significantly associated with syndesmophytes at baseline. Significantly more radiographic progression was seen in patients with versus without syndesmophytes (2.0 vs. 0.5 mSASSS units per 2 years) and in patients >40 versus <= 40 years of age (1.8 vs. 0.7 mSASSS units per 2 years). No longitudinal associations between radiographic progression and clinical assessments were found. Conclusions This prospective longitudinal observational cohort study in daily clinical practice shows overall slow and linear spinal radiographic progression in AS patients treated with TNF-alpha blocking therapy. At the individual level, progression was highly variable. Patients with syndesmophytes at baseline showed a 4-fold higher radiographic progression rate than patients without syndesmophytes.	[Maas, Fiona; Spoorenberg, Anneke; Brouwer, Elisabeth; Chaudhry, Rizwana N.; Bootsma, Hendrika; Arends, Suzanne] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Spoorenberg, Anneke; Bos, Reinhard; Efde, Monique; Arends, Suzanne] Med Ctr Leeuwarden, Dept Rheumatol, Leeuwarden, Netherlands; [Veeger, Nic J. G. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Ooijen, Peter M. A.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands; [Wolf, Rinze] Med Ctr Leeuwarden, Dept Radiol, Leeuwarden, Netherlands; [van der Veer, Eveline] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Groningen, Netherlands	University of Groningen; Medical Center Leeuwarden; University of Groningen; University of Groningen; Medical Center Leeuwarden; University of Groningen	Maas, F (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	f.maas@umcg.nl	Arends, Suzanne/M-5436-2015; Veeger, Nic JGM/F-2966-2013; van Ooijen, Peter/B-9150-2008; Bos, Reinhard/AAS-1726-2020; Brouwer, Elisabeth/AAL-9029-2020; Brouwer, Elisabeth/A-3198-2015	Arends, Suzanne/0000-0002-4422-7640; Veeger, Nic JGM/0000-0002-1492-7937; van Ooijen, Peter/0000-0002-8995-1210; Brouwer, Elisabeth/0000-0002-5652-4423; Brouwer, Elisabeth/0000-0002-5652-4423; Bos, Reinhard/0000-0003-1094-5596	Pfizer pharmaceuticals	Pfizer pharmaceuticals(Pfizer)	The GLAS cohort was supported by an unrestricted grant from Pfizer pharmaceuticals. Pfizer had no role in the design, conduct, interpretation, or publication of this study.	Arends S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3823; Arends S, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3369; Baraliakos X, 2007, RHEUMATOLOGY, V46, P1450, DOI 10.1093/rheumatology/kem166; Baraliakos X, 2007, ANN RHEUM DIS, V66, P910, DOI 10.1136/ard.2006.066415; Baraliakos X, 2005, ANN RHEUM DIS, V64, P1462, DOI 10.1136/ard.2004.033472; Baraliakos X, 2014, ANN RHEUM DIS, V73, P710, DOI 10.1136/annrheumdis-2012-202698; Baraliakos X, 2009, J RHEUMATOL, V36, P997, DOI 10.3899/jrheum.080871; Braun J, 2006, ANN RHEUM DIS, V65, P316, DOI 10.1136/ard.2005.040758; Braun J, 2007, LANCET, V369, P1379, DOI 10.1016/S0140-6736(07)60635-7; Braun J, 2014, ANN RHEUM DIS, V73, P1107, DOI 10.1136/annrheumdis-2012-203075; Dougados M, 2011, ANN RHEUM DIS, V70, P249, DOI 10.1136/ard.2010.133488; GARRETT S, 1994, J RHEUMATOL, V21, P2286; Haroon N, 2013, ARTHRITIS RHEUM-US, V65, P2645, DOI 10.1002/art.38070; Kroon F, 2012, ANN RHEUM DIS, V71, P1623, DOI 10.1136/annrheumdis-2012-201370; Lukas C, 2009, ANN RHEUM DIS, V68, P18, DOI 10.1136/ard.2008.094870; Machado P, 2011, ANN RHEUM DIS, V70, P47, DOI 10.1136/ard.2010.138594; Poddubnyy D, 2012, ANN RHEUM DIS, V71, P1616, DOI 10.1136/annrheumdis-2011-201252; Poddubnyy D, 2012, ARTHRITIS RHEUM-US, V64, P1388, DOI 10.1002/art.33465; Ramiro S, 2015, ANN RHEUM DIS, V74, P52, DOI 10.1136/annrheumdis-2013-204055; Ramiro S, 2014, ANN RHEUM DIS, V73, P1455, DOI 10.1136/annrheumdis-2014-205178; Rudwaleit M, 2009, ARTHRITIS RHEUM-US, V60, P717, DOI 10.1002/art.24483; Spoorenberg A, 2004, J RHEUMATOL, V31, P125; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P1324, DOI 10.1002/art.23471; van der Heijde D, 2009, ANN RHEUM DIS, V68, P1811, DOI 10.1136/ard.2008.100826; van der Heijde D, 2008, ARTHRITIS RHEUM-US, V58, P3063, DOI 10.1002/art.23901; van der Heijde D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2794; van Tubergen A, 2012, ANN RHEUM DIS, V71, P518, DOI 10.1136/annrheumdis-2011-200411; van Tuyl LHD, 2014, ANN RHEUM DIS, V73, P391, DOI 10.1136/annrheumdis-2012-202876; VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361; Wanders AJB, 2004, ARTHRITIS RHEUM-US, V50, P2622, DOI 10.1002/art.20446	30	44	44	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122693	10.1371/journal.pone.0122693	http://dx.doi.org/10.1371/journal.pone.0122693			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879956	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500025
J	Puccetti, P; Fallarino, F; Italiano, A; Soubeyran, I; MacGrogan, G; Debled, M; Velasco, V; Bodet, D; Eimer, S; Veldhoen, M; Prendergast, GC; Platten, M; Bessede, A; Guillemin, GJ				Puccetti, Paolo; Fallarino, Francesca; Italiano, Antoine; Soubeyran, Isabelle; MacGrogan, Gaetan; Debled, Marc; Velasco, Valerie; Bodet, Dominique; Eimer, Sandrine; Veldhoen, Marc; Prendergast, Georges C.; Platten, Michael; Bessede, Alban; Guillemin, Gilles J.			Accumulation of an Endogenous Tryptophan-Derived Metabolite in Colorectal and Breast Cancers	PLOS ONE			English	Article							INDOLEAMINE 2,3-DIOXYGENASE EXPRESSION; TUMORAL IMMUNE RESISTANCE; 3-HYDROXYANTHRANILIC ACID; KYNURENINE PATHWAY; T-CELLS; IMMUNOTHERAPY; DEGRADATION; MECHANISM; PREDICTS; TARGET	Tumor immune escape mechanisms are being regarded as suitable targets for tumor therapy. Among these, tryptophan catabolism plays a central role in creating an immunosuppressive environment, leading to tolerance to potentially immunogenic tumor antigens. Tryptophan catabolism is initiated by either indoleamine 2,3-dioxygenase (IDO-1/-2) or tryptophan 2,3-dioxygenase 2 (TDO2), resulting in biostatic tryptophan starvation and L-kynurenine production, which participates in shaping the dynamic relationship of the host's immune system with tumor cells. Current immunotherapy strategies include blockade of IDO-1/-2 or TDO2, to restore efficient antitumor responses. Patients who might benefit from this approach are currently identified based on expression analyses of IDO-1/-2 or TDO2 in tumor tissue and/or enzymatic activity assessed by kynurenine/tryptophan ratios in the serum. We developed a monoclonal antibody targeting L-kynurenine as an in situ biomarker of IDO-1/-2 or TDO2 activity. Using Tissue Micro Array technology and immunostaining, colorectal and breast cancer patients were phenotyped based on L-kynurenine production. In colorectal cancer L-kynurenine was not unequivocally associated with IDO-1 expression, suggesting that the mere expression of tryptophan catabolic enzymes is not sufficiently informative for optimal immunotherapy.	[Puccetti, Paolo; Fallarino, Francesca] Univ Perugia, Dept Expt Med, I-06100 Perugia, Italy; [Italiano, Antoine; Soubeyran, Isabelle; MacGrogan, Gaetan; Debled, Marc; Velasco, Valerie] Inst Bergonie, Dept Med Oncol, Bordeaux, France; [Bodet, Dominique; Bessede, Alban] ImmuSmol, Pessac, France; [Eimer, Sandrine] Univ Bordeaux Segalen, Histol & Mol Pathol Tumors Lab EA 2406, Bordeaux, France; [Veldhoen, Marc] Babraham Inst, Lab Lymphocyte Signalling & Dev, Cambridge, England; [Prendergast, Georges C.] Lankenau Inst Med Res, Wynnewood, PA USA; [Platten, Michael] German Canc Res Ctr, CCU Neuroimmunol & Brain Tumor Immunol, Heidelberg, Germany; [Platten, Michael] Univ Hosp, Dept Neurooncol, Heidelberg, Germany; [Guillemin, Gilles J.] Macquarie Univ, Fac Med, Neuroinflammat Grp, Sydney, NSW 2109, Australia; [Guillemin, Gilles J.] St Vincents Ctr Appl Med Res, Peter Duncan Neurosci Res Unit, Appl Neurosci Program, Darlinghurst, NSW, Australia	University of Perugia; UNICANCER; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Lankenau Medical Center; Lankenau Institute for Medical Research; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Macquarie University	Bessede, A (corresponding author), ImmuSmol, Pessac, France.	abessede@immusmol.com; gilles.guillemin@mq.edu.au	Veldhoen, Marc/AAM-5357-2021; Platten, Michael/F-2902-2013; Guillemin, Gilles J/C-3878-2015; Veldhoen, Marc/AAJ-2759-2020; Fallarino, Francesca/O-3358-2013	Platten, Michael/0000-0002-4746-887X; Guillemin, Gilles J/0000-0001-8105-4470; Veldhoen, Marc/0000-0002-1478-9562; MacGrogan, Gaetan/0000-0002-3483-9758; Puccetti, Paolo/0000-0001-6674-2128; Fallarino, Francesca/0000-0002-8501-2136	ImmuSmol; Italian Association for Cancer Research (AIRC); BBSRC [BB/E021638/1, BBS/E/B/0000S042, BBS/E/B/000C0409] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E021638/1, BBS/E/B/000C0409, BBS/E/B/0000S042] Funding Source: researchfish	ImmuSmol; Italian Association for Cancer Research (AIRC)(Fondazione AIRC per la ricerca sul cancro); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was fully supported by ImmuSmol (DB, AB) and the Italian Association for Cancer Research (AIRC) (PP). ImmuSmol, through Dr. Alban Bessede, contributed to study design, decision to publish and preparation of the manuscript The Italian Association for Cancer Research (AIRC) (http://www.airc.it/) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112945; Adams S, 2012, CANCER RES, V72, P5649, DOI 10.1158/0008-5472.CAN-12-0549; Arpinati M, 2014, IMMUNOTHERAPY-UK, V6, P95, DOI 10.2217/imt.13.152; Austin CJ, 2014, DRUG DISCOVERY TODAY; Bessede A, 2014, NATURE; Blaschitz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021774; Brandacher G, 2006, CLIN CANCER RES, V12, P1144, DOI 10.1158/1078-0432.CCR-05-1966; Chevolet I, 2014, BRIT J DERMATOL, V171, P987, DOI 10.1111/bjd.13100; Choe JY, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-335; Fallarino I, 2002, CELL DEATH DIFFER, V9, P1069, DOI 10.1038/sj.cdd.4401073; Gao YF, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-71; Godin-Ethier J, 2011, CLIN CANCER RES, V17, P6985, DOI 10.1158/1078-0432.CCR-11-1331; Hiramatsu R, 2008, J CELL BIOCHEM, V103, P42, DOI 10.1002/jcb.21384; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Metz R, 2007, CANCER RES, V67, P7082, DOI 10.1158/0008-5472.CAN-07-1872; Mezrich JD, 2010, J IMMUNOL; Munn DH, 2007, J CLIN INVEST, V117, P1147, DOI 10.1172/JCI31178; Munn DH, 2013, TRENDS IMMUNOL, V34, P137, DOI 10.1016/j.it.2012.10.001; Munn DH, 2002, SCIENCE, V297, P1867, DOI 10.1126/science.1073514; Opitz CA, 2011, NATURE; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Pardoll DM, 2012, NAT IMMUNOL, V13, P1129, DOI 10.1038/ni.2392; Pilotte L, 2012, P NATL ACAD SCI USA, V109, P2497, DOI 10.1073/pnas.1113873109; Rodriguez-Blanco G, 2014, CLIN BIOCH; Sakurai Kenichi, 2013, Gan To Kagaku Ryoho, V40, P1590; Schrocksnadel K, 2006, CLIN CHIM ACTA, V364, P82, DOI 10.1016/j.cca.2005.06.013; Schroecksnadel K, 2007, J CANCER RES CLIN, V133, P477, DOI 10.1007/s00432-007-0191-3; Sperner-Unterweger B, 2011, IMMUNOBIOLOGY, V216, P296, DOI 10.1016/j.imbio.2010.07.010; Stone TW, 2013, BRIT J PHARMACOL, V169, P1211, DOI 10.1111/bph.12230; Suzuki Y, 2010, LUNG CANCER, V67, P361, DOI 10.1016/j.lungcan.2009.05.001; Theate I, 2014, CANC IMMUNOLOGY RES; Uyttenhove C, 2003, NAT MED, V9, P1269, DOI 10.1038/nm934; Vanderstraeten A, 2014, CANCER IMMUNOL IMMUN, V63, P545, DOI 10.1007/s00262-014-1537-8; Weber WP, 2006, EUR J IMMUNOL, V36, P296, DOI 10.1002/eji.200535616; Weinlich G, 2007, DERMATOLOGY, V214, P8, DOI 10.1159/000096906; Yoshikawa T, 2010, EUR J HAEMATOL, V84, P304, DOI 10.1111/j.1600-0609.2009.01393.x	36	51	52	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122046	10.1371/journal.pone.0122046	http://dx.doi.org/10.1371/journal.pone.0122046			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881064	Green Published, gold			2022-12-27	WOS:000353016500015
J	Jeong, BH; Ko, MG; Nam, J; Yoo, H; Chung, CR; Suh, GY; Jeon, K				Jeong, Byeong Ho; Ko, Myeong Gyun; Nam, Jimyoung; Yoo, Hongseok; Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman			Differences in Clinical Outcomes According to Weaning Classifications in Medical Intensive Care Units	PLOS ONE			English	Article							MECHANICAL VENTILATION; FAILURE	Background Although the weaning classification based on the difficulty and duration of the weaning process has been evaluated in the different type of intensive care units (ICUs), little is known about clinical outcomes and validity among the three groups in medical ICU. The objectives of this study were to evaluate the clinical relevance of weaning classification and its association with hospital mortality in a medical ICU with a protocol-based weaning program. Methods All consecutive patients admitted to the medical ICU and requiring mechanical ventilation (MV) for more than 24 hours were prospectively registered and screened for weaning readiness by a standardized weaning program between July 2010 and June 2013. Baseline characteristics and outcomes were compared across weaning classifications. Results During the study period, a total of 680 patients were weaned according to the standardized weaning protocol. Of these, 457 (67%) were classified as simple weaning, 136 (20%) as difficult weaning, and 87 (13%) as prolonged weaning. Ventilator-free days within 28 days decreased significantly from simple to difficult to prolonged weaning groups (P < 0.001, test for trends). In addition, reintubation within 48 hours after extubation (P < 0.001) and need for tracheostomy during the weaning process (P < 0.001) increased significantly across weaning groups. Finally, ICU (P < 0.001), post-ICU (P = 0.001), and hospital (P < 0.001) mortalities significantly increased across weaning groups. In a multiple logistic regression model, prolonged weaning but not difficult weaning was still independently associated with ICU (adjusted OR 8.265, 95% CI 3.484-19.605, P < 0.001), and post-ICU (adjusted OR 3.180, 95% CI 1.349-7.497, P = 0.005), and hospital (adjusted OR 5.528, 95% CI 2.801-10.910, P < 0.001) mortalities. Conclusions Weaning classification based on the difficulty and duration of the weaning process may provide prognostic information for mechanically ventilated patients who undergo the weaning process.	[Jeong, Byeong Ho; Yoo, Hongseok; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea; [Ko, Myeong Gyun; Nam, Jimyoung] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Intens Care Unit,Nursing Dept, Seoul, South Korea; [Chung, Chi Ryang; Suh, Gee Young; Jeon, Kyeongman] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Crit Care Med, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Jeon, K (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med,Div Pulm & Crit Care Med, Seoul, South Korea.	kjeon@skku.edu	Yoo, Hongseok/AAZ-8139-2020; Suh, Gee Young/O-3676-2019; Jeon, Kyeongman/F-5963-2019	Suh, Gee Young/0000-0001-5473-1712; Jeon, Kyeongman/0000-0002-4822-1772; Yoo, Hongseok/0000-0002-2227-6441; Jeong, Byeong-Ho/0000-0002-3124-1718	Samsung Medical Center grant [CRO1121611]	Samsung Medical Center grant(Samsung)	This work was supported by Samsung Medical Center grant (CRO1121611). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bewick V, 2004, CRIT CARE, V8, P46, DOI 10.1186/cc2428; Bewick Viv, 2004, Crit Care, V8, P196, DOI 10.1186/cc2857; Blackwood B, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7237; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Cheng KC, 2006, CRIT CARE MED, V34, P1345, DOI 10.1097/01.CCM.0000214678.92134.BD; Cox CE, 2004, CRIT CARE MED, V32, P2219, DOI 10.1097/01.CCM.0000145232.46143.40; Epstein SK, 2009, CURR OPIN CRIT CARE, V15, P36, DOI 10.1097/MCC.0b013e3283220e07; Esteban A, 2002, JAMA-J AM MED ASSOC, V287, P345, DOI 10.1001/jama.287.3.345; Esteban A, 2008, AM J RESP CRIT CARE, V177, P170, DOI 10.1164/rccm.200706-893OC; Frutos-Vivar F, 2006, CHEST, V130, P1664, DOI 10.1378/chest.130.6.1664; Funk GC, 2010, EUR RESPIR J, V35, P88, DOI 10.1183/09031936.00056909; Kriner Eric J, 2005, Respir Care, V50, P1632; McConville JF, 2012, NEW ENGL J MED, V367, P2233, DOI 10.1056/NEJMra1203367; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Patel KN, 2009, RESP CARE, V54, P1462; Penuelas O, 2011, AM J RESP CRIT CARE, V184, P430, DOI 10.1164/rccm.201011-1887OC; Sellares J, 2011, INTENS CARE MED, V37, P775, DOI 10.1007/s00134-011-2179-3; Tonnelier A, 2011, RESP CARE, V56, P583, DOI 10.4187/respcare.00842; Vallverdu I, 1998, AM J RESP CRIT CARE, V158, P1855, DOI 10.1164/ajrccm.158.6.9712135; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751	20	35	39	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0122810	10.1371/journal.pone.0122810	http://dx.doi.org/10.1371/journal.pone.0122810			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EL	25876004	gold, Green Published, Green Submitted			2022-12-27	WOS:000353015800077
J	Cohen, AA; Li, Q; Milot, E; Leroux, M; Faucher, S; Morissette-Thomas, V; Legault, V; Fried, LP; Ferrucci, L				Cohen, Alan A.; Li, Qing; Milot, Emmanuel; Leroux, Maxime; Faucher, Samuel; Morissette-Thomas, Vincent; Legault, Veronique; Fried, Linda P.; Ferrucci, Luigi			Statistical Distance as a Measure of Physiological Dysregulation Is Largely Robust to Variation in Its Biomarker Composition	PLOS ONE			English	Article							ALLOSTATIC LOAD; OLDER-ADULTS; DEFICIT ACCUMULATION; STOCHASTIC-MODEL; ELDERLY-PEOPLE; MORTALITY; FRAILTY; HEALTH; POPULATION; AGE	Physiological dysregulation may underlie aging and many chronic diseases, but is challenging to quantify because of the complexity of the underlying systems. Recently, we described a measure of physiological dysregulation, D-M, that uses statistical distance to assess the degree to which an individual's biomarker profile is normal versus aberrant. However, the sensitivity of D-M to details of the calculation method has not yet been systematically assessed. In particular, the number and choice of biomarkers and the definition of the reference population (RP, the population used to define a "normal" profile) may be important. Here, we address this question by validating the method on 44 common clinical biomarkers from three longitudinal cohort studies and one cross-sectional survey. D(M)s calculated on different biomarker subsets show that while the signal of physiological dysregulation increases with the number of biomarkers included, the value of additional markers diminishes as more are added and inclusion of 10-15 is generally sufficient. As long as enough markers are included, individual markers have little effect on the final metric, and even DMs calculated from mutually exclusive groups of markers correlate with each other at r similar to 0.4-0.5. We also used data subsets to generate thousands of combinations of study populations and RPs to address sensitivity to differences in age range, sex, race, data set, sample size, and their interactions. Results were largely consistent (but not identical) regardless of the choice of RP; however, the signal was generally clearer with a younger and healthier RP, and RPs too different from the study population performed poorly. Accordingly, biomarker and RP choice are not particularly important in most cases, but caution should be used across very different populations or for fine-scale analyses. Biologically, the lack of sensitivity to marker choice and better performance of younger, healthier RPs confirm an interpretation of D-M physiological dysregulation and as an emergent property of a complex system.	[Cohen, Alan A.; Li, Qing; Faucher, Samuel; Morissette-Thomas, Vincent; Legault, Veronique] Univ Sherbrooke, Dept Family Med, Grp Rech PRIMUS, Sherbrooke, PQ J1H 5N4, Canada; [Milot, Emmanuel] Univ Quebec Trois Rivieres, Dept Chem Biochem & Phys, Trois Rivieres, PQ G9A 5H7, Canada; [Leroux, Maxime] Univ Quebec, ESG, Dept Econ, Montreal, PQ H2X 3X2, Canada; [Fried, Linda P.] Columbia Univ, Mailman Sch Publ Hlth, New York, NY 10032 USA; [Ferrucci, Luigi] MedStar Harbor Hosp, Translat Gerontol Branch, Longitudinal Studies Sect, NIA,NIH, Baltimore, MD USA	University of Sherbrooke; University of Quebec; University of Quebec Trois Rivieres; University of Quebec; University of Quebec Montreal; Columbia University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Cohen, AA (corresponding author), Univ Sherbrooke, Dept Family Med, Grp Rech PRIMUS, 3001 12e Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Alan.Cohen@USherbrooke.ca		Li, Qing/0000-0002-4191-9596; Cohen, Alan/0000-0003-4113-3988	FRQ-S; CIHR [110789, 120305, 119485]; NSERC Discovery Grant [402079-2011]; Intramural Research Program of the National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000995] Funding Source: NIH RePORTER	FRQ-S; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); Intramural Research Program of the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	AAC is a member of the FRQ-S-supported Centre de recherche sur le vieillissement and Centre de recherche du CHUS, and is a funded Research Scholar of the FRQ-S. This research was supported by CIHR grant #s 110789, 120305, 119485 and by NSERC Discovery Grant # 402079-2011, as well as by the Intramural Research Program of the National Institute on Aging. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbeev KG, 2011, MECH AGEING DEV, V132, P93, DOI 10.1016/j.mad.2011.01.001; BOUND J, 1991, J HUM RESOUR, V26, P106, DOI 10.2307/145718; Centers for Disease Control and Prevention, NAT HLTH NUTR EX SUR; Cohen AA, 2014, EXP GERONTOL, V57, P203, DOI 10.1016/j.exger.2014.04.016; Cohen AA, 2013, MECH AGEING DEV, V134, P110, DOI 10.1016/j.mad.2013.01.004; Cohen AA, 2012, TRENDS ECOL EVOL, V27, P428, DOI 10.1016/j.tree.2012.04.008; Crimmins EM, 2003, EXP GERONTOL, V38, P731, DOI 10.1016/S0531-5565(03)00099-8; Ferrucci L, 2000, J AM GERIATR SOC, V48, P1618, DOI 10.1111/j.1532-5415.2000.tb03873.x; Ferrucci L., 2009, G GERONTOL, V57, P3; Ferrucci Luigi, 2005, Genus, V61, P39; Fried Linda P, 2005, Sci Aging Knowledge Environ, V2005, ppe24, DOI 10.1126/sageke.2005.31.pe24; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fried LP, 2000, J GERONTOL A-BIOL, V55, pM43; Glei DA, 2007, PSYCHOSOM MED, V69, P769, DOI 10.1097/PSY.0b013e318157cba6; Gruenewald TL, 2009, J AM GERIATR SOC, V57, P1525, DOI 10.1111/j.1532-5415.2009.02389.x; Guralnik Fried LP., 1995, WOMENS HLTH AGING ST; Hill GE, 2011, ECOL LETT, V14, P625, DOI 10.1111/j.1461-0248.2011.01622.x; Howlett SE, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0171-9; Karlamangla AS, 2002, J CLIN EPIDEMIOL, V55, P696, DOI 10.1016/S0895-4356(02)00399-2; Kirkwood TBL, 2005, CELL, V120, P437, DOI 10.1016/j.cell.2005.01.027; Levine ME, 2013, J GERONTOL A-BIOL, V68, P667, DOI 10.1093/gerona/gls233; Li Q, 2014, STAT NEERL, V68, P118, DOI 10.1111/stan.12025; Mahalanobis PC, 1936, P NATL I SCI INDIA, V49, P234, DOI DOI 10.1016/S0169-7439(99)00047-7; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; MEDVEDEV ZA, 1990, BIOL REV, V65, P375, DOI 10.1111/j.1469-185X.1990.tb01428.x; Meijer E, 2011, HEALTH ECON, V20, P600, DOI 10.1002/hec.1620; Milot E, 2014, MECH AGEING DEV, V141, P56, DOI 10.1016/j.mad.2014.10.001; Milot E, 2014, METHODS ECOL EVOL, V5, P146, DOI 10.1111/2041-210X.12145; Mitnitski A, 2006, MECH AGEING DEV, V127, P490, DOI 10.1016/j.mad.2006.01.007; Rockwood K, 2005, CAN MED ASSOC J, V173, P489, DOI 10.1503/cmaj.050051; Rockwood K, 2006, J AM GERIATR SOC, V54, P975, DOI 10.1111/j.1532-5415.2006.00738.x; Saltelli A., 2008, GLOBAL SENSITIVITY A; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Seeman TE, 2001, P NATL ACAD SCI USA, V98, P4770, DOI 10.1073/pnas.081072698; Seplaki CL, 2006, DEMOGRAPHY, V43, P165, DOI 10.1353/dem.2006.0009; Seplaki CL, 2005, EXP GERONTOL, V40, P438, DOI 10.1016/j.exger.2005.03.002; Singer B., 2004, ALLOSTASIS HOMEOSTAS, P113, DOI [10.1017/CBO9781316257081.007, DOI 10.1017/CBO9781316257081.007]; Szanton SL, 2009, BIOL RES NURS, V10, P248, DOI 10.1177/1099800408323452; Vaillant N, 2012, J EPIDEMIOL GLOB HEA, V2, P83, DOI 10.1016/j.jegh.2012.04.003; Yashin AI, 2007, MATH BIOSCI, V208, P538, DOI 10.1016/j.mbs.2006.11.006	40	34	34	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122541	10.1371/journal.pone.0122541	http://dx.doi.org/10.1371/journal.pone.0122541			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875923	Green Submitted, Green Published, gold			2022-12-27	WOS:000352845100081
J	Jansen, H; Wijga, AH; Scholtens, S; Koppelman, GH; Postma, DS; Brunekreef, B; de Jongste, JC; Smit, HA; Stolk, RP				Jansen, Hanneke; Wijga, Alet H.; Scholtens, Salome; Koppelman, Gerard H.; Postma, Dirkje S.; Brunekreef, Bert; de Jongste, Johan C.; Smit, Henriette A.; Stolk, Ronald P.			Change in HbA1c Levels between the Age of 8 Years and the Age of 12 Years in Dutch Children without Diabetes: The PIAMA Birth Cohort Study	PLOS ONE			English	Article							NUTRITION EXAMINATION SURVEY; 3RD NATIONAL-HEALTH; GLYCATED HEMOGLOBIN; INSULIN-RESISTANCE; HBA(1C) LEVELS; BODY-FAT; GLUCOSE; ADULTS; ASSOCIATION; CANCER	Objective HbA1c is associated with cardiovascular risk in persons without diabetes and cardiovascular risk accumulates over the life course. Therefore, insight in factors determining HbA1c from childhood onwards is important. We investigated (lifestyle) determinants of HbA1c at age 12 years and the effects of growth on change in HbA1c and the tracking of HbA1c between the age of 8 and 12 years. Study Design and Methods Anthropometric measurements were taken and HbA1c levels were assessed in 955 children without diabetes aged around 12 years participating in the PIAMA birth cohort study. In 363 of these children HbA1c was also measured at age 8 years. Data on parents and children were collected prospectively by questionnaires. Results We found no significant association between known risk factors for diabetes and HbA1c at age 12 years. Mean(SD) change in HbA1c between ages 8 and 12 years was 0.6(0.7) mmol/mol per year (or 0.1(0.1) %/yr). Anthropometric measures at age 8 and their change between age 8 and 12 years were not associated with the change in HbA1c. 68.9% of the children remained in the same quintile or had an HbA1c one quintile higher or lower at age 8 years compared to age 12 years. Conclusion The lack of association between known risk factors for diabetes and HbA1c suggest that HbA1c in children without diabetes is relatively unaffected by factors associated with glycaemia. HbA1c at age 8 years is by far the most important predictor of HbA1c at age 12. Therefore, the ranking of HbA1c levels appear to be fairly stable over time.	[Jansen, Hanneke; Scholtens, Salome; Stolk, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Koppelman, Gerard H.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat Pulmonol & Pediat Allergol, Groningen, Netherlands; [Postma, Dirkje S.] Univ Groningen, Univ Med Ctr Groningen, Dept Pulmonol, GRIAC Res Inst, Groningen, Netherlands; [Wijga, Alet H.] Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands; [Brunekreef, Bert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Brunekreef, Bert; Smit, Henriette A.] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [de Jongste, Johan C.] Erasmus MC, Sophia Childrens Hosp, Dept Paediat, Rotterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; Netherlands National Institute for Public Health & the Environment; Utrecht University; Utrecht University; Utrecht University Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital	Wijga, AH (corresponding author), Natl Inst Publ Hlth & Environm RIVM, Ctr Nutr Prevent & Hlth Serv, Bilthoven, Netherlands.	alet.wijga@rivm.nl	Koppelman, Gerard/AAG-9187-2020	Stolk, Ronald/0000-0002-0518-1205; Koppelman, Gerard/0000-0001-8567-3252; Scholtens, Salome/0000-0002-0651-5203	Netherlands Organization for Health Research and Development; Netherlands Organization for Scientific Research; Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Asthma Fund; Netherlands Ministry of Spatial Planning Housing and the Environment; Netherlands Ministry of Health, Welfare and Sport	Research relating to this manuscript was funded by The Netherlands Organization for Health Research and Development, The Netherlands Organization for Scientific Research, The Netherlands Asthma Fund, The Netherlands Ministry of Spatial Planning Housing and the Environment, and The Netherlands Ministry of Health, Welfare and Sport. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeing H, 2000, AM J CLIN NUTR, V71, P1115; Brunekreef B, 2002, PEDIAT ALLERG IMM-UK, V13, P55, DOI 10.1034/j.1399-3038.13.s.15.1.x; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; DUNN PJ, 1979, ANN INTERN MED, V91, P390, DOI 10.7326/0003-4819-91-3-390; Eldeirawi K, 2003, AM J EPIDEMIOL, V157, P624, DOI 10.1093/aje/kwg023; Fredriks AM, 2005, EUR J PEDIATR, V164, P216, DOI 10.1007/s00431-004-1586-7; Fredriks AM, 2000, ARCH DIS CHILD, V82, P107, DOI 10.1136/adc.82.2.107; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Jansen H, 2009, DIABETIC MED, V26, P122, DOI 10.1111/j.1464-5491.2008.02641.x; Khaw KT, 2004, ANN INTERN MED, V141, P413, DOI 10.7326/0003-4819-141-6-200409210-00006; Meigs JB, 1996, J CLIN EPIDEMIOL, V49, P411, DOI 10.1016/0895-4356(95)00513-7; MODAN M, 1988, DIABETES CARE, V11, P422, DOI 10.2337/diacare.11.5.422; Pettitt DJ, 2004, DIABETES RES CLIN PR, V65, P45, DOI 10.1016/j.diabres.2003.11.010; Roemmich JN, 2002, INT J OBESITY, V26, P701, DOI 10.1038/sj.ijo.0801975; Saaddine JB, 2002, DIABETES CARE, V25, P1326, DOI 10.2337/diacare.25.8.1326; Sardinha LB, 2008, DIABETES CARE, V31, P569, DOI 10.2337/dc07-1286; Selvin E, 2010, NEW ENGL J MED, V362, P800, DOI 10.1056/NEJMoa0908359; Shultis WA, 2006, DIABETIC MED, V23, P1357, DOI 10.1111/j.1464-5491.2006.01990.x; World Health Organization, 2011, US GLYC HAEM HBA1C D	19	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0119615	10.1371/journal.pone.0119615	http://dx.doi.org/10.1371/journal.pone.0119615			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875773	gold, Green Published			2022-12-27	WOS:000352845100017
J	Ravi, S; Chacko, B; Sawada, H; Kramer, PA; Johnson, MS; Benavides, GA; O'Donnell, V; Marques, MB; Darley-Usmar, VM				Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; O'Donnell, Valerie; Marques, Marisa B.; Darley-Usmar, Victor M.			Metabolic Plasticity in Resting and Thrombin Activated Platelets	PLOS ONE			English	Article							PERMEABILITY TRANSITION PORE; FATTY-ACID-METABOLISM; ENERGY-METABOLISM; ADENOSINE-TRIPHOSPHATE; MICROPLATE READER; GLUCOSE-OXIDATION; MITOCHONDRIAL; AGGREGATION; BLOOD; MECHANISMS	Platelet thrombus formation includes several integrated processes involving aggregation, secretion of granules, release of arachidonic acid and clot retraction, but it is not clear which metabolic fuels are required to support these events. We hypothesized that there is flexibility in the fuels that can be utilized to serve the energetic and metabolic needs for resting and thrombin-dependent platelet aggregation. Using platelets from healthy human donors, we found that there was a rapid thrombin-dependent increase in oxidative phosphorylation which required both glutamine and fatty acids but not glucose. Inhibition of fatty acid oxidation or glutamine utilization could be compensated for by increased glycolytic flux. No evidence for significant mitochondrial dysfunction was found, and ATP/ADP ratios were maintained following the addition of thrombin, indicating the presence of functional and active mitochondrial oxidative phosphorylation during the early stages of aggregation. Interestingly, inhibition of fatty acid oxidation and glutaminolysis alone or in combination is not sufficient to prevent platelet aggregation, due to compensation from glycolysis, whereas inhibitors of glycolysis inhibited aggregation approximately 50%. The combined effects of inhibitors of glycolysis and oxidative phosphorylation were synergistic in the inhibition of platelet aggregation. In summary, both glycolysis and oxidative phosphorylation contribute to platelet metabolism in the resting and activated state, with fatty acid oxidation and to a smaller extent glutaminolysis contributing to the increased energy demand.	[Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; Marques, Marisa B.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, UAB Mitochondrial Med Lab, Birmingham, AL 35294 USA; [Ravi, Saranya; Chacko, Balu; Sawada, Hirotaka; Kramer, Philip A.; Johnson, Michelle S.; Benavides, Gloria A.; Darley-Usmar, Victor M.] Univ Alabama Birmingham, Ctr Free Radical Biol, Birmingham, AL 35294 USA; [O'Donnell, Valerie] Cardiff Univ, Dept Med Biochem, Cardiff CF10 3AX, S Glam, Wales	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Cardiff University	Darley-Usmar, VM (corresponding author), Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA.	darley@uab.edu	Kramer, Philip/GYJ-8215-2022	Darley-Usmar, Victor/0000-0001-8921-7086; Marques, Marisa/0000-0002-6689-7856; Kramer, Philip/0000-0001-6554-631X; Sawada, Hirotaka/0000-0001-9785-750X; /0000-0003-4089-8460	American Heart Association [13PRE16390001]; NIDDK Diabetic Complications Consortium (DiaComp) [DK076169]; O'Brien Center [P30 DK079337]; British Heart Foundation [RG/12/11/29815] Funding Source: researchfish	American Heart Association(American Heart Association); NIDDK Diabetic Complications Consortium (DiaComp); O'Brien Center; British Heart Foundation(British Heart Foundation)	This work was supported by American Heart Association 13PRE16390001 (SR), NIDDK Diabetic Complications Consortium (DiaComp, www.diacomp.org) grant DK076169 (subaward VDU), and the O'Brien Center P30 DK079337 (VDU). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKKERMAN JWN, 1981, BLOOD, V57, P956; ASTARIEDEQUEKER C, 1994, J CARDIOVASC PHARM, V23, P401, DOI 10.1097/00005344-199423030-00007; ATKINSON DE, 1969, ANNU REV MICROBIOL, V23, P47, DOI 10.1146/annurev.mi.23.100169.000403; Barile CJ, 2012, P NATL ACAD SCI USA, V109, P2539, DOI 10.1073/pnas.1120645109; Bassit RA, 2002, NUTRITION, V18, P376, DOI 10.1016/S0899-9007(02)00753-0; BEDNAR B, 1995, THROMB RES, V77, P453, DOI 10.1016/0049-3848(95)93881-Y; BORST P, 1962, BIOCHIM BIOPHYS ACTA, V62, P509, DOI 10.1016/0006-3002(62)90232-9; Chacko BK, 2013, LAB INVEST, V93, P690, DOI 10.1038/labinvest.2013.53; CHAUDHRY AA, 1973, BLOOD, V41, P249, DOI 10.1182/blood.V41.2.249.249; COHEN P, 1970, J CLIN INVEST, V49, P128, DOI 10.1172/JCI106211; Coolen EJCM, 2008, J CHROMATOGR B, V864, P43, DOI 10.1016/j.jchromb.2008.01.033; DERKSEN A, 1975, J BIOL CHEM, V250, P9342; DOERY JCG, 1970, BLOOD-J HEMATOL, V36, P159, DOI 10.1182/blood.V36.2.159.159; DONABEDIAN R, 1971, AM J PHYSIOL, V221, P1283, DOI 10.1152/ajplegacy.1971.221.5.1283; FUKAMI MH, 1976, BIOCHIM BIOPHYS ACTA, V444, P633, DOI 10.1016/0304-4165(76)90310-X; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Galbusera M, 2009, SEMIN DIALYSIS, V22, P279, DOI 10.1111/j.1525-139X.2008.00556.x; Halestrap AP, 2004, CARDIOVASC RES, V61, P372, DOI 10.1016/S0008-6363(03)00533-9; Halestrap AP, 2006, BIOCHEM SOC T, V34, P232, DOI 10.1042/BST0340232; HOLMSEN H, 1974, BIOCHEM J, V144, P385, DOI 10.1042/bj1440385; HOLMSEN H, 1982, BIOCHEM J, V208, P9, DOI 10.1042/bj2080009; Jobe SM, 2008, BLOOD, V111, P1257, DOI 10.1182/blood-2007-05-092684; Kantor PF, 2000, CIRC RES, V86, P580, DOI 10.1161/01.RES.86.5.580; KATTLOVE HE, 1974, AM J PHYSIOL, V226, P325, DOI 10.1152/ajplegacy.1974.226.2.325; Kim SJ, 2013, CONTRIB NEPHROL, V179, P119, DOI 10.1159/000346730; Kramer PA, 2014, JOVE-J VIS EXP, DOI 10.3791/51301; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Levi M, 2013, SEMIN THROMB HEMOST, V39, P559, DOI 10.1055/s-0033-1343894; Leytin V, 2006, J THROMB HAEMOST, V4, P2656, DOI 10.1111/j.1538-7836.2006.02200.x; Leytin V, 2009, LAB INVEST, V89, P374, DOI 10.1038/labinvest.2009.13; Liu F, 2013, J BIOL CHEM, V288, P30672, DOI 10.1074/jbc.M113.472688; MAJERUS PW, 1969, J CLIN INVEST, V48, P156, DOI 10.1172/JCI105964; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; MISSELWITZ F, 1987, THROMB RES, V46, P233, DOI 10.1016/0049-3848(87)90285-4; Misztal T, 2013, THROMB RES, V131, pE17, DOI 10.1016/j.thromres.2012.11.010; Mookerjee SA, 2015, BBA-BIOENERGETICS, V1847, P171, DOI 10.1016/j.bbabio.2014.10.005; Newsholme P, 2001, J NUTR, V131, p2515S, DOI 10.1093/jn/131.9.2515S; Niu X, 1997, BRIT J HAEMATOL, V97, P908, DOI 10.1046/j.1365-2141.1997.1442963.x; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Pike LS, 2011, BBA-BIOENERGETICS, V1807, P726, DOI 10.1016/j.bbabio.2010.10.022; REAVEN GM, 1988, DIABETES, V37, P28, DOI 10.2337/diabetes.37.1.28; Remenyi G, 2005, ARTERIOSCL THROM VAS, V25, P467, DOI 10.1161/01.ATV.0000152726.49229.bf; ROTTENBERG H, 1986, FEBS LETT, V202, P314, DOI 10.1016/0014-5793(86)80708-6; Rusak T, 2006, ACTA BIOCHIM POL, V53, P769, DOI 10.18388/abp.2006_3305; Salabei JK, 2014, NAT PROTOC, V9, P421, DOI 10.1038/nprot.2014.018; Samartsev V. N., 2013, Biofizika, V58, P481; Siddiqui TI, 2013, CURR MED CHEM, V20, P2779, DOI 10.2174/0929867311320220004; Thangavelu K, 2014, SCI REP-UK, V4, DOI 10.1038/srep03827; Thon Jonathan N, 2012, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-29423-5_1; VASTA V, 1995, BBA-GEN SUBJECTS, V1243, P43, DOI 10.1016/0304-4165(94)00118-H; VASTA V, 1993, J BIOCHEM-TOKYO, V114, P163, DOI 10.1093/oxfordjournals.jbchem.a124148; Walkowiak B, 1997, THROMB RES, V87, P95, DOI 10.1016/S0049-3848(97)00108-4; Wanders RJA, 2001, BIOCHEM SOC T, V29, P250, DOI 10.1042/0300-5127:0290250; Willoughby SR, 1998, EUR J PHARMACOL, V356, P207, DOI 10.1016/S0014-2999(98)00527-5; Yamagishi S, 2001, DIABETES, V50, P1491, DOI 10.2337/diabetes.50.6.1491	55	66	69	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123597	10.1371/journal.pone.0123597	http://dx.doi.org/10.1371/journal.pone.0123597			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875958	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000352845100192
J	Heinzmann, D; Bangert, A; Muller, AM; von Ungern-Sternberg, SNI; Emschermann, F; Schonberger, T; Chatterjee, M; Mack, AF; Klingel, K; Kandolf, R; Malesevic, M; Borst, O; Gawaz, M; Langer, HF; Katus, H; Fischer, G; May, AE; Kaya, Z; Seizer, P				Heinzmann, David; Bangert, Anna; Mueller, Anna-Maria; von Ungern-Sternberg, Saskia N. I.; Emschermann, Frederic; Schoenberger, Tanja; Chatterjee, Madhumita; Mack, Andreas F.; Klingel, Karin; Kandolf, Reinhard; Malesevic, Miroslav; Borst, Oliver; Gawaz, Meinrad; Langer, Harald F.; Katus, Hugo; Fischer, Gunter; May, Andreas E.; Kaya, Ziya; Seizer, Peter			The Novel Extracellular Cyclophilin A (CyPA) - Inhibitor MM284 Reduces Myocardial Inflammation and Remodeling in a Mouse Model of Troponin I - Induced Myocarditis	PLOS ONE			English	Article							OXIDATIVE STRESS; CYCLOSPORINE-A; HEART-FAILURE; EMMPRIN CD147; FIBROSIS; VIRUS; VITRO	Cyclophilins are a group of highly conserved cytosolic enzymes that have a peptidylprolyl cis/trans isomerase activity. Cyclophilin A (CyPA) can be secreted in the extracellular space by inflammatory cells and upon cell death. The presence of CyPA in patients with nonischemic cardiomyopathy is associated with poor clinical prognosis. Here, we investigated the inhibition of extracellular CyPA in a mouse model of troponin I-induced autoimmune myocarditis using the strictly extracellular CyPA-inhibitor MM284. Since A/J mice develop severe inflammation and fibrosis after immunization with murine cardiac troponin I (mcTn I), we used this model to analyze the effects of an extracellular CyPA inhibition. As extracellular CyPA-inhibitor we used the recently described CsA-derivate MM284. In vitro studies confirmed that MM284 inhibits CyPA-induced monocytic migration and adhesion. A/J mice immunized with mcTnI were treated with MM284 or vehicle every second day. After 28 days, we found a considerable reduction of myocardial injury and fibrosis. Further analysis revealed a reduced myocardial presence of T-cells and macrophages compared to control treated animals. Whereas MMP-9 expression was reduced significantly by MM284, we observed no significant reduction of inflammatory cytokines such as IL-6 or TNF alpha. Extracellular CyPA plays an important role in autoimmune myocarditis for myocardial damage and fibrosis. Our data suggest a new pharmacological approach for the treatment of myocardial inflammation and reduction of cardiac fibrosis by inhibition of extracellular CyPA.	[Heinzmann, David; von Ungern-Sternberg, Saskia N. I.; Emschermann, Frederic; Schoenberger, Tanja; Chatterjee, Madhumita; Borst, Oliver; Gawaz, Meinrad; Langer, Harald F.; May, Andreas E.; Seizer, Peter] Univ Tubingen, Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany; [Bangert, Anna; Mueller, Anna-Maria; Katus, Hugo; Kaya, Ziya] Heidelberg Univ, Dept Internal Med 3, Heidelberg, Germany; [Mack, Andreas F.] Univ Tubingen, Inst Anat, Tubingen, Germany; [Klingel, Karin; Kandolf, Reinhard] Univ Tubingen, Inst Pathol & Neuropathol, Dept Mol Pathol, Tubingen, Germany; [Malesevic, Miroslav] Univ Halle Wittenberg, Inst Biochem, Abt Enzymol, Projektgrp gFP5, D-06108 Halle, Saale, Germany; [Fischer, Gunter] Max Planck Inst Biophys Chem, BO Halle, D-37077 Gottingen, Germany	Eberhard Karls University of Tubingen; Ruprecht Karls University Heidelberg; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Martin Luther University Halle Wittenberg; Max Planck Society	Seizer, P (corresponding author), Univ Tubingen, Kardiol & Kreislauferkrankungen, Med Klin 3, Tubingen, Germany.	peter.seizer@med.uni-tuebingen.de	Malesevic, Miroslav/D-8128-2012; Chatterjee, Madhumita/AAJ-1802-2020	Malesevic, Miroslav/0000-0002-1484-3709; Chatterjee, Madhumita/0000-0002-3428-4107; Mack, Andreas/0000-0001-7591-4374; Borst, Oliver/0000-0003-4002-4085; Emschermann, Frederic/0000-0002-9564-2000	Deutsche Forschungsgemeinschaft [Transregio SFB19]; Klinische Forschergruppe [KFO274]; German Cardiac Society (DGK) [KA 1797/6-1]; Volkswagen Foundation (Lichtenberg program)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Klinische Forschergruppe; German Cardiac Society (DGK); Volkswagen Foundation (Lichtenberg program)	This work was supported by grants from the Deutsche Forschungsgemeinschaft (Transregio SFB19, the Klinische Forschergruppe [KFO274] to HFL, MG, AEM, and PS. This work was furthermore supported by a research grant of the German Cardiac Society (DGK) to DH, [KA 1797/6-1] to ZK, and the Tuebingen Platelet Investigative Consortium (TuePIC). This work was furthermore supported by the Volkswagen Foundation (Lichtenberg program)	Balsley MA, 2010, J IMMUNOL, V185, P7663, DOI 10.4049/jimmunol.1001707; Calderon-Sanchez E, 2011, CURR MED CHEM, V18, P5408, DOI 10.2174/092986711798194379; Cooper LT, 2009, NEW ENGL J MED, V360, P1526, DOI 10.1056/NEJMra0800028; Elrod JW, 2010, J CLIN INVEST, V120, P3680, DOI 10.1172/JCI43171; Goser S, 2006, CIRCULATION, V114, P1693, DOI 10.1161/CIRCULATIONAHA.106.635664; Jin ZG, 2000, CIRC RES, V87, P789, DOI 10.1161/01.RES.87.9.789; Kaya Z, 2010, CLIN IMMUNOL, V134, P80, DOI 10.1016/j.clim.2009.04.008; Kindermann I, 2012, J AM COLL CARDIOL, V59, P779, DOI 10.1016/j.jacc.2011.09.074; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Malesevic M, 2013, J MED CHEM, V56, P7302, DOI 10.1021/jm4007577; Malesevic M, 2010, ANGEW CHEM INT EDIT, V49, P213, DOI 10.1002/anie.200904529; Nigro P, 2011, J EXP MED, V208, P53, DOI 10.1084/jem.20101174; Satoh K, 2009, NAT MED, V15, P649, DOI 10.1038/nm.1958; Seizer P, 2015, ARTERIOSCL THROM VAS, V35, P655, DOI 10.1161/ATVBAHA.114.305112; Seizer P, 2014, CARDIOVASC RES, V102, P17, DOI 10.1093/cvr/cvu035; Seizer P, 2013, INT J CARDIOL, V163, P299, DOI 10.1016/j.ijcard.2011.06.049; Seizer P, 2012, J MOL CELL CARDIOL, V53, P6, DOI 10.1016/j.yjmcc.2012.03.004; Seizer P, 2011, ARTERIOSCL THROM VAS, V31, P1377, DOI 10.1161/ATVBAHA.111.225771; SHERRY B, 1992, P NATL ACAD SCI USA, V89, P3511, DOI 10.1073/pnas.89.8.3511; Van Linthout S, 2014, CARDIOVASC RES, V102, P258, DOI 10.1093/cvr/cvu062; Wang H, 2011, J GASTROEN HEPATOL, V26, P558, DOI 10.1111/j.1440-1746.2010.06406.x; Zuern CS, 2013, EUR J HEART FAIL, V15, P176, DOI 10.1093/eurjhf/hfs185	23	34	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124606	10.1371/journal.pone.0124606	http://dx.doi.org/10.1371/journal.pone.0124606			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894208	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700109
J	Ish-Am, O; Kristensen, DM; Ruppin, E				Ish-Am, Oren; Kristensen, David M.; Ruppin, Eytan			Evolutionary Conservation of Bacterial Essential Metabolic Genes across All Bacterial Culture Media	PLOS ONE			English	Article							PROTEIN DISPENSABILITY; NONESSENTIAL GENES; GLOBAL-NETWORK; OPTIMIZATION; PROKARYOTES; DATABASE; GENOMES; MODELS	One of the basic postulates of molecular evolution is that functionally important genes should evolve slower than genes of lesser significance. Essential genes, whose knockout leads to a lethal phenotype are considered of high functional importance, yet whether they are truly more conserved than nonessential genes has been the topic of much debate, fuelled by a host of contradictory findings. Here we conduct the first large-scale study utilizing genome-scale metabolic modeling and spanning many bacterial species, which aims to answer this question. Using the novel Media Variation Analysis, we examine the range of conservation of essential vs. nonessential metabolic genes in a given species across all possible media. We are thus able to obtain for the first time, exact upper and lower bounds on the levels of differential conservation of essential genes for each of the species studied. The results show that bacteria do exhibit an overall tendency for differential conservation of their essential genes vs. their non-essential ones, yet this tendency is highly variable across species. We show that the model bacterium E. coli K12 may or may not exhibit differential conservation of essential genes depending on its growth medium, shedding light on previous experimental studies showing opposite trends.	[Ish-Am, Oren; Ruppin, Eytan] Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel; [Kristensen, David M.] NIH, Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20892 USA; [Ruppin, Eytan] Tel Aviv Univ, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Ruppin, Eytan] Univ Maryland, Dept Comp Sci, College Pk, MD USA; [Ruppin, Eytan] Univ Maryland, Ctr Bioinformat & Computat Biol, College Pk, MD USA	Tel Aviv University; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Tel Aviv University; Sackler Faculty of Medicine; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ruppin, E (corresponding author), Tel Aviv Univ, Blavatnik Sch Comp Sci, IL-69978 Tel Aviv, Israel.	ishamor@gmail.com; eyruppin@gmail.com	Ruppin, Eytan/R-9698-2017	Ruppin, Eytan/0000-0002-7862-3940	MICROME project; INFECT FP7 EU project; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation [41/11]	MICROME project; INFECT FP7 EU project; I-CORE Program of the Planning and Budgeting Committee; Israel Science Foundation(Israel Science Foundation)	This work was supported by grants from the MICROME and the INFECT FP7 EU projects, the I-CORE Program of the Planning and Budgeting Committee and The Israel Science Foundation (grant No 41/11), supporting ER's research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barve A, 2012, P NATL ACAD SCI USA, V109, pE1121, DOI 10.1073/pnas.1113065109; Buescher JM, 2012, SCIENCE, V335, P1099, DOI 10.1126/science.1206871; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Chandrasekaran S, 2010, P NATL ACAD SCI USA, V107, P17845, DOI 10.1073/pnas.1005139107; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; Dotsch A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-234; Gong XD, 2008, MOL GENET GENOMICS, V279, P87, DOI 10.1007/s00438-007-0298-x; Heinemann M, 2010, SCIENCEDIRECT; Henry CS, 2010, NAT BIOTECHNOL, V28, P977, DOI 10.1038/nbt.1672; Hirsh AE, 2003, NATURE, V421, P497, DOI 10.1038/421497a; Hirsh AE, 2001, NATURE, V411, P1046, DOI 10.1038/35082561; Hurst LD, 1999, CURR BIOL, V9, P747, DOI 10.1016/S0960-9822(99)80334-0; Jordan IK, 2002, GENOME RES, V12, P962, DOI 10.1101/gr.87702; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Nogales J, 2012, P NATL ACAD SCI USA, V109, P2678, DOI 10.1073/pnas.1117907109; Novichkov PS, 2009, NUCLEIC ACIDS RES, V37, pD448, DOI 10.1093/nar/gkn684; Novichkov PS, 2009, J BACTERIOL, V191, P65, DOI 10.1128/JB.01237-08; Pal C, 2003, NATURE, V421, P496, DOI 10.1038/421496b; Papp B, 2011, NAT REV GENET, V12, P591, DOI 10.1038/nrg3033; Parter M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-169; Plata G, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.60; Price ND, 2004, NAT REV MICROBIOL, V2, P886, DOI 10.1038/nrmicro1023; Rocha EPC, 2004, MOL BIOL EVOL, V21, P108, DOI 10.1093/molbev/msh004; Snitkin ES, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r140; Trawick JD, 2006, BIOCHEM PHARMACOL, V71, P1026, DOI 10.1016/j.bcp.2005.10.049; VARMA A, 1994, BIO-TECHNOL, V12, P994, DOI 10.1038/nbt1094-994; Wang Z, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000329; WILSON AC, 1977, ANNU REV BIOCHEM, V46, P573, DOI 10.1146/annurev.bi.46.070177.003041; Wolf YI, 2006, TRENDS GENET, V22, P354, DOI 10.1016/j.tig.2006.04.009; Zhang JZ, 2005, MOL BIOL EVOL, V22, P1147, DOI 10.1093/molbev/msi101; Zhang R, 2009, NUCLEIC ACIDS RES, V37, pD455, DOI 10.1093/nar/gkn858	32	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123785	10.1371/journal.pone.0123785	http://dx.doi.org/10.1371/journal.pone.0123785			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894004	Green Published, Green Submitted, gold			2022-12-27	WOS:000353211700057
J	Kawao, N; Tamura, Y; Horiuchi, Y; Okumoto, K; Yano, M; Okada, K; Matsuo, O; Kaji, H				Kawao, Naoyuki; Tamura, Yukinori; Horiuchi, Yoshitaka; Okumoto, Katsumi; Yano, Masato; Okada, Kiyotaka; Matsuo, Osamu; Kaji, Hiroshi			The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice	PLOS ONE			English	Article							PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; INFLAMMATORY PROTEIN-1-ALPHA; OSTEOBLASTS; UROKINASE; RECEPTOR; CELLS; GENE; ANGIOGENESIS; OSTEOCLASTS	Macrophages play crucial roles in repair process of various tissues. However, the details in the role of macrophages during bone repair still remains unknown. Herein, we examined the contribution of the tissue fibrinolytic system to the macrophage functions in bone repair after femoral bone defect by using male mice deficient in plasminogen (Plg(-/-)), urokinase-type plasminogen activator (uPA(-/-)) or tissue-type plasminogen activator (tPA(-/-)) genes and their wild-type littermates. Bone repair of the femur was delayed in uPA(-/-) mice until day 6, compared with wild-type (uPA(+/+)) mice. Number of Osterix-positive cells and vessel formation were decreased in uPA(-/-) mice at the bone injury site on day 4, compared with those in uPA(+/+) mice. Number of macrophages and their phagocytosis at the bone injury site were reduced in uPA(-/-) and Plg(-/-), but not in tPA(-/-) mice on day 4. Although uPA or plasminogen deficiency did not affect the levels of cytokines, including TNF-alpha, IL-1 beta, IL-6, IL-4 and IFN-gamma mRNA in the damaged femur, the elevation in CCL3 mRNA levels was suppressed in uPA(-/-) and Plg(-/-), but not in tPA(-/-) mice. Neutralization of CCL3 antagonized macrophage recruitment to the site of bone injury and delayed bone repair in uPA(+/+), but not in uPA(-/-) mice. Our results provide novel evidence that the tissue fibrinolytic system contributes to the induction of macrophage recruitment and CCL3 at the bone injury site, thereby, leading to the enhancement of the repair process.	[Kawao, Naoyuki; Tamura, Yukinori; Yano, Masato; Okada, Kiyotaka; Matsuo, Osamu; Kaji, Hiroshi] Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama, Japan; [Horiuchi, Yoshitaka; Okumoto, Katsumi] Kinki Univ, Life Sci Res Inst, Osaka, Japan	Kindai University (Kinki University); Kindai University (Kinki University)	Kaji, H (corresponding author), Kinki Univ, Fac Med, Dept Physiol & Regenerat Med, Osakasayama, Japan.	hkaji@med.kindai.ac.jp	Kaji, Hiroshi/AAI-5628-2020; MATSUO, OSAMU/AAM-9703-2020	Matsuo, Osamu/0000-0002-9806-2204; Kawao, Naoyuki/0000-0002-4148-5476	Kinki University Research; Ministry of Education, Culture, Sports, Science, and Technology of Japan [25460305, 24590289]	Kinki University Research; Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was partly supported by a grant from a Kinki University Research and Grant-in-Aid for Scientific Research (C: 25460305) to N.K. and (C: 24590289) to H.K. from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander KA, 2011, J BONE MINER RES, V26, P1517, DOI 10.1002/jbmr.354; ALLAN EH, 1995, J CELL PHYSIOL, V165, P521, DOI 10.1002/jcp.1041650310; Berkman N, 1996, AM J RESP CELL MOL, V15, P382, DOI 10.1165/ajrcmb.15.3.8810643; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Bostrom K, 2004, J BIOL CHEM, V279, P52904, DOI 10.1074/jbc.M406868200; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; CARMELIET P, 1994, NATURE, V368, P419, DOI 10.1038/368419a0; Carmeliet P, 1997, CIRC RES, V81, P829; Castellino FJ, 2005, THROMB HAEMOSTASIS, V93, P647, DOI 10.1160/TH04-12-0842; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Daci E, 2003, J BONE MINER RES, V18, P1167, DOI 10.1359/jbmr.2003.18.7.1167; Daci E, 2000, J BONE MINER RES, V15, P1510, DOI 10.1359/jbmr.2000.15.8.1510; Taddei SRD, 2013, BONE, V52, P259, DOI 10.1016/j.bone.2012.09.036; Deckers MML, 2002, ENDOCRINOLOGY, V143, P1545, DOI 10.1210/en.143.4.1545; FUKUMOTO S, 1992, J CELL PHYSIOL, V152, P346, DOI 10.1002/jcp.1041520216; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; HAMILTON JA, 1985, ENDOCRINOLOGY, V116, P2186, DOI 10.1210/endo-116-6-2186; Han JH, 2001, BLOOD, V97, P3349, DOI 10.1182/blood.V97.11.3349; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Kawao N, 2010, J THROMB HAEMOST, V8, P1555, DOI 10.1111/j.1538-7836.2010.03870.x; Kawao N, 2014, AM J PHYSIOL-ENDOC M, V307, pE278, DOI 10.1152/ajpendo.00129.2014; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; Kawao N, 2012, THROMB HAEMOSTASIS, V107, P749, DOI 10.1160/TH11-08-0567; Kawao N, 2011, THROMB HAEMOSTASIS, V105, P892, DOI 10.1160/TH10-08-0516; Kawao N, 2010, THROMB RES, V125, pE214, DOI 10.1016/j.thromres.2009.12.009; Lijnen HR, 2001, THROMB HAEMOSTASIS, V86, P324; Mao L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092686; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Ohta TM, 1998, INFLAMM RES, V47, P361, DOI 10.1007/s000110050345; PLOPLIS VA, 1995, CIRCULATION, V92, P2585, DOI 10.1161/01.CIR.92.9.2585; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Sowa H, 2003, J BIOL CHEM, V278, P21058, DOI 10.1074/jbc.M302044200; Stout RD, 2005, J IMMUNOL, V175, P342, DOI 10.4049/jimmunol.175.1.342; Taichman RS, 2000, BRIT J HAEMATOL, V108, P275; Tamura Y, 2013, DIABETES, V62, P3170, DOI 10.2337/db12-1552; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Vallet S, 2011, LEUKEMIA, V25, P1174, DOI 10.1038/leu.2011.43; Xing ZQ, 2010, DIS MODEL MECH, V3, P451, DOI 10.1242/dmm.003186; Yang JN, 1997, J BONE MINER RES, V12, P761, DOI 10.1359/jbmr.1997.12.5.761; Yu XF, 2004, J BONE MINER RES, V19, P2065, DOI 10.1359/JBMR.040910	43	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123982	10.1371/journal.pone.0123982	http://dx.doi.org/10.1371/journal.pone.0123982			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893677	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700068
J	Liu, W; Li, W; He, QL; Daud, MK; Chen, JH; Zhu, SJ				Liu, Wei; Li, Wei; He, Qiuling; Daud, Muhammad Khan; Chen, Jinhong; Zhu, Shuijin			Characterization of 19 Genes Encoding Membrane-Bound Fatty Acid Desaturases and their Expression Profiles in Gossypium raimondii Under Low Temperature	PLOS ONE			English	Article							OMEGA-3-FATTY-ACID DESATURASE; DELTA(8)-SPHINGOLIPID DESATURASE; FUNCTIONAL-CHARACTERIZATION; OMEGA-3 DESATURASE; MOLECULAR-CLONING; TOLERANCE; EVOLUTION; GENOME; PLANTS; COLD	To produce unsaturated fatty acids, membrane-bound fatty acid desaturases (FADs) can be exploited to introduce double bonds into the acyl chains of fatty acids. In this study, 19 membrane-bound FAD genes were identified in Gossypium raimondii through database searches and were classified into four different subfamilies based on phylogenetic analysis. All 19 membrane-bound FAD proteins shared three highly conserved histidine boxes, except for GrFAD2.1, which lost the third histidine box in the C-terminal region. In the G. raimondii genome, tandem duplication might have led to the increasing size of the FAD2 cluster in the Omega Desaturase subfamily, whereas segmental duplication appeared to be the dominant mechanism for the expansion of the Sphingolipid and Front-end Desaturase subfamilies. Gene expression analysis showed that seven membrane-bound FAD genes were significantly up-regulated and that five genes were greatly suppressed in G. raimondii leaves exposed to low temperature conditions.	[Liu, Wei; Li, Wei; He, Qiuling; Daud, Muhammad Khan; Chen, Jinhong; Zhu, Shuijin] Zhejiang Univ, Dept Agron, Hangzhou 310058, Zhejiang, Peoples R China; [Daud, Muhammad Khan] Kohat Univ Sci & Technol, Dept Biotechnol & Genet Engn, Kohat 26000, Pakistan; [Chen, Jinhong; Zhu, Shuijin] Jiangsu Collaborat Innovat Ctr Modern Crop Prod, Nanjing 210095, Jiangsu, Peoples R China	Zhejiang University; Kohat University of Science & Technology	Chen, JH (corresponding author), Zhejiang Univ, Dept Agron, Hangzhou 310058, Zhejiang, Peoples R China.	jinhongchen@zju.edu.cn; shjzhu@zju.edu.cn	Khan, Muhammad Daud/AAF-1011-2021					Alonso DL, 2003, BIOCHEM SYST ECOL, V31, P1111, DOI 10.1016/S0305-1978(03)00041-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Berberich T, 1998, PLANT MOL BIOL, V36, P297, DOI 10.1023/A:1005993408270; BROWSE J, 1993, J BIOL CHEM, V268, P16345; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Chapman KD, 2001, J AM OIL CHEM SOC, V78, P941, DOI 10.1007/s11746-001-0368-y; Chen M, 2012, PLANT J, V69, P769, DOI 10.1111/j.1365-313X.2011.04829.x; Chen MJ, 2013, PLANT CELL, V25, P1430, DOI 10.1105/tpc.113.111179; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Chi XY, 2011, PLANT MOL BIOL REP, V29, P769, DOI 10.1007/s11105-010-0284-z; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; FALCONE DL, 1994, PLANT PHYSIOL, V106, P1453, DOI 10.1104/pp.106.4.1453; Flores T, 2008, TRANSGENIC RES, V17, P839, DOI 10.1007/s11248-008-9167-6; GIBSON S, 1994, PLANT PHYSIOL, V106, P1615, DOI 10.1104/pp.106.4.1615; Guo An-Yuan, 2007, Yichuan, V29, P1023, DOI 10.1360/yc-007-1023; Hashimoto K, 2008, J LIPID RES, V49, P183, DOI 10.1194/jlr.M700377-JLR200; Haun W, 2014, PLANT BIOTECHNOL J, V12, P934, DOI 10.1111/pbi.12201; Heilmann I, 2004, P NATL ACAD SCI USA, V101, P10266, DOI 10.1073/pnas.0402200101; IBA K, 1993, J BIOL CHEM, V268, P24099; Iba K, 2002, ANNU REV PLANT BIOL, V53, P225, DOI 10.1146/annurev.arplant.53.100201.160729; Im YJ, 2002, MOL CELLS, V13, P264; Kargiotidou A, 2008, J EXP BOT, V59, P2043, DOI 10.1093/jxb/ern065; Khodakovskaya M, 2006, PLANTA, V223, P1090, DOI 10.1007/s00425-005-0161-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Li SF, 2012, J GENET GENOMICS, V39, P47, DOI 10.1016/j.jgg.2011.12.002; Li-Beisson Yonghua, 2010, Arabidopsis Book, V8, pe0133, DOI [10.1199/tab.0133, 10.1199/tab.0161]; Liu Q, 2002, PLANT PHYSIOL, V129, P1732, DOI 10.1104/pp.001933; Liu Q, 1999, AUST J PLANT PHYSIOL, V26, P101, DOI 10.1071/PP98118; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098189; Liu XY, 2006, J INTEGR PLANT BIOL, V48, P1096, DOI 10.1111/j.1744-7909.2006.00335.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Los DA, 1998, BBA-LIPID LIPID MET, V1394, P3, DOI 10.1016/S0005-2760(98)00091-5; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Maere S, 2005, P NATL ACAD SCI USA, V102, P5454, DOI 10.1073/pnas.0501102102; McCartney AW, 2004, PLANT J, V37, P156, DOI 10.1111/j.1365-313X.2004.01949.x; MCCONN M, 1994, PLANT PHYSIOL, V106, P1609, DOI 10.1104/pp.106.4.1609; Michaelson LV, 2009, PLANT PHYSIOL, V149, P487, DOI 10.1104/pp.108.129411; Moreno-Perez AJ, 2011, J PLANT PHYSIOL, V168, P831, DOI 10.1016/j.jplph.2010.11.015; Nair PMG, 2009, PLANT CELL TISS ORG, V98, P87, DOI 10.1007/s11240-009-9541-y; Nishida I, 1996, ANNU REV PLANT PHYS, V47, P541, DOI 10.1146/annurev.arplant.47.1.541; OKULEY J, 1994, PLANT CELL, V6, P147, DOI 10.1105/tpc.6.1.147; Paterson AH, 2012, NATURE, V492, P423, DOI 10.1038/nature11798; Pirtle IL, 2001, BBA-GENE STRUCT EXPR, V1522, P122, DOI 10.1016/S0167-4781(01)00312-8; Roman A, 2012, J EXP BOT, V63, P4973, DOI 10.1093/jxb/ers174; Sakamoto T, 2002, CURR OPIN MICROBIOL, V5, P206, DOI 10.1016/S1369-5274(02)00306-5; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shi W, 2013, BMC GENOMICS, V14, DOI [10.1186/1471-2164-14-103, 10.1186/1471-2164-14-433]; SOMERVILLE C, 1991, SCIENCE, V252, P80, DOI 10.1126/science.252.5002.80; Sperling P, 2003, PROSTAG LEUKOTR ESS, V68, P73, DOI 10.1016/S0952-3278(02)00258-2; Sperling P, 2003, BBA-MOL CELL BIOL L, V1632, P1, DOI 10.1016/S1388-1981(03)00033-7; Sperling P, 2001, ARCH BIOCHEM BIOPHYS, V388, P293, DOI 10.1006/abbi.2001.2308; Sunilkumar G, 2005, PLANT BIOTECHNOL J, V3, P319, DOI 10.1111/j.1467-7652.2005.00126.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Wagner N, 2011, PLANT BIOTECHNOL J, V9, P723, DOI 10.1111/j.1467-7652.2010.00573.x; Wang HS, 2014, PLANT CELL REP, V33, P131, DOI 10.1007/s00299-013-1517-z; Wang JW, 2006, BIOCHEM BIOPH RES CO, V340, P1209, DOI 10.1016/j.bbrc.2005.12.126; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wei Hengling, 2013, PLoS One, V8, pe68435, DOI 10.1371/journal.pone.0068435; Wu Q, 2009, AFR J BIOTECHNOL, V8, P1782; Yukawa Y, 1996, PLANT CELL PHYSIOL, V37, P201, DOI 10.1093/oxfordjournals.pcp.a028932; Yurchenko OP, 2014, BMC PLANT BIOL, V14, DOI 10.1186/s12870-014-0312-5; Zhang DY, 2009, PLANT PHYSIOL BIOCH, V47, P462, DOI 10.1016/j.plaphy.2008.12.024; Zhang JT, 2009, BIOCHEM BIOPH RES CO, V390, P469, DOI 10.1016/j.bbrc.2009.09.095; Zhang JT, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030355, 10.1371/journal.pone.0041657]; Zhao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028488	67	27	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123281	10.1371/journal.pone.0123281	http://dx.doi.org/10.1371/journal.pone.0123281			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25894196	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700032
J	Gardner, JK; Mamotte, CDS; Patel, P; Yeoh, TL; Jackaman, C; Nelson, DJ				Gardner, Joanne K.; Mamotte, Cyril D. S.; Patel, Priya; Yeoh, Teong Ling; Jackaman, Connie; Nelson, Delia J.			Mesothelioma Tumor Cells Modulate Dendritic Cell Lipid Content, Phenotype and Function	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; KAPPA-B ACTIVATION; T-CELLS; MALIGNANT MESOTHELIOMA; ANTITUMOR IMMUNITY; ALTERED MATURATION; CD1 MOLECULES; BREAST-CANCER; DIFFERENTIATION; INHIBITION	Dendritic cells (DCs) play an important role in the generation of anti-cancer immune responses, however there is evidence that DCs in cancer patients are dysfunctional. Lipid accumulation driven by tumor-derived factors has recently been shown to contribute to DC dysfunction in several human cancers, but has not yet been examined in mesothelioma. This study investigated if mesothelioma tumor cells and/ or their secreted factors promote increases in DC lipid content and modulate DC function. Human monocyte-derived DCs (MoDCs) were exposed to human mesothelioma tumor cells and tumor-derived factors in the presence or absence of lipoproteins. The data showed that immature MoDCs exposed to mesothelioma cells or factors contained increased lipid levels relative to control DCs. Lipid accumulation was associated with reduced antigen processing ability (measured using a DQ OVA assay), upregulation of the co-stimulatory molecule, CD86, and production of the tolerogenic cytokine, IL-10. Increases in DC lipid content were further enhanced by co-exposure to mesothelioma-derived factors and triglyceride-rich lipoproteins, but not low-density lipoproteins. In vivo studies using a murine mesothelioma model showed that the lipid content of tumor-infiltrating CD4+ CD8(alpha-)DCs, CD(4-)CD8(alpha-)DCs and plasmacytoid DCs increased with tumor progression. Moreover, increasing tumor burden was associated with reduced proliferation of tumor-antigen-specific CD8+ T cells in tumor-draining lymph nodes. This study shows that mesothelioma promotes DC lipid acquisition, which is associated with altered activation status and reduced capacity to process and present antigens, which may impair the ability of DCs to generate effective anti mesothelioma T cell responses.	[Gardner, Joanne K.; Patel, Priya; Yeoh, Teong Ling; Jackaman, Connie; Nelson, Delia J.] Curtin Univ, Immunol & Canc Grp, Sch Biomed Sci, Perth, WA 6845, Australia; [Gardner, Joanne K.; Mamotte, Cyril D. S.; Patel, Priya; Yeoh, Teong Ling; Jackaman, Connie; Nelson, Delia J.] Curtin Univ, CHIRI Biosci Res Precinct, Perth, WA 6845, Australia	Curtin University; Curtin University	Nelson, DJ (corresponding author), Curtin Univ, Immunol & Canc Grp, Sch Biomed Sci, Perth, WA 6845, Australia.	Delia.Nelson@curtin.edu.au	Mamotte, Cyril/AAF-9603-2020	Mamotte, Cyril/0000-0003-1831-3921; Nelson, Delia/0000-0002-8698-5300; Jackaman, Connie/0000-0002-4583-7029	Dust Disease Board of New South Wales, Australia	Dust Disease Board of New South Wales, Australia	This study was funded by a grant received by DJN from the Dust Disease Board of New South Wales, Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 1998, EUR J IMMUNOL, V28, P359, DOI 10.1002/(SICI)1521-4141(199801)28:01<359::AID-IMMU359>3.0.CO;2-4; Almand B, 2000, CLIN CANCER RES, V6, P1755; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Beckebaum S, 2004, CLIN CANCER RES, V10, P7260, DOI 10.1158/1078-0432.CCR-04-0872; Bellone G, 2006, J IMMUNOL, V177, P3448, DOI 10.4049/jimmunol.177.5.3448; Biswas S, 2007, J CLIN INVEST, V117, P1305, DOI 10.1172/JCI30740; Brown RD, 2001, BLOOD, V98, P2992, DOI 10.1182/blood.V98.10.2992; Caldwell S, 2003, J IMMUNOL, V171, P1676, DOI 10.4049/jimmunol.171.4.1676; Cao XC, 2002, J IMMUNOL, V169, P4770, DOI 10.4049/jimmunol.169.9.4770; Coventry B, 2004, TRENDS IMMUNOL, V25, P242, DOI 10.1016/j.it.2004.03.002; Coventry BJ, 2003, BRIT J CANCER, V89, P533, DOI 10.1038/sj.bjc.6601114; Della Bella S, 2003, BRIT J CANCER, V89, P1463, DOI 10.1038/sj.bjc.6601243; Diao J, 2011, J IMMUNOL, V186, P5058, DOI 10.4049/jimmunol.1004125; Furumoto K, 2004, J CLIN INVEST, V113, P774, DOI 10.1172/JCI200419762; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 1999, CLIN CANCER RES, V5, P2963; Gerlini G, 2004, AM J PATHOL, V165, P1853, DOI 10.1016/S0002-9440(10)63238-5; Gerner MY, 2009, J IMMUNOL, V182, P2726, DOI 10.4049/jimmunol.0803479; Gogolak P, 2007, BLOOD, V109, P643, DOI 10.1182/blood-2006-04-016840; Goldman SA, 1998, ARCH OTOLARYNGOL, V124, P641, DOI 10.1001/archotol.124.6.641; Gottfried E, 2008, CYTOKINE GROWTH F R, V19, P65, DOI 10.1016/j.cytogfr.2007.10.008; Granucci F, 2001, EUR J IMMUNOL, V31, P2539, DOI 10.1002/1521-4141(200109)31:9<2539::AID-IMMU2539>3.0.CO;2-9; Hegmans JPJJ, 2006, EUR RESPIR J, V27, P1086, DOI 10.1183/09031936.06.00135305; Herber DL, 2010, NAT MED, V16, P880, DOI 10.1038/nm.2172; Hilkens CMU, 1997, BLOOD, V90, P1920, DOI 10.1182/blood.V90.5.1920; Inoshima N, 2002, CLIN CANCER RES, V8, P3480; Jackaman C, 2003, J IMMUNOL, V171, P5051, DOI 10.4049/jimmunol.171.10.5051; KE Y, 1989, AM J PATHOL, V134, P979; Kiertscher SM, 2000, J IMMUNOL, V164, P1269, DOI 10.4049/jimmunol.164.3.1269; Le Naour F, 2001, J BIOL CHEM, V276, P17920, DOI 10.1074/jbc.M100156200; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; Mamotte CDS, 1996, ATHEROSCLEROSIS, V125, P103, DOI 10.1016/0021-9150(96)05867-4; MANNING LS, 1991, INT J CANCER, V47, P285, DOI 10.1002/ijc.2910470219; Moretto MM, 2010, INFECT IMMUN, V78, P2505, DOI 10.1128/IAI.00753-09; Nakano H, 2001, J EXP MED, V194, P1171, DOI 10.1084/jem.194.8.1171; Oyama T, 1998, J IMMUNOL, V160, P1224; Parish CR, 1999, IMMUNOL CELL BIOL, V77, P499, DOI 10.1046/j.1440-1711.1999.00877.x; Peguet-Navarro J, 2003, J IMMUNOL, V170, P3488, DOI 10.4049/jimmunol.170.7.3488; Pooley JL, 2001, J IMMUNOL, V166, P5327, DOI 10.4049/jimmunol.166.9.5327; Robinson BWS, 2005, LANCET, V366, P397, DOI 10.1016/S0140-6736(05)67025-0; Saito T, 2008, CANCER SCI, V99, P2028, DOI 10.1111/j.1349-7006.2008.00907.x; Shortman K, 2002, NAT REV IMMUNOL, V2, P151, DOI 10.1038/nri746; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Sombroek CC, 2002, J IMMUNOL, V168, P4333, DOI 10.4049/jimmunol.168.9.4333; Torres-Aguilar H, 2010, J IMMUNOL, V184, P1765, DOI 10.4049/jimmunol.0902133; Villablanca EJ, 2010, NAT MED, V16, P98, DOI 10.1038/nm.2074; Yang AS, 2003, CANCER RES, V63, P2150; Zeyda M, 2005, J BIOL CHEM, V280, P14293, DOI 10.1074/jbc.M410000200	49	28	29	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123563	10.1371/journal.pone.0123563	http://dx.doi.org/10.1371/journal.pone.0123563			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886502	Green Published, Green Submitted, gold			2022-12-27	WOS:000353017000073
J	Kirchberger, J; Eisenhauer, N; Weisser, WW; Turke, M				Kirchberger, Johannes; Eisenhauer, Nico; Weisser, Wolfgang W.; Tuerke, Manfred			Experimental Evaluation of Herbivory on Live Plant Seedlings by the Earthworm Lumbricus terrestris L. in the Presence and Absence of Soil Surface Litter	PLOS ONE			English	Article							INVERTEBRATE HERBIVORY; GRASSLAND; PALATABILITY; COMMUNITIES; DIVERSITY; PATTERNS; SEEDS	Background Recent studies suggested that the earthworm Lumbricus terrestris might act as a seedling predator by ingesting emerging seedlings, and individuals were observed damaging fresh leaves of various plant species in the field. To evaluate the significance of herbivore behavior of L. terrestris for plant and earthworm performance we exposed 23-to 33-days-old seedlings of six plant species to earthworms in two microcosm experiments. Plants belonged to the three functional groups grasses, non-leguminous herbs, and legumes. Leaf damage, leaf mortality, the number of leaves as well as mortality and growth of seedlings were followed over a period of up to 26 days. In a subset of replicates 0.1 g of soil surface litter of each of the six plant species was provided and consumption was estimated regularly to determine potential feeding preferences of earthworms. Results There was no difference in seedling growth, the number of live seedlings and dead leaves between treatments with or without worms. Fresh leaves were damaged eight times during the experiment, most likely by L. terrestris, with two direct observations of earthworms tearing off leaf parts. Another nine leaves were partly pulled into earthworm burrows. Lumbricus terrestris preferred to consume legume litter over litter of the other plant functional groups. Earthworms that consumed litter lost less weight than individuals that were provided with soil and live plants only, indicating that live plants are not a suitable substitute for litter in earthworm nutrition. Conclusion Our results demonstrate that L. terrestris damages live plants; however, this behavior occurs only rarely. Pulling live plants into earthworm burrows might induce microbial decomposition of leaves to make them suitable for later consumption. Herbivory on plants beyond the initial seedling stage may only play a minor role in earthworm nutrition and has limited potential to influence plant growth.	[Kirchberger, Johannes; Weisser, Wolfgang W.; Tuerke, Manfred] Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, D-85354 Freising Weihenstephan, Germany; [Eisenhauer, Nico; Tuerke, Manfred] German Ctr Integrat Biodivers Res iDiv, D-04103 Leipzig, Germany; [Eisenhauer, Nico; Tuerke, Manfred] Univ Leipzig, Inst Biol, D-04103 Leipzig, Germany	Technical University of Munich; Leipzig University	Turke, M (corresponding author), Tech Univ Munich, Terr Ecol Res Grp, Dept Ecol & Ecosyst Management, Hans Carl von Carlowitz Pl 2, D-85354 Freising Weihenstephan, Germany.	manfred.tuerke@gmx.net	Eisenhauer, Nico/I-5932-2012; Weisser, Wolfgang W/B-9718-2014; Eisenhauer, Nico/I-3191-2019; Türke, Manfred/AFE-8308-2022	Eisenhauer, Nico/0000-0002-0371-6720; Weisser, Wolfgang W/0000-0002-2757-8959; Eisenhauer, Nico/0000-0002-0371-6720; Türke, Manfred/0000-0002-8957-5454	German Ministry for Research and Education (BMBF) within the LEGATO-project [FKZ 01LL09 170]; German Centre for Integrative Biodiversity Research (iDiv) - German Science Foundation DFG [FZT 118]; DFG [FOR 1451]; Technische Universitat Munchen	German Ministry for Research and Education (BMBF) within the LEGATO-project(Federal Ministry of Education & Research (BMBF)); German Centre for Integrative Biodiversity Research (iDiv) - German Science Foundation DFG; DFG(German Research Foundation (DFG)); Technische Universitat Munchen	MT was funded by the German Ministry for Research and Education (BMBF funding measure 'Sustainable land management') within the LEGATO-project (FKZ 01LL09 170). NE was supported by the German Centre for Integrative Biodiversity Research (iDiv), funded by the German Science Foundation DFG (FZT 118). WWW was supported by the DFG (FOR 1451). This publication was financially supported by the DFG and the Technische Universitat Munchen in the framework of the program 'Open-Access-Publishing'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2014, R LANG ENV STAT COMP; Barton KE, 2013, ANN BOT-LONDON, V112, P643, DOI 10.1093/aob/mct139; BELSKY AJ, 1986, AM NAT, V127, P870, DOI 10.1086/284531; Carson WP, 2000, ECOL MONOGR, V70, P73, DOI 10.1890/0012-9615(2000)070[0073:HAPSCC]2.0.CO;2; Cole L, 2006, APPL SOIL ECOL, V33, P186, DOI 10.1016/j.apsoil.2005.11.003; Curry J. P., 2007, PEDOBIOLOGIA, V50, P463, DOI DOI 10.1016/j.pedobi.2006.09.001; Daniel O, 1996, SOIL BIOL BIOCHEM, V28, P1235, DOI 10.1016/0038-0717(96)00121-6; Darwin C, 1882, FORMATION VEGETABLE; Doube BM, 1997, SOIL BIOL BIOCHEM, V29, P569, DOI 10.1016/S0038-0717(96)00032-6; Edwards CA, 1996, BIOL ECOLOGY EARTHWO, DOI DOI 10.1016/S0167-8809(97)88859-7; Eisenhauer N, 2012, OIKOS, V121, P1121, DOI 10.1111/j.1600-0706.2011.19807.x; Eisenhauer N, 2010, SOIL BIOL BIOCHEM, V42, P1245, DOI 10.1016/j.soilbio.2010.04.012; Eisenhauer N, 2009, PEDOBIOLOGIA, V52, P151, DOI 10.1016/j.pedobi.2008.07.002; Forey E, 2011, ACTA OECOL, V37, P594, DOI 10.1016/j.actao.2011.03.001; Frund HC, 2010, PEDOBIOLOGIA, V53, P119, DOI 10.1016/j.pedobi.2009.07.002; Griffith B, 2013, EUR J SOIL BIOL, V55, P62, DOI 10.1016/j.ejsobi.2012.12.002; Hulme PE, 1996, J ECOL, V84, P43, DOI 10.2307/2261698; Loranger H, 2014, OECOLOGIA, V174, P183, DOI 10.1007/s00442-013-2741-5; Prather CM, 2013, BIOL REV, V88, P327, DOI 10.1111/brv.12002; Scheu S, 2003, PEDOBIOLOGIA, V47, P846, DOI 10.1016/s0031-4056(04)70279-6; Schonholzer F, 1998, SOIL BIOL BIOCHEM, V30, P1805, DOI 10.1016/S0038-0717(98)00049-2; Shumway DL, 1994, APPL SOIL ECOL, V1, P11, DOI 10.1016/0929-1393(94)90019-1; Stein C, 2010, ECOLOGY, V91, P1639, DOI 10.1890/09-0600.1; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Weisser W.W., 2004, INSECTS ECOSYSTEM FU; Zaller JG, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-20	26	6	6	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123465	10.1371/journal.pone.0123465	http://dx.doi.org/10.1371/journal.pone.0123465			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885861	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000068
J	Levine, AP; Duchen, MR; de Villiers, S; Rich, PR; Segal, AW				Levine, Adam P.; Duchen, Michael R.; de Villiers, Simon; Rich, Peter R.; Segal, Anthony W.			Alkalinity of Neutrophil Phagocytic Vacuoles Is Modulated by HVCN1 and Has Consequences for Myeloperoxidase Activity	PLOS ONE			English	Article							NADPH OXIDASE; INTRACELLULAR PH; PROTON CHANNELS; SUPEROXIDE-PRODUCTION; PHAGOSOMAL PH; CATHEPSIN-G; VOLTAGE; CHLORINATION; TRANSPORT; SENSITIVITY	The NADPH oxidase of neutrophils, essential for innate immunity, passes electrons across the phagocytic membrane to form superoxide in the phagocytic vacuole. Activity of the oxidase requires that charge movements across the vacuolar membrane are balanced. Using the pH indicator SNARF, we measured changes in pH in the phagocytic vacuole and cytosol of neutrophils. In human cells, the vacuolar pH rose to similar to 9, and the cytosol acidified slightly. By contrast, in Hvcn1 knock out mouse neutrophils, the vacuolar pH rose above 11, vacuoles swelled, and the cytosol acidified excessively, demonstrating that ordinarily this channel plays an important role in charge compensation. Proton extrusion was not diminished in Hvcn1(-/-) mouse neutrophils arguing against its role in maintaining pH homeostasis across the plasma membrane. Conditions in the vacuole are optimal for bacterial killing by the neutral proteases, cathepsin G and elastase, and not by myeloperoxidase, activity of which was unphysiologically low at alkaline pH.	[Levine, Adam P.; Segal, Anthony W.] UCL, Div Med, London, England; [Duchen, Michael R.] UCL, Dept Cell & Dev Biol, London, England; [de Villiers, Simon; Rich, Peter R.] UCL, Glynn Lab Bioenerget, Dept Biol, London, England	University of London; University College London; University of London; University College London; University of London; University College London	Segal, AW (corresponding author), UCL, Div Med, London, England.	t.segal@ucl.ac.uk	duchen, michael/A-2116-2009	duchen, michael/0000-0003-2548-4294; Levine, Adam/0000-0003-1333-9938; Segal, Anthony/0000-0001-7602-9043	Wellcome Trust [WT081695]; Biotechnology and Biological Sciences Research Council; Irwin Joffe Memorial Fellowship; BBSRC [BB/K001094/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K001094/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Irwin Joffe Memorial Fellowship; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Wellcome Trust Grant WT081695, the Biotechnology and Biological Sciences Research Council, and the Irwin Joffe Memorial Fellowship (APL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BASSNETT S, 1990, AM J PHYSIOL, V258, pC171, DOI 10.1152/ajpcell.1990.258.1.C171; BORREGAARD N, 1984, J CLIN INVEST, V74, P455, DOI 10.1172/JCI111442; Bourque CW, 2008, NAT REV NEUROSCI, V9, P519, DOI 10.1038/nrn2400; CECH P, 1984, BLOOD, V63, P88; Clanton TL, 2013, COMPR PHYSIOL, V3, P1135, DOI 10.1002/cphy.c120030; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Czirjak G, 2006, MOL PHARMACOL, V69, P1024, DOI 10.1124/mol.105.018556; DALE WE, 1991, ANN NY ACAD SCI, V639, P616, DOI 10.1111/j.1749-6632.1991.tb17359.x; DeCoursey TE, 2003, NATURE, V422, P531, DOI 10.1038/nature01523; Dri P, 2002, CYTOMETRY, V48, P159, DOI 10.1002/cyto.10123; EGLINTON DG, 1982, BIOCHIM BIOPHYS ACTA, V703, P187, DOI 10.1016/0167-4838(82)90047-4; El Chemaly A, 2014, J LEUKOCYTE BIOL, V95, P827, DOI 10.1189/jlb.0513251; El Chemaly A, 2010, J EXP MED, V207, P129, DOI 10.1084/jem.20091837; Feldmesser M, 2006, INFECT IMMUN, V74, P6514, DOI 10.1128/IAI.01551-06; GRINSTEIN S, 1992, J EXP BIOL, V172, P179; GRINSTEIN S, 1986, AM J PHYSIOL, V251, pC55, DOI 10.1152/ajpcell.1986.251.1.C55; Grinstein S, AMJPHYSIOL, V250, pC283; Hahn I, 2011, INFECT IMMUN, V79, P4893, DOI 10.1128/IAI.05593-11; HENDERSON LM, 1987, BIOCHEM J, V246, P325, DOI 10.1042/bj2460325; HENDERSON LM, 1988, BIOCHEM J, V255, P285; HENDERSON LM, 1988, BIOCHEM J, V251, P563, DOI 10.1042/bj2510563; HILLAR A, 1995, ARCH BIOCHEM BIOPHYS, V323, P438, DOI 10.1006/abbi.1995.0065; HOLLAND PC, 1971, BIOCHEM J, V121, pP42; Holland SM, 2013, HEMATOL ONCOL CLIN N, V27, P89, DOI 10.1016/j.hoc.2012.11.002; HURST JK, 1984, J BIOL CHEM, V259, P4812; Ishida Y, 2013, J GEN PHYSIOL, V141, P705, DOI 10.1085/jgp.201210930; Jankowski A, 2002, J BIOL CHEM, V277, P6059, DOI 10.1074/jbc.M110059200; Jiang LL, 2012, J CELL SCI, V125, P5479, DOI 10.1242/jcs.110072; Jiang Q, 1997, CHEM RES TOXICOL, V10, P1080, DOI 10.1021/tx9700984; Johnson RP, 2004, AM J PHYSIOL-CELL PH, V286, pC391, DOI 10.1152/ajpcell.00401.2003; KETTLE AJ, 1995, BIOCHEM J, V308, P559, DOI 10.1042/bj3080559; KETTLE AJ, 1988, BIOCHEM J, V252, P529, DOI 10.1042/bj2520529; KETTLE AJ, 1988, BIOCHIM BIOPHYS ACTA, V957, P185, DOI 10.1016/0167-4838(88)90271-3; Klebanoff SJ, 2013, J LEUKOCYTE BIOL, V93, P185, DOI 10.1189/jlb.0712349; Korkmaz B, 2008, BIOCHIMIE, V90, P227, DOI 10.1016/j.biochi.2007.10.009; Lardner A, 2001, J LEUKOCYTE BIOL, V69, P522; MAYER SJ, 1989, J LEUKOCYTE BIOL, V45, P239, DOI 10.1002/jlb.45.3.239; MCRIPLEY RJ, 1967, J BACTERIOL, V94, P1425, DOI 10.1128/JB.94.5.1425-1430.1967; Meech Robert, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P533; MOLSKI TFP, 1980, BIOCHEM BIOPH RES CO, V94, P508, DOI 10.1016/0006-291X(80)91260-7; Moreland JG, 2006, J BIOL CHEM, V281, P12277, DOI 10.1074/jbc.M511030200; Morgan D, 2005, J PHYSIOL-LONDON, V569, P419, DOI 10.1113/jphysiol.2005.094748; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; Murphy EJ, 2010, BIOCHEMISTRY-US, V49, P2150, DOI 10.1021/bi9021507; NAUSEEF WM, 1983, BLOOD, V61, P483; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; Osteen JD, 2008, BIOPHYS J, V95, P4668, DOI 10.1529/biophysj.108.137158; OWEN CS, 1992, ANAL BIOCHEM, V204, P65, DOI 10.1016/0003-2697(92)90140-3; Painter RG, 2010, J LEUKOCYTE BIOL, V87, P933, DOI 10.1189/jlb.1009655; Pulli B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067976; Rada BK, 2004, BLOOD, V104, P2947, DOI 10.1182/blood-2004-03-1005; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Reeves EP, 2002, NATURE, V416, P291, DOI 10.1038/416291a; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Schrenzel J, 1998, NATURE, V392, P734, DOI 10.1038/33725; SEGAL AW, 1978, BIOCHEM BIOPH RES CO, V84, P611, DOI 10.1016/0006-291X(78)90749-0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; Sewell GW, 2012, INFLAMM BOWEL DIS, V18, P2120, DOI 10.1002/ibd.22952; Shi YJ, 2013, ADV EXP MED BIOL, V961, P411, DOI 10.1007/978-1-4614-4756-6_35; SIMCHOWITZ L, 1985, J GEN PHYSIOL, V85, P443, DOI 10.1085/jgp.85.3.443; Stauber T, 2013, ANNU REV PHYSIOL, V75, P453, DOI 10.1146/annurev-physiol-030212-183702; Sun HS, 2007, BIOPHYS J, V93, P1175, DOI 10.1529/biophysj.106.103333; Sun YT, 2012, J PHYSIOL-LONDON, V590, P3231, DOI 10.1113/jphysiol.2011.225300; TAKAHASHI T, 1985, CRYOBIOLOGY, V22, P215, DOI 10.1016/0011-2240(85)90143-9; TINGBEALL HP, 1993, BLOOD, V81, P2774; Tkalcevic J, 2000, IMMUNITY, V12, P201, DOI 10.1016/S1074-7613(00)80173-9	67	53	53	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125906	10.1371/journal.pone.0125906	http://dx.doi.org/10.1371/journal.pone.0125906			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885273	gold, Green Published, Green Submitted			2022-12-27	WOS:000353017000164
J	Nguyen, TT; Collins, PJ; Ebert, PR				Nguyen, Tam T.; Collins, Patrick J.; Ebert, Paul R.			Inheritance and Characterization of Strong Resistance to Phosphine in Sitophilus oryzae (L.)	PLOS ONE			English	Article							COLEOPTERA; DOMINANCE; GENETICS	Sitophilus oryzae (Linnaeus) is a major pest of stored grain across Southeast Asia and is of increasing concern in other regions due to the advent of strong resistance to phosphine, the fumigant used to protect stored grain from pest insects. We investigated the inheritance of genes controlling resistance to phosphine in a strongly resistant S. oryzae strain (NNSO7525) collected in Australia and find that the trait is autosomally inherited and incompletely recessive with a degree of dominance of -0.66. The strongly resistant strain has an LC50 52 times greater than a susceptible reference strain (LS2) and 9 times greater than a weakly resistant strain (QSO335). Analysis of F2 and backcross progeny indicates that two or more genes are responsible for strong resistance, and that one of these genes, designated So_rph1, not only contributes to strong resistance, but is also responsible for the weak resistance phenotype of strain QSO335. These results demonstrate that the genetic mechanism of phosphine resistance in S. oryzae is similar to that of other stored product insect pests. A unique observation is that a subset of the progeny of an F1 backcross generation are more strongly resistant to phosphine than the parental strongly resistant strain, which may be caused by multiple alleles of one of the resistance genes.	[Nguyen, Tam T.; Ebert, Paul R.] Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia; [Nguyen, Tam T.] Hanoi Natl Univ Educ, Fac Biol, Hanoi, Vietnam; [Collins, Patrick J.] Ecosci Precinct, Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia	University of Queensland; Hanoi National University of Education; Queensland Department of Agriculture & Fisheries	Ebert, PR (corresponding author), Univ Queensland, Sch Biol Sci, St Lucia, Qld, Australia.	p.ebert@ug.edu.au		Ebert, Paul/0000-0002-4435-0737	Australia-India Strategic Research Fund Grand Challenge Grant [GCF010006]	Australia-India Strategic Research Fund Grand Challenge Grant(Australian GovernmentDepartment of Industry, Innovation and Science)	Funding provided by Australia-India Strategic Research Fund Grand Challenge Grant http://www.industry.gov.au/Science/InternationalCollaboration/aisrf/Pages/default.aspx#grand GCF010006 Awarded to: PJC PRE. AusAid Postgraduate Scholarship http://aid.dfat.gov.au/australia-awards/pages/studyin.aspx Awarded to: TTN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; [Anonymous], 1975, FAO PLANT PROTECT B, V23, P12; Ansell M, 1991, P 5 INT WORK C STOR, P961; Bell CH, 2000, CROP PROT, V19, P563, DOI 10.1016/S0261-2194(00)00073-9; Bengston M, 1999, J ECON ENTOMOL, V92, P17, DOI 10.1093/jee/92.1.17; CHAMP BR, 1977, FAO PLANT PROTECT B, V25, P49; Chaudhry M. Q., 2000, Pesticide Outlook, V11, P88, DOI 10.1039/b006348g; Collins PJ, 2002, J ECON ENTOMOL, V95, P862, DOI 10.1603/0022-0493-95.4.862; Committee G, 2008, GENST REL 11 1; Daglish GJ, 2002, PEST MANAG SCI, V58, P1015, DOI 10.1002/ps.532; Daglish GJ, 2014, J STORED PROD RES, V59, P237, DOI 10.1016/j.jspr.2014.03.007; Emery R.N., 2003, STORED GRAIN AUSTR 2, P142; FINNEY D J, 1971, P333; GEORGHIOU GP, 1969, EXP PARASITOL, V26, P224, DOI 10.1016/0014-4894(69)90116-7; Jagadeesan R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031582; Kaur R, 2012, J STORED PROD RES, V51, P74, DOI 10.1016/j.jspr.2012.08.002; Li Yan-Sheng, 1994, Acta Entomologica Sinica, V37, P271; LI YS, 1994, STORED PRODUCT PROTECTION, VOLS 1 AND 2, P113; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034027; Mau YS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031541; Mills K.A., 2000, P INT C CONTR ATM FU, P583; PREISLER HK, 1990, J ECON ENTOMOL, V83, P1649, DOI 10.1093/jee/83.5.1649; Rajendran S., 1999, P 7 INT WORK C STOR, P635; Robertson J.L., 2007, BIOASSAYS ARTHROPODS, V2nd; Schlipalius D, 2010, DIAGNOSTIC TECHNOLOG; Schlipalius DI, 2012, SCIENCE, V338, P807, DOI 10.1126/science.1224951; Schlipalius DI, 2002, GENETICS, V161, P773; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; TABASHNIK BE, 1991, J ECON ENTOMOL, V84, P703, DOI 10.1093/jee/84.3.703; TSUKAMOTO MASUHISA, 1963, BOTYU KAGAKU BUL INST CONTR, V28, P91; Zeng L., 2003, STORED PRODUCTS PROT, P642	31	30	33	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124335	10.1371/journal.pone.0124335	http://dx.doi.org/10.1371/journal.pone.0124335			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886629	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000115
J	Xiao, D; Peng, SP; Wang, EY				Xiao, Dong; Peng, Su-Ping; Wang, En-Yuan			Fermentation Enhancement of Methanogenic Archaea Consortia from an Illinois Basin Coalbed via DOL Emulsion Nutrition	PLOS ONE			English	Article							BIOGENIC METHANE; USA	Microbially enhanced coalbed methane technology must be used to increase the methane content in mining and generate secondary biogenic gas. In this technology, the metabolic processes of methanogenic consortia are the basis for the production of biomethane from some of the organic compounds in coal. Thus, culture nutrition plays an important role in re-mediating the nutritional deficiency of a coal seam. To enhance the methane production rates for microorganism consortia, different types of nutrition solutions were examined in this study. Emulsion nutrition solutions containing a novel nutritional supplement, called dystrophy optional modification latex, increased the methane yield for methanogenic consortia. This new nutritional supplement can help methanogenic consortia form an enhanced anaerobic environment, optimize the microbial balance in the consortia, and improve the methane biosynthesis rate.	[Xiao, Dong] China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Xuzhou, Jiang Su Provin, Peoples R China; [Peng, Su-Ping] China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Beijing, Peoples R China; [Wang, En-Yuan] China Univ Min & Technol, Fac Safety Engn, Xuzhou, Jiang Su Provin, Peoples R China	China University of Mining & Technology; China University of Mining & Technology; China University of Mining & Technology	Xiao, D (corresponding author), China Univ Min & Technol, State Key Lab Coal Resources & Safe Min, Xuzhou, Jiang Su Provin, Peoples R China.	dong.shaw@gmail.com		Wang, Enyuan/0000-0003-0239-3015; Xiao, Dong/0000-0001-9055-598X	Youth Science and Technology Found from Jiangsu Science and Technology Project [BK20140199]; Youth Science and Technology Found from CUMT Basic Scientific Research Project [2014QNB41]; State Key Laboratory of Coal Resources and Safe Mining, CUMT [SKLCRSM12X08]; Science and Technology Enterprise Innovation Fund from Jiangsu Science and Technology Department [BC2014066]; Development of Jiangsu Higher Education Institutions (PAPD) [SZBF2011-6-B35]	Youth Science and Technology Found from Jiangsu Science and Technology Project; Youth Science and Technology Found from CUMT Basic Scientific Research Project; State Key Laboratory of Coal Resources and Safe Mining, CUMT; Science and Technology Enterprise Innovation Fund from Jiangsu Science and Technology Department; Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported by Youth Science and Technology Found BK20140199 from Jiangsu Science and Technology Project (http://www.jskjjh.gov.cn), by Youth Science and Technology Found 2014QNB41 from CUMT Basic Scientific Research Project, by State Key Laboratory of Coal Resources and Safe Mining, CUMT (SKLCRSM12X08) (http://skl.cumt.edu.cn/), and by Science and Technology Enterprise Innovation Fund (BC2014066) from Jiangsu Science and Technology Department (http://www.jskjjh.gov.cn), by Development of Jiangsu Higher Education Institutions (PAPD) SZBF2011-6-B35 (http://www.cumt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARCTECH Inc., 1993, TR101572 EPRI, P36; ARCTECH Inc., 1990, BIOL GAS COALS, P130; Barik S, 1998, PREPR PAP AM CHEM SO, V33, P548; Barik S, 1989, INVESTIGATION METABO, P193; Barik S, 1998, P 2 INT S BIOL PROC, P23; Faison B, MICROBIAL TRANSFORMA, P1; Gateway Mine, 2014, PEAB EN; Green MS, 2008, INT J COAL GEOL, V76, P34, DOI 10.1016/j.coal.2008.05.001; Jones EJP, 2008, INT J COAL GEOL, V76, P138, DOI 10.1016/j.coal.2008.05.011; Martini AM, 1998, GEOCHIM COSMOCHIM AC, V62, P1699, DOI 10.1016/S0016-7037(98)00090-8; MCINERNEY MJ, 1988, CAN J MICROBIOL, V34, P487, DOI 10.1139/m88-083; McIntosh J, 2008, INT J COAL GEOL, V76, P111, DOI 10.1016/j.coal.2008.03.004; Olson GJ, 1986, PROCESSING COAL MICR; Patrick CG, 2007, WORLD OIL, V228, P37; Scott AR, 1990, COALBED METHANE SCI, P89; TANNER RS, 2002, MANUAL ENV MICROBIOL, P62; THIELE JH, 1988, APPL ENVIRON MICROB, V54, P20, DOI 10.1128/AEM.54.1.20-29.1988; Winfrey M.R., 1984, PETROLEUM MICROBIOLO, P153	18	5	5	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124386	10.1371/journal.pone.0124386	http://dx.doi.org/10.1371/journal.pone.0124386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884952	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000122
J	Gabaldon, C; Carmona, MJ; Montero-Pau, J; Serra, M				Gabaldon, Carmen; Jose Carmona, Maria; Montero-Pau, Javier; Serra, Manuel			Long-Term Competitive Dynamics of Two Cryptic Rotifer Species: Diapause and Fluctuating Conditions	PLOS ONE			English	Article							RESOURCE COMPETITION; MORPHOLOGICAL STASIS; NICHE CONSERVATISM; EGG BANKS; BRACHIONUS; COEXISTENCE; COMPLEX; DIVERSITY; PATTERNS; POPULATIONS	Life-history traits may have an important role in promoting species coexistence. However, the complexity of certain life cycles makes it difficult to draw conclusions about the conditions for coexistence or exclusion based on the study of short-term competitive dynamics. Brachionus plicatilis and B. manjavacasare two cryptic rotifer species co-occurring in many lakes on the Iberian Peninsula. They have a complex life cycle in which cyclical parthenogenesis occurs with diapausing stages being the result of sexual reproduction. B. plicatilis and B. manjavacasare identical in morphology and size, their biotic niches are broadly overlapping, and they have similar competitive abilities. However, the species differ in life-history traits involving sexual reproduction and diapause, and respond differently to salinity and temperature. As in the case of certain other species that are extremely similar in morphology, a fluctuating environment are considered to be important for their coexistence. We studied the long-term competitive dynamics of B. plicatilis and B. manjavacas under different salinity regimes (constant and fluctuating). Moreover, we focused on the dynamics of the diapausing egg bank to explore how the outcome of the entire life cycle of these rotifers can work to mediate stable coexistence. We demonstrated that these species do not coexist under constant-salinity environment, as the outcome of competition is affected by the level of salinity-at low salinity, B. plicatilis excluded B. manjavacas, and the opposite outcome occurred at high salinity. Competitive dynamics under fluctuating salinity showed that the dominance of one species over the other also tended to fluctuate. The duration of co-occurrence of these species was favoured by salinity fluctuation and perhaps by the existence of a diapausing egg bank. Stable coexistence was not found in our system, which suggests that other factors or other salinity fluctuation patterns might act as stabilizing processes in the wild.	[Gabaldon, Carmen; Jose Carmona, Maria; Montero-Pau, Javier; Serra, Manuel] Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain	University of Valencia	Gabaldon, C (corresponding author), Univ Valencia, Inst Cavanilles Biodiversitat & Biol Evolut, Valencia, Spain.	carmen.gabaldon-tebar@uv.es	Carmona, María José/H-6452-2015; Montero-Pau, Javier/H-6711-2015; GABALDÓN, CARMEN/N-3245-2017; Serra, Manuel/H-7817-2015; Carmona, María José/AAM-4340-2020	Carmona, María José/0000-0002-4835-6933; Montero-Pau, Javier/0000-0002-0864-8157; Serra, Manuel/0000-0003-1731-1529; Carmona, María José/0000-0002-4835-6933	Ministerio de Ciencia; FEDER funds [CGL2009-07364]; Spanish Ministerio de Ciencia e Innovacion [BES2010-036384]	Ministerio de Ciencia(Spanish Government); FEDER funds(European Commission); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government)	This work was funded by a grant to M.S. from the Ministerio de Ciencia co-financed by FEDER funds (project CGL2009-07364). C.G. was supported by a fellowship by the Spanish Ministerio de Ciencia e Innovacion (BES2010-036384). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; [Anonymous], 1877, DIFFERENT FORMS FLOW; [Anonymous], 2014, R LANG ENV STAT COMP; BOERSMA M, 1995, OECOLOGIA, V103, P309, DOI 10.1007/BF00328619; Campillo S, 2005, HYDROBIOLOGIA, V546, P181, DOI 10.1007/s10750-005-4120-7; CHESSON P, 1989, TRENDS ECOL EVOL, V4, P293, DOI 10.1016/0169-5347(89)90024-4; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Ciros-Perez J, 2004, LIMNOL OCEANOGR, V49, P40, DOI 10.4319/lo.2004.49.1.0040; Ciros-Perez J, 2001, J PLANKTON RES, V23, P1311, DOI 10.1093/plankt/23.12.1311; Ciros-Perez J, 2002, OECOLOGIA, V131, P35, DOI 10.1007/s00442-001-0856-6; Ciros-Perez J, 2001, LIMNOL OCEANOGR, V46, P1511, DOI 10.4319/lo.2001.46.6.1511; Comin F.A., 1992, Limnetica, V8, P79; Fontaneto D, 2007, HYDROBIOLOGIA, V583, P297, DOI 10.1007/s10750-007-0573-1; Fournet S, 2000, ENTOMOL EXP APPL, V96, P205, DOI 10.1023/A:1004009205480; Gabaldon C, 2015, J PLANKTON RES; Gabaldon C, 2015, J EXP MAR BIOL ECOL, V465, P142, DOI 10.1016/j.jembe.2015.01.016; Gabaldon C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057087; Garcia-Roger EM, 2006, J EXP MAR BIOL ECOL, V336, P198, DOI 10.1016/j.jembe.2006.05.009; Gomez A, 2002, EVOLUTION, V56, P1431; Gomez A, 1996, J EVOLUTION BIOL, V9, P953, DOI 10.1046/j.1420-9101.1996.9060953.x; Gomez A, 2007, MOL ECOL, V16, P3228, DOI 10.1111/j.1365-294X.2007.03372.x; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; HAGIWARA A, 1985, B JPN SOC SCI FISH, V51, P755; HAGIWARA A, 1989, HYDROBIOLOGIA, V186, P415, DOI 10.1007/BF00048940; HARDIN G, 1960, SCIENCE, V131, P1292, DOI 10.1126/science.131.3409.1292; Hebert PDN, 2004, P NATL ACAD SCI USA, V101, P14812, DOI 10.1073/pnas.0406166101; HEBERT PDN, 1982, ANN ZOOL FENN, V19, P349; IBM Corp R, 2010, IBM SPSS STAT WIND V; King RA, 2008, MOL ECOL, V17, P4684, DOI 10.1111/j.1365-294X.2008.03931.x; Kotani T, 2001, HYDROBIOLOGIA, V446, P283, DOI 10.1023/A:1017584230439; Levin S. A., 2000, ENCY BIODIVERSITY, P79; LOREAU M, 1994, THEOR POPUL BIOL, V46, P58, DOI 10.1006/tpbi.1994.1019; Losos JB, 2008, ECOL LETT, V11, P995, DOI 10.1111/j.1461-0248.2008.01229.x; MINKOFF G, 1983, HYDROBIOLOGIA, V104, P61, DOI 10.1007/BF00045953; Moll JD, 2008, AM NAT, V171, P839, DOI 10.1086/587517; Montero-Pau J, 2014, ECOL MODEL, V272, P76, DOI 10.1016/j.ecolmodel.2013.09.020; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021530; Montero-Pau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020314; Montes C., 1987, SEM BAS CIENT PROT H; Murray TE, 2008, CONSERV GENET, V9, P653, DOI 10.1007/s10592-007-9394-z; Nicholls B, 2006, ECOGRAPHY, V29, P697, DOI 10.1111/j.2006.0906-7590.04575.x; Ortells R, 2003, FRESHWATER BIOL, V48, P2194, DOI 10.1046/j.1365-2427.2003.01159.x; Ortells R, 2000, ARCH HYDROBIOL, V149, P529; Reznick D, 2000, TRENDS ECOL EVOL, V15, P421, DOI 10.1016/S0169-5347(00)01941-8; SEITZ A, 1980, OECOLOGIA, V45, P117, DOI 10.1007/BF00346716; Spaak P, 1994, GENETICAL ECOLOGY CO; Stelzer CP, 2006, LIMNOL OCEANOGR, V51, P125, DOI 10.4319/lo.2006.51.1.0125; Stuart BL, 2006, BIOL LETTERS, V2, P470, DOI 10.1098/rsbl.2006.0505; Tilman D., 1982, Monographs in Population Biology, pi; Violle C, 2011, ECOL LETT, V14, P782, DOI 10.1111/j.1461-0248.2011.01644.x; Wellborn GA, 2007, OECOLOGIA, V154, P175, DOI 10.1007/s00442-007-0816-x; Wiens JJ, 2004, TRENDS ECOL EVOL, V19, P639, DOI 10.1016/j.tree.2004.09.011; Wiens JJ, 2010, ECOL LETT, V13, P1310, DOI 10.1111/j.1461-0248.2010.01515.x	53	12	12	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124406	10.1371/journal.pone.0124406	http://dx.doi.org/10.1371/journal.pone.0124406			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881307	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500098
J	Mahale, A; Othman, MW; Al Shahwan, S; Al Jadaan, I; Owaydha, O; Khan, Z; Edward, DP				Mahale, Alka; Othman, Maha W.; Al Shahwan, Sami; Al Jadaan, Ibrahim; Owaydha, Ohood; Khan, Zahid; Edward, Deepak P.			Altered Expression of Fibrosis Genes in Capsules of Failed Ahmed Glaucoma Valve Implants	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; FILTRATION SURGERY; MOLTENO IMPLANTS; AQUEOUS-HUMOR; IMMUNOHISTOCHEMICAL ANALYSIS; TRABECULAR MESHWORK; DRAINAGE IMPLANTS; BLEB CAPSULES; MITOMYCIN-C; IN-VITRO	Purpose Ahmed glaucoma valve (AGV) implant is an aqueous shunt device used to control intraocular pressure in glaucoma. Implant failure results from impervious encapsulation of the shunt plate causing increased hydraulic resistance and raised intraocular pressure. We hypothesized that deregulation of fibrosis pathway contributes to capsular resistance. We tested this by studying fibrosis related gene expression in failed AGV implants. Methods Differential gene expression was examined in failed AGV capsules and compared to normal control tenon. Following total RNA extraction, 84 key genes in fibrosis pathway were examined by real-time PCR using RT2 Profiler PCR Array. Relative gene expression was calculated using Delta Delta C-t method. Gene specific TaqMan assays were used to validate select genes with >= 2 fold differential expression in the array expression profile. Results We observed differential expression in several genes in the fibrosis pathway. Almost half (39/84) of examined genes showed >= 2 fold differential expression in majority of capsules examined on the array. TaqMan assays for select genes including CCN2 (CTGF), THBS1, SERPINE1, THBS2, COL3A1, MMP3, and IL1A in an increased validation sample set showed significant changes in expression (p value from <0.001 to 0.022) at a high frequency in concurrence with our array results. Conclusions Pathway-focused analyses identified candidate genes with altered expression providing molecular evidence for deregulation of the fibrosis pathway in AGV failure.	[Mahale, Alka; Othman, Maha W.; Al Shahwan, Sami; Al Jadaan, Ibrahim; Owaydha, Ohood; Edward, Deepak P.] King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia; [Khan, Zahid] King Saud Univ, Coll Sci, Dept Biochem, Genome Res Chair, Riyadh 11451, Saudi Arabia; [Edward, Deepak P.] Johns Hopkins Univ, Sch Med, Wilmer Eye Inst, Baltimore, MD 21205 USA	King Khaled Eye Specialist Hospital; King Saud University; Johns Hopkins University; Johns Hopkins Medicine	Mahale, A (corresponding author), King Khalid Eye Specialist Hosp, Riyadh, Saudi Arabia.	amahale@kkesh.med.sa						ADDICKS EM, 1983, ARCH OPHTHALMOL-CHIC, V101, P795; Al-Mobarak F, 2009, OPHTHALMOLOGY, V116, P1862, DOI 10.1016/j.ophtha.2009.03.030; Amini H, 2010, OPHTHALMIC VIS RES, V5, P158; Ayyala RS, 2001, OPHTHALMIC SURG LAS, V32, P248; Bae Kunho, 2012, Korean J Ophthalmol, V26, P265, DOI 10.3341/kjo.2012.26.4.265; Brigstock DR, 2010, J CELL COMMUN SIGNAL, V4, P1, DOI 10.1007/s12079-009-0071-5; Browne JG, 2011, J OPHTHALMOL, V4, P480, DOI [10.3980/j.iss.2222-3959.2011.05.04, DOI 10.3980/J.ISSN.2222-3959.2011.05.04]; Budenz DL, 2011, OPHTHALMOLOGY, V118, P443, DOI 10.1016/j.ophtha.2010.07.016; Chudgar SM, 2006, MOL VIS, V12, P1117; Classen L, 1996, AM J OPHTHALMOL, V122, P205, DOI 10.1016/S0002-9394(14)72011-2; Cordeiro MF, 2003, GENE THER, V10, P59, DOI 10.1038/sj.gt.3301865; Cordeiro MF, 1999, INVEST OPHTH VIS SCI, V40, P2225; Cornish KS, 2009, EYE, V23, P979, DOI 10.1038/eye.2008.113; Costa VP, 2004, OPHTHALMOLOGY, V111, P1071, DOI 10.1016/j.ophtha.2003.09.037; Cui XQ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-210; Dalman MR, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S2-S11; Dempster AG, 2011, INVEST OPHTH VIS SCI, V52, P8300, DOI 10.1167/iovs.11-7772; Desai Manishi A, 2011, Ophthalmic Surg Lasers Imaging, V42, P202, DOI [10.3928/15428877-20110224-94, 10.3928/15428877-20110224-04]; Donaldson DD, 1998, J IMMUNOL, V161, P2317; Eibschitz-Tsimhoni M, 2005, J GLAUCOMA, V14, P276, DOI 10.1097/01.ijg.0000169391.94555.c1; Esson DW, 2004, INVEST OPHTH VIS SCI, V45, P485, DOI 10.1167/iovs.03-0485; Fichtner-Feigl S, 2006, NAT MED, V12, P99, DOI 10.1038/nm1332; Flugel-Koch C, 2004, EXP EYE RES, V79, P649, DOI 10.1016/j.exer.2004.07.005; Freedman J, 2013, INVEST OPHTH VIS SCI, V54, P4851, DOI 10.1167/iovs.13-12274; Friedlander M, 2007, J CLIN INVEST, V117, P576, DOI 10.1172/JCI31030; Hill RA, 2000, AM J OPHTHALMOL, V129, P608, DOI 10.1016/S0002-9394(99)00465-1; Hiscott P, 2006, PROG RETIN EYE RES, V25, P1, DOI 10.1016/j.preteyeres.2005.05.001; JAMPEL HD, 1988, ARCH OPHTHALMOL-CHIC, V106, P89; Jung KI, 2013, OPHTHALMOLOGY, V120, P978, DOI 10.1016/j.ophtha.2012.10.015; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Kahook MY, 2010, AM J OPHTHALMOL, V150, P399, DOI 10.1016/j.ajo.2010.03.025; KARALEKAS D, 1994, INVEST OPHTH VIS SCI, V35, P1898; Kim J, 2014, J GLAUCOMA, V23, pE91, DOI 10.1097/IJG.0b013e3182955d73; Lama PJ, 2003, SURV OPHTHALMOL, V48, P314, DOI 10.1016/S0039-6257(03)00038-9; Lehmann OJ, 2000, BRIT J OPHTHALMOL, V84, P1349, DOI 10.1136/bjo.84.12.1349; Lockwood A, 2013, CURR OPIN PHARMACOL, V13, P65, DOI 10.1016/j.coph.2012.10.008; LOEFFLER KU, 1988, BRIT J OPHTHALMOL, V72, P29, DOI 10.1136/bjo.72.1.29; Meyer-ter-Vehn T, 2008, MOL VIS, V14, P136; Minckler DS, 2008, OPHTHALMOLOGY, V115, P1089, DOI 10.1016/j.ophtha.2008.03.031; Molteno ACB, 2003, OPHTHALMOLOGY, V110, P2198, DOI 10.1016/S0161-6420(03)00803-0; Molteno ACB, 2006, INVEST OPHTH VIS SCI, V47, P1975, DOI 10.1167/iovs.05-0988; Morgan WH, 2012, CLIN EXP OPHTHALMOL, V40, P388, DOI 10.1111/j.1442-9071.2012.02769.x; Patel S, 2010, SEMIN OPHTHALMOL, V25, P265, DOI 10.3109/08820538.2010.518840; RUBIN B, 1990, AM J OPHTHALMOL, V110, P371, DOI 10.1016/S0002-9394(14)77017-5; Sapitro J, 2010, MOL VIS, V16, P1880; Schwartz KS, 2006, CURR OPIN OPHTHALMOL, V17, P181, DOI 10.1097/01.icu.0000193080.55240.7e; Sherwood Mark Brian, 2006, Trans Am Ophthalmol Soc, V104, P478; Thieme H, 2011, J GLAUCOMA, V20, P246, DOI 10.1097/IJG.0b013e3181e080ef; Tripathi R C, 1994, J Glaucoma, V3, P248; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Valimaki J, 2014, ACTA OPHTHALMOL, V92, P524, DOI 10.1111/aos.12267; Van Bergen T, 2014, CLIN OPHTHALMOL, V8, P857, DOI 10.2147/OPTH.S48745; VANBUSKIRK EM, 1982, AM J OPHTHALMOL, V94, P522, DOI 10.1016/0002-9394(82)90248-3; Wallace DM, 2014, MATRIX BIOL; Wang JM, 2011, INVEST OPHTH VIS SCI, V52, P3660, DOI [10.1167/iovs.10-5209, DOI 10.1167/I0VS.10-5209]; Watson JC, 2005, BIOMED SCI INSTRUM, V41, P394; Wong TT, 2009, OPHTHALMOLOGY, V116, P175, DOI 10.1016/j.ophtha.2008.09.049; Wood N, 2003, J EXP MED, V197, P703, DOI 10.1084/jem.20020906	58	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122409	10.1371/journal.pone.0122409	http://dx.doi.org/10.1371/journal.pone.0122409			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879570	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500021
J	Pegurri, E; Konings, E; Crandall, B; Haile-Selassie, H; Matinhure, N; Naamara, W; Assefa, Y				Pegurri, Elisabetta; Konings, Elke; Crandall, Bud; Haile-Selassie, Hiwot; Matinhure, Nelia; Naamara, Warren; Assefa, Yibeltal			The Missed HIV-Positive Children of Ethiopia	PLOS ONE			English	Article							ADOLESCENTS; INFECTION; AFRICA; ADULTS	Objective As elsewhere, due to scarcity of data and limited awareness of HIV infection, especially in older children, the HIV epidemic among Ethiopian children appears neglected in national programs (children ART coverage is of only 12% in 2013). This paper estimates the country burden of HIV in older children and investigates the prevalence of HIV in orphans and vulnerable children (OVC) households. Design/Methods We analyzed national HIV data for Ethiopia, using Spectrum/Estimation and Projection Package (EPP) and primary data on children living in households with at least one HIV-positive adult in the Amhara and Tigrai regions. Descriptive analysis of the age and sex distribution of HIV-positive OVC in Ethiopia was performed. Results Our Spectrum/EPP analysis estimated the population of HIV-positive children under 15 years old to be 160,000 in 2013. The majority of children (81.6%) were aged five to 14 years. The estimated number of orphans due to AIDS was 800,000. The empirical data from almost 10,000 OVC under 18 years showed 11. 9% were HIV-positive, the majority of whom were between five and 10 years old with no significant difference between males and females. Conclusions There is a large population of children living with HIV in Ethiopia, the magnitude of which not previously recognized. The majority were vertically infected and never identified nor linked into treatment. OVC represent a reachable group which could account for a substantial proportion of the HIV infected older children. We recommend that HIV programs urgently synergize with social protection sectors and address these children with HIV testing and related services.	[Pegurri, Elisabetta; Naamara, Warren] Joint United Nations Programme HIV AIDS UNAIDS, Addis Ababa, Ethiopia; [Konings, Elke; Crandall, Bud] Management Sci Hlth, Addis Ababa, Ethiopia; [Matinhure, Nelia] Save Children, Addis Ababa, Ethiopia; [Assefa, Yibeltal] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia	Save the Children	Pegurri, E (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, Addis Ababa, Ethiopia.	pegurrie@unaids.org	Assefa, Yibeltal/N-5984-2016; Assefa, Yibeltal/ABI-8057-2020	Assefa, Yibeltal/0000-0003-2393-1492; Assefa, Yibeltal/0000-0003-2393-1492	PEPFAR; United States Agency for International Development (USAID) [RFA: 663-11-000005]	PEPFAR; United States Agency for International Development (USAID)(United States Agency for International Development (USAID))	The empirical data from Amhara and Tigrai was obtained through the USAID ENHAT-CS program, which is funded by PEPFAR and implemented by an MSH-led consortium of international and Ethiopian organizations; the publication thereof was made possible by the generous support of the American People through the United States Agency for International Development (USAID) under RFA: 663-11-000005. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the United States Government nor the Joint United Nations Programme on HIV/AIDS (UNAIDS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Augusto GF, 2012, LANCET INFECT DIS, V12, P664, DOI 10.1016/S1473-3099(12)70211-6; Braitstein P, 2011, 6 IAS C HIV PATH TRE; EFMOH, 2013, NAT STRAT PLAN EL MO; Ethiopia CSA, 2012, ETH DEM HLTH SURV 20; Ethiopian Health and Nutrition Institute (EHNRI) and Ethiopia Ministry of Health (EMOH), 2012, HIV REL EST PROJ ETH; Ferrand RA, 2011, AM J PUBLIC HEALTH, V101, P2325, DOI 10.2105/AJPH.2011.300250; Ferrand RA, 2011, TROP MED INT HEALTH, V16, P349, DOI 10.1111/j.1365-3156.2010.02708.x; Ferrand RA, 2010, CLIN INFECT DIS, V51, P844, DOI 10.1086/656361; Ferrand RA, 2009, AIDS, V23, P2039, DOI 10.1097/QAD.0b013e32833016ce; FHAPCO, 2013, ANN PERF REP EFY 200; FHAPCO, 2007, GUID HIV COUNS TEST; IDF (International Diabetes Federation), 2021, CONSOLIDATED GUIDELI, V10th ed.; Lowenthal ED, 2014, LANCET INFECT DIS, V14, P627, DOI 10.1016/S1473-3099(13)70363-3; Marston M, 2011, INT J EPIDEMIOL, V40, P385, DOI 10.1093/ije/dyq255; MOWCYA, 2010, STAND SERV DEL GUID; Musoke P., 2011, 3 HIV PED WORKSH 201; Nachega JB, 2009, JAIDS-J ACQ IMM DEF, V51, P65, DOI 10.1097/QAI.0b013e318199072e; Operario D, 2011, J INT AIDS SOC, V14, DOI 10.1186/1758-2652-14-25; Pitorak H, 2013, MAPPING HIV SERVICES; Stover J, 2012, SEX TRANSM INFECT, V88, pI11, DOI 10.1136/sextrans-2012-050640; TRHB/THAPCO FHAPCO UNAIDS, 2012, TIGR REG STAT SYNTH; UNAIDS, 2013, REP GLOB AIDS EP; UNAIDS, 2014, THE GAP REP; UNAIDS (Joint United Nations Programme on HIV/AIDS), 2015, TREATM 2015; Vreeman RC, 2011, PRESENTED AT THE 3TH; WHO, 2011, WHOHIV1102	26	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124041	10.1371/journal.pone.0124041	http://dx.doi.org/10.1371/journal.pone.0124041			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879446	gold, Green Submitted, Green Published			2022-12-27	WOS:000353016500080
J	Ramsay, DS; Al-Noori, S; Shao, JS; Leroux, BG; Woods, SC; Kaiyala, KJ				Ramsay, Douglas S.; Al-Noori, Salwa; Shao, Jason; Leroux, Brian G.; Woods, Stephen C.; Kaiyala, Karl J.			Predicting Addictive Vulnerability: Individual Differences in Initial Responding to a Drug's Pharmacological Effects	PLOS ONE			English	Article							NITROUS-OXIDE; SUBJECTIVE RESPONSE; ALCOHOL CHALLENGE; NUCLEUS-ACCUMBENS; GENERAL-THEORY; STRESS; TOLERANCE; LEVEL; HYPOTHERMIA; TRANSITION	Considerable data suggest that individuals who appear minimally disrupted during an initial drug administration have elevated risk for abusing the drug later. A better understanding of this association could lead to more effective strategies for preventing and treating drug addiction. To investigate this phenomenon using a rigorous experimental model, we first administered the abused inhalant nitrous oxide (N2O) to rats in a total calorimetry and temperature system to identify groups that were sensitive or insensitive to the drug's hypothermic effect. We then enrolled the two groups in a novel N2O self-administration paradigm. The initially insensitive rats self-administered significantly more N2O than sensitive rats, an important step in the transition to addiction. Continuous non-invasive measurement of core temperature and its underlying determinants during screening revealed that both groups had similarly increased heat loss during initial N2O administration, but that insensitive rats generated more heat and thereby remained relatively normothermic. Calorimetry testing conducted after self-administration revealed that whereas N2O's effect on heat loss persisted comparably for both groups, initially insensitive rats actually over-responded by generating excess heat and becoming hyperthermic. Thus, rats with the greatest initial heat-producing compensatory response(s) appeared initially insensitive to N2O-induced hypothermia, subsequently self-administered more N2O, and developed hyperthermic overcompensation during N2O inhalation, consistent with increased abuse potential and an allostatic model of addictive vulnerability.	[Ramsay, Douglas S.; Al-Noori, Salwa; Leroux, Brian G.; Kaiyala, Karl J.] Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA; [Shao, Jason; Leroux, Brian G.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Woods, Stephen C.] Univ Cincinnati, Dept Psychiat & Behav Neurosci, Cincinnati, OH USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Cincinnati	Ramsay, DS (corresponding author), Univ Washington, Dept Oral Hlth Sci, Seattle, WA 98195 USA.	ramsay@uw.edu	Leroux, Brian G/H-2254-2015		National Institute on Drug Abuse [R01DA023484]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [T90DE021984] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA023484] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by grant #R01DA023484 (DSR) from the National Institute on Drug Abuse. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitchison J, 2003, STAT ANAL COMPOSITIO; Balster RL, 1998, DRUG ALCOHOL DEPEN, V51, P207, DOI 10.1016/S0376-8716(98)00078-7; Barrot M, 2000, EUR J NEUROSCI, V12, P973, DOI 10.1046/j.1460-9568.2000.00996.x; Belin D, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a011940; Blanchard MM, 2009, NEUROSCI BIOBEHAV R, V33, P1145, DOI 10.1016/j.neubiorev.2009.05.009; Crabbe JC, 2010, ADDICT BIOL, V15, P125, DOI 10.1111/j.1369-1600.2009.00191.x; de Wit H, 2012, NEUROSCI BIOBEHAV R, V36, P1565, DOI 10.1016/j.neubiorev.2012.04.005; Deroche-Gamonet V, 2004, SCIENCE, V305, P1014, DOI 10.1126/science.1099020; Dworkin BR, 1993, LEARNING PHYSL REGUL; Grubman J, 1982, INT C SERIES, V620, P259; HAEFELY W, 1986, PHARMACOPSYCHIATRY, V19, P353, DOI 10.1055/s-2007-1025061; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P243, DOI 10.1007/s00213-006-0657-z; Kaiyala KJ, 2007, PSYCHOPHARMACOLOGY, V191, P233, DOI 10.1007/s00213-006-0655-1; Kaiyala KJ, 2012, J THERM BIOL, V37, P30, DOI 10.1016/j.jtherbio.2011.10.004; Kaiyala KJ, 2011, COMP BIOCHEM PHYS A, V158, P252, DOI 10.1016/j.cbpa.2010.04.013; Kaiyala KJ, 2005, AM J PHYSIOL-REG I, V288, pR692, DOI 10.1152/ajpregu.00412.2004; Koob GF, 2008, ANNU REV PSYCHOL, V59, P29, DOI 10.1146/annurev.psych.59.103006.093548; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Marinelli M, 2002, EUR J NEUROSCI, V16, P387, DOI 10.1046/j.1460-9568.2002.02089.x; MCEWEN BS, 1993, ARCH INTERN MED, V153, P2093, DOI 10.1001/archinte.153.18.2093; Pawlowsky-Glahn V, 2006, GEOL SOC SPEC PUBL, V264, P1, DOI 10.1144/GSL.SP.2006.264.01.01; Peters A, 2012, PHYSIOL BEHAV, V106, P1, DOI 10.1016/j.physbeh.2011.12.019; Piazza PV, 2014, PSYCHOPHARMACOLOGY, V231, P3929, DOI 10.1007/s00213-014-3628-9; Piazza PV, 2013, PSYCHOPHARMACOLOGY, V229, P387, DOI 10.1007/s00213-013-3224-4; Piazza PV, 1998, TRENDS PHARMACOL SCI, V19, P67, DOI 10.1016/S0165-6147(97)01115-2; PIAZZA PV, 1989, SCIENCE, V245, P1511, DOI 10.1126/science.2781295; Piazza PV, 1996, ANNU REV PHARMACOL, V36, P359, DOI 10.1146/annurev.pa.36.040196.002043; Quinn PD, 2011, ALCOHOL CLIN EXP RES, V35, P1759, DOI 10.1111/j.1530-0277.2011.01521.x; Ramsay Douglas S, 2014, Temperature (Austin), V1, P157, DOI 10.4161/23328940.2014.982048; Ramsay DS, 2014, PSYCHOL REV, V121, P225, DOI 10.1037/a0035942; Ramsay DS, 2005, PSYCHOPHARMACOLOGY, V181, P48, DOI 10.1007/s00213-005-2219-1; Ramsay DS, 2003, PHARMACOL BIOCHEM BE, V74, P623, DOI 10.1016/S0091-3057(02)01048-1; Ramsay DS, 1997, PSYCHOL REV, V104, P170, DOI 10.1037/0033-295X.104.1.170; Ramsay DS, 2014, TEMPERATURE, V1, P162, DOI [10.1093/emph/eou030, DOI 10.1093/EMPH/E0U030]; Ramsay DS, 2014, TEMPERATURE, V1, P151, DOI [10.1182/asheducation-2014.1.151, DOI 10.1182/ASHEDUCATION-2014.1.151]; Rouge-Pont F, 1998, EUR J NEUROSCI, V10, P3903, DOI 10.1046/j.1460-9568.1998.00438.x; Schilling K, 2012, J NEUROSCI, V32, P12651, DOI 10.1523/JNEUROSCI.1452-12.2012; Schuckit MA, 1996, ARCH GEN PSYCHIAT, V53, P202; SCHUCKIT MA, 1980, J STUD ALCOHOL, V41, P242, DOI 10.15288/jsa.1980.41.242; SCHUCKIT MA, 1988, ARCH GEN PSYCHIAT, V45, P211; SCHUCKIT MA, 1994, AM J PSYCHIAT, V151, P184; Schuckit MA, 2011, ALCOHOL CLIN EXP RES, V35, P1723, DOI 10.1111/j.1530-0277.2011.01561.x; Schuckit MA, 2009, J SUBST ABUSE TREAT, V36, pS5, DOI 10.1016/j.jsat.2008.05.012; Siegel S, 2000, EXP CLIN PSYCHOPHARM, V8, P276, DOI 10.1037/1064-1297.8.3.276; Trudell J.R., 1985, NITROUS OXIDE N2O, P203; van den Boogaart K, 2013, ANAL COMPOSITIONAL D; Walker DJ, 2002, DRUG ALCOHOL DEPEN, V66, P93, DOI 10.1016/S0376-8716(01)00188-0; WOOD RW, 1977, J PHARMACOL EXP THER, V202, P491	48	9	9	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124740	10.1371/journal.pone.0124740	http://dx.doi.org/10.1371/journal.pone.0124740			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880426	gold, Green Published, Green Submitted			2022-12-27	WOS:000353016500109
J	Wang, SX; Zhai, X; Li, SY; McCabe, MF; Wang, X; Rong, PJ				Wang, Shuxing; Zhai, Xu; Li, Shaoyuan; McCabe, Michael F.; Wang, Xing; Rong, Peijing			Transcutaneous Vagus Nerve Stimulation Induces Tidal Melatonin Secretion and Has an Antidiabetic Effect in Zucker Fatty Rats	PLOS ONE			English	Article							FAR-FIELD POTENTIALS; BRAIN-STEM; HALF-LIFE; CELLS; RECEPTORS; INSULIN; MOUSE; OBESITY; PLASMA	Melatonin plays a protective role in type 2 diabetes (T2D) through regulation of glucose metabolism. Whether transcutaneous vagus nerve stimulation (taVNS) is antidiabetic and whether a modulated melatonin production is involved in the antidiabetic mechanism of taVNS is unknown. In this study, once daily 30min noninvasive taVNS was administered in Zucker diabetic fatty (ZDF, fa/fa) and Zucker lean (ZL, +/fa) littermates under anesthesia for 5 consecutive weeks. The acute and chronic influences of taVNS on the secretion of melatonin were studied as well as the effects of taVNS on blood glucose metabolism. We found that naive ZDF rats develop hyperglycemia naturally with age. Each taVNS session would trigger a tidal secretion of melatonin both during and after the taVNS procedure and induce an acute two-phase glycemic change, a steep increase followed by a gradual decrease. Once daily taVNS sessions eventually reduced the glucose concentration to a normal level in seven days and effectively maintained the normal glycemic and plasma glycosylated hemoglobin (HbA(lc)) levels when applied for five consecutive weeks. These beneficial effects of taVNS also exist in pinealectomized rats, which otherwise would show overt and continuous hyperglycemia, hyperinsulinemia, and high HbA(lc) levels. We concluded that multiple taVNS sessions are antidiabetic in T2D through triggering of tidal secretion of melatonin. This finding may have potential importance in developing new approaches to the treatment of T2D, which is highly prevalent, incurable with any current approaches, and very costly to the world.	[Wang, Shuxing; Wang, Xing] Xinxiang Med Univ, Dept Anat, Xinxiang, Henan Province, Peoples R China; [Wang, Shuxing; Zhai, Xu; Li, Shaoyuan; Rong, Peijing] China Acad Chinese Med Sci, Inst Acupuncture & Moxibust, Dept Physiol, Beijing, Peoples R China; [Wang, Shuxing; McCabe, Michael F.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, MGH Ctr Translat Pain Res,Dept Anesthesia Crit Ca, Boston, MA USA; [Wang, Shuxing] Guangdong Landau Biotechnol Inc Ltd, Guangzhou, Guangdong, Peoples R China	Xinxiang Medical University; China Academy of Chinese Medical Sciences; Institute of Acupuncture & Moxibustion, CACMS; Harvard University; Harvard Medical School; Massachusetts General Hospital	Wang, SX (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	shuxingw@yahoo.com; rongpj@hotmail.com			National Natural Science Foundation of China [81271243, 81473780]; Natural Science Foundation of Beijing [7111007]; National Basic Research Program of China (973 Program) [2012CB518503];  [2012BAF14B10]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); National Basic Research Program of China (973 Program)(National Basic Research Program of China); 	This work was supported by National Natural Science Foundation of China-81271243, 81473780; Natural Science Foundation of Beijing, 7111007; National Basic Research Program of China (973 Program) -2012CB518503; and Project Supported National Science and Technology Ministry-2012BAF14B10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahr I, 2011, J PINEAL RES, V50, P336, DOI 10.1111/j.1600-079X.2010.00848.x; Belivani M, 2013, ACUPUNCT MED, V31, P88, DOI 10.1136/acupmed-2012-010247; Bubenik GA, 2002, DIGEST DIS SCI, V47, P2336, DOI 10.1023/A:1020107915919; Conti A, 2000, J PINEAL RES, V28, P193, DOI 10.1034/j.1600-079X.2000.280401.x; Contreras-Alcantara S, 2010, OBESITY, V18, P1861, DOI 10.1038/oby.2010.24; Dantzer R, 2000, AUTON NEUROSCI-BASIC, V85, P60, DOI 10.1016/S1566-0702(00)00220-4; Dubocovich ML, 2010, PHARMACOL REV, V62, P343, DOI 10.1124/pr.110.002832; Fallgatter AJ, 2005, INT J PSYCHOPHYSIOL, V56, P37, DOI 10.1016/j.ijpsycho.2004.09.007; Fallgatter AJ, 2003, J NEURAL TRANSM, V110, P1437, DOI 10.1007/s00702-003-0087-6; Frese T, 2009, LIFE SCI, V85, P526, DOI 10.1016/j.lfs.2009.08.004; Fu Z, 2013, CURR DIABETES REV, V9, P25, DOI 10.2174/157339913804143225; Gerdin MJ, 2004, BIOCHEM PHARMACOL, V67, P2023, DOI 10.1016/j.bcp.2004.01.027; GIBBS FP, 1981, ENDOCRINOLOGY, V109, P1796, DOI 10.1210/endo-109-5-1796; Kniaz'kin I V, 2008, Adv Gerontol, V21, P80; La Marca R, 2010, CLIN SCI, V118, P537, DOI 10.1042/CS20090264; Langenberg C, 2009, DIABETOLOGIA, V52, P1537, DOI 10.1007/s00125-009-1392-x; Li SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111100; Liu RP, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/789674; Maganhin CC, 2009, ACTA CIR BRAS, V24, P321, DOI 10.1590/S0102-86502009000400013; MATTHEWS DR, 1985, CLIN ENDOCRINOL, V23, P71, DOI 10.1111/j.1365-2265.1985.tb00185.x; McMullan CJ, 2013, JAMA-J AM MED ASSOC, V309, P1388, DOI 10.1001/jama.2013.2710; Muhlbauer E, 2012, J PINEAL RES, V52, P446, DOI 10.1111/j.1600-079X.2012.00959.x; Nagorny CLF, 2011, J PINEAL RES, V50, P412, DOI 10.1111/j.1600-079X.2011.00859.x; Nogueira TC, 2011, ENDOCRINOLOGY, V152, P1253, DOI 10.1210/en.2010-1088; Oleson T, 2002, NEUROREHABILITATION, V17, P49; OZAKI Y, 1976, ENDOCRINOLOGY, V99, P641, DOI 10.1210/endo-99-2-641; Peplow PV, 2012, J ACUPUNCT MERIDIAN, V5, P1, DOI 10.1016/j.jams.2011.11.018; Peschke E, 2007, J PINEAL RES, V42, P350, DOI 10.1111/j.1600-079X.2007.00426.x; Rong PJ, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-255; Round R., 2013, EVID-BASED COMPL ALT, V2013, P984763, DOI DOI 10.1155/2013/984763; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; Stumpf I, 2009, J PINEAL RES, V46, P140, DOI 10.1111/j.1600-079X.2008.00638.x; Vinik AI, 2011, DIABETIC MED, V28, P643, DOI 10.1111/j.1464-5491.2010.03184.x; WURTMAN RJ, 1978, J NEURAL TRANSM, P59	34	22	26	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124195	10.1371/journal.pone.0124195	http://dx.doi.org/10.1371/journal.pone.0124195			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880500	Green Published, Green Submitted, gold			2022-12-27	WOS:000353016500089
J	Zhang, Q; Zhou, W; Liang, GQ; Wang, XB; Sun, JW; He, P; Li, LJ				Zhang, Qian; Zhou, Wei; Liang, Guoqing; Wang, Xiubin; Sun, Jingwen; He, Ping; Li, Lujiu			Effects of Different Organic Manures on the Biochemical and Microbial Characteristics of Albic Paddy Soil in a Short-Term Experiment	PLOS ONE			English	Article							BACTERIAL COMMUNITY STRUCTURE; ENZYME-ACTIVITY; AGRICULTURAL MANAGEMENT; INORGANIC FERTILIZERS; CARBON; NITROGEN; DIVERSITY; BIOMASS; DECOMPOSITION; AMENDMENTS	This study aimed to evaluate the effects of chemical fertilizer (NPK), NPK with livestock manure (NPK+M), NPK with straw (NPK+S), and NPK with green manure (NPK+G) on soil enzyme activities and microbial characteristics of albic paddy soil, which is a typical soil with low productivity in China. The responses of extracellular enzyme activities and the microbial community diversity (determined by phospholipid fatty acid analysis [PLFA] and denaturing gradient gel electrophoresis [DGGE]) were measured. The results showed that NPK+M and NPK+S significantly increased rice yield, with NPK+M being approximately 24% greater than NPK. The NPK+M significantly increased soil organic carbon (SOC) and available phosphate (P) and enhanced phosphatase, beta-cellobiosidase, L-leucine aminopeptidase and urease activities. The NPK+S significantly increased SOC and available potassium (K) and significantly enhanced N-acetyl-glucosamidase, beta-xylosidase, urease, and phenol oxidase activities. The NPK+G significantly improved total nitrogen (N), ammonium N, available P, and N-acetyl-glucosamidase activity. The PLFA biomass was highest under NPK+S, followed by NPK+M and NPK+G treatments. Principal component analysis (PCA) of the PLFA indicated that soils with NPK+M and NPK+S contained higher proportions of unsaturated and cyclopropane fatty acids (biomarkers of fungi and gram-negative bacteria) and soil under NPK+G contained more straight chain saturated fatty acids (representing gram-positive bacteria). PCA of the DGGE patterns showed that organic amendments had a greater influence on fungal community. Cluster analysis of fungal DGGE patterns revealed that NPK+G was clearly separated. Meanwhile, the bacterial community of NPK+M treatment was the most distinct. RDA analysis revealed changes of microbial community composition mostly depended on beta-xylosidase, beta-cellobiosidase activities, total N and available K contents. The abundances of gram-negative bacterial and fungal PLFAs probably effective in improving fertility of low-yield albic paddy soil because of their significant influence on DGGE profile.	[Zhang, Qian; Zhou, Wei; Liang, Guoqing; Wang, Xiubin; Sun, Jingwen; He, Ping] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizat, Beijing 100193, Peoples R China; [Li, Lujiu] Anhui Acad Agr Sci, Inst Soil & Fertilizer, Hefei, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Anhui Academy of Agricultural Sciences	Zhou, W (corresponding author), Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Minist Agr, Key Lab Plant Nutr & Fertilizat, Beijing 100193, Peoples R China.	wzhou@caas.ac.cn; gqliang@caas.ac.cn	Zhang, Kevin/F-5215-2010; He, Ping/HGD-5389-2022		earmarked fund for China Agriculture Research System [CARS-01-31]; National Basic Research Program of China [2013CB127405]; National Natural Science Foundation of China [31471943]; Special Fund for Agro-scientific Research in the Public Interest [201003016]	earmarked fund for China Agriculture Research System; National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This research was supported by the earmarked fund for China Agriculture Research System (CARS-01-31), the National Basic Research Program of China (2013CB127405), the National Natural Science Foundation of China (Grant no. 31471943), and the Special Fund for Agro-scientific Research in the Public Interest (201003016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Ai C, 2012, GEODERMA, V173, P330, DOI 10.1016/j.geoderma.2011.07.020; Allison SD, 2006, SOIL BIOL BIOCHEM, V38, P3245, DOI 10.1016/j.soilbio.2006.04.011; Anderson IC, 2003, ENVIRON MICROBIOL, V5, P1121, DOI [10.1046/j.1462-2920.2003.00522.x, 10.1046/j.1462-2920.2003.00383.x]; Anderson TH, 2003, AGR ECOSYST ENVIRON, V98, P285, DOI 10.1016/S0167-8809(03)00088-4; Barzegar AR, 2002, PLANT SOIL, V247, P295, DOI 10.1023/A:1021561628045; Bending GD, 2004, SOIL BIOL BIOCHEM, V36, P1785, DOI 10.1016/j.soilbio.2004.04.035; Bohme L, 2006, EUR J SOIL BIOL, V42, P1, DOI 10.1016/j.ejsobi.2005.08.001; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; Bossio DA, 1998, MICROBIAL ECOL, V35, P265, DOI 10.1007/s002489900082; BOWEN RM, 1990, SOIL BIOL BIOCHEM, V22, P393, DOI 10.1016/0038-0717(90)90118-J; Bremner J.M., 1982, METHODS SOIL ANAL, P575, DOI [DOI 10.2134/AGRONMONOGR9.2.2ED.C31, DOI 10.2134/AGR0NM0N0GR9.2.2ED.C31]; Buyer JS, 2010, SOIL BIOL BIOCHEM, V42, P831, DOI 10.1016/j.soilbio.2010.01.020; Caliz J, 2011, FEMS MICROBIOL ECOL, V78, P150, DOI 10.1111/j.1574-6941.2011.01093.x; CHRISTENSEN BT, 1986, SOIL BIOL BIOCHEM, V18, P523, DOI 10.1016/0038-0717(86)90010-6; Chu HY, 2007, SOIL BIOL BIOCHEM, V39, P2971, DOI 10.1016/j.soilbio.2007.05.031; Chu HY, 2010, ENVIRON MICROBIOL, V12, P2998, DOI 10.1111/j.1462-2920.2010.02277.x; Dai ZhiGang, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P272; de Vries FT, 2006, SOIL BIOL BIOCHEM, V38, P2092, DOI 10.1016/j.soilbio.2006.01.008; de Vries FT, 2012, ECOL LETT, V15, P1230, DOI 10.1111/j.1461-0248.2012.01844.x; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Deng SP, 2006, APPL SOIL ECOL, V33, P258, DOI 10.1016/j.apsoil.2005.10.004; Dinesh R, 2010, BIORESOURCE TECHNOL, V101, P4697, DOI 10.1016/j.biortech.2010.01.108; Drenovsky RE, 2004, MICROB ECOL, V48, P424, DOI 10.1007/s00248-003-1063-2; Esperschutz J, 2009, SOIL BIOL BIOCHEM, V41, P1976, DOI 10.1016/j.soilbio.2009.07.002; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Gil-Sotres F, 2005, SOIL BIOL BIOCHEM, V37, P877, DOI 10.1016/j.soilbio.2004.10.003; Green CT, 2000, HYDROGEOL J, V8, P126, DOI 10.1007/s100400050013; Hao XH, 2008, NUTR CYCL AGROECOSYS, V81, P17, DOI 10.1007/s10705-007-9145-z; Helgason BL, 2010, APPL SOIL ECOL, V46, P390, DOI 10.1016/j.apsoil.2010.10.002; Hill GT, 2000, APPL SOIL ECOL, V15, P25, DOI 10.1016/S0929-1393(00)00069-X; Horwath W.R., 1996, METHODS SOIL ANAL PA, P753; Huang QR, 2009, PEDOSPHERE, V19, P727, DOI 10.1016/S1002-0160(09)60168-5; Jin G, 2007, J ENVIRON SCI HEAL A, V42, P1639, DOI 10.1080/10934520701518125; Jones RT, 2009, ISME J, V3, P442, DOI 10.1038/ismej.2008.127; KALEMBASA SJ, 1973, J SCI FOOD AGR, V24, P1085, DOI 10.1002/jsfa.2740240910; KENNEDY AC, 1995, PLANT SOIL, V170, P75, DOI 10.1007/BF02183056; Kimura M, 2006, BIOL FERT SOILS, V43, P20, DOI 10.1007/s00374-005-0057-2; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Larkin RP, 2006, BIOL FERT SOILS, V43, P51, DOI 10.1007/s00374-005-0060-7; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Li FengYu, 2009, Plant Nutrition and Fertilizer Science, V15, P374; Ling N, 2014, BIOL FERT SOILS, V50, P901, DOI 10.1007/s00374-014-0911-1; Liu MQ, 2009, APPL SOIL ECOL, V42, P166, DOI 10.1016/j.apsoil.2009.03.006; Lu RK, 2000, AGR SCI TECHNOLOGY; Mandal A, 2007, BIORESOURCE TECHNOL, V98, P3585, DOI 10.1016/j.biortech.2006.11.027; Marschner P, 2003, SOIL BIOL BIOCHEM, V35, P453, DOI 10.1016/S0038-0717(02)00297-3; Mele PM, 2008, AGR ECOSYST ENVIRON, V126, P139, DOI 10.1016/j.agee.2007.12.008; Moeskops B, 2012, PEDOBIOLOGIA, V55, P175, DOI 10.1016/j.pedobi.2012.03.001; Moeskops B, 2010, APPL SOIL ECOL, V45, P112, DOI 10.1016/j.apsoil.2010.03.005; Muyzer G, 1999, CURR OPIN MICROBIOL, V2, P317, DOI 10.1016/S1369-5274(99)80055-1; Nakatsu CH, 2000, SOIL SCI SOC AM J, V64, P1382, DOI 10.2136/sssaj2000.6441382x; Nannipieri P, 2012, BIOL FERT SOILS, V48, P743, DOI 10.1007/s00374-012-0723-0; Navarrete AA, 2013, FEMS MICROBIOL ECOL, V83, P607, DOI 10.1111/1574-6941.12018; Nelson P. N., 1998, SODIC SOILS DISTRIBU, P51; Olsen S. R., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P403; Pan GX, 2004, GLOBAL CHANGE BIOL, V10, P79, DOI 10.1111/j.1365-2486.2003.00717.x; Potthoff M, 2001, SOIL BIOL BIOCHEM, V33, P583, DOI 10.1016/S0038-0717(00)00200-5; Rajendran N, 1997, MAR POLLUT BULL, V34, P26, DOI 10.1016/S0025-326X(96)00057-4; Ramesh P, 2006, INDIAN J AGR SCI, V76, P252; Rashid MI, 2013, SOIL BIOL BIOCHEM, V57, P320, DOI 10.1016/j.soilbio.2012.10.005; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Shen CC, 2013, SOIL BIOL BIOCHEM, V57, P204, DOI 10.1016/j.soilbio.2012.07.013; Stark C, 2007, APPL SOIL ECOL, V35, P79, DOI 10.1016/j.apsoil.2006.05.001; Stark CH, 2008, SOIL BIOL BIOCHEM, V40, P1352, DOI 10.1016/j.soilbio.2007.09.025; Gil SV, 2011, EUR J SOIL BIOL, V47, P55, DOI 10.1016/j.ejsobi.2010.11.006; Wang QL, 2008, GEODERMA, V144, P502, DOI 10.1016/j.geoderma.2008.01.003; Wittmann C, 2004, SOIL BIOL BIOCHEM, V36, P425, DOI 10.1016/j.soilbio.2003.10.019; Wu YP, 2009, GEODERMA, V150, P171, DOI 10.1016/j.geoderma.2009.02.003; Yao H, 2000, MICROB ECOL, V40, P223; [于群英 Yu Qunying], 2004, [安徽农业科学, Journal of anhui agricultural sciences], V32, P1161; Zhao JP, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085054, 10.1371/journal.pone.0108005]; Zhong WH, 2007, APPL SOIL ECOL, V36, P84, DOI 10.1016/j.apsoil.2006.12.001; Zhong WH, 2007, PEDOSPHERE, V17, P419, DOI 10.1016/S1002-0160(07)60051-4; Zhong WH, 2010, PLANT SOIL, V326, P511, DOI 10.1007/s11104-009-9988-y	76	39	41	7	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124096	10.1371/journal.pone.0124096	http://dx.doi.org/10.1371/journal.pone.0124096			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879759	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500083
J	Morlais, I; Nsango, SE; Toussile, W; Abate, L; Annan, Z; Tchioffo, MT; Cohuet, A; Awono-Ambene, PH; Fontenille, D; Rousset, F; Berry, A				Morlais, Isabelle; Nsango, Sandrine E.; Toussile, Wilson; Abate, Luc; Annan, Zeinab; Tchioffo, Majoline T.; Cohuet, Anna; Awono-Ambene, Parfait H.; Fontenille, Didier; Rousset, Francois; Berry, Antoine			Plasmodium falciparum Mating Patterns and Mosquito Infectivity of Natural Isolates of Gametocytes	PLOS ONE			English	Article							DIVERSE MALARIA INFECTIONS; POPULATION-STRUCTURE; TRANSMISSION; PARASITES; COMPETITION; ANOPHELES; VIRULENCE; EVOLUTION; DYNAMICS; CAMEROON	Plasmodium falciparum infections in malaria endemic areas often harbor multiple clones of parasites. However, the transmission success of the different genotypes within the mosquito vector has remained elusive so far. The genetic diversity of malaria parasites was measured by using microsatellite markers in gametocyte isolates from 125 asymptomatic carriers. For a subset of 49 carriers, the dynamics of co-infecting genotypes was followed until their development within salivary glands. Also, individual oocysts from midguts infected with blood from 9 donors were genotyped to assess mating patterns. Multiplicity of infection (MOI) was high both in gametocyte isolates and sporozoite populations, reaching up to 10 genotypes. Gametocyte isolates with multiple genotypes gave rise to lower infection prevalence and intensity. Fluctuations of genotype number occurred during the development within the mosquito and sub-patent genotypes, not detected in gametocyte isolates, were identified in the vector salivary glands. The inbreeding coefficient Fis was positively correlated to the oocyst loads, suggesting that P. falciparum parasites use different reproductive strategies according to the genotypes present in the gametocyte isolate. The number of parasite clones within an infection affects the transmission success and the mosquito has an important role in maintaining P. falciparum genetic diversity. Our results emphasize the crucial importance of discriminating between the different genotypes within an infection when studying the A. gambiae natural resistance to P. falciparum, and the need to monitor parasite diversity in areas where malaria control interventions are implemented.	[Morlais, Isabelle; Nsango, Sandrine E.; Awono-Ambene, Parfait H.] Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon; [Morlais, Isabelle; Nsango, Sandrine E.; Abate, Luc; Annan, Zeinab; Tchioffo, Majoline T.; Cohuet, Anna; Fontenille, Didier] Inst Rech Dev, Montpellier, France; [Nsango, Sandrine E.] Fac Med & Sci Pharmaceut, Douala, Cameroon; [Toussile, Wilson] Univ Paris 11, Villejuif, France; [Rousset, Francois] Inst Sci Evolut, Montpellier, France; [Berry, Antoine] Ctr Hosp Univ Toulouse, Toulouse, France; [Berry, Antoine] Ctr Physiopathol Toulouse Purpan, Toulouse, France	Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Morlais, I (corresponding author), Org Coordinat Lutte Endemies Afrique Cent, Yaounde, Cameroon.	isabelle.morlais@ird.fr	Rousset, Francois/GRJ-3980-2022; Cohuet, Anna/B-2745-2017; Berry, Antoine/J-9352-2014; Morlais, Isabelle/F-5078-2014; Rousset, Francois/C-7360-2008; TSAPI, Majoline TCHIOFFO/S-3007-2019; Morlais, Isabelle/Q-2171-2019	Rousset, Francois/0000-0003-4670-0371; Cohuet, Anna/0000-0002-1876-5656; Morlais, Isabelle/0000-0002-2962-7670; Rousset, Francois/0000-0003-4670-0371; TSAPI, Majoline TCHIOFFO/0000-0001-9517-3665; Morlais, Isabelle/0000-0002-2962-7670; FONTENILLE, didier/0000-0002-0544-3885; abate, luc/0000-0003-3973-3036; Berry, Antoine/0000-0002-6626-7766	Institut de Recherche pour le Developpement; Institut de Medecine et d'Epidemiologie Appliquee [IMEA-AO-07]; Agence Nationale de la Recherche [ANR-11-BSV7-009-01]; European Union Seventh Framework Programme [GA242095-EviMalaR]	Institut de Recherche pour le Developpement; Institut de Medecine et d'Epidemiologie Appliquee; Agence Nationale de la Recherche(French National Research Agency (ANR)); European Union Seventh Framework Programme(European Commission)	This work was supported by the Institut de Recherche pour le Developpement (scholarships awarded to SEN and WT), the Institut de Medecine et d'Epidemiologie Appliquee (IMEA-AO-07 to AB), the Agence Nationale de la Recherche (ANR-11-BSV7-009-01 to IM), and the European Union Seventh Framework Programme (GA242095-EviMalaR to DF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKAIKE H, 1981, J ECONOMETRICS, V16, P3, DOI 10.1016/0304-4076(81)90071-3; Alizon S, 2013, ECOL LETT, V16, P556, DOI 10.1111/ele.12076; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; Anderson TJC, 2000, GENET RES, V75, P285, DOI 10.1017/S0016672300004481; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Antonio-Nkondjio C, 2002, J MED ENTOMOL, V39, P350, DOI 10.1603/0022-2585-39.2.350; Arez AP, 2003, AM J TROP MED HYG, V68, P161, DOI 10.4269/ajtmh.2003.68.2.0680161; Babiker HA, 2008, TRENDS PARASITOL, V24, P525, DOI 10.1016/j.pt.2008.08.001; Boissiere A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054820; Boissiere A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002742; Bonnet S, 2003, T ROY SOC TROP MED H, V97, P53, DOI 10.1016/S0035-9203(03)90022-8; Bousema T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042821; Campino S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020251; Choisy M, 2010, AM NAT, V175, pE105, DOI 10.1086/651587; Churcher TS, 2013, ELIFE, V2, DOI 10.7554/eLife.00626; Cohuet A, 2006, EMBO REP, V7, P1285, DOI 10.1038/sj.embor.7400831; de Roode JC, 2005, P NATL ACAD SCI USA, V102, P7624, DOI 10.1073/pnas.0500078102; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harris C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030849; Hastings IM, 2006, PARASITOLOGY, V132, P615, DOI 10.1017/S0031182005009790; Lefevre T, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003365; Mackinnon MJ, 2010, SCIENCE, V328, P866, DOI 10.1126/science.1185410; Mendes AM, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000069; Molina-Cruz A, 2012, PROC NATL ACAD SCI U; MULLAHY J, 1986, J ECONOMETRICS, V33, P341, DOI 10.1016/0304-4076(86)90002-3; Mzilahowa T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000613; NEI M, 1978, GENETICS, V89, P583; Nkhoma SC, 2012, P BIOL SCI; Nsango SE, 2012, INT J PARASITOL, V42, P589, DOI 10.1016/j.ijpara.2012.03.008; Nwakanma D, 2008, INT J PARASITOL, V38, P219, DOI 10.1016/j.ijpara.2007.07.003; Ouedraogo AL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008410; Raberg L, 2006, AM NAT, V168, P41, DOI 10.1086/505160; Razakandrainibe FG, 2005, P NATL ACAD SCI USA, V102, P17388, DOI 10.1073/pnas.0508871102; Reece SE, 2008, NATURE, V453, P609, DOI 10.1038/nature06954; Ribaut C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-45; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schneider P, 2006, INT J PARASITOL, V36, P403, DOI 10.1016/j.ijpara.2006.01.002; Skaug H, 2012, GLMMADMB GENERALIZED; Team RDC, 2012, R LANG ENV STAT COMP, DOI [10.1002/jcc.22917, DOI 10.1002/JCC.22917]; Wampfler R, 2014, J INFECT DIS, V210, P1188, DOI 10.1093/infdis/jiu236; Wargo AR, 2007, P ROY SOC B-BIOL SCI, V274, P2629, DOI 10.1098/rspb.2007.0873; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x	42	29	29	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0123777	10.1371/journal.pone.0123777	http://dx.doi.org/10.1371/journal.pone.0123777			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875840	Green Published, Green Submitted, gold			2022-12-27	WOS:000353014700043
J	Fan, LC; Yang, MZ; Han, WY				Fan, Li-Chao; Yang, Ming-Zhen; Han, Wen-Yan			Soil Respiration under Different Land Uses in Eastern China	PLOS ONE			English	Article							CO2 EFFLUX; TEMPERATURE SENSITIVITY; TROPICAL FOREST; ORGANIC-MATTER; LOESS PLATEAU; WATER-CONTENT; CARBON; RESPONSES; VEGETATION; DYNAMICS	Land-use change has a crucial influence on soil respiration, which further affects soil nutrient availability and carbon stock. We monitored soil respiration rates under different land-use types (tea gardens with three production levels, adjacent woodland, and a vegetable field) in Eastern China at weekly intervals over a year using the dynamic closed chamber method. The relationship between soil respiration and environmental factors was also evaluated. The soil respiration rate exhibited a remarkable single peak that was highest in July/August and lowest in January. The annual cumulative respiration flux increased by 25.6% and 20.9% in the tea garden with high production (HP) and the vegetable field (VF), respectively, relative to woodland (WL). However, no significant differences were observed between tea gardens with medium production (MP), low production (LP), WL, and VF. Soil respiration rates were significantly and positively correlated with organic carbon, total nitrogen, and available phosphorous content. Each site displayed a significant exponential relationship between soil respiration and soil temperature measured at 5 cm depth, which explained 84-98% of the variation in soil respiration. The model with a combination of soil temperature and moisture was better at predicting the temporal variation of soil respiration rate than the single temperature model for all sites. Q(10) was 2.40, 2.00, and 1.86-1.98 for VF, WL, and tea gardens, respectively, indicating that converting WL to VF increased and converting to tea gardens decreased the sensitivity of soil respiration to temperature. The equation of the multiple linear regression showed that identical factors, including soil organic carbon (SOC), soil water content (SWC), pH, and water soluble aluminum (WSAl), drove the changes in soil respiration and Q(10) after conversion of land use. Temporal variations of soil respiration were mainly controlled by soil temperature, whereas spatial variations were influenced by SOC, SWC, pH, and WSAl.	[Fan, Li-Chao; Yang, Ming-Zhen; Han, Wen-Yan] Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China; [Fan, Li-Chao] Chinese Acad Agr Sci, Grad Sch, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Tea Research Institute, CAAS; Chinese Academy of Agricultural Sciences; Graduate School, CAAS	Han, WY (corresponding author), Chinese Acad Agr Sci, Tea Res Inst, Hangzhou, Zhejiang, Peoples R China.	hanwy@mail.tricaas.com	fan, lichao/J-6206-2019	fan, lichao/0000-0003-1349-3134	National Natural Science Foundation of China [41171218]; Innovation Project of the Chinese Academy of Agricultural Sciences; Key Innovation Team of Tea Industry in Zhejiang Province [2011R50024]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovation Project of the Chinese Academy of Agricultural Sciences; Key Innovation Team of Tea Industry in Zhejiang Province	This work was supported by the National Natural Science Foundation of China (project No. 41171218), the Innovation Project of the Chinese Academy of Agricultural Sciences, and the Key Innovation Team of Tea Industry in Zhejiang Province (2011R50024). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arneth A, 2010, NAT GEOSCI, V3, P525, DOI [10.1038/NGEO905, 10.1038/ngeo905]; Bahn M, 2010, NEW PHYTOL, V186, P292, DOI 10.1111/j.1469-8137.2010.03237.x; Battin TJ, 2009, NAT GEOSCI, V2, P598, DOI 10.1038/ngeo618; Bossio DA, 2005, MICROB ECOL, V49, P50, DOI 10.1007/s00248-003-0209-6; Brito P, 2013, ACTA OECOL, V48, P1, DOI 10.1016/j.actao.2013.01.006; Cable JM, 2009, PLANT SOIL, V320, P153, DOI 10.1007/s11104-008-9880-1; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Cui Xiaoyong, 2000, Yingyong Shengtai Xuebao, V11, P390; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 1998, GLOBAL CHANGE BIOL, V4, P217, DOI 10.1046/j.1365-2486.1998.00128.x; Deng Q, 2013, ECOL ENG, V61, P65, DOI 10.1016/j.ecoleng.2013.09.063; Devine S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084988; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; [范利超 Fan Lichao], 2014, [土壤通报, Chinese Journal of Soil Science], V45, P1383; Fenn KM, 2010, SOIL BIOL BIOCHEM, V42, P1685, DOI 10.1016/j.soilbio.2010.05.028; Foti S, 2014, GEODERMA, V213, P245, DOI 10.1016/j.geoderma.2013.08.009; Han GX, 2007, PLANT SOIL, V291, P15, DOI 10.1007/s11104-006-9170-8; Han GX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091182; Han WY, 2012, SOIL SCI PLANT NUTR, V58, P173, DOI 10.1080/00380768.2012.664783; Han WY, 2007, SOIL BIOL BIOCHEM, V39, P1468, DOI 10.1016/j.soilbio.2006.12.029; Jia B, 2006, J ARID ENVIRON, V67, P60, DOI 10.1016/j.jaridenv.2006.02.002; KIRSCHBAUM MUF, 1995, SOIL BIOL BIOCHEM, V27, P753, DOI 10.1016/0038-0717(94)00242-S; Lai LM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077659; Lai LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048011; Leff JW, 2012, GLOBAL CHANGE BIOL, V18, P2969, DOI 10.1111/j.1365-2486.2012.02749.x; Li CF, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034642, 10.1371/journal.pone.0030026, 10.1371/journal.pone.0047442]; Liu J, 2011, FOREST ECOL MANAG, V262, P1131, DOI 10.1016/j.foreco.2011.06.015; McGuire AD, 1992, GLOBAL BIOGEOCHEM CY, V6, P101, DOI 10.1029/92GB00219; Mikan CJ, 2002, SOIL BIOL BIOCHEM, V34, P1785, DOI 10.1016/S0038-0717(02)00168-2; Motavalli PP, 2000, AGR ECOSYST ENVIRON, V79, P17, DOI 10.1016/S0167-8809(99)00139-5; Moyano FE, 2013, SOIL BIOL BIOCHEM, V59, P72, DOI 10.1016/j.soilbio.2013.01.002; Pang XY, 2013, AGR FOREST METEOROL, V171, P57, DOI 10.1016/j.agrformet.2012.12.001; Qi Y, 2002, ECOL MODEL, V153, P131, DOI 10.1016/S0304-3800(01)00506-3; RAICH JW, 1992, TELLUS B, V44, P81, DOI 10.1034/j.1600-0889.1992.t01-1-00001.x; REINKE JJ, 1981, SOIL SCI SOC AM J, V45, P620, DOI 10.2136/sssaj1981.03615995004500030036x; Ross DJ, 1999, SOIL BIOL BIOCHEM, V31, P803, DOI 10.1016/S0038-0717(98)00180-1; Sayer EJ, 2011, NAT CLIM CHANGE, V1, P304, DOI 10.1038/NCLIMATE1190; Schlesinger WH, 2000, BIOGEOCHEMISTRY, V48, P7, DOI 10.1023/A:1006247623877; Shi WY, 2012, SOIL BIOL BIOCHEM, V52, P99, DOI 10.1016/j.soilbio.2012.04.020; Sotta ED, 2004, GLOBAL CHANGE BIOL, V10, P601, DOI 10.1111/j.1529-8817.2003.00761.x; Tian SZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073450; Tjoelker MG, 2001, GLOBAL CHANGE BIOL, V7, P223, DOI 10.1046/j.1365-2486.2001.00397.x; Tufekcioglu A, 2001, PLANT SOIL, V229, P117, DOI 10.1023/A:1004818422908; Wang ChunYan, 2013, Acta Pedologica Sinica, V50, P974; Wang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071986; Wang XW, 2010, J ENVIRON SCI-CHINA, V22, P1057, DOI 10.1016/S1001-0742(09)60217-5; [王小国 WANG XiaoGuo], 2007, [生态学报, Acta Ecologica Sinica], V27, P1960; Xiaojun Nie, 2013, PLoS One, V8, pe64059, DOI 10.1371/journal.pone.0064059; Xu M, 2001, GLOBAL CHANGE BIOL, V7, P667, DOI 10.1046/j.1354-1013.2001.00435.x; Yu XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028397; Zhang T, 2013, ATMOS ENVIRON, V77, P856, DOI 10.1016/j.atmosenv.2013.06.011; Zhou WP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092531; Zhou ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081793; Zhou ZY, 2013, SOIL BIOL BIOCHEM, V57, P135, DOI 10.1016/j.soilbio.2012.08.010; Zhu LQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088900	55	17	18	8	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0124198	10.1371/journal.pone.0124198	http://dx.doi.org/10.1371/journal.pone.0124198			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875998	gold, Green Submitted, Green Published			2022-12-27	WOS:000352845100245
J	Gandji, LY; Proust, R; Larue, L; Gesbert, F				Gandji, Leslie Yewakon; Proust, Richard; Larue, Lionel; Gesbert, Franck			The Tyrosine Phosphatase SHP2 Associates with CUB Domain-Containing Protein-1 (CDCP1), Regulating Its Expression at the Cell Surface in a Phosphorylation-Dependent Manner	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; FOCAL ADHESION KINASE; PKC-DELTA; SRC; IDENTIFICATION; SUBSTRATE; SPECIFICITY; RECOGNITION; ACTIVATION; SURVIVAL	CUB domain-containing protein-1 (CDCP1) is a transmembrane glycoprotein that is phosphorylated by SRC family kinases (SFK) before recruiting and activating PKC delta. CDCP1 is overproduced in many cancers. It promotes metastasis and resistance to anoikis. The robust production of CDCP1 would be associated with stemness and has been proposed as a novel prognosis marker. The natural transmembrane location of CDCP1 makes it an ideal therapeutic target and treatments based on the use of appropriate antibodies are currently being evaluated. However, we still know very little about the molecular fate of CDCP1 and its downstream signaling events. Improvements in our understanding of the molecular events occurring downstream of CDCP1 are required to make use of changes of CDCP1 production or functions for therapeutic purposes. By the mean of co-immunoprecipitation and affinity precipitation we show here, for the first time, that CDCP1 interacts directly, with the cytosolic tyrosine phosphatase SHP2. Point mutants of CDCP1 show that residues Y734 and Y743 are responsible for its interaction with SHP2. It may therefore compete with SFK. We also demonstrate that a shRNA-mediated down regulation of SHP2 is associated with a stronger CDCP1 phosphorylation and an impairment of antibody-mediated CDCP1 internalization.	[Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Inst Curie, Normal & Pathol Dev Melanocytes, F-91405 Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Univ Paris 11, Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] CNRS, UMR3347, F-91405 Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Univ Paris 11, INSERM, U1021, F-91405 Orsay, France; [Gandji, Leslie Yewakon; Larue, Lionel; Gesbert, Franck] Equipe Labellisee Ligue Natl Canc, Orsay, France; [Proust, Richard] Hop Paul Brousse, INSERM, UMR S972, Villejuif, France	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm)	Gesbert, F (corresponding author), Inst Curie, Normal & Pathol Dev Melanocytes, F-91405 Orsay, France.	franck.gesbert@u-psud.fr	Larue, Lionel/I-6532-2016	Gesbert, Franck/0000-0002-5800-8385	Ministere de l'Education Nationale et de l'Enseignement Superieur Ph.D. fellowship; Ligue Nationale Contre le Cancer (Equipe labellisee); Institut National du Cancer (INCa); Pair Melanome	Ministere de l'Education Nationale et de l'Enseignement Superieur Ph.D. fellowship; Ligue Nationale Contre le Cancer (Equipe labellisee)(Ligue nationale contre le cancer); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Pair Melanome	LG was supported by a Ministere de l'Education Nationale et de l'Enseignement Superieur Ph.D. fellowship. This work was supported by the Ligue Nationale Contre le Cancer (Equipe labellisee), Institut National du Cancer (INCa) and Pair Melanome (LL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agazie YM, 2003, J BIOL CHEM, V278, P13952, DOI 10.1074/jbc.M210670200; Alvares SM, 2008, BBA-GEN SUBJECTS, V1780, P486, DOI 10.1016/j.bbagen.2008.01.010; Awakura Y, 2008, J CANCER RES CLIN, V134, P1363, DOI 10.1007/s00432-008-0412-4; Barford D, 1998, STRUCTURE, V6, P249, DOI 10.1016/S0969-2126(98)00027-6; Benes C, 2001, AM J PHYSIOL-CELL PH, V280, pC1498, DOI 10.1152/ajpcell.2001.280.6.C1498; Benes CH, 2012, ONCOGENE, V31, P653, DOI 10.1038/onc.2011.262; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bentires-Alj M, 2004, CANCER RES, V64, P8816, DOI 10.1158/0008-5472.CAN-04-1923; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; Buhring HJ, 2004, STEM CELLS, V22, P334, DOI 10.1634/stemcells.22-3-334; Casar B, 2012, ONCOGENE, V31, P3924, DOI 10.1038/onc.2011.555; CASE RD, 1994, J BIOL CHEM, V269, P10467; Chan G, 2008, CANCER METAST REV, V27, P179, DOI 10.1007/s10555-008-9126-y; Chan RJ, 2007, BLOOD, V109, P862, DOI 10.1182/blood-2006-07-028829; Conze T, 2003, ANN NY ACAD SCI, V996, P222, DOI 10.1111/j.1749-6632.2003.tb03249.x; Eck MJ, 1996, NATURE, V379, P277, DOI 10.1038/379277a0; FENG GS, 1993, SCIENCE, V259, P1607, DOI 10.1126/science.8096088; Gesbert F, 1998, J BIOL CHEM, V273, P18273, DOI 10.1074/jbc.273.29.18273; Grossmann KS, 2010, ADV CANCER RES, V106, P53, DOI 10.1016/S0065-230X(10)06002-1; Gusenbauer S, 2013, ONCOGENE, V32, P3846, DOI 10.1038/onc.2012.396; Hakak Y, 2000, ONCOGENE, V19, P3164, DOI 10.1038/sj.onc.1203655; Hara K, 2011, CANCER RES, V71, P1229, DOI 10.1158/0008-5472.CAN-10-3431; Hartman ZR, 2013, MOL CANCER RES, V11, P651, DOI 10.1158/1541-7786.MCR-12-0578; He Y, 2010, J BIOL CHEM, V285, P26162, DOI 10.1074/jbc.M109.096453; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; Hooper JD, 2003, ONCOGENE, V22, P1783, DOI 10.1038/sj.onc.1206220; Ikeda JI, 2009, CANCER SCI, V100, P429, DOI 10.1111/j.1349-7006.2008.01066.x; JIA ZC, 1995, SCIENCE, V268, P1754, DOI 10.1126/science.7540771; Jo A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091582; Kollmorgen G, 2013, MOL ONCOL, V7, P1142, DOI 10.1016/j.molonc.2013.08.009; Lee HH, 2008, J CELL BIOL, V181, P999, DOI 10.1083/jcb.200710187; Liu H, 2011, P NATL ACAD SCI USA, V108, P1379, DOI 10.1073/pnas.1017228108; Miyazawa Y, 2010, CANCER RES, V70, P5136, DOI 10.1158/0008-5472.CAN-10-0220; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Spassov DS, 2012, ONCOGENE, V31, P419, DOI 10.1038/onc.2011.246; Spassov DS, 2013, CANCER RES, V73, P1168, DOI 10.1158/0008-5472.CAN-12-2496; Spassov DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019154; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wortmann A, 2011, J BIOL CHEM, V286, P42303, DOI 10.1074/jbc.M111.227462; Wortmann A, 2009, IUBMB LIFE, V61, P723, DOI 10.1002/iub.198; ZHANG ZY, 1994, P NATL ACAD SCI USA, V91, P1624, DOI 10.1073/pnas.91.5.1624; ZHOU GC, 1994, J BIOL CHEM, V269, P28084; Zhou XD, 2008, CELL DEATH DIFFER, V15, P988, DOI 10.1038/cdd.2008.54	44	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0123472	10.1371/journal.pone.0123472	http://dx.doi.org/10.1371/journal.pone.0123472			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876044	gold, Green Published, Green Submitted			2022-12-27	WOS:000352845100180
J	Li, XM; Chen, LP; Zhu, YQ; Yu, X; Cao, J; Wang, R; Lv, XY; He, J; Guo, AZ; Huang, HR; Zheng, HJ; Liu, SG				Li, Xuming; Chen, Liping; Zhu, Yongqiang; Yu, Xia; Cao, Jun; Wang, Rui; Lv, Xinyan; He, Jin; Guo, Aizhen; Huang, Hairong; Zheng, Huajun; Liu, Siguo			Genomic Analysis of a Mycobacterium Bovisbacillus Calmette-Guerin Strain Isolated from an Adult Patient with Pulmonary Tuberculosis	PLOS ONE			English	Article							BOVIS BCG; VIRULENCE FACTORS; IMMUNE-RESPONSES; VACCINE STRAINS; RNA GENES; SEQUENCE; DNAA; ATTENUATION; EVOLUTION; EFFICACY	For years, bacillus Calmette-Guerin (BCG) has served as the unique vaccine against tuberculosis and has generally been regarded as safe. However, a clinical strain labeled 3281 that was isolated from a TB patient was identified to be BCG. Via the combination of next-generation sequencing (NGS) and comparative genomic analysis, unique 3281 genetic characteristics were revealed. A region containing the dnaA and dnaN genes that is closely related to the initial chromosome replication was found to repeat three times on the BCG Pasteur-specific tandem duplication region DU1. Due to the minimum number of epitopes in BCG strains, 3281 was inferred to have a high possibility for immune evasion. Additionally, variations in the virulence genes and predictions for potential virulence factors were analyzed. Overall, we report a pathogen that has never previously been thought to be pathogenic and initial insights that are focused on the genetic characteristics of virulent BCG.	[Li, Xuming; Chen, Liping; Cao, Jun; Liu, Siguo] Chinese Acad Agr, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Div Bacterial Dis, Harbin 150001, Peoples R China; [Li, Xuming; He, Jin; Guo, Aizhen] Huazhong Agr Univ, Coll Life Sci & Technol, Stake Key Lab Agr Microbiol, Wuhan 430070, Hunan, Peoples R China; [Zhu, Yongqiang; Wang, Rui; Lv, Xinyan; Zheng, Huajun] Chinese Natl Human Genome Ctr Shanghai, Shanghai MOST Key Lab Hlth & Dis Genom, Shanghai 201203, Peoples R China; [Yu, Xia; Huang, Hairong] Capital Med Univ, Natl Clin Lab TB, Beijing Key Lab Drug Resistant TB Res, Beijing TB & Thorac Tumor Inst,Beijing Chest Hosp, Beijing 101149, Peoples R China; [Zheng, Huajun] Shanghai Inst Planned Parenthood Res, Lab Med Foods, Shanghai 200032, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Huazhong Agricultural University; Capital Medical University	Guo, AZ (corresponding author), Huazhong Agr Univ, Coll Life Sci & Technol, Stake Key Lab Agr Microbiol, Wuhan 430070, Hunan, Peoples R China.	aizhen@mail.hzau.edu.cn; hairong.huangcn@gmail.com; zhenghj@chgc.sh.cn; siguo_liu@hvri.ac.cn	, 苹/AAV-3159-2020; Zheng, Huajun/AAN-4973-2020	Li, Xuming/0000-0002-5049-9706	Major State Basic Research Development Program of China (973 program) [2012CB518800]; National Natural Science Foundation of China [31201920, 31272538]; Bank of clinical resourceson Tuberculosis [D09050704640000]; Transmission Mode of Tuberculosis project of the National Key Program of Mega Infectious Diseases [2013ZX10003006-002]	Major State Basic Research Development Program of China (973 program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bank of clinical resourceson Tuberculosis; Transmission Mode of Tuberculosis project of the National Key Program of Mega Infectious Diseases	This work was supported by the Major State Basic Research Development Program of China (973 program, No. 2012CB518800), the National Natural Science Foundation of China (Nos. 31201920, 31272538), Bank of clinical resourceson Tuberculosis (D09050704640000), and the Transmission Mode of Tuberculosis project of the National Key Program of Mega Infectious Diseases (2013ZX10003006-002).	Behr MA, 1997, NATURE, V389, P133, DOI 10.1038/38151; Brennan MJ, 2012, TUBERCULOSIS, V92, pS6, DOI 10.1016/S1472-9792(12)70005-7; Brosch R, 2000, YEAST, V17, P111, DOI 10.1002/1097-0061(20000630)17:2<111::AID-YEA17>3.0.CO;2-G; Brosch R, 2007, P NATL ACAD SCI USA, V104, P5596, DOI 10.1073/pnas.0700869104; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Collins DM, 2003, MICROBIOL-SGM, V149, P3203, DOI 10.1099/mic.0.26469-0; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; D'Auria G, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-181; Darling AE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011147; Davids V, 2006, J INFECT DIS, V193, P531, DOI 10.1086/499825; Delcher AL, 2007, BIOINFORMATICS, V23, P673, DOI 10.1093/bioinformatics/btm009; Du YF, 2011, RES VET SCI, V90, P385, DOI 10.1016/j.rvsc.2010.07.020; Duarte EL, 2008, VET MICROBIOL, V130, P415, DOI 10.1016/j.vetmic.2008.02.012; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Fouts DE, 2006, NUCLEIC ACIDS RES, V34, P5839, DOI 10.1093/nar/gkl732; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hoover SE, 2010, J BACTERIOL, V192, P3915, DOI 10.1128/JB.00210-10; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Lagranderie MRR, 1996, INFECT IMMUN, V64, P1; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Liu J, 2009, HUM VACCINES, V5, P70, DOI 10.4161/hv.5.2.7210; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mostowy S, 2005, J BACTERIOL, V187, P6386, DOI 10.1128/JB.187.18.6386-6395.2005; Mostowy S, 2003, VACCINE, V21, P4270, DOI 10.1016/S0264-410X(03)00484-5; Pelayo MCG, 2009, INFECT IMMUN, V77, P2230, DOI 10.1128/IAI.01099-08; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Shuvaev A, 2014, CELL BIOCHEM BIOPHYS, V70, P295, DOI 10.1007/s12013-014-9908-5; Tang B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-289; Vaughan K, 2014, HUMAN IMMUNOLOGY; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Zhang Q, 2012, J THEOR BIOL, V314, P164, DOI 10.1016/j.jtbi.2012.08.045; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071243; Zhao YB, 2012, BIOINFORMATICS, V28, P416, DOI 10.1093/bioinformatics/btr655	36	4	4	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122403	10.1371/journal.pone.0122403	http://dx.doi.org/10.1371/journal.pone.0122403			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25876043	Green Published, gold			2022-12-27	WOS:000352845100071
J	Henry, JD; Joeffry, S; Terrett, G; Ballhausen, N; Kliegel, M; Rendell, PG				Henry, Julie D.; Joeffry, Sebastian; Terrett, Gill; Ballhausen, Nicola; Kliegel, Matthias; Rendell, Peter G.			Prospective Memory Function in Late Adulthood: Affect at Encoding and Resource Allocation Costs	PLOS ONE			English	Article							AGE-DIFFERENCES; VALENCE; METAANALYSIS	Some studies have found that prospective memory (PM) cues which are emotionally valenced influence age effects in prospective remembering, but it remains unclear whether this effect reflects the operation of processes implemented at encoding or retrieval. In addition, none of the prior ageing studies of valence on PM function have examined potential costs of engaging in different valence conditions, or resource allocation trade-offs between the PM and the ongoing task. In the present study, younger, young-old and old-old adults completed a PM task in which the valence of the cues varied systematically (positive, negative or neutral) at encoding, but was kept constant (neutral) at retrieval. The results indicated that PM accuracy did not vary as a function of affect at encoding, and that this effect did not interact with age group. There was also no main or interaction effect of valence on PM reaction time in PM cue trials, indicating that valence costs across the three encoding conditions were equivalent. Old-old adults' PM accuracy was reduced relative to both young-old and younger adults. Prospective remembering incurred dual-task costs for all three groups. Analyses of reaction time data suggested that for both young-old and old-old, these costs were greater, implying differential resource allocation cost trade-offs. However, when reaction time data were expressed as a proportional change that adjusted for the general slowing of the older adults, costs did not differ as a function of group.	[Henry, Julie D.; Joeffry, Sebastian] Univ Queensland, Sch Psychol, Brisbane, Qld, Australia; [Terrett, Gill; Rendell, Peter G.] Australian Catholic Univ, Sch Psychol, Melbourne, Vic, Australia; [Ballhausen, Nicola; Kliegel, Matthias] Univ Geneva, Geneva, Switzerland	University of Queensland; Australian Catholic University; University of Geneva	Henry, JD (corresponding author), Univ Queensland, Sch Psychol, Brisbane, Qld, Australia.	Julie.henry@uq.edu.au	Ballhausen, Nicola/AAB-5781-2020; Terrett, Gill/D-7165-2019; Rendell, Peter/E-7539-2010	Ballhausen, Nicola/0000-0002-2268-3354; Terrett, Gill/0000-0003-2500-6428; Rendell, Peter/0000-0002-4829-4322; Kliegel, Matthias/0000-0002-2001-2522; Henry, Julie/0000-0002-2081-3717	Discovery Project Grant from the Australian Research Council [DP0984844]	Discovery Project Grant from the Australian Research Council(Australian Research Council)	This work was supported by a Discovery Project Grant from the Australian Research Council (DP0984844). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altgassen M, 2010, Q J EXP PSYCHOL, V63, P1057, DOI 10.1080/17470211003770920; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Baltes PB, 2003, GERONTOLOGY, V49, P123, DOI 10.1159/000067946; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; Gilbert SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059852; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Guynn MJ, 2001, MEMORY ACTION DISTIN, P25; HASHER L, 1979, J EXP PSYCHOL GEN, V108, P356, DOI 10.1037/0096-3445.108.3.356; Henry JD, 2004, PSYCHOL AGING, V19, P27, DOI 10.1037/0882-7974.19.1.27; Kliegel M, 2008, PSYCHOL AGING, V23, P203, DOI 10.1037/0882-7974.23.1.203; Lang P.J., 2008, INT AFFECTIVE PICTUR; Levine TR, 2002, HUM COMMUN RES, V28, P612, DOI 10.1093/hcr/28.4.612; McDaniel M. A., 2008, PROSPECTIVE MEMORY C, P141; McDaniel MA, 2000, APPL COGNITIVE PSYCH, V14, pS127, DOI 10.1002/acp.775; McDaniel MA, 2009, AGING NEUROPSYCHOL C, V16, P563, DOI 10.1080/13825580902866646; MILLER GA, 1956, PSYCHOL REV, V63, P81, DOI 10.1037/h0043158; NEUGARTEN BL, 1974, ANN AM ACAD POLIT SS, V415, P187, DOI 10.1177/000271627441500114; Reed AE, 2014, PSYCHOL AGING, V29, P1, DOI 10.1037/a0035194; Rendell PG, 2011, COGNITION EMOTION, V25, P916, DOI 10.1080/02699931.2010.508610; SALTHOUSE TA, 1988, DEV REV, V8, P238, DOI 10.1016/0273-2297(88)90006-8; Schnitzspahn KM, 2012, PSYCHOL AGING, V27, P498, DOI 10.1037/a0025021; Schnitzspahn KM, 2011, INT PSYCHOGERIATR, V23, P583, DOI 10.1017/S1041610210001651; Smith RE, 2004, J EXP PSYCHOL LEARN, V30, P756, DOI 10.1037/0278-7393.30.4.756; Smith RE, 2007, J EXP PSYCHOL LEARN, V33, P734, DOI 10.1037/0278-7393.33.4.734; Wilson B, 1984, EVERYDAY MEMORY ACTI, P207	28	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0125124	10.1371/journal.pone.0125124	http://dx.doi.org/10.1371/journal.pone.0125124			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG3XA	25893540	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700132
J	Sugyo, A; Tsuji, AB; Sudo, H; Okada, M; Koizumi, M; Satoh, H; Kurosawa, G; Kurosawa, Y; Saga, T				Sugyo, Aya; Tsuji, Atsushi B.; Sudo, Hitomi; Okada, Maki; Koizumi, Mitsuru; Satoh, Hirokazu; Kurosawa, Gene; Kurosawa, Yoshikazu; Saga, Tsuneo			Evaluation of Efficacy of Radioimmunotherapy with Y-90- Labeled Fully Human Anti-Transferrin Receptor Monoclonal Antibody in Pancreatic Cancer Mouse Models	PLOS ONE			English	Article							EXTERNAL-BEAM RADIOTHERAPY; TRANSFERRIN RECEPTOR; THERAPEUTIC AGENTS; TARGETED DELIVERY; CELL-GROWTH; GEMCITABINE; INHIBITION; CHEMOTHERAPY; METASTASES; BIOLOGY	Objective Pancreatic cancer is an aggressive tumor and the prognosis remains poor. Therefore, development of more effective therapy is needed. We previously reported that Zr-89-labeled TSP-A01, an antibody against transferrin receptor (TfR), is highly accumulated in a pancreatic cancer xenograft, but not in major normal organs. In the present study, we evaluated the efficacy of radioimmunotherapy (RIT) with Y-90-TSP-A01 in pancreatic cancer mouse models. Methods TfR expression in pancreatic cancer cell lines (AsPC-1, BxPC-3, MIAPaCa-2) was evaluated by immunofluorescence staining. In-111-labeled anti-TfR antibodies (TSP-A01, TSP-A02) were evaluated in vitro by cell binding assay with the three cell lines and by competitive inhibition assay with MIAPaCa-2. In vivo biodistribution was evaluated in mice bearing BxPC-3 and MIAPaCa-2 xenografts. Tumor volumes of BxPC-3 and MIAPaCa-2 were sequentially measured after Y-90-TSP-A01 injection and histological analysis of tumors was conducted. Results MIAPaCa-2 cells showed the highest TfR expression, followed by AsPC-1 and BxPC-3 cells. In-111-TSP-A01 and In-111-TSP-A02 bound specifically to the three cell lines according to TfR expression. The dissociation constants for TSP-A01, DOTA-TSP-A01, TSP-A02, and DOTA-TSP-A02 were 0.22, 0.28, 0.17, and 0.22 nM, respectively. In-111-TSP-A01 was highly accumulated in tumors, especially in MIAPaCa-2, but this was not true of In-111-TSP-A02. The absorbed dose for Y-90- TSP-A01 was estimated to be 8.3 Gy/MBq to BxPC-3 and 12.4 Gy/MBq to MIAPaCa-2. MIAPaCa-2 tumors treated with 3.7 MBq of Y-90-TSP-A01 had almost completely disappeared around 3 weeks after injection and regrowth was not observed. Growth of BxPC-3 tumors was inhibited by 3.7 MBq of Y-90-TSP-A01, but the tumor size was not reduced. Conclusion Y-90-TSP-A01 treatment achieved an almost complete response in MIAPaCa-2 tumors, whereas it merely inhibited the growth of BxPC-3 tumors. Y-90-TSP-A01 is a promising RIT agent for pancreatic cancer, although further investigation is necessary to improve the efficacy for the radioresistant types like BxPC-3.	[Sugyo, Aya; Tsuji, Atsushi B.; Sudo, Hitomi; Saga, Tsuneo] Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, Chiba 260, Japan; [Okada, Maki] Natl Inst Radiol Sci, Mol Imaging Ctr, Mol Probe Program, Inage Ku, Chiba 260, Japan; [Koizumi, Mitsuru] Canc Inst Hosp, Dept Nucl Med, Koto Ku, Tokyo, Japan; [Satoh, Hirokazu] Perseus Prote Inc, Reserch & Dev Div, Meguro Ku, Tokyo, Japan; [Kurosawa, Gene; Kurosawa, Yoshikazu] Fujita Hlth Univ, Sch Med, Innovat Ctr Adv Med, Toyoake, Aichi 47011, Japan	National Institutes for Quantum Science & Technology; National Institutes for Quantum Science & Technology; Fujita Health University	Tsuji, AB (corresponding author), Natl Inst Radiol Sci, Mol Imaging Ctr, Diagnost Imaging Program, Inage Ku, Chiba 260, Japan.	a_tsuji@nirs.go.jp	TSUJI, Atsushi B/I-9922-2019; Kurosawa, Gene/R-6508-2018	TSUJI, Atsushi B/0000-0003-2726-288X; Kurosawa, Gene/0000-0001-9477-7467; Satoh, Hirokazu/0000-0001-7629-3346	Ministry of Education, Culture, Sports, Science and Technology of Japan [KAKENHI 25861140]; National Institute of Radiological Sciences	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Radiological Sciences	This study was supported by the grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan (KAKENHI 25861140 to AS) and the National Institute of Radiological Sciences (to TS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barendswaard EC, 1999, J NUCL MED, V40, P1764; Boyle P, 2008, WORLD CANC REPORT; BURAS RR, 1993, INT J RADIAT ONCOL, V25, P473, DOI 10.1016/0360-3016(93)90069-8; Cheson BD, 2003, BLOOD, V101, P391, DOI 10.1182/blood-2002-06-1793; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2006, CLIN IMMUNOL, V121, P159, DOI 10.1016/j.clim.2006.06.006; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Donohue E, 2013, J CANCER, V4, P585, DOI 10.7150/jca.7030; Eckerman KF, 2008, MIRD RADIONUCLIDE DA; Evans J, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004215; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Graf F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088239; Halperin E C, 2008, PEREZ BRADYS PRINCIP; Hidalgo M, 2010, NEW ENGL J MED, V362, P1605, DOI 10.1056/NEJMra0901557; Illidge TM, 2014, J CLIN ONCOL, V32, P212, DOI 10.1200/JCO.2013.50.3110; Kano MR, 2007, P NATL ACAD SCI USA, V104, P3460, DOI 10.1073/pnas.0611660104; Kassis AI, 2008, SEMIN NUCL MED, V38, P358, DOI 10.1053/j.semnuclmed.2008.05.002; Klee GG, 2000, ARCH PATHOL LAB MED, V124, P921; Knoop RF, 2014, NEOPLASIA, V16, P463, DOI 10.1016/j.neo.2014.05.010; Koppe MJ, 2006, CANCER BIOTHER RADIO, V21, P506, DOI 10.1089/cbr.2006.21.506; LESLEY JF, 1985, MOL CELL BIOL, V5, P1814, DOI 10.1128/MCB.5.8.1814; LINDMO T, 1984, J IMMUNOL METHODS, V72, P77, DOI 10.1016/0022-1759(84)90435-6; Matsumura Y, 2012, ADV DRUG DELIVER REV, V64, P710, DOI 10.1016/j.addr.2011.12.010; MEARES CF, 1990, BRIT J CANCER, V62, P21; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; NIITSU Y, 1987, TOHOKU J EXP MED, V153, P239, DOI 10.1620/tjem.153.239; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; PANACCIO M, 1987, IMMUNOL CELL BIOL, V65, P461, DOI 10.1038/icb.1987.55; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; Rucki AA, 2014, WORLD J GASTROENTERO, V20, P2237, DOI 10.3748/wjg.v20.i9.2237; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sogawa C, 2010, NUCL MED BIOL, V37, P179, DOI 10.1016/j.nucmedbio.2009.10.008; Sudo H, 2012, CANCER SCI, V103, P203, DOI 10.1111/j.1349-7006.2011.02126.x; Sugyo A, 2015, NUCL MED COMMUN, V36, P286, DOI 10.1097/MNM.0000000000000245; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; van Bree C, 2008, BRIT J CANCER, V98, P1226, DOI 10.1038/sj.bjc.6604287; Vogel CA, 1997, CANCER RES, V57, P447; Yoshida C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059248	40	19	20	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123761	10.1371/journal.pone.0123761	http://dx.doi.org/10.1371/journal.pone.0123761			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893775	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700055
J	Thompson, LL; McManus, KJ				Thompson, Laura L.; McManus, Kirk J.			A Novel Multiplexed, Image-Based Approach to Detect Phenotypes That Underlie Chromosome Instability in Human Cells	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; GENOMIC INSTABILITY; NUCLEAR-ENVELOPE; GENE-EXPRESSION; CANCER; COHESIN; PLOIDY; MICRONUCLEUS; CHROMATIN; MITOSIS	Chromosome instability (CIN) is characterized by a progressive change in chromosome numbers. It is a characteristic common to virtually all tumor types, and is commonly observed in highly aggressive and drug resistant tumors. Despite this information, the majority of human CIN genes have yet to be elucidated. In this study, we developed and validated a multiplexed, image-based screen capable of detecting three different phenotypes associated with CIN. Large-scale chromosome content changes were detected by quantifying changes in nuclear volumes following RNAi-based gene silencing. Using a DsRED-LacI reporter system to fluorescently label chromosome 11 within a human fibrosarcoma cell line, we were able to detect deviations from the expected number of two foci per nucleus (one focus/labelled chromosome) that occurred following CIN gene silencing. Finally, micronucleus enumeration was performed, as an increase in micronucleus formation is a classic hallmark of CIN. To validate the ability of each assay to detect phenotypes that underlie CIN, we silenced the established CIN gene, SMC1A. Following SMC1A silencing we detected an increase in nuclear volumes, a decrease in the number of nuclei harboring two DsRED-LacI foci, and an increase in micronucleus formation relative to controls (untreated and siGAPDH). Similar results were obtained in an unrelated human fibroblast cell line. The results of this study indicate that each assay is capable of detecting CIN-associated phenotypes, and can be utilized in future experiments to uncover novel human CIN genes, which will provide novel insight into the pathogenesis of cancer.	[Thompson, Laura L.; McManus, Kirk J.] Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada; [Thompson, Laura L.; McManus, Kirk J.] Manitoba Inst Cell Biol, Winnipeg, MB R3E 0V9, Canada	University of Manitoba	McManus, KJ (corresponding author), Univ Manitoba, Dept Biochem & Med Genet, Winnipeg, MB, Canada.	Kirk.McManus@umanitoba.ca		McManus, Kirk/0000-0003-0081-8737	NSERC [RGPIN401851-2012]; Terry Fox Research Institute; Research Manitoba; CancerCare Manitoba Foundation; Manitoba Institute of Cell Biology	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Terry Fox Research Institute; Research Manitoba; CancerCare Manitoba Foundation; Manitoba Institute of Cell Biology	The authors acknowledge NSERC (http://www.nserc-crsng.gc.ca/index_eng.asp)(RGPIN 401851-2012) for operational funds (KJM), and the Terry Fox Research Institute (http://www.tfri.ca/en/), Research Manitoba (http://researchmanitoba.ca/) and CancerCare Manitoba Foundation (http://www.cancercarefdn.mb.ca/) for studentships (LLT). The authors also acknowledge the strong support of the Manitoba Institute of Cell Biology, which is funded in part by the CancerCare Manitoba Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bakhoum SF, 2012, J CLIN INVEST, V122, P1138, DOI 10.1172/JCI59954; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Bauerschmidt C, 2011, EXP CELL RES, V317, P330, DOI 10.1016/j.yexcr.2010.10.021; Bauerschmidt C, 2010, NUCLEIC ACIDS RES, V38, P477, DOI 10.1093/nar/gkp976; Beheshti B, 2001, NEOPLASIA, V3, P62, DOI 10.1038/sj.neo.7900125; Bhatia A, 2013, APMIS, V121, P569, DOI 10.1111/apm.12033; Bozkurt S, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0443-1; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Cogan N, 2010, MUTAT RES-FUND MOL M, V683, P1, DOI 10.1016/j.mrfmmm.2009.09.012; COX DM, 1973, CYTOGENET CELL GENET, V12, P165, DOI 10.1159/000130452; Dorsett D, 2012, CURR BIOL, V22, pR240, DOI 10.1016/j.cub.2012.02.046; Fenech M, 2002, DRUG DISCOV TODAY, V7, P1128, DOI 10.1016/S1359-6446(02)02502-3; Fenech M, 2007, NAT PROTOC, V2, P1084, DOI 10.1038/nprot.2007.77; Ferlay J, 2013, IARC CANCERBASE; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Fischer AH, 2014, ADV EXP MED BIOL, V773, P49, DOI 10.1007/978-1-4899-8032-8_3; FLIEDNER TM, 1964, BLOOD, V23, P471, DOI 10.1182/blood.V23.4.471.471; Geigl JB, 2008, TRENDS GENET, V24, P64, DOI 10.1016/j.tig.2007.11.006; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; Iwaizumi M, 2009, GUT, V58, P249, DOI 10.1136/gut.2008.149468; Kong XD, 2009, MOL BIOL CELL, V20, P1289, DOI 10.1091/mbc.E08-04-0419; Lee AJX, 2011, CANCER RES, V71, P1858, DOI 10.1158/0008-5472.CAN-10-3604; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Leonard JM, 2008, J CELL BIOL, V183, P385, DOI 10.1083/jcb.200804042; Mannini L, 2010, HUM MUTAT, V31, P623, DOI 10.1002/humu.21252; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; NIELSEN K, 1989, APMIS, V97, P949, DOI 10.1111/j.1699-0463.1989.tb00503.x; Niu Y, 2013, PATHOL RES PRACT, V209, P221, DOI 10.1016/j.prp.2012.12.006; Nowak MA, 2002, P NATL ACAD SCI USA, V99, P16226, DOI 10.1073/pnas.202617399; Orr B, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00164; Pantazi E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.535; Petersen I, 2009, LUNG CANCER, V65, P312, DOI 10.1016/j.lungcan.2008.12.013; Podgornova MN, 2009, B EXP BIOL MED+, V148, P643, DOI 10.1007/s10517-010-0785-7; Rajagopalan H, 2003, NAT REV CANCER, V3, P695, DOI 10.1038/nrc1165; RUDD NL, 1991, MUTAT RES, V261, P57, DOI 10.1016/0165-1218(91)90098-7; Sajesh BV, 2013, GENETICS, V195, P757, DOI 10.1534/genetics.113.156836; Sajesh BV, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-391; Solomon DA, 2014, BMB REP, V47, P299, DOI 10.5483/BMBRep.2014.47.6.092; Sotillo R, 2010, NATURE, V464, P436, DOI 10.1038/nature08803; Stirling PC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002057; Stopper H, 1997, TOXICOL IN VITRO, V11, P661, DOI 10.1016/S0887-2333(97)00084-2; Thompson SL, 2010, CURR BIOL, V20, pR285, DOI 10.1016/j.cub.2010.01.034; Thomson I, 2004, CURR BIOL, V14, P166, DOI 10.1016/j.cub.2003.12.024; van Pel DM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003254; Wang ZH, 2004, CANCER RES, V64, P2998, DOI 10.1158/0008-5472.CAN-04-0587; Webster M, 2009, J CELL SCI, V122, P1477, DOI 10.1242/jcs.037333; Wirth KG, 2006, J CELL BIOL, V172, P847, DOI 10.1083/jcb.200506119; Yuen KWY, 2007, P NATL ACAD SCI USA, V104, P3925, DOI 10.1073/pnas.0610642104; Zeimet AG, 2011, GYNECOL ONCOL, V121, P24, DOI 10.1016/j.ygyno.2010.12.332	52	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0123200	10.1371/journal.pone.0123200	http://dx.doi.org/10.1371/journal.pone.0123200			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893404	Green Submitted, Green Published, gold			2022-12-27	WOS:000353211700027
J	Wang, L; Zhong, CG; Gao, PX; Xi, WM; Zhang, SX				Wang, Lai; Zhong, Chonggao; Gao, Pengxiang; Xi, Weimin; Zhang, Shuoxin			Soil Infiltration Characteristics in Agroforestry Systems and Their Relationships with the Temporal Distribution of Rainfall on the Loess Plateau in China	PLOS ONE			English	Article							DEFINING COMPETITION VECTORS; ALLEY CROPPING SYSTEM; INTERCROPPING SYSTEM; WATER INFILTRATION; MIDWESTERN USA; FINE-ROOT; VEGETATION; TILLAGE; RUNOFF; YIELD	Many previous studies have shown that land use patterns are the main factors influencing soil infiltration. Thus, increasing soil infiltration and reducing runoff are crucial for soil and water conservation, especially in semi-arid environments. To explore the effects of agroforestry systems on soil infiltration and associated properties in a semi-arid area of the Loess Plateau in China, we compared three plant systems: a walnut (Juglans regia) monoculture system (JRMS), a wheat (Triticum aestivum) monoculture system (TAMS), and a walnut-wheat alley cropping system (JTACS) over a period of 11 years. Our results showed that the JTACS facilitated infiltration, and its infiltration rate temporal distribution showed a stronger relationship coupled with the rainfall temporal distribution compared with the two monoculture systems during the growing season. However, the effect of JTACS on the infiltration capacity was only significant in shallow soil layer, i.e., the 0-40 cm soil depth. Within JTACS, the speed of the wetting front's downward movement was significantly faster than that in the two monoculture systems when the amount of rainfall and its intensity were higher. The soil infiltration rate was improved, and the two peaks of soil infiltration rate temporal distribution and the rainfall temporal distribution coupled in rainy season in the alley cropping system, which has an important significance in soil and water conservation. The results of this empirical study provide new insights into the sustainability of agroforestry, which may help farmers select rational planting patterns in this region, as well as other regions with similar climatic and environmental characteristics throughout the world.	[Wang, Lai; Zhong, Chonggao; Gao, Pengxiang; Zhang, Shuoxin] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Zhang, Shuoxin] Qingling Natl Forest Ecosyst Res Stn, Yangling, Shaanxi, Peoples R China; [Xi, Weimin] Texas A&M Univ, Dept Biol & Hlth Sci, Kingsville, TX USA	Northwest A&F University - China; Texas A&M University System; Texas A&M University Kingsville	Zhang, SX (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	sxzhang@nwsuaf.edu.cn		Xi, Weimin/0000-0002-2827-8851	Chinese National Science and Technology Research Plan [2011BAD38B0202]; CFERN GENE	Chinese National Science and Technology Research Plan; CFERN GENE	This research was supported by the Chinese National Science and Technology Research Plan (2011BAD38B0202). This specific study was supported by CFERN & GENE Award Funds for Ecological Papers (http://www.cfern.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed A., 1990, AMA, Agricultural Mechanization in Asia, Africa and Latin America, V21, P24; [Anonymous], 2011, 19522011 LYT; Armstrong AC, 1999, SOIL USE MANAGE, V15, P240, DOI 10.1111/j.1475-2743.1999.tb00096.x; Arnau-Rosalen E, 2008, GEOMORPHOLOGY, V101, P595, DOI 10.1016/j.geomorph.2008.03.001; Cao FL, 2012, AGROFOREST SYST, V84, P401, DOI 10.1007/s10457-012-9485-9; Cerda A, 1997, J HYDROL, V198, P209, DOI 10.1016/S0022-1694(96)03295-7; Cerda A, 1996, GEODERMA, V69, P217, DOI 10.1016/0016-7061(95)00062-3; Chartier MP, 2011, J ARID ENVIRON, V75, P656, DOI 10.1016/j.jaridenv.2011.02.007; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Ding SS, 2010, AGROFOREST SYST, V80, P117, DOI 10.1007/s10457-010-9287-x; Fan Wei, 2000, Scientia Silvae Sinicae, V36, P16; Fang ZS, 1958, INVESTIGATION TERRAC, P53; Gao LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070739; Gillespie AR, 2000, AGROFOREST SYST, V48, P25, DOI 10.1023/A:1006285205553; Gomez JA, 1999, SOIL TILL RES, V52, P167, DOI 10.1016/S0167-1987(99)00078-1; Guo ZS, 2003, ACTA ECOLOGICA SINIC, V23, P1460; Hangen E, 2002, SOIL TILL RES, V63, P181, DOI 10.1016/S0167-1987(01)00234-3; [花伟东 HUA Weidong], 2008, [水土保持学报, Journal of Soil and Water Conservation], V22, P213; Jose S, 2000, AGROFOREST SYST, V48, P41, DOI 10.1023/A:1006289322392; Jouquet P, 2012, BIOL FERT SOILS, V48, P561, DOI 10.1007/s00374-011-0652-3; Khan S, 2009, AGR WATER MANAGE, V96, P349, DOI 10.1016/j.agwat.2008.09.022; Kostiakov AN, 1932, DYNAMICS COEFFICIE A, P15; Li FD, 2008, AGROFOREST SYST, V74, P163, DOI 10.1007/s10457-008-9122-9; Li W., 1994, AGROFORESTRY CHINA, P14; Livesley SJ, 2000, PLANT SOIL, V227, P149, DOI 10.1023/A:1026551616754; Ludwig JA, 2005, ECOLOGY, V86, P288, DOI 10.1890/03-0569; Marin CT, 2000, J HYDROL, V237, P40, DOI 10.1016/S0022-1694(00)00301-2; Matula S, 2003, PLANT SOIL ENVIRON, V49, P298, DOI 10.17221/4128-PSE; Meng Ping, 2002, Forest Research, V15, P369; Michaelides K, 2009, HYDROL PROCESS, V23, P1617, DOI 10.1002/hyp.7293; Mulumba LN, 2008, SOIL TILL RES, V98, P106, DOI 10.1016/j.still.2007.10.011; Neris J, 2012, CATENA, V98, P55, DOI 10.1016/j.catena.2012.06.006; Peng XB, 2009, AGROFOREST SYST, V76, P569, DOI 10.1007/s10457-009-9227-9; [任宗萍 Ren Zongping], 2012, [水土保持学报, Journal of Soil and Water Conservation], V26, P94; Rivest D, 2010, AGROFOREST SYST, V80, P33, DOI 10.1007/s10457-010-9342-7; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Sun H, 2008, AGROFOREST SYST, V73, P65, DOI 10.1007/s10457-008-9113-x; van Schaik NLMB, 2009, CATENA, V78, P36, DOI 10.1016/j.catena.2009.02.017; Wu Q. X., 2005, SOIL WATER CONSERVAT, P118; Xu HS, 2013, INT J AGRIC BIOL, V15, P998; Zhang W, 2013, AGROFOREST SYST, V87, P929, DOI 10.1007/s10457-013-9609-x; [朱良君 Zhu Liangjun], 2012, [水土保持通报, Bulletin of Soil and Water Conservation], V32, P163; Zhu Q., 2003, SUSTAINABLE MANAGEME, P160; Zimmermann B, 2006, FOREST ECOL MANAG, V222, P29, DOI 10.1016/j.foreco.2005.10.070	44	7	7	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124767	10.1371/journal.pone.0124767	http://dx.doi.org/10.1371/journal.pone.0124767			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893832	Green Published, gold, Green Submitted			2022-12-27	WOS:000353211700120
J	Yokogawa, N; Toribatake, Y; Murakami, H; Hayashi, H; Yoneyama, T; Watanabe, T; Tsuchiya, H				Yokogawa, Noriaki; Toribatake, Yasumitsu; Murakami, Hideki; Hayashi, Hiroyuki; Yoneyama, Takeshi; Watanabe, Tetsuyou; Tsuchiya, Hiroyuki			Differences in Gait Characteristics of Patients with Lumbar Spinal Canal Stenosis (L4 Radiculopathy) and Those with Osteoarthritis of the Hip	PLOS ONE			English	Article							WALKING PATTERNS; NORMAL MEN	It is important to differentially diagnose thigh pain from lumbar spinal stenosis (particularly lumbar fourth nerve root radiculopathy) and osteoarthritis of the hip. In this study, using a treadmill and a motion analysis method, gait characteristics were compared between these conditions. Patients with lumbar fourth nerve root radiculopathy had increased physiological knee flexion immediately after foot-ground contact, possibly owing to a slight decrease in the muscle strength of the quadriceps femoris muscle. Patients with osteoarthritis of the hip had decreased range of motion of the hip joint probably due to anatomically limited mobility as well as gait strategy to avoid pain resulting from increased internal pressure on the hip joint during its extension. Our facile and noninvasive method can be useful for the differential diagnosis of lumbar spinal canal stenosis from osteoarthritis of the hip.	[Yokogawa, Noriaki; Murakami, Hideki; Hayashi, Hiroyuki; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa, Japan; [Toribatake, Yasumitsu] Kouseiren Takaoka Hosp, Dept Orthoped Surg, Takaoka, Toyama, Japan; [Yoneyama, Takeshi; Watanabe, Tetsuyou] Kanazawa Univ, Coll Sci & Engn, Sch Mech Engn, Kanazawa, Ishikawa, Japan	Kanazawa University; Kanazawa University	Yokogawa, N (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthoped Surg, Kanazawa, Ishikawa, Japan.	chakkun1981chakkun@yahoo.co.jp	Watanabe, Tetsuyou/L-3532-2015	Watanabe, Tetsuyou/0000-0003-2549-1435				KELLGREN JH, 1957, ANN RHEUM DIS, V16, P494, DOI 10.1136/ard.16.4.494; Murray M P, 1970, Arch Phys Med Rehabil, V51, P637; MURRAY MP, 1971, J BONE JOINT SURG AM, VA 53, P259, DOI 10.2106/00004623-197153020-00006; MURRAY MP, 1964, J BONE JOINT SURG AM, V46, P335, DOI 10.2106/00004623-196446020-00009; MURRAY MP, 1969, J GERONTOL, V24, P169, DOI 10.1093/geronj/24.2.169; OFFIERSKI CM, 1983, SPINE, V8, P316, DOI 10.1097/00007632-198304000-00014; Pietraszewski B, 2012, ACTA BIOENG BIOMECH, V14, P9, DOI 10.5277/abb120302; Suda Y, 2002, SPINE, V27, P2509, DOI 10.1097/00007632-200211150-00016; White SC, 1998, MED SCI SPORT EXER, V30, P1537, DOI 10.1097/00005768-199810000-00011	9	11	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2015	10	4							e0124745	10.1371/journal.pone.0124745	http://dx.doi.org/10.1371/journal.pone.0124745			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG3XA	25893667	gold, Green Published, Green Submitted			2022-12-27	WOS:000353211700119
J	Ellis, MK; Elliott, KS; Rautanen, A; Crook, DW; Hill, AVS; Chapman, SJ				Ellis, Magda K.; Elliott, Katherine S.; Rautanen, Anna; Crook, Derrick W.; Hill, Adrian V. S.; Chapman, Stephen J.			Rare Variants in MYD88, IRAK4 and IKBKG and Susceptibility to Invasive Pneumococcal Disease: A Population-Based Case-Control Study	PLOS ONE			English	Article							PYOGENIC BACTERIAL-INFECTIONS; GENOME-WIDE ASSOCIATION; HEALTHY-CHILDREN; GENOTYPE; POLYMORPHISMS; MUTATIONS; DATABASE; DEFECTS; HUMANS; TLR4	Although rare variants within the Toll-like receptor signalling pathway genes have been found to underlie human primary immunodeficiencies associated with selective predisposition to invasive pneumococcal disease (IPD), the contribution of variants in these genes to IPD susceptibility at the population level remains unknown. Complete re-sequencing of IRAK4, MYD88 and IKBKG genes was undertaken in 164 IPD cases from the UK and 164 geographically-matched population-based controls. 233 single-nucleotide variants (SNVs) were identified, of which ten were in coding regions. Four rare coding variants were predicted to be deleterious, two variants in MYD88 and two in IRAK4. The predicted deleterious variants in MYD88 were observed as two heterozygote cases but not seen in controls. Frequencies of predicted deleterious IRAK4 SNVs were the same in cases and controls. Our findings suggest that rare, functional variants in MYD88, IRAK4 or IKBKG do not significantly contribute to IPD susceptibility in adults at the population level.	[Ellis, Magda K.; Elliott, Katherine S.; Rautanen, Anna; Hill, Adrian V. S.; Chapman, Stephen J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England; [Ellis, Magda K.] Queensland Inst Med Res, Brisbane, Qld 4006, Australia; [Ellis, Magda K.] Univ Sydney, Centenary Inst, Sydney, NSW 2006, Australia; [Ellis, Magda K.] Univ Sydney, Sydney Med Sch, Sydney, NSW 2006, Australia; [Crook, Derrick W.] John Radcliffe Hosp, Dept Microbiol, Oxford OX3 9DU, England; [Chapman, Stephen J.] Oxford Univ Hosp, Oxford Ctr Resp Med, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics; QIMR Berghofer Medical Research Institute; University of Sydney; Centenary Institute; University of Sydney; University of Oxford	Ellis, MK (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX1 2JD, England.	m.ellis@centenary.org.au			Medical Research Council, UK; Wellcome Trust Centre for Human Genetics core grant [090532/Z/09/Z]; NIHR Biomedical Research Centre, Oxford; NHMRC Training Fellowship, Australia [GNT0552496]; Wellcome Trust [076113/C/04/Z]; Juvenile Diabetes Research Foundation [WT061858]; National Institute of Health Research of England; MRC [G1001712] Funding Source: UKRI; Medical Research Council [G1001712] Funding Source: researchfish; National Institute for Health Research [CL-2006-13-003, NF-SI-0512-10047] Funding Source: researchfish	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust Centre for Human Genetics core grant(Wellcome Trust); NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NHMRC Training Fellowship, Australia(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); National Institute of Health Research of England(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This study was supported by the Medical Research Council, UK (www.mrc.ac.uk) and the Wellcome Trust Centre for Human Genetics core grant 090532/Z/09/Z (www.well.ox.ac.uk). SJC is supported by the NIHR Biomedical Research Centre, Oxford (oxcam.gpp.nih.gov). MKE is supported by an NHMRC Training Fellowship GNT0552496, Australia (www.nhmrc.gov.au). We acknowledge the use of DNA from The UK Blood Services collection of Common Controls (UKBS collection), funded by the Wellcome Trust grant 076113/C/04/Z, by the Juvenile Diabetes Research Foundation grant WT061858 (www.jdrf.org.uk), and by the National Institute of Health Research of England (www.nihr.ac.uk). The collection was established as part of the Wellcome Trust Case-Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Black RE, 2010, LANCET, V375, P1969, DOI 10.1016/S0140-6736(10)60549-1; Brouwer MC, 2009, LANCET INFECT DIS, V9, P31, DOI 10.1016/S1473-3099(08)70261-5; Burns K, 2003, J EXP MED, V197, P263, DOI 10.1084/jem.20021790; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Chapman SJ, 2012, NAT REV GENET, V13, P175, DOI 10.1038/nrg3114; Chapman SJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9377; Courtois G, 2006, CELL DEATH DIFFER, V13, P843, DOI 10.1038/sj.cdd.4401841; George J, 2011, J BIOL CHEM, V286, P1341, DOI 10.1074/jbc.M110.159996; Hanson EP, 2008, J ALLERGY CLIN IMMUN, V122, P1169, DOI 10.1016/j.jaci.2008.08.018; Hirschfeld AF, 2007, CLIN IMMUNOL, V122, P271, DOI 10.1016/j.clim.2006.10.012; Johansen CT, 2012, CIRC-CARDIOVASC GENE, V5, P66, DOI 10.1161/CIRCGENETICS.111.960864; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Ku CL, 2007, J EXP MED, V204, P2407, DOI 10.1084/jem.20070628; Ku CL, 2007, J MED GENET, V44, P16, DOI 10.1136/jmg.2006.044446; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; McClellan J, 2010, CELL, V141, P210, DOI 10.1016/j.cell.2010.03.032; Moens L, 2006, CLIN IMMUNOL, V118, P20, DOI 10.1016/j.clim.2005.08.002; Moens L, 2006, HUM IMMUNOL, V67, P605, DOI 10.1016/j.humimm.2006.04.014; Newport MJ, 2011, BRIEF FUNCT GENOMICS, V10, P98, DOI 10.1093/bfgp/elq037; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Picard C, 2003, SCIENCE, V299, P2076, DOI 10.1126/science.1081902; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Picard C, 2010, MEDICINE, V89, P403, DOI 10.1097/MD.0b013e3181fd8ec3; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Rivas MA, 2011, NAT GENET, V43, P1066, DOI 10.1038/ng.952; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Roy S, 2002, LANCET, V359, P1569, DOI 10.1016/S0140-6736(02)08516-1; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Uzel G, 2005, CURR OPIN ALLERGY CL, V5, P513, DOI 10.1097/01.all.0000191241.66373.74; van der Poll T, 2009, LANCET, V374, P1543, DOI 10.1016/S0140-6736(09)61114-4; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; Yuan FF, 2008, IMMUNOL CELL BIOL, V86, P268, DOI 10.1038/sj.icb.7100155	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123532	10.1371/journal.pone.0123532	http://dx.doi.org/10.1371/journal.pone.0123532			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886387	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000072
J	Grutters, BMC; Pollux, BJA; Verberk, WCEP; Bakker, ES				Grutters, Bart M. C.; Pollux, Bart J. A.; Verberk, Wilco C. E. P.; Bakker, Elisabeth S.			Native and Non-Native Plants Provide Similar Refuge to Invertebrate Prey, but Less than Artificial Plants	PLOS ONE			English	Article							SUBMERGED AQUATIC VEGETATION; STRUCTURAL COMPLEXITY; HABITAT COMPLEXITY; FORAGING SUCCESS; INTRAGUILD PREDATION; LARGEMOUTH BASS; FISH; MACROPHYTE; DAPHNIA; SIZE	Non-native species introductions are widespread and can affect ecosystem functioning by altering the structure of food webs. Invading plants often modify habitat structure, which may affect the suitability of vegetation as refuge and could thus impact predator-prey dynamics. Yet little is known about how the replacement of native by non-native vegetation affects predator-prey dynamics. We hypothesize that plant refuge provisioning depends on (1) the plant's native status, (2) plant structural complexity and morphology, (3) predator identity, and (4) prey identity, as well as that (5) structurally similar living and artificial plants provide similar refuge. We used aquatic communities as a model system and compared the refuge provided by plants to macroinvertebrates (Daphnia pulex, Gammarus pulex and damselfly larvae) in three short-term laboratory predation experiments. Plant refuge provisioning differed between plant species, but was generally similar for native (Myriophyllum spicatum, Ceratophyllum demersum, Potamogeton perfoliatus) and non-native plants (Vallisneria spiralis, Myriophyllum heterophyllum, Cabomba caroliniana). However, plant refuge provisioning to macroinvertebrate prey depended primarily on predator (mirror carp: Cyprinus carpio carpio and dragonfly larvae: Anax imperator) and prey identity, while the effects of plant structural complexity were only minor. Contrary to living plants, artificial plant analogues did improve prey survival, particularly with increasing structural complexity and shoot density. As such, plant rigidity, which was high for artificial plants and one of the living plant species evaluated in this study (Ceratophyllum demersum), may interact with structural complexity to play a key role in refuge provisioning to specific prey (Gammarus pulex). Our results demonstrate that replacement of native by structurally similar non-native vegetation is unlikely to greatly affect predator-prey dynamics. We propose that modification of predator-prey interactions through plant invasions only occurs when invading plants radically differ in growth form, density and rigidity compared to native plants.	[Grutters, Bart M. C.; Bakker, Elisabeth S.] Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands; [Pollux, Bart J. A.] Wageningen Univ, Dept Anim Sci, Expt Zool Grp, NL-6700 AP Wageningen, Netherlands; [Verberk, Wilco C. E. P.] Radboud Univ Nijmegen, Inst Water & Wetland Res, Dept Anim Ecol & Ecophysiol, NL-6525 ED Nijmegen, Netherlands	Royal Netherlands Academy of Arts & Sciences; Netherlands Institute of Ecology (NIOO-KNAW); Wageningen University & Research; Radboud University Nijmegen	Grutters, BMC (corresponding author), Netherlands Inst Ecol NIOO KNAW, Dept Aquat Ecol, Wageningen, Netherlands.	b.grutters@nioo.knaw.nl	Verberk, Wilco/E-6337-2011; Bakker, Elisabeth S/B-7185-2008; KNAW, NIOO-KNAW/A-4320-2012	Verberk, Wilco/0000-0002-0691-583X; Bakker, Elisabeth S/0000-0002-5900-9136; KNAW, NIOO-KNAW/0000-0002-3835-159X	Netherlands Organisation for Scientific Research [841.11.011, 821.02.024]; Marie Curie FP7-PEOPLE-IIF grant [299048]	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Marie Curie FP7-PEOPLE-IIF grant	BMCG and ESB were supported by the Netherlands Organisation for Scientific Research (Earth and Life Sciences - Research Program: Biodiversity works, grant 841.11.011, http://www.nwo.nl). BJAP was supported by Marie Curie FP7-PEOPLE-2011-IIF grant 299048 (http://ec.europa.eu/research/mariecurieactions) and by Netherlands Organisation for Scientific Research (Earth and Life Sciences - Open Programme, grant 821.02.024, http://www.nwo.nl). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bal KD, 2011, FUNCT ECOL, V25, P1197, DOI 10.1111/j.1365-2435.2011.01909.x; Bartholomew A, 2000, MAR ECOL PROG SER, V206, P45, DOI 10.3354/meps206045; Bartholomew A, 2002, ESTUARIES, V25, P1045, DOI 10.1007/BF02691351; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bridgewater P, 2011, FRONT ECOL ENVIRON, V9, P423, DOI 10.1890/1540-9295-9.8.423; Burks RL, 2001, LIMNOL OCEANOGR, V46, P230, DOI 10.4319/lo.2001.46.2.0230; Burks RL, 2002, J CHEM ECOL, V28, P1901, DOI 10.1023/A:1020785525081; Calcagno V, 2011, AM NAT, V177, pE1, DOI 10.1086/657436; Cazzanelli M, 2008, HYDROBIOLOGIA, V605, P113, DOI 10.1007/s10750-008-9324-1; Chaplin GI, 2009, ESTUAR COAST, V32, P319, DOI 10.1007/s12237-008-9117-9; COBLE DW, 1985, CAN J FISH AQUAT SCI, V42, P791, DOI 10.1139/f85-101; Corbet P. S., 1999, DRAGONFLIES BEHAV EC; Crooks JA, 2002, OIKOS, V97, P153, DOI 10.1034/j.1600-0706.2002.970201.x; DIEHL S, 1988, OIKOS, V53, P207, DOI 10.2307/3566064; Dorner H, 2003, J FISH BIOL, V62, P1021, DOI 10.1046/j.1095-8649.2003.00092.x; Dutra HP, 2011, OECOLOGIA, V166, P649, DOI 10.1007/s00442-010-1895-7; EHLINGER TJ, 1989, ANIM BEHAV, V38, P643, DOI 10.1016/S0003-3472(89)80010-7; Figueiredo BRS, 2013, HYDROBIOLOGIA, V716, P21, DOI 10.1007/s10750-013-1540-7; Finke DL, 2006, OECOLOGIA, V149, P265, DOI 10.1007/s00442-006-0443-y; Flynn KE, 2011, HYDROBIOLOGIA, V675, P97, DOI 10.1007/s10750-011-0805-2; FOLSOM TC, 1984, OIKOS, V42, P105, DOI 10.2307/3544615; Fox J., 2019, R COMPANION APPL REG, V.; GOTCEITAS V, 1989, OECOLOGIA, V80, P158, DOI 10.1007/BF00380145; Grime JP, 1997, SCIENCE, V277, P1260, DOI 10.1126/science.277.5330.1260; Horinouchi M, 2009, MAR ECOL PROG SER, V377, P43, DOI 10.3354/meps07869; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; Hughes AR, 2006, OECOLOGIA, V149, P256, DOI 10.1007/s00442-006-0439-7; Hussner A, 2012, WEED RES, V52, P297, DOI 10.1111/j.1365-3180.2012.00926.x; Katayama M, 2014, HYDROBIOLOGIA, V732, P173, DOI 10.1007/s10750-014-1857-x; KEAST A, 1984, CAN J ZOOL, V62, P1289, DOI 10.1139/z84-186; Klecka J, 2014, OECOLOGIA, V176, P183, DOI 10.1007/s00442-014-3007-6; Klecka J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037741; Kouwen N., 1973, J HYDRAUL DIV, V99, P713, DOI DOI 10.1061/JYCEAJ.0003643; Lauridsen TL, 1996, LIMNOL OCEANOGR, V41, P794, DOI 10.4319/lo.1996.41.4.0794; Macneil C, 1999, BIOL REV, V74, P375, DOI 10.1017/S0006323199005368; Manatunge J, 2000, ENVIRON BIOL FISH, V58, P425, DOI 10.1023/A:1007691425268; Martin CW, 2011, ESTUAR COAST, V34, P364, DOI 10.1007/s12237-010-9274-5; Martin CW, 2010, OECOLOGIA, V162, P893, DOI 10.1007/s00442-010-1564-x; Mattos KJ, 2010, BEHAV ECOL, V21, P556, DOI 10.1093/beheco/arq020; McAbendroth L, 2005, OIKOS, V111, P279, DOI 10.1111/j.0030-1299.2005.13804.x; Michel MJ, 2009, BEHAV ECOL, V20, P313, DOI 10.1093/beheco/arp005; Orrock J.L., 2010, OPEN ECOL J, V3, P22, DOI [10.2174/1874213001003030022, DOI 10.2174/1874213001003030022]; Orrock JL, 2013, ECOLOGY, V94, P573, DOI 10.1890/12-0502.1; Padial AA, 2009, HYDROBIOLOGIA, V624, P161, DOI 10.1007/s10750-008-9690-8; PENNAK R W, 1973, Internationale Revue der Gesamten Hydrobiologie, V58, P569, DOI 10.1002/iroh.19730580406; R Core Team, 2021, R LANGUAGE ENV STAT; Rantala MJ, 2004, AQUAT ECOL, V38, P77; RYER CH, 1988, MAR ECOL PROG SER, V48, P37, DOI 10.3354/meps048037; Sagrario G, 2009, FRESHWATER BIOL, V54, P1042, DOI 10.1111/j.1365-2427.2008.02152.x; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111&lt;255:PIBLBA&gt;2.0.CO;2; Scheinin M, 2012, OIKOS, V121, P1093, DOI 10.1111/j.1600-0706.2011.19941.x; Scheipl F., 2020, LINEAR MIXED EFFECTS, DOI 10.18637/jss.v067.i01; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz R, 2012, HYDROBIOLOGIA, V684, P1, DOI 10.1007/s10750-011-0978-8; SHELDON RB, 1977, AM MIDL NAT, V97, P248, DOI 10.2307/2424706; Simberloff D, 2011, BIOL INVASIONS, V13, P1255, DOI 10.1007/s10530-011-9956-3; Stiers I, 2011, BIOL INVASIONS, V13, P2715, DOI 10.1007/s10530-011-9942-9; STONER AW, 1982, J EXP MAR BIOL ECOL, V58, P271, DOI 10.1016/0022-0981(82)90134-4; Strayer DL, 2003, FRESHWATER BIOL, V48, P1938, DOI 10.1046/j.1365-2427.2003.01142.x; Tavsanoglu UN, 2012, FRESHWATER BIOL, V57, P795, DOI 10.1111/j.1365-2427.2012.02745.x; Tokeshi M, 2012, HYDROBIOLOGIA, V685, P27, DOI 10.1007/s10750-011-0832-z; Valinoti CE, 2011, J EXP MAR BIOL ECOL, V409, P42, DOI 10.1016/j.jembe.2011.08.001; Valley RD, 2002, T AM FISH SOC, V131, P234, DOI 10.1577/1548-8659(2002)131&lt;0234:EOMBAO&gt;2.0.CO;2; Van de Meutter F, 2005, OECOLOGIA, V144, P327, DOI 10.1007/s00442-005-0050-3; Van de Meutter F, 2004, OIKOS, V107, P265, DOI 10.1111/j.0030-1299.2004.13221.x; van Kleunen M, 2014, BASIC APPL ECOL, V15, P1, DOI 10.1016/j.baae.2013.10.006; Venables WN., 2002, MODERN APPL STAT S 4; Verberk WCEP, 2013, FRESHW SCI, V32, P531, DOI 10.1899/12-092.1; Vila M, 2011, ECOL LETT, V14, P702, DOI 10.1111/j.1461-0248.2011.01628.x; Warburton K, 2003, FISH FISH, V4, P203, DOI 10.1046/j.1467-2979.2003.00125.x; Warfe DM, 2006, OECOLOGIA, V150, P141, DOI 10.1007/s00442-006-0505-1; Warfe DM, 2004, OECOLOGIA, V141, P171, DOI 10.1007/s00442-004-1644-x; Wellborn GA, 1996, ANNU REV ECOL SYST, V27, P337, DOI 10.1146/annurev.ecolsys.27.1.337; WERNER EE, 1981, ECOLOGY, V62, P116, DOI 10.2307/1936675; Wimp GM, 2013, OECOLOGIA, V171, P505, DOI 10.1007/s00442-012-2435-4; WRIGHT D, 1990, FRESHWATER BIOL, V24, P43, DOI 10.1111/j.1365-2427.1990.tb00306.x	77	32	32	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124455	10.1371/journal.pone.0124455	http://dx.doi.org/10.1371/journal.pone.0124455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25885967	Green Submitted, Green Published, gold			2022-12-27	WOS:000353017000129
J	Gwak, JM; Jang, MH; Kim, DI; Seo, AN; Park, SY				Gwak, Jae Moon; Jang, Min Hye; Kim, Dong Il; Seo, An Na; Park, So Yeon			Prognostic Value of Tumor-Associated Macrophages According to Histologic Locations and Hormone Receptor Status in Breast Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; PROGRESSION; CARCINOMA; THERAPY; ANGIOGENESIS; INFILTRATION; METASTASIS; CELLS	Tumor-associated macrophages (TAMs) are involved in tumor progression by promoting epithelial-mesenchymal transition (EMT), tumor cell invasion, migration and angiogenesis. However, in breast cancer, the clinical relevance of the TAM infiltration according to distinct histologic locations (intratumoral vs. stromal) and hormone receptor status is unclear. We investigated the significance of the levels of TAM infiltration in distinct histologic locations in invasive breast cancer. We also examined the relationship of the TAM levels with the clinicopathologic features of tumors, expression of EMT markers, and clinical outcomes. Finally, we analyzed the prognostic value of TAM levels according to hormone receptor status. High levels of infiltration of intratumoral, stromal and total TAMs were associated with high histologic grade, p53 overexpression, high Ki-67 proliferation index and negative hormone receptor status. Infiltration of TAMs was also correlated with overexpression of vimentin, smooth muscle actin and alteration of beta-catenin. Overall, a high level of infiltration of intratumoral TAMs was associated with poor disease-free survival, and was found to be an independent prognostic factor. In subgroup analyses by hormone receptor status, a high level of infiltration of intratumoral TAM was an independent prognostic factor in the hormone receptor-positive subgroup, but not in the hormone-receptor negative subgroup. Our findings suggest that intratumoral TAMs play an important role in tumor progression in breast cancer, especially in the hormone receptor-positive group, and the level of TAM infiltration may be used as a prognostic factor and even a therapeutic target in breast cancer.	[Gwak, Jae Moon; Park, So Yeon] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Jang, Min Hye; Park, So Yeon] Seoul Natl Univ, Bundang Hosp, Dept Pathol, Songnam, Gyeonggi, South Korea; [Kim, Dong Il] Green Cross Lab, Yongin, Gyeonggi, South Korea; [Seo, An Na] Kyungpook Natl Univ, Sch Med, Kyungpook Natl Univ Hosp, Dept Pathol, Daegu, South Korea	Seoul National University (SNU); Seoul National University (SNU); Kyungpook National University; Kyungpook National University Hospital	Park, SY (corresponding author), Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea.	sypmd@snu.ac.kr		Park, So Yeon/0000-0002-0299-7268	Green Cross Laboratory	Green Cross Laboratory	Green Cross Laboratory provided support in the form of salaries for author Dong Il Kim, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Bonde AK, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-35; Campbell MJ, 2011, BREAST CANCER RES TR, V128, P703, DOI 10.1007/s10549-010-1154-y; Ch'ng ES, 2013, VIRCHOWS ARCH, V462, P257, DOI 10.1007/s00428-012-1362-4; Choi Y, 2013, HUM PATHOL, V44, P2581, DOI 10.1016/j.humpath.2013.07.003; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Denkert C, 2010, J CLIN ONCOL, V28, P105, DOI 10.1200/JCO.2009.23.7370; Fan QM, 2014, CANCER LETT, V352, P160, DOI 10.1016/j.canlet.2014.05.008; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Jang MH, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3239; Krol M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083995; Leek RD, 1999, BRIT J CANCER, V79, P991, DOI 10.1038/sj.bjc.6690158; Leek RD, 1996, CANCER RES, V56, P4625; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Liu CY, 2013, LAB INVEST, V93, P844, DOI 10.1038/labinvest.2013.69; Mahmoud SMA, 2012, J CLIN PATHOL, V65, P159, DOI 10.1136/jclinpath-2011-200355; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Ohno S, 2002, ANTICANCER RES, V22, P4269; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Seo AN, 2013, BRIT J CANCER, V109, P2705, DOI 10.1038/bjc.2013.634; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Singh RP, 2014, BRIT J OPHTHALMOL, V98, P1, DOI 10.1136/bjophthalmol-2014-305502; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Su SC, 2014, CANCER CELL, V25, P605, DOI 10.1016/j.ccr.2014.03.021; Tang XQ, 2013, CANCER LETT, V332, P3, DOI 10.1016/j.canlet.2013.01.024; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076147	31	85	91	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0125728	10.1371/journal.pone.0125728	http://dx.doi.org/10.1371/journal.pone.0125728			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884955	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000162
J	Nalbandian, A; Llewellyn, KJ; Nguyen, C; Yazdi, PG; Kimonis, VE				Nalbandian, Angele; Llewellyn, Katrina J.; Nguyen, Christopher; Yazdi, Puya G.; Kimonis, Virginia E.			Rapamycin and Chloroquine: The In Vitro and In Vivo Effects of Autophagy-Modifying Drugs Show Promising Results in Valosin Containing Protein Multisystem Proteinopathy	PLOS ONE			English	Article							INCLUSION-BODY MYOPATHY; PAGET-DISEASE; FRONTOTEMPORAL DEMENTIA; LIFE-SPAN; MUSCULAR-DYSTROPHY; VCP MUTATIONS; MOUSE MODEL; BONE; FAMILY; YEAST	Mutations in the valosin containing protein (VCP) gene cause hereditary Inclusion body myopathy (hIBM) associated with Paget disease of bone (PD B), frontotemporal dementia (FTD), more recently termed multisystem proteinopathy (MSP). Affected individuals exhibit scapular winging and die from progressive muscle weakness, and cardiac and respiratory failure, typically in their 40s to 50s. Histologically, patients show the presence of rimmed vacuoles and TAR DNA-binding protein 43 (TDP-43)-positive large ubiquitinated inclusion bodies in the muscles. We have generated a VCPR155H+ mouse model which recapitulates the disease phenotype and impaired autophagy typically observed in patients with VCP disease. Autophagy-modifying agents, such as rapamycin and chloroquine, at pharmacological doses have previously shown to alter the autophagic flux. Herein, we report results of administration of rapamycin, a specific inhibitor of the mechanistic target of rapamycin (mTOR) signaling pathway, and chloroquine, a lysosomal inhibitor which reverses autophagy by accumulating in lysosomes, responsible for blocking autophagy in 20-month old VCPR155H+- mice. Rapamycin-treated mice demonstrated significant improvement in muscle performance, quadriceps histological analysis, and rescue of ubiquitin, and TDP-43 pathology and defective autophagy as indicated by decreased protein expression levels of LC3-1/1I, p62/SQSTM1, optineurin and inhibiting the mTORC1 substrates. Conversely, chloroquine-treated VCPR155H+ mice revealed progressive muscle weakness, cytoplasmic accumulation of TDP-43, ubiquitin-positive inclusion bodies and increased LC3-1/1I, p62/SQSTM1, and optineurin expression levels. Our in vitro patient myoblasts studies treated with rapamycin demonstrated an overall improvement in the autophagy markers. Targeting the mTOR pathway ameliorates an increasing list of disorders, and these findings suggest that VCP disease and related neurodegenerative multisystem proteinopathies can now be included as disorders that can potentially be ameliorated by rapalogs.	[Nalbandian, Angele; Llewellyn, Katrina J.; Nguyen, Christopher; Kimonis, Virginia E.] Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA; [Nalbandian, Angele; Llewellyn, Katrina J.; Yazdi, Puya G.; Kimonis, Virginia E.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Irvine, CA USA; [Yazdi, Puya G.] Syst Hlth LLC, Los Angeles, CA USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Nalbandian, A (corresponding author), Univ Calif Irvine, Dept Pediat, Div Genet & Metab, Irvine, CA 92717 USA.	asialbandian@uci.edu; vkimonis@uci.edu		Yazdi, Puya/0000-0003-3456-8043	National Institutes of Health (NIH) [R21 AR063360]; Muscular Dystrophy Association (MDA) [175682]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR063360] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Muscular Dystrophy Association (MDA)(Muscular Dystrophy Association); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by National Institutes of Health (NIH) grant R21 AR063360 and Muscular Dystrophy Association (MDA) funding 175682 to VEK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badadani M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013183; Bays NW, 2002, CURR BIOL, V12, pR366, DOI 10.1016/S0960-9822(02)00862-X; Bersano A, 2007, NEUROBIOL AGING; Bibee KP, 2014, FASEB J, V28, P2047, DOI 10.1096/fj.13-237388; Bove J, 2011, NAT REV NEUROSCI, V12, P437, DOI 10.1038/nrn3068; Caccamo A, 2014, J NEUROSCI, V34, P7988, DOI 10.1523/JNEUROSCI.0777-14.2014; Ching JK, 2013, AUTOPHAGY, V9, P799, DOI 10.4161/auto.23958; Ching JK, 2013, HUM MOL GENET, V22, P1167, DOI 10.1093/hmg/dds524; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Djamshidian A, 2009, MUSCLE NERVE, V39, P389, DOI 10.1002/mus.21225; Fanganiello RD, 2011, EXPT BRAIN RES UNPUB; FROHLICH KU, 1991, J CELL BIOL, V114, P443, DOI 10.1083/jcb.114.3.443; Fu XR, 2003, J CELL BIOL, V163, P21, DOI 10.1083/jcb.200307025; Ghosh I, 2014, INDIAN J MED PAEDIAT, V35, P99, DOI 10.4103/0971-5851.133733; Guyant-Marechal L, 2006, NEUROLOGY, V67, P644, DOI 10.1212/01.wnl.0000225184.14578.d3; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Haubenberger D, 2005, NEUROLOGY, V65, P1304, DOI 10.1212/01.wnl.0000180407.15369.92; Jiang D, 2014, ACTA PHARMACOL SIN, V35, P135, DOI 10.1038/aps.2013.144; Johnson JO, 2010, NEURON, V68, P857, DOI 10.1016/j.neuron.2010.11.036; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Ju JS, 2008, J BIOL CHEM, V283, P30289, DOI 10.1074/jbc.M805517200; Ju JS, 2009, J CELL BIOL, V187, P875, DOI 10.1083/jcb.200908115; Ju JS, AUTOPHAGY, V6; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kawai T, 1997, ORAL SURG ORAL MED O, V84, P449, DOI 10.1016/S1079-2104(97)90047-0; Kim EJ, 2011, ARCH NEUROL-CHICAGO, V68, P787, DOI 10.1001/archneurol.2010.376; Kimonis V, 2011, INCLUSION BODY MYOPA; Kimonis VE, 2005, ALZ DIS ASSOC DIS, V19, pS44, DOI 10.1097/01.wad.0000183081.76820.5a; Kimonis VE, 2000, GENET MED, V2, P232, DOI 10.1097/00125817-200007000-00006; Kimonis VE, 2008, AM J MED GENET A, V146A, P745, DOI 10.1002/ajmg.a.31862; Kimonis VE, 2008, BBA-MOL BASIS DIS, V1782, P744, DOI 10.1016/j.bbadis.2008.09.003; Komatsu J, 2013, MUSCLE NERVE, V48, P995, DOI 10.1002/mus.23960; Komatsu M, 2006, AUTOPHAGY, V2, P315, DOI 10.4161/auto.2974; Kovach MJ, 2001, MOL GENET METAB, V74, P458, DOI 10.1006/mgme.2001.3256; Kumar KR, 2010, NEUROMUSCULAR DISORD, V20, P330, DOI 10.1016/j.nmd.2010.03.002; Lamb JR, 2001, J BIOL CHEM, V276, P21512, DOI 10.1074/jbc.M100235200; Leon A, 1999, MOL BIOL CELL, V10, P3825, DOI 10.1091/mbc.10.11.3825; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Llewellyn K NA, 2013, HUM MOL GENET; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; Miller TD, 2009, J NEUROL NEUROSUR PS, V80, P583, DOI 10.1136/jnnp.2008.148676; Muzic JG, 2014, JAMA DERMATOL, V150, P1024, DOI 10.1001/jamadermatol.2014.87; Nalbandian A, 2012, MUSCLE NERVE; Nalbandian A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046308; Nalbandian A, 2013, MUSCLE NERVE, V47, P260, DOI 10.1002/mus.23522; Peng ZF, 2014, J UROLOGY, V192, P1424, DOI 10.1016/j.juro.2014.04.096; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rodriguez-Caruncho C, 2014, ACTAS DERMO-SIFILOGR, V105, P243, DOI [10.1016/j.ad.2012.10.005, 10.1016/j.adengl.2012.10.021]; Schroder R, 2005, ANN NEUROL, V57, P457, DOI 10.1002/ana.20407; Spina S, 2008, FASEB J, V22, P584; Tung YT, 2012, J BIOSCIENCES, V37, P157, DOI 10.1007/s12038-011-9176-0; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Vesa J, 2009, NEUROMUSCULAR DISORD, V19, P766, DOI 10.1016/j.nmd.2009.08.003; Viassolo V, 2008, CLIN GENET, V74, P54, DOI 10.1111/j.1399-0004.2008.00984.x; Watts GDJ, 2007, CLIN GENET, V72, P420, DOI 10.1111/j.1399-0004.2007.00887.x; Watts GDJ, 2004, NAT GENET, V36, P377, DOI 10.1038/ng1332; Watts GDJ, 2003, NEUROMUSCULAR DISORD, V13, P559, DOI 10.1016/S0960-8966(03)00070-1; Wojcik C, 2004, J CELL SCI, V117, P281, DOI 10.1242/jcs.00841; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Yin HZ, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.115	65	55	56	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0122888	10.1371/journal.pone.0122888	http://dx.doi.org/10.1371/journal.pone.0122888			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884947	gold, Green Published			2022-12-27	WOS:000353017000042
J	Ottl, B; Jager, G; Kaup, B				Oettl, Birgit; Jaeger, Gerhard; Kaup, Barbara			Does Formal Complexity Reflect Cognitive Complexity? Investigating Aspects of the Chomsky Hierarchy in an Artificial Language Learning Study	PLOS ONE			English	Article							GRAMMAR; DEPENDENCIES; CONSTRAINTS; SENTENCES; HUMANS; PIRAHA	This study investigated whether formal complexity, as described by the Chomsky Hierarchy, corresponds to cognitive complexity during language learning. According to the Chomsky Hierarchy, nested dependencies (context-free) are less complex than cross-serial dependencies (mildly context-sensitive). In two artificial grammar learning (AGL) experiments participants were presented with a language containing either nested or cross-serial dependencies. A learning effect for both types of dependencies could be observed, but no difference between dependency types emerged. These behavioral findings do not seem to reflect complexity differences as described in the Chomsky Hierarchy. This study extends previous findings in demonstrating learning effects for nested and cross-serial dependencies with more natural stimulus materials in a classical AGL paradigm after only one hour of exposure. The current findings can be taken as a starting point for further exploring the degree to which the Chomsky Hierarchy reflects cognitive processes.	[Oettl, Birgit; Kaup, Barbara] Univ Tubingen, Dept Psychol, Tubingen, Germany; [Jaeger, Gerhard] Univ Tubingen, Dept Linguist, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen	Ottl, B (corresponding author), Univ Tubingen, Dept Psychol, Tubingen, Germany.	birgit.oettl@uni-tuebingen.de	Kaup, Barbara/M-6786-2013	Kaup, Barbara/0000-0002-7400-0789; Jager, Gerhard/0000-0002-9642-9359	German National Academic Foundation; German Research Foundation [SFB 833]; ERC [324246]	German National Academic Foundation; German Research Foundation(German Research Foundation (DFG)); ERC(European Research Council (ERC)European Commission)	While conducting this research the first author received support from the German National Academic Foundation. In addition, this research was supported by a grant from the German Research Foundation awarded to Barbara Kaup (SFB 833, Project B4) as well as by the ERC Advanced Grant 324246 Language Evolution: The Empirical Turn to Gerhard Jager. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bach E., 1986, LANG COGNITIVE PROC, V1, P249, DOI 10.1080/01690968608404677; Bahlmann J, 2008, NEUROIMAGE, V42, P525, DOI 10.1016/j.neuroimage.2008.04.249; Bahlmann J, 2006, J COGNITIVE NEUROSCI, V18, P1829, DOI 10.1162/jocn.2006.18.11.1829; Berent I, 2013, TRENDS COGN SCI, V17, P319, DOI 10.1016/j.tics.2013.05.004; Chesi C, 2014, MEASURING GRAMMATICA, P264; CHOMSKY N, 1956, IRE T INFORM THEOR, V2, P113; Chomsky N., 1957, SYNTACTIC STRUCTURE; Chomsky Noam., 1965, ASPECTS THEORY SYNTA; de Vries MH, 2008, COGNITION, V107, P763, DOI 10.1016/j.cognition.2007.09.002; de Vries MH, 2011, BIOLINGUISTICS, V5, P10; de Vries MH, 2012, PHILOS T R SOC B, V367, P2065, DOI 10.1098/rstb.2011.0414; Evans N, 2009, BEHAV BRAIN SCI, V32, P429, DOI 10.1017/S0140525X0999094X; Everett DL, 2005, CURR ANTHROPOL, V46, P621, DOI 10.1086/431525; Fitch WT, 2004, SCIENCE, V303, P377, DOI 10.1126/science.1089401; Friederici AD, 2006, P NATL ACAD SCI USA, V103, P2458, DOI 10.1073/pnas.0509389103; Friederici AD, 2004, TRENDS COGN SCI, V8, P245, DOI 10.1016/S1364-6613(04)00116-0; Gasarch W, 2014, ADV COMPUT, V95, P239, DOI 10.1016/B978-0-12-800160-8.00005-X; Gervain J, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00689; Gibson E, 1998, COGNITION, V68, P1, DOI 10.1016/S0010-0277(98)00034-1; HAUTUS MJ, 1995, BEHAV RES METH INS C, V27, P46, DOI 10.3758/BF03203619; Hochmann JR, 2008, COGNITIVE SCI, V32, P1021, DOI 10.1080/03640210801897849; Huybregts Riny, 1984, PERIFERIE NAAR KERN, P81; Jager G, 2012, PHILOS T R SOC B, V367, P1956, DOI 10.1098/rstb.2012.0077; Joshi A.K., 1985, NATURAL LANGUAGE PRO, P206, DOI [10.1017/CBO9780511597855.007, DOI 10.1017/CBO9780511597855]; Joshi A.K., 1991, FDN ISSUES NATURAL L, P31; MILLER GA, 1964, Q J EXP PSYCHOL, V16, P297, DOI 10.1080/17470216408416385; Nevins A, 2009, LANGUAGE, V85, P355; Perruchet P, 2005, PSYCHON B REV, V12, P307, DOI 10.3758/BF03196377; REBER AS, 1967, J VERB LEARN VERB BE, V6, P855, DOI 10.1016/S0022-5371(67)80149-X; Rohrmeier M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045885; SAVIN HB, 1965, J VERB LEARN VERB BE, V4, P348, DOI 10.1016/S0022-5371(65)80070-6; Udden J, 2012, COGNITIVE SCI, V36, P1078, DOI 10.1111/j.1551-6709.2012.01235.x	32	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123059	10.1371/journal.pone.0123059	http://dx.doi.org/10.1371/journal.pone.0123059			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EX	25885790	Green Published, gold			2022-12-27	WOS:000353017000048
J	Venderbosch, S; van Lent-van Vliet, S; de Haan, AFJ; Ligtenberg, MJ; Goossens, M; Punt, CJA; Koopman, M; Nagtegaal, ID				Venderbosch, Sabine; van Lent-van Vliet, Shannon; de Haan, Anton F. J.; Ligtenberg, Marjolijn J.; Goossens, Monique; Punt, Cornelis J. A.; Koopman, Miriam; Nagtegaal, Iris D.			EMAST Is Associated with a Poor Prognosis in Microsatellite Instable Metastatic Colorectal Cancer	PLOS ONE			English	Article							TETRANUCLEOTIDE REPEATS; COLON-CANCER; MUTATOR PHENOTYPE; HMLH1 PROMOTER; INSTABILITY; REPAIR; MUTATIONS; CARCINOMA; CELLS; HMSH6	Purpose To determine the frequency and prognostic value of elevated microsatellite alterations at selected tetranucleotide repeats (EMAST) in metastatic colorectal cancer (mCRC) patients in relation to microsatellite instability (MSI) status and MSH3 protein expression. Material and Methods The frequency of EMAST was evaluated in mCRC patients with MSI tumors and microsatellite stable (MSS) tumors. A literature overview was performed to compare the frequency of EMAST in our study with existing data. Immunohistochemistry for MSH3 was compared with EMAST status. Outcome was studied in terms of overall survival (OS) of mCRC patients with MSI and MSS tumors. Results EMAST was evaluated in 89 patients with MSI tumors (including 39 patients with Lynch syndrome) and 94 patients with MSS tumors. EMAST was observed in 45.9% (84 out of 183) of patients, with an increased frequency in MSI tumors (79.8% versus 13.8%, p < 0.001). We found no correlation between EMAST and MSH3 protein expression. There was no effect of EMAST on prognosis in patients with MSS tumors, but patients with MSI/non-EMAST tumors had a significantly better prognosis than patients with MSI/EMAST tumors (OS: HR 3.22, 95% CI 1.25-8.30). Conclusion Frequency of EMAST was increased in mCRC patients with MSI tumors, compared to MSS tumors. Our data suggest that the presence of EMAST correlates with worse OS in these patients. There was no effect of EMAST on the prognosis of patients with MSS tumors. A limitation of our study is the small number of patients in our subgroup analysis.	[Venderbosch, Sabine; van Lent-van Vliet, Shannon; Ligtenberg, Marjolijn J.; Goossens, Monique; Nagtegaal, Iris D.] Radboud Univ Nijmegen, Med Ctr, Dept Pathol, NL-6500 HB Nijmegen, Netherlands; [de Haan, Anton F. J.] Radboud Univ Nijmegen, Med Ctr, Dept Hlth Evidence, NL-6500 HB Nijmegen, Netherlands; [Venderbosch, Sabine; Punt, Cornelis J. A.] Univ Amsterdam, Acad Med Ctr, Dept Med Oncol, NL-1100 DD Amsterdam, Netherlands; [Ligtenberg, Marjolijn J.] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6500 HB Nijmegen, Netherlands; [Koopman, Miriam] Univ Med Ctr Utrecht, Dept Med Oncol, NL-3508 GA Utrecht, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center	Nagtegaal, ID (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Pathol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	Iris.Nagtegaal@radboudumc.nl	Nagtegaal, Iris D/A-2448-2014; de Haan, Antonius F J/L-4344-2015; Ligtenberg, Marjolijn/N-9666-2013	Nagtegaal, Iris D/0000-0003-0887-4127; Ligtenberg, Marjolijn/0000-0003-1290-1474	Dutch Colorectal Cancer Group (DCCG)	Dutch Colorectal Cancer Group (DCCG)	This study was supported by a grant from the Dutch Colorectal Cancer Group (DCCG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya S, 1996, P NATL ACAD SCI USA, V93, P13629, DOI 10.1073/pnas.93.24.13629; Ahrendt SA, 2000, CANCER RES, V60, P2488; Baranovskaya S, 2001, P NATL ACAD SCI USA, V98, P15107, DOI 10.1073/pnas.251234498; Burger M, 2006, J MOL MED, V84, P833, DOI 10.1007/s00109-006-0074-0; Campregher C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050541; Chang DK, 2000, J BIOL CHEM, V275, P29178; Choi YD, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-88; Cunningham JM, 1998, CANCER RES, V58, P3455; Danaee H, 2002, ONCOGENE, V21, P4894, DOI 10.1038/sj.onc.1205619; Devaraj B, 2010, J GASTROINTEST SURG, V14, P1521, DOI 10.1007/s11605-010-1340-6; Edelmann W, 1997, CELL, V91, P467, DOI 10.1016/S0092-8674(00)80433-X; Garcia M, 2012, GASTROENTEROLOGY, V143, P48, DOI 10.1053/j.gastro.2012.03.034; Genschel J, 1998, J BIOL CHEM, V273, P19895, DOI 10.1074/jbc.273.31.19895; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Haugen AC, 2008, CANCER RES, V68, P8465, DOI 10.1158/0008-5472.CAN-08-0002; Heideman DAM, 2012, J MOL DIAGN, V14, P247, DOI 10.1016/j.jmoldx.2012.01.011; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jass JR, 2006, WORLD J GASTROENTERO, V12, P4943, DOI 10.3748/wjg.v12.i31.4943; Jass JR, 1998, GUT, V42, P673, DOI 10.1136/gut.42.5.673; Kane MF, 1997, CANCER RES, V57, P808; Klarskov L, 2011, AM J SURG PATHOL, V35, P1391, DOI 10.1097/PAS.0b013e318225c3f0; Koopman M, 2009, BRIT J CANCER, V100, P266, DOI 10.1038/sj.bjc.6604867; Koopman M, 2007, LANCET, V370, P135, DOI 10.1016/S0140-6736(07)61086-1; Lee SY, 2012, DIGEST DIS SCI, V57, P72, DOI 10.1007/s10620-011-1825-5; Lee SY, 2010, GASTROENTEROLOGY, V139, P1519, DOI 10.1053/j.gastro.2010.08.001; Ohmiya N, 2001, GENE, V272, P301, DOI 10.1016/S0378-1119(01)00517-0; PAPADOPOULOS N, 1995, SCIENCE, V268, P1915, DOI 10.1126/science.7604266; Popat S, 2005, J CLIN ONCOL, V23, P609, DOI 10.1200/JCO.2005.01.086; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Samowitz WS, 2008, EXP MOL PATHOL, V85, P64, DOI 10.1016/j.yexmp.2008.03.008; Samowitz WS, 2001, AM J PATHOL, V158, P1517, DOI 10.1016/S0002-9440(10)64102-8; Singer G, 2004, INT J CANCER, V112, P643, DOI 10.1002/ijc.20455; Slebos RJC, 2002, CANCER RES, V62, P6052; Snover DC, 2011, HUM PATHOL, V42, P1, DOI 10.1016/j.humpath.2010.06.002; Tol J, 2010, EUR J CANCER, V46, P1997, DOI 10.1016/j.ejca.2010.03.036; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; Tseng-Rogenski SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050616; Xu LH, 2001, INT J CANCER, V91, P200, DOI 10.1002/1097-0215(200002)9999:9999<::AID-IJC1031>3.0.CO;2-0; Yamada K, 2010, ONCOL REP, V23, P551, DOI 10.3892/or_00000669	39	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0124538	10.1371/journal.pone.0124538	http://dx.doi.org/10.1371/journal.pone.0124538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25884216	Green Published, gold, Green Submitted			2022-12-27	WOS:000353017000136
J	Weme, RGJDO; Kovacs, AT; de Jong, SJG; Veening, JW; Siebring, J; Kuipers, OP				Weme, Ruud G. J. Detert Oude; Kovacs, Akos T.; de Jong, Sander J. G.; Veening, Jan-Willem; Siebring, Jeroen; Kuipers, Oscar P.			Single Cell FRET Analysis for the Identification of Optimal FRET-Pairs in Bacillus subtilis Using a Prototype MEM-FLIM System	PLOS ONE			English	Article							RESONANCE ENERGY-TRANSFER; RED FLUORESCENT PROTEIN; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; IMAGING MICROSCOPY; MONOMERIC RED; ACQUISITION; BACTERIA; LIFETIME; VARIANT	Protein-protein interactions can be studied in vitro, e.g. with bacterial or yeast two-hybrid systems or surface plasmon resonance. In contrast to in vitro techniques, in vivo studies of protein-protein interactions allow examination of spatial and temporal behavior of such interactions in their native environment. One approach to study protein-protein interactions in vivo is via Forster Resonance Energy Transfer (FRET). Here, FRET efficiency of selected FRET-pairs was studied at the single cell level using sensitized emission and Frequency Domain-Fluorescence Lifetime Imaging Microscopy (FD-FLIM). For FRET-FLIM, a prototype Modulated Electron-Multiplied FLIM system was used, which is, to the best of our knowledge, the first account of Frequency Domain FLIM to analyze FRET in single bacterial cells. To perform FRET-FLIM, we first determined and benchmarked the best fluorescent protein-pair for FRET in Bacillus subtilis using a novel BglBrick-compatible integration vector. We show that GFP-tagRFP is an excellent donor-acceptor pair for B. subtilis in vivo FRET studies. As a proof of concept, selected donor and acceptor fluorescent proteins were fused using a linker that contained a tobacco etch virus (TEV)-protease recognition sequence. Induction of TEV-protease results in loss of FRET efficiency and increase in fluorescence lifetime. The loss of FRET efficiency after TEV induction can be followed in time in single cells via time-lapse microscopy. This work will facilitate future studies of in vivo dynamics of protein complexes in single B. subtilis cells.	[Weme, Ruud G. J. Detert Oude; Kovacs, Akos T.; Veening, Jan-Willem; Siebring, Jeroen; Kuipers, Oscar P.] Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands; [de Jong, Sander J. G.] Lambert Instruments BV, NL-9301 ZP Roden, Netherlands	University of Groningen	Kuipers, OP (corresponding author), Univ Groningen, Mol Genet Grp, Groningen Biomol Sci & Biotechnol Inst, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands.	o.p.kuipers@rug.nl	Kovács, Ákos T/A-9433-2015; Kuipers, Oscar/B-6752-2009	Kovács, Ákos T/0000-0002-4465-1636; Kuipers, Oscar/0000-0001-5596-7735; Veening, Jan-Willem/0000-0002-3162-6634	EMBO Young Investigator Programme; VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW) [864.12.001]; ERC [337399]; STW grants (NWO); EU; ALW-NWO; Lambert Instruments B.V.	EMBO Young Investigator Programme(European Molecular Biology Organization (EMBO)); VIDI fellowship from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW)(Netherlands Organization for Scientific Research (NWO)); ERC(European Research Council (ERC)European Commission); STW grants (NWO); EU(European Commission); ALW-NWO(Netherlands Organization for Scientific Research (NWO)); Lambert Instruments B.V.	J.W.V. is supported by the EMBO Young Investigator Programme, a VIDI fellowship (864.12.001) from the Netherlands Organisation for Scientific Research, Earth and Life Sciences (NWO-ALW) and ERC starting grant 337399-PneumoCell. O.P.K. was supported by several STW grants (NWO), two EU FW7 grants: SynPeptide and BachBerry and R.D.O.W. and O.P.K. by a specific SYSMO2 grant from ALW-NWO. Lambert Instruments B.V. provided support in the form of salary for author S.J., but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Alexeeva S, 2010, MOL MICROBIOL, V77, P384, DOI 10.1111/j.1365-2958.2010.07211.x; ANAGNOSTOPOULOS C, 1961, J BACTERIOL, V81, P741, DOI 10.1128/JB.81.5.741-746.1961; Anderson J Christopher, 2010, J Biol Eng, V4, P1, DOI 10.1186/1754-1611-4-1; Crivat G, 2012, TRENDS BIOTECHNOL, V30, P8, DOI 10.1016/j.tibtech.2011.08.002; Day RN, 2009, CHEM SOC REV, V38, P2887, DOI 10.1039/b901966a; de Jong IG, 2011, JOVE-J VIS EXP, DOI 10.3791/3145; DOUGHERTY WG, 1989, VIROLOGY, V172, P302, DOI 10.1016/0042-6822(89)90132-3; Forster T., 1948, ANN PHYS, V2, P55; Goedhart J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001011; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; Gruber S, 2014, CURR BIOL; GueroutFleury AM, 1996, GENE, V180, P57, DOI 10.1016/S0378-1119(96)00404-0; Harwood CR, 1990, MOL BIOL METHODS BAC; Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Knight T., 2003, IDEMPOTENT VECTOR DE; Kramer N, 2007, MOL MICROBIOL, V65, P454, DOI 10.1111/j.1365-2958.2007.05799.x; Kunst F, 1997, NATURE, V390, P249, DOI 10.1038/36786; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE; Lakowicz JR., 2006, ANONYMOUS PRINCIPLES, P157; Lakowicz JR., 2006, ANONYMOUS PRINCIPLES, P443; Marchadier E, 2011, PROTEOMICS, V11, P2981, DOI 10.1002/pmic.201000791; Merzlyak EM, 2007, NAT METHODS, V4, P555, DOI 10.1038/NMETH1062; Mika JT, 2010, MOL MICROBIOL, V77, P200, DOI 10.1111/j.1365-2958.2010.07201.x; Munster vEB, 2005, ADV BIOCHEM ENG BIOT, P143; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nagy P, 1998, EUR BIOPHYS J BIOPHY, V27, P377, DOI 10.1007/s002490050145; Overkamp W, 2013, APPL ENVIRON MICROB, V79, P6481, DOI 10.1128/AEM.02033-13; Padilla-Parra S, 2009, BIOPHYS J, V97, P2368, DOI 10.1016/j.bpj.2009.07.044; Poyales DA, 1994, FOCUS, V16, P1; Remington SJ, 2011, PROTEIN SCI, V20, P1509, DOI 10.1002/pro.684; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rudner DZ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000307; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Scheu PD, 2012, J BACTERIOL, V194, P636, DOI 10.1128/JB.06345-11; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shcherbo D, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-24; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; van der Krogt GNM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001916; Van Munster EB, 2004, J MICROSC-OXFORD, V213, P29, DOI 10.1111/j.1365-2818.2004.01249.x; van Rheenen J, 2004, BIOPHYS J, V86, P2517, DOI 10.1016/S0006-3495(04)74307-6; W. M. Keck Center for Cellular Imaging, 7 IM REQ FRET DAT PR; Wade JT, 2007, MOL MICROBIOL, V65, P21, DOI 10.1111/j.1365-2958.2007.05781.x; Zhao QL, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.12.126020	46	9	9	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2015	10	4							e0123239	10.1371/journal.pone.0123239	http://dx.doi.org/10.1371/journal.pone.0123239			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EX	25886351	Green Submitted, gold, Green Published			2022-12-27	WOS:000353017000052
J	Dhondt, AA; Dhondt, KV; Hochachka, WM				Dhondt, Andre A.; Dhondt, Keila V.; Hochachka, Wesley M.			Response of Black-Capped Chickadees to House Finch Mycoplasma gallisepticum	PLOS ONE			English	Article							CARPODACUS-MEXICANUS; EXPERIMENTAL-INFECTION; WILDLIFE DISEASE; NORTH-AMERICA; CONJUNCTIVITIS; SONGBIRDS; DYNAMICS; BIRDS	Tests for the presence of pathogen DNA or antibodies are routinely used to survey for current or past infections. In diseases that emerge following a host jump estimates of infection rate might be under-or overestimated. We here examine whether observed rates of infection are biased for a non-focal host species in a model system. The bacterium Mycoplasma gallisepticum is a widespread pathogen in house finches (Haemorhous mexicanus), a fringillid finch, but an unknown proportion of individuals of other songbird species are also infected. Our goal is to determine the extent to which detection of M. gallisepticum DNA or antibodies against the bacteria in a non-fringillid bird species is over-or underestimated using black-capped chickadees Poecile atricapillus, a species in which antibodies against M. gallisepticum are frequently detected in free-living individuals. After keeping black-capped chickadees in captivity for 12 weeks, during which period the birds remained negative for M. gallisepticum, four were inoculated with M. gallisepticum and four were sham inoculated in both eyes to serve as negative controls. Simultaneously we inoculated six house finches with the same isolate of M. gallisepticum as a positive control. All inoculated birds of both species developed infections detectable by qPCR in the conjunctiva. For the 6 weeks following inoculation we detected antibodies in all M. gallisepticum-inoculated house finches but in only three of the four M. gallisepticum-inoculated black-capped chickadees. All house finches developed severe eye lesions but none of the black-capped chickadees did. Modeling the Rapid Plate Agglutination test results of black-capped chickadees shows that the rate of false-positive tests would be not more than 3.2%, while the estimated rate of false negatives is 55%. We conclude that the proportion of wild-caught individuals in which we detect M. gallisepticum-specific antibodies using Rapid Plate Agglutination is, if anything, substantially underestimated.	[Dhondt, Andre A.; Hochachka, Wesley M.] Cornell Univ, Ornithol Lab, Bird Populat Studies, Ithaca, NY 14850 USA; [Dhondt, Keila V.] Cornell Univ, Coll Vet Med, Dept Microbiol & Immunol, Ithaca, NY 14850 USA	Cornell University; Cornell University	Dhondt, AA (corresponding author), Cornell Univ, Ornithol Lab, Bird Populat Studies, Ithaca, NY 14850 USA.	aad4@cornell.edu	Hochachka, Wesley M./J-9768-2012	Hochachka, Wesley M./0000-0002-0595-7827; Dhondt, Andre/0000-0002-4946-1401	National Institutes of Health [R01GM085232]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085232, R01GM105245] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The work was supported by National Institutes of Health Grant #R01GM085232 to Dana M. Hawley as part of the joint NIH-NSF-USDA Ecology and Evolution of Infectious Diseases program.	Dhondt AA, 1998, J WILDLIFE DIS, V34, P265, DOI 10.7589/0090-3558-34.2.265; Dhondt AA, 2007, AVIAN PATHOL, V36, P205, DOI 10.1080/03079450701286277; Dhondt AA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103553; Dhondt AA, 2012, J ANIM ECOL, V81, P996, DOI 10.1111/j.1365-2656.2012.01986.x; Dhondt AA, 2008, AVIAN PATHOL, V37, P635, DOI 10.1080/03079450802499100; Farmer KL, 2005, J WILDLIFE DIS, V41, P317, DOI 10.7589/0090-3558-41.2.317; Feberwee A, 2005, AVIAN DIS, V49, P260, DOI 10.1637/7274-090804R; Fischer JR, 1997, EMERG INFECT DIS, V3, P69, DOI 10.3201/eid0301.970110; Grodio JL, 2008, AVIAN PATHOL, V37, P385, DOI 10.1080/03079450802216629; Hartup BK, 2000, J WILDLIFE DIS, V36, P257, DOI 10.7589/0090-3558-36.2.257; Hartup BK, 2001, J WILDLIFE DIS, V37, P72, DOI 10.7589/0090-3558-37.1.72; Hawley DM, 2010, J EVOLUTION BIOL, V23, P1680, DOI 10.1111/j.1420-9101.2010.02035.x; Hawley DM, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001570; Hawley DM, 2011, AVIAN PATHOL, V40, P321, DOI 10.1080/03079457.2011.571660; Hill GE, 2005, NATURWISSENSCHAFTEN, V92, P30, DOI 10.1007/s00114-004-0582-0; Hochachka WM, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1068; Kleven SH, 2008, LAB MANUAL ISOLATION; Kollias GV, 2004, J WILDLIFE DIS, V40, P79, DOI 10.7589/0090-3558-40.1.79; Ley DH, 1996, AVIAN DIS, V40, P480, DOI 10.2307/1592250; Luttrell MP, 2001, AVIAN DIS, V45, P321, DOI 10.2307/1592971; Luttrell MP, 1996, AVIAN DIS, V40, P335, DOI 10.2307/1592229; Mikaelian I, 2001, J WILDLIFE DIS, V37, P826, DOI 10.7589/0090-3558-37.4.826; SAS Institute Inc, 2008, SAS STAT 9 2 US GUID; Sydenstricker KV, 2005, J WILDLIFE DIS, V41, P326, DOI 10.7589/0090-3558-41.2.326	24	10	10	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124820	10.1371/journal.pone.0124820	http://dx.doi.org/10.1371/journal.pone.0124820			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25880849	Green Submitted, gold, Green Published			2022-12-27	WOS:000353016500113
J	Fusaroli, R; Perlman, M; Mislove, A; Paxton, A; Matlock, T; Dale, R				Fusaroli, Riccardo; Perlman, Marcus; Mislove, Alan; Paxton, Alexandra; Matlock, Teenie; Dale, Rick			Timescales of Massive Human Entrainment	PLOS ONE			English	Article							LEADERSHIP; EMERGENCE; EVOLUTION; DYNAMICS	The past two decades have seen an upsurge of interest in the collective behaviors of complex systems composed of many agents entrained to each other and to external events. In this paper, we extend the concept of entrainment to the dynamics of human collective attention. We conducted a detailed investigation of the unfolding of human entrainment-as expressed by the content and patterns of hundreds of thousands of messages on Twitter-during the 2012 US presidential debates. By time-locking these data sources, we quantify the impact of the unfolding debate on human attention at three time scales. We show that collective social behavior covaries second-by-second to the interactional dynamics of the debates: A candidate speaking induces rapid increases in mentions of his name on social media and decreases in mentions of the other candidate. Moreover, interruptions by an interlocutor increase the attention received. We also highlight a distinct time scale for the impact of salient content during the debates: Across well-known remarks in each debate, mentions in social media start within 5-10 seconds after it occurs; peak at approximately one minute; and slowly decay in a consistent fashion across well-known events during the debates. Finally, we show that public attention after an initial burst slowly decays through the course of the debates. Thus we demonstrate that large-scale human entrainment may hold across a number of distinct scales, in an exquisitely time-locked fashion. The methods and results pave the way for careful study of the dynamics and mechanisms of large-scale human entrainment.	[Fusaroli, Riccardo] Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark; [Fusaroli, Riccardo] Aarhus Univ, Ctr Semiot, Aarhus, Denmark; [Perlman, Marcus] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA; [Mislove, Alan] Northeastern Univ, Coll Comp & Informat Sci, Boston, MA 02115 USA; [Paxton, Alexandra; Matlock, Teenie; Dale, Rick] Univ Calif Merced, Cognit & Informat Sci, Merced, CA USA	Aarhus University; Aarhus University; University of Wisconsin System; University of Wisconsin Madison; Northeastern University; University of California System; University of California Merced	Fusaroli, R (corresponding author), Aarhus Univ, Interacting Minds Ctr, Aarhus, Denmark.	fusaroli@gmail.com	Perlman, Marcus/K-6972-2018; Fusaroli, Riccardo/A-8892-2010	Perlman, Marcus/0000-0002-1269-3882; Fusaroli, Riccardo/0000-0003-4775-5219	Danish Council for Independent Research; EUROCORES EuroUnderstanding program; Interacting Minds Center; NSF [BCS-0826825]; Danish Council for Independent Research; EUROCORES EuroUnderstanding program; Interacting Minds Center; NSF [BCS-0826825]; Direct For Computer & Info Scie & Enginr [1054233] Funding Source: National Science Foundation	Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); EUROCORES EuroUnderstanding program; Interacting Minds Center; NSF(National Science Foundation (NSF)); Danish Council for Independent Research(Det Frie Forskningsrad (DFF)); EUROCORES EuroUnderstanding program; Interacting Minds Center; NSF(National Science Foundation (NSF)); Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))	This work was supported by the Danish Council for Independent Research (RF), the EUROCORES EuroUnderstanding program (RF), the Interacting Minds Center (RF) and NSF BCS-0826825 (RD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ames DR, 2007, J PERS SOC PSYCHOL, V92, P307, DOI 10.1037/0022-3514.92.2.307; Ancona D, 1996, RES ORGAN BEHAV, V18, P251; Angus D, 2012, IEEE T AUDIO SPEECH, V20, P1795, DOI 10.1109/TASL.2012.2189566; Bass BM, 2008, BASS HDB LEADERSHIP, Vxix; Benoit WL, 2003, COMMUN MONOGR, V70, P335, DOI 10.1080/0363775032000179133; Benoit WL, 2001, COMMUN MONOGR, V68, P259, DOI 10.1080/03637750128060; Boersma Paul, 2002, GLOT INT, V5, P341; Boillot A, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0052708, 10.1371/journal.pone.0064417]; Bollen J, 2011, J COMPUT SCI-NETH, V2, P1, DOI 10.1016/j.jocs.2010.12.007; Boutet A, 2012, ICWSM; Bucy Erik P, 2008, Politics Life Sci, V27, P78, DOI 10.2990/27_1_78; Carlin DP, 1994, 1992 PRESIDENTIAL DE, P3; Ciulla F, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds8; CLAYMAN SE, 1995, J COMMUN, V45, P118, DOI 10.1111/j.1460-2466.1995.tb00746.x; Conover MD, 2012, EPJ DATA SCI, V1, DOI 10.1140/epjds6; Crane R, 2008, P NATL ACAD SCI USA, V105, P15649, DOI 10.1073/pnas.0803685105; Culotta A., 2010, P 1 WORKSHOP SOCIAL, P115, DOI [10.1145/1964858.1964874, DOI 10.1145/1964858.1964874]; Dale R, 2013, PSYCHOL LEARN MOTIV, V59, P43, DOI 10.1016/B978-0-12-407187-2.00002-2; Dorfler F, 2014, AUTOMATICA; Fusaroli R., COGNITIVE S IN PRESS; Fusaroli R, 2014, SPRINGER P MATH STAT, V103, P137, DOI 10.1007/978-3-319-09531-8_9; Fusaroli R, 2014, NEW IDEAS PSYCHOL, V32, P147, DOI 10.1016/j.newideapsych.2013.03.005; Galantucci B, 2010, INTERACT STUD, V11, P1, DOI 10.1075/is.11.1.olgal; Golder SA, 2011, SCIENCE, V333, P1878, DOI 10.1126/science.1202775; Grimshaw A.D., 1990, CONFLICT TALK SOCIOL; Hamby P, 2012, 5 THINGS WE LEARNED; Hannak A., 2012, PROC INT AAAI C WEB, V6, P479; Hogan J, 2003, J APPL PSYCHOL, V88, P100, DOI 10.1037/0021-9010.88.1.100; House RJ, 1997, J MANAGE, V23, P409, DOI 10.1016/S0149-2063(97)90037-4; Jamieson K.H., 1988, PRESIDENTIAL DEBATES; Judge TA, 2004, J APPL PSYCHOL, V89, P542, DOI 10.1037/0021-9010.89.3.542; Kauffman S., 1995, HOME UNIVERSE SEARCH; King AJ, 2009, CURR BIOL, V19, pR911, DOI 10.1016/j.cub.2009.07.027; Lehmann J., 2012, P 21 INT C WORLD WID, P251, DOI [10.1145/2187836.2187871, DOI 10.1145/2187836.2187871]; Lin Y.R., 2013, P 22 INT C WORLD WID, P737, DOI DOI 10.1145/2488388.2488453; Lin Y.R., 2013, P 7 INT C WEBL SOC M, P370; Lin YR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094093; Livne Avishay, 2011, ICWSM; Loreto V, 2007, NAT PHYS, V3, P758, DOI 10.1038/nphys770; MacWhinney B., 1999, EMERGENCE LANGUAGE; Masters R.D., 1993, EXPLORATIONS POLITIC, P150; Matlock T, 2012, AM SCI, V100, P478, DOI 10.1511/2012.99.478; Metaxas PT, 2012, SCIENCE, V338, P472, DOI 10.1126/science.1230456; Miller G, 2011, SCIENCE, V333, P1814, DOI 10.1126/science.333.6051.1814; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Morello JT, 1992, SO COMMUNICATION J, V57, P205, DOI DOI 10.1080/10417949209372866; Patel AD, 2009, CURR BIOL, V19, P827, DOI 10.1016/j.cub.2009.03.038; PATTERSON ML, 1992, COMMUN MONOGR, V59, P231, DOI 10.1080/03637759209376267; Pennacchiotti M., 2011, P 17 ACM SIGKDD INT, P430, DOI DOI 10.1145/2020408.2020477; Pfau M., 2002, ARGUMENT ADVOCACY, V38, P251, DOI [10.1080/00028533.2002.11821571, DOI 10.1080/00028533.2002.11821571]; Pikovsky A., 2001, CAMBRIDGE NONLINEAR; Sasahara K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061823; Schmidt RC, 2007, J EXP PSYCHOL HUMAN, V33, P860, DOI 10.1037/0096-1523.33.4.860; Schroeder A., 2008, PRESIDENTIAL DEBATES; Shockley K, 2009, TOP COGN SCI, V1, P305, DOI 10.1111/j.1756-8765.2009.01021.x; Slatcher RB, 2007, J RES PERS, V41, P63, DOI 10.1016/j.jrp.2006.01.006; STROGATZ SH, 1993, SCI AM, V269, P102, DOI 10.1038/scientificamerican1293-102; Strogatz SH, 2003, SYNC EMERGING SCI SP, Vviii; Sullivan D.G., 1994, RES BIOPOLITICS, V2, P237; Tylen K, 2013, SEMIOTICA, V194, P39, DOI 10.1515/sem-2013-0021; WARD J, 2012, POPULAR SCI NY, V281, P4; Weng L, 2012, SCI REP-UK, V2, P1, DOI 10.1038/srep00335; Wu F, 2007, P NATL ACAD SCI USA, V104, P17599, DOI 10.1073/pnas.0704916104; Yu S, 2012, ARXIV12031647	64	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122742	10.1371/journal.pone.0122742	http://dx.doi.org/10.1371/journal.pone.0122742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25880357	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500028
J	Harris, JW; Cowper-Smith, CD; Klein, RM; Westwood, DA				Harris, Jonathan W.; Cowper-Smith, Christopher D.; Klein, Raymond M.; Westwood, David A.			Further Evidence against a Momentum Explanation for IOR	PLOS ONE			English	Article							ATTENTIONAL MOMENTUM; RETURN; INHIBITION	Reaction times to targets presented in the same location as a preceding cue are greater than those to targets presented opposite the cued location. This observation can be explained as a result of inhibition at the attended location (IOR), or as facilitation at the location opposite the cue (opposite facilitation effect or OFE). Past research has demonstrated that IOR is observed reliably, whereas OFE is observed only occasionally. The present series of four experiments allows us to determine whether or not OFE can be explained by eye movements as suggested by previous authors. Participants' eye movements were monitored as they were presented with an array of four placeholders aligned with the four cardinal axes. Exogenous cues and targets were presented successively. Participants (N=37) completed either: i.) cue-manual and cue-saccade experiments, ignoring the cue and then responding with a keypress or saccade, respectively, or ii.) manual-manual and saccade-saccade experiments, responding to both the cue and the target with a keypress or saccade respectively. Results demonstrated a reliable IOR effect in each of the four experiments (reaction time greater for same versus adjacent and opposite cue-target trials). None of the four experiments demonstrated evidence of an OFE (reaction times were not significantly lower for opposite versus adjacent cue-target trials). These results are inconsistent with a momentum-based account of cue-target task performance, and furthermore suggest that the OFE cannot be attributed to occasional eye movements to the cue and/or target in previous studies.	[Harris, Jonathan W.; Westwood, David A.] Dalhousie Univ, Fac Hlth Profess, Div Kinesiol, Sch Hlth & Human Performance, Halifax, NS, Canada; [Cowper-Smith, Christopher D.; Klein, Raymond M.] Dalhousie Univ, Fac Sci, Dept Psychol & Neurosci, Halifax, NS, Canada	Dalhousie University; Dalhousie University	Harris, JW (corresponding author), Dalhousie Univ, Fac Hlth Profess, Sch Occupat Therapy, Halifax, NS, Canada.	David.Westwood@dal.ca		Westwood, David/0000-0003-3317-0447	Natural Sciences and Engineering Research Council (Canada) Discovery Grant [250235]	Natural Sciences and Engineering Research Council (Canada) Discovery Grant	DAW: Natural Sciences and Engineering Research Council (Canada) Discovery Grant 250235 (http://www.nserc-crsng.gc.ca/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bourgeois A, 2013, CORTEX, V49, P2229, DOI 10.1016/j.cortex.2012.10.017; Machado L, 2004, Q J EXP PSYCHOL-A, V57, P789, DOI 10.1080/02724980343000486; MAYLOR EA, 1985, J EXP PSYCHOL HUMAN, V11, P777, DOI 10.1037/0096-1523.11.6.777; POSNER MI, 1985, COGNITIVE NEUROPSYCH, V2, P211, DOI 10.1080/02643298508252866; POSNER MI, 1984, ATTENTION PERFORM, V10, P531; Pratt J, 1999, J EXP PSYCHOL HUMAN, V25, P730, DOI 10.1037/0096-1523.25.3.730; Snyder JJ, 2009, J EXP PSYCHOL HUMAN, V35, P1726, DOI 10.1037/a0016885; Snyder JJ, 2001, J EXP PSYCHOL HUMAN, V27, P1420, DOI 10.1037//0096-1523.27.6.1420; Spalek TM, 2004, PERCEPT PSYCHOPHYS, V66, P219, DOI 10.3758/BF03194874	9	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0123666	10.1371/journal.pone.0123666	http://dx.doi.org/10.1371/journal.pone.0123666			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881269	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500058
J	Maggioli, MF; Palmer, MV; Thacker, TC; Vordermeier, HM; Waters, WR				Maggioli, Mayara F.; Palmer, Mitchell V.; Thacker, Tyler C.; Vordermeier, H. Martin; Waters, W. Ray			Characterization of Effector and Memory T Cell Subsets in the Immune Response to Bovine Tuberculosis in Cattle	PLOS ONE			English	Article							MYCOBACTERIUM-BOVIS; GAMMA-INTERFERON; HISTORICAL PERSPECTIVES; BCG; PROTECTION; INFECTION; VACCINES; VACCINATION; EXPRESSION; MIGRATION	Cultured IFN-gamma ELISPOT assays are primarily a measure of central memory T cell (Tcm) responses with humans; however, this important subset of lymphocytes is poorly characterized in cattle. Vaccine-elicited cultured IFN-gamma ELISPOT responses correlate with protection against bovine tuberculosis in cattle. However, whether this assay measures cattle Tcm responses or not is uncertain. The objective of the present study was to characterize the relative contribution of Tcm (CCR7(+), CD62L(hi), CD45RO(+)), T effector memory (Tem, defined as: CCR7(-), CD62L(low/int), CD45RO(+)), and T effector cells (CCR7(-), CD62L(-/low), CD45RO(-)), in the immune response to Mycobacterium bovis. Peripheral blood mononuclear cells (PBMC) from infected cattle were stimulated with a cocktail of M. bovis purified protein derivative, rTb10.4 and rAg85A for 13 days with periodic addition of fresh media and rIL-2. On day 13, cultured PBMC were re-stimulated with medium alone, rESAT-6:CFP10 or PPDb with fresh autologous adherent cells for antigen presentation. Cultured cells (13 days) or fresh PBMCs (ex vivo response) from the same calves were analyzed for IFN-gamma production, proliferation, and CD4, CD45RO, CD62L, CD44, and CCR7 expression via flow cytometry after overnight stimulation. In response to mycobacterial antigens, similar to 75% of CD4(+) IFN-gamma(+) cells in long-term cultures expressed a Tcm phenotype while less than 10% of the ex vivo response consisted of Tcm cells. Upon re-exposure to antigen, long-term cultured cells were highly proliferative, a distinctive characteristic of Tcm, and the predominant phenotype within the long-term cultures switched from Tcm to Tem. These findings suggest that proliferative responses of Tcm cells to some extent occurs simultaneously with reversion to effector phenotypes (mostly Tem). The present study characterizes Tcm cells of cattle and their participation in the response to M. bovis infection.	[Maggioli, Mayara F.; Palmer, Mitchell V.; Thacker, Tyler C.; Waters, W. Ray] Natl Anim Dis Ctr, Infect Bacterial Dis Livestock Res Unit, Ames, IA 50010 USA; [Maggioli, Mayara F.] Iowa State Univ, Coll Vet Med, Dept Vet Pathol, Ames, IA USA; [Vordermeier, H. Martin] Anim Hlth & Vet Labs Agcy Weybridge, TB Res Grp, Addlestone, Surrey, England	United States Department of Agriculture (USDA); Iowa State University; Veterinary Laboratories Agency	Maggioli, MF (corresponding author), Natl Anim Dis Ctr, Infect Bacterial Dis Livestock Res Unit, Ames, IA 50010 USA.	mayaramaggioli@gmail.com	Palmer, Mitchell/R-7091-2018; Vordermeier, H Martin/C-6936-2011	Palmer, Mitchell/0000-0002-5902-3333; 				Alexander KA, 2010, EMERG INFECT DIS, V16, P1296, DOI 10.3201/eid1608.100314; Andersen P, 2000, INFECT IMMUN, V68, P621, DOI 10.1128/IAI.68.2.621-629.2000; Baaten BJG, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00023; Baaten BJG, 2010, IMMUNITY, V32, P104, DOI 10.1016/j.immuni.2009.10.011; Bass KE, 2013, CLIN VACCINE IMMUNOL, V20, P1827, DOI 10.1128/CVI.00519-13; Beaulieu AM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015120; Behr MA, 1999, SCIENCE, V284, P1520, DOI 10.1126/science.284.5419.1520; Bold TD, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002063; Bold TD, 2009, CELL, V136, P17, DOI 10.1016/j.cell.2008.12.032; Caccamo N, 2012, UNDERSTANDING TUBERCULOSIS - ANALYZING THE ORIGIN OF MYCOBACTERIUM TUBERCULOSIS PATHOGENICITY, P313; Calarota SA, 2008, J IMMUNOL, V180, P5907, DOI 10.4049/jimmunol.180.9.5907; Caminero JA, 2001, AM J RESP CRIT CARE, V163, P717, DOI 10.1164/ajrccm.163.3.2003070; Champagne P, 2001, NATURE, V410, P106, DOI 10.1038/35065118; Comas I, 2013, NAT GENET, V45, P1176, DOI 10.1038/ng.2744; Cooper AM, 2007, CURR OPIN IMMUNOL, V19, P441, DOI 10.1016/j.coi.2007.07.004; Cooper AM, 2009, ANNU REV IMMUNOL, V27, P393, DOI 10.1146/annurev.immunol.021908.132703; Dailey MO, 1998, CRIT REV IMMUNOL, V18, P153, DOI 10.1615/CritRevImmunol.v18.i3.10; de la Rua-Domenech R, 2006, RES VET SCI, V81, P190, DOI 10.1016/j.rvsc.2005.11.005; Dean G, 2014, VACCINE, V32, P1304, DOI 10.1016/j.vaccine.2013.11.045; Diedrich CR, 2011, INFECT IMMUN, V79, P1407, DOI 10.1128/IAI.01126-10; Ebert LA, 2005, MOL IMMUNOL, V42, P799, DOI 10.1016/j.molimm.2004.06.040; FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249; Godkin AJ, 2002, J IMMUNOL, V169, P2210, DOI 10.4049/jimmunol.169.4.2210; Goletti D, 2006, J INFECT DIS, V194, P984, DOI 10.1086/507427; Hogg AE, 2009, VACCINE, V27, P270, DOI 10.1016/j.vaccine.2008.10.053; Houlihan MG, 2008, VET REC, V163, P357, DOI 10.1136/vr.163.12.357; Jozefowski S, 2008, BIOESSAYS, V30, P943, DOI 10.1002/bies.20815; Kaveh DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021566; Keating SM, 2005, J IMMUNOL, V175, P5675, DOI 10.4049/jimmunol.175.9.5675; Kovjazin R, 2013, CLIN VACCINE IMMUNOL, V20, P328, DOI 10.1128/CVI.00586-12; Lindenstrom T, 2013, J IMMUNOL, V190, P6311, DOI 10.4049/jimmunol.1300248; MacHugh ND, 1997, IMMUNOLOGY, V92, P340, DOI 10.1046/j.1365-2567.1997.00350.x; MACKAY CR, 1990, J EXP MED, V171, P801, DOI 10.1084/jem.171.3.801; Mahairas GG, 1996, J BACTERIOL, V178, P1274, DOI 10.1128/jb.178.5.1274-1282.1996; Mahnke YD, 2013, EUR J IMMUNOL, V43, P2797, DOI 10.1002/eji.201343751; Masopust D, 2012, J IMMUNOL, V188, P5811, DOI 10.4049/jimmunol.1102695; Maue AC, 2005, INFECT IMMUN, V73, P6659, DOI 10.1128/IAI.73.10.6659-6667.2005; Millington KA, 2010, J INFECT DIS, V202, P1685, DOI 10.1086/656772; Palmer MV, 2002, TUBERCULOSIS, V82, P275, DOI 10.1054/tube.2002.0341; Pollock JM, 2002, VET J, V163, P115, DOI 10.1053/tvjl.2001.0655; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Pym AS, 2002, MOL MICROBIOL, V46, P709, DOI 10.1046/j.1365-2958.2002.03237.x; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; Rhodes SG, 2014, CLIN VACCINE IMMUNOL, V21, P39, DOI 10.1128/CVI.00522-13; Rodriguez-Campos S, 2014, RES VET SCI, V97, pS5, DOI 10.1016/j.rvsc.2014.02.009; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Sallusto F, 2010, IMMUNITY, V33, P451, DOI 10.1016/j.immuni.2010.10.008; Schiller I, 2010, TRANSBOUND EMERG DIS, V57, P205, DOI 10.1111/j.1865-1682.2010.01148.x; Thom ML, 2012, CLIN VACCINE IMMUNOL, V19, P1254, DOI 10.1128/CVI.00301-12; Todryk SM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002027; Todryk SM, 2009, IMMUNOLOGY, V128, P83, DOI 10.1111/j.1365-2567.2009.03073.x; Torrado E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002196; Totte P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057509; Totte P, 2010, CLIN VACCINE IMMUNOL, V17, P1211, DOI 10.1128/CVI.00132-10; Totte P, 2010, DEV COMP IMMUNOL, V34, P177, DOI 10.1016/j.dci.2009.09.005; Van Pittius NCG, 2001, GENOME BIOL, V2; Vordermeier HM, 2009, INFECT IMMUN, V77, P3364, DOI 10.1128/IAI.00287-09; Vordermeier HM, 2004, IMMUNOLOGY, V112, P461, DOI 10.1111/j.1365-2567.2004.01903.x; Vordermeier HM, 2002, INFECT IMMUN, V70, P3026, DOI 10.1128/IAI.70.6.3026-3032.2002; Vordermeier M, 2011, EXPERT REV VACCINES, V10, P1083, DOI [10.1586/erv.11.22, 10.1586/ERV.11.22]; Vrieling M, 2012, J IMMUNOL, V188, P578, DOI 10.4049/jimmunol.1101972; Walzl G, 2011, NAT REV IMMUNOL, V11, P343, DOI 10.1038/nri2960; Wangoo A, 2005, J COMP PATHOL, V133, P223, DOI 10.1016/j.jcpa.2005.05.001; Waters WR, 2014, J COMP PATHOL, V151, P410, DOI 10.1016/j.jcpa.2014.08.007; Waters WR, 2014, VET IMMUNOL IMMUNOP, V159, P113, DOI 10.1016/j.vetimm.2014.02.009; Waters WR, 2012, VACCINE, V30, P2611, DOI 10.1016/j.vaccine.2012.02.018; Waters WR, 2009, VACCINE, V27, P1201, DOI 10.1016/j.vaccine.2008.12.018; Waters WR, 2003, CLIN DIAGN LAB IMMUN, V10, P960, DOI 10.1128/CDLI.10.5.960-966.2003; Waters WR, 2003, INFECT IMMUN, V71, P317, DOI 10.1128/IAI.71.1.317-326.2003; Wedlock DN, 2007, VET IMMUNOL IMMUNOP, V118, P50, DOI 10.1016/j.vetimm.2007.04.005; Whelan AO, 2008, VACCINE, V26, P166, DOI 10.1016/j.vaccine.2007.11.005; Whelan AO, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029194; Wilkinson KA, 2010, EUR J IMMUNOL, V40, P2139, DOI 10.1002/eji.201040731; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; Woodland DL, 2009, NAT REV IMMUNOL, V9, P153, DOI 10.1038/nri2496; Yang SH, 2006, GENE THER, V13, P1110, DOI 10.1038/sj.gt.3302751	76	29	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0122571	10.1371/journal.pone.0122571	http://dx.doi.org/10.1371/journal.pone.0122571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25879774	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500023
J	Thachil, A; Gerber, PF; Xiao, CT; Huang, YW; Opriessnig, T				Thachil, Anil; Gerber, Priscilla F.; Xiao, Chao-Ting; Huang, Yao-Wei; Opriessnig, Tanja			Development and Application of an ELISA for the Detection of Porcine Deltacoronavirus IgG Antibodies	PLOS ONE			English	Article							EPIDEMIC-DIARRHEA-VIRUS; TRANSMISSIBLE GASTROENTERITIS VIRUS; PHYLOGENETIC ANALYSIS; AVIAN CORONAVIRUSES; COMPETITION ELISA; SERUM; PROTEIN; PLASMA; STATES; SWINE	Porcine deltacoronavirus (PDCoV), also known as porcine coronavirus HKU15, was first detected in North America in early 2014 and associated with enteric disease in pigs, resulting in an urgent need to further investigate the ecology of this virus. While assays detecting nucleic acids were implemented quickly, assays to detect anti-PDCoV antibodies have not been available. In this study, an indirect anti-PDCoV IgG enzyme-linked immunosorbent assay (ELISA) based on the putative S1 portion of the spike protein was developed and utilized to determine the prevalence of anti-PDCoV IgG in U.S. pigs. The diagnostic sensitivity of the PDCoV ELISA was 91% with a diagnostic specificity of 95%. A total of 968 serum samples were tested including samples with confirmed infection with PDCoV, porcine epidemic diarrhea virus (PEDV), transmissible gastroenteritis virus or porcine respiratory coronavirus. There was no cross-reactivity with any of the other coronaviruses. Among 355 arbitrarily selected serum samples collected in 2014 and originating from 51 farms across 18 U.S. states, anti-PDCoV IgG antibodies were detected in 8.7% of the samples and in 25.5% of the farms whereas anti-PEDV IgG was detected in 22.8% of the samples and in 54.9% of the farms. In addition, anti-PDCoV IgG antibodies were detected in archived samples collected in 2010, perhaps indicating an earlier undetected introduction into the U.S. pig population. Overall, the obtained data suggest that PDCoV seroprevalence in U.S. pigs is lower compared to PEDV and PDCoV may have been introduced to the U.S. prior to PEDV.	[Thachil, Anil; Xiao, Chao-Ting; Opriessnig, Tanja] Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA; [Gerber, Priscilla F.; Opriessnig, Tanja] Univ Edinburgh, Roslin Inst, Edinburgh EH8 9YL, Midlothian, Scotland; [Gerber, Priscilla F.; Opriessnig, Tanja] Univ Edinburgh, Royal Dick Sch Vet Studies, Edinburgh EH8 9YL, Midlothian, Scotland; [Huang, Yao-Wei] Zhejiang Univ, Coll Anim Sci, Inst Prevent Vet Med, Hangzhou 310003, Zhejiang, Peoples R China	Iowa State University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; Zhejiang University	Opriessnig, T (corresponding author), Iowa State Univ, Dept Vet Diagnost & Prod Anim Med, Ames, IA 50011 USA.	Tanja.Opriessnig@roslin.ed.ac.uk	Gerber, Priscilla F/K-4771-2012; Huang, Yaowei/B-1468-2009; Opriessnig, Tanja/F-2984-2012; Huang, Yao-Wei/Q-9409-2019; Gerber, Priscilla/U-9385-2019; Hegde, Nagendra/J-5920-2014; Xiao, Chaoting/H-3997-2014	Gerber, Priscilla F/0000-0002-8343-8299; Huang, Yaowei/0000-0001-9755-8411; Opriessnig, Tanja/0000-0001-9642-0904; Huang, Yao-Wei/0000-0001-9755-8411; Gerber, Priscilla/0000-0002-8343-8299; Hegde, Nagendra/0000-0001-5260-2159; Xiao, Chaoting/0000-0001-5299-5650	BBSRC [BBS/E/D/20241864] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/D/20241864] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Brian DA, 2005, CURR TOP MICROBIOL, V287, P1, DOI 10.1007/3-540-26765-4_1; Chen Q, 2014, J CLIN MICROBIOL, V52, P234, DOI 10.1128/JCM.02820-13; Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07; DYCKMAN JD, 1980, J CLIN MICROBIOL, V11, P16, DOI 10.1128/JCM.11.1.16-18.1980; Elia G, 2010, J VIROL METHODS, V163, P309, DOI 10.1016/j.jviromet.2009.10.015; Gerber PF, 2014, VET J, V202, P33, DOI 10.1016/j.tvjl.2014.07.018; Glor SB, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-85; Huang YW, 2013, MBIO, V4, DOI 10.1128/mBio.00737-13; KNUCHEL M, 1992, VET MICROBIOL, V32, P117, DOI 10.1016/0378-1135(92)90100-8; Li G, 2014, GENOME ANNOUNC, V2, P2, DOI DOI 10.1128/GEN0MEA.00278-14; Liu DQ, 2012, APPL MICROBIOL BIOT, V93, P2437, DOI 10.1007/s00253-011-3734-0; Marthaler D, 2014, GENOME ANNOUNC, V2, DOI [10.1128/genomeA.00218-14, DOI 10.1128/GEN0MEA.00218-14]; Marthaler D, 2014, EMERG INFECT DIS, V20, P1347, DOI [10.3201/eid2008.14-0526, 10.3201/eid2008.140526]; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Mole B, 2013, NATURE, V499, P388, DOI 10.1038/499388a; National Pork Board PEDV Research Updates, 2014, NAT PORK BOARD PEDV; OIE, 2013, MANUAL DIAGNOSTIC TE; Opriessnig T, 2014, VET MICROBIOL, V173, P9, DOI 10.1016/j.vetmic.2014.06.024; Scott Y, 1996, TRANSFUSION MED, V6, P65, DOI 10.1046/j.1365-3148.1996.d01-54.x; Sestak K, 1999, J VET DIAGN INVEST, V11, P205, DOI 10.1177/104063879901100301; Shen HG, 2011, J ANIM SCI, V89, P1930, DOI 10.2527/jas.2010-3502; Shen HG, 2012, J GEN VIROL, V93, P1345, DOI 10.1099/vir.0.039552-0; Siev M, 2011, CLIN VACCINE IMMUNOL, V18, P173, DOI 10.1128/CVI.00325-10; SIMKINS RA, 1993, AM J VET RES, V54, P254; Song D, 2012, VIRUS GENES, V44, P167, DOI 10.1007/s11262-012-0713-1; Stevenson GW, 2013, J VET DIAGN INVEST, V25, P649, DOI 10.1177/1040638713501675; Sun DB, 2007, ACTA VIROL, V51, P149; United States Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services, 2014, SWIN ENT COR DIS TES; USDA, 2014, REP HERD MON MAN NOV; Wang LY, 2014, EMERG INFECT DIS, V20, P1594, DOI 10.3201/eid2009.140756; Wang LY, 2014, EMERG INFECT DIS, V20, P1227, DOI 10.3201/eid2007.140296; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Woo PCY, 2010, VIRUSES-BASEL, V2, P1804, DOI 10.3390/v2081803; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08	34	37	59	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0124363	10.1371/journal.pone.0124363	http://dx.doi.org/10.1371/journal.pone.0124363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1ES	25881086	Green Published, gold, Green Submitted			2022-12-27	WOS:000353016500095
J	McLeod, H; Blissett, D; Wyatt, S; Mohammed, MA				McLeod, Hugh; Blissett, Deirdre; Wyatt, Steven; Mohammed, Mohammed A.			Effect of Pay-For-Outcomes and Encouraging New Providers on National Health Service Smoking Cessation Services in England: A Cluster Controlled Study	PLOS ONE			English	Article							PRIMARY-CARE; PERFORMANCE; PAYMENT; SMOKERS; FRAMEWORK; COSTS	Background Payment incentives are known to influence healthcare but little is known about the impact of paying directly for achieved outcomes. In England, novel purchasing (commissioning) of National Health Service (NHS) stop smoking services, which paid providers for quits achieved whilst encouraging new market entrants, was implemented in eight localities (primary care trusts (PCTs)) in April 2010. This study examines the impact of the novel commissioning on these services. Methods Accredited providers were paid standard tariffs for each smoker who was supported to quit for four and 12 weeks. A cluster-controlled study design was used with the eight intervention PCTs (representing 2,138,947 adult population) matched with a control group of all other (n=64) PCTs with similar demographics which did not implement the novel commissioning arrangements. The primary outcome measure was changes in quits at four weeks between April 2009 and March 2013. A secondary outcome measure was the number of new market entrants within the group of the largest two providers at PCT-level. Results The number of four-week quits per 1,000 adult population increased per year on average by 9.6% in the intervention PCTs compared to a decrease of 1.1% in the control PCTs (incident rate ratio 1.108, p<0.001, 95% CI 1.059 to 1.160). Eighty-five providers held 'any qualified provider' contracts for stop smoking services across the eight intervention PCTs in 2011/12, and 84% of the four-week quits were accounted for by the largest two providers at PCT-level. Three of these 10 providers were new market entrants. To the extent that the intervention incentivized providers to overstate quits in order to increase income, caution is appropriate when considering the findings. Conclusions Novel commissioning to incentivize achievement of specific clinical outcomes and attract new service providers can increase the effectiveness and supply of NHS stop smoking services.	[McLeod, Hugh; Blissett, Deirdre] Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England; [Wyatt, Steven] NHS Midlands & Lancashire Commissioning Support U, West Bromwich B70 9LD, W Midlands, England; [Mohammed, Mohammed A.] Univ Bradford, Sch Hlth Studies, Bradford BD7 1DP, W Yorkshire, England	University of Birmingham; University of Bradford	McLeod, H (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Hlth Econ Unit, Birmingham B15 2TT, W Midlands, England.	h.s.t.mcleod@bham.ac.uk		wyatt, steven/0000-0002-3332-0866; McLeod, Hugh/0000-0002-2266-7303	West Midlands Strategic Health Authority	West Midlands Strategic Health Authority	Steven Wyatt was employed by West Midlands Strategic Health Authority and contributed to the design and management of the stop smoking services intervention. Deirdre Blissett (nee O'Brien) contributed to an evaluation [20] of the intervention's implementation while employed by GHK Consulting Ltd, which was funded by West Midlands Strategic Health Authority. Hugh McLeod and Mohammed A Mohammed do not have any conflicts of interest.	Ahmad N, 2012, LIFESTYLE SERVICES T; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Christianson JB, 2008, MED CARE RES REV, V65, p5S, DOI 10.1177/1077558708324236; Coleman T, 2001, BRIT MED J, V323, P435, DOI 10.1136/bmj.323.7310.435; Coleman T, 2001, BMJ-BRIT MED J, V323, P1; Department of Health, 2011, LOC STOP SMOK SERV S; Department of Health, 2010 11 PROGR BUDG P; Department of Health, 2011, TECHN GUID 2011 12 O; Department of Health, 2011, OP GUID NHS EXT PAT; Department of Health, 2002, IMPR EXP REF NEXT 3; Disley E, 2001, LESSONS LEARNED PLAN; Ellis Libby, 2009, Health Stat Q, P7; Emmert M, 2012, EUR J HEALTH ECON, V13, P755, DOI 10.1007/s10198-011-0329-8; Farrar S, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3047; Ferguson J, 2005, ADDICTION, V100, P59, DOI 10.1111/j.1360-0443.2005.01028.x; Gillam SJ, 2012, ANN FAM MED, V10, P461, DOI 10.1370/afm.1377; Godfrey C, 2005, ADDICTION, V100, P70, DOI 10.1111/j.1360-0443.2005.01071.x; Government HM, 2011, HLTH LIVES HLTH PEOP; Hamilton FL, 2013, TOB CONTROL, V22, P3, DOI 10.1136/tobaccocontrol-2011-050048; Health and Social Care Information Centre, 2013, STAT NHS STOP SMOK S; Hughes JR, 2004, ADDICTION, V99, P29, DOI 10.1111/j.1360-0443.2004.00540.x; Kotz D, 2009, ADDICTION, V104, P1403, DOI 10.1111/j.1360-0443.2009.02639.x; Lancaster T, 2005, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001292.pub2, 10.1002/14651858.CD001292.pub3]; Marini G, 2007, HEALTH POLICY, V83, P17, DOI 10.1016/j.healthpol.2006.11.007; Maynard A, 2012, HEALTH ECON, V21, P3, DOI 10.1002/hec.1810; Maynard A, 2011, ADDICTION, V106, P1725, DOI 10.1111/j.1360-0443.2011.03503.x; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; National Institute for Health and Clinical Excellence, 2008, SMOK CESS SERV PRIM; National Institute for Health and Clinical Excellence, 2006, EFF NAT HLTH SERV IN; NHS Commissioning Board, 2012, ENH SERV COMM FACT S; Office for National Statistics, 2013, REV MID 2002 MID 201; Office for National Statistics, 2013, GEN LIF SURV OV REP; Office for National Statistics, 2013, INT MID 2012 POP EST; Office for National Statistics, CLUST SUMM HLTH AR; PbRDR evaluation team, 2012, DRUGS ALC PBR PIL EV; Peto R, 2012, MORTALITY SMOKING DE; Salize HJ, 2009, ARCH INTERN MED, V169, P230, DOI 10.1001/archinternmed.2008.556; Sarkar D, 2008, USE R, P1; Scott A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008451.pub2; StataCorp, 2011, STAT STAT SOFTW REL; Sutton M, 2012, NEW ENGL J MED, V367, P1821, DOI 10.1056/NEJMsa1114951; Tenders Direct, SMOK CESS STOP SMOK; Twardella D, 2007, TOB CONTROL, V16, P15, DOI 10.1136/tc.2006.016253; West R., 2005, ASSESSING SMOKING CE; West R, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4921	45	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 15	2015	10	4							e0123349	10.1371/journal.pone.0123349	http://dx.doi.org/10.1371/journal.pone.0123349			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1EL	25875959	Green Published, Green Submitted, gold			2022-12-27	WOS:000353015800094
J	Gorressen, S; Stern, M; van de Sandt, AM; Cortese-Krott, MM; Ohlig, J; Rassaf, T; Godecke, A; Fischer, JW; Heusch, G; Merx, MW; Kelm, M				Gorressen, Simone; Stern, Manuel; van de Sandt, Annette M.; Cortese-Krott, Miriam M.; Ohlig, Jan; Rassaf, Tienush; Goedecke, Axel; Fischer, Jens W.; Heusch, Gerd; Merx, Marc W.; Kelm, Malte			Circulating NOS3 Modulates Left Ventricular Remodeling following Reperfused Myocardial Infarction	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; RED-BLOOD-CELLS; HEART-FAILURE; MESSENGER-RNAS; COLLAGEN; EXPRESSION; BIGLYCAN; MICE; ENDOTHELIUM; ISCHEMIA	Purpose Nitric oxide (NO) is constitutively produced and released from the endothelium and several blood cell types by the isoform 3 of the NO synthase (NOS3). We have shown that NO protects against myocardial ischemia/reperfusion (I/R) injury and that depletion of circulating NOS3 increases within 24h of ischemia/reperfusion the size of myocardial infarction (MI) in chimeric mice devoid of circulating NOS3. In the current study we hypothesized that circulating NOS3 also affects remodeling of the left ventricle following reperfused MI. Methods To analyze the role of circulating NOS3 we transplanted bone marrow of NOS3(-/-) and wild type (WT) mice into WT mice, producing chimerae expressing NOS3 only in vascular endothelium (BC-/EC+) or in both, blood cells and vascular endothelium (BC+/EC+). Both groups underwent 60 min of coronary occlusion in a closed-chest model of reperfused MI. During the 3 weeks post MI, structural and functional LV remodeling was serially assessed (24h, 4d, 1w, 2w and 3w) by echocardiography. At 72 hours post MI, gene expression of several extracellular matrix (ECM) modifying molecules was determined by quantitative RTPCR analysis. At 3 weeks post MI, hemodynamics were obtained by pressure catheter, scar size and collagen content were quantified post mortem by Gomori's One-step trichrome staining. Results Three weeks post MI, LV end-systolic (53.2 +/- 5.9 mu l;*** p <= 0.001;n = 5) and end-diastolic volumes (82.7 +/- 5.6 mu l;*p<0.05; n = 5) were significantly increased in BC-/EC+, along with decreased LV developed pressure (67.5 +/- 1.8mmHg;n = 18;*** p <= 0.001) and increased scar size/left ventricle (19.5 +/- 1.5%;n = 13;**p <= 0.01) compared to BC+/EC+ (ESV: 35.6 +/- 2.2 mu l; EDV: 69.1 +/- 2.6 mu l n = 8; LVDP:83.2 +/- 3.2mmHg;n = 24; scar size/LV13.8 +/- 0.7%;n = 16). Myocardial scar of BC-/EC+ was characterized by increased total collagen content (20.2 +/- 0.8%;n = 13;*** p <= 0.001) compared to BC+/EC+ (15.9 +/- 0.5;n = 16), and increased collagen type I and III subtypes. Conclusion Circulating NOS3 ameliorates maladaptive left ventricular remodeling following reperfused myocardial infarction.	[Gorressen, Simone; Stern, Manuel; van de Sandt, Annette M.; Cortese-Krott, Miriam M.; Ohlig, Jan; Rassaf, Tienush; Merx, Marc W.; Kelm, Malte] Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany; [Goedecke, Axel] Univ Dusseldorf, Dept Cardiovasc Physiol, Fac Med, Dusseldorf, Germany; [Goedecke, Axel; Fischer, Jens W.] CARID, Cardiovasc Res Inst Dusseldorf, Dusseldorf, Germany; [Fischer, Jens W.] Univ Dusseldorf, Cardiovasc Res Inst Dusseldorf CARID, Fac Med, Inst Pharmacol & Clin Pharmacol, Dusseldorf, Germany; [Merx, Marc W.] Univ Essen Gesamthsch, Sch Med, Inst Pathophysiol, West German Heart & Vasc Ctr Essen, Essen, Germany; [Merx, Marc W.] Klinikum Reg Hannover, Robert Koch Krankenhaus, Dept Cardiol Vasc Med & Intens Care Med, Hannover, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Duisburg Essen	Kelm, M (corresponding author), Univ Dusseldorf, Div Cardiol Pulmonol & Vasc Med, Fac Med, Dusseldorf, Germany.	malte.kelm@med.uni-duesseldorf.de	Cortese-Krott, Miriam/I-7513-2012; Heusch, Gerd/ABE-6675-2020	Cortese-Krott, Miriam/0000-0002-0593-1192; Kelm, Malte/0000-0003-0060-1052	Susanne-Bunnenberg-Stiftung at Dusseldorf Heart Center;  [ME1821/2-3];  [ME1821/3-1 [FOR809]];  [RA969/4-2];  [RA969/7-2];  [KE405/5-1];  [SFB1116]	Susanne-Bunnenberg-Stiftung at Dusseldorf Heart Center; ; ; ; ; ; 	This work was supported in part by ME1821/2-3 to MWM and ME1821/3-1 [FOR809] to MWM and MK, RA969/4-2 and RA969/7-2 to TR, KE405/5-1 and the SFB1116 to MK and the Susanne-Bunnenberg-Stiftung at Dusseldorf Heart Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MR, 1997, CIRCULATION, V95, P662, DOI 10.1161/01.CIR.95.3.662; Agarwal Anil K, 2010, Heart Fail Clin, V6, P323, DOI 10.1016/j.hfc.2010.03.006; Anand I, 2004, CIRCULATION, V110, P149, DOI 10.1161/01.CIR.0000134279.79571.73; Campbell Patrick H., 2008, Molecular & Cellular Biomechanics, V5, P27; CLANCY RM, 1992, J CLIN INVEST, V90, P1116, DOI 10.1172/JCI115929; Cleutjens JPM, 1999, CARDIOVASC RES, V44, P232, DOI 10.1016/S0008-6363(99)00212-6; Cortese-Krott MM, 2012, BLOOD, V120, P4229, DOI 10.1182/blood-2012-07-442277; Csont T, 2010, J MOL CELL CARDIOL, V48, P649, DOI 10.1016/j.yjmcc.2010.01.013; DAVENPECK KL, 1994, GASTROENTEROLOGY, V107, P1050, DOI 10.1016/0016-5085(94)90229-1; EGHBALI M, 1989, J MOL CELL CARDIOL, V21, P103, DOI 10.1016/0022-2828(89)91498-3; EGHBALI M, 1988, J MOL CELL CARDIOL, V20, P267, DOI 10.1016/S0022-2828(88)80059-2; EGHBALI M, 1990, MOL CELL BIOCHEM, V96, P1; Frangogiannis NG, 2006, CURR MED CHEM, V13, P1877, DOI 10.2174/092986706777585086; French Brent A, 2007, Drug Discov Today Dis Mech, V4, P185, DOI 10.1016/j.ddmec.2007.12.006; Godecke A, 1998, CIRC RES, V82, P186; Heusch G, 2000, CIRC RES, V87, P146, DOI 10.1161/01.RES.87.2.146; Heusch G, 2014, LANCET, V383, P1933, DOI 10.1016/S0140-6736(14)60107-0; Hofmann U, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0356-y; Jivraj N, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0397-2; Jugdutt Bodh I, 2002, Heart Fail Rev, V7, P391, DOI 10.1023/A:1020718619155; Kleinbongard P, 2006, BLOOD, V107, P2943, DOI 10.1182/blood-2005-10-3992; Krusche CA, 2011, BASIC RES CARDIOL, V106, P617, DOI 10.1007/s00395-011-0175-y; Ky B, 2013, J AM COLL CARDIOL, V62, P1165, DOI 10.1016/j.jacc.2013.03.085; Liehn EA, 2011, J AM COLL CARDIOL, V58, P2415, DOI 10.1016/j.jacc.2011.08.033; MA XL, 1993, CIRC RES, V72, P403, DOI 10.1161/01.RES.72.2.403; Merx MW, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-013-0398-1; MITCHELL GF, 1992, J AM COLL CARDIOL, V19, P1136, DOI 10.1016/0735-1097(92)90314-D; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Reiling N, 1996, EUR J IMMUNOL, V26, P511, DOI 10.1002/eji.1830260302; Roy S, 2006, PHYSIOL GENOMICS, V25, P364, DOI 10.1152/physiolgenomics.00013.2006; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Szelid Z, 2010, BASIC RES CARDIOL, V105, P169, DOI 10.1007/s00395-009-0077-4; Takimoto E, 2007, HYPERTENSION, V49, P241, DOI 10.1161/01.HYP.0000254415.31362.a7; Trueblood NA, 2001, CIRC RES, V88, P1080, DOI 10.1161/hh1001.090842; van de Sandt AM, 2013, BASIC RES CARDIOL, V108, DOI 10.1007/s00395-013-0330-8; Weber KT, 1997, CIRCULATION, V96, P2488; Weis SM, 2005, MATRIX BIOL, V24, P313, DOI 10.1016/j.matbio.2005.05.003; Westermann D, 2008, CIRCULATION, V117, P1269, DOI 10.1161/CIRCULATIONAHA.107.714147; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Wood KC, 2013, ARTERIOSCL THROM VAS, V33, P1861, DOI 10.1161/ATVBAHA.112.301068; Yamamoto K, 1998, J MOL CELL CARDIOL, V30, P1749, DOI 10.1006/jmcc.1998.0737; Zanardo RCO, 1997, P NATL ACAD SCI USA, V94, P14111, DOI 10.1073/pnas.94.25.14111	43	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 14	2015	10	4							e0120961	10.1371/journal.pone.0120961	http://dx.doi.org/10.1371/journal.pone.0120961			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG1EB	25875863	Green Submitted, Green Published, gold			2022-12-27	WOS:000353014700007
J	Kotter, T; da Costa, BR; Fassler, M; Blozik, E; Linde, K; Juni, P; Reichenbach, S; Scherer, M				Koetter, Thomas; da Costa, Bruno R.; Faessler, Margrit; Blozik, Eva; Linde, Klaus; Jueni, Peter; Reichenbach, Stephan; Scherer, Martin			Metamizole-Associated Adverse Events: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							POSTOPERATIVE PAIN RELIEF; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DOUBLE-BLIND; DEXKETOPROFEN TROMETAMOL; ABDOMINAL-SURGERY; INTRAVENOUS INDOMETHACIN; ACETYLSALICYLIC-ACID; ANALGESIC EFFICACY; IV PARACETAMOL; OBSERVER-BLIND	Background Metamizole is used to treat pain in many parts of the world. Information on the safety profile of metamizole is scarce; no conclusive summary of the literature exists. Objective To determine whether metamizole is clinically safe compared to placebo and other analgesics. Methods We searched CENTRAL, MEDLINE, EMBASE, CINAHL, and several clinical trial registries. We screened the reference lists of included trials and previous systematic reviews. We included randomized controlled trials that compared the effects of metamizole, administered to adults in any form and for any indication, to other analgesics or to placebo. Two authors extracted data regarding trial design and size, indications for pain medication, patient characteristics, treatment regimens, and methodological characteristics. Adverse events (AEs), serious adverse events (SAEs), and dropouts were assessed. We conducted separate meta-analyses for each metamizole comparator, using standard inverse-variance random effects meta-analysis to pool the estimates across trials, reported as risk ratios (RRs). We calculated the DerSimonian and Laird variance estimate T-2 to measure heterogeneity between trials. The pre-specified primary end point was any AE during the trial period. Results Of the 696 potentially eligible trials, 79 trials including almost 4000 patients with short-term metamizole use of less than two weeks met our inclusion criteria. Fewer AEs were reported for metamizole compared to opioids, RR = 0.79 (confidence interval 0.79 to 0.96). We found no differences between metamizole and placebo, paracetamol and NSAIDs. Only a few SAEs were reported, with no difference between metamizole and other analgesics. No agranulocytosis or deaths were reported. Our results were limited by the mediocre overall quality of the reports. Conclusion For short-term use in the hospital setting, metamizole seems to be a safe choice when compared to other widely used analgesics. High-quality, adequately sized trials assessing the intermediate- and long-term safety of metamizole are needed.	[Koetter, Thomas] Med Univ Lubeck, Inst Social Med & Epidemiol, D-23538 Lubeck, Germany; [Koetter, Thomas; Blozik, Eva; Scherer, Martin] Univ Med Ctr Hamburg Eppendorf, Dept Primary Med Care, Hamburg, Germany; [da Costa, Bruno R.; Jueni, Peter] Univ Bern, Inst Primary Hlth Care BIHAM, Bern, Switzerland; [Faessler, Margrit; Linde, Klaus] Tech Univ Munich, Inst Gen Practice, D-80290 Munich, Germany; [Faessler, Margrit] Univ Zurich, Inst Biomed Eth, Zurich, Switzerland; [Reichenbach, Stephan] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Reichenbach, Stephan] Univ Hosp Bern, CH-3010 Bern, Switzerland	University of Lubeck; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Bern; Technical University of Munich; University of Zurich; University of Bern; University of Bern; University Hospital of Bern	Reichenbach, S (corresponding author), Univ Bern, Inst Social & Prevent Med, Bern, Switzerland.	stephan.reichenbach@ispm.unibe.ch	Juni, Peter/Q-8700-2016	Juni, Peter/0000-0002-5985-0670; Reichenbach, Stephan/0000-0001-8098-6567; Linde, Klaus/0000-0002-2902-970X; R. da Costa, Bruno/0000-0002-1786-6332	German Federal Ministry of Research and Education [01KG1017]	German Federal Ministry of Research and Education	The study was funded by the German Federal Ministry of Research and Education (Grant-No. 01KG1017). The funding source did not play a role in the design, conduct or reporting of the study, or the decision to submit the manuscript for publication.	AJGAONKAR VS, 1985, CURR THER RES CLIN E, V37, P440; Andersohn F, 2007, ANN INTERN MED, V146, P657, DOI 10.7326/0003-4819-146-9-200705010-00009; Andrade SE, 1998, J CLIN EPIDEMIOL, V51, P1357, DOI 10.1016/S0895-4356(98)00076-6; Aronson JK., 2019, IMPORTANT DIFFERENCE; Atalay H, 1995, AGR DERG, V7, P22; BABEJDOLLE R, 1994, INT J CLIN PHARM TH, V32, P204; Bagan JV, 1998, J CLIN PHARMACOL, V38, p55S; BARROSO MH, 1982, INVEST MED INT, V9, P164; Bensenor I M, 2001, Sao Paulo Med J, V119, P190; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; BHAUMIK S, 2013, BMJ-BRIT MED J, V347, DOI DOI 10.1136/BMJ.F4366; Bigal ME, 2002, HEADACHE, V42, P862, DOI 10.1046/j.1526-4610.2002.02204.x; Bilgin M, 2003, J THORAC CARDIOV SUR, V126, P1580, DOI 10.1016/S0022-5223(03)00701-3; BLENDINGER I, 1980, BRIT J CLIN PHARMACO, V10, pS339, DOI 10.1111/j.1365-2125.1980.tb01819.x; BLOCH B, 1985, S AFR MED J, V67, P325; Boraks S, 1987, ARQUIVOS BRASILEIROS, V61, P424; Braun R, 1999, ACUTE PAIN, V2, P167; Brodner G, 2011, EUR J ANAESTH, V28, P125, DOI 10.1097/EJA.0b013e32833fedfa; Castro F, 2000, REV SOC ESPANOLA DOL, V7, P12; Castro Gonzalez F, 1986, COMPEND INVEST CLIN, V6, P61; Cruz P, 2002, Rev Esp Anestesiol Reanim, V49, P391; de Abajo FJ, 2014, PHARMACOEPIDEM DR S, V23, P1128, DOI 10.1002/pds.3617; Derry S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003227.pub3; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Diaz-Chavez Emilio Prieto, 2009, Cir Cir, V77, P45; Dos Santos Pereira E, 1986, FOLHA MED, V92, P99; Edwards JE, 2002, LANCET, V360, P1438, DOI 10.1016/S0140-6736(02)11489-9; Edwards JE, 1999, J PAIN SYMPTOM MANAG, V18, P427, DOI 10.1016/S0885-3924(99)00093-7; Fernandes SMM, 2006, ARQ NEURO-PSIQUIAT, V64, P1005, DOI 10.1590/S0004-282X2006000600023; Ferrario F, 1984, EUR REV MED PHARMACO, V6, P147; Flather MD, 1997, CONTROL CLIN TRIALS, V18, P568, DOI 10.1016/S0197-2456(97)00024-X; GARCIAALONSO F, 1991, EUR J CLIN PHARMACOL, V40, P543; Gomez-Marquez JDJ, 2004, REV MEX ANESTESIOL, V27, P152; GONZALEZGARCIA CA, 1994, P W PHARMACOL SOC, V37, P121; Grundmann U, 2006, ANESTH ANALG, V103, P217, DOI 10.1213/01.ane.0000221438.08990.06; Guberti A, 1992, ACTA ANAESTHESIOL IT, V33, P697; Hedenmalm K, 2002, EUR J CLIN PHARMACOL, V58, P265, DOI 10.1007/s00228-002-0465-2; HEIMPEL H, 1988, MED TOXICOL ADV DRUG, V3, P449, DOI 10.1007/BF03259896; Hernandez LG, 1997, ANEST EN MEX, V9, P137; Hoigne R, 1986, Agents Actions Suppl, V19, P189; Ibarra-Ibarra L G, 1993, Proc West Pharmacol Soc, V36, P133; Jage J, 1990, Schmerz, V4, P29, DOI 10.1007/BF02527827; Jovic R, 2008, J BUON, V13, P519; Kampe S, 2006, CURR MED RES OPIN, V22, P1949, DOI 10.1185/030079906X132659; Karaman Y, 2010, NOBEL MED, V6, P47; Kemal SO, 2007, AGRI, V19, P24; Knusel O, 1982, THERAPIEWOCHE, V32, P4933; KRAMER MS, 1988, J CLIN EPIDEMIOL, V41, P613, DOI 10.1016/0895-4356(88)90069-8; Krymchantowski AV, 2008, ARQ NEURO-PSIQUIAT, V66, P216, DOI 10.1590/S0004-282X2008000200015; Landwehr S, 2005, CURR MED RES OPIN, V21, P1569, DOI 10.1185/030079905X61857; Lehmann KA, 2001, ANAESTHESIST, V50, P750, DOI 10.1007/s001010100206; LEHTONEN T, 1983, ANN CLIN RES, V15, P197; MarinBertolin S, 1997, ANN PLAS SURG, V38, P478, DOI 10.1097/00000637-199705000-00007; MartinDuce A, 1997, PAIN CLINIC, V10, P27; Martinez-Martin P, 2001, CEPHALALGIA, V21, P604, DOI 10.1046/j.1468-2982.2001.00216.x; MATEU M, 1992, CURR THER RES CLIN E, V51, P626; MEHTA SD, 1986, J INT MED RES, V14, P63, DOI 10.1177/030006058601400202; Monso A, 1996, BRIT J CLIN PHARMACO, V42, P307, DOI 10.1046/j.1365-2125.1996.04124.x; MURIEL C, 1993, METHOD FIND EXP CLIN, V15, P465; MURIELVILLORIA C, 1995, EUR J CLIN PHARMACOL, V48, P103; Ocampo Flores P, 1986, ADM, V43, P132; Pardo A, 1984, Arch Esp Urol, V37, P94; PATEL CV, 1980, BRIT J CLIN PHARMACO, V10, pS351, DOI 10.1111/j.1365-2125.1980.tb01822.x; Pavlik I, 2004, CLIN THER, V26, P1061, DOI 10.1016/S0149-2918(04)90178-6; Peiro AM, 2008, PANCREATOLOGY, V8, P25, DOI 10.1159/000114852; Pernia A, 2000, REV SOC ESP DOLOR, V7, P354; Pinto J, 1984, REV BRASILEIRA CIRUR, V74, P185; Planas ME, 1998, EUR J CLIN PHARMACOL, V53, P405, DOI 10.1007/s002280050400; Prada A, 1974, Minerva Anestesiol, V40, P527; PRIMUS G, 1989, UROLOGE A, V28, P103; Ramacciotti AS, 2014, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004842.pub3, 10.1002/14651858.CD004842.pub2]; Rawal N, 2001, ANESTH ANALG, V92, P347; REJMAN F, 1984, IRCS MED SCI-BIOCHEM, V12, P399; Reyes Armijo E, 1974, J INT MED RES, V2, P32; REYES F, 1988, Compendium de Investigaciones Clinicas Latinoamericanas, V8, P65; Rivero CD, 1997, CLIN DRUG INVEST, V14, P276; RODRIGUEZ M, 1994, EUR J CANCER, V30A, P584, DOI 10.1016/0959-8049(94)90524-X; RUBINSTEIN I, 1986, Folha Medica, V92, P201; Rutjes AWS, 2012, ANN INTERN MED, V157, P180, DOI 10.7326/0003-4819-157-3-201208070-00473; Sanchez-Carpena J, 2003, CLIN DRUG INVEST, V23, P139, DOI 10.2165/00044011-200323030-00001; Sanchez-Carpena J, 2007, EUR J CLIN PHARMACOL, V63, P751, DOI 10.1007/s00228-007-0322-4; Saray A, 2001, Acta Chir Plast, V43, P71; Savoca G, 1985, Boll Chim Farm, V124, p113S; SCHMIEDER G, 1993, ARZNEIMITTEL-FORSCH, V43-2, P1216; Sener M, 2008, J CLIN ANESTH, V20, P103, DOI 10.1016/j.jclinane.2007.09.009; Souza JFD, 2007, SUPPORT CARE CANCER, V15, P1319, DOI 10.1007/s00520-007-0327-7; Spacek A, 2003, ACUTE PAIN, V5, P3; Spiegelhalter DJ., 2004, BAYESIAN APPROACHES, V13; Stankov G, 1995, EUR J PAIN, V16, P56; Steffen P, 1997, CHIRURG, V68, P806, DOI 10.1007/s001040050275; STRIEBEL HW, 1992, ANAESTHESIST, V41, P354; Tempel G, 1996, INTENS CARE MED, V22, P1043, DOI 10.1007/s001340050210; Tonolli Jacob B, 1986, ARQ BRAS MED, V60, P337; Torres L M, 1993, Rev Esp Anestesiol Reanim, V40, P181; Torres LM, 2001, REGION ANESTH PAIN M, V26, P118, DOI 10.1053/rapm.2001.21437; Trelle S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.c7086; Uzun S, 2010, TURK NEUROSURG, V20, P341, DOI 10.5137/1019-5149.JTN.3081-10.3; VONSZEGED AV, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1110; Wiffen PJ, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005452.pub2; Wonca International Classification Committee, INTR INT CLASS PRIM	100	83	89	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 13	2015	10	4							e0122918	10.1371/journal.pone.0122918	http://dx.doi.org/10.1371/journal.pone.0122918			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF8XK	25875821	Green Published, gold, Green Submitted			2022-12-27	WOS:000352845100118
J	Abebe, AS; Mikko, S; Johansson, AM				Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.			Genetic Diversity of Five Local Swedish Chicken Breeds Detected by Microsatellite Markers	PLOS ONE			English	Article							POPULATION-STRUCTURE; COMPUTER-PROGRAM; MANAGEMENT; SOFTWARE; CLUSTERS; DISTANCE; NUMBER	This study aimed at investigating the genetic diversity, relationship and population structure of 110 local Swedish chickens derived from five breeds (Gotlandshona, Hedemorahona, Olandsk dvarghona, Skansk blommehona, and Bohuslan-Dals svarthona, in the rest of the paper the shorter name Svarthona is used) using 24 microsatellite markers. In total, one hundred thirteen alleles were detected in all populations, with a mean of 4.7 alleles per locus. For the five chicken breeds, the observed and expected heterozygosity ranged from 0.225 to 0.408 and from 0.231 to 0.515, with the lowest scores for the Svarthona and the highest scores for the Skansk blommehona breeds, respectively. Similarly, the average within breed molecular kinship varied from 0.496 to 0.745, showing high coancestry, with Skansk blommehona having the lowest and Svarthona the highest coancestry. Furthermore, all breeds showed significant deviations from Hardy-Weinberg expectations. Across the five breeds, the global heterozygosity deficit (FIT) was 0.545, population differentiation index (F-ST) was 0.440, and the global inbreeding of individuals within breed (F-IS) was 0.187. The phylogenetic relationships of chickens were examined using neighbor-joining trees constructed at the level of breeds and individual samples. The neighbor-joining tree constructed at breed level revealed two main clusters, with Hedemorahona and Olandsk dvarghona breeds in one cluster, and Gotlandshona and Svarthona breeds in the second cluster leaving the Skansk blommehona in the middle. Based on the results of the STRUCTURE analysis, the most likely number of clustering of the five breeds was at K = 4, with Hedemorahona, Gotlandshona and Svarthona breeds forming their own distinct clusters, while Olandsk dvarghona and Skansk blommehona breeds clustered together. Losses in the overall genetic diversity of local Swedish chickens due to breeds extinction varied from -1.46% to -6.723%. The results of the current study can be used as baseline genetic information for genetic conservation program, for instance, to control inbreeding and to implement further genetic studies in local Swedish chickens.	[Abebe, Abiye Shenkut; Mikko, Sofia; Johansson, Anna M.] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden	Swedish University of Agricultural Sciences	Johansson, AM (corresponding author), Swedish Univ Agr Sci, Dept Anim Breeding & Genet, Uppsala, Sweden.	Anna.Johansson@slu.se	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	Erik PhilipSorensen foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	AMJ received funding for the collection of blood samples and genotyping from the Erik PhilipSorensen foundation (www.epss.se). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anmarkrud JA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-138; [Anonymous], 2000, GENETICS DEMOGRAPHY, DOI [DOI 10.1017/CBO9780511623448, 10.1017/CBO9780511623448.008]; Barker JSF, 2001, CAN J FOREST RES, V31, P588, DOI 10.1139/cjfr-31-4-588; Blackburn HD, 2006, POULTRY SCI, V85, P210, DOI 10.1093/ps/85.2.210; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Caballero A, 2002, CONSERV GENET, V3, P289, DOI 10.1023/A:1019956205473; Chen GH, 2008, ASIAN AUSTRAL J ANIM, V21, P331, DOI 10.5713/ajas.2008.70125; Cuc NTK, 2010, ANIM GENET, V41, P545, DOI 10.1111/j.1365-2052.2010.02039.x; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Dorshorst B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002412; Englund T, 2014, HEREDITAS, V151, P229, DOI 10.1111/hrd2.00064; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; FAO, 2011, AN PROD HLTH GUID, V9; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Food and Agriculture Organization, 2007, SUB REG REP AN GEN R; Frankham R., 2010, INTRO CONSERVATION G, V2, DOI [10.1017/CBO9780511809002, 10.1017/CBO9780511808999]; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Granevitze Z, 2007, ANIM GENET, V38, P576, DOI 10.1111/j.1365-2052.2007.01650.x; Guo XQ, 1999, HUM HERED, V49, P112, DOI 10.1159/000022855; Gutierrez JP, 2005, J HERED, V96, P718, DOI 10.1093/jhered/esi118; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1051/gse:2003038, 10.1186/1297-9686-35-6-533]; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kalinowski ST, 2011, HEREDITY, V106, P625, DOI 10.1038/hdy.2010.95; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaya M, 2008, BIOCHEM GENET, V46, P480, DOI 10.1007/s10528-008-9164-8; Meuwissen THE, 1997, J ANIM SCI, V75, P934; Muchadeyi FC, 2007, ANIM GENET, V38, P332, DOI 10.1111/j.1365-2052.2007.01606.x; NEI M, 1972, AM NAT, V106, P283, DOI 10.1086/282771; NEI M, 1974, GENETICS, V76, P379; Nei M., 1987, MOL EVOLUTIONARY GEN; Pritchard JK, 2000, GENETICS, V155, P945; Rajkumar U., 2007, Indian Journal of Animal Sciences, V77, P1194; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rosenberg NA, 2001, GENETICS, V159, P699; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Tadano R, 2008, ANIM GENET, V39, P71, DOI 10.1111/j.1365-2052.2007.01690.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilkinson S, 2012, ANIM GENET, V43, P552, DOI 10.1111/j.1365-2052.2011.02296.x; Zanetti E, 2010, POULTRY SCI, V89, P420, DOI 10.3382/ps.2009-00324	40	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 9	2015	10	4							e0120580	10.1371/journal.pone.0120580	http://dx.doi.org/10.1371/journal.pone.0120580			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CF5HQ	25855978	gold, Green Published, Green Submitted			2022-12-27	WOS:000352588500013
J	Rana, Y; Haberer, J; Huang, HJ; Kambugu, A; Mukasa, B; Thirumurthy, H; Wabukala, P; Wagner, GJ; Linnemayr, S				Rana, Yashodhara; Haberer, Jessica; Huang, Haijing; Kambugu, Andrew; Mukasa, Barbara; Thirumurthy, Harsha; Wabukala, Peter; Wagner, Glenn J.; Linnemayr, Sebastian			Short Message Service (SMS)-Based Intervention to Improve Treatment Adherence among HIV-Positive Youth in Uganda: Focus Group Findings	PLOS ONE			English	Article							BEHAVIORAL SKILLS MODEL; ANTIRETROVIRAL THERAPY; ADOLESCENTS; INFORMATION; MOTIVATION	This paper presents one of the first qualitative studies to discuss programmatic barriers to SMS-based interventions for HIV-positive youth and discusses pathways through which youth perceive them to work. We conducted six focus groups with 20 male and 19 female HIV-positive youths in two clinics in Kampala, Uganda. We find that youth commonly use SMS as over 90% of this study's youths knew how to read, write and send messages and almost three-fourths of them had phones. Youth strongly felt that the success of this intervention hinged on ensuring confidentiality about their HIV-positive status. Key programmatic challenges discussed where restrictions on phone use and phone sharing that could exclude some youth. Participants felt that the intervention would improve their adherence by providing them with needed reminders and social support. Youths' suggestions about intervention logistics related to content, frequency, timing and two-way messages will be helpful to practitioners in the field.	[Rana, Yashodhara; Huang, Haijing; Wagner, Glenn J.; Linnemayr, Sebastian] RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA; [Haberer, Jessica] Massachusetts Gen Hosp, Ctr Global Hlth, Boston, MA 02114 USA; [Kambugu, Andrew] Infect Dis Inst, Kampala, Uganda; [Mukasa, Barbara; Wabukala, Peter] Mildmay Uganda, Kampala, Uganda; [Thirumurthy, Harsha] Univ N Carolina, Dept Hlth Policy & Management, Chapel Hill, NC USA	RAND Corporation; Harvard University; Massachusetts General Hospital; University of North Carolina; University of North Carolina Chapel Hill	Rana, Y (corresponding author), RAND Corp, RAND Hlth, Santa Monica, CA 90401 USA.	yrana@rand.org	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	National Institute of Child Health and Human Development [R01HD074925]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This research was sponsored by Grant R01HD074925 from The National Institute of Child Health and Human Development (PI Sebastian Linnemayr). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amico KR, 2005, AIDS CARE, V17, P661, DOI 10.1080/09540120500038058; [Anonymous], PUTT YOUNG PEOPL CTR; Bikaako-Kajura W, 2006, AIDS BEHAV, V10, pS85, DOI 10.1007/s10461-006-9141-3; CRAMER J, 1995, EPILEPSIA, V36, P1111, DOI 10.1111/j.1528-1157.1995.tb00469.x; Curioso Walter H, 2009, AMIA Annu Symp Proc, V2009, P129; DellaVigna S, 2009, J ECON LIT, V47, P315, DOI 10.1257/jel.47.2.315; Dowshen N, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.2015; Ferrer-Roca O, 2004, J TELEMED TELECARE, V10, P282, DOI 10.1258/1357633042026341; Finitsis DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088166; Fisher JD, 2006, HEALTH PSYCHOL, V25, P462, DOI 10.1037/0278-6133.25.4.462; Gray WN, 2011, J HEALTH PSYCHOL, V16, P828, DOI 10.1177/1359105310394230; Katz IT, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.3.18640; Kitara D L, 2012, Afr J Infect Dis, V6, P12; Lester RT, 2010, LANCET, V376, P1838, DOI 10.1016/S0140-6736(10)61997-6; Mbuagbaw L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046909; Mitchell KJ, 2011, HEALTH EDUC RES, V26, P770, DOI 10.1093/her/cyr022; Mohammed S, 2012, J TELEMED TELECARE, V18, P404, DOI 10.1258/jtt.2012.120311; O'Donoghue T, 1999, AM ECON REV, V89, P103, DOI 10.1257/aer.89.1.103; Pop-Eleches C, 2011, AIDS, V25, P825, DOI 10.1097/QAD.0b013e32834380c1; Rao D, 2007, AIDS CARE, V19, P28, DOI 10.1080/09540120600652303; Simoni JM, 2007, PEDIATRICS, V119, pE1371, DOI 10.1542/peds.2006-1232; Steinberg L, 2008, DEV REV, V28, P78, DOI 10.1016/j.dr.2007.08.002; Steinberg L, 2009, CHILD DEV, V80, P28, DOI 10.1111/j.1467-8624.2008.01244.x; Strandbygaard U, 2010, RESP MED, V104, P166, DOI 10.1016/j.rmed.2009.10.003; Thaler R.H., 2021, NUDGE FINAL EDITION	25	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 16	2015	10	4							e0125187	10.1371/journal.pone.0125187	http://dx.doi.org/10.1371/journal.pone.0125187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	CG1ES	25855978	Green Submitted, Green Published, gold			2022-12-27	WOS:000353016500115
J	Lodwick, RK; Nakagawa, F; van Sighem, A; Sabin, CA; Phillips, AN				Lodwick, Rebecca K.; Nakagawa, Fumiyo; van Sighem, Ard; Sabin, Caroline A.; Phillips, Andrew N.			Use of Surveillance Data on HIV Diagnoses with HIV-Related Symptoms to Estimate the Number of People Living with Undiagnosed HIV in Need of Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; PROGRESSION; PREVALENCE; INFECTION; DISEASE; SIZE	Background It is important to have methods available to estimate the number of people who have undiagnosed HIV and are in need of antiretroviral therapy (ART). Methods The method uses the concept that a predictable level of occurrence of AIDS or other HIV-related clinical symptoms which lead to presentation for care, and hence diagnosis of HIV, arises in undiagnosed people with a given CD4 count. The method requires surveillance data on numbers of new HIV diagnoses with HIV-related symptoms, and the CD4 count at diagnosis. The CD4 count-specific rate at which HIV-related symptoms develop are estimated from cohort data. 95% confidence intervals can be constructed using a simple simulation method. Results For example, if there were 13 HIV diagnoses with HIV-related symptoms made in one year with CD4 count at diagnosis between 150-199 cells/mm(3), then since the CD4 count-specific rate of HIV-related symptoms is estimated as 0.216 per person-year, the estimated number of person years lived in people with undiagnosed HIV with CD4 count 150-199 cells/mm3 is 13/0.216 = 60 (95% confidence interval: 29-100), which is considered an estimate of the number of people living with undiagnosed HIV in this CD4 count stratum. Conclusions The method is straightforward to implement within a short period once a surveillance system of all new HIV diagnoses, collecting data on HIV-related symptoms at diagnosis, is in place and is most suitable for estimating the number of undiagnosed people with CD4 count <200 cells/mm3 due to the low rate of developing HIV-related symptoms at higher CD4 counts. A potential source of bias is under-diagnosis and under-reporting of diagnoses with HIV-related symptoms. Although this method has limitations as with all approaches, it is important for prompting increased efforts to identify undiagnosed people, particularly those with low CD4 count, and for informing levels of unmet need for ART.	[Lodwick, Rebecca K.] UCL, Res Dept Primary Care & Populat Hlth, London, England; [Nakagawa, Fumiyo; Sabin, Caroline A.; Phillips, Andrew N.] UCL, Res Dept Infect & Populat Hlth, London, England; [van Sighem, Ard] Stichting HIV Monitoring, Amsterdam, Netherlands	University of London; University College London; University of London; University College London	Nakagawa, F (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	f.nakagawa@ucl.ac.uk	Abebe, Abiye/AAZ-9901-2020; Phillips, Andrew N/B-4427-2008; Lodwick, Rebecca/B-7578-2015; Johansson, Anna M/N-2502-2019; Sabin, Caroline/C-2464-2008; Mikko, Sofia/F-1347-2017; Johansson, Anna M/G-4759-2013; Haberer, Jessica/AAH-7976-2019	Phillips, Andrew N/0000-0003-2384-4807; Lodwick, Rebecca/0000-0003-2558-4762; Johansson, Anna M/0000-0002-9762-0497; Sabin, Caroline/0000-0001-5173-2760; Mikko, Sofia/0000-0002-6375-1376; Haberer, Jessica/0000-0001-5845-3190; Nakagawa, Fumiyo/0000-0002-6646-8744; Thirumurthy, Harsha/0000-0002-3308-7603	HIV in Europe; European Centre for Disease Prevention and Control (ECDC) [FWC/ECDC/012/050]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P2CHD050924, R01HD074925] Funding Source: NIH RePORTER	HIV in Europe; European Centre for Disease Prevention and Control (ECDC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Funding: The authors acknowledge funding from HIV in Europe and European Centre for Disease Prevention and Control (ECDC) framework contract FWC/ECDC/012/050. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1992, MMWR-MORBID MORTAL W, V41; Antinori A, 2011, HIV MED, V12, P61, DOI 10.1111/j.1468-1293.2010.00857.x; Babiker A, 2000, LANCET, V355, P1131, DOI 10.1016/S0140-6736(00)02061-4; Beral V, 2004, AIDS, V18, P51, DOI [10.1097/00002030-200401020-00006, 10.1097/01.aids.0000096908.73209.5d]; British HIV Association Audit & Standards Sub-Committee, 2010 11 SURV HIV TES; BROOKMEYER R, 1986, LANCET, V2, P1320; BROOKMEYER R, 1988, J AM STAT ASSOC, V83, P301, DOI 10.2307/2288844; Brown T, 2010, SEX TRANSM INFECT, V86, pI3, DOI 10.1136/sti.2010.044784; European AIDS Clinical Society, 2011, EACS GUID VERS 6 1; FLEGG PJ, 1994, J INFECTION, V29, P311, DOI 10.1016/S0163-4453(94)91266-1; Goubar A, 2008, J R STAT SOC A STAT, V171, P541, DOI 10.1111/j.1467-985X.2007.00537.x; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; LEE CA, 1991, BMJ-BRIT MED J, V303, P1093, DOI 10.1136/bmj.303.6810.1093; Lyerla R, 2006, SEX TRANSM INFECT, V82, pIII41, DOI 10.1136/sti.2006.020198; Morgan D, 2002, BRIT MED J, V324, P193, DOI 10.1136/bmj.324.7331.193; Ndawinz JDA, 2011, AIDS, V25, P1905, DOI 10.1097/QAD.0b013e32834af619; Porter K., 2011, COMMUNICATION; Sommen C, 2009, STAT MED, V28, P1554, DOI 10.1002/sim.3570; Sweeting MJ, 2005, STAT MED, V24, P3991, DOI 10.1002/sim.2432; Van Sighem A, 2014, C RETR OPP INF CROI; Wand H, 2010, HIV MED, V11, P395, DOI 10.1111/j.1468-1293.2009.00804.x; Working Group on Estimation of HIV Prevalence in Europe, 2011, AIDS, V25, P1017, DOI 10.1097/QAD.0b013e3283467087	22	136	159	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 13	2015	10	3							e0121992	10.1371/journal.pone.0121992	http://dx.doi.org/10.1371/journal.pone.0121992			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CD7NO	25855978	Green Published, gold			2022-12-27	WOS:000351277500146
